Citrus Sinensis ID: 022799

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290--
Protein Sequence
MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLGL
Secondary Structure (PSIPRED)
ccccccccEEEEcEEEccccccccEEEEEEEEcccccHHHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccEEEEEEccccHHHHHHcccccccHHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHcccccHHHHHHHccccccccccccccccccccccccccHHHHHHHHHHccccccccccHHHHHccccccccccccccccccccccccccccHHHcccccHHHHHHccHHHHHHHHHcccc
Secondary Structure Prediction (SSPRO)
ccccccccEEEEEEEEEcccccccEEEEEEEEcccEEHHHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEccccccEEEccccccEEcccccccccccccHHHccHHHHccccccccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHccccHHHHHHHcHHHccccccccccccHHHHccccccHHHHHHHHccccccHHHcccHHHHHHcHHHHHHHccccEcccccEccccccccHHHHcccHHHHHHHHccHHHHHHHHHccc
Coil and Loop (DISEMBL)
mrlldhpnvvslkhcffstteKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTigvchrdikpqnllvnphthqlklcdfgsakvlvkgepnisyicsryyrapelifgateyTAAIDIWSAGCVLAELllgqplfpgesgVDQLVEIIKVLGtptreeikcmnpnytefkfpqikahpwhkifqkrmppeAVDLVSRLLQYSPNLRSTALEALIhpffdelrdpntrlpngrflpplfnfkphelkgvpvDMLVKLIPEHARKQCAFLGL
Flexible Loop (DISEMBL)
mrlldhpnvvslKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHhykmsqrmPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLGL
Low Complexity Region (SEG)
MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLGL
Disordered region (IsUnstruct)
*******NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAF***
Disordered Region (DISOPRED)
MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQC*****
Disordered Region (DISEMBL)
MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLGL
Disordered Region (DISPRO)
***LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCA****
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLGL
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	292	2.2.26 [Sep-21-2011]
P51139	411	Glycogen synthase kinase-	N/A	no	0.996	0.708	0.917	1e-162
P43288	405	Shaggy-related protein ki	yes	no	1.0	0.720	0.914	1e-160
P51138	411	Glycogen synthase kinase-	N/A	no	0.996	0.708	0.907	1e-160
P43289	409	Shaggy-related protein ki	no	no	1.0	0.713	0.904	1e-159
Q8VZD5	410	Shaggy-related protein ki	no	no	1.0	0.712	0.893	1e-159
P51137	411	Glycogen synthase kinase-	N/A	no	1.0	0.710	0.900	1e-157
Q40518	409	Shaggy-related protein ki	N/A	no	1.0	0.713	0.900	1e-156
Q39019	421	Shaggy-related protein ki	no	no	1.0	0.693	0.808	1e-144
Q9FVS6	420	Shaggy-related protein ki	no	no	1.0	0.695	0.808	1e-143
Q96287	472	Shaggy-related protein ki	no	no	0.972	0.601	0.806	1e-140

>sp|P51139|MSK3_MEDSA Glycogen synthase kinase-3 homolog MsK-3 OS=Medicago sativa GN=MSK-3 PE=2 SV=2

 Score =  570 bits (1468), Expect = e-162,   Method: Compositional matrix adjust.
 Identities = 267/291 (91%), Positives = 280/291 (96%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETV RVI+H+ KM+QRMP+IYVKLY
Sbjct: 119 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVSRVIRHYNKMNQRMPMIYVKLY 178

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
            YQICRALAYIHN+IGVCHRDIKPQNLLVNPHTHQLK+CDFGSAKVLVKGEPNISYICSR
Sbjct: 179 SYQICRALAYIHNSIGVCHRDIKPQNLLVNPHTHQLKICDFGSAKVLVKGEPNISYICSR 238

Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 180
           YYRAPELIFGATEYT AIDIWSAGCVL ELLLGQPLFPGESGVDQLVEIIKVLGTPTREE
Sbjct: 239 YYRAPELIFGATEYTTAIDIWSAGCVLGELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 298

Query: 181 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
           IKCMNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLRSTALEAL+HPF+
Sbjct: 299 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSTALEALVHPFY 358

Query: 241 DELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLG 291
           D++RDPNTRLPNGRFLPPLFNFK +ELKGVP +MLVKL+P HARKQCA  G
Sbjct: 359 DDVRDPNTRLPNGRFLPPLFNFKVNELKGVPAEMLVKLVPPHARKQCALFG 409

Medicago sativa (taxid: 3879)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|P43288|KSG1_ARATH Shaggy-related protein kinase alpha OS=Arabidopsis thaliana GN=ASK1 PE=2 SV=3

 Score =  565 bits (1456), Expect = e-160,   Method: Compositional matrix adjust.
 Identities = 267/292 (91%), Positives = 280/292 (95%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH+ K++QRMPLIYVKLY
Sbjct: 114 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLIYVKLY 173

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
            YQI RAL+YIH  IGVCHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPNISYICSR
Sbjct: 174 TYQIFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 233

Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 180
           YYRAPELIFGATEYT AID+WSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE
Sbjct: 234 YYRAPELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 293

Query: 181 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
           IKCMNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLRS AL+ L+HPFF
Sbjct: 294 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSAALDTLVHPFF 353

Query: 241 DELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLGL 292
           DELRDPN RLPNGRFLPPLFNFKPHELKGVP++M+ KL+PEHARKQC +LGL
Sbjct: 354 DELRDPNARLPNGRFLPPLFNFKPHELKGVPLEMVAKLVPEHARKQCPWLGL 405

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P51138|MSK2_MEDSA Glycogen synthase kinase-3 homolog MsK-2 OS=Medicago sativa GN=MSK-2 PE=2 SV=1

 Score =  565 bits (1455), Expect = e-160,   Method: Compositional matrix adjust.
 Identities = 264/291 (90%), Positives = 278/291 (95%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           MRLLDHPNVV+LKHCFFSTTEKDELYLNLVLE+VPETVHRVI+H+ KM+QRMPLIYVKLY
Sbjct: 119 MRLLDHPNVVTLKHCFFSTTEKDELYLNLVLEFVPETVHRVIRHYSKMNQRMPLIYVKLY 178

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
            YQICR+LAYIHN +GV HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR
Sbjct: 179 SYQICRSLAYIHNCVGVSHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 238

Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 180
           YYRAPELIFGATEYT+AIDIWSAGCVL ELLLGQPLFPG SGVDQLVEIIKVLGTPTREE
Sbjct: 239 YYRAPELIFGATEYTSAIDIWSAGCVLGELLLGQPLFPGASGVDQLVEIIKVLGTPTREE 298

Query: 181 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
           IKCMNPNYTEFKFPQIKAHPWHKIF+KRMPPEAVDLVSRLLQYSPNLRSTALEAL+HPFF
Sbjct: 299 IKCMNPNYTEFKFPQIKAHPWHKIFRKRMPPEAVDLVSRLLQYSPNLRSTALEALVHPFF 358

Query: 241 DELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLG 291
           DELRDPNTRLPNGR LPPLFNFK +ELKGVP +MLVKL+P HARKQC+   
Sbjct: 359 DELRDPNTRLPNGRHLPPLFNFKANELKGVPAEMLVKLVPSHARKQCSLFA 409

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P43289|KSG3_ARATH Shaggy-related protein kinase gamma OS=Arabidopsis thaliana GN=ASK3 PE=2 SV=1

 Score =  561 bits (1446), Expect = e-159,   Method: Compositional matrix adjust.
 Identities = 264/292 (90%), Positives = 279/292 (95%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH+ K++QRMPL+YVKLY
Sbjct: 118 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLVYVKLY 177

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
            YQI R+L+YIH  IGVCHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPNISYICSR
Sbjct: 178 TYQIFRSLSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 237

Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 180
           YYRAPELIFGATEYT AID+WSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE
Sbjct: 238 YYRAPELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 297

Query: 181 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
           IKCMNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLR  AL++L+HPFF
Sbjct: 298 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCAALDSLVHPFF 357

Query: 241 DELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLGL 292
           DELRDPN RLPNGRFLPPLFNFKPHELKGVPV+M+ KL+PEHARKQC +L L
Sbjct: 358 DELRDPNARLPNGRFLPPLFNFKPHELKGVPVEMVAKLVPEHARKQCPWLSL 409

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8VZD5|KSG5_ARATH Shaggy-related protein kinase epsilon OS=Arabidopsis thaliana GN=ASK5 PE=2 SV=1

 Score =  559 bits (1441), Expect = e-159,   Method: Compositional matrix adjust.
 Identities = 261/292 (89%), Positives = 276/292 (94%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETV+RV KH+ + +QRMP+IYVKLY
Sbjct: 119 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVYRVSKHYSRANQRMPIIYVKLY 178

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
            YQICRALAYIH  +GVCHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPNISYICSR
Sbjct: 179 TYQICRALAYIHGGVGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 238

Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 180
           YYRAPELIFGATEYT  IDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE
Sbjct: 239 YYRAPELIFGATEYTTTIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 298

Query: 181 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
           IKCMNPNYTEFKFPQIKAHPWHKIF KR PPEAVDLVSRLLQYSPNLRSTA+EA++HPFF
Sbjct: 299 IKCMNPNYTEFKFPQIKAHPWHKIFHKRTPPEAVDLVSRLLQYSPNLRSTAMEAIVHPFF 358

Query: 241 DELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLGL 292
           DELRDPNTRLPNGR LPPLFNFKP ELKG  +++L KLIP+HARKQC+FL L
Sbjct: 359 DELRDPNTRLPNGRALPPLFNFKPQELKGASLELLSKLIPDHARKQCSFLAL 410

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P51137|MSK1_MEDSA Glycogen synthase kinase-3 homolog MsK-1 OS=Medicago sativa GN=MSK-1 PE=2 SV=1

 Score =  554 bits (1428), Expect = e-157,   Method: Compositional matrix adjust.
 Identities = 263/292 (90%), Positives = 274/292 (93%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH+ K++QRMP+IYVKLY
Sbjct: 120 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYSKLNQRMPMIYVKLY 179

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
            YQI RAL+YIH  IGVCHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPNISYICSR
Sbjct: 180 TYQIFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 239

Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 180
           YYRAPELIFGATEYT AID+WS GCVLAELLLGQPLFPGE GVDQLVEIIKVLGTPTREE
Sbjct: 240 YYRAPELIFGATEYTTAIDVWSVGCVLAELLLGQPLFPGERGVDQLVEIIKVLGTPTREE 299

Query: 181 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
           IKCMNPNYTEFKFPQIKAHPWHKIF KRMP EAVDLVSRLLQYSPNLR  AL+ L HPFF
Sbjct: 300 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPAEAVDLVSRLLQYSPNLRCQALDCLTHPFF 359

Query: 241 DELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLGL 292
           DELRDPN RLP GRFLPPLFNFKPHELKGVPV+ L+KL+PEHARKQC FLGL
Sbjct: 360 DELRDPNARLPTGRFLPPLFNFKPHELKGVPVETLMKLVPEHARKQCPFLGL 411

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q40518|MSK1_TOBAC Shaggy-related protein kinase NtK-1 OS=Nicotiana tabacum GN=NTK-1 PE=2 SV=1

 Score =  550 bits (1418), Expect = e-156,   Method: Compositional matrix adjust.
 Identities = 263/292 (90%), Positives = 274/292 (93%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           MRLLDHPNVV LKHCFFSTTEKDE+YLNLVLEYVPETVHRVIKH+ K++QRMPLI VKLY
Sbjct: 118 MRLLDHPNVVCLKHCFFSTTEKDEVYLNLVLEYVPETVHRVIKHYNKLNQRMPLILVKLY 177

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
            YQI RAL+YIH+TIGVCHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPNISYICSR
Sbjct: 178 TYQIFRALSYIHHTIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 237

Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 180
           YYRAPELIFGATEYT AIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE
Sbjct: 238 YYRAPELIFGATEYTTAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 297

Query: 181 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
           IKCMNPNY EFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLR TALEA+ H FF
Sbjct: 298 IKCMNPNYNEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAVTHAFF 357

Query: 241 DELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLGL 292
           DELRDPNTRLPNGR LPPLFNFK HELKGV  + L+KL+PEHARKQC  LGL
Sbjct: 358 DELRDPNTRLPNGRVLPPLFNFKAHELKGVSAENLLKLVPEHARKQCPSLGL 409

May mediate extracellular signals to regulate transcription in differentiating cells.

Nicotiana tabacum (taxid: 4097)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q39019|KSG10_ARATH Shaggy-related protein kinase kappa OS=Arabidopsis thaliana GN=ASK10 PE=2 SV=2

 Score =  512 bits (1318), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 236/292 (80%), Positives = 264/292 (90%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M++LDHPN V+LKH FFS T+ +E+YLNLVLE+VPETV+RV + + + +Q MPLIYVKLY
Sbjct: 128 MQMLDHPNAVALKHSFFSRTDNEEVYLNLVLEFVPETVNRVARSYSRTNQLMPLIYVKLY 187

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
            YQICRALAYIHN+ G+CHRDIKPQNLLVNPHTHQLK+CDFGSAKVLVKGEPN+SYICSR
Sbjct: 188 TYQICRALAYIHNSFGLCHRDIKPQNLLVNPHTHQLKICDFGSAKVLVKGEPNVSYICSR 247

Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 180
           YYRAPELIFGA+EYT AIDIWS GCV+AELLLGQPLFPGESGVDQLVEIIKVLGTPTREE
Sbjct: 248 YYRAPELIFGASEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 307

Query: 181 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
           IKCMNPNYTEFKFPQIK HPWHK+FQKR+PPEAVDL+ R  QYSPNLR TALEA IHP F
Sbjct: 308 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLLCRFFQYSPNLRCTALEACIHPLF 367

Query: 241 DELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLGL 292
           DELRDPNTRLPNGR LPPLFNFKP EL G+P +++ +L+PEHARKQ  F+ L
Sbjct: 368 DELRDPNTRLPNGRPLPPLFNFKPQELSGIPPEIVNRLVPEHARKQNLFMAL 419

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FVS6|KSG4_ARATH Shaggy-related protein kinase delta OS=Arabidopsis thaliana GN=ASK4 PE=2 SV=1

 Score =  508 bits (1308), Expect = e-143,   Method: Compositional matrix adjust.
 Identities = 236/292 (80%), Positives = 261/292 (89%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M++LDHPNVV LKH F+S TE +E+YLNLVLE+VPETV+R  + + +M+Q MPLIYVKLY
Sbjct: 127 MQMLDHPNVVCLKHSFYSRTENEEVYLNLVLEFVPETVNRTARSYSRMNQLMPLIYVKLY 186

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
            YQICR LAY+HN  G+CHRDIKPQNLLVNPHTHQLK+CDFGSAKVLVKGEPNISYICSR
Sbjct: 187 TYQICRGLAYLHNCCGLCHRDIKPQNLLVNPHTHQLKICDFGSAKVLVKGEPNISYICSR 246

Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 180
           YYRAPELIFGATEYT AIDIWS GCV+AELLLGQPLFPGESGVDQLVEIIKVLGTPTREE
Sbjct: 247 YYRAPELIFGATEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 306

Query: 181 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
           IKCMNPNYTEFKFPQIK HPWHK+FQKR+PPEAVDL+ R  QYSPNLR TA+EA IHPFF
Sbjct: 307 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLLCRFFQYSPNLRCTAVEACIHPFF 366

Query: 241 DELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLGL 292
           DELRDPN RLPNGR LPPLFNFKP EL G+P + + +L+PEHARKQ  F+ L
Sbjct: 367 DELRDPNARLPNGRPLPPLFNFKPQELSGIPPETVDRLVPEHARKQNHFMAL 418

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q96287|KSG8_ARATH Shaggy-related protein kinase theta OS=Arabidopsis thaliana GN=ASK8 PE=2 SV=3

 Score =  498 bits (1283), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 229/284 (80%), Positives = 251/284 (88%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           MRL DHPNVV L+H FFSTT+KDELYLNLVLEYVPETV+R  KH+ KM+Q MP+I+V+LY
Sbjct: 183 MRLQDHPNVVRLRHSFFSTTDKDELYLNLVLEYVPETVYRASKHYTKMNQHMPIIFVQLY 242

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
            YQICRAL Y+H  +GVCHRDIKPQNLLVNP THQLK+CDFGSAK+LV GEPNISYICSR
Sbjct: 243 TYQICRALNYLHRVVGVCHRDIKPQNLLVNPQTHQLKICDFGSAKMLVPGEPNISYICSR 302

Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 180
           YYRAPELIFGATEYT AID+WS GCV+AELLLGQPLFPGESG+DQLVEIIK+LGTPTREE
Sbjct: 303 YYRAPELIFGATEYTNAIDMWSGGCVMAELLLGQPLFPGESGIDQLVEIIKILGTPTREE 362

Query: 181 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
           I+CMNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLR TALEA  HPFF
Sbjct: 363 IRCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACAHPFF 422

Query: 241 DELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHAR 284
           D+LRDPN  LPNGR LPPLFNF   EL G   ++  +LIP H +
Sbjct: 423 DDLRDPNVSLPNGRALPPLFNFTAQELAGASTELRQRLIPAHCQ 466

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	292
224068663	409	predicted protein [Populus trichocarpa]	1.0	0.713	0.969	1e-168
224128207	409	predicted protein [Populus trichocarpa]	1.0	0.713	0.962	1e-167
255548323	409	Glycogen synthase kinase-3 beta, putativ	1.0	0.713	0.962	1e-166
225437683	409	PREDICTED: glycogen synthase kinase-3 ho	1.0	0.713	0.958	1e-164
297744035	381	unnamed protein product [Vitis vinifera]	1.0	0.766	0.958	1e-164
164521171	409	serine/threonine protein kinase [Adonis	1.0	0.713	0.955	1e-164
449461703	409	PREDICTED: glycogen synthase kinase-3 ho	0.996	0.711	0.951	1e-164
226533162	408	glycogen synthase kinase-3 MsK-3 [Zea ma	1.0	0.715	0.928	1e-164
242052465	408	hypothetical protein SORBIDRAFT_03g00958	1.0	0.715	0.924	1e-163
414876820	408	TPA: putative glycogen synthase kinase f	0.996	0.713	0.920	1e-163

>gi|224068663|ref|XP_002302794.1| predicted protein [Populus trichocarpa] gi|222844520|gb|EEE82067.1| predicted protein [Populus trichocarpa]

 Score =  597 bits (1538), Expect = e-168,   Method: Compositional matrix adjust.
 Identities = 283/292 (96%), Positives = 288/292 (98%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPET+HRVIKH+YKMSQRMPLIYVKLY
Sbjct: 118 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETIHRVIKHYYKMSQRMPLIYVKLY 177

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
           FYQICRALAYIHN+IGVCHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPNISYICSR
Sbjct: 178 FYQICRALAYIHNSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 237

Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 180
           YYRAPELIFGATEYT AIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE
Sbjct: 238 YYRAPELIFGATEYTTAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 297

Query: 181 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
           IKCMNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF
Sbjct: 298 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 357

Query: 241 DELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLGL 292
           DELRDPN RLPNGR LPPLFNFKPHELKGVPV+MLVKLIPEHARKQCAFLGL
Sbjct: 358 DELRDPNARLPNGRILPPLFNFKPHELKGVPVEMLVKLIPEHARKQCAFLGL 409

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224128207|ref|XP_002320270.1| predicted protein [Populus trichocarpa] gi|222861043|gb|EEE98585.1| predicted protein [Populus trichocarpa]

 Score =  593 bits (1530), Expect = e-167,   Method: Compositional matrix adjust.
 Identities = 281/292 (96%), Positives = 289/292 (98%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPET+HRVIKH+ KMSQRMPLIYVKLY
Sbjct: 118 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETIHRVIKHYSKMSQRMPLIYVKLY 177

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
           FY+ICRALAYIHN+IGVCHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPNISYICSR
Sbjct: 178 FYEICRALAYIHNSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 237

Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 180
           YYRAPELIFGATEYT+AIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE
Sbjct: 238 YYRAPELIFGATEYTSAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 297

Query: 181 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
           IKCMNPNYTEFKFPQIKAHPWHKIF KR PPEAVDLVSRLLQYSPNLRSTALEALIHPFF
Sbjct: 298 IKCMNPNYTEFKFPQIKAHPWHKIFHKRTPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 357

Query: 241 DELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLGL 292
           DELRDPNTRLPNGRFLPPLFNFKPHELKGVP++MLVKLIPEHARKQCAFLGL
Sbjct: 358 DELRDPNTRLPNGRFLPPLFNFKPHELKGVPLEMLVKLIPEHARKQCAFLGL 409

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255548323|ref|XP_002515218.1| Glycogen synthase kinase-3 beta, putative [Ricinus communis] gi|223545698|gb|EEF47202.1| Glycogen synthase kinase-3 beta, putative [Ricinus communis]

 Score =  590 bits (1520), Expect = e-166,   Method: Compositional matrix adjust.
 Identities = 281/292 (96%), Positives = 287/292 (98%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH+ KM QRMPLIYVKLY
Sbjct: 118 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKMGQRMPLIYVKLY 177

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
           FYQICRALAYIHN+IGVCHRDIKP NLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR
Sbjct: 178 FYQICRALAYIHNSIGVCHRDIKPHNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 237

Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 180
           YYRAPELIFGATEYT AIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE
Sbjct: 238 YYRAPELIFGATEYTTAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 297

Query: 181 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
           IKCMNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLRSTAL+ALIHPFF
Sbjct: 298 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSTALDALIHPFF 357

Query: 241 DELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLGL 292
           DELRDPNTRLPNGRFLPPLFNF+PHELKGVPV++LVKLIPEHARKQCAFLGL
Sbjct: 358 DELRDPNTRLPNGRFLPPLFNFRPHELKGVPVEVLVKLIPEHARKQCAFLGL 409

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225437683|ref|XP_002279596.1| PREDICTED: glycogen synthase kinase-3 homolog MsK-3 [Vitis vinifera] gi|147767229|emb|CAN75652.1| hypothetical protein VITISV_017659 [Vitis vinifera]

 Score =  585 bits (1507), Expect = e-164,   Method: Compositional matrix adjust.
 Identities = 280/292 (95%), Positives = 285/292 (97%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           MRLLDHPNVVSLKHCFFSTTEK+ELYLNLVLEYVPETVHRVIKH+ KM+QRMP+IYVKLY
Sbjct: 118 MRLLDHPNVVSLKHCFFSTTEKEELYLNLVLEYVPETVHRVIKHYNKMNQRMPMIYVKLY 177

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
            YQICRALAYIH  IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE NISYICSR
Sbjct: 178 TYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGELNISYICSR 237

Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 180
           YYRAPELIFGATEYT AIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE
Sbjct: 238 YYRAPELIFGATEYTTAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 297

Query: 181 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
           IKCMNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF
Sbjct: 298 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 357

Query: 241 DELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLGL 292
           DELR+PNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLGL
Sbjct: 358 DELREPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLGL 409

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297744035|emb|CBI37005.3| unnamed protein product [Vitis vinifera]

 Score =  584 bits (1506), Expect = e-164,   Method: Compositional matrix adjust.
 Identities = 280/292 (95%), Positives = 285/292 (97%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           MRLLDHPNVVSLKHCFFSTTEK+ELYLNLVLEYVPETVHRVIKH+ KM+QRMP+IYVKLY
Sbjct: 90  MRLLDHPNVVSLKHCFFSTTEKEELYLNLVLEYVPETVHRVIKHYNKMNQRMPMIYVKLY 149

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
            YQICRALAYIH  IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE NISYICSR
Sbjct: 150 TYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGELNISYICSR 209

Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 180
           YYRAPELIFGATEYT AIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE
Sbjct: 210 YYRAPELIFGATEYTTAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 269

Query: 181 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
           IKCMNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF
Sbjct: 270 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 329

Query: 241 DELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLGL 292
           DELR+PNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLGL
Sbjct: 330 DELREPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLGL 381

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|164521171|gb|ABY60447.1| serine/threonine protein kinase [Adonis aestivalis var. palaestina]

 Score =  584 bits (1505), Expect = e-164,   Method: Compositional matrix adjust.
 Identities = 279/292 (95%), Positives = 284/292 (97%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPET HRVIKH+ KM+QRMPLIYVKLY
Sbjct: 118 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETAHRVIKHYNKMNQRMPLIYVKLY 177

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
            YQICRALAYIH TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR
Sbjct: 178 TYQICRALAYIHGTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 237

Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 180
           YYRAPELIFGATEYT AIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE
Sbjct: 238 YYRAPELIFGATEYTTAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 297

Query: 181 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
           IKCMNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLRSTAL+ALIHPFF
Sbjct: 298 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSTALDALIHPFF 357

Query: 241 DELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLGL 292
           DELRDP TRLPNGRFLPPLFNFKPHELKGVPV++L KLIPEHARKQCAFLGL
Sbjct: 358 DELRDPTTRLPNGRFLPPLFNFKPHELKGVPVEILGKLIPEHARKQCAFLGL 409

Source: Adonis aestivalis var. palaestina

Species: Adonis aestivalis

Genus: Adonis

Family: Ranunculaceae

Order: Ranunculales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449461703|ref|XP_004148581.1| PREDICTED: glycogen synthase kinase-3 homolog MsK-3-like [Cucumis sativus] gi|449511511|ref|XP_004163975.1| PREDICTED: glycogen synthase kinase-3 homolog MsK-3-like [Cucumis sativus]

 Score =  583 bits (1504), Expect = e-164,   Method: Compositional matrix adjust.
 Identities = 277/291 (95%), Positives = 285/291 (97%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH+ KM+QRMPLIYVKLY
Sbjct: 118 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKMNQRMPLIYVKLY 177

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
           FYQICRAL+YIHN+IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV+GEPNI+YICSR
Sbjct: 178 FYQICRALSYIHNSIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVRGEPNIAYICSR 237

Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 180
           YYRAPELIFGATEYT AIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE
Sbjct: 238 YYRAPELIFGATEYTTAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 297

Query: 181 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
           IKCMNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF
Sbjct: 298 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 357

Query: 241 DELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLG 291
           DELRDPNTRLPNGRFLPPLFNFK HELKGVP +MLV+LIPEHARKQC FLG
Sbjct: 358 DELRDPNTRLPNGRFLPPLFNFKAHELKGVPPEMLVRLIPEHARKQCNFLG 408

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|226533162|ref|NP_001148880.1| glycogen synthase kinase-3 MsK-3 [Zea mays] gi|195622888|gb|ACG33274.1| glycogen synthase kinase-3 MsK-3 [Zea mays] gi|413947048|gb|AFW79697.1| putative glycogen synthase kinase family protein [Zea mays]

 Score =  583 bits (1503), Expect = e-164,   Method: Compositional matrix adjust.
 Identities = 271/292 (92%), Positives = 284/292 (97%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           MRLLDHPNVV+LKHCFFSTTEKDELYLNLVLEYVPETVHRV+KHH KM+QRMPLIYVKLY
Sbjct: 117 MRLLDHPNVVALKHCFFSTTEKDELYLNLVLEYVPETVHRVVKHHNKMNQRMPLIYVKLY 176

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
            YQICRALAYIH TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR
Sbjct: 177 MYQICRALAYIHGTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 236

Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 180
           YYRAPELIFGATEYT AIDIWSAGCVLAEL+LGQPLFPGESGVDQLVEIIKVLGTPTREE
Sbjct: 237 YYRAPELIFGATEYTTAIDIWSAGCVLAELMLGQPLFPGESGVDQLVEIIKVLGTPTREE 296

Query: 181 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
           IKCMNPNYTEFKFPQIKAHPWHK+F KRMPPEAVDLVSRLLQYSPNLR TA+EAL+HPFF
Sbjct: 297 IKCMNPNYTEFKFPQIKAHPWHKVFHKRMPPEAVDLVSRLLQYSPNLRCTAMEALVHPFF 356

Query: 241 DELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLGL 292
           DELRDPNTRLPNGRFLPPLFNFKPHELKGVP D++ KLIPEHA+KQC+++GL
Sbjct: 357 DELRDPNTRLPNGRFLPPLFNFKPHELKGVPSDIVAKLIPEHAKKQCSYVGL 408

Source: Zea mays

Species: Zea mays

Genus: Zea

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|242052465|ref|XP_002455378.1| hypothetical protein SORBIDRAFT_03g009580 [Sorghum bicolor] gi|241927353|gb|EES00498.1| hypothetical protein SORBIDRAFT_03g009580 [Sorghum bicolor]

 Score =  581 bits (1497), Expect = e-163,   Method: Compositional matrix adjust.
 Identities = 270/292 (92%), Positives = 283/292 (96%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           MRLLDHPNVV+LKHCFFSTTEKDELYLNLVLEYVPETVHRV+KHH KM+QRMPLIYVKLY
Sbjct: 117 MRLLDHPNVVALKHCFFSTTEKDELYLNLVLEYVPETVHRVVKHHNKMNQRMPLIYVKLY 176

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
            YQICRALAYIH TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR
Sbjct: 177 MYQICRALAYIHGTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 236

Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 180
           YYRAPELIFGATEYT AIDIWSAGCVLAEL+LGQPLFPGESGVDQLVEIIKVLGTPTREE
Sbjct: 237 YYRAPELIFGATEYTTAIDIWSAGCVLAELMLGQPLFPGESGVDQLVEIIKVLGTPTREE 296

Query: 181 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
           IKCMNPNYTEFKFPQIKAHPWHK+F KRMPPEAVDLVSRLLQYSPNLR TA+EAL+HPFF
Sbjct: 297 IKCMNPNYTEFKFPQIKAHPWHKVFHKRMPPEAVDLVSRLLQYSPNLRCTAVEALVHPFF 356

Query: 241 DELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLGL 292
           DELRDPNTRLPNGRFLPPLFNFK HELKGVP D++ KLIPEHA+KQC+++GL
Sbjct: 357 DELRDPNTRLPNGRFLPPLFNFKAHELKGVPADIVAKLIPEHAKKQCSYVGL 408

Source: Sorghum bicolor

Species: Sorghum bicolor

Genus: Sorghum

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|414876820|tpg|DAA53951.1| TPA: putative glycogen synthase kinase family protein [Zea mays]

 Score =  579 bits (1492), Expect = e-163,   Method: Compositional matrix adjust.
 Identities = 268/291 (92%), Positives = 282/291 (96%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           MRLLDHPNVV+LKHCFFSTTEKDELYLNLVLEYVPETVHRV+KHH KM QRMPLIYVKLY
Sbjct: 117 MRLLDHPNVVALKHCFFSTTEKDELYLNLVLEYVPETVHRVVKHHNKMHQRMPLIYVKLY 176

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
            YQICRALAYIH TIGVCHRDIKPQNLLVNPHTHQLK+CDFGSAKVLVKGEPNISYICSR
Sbjct: 177 MYQICRALAYIHGTIGVCHRDIKPQNLLVNPHTHQLKICDFGSAKVLVKGEPNISYICSR 236

Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 180
           YYRAPELIFGATEYT AIDIWSAGCVLAEL+LGQPLFPGESGVDQLVEIIKVLGTPTREE
Sbjct: 237 YYRAPELIFGATEYTTAIDIWSAGCVLAELMLGQPLFPGESGVDQLVEIIKVLGTPTREE 296

Query: 181 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
           IKCMNPNYTEFKFPQIKAHPWHK+F KRMPPEAVDLVSRLLQYSPNLR TA+EAL+HPFF
Sbjct: 297 IKCMNPNYTEFKFPQIKAHPWHKVFNKRMPPEAVDLVSRLLQYSPNLRCTAVEALVHPFF 356

Query: 241 DELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLG 291
           DELRDPNTRLPNGRFLPPLFNFKPHELKGVP D++ KL+PEHA+KQC+++G
Sbjct: 357 DELRDPNTRLPNGRFLPPLFNFKPHELKGVPADIVAKLVPEHAKKQCSYVG 407

Source: Zea mays

Species: Zea mays

Genus: Zea

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	292
TAIR|locus:2832141	405	SK 11 "AT5G26751" [Arabidopsis	1.0	0.720	0.914	3.8e-149
TAIR|locus:2074464	409	ATSK12 [Arabidopsis thaliana (	1.0	0.713	0.904	5.5e-148
TAIR|locus:2222642	410	SK13 "shaggy-like kinase 13" [	1.0	0.712	0.893	1.9e-145
TAIR|locus:2024341	421	SK41 "shaggy-like protein kina	1.0	0.693	0.808	2.3e-133
TAIR|locus:2126993	472	SK32 "shaggy-like protein kina	0.972	0.601	0.806	2.8e-128
TAIR|locus:2202255	407	GSK1 "GSK3/SHAGGY-like protein	0.976	0.700	0.793	1.6e-127
TAIR|locus:2052861	412	SKdZeta "SHAGGY-related protei	0.976	0.691	0.797	4.2e-127
TAIR|locus:2124082	380	BIN2 "BRASSINOSTEROID-INSENSIT	0.986	0.757	0.770	8.9e-125
TAIR|locus:2098896	438	AT3G61160 [Arabidopsis thalian	0.976	0.650	0.747	1.4e-119
UNIPROTKB|F1NPL8	390	GSK3B "Uncharacterized protein	0.979	0.733	0.702	2.6e-109

TAIR|locus:2832141 SK 11 "AT5G26751" [Arabidopsis thaliana (taxid:3702)]

 Score = 1456 (517.6 bits), Expect = 3.8e-149, P = 3.8e-149
 Identities = 267/292 (91%), Positives = 280/292 (95%)

Query:     1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
             MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH+ K++QRMPLIYVKLY
Sbjct:   114 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLIYVKLY 173

Query:    61 FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
              YQI RAL+YIH  IGVCHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPNISYICSR
Sbjct:   174 TYQIFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 233

Query:   121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 180
             YYRAPELIFGATEYT AID+WSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE
Sbjct:   234 YYRAPELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 293

Query:   181 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
             IKCMNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLRS AL+ L+HPFF
Sbjct:   294 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSAALDTLVHPFF 353

Query:   241 DELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLGL 292
             DELRDPN RLPNGRFLPPLFNFKPHELKGVP++M+ KL+PEHARKQC +LGL
Sbjct:   354 DELRDPNARLPNGRFLPPLFNFKPHELKGVPLEMVAKLVPEHARKQCPWLGL 405

GO:0004672 "protein kinase activity" evidence=ISS;IDA

GO:0005634 "nucleus" evidence=ISM

GO:0009933 "meristem structural organization" evidence=IMP

GO:0005829 "cytosol" evidence=IDA

GO:0042538 "hyperosmotic salinity response" evidence=IMP

GO:0016310 "phosphorylation" evidence=IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

TAIR|locus:2074464 ATSK12 [Arabidopsis thaliana (taxid:3702)]

 Score = 1445 (513.7 bits), Expect = 5.5e-148, P = 5.5e-148
 Identities = 264/292 (90%), Positives = 279/292 (95%)

Query:     1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
             MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH+ K++QRMPL+YVKLY
Sbjct:   118 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLVYVKLY 177

Query:    61 FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
              YQI R+L+YIH  IGVCHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPNISYICSR
Sbjct:   178 TYQIFRSLSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 237

Query:   121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 180
             YYRAPELIFGATEYT AID+WSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE
Sbjct:   238 YYRAPELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 297

Query:   181 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
             IKCMNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLR  AL++L+HPFF
Sbjct:   298 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCAALDSLVHPFF 357

Query:   241 DELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLGL 292
             DELRDPN RLPNGRFLPPLFNFKPHELKGVPV+M+ KL+PEHARKQC +L L
Sbjct:   358 DELRDPNARLPNGRFLPPLFNFKPHELKGVPVEMVAKLVPEHARKQCPWLSL 409

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009933 "meristem structural organization" evidence=IMP

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0016310 "phosphorylation" evidence=IDA

TAIR|locus:2222642 SK13 "shaggy-like kinase 13" [Arabidopsis thaliana (taxid:3702)]

 Score = 1421 (505.3 bits), Expect = 1.9e-145, P = 1.9e-145
 Identities = 261/292 (89%), Positives = 276/292 (94%)

Query:     1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
             MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETV+RV KH+ + +QRMP+IYVKLY
Sbjct:   119 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVYRVSKHYSRANQRMPIIYVKLY 178

Query:    61 FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
              YQICRALAYIH  +GVCHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPNISYICSR
Sbjct:   179 TYQICRALAYIHGGVGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 238

Query:   121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 180
             YYRAPELIFGATEYT  IDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE
Sbjct:   239 YYRAPELIFGATEYTTTIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 298

Query:   181 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
             IKCMNPNYTEFKFPQIKAHPWHKIF KR PPEAVDLVSRLLQYSPNLRSTA+EA++HPFF
Sbjct:   299 IKCMNPNYTEFKFPQIKAHPWHKIFHKRTPPEAVDLVSRLLQYSPNLRSTAMEAIVHPFF 358

Query:   241 DELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLGL 292
             DELRDPNTRLPNGR LPPLFNFKP ELKG  +++L KLIP+HARKQC+FL L
Sbjct:   359 DELRDPNTRLPNGRALPPLFNFKPQELKGASLELLSKLIPDHARKQCSFLAL 410

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006972 "hyperosmotic response" evidence=IEP

GO:0009651 "response to salt stress" evidence=IEP

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2024341 SK41 "shaggy-like protein kinase 41" [Arabidopsis thaliana (taxid:3702)]

 Score = 1307 (465.1 bits), Expect = 2.3e-133, P = 2.3e-133
 Identities = 236/292 (80%), Positives = 264/292 (90%)

Query:     1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
             M++LDHPN V+LKH FFS T+ +E+YLNLVLE+VPETV+RV + + + +Q MPLIYVKLY
Sbjct:   128 MQMLDHPNAVALKHSFFSRTDNEEVYLNLVLEFVPETVNRVARSYSRTNQLMPLIYVKLY 187

Query:    61 FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
              YQICRALAYIHN+ G+CHRDIKPQNLLVNPHTHQLK+CDFGSAKVLVKGEPN+SYICSR
Sbjct:   188 TYQICRALAYIHNSFGLCHRDIKPQNLLVNPHTHQLKICDFGSAKVLVKGEPNVSYICSR 247

Query:   121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 180
             YYRAPELIFGA+EYT AIDIWS GCV+AELLLGQPLFPGESGVDQLVEIIKVLGTPTREE
Sbjct:   248 YYRAPELIFGASEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 307

Query:   181 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
             IKCMNPNYTEFKFPQIK HPWHK+FQKR+PPEAVDL+ R  QYSPNLR TALEA IHP F
Sbjct:   308 IKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLLCRFFQYSPNLRCTALEACIHPLF 367

Query:   241 DELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLGL 292
             DELRDPNTRLPNGR LPPLFNFKP EL G+P +++ +L+PEHARKQ  F+ L
Sbjct:   368 DELRDPNTRLPNGRPLPPLFNFKPQELSGIPPEIVNRLVPEHARKQNLFMAL 419

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0019344 "cysteine biosynthetic process" evidence=RCA

TAIR|locus:2126993 SK32 "shaggy-like protein kinase 32" [Arabidopsis thaliana (taxid:3702)]

 Score = 1259 (448.2 bits), Expect = 2.8e-128, P = 2.8e-128
 Identities = 229/284 (80%), Positives = 251/284 (88%)

Query:     1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
             MRL DHPNVV L+H FFSTT+KDELYLNLVLEYVPETV+R  KH+ KM+Q MP+I+V+LY
Sbjct:   183 MRLQDHPNVVRLRHSFFSTTDKDELYLNLVLEYVPETVYRASKHYTKMNQHMPIIFVQLY 242

Query:    61 FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
              YQICRAL Y+H  +GVCHRDIKPQNLLVNP THQLK+CDFGSAK+LV GEPNISYICSR
Sbjct:   243 TYQICRALNYLHRVVGVCHRDIKPQNLLVNPQTHQLKICDFGSAKMLVPGEPNISYICSR 302

Query:   121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 180
             YYRAPELIFGATEYT AID+WS GCV+AELLLGQPLFPGESG+DQLVEIIK+LGTPTREE
Sbjct:   303 YYRAPELIFGATEYTNAIDMWSGGCVMAELLLGQPLFPGESGIDQLVEIIKILGTPTREE 362

Query:   181 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
             I+CMNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLR TALEA  HPFF
Sbjct:   363 IRCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACAHPFF 422

Query:   241 DELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHAR 284
             D+LRDPN  LPNGR LPPLFNF   EL G   ++  +LIP H +
Sbjct:   423 DDLRDPNVSLPNGRALPPLFNFTAQELAGASTELRQRLIPAHCQ 466

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

GO:0009741 "response to brassinosteroid stimulus" evidence=IMP

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2202255 GSK1 "GSK3/SHAGGY-like protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1252 (445.8 bits), Expect = 1.6e-127, P = 1.6e-127
 Identities = 227/286 (79%), Positives = 258/286 (90%)

Query:     1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
             MR +DHPNV+SLKHCFFSTT +DEL+LNLV+EYVPET++RV++H+   +QRMP+ YVKLY
Sbjct:   115 MRPMDHPNVISLKHCFFSTTSRDELFLNLVMEYVPETLYRVLRHYTSSNQRMPIFYVKLY 174

Query:    61 FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
              YQI R LAYIH   GVCHRD+KPQNLLV+P THQ+KLCDFGSAKVLVKGEPNISYICSR
Sbjct:   175 TYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLCDFGSAKVLVKGEPNISYICSR 234

Query:   121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 180
             YYRAPELIFGATEYTA+IDIWSAGCVLAELLLGQPLFPGE+ VDQLVEIIKVLGTPTREE
Sbjct:   235 YYRAPELIFGATEYTASIDIWSAGCVLAELLLGQPLFPGENSVDQLVEIIKVLGTPTREE 294

Query:   181 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
             I+CMNPNYT+F+FPQIKAHPWHK+F KRMPPEA+DL SRLLQYSP+LR TALEA  HPFF
Sbjct:   295 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 354

Query:   241 DELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQ 286
             +ELR+PN RLPNGR LPPLFNFK  EL G  ++++ +LIPEH R+Q
Sbjct:   355 NELREPNARLPNGRPLPPLFNFK-QELGGASMELINRLIPEHVRRQ 399

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0042538 "hyperosmotic salinity response" evidence=IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IPI

GO:0032880 "regulation of protein localization" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0051049 "regulation of transport" evidence=RCA

TAIR|locus:2052861 SKdZeta "SHAGGY-related protein kinase dZeta" [Arabidopsis thaliana (taxid:3702)]

 Score = 1248 (444.4 bits), Expect = 4.2e-127, P = 4.2e-127
 Identities = 228/286 (79%), Positives = 256/286 (89%)

Query:     1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
             MRL+DHPNVVSLKHCFFSTT +DEL+LNLV+EYVPET++RV+KH+   +QRMP+ YVKLY
Sbjct:   117 MRLMDHPNVVSLKHCFFSTTTRDELFLNLVMEYVPETLYRVLKHYTSSNQRMPIFYVKLY 176

Query:    61 FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
              YQI R LAYIH   GVCHRD+KPQNLLV+P THQ KLCDFGSAKVLVKGE NISYICSR
Sbjct:   177 TYQIFRGLAYIHTAPGVCHRDVKPQNLLVDPLTHQCKLCDFGSAKVLVKGEANISYICSR 236

Query:   121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 180
             YYRAPELIFGATEYT++IDIWSAGCVLAELLLGQPLFPGE+ VDQLVEIIKVLGTPTREE
Sbjct:   237 YYRAPELIFGATEYTSSIDIWSAGCVLAELLLGQPLFPGENSVDQLVEIIKVLGTPTREE 296

Query:   181 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
             I+CMNPNYT+F+FPQIKAHPWHK+F KRMPPEA+DL SRLLQYSP+LR TALEA  HPFF
Sbjct:   297 IRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTALEACAHPFF 356

Query:   241 DELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQ 286
             +ELR+PN RLPNGR LPPLFNFK  EL G   +++ +LIPEH R+Q
Sbjct:   357 NELREPNARLPNGRPLPPLFNFK-QELSGASPELINRLIPEHVRRQ 401

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IPI

GO:0032880 "regulation of protein localization" evidence=RCA;IDA

TAIR|locus:2124082 BIN2 "BRASSINOSTEROID-INSENSITIVE 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1226 (436.6 bits), Expect = 8.9e-125, P = 8.9e-125
 Identities = 225/292 (77%), Positives = 257/292 (88%)

Query:     1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
             MR++DHPNVV LKHCFFSTT KDEL+LNLV+EYVPE+++RV+KH+   +QRMPL+YVKLY
Sbjct:    85 MRVMDHPNVVCLKHCFFSTTSKDELFLNLVMEYVPESLYRVLKHYSSANQRMPLVYVKLY 144

Query:    61 FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
              YQI R LAYIHN  GVCHRD+KPQNLLV+P THQ+K+CDFGSAK LVKGE NISYICSR
Sbjct:   145 MYQIFRGLAYIHNVAGVCHRDLKPQNLLVDPLTHQVKICDFGSAKQLVKGEANISYICSR 204

Query:   121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 180
             +YRAPELIFGATEYT +IDIWSAGCVLAELLLGQPLFPGE+ VDQLVEIIKVLGTPTREE
Sbjct:   205 FYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPGENAVDQLVEIIKVLGTPTREE 264

Query:   181 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
             I+CMNP+YT+F+FPQIKAHPWHKIF KRMPPEA+D  SRLLQYSP+LR TALEA  HPFF
Sbjct:   265 IRCMNPHYTDFRFPQIKAHPWHKIFHKRMPPEAIDFASRLLQYSPSLRCTALEACAHPFF 324

Query:   241 DELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLGL 292
             DELR+PN RLPNGR  PPLFNFK  E+ G   +++ KLIP+H ++Q   LGL
Sbjct:   325 DELREPNARLPNGRPFPPLFNFK-QEVAGSSPELVNKLIPDHIKRQ---LGL 372

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IPI

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009729 "detection of brassinosteroid stimulus" evidence=IMP

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IMP

GO:0009733 "response to auxin stimulus" evidence=IMP

GO:0009825 "multidimensional cell growth" evidence=IMP

GO:0009965 "leaf morphogenesis" evidence=IMP

GO:0005515 "protein binding" evidence=IPI

GO:0005886 "plasma membrane" evidence=IDA

GO:0046827 "positive regulation of protein export from nucleus" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0006096 "glycolysis" evidence=RCA

GO:0006833 "water transport" evidence=RCA

GO:0006972 "hyperosmotic response" evidence=RCA

GO:0007030 "Golgi organization" evidence=RCA

GO:0009266 "response to temperature stimulus" evidence=RCA

GO:0009651 "response to salt stress" evidence=RCA

GO:0046686 "response to cadmium ion" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

TAIR|locus:2098896 AT3G61160 [Arabidopsis thaliana (taxid:3702)]

 Score = 1177 (419.4 bits), Expect = 1.4e-119, P = 1.4e-119
 Identities = 213/285 (74%), Positives = 245/285 (85%)

Query:     1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
             MR+LDHPNVV LKH FFSTTEKDELYLNLVLEYVPET++R  + + KM+Q MPLIY++LY
Sbjct:   154 MRMLDHPNVVELKHSFFSTTEKDELYLNLVLEYVPETIYRASRSYTKMNQHMPLIYIQLY 213

Query:    61 FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
              YQICRA+ Y+H  +GVCHRDIKPQNLLVN  TH++K+CDFGSAK+L+ GEPNISYICSR
Sbjct:   214 TYQICRAMNYLHQVVGVCHRDIKPQNLLVNNVTHEVKICDFGSAKMLIPGEPNISYICSR 273

Query:   121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 180
             YYRAPELIFGATEYT+AID+WS GCV+AEL LG PLFPGE+ VDQLVEIIK+LGTP REE
Sbjct:   274 YYRAPELIFGATEYTSAIDMWSVGCVMAELFLGHPLFPGETSVDQLVEIIKILGTPAREE 333

Query:   181 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
             IK MNP Y +FKFPQIKA PWHKIF++++ PEA+DL SRLLQYSPNLR TALEA  HPFF
Sbjct:   334 IKNMNPRYNDFKFPQIKAQPWHKIFRRQVSPEAMDLASRLLQYSPNLRCTALEACAHPFF 393

Query:   241 DELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARK 285
             D+LRDP   LPNGR LPPLF+F   EL G  V++  +LIPEHARK
Sbjct:   394 DDLRDPRASLPNGRALPPLFDFTAQELAGASVELRHRLIPEHARK 438

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

UNIPROTKB|F1NPL8 GSK3B "Uncharacterized protein" [Gallus gallus (taxid:9031)]

 Score = 1080 (385.2 bits), Expect = 2.6e-109, P = 2.6e-109
 Identities = 203/289 (70%), Positives = 239/289 (82%)

Query:     1 MRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL 59
             MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +  Q +P+IYVKL
Sbjct:    71 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPMIYVKL 130

Query:    60 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
             Y YQ+ R+LAYIH+  G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+SYICS
Sbjct:   131 YMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS 189

Query:   120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
             RYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE
Sbjct:   190 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 249

Query:   180 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
             +I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  R T LEA  H F
Sbjct:   250 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 309

Query:   240 FDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCA 288
             FDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR Q A
Sbjct:   310 FDELRDPNVKLPNGREKPALFNFTTQELSSNP-SLASILIPAHARNQAA 357

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0000320 "re-entry into mitotic cell cycle" evidence=IEA

GO:0001085 "RNA polymerase II transcription factor binding" evidence=IEA

GO:0001837 "epithelial to mesenchymal transition" evidence=IEA

GO:0001954 "positive regulation of cell-matrix adhesion" evidence=IEA

GO:0002039 "p53 binding" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0005813 "centrosome" evidence=IEA

GO:0005829 "cytosol" evidence=IEA

GO:0005886 "plasma membrane" evidence=IEA

GO:0005977 "glycogen metabolic process" evidence=IEA

GO:0006349 "regulation of gene expression by genetic imprinting" evidence=IEA

GO:0006611 "protein export from nucleus" evidence=IEA

GO:0006983 "ER overload response" evidence=IEA

GO:0007409 "axonogenesis" evidence=IEA

GO:0007520 "myoblast fusion" evidence=IEA

GO:0008013 "beta-catenin binding" evidence=IEA

GO:0009887 "organ morphogenesis" evidence=IEA

GO:0010800 "positive regulation of peptidyl-threonine phosphorylation" evidence=IEA

GO:0016477 "cell migration" evidence=IEA

GO:0018105 "peptidyl-serine phosphorylation" evidence=IEA

GO:0021766 "hippocampus development" evidence=IEA

GO:0030426 "growth cone" evidence=IEA

GO:0030529 "ribonucleoprotein complex" evidence=IEA

GO:0030877 "beta-catenin destruction complex" evidence=IEA

GO:0031333 "negative regulation of protein complex assembly" evidence=IEA

GO:0031334 "positive regulation of protein complex assembly" evidence=IEA

GO:0031625 "ubiquitin protein ligase binding" evidence=IEA

GO:0032091 "negative regulation of protein binding" evidence=IEA

GO:0032092 "positive regulation of protein binding" evidence=IEA

GO:0032855 "positive regulation of Rac GTPase activity" evidence=IEA

GO:0032886 "regulation of microtubule-based process" evidence=IEA

GO:0033138 "positive regulation of peptidyl-serine phosphorylation" evidence=IEA

GO:0034236 "protein kinase A catalytic subunit binding" evidence=IEA

GO:0035372 "protein localization to microtubule" evidence=IEA

GO:0035556 "intracellular signal transduction" evidence=IEA

GO:0043025 "neuronal cell body" evidence=IEA

GO:0043066 "negative regulation of apoptotic process" evidence=IEA

GO:0043198 "dendritic shaft" evidence=IEA

GO:0044027 "hypermethylation of CpG island" evidence=IEA

GO:0044337 "canonical Wnt receptor signaling pathway involved in positive regulation of apoptotic process" evidence=IEA

GO:0045444 "fat cell differentiation" evidence=IEA

GO:0045944 "positive regulation of transcription from RNA polymerase II promoter" evidence=IEA

GO:0046827 "positive regulation of protein export from nucleus" evidence=IEA

GO:0048471 "perinuclear region of cytoplasm" evidence=IEA

GO:0050321 "tau-protein kinase activity" evidence=IEA

GO:0051059 "NF-kappaB binding" evidence=IEA

GO:0051534 "negative regulation of NFAT protein import into nucleus" evidence=IEA

GO:0071109 "superior temporal gyrus development" evidence=IEA

GO:2000738 "positive regulation of stem cell differentiation" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
P43289	KSG3_ARATH	2, ., 7, ., 1, 1, ., 1	0.9041	1.0	0.7139	no	no
P43288	KSG1_ARATH	2, ., 7, ., 1, 1, ., 1	0.9143	1.0	0.7209	yes	no
Q10452	GSK3_SCHPO	2, ., 7, ., 1, 1, ., 1	0.6198	0.9657	0.7286	yes	no
P38615	RIM11_YEAST	2, ., 7, ., 1, 1, ., 1	0.5655	0.8321	0.6567	yes	no
Q9U2Q9	GSK3_CAEEL	2, ., 7, ., 1, 1, ., 2, 6	0.6961	0.8835	0.7127	yes	no
Q40518	MSK1_TOBAC	2, ., 7, ., 1, 1, ., 1	0.9006	1.0	0.7139	N/A	no
Q9WV60	GSK3B_MOUSE	2, ., 7, ., 1, 1, ., 1	0.7024	0.9794	0.6809	yes	no
P51136	GSK3_DICDI	2, ., 7, ., 1, 1, ., 2, 6	0.6236	0.9726	0.6081	yes	no
P51137	MSK1_MEDSA	2, ., 7, ., 1, 1, ., 1	0.9006	1.0	0.7104	N/A	no
P51138	MSK2_MEDSA	2, ., 7, ., 1, 1, ., 1	0.9072	0.9965	0.7080	N/A	no
P51139	MSK3_MEDSA	2, ., 7, ., 1, 1, ., 1	0.9175	0.9965	0.7080	N/A	no
O04160	KSGT_BRANA	2, ., 7, ., 1, 1, ., 1	0.7992	0.9726	0.6068	N/A	no
P18266	GSK3B_RAT	2, ., 7, ., 1, 1, ., 1	0.7024	0.9794	0.6809	yes	no
P49841	GSK3B_HUMAN	2, ., 7, ., 1, 1, ., 1	0.7024	0.9794	0.6809	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.991
3rd Layer	2.7.11	0.976

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: estExt_fgenesh4_pm.C_LG_II0912 hypothetical protein (409 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	292
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-111
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-80
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-74
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	4e-70
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-69
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-67
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-65
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-65
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	5e-64
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-63
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-63
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	3e-60
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	4e-59
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-58
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-57
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-56
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-56
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-53
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	7e-53
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-52
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	5e-52
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	6e-52
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-51
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-51
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	4e-51
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	4e-51
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-47
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	7e-47
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	9e-47
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-46
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-46
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-46
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	9e-46
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-45
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-44
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-44
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	3e-44
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	7e-44
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	7e-44
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-43
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-43
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-43
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	6e-42
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	7e-42
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	8e-42
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	9e-42
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-41
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	6e-41
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	7e-41
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-40
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	4e-40
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-37
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-35
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	7e-34
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-33
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	8e-33
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	4e-32
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	6e-32
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-31
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-31
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-31
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-31
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-29
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-29
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-29
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-28
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	4e-28
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	5e-27
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	6e-27
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	7e-27
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-26
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-25
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	9e-24
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	4e-23
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-22
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-22
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	6e-22
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	9e-22
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-21
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-21
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	6e-21
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-20
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-20
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	5e-20
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	8e-20
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-19
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-19
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	5e-19
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	7e-19
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-18
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-18
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	5e-18
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	7e-18
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-17
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-17
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-17
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-17
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	8e-17
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-16
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-16
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-16
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-16
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	4e-16
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	5e-16
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	5e-16
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	7e-16
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	8e-16
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-15
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-15
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-15
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-15
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-15
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-15
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-15
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	7e-15
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	8e-15
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	8e-15
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	8e-15
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	9e-15
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-14
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-14
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-14
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-14
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-14
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-14
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	4e-14
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	4e-14
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	5e-14
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	7e-14
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	7e-14
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	7e-14
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	9e-14
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-13
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-13
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-13
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-13
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-13
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-13
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-13
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	3e-13
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-13
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	3e-13
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	4e-13
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	4e-13
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	4e-13
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	5e-13
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	7e-13
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-12
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-12
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-12
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-12
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	3e-12
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-12
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	4e-12
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	5e-12
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	5e-12
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	6e-12
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	7e-12
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	7e-12
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	8e-12
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	8e-12
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-11
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	1e-11
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-11
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-11
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-11
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	1e-11
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-11
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-11
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-11
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-11
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-11
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-11
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-11
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-11
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	3e-11
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	5e-11
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	6e-11
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	6e-11
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	6e-11
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	9e-11
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-10
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-10
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-10
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-10
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	4e-10
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	5e-10
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	6e-10
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	6e-10
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	8e-10
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	8e-10
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	9e-10
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-09
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-09
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-09
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-09
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-09
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-09
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	4e-09
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	4e-09
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	8e-09
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	9e-09
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-08
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-08
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-08
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-08
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	3e-08
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-08
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	4e-08
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	4e-08
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	5e-08
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	1e-07
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-07
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-07
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-07
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	4e-07
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	4e-07
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	5e-07
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	7e-07
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	7e-07
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	8e-07
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-06
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-06
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-06
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-06
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-06
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	4e-06
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	5e-06
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	5e-06
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	8e-06
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	8e-06
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-05
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-05
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	3e-05
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	4e-05
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	4e-05
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	5e-05
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	6e-05
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	6e-05
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	6e-05
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	6e-05
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	6e-05
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	6e-05
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	8e-05
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	1e-04
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-04
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-04
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-04
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-04
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	3e-04
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-04
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	3e-04
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	4e-04
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	4e-04
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	5e-04
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	5e-04
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	8e-04
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	9e-04
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	0.001
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	0.001
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	0.001
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	0.002
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	0.003
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	0.004
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	0.004

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score =  328 bits (843), Expect = e-111
 Identities = 147/285 (51%), Positives = 209/285 (73%), Gaps = 5/285 (1%)

Query: 1   MRLLDHPNVVSLKHCFFSTT-EKDE--LYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           M+ L+H N++ LK  +++   +K+E  ++LN+V+E++P+TVH+ +KH+ + +  +PL  V
Sbjct: 113 MKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLV 172

Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           KLY YQ+CRALAYIH+   +CHRD+KPQNLL++P+TH LKLCDFGSAK L+ G+ ++SYI
Sbjct: 173 KLYSYQLCRALAYIHSKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYI 231

Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
           CSR+YRAPEL+ GAT YT  ID+WS GC++AE++LG P+F G+S VDQLV II+VLGTPT
Sbjct: 232 CSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPT 291

Query: 178 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 237
            +++K MNPNY + KFP +K     K+F K  P +A++ +S+ L+Y P  R   +EAL  
Sbjct: 292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351

Query: 238 PFFDELRDPNTRLPNG-RFLPPLFNFKPHELKGVPVDMLVKLIPE 281
           PFFD+LRDP  +LP     LP LFNF   E+K +      K+IP+
Sbjct: 352 PFFDDLRDPCIKLPKYIDKLPDLFNFCDAEIKEMSDACRRKIIPK 396

Length = 440

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  245 bits (629), Expect = 2e-80
 Identities = 106/288 (36%), Positives = 160/288 (55%), Gaps = 22/288 (7%)

Query: 1   MRLLDHPNVVSLKHCF--FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 58
           +R L H N++ L       S  + +++Y+  V E +   +H+VIK      Q +   +++
Sbjct: 53  LRHLRHENIIGLLDILRPPSPEDFNDVYI--VTELMETDLHKVIK----SPQPLTDDHIQ 106

Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS--- 115
            + YQI R L Y+H +  V HRD+KP N+LVN     LK+CDFG A+ +   E       
Sbjct: 107 YFLYQILRGLKYLH-SANVIHRDLKPSNILVN-SNCDLKICDFGLARGVDPDEDEKGFLT 164

Query: 116 -YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 174
            Y+ +R+YRAPEL+  ++ YT AIDIWS GC+ AELL  +PLFPG   +DQL  I++VLG
Sbjct: 165 EYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLG 224

Query: 175 TPTREEIKCM-NPNYTEF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 231
           TP+ E++K + +     +    P+    P  K+F     PEA+DL+ ++L + P  R TA
Sbjct: 225 TPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPG-ASPEAIDLLEKMLVFDPKKRITA 283

Query: 232 LEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI 279
            EAL HP+  +L DP    P      P F+F   +   +  + L +LI
Sbjct: 284 DEALAHPYLAQLHDPE-DEPVA---KPPFDFDFFDDDELTEEELKELI 327

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  229 bits (586), Expect = 1e-74
 Identities = 96/248 (38%), Positives = 143/248 (57%), Gaps = 25/248 (10%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ L HPN+V L     +   + +LYL  V EY    + + +    K    +    +K  
Sbjct: 52  LKELKHPNIVKLLDVIHT---ERKLYL--VFEYCDMDLKKYLD---KRPGPLSPNLIKSI 103

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---I 117
            YQ+ R LAY H +  + HRD+KPQN+L+N     LKL DFG A+    G P  +Y   +
Sbjct: 104 MYQLLRGLAYCH-SHRILHRDLKPQNILIN-RDGVLKLADFGLARAF--GIPLRTYTHEV 159

Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            + +YRAPE++ G+  Y+ A+DIWS GC+ AE++ G+PLFPG+S +DQL +I ++LGTPT
Sbjct: 160 VTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPT 219

Query: 178 REEIKCMNPNYTEFK-----FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAL 232
            E      P  T+       FP+       K+   R+ PE +DL+S++LQY+P  R +A 
Sbjct: 220 EESW----PGVTKLPDYKPTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAK 274

Query: 233 EALIHPFF 240
           EAL HP+F
Sbjct: 275 EALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  218 bits (557), Expect = 4e-70
 Identities = 93/245 (37%), Positives = 141/245 (57%), Gaps = 17/245 (6%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++   HP VV L   F            LV+EY+P  +  V++      + +P   VK Y
Sbjct: 53  LQACQHPYVVKLLDVF-----PHGSGFVLVMEYMPSDLSEVLRD---EERPLPEAQVKSY 104

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY--IC 118
              + + +AY+H   G+ HRD+KP NLL++     LK+ DFG A++  + EP +    + 
Sbjct: 105 MRMLLKGVAYMHAN-GIMHRDLKPANLLISADGV-LKIADFGLARLFSEEEPRLYSHQVA 162

Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 178
           +R+YRAPEL++GA +Y   +D+W+ GC+ AELL G PLFPGE+ ++QL  + + LGTP  
Sbjct: 163 TRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNE 222

Query: 179 E---EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 235
           E    +  + P+Y +  FP+ K  P  +IF     PEA+DL+  LL Y P+ R +A EAL
Sbjct: 223 ETWPGLTSL-PDYNKITFPESKPIPLEEIFPD-ASPEALDLLKGLLVYDPSKRLSAAEAL 280

Query: 236 IHPFF 240
            HP+F
Sbjct: 281 RHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  216 bits (552), Expect = 2e-69
 Identities = 97/243 (39%), Positives = 144/243 (59%), Gaps = 14/243 (5%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ L+HPN++ L   F     K +LYL  V E++   ++++IK   +    +P   +K Y
Sbjct: 52  LKELNHPNIIKLLDVFR---HKGDLYL--VFEFMDTDLYKLIKDRQRG---LPESLIKSY 103

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNISYICS 119
            YQ+ + LA+ H+  G+ HRD+KP+NLL+N     LKL DFG A+       P   Y+ +
Sbjct: 104 LYQLLQGLAFCHSH-GILHRDLKPENLLINTEG-VLKLADFGLARSFGSPVRPYTHYVVT 161

Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
           R+YRAPEL+ G   Y+  +DIWS GC+ AELL  +PLFPG+S +DQL +I + LGTP  E
Sbjct: 162 RWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPE 221

Query: 180 EIKCMNPN--YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 237
                       +F FP+    P  K+F     P+A+DL+S++L Y P+ R TA +AL H
Sbjct: 222 VWPKFTSLARNYKFSFPKKAGMPLPKLFPN-ASPQALDLLSQMLHYDPHKRITAEQALAH 280

Query: 238 PFF 240
           P+F
Sbjct: 281 PYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  212 bits (542), Expect = 3e-67
 Identities = 96/254 (37%), Positives = 150/254 (59%), Gaps = 20/254 (7%)

Query: 2   RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 61
            L DHPN+V L +   +  +KD +YL  V EY+   +H VI+ +         ++ +   
Sbjct: 62  ELGDHPNIVKLLNVIKAENDKD-IYL--VFEYMETDLHAVIRANILED-----VHKRYIM 113

Query: 62  YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS------ 115
           YQ+ +AL YIH +  V HRD+KP N+L+N     +KL DFG A+ L + E N        
Sbjct: 114 YQLLKALKYIH-SGNVIHRDLKPSNILLNSDCR-VKLADFGLARSLSELEENPENPVLTD 171

Query: 116 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
           Y+ +R+YRAPE++ G+T YT  +D+WS GC+L E+LLG+PLFPG S ++QL +II+V+G 
Sbjct: 172 YVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGP 231

Query: 176 PTREEIKCMNPNYTEF---KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAL 232
           P+ E+I+ +   +        P     P  ++   +   +A+DL+ +LL ++PN R TA 
Sbjct: 232 PSAEDIESIKSPFAATMLDSLPSRPRKPLDELL-PKASDDALDLLKKLLVFNPNKRLTAE 290

Query: 233 EALIHPFFDELRDP 246
           EAL HP+  +  +P
Sbjct: 291 EALEHPYVAQFHNP 304

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  205 bits (523), Expect = 2e-65
 Identities = 87/241 (36%), Positives = 127/241 (52%), Gaps = 38/241 (15%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           ++ L HPN+V L   F    ++D+LYL  V+EY     +  ++K   ++S+       + 
Sbjct: 51  LKKLKHPNIVRLYDVF---EDEDKLYL--VMEYCEGGDLFDLLKKRGRLSEDE----ARF 101

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           Y  QI  AL Y+H+  G+ HRD+KP+N+L++   H +KL DFG A+ L  GE   +++ +
Sbjct: 102 YLRQILSALEYLHS-KGIVHRDLKPENILLDEDGH-VKLADFGLARQLDPGEKLTTFVGT 159

Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
             Y APE++ G   Y  A+DIWS G +L ELL G+P FPG+   DQL+E+ K +G P   
Sbjct: 160 PEYMAPEVLLG-KGYGKAVDIWSLGVILYELLTGKPPFPGD---DQLLELFKKIGKPKPP 215

Query: 180 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
                                        + PEA DL+ +LL   P  R TA EAL HPF
Sbjct: 216 FPPPEWD----------------------ISPEAKDLIRKLLVKDPEKRLTAEEALQHPF 253

Query: 240 F 240
           F
Sbjct: 254 F 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  205 bits (524), Expect = 3e-65
 Identities = 94/245 (38%), Positives = 138/245 (56%), Gaps = 15/245 (6%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           +R L H N+V+LK  F     K  LYL  V EYV  T+  +++        +P   V+ Y
Sbjct: 54  LRQLRHENIVNLKEAFRR---KGRLYL--VFEYVERTLLELLE---ASPGGLPPDAVRSY 105

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEPNISYIC 118
            +Q+ +A+AY H+   + HRDIKP+N+LV+     LKLCDFG A+ L      P   Y+ 
Sbjct: 106 IWQLLQAIAYCHSH-NIIHRDIKPENILVSESG-VLKLCDFGFARALRARPASPLTDYVA 163

Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG--TP 176
           +R+YRAPEL+ G T Y   +D+W+ GC++AELL G+PLFPG+S +DQL  I K LG   P
Sbjct: 164 TRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPP 223

Query: 177 TREEIKCMNPNYTEFKFPQIKA-HPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 235
           + +E+   NP +    FP+        + +  ++   A+D +   L+  P  R T  E L
Sbjct: 224 SHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELL 283

Query: 236 IHPFF 240
            HP+F
Sbjct: 284 QHPYF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  202 bits (517), Expect = 5e-64
 Identities = 98/245 (40%), Positives = 134/245 (54%), Gaps = 20/245 (8%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ L HPN++ L   F     K    +NLV E++   + +VIK     S  +    +K Y
Sbjct: 56  LQELKHPNIIGLLDVF---GHKS--NINLVFEFMETDLEKVIK---DKSIVLTPADIKSY 107

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-- 118
                R L Y+H+   + HRD+KP NLL+      LKL DFG A+    G PN       
Sbjct: 108 MLMTLRGLEYLHSN-WILHRDLKPNNLLIASDG-VLKLADFGLARSF--GSPNRKMTHQV 163

Query: 119 -SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +R+YRAPEL+FGA  Y   +D+WS GC+ AELLL  P  PG+S +DQL +I + LGTPT
Sbjct: 164 VTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPT 223

Query: 178 REEIKCMN--PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 235
            E    +   P+Y EFK       P  +IF      +A+DL+ RLL  +PN R TA +AL
Sbjct: 224 EENWPGVTSLPDYVEFKP--FPPTPLKQIF-PAASDDALDLLQRLLTLNPNKRITARQAL 280

Query: 236 IHPFF 240
            HP+F
Sbjct: 281 EHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  200 bits (512), Expect = 1e-63
 Identities = 79/241 (32%), Positives = 117/241 (48%), Gaps = 33/241 (13%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           +R L HPN+V L   F    +KD LYL  V+EY           +      +     K  
Sbjct: 52  LRRLSHPNIVRLIDAF---EDKDHLYL--VMEYCEGGDL---FDYLSRGGPLSEDEAKKI 103

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-GEPNISYICS 119
             QI R L Y+H+  G+ HRD+KP+N+L++     +K+ DFG AK L+K      +++ +
Sbjct: 104 ALQILRGLEYLHS-NGIIHRDLKPENILLD-ENGVVKIADFGLAKKLLKSSSSLTTFVGT 161

Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
            +Y APE++ G   Y   +D+WS G +L ELL G+P F GE+ +DQL  I ++LG P   
Sbjct: 162 PWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEF 221

Query: 180 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
           +    +                          EA DL+ + L   P+ R TA E L HP+
Sbjct: 222 DEPKWSS----------------------GSEEAKDLIKKCLNKDPSKRPTAEEILQHPW 259

Query: 240 F 240
           F
Sbjct: 260 F 260

Length = 260

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  200 bits (511), Expect = 3e-63
 Identities = 94/244 (38%), Positives = 144/244 (59%), Gaps = 16/244 (6%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
            +L +HPN+V LK  F    E DELY   V EY+   +++++K      +      ++  
Sbjct: 52  RKLNEHPNIVKLKEVF---RENDELYF--VFEYMEGNLYQLMKDRKG--KPFSESVIRSI 104

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
            YQI + LA+IH   G  HRD+KP+NLLV+     +K+ DFG A+ +    P   Y+ +R
Sbjct: 105 IYQILQGLAHIHKH-GFFHRDLKPENLLVSGPE-VVKIADFGLAREIRSRPPYTDYVSTR 162

Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 180
           +YRAPE++  +T Y++ +DIW+ GC++AEL   +PLFPG S +DQL +I  VLGTPT+++
Sbjct: 163 WYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQD 222

Query: 181 ----IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 236
                K  +     F+FPQ      H++      PEA+DL+  +L++ P  R TA +AL 
Sbjct: 223 WPEGYKLASK--LGFRFPQFAPTSLHQLIP-NASPEAIDLIKDMLRWDPKKRPTASQALQ 279

Query: 237 HPFF 240
           HP+F
Sbjct: 280 HPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  193 bits (492), Expect = 3e-60
 Identities = 82/245 (33%), Positives = 131/245 (53%), Gaps = 16/245 (6%)

Query: 2   RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHH-YKMSQRMPLIYVKLY 60
           + L HPN+V LK      T K +  + +V EY+   +  ++     K ++      +K Y
Sbjct: 53  QKLRHPNIVRLKEI---VTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTES----QIKCY 105

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI--SYIC 118
             Q+   L Y+H+  G+ HRDIK  N+L+N     LKL DFG A+   K       + + 
Sbjct: 106 MKQLLEGLQYLHS-NGILHRDIKGSNILINNDGV-LKLADFGLARPYTKRNSADYTNRVI 163

Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 178
           + +YR PEL+ GAT Y   +D+WS GC+LAEL LG+P+F G + ++QL +I ++ G+PT 
Sbjct: 164 TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTD 223

Query: 179 E---EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 235
           E    +  + P +   K  +       + F+  + P A+DL+ +LL   P  R +A +AL
Sbjct: 224 ENWPGVSKL-PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQAL 282

Query: 236 IHPFF 240
            H +F
Sbjct: 283 QHEYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  191 bits (487), Expect = 4e-59
 Identities = 92/260 (35%), Positives = 154/260 (59%), Gaps = 24/260 (9%)

Query: 1   MRLL---DHPNVVSLKHCFFSTT--EKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 55
           +++L    H N++ +       +    +++Y+  V E +   ++++IK     +Q +   
Sbjct: 54  IKILRRFKHENIIGILDIIRPPSFESFNDVYI--VQELMETDLYKLIK-----TQHLSND 106

Query: 56  YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS 115
           +++ + YQI R L YIH+   V HRD+KP NLL+N     LK+CDFG A++      +  
Sbjct: 107 HIQYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLN-TNCDLKICDFGLARIADPEHDHTG 164

Query: 116 ----YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 171
               Y+ +R+YRAPE++  +  YT AIDIWS GC+LAE+L  +PLFPG+  + QL  I+ 
Sbjct: 165 FLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILG 224

Query: 172 VLGTPTREEIKCM-NP---NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL 227
           VLGTP++E++ C+ +    NY +   P     PW+K+F     P+A+DL+ ++L ++P+ 
Sbjct: 225 VLGTPSQEDLNCIISLRARNYIK-SLPFKPKVPWNKLFPN-ADPKALDLLDKMLTFNPHK 282

Query: 228 RSTALEALIHPFFDELRDPN 247
           R T  EAL HP+ ++  DP+
Sbjct: 283 RITVEEALAHPYLEQYHDPS 302

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  190 bits (484), Expect = 1e-58
 Identities = 92/255 (36%), Positives = 141/255 (55%), Gaps = 18/255 (7%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           +R   H N+++++         D   + +V++ +   +H +I       Q +   +++ +
Sbjct: 58  LRHFKHDNIIAIRD-ILRPPGADFKDVYVVMDLMESDLHHIIHS----DQPLTEEHIRYF 112

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-----IS 115
            YQ+ R L YIH+   V HRD+KP NLLVN     L++ DFG A+ L             
Sbjct: 113 LYQLLRGLKYIHSA-NVIHRDLKPSNLLVNEDCE-LRIGDFGMARGLSSSPTEHKYFMTE 170

Query: 116 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
           Y+ +R+YRAPEL+    EYT AID+WS GC+ AE+L  + LFPG++ V QL  I+ VLG+
Sbjct: 171 YVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGS 230

Query: 176 PTREEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 231
           P+ E +  +       Y +   P+ +  PW KIF K   PEA+DL+S++LQ+ P  R T 
Sbjct: 231 PSEEVLNRIGSDRVRKYIQ-NLPRKQPVPWSKIFPKA-SPEALDLLSQMLQFDPEERITV 288

Query: 232 LEALIHPFFDELRDP 246
            +AL HPF  +  DP
Sbjct: 289 EQALQHPFLAQYHDP 303

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  186 bits (475), Expect = 3e-57
 Identities = 89/255 (34%), Positives = 141/255 (55%), Gaps = 19/255 (7%)

Query: 1   MRLL---DHPNVVSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIY 56
           +RLL   DH NV+ L   F   +  ++   + LV   +   ++ ++K      Q++   +
Sbjct: 65  LRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVK-----CQKLSDDH 119

Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
           ++   YQI R L YIH+  G+ HRD+KP N+ VN    +LK+ DFG A+     +    Y
Sbjct: 120 IQFLVYQILRGLKYIHSA-GIIHRDLKPSNIAVNEDC-ELKILDFGLARH--TDDEMTGY 175

Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
           + +R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I+ ++GTP
Sbjct: 176 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTP 235

Query: 177 TREEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAL 232
             E ++ ++     NY +   PQ+    + ++F     P A+DL+ ++L   P+ R TA 
Sbjct: 236 DEELLQKISSESARNYIQ-SLPQMPKKDFKEVFS-GANPLAIDLLEKMLVLDPDKRITAA 293

Query: 233 EALIHPFFDELRDPN 247
           EAL HP+  E  DP 
Sbjct: 294 EALAHPYLAEYHDPE 308

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  184 bits (470), Expect = 2e-56
 Identities = 99/283 (34%), Positives = 156/283 (55%), Gaps = 16/283 (5%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           +R LDH NV+++K        +    + +V E +   +H++I+     SQ +   + + +
Sbjct: 58  LRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRS----SQTLSDDHCQYF 113

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNISYICS 119
            YQ+ R L YIH+   V HRD+KP NLL+N +   LK+CDFG A+    KG+    Y+ +
Sbjct: 114 LYQLLRGLKYIHSA-NVLHRDLKPSNLLLNANC-DLKICDFGLARTTSEKGDFMTEYVVT 171

Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
           R+YRAPEL+   +EYT AID+WS GC+ AELL  +PLFPG+  V QL  I ++LG+P+ E
Sbjct: 172 RWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEE 231

Query: 180 EIKCM-NPNYTEF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 236
           ++  + N     +    P      + ++F     P A+DL+ ++L + P+ R T  EAL 
Sbjct: 232 DLGFIRNEKARRYIRSLPYTPRQSFARLF-PHANPLAIDLLEKMLVFDPSKRITVEEALA 290

Query: 237 HPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI 279
           HP+   L DP+         P  F+F+   L     + + +LI
Sbjct: 291 HPYLASLHDPSDEPVCQT--PFSFDFEEDALTE---EDIKELI 328

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  182 bits (465), Expect = 2e-56
 Identities = 86/243 (35%), Positives = 134/243 (55%), Gaps = 20/243 (8%)

Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 63
           L+HPN+V L     S     E  L LV E++   + + +         +    +K Y YQ
Sbjct: 55  LNHPNIVRLLDVVHS-----ENKLYLVFEFLDLDLKKYMDSSPLTG--LDPPLIKSYLYQ 107

Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSR 120
           + + +AY H +  V HRD+KPQNLL++     LKL DFG A+    G P  +Y   + + 
Sbjct: 108 LLQGIAYCH-SHRVLHRDLKPQNLLID-REGALKLADFGLARAF--GVPVRTYTHEVVTL 163

Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE- 179
           +YRAPE++ G+ +Y+  +DIWS GC+ AE++  +PLFPG+S +DQL  I + LGTP  + 
Sbjct: 164 WYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDV 223

Query: 180 --EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 237
              +  + P+Y    FP+       K+    +  + +DL+S++L Y P  R +A  AL H
Sbjct: 224 WPGVTSL-PDYKP-TFPKWARQDLSKVVP-NLDEDGLDLLSKMLVYDPAKRISAKAALQH 280

Query: 238 PFF 240
           P+F
Sbjct: 281 PYF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  175 bits (445), Expect = 2e-53
 Identities = 89/242 (36%), Positives = 127/242 (52%), Gaps = 15/242 (6%)

Query: 2   RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIK--HHYKMSQRMPLIYVKL 59
           RL  HPN++ L    F         L LV E +   ++ +IK        +R     VK 
Sbjct: 53  RLSPHPNILRLIEVLFDRKTGR---LALVFELMDMNLYELIKGRKRPLPEKR-----VKS 104

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           Y YQ+ ++L ++H   G+ HRDIKP+N+L+      LKL DFGS + +    P   YI +
Sbjct: 105 YMYQLLKSLDHMHR-NGIFHRDIKPENILIKDDI--LKLADFGSCRGIYSKPPYTEYIST 161

Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
           R+YRAPE +     Y   +DIW+ GCV  E+L   PLFPG + +DQ+ +I  VLGTP  E
Sbjct: 162 RWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAE 221

Query: 180 EIKCMNP-NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 238
            +K      +  + FP  K     K+       E +DL+ +LL Y P+ R TA +AL HP
Sbjct: 222 VLKKFRKSRHMNYNFPSKKGTGLRKLLPN-ASAEGLDLLKKLLAYDPDERITAKQALRHP 280

Query: 239 FF 240
           +F
Sbjct: 281 YF 282

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  175 bits (445), Expect = 7e-53
 Identities = 92/250 (36%), Positives = 147/250 (58%), Gaps = 19/250 (7%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ L H N++SL   F S  E  ++Y   V E +   +HR++      S+ +   +++ +
Sbjct: 63  LKHLRHENIISLSDIFISPLE--DIYF--VTELLGTDLHRLLT-----SRPLEKQFIQYF 113

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-YICS 119
            YQI R L Y+H+  GV HRD+KP N+L+N +   LK+CDFG A++    +P ++ Y+ +
Sbjct: 114 LYQILRGLKYVHSA-GVVHRDLKPSNILINENC-DLKICDFGLARI---QDPQMTGYVST 168

Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
           RYYRAPE++    +Y   +DIWSAGC+ AE+L G+PLFPG+  V+Q   I  +LGTP  +
Sbjct: 169 RYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDD 228

Query: 180 EIKCM-NPNYTEF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 236
            I  + + N   F    P+ +  P+ + F+    P A+DL+ ++L + P  R +A EAL 
Sbjct: 229 VINTICSENTLRFVQSLPKREPVPFSEKFKN-ADPSAIDLLEKMLVFDPQKRISAAEALA 287

Query: 237 HPFFDELRDP 246
           HP+     DP
Sbjct: 288 HPYLAPYHDP 297

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  173 bits (440), Expect = 1e-52
 Identities = 94/247 (38%), Positives = 140/247 (56%), Gaps = 24/247 (9%)

Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 63
           L HPN+V++K     +   D++Y+  V+EYV   +  +++    M Q      VK    Q
Sbjct: 61  LQHPNIVTVKEVVVGSNL-DKIYM--VMEYVEHDLKSLMET---MKQPFLQSEVKCLMLQ 114

Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSR 120
           +   +A++H+   + HRD+K  NLL+N +   LK+CDFG A+    G P   Y   + + 
Sbjct: 115 LLSGVAHLHDN-WILHRDLKTSNLLLN-NRGILKICDFGLAREY--GSPLKPYTQLVVTL 170

Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 180
           +YRAPEL+ GA EY+ AID+WS GC+ AELL  +PLFPG+S +DQL +I K+LGTPT + 
Sbjct: 171 WYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKI 230

Query: 181 IKCMNPNYTEFKFPQIKAHPWHKIFQ--KRMPP-----EAVDLVSRLLQYSPNLRSTALE 233
                P ++E    + K    +   Q  K+ P         DL++RLL Y P  R +A +
Sbjct: 231 W----PGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAED 286

Query: 234 ALIHPFF 240
           AL HP+F
Sbjct: 287 ALKHPYF 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  171 bits (436), Expect = 5e-52
 Identities = 93/249 (37%), Positives = 140/249 (56%), Gaps = 25/249 (10%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHH-----YKMSQRMPLI 55
           ++ L H N+V+L   F     K  LYL  V E+V  TV   ++ +         ++    
Sbjct: 54  LKQLRHENLVNLIEVF---RRKKRLYL--VFEFVDHTVLDDLEKYPNGLDESRVRK---- 104

Query: 56  YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-GEPNI 114
               Y +QI R + + H+   + HRDIKP+N+LV+  +  +KLCDFG A+ L   GE   
Sbjct: 105 ----YLFQILRGIEFCHSH-NIIHRDIKPENILVSQ-SGVVKLCDFGFARTLAAPGEVYT 158

Query: 115 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 174
            Y+ +R+YRAPEL+ G T+Y  A+DIW+ GC++ E+L G+PLFPG+S +DQL  IIK LG
Sbjct: 159 DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLG 218

Query: 175 T--PTREEIKCMNPNYTEFKFPQIK-AHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 231
              P  +EI   NP +   + P++K   P  K F K +    +DL  + L+  P+ R ++
Sbjct: 219 NLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPK-LSGLVLDLAKQCLRIDPDDRPSS 277

Query: 232 LEALIHPFF 240
            + L H FF
Sbjct: 278 SQLLHHEFF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  172 bits (439), Expect = 6e-52
 Identities = 92/251 (36%), Positives = 132/251 (52%), Gaps = 18/251 (7%)

Query: 6   HPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQI 64
           H N+  L           +ELYL    E +   +H++I+      Q +   + + + YQI
Sbjct: 61  HKNITCLYDMDIVFPGNFNELYL--YEELMEADLHQIIRS----GQPLTDAHFQSFIYQI 114

Query: 65  CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK----VLVKGEPNIS-YICS 119
              L YIH+   V HRD+KP NLLVN    +LK+CDFG A+       +    ++ Y+ +
Sbjct: 115 LCGLKYIHSA-NVLHRDLKPGNLLVNADC-ELKICDFGLARGFSENPGENAGFMTEYVAT 172

Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
           R+YRAPE++     YT AID+WS GC+LAELL  +P+F G+  VDQL +I++VLGTP  E
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232

Query: 180 ---EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 236
               I            P I   P+  IF     P A+DL+ +LL + P  R +  EAL 
Sbjct: 233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPN-ANPLALDLLEKLLAFDPTKRISVEEALE 291

Query: 237 HPFFDELRDPN 247
           HP+     DP+
Sbjct: 292 HPYLAIWHDPD 302

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  170 bits (432), Expect = 2e-51
 Identities = 88/244 (36%), Positives = 133/244 (54%), Gaps = 19/244 (7%)

Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 63
           L H N+V+L H    T +     L LV EY+   + + +         + +  V+L+ +Q
Sbjct: 60  LKHANIVTL-HDIIHTKKT----LTLVFEYLDTDLKQYMDDC---GGGLSMHNVRLFLFQ 111

Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSR 120
           + R LAY H    V HRD+KPQNLL++    +LKL DFG A+   K  P+ +Y   + + 
Sbjct: 112 LLRGLAYCHQR-RVLHRDLKPQNLLIS-ERGELKLADFGLARA--KSVPSKTYSNEVVTL 167

Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV-DQLVEIIKVLGTPTRE 179
           +YR P+++ G+TEY+ ++D+W  GC+  E+  G+PLFPG + V DQL +I +VLGTPT E
Sbjct: 168 WYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEE 227

Query: 180 EIK--CMNPNYTEFKFPQIKAHPWHKIFQK-RMPPEAVDLVSRLLQYSPNLRSTALEALI 236
                  NP +  + FP     P      +    P   +L  + LQY P  R +A EA+ 
Sbjct: 228 TWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287

Query: 237 HPFF 240
           HP+F
Sbjct: 288 HPYF 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  169 bits (431), Expect = 3e-51
 Identities = 86/228 (37%), Positives = 129/228 (56%), Gaps = 18/228 (7%)

Query: 22  KDELYLNLVLEYVPETVHRVIKHHYKMSQR-MPLIYVKLYFYQICRALAYIHNTIGVCHR 80
           K  LYL  V EY+   + + +  + +   R +P   +K + YQ+ + +A+ H   GV HR
Sbjct: 78  KPSLYL--VFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK-HGVMHR 134

Query: 81  DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEYTAA 137
           D+KPQNLLV+     LK+ D G  +      P  SY   I + +YRAPE++ G+T Y+  
Sbjct: 135 DLKPQNLLVDKQKGLLKIADLGLGRAFSI--PVKSYTHEIVTLWYRAPEVLLGSTHYSTP 192

Query: 138 IDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK----F 193
           +DIWS GC+ AE+   QPLFPG+S + QL+ I K+LGTPT +      P  ++ +    F
Sbjct: 193 VDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW----PGVSKLRDWHEF 248

Query: 194 PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFD 241
           PQ K     +     + PE +DL+ ++L+Y P  R +A  AL HP+FD
Sbjct: 249 PQWKPQDLSRAVPD-LSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score =  170 bits (433), Expect = 4e-51
 Identities = 100/253 (39%), Positives = 146/253 (57%), Gaps = 19/253 (7%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           +RLL HP++V +KH     + ++   + +V E +   +H+VIK +  ++      + + +
Sbjct: 53  LRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPE----HHQFF 108

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN----ISY 116
            YQ+ RAL YIH T  V HRD+KP+N+L N    +LK+CDFG A+V     P       Y
Sbjct: 109 LYQLLRALKYIH-TANVFHRDLKPKNILANADC-KLKICDFGLARVAFNDTPTAIFWTDY 166

Query: 117 ICSRYYRAPELIFGA--TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 174
           + +R+YRAPEL  G+  ++YT AIDIWS GC+ AE+L G+PLFPG++ V QL  I  +LG
Sbjct: 167 VATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLG 225

Query: 175 TPTREEI-KCMNPNYTEFKFPQIKAHPWHKIFQKRMP---PEAVDLVSRLLQYSPNLRST 230
           TP+ E I +  N     +     K  P    F ++ P   P A+ L+ RLL + P  R T
Sbjct: 226 TPSPETISRVRNEKARRYLSSMRKKQP--VPFSQKFPNADPLALRLLERLLAFDPKDRPT 283

Query: 231 ALEALIHPFFDEL 243
           A EAL  P+F  L
Sbjct: 284 AEEALADPYFKGL 296

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  169 bits (429), Expect = 4e-51
 Identities = 91/245 (37%), Positives = 143/245 (58%), Gaps = 17/245 (6%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M+ L H N+V L H    T  K    L LV EY+ + + + +  H  +   +    VK +
Sbjct: 52  MKELKHENIVRL-HDVIHTENK----LMLVFEYMDKDLKKYMDTH-GVRGALDPNTVKSF 105

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---I 117
            YQ+ + +A+ H    V HRD+KPQNLL+N    +LKL DFG A+    G P  ++   +
Sbjct: 106 TYQLLKGIAFCHEN-RVLHRDLKPQNLLINKRG-ELKLADFGLARAF--GIPVNTFSNEV 161

Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            + +YRAP+++ G+  Y+ +IDIWS GC++AE++ G+PLFPG +  DQL++I +++GTPT
Sbjct: 162 VTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPT 221

Query: 178 REEIKCMN--PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 235
                 ++  P Y +  FP+       ++F     P  +DL+ RLLQ +P LR +A +AL
Sbjct: 222 ESTWPGISQLPEY-KPTFPRYPPQDLQQLF-PHADPLGIDLLHRLLQLNPELRISAHDAL 279

Query: 236 IHPFF 240
            HP+F
Sbjct: 280 QHPWF 284

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  159 bits (404), Expect = 3e-47
 Identities = 88/246 (35%), Positives = 134/246 (54%), Gaps = 19/246 (7%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ L HPN+V+L   F     + +  L+LV EY   TV   ++ +    + +P   +K  
Sbjct: 54  LKQLKHPNLVNLIEVF-----RRKRKLHLVFEYCDHTVLNELEKN---PRGVPEHLIKKI 105

Query: 61  FYQICRALAYIH--NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-YI 117
            +Q  +A+ + H  N I   HRD+KP+N+L+     Q+KLCDFG A++L     + + Y+
Sbjct: 106 IWQTLQAVNFCHKHNCI---HRDVKPENILITKQ-GQIKLCDFGFARILTGPGDDYTDYV 161

Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG--T 175
            +R+YRAPEL+ G T+Y   +D+W+ GCV AELL GQPL+PG+S VDQL  I K LG   
Sbjct: 162 ATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLI 221

Query: 176 PTREEIKCMNPNYTEFKFPQIKA-HPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 234
           P  ++I   N  +     P+ +   P    F   +   A+  +   LQ  P  R +  E 
Sbjct: 222 PRHQQIFSTNQFFKGLSIPEPETREPLESKFPN-ISSPALSFLKGCLQMDPTERLSCEEL 280

Query: 235 LIHPFF 240
           L HP+F
Sbjct: 281 LEHPYF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  158 bits (401), Expect = 7e-47
 Identities = 91/247 (36%), Positives = 139/247 (56%), Gaps = 17/247 (6%)

Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 63
           + H N+V L+    S     E  L LV EY+   + + +      ++   LI  K Y YQ
Sbjct: 58  MQHGNIVRLQDVVHS-----EKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLI--KTYLYQ 110

Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSR 120
           I R +AY H+   V HRD+KPQNLL++  T+ LKL DFG A+    G P  ++   + + 
Sbjct: 111 ILRGIAYCHSH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAF--GIPVRTFTHEVVTL 167

Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 180
           +YRAPE++ G+  Y+  +DIWS GC+ AE++  +PLFPG+S +D+L +I ++LGTP  E 
Sbjct: 168 WYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEET 227

Query: 181 IKCMN--PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 238
              +   P+Y    FP+        +    + P  VDL+S++L+  P+ R TA  AL H 
Sbjct: 228 WPGVTSLPDYKS-AFPKWPPKDLATVVPT-LEPAGVDLLSKMLRLDPSKRITARAALEHE 285

Query: 239 FFDELRD 245
           +F +L D
Sbjct: 286 YFKDLGD 292

Length = 294

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  158 bits (403), Expect = 9e-47
 Identities = 99/268 (36%), Positives = 135/268 (50%), Gaps = 37/268 (13%)

Query: 2   RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHY-KMSQRMPLIYVKLY 60
           R L H NVVSL   F    +K  +YL  + +Y    + ++IK H       +P   VK  
Sbjct: 57  RELKHENVVSLVEVFLEHADK-SVYL--LFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSL 113

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSA-------KVLVKG 110
            +QI   + Y+H+   V HRD+KP N+LV    P    +K+ D G A       K L   
Sbjct: 114 LWQILNGVHYLHSNW-VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADL 172

Query: 111 EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG-------- 162
           +P +  I   +YRAPEL+ GA  YT AIDIW+ GC+ AELL  +P+F G           
Sbjct: 173 DPVVVTI---WYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPF 229

Query: 163 -VDQLVEIIKVLGTPTREE---IKCMNPNY----TEFKFPQIKAHPWHKIFQKRMP--PE 212
             DQL  I +VLGTPT ++   IK M P Y     +FK     ++   K  +K      +
Sbjct: 230 QRDQLERIFEVLGTPTEKDWPDIKKM-PEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQ 288

Query: 213 AVDLVSRLLQYSPNLRSTALEALIHPFF 240
             DL+ +LL+Y P  R TA EAL HP+F
Sbjct: 289 GFDLLRKLLEYDPTKRITAEEALEHPYF 316

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  159 bits (403), Expect = 1e-46
 Identities = 91/255 (35%), Positives = 139/255 (54%), Gaps = 19/255 (7%)

Query: 1   MRLLDH---PNVVSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIY 56
           +RLL H    NV+ L   F      D  +   LV+ ++   + +++KH      R     
Sbjct: 65  LRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDR----- 119

Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
           ++   YQ+ + L YIH   G+ HRD+KP NL VN    +LK+ DFG A+          Y
Sbjct: 120 IQFLVYQMLKGLKYIHAA-GIIHRDLKPGNLAVNEDC-ELKILDFGLARQ--TDSEMTGY 175

Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
           + +R+YRAPE+I     YT  +DIWS GC++AE+L G+PLF G   +DQL+EI+KV GTP
Sbjct: 176 VVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTP 235

Query: 177 TREEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAL 232
           ++E ++ +      NY + K P+ +   +  +      P AV+++ ++L      R TA 
Sbjct: 236 SKEFVQKLQSEDAKNYVK-KLPRFRKKDFRSLL-PNANPLAVNVLEKMLVLDAESRITAA 293

Query: 233 EALIHPFFDELRDPN 247
           EAL HP+F+E  DP 
Sbjct: 294 EALAHPYFEEFHDPE 308

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  157 bits (398), Expect = 2e-46
 Identities = 81/247 (32%), Positives = 132/247 (53%), Gaps = 29/247 (11%)

Query: 5   DHPNVVSLKH-CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 63
           +HPN+V L   C    T++ EL L LV E+V + +   +    K    +P   +K    Q
Sbjct: 59  EHPNIVRLLDVCHGPRTDR-ELKLTLVFEHVDQDLATYLSKCPKPG--LPPETIKDLMRQ 115

Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 123
           + R + ++H +  + HRD+KPQN+LV     Q+K+ DFG A++        S + + +YR
Sbjct: 116 LLRGVDFLH-SHRIVHRDLKPQNILVT-SDGQVKIADFGLARIYSFEMALTSVVVTLWYR 173

Query: 124 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 183
           APE++  ++ Y   +D+WS GC+ AEL   +PLF G S  DQL +I  V+G P+ EE   
Sbjct: 174 APEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE--- 229

Query: 184 MNPNYTEFKFPQIKAHPWH-------KIFQKRMP---PEAVDLVSRLLQYSPNLRSTALE 233
                    +P+  + P         + F+  +P    E +DL+ ++L ++P+ R +A E
Sbjct: 230 ---------WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFE 280

Query: 234 ALIHPFF 240
           AL HP+F
Sbjct: 281 ALQHPYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  158 bits (401), Expect = 3e-46
 Identities = 87/253 (34%), Positives = 139/253 (54%), Gaps = 19/253 (7%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL 59
           ++ + H NV+ L   F S    DE     LV+ Y+   + +++ H     +      V+ 
Sbjct: 68  LKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDK------VQY 121

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-YIC 118
             YQ+   L YIH+  G+ HRD+KP NL VN    +LK+ DFG A+     +  ++ Y+ 
Sbjct: 122 LVYQMLCGLKYIHSA-GIIHRDLKPGNLAVNEDC-ELKILDFGLAR---HADAEMTGYVV 176

Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 178
           +R+YRAPE+I     Y   +DIWS GC++AE+L G+ LF G+  +DQL +I+KV G P  
Sbjct: 177 TRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGP 236

Query: 179 EEIKCMN----PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 234
           E ++ +      +Y +   P+     +  +F  +  P+AVDL+ ++L+   + R TA EA
Sbjct: 237 EFVQKLEDKAAKSYIK-SLPKYPRKDFSTLF-PKASPQAVDLLEKMLELDVDKRLTATEA 294

Query: 235 LIHPFFDELRDPN 247
           L HP+FD  RD +
Sbjct: 295 LEHPYFDSFRDAD 307

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  157 bits (398), Expect = 9e-46
 Identities = 79/266 (29%), Positives = 140/266 (52%), Gaps = 44/266 (16%)

Query: 1   MRLLDHPNVVSLKHCFFST-----------TEKDELYLNLVLEYVPETVHRVIKHHYKMS 49
           +R LDH N+V +      +           TE + +Y+  V EY+   +  V++      
Sbjct: 56  IRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYI--VQEYMETDLANVLEQ----- 108

Query: 50  QRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 109
             +   + +L+ YQ+ R L YIH+   V HRD+KP N+ +N     LK+ DFG A+++  
Sbjct: 109 GPLSEEHARLFMYQLLRGLKYIHSA-NVLHRDLKPANVFINTEDLVLKIGDFGLARIV-- 165

Query: 110 GEPNISY-------ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG 162
            +P+ S+       + +++YR+P L+     YT AID+W+AGC+ AE+L G+PLF G   
Sbjct: 166 -DPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHE 224

Query: 163 VDQL---VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPW--HKIFQKRMP---PEAV 214
           ++Q+   +E + V+    R E+  + P++       ++       +  +  +P   PEA+
Sbjct: 225 LEQMQLILESVPVVREEDRNELLNVIPSF-------VRNDGGEPRRPLRDLLPGVNPEAL 277

Query: 215 DLVSRLLQYSPNLRSTALEALIHPFF 240
           D + ++L ++P  R TA EAL+HP+ 
Sbjct: 278 DFLEQILTFNPMDRLTAEEALMHPYM 303

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  154 bits (392), Expect = 2e-45
 Identities = 94/253 (37%), Positives = 140/253 (55%), Gaps = 34/253 (13%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR--MPLIYVK 58
           ++ L+HPN+V L     +   +++LYL  V E++    H+ +K     S    +PL  +K
Sbjct: 53  LKELNHPNIVKLLDVIHT---ENKLYL--VFEFL----HQDLKKFMDASPLSGIPLPLIK 103

Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-- 116
            Y +Q+ + LA+ H+   V HRD+KPQNLL+N     +KL DFG A+    G P  +Y  
Sbjct: 104 SYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEGA-IKLADFGLARAF--GVPVRTYTH 159

Query: 117 -ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
            + + +YRAPE++ G   Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGT
Sbjct: 160 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT 219

Query: 176 PTREEIKCMNPNYTEFK-----FPQIKAHPWHKIFQKRMPP---EAVDLVSRLLQYSPNL 227
           P       + P  T        FP+         F K +PP   +  DL+S++L Y PN 
Sbjct: 220 PDEV----VWPGVTSLPDYKPSFPKWARQD----FSKVVPPLDEDGRDLLSQMLHYDPNK 271

Query: 228 RSTALEALIHPFF 240
           R +A  AL HPFF
Sbjct: 272 RISAKAALAHPFF 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  152 bits (385), Expect = 2e-44
 Identities = 93/247 (37%), Positives = 142/247 (57%), Gaps = 19/247 (7%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ L H N+V L H    T E     L  V EY+   + + +  H      +    V+L+
Sbjct: 57  LKGLKHANIVLL-HDIIHTKET----LTFVFEYMHTDLAQYMIQH---PGGLHPYNVRLF 108

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---I 117
            +Q+ R LAYIH    + HRD+KPQNLL++ +  +LKL DFG A+   K  P+ +Y   +
Sbjct: 109 MFQLLRGLAYIHGQ-HILHRDLKPQNLLIS-YLGELKLADFGLARA--KSIPSQTYSSEV 164

Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV-DQLVEIIKVLGTP 176
            + +YR P+++ GAT+Y++A+DIW AGC+  E+L GQP FPG S V +QL +I  VLG P
Sbjct: 165 VTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVP 224

Query: 177 TREEIKCMN--PNYTEFKFPQIKAHPWHKIFQK-RMPPEAVDLVSRLLQYSPNLRSTALE 233
           T +    ++  PNY    F   K      ++++   PP+A DL S++L   P  R +A +
Sbjct: 225 TEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQD 284

Query: 234 ALIHPFF 240
           AL+HP+F
Sbjct: 285 ALLHPYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score =  154 bits (390), Expect = 2e-44
 Identities = 81/203 (39%), Positives = 116/203 (57%), Gaps = 13/203 (6%)

Query: 50  QRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 109
           Q +   +VK++ YQI R L Y+H + G+ HRDIKP NLLVN +   LK+CDFG A+V   
Sbjct: 98  QPLSSDHVKVFLYQILRGLKYLH-SAGILHRDIKPGNLLVNSNC-VLKICDFGLARV--- 152

Query: 110 GEPNISY-----ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD 164
            EP+ S      + ++YYRAPE++ G+  YT+A+DIWS GC+ AELL  + LF  +S + 
Sbjct: 153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ 212

Query: 165 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPP---EAVDLVSRLL 221
           QL  I  +LGTP+ E ++                 P   +          EAV L+ R+L
Sbjct: 213 QLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRML 272

Query: 222 QYSPNLRSTALEALIHPFFDELR 244
            + P+ R +A +AL HP+ DE R
Sbjct: 273 VFDPDKRISAADALAHPYLDEGR 295

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  151 bits (383), Expect = 3e-44
 Identities = 84/242 (34%), Positives = 133/242 (54%), Gaps = 17/242 (7%)

Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 63
           L HPN+V L+       ++  LYL  + E++   + + +       Q M    VK Y YQ
Sbjct: 56  LQHPNIVCLQDVLM---QESRLYL--IFEFLSMDLKKYLDS-LPKGQYMDAELVKSYLYQ 109

Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSR 120
           I + + + H+   V HRD+KPQNLL++ +   +KL DFG A+    G P   Y   + + 
Sbjct: 110 ILQGILFCHSR-RVLHRDLKPQNLLID-NKGVIKLADFGLARAF--GIPVRVYTHEVVTL 165

Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 180
           +YRAPE++ G+  Y+  +DIWS G + AE+   +PLF G+S +DQL  I ++LGTPT + 
Sbjct: 166 WYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDV 225

Query: 181 IKCMN--PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 238
              +   P+Y    FP+ K     +   K +  + +DL+ ++L Y P  R +A +AL HP
Sbjct: 226 WPGVTSLPDYKN-TFPKWKK-GSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHP 283

Query: 239 FF 240
           +F
Sbjct: 284 YF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  150 bits (381), Expect = 7e-44
 Identities = 88/247 (35%), Positives = 134/247 (54%), Gaps = 22/247 (8%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ L H N+V L     S  +     L LV EY  + +    K+    +  +    VK +
Sbjct: 53  LKELKHKNIVRLYDVLHSDKK-----LTLVFEYCDQDLK---KYFDSCNGDIDPEIVKSF 104

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---I 117
            +Q+ + LA+ H+   V HRD+KPQNLL+N +  +LKL DFG A+    G P   Y   +
Sbjct: 105 MFQLLKGLAFCHSH-NVLHRDLKPQNLLINKNG-ELKLADFGLARAF--GIPVRCYSAEV 160

Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTP 176
            + +YR P+++FGA  Y+ +ID+WSAGC+ AEL   G+PLFPG    DQL  I ++LGTP
Sbjct: 161 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP 220

Query: 177 TREEIKCMN--PNYTEF-KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
           T E    ++  P+Y  +  +P   +     +   ++     DL+  LL  +P  R +A E
Sbjct: 221 TEESWPGVSKLPDYKPYPMYPATTS--LVNVV-PKLNSTGRDLLQNLLVCNPVQRISAEE 277

Query: 234 ALIHPFF 240
           AL HP+F
Sbjct: 278 ALQHPYF 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  150 bits (381), Expect = 7e-44
 Identities = 89/257 (34%), Positives = 143/257 (55%), Gaps = 18/257 (7%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ L H N+V+L       TEK    L LV EY+ + + + +         + +  VKL+
Sbjct: 58  LKDLKHANIVTLHDIIH--TEKS---LTLVFEYLDKDLKQYLD---DCGNSINMHNVKLF 109

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---I 117
            +Q+ R L Y H    V HRD+KPQNLL+N    +LKL DFG A+   K  P  +Y   +
Sbjct: 110 LFQLLRGLNYCHRR-KVLHRDLKPQNLLINERG-ELKLADFGLARA--KSIPTKTYSNEV 165

Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            + +YR P+++ G+T+Y+  ID+W  GC+  E+  G+PLFPG +  +QL  I ++LGTPT
Sbjct: 166 VTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPT 225

Query: 178 REEIKCM--NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 235
            E    +  N  +  + +P+ +A   H     R+  +  +L+S+LLQ+    R +A EA+
Sbjct: 226 EETWPGILSNEEFKSYNYPKYRADCLHN-HAPRLDSDGAELLSKLLQFEGRKRISAEEAM 284

Query: 236 IHPFFDELRDPNTRLPN 252
            HP+F  L +   +LP+
Sbjct: 285 KHPYFHCLGERIHKLPD 301

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  150 bits (381), Expect = 1e-43
 Identities = 89/246 (36%), Positives = 128/246 (52%), Gaps = 20/246 (8%)

Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 63
           L HPN+V LK         D ++L  V+EY  + +  ++     M        VK    Q
Sbjct: 63  LRHPNIVELKEVVVGK-HLDSIFL--VMEYCEQDLASLL---DNMPTPFSESQVKCLMLQ 116

Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSR 120
           + R L Y+H    + HRD+K  NLL+      LK+ DFG A+    G P       + + 
Sbjct: 117 LLRGLQYLHENF-IIHRDLKVSNLLLTDKGC-LKIADFGLARTY--GLPAKPMTPKVVTL 172

Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 180
           +YRAPEL+ G T YT AID+W+ GC+LAELL  +PL PG+S ++QL  II++LGTP    
Sbjct: 173 WYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESI 232

Query: 181 IKCMN--PNYTEFKFPQIKAHPWHKIFQK-RMPPEA-VDLVSRLLQYSPNLRSTALEALI 236
               +  P   +F  P+    P++ +  K     EA + L++ LL Y P  R+TA EAL 
Sbjct: 233 WPGFSDLPLVGKFTLPK---QPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289

Query: 237 HPFFDE 242
             +F E
Sbjct: 290 SSYFKE 295

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  149 bits (378), Expect = 2e-43
 Identities = 96/246 (39%), Positives = 140/246 (56%), Gaps = 18/246 (7%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           +R L   N+V LK  F     + +LYL  V EYV + +  +++        +P   V+ Y
Sbjct: 54  LRTLKQENIVELKEAF---RRRGKLYL--VFEYVEKNMLELLEEM---PNGVPPEKVRSY 105

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNIS-YIC 118
            YQ+ +A+ + H    + HRDIKP+NLL++ H   LKLCDFG A+ L +G   N + Y+ 
Sbjct: 106 IYQLIKAIHWCHKN-DIVHRDIKPENLLIS-HNDVLKLCDFGFARNLSEGSNANYTEYVA 163

Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 178
           +R+YR+PEL+ GA  Y  A+D+WS GC+L EL  GQPLFPGES +DQL  I KVLG    
Sbjct: 164 TRWYRSPELLLGAP-YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPA 222

Query: 179 EEIKCM--NPNYTEFKFPQIKAHP--WHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 234
           E++K    NP +   +FP +  HP    + +   +    +DL+  LL+ +P  R    + 
Sbjct: 223 EQMKLFYSNPRFHGLRFPAV-NHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQC 281

Query: 235 LIHPFF 240
           L HP F
Sbjct: 282 LNHPAF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  148 bits (376), Expect = 2e-43
 Identities = 77/243 (31%), Positives = 108/243 (44%), Gaps = 38/243 (15%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           +  L HPN+V     + S  ++++  LN+ LEYV       +    K   ++P   ++ Y
Sbjct: 53  LSSLQHPNIV---RYYGSERDEEKNTLNIFLEYVSG---GSLSSLLKKFGKLPEPVIRKY 106

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
             QI   LAY+H+  G+ HRDIK  N+LV+     +KL DFG AK L   E        R
Sbjct: 107 TRQILEGLAYLHSN-GIVHRDIKGANILVDS-DGVVKLADFGCAKRLGDIETGEGTGSVR 164

Query: 121 ---YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
              Y+ APE+I G  EY  A DIWS GC + E+  G+P +         +  I   G P 
Sbjct: 165 GTPYWMAPEVIRG-EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEP- 222

Query: 178 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 237
                           P+I  H         +  EA D + + L+  P  R TA E L H
Sbjct: 223 ----------------PEIPEH---------LSEEAKDFLRKCLRRDPKKRPTADELLQH 257

Query: 238 PFF 240
           PF 
Sbjct: 258 PFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  146 bits (371), Expect = 6e-42
 Identities = 84/258 (32%), Positives = 130/258 (50%), Gaps = 33/258 (12%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M  + H N++ L   +    E D  ++NLV++ +   + +V+    ++++      VK  
Sbjct: 74  MNEIKHENIMGLVDVY---VEGD--FINLVMDIMASDLKKVVDRKIRLTES----QVKCI 124

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK-----VLVKGEPNIS 115
             QI   L  +H    + HRD+ P N+ +N      K+ DFG A+               
Sbjct: 125 LLQILNGLNVLHKWYFM-HRDLSPANIFINSKG-ICKIADFGLARRYGYPPYSDTLSKDE 182

Query: 116 YICSR----------YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQ 165
            +  R          +YRAPEL+ GA +Y  A+D+WS GC+ AELL G+PLFPGE+ +DQ
Sbjct: 183 TMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ 242

Query: 166 LVEIIKVLGTPTRE---EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQ 222
           L  I ++LGTP  +   + K + P YTEF   + K      IF      +A+DL+  LL+
Sbjct: 243 LGRIFELLGTPNEDNWPQAKKL-PLYTEFTPRKPKD--LKTIFPNA-SDDAIDLLQSLLK 298

Query: 223 YSPNLRSTALEALIHPFF 240
            +P  R +A EAL H +F
Sbjct: 299 LNPLERISAKEALKHEYF 316

Length = 335

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score =  147 bits (372), Expect = 7e-42
 Identities = 87/268 (32%), Positives = 140/268 (52%), Gaps = 38/268 (14%)

Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIK---HHYKMSQRMPL 54
           M+L++H N++ L + F    S  E  ++YL  V+E +   + +VI+    H +MS     
Sbjct: 69  MKLVNHKNIIGLLNVFTPQKSLEEFQDVYL--VMELMDANLCQVIQMDLDHERMS----- 121

Query: 55  IYVKLYF-YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 113
                Y  YQ+   + ++H+  G+ HRD+KP N++V      LK+ DFG A+        
Sbjct: 122 -----YLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMM 174

Query: 114 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL 173
             Y+ +RYYRAPE+I G   Y   +DIWS GC++ E++ G  LFPG   +DQ  +II+ L
Sbjct: 175 TPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQL 233

Query: 174 GTPTREEIKCMNP---NYTEFKFPQIKAHPWHKIF------------QKRMPPEAVDLVS 218
           GTP+ E +  + P   NY E + P+   + + ++F             K    +A DL+S
Sbjct: 234 GTPSDEFMSRLQPTVRNYVENR-PKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLS 292

Query: 219 RLLQYSPNLRSTALEALIHPFFDELRDP 246
           ++L   P  R +  +AL HP+ +   DP
Sbjct: 293 KMLVIDPEKRISVDDALQHPYINVWYDP 320

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score =  146 bits (370), Expect = 8e-42
 Identities = 85/252 (33%), Positives = 136/252 (53%), Gaps = 16/252 (6%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL 59
           ++ + H NV+ L   F      +E   + LV   +   ++ ++K      Q++   +V+ 
Sbjct: 70  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQF 124

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
             YQI R L YIH+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +
Sbjct: 125 LIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVAT 180

Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
           R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E
Sbjct: 181 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 240

Query: 180 EIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 235
            +K ++     NY +    Q+    +  +F     P AVDL+ ++L    + R TA +AL
Sbjct: 241 LLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQAL 298

Query: 236 IHPFFDELRDPN 247
            H +F +  DP+
Sbjct: 299 AHAYFAQYHDPD 310

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score =  146 bits (370), Expect = 9e-42
 Identities = 86/253 (33%), Positives = 139/253 (54%), Gaps = 18/253 (7%)

Query: 1   MRLLDHPNVVSLKHCFFSTT---EKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++ + H NV+ L   F   T     +E+YL  V   +   ++ ++K      Q++   +V
Sbjct: 68  LKHMKHENVIGLLDVFTPATSIENFNEVYL--VTNLMGADLNNIVK-----CQKLSDEHV 120

Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           +   YQ+ R L YIH+  G+ HRD+KP N+ VN    +L++ DFG A+     +    Y+
Sbjct: 121 QFLIYQLLRGLKYIHSA-GIIHRDLKPSNVAVNEDC-ELRILDFGLARQ--ADDEMTGYV 176

Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++V+GTP+
Sbjct: 177 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPS 236

Query: 178 REEIKCMNPNYTEFKF---PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 234
            E +K ++  +        P +      KIF +   P A+DL+ ++L    + R +A EA
Sbjct: 237 PEVLKKISSEHARKYIQSLPHMPQQDLKKIF-RGANPLAIDLLEKMLVLDSDKRISASEA 295

Query: 235 LIHPFFDELRDPN 247
           L HP+F +  DP 
Sbjct: 296 LAHPYFSQYHDPE 308

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  144 bits (365), Expect = 2e-41
 Identities = 89/248 (35%), Positives = 138/248 (55%), Gaps = 18/248 (7%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ L H N+V+L H    T +     L LV EY+ + + + +         M +  VK++
Sbjct: 58  LKDLKHANIVTL-HDIVHTDKS----LTLVFEYLDKDLKQYMD---DCGNIMSMHNVKIF 109

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---I 117
            YQI R LAY H    V HRD+KPQNLL+N    +LKL DFG A+   K  P  +Y   +
Sbjct: 110 LYQILRGLAYCHRR-KVLHRDLKPQNLLINERG-ELKLADFGLARA--KSVPTKTYSNEV 165

Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            + +YR P+++ G++EY+  ID+W  GC+  E+  G+PLFPG +  D+L  I ++LGTPT
Sbjct: 166 VTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPT 225

Query: 178 REEIKCMNPN--YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 235
            E    ++ N  +  + FP+ K  P       R+  E ++L+++ LQY    R +A EA+
Sbjct: 226 EETWPGISSNDEFKNYNFPKYKPQPLIN-HAPRLDTEGIELLTKFLQYESKKRISAEEAM 284

Query: 236 IHPFFDEL 243
            H +F  L
Sbjct: 285 KHAYFRSL 292

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  143 bits (363), Expect = 6e-41
 Identities = 83/268 (30%), Positives = 119/268 (44%), Gaps = 45/268 (16%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVH---------RVIKHHYKMSQR 51
           ++ L HPNVV L        +K +     V    P   H          V       SQ 
Sbjct: 61  LKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSV---KLTESQ- 116

Query: 52  MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 111
                +K Y  Q+   + Y+H    + HRDIK  N+L++ +   LK+ DFG A+      
Sbjct: 117 -----IKCYMLQLLEGINYLHEN-HILHRDIKAANILID-NQGILKIADFGLARPYDGPP 169

Query: 112 PNISY------------ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG 159
           PN               + +R+YR PEL+ G   YT A+DIW  GCV AE+   +P+  G
Sbjct: 170 PNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQG 229

Query: 160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQ-------KRMPPE 212
           +S +DQL  I K+ GTPT E      P +     P  +       +         ++ PE
Sbjct: 230 KSDIDQLHLIFKLCGTPTEETW----PGWR--SLPGCEGVHSFTNYPRTLEERFGKLGPE 283

Query: 213 AVDLVSRLLQYSPNLRSTALEALIHPFF 240
            +DL+S+LL   P  R TA +AL HP+F
Sbjct: 284 GLDLLSKLLSLDPYKRLTASDALEHPYF 311

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  142 bits (360), Expect = 7e-41
 Identities = 87/245 (35%), Positives = 135/245 (55%), Gaps = 18/245 (7%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ L H N+V+L H    T    E  L LV EY+   + + + +       M +  VK++
Sbjct: 57  LKNLKHANIVTL-HDIIHT----ERCLTLVFEYLDSDLKQYLDN---CGNLMSMHNVKIF 108

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---I 117
            +Q+ R L+Y H    + HRD+KPQNLL+N    +LKL DFG A+   K  P  +Y   +
Sbjct: 109 MFQLLRGLSYCHKR-KILHRDLKPQNLLINEKG-ELKLADFGLARA--KSVPTKTYSNEV 164

Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            + +YR P+++ G+TEY+  ID+W  GC+L E+  G+P+FPG +  ++L  I ++LGTPT
Sbjct: 165 VTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPT 224

Query: 178 REEIK--CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 235
            E       N  +  + FPQ +A P       R+  + +DL+S LL Y    R +A  AL
Sbjct: 225 EETWPGITSNEEFRSYLFPQYRAQPL-INHAPRLDTDGIDLLSSLLLYETKSRISAEAAL 283

Query: 236 IHPFF 240
            H +F
Sbjct: 284 RHSYF 288

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  144 bits (364), Expect = 1e-40
 Identities = 75/266 (28%), Positives = 109/266 (40%), Gaps = 37/266 (13%)

Query: 2   RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 61
            L   PN+V L   F     +DE  L LV+EYV       +         +         
Sbjct: 53  SLNHPPNIVKLYDFF-----QDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFIL 107

Query: 62  YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI------- 114
            QI  AL Y+H + G+ HRDIKP+N+L++     +KL DFG AK+L              
Sbjct: 108 AQILSALEYLH-SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPS 166

Query: 115 SYICSRYYRAPELIFGATE--YTAAIDIWSAGCVLAELLLGQPLFPGESG---VDQLVEI 169
           + + +  Y APE++ G +    +++ DIWS G  L ELL G P F GE       Q ++I
Sbjct: 167 TSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKI 226

Query: 170 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS 229
           I  L TP                     A P      + +   A DL+ +LL   P  R 
Sbjct: 227 ILELPTP-------------------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRL 267

Query: 230 TALEALIHPFFDELRDPNTRLPNGRF 255
           ++   L H     L+   + L +   
Sbjct: 268 SSSSDLSHDLLAHLKLKESDLSDLLK 293

Length = 384

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  138 bits (350), Expect = 4e-40
 Identities = 55/203 (27%), Positives = 97/203 (47%), Gaps = 35/203 (17%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           ++ L+HPN+V L   F     +DE +L LV+EY    ++  ++K +     ++    +  
Sbjct: 45  LKKLNHPNIVKLYGVF-----EDENHLYLVMEYCEGGSLKDLLKEN---EGKLSEDEILR 96

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC- 118
              QI   L Y+H+  G+ HRD+KP+N+L++    ++KL DFG +K+L   +  +  I  
Sbjct: 97  ILLQILEGLEYLHS-NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVG 155

Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 178
           +  Y APE++ G   Y+   DIWS G +L EL              +L ++I+       
Sbjct: 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------PELKDLIR------- 195

Query: 179 EEIKCMNPNYTE-FKFPQIKAHP 200
              K +  +  +     +I  H 
Sbjct: 196 ---KMLQKDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  132 bits (335), Expect = 2e-37
 Identities = 77/246 (31%), Positives = 115/246 (46%), Gaps = 48/246 (19%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVK 58
           +  ++HP +V L + F     + E  L LVLEY P  E +   +    + S+       +
Sbjct: 47  LSRINHPFIVKLHYAF-----QTEEKLYLVLEYAPGGE-LFSHLSKEGRFSEER----AR 96

Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 118
            Y  +I  AL Y+H+ +G+ +RD+KP+N+L++   H +KL DFG AK L       +  C
Sbjct: 97  FYAAEIVLALEYLHS-LGIIYRDLKPENILLDADGH-IKLTDFGLAKELSSEGSRTNTFC 154

Query: 119 -SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +  Y APE++ G   Y  A+D WS G +L E+L G+P F  E    ++ E I       
Sbjct: 155 GTPEYLAPEVLLGK-GYGKAVDWWSLGVLLYEMLTGKPPFYAED-RKEIYEKIL------ 206

Query: 178 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA-LI 236
                         +FP            + + PEA DL+S LLQ  P  R  +  A  I
Sbjct: 207 ----------KDPLRFP------------EFLSPEARDLISGLLQKDPTKRLGSGGAEEI 244

Query: 237 --HPFF 240
             HPFF
Sbjct: 245 KAHPFF 250

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  129 bits (325), Expect = 2e-35
 Identities = 75/261 (28%), Positives = 122/261 (46%), Gaps = 41/261 (15%)

Query: 1   MRLLDHPNVVSLKHCFFSTTE-----KDELYLNLVLEYVPETVHRVIKH---HYKMSQRM 52
           +R L+H N+V+LK       +     KD+    LV EY+   +  +++    H+      
Sbjct: 60  LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDH-- 117

Query: 53  PLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE- 111
               +K +  Q+   L Y H      HRDIK  N+L+N +  Q+KL DFG A++    E 
Sbjct: 118 ----IKSFMKQLLEGLNYCHKK-NFLHRDIKCSNILLN-NKGQIKLADFGLARLYNSEES 171

Query: 112 -PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 170
            P  + + + +YR PEL+ G   Y  AID+WS GC+L EL   +P+F     + QL  I 
Sbjct: 172 RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELIS 231

Query: 171 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRM------------PPEAVDLVS 218
           ++ G+P       + P+  +  +       ++ +  K+             P  A+DL+ 
Sbjct: 232 RLCGSPC----PAVWPDVIKLPY-------FNTMKPKKQYRRRLREEFSFIPTPALDLLD 280

Query: 219 RLLQYSPNLRSTALEALIHPF 239
            +L   P+ R TA EAL  P+
Sbjct: 281 HMLTLDPSKRCTAEEALNSPW 301

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score =  124 bits (313), Expect = 7e-34
 Identities = 87/250 (34%), Positives = 132/250 (52%), Gaps = 19/250 (7%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ L H N+V L H    T E     L LV EYV   + + +  H      +    VKL+
Sbjct: 57  LKGLKHANIVLL-HDIIHTKET----LTLVFEYVHTDLCQYMDKH---PGGLHPENVKLF 108

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---I 117
            +Q+ R L+YIH    + HRD+KPQNLL++  T +LKL DFG A+   K  P+ +Y   +
Sbjct: 109 LFQLLRGLSYIHQRY-ILHRDLKPQNLLIS-DTGELKLADFGLARA--KSVPSHTYSNEV 164

Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV-DQLVEIIKVLGTP 176
            + +YR P+++ G+TEY+  +D+W  GC+  E++ G   FPG   + DQL  I  VLGTP
Sbjct: 165 VTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTP 224

Query: 177 TREEIKCMN--PNYTEFKFPQIKAHPWHKIFQK-RMPPEAVDLVSRLLQYSPNLRSTALE 233
             +    ++  P++   +F         + + K      A DL S+LLQ  P  R +A  
Sbjct: 225 NEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQA 284

Query: 234 ALIHPFFDEL 243
           AL H +F +L
Sbjct: 285 ALSHEYFSDL 294

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  122 bits (308), Expect = 2e-33
 Identities = 62/240 (25%), Positives = 106/240 (44%), Gaps = 38/240 (15%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           ++   HPN+V     +    +KDEL++  V+E+    ++  ++K     +Q +    +  
Sbjct: 51  LKKCKHPNIVKYYGSYL---KKDELWI--VMEFCSGGSLKDLLKST---NQTLTESQIAY 102

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
              ++ + L Y+H+  G+ HRDIK  N+L+     ++KL DFG +  L   +   + + +
Sbjct: 103 VCKELLKGLEYLHS-NGIIHRDIKAANILLT-SDGEVKLIDFGLSAQLSDTKARNTMVGT 160

Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
            Y+ APE+I G   Y    DIWS G    EL  G+P +  E    + +  I   G P   
Sbjct: 161 PYWMAPEVING-KPYDYKADIWSLGITAIELAEGKPPY-SELPPMKALFKIATNGPPG-- 216

Query: 180 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
                       + P            ++   E  D + + LQ +P  R TA + L HPF
Sbjct: 217 -----------LRNP------------EKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score =  123 bits (310), Expect = 8e-33
 Identities = 83/261 (31%), Positives = 136/261 (52%), Gaps = 25/261 (9%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL 59
           ++ ++H N++SL + F      +E   + LV+E +   + +VI H     +RM  +    
Sbjct: 74  LKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI-HMELDHERMSYL---- 128

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
             YQ+   + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +
Sbjct: 129 -LYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNFMMTPYVVT 185

Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
           RYYRAPE+I G   Y   +DIWS GC++ EL+ G  +F G   +DQ  ++I+ LGTP+ E
Sbjct: 186 RYYRAPEVILG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAE 244

Query: 180 EIKCMNP---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSP 225
            +  + P   NY E + PQ     + ++F   + P           +A DL+S++L   P
Sbjct: 245 FMNRLQPTVRNYVENR-PQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDP 303

Query: 226 NLRSTALEALIHPFFDELRDP 246
           + R +  EAL HP+     DP
Sbjct: 304 DKRISVDEALRHPYITVWYDP 324

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score =  121 bits (304), Expect = 4e-32
 Identities = 84/261 (32%), Positives = 137/261 (52%), Gaps = 25/261 (9%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL 59
           M+ ++H N++SL + F      +E   + LV+E +   + +VI+      +RM  +    
Sbjct: 70  MKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELD-HERMSYL---- 124

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
             YQ+   + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +
Sbjct: 125 -LYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVT 181

Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
           RYYRAPE+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E
Sbjct: 182 RYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 240

Query: 180 EIKCMNP---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQYSP 225
            +K + P   NY E + P+     + K+F   + P           +A DL+S++L   P
Sbjct: 241 FMKKLQPTVRNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 299

Query: 226 NLRSTALEALIHPFFDELRDP 246
             R +  EAL HP+ +   DP
Sbjct: 300 AKRISVDEALQHPYINVWYDP 320

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score =  121 bits (304), Expect = 6e-32
 Identities = 82/264 (31%), Positives = 137/264 (51%), Gaps = 31/264 (11%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIY 56
           M+ ++H N++ L + F      +E   + +V+E +   + +VI+    H +MS  +    
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLL---- 132

Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
                YQ+   + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y
Sbjct: 133 -----YQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPY 185

Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
           + +RYYRAPE+I G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LGTP
Sbjct: 186 VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP 244

Query: 177 TREEIKCMNP---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQ 222
             E +K + P    Y E + P+   + + K+F   + P           +A DL+S++L 
Sbjct: 245 CPEFMKKLQPTVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLV 303

Query: 223 YSPNLRSTALEALIHPFFDELRDP 246
              + R +  EAL HP+ +   DP
Sbjct: 304 IDASKRISVDEALQHPYINVWYDP 327

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  118 bits (297), Expect = 1e-31
 Identities = 70/237 (29%), Positives = 113/237 (47%), Gaps = 7/237 (2%)

Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 63
            DHPN+V L     ++    E  + LV E+V + +   +         +P   +K    Q
Sbjct: 59  FDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDK--VPPPGLPAETIKDLMRQ 116

Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 123
             R L ++H    + HRD+KP+N+LV     Q+KL DFG A++          + + +YR
Sbjct: 117 FLRGLDFLH-ANCIVHRDLKPENILVTSGG-QVKLADFGLARIYSCQMALTPVVVTLWYR 174

Query: 124 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 183
           APE++  +T Y   +D+WS GC+ AE+   +PLF G S  DQL +I  ++G P  ++   
Sbjct: 175 APEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP- 232

Query: 184 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
            +       F      P        +      L+  +L ++P+ R +A  AL HPFF
Sbjct: 233 RDVTLPRGAFSPRGPRPVQS-VVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  117 bits (294), Expect = 2e-31
 Identities = 76/237 (32%), Positives = 111/237 (46%), Gaps = 39/237 (16%)

Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFY 62
           L HPN+V      +  TE++E  L + LE VP  ++ ++     K     P   ++LY  
Sbjct: 59  LQHPNIVQ-----YLGTEREEDNLYIFLELVPGGSLAKL----LKKYGSFPEPVIRLYTR 109

Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 122
           QI   L Y+H+     HRDIK  N+LV+     +KL DFG AK +V+     S+  S Y+
Sbjct: 110 QILLGLEYLHDR-NTVHRDIKGANILVDT-NGVVKLADFGMAKQVVEFSFAKSFKGSPYW 167

Query: 123 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 182
            APE+I     Y  A DIWS GC + E+  G+P +   S ++ +  + K+  +     I 
Sbjct: 168 MAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPW---SQLEGVAAVFKIGRSKELPPI- 223

Query: 183 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
                            P H      +  EA D + + LQ  P+LR TA E L HPF
Sbjct: 224 -----------------PDH------LSDEAKDFILKCLQRDPSLRPTAAELLEHPF 257

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  117 bits (295), Expect = 2e-31
 Identities = 76/250 (30%), Positives = 108/250 (43%), Gaps = 54/250 (21%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           ++ L+HPN++     F    EK    L +V+EY     + + IK   K  +  P   +  
Sbjct: 53  LKKLNHPNIIKYYESFE---EKG--KLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILD 107

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---------VKG 110
           +F Q+C AL Y+H +  + HRDIKPQN+ +      +KL DFG +KVL         V G
Sbjct: 108 WFVQLCLALKYLH-SRKILHRDIKPQNIFLT-SNGLVKLGDFGISKVLSSTVDLAKTVVG 165

Query: 111 EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 170
            P        YY +PEL      Y    DIWS GCVL EL   +  F GE+ + +L    
Sbjct: 166 TP--------YYLSPELCQNK-PYNYKSDIWSLGCVLYELCTLKHPFEGEN-LLELAL-- 213

Query: 171 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 230
           K+L    + +   +   Y                       E  +LVS LLQ  P  R +
Sbjct: 214 KIL----KGQYPPIPSQY---------------------SSELRNLVSSLLQKDPEERPS 248

Query: 231 ALEALIHPFF 240
             + L  PF 
Sbjct: 249 IAQILQSPFI 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  116 bits (294), Expect = 3e-31
 Identities = 73/243 (30%), Positives = 108/243 (44%), Gaps = 49/243 (20%)

Query: 5   DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQ 63
           + P VV     F+      E  +++VLEY+   ++  ++K   K+ + +    +     Q
Sbjct: 57  ESPYVVKCYGAFYK-----EGEISIVLEYMDGGSLADLLKKVGKIPEPV----LAYIARQ 107

Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-- 121
           I + L Y+H    + HRDIKP NLL+N    ++K+ DFG +KVL     N    C+ +  
Sbjct: 108 ILKGLDYLHTKRHIIHRDIKPSNLLIN-SKGEVKIADFGISKVL----ENTLDQCNTFVG 162

Query: 122 ---YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-P-LFPGESGVDQLVEIIKVLGTP 176
              Y +PE I G + Y+ A DIWS G  L E  LG+ P L PG+    +L++ I      
Sbjct: 163 TVTYMSPERIQGES-YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI------ 215

Query: 177 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 236
                 C          P            +   PE  D +S  LQ  P  R +A E L 
Sbjct: 216 ------CD--------GPPPSLPA------EEFSPEFRDFISACLQKDPKKRPSAAELLQ 255

Query: 237 HPF 239
           HPF
Sbjct: 256 HPF 258

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score =  113 bits (283), Expect = 1e-29
 Identities = 80/240 (33%), Positives = 124/240 (51%), Gaps = 13/240 (5%)

Query: 4   LDHPNVVSL-KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 62
            +HPNVV L   C  S T++ E  L LV E+V + +   +         +P   +K   +
Sbjct: 61  FEHPNVVRLFDVCTVSRTDR-ETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMF 117

Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 122
           Q+ R L ++H+   V HRD+KPQN+LV   + Q+KL DFG A++        S + + +Y
Sbjct: 118 QLLRGLDFLHSH-RVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVVTLWY 175

Query: 123 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 182
           RAPE++  ++ Y   +D+WS GC+ AE+   +PLF G S VDQL +I+ V+G P  E+  
Sbjct: 176 RAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW- 233

Query: 183 CMNPNYTEFKFPQIKAHPWHKI--FQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
              P           +     I  F   +     DL+ + L ++P  R +A  AL HP+F
Sbjct: 234 ---PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  112 bits (281), Expect = 2e-29
 Identities = 72/247 (29%), Positives = 115/247 (46%), Gaps = 44/247 (17%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           + LL HPN+V     +     ++++Y+   +EY    T+  +++H   + + +    +++
Sbjct: 53  LELLKHPNLVK---YYGVEVHREKVYI--FMEYCSGGTLEELLEHGRILDEHV----IRV 103

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-----GEPNI 114
           Y  Q+   LAY+H + G+ HRDIKP N+ ++ H   +KL DFG A  L       GE   
Sbjct: 104 YTLQLLEGLAYLH-SHGIVHRDIKPANIFLD-HNGVIKLGDFGCAVKLKNNTTTMGEEVQ 161

Query: 115 SYICSRYYRAPELIFGAT--EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 172
           S   +  Y APE+I G     +  A DIWS GCV+ E+  G+  +   S +D   +I+  
Sbjct: 162 SLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPW---SELDNEFQIMFH 218

Query: 173 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAL 232
           +G          +        P I           ++ PE  D + R L+  P  R TA 
Sbjct: 219 VGA--------GHK-------PPIPDS-------LQLSPEGKDFLDRCLESDPKKRPTAS 256

Query: 233 EALIHPF 239
           E L HPF
Sbjct: 257 ELLQHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  111 bits (280), Expect = 3e-29
 Identities = 79/250 (31%), Positives = 122/250 (48%), Gaps = 56/250 (22%)

Query: 6   HPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQI 64
            P VV L   ++S   K  LYL  V+EY+P   +  ++++   + + +     ++Y  +I
Sbjct: 52  SPYVVKL---YYSFQGKKNLYL--VMEYLPGGDLASLLENVGSLDEDV----ARIYIAEI 102

Query: 65  CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNISY------- 116
             AL Y+H+  G+ HRD+KP N+L++ + H LKL DFG +KV LV+ + N++        
Sbjct: 103 VLALEYLHS-NGIIHRDLKPDNILIDSNGH-LKLTDFGLSKVGLVRRQINLNDDEKEDKR 160

Query: 117 -ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
            + +  Y APE+I G   ++  +D WS GC+L E L+G P F GE               
Sbjct: 161 IVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGE--------------- 204

Query: 176 PTREEIKCMNPNYTEFKFPQIKAH--PWHKIFQKRMPPEAVDLVSRLLQYSPNLR---ST 230
            T EEI           F  I      W +  +  +  EA+DL+S+LL   P  R    +
Sbjct: 205 -TPEEI-----------FQNILNGKIEWPEDVE--VSDEAIDLISKLLVPDPEKRLGAKS 250

Query: 231 ALEALIHPFF 240
             E   HPFF
Sbjct: 251 IEEIKNHPFF 260

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score =  110 bits (277), Expect = 1e-28
 Identities = 88/273 (32%), Positives = 131/273 (47%), Gaps = 40/273 (14%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHY-----KMSQRMPLI 55
           +R L HPNV+SL+  F S  ++    + L+ +Y    +  +IK H      K   ++P  
Sbjct: 52  LRELKHPNVISLQKVFLSHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRG 108

Query: 56  YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEP 112
            VK   YQI   + Y+H    V HRD+KP N+LV    P   ++K+ D G A++      
Sbjct: 109 MVKSLLYQILDGIHYLHAN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 167

Query: 113 NIS----YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF---------PG 159
            ++     + + +YRAPEL+ GA  YT AIDIW+ GC+ AELL  +P+F           
Sbjct: 168 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN 227

Query: 160 ESGVDQLVEIIKVLGTPTR---EEIKCMNPNYTEFK---------FPQIKAHPWHKIFQK 207
               DQL  I  V+G P     E+IK M  + T  K            IK    HK+   
Sbjct: 228 PYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKV--- 284

Query: 208 RMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
           +   +A  L+ +LL   P  R T+ +A+  P+F
Sbjct: 285 KPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score =  110 bits (275), Expect = 4e-28
 Identities = 86/271 (31%), Positives = 134/271 (49%), Gaps = 36/271 (13%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHY-----KMSQRMPLI 55
           +R L HPNV++L+  F S +++    + L+ +Y    +  +IK H      K   ++P  
Sbjct: 52  LRELKHPNVIALQKVFLSHSDRK---VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRS 108

Query: 56  YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEP 112
            VK   YQI   + Y+H    V HRD+KP N+LV    P   ++K+ D G A++      
Sbjct: 109 MVKSLLYQILDGIHYLHAN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 167

Query: 113 NIS----YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF---------PG 159
            ++     + + +YRAPEL+ GA  YT AIDIW+ GC+ AELL  +P+F           
Sbjct: 168 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN 227

Query: 160 ESGVDQLVEIIKVLGTPTR---EEIKCMNPNY----TEFKFPQIKAHPWHKIFQK-RMPP 211
               DQL  I  V+G P     E+I+ M P Y     +F+          K  +K ++ P
Sbjct: 228 PFHHDQLDRIFSVMGFPADKDWEDIRKM-PEYPTLQKDFRRTTYANSSLIKYMEKHKVKP 286

Query: 212 EA--VDLVSRLLQYSPNLRSTALEALIHPFF 240
           ++    L+ +LL   P  R T+ +AL  P+F
Sbjct: 287 DSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  105 bits (264), Expect = 5e-27
 Identities = 76/243 (31%), Positives = 106/243 (43%), Gaps = 50/243 (20%)

Query: 5   DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP----ETVHRVIKHHYKMSQRMPLIYVKLY 60
           + P V  L   ++S   KD  YL LV+EY+      ++        K    +P  + K Y
Sbjct: 55  ESPYVAKL---YYSFQSKD--YLYLVMEYLNGGDCASL-------IKTLGGLPEDWAKQY 102

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
             ++   +  +H   G+ HRDIKP+NLL++   H LKL DFG ++    G  N  ++ + 
Sbjct: 103 IAEVVLGVEDLHQR-GIIHRDIKPENLLIDQTGH-LKLTDFGLSRN---GLENKKFVGTP 157

Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 180
            Y APE I G  +     D WS GCV+ E L G P F  E+  D + + I          
Sbjct: 158 DYLAPETILGVGD-DKMSDWWSLGCVIFEFLFGYPPFHAET-PDAVFDNI------LSRR 209

Query: 181 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA---LEALIH 237
           I     N+ E                    PEAVDL++RLL   P  R  A    E   H
Sbjct: 210 I-----NWPEEVKEFCS-------------PEAVDLINRLLCMDPAKRLGANGYQEIKSH 251

Query: 238 PFF 240
           PFF
Sbjct: 252 PFF 254

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  105 bits (263), Expect = 6e-27
 Identities = 71/246 (28%), Positives = 102/246 (41%), Gaps = 56/246 (22%)

Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFY 62
           L HPN+V           +    L ++LEY    ++ ++IK      + +    V +Y Y
Sbjct: 56  LKHPNIVKYIGSI-----ETSDSLYIILEYAENGSLRQIIKKFGPFPESL----VAVYVY 106

Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-SYICSRY 121
           Q+ + LAY+H   GV HRDIK  N+L       +KL DFG A  L     +  S + + Y
Sbjct: 107 QVLQGLAYLHEQ-GVIHRDIKAANILTTKDGV-VKLADFGVATKLNDVSKDDASVVGTPY 164

Query: 122 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 181
           + APE+I   +  + A DIWS GC + ELL G P +                        
Sbjct: 165 WMAPEVIEM-SGASTASDIWSLGCTVIELLTGNPPYYD---------------------- 201

Query: 182 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPP-------EAVDLVSRLLQYSPNLRSTALEA 234
             +NP                +I Q   PP       E  D + +  Q  PNLR TA + 
Sbjct: 202 --LNP-----------MAALFRIVQDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQL 248

Query: 235 LIHPFF 240
           L HP+ 
Sbjct: 249 LKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  105 bits (265), Expect = 7e-27
 Identities = 71/268 (26%), Positives = 113/268 (42%), Gaps = 71/268 (26%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
            RL  HP ++ L + F     +DE  L  VLEY P   + + I+ +  + ++      + 
Sbjct: 56  TRLNGHPGIIKLYYTF-----QDEENLYFVLEYAPNGELLQYIRKYGSLDEKC----TRF 106

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL----VKGEPNIS 115
           Y  +I  AL Y+H+  G+ HRD+KP+N+L++   H +K+ DFG+AKVL            
Sbjct: 107 YAAEILLALEYLHS-KGIIHRDLKPENILLDKDMH-IKITDFGTAKVLDPNSSPESNKGD 164

Query: 116 YICSRY-----------------YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP 158
                                  Y +PEL+        + D+W+ GC++ ++L G+P F 
Sbjct: 165 ATNIDSQIEKNRRRFASFVGTAEYVSPELL-NEKPAGKSSDLWALGCIIYQMLTGKPPFR 223

Query: 159 GESGVDQLV--EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDL 216
           G +  + L   +I+K                  E+ FP               PP+A DL
Sbjct: 224 GSN--EYLTFQKILK-----------------LEYSFPPN------------FPPDAKDL 252

Query: 217 VSRLLQYSPNLRSTALEALI----HPFF 240
           + +LL   P  R    E       HPFF
Sbjct: 253 IEKLLVLDPQDRLGVNEGYDELKAHPFF 280

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  103 bits (260), Expect = 3e-26
 Identities = 62/241 (25%), Positives = 102/241 (42%), Gaps = 42/241 (17%)

Query: 5   DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQI 64
           + P +V     F++  +     +++ +EY+       I    ++  R+P   +      +
Sbjct: 57  NSPYIVGFYGAFYNNGD-----ISICMEYMDGGSLDKILK--EVQGRIPERILGKIAVAV 109

Query: 65  CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 124
            + L Y+H    + HRD+KP N+LVN    Q+KLCDFG +  LV      +++ +  Y A
Sbjct: 110 LKGLTYLHEKHKIIHRDVKPSNILVN-SRGQIKLCDFGVSGQLVNSLAK-TFVGTSSYMA 167

Query: 125 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG-----VDQLVEIIKVLGTPTRE 179
           PE I G  +Y+   DIWS G  L EL  G+  +P E+       + L  I+         
Sbjct: 168 PERIQG-NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN-------- 218

Query: 180 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
                 P       P++ +  +         P+  D V+  L   P  R +  E L HPF
Sbjct: 219 ----EPP-------PRLPSGKF--------SPDFQDFVNLCLIKDPRERPSYKELLEHPF 259

Query: 240 F 240
            
Sbjct: 260 I 260

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  102 bits (257), Expect = 1e-25
 Identities = 75/257 (29%), Positives = 116/257 (45%), Gaps = 28/257 (10%)

Query: 1   MRLLDHPNVVSLKH-CFFSTTE----KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 55
           ++LL H NVV+L   C    T     K   YL  V E+    +  ++ +    + +  L 
Sbjct: 65  LQLLKHENVVNLIEICRTKATPYNRYKGSFYL--VFEFCEHDLAGLLSN---KNVKFTLS 119

Query: 56  YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV---KGEP 112
            +K     +   L YIH    + HRD+K  N+L+      LKL DFG A+        +P
Sbjct: 120 EIKKVMKMLLNGLYYIHRN-KILHRDMKAANILITKDG-ILKLADFGLARAFSLSKNSKP 177

Query: 113 N--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 170
           N   + + + +YR PEL+ G  +Y   ID+W AGC++AE+    P+  G +   QL  I 
Sbjct: 178 NRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLIS 237

Query: 171 KVLGTPTREEI-KCMN-PNYTEFKFPQ-----IKAHPWHKIFQKRMPPEAVDLVSRLLQY 223
           ++ G+ T E          + + + PQ     +K      +      P A+DL+ +LL  
Sbjct: 238 QLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYV----KDPHALDLIDKLLVL 293

Query: 224 SPNLRSTALEALIHPFF 240
            P  R  A  AL H FF
Sbjct: 294 DPAKRIDADTALNHDFF 310

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 96.9 bits (242), Expect = 9e-24
 Identities = 66/247 (26%), Positives = 111/247 (44%), Gaps = 43/247 (17%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKL 59
           +   +HP +V L +  F    KD+ Y+ +++EY     +  +++      +       + 
Sbjct: 47  LEECNHPFIVKL-YRTF----KDKKYIYMLMEYCLGGELWTILRDRGLFDEYT----ARF 97

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           Y   +  A  Y+HN  G+ +RD+KP+NLL++     +KL DFG AK L  G+   ++  +
Sbjct: 98  YIACVVLAFEYLHN-RGIIYRDLKPENLLLD-SNGYVKLVDFGFAKKLKSGQKTWTFCGT 155

Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
             Y APE+I     Y  ++D WS G +L ELL G+P F GE   D +             
Sbjct: 156 PEYVAPEIILNKG-YDFSVDYWSLGILLYELLTGRPPF-GEDDEDPME---------IYN 204

Query: 180 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSP-----NLRSTALEA 234
           +I   N      +FP              +   A DL+ +LL+ +P     NL+    + 
Sbjct: 205 DILKGNGKL---EFPNY------------IDKAAKDLIKQLLRRNPEERLGNLKGGIKDI 249

Query: 235 LIHPFFD 241
             H +F+
Sbjct: 250 KKHKWFN 256

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 95.0 bits (237), Expect = 4e-23
 Identities = 53/179 (29%), Positives = 84/179 (46%), Gaps = 16/179 (8%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           +R L HPN+V         + +    L +V+EY     + ++I+   K  + +   ++  
Sbjct: 53  LRELKHPNIVRYYDRIIDRSNQT---LYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWR 109

Query: 60  YFYQICRALAYIHNTIG----VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI- 114
              Q+  AL   HN       V HRD+KP N+ ++   + +KL DFG AK+L  G  +  
Sbjct: 110 ILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLD-ANNNVKLGDFGLAKIL--GHDSSF 166

Query: 115 --SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 171
             +Y+ + YY +PE +   + Y    DIWS GC++ EL    P F       QL   IK
Sbjct: 167 AKTYVGTPYYMSPEQLNHMS-YDEKSDIWSLGCLIYELCALSPPFTA-RNQLQLASKIK 223

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 94.5 bits (236), Expect = 1e-22
 Identities = 70/248 (28%), Positives = 117/248 (47%), Gaps = 53/248 (21%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVK 58
           ++ + HP +V+L   F     +D+  L LV+EYVP  E     +  H + S R P    +
Sbjct: 55  LQSIRHPFLVNLYGSF-----QDDSNLYLVMEYVPGGE-----LFSHLRKSGRFPEPVAR 104

Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 118
            Y  Q+  AL Y+H+ + + +RD+KP+NLL++   + +K+ DFG AK +   +     +C
Sbjct: 105 FYAAQVVLALEYLHS-LDIVYRDLKPENLLLDSDGY-IKITDFGFAKRV---KGRTYTLC 159

Query: 119 -SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +  Y APE+I     Y  A+D W+ G ++ E+L G P F  ++   Q+ E I       
Sbjct: 160 GTPEYLAPEIILS-KGYGKAVDWWALGILIYEMLAGYPPFFDDN-PIQIYEKI------- 210

Query: 178 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSP-----NLRSTAL 232
              ++       + +FP                P+A DL+  LLQ        NL++   
Sbjct: 211 ---LEG------KVRFP------------SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVN 249

Query: 233 EALIHPFF 240
           +   HP+F
Sbjct: 250 DIKNHPWF 257

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 93.0 bits (231), Expect = 3e-22
 Identities = 64/245 (26%), Positives = 104/245 (42%), Gaps = 39/245 (15%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M  L+HP+++       +T E    + NL +E++       +   Y   +   +I    Y
Sbjct: 57  MARLNHPHII---RMLGATCEDS--HFNLFVEWMAGGSVSHLLSKYGAFKEAVIIN---Y 108

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-----GEPNIS 115
             Q+ R L+Y+H    + HRD+K  NLL++    +L++ DFG+A  L       GE    
Sbjct: 109 TEQLLRGLSYLHEN-QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQ 167

Query: 116 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
            + +  + APE++ G  +Y  + D+WS GCV+ E+   +P +  E   + L  I K    
Sbjct: 168 LLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFK---- 222

Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 235
                I            P I  H         + P   D+  R L+  P  R  + E L
Sbjct: 223 -----IASATTA------PSIPEH---------LSPGLRDVTLRCLELQPEDRPPSRELL 262

Query: 236 IHPFF 240
            HP F
Sbjct: 263 KHPVF 267

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 92.3 bits (230), Expect = 6e-22
 Identities = 64/249 (25%), Positives = 104/249 (41%), Gaps = 53/249 (21%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEY--------VPETVHRVIKHHYKMSQRM 52
           M+   HPN+V     +          L +V+EY        +      + ++  +M++  
Sbjct: 69  MKDCKHPNIVDYYDSY-----LVGDELWVVMEYMDGGSLTDI------ITQNFVRMNEPQ 117

Query: 53  PLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 112
            + YV     ++ + L Y+H+   V HRDIK  N+L++     +KL DFG A  L K + 
Sbjct: 118 -IAYVCR---EVLQGLEYLHSQ-NVIHRDIKSDNILLS-KDGSVKLADFGFAAQLTKEKS 171

Query: 113 N-ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 171
              S + + Y+ APE+I    +Y   +DIWS G +  E+  G+P +  E  +  L  I  
Sbjct: 172 KRNSVVGTPYWMAPEVIKR-KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT 230

Query: 172 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 231
             G P    +K                  W   F+        D +++ L   P  R +A
Sbjct: 231 -KGIP---PLK--------------NPEKWSPEFK--------DFLNKCLVKDPEKRPSA 264

Query: 232 LEALIHPFF 240
            E L HPF 
Sbjct: 265 EELLQHPFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 91.8 bits (228), Expect = 9e-22
 Identities = 72/245 (29%), Positives = 117/245 (47%), Gaps = 41/245 (16%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           ++ LDH N+V          E  E YL++ LEYVP  ++   ++ + +  +++    V+ 
Sbjct: 62  LKDLDHLNIVQYLGF-----ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL----VRF 112

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV---LVKGEPNISY 116
           +  Q+   LAY+H+  G+ HRD+K  NLLV+      K+ DFG +K    +   + N+S 
Sbjct: 113 FTEQVLEGLAYLHSK-GILHRDLKADNLLVD-ADGICKISDFGISKKSDDIYDNDQNMSM 170

Query: 117 ICSRYYRAPELIFGATE-YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
             S ++ APE+I   ++ Y+A +DIWS GCV+ E+  G+  +  E               
Sbjct: 171 QGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE--------------- 215

Query: 176 PTREEIKCMNPNYTEFK-FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 234
              E I  M      FK   +  A P        + P A+D ++     +P+ R TA E 
Sbjct: 216 ---EAIAAM------FKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTAREL 266

Query: 235 LIHPF 239
           L HPF
Sbjct: 267 LQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 92.4 bits (230), Expect = 2e-21
 Identities = 76/269 (28%), Positives = 112/269 (41%), Gaps = 72/269 (26%)

Query: 5   DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFY 62
           D P +V L +  F    +DE +L LV+EY+P  + ++ +I+         P    + Y  
Sbjct: 59  DSPWIVKL-YYSF----QDEEHLYLVMEYMPGGDLMNLLIRKD-----VFPEETARFYIA 108

Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK----------------- 105
           ++  AL  +H  +G  HRDIKP N+L++   H +KL DFG  K                 
Sbjct: 109 ELVLALDSVHK-LGFIHRDIKPDNILIDADGH-IKLADFGLCKKMNKAKDREYYLNDSHN 166

Query: 106 ------VLVKGEPNISYICSRY-------YRAPELIFGATEYTAAIDIWSAGCVLAELLL 152
                 VLV+   +               Y APE++ G T Y    D WS G +L E+L 
Sbjct: 167 LLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLY 225

Query: 153 GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE-FKFPQIKAHPWHKIFQKRMPP 211
           G P F  ++    L E        T  +I     N+ E  +FP              + P
Sbjct: 226 GFPPFYSDT----LQE--------TYNKII----NWKESLRFPP----------DPPVSP 259

Query: 212 EAVDLVSRLLQYSPNLRSTALEALIHPFF 240
           EA+DL+ RLL    +   +  E   HPFF
Sbjct: 260 EAIDLICRLLCDPEDRLGSFEEIKSHPFF 288

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 90.3 bits (224), Expect = 3e-21
 Identities = 75/249 (30%), Positives = 111/249 (44%), Gaps = 52/249 (20%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ L H N+V            D  +LN+ LEYVP      + ++Y          V+ +
Sbjct: 60  LKELQHENIVQYLGS-----SLDADHLNIFLEYVPGGSVAALLNNYGA---FEETLVRNF 111

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI------ 114
             QI + L Y+HN  G+ HRDIK  N+LV+ +   +K+ DFG +K   K E N       
Sbjct: 112 VRQILKGLNYLHNR-GIIHRDIKGANILVD-NKGGIKISDFGISK---KLEANSLSTKTN 166

Query: 115 ----SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 170
               S   S ++ APE++   T YT   DIWS GC++ E+L G+  FP      QL  I 
Sbjct: 167 GARPSLQGSVFWMAPEVV-KQTSYTRKADIWSLGCLVVEMLTGKHPFP---DCTQLQAIF 222

Query: 171 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 230
           K+                 E   P+I ++         +  EA+D + +  +   N R T
Sbjct: 223 KI----------------GENASPEIPSN---------ISSEAIDFLEKTFEIDHNKRPT 257

Query: 231 ALEALIHPF 239
           A E L HPF
Sbjct: 258 AAELLKHPF 266

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 89.4 bits (222), Expect = 6e-21
 Identities = 57/162 (35%), Positives = 81/162 (50%), Gaps = 10/162 (6%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           ++ LDHPNV+     F    E     LN+VLE      + R+IKH  K  + +P   +  
Sbjct: 56  LKQLDHPNVIKYLASFIENNE-----LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWK 110

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV-KGEPNISYIC 118
           YF Q+C AL ++H+   + HRDIKP N+ +   T  +KL D G  +    K     S + 
Sbjct: 111 YFVQLCSALEHMHSK-RIMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVG 168

Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 160
           + YY +PE I     Y    DIWS GC+L E+   Q  F G+
Sbjct: 169 TPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 87.5 bits (217), Expect = 2e-20
 Identities = 73/247 (29%), Positives = 101/247 (40%), Gaps = 56/247 (22%)

Query: 3   LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYF 61
           LL HPN+++  + F      D+  L + +EY    T++  I       Q      V  Y 
Sbjct: 55  LLQHPNIIAYYNHFM-----DDNTLLIEMEYANGGTLYDKIVRQKG--QLFEEEMVLWYL 107

Query: 62  YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---------VKGEP 112
           +QI  A++YIH   G+ HRDIK  N+ +      +KL DFG +K+L         V G P
Sbjct: 108 FQIVSAVSYIHK-AGILHRDIKTLNIFLT-KAGLIKLGDFGISKILGSEYSMAETVVGTP 165

Query: 113 NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 172
                   YY +PEL  G  +Y    DIW+ GCVL ELL  +  F         + ++  
Sbjct: 166 --------YYMSPELCQGV-KYNFKSDIWALGCVLYELLTLKRTFDA----TNPLNLV-- 210

Query: 173 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAL 232
                   +K +  NYT                      E + LV  LLQ  P  R TA 
Sbjct: 211 --------VKIVQGNYTPVVSVYSS--------------ELISLVHSLLQQDPEKRPTAD 248

Query: 233 EALIHPF 239
           E L  P 
Sbjct: 249 EVLDQPL 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 88.3 bits (219), Expect = 2e-20
 Identities = 81/276 (29%), Positives = 124/276 (44%), Gaps = 60/276 (21%)

Query: 5   DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQ 63
           ++P VVS+  C F T      +L +V+EYV       ++K+       +P+   ++YF +
Sbjct: 59  ENPFVVSM-FCSFETKR----HLCMVMEYVEGGDCATLLKN----IGALPVDMARMYFAE 109

Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNI-------- 114
              AL Y+HN  G+ HRD+KP NLL+    H +KL DFG +K+ L+    N+        
Sbjct: 110 TVLALEYLHN-YGIVHRDLKPDNLLITSMGH-IKLTDFGLSKIGLMSLTTNLYEGHIEKD 167

Query: 115 ------SYIC-SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV 167
                   +C +  Y APE+I     Y   +D W+ G +L E L+G   F G++  +   
Sbjct: 168 TREFLDKQVCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG 226

Query: 168 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL 227
           ++I        ++I    P   E                  +P +A DL+SRLL+ +P  
Sbjct: 227 QVIS-------DDI--EWPEGDE-----------------ALPADAQDLISRLLRQNPLE 260

Query: 228 R---STALEALIHPFFDELRDPNTRL-PNGRFLPPL 259
           R     A E   H FF  L D N  L     F+P L
Sbjct: 261 RLGTGGAFEVKQHRFFLGL-DWNGLLRQKAEFIPQL 295

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 86.6 bits (215), Expect = 5e-20
 Identities = 66/241 (27%), Positives = 108/241 (44%), Gaps = 43/241 (17%)

Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI--YVKLYF 61
           L+HP +V+L + F     +DE  + LV++ +     R     Y +SQ++      VK + 
Sbjct: 57  LNHPFLVNLWYSF-----QDEENMYLVVDLLLGGDLR-----YHLSQKVKFSEEQVKFWI 106

Query: 62  YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY 121
            +I  AL Y+H+  G+ HRDIKP N+L++   H + + DF  A  +       S   +  
Sbjct: 107 CEIVLALEYLHSK-GIIHRDIKPDNILLDEQGH-VHITDFNIATKVTPDTLTTSTSGTPG 164

Query: 122 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 181
           Y APE++     Y+ A+D WS G    E L G+  + G S                R++I
Sbjct: 165 YMAPEVLCRQG-YSVAVDWWSLGVTAYECLRGKRPYRGHS-------------RTIRDQI 210

Query: 182 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-STALEALI-HPF 239
           +            Q  A     ++      EA+D +++LL+  P  R    L+ L  HP+
Sbjct: 211 RAK----------QETADV---LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPY 257

Query: 240 F 240
           F
Sbjct: 258 F 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 86.0 bits (214), Expect = 8e-20
 Identities = 57/186 (30%), Positives = 90/186 (48%), Gaps = 38/186 (20%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVK 58
           MR LDHPNVV L       TE++ LY  +V+EY+     +  + K+  K+S         
Sbjct: 55  MRKLDHPNVVKLLGV---CTEEEPLY--IVMEYMEGGDLLSYLRKNRPKLSLSD-----L 104

Query: 59  LYF-YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           L F  QI R + Y+ +     HRD+  +N LV      +K+ DFG ++ L   +      
Sbjct: 105 LSFALQIARGMEYLES-KNFIHRDLAARNCLVG-ENLVVKISDFGLSRDLYDDD------ 156

Query: 118 CSRYYR-----------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQ 165
              YYR           APE +    ++T+  D+WS G +L E+  LG+  +PG S  ++
Sbjct: 157 ---YYRKRGGKLPIRWMAPESLK-EGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMS-NEE 211

Query: 166 LVEIIK 171
           ++E +K
Sbjct: 212 VLEYLK 217

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 85.2 bits (211), Expect = 2e-19
 Identities = 61/212 (28%), Positives = 91/212 (42%), Gaps = 30/212 (14%)

Query: 43  KHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG 102
           K  Y     +P   +      I +AL Y+H+ + V HRD+KP N+L+N    Q+KLCDFG
Sbjct: 91  KKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLIN-RNGQVKLCDFG 149

Query: 103 SAKVLVKGEPNISYICSRYYRAPELIFGATE---YTAAIDIWSAGCVLAELLLGQPLFPG 159
            +  LV           + Y APE I        Y    D+WS G  + EL  G+  FP 
Sbjct: 150 ISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGR--FPY 207

Query: 160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSR 219
           +S             TP  +++K            Q+   P  ++  ++  PE  D V++
Sbjct: 208 DS-----------WKTPF-QQLK------------QVVEEPSPQLPAEKFSPEFQDFVNK 243

Query: 220 LLQYSPNLRSTALEALIHPFFDELRDPNTRLP 251
            L+ +   R    E L HPFF+     NT + 
Sbjct: 244 CLKKNYKERPNYPELLQHPFFELHLSKNTDVA 275

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 84.9 bits (210), Expect = 2e-19
 Identities = 62/245 (25%), Positives = 110/245 (44%), Gaps = 44/245 (17%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           ++ L H  +V    C      +D+  L++ +EY+P  +V   +K +  +++ +     + 
Sbjct: 58  LKNLQHERIVQYYGC-----LRDDETLSIFMEYMPGGSVKDQLKAYGALTETV----TRK 108

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL----VKGEPNIS 115
           Y  QI   + Y+H+ + + HRDIK  N+L +     +KL DFG++K L      G    S
Sbjct: 109 YTRQILEGVEYLHSNM-IVHRDIKGANILRDS-AGNVKLGDFGASKRLQTICSSGTGMKS 166

Query: 116 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
              + Y+ +PE+I G   Y    D+WS GC + E+L  +P +   +  + +  I K+   
Sbjct: 167 VTGTPYWMSPEVISGEG-YGRKADVWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQ 222

Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 235
           PT                PQ+ +H         + P+A + + R    +   R +A E L
Sbjct: 223 PTN---------------PQLPSH---------VSPDARNFLRRTFVENAKKRPSAEELL 258

Query: 236 IHPFF 240
            H F 
Sbjct: 259 RHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 83.8 bits (208), Expect = 5e-19
 Identities = 53/185 (28%), Positives = 89/185 (48%), Gaps = 35/185 (18%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVK 58
           MR LDHPN+V L       TE++ L   +V+EY+P    +  + K+  K    + L  + 
Sbjct: 55  MRKLDHPNIVKLLGV---CTEEEPLM--IVMEYMPGGDLLDYLRKNRPK---ELSLSDLL 106

Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 118
            +  QI R + Y+ +     HRD+  +N LV      +K+ DFG ++ L   +       
Sbjct: 107 SFALQIARGMEYLES-KNFIHRDLAARNCLVG-ENLVVKISDFGLSRDLYDDD------- 157

Query: 119 SRYYR-----------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQL 166
             YY+           APE +    ++T+  D+WS G +L E+  LG+  +PG S   ++
Sbjct: 158 --YYKVKGGKLPIRWMAPESLK-EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMS-NAEV 213

Query: 167 VEIIK 171
           +E +K
Sbjct: 214 LEYLK 218

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 84.0 bits (208), Expect = 7e-19
 Identities = 71/252 (28%), Positives = 119/252 (47%), Gaps = 39/252 (15%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           MR   HPN+V +   + S    DEL++  V+E++       I  H +M++   +  V L 
Sbjct: 70  MRDYQHPNIVEM---YSSYLVGDELWV--VMEFLEGGALTDIVTHTRMNEEQ-IATVCL- 122

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-ISYICS 119
              + +AL+++H   GV HRDIK  ++L+     ++KL DFG    + K  P   S + +
Sbjct: 123 --AVLKALSFLHAQ-GVIHRDIKSDSILLT-SDGRVKLSDFGFCAQVSKEVPRRKSLVGT 178

Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
            Y+ APE+I     Y   +DIWS G ++ E++ G+P +  E  +  +            +
Sbjct: 179 PYWMAPEVI-SRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM------------K 225

Query: 180 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
            I+   P       P++K    HK+      P     + R+L   P  R+TA E L HPF
Sbjct: 226 RIRDNLP-------PKLKNL--HKV-----SPRLRSFLDRMLVRDPAQRATAAELLNHPF 271

Query: 240 FDELRDPNTRLP 251
             +   P++ +P
Sbjct: 272 LAKAGPPSSIVP 283

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 83.4 bits (206), Expect = 2e-18
 Identities = 79/265 (29%), Positives = 118/265 (44%), Gaps = 49/265 (18%)

Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 63
           ++ P +V LK   FS    ++LYL L      E     + HH +   R  L   + Y  +
Sbjct: 50  VNCPFIVPLK---FSFQSPEKLYLVLAFINGGE-----LFHHLQREGRFDLSRARFYTAE 101

Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYY 122
           +  AL  +H    V +RD+KP+N+L++ +   + LCDFG  K+ +K +   +  C +  Y
Sbjct: 102 LLCALENLH-KFNVIYRDLKPENILLD-YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEY 159

Query: 123 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 182
            APEL+ G   YT A+D W+ G +L E+L G P F  E+ V+++    K+L  P R    
Sbjct: 160 LAPELLLGHG-YTKAVDWWTLGVLLYEMLTGLPPFYDEN-VNEMYR--KILQEPLR---- 211

Query: 183 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR---STALEALIHPF 239
                                 F      +A DL+  LL   P  R   + A E   HPF
Sbjct: 212 ----------------------FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPF 249

Query: 240 FDELRDPNTRLPNGRFLPPLFNFKP 264
           F +L     +L      PP   FKP
Sbjct: 250 FSQLS--WKKLLMKGIQPP---FKP 269

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 82.4 bits (204), Expect = 2e-18
 Identities = 63/251 (25%), Positives = 98/251 (39%), Gaps = 47/251 (18%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMS-QRMPLIYVK 58
           M   +HPNVV   +  F     DEL+L  V+ Y+   ++  ++K  Y        +I   
Sbjct: 53  MSQCNHPNVVKY-YTSF--VVGDELWL--VMPYLSGGSLLDIMKSSYPRGGLDEAIIATV 107

Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS--- 115
           L   ++ + L Y+H+  G  HRDIK  N+L+      +K+ DFG +  L  G        
Sbjct: 108 LK--EVLKGLEYLHSN-GQIHRDIKAGNILLGEDG-SVKIADFGVSASLADGGDRTRKVR 163

Query: 116 --YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQP----LFPGESGVDQLVEI 169
             ++ +  + APE++     Y    DIWS G    EL  G        P +     L+  
Sbjct: 164 KTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV----LMLT 219

Query: 170 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS 229
           ++    P+ E           F+                       ++S  LQ  P+ R 
Sbjct: 220 LQN-DPPSLETGADYKKYSKSFR----------------------KMISLCLQKDPSKRP 256

Query: 230 TALEALIHPFF 240
           TA E L H FF
Sbjct: 257 TAEELLKHKFF 267

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 81.3 bits (201), Expect = 5e-18
 Identities = 67/243 (27%), Positives = 100/243 (41%), Gaps = 43/243 (17%)

Query: 1   MRLL---DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPET-VHRVIKHHYKMSQRMPLIY 56
           +R+L   +HPN++S K  F      D   L +V+EY P   + + I    K  + +P   
Sbjct: 50  IRILASVNHPNIISYKEAFL-----DGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQE 104

Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNIS 115
           +   F Q+ R L  +H    + HRD+K  N LLV      +K+ D G +KVL K     +
Sbjct: 105 IWRIFIQLLRGLQALHEQ-KILHRDLKSANILLVAND--LVKIGDLGISKVLKKNMAK-T 160

Query: 116 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
            I + +Y APE ++    Y+   DIWS GC+L E+    P F   S  D      KV   
Sbjct: 161 QIGTPHYMAPE-VWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRY---KVQRG 216

Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 235
                           K+P I               +  + +  +LQ  P LR    + L
Sbjct: 217 ----------------KYPPIPP---------IYSQDLQNFIRSMLQVKPKLRPNCDKIL 251

Query: 236 IHP 238
             P
Sbjct: 252 ASP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 81.7 bits (202), Expect = 7e-18
 Identities = 59/207 (28%), Positives = 87/207 (42%), Gaps = 20/207 (9%)

Query: 47  KMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV 106
           K + R+P   +      + R L Y+     + HRD+KP N+LVN    ++KLCDFG +  
Sbjct: 91  KKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQ 149

Query: 107 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQL 166
           L+    N S++ +R Y +PE + G T YT   DIWS G  L E+ +G+   P        
Sbjct: 150 LIDSMAN-SFVGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPDA---- 203

Query: 167 VEIIKVLGTPTREEIKCMNPNYTEFKFPQ-------------IKAHPWHKIFQKRMPPEA 213
            E+  + G P  E     +        P              I   P  K+       E 
Sbjct: 204 KELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEF 263

Query: 214 VDLVSRLLQYSPNLRSTALEALIHPFF 240
            D V + L+ +P  R+   E   HPF 
Sbjct: 264 QDFVDKCLKKNPKERADLKELTKHPFI 290

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 81.0 bits (200), Expect = 1e-17
 Identities = 72/243 (29%), Positives = 111/243 (45%), Gaps = 41/243 (16%)

Query: 7   PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 66
           P +V+L H  F T  K    L+L+L+YV      +  H Y+  +      V++Y  +I  
Sbjct: 65  PFLVTL-HYAFQTDTK----LHLILDYV--NGGELFTHLYQ-REHFTESEVRVYIAEIVL 116

Query: 67  ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN--ISYICSRYYRA 124
           AL ++H  +G+ +RDIK +N+L++   H + L DFG +K  +  E     S+  +  Y A
Sbjct: 117 ALDHLHQ-LGIIYRDIKLENILLDSEGH-VVLTDFGLSKEFLAEEEERAYSFCGTIEYMA 174

Query: 125 PELIFGATE-YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 183
           PE+I G +  +  A+D WS G +  ELL G   F  +   +   EI       +R  +K 
Sbjct: 175 PEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI-------SRRILKS 227

Query: 184 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR---STALEALIHPFF 240
             P                  F K M  EA D + +LL+  P  R   + A E   HPFF
Sbjct: 228 KPP------------------FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFF 269

Query: 241 DEL 243
             +
Sbjct: 270 QGI 272

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 81.0 bits (200), Expect = 1e-17
 Identities = 75/261 (28%), Positives = 113/261 (43%), Gaps = 47/261 (18%)

Query: 6   HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 65
           HP +  L  C F T E    +L  V+EY+       +  H + S R      + Y  +I 
Sbjct: 55  HPFLTHL-FCTFQTKE----HLFFVMEYLNGGD---LMFHIQSSGRFDEARARFYAAEII 106

Query: 66  RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRA 124
             L ++H   G+ +RD+K  N+L++   H +K+ DFG  K  + GE   S  C +  Y A
Sbjct: 107 CGLQFLH-KKGIIYRDLKLDNVLLDKDGH-IKIADFGMCKENMNGEGKASTFCGTPDYIA 164

Query: 125 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 184
           PE++ G  +Y  ++D WS G +L E+L+GQ  F GE   D+L + I         +    
Sbjct: 165 PEILKG-QKYNESVDWWSFGVLLYEMLIGQSPFHGE-DEDELFDSI-------LNDR--- 212

Query: 185 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-STALEALIHPFFDEL 243
                          P    F + +  EA D +S+L +  P  R     +   HPFF  +
Sbjct: 213 ---------------PH---FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGI 254

Query: 244 RDPNTRLPNGRFLPPLFNFKP 264
                RL      PP   FKP
Sbjct: 255 D--WERLEKREIPPP---FKP 270

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 80.2 bits (198), Expect = 1e-17
 Identities = 49/167 (29%), Positives = 79/167 (47%), Gaps = 15/167 (8%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           +R    PN+      +          L +++EY      R +     ++++    Y+ + 
Sbjct: 56  LRQSQPPNITKYYGSYLKGPR-----LWIIMEYAEGGSVRTLMKAGPIAEK----YISVI 106

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICS 119
             ++  AL YIH  +GV HRDIK  N+LV  +T  +KLCDFG A +L +      +++ +
Sbjct: 107 IREVLVALKYIHK-VGVIHRDIKAANILVT-NTGNVKLCDFGVAALLNQNSSKRSTFVGT 164

Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQL 166
            Y+ APE+I     Y    DIWS G  + E+  G P +   S VD  
Sbjct: 165 PYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPY---SDVDAF 208

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 79.1 bits (195), Expect = 3e-17
 Identities = 49/162 (30%), Positives = 81/162 (50%), Gaps = 10/162 (6%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           ++LL HPN++     F          L +V+EY P  T+   I+   + +  +    +  
Sbjct: 53  LKLLSHPNIIEYYENFLEDKA-----LMIVMEYAPGGTLAEYIQK--RCNSLLDEDTILH 105

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           +F QI  AL ++H  + + HRD+K QN+L++ H   +K+ DFG +K+L       + + +
Sbjct: 106 FFVQILLALHHVHTKL-ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGT 164

Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 161
             Y +PEL  G   Y    DIW+ GCVL EL   +  F   +
Sbjct: 165 PCYISPELCEG-KPYNQKSDIWALGCVLYELASLKRAFEAAN 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 78.4 bits (193), Expect = 8e-17
 Identities = 54/194 (27%), Positives = 84/194 (43%), Gaps = 38/194 (19%)

Query: 62  YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY 121
           Y + + L ++     + HRD+KP N+LVN +  Q+KLCDFG +  LV      +  C  Y
Sbjct: 109 YAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNG-QVKLCDFGVSGNLVASLAKTNIGCQSY 167

Query: 122 YRAPELI-----FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD---QLVEIIKVL 173
             APE I          YT   D+WS G  + E+ LG+  +P E+  +   QL  I+   
Sbjct: 168 M-APERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD-- 224

Query: 174 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
           G P       +   Y+                      +A D V++ L   PN R T  +
Sbjct: 225 GDPPT-----LPSGYS---------------------DDAQDFVAKCLNKIPNRRPTYAQ 258

Query: 234 ALIHPFFDELRDPN 247
            L HP+  + ++ +
Sbjct: 259 LLEHPWLVKYKNAD 272

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 77.6 bits (191), Expect = 1e-16
 Identities = 56/185 (30%), Positives = 84/185 (45%), Gaps = 29/185 (15%)

Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-S 115
           +  Y  QI   L Y+H+   + HRDIK  N+LVN ++  +K+ DFG++K L    P   +
Sbjct: 110 IIFYTKQILEGLKYLHDN-QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET 168

Query: 116 YICSRYYRAPELI-FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 174
           +  +  Y APE+I  G   Y A  DIWS GC + E+  G+P F                 
Sbjct: 169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF----------------- 211

Query: 175 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 234
                 I+   P    FK    K HP      + +  EA + + R  +  P+ R++A + 
Sbjct: 212 ------IELGEPQAAMFKVGMFKIHP---EIPESLSAEAKNFILRCFEPDPDKRASAHDL 262

Query: 235 LIHPF 239
           L  PF
Sbjct: 263 LQDPF 267

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 77.2 bits (191), Expect = 1e-16
 Identities = 46/178 (25%), Positives = 78/178 (43%), Gaps = 34/178 (19%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M+ L HPN+V L       T+ + LY  +V EY+P      +    +       +   L 
Sbjct: 55  MKKLSHPNIVRLLGVC---TQGEPLY--IVTEYMP---GGDLLDFLRKHGEKLTLKDLLQ 106

Query: 61  F-YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
              QI + + Y+ +     HRD+  +N LV      +K+ DFG ++ + + +        
Sbjct: 107 MALQIAKGMEYLES-KNFVHRDLAARNCLVT-ENLVVKISDFGLSRDIYEDD-------- 156

Query: 120 RYYR------------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 164
            YYR            APE +    ++T+  D+WS G +L E+  LG+  +PG S  +
Sbjct: 157 -YYRKRGGGKLPIKWMAPESLK-DGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE 212

Length = 258

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 77.8 bits (192), Expect = 2e-16
 Identities = 66/244 (27%), Positives = 100/244 (40%), Gaps = 46/244 (18%)

Query: 6   HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 65
           HP +  L H  F T  KD L+   V+EYV       +  H + S R      + Y  +I 
Sbjct: 55  HPFLTQL-HSCFQT--KDRLFF--VMEYVNGGD---LMFHIQRSGRFDEPRARFYAAEIV 106

Query: 66  RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRA 124
             L ++H   G+ +RD+K  N+L++   H +K+ DFG  K  + G    S  C +  Y A
Sbjct: 107 LGLQFLHER-GIIYRDLKLDNVLLDSEGH-IKIADFGMCKEGILGGVTTSTFCGTPDYIA 164

Query: 125 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 184
           PE++     Y  A+D W+ G +L E+L GQ  F G+   D+L                  
Sbjct: 165 PEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGD-DEDEL------------------ 204

Query: 185 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA-----LIHPF 239
                   F  I        + + +  EA  ++   L  +P  R   L         HPF
Sbjct: 205 --------FQSILEDEVR--YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPF 254

Query: 240 FDEL 243
           F E+
Sbjct: 255 FREI 258

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 77.0 bits (189), Expect = 2e-16
 Identities = 58/162 (35%), Positives = 81/162 (50%), Gaps = 10/162 (6%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           ++ L+HPNV+     F    E     LN+VLE      + R+IKH  K  + +P   V  
Sbjct: 56  LKQLNHPNVIKYYASFIEDNE-----LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWK 110

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNISYIC 118
           YF Q+C AL ++H+   V HRDIKP N+ +   T  +KL D G  +    K     S + 
Sbjct: 111 YFVQLCSALEHMHSR-RVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVG 168

Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 160
           + YY +PE I     Y    DIWS GC+L E+   Q  F G+
Sbjct: 169 TPYYMSPERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 75.8 bits (187), Expect = 4e-16
 Identities = 61/242 (25%), Positives = 97/242 (40%), Gaps = 39/242 (16%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEY-VPETVHRVIKHHYKMSQRMPLIYVKL 59
           ++  D P +V     +F  T+     L +V+EY    +V  ++K     ++ +    +  
Sbjct: 52  LKQCDSPYIVKYYGSYFKNTD-----LWIVMEYCGAGSVSDIMK---ITNKTLTEEEIAA 103

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-SYIC 118
             YQ  + L Y+H+     HRDIK  N+L+N    Q KL DFG +  L        + I 
Sbjct: 104 ILYQTLKGLEYLHSN-KKIHRDIKAGNILLN-EEGQAKLADFGVSGQLTDTMAKRNTVIG 161

Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 178
           + ++ APE+I     Y    DIWS G    E+  G+P +     +  +  I         
Sbjct: 162 TPFWMAPEVIQE-IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN------- 213

Query: 179 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 238
                  P  T    P            ++  PE  D V + L   P  R +A++ L HP
Sbjct: 214 ------KPPPT-LSDP------------EKWSPEFNDFVKKCLVKDPEERPSAIQLLQHP 254

Query: 239 FF 240
           F 
Sbjct: 255 FI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 76.0 bits (187), Expect = 5e-16
 Identities = 51/174 (29%), Positives = 75/174 (43%), Gaps = 21/174 (12%)

Query: 68  LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 127
           L Y++N   + HRDIKP N+LVN    Q+KLCDFG +  L+    + +++ +  Y +PE 
Sbjct: 116 LTYLYNVHRIMHRDIKPSNILVNSRG-QIKLCDFGVSGELINSIAD-TFVGTSTYMSPER 173

Query: 128 IFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 186
           I G  +YT   D+WS G  + EL LG+ P        D   + + +L             
Sbjct: 174 IQGG-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL----------- 221

Query: 187 NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
                   QI   P  ++     P +  D V   L   P  R T  +    P F
Sbjct: 222 ------LQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 76.0 bits (187), Expect = 5e-16
 Identities = 71/265 (26%), Positives = 113/265 (42%), Gaps = 48/265 (18%)

Query: 7   PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHH-YKMSQR-MPLIYVKLYFYQI 64
             +VSL + F +   KD+L L + L    +     +K+H Y + +   P      Y  QI
Sbjct: 53  RFIVSLAYAFET---KDDLCLVMTLMNGGD-----LKYHIYNVGEPGFPEARAIFYAAQI 104

Query: 65  CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 124
              L ++H    + +RD+KP+N+L++ H + +++ D G A  L  G+       +  Y A
Sbjct: 105 ICGLEHLHQR-RIVYRDLKPENVLLDDHGN-VRISDLGLAVELKGGKKIKGRAGTPGYMA 162

Query: 125 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 184
           PE++ G   Y  ++D ++ GC L E++ G+  F       Q  E ++      +EE+K  
Sbjct: 163 PEVLQGE-VYDFSVDWFALGCTLYEMIAGRSPF------RQRKEKVE------KEELKRR 209

Query: 185 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPF 239
                               +  +  PEA DL   LLQ  P  R      +A E   HP 
Sbjct: 210 -----------TLEMAVE--YPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPL 256

Query: 240 FDELRDPNTRLPNGRFLPPLFNFKP 264
           F +L     RL  G   PP   F P
Sbjct: 257 FKDLNWR--RLEAGMLEPP---FIP 276

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 76.3 bits (188), Expect = 7e-16
 Identities = 71/269 (26%), Positives = 109/269 (40%), Gaps = 64/269 (23%)

Query: 6   HPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-------TVHRVIKHHYKMSQRMPLIYVK 58
              +V L + F     +D+ YL L +EYVP            V+   +           +
Sbjct: 60  SEWLVKLLYAF-----QDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDH----------AR 104

Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 118
            Y  ++  A+  +H  +G  HRD+KP+N L++   H +KL DFG +K +V      S + 
Sbjct: 105 FYMAEMFEAVDALHE-LGYIHRDLKPENFLIDASGH-IKLTDFGLSKGIV--TYANSVVG 160

Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 178
           S  Y APE++ G   Y   +D WS GC+L E L G P F G                   
Sbjct: 161 SPDYMAPEVLRG-KGYDFTVDYWSLGCMLYEFLCGFPPFSGS------------------ 201

Query: 179 EEIKCMNPNYTEFKFPQIKAHPWHKIFQK--------RMPPEAVDLVSRLLQYSPNLRST 230
                  PN T   +  +K   W +  Q+         +  EA DL+++L+        +
Sbjct: 202 ------TPNET---WENLKY--WKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGS 250

Query: 231 ALEALIHPFFDELRDPNTRLPNGRFLPPL 259
             +   HPFF E+     R     F+P L
Sbjct: 251 LEDIKNHPFFKEVDWNELRELKPPFVPEL 279

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 75.6 bits (186), Expect = 8e-16
 Identities = 64/250 (25%), Positives = 101/250 (40%), Gaps = 42/250 (16%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ L HPN +  K C+       E    LV+EY   +   +++ H K  Q + +  +   
Sbjct: 69  LQQLRHPNTIEYKGCYLR-----EHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICH- 122

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
                + LAY+H+     HRDIK  N+L+      +KL DFGSA ++    P  S++ + 
Sbjct: 123 --GALQGLAYLHS-HERIHRDIKAGNILLTEPG-TVKLADFGSASLV---SPANSFVGTP 175

Query: 121 YYRAPELIFGATE--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 178
           Y+ APE+I    E  Y   +D+WS G    EL   +P     + +  L  I         
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI--------- 226

Query: 179 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 238
                      +   P + ++ W   F         + V   LQ  P  R ++ E L H 
Sbjct: 227 ----------AQNDSPTLSSNDWSDYF--------RNFVDSCLQKIPQDRPSSEELLKHR 268

Query: 239 FFDELRDPNT 248
           F    R P  
Sbjct: 269 FVLRERPPTV 278

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 74.9 bits (185), Expect = 1e-15
 Identities = 49/179 (27%), Positives = 75/179 (41%), Gaps = 38/179 (21%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETV-------HRVIKHHYKMSQRMP 53
           M+ L HPNVV L       TE++ LY  LVLEY+            R           + 
Sbjct: 50  MKKLGHPNVVRLLGV---CTEEEPLY--LVLEYMEGGDLLDYLRKSRP-VFPSPEKSTLS 103

Query: 54  LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 113
           L  +  +  QI + + Y+ +     HRD+  +N LV      +K+ DFG ++ +   +  
Sbjct: 104 LKDLLSFAIQIAKGMEYLAS-KKFVHRDLAARNCLVG-EDLVVKISDFGLSRDVYDDD-- 159

Query: 114 ISYICSRYYR------------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 159
                  YYR            APE +     +T+  D+WS G +L E+  LG   +PG
Sbjct: 160 -------YYRKKTGGKLPIRWMAPESLKDGI-FTSKSDVWSFGVLLWEIFTLGATPYPG 210

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 75.9 bits (187), Expect = 1e-15
 Identities = 72/279 (25%), Positives = 107/279 (38%), Gaps = 81/279 (29%)

Query: 5   DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFY 62
           D+P VV L + F     +DE YL L++EY+P  + +  ++K     ++     Y+     
Sbjct: 59  DNPWVVKLYYSF-----QDENYLYLIMEYLPGGDMMTLLMKKD-TFTEEETRFYIA---- 108

Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG------------SAKVLVKG 110
           +   A+  IH  +G  HRDIKP NLL++   H +KL DFG              ++L   
Sbjct: 109 ETILAIDSIH-KLGYIHRDIKPDNLLLDAKGH-IKLSDFGLCTGLKKSHRTEFYRILSHA 166

Query: 111 EPNISYICSR--------------------Y-------YRAPELIFGATEYTAAIDIWSA 143
            P+                           Y       Y APE +F  T Y    D WS 
Sbjct: 167 LPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPE-VFLQTGYNKECDWWSL 225

Query: 144 GCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHK 203
           G ++ E+L+G P F  +               P     K +N   T  +FP         
Sbjct: 226 GVIMYEMLVGYPPFCSD--------------NPQETYRKIINWKET-LQFPD-------- 262

Query: 204 IFQKRMPPEAVDLVSRLLQYSPNL--RSTALEALIHPFF 240
             +  + PEA DL+ RL   +      +   E   HPFF
Sbjct: 263 --EVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSHPFF 299

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 74.5 bits (183), Expect = 1e-15
 Identities = 49/173 (28%), Positives = 84/173 (48%), Gaps = 18/173 (10%)

Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFY 62
           LD   ++     F      D+  LN+V+EY     +H+++K      + +P   V  +F 
Sbjct: 56  LDSSYIIRYYESFL-----DKGKLNIVMEYAENGDLHKLLKMQ--RGRPLPEDQVWRFFI 108

Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY----IC 118
           QI   LA++H+   + HRDIK  NL ++ +   +K+ D G AK+L     N ++    + 
Sbjct: 109 QILLGLAHLHSK-KILHRDIKSLNLFLDAYD-NVKIGDLGVAKLL---SDNTNFANTIVG 163

Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 171
           + YY +PEL      Y    D+W+ G VL E   G+  F   +    +++II+
Sbjct: 164 TPYYLSPELC-EDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR 215

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 74.6 bits (184), Expect = 1e-15
 Identities = 51/162 (31%), Positives = 80/162 (49%), Gaps = 17/162 (10%)

Query: 5   DHPNVVSLKHCFF---STTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLY 60
           +HPN+ +    F         D+L+L  V+E     +V  ++K   K  +R+   ++   
Sbjct: 61  NHPNIATFYGAFIKKNPPGNDDQLWL--VMELCGGGSVTDLVKGLRKKGKRLKEEWIAYI 118

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICS 119
             +  R LAY+H    V HRDIK QN+L+     ++KL DFG SA++        ++I +
Sbjct: 119 LRETLRGLAYLHEN-KVIHRDIKGQNILLT-KNAEVKLVDFGVSAQLDSTLGRRNTFIGT 176

Query: 120 RYYRAPELIFGATE------YTAAIDIWSAGCVLAELLLGQP 155
            Y+ APE+I  A +      Y A  D+WS G    EL  G+P
Sbjct: 177 PYWMAPEVI--ACDEQPDASYDARSDVWSLGITAIELADGKP 216

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 75.0 bits (184), Expect = 2e-15
 Identities = 74/247 (29%), Positives = 111/247 (44%), Gaps = 48/247 (19%)

Query: 7   PNVVSLKHCFFSTTEKDELYLNLVLEYVPET---VHRVIKHHYKMSQRMPLIYVKLYFYQ 63
           P +V+L H  F T  K    L+L+L+YV       H   + ++   +      V+ Y  +
Sbjct: 65  PFLVTL-HYAFQTEAK----LHLILDYVSGGEMFTHLYQRDNFSEDE------VRFYSGE 113

Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-ICSRY- 121
           I  AL ++H  +G+ +RDIK +N+L++   H + L DFG +K  +  E   +Y  C    
Sbjct: 114 IILALEHLHK-LGIVYRDIKLENILLDSEGH-VVLTDFGLSKEFLSEEKERTYSFCGTIE 171

Query: 122 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 181
           Y APE+I G   +  A+D WS G ++ ELL G   F  E   +   E+       +R  +
Sbjct: 172 YMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV-------SRRIL 224

Query: 182 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALI 236
           KC  P                  F   + PEA DL+ +LL+  P  R       A E   
Sbjct: 225 KCDPP------------------FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266

Query: 237 HPFFDEL 243
           HPFF  L
Sbjct: 267 HPFFKGL 273

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 73.5 bits (180), Expect = 3e-15
 Identities = 55/162 (33%), Positives = 81/162 (50%), Gaps = 10/162 (6%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           ++ L+HPNV+     F    E     LN+VLE      + ++IK+  K  + +P   V  
Sbjct: 56  LKQLNHPNVIKYLDSFIEDNE-----LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWK 110

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNISYIC 118
           YF Q+C A+ ++H+   V HRDIKP N+ +   T  +KL D G  +    K     S + 
Sbjct: 111 YFVQLCSAVEHMHSR-RVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVG 168

Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 160
           + YY +PE I     Y    DIWS GC+L E+   Q  F G+
Sbjct: 169 TPYYMSPERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 73.9 bits (181), Expect = 3e-15
 Identities = 64/248 (25%), Positives = 101/248 (40%), Gaps = 42/248 (16%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ L HPN +  K C+       E    LV+EY   +   +++ H K  Q + +  +   
Sbjct: 75  LQQLKHPNTIEYKGCYLK-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAIT-- 127

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
            +   + LAY+H+   + HRDIK  N+L+     Q+KL DFGSA       P  S++ + 
Sbjct: 128 -HGALQGLAYLHSHNMI-HRDIKAGNILLT-EPGQVKLADFGSASKS---SPANSFVGTP 181

Query: 121 YYRAPELIFGATE--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 178
           Y+ APE+I    E  Y   +D+WS G    EL   +P     + +  L  I         
Sbjct: 182 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI--------- 232

Query: 179 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 238
                      +   P ++++ W   F+          V   LQ  P  R  + E L H 
Sbjct: 233 ----------AQNDSPTLQSNEWTDSFRG--------FVDYCLQKIPQERPASAELLRHD 274

Query: 239 FFDELRDP 246
           F    R  
Sbjct: 275 FVRRDRPA 282

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 72.9 bits (179), Expect = 7e-15
 Identities = 50/168 (29%), Positives = 87/168 (51%), Gaps = 27/168 (16%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           ++ + HP ++ L       TE D+ +L +++EYVP   +   +++  + S    L Y   
Sbjct: 55  LKEVSHPFIIRLF-----WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYAS- 108

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK------GEPN 113
              +I  AL Y+H +  + +RD+KP+N+L++   H +KL DFG AK L        G P 
Sbjct: 109 ---EIVCALEYLH-SKEIVYRDLKPENILLDKEGH-IKLTDFGFAKKLRDRTWTLCGTPE 163

Query: 114 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 161
                   Y APE+I  +  +  A+D W+ G ++ E+L+G P F  ++
Sbjct: 164 --------YLAPEVI-QSKGHNKAVDWWALGILIYEMLVGYPPFFDDN 202

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 72.8 bits (178), Expect = 8e-15
 Identities = 58/189 (30%), Positives = 88/189 (46%), Gaps = 30/189 (15%)

Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-ISYICSRYY 122
           + +AL Y+H+  GV HRDIK  ++L+     ++KL DFG    + K  P   S + + Y+
Sbjct: 126 VLQALCYLHSQ-GVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDVPKRKSLVGTPYW 183

Query: 123 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 182
            APE+I   T Y   +DIWS G ++ E++ G+P +  +S V  +  +        R+   
Sbjct: 184 MAPEVI-SRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL--------RDS-- 232

Query: 183 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 242
                      P  K    HKI      P   D + R+L   P  R+TA E L HPF  +
Sbjct: 233 -----------PPPKLKNAHKI-----SPVLRDFLERMLTREPQERATAQELLDHPFLLQ 276

Query: 243 LRDPNTRLP 251
              P   +P
Sbjct: 277 TGLPECLVP 285

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 72.8 bits (179), Expect = 8e-15
 Identities = 53/172 (30%), Positives = 76/172 (44%), Gaps = 33/172 (19%)

Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS----YICS 119
           + + L+Y+H +  + HRDIKP N+L+     Q+KLCDFG     V GE   S    +  +
Sbjct: 114 VLKGLSYLH-SRKIIHRDIKPSNILLTRKG-QVKLCDFG-----VSGELVNSLAGTFTGT 166

Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES----GVDQLVEIIKVLGT 175
            +Y APE I G   Y+   D+WS G  L E+   +  FP E     G  +L+  I  +  
Sbjct: 167 SFYMAPERIQGKP-YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPN 225

Query: 176 PT-----------REEIK-----CMNPNYTEFKFP-QIKAHPWHKIFQKRMP 210
           P             EE K     C+  + T    P  +  HPW K   K+  
Sbjct: 226 PELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKKV 277

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 72.3 bits (178), Expect = 8e-15
 Identities = 55/185 (29%), Positives = 78/185 (42%), Gaps = 43/185 (23%)

Query: 62  YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR- 120
            ++   L Y+H   G  HRDIK  N+L++     +KL DFG     V G+   S +  R 
Sbjct: 105 REVLLGLEYLHEE-GKIHRDIKAANILLSEEG-DVKLADFG-----VSGQLT-STMSKRN 156

Query: 121 ------YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 174
                 ++ APE+I   + Y    DIWS G    EL  G+P  P  S +  +    +VL 
Sbjct: 157 TFVGTPFWMAPEVIKQ-SGYDEKADIWSLGITAIELAKGEP--P-LSDLHPM----RVL- 207

Query: 175 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 234
                  K  NP       P ++ + + K F+        D VS  L   P  R +A E 
Sbjct: 208 ---FLIPKN-NP-------PSLEGNKFSKPFK--------DFVSLCLNKDPKERPSAKEL 248

Query: 235 LIHPF 239
           L H F
Sbjct: 249 LKHKF 253

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 73.3 bits (180), Expect = 9e-15
 Identities = 52/171 (30%), Positives = 83/171 (48%), Gaps = 22/171 (12%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M   +   +V L H  F    +D+ YL +V+EY+P      +  +Y + ++    + + Y
Sbjct: 97  MAHANSEWIVQL-HYAF----QDDKYLYMVMEYMPGGDLVNLMSNYDIPEK----WARFY 147

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
             ++  AL  IH+ +G  HRD+KP N+L++   H LKL DFG+    +K + N    C  
Sbjct: 148 TAEVVLALDAIHS-MGFIHRDVKPDNMLLDKSGH-LKLADFGTC---MKMDANGMVRCDT 202

Query: 121 Y-----YRAPELIF---GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 163
                 Y +PE++    G   Y    D WS G  L E+L+G   F  +S V
Sbjct: 203 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 253

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 72.1 bits (177), Expect = 1e-14
 Identities = 54/195 (27%), Positives = 76/195 (38%), Gaps = 45/195 (23%)

Query: 62  YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSR 120
            Q+  AL ++H+   V HRD+K  N+L+      +KL DFG SAK     +   ++I + 
Sbjct: 110 RQMLEALNFLHSHK-VIHRDLKAGNILLTLDG-DVKLADFGVSAKNKSTLQKRDTFIGTP 167

Query: 121 YYRAPELI----FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
           Y+ APE++    F    Y    DIWS G  L EL   +P                    P
Sbjct: 168 YWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEP--------------------P 207

Query: 177 TREEIKCMNPNYTEFKFPQ------IKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 230
             E    +NP     K  +       +   W   F         D +   L   P+ R T
Sbjct: 208 HHE----LNPMRVLLKILKSEPPTLDQPSKWSSSFN--------DFLKSCLVKDPDDRPT 255

Query: 231 ALEALIHPFFDELRD 245
           A E L HPF  +  D
Sbjct: 256 AAELLKHPFVSDQSD 270

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 72.0 bits (176), Expect = 2e-14
 Identities = 71/254 (27%), Positives = 118/254 (46%), Gaps = 47/254 (18%)

Query: 2   RLLDH----PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++L+H    P +V+L + F + T+     L+L+L+Y+       +  H    +R     V
Sbjct: 56  QVLEHIRQSPFLVTLHYAFQTDTK-----LHLILDYINGGE---LFTHLSQRERFKEQEV 107

Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY- 116
           ++Y  +I  AL ++H  +G+ +RDIK +N+L++ + H + L DFG +K   + E   +Y 
Sbjct: 108 QIYSGEIVLALEHLHK-LGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFHEDEVERAYS 165

Query: 117 ICSRY-YRAPELIFGA-TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 174
            C    Y AP+++ G    +  A+D WS G ++ ELL G   F  +   +   EI     
Sbjct: 166 FCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEI----- 220

Query: 175 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----S 229
             +R  +K   P      +PQ             M   A D++ RLL   P  R     S
Sbjct: 221 --SRRILKSEPP------YPQ------------EMSALAKDIIQRLLMKDPKKRLGCGPS 260

Query: 230 TALEALIHPFFDEL 243
            A E   HPFF ++
Sbjct: 261 DADEIKKHPFFQKI 274

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 71.1 bits (174), Expect = 2e-14
 Identities = 67/241 (27%), Positives = 106/241 (43%), Gaps = 43/241 (17%)

Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYF 61
           + HPN+V+    F S  E   L++  V+EY    + + R+ +    +     ++    +F
Sbjct: 56  MKHPNIVTF---FASFQENGRLFI--VMEYCDGGDLMKRINRQRGVLFSEDQIL---SWF 107

Query: 62  YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC--S 119
            QI   L +IH+   + HRDIK QN+ ++ +    KL DFG A+ L      ++Y C  +
Sbjct: 108 VQISLGLKHIHDR-KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-NDSMELAYTCVGT 165

Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
            YY +PE I     Y    DIWS GCVL EL   +  F G + + QLV  I       + 
Sbjct: 166 PYYLSPE-ICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-LHQLVLKI------CQG 217

Query: 180 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
               ++PN++                      +   L+S+L + SP  R +    L  PF
Sbjct: 218 YFAPISPNFSR---------------------DLRSLISQLFKVSPRDRPSITSILKRPF 256

Query: 240 F 240
            
Sbjct: 257 L 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 72.0 bits (176), Expect = 2e-14
 Identities = 46/131 (35%), Positives = 72/131 (54%), Gaps = 9/131 (6%)

Query: 47  KMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV 106
           K ++R+P   +      + R LAY+     + HRD+KP N+LVN    ++KLCDFG +  
Sbjct: 95  KEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRG-EIKLCDFGVSGQ 153

Query: 107 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQ 165
           L+    N S++ +R Y +PE + G T Y+   DIWS G  L EL +G+ P+ P ++    
Sbjct: 154 LIDSMAN-SFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVELAIGRYPIPPPDAK--- 208

Query: 166 LVEIIKVLGTP 176
             E+  + G P
Sbjct: 209 --ELEAIFGRP 217

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 71.5 bits (175), Expect = 3e-14
 Identities = 72/253 (28%), Positives = 117/253 (46%), Gaps = 46/253 (18%)

Query: 14  HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 73
           +C F T  K+ L+   V+E++       +  H +   R  L     Y  +I   L ++H+
Sbjct: 62  YCTFQT--KEHLFF--VMEFLNGGD---LMFHIQDKGRFDLYRATFYAAEIVCGLQFLHS 114

Query: 74  TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGAT 132
             G+ +RD+K  N++++   H +K+ DFG  K  V G+   S  C +  Y APE++ G  
Sbjct: 115 K-GIIYRDLKLDNVMLDRDGH-IKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQG-L 171

Query: 133 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 192
           +YT ++D WS G +L E+L+GQ  F G+   D+L E I+V  TP                
Sbjct: 172 KYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-DELFESIRV-DTP---------------H 214

Query: 193 FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL-IHPFFDELRDPNTRLP 251
           +P+     W       +  E+ D++ +L +  P  R   +  +  HPFF  +    T L 
Sbjct: 215 YPR-----W-------ITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTIN--WTALE 260

Query: 252 NGRFLPPLFNFKP 264
                PP   FKP
Sbjct: 261 KRELDPP---FKP 270

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 70.8 bits (173), Expect = 3e-14
 Identities = 72/252 (28%), Positives = 115/252 (45%), Gaps = 39/252 (15%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           MR   H NVV + + +      DEL++  V+E++       I  H +M++      +   
Sbjct: 71  MRDYQHENVVEMYNSYLV---GDELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAV 121

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-ISYICS 119
              + +AL+ +H   GV HRDIK  ++L+  H  ++KL DFG    + K  P   S + +
Sbjct: 122 CLAVLKALSVLHAQ-GVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKSLVGT 179

Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
            Y+ APELI     Y   +DIWS G ++ E++ G+P +  E               P  +
Sbjct: 180 PYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLK 223

Query: 180 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
            +K +  N      P++K    HK+      P     + RLL   P  R+TA E L HPF
Sbjct: 224 AMKMIRDNLP----PKLKN--LHKV-----SPSLKGFLDRLLVRDPAQRATAAELLKHPF 272

Query: 240 FDELRDPNTRLP 251
             +   P+  +P
Sbjct: 273 LAKAGPPSCIVP 284

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 71.0 bits (174), Expect = 4e-14
 Identities = 68/242 (28%), Positives = 108/242 (44%), Gaps = 47/242 (19%)

Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 63
           L HP +V++   F    +++ +Y   +LE+V   V   +  H + + R P    K Y  +
Sbjct: 75  LSHPFIVNMMCSF---QDENRVYF--LLEFV---VGGELFTHLRKAGRFPNDVAKFYHAE 126

Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 123
           +  A  Y+H+   + +RD+KP+NLL++   H +K+ DFG AK +   +   +   +  Y 
Sbjct: 127 LVLAFEYLHSK-DIIYRDLKPENLLLDNKGH-VKVTDFGFAKKVP--DRTFTLCGTPEYL 182

Query: 124 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 183
           APE+I  +  +  A+D W+ G +L E + G P F  +              TP R   K 
Sbjct: 183 APEVI-QSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD--------------TPFRIYEKI 227

Query: 184 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI-----HP 238
           +       KFP      W   F  R    A DLV  LLQ     R   L+  +     HP
Sbjct: 228 LA---GRLKFPN-----W---FDGR----ARDLVKGLLQTDHTKRLGTLKGGVADVKNHP 272

Query: 239 FF 240
           +F
Sbjct: 273 YF 274

Length = 329

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 70.0 bits (171), Expect = 4e-14
 Identities = 49/150 (32%), Positives = 79/150 (52%), Gaps = 14/150 (9%)

Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYF 61
           + HPN+V+ K  F     + + +L +V+EY    + + ++     K+    P   +  +F
Sbjct: 55  MKHPNIVAFKESF-----EADGHLYIVMEYCDGGDLMQKIKLQRGKL---FPEDTILQWF 106

Query: 62  YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-GEPNISYICSR 120
            Q+C  + +IH    V HRDIK +N+ +     ++KL DFGSA++L   G    +Y+ + 
Sbjct: 107 VQMCLGVQHIHEK-RVLHRDIKSKNIFLT-QNGKVKLGDFGSARLLTSPGAYACTYVGTP 164

Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAEL 150
           YY  PE I+    Y    DIWS GC+L EL
Sbjct: 165 YYVPPE-IWENMPYNNKSDIWSLGCILYEL 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 70.6 bits (173), Expect = 5e-14
 Identities = 68/271 (25%), Positives = 122/271 (45%), Gaps = 53/271 (19%)

Query: 5   DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQI 64
           +HP +V L  CF + +      L  V+E+V       +  H +  +++P  + + Y  +I
Sbjct: 54  NHPFLVGLHSCFQTESR-----LFFVIEFVSGGD---LMFHMQRQRKLPEEHARFYSAEI 105

Query: 65  CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNISYICSRYYR 123
             AL ++H   G+ +RD+K  N+L++   H +KL D+G  K  +  G+   ++  +  Y 
Sbjct: 106 SLALNFLHER-GIIYRDLKLDNVLLDAEGH-IKLTDYGMCKEGIRPGDTTSTFCGTPNYI 163

Query: 124 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLF--------PGESGVDQLVEII--KVL 173
           APE++ G  +Y  ++D W+ G ++ E++ G+  F        P ++  D L ++I  K +
Sbjct: 164 APEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI 222

Query: 174 GTPTREEIKC-------MNPNYTE-------FKFPQIKAHP------WHKIFQKRMPPEA 213
             P    +K        +N +  E         F  IK+HP      W  + QK++ P  
Sbjct: 223 RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQKQVLPP- 281

Query: 214 VDLVSRLLQYSPNLRST-ALEALIHPFFDEL 243
                    Y PN+ S   L+     F DE 
Sbjct: 282 ---------YKPNIESDRDLDNFDPQFTDEP 303

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 69.6 bits (170), Expect = 7e-14
 Identities = 64/254 (25%), Positives = 106/254 (41%), Gaps = 60/254 (23%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           ++ L H N+V      +  T  D+  +++ +E+VP  ++  ++         +P      
Sbjct: 56  LKSLKHVNIVQ-----YLGTCLDDNTISIFMEFVPGGSISSILNRF----GPLPEPVFCK 106

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI-- 117
           Y  QI   +AY+HN   V HRDIK  N+++ P    +KL DFG A+ L     + ++   
Sbjct: 107 YTKQILDGVAYLHNN-CVVHRDIKGNNVMLMP-NGIIKLIDFGCARRLAWVGLHGTHSNM 164

Query: 118 -----CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 172
                 + Y+ APE+I   + Y    DIWS GC + E+  G+P     + +D+L  +   
Sbjct: 165 LKSMHGTPYWMAPEVI-NESGYGRKSDIWSIGCTVFEMATGKPPL---ASMDRLAAMF-- 218

Query: 173 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPP-------EAVDLVSRLLQYSP 225
                                  I AH      +  MP         A+D V+  L    
Sbjct: 219 ----------------------YIGAH------RGLMPRLPDSFSAAAIDFVTSCLTRDQ 250

Query: 226 NLRSTALEALIHPF 239
           + R +AL+ L H F
Sbjct: 251 HERPSALQLLRHDF 264

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 70.1 bits (171), Expect = 7e-14
 Identities = 63/241 (26%), Positives = 104/241 (43%), Gaps = 42/241 (17%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ + HPN +  K C+       E    LV+EY   +   +++ H K  Q + +  +   
Sbjct: 79  LQRIKHPNSIEYKGCYLR-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAIT-- 131

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
            +   + LAY+H+   + HRDIK  N+L+     Q+KL DFGSA +     P  S++ + 
Sbjct: 132 -HGALQGLAYLHSH-NMIHRDIKAGNILLT-EPGQVKLADFGSASIA---SPANSFVGTP 185

Query: 121 YYRAPELIFGATE--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 178
           Y+ APE+I    E  Y   +D+WS G    EL   +P     + +  L  I         
Sbjct: 186 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI--------- 236

Query: 179 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 238
                      + + P ++++ W   F+        + V   LQ  P  R T+ E L H 
Sbjct: 237 ----------AQNESPTLQSNEWSDYFR--------NFVDSCLQKIPQDRPTSEELLKHM 278

Query: 239 F 239
           F
Sbjct: 279 F 279

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 70.2 bits (172), Expect = 7e-14
 Identities = 50/155 (32%), Positives = 77/155 (49%), Gaps = 12/155 (7%)

Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 63
           + HP +V L H  F T +K    L  VL+YV       +  H +  +  P    + Y  +
Sbjct: 53  VKHPFLVGL-HYSFQTADK----LYFVLDYVNGGE---LFFHLQRERSFPEPRARFYAAE 104

Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYY 122
           I  AL Y+H ++ + +RD+KP+N+L++   H + L DFG  K  ++     S  C +  Y
Sbjct: 105 IASALGYLH-SLNIIYRDLKPENILLDSQGH-VVLTDFGLCKEGIEHSKTTSTFCGTPEY 162

Query: 123 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 157
            APE++     Y   +D W  G VL E+L G P F
Sbjct: 163 LAPEVLR-KQPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 69.5 bits (170), Expect = 9e-14
 Identities = 49/185 (26%), Positives = 81/185 (43%), Gaps = 24/185 (12%)

Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 123
           + + L Y+  ++ + HRD+KP N+LVN    Q+KLCDFG +  LV      +Y+ +  Y 
Sbjct: 104 VVKGLTYLW-SLKILHRDVKPSNMLVNTRG-QVKLCDFGVSTQLVNSIAK-TYVGTNAYM 160

Query: 124 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 183
           APE I G  +Y    D+WS G    EL LG+  +P        +  +++L     E+   
Sbjct: 161 APERISG-EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP-- 217

Query: 184 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 243
                     P +    + + F        V  +++ ++  P  R      + HPF  + 
Sbjct: 218 ----------PVLPVGQFSEKF--------VHFITQCMRKQPKERPAPENLMDHPFIVQY 259

Query: 244 RDPNT 248
            D N 
Sbjct: 260 NDGNA 264

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 69.4 bits (170), Expect = 1e-13
 Identities = 50/160 (31%), Positives = 77/160 (48%), Gaps = 22/160 (13%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHY--KMSQRMPLIYVK 58
           +R LDH N+V  K        +    L L++EY+P    R     Y  +   ++ L  + 
Sbjct: 60  LRTLDHENIVKYKGVCEKPGGRS---LRLIMEYLPSGSLR----DYLQRHRDQINLKRLL 112

Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------E 111
           L+  QIC+ + Y+ +     HRD+  +N+LV      +K+ DFG AKVL +        E
Sbjct: 113 LFSSQICKGMDYLGSQ-RYIHRDLAARNILVE-SEDLVKISDFGLAKVLPEDKDYYYVKE 170

Query: 112 PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL 151
           P  S I   +Y APE +  +   +A+ D+WS G  L EL 
Sbjct: 171 PGESPI--FWY-APECLRTSKFSSAS-DVWSFGVTLYELF 206

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 69.6 bits (170), Expect = 1e-13
 Identities = 70/263 (26%), Positives = 113/263 (42%), Gaps = 49/263 (18%)

Query: 5   DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQI 64
           +HP +  L +C F T E     L  V+EY+       +  H +   +  L     Y  +I
Sbjct: 54  EHPFLTHL-YCTFQTKE----NLFFVMEYLNGGD---LMFHIQSCHKFDLPRATFYAAEI 105

Query: 65  CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYR 123
              L ++H+  G+ +RD+K  N+L++   H +K+ DFG  K  + G+      C +  Y 
Sbjct: 106 ICGLQFLHSK-GIVYRDLKLDNILLDTDGH-IKIADFGMCKENMLGDAKTCTFCGTPDYI 163

Query: 124 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 183
           APE++ G  +Y  ++D WS G +L E+L+GQ  F G    +              + I+ 
Sbjct: 164 APEILLG-QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELF------------QSIRM 210

Query: 184 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI--HPFFD 241
            NP Y  +                 +  EA D++ +L    P  R   ++  I  HPFF 
Sbjct: 211 DNPCYPRW-----------------LTREAKDILVKLFVREPE-RRLGVKGDIRQHPFFR 252

Query: 242 ELRDPNTRLPNGRFLPPLFNFKP 264
           E+    + L      PP   FKP
Sbjct: 253 EID--WSALEEREIEPP---FKP 270

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 69.8 bits (171), Expect = 1e-13
 Identities = 69/243 (28%), Positives = 103/243 (42%), Gaps = 50/243 (20%)

Query: 6   HPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQ 63
           HP +V L    F T  K    L L+LEY+   E    + +    M           Y  +
Sbjct: 59  HPFIVDL-IYAFQTGGK----LYLILEYLSGGELFMHLEREGIFMEDT-----ACFYLSE 108

Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-Y 122
           I  AL ++H   G+ +RD+KP+N+L++   H +KL DFG  K  +         C    Y
Sbjct: 109 ISLALEHLH-QQGIIYRDLKPENILLDAQGH-VKLTDFGLCKESIHEGTVTHTFCGTIEY 166

Query: 123 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 182
            APE I   + +  A+D WS G ++ ++L G P F  E+    + +I+K          K
Sbjct: 167 MAPE-ILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG---------K 216

Query: 183 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIH 237
              P Y                    + PEA DL+ +LL+ +P+ R       A E   H
Sbjct: 217 LNLPPY--------------------LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256

Query: 238 PFF 240
           PFF
Sbjct: 257 PFF 259

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 69.7 bits (170), Expect = 1e-13
 Identities = 46/157 (29%), Positives = 78/157 (49%), Gaps = 15/157 (9%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ L HPN +  + C+       E    LV+EY   +   +++ H K  Q + +  V   
Sbjct: 69  LQKLRHPNTIQYRGCYLR-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVT-- 121

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
            +   + LAY+H+   + HRD+K  N+L++     +KL DFGSA ++    P   ++ + 
Sbjct: 122 -HGALQGLAYLHSH-NMIHRDVKAGNILLS-EPGLVKLGDFGSASIM---APANXFVGTP 175

Query: 121 YYRAPELIFGATE--YTAAIDIWSAGCVLAELLLGQP 155
           Y+ APE+I    E  Y   +D+WS G    EL   +P
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 212

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 68.5 bits (168), Expect = 2e-13
 Identities = 55/188 (29%), Positives = 79/188 (42%), Gaps = 43/188 (22%)

Query: 64  ICR----ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK--GEPNISYI 117
           +CR     LAY+H T G  HRDIK  N+L+      +KL DFG +  L     +   S+I
Sbjct: 106 VCRETLKGLAYLHET-GKIHRDIKGANILLTEDGD-VKLADFGVSAQLTATIAKRK-SFI 162

Query: 118 CSRYYRAPELIFGATE----YTAAIDIWSAGCVLAELLLGQP-LFPGESGVDQLVEIIKV 172
            + Y+ APE+   A E    Y    DIW+ G    EL   QP +F         +  ++ 
Sbjct: 163 GTPYWMAPEVA--AVERKGGYDGKCDIWALGITAIELAELQPPMFD--------LHPMRA 212

Query: 173 LGTPTREEIKCMNPNYTEFKFPQIKA-HPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 231
           L   ++            F  P++K    W  +F         D + + L   P  R TA
Sbjct: 213 LFLISKSN----------FPPPKLKDKEKWSPVFH--------DFIKKCLTKDPKKRPTA 254

Query: 232 LEALIHPF 239
            + L HPF
Sbjct: 255 TKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 69.3 bits (169), Expect = 2e-13
 Identities = 61/242 (25%), Positives = 107/242 (44%), Gaps = 50/242 (20%)

Query: 5   DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQI 64
           +HP +V L  CF     + E  L  V+EYV       +  H +  +++P  + + Y  +I
Sbjct: 54  NHPFLVGLHSCF-----QTESRLFFVIEYVNGGD---LMFHMQRQRKLPEEHARFYSAEI 105

Query: 65  CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYR 123
             AL Y+H   G+ +RD+K  N+L++   H +KL D+G  K  ++     S  C +  Y 
Sbjct: 106 SLALNYLHER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYI 163

Query: 124 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLF--------PGESGVDQLVEII----- 170
           APE++ G  +Y  ++D W+ G ++ E++ G+  F        P ++  D L ++I     
Sbjct: 164 APEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 222

Query: 171 ---------------KVLGTPTREEIKCMNPNYTEFKFPQIKAHP------WHKIFQKRM 209
                            L    +E + C      +  F  I+ HP      W  + QK++
Sbjct: 223 RIPRSLSVKAASVLKSFLNKDPKERLGCH----PQTGFADIQGHPFFRNVDWDLMEQKQV 278

Query: 210 PP 211
            P
Sbjct: 279 VP 280

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 68.4 bits (167), Expect = 2e-13
 Identities = 48/192 (25%), Positives = 83/192 (43%), Gaps = 28/192 (14%)

Query: 45  HYKMSQRMPLIYVKLYFY--QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG 102
           HY +SQ       ++ FY  +I   L ++HN   V +RD+KP N+L++ H H +++ D G
Sbjct: 85  HYHLSQHGVFSEAEMRFYAAEIILGLEHMHNR-FVVYRDLKPANILLDEHGH-VRISDLG 142

Query: 103 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-------- 154
            A    K +P+ S + +  Y APE++     Y ++ D +S GC+L +LL G         
Sbjct: 143 LACDFSKKKPHAS-VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 201

Query: 155 --------------PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK-FPQIKAH 199
                            P     +    +  +L       + C+     E K  P  ++ 
Sbjct: 202 KDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSL 261

Query: 200 PWHKIFQKRMPP 211
            W  +F ++ PP
Sbjct: 262 DWQMVFLQKYPP 273

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 69.3 bits (169), Expect = 3e-13
 Identities = 81/317 (25%), Positives = 128/317 (40%), Gaps = 94/317 (29%)

Query: 16  FFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 73
           ++S  +KD LY   V++Y+P  + +  +I+      +  P +  + Y  ++  A+  +H 
Sbjct: 67  YYSFQDKDNLYF--VMDYIPGGDMMSLLIR-----MEVFPEVLARFYIAELTLAIESVHK 119

Query: 74  TIGVCHRDIKPQNLLVNPHTHQLKLCDFG---------SAKVLVKG--------EPNI-- 114
            +G  HRDIKP N+L++   H +KL DFG         ++K   KG        EP+   
Sbjct: 120 -MGFIHRDIKPDNILIDLDGH-IKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLW 177

Query: 115 -----------------------------SYICSRYYRAPELIFGATEYTAAIDIWSAGC 145
                                        S + +  Y APE++     YT   D WS G 
Sbjct: 178 DDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-RKGYTQLCDWWSVGV 236

Query: 146 VLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIF 205
           +L E+L+GQP F              +  TPT  ++K +N   T    PQ+K        
Sbjct: 237 ILFEMLVGQPPF--------------LAPTPTETQLKVINWENTLHIPPQVK-------- 274

Query: 206 QKRMPPEAVDLVSRLLQYSPNL--RSTALEALIHPFFDEL-------RDPNTRLPNGRFL 256
              + PEAVDL+++L   +     R+ A +   HPFF E+         P   +P     
Sbjct: 275 ---LSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDFSSDIRTQPAPYVPKISHP 331

Query: 257 PPLFNFKPHELKGVPVD 273
               NF P E +    D
Sbjct: 332 MDTSNFDPVEEESPWND 348

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 68.5 bits (167), Expect = 3e-13
 Identities = 42/119 (35%), Positives = 66/119 (55%), Gaps = 4/119 (3%)

Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 123
           + + L Y+     + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y 
Sbjct: 112 VIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYM 169

Query: 124 APELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEI 181
           +PE + G T Y+   DIWS G  L E+ +G+ P+ P ++   +L+    V G P   E 
Sbjct: 170 SPERLQG-THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESET 227

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 67.9 bits (166), Expect = 3e-13
 Identities = 49/182 (26%), Positives = 81/182 (44%), Gaps = 14/182 (7%)

Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVL-EYVPETVHRVI---KHHYKMSQRMPLIYVKL 59
           L HPN+V     F    E D LY+ + L E  P   H      K      +R+  I+V  
Sbjct: 66  LRHPNIVRYYKTF---LENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV-- 120

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
              Q+  AL Y+H    + HRD+ P N+++     ++ + DFG AK         S + +
Sbjct: 121 ---QMVLALRYLHKEKRIVHRDLTPNNIMLG-EDDKVTITDFGLAKQKQPESKLTSVVGT 176

Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
             Y  PE++     Y    D+W+ GC+L ++   QP F   + +    +I++ +  P  E
Sbjct: 177 ILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPE 235

Query: 180 EI 181
            +
Sbjct: 236 GM 237

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 67.8 bits (166), Expect = 4e-13
 Identities = 50/178 (28%), Positives = 81/178 (45%), Gaps = 22/178 (12%)

Query: 62  YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY 121
               +AL Y+   + + HRD+KP N+L++ + + +KLCDFG +  LV           R 
Sbjct: 114 VATVKALNYLKEELKIIHRDVKPSNILLDRNGN-IKLCDFGISGQLVDSIAKTRDAGCRP 172

Query: 122 YRAPELI--FGATEYTAAIDIWSAGCVLAELLLGQPLFPG-ESGVDQLVEIIKVLGTPTR 178
           Y APE I       Y    D+WS G  L E+  G+  +P   S  DQL +++K  G P  
Sbjct: 173 YMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVK--GDPPI 230

Query: 179 ---EEIKCMNPNYTEF-------------KFPQIKAHPWHKIFQKRMPPEAVDLVSRL 220
               E +  +P++  F             K+ ++  HP+ K +++R    A  +   L
Sbjct: 231 LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEERNVDVAAYVQRIL 288

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 67.4 bits (164), Expect = 4e-13
 Identities = 63/244 (25%), Positives = 110/244 (45%), Gaps = 43/244 (17%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           ++ L H  +V    C     EK    L + +EY+P  +V   +K +  +++ +   Y + 
Sbjct: 58  LKNLQHERIVQYYGCLRDRAEKT---LTIFMEYMPGGSVKDQLKAYGALTESVTRKYTR- 113

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL----VKGEPNIS 115
              QI   ++Y+H+ + + HRDIK  N+L +     +KL DFG++K L    + G    S
Sbjct: 114 ---QILEGMSYLHSNM-IVHRDIKGANILRDS-AGNVKLGDFGASKRLQTICMSGTGIRS 168

Query: 116 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
              + Y+ +PE+I G   Y    D+WS GC + E+L  +P +   +  + +  I K+   
Sbjct: 169 VTGTPYWMSPEVISGEG-YGRKADVWSLGCTVVEMLTEKPPW---AEYEAMAAIFKIATQ 224

Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 235
           PT                PQ+ +H         +   A D +  +   + + R +A E L
Sbjct: 225 PTN---------------PQLPSH---------ISEHARDFLGCIFVEARH-RPSAEELL 259

Query: 236 IHPF 239
            HPF
Sbjct: 260 RHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 68.5 bits (167), Expect = 4e-13
 Identities = 56/183 (30%), Positives = 89/183 (48%), Gaps = 32/183 (17%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M   + P VV L  C F    +D+ YL +V+EY+P      +  +Y + ++    + K Y
Sbjct: 97  MAFANSPWVVQL-FCAF----QDDKYLYMVMEYMPGGDLVNLMSNYDVPEK----WAKFY 147

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK----------G 110
             ++  AL  IH ++G+ HRD+KP N+L++ H H LKL DFG+   + +          G
Sbjct: 148 TAEVVLALDAIH-SMGLIHRDVKPDNMLLDKHGH-LKLADFGTCMKMDETGMVRCDTAVG 205

Query: 111 EPNISYICSRYYRAPELIF---GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV 167
            P+        Y +PE++    G   Y    D WS G  L E+L+G   F  +S V    
Sbjct: 206 TPD--------YISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYS 257

Query: 168 EII 170
           +I+
Sbjct: 258 KIM 260

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 67.9 bits (166), Expect = 5e-13
 Identities = 53/177 (29%), Positives = 86/177 (48%), Gaps = 26/177 (14%)

Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
           VK Y  ++  AL ++H ++G+ +RD+KP+N+L++   H +KL DFG +K  +  E     
Sbjct: 100 VKFYLAELALALDHLH-SLGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYS 157

Query: 117 ICSRY-YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV-LG 174
            C    Y APE++     +T + D WS G ++ E+L G   F G+   + +  I+K  LG
Sbjct: 158 FCGTVEYMAPEVV-NRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLG 216

Query: 175 TPT----------REEIKCMNPNYTEFKFPQ----IKAHP------WHKIFQKRMPP 211
            P           R   K  NP       P     IK HP      W+K++++ + P
Sbjct: 217 MPQFLSPEAQSLLRALFK-RNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKP 272

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 67.5 bits (165), Expect = 7e-13
 Identities = 69/267 (25%), Positives = 112/267 (41%), Gaps = 55/267 (20%)

Query: 6   HPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQ 63
           HP + +LK+ F      D   L  V+EY    E    + +       R      + Y  +
Sbjct: 54  HPFLTALKYSF---QTHD--RLCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAE 103

Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYY 122
           I  AL Y+H+   V +RD+K +NL+++   H +K+ DFG  K  +     +   C +  Y
Sbjct: 104 IVSALGYLHSC-DVVYRDLKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEY 161

Query: 123 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 182
            APE +    +Y  A+D W  G V+ E++ G+  F  +   ++L E+I +      EEI+
Sbjct: 162 LAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR 213

Query: 183 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIH 237
                                 F + + PEA  L++ LL+  P  R       A E + H
Sbjct: 214 ----------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251

Query: 238 PFFDELRDPNTRLPNGRFLPPLFNFKP 264
            FF  +      +   +  PP   FKP
Sbjct: 252 RFFASIN--WQDVVQKKLEPP---FKP 273

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 66.0 bits (162), Expect = 1e-12
 Identities = 63/247 (25%), Positives = 102/247 (41%), Gaps = 59/247 (23%)

Query: 5   DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-----ETVHRVIKHHYKMSQRMPLIYVKL 59
           D+PN + L +    TT K  +   L+++Y+      + +        K   ++    VK 
Sbjct: 67  DNPNFIKLYYSV--TTLKGHV---LIMDYIKDGDLFDLL--------KKEGKLSEAEVKK 113

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
              Q+  AL  +H    + H DIK +N+L +    ++ LCD+G  K  + G P      S
Sbjct: 114 IIRQLVEALNDLHKHNII-HNDIKLENVLYDRAKDRIYLCDYGLCK--IIGTP------S 164

Query: 120 RY-----YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 174
            Y     Y +PE I G   Y  + D W+ G +  ELL G+   P +   D   E +    
Sbjct: 165 CYDGTLDYFSPEKIKGHN-YDVSFDWWAVGVLTYELLTGK--HPFKEDED---EEL---- 214

Query: 175 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 234
                +++ +     + K P          F K +   A D V  +L+Y+ N R T    
Sbjct: 215 -----DLESLLKRQ-QKKLP----------FIKNVSKNANDFVQSMLKYNINYRLTNYNE 258

Query: 235 LI-HPFF 240
           +I HPF 
Sbjct: 259 IIKHPFL 265

Length = 267

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 66.2 bits (161), Expect = 1e-12
 Identities = 72/252 (28%), Positives = 117/252 (46%), Gaps = 39/252 (15%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           MR   H NVV +   + S    DEL++  V+E++       I  H +M++      +   
Sbjct: 73  MRDYHHENVVDM---YNSYLVGDELWV--VMEFLEGGALTDIVTHTRMNEEQ----IATV 123

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-ISYICS 119
              + RAL+Y+HN  GV HRDIK  ++L+     ++KL DFG    + K  P   S + +
Sbjct: 124 CLSVLRALSYLHNQ-GVIHRDIKSDSILLTSDG-RIKLSDFGFCAQVSKEVPKRKSLVGT 181

Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
            Y+ APE+I     Y   +DIWS G ++ E++ G+P +  E  +  +  I        R+
Sbjct: 182 PYWMAPEVI-SRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI--------RD 232

Query: 180 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
            +            P++K    HK+    +    +DL   +L   P+ R+TA E L HPF
Sbjct: 233 NLP-----------PRVKDS--HKV--SSVLRGFLDL---MLVREPSQRATAQELLQHPF 274

Query: 240 FDELRDPNTRLP 251
                 P+  +P
Sbjct: 275 LKLAGPPSCIVP 286

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 66.6 bits (162), Expect = 1e-12
 Identities = 54/180 (30%), Positives = 94/180 (52%), Gaps = 20/180 (11%)

Query: 6   HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 65
           +P +V L  CF +T+      L LV+EYV       +  H +  +++P  + + Y  +IC
Sbjct: 55  NPFLVGLHSCFQTTSR-----LFLVIEYVNGGD---LMFHMQRQRKLPEEHARFYAAEIC 106

Query: 66  RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNISYICSRYYRA 124
            AL ++H   G+ +RD+K  N+L++   H +KL D+G  K  L  G+   ++  +  Y A
Sbjct: 107 IALNFLHER-GIIYRDLKLDNVLLDADGH-IKLTDYGMCKEGLGPGDTTSTFCGTPNYIA 164

Query: 125 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLF------PGESGVDQLVEIIKVLGTPTR 178
           PE++ G  EY  ++D W+ G ++ E++ G+  F      P  +  D L ++I  L  P R
Sbjct: 165 PEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI--LEKPIR 221

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 66.0 bits (161), Expect = 2e-12
 Identities = 70/277 (25%), Positives = 115/277 (41%), Gaps = 64/277 (23%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVK 58
           + + + P +  L++ F    +KD LYL  V+EY P  + +  + ++  +  + M     +
Sbjct: 55  LSISNSPWIPQLQYAF---QDKDNLYL--VMEYQPGGDLLSLLNRYEDQFDEDM----AQ 105

Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-------KVLVK-- 109
            Y  ++  A+  +H  +G  HRDIKP+N+L++   H +KL DFGSA        V  K  
Sbjct: 106 FYLAELVLAIHSVH-QMGYVHRDIKPENVLIDRTGH-IKLADFGSAARLTANKMVNSKLP 163

Query: 110 -GEPNISYICSRYYRAPELI-----FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 163
            G P+        Y APE++      G   Y    D WS G +  E++ G+  F   +  
Sbjct: 164 VGTPD--------YIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA 215

Query: 164 DQLVEIIKVLGTPTREEIKCMNPNYTEF-KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQ 222
                I+                N+  F KFP+            ++  + +DL+  LL 
Sbjct: 216 KTYNNIM----------------NFQRFLKFPE----------DPKVSSDFLDLIQSLLC 249

Query: 223 YSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPL 259
                R        HPFF ++   N R     F+P L
Sbjct: 250 -GQKERLGYEGLCCHPFFSKIDWNNIRNSLPPFVPTL 285

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 65.6 bits (160), Expect = 3e-12
 Identities = 90/351 (25%), Positives = 134/351 (38%), Gaps = 103/351 (29%)

Query: 5   DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFY 62
           D P VVSL + F     +D  YL L++E++P  + +  +IK+    S+ +     + Y  
Sbjct: 59  DSPWVVSLYYSF-----QDAQYLYLIMEFLPGGDLMTMLIKYD-TFSEDV----TRFYMA 108

Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG------------SAKVLVKG 110
           +   A+  +H  +G  HRDIKP N+L++   H +KL DFG              + L++G
Sbjct: 109 ECVLAIEAVHK-LGFIHRDIKPDNILIDRGGH-IKLSDFGLSTGFHKQHDSAYYQKLLQG 166

Query: 111 EPNISYICSRY------------------------------------YRAPELIFGATEY 134
           + N + I +R                                     Y APE IF    Y
Sbjct: 167 KSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPE-IFLQQGY 225

Query: 135 TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE-FKF 193
               D WS G ++ E L+G P F  E+  +   +II                N+ E   F
Sbjct: 226 GQECDWWSLGAIMFECLIGWPPFCSENSHETYRKII----------------NWRETLYF 269

Query: 194 PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL--RSTALEALIHPFFDELRDPNTRLP 251
           P              +  EA DL+ RL+  + N   R  A E   HPFF  +     R  
Sbjct: 270 PD----------DIHLSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFFRGVDWDTIRQI 319

Query: 252 NGRFLPPLFN------FKPHELKGVPVDMLVKL-----IPEHARKQCAFLG 291
              F+P L +      F   EL+ VP    +K        E      AF+G
Sbjct: 320 RAPFIPQLKSITDTSYFPTDELEQVPEAPALKQAAPAQQEESVELDLAFIG 370

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 65.0 bits (158), Expect = 3e-12
 Identities = 48/186 (25%), Positives = 93/186 (50%), Gaps = 18/186 (9%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           ++ L H  +V    C     EK    L++ +EY+P  ++   +K +  +++ +     + 
Sbjct: 58  LKNLRHDRIVQYYGCLRDPEEKK---LSIFVEYMPGGSIKDQLKAYGALTENV----TRR 110

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK----VLVKGEPNIS 115
           Y  QI + ++Y+H+ + + HRDIK  N+L +     +KL DFG++K    + + G    S
Sbjct: 111 YTRQILQGVSYLHSNM-IVHRDIKGANILRDS-AGNVKLGDFGASKRIQTICMSGTGIKS 168

Query: 116 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
              + Y+ +PE+I G   Y    D+WS  C + E+L  +P +   +  + +  I K+   
Sbjct: 169 VTGTPYWMSPEVISGEG-YGRKADVWSVACTVVEMLTEKPPW---AEYEAMAAIFKIATQ 224

Query: 176 PTREEI 181
           PT+  +
Sbjct: 225 PTKPML 230

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 64.7 bits (157), Expect = 4e-12
 Identities = 49/186 (26%), Positives = 92/186 (49%), Gaps = 18/186 (9%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           ++ L H  +V    C     E+    L++ +E++P  ++   +K +  +++ +     + 
Sbjct: 58  LKNLLHERIVQYYGCLRDPMERT---LSIFMEHMPGGSIKDQLKSYGALTENV----TRK 110

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL----VKGEPNIS 115
           Y  QI   ++Y+H+ + + HRDIK  N+L +     +KL DFG++K L    + G    S
Sbjct: 111 YTRQILEGVSYLHSNM-IVHRDIKGANILRDS-VGNVKLGDFGASKRLQTICLSGTGMKS 168

Query: 116 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
              + Y+ +PE+I G   Y    DIWS GC + E+L  +P +   +  + +  I K+   
Sbjct: 169 VTGTPYWMSPEVISGEG-YGRKADIWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQ 224

Query: 176 PTREEI 181
           PT   +
Sbjct: 225 PTNPVL 230

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 65.4 bits (159), Expect = 5e-12
 Identities = 54/183 (29%), Positives = 87/183 (47%), Gaps = 32/183 (17%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M   + P VV L + F     +D+ YL +V+EY+P      +  +Y + ++    + + Y
Sbjct: 97  MAFANSPWVVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMSNYDVPEK----WARFY 147

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK----------G 110
             ++  AL  IH ++G  HRD+KP N+L++   H LKL DFG+   + K          G
Sbjct: 148 TAEVVLALDAIH-SMGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVG 205

Query: 111 EPNISYICSRYYRAPELIF---GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV 167
            P+        Y +PE++    G   Y    D WS G  L E+L+G   F  +S V    
Sbjct: 206 TPD--------YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS 257

Query: 168 EII 170
           +I+
Sbjct: 258 KIM 260

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 64.1 bits (156), Expect = 5e-12
 Identities = 52/153 (33%), Positives = 77/153 (50%), Gaps = 18/153 (11%)

Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQR---MPLIYVKL 59
           + HPN+V  +  F    E   LY+  V++Y     +++ I      +QR    P   +  
Sbjct: 56  MKHPNIVQYQESF---EENGNLYI--VMDYCEGGDLYKKIN-----AQRGVLFPEDQILD 105

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNISYIC 118
           +F QIC AL ++H+   + HRDIK QN+ +      +KL DFG A+VL    E   + I 
Sbjct: 106 WFVQICLALKHVHDR-KILHRDIKSQNIFLTKDG-TIKLGDFGIARVLNSTVELARTCIG 163

Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELL 151
           + YY +PE I     Y    DIW+ GCVL E+ 
Sbjct: 164 TPYYLSPE-ICENRPYNNKSDIWALGCVLYEMC 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 64.6 bits (157), Expect = 6e-12
 Identities = 52/158 (32%), Positives = 79/158 (50%), Gaps = 12/158 (7%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ + HP +V L H  F TTEK    L  VL++V       +  H +  +  P    + Y
Sbjct: 50  LKNVKHPFLVGL-HYSFQTTEK----LYFVLDFVNGGE---LFFHLQRERSFPEPRARFY 101

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-S 119
             +I  AL Y+H +I + +RD+KP+N+L++   H + L DFG  K  +      +  C +
Sbjct: 102 AAEIASALGYLH-SINIVYRDLKPENILLDSQGH-VVLTDFGLCKEGIAQSDTTTTFCGT 159

Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 157
             Y APE+I     Y   +D W  G VL E+L G P F
Sbjct: 160 PEYLAPEVI-RKQPYDNTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 64.9 bits (158), Expect = 7e-12
 Identities = 61/259 (23%), Positives = 114/259 (44%), Gaps = 28/259 (10%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ ++HP+V+ +K    S          +VL +    ++  +    K S+ +P+    + 
Sbjct: 111 LQNVNHPSVIRMKDTLVSGA-----ITCMVLPHYSSDLYTYLT---KRSRPLPIDQALII 162

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
             QI   L Y+H    + HRD+K +N+ +N    Q+ + D G+A+  V     +    + 
Sbjct: 163 EKQILEGLRYLHAQ-RIIHRDVKTENIFIN-DVDQVCIGDLGAAQFPVVAPAFLGLAGTV 220

Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLL----------GQPLFPGESGVDQLVEII 170
              APE +    +Y +  DIWSAG VL E+L             P    +S    L++II
Sbjct: 221 ETNAPE-VLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKII 279

Query: 171 KVLGT-----PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQK-RMPPEAVDLVSRLLQYS 224
             L       P     + +   + E+   + + +  +  FQ+  +P +   LV ++L + 
Sbjct: 280 STLKVHPEEFPRDPGSR-LVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFD 338

Query: 225 PNLRSTALEALIHPFFDEL 243
             +R +A E L +P F +L
Sbjct: 339 AAMRPSAEEILNYPMFAQL 357

Length = 357

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 64.2 bits (156), Expect = 7e-12
 Identities = 52/171 (30%), Positives = 84/171 (49%), Gaps = 12/171 (7%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           + L D P  ++  H  F T   D LY   V+EYV       + +H +   +        Y
Sbjct: 54  LALQDKPPFLTQLHSCFQTV--DRLYF--VMEYVNGGD---LMYHIQQVGKFKEPQAVFY 106

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNISYICS 119
             +I   L ++H   G+ +RD+K  N++++   H +K+ DFG  K  +V G    ++  +
Sbjct: 107 AAEISVGLFFLHRR-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKEHMVDGVTTRTFCGT 164

Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 170
             Y APE+I     Y  ++D W+ G +L E+L GQP F GE   D+L + I
Sbjct: 165 PDYIAPEII-AYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-DELFQSI 213

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 64.4 bits (157), Expect = 8e-12
 Identities = 68/250 (27%), Positives = 107/250 (42%), Gaps = 48/250 (19%)

Query: 22  KDELYLNLVLEY-VPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR 80
           +DE  L LV++Y V   +  ++    K   R+P    + Y  ++  A+  +H  +G  HR
Sbjct: 71  QDENNLYLVMDYYVGGDLLTLLS---KFEDRLPEDMARFYLAEMVLAIDSVHQ-LGYVHR 126

Query: 81  DIKPQNLLVNPHTHQLKLCDFGSAKVLVK----------GEPNISYICSRYYRAPELIFG 130
           DIKP N+L++ + H ++L DFGS   L+           G P+  YI     +A E   G
Sbjct: 127 DIKPDNVLLDKNGH-IRLADFGSCLRLLADGTVQSNVAVGTPD--YISPEILQAME--DG 181

Query: 131 ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 190
              Y    D WS G  + E+L G+  F  ES V+   +I+                N+ E
Sbjct: 182 KGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM----------------NHKE 225

Query: 191 -FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL--RSTALEALIHPFFDELRDPN 247
            F+FP              +  EA DL+ RL+        R+   +   HPFF+ +   N
Sbjct: 226 HFQFPPD---------VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWDN 276

Query: 248 TRLPNGRFLP 257
            R     ++P
Sbjct: 277 IRNSTAPYVP 286

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 64.2 bits (157), Expect = 8e-12
 Identities = 68/276 (24%), Positives = 111/276 (40%), Gaps = 72/276 (26%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKL 59
           +  LDHP + +L   F + T     YL LV++Y P   + R+++      + +     + 
Sbjct: 55  LATLDHPFLPTLYASFQTET-----YLCLVMDYCPGGELFRLLQRQPG--KCLSEEVARF 107

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF------------------ 101
           Y  ++  AL Y+H  +G+ +RD+KP+N+L++   H + L DF                  
Sbjct: 108 YAAEVLLALEYLHL-LGIVYRDLKPENILLHESGH-IMLSDFDLSKQSDVEPPPVSKALR 165

Query: 102 -GSAKVLVKGEPNISYICS-----------RYYRAPELIFGATEYTAAIDIWSAGCVLAE 149
            GS +  V   P+ ++                Y APE+I G   + +A+D W+ G +L E
Sbjct: 166 KGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYE 224

Query: 150 LLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRM 209
           +L G   F G +  +    I+K                  E  FP              +
Sbjct: 225 MLYGTTPFKGSNRDETFSNILK-----------------KEVTFPG----------SPPV 257

Query: 210 PPEAVDLVSRLLQYSPNLR----STALEALIHPFFD 241
              A DL+ +LL   P+ R      A E   HPFF 
Sbjct: 258 SSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFR 293

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 63.8 bits (155), Expect = 1e-11
 Identities = 51/164 (31%), Positives = 82/164 (50%), Gaps = 32/164 (19%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHR--VIKHHYKMSQRMPLIYVK 58
           ++ L H N+V  K C    +E+    L L++EYVP    R  + KH   ++Q +      
Sbjct: 60  LKTLYHENIVKYKGC---CSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLL------ 110

Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 118
           L+  QIC  +AY+H+   + HRD+  +N+L++ +   +K+ DFG AK + +G        
Sbjct: 111 LFAQQICEGMAYLHSQHYI-HRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGH------- 161

Query: 119 SRYYRAPE-----LIFGATE------YTAAIDIWSAGCVLAELL 151
             YYR  E     + + A E      ++ A D+WS G  L ELL
Sbjct: 162 -EYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELL 204

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 64.6 bits (157), Expect = 1e-11
 Identities = 58/229 (25%), Positives = 98/229 (42%), Gaps = 35/229 (15%)

Query: 62  YQICRALAYIHNTIGVCHRDIKPQNLL-------VNPHTHQ--------LKLCDFGSAKV 106
           +Q   AL Y H  + + H D+KP+N+L       V+P T++        +++CD G    
Sbjct: 238 FQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGC-- 295

Query: 107 LVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQL 166
             +     + + +R+YR+PE++ G   +  + D+WS GC++ EL  G+ L+     ++ L
Sbjct: 296 CDERHSRTAIVSTRHYRSPEVVLGLG-WMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHL 354

Query: 167 VEIIKVLGT-PTREEIKCMNPN----YTEFKFPQIKAHPWH--KIFQKRMPPEAV----- 214
             + K LG  P+    +C        Y      +    P H  +I + R   E +     
Sbjct: 355 HLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLL 414

Query: 215 -DLVSRLLQYSPNLRSTALEALIHP----FFDELRDPNTRLPNGRFLPP 258
            DL+  LL Y    R  A +   HP    ++ E R       N   L P
Sbjct: 415 CDLIYGLLHYDRQKRLNARQMTTHPYVLKYYPECRQHPNYPDNRSMLRP 463

Length = 467

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 64.2 bits (156), Expect = 1e-11
 Identities = 68/270 (25%), Positives = 114/270 (42%), Gaps = 45/270 (16%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR-MPLIYVKL 59
           +R ++HP+++ LK  F         Y       +P   ++   + Y  ++R + +  +  
Sbjct: 137 LRAINHPSIIQLKGTF--------TYNKFTCLILPR--YKTDLYCYLAAKRNIAICDILA 186

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
               + RA+ Y+H    + HRDIK +N+ +N H   + L DFG+A   V    N      
Sbjct: 187 IERSVLRAIQYLHEN-RIIHRDIKAENIFIN-HPGDVCLGDFGAACFPVDINAN------ 238

Query: 120 RYY--------RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD------- 164
           +YY         APEL+     Y  A+DIWSAG VL E+         + G+D       
Sbjct: 239 KYYGWAGTIATNAPELL-ARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDR 297

Query: 165 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK-------AHP-WHKIFQKRMPPEAVDL 216
           Q+  II+  GT   E       N  E      K       + P W  +++  +P +   L
Sbjct: 298 QIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYE--LPIDLEYL 355

Query: 217 VSRLLQYSPNLRSTALEALIHPFFDELRDP 246
           + ++L +  + R +A   L    F ++ DP
Sbjct: 356 ICKMLAFDAHHRPSAEALLDFAAFQDIPDP 385

Length = 391

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 64.8 bits (157), Expect = 1e-11
 Identities = 55/197 (27%), Positives = 93/197 (47%), Gaps = 31/197 (15%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           MR L H N+V     F +   + +LY+  ++E+     + R I+  YKM  ++    +  
Sbjct: 66  MRELKHKNIVRYIDRFLNKANQ-KLYI--LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVD 122

Query: 60  YFYQICRALAYIHNTIG------VCHRDIKPQNLLVNPHTHQL----------------K 97
              Q+  ALAY HN         V HRD+KPQN+ ++     +                K
Sbjct: 123 ITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAK 182

Query: 98  LCDFGSAKVLVKGEPNISYIC--SRYYRAPELIFGATE-YTAAIDIWSAGCVLAELLLGQ 154
           + DFG +K +  G  ++++ C  + YY +PEL+   T+ Y    D+W+ GC++ EL  G+
Sbjct: 183 IGDFGLSKNI--GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240

Query: 155 PLFPGESGVDQLVEIIK 171
             F   +   QL+  +K
Sbjct: 241 TPFHKANNFSQLISELK 257

Length = 1021

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 63.9 bits (156), Expect = 1e-11
 Identities = 60/247 (24%), Positives = 96/247 (38%), Gaps = 59/247 (23%)

Query: 6   HPNVVSLKHCFFSTTEKDELYLNLVLEYVP-----ETVHRVIKHHYKMSQRMPLIYVKLY 60
           HP +V+L  CF     +D +    V+EY         +H                    Y
Sbjct: 61  HPFLVNLFACF---QTEDHVCF--VMEYAAGGDLMMHIHT---------DVFSEPRAVFY 106

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-S 119
              +   L Y+H    + +RD+K  NLL++     +K+ DFG  K  +      S  C +
Sbjct: 107 AACVVLGLQYLHEN-KIVYRDLKLDNLLLDTEGF-VKIADFGLCKEGMGFGDRTSTFCGT 164

Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
             + APE++   T YT A+D W  G ++ E+L+G+  FPG+                  E
Sbjct: 165 PEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGD----------------DEE 207

Query: 180 EIKCMNPNYTEFKFPQIKA-HPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALE 233
           E+           F  I      +  F   +  EA+ ++ RLL+ +P  R       A +
Sbjct: 208 EV-----------FDSIVNDEVRYPRF---LSREAISIMRRLLRRNPERRLGSGEKDAED 253

Query: 234 ALIHPFF 240
               PFF
Sbjct: 254 VKKQPFF 260

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 63.7 bits (155), Expect = 1e-11
 Identities = 76/323 (23%), Positives = 111/323 (34%), Gaps = 109/323 (33%)

Query: 5   DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFY 62
           D+  VV L   ++S  +KD LY   V++Y+P  + +  +I+              + Y  
Sbjct: 59  DNEWVVKL---YYSFQDKDNLYF--VMDYIPGGDMMSLLIRLGI-----FEEDLARFYIA 108

Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPH----------------THQLKL-------- 98
           ++  A+  +H  +G  HRDIKP N+L++                  TH  K         
Sbjct: 109 ELTCAIESVHK-MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHR 167

Query: 99  ---------------CDFGSAKVLVK------------GEPNISYICSRYYRAPELIFGA 131
                          C     +   K            G PN        Y APE++   
Sbjct: 168 QDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPN--------YIAPEVLL-R 218

Query: 132 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 191
           T YT   D WS G +L E+L+GQP F  +              TP   ++K +N   T  
Sbjct: 219 TGYTQLCDWWSVGVILYEMLVGQPPFLAD--------------TPAETQLKVINWE-TTL 263

Query: 192 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR---STALEALIHPFF-------D 241
             P           Q ++  EA DL+ RL       R   + A E   HPFF        
Sbjct: 264 HIP----------SQAKLSREASDLILRLCC-GAEDRLGKNGADEIKAHPFFKGIDFASL 312

Query: 242 ELRDPNTRLPNGRFLPPLFNFKP 264
             R     +P         NF P
Sbjct: 313 IRRQKAPYIPKITHPTDTSNFDP 335

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 63.4 bits (154), Expect = 2e-11
 Identities = 69/277 (24%), Positives = 115/277 (41%), Gaps = 48/277 (17%)

Query: 3   LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 62
           L + P +V LK   FS     +LYL  V +Y+       +  H +   R      K Y  
Sbjct: 52  LDESPFIVGLK---FSFQTDSDLYL--VTDYMSGGE---LFWHLQKEGRFSEDRAKFYIA 103

Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNISYICSRY 121
           ++  AL ++H    + +RD+KP+N+L++   H + LCDFG +K  L   +   ++  +  
Sbjct: 104 ELVLALEHLHKY-DIVYRDLKPENILLDATGH-IALCDFGLSKANLTDNKTTNTFCGTTE 161

Query: 122 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII---------KV 172
           Y APE++     YT  +D WS G ++ E+  G   F  E    Q+   I          V
Sbjct: 162 YLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED-TQQMYRNIAFGKVRFPKNV 220

Query: 173 LGTPTREEIKCM---NPNY---TEFKFPQIKAHP------WHKIFQKRMPPEAVDLVSRL 220
           L    R+ +K +   NP +         ++K HP      W  + +K++ P         
Sbjct: 221 LSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDLLSKKQITPP-------- 272

Query: 221 LQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLP 257
             + P + S    +   P F      N+ L N   +P
Sbjct: 273 --FKPIVDSDEDVSNFDPEFT-----NSSLLNAGIVP 302

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 63.5 bits (154), Expect = 2e-11
 Identities = 72/268 (26%), Positives = 118/268 (44%), Gaps = 55/268 (20%)

Query: 6   HPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQ 63
           HP + +LK+ F  T ++    L  V+EY    E    + +      +R      + Y  +
Sbjct: 54  HPFLTALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAE 103

Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYY 122
           I  AL Y+H+   V +RDIK +NL+++   H +K+ DFG  K  +     +   C +  Y
Sbjct: 104 IVSALEYLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEY 161

Query: 123 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 182
            APE +    +Y  A+D W  G V+ E++ G+  F  +   ++L E+I +      EEI+
Sbjct: 162 LAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR 213

Query: 183 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIH 237
                                 F + + PEA  L++ LL+  P  R     S A E + H
Sbjct: 214 ----------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251

Query: 238 PFFDELRDPNTRLPNGRFLPPLFNFKPH 265
            FF  +   +  +   + LPP   FKP 
Sbjct: 252 RFFLSINWQD--VVQKKLLPP---FKPQ 274

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 63.5 bits (154), Expect = 2e-11
 Identities = 51/158 (32%), Positives = 78/158 (49%), Gaps = 12/158 (7%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ L HP +V L H  F T EK    L  VL+YV       +  H +  +       + Y
Sbjct: 50  LKNLKHPFLVGL-HYSFQTAEK----LYFVLDYVNGGE---LFFHLQRERCFLEPRARFY 101

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-S 119
             ++  A+ Y+H ++ + +RD+KP+N+L++   H + L DFG  K  V+ E   S  C +
Sbjct: 102 AAEVASAIGYLH-SLNIIYRDLKPENILLDSQGHVV-LTDFGLCKEGVEPEETTSTFCGT 159

Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 157
             Y APE +     Y   +D W  G VL E+L G P F
Sbjct: 160 PEYLAPE-VLRKEPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 62.7 bits (152), Expect = 2e-11
 Identities = 40/115 (34%), Positives = 65/115 (56%), Gaps = 5/115 (4%)

Query: 45  HYKMSQRMPLIYVKLYFY--QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG 102
           HY +SQ       ++ FY  +I   L ++HN   V +RD+KP N+L++ H H +++ D G
Sbjct: 85  HYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF-VVYRDLKPANILLDEHGH-VRISDLG 142

Query: 103 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 157
            A    K +P+ S + +  Y APE++   T Y ++ D +S GC+L +LL G   F
Sbjct: 143 LACDFSKKKPHAS-VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 63.0 bits (153), Expect = 2e-11
 Identities = 63/245 (25%), Positives = 105/245 (42%), Gaps = 47/245 (19%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           MR   HPN+V+    +      DEL++  V+EY+       +     M +          
Sbjct: 70  MRENKHPNIVNYLDSYLVG---DELWV--VMEYLAGGSLTDVVTETCMDEGQ-------- 116

Query: 61  FYQICR----ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNIS 115
              +CR    AL ++H+   V HRDIK  N+L+      +KL DFG  A++  +     +
Sbjct: 117 IAAVCRECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRST 174

Query: 116 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
            + + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   GT
Sbjct: 175 MVGTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGT 232

Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 235
           P             E + P+            ++     D ++R L+     R +A E L
Sbjct: 233 P-------------ELQNPE------------KLSAIFRDFLNRCLEMDVEKRGSAKELL 267

Query: 236 IHPFF 240
            HPF 
Sbjct: 268 QHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 63.0 bits (153), Expect = 2e-11
 Identities = 78/286 (27%), Positives = 123/286 (43%), Gaps = 61/286 (21%)

Query: 5   DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQI 64
           +HP +  L +C F T ++    L  V+E+V       +  H + S+R      + Y  +I
Sbjct: 54  NHPFLTQL-YCCFQTPDR----LFFVMEFVNGGD---LMFHIQKSRRFDEARARFYAAEI 105

Query: 65  CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYR 123
             AL ++H+  G+ +RD+K  N+L++ H    KL DFG  K  +      S  C +  Y 
Sbjct: 106 TSALMFLHDK-GIIYRDLKLDNVLLD-HEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYI 163

Query: 124 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 183
           APE I     Y  ++D W+ G +L E+L G   F  E+  D L E I        +E+  
Sbjct: 164 APE-ILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-DDLFEAI------LNDEV-- 213

Query: 184 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR--STAL---EALI-H 237
                               ++   +  +AVD++   +  +P +R  S  L   EA++ H
Sbjct: 214 --------------------VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253

Query: 238 PFFDELRDPNTRLPNGRFLPPLF-----------NFKPHELKGVPV 272
           PFF EL   +    N R + P F           NF P  +K  PV
Sbjct: 254 PFFKEL---DWEKLNRRQIEPPFRPRIKSREDVSNFDPDFIKEDPV 296

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 62.9 bits (153), Expect = 2e-11
 Identities = 51/168 (30%), Positives = 87/168 (51%), Gaps = 17/168 (10%)

Query: 6   HPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQ 63
           HP + +L HC F T ++    L  V+EYV   + + ++ +     S++      + Y  +
Sbjct: 55  HPFLTAL-HCCFQTKDR----LFFVMEYVNGGDLMFQIQR-----SRKFDEPRSRFYAAE 104

Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNISYICSRYY 122
           +  AL ++H   GV +RD+K  N+L++   H  KL DFG  K  ++ G    ++  +  Y
Sbjct: 105 VTLALMFLHRH-GVIYRDLKLDNILLDAEGH-CKLADFGMCKEGILNGVTTTTFCGTPDY 162

Query: 123 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 170
            APE I    EY  ++D W+ G ++ E++ GQP F  ++  D L E I
Sbjct: 163 IAPE-ILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE-DDLFESI 208

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 62.5 bits (152), Expect = 2e-11
 Identities = 53/159 (33%), Positives = 81/159 (50%), Gaps = 22/159 (13%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHR--VIKHHYKMSQRMPLIYVK 58
           ++ L H N+V  K   +S   ++   L LV+EY+P    R  + KH  ++  R  L    
Sbjct: 59  LKSLQHDNIVKYKGVCYSAGRRN---LRLVMEYLPYGSLRDYLQKHRERLDHRKLL---- 111

Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-------VKGE 111
           LY  QIC+ + Y+ +   V HRD+  +N+LV      +K+ DFG  KVL          E
Sbjct: 112 LYASQICKGMEYLGSKRYV-HRDLATRNILVESENR-VKIGDFGLTKVLPQDKEYYKVRE 169

Query: 112 PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAEL 150
           P  S I   ++ APE +   ++++ A D+WS G VL EL
Sbjct: 170 PGESPI---FWYAPESL-TESKFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 62.0 bits (151), Expect = 3e-11
 Identities = 48/167 (28%), Positives = 77/167 (46%), Gaps = 23/167 (13%)

Query: 62  YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-SYICSR 120
             I +AL Y+    GV HRD+KP N+L++  +  +KLCDFG +  LV  +    S  C+ 
Sbjct: 121 VAIVKALHYLKEKHGVIHRDVKPSNILLD-ASGNVKLCDFGISGRLVDSKAKTRSAGCAA 179

Query: 121 YYRAPELIFGAT---EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT-- 175
           Y  APE I       +Y    D+WS G  L EL  GQ  FP ++   +   + K+L    
Sbjct: 180 YM-APERIDPPDPNPKYDIRADVWSLGISLVELATGQ--FPYKNCKTEFEVLTKILQEEP 236

Query: 176 ---PTREE---------IKCMNPNYTEF-KFPQIKAHPWHKIFQKRM 209
              P  E            C+  ++ +  K+ ++  HP+ + ++   
Sbjct: 237 PSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAE 283

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 62.0 bits (150), Expect = 5e-11
 Identities = 66/243 (27%), Positives = 107/243 (44%), Gaps = 49/243 (20%)

Query: 6   HPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQ 63
           HP + +LK+ F  T ++    L  V+EY    E    + +       R      + Y  +
Sbjct: 54  HPFLTALKYSF-QTHDR----LCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAE 103

Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYY 122
           I  AL Y+H+   V +RD+K +NL+++   H +K+ DFG  K  +K    +   C +  Y
Sbjct: 104 IVSALDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEY 162

Query: 123 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 182
            APE +    +Y  A+D W  G V+ E++ G+  F  +   ++L E+I +      EEI+
Sbjct: 163 LAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR 214

Query: 183 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIH 237
                                 F + + PEA  L+S LL+  P  R       A E + H
Sbjct: 215 ----------------------FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252

Query: 238 PFF 240
            FF
Sbjct: 253 KFF 255

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 61.4 bits (149), Expect = 6e-11
 Identities = 55/214 (25%), Positives = 88/214 (41%), Gaps = 40/214 (18%)

Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
              Y  +I   L  +H    + +RD+KP+N+L++ + H +++ D G A  + +GE     
Sbjct: 104 AVFYAAEITCGLEDLHRE-RIVYRDLKPENILLDDYGH-IRISDLGLAVEIPEGETIRGR 161

Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
           + +  Y APE++     YT + D W  GC++ E++ G+  F          E +K     
Sbjct: 162 VGTVGYMAPEVV-KNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK------EKVK----- 209

Query: 177 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STA 231
            REE++       E              + ++    A  +  +LL   P  R       A
Sbjct: 210 -REEVERRVKEDQE-------------EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGA 255

Query: 232 LEALIHPFFDELRDPN-TRLPNGRFLPPLFNFKP 264
            E   HPFF   R  N  RL  G   PP   F P
Sbjct: 256 EEVKAHPFF---RTANFKRLEAGMLEPP---FCP 283

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 61.3 bits (149), Expect = 6e-11
 Identities = 53/165 (32%), Positives = 80/165 (48%), Gaps = 23/165 (13%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           MR  DHP++V L         ++ +++  V+E  P    R      K    + L  + LY
Sbjct: 61  MRQFDHPHIVKL----IGVITENPVWI--VMELAPLGELRSYLQVNK--YSLDLASLILY 112

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLV-NPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
            YQ+  ALAY+ +   V HRDI  +N+LV +P    +KL DFG ++ L   E    Y  S
Sbjct: 113 SYQLSTALAYLESKRFV-HRDIAARNVLVSSPDC--VKLGDFGLSRYL---EDESYYKAS 166

Query: 120 R-----YYRAPELIFGATEYTAAIDIWSAG-CVLAELLLG-QPLF 157
           +      + APE I     +T+A D+W  G C+   L+LG +P  
Sbjct: 167 KGKLPIKWMAPESI-NFRRFTSASDVWMFGVCMWEILMLGVKPFQ 210

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 61.2 bits (148), Expect = 6e-11
 Identities = 62/227 (27%), Positives = 97/227 (42%), Gaps = 39/227 (17%)

Query: 44  HHYKMSQR-MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG 102
           H Y M +          Y  +IC  L  +H    + +RD+KP+N+L++ H H +++ D G
Sbjct: 90  HIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE-RIVYRDLKPENILLDDHGH-IRISDLG 147

Query: 103 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG 162
            A  + +G+     + +  Y APE++     YT + D W+ GC+L E++ GQ  F     
Sbjct: 148 LAVHVPEGQTIKGRVGTVGYMAPEVV-KNERYTFSPDWWALGCLLYEMIAGQSPF----- 201

Query: 163 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQ 222
             Q  + IK      REE++ +     E              + ++  P+A  L   LL 
Sbjct: 202 -QQRKKKIK------REEVERLVKEVQE-------------EYSEKFSPDARSLCKMLLC 241

Query: 223 YSPNLR-----STALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKP 264
             P  R       A E   HP F ++     RL  G   PP   FKP
Sbjct: 242 KDPKERLGCQGGGAREVKEHPLFKQIN--FKRLEAGMLEPP---FKP 283

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 61.3 bits (149), Expect = 9e-11
 Identities = 59/230 (25%), Positives = 97/230 (42%), Gaps = 31/230 (13%)

Query: 3   LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 62
           L   P  ++  H  F T   D LY   V+EYV       + +H +   +    +   Y  
Sbjct: 56  LPGKPPFLTQLHSCFQTM--DRLYF--VMEYVNGGD---LMYHIQQVGKFKEPHAVFYAA 108

Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRY 121
           +I   L ++H+  G+ +RD+K  N++++   H +K+ DFG  K  + G       C +  
Sbjct: 109 EIAIGLFFLHSK-GIIYRDLKLDNVMLDAEGH-IKIADFGMCKENIFGGKTTRTFCGTPD 166

Query: 122 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE-------SGVDQLVEIIKVLG 174
           Y APE+I     Y  ++D W+ G +L E+L GQP F GE       S ++  V   K L 
Sbjct: 167 YIAPEII-AYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLS 225

Query: 175 TPTREEIKCM---NPNY----TEFKFPQIKAHP------WHKIFQKRMPP 211
                  K +   +P             I+ H       W K+ ++ + P
Sbjct: 226 KEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKLERREIQP 275

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 61.2 bits (148), Expect = 1e-10
 Identities = 49/160 (30%), Positives = 80/160 (50%), Gaps = 16/160 (10%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVK 58
           ++ + HP +V L H  F T +K    L  VL+Y+   E  + + +    +  R      +
Sbjct: 50  LKNVKHPFLVGL-HFSFQTADK----LYFVLDYINGGELFYHLQRERCFLEPR-----AR 99

Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 118
            Y  +I  AL Y+H ++ + +RD+KP+N+L++   H + L DFG  K  ++     S  C
Sbjct: 100 FYAAEIASALGYLH-SLNIVYRDLKPENILLDSQGH-IVLTDFGLCKENIEHNGTTSTFC 157

Query: 119 -SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 157
            +  Y APE++     Y   +D W  G VL E+L G P F
Sbjct: 158 GTPEYLAPEVLH-KQPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 59.6 bits (144), Expect = 2e-10
 Identities = 61/237 (25%), Positives = 99/237 (41%), Gaps = 37/237 (15%)

Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 63
           L HPN+V+ +  +    E   LY+ +      +  H++ +   K+   +P   V  +F Q
Sbjct: 56  LKHPNIVAYRESW--EGEDGLLYIVMGFCEGGDLYHKLKEQKGKL---LPENQVVEWFVQ 110

Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-YICSRYY 122
           I  AL Y+H    + HRD+K QN+ +   T+ +K+ D G A+VL       S  I + YY
Sbjct: 111 IAMALQYLHEK-HILHRDLKTQNVFLT-RTNIIKVGDLGIARVLENQCDMASTLIGTPYY 168

Query: 123 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 182
            +PEL F    Y    D+W+ GC + E+   +  F  +     +  II            
Sbjct: 169 MSPEL-FSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRII------------ 215

Query: 183 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
                  E K P +          K   PE  +L++ +L   P  R +    L  P+
Sbjct: 216 -------EGKLPPMP---------KDYSPELGELIATMLSKRPEKRPSVKSILRQPY 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 60.0 bits (145), Expect = 2e-10
 Identities = 69/245 (28%), Positives = 109/245 (44%), Gaps = 38/245 (15%)

Query: 22  KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRD 81
           +DE YL LV++Y       ++    K   R+P    + Y  ++  A+  IH    V HRD
Sbjct: 71  QDENYLYLVMDYY--VGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYV-HRD 127

Query: 82  IKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISY-ICSRYYRAPELIF----GATEYT 135
           IKP N+L++ + H ++L DFGS  K+   G    S  + +  Y +PE++     G  +Y 
Sbjct: 128 IKPDNVLLDMNGH-IRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYG 186

Query: 136 AAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE-FKFP 194
              D WS G  + E+L G+  F  ES V+   +I+                N+ E F+FP
Sbjct: 187 PECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM----------------NHEERFQFP 230

Query: 195 QIKAHPWHKIFQKRMPPEAVDLVSRLL-QYSPNLRSTALEAL-IHPFFDELRDPNTRLPN 252
              +H         +  EA DL+ RL+      L    +E    H FF+ +   N R   
Sbjct: 231 ---SH------ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWENIRNLE 281

Query: 253 GRFLP 257
             ++P
Sbjct: 282 APYIP 286

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 59.7 bits (144), Expect = 3e-10
 Identities = 66/244 (27%), Positives = 97/244 (39%), Gaps = 48/244 (19%)

Query: 5   DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQI 64
           +HP +V L   F+   +     L +++E+ P      I          P I V      I
Sbjct: 67  NHPYIVKLLGAFYWDGK-----LWIMIEFCPGGAVDAIMLELDRGLTEPQIQV------I 115

Query: 65  CR----ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICS 119
           CR    AL Y+H ++ + HRD+K  N+L+      +KL DFG SAK +   +   S+I +
Sbjct: 116 CRQMLEALQYLH-SMKIIHRDLKAGNVLLT-LDGDIKLADFGVSAKNVKTLQRRDSFIGT 173

Query: 120 RYYRAPELIFGAT----EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
            Y+ APE++   T     Y    DIWS G  L E+   +P                    
Sbjct: 174 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP-------------------- 213

Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 235
           P  E    +NP     K    K+ P       +   E  D +   L   P  R +A + L
Sbjct: 214 PHHE----LNPMRVLLKIA--KSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLL 267

Query: 236 IHPF 239
            HPF
Sbjct: 268 EHPF 271

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 59.3 bits (143), Expect = 4e-10
 Identities = 71/268 (26%), Positives = 115/268 (42%), Gaps = 55/268 (20%)

Query: 6   HPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQ 63
           HP + SLK+ F     KD L    V+EYV   E    + +       R      + Y  +
Sbjct: 54  HPFLTSLKYSF---QTKDRLCF--VMEYVNGGELFFHLSRERVFSEDR-----TRFYGAE 103

Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYY 122
           I  AL Y+H+   + +RD+K +NL+++   H +K+ DFG  K  +     +   C +  Y
Sbjct: 104 IVSALDYLHSG-KIVYRDLKLENLMLDKDGH-IKITDFGLCKEGITDAATMKTFCGTPEY 161

Query: 123 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 182
            APE +    +Y  A+D W  G V+ E++ G+  F  +   ++L E+I +      E+IK
Sbjct: 162 LAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EDIK 213

Query: 183 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIH 237
                                 F + +  +A  L+S LL   PN R       A E + H
Sbjct: 214 ----------------------FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251

Query: 238 PFFDELRDPNTRLPNGRFLPPLFNFKPH 265
            FF  +   +    + + +PP   FKP 
Sbjct: 252 SFFTGVNWQDVY--DKKLVPP---FKPQ 274

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 58.5 bits (142), Expect = 5e-10
 Identities = 54/195 (27%), Positives = 84/195 (43%), Gaps = 39/195 (20%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           M  LDHP +V L        + + L   LV+E  P   + + +K      + +P+  +K 
Sbjct: 50  MAQLDHPCIVRL----IGVCKGEPLM--LVMELAPLGPLLKYLKKR----REIPVSDLKE 99

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 118
             +Q+   +AY+ +   V HRD+  +N LLVN   HQ K+ DFG ++ L  G        
Sbjct: 100 LAHQVAMGMAYLESKHFV-HRDLAARNVLLVN--RHQAKISDFGMSRALGAG-------- 148

Query: 119 SRYYR------------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD- 164
           S YYR            APE I     +++  D+WS G  L E    G   +    G + 
Sbjct: 149 SDYYRATTAGRWPLKWYAPECINYGK-FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEV 207

Query: 165 -QLVEIIKVLGTPTR 178
             ++E  + L  P  
Sbjct: 208 IAMLESGERLPRPEE 222

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 58.8 bits (142), Expect = 6e-10
 Identities = 50/158 (31%), Positives = 80/158 (50%), Gaps = 15/158 (9%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           +  ++HP  V+L   F     KDE YL LVLE+V   +        + ++R P      Y
Sbjct: 85  LNYINHPFCVNLYGSF-----KDESYLYLVLEFV---IGGEFFTFLRRNKRFPNDVGCFY 136

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-S 119
             QI     Y+  ++ + +RD+KP+NLL++     +K+ DFG AKV+   +     +C +
Sbjct: 137 AAQIVLIFEYLQ-SLNIVYRDLKPENLLLDKDGF-IKMTDFGFAKVV---DTRTYTLCGT 191

Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 157
             Y APE++       AA D W+ G  + E+L+G P F
Sbjct: 192 PEYIAPEILLNVGHGKAA-DWWTLGIFIYEILVGCPPF 228

Length = 340

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 58.6 bits (141), Expect = 6e-10
 Identities = 51/182 (28%), Positives = 84/182 (46%), Gaps = 34/182 (18%)

Query: 64  ICR----ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYIC 118
           +CR    AL ++H+   V HRDIK  N+L+      +KL DFG  A++  +     + + 
Sbjct: 120 VCRECLQALDFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVG 177

Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 178
           + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   GTP  
Sbjct: 178 TPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTP-- 233

Query: 179 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 238
              +  NP                    +R+     D ++R L+   + R +A E L HP
Sbjct: 234 ---ELQNP--------------------ERLSAVFRDFLNRCLEMDVDRRGSAKELLQHP 270

Query: 239 FF 240
           F 
Sbjct: 271 FL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 59.0 bits (143), Expect = 8e-10
 Identities = 55/221 (24%), Positives = 88/221 (39%), Gaps = 67/221 (30%)

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
             QI  AL  +H+T G+ HRD+KPQN++ +  +   K+ D G+A  L  G   I+YI   
Sbjct: 261 MRQILFALDGLHST-GIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVG---INYIPKE 316

Query: 121 Y-----YRAPELIFGATEYTAA---------------------IDIWSAGCVLAELLLGQ 154
           +     Y APE    +T+  +A                      DI+SAG     L+  Q
Sbjct: 317 FLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG-----LIFLQ 371

Query: 155 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPP--- 211
             FP       L++           ++K  + +             W K+ + R  P   
Sbjct: 372 MAFPNLRSDSNLIQF--------NRQLKRNDYDLVA----------WRKLVEPRASPDLR 413

Query: 212 ---EAVD--------LVSRLLQYSPNLRSTALEALIHPFFD 241
              E +D        L+  ++++    R +A  AL HP+FD
Sbjct: 414 RGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFD 454

Length = 566

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 58.1 bits (141), Expect = 8e-10
 Identities = 60/276 (21%), Positives = 104/276 (37%), Gaps = 32/276 (11%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
            R L HPN++     F       ELY+  V   +   +   ++K H+     +P + +  
Sbjct: 53  SRQLQHPNILPYVTSF---IVDSELYV--VSPLMAYGSCEDLLKTHFPEG--LPELAIAF 105

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--------E 111
               +  AL YIH+  G  HR +K  ++L++     + L     +  ++K         +
Sbjct: 106 ILKDVLNALDYIHSK-GFIHRSVKASHILLSGDGK-VVLSGLRYSVSMIKHGKRQRVVHD 163

Query: 112 PNISYICSRYYRAPELIFGATE-YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 170
              S + +  + +PE++    + Y    DI+S G    EL  G   F        L+E  
Sbjct: 164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLE-- 221

Query: 171 KVLGTPTR--------EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQ 222
           KV GT                M+ + +  + P  +       + +         V   LQ
Sbjct: 222 KVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSV-DHPYTRTFSEHFHQFVELCLQ 280

Query: 223 YSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPP 258
             P  R +A + L H FF + +  NT L +   L P
Sbjct: 281 RDPESRPSASQLLNHSFFKQCKRRNTSLLD--LLKP 314

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 58.3 bits (141), Expect = 9e-10
 Identities = 51/196 (26%), Positives = 86/196 (43%), Gaps = 36/196 (18%)

Query: 67  ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY----- 121
           ALAY+H   G+ HRD+K +N+ ++   + + L DFG+A  L       +  C  +     
Sbjct: 197 ALAYLHGR-GIIHRDVKTENIFLDEPENAV-LGDFGAACKL--DAHPDTPQCYGWSGTLE 252

Query: 122 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREE 180
             +PEL+     Y A  DIWSAG VL E+ +    LF  +         +K   +  R  
Sbjct: 253 TNSPELL-ALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ---------VKSSSSQLRSI 302

Query: 181 IKCMNPNYTEF-------------KFPQIKAHPWH--KIFQKRMPPEAVD-LVSRLLQYS 224
           I+CM  +  EF             ++  +   P+    + +K      V+ L++++L + 
Sbjct: 303 IRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFD 362

Query: 225 PNLRSTALEALIHPFF 240
              R +A + L  P F
Sbjct: 363 QEFRPSAQDILSLPLF 378

Length = 392

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 57.8 bits (139), Expect = 1e-09
 Identities = 64/245 (26%), Positives = 106/245 (43%), Gaps = 47/245 (19%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M+ L +PN+V+    F      DEL++  V+EY+       +     M +          
Sbjct: 70  MKELKNPNIVNFLDSFLV---GDELFV--VMEYLAGGSLTDVVTETCMDEAQ-------- 116

Query: 61  FYQICR----ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNIS 115
              +CR    AL ++H    V HRDIK  N+L+      +KL DFG  A++  +     +
Sbjct: 117 IAAVCRECLQALEFLHAN-QVIHRDIKSDNVLLGMDG-SVKLTDFGFCAQITPEQSKRST 174

Query: 116 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
            + + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   GT
Sbjct: 175 MVGTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGT 232

Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 235
           P     +  NP                    +++ P   D ++R L+     R +A E L
Sbjct: 233 P-----ELQNP--------------------EKLSPIFRDFLNRCLEMDVEKRGSAKELL 267

Query: 236 IHPFF 240
            HPF 
Sbjct: 268 QHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 57.3 bits (138), Expect = 1e-09
 Identities = 62/244 (25%), Positives = 99/244 (40%), Gaps = 36/244 (14%)

Query: 3   LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYF 61
           L DHPNVV     ++    K+   L LVLE     +V  ++K   K  +RM    +    
Sbjct: 71  LSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYIL 130

Query: 62  YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSR 120
           ++    L ++H    + HRD+K  N+L+      +KL DFG SA++        + + + 
Sbjct: 131 HEALMGLQHLHVNKTI-HRDVKGNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGTP 188

Query: 121 YYRAPELIFGA----TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
           ++ APE+I       + Y A  D+WS G    EL  G P                    P
Sbjct: 189 FWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDP--------------------P 228

Query: 177 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRM-PPEAVDLVSRLLQYSPNLRSTALEAL 235
             +    ++P    FK P+   +P   + Q  +   E  D + + L      R T  + L
Sbjct: 229 LAD----LHPMRALFKIPR---NPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLL 281

Query: 236 IHPF 239
            H F
Sbjct: 282 QHVF 285

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 57.3 bits (138), Expect = 1e-09
 Identities = 55/209 (26%), Positives = 87/209 (41%), Gaps = 37/209 (17%)

Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
              Y  +I   L  +H      +RD+KP+N+L++ + H +++ D G A  + +GE     
Sbjct: 104 ALFYAAEILCGLEDLHRE-NTVYRDLKPENILLDDYGH-IRISDLGLAVKIPEGESIRGR 161

Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
           + +  Y APE++     YT + D W  GC++ E++ GQ  F G        E +K     
Sbjct: 162 VGTVGYMAPEVL-NNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRK------EKVK----- 209

Query: 177 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STA 231
            REE+               +     +++  +   EA  +   LL   P  R       A
Sbjct: 210 -REEV-------------DRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGA 255

Query: 232 LEALIHPFFDELRDPN-TRLPNGRFLPPL 259
            E   HPFF   R+ N  RL  G   PP 
Sbjct: 256 GEVKRHPFF---RNMNFKRLEAGMLDPPF 281

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 56.6 bits (136), Expect = 2e-09
 Identities = 48/178 (26%), Positives = 74/178 (41%), Gaps = 32/178 (17%)

Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRY 121
           +I + L Y+H+   + HRDIK  N+L++     +KL DFG A  L   +    +++ + +
Sbjct: 109 EILKGLDYLHSEKKI-HRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNTFVGTPF 166

Query: 122 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 181
           + APE+I   + Y +  DIWS G    EL  G+P                    P  +  
Sbjct: 167 WMAPEVI-QQSAYDSKADIWSLGITAIELAKGEP--------------------PNSD-- 203

Query: 182 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
             M+P    F  P+         F K       + +   L   P+ R TA E L H F
Sbjct: 204 --MHPMRVLFLIPKNNPPTLTGEFSKPFK----EFIDACLNKDPSFRPTAKELLKHKF 255

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 57.1 bits (138), Expect = 3e-09
 Identities = 72/271 (26%), Positives = 109/271 (40%), Gaps = 58/271 (21%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP----ETVHRVIKHHYKMSQRMPLIY 56
           +R ++HPNVV     F    E     + ++LE++     E  H  I     ++       
Sbjct: 126 LRDVNHPNVVKCHDMFDHNGE-----IQVLLEFMDGGSLEGTH--IADEQFLAD------ 172

Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNIS 115
                 QI   +AY+H    + HRDIKP NLL+N     +K+ DFG +++L +  +P  S
Sbjct: 173 ---VARQILSGIAYLHRR-HIVHRDIKPSNLLINS-AKNVKIADFGVSRILAQTMDPCNS 227

Query: 116 YICSRYYRAPELI-----FGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEI 169
            + +  Y +PE I      GA +  A  DIWS G  + E  LG+ P   G  G D    +
Sbjct: 228 SVGTIAYMSPERINTDLNHGAYDGYAG-DIWSLGVSILEFYLGRFPFGVGRQG-DWASLM 285

Query: 170 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS 229
             +          CM+        P+  A             E    +S  LQ  P  R 
Sbjct: 286 CAI----------CMSQP------PEAPAT---------ASREFRHFISCCLQREPAKRW 320

Query: 230 TALEALIHPFFDELRDPNTRLPNGR--FLPP 258
           +A++ L HPF    +    +        LPP
Sbjct: 321 SAMQLLQHPFILRAQPGQGQGGPNLHQLLPP 351

Length = 353

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 56.9 bits (137), Expect = 3e-09
 Identities = 50/146 (34%), Positives = 75/146 (51%), Gaps = 11/146 (7%)

Query: 22  KDELYLNLVLEY-VPETVHRVIKHHYKMSQRMPL--IYVKLYFYQICRALAYIHNTIGVC 78
           K +  L L++EY     +++ IK   ++ + +P     V L FYQI  AL  +H+   + 
Sbjct: 135 KSDDKLLLIMEYGSGGDLNKQIKQ--RLKEHLPFQEYEVGLLFYQIVLALDEVHSR-KMM 191

Query: 79  HRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYICSRYYRAPELIFGATEYT 135
           HRD+K  N+ + P T  +KL DFG +K     V  +   S+  + YY APEL +    Y+
Sbjct: 192 HRDLKSANIFLMP-TGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPEL-WERKRYS 249

Query: 136 AAIDIWSAGCVLAELLLGQPLFPGES 161
              D+WS G +L ELL     F G S
Sbjct: 250 KKADMWSLGVILYELLTLHRPFKGPS 275

Length = 478

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 57.2 bits (138), Expect = 4e-09
 Identities = 51/171 (29%), Positives = 73/171 (42%), Gaps = 25/171 (14%)

Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 63
           L HPN+V+L      + E     L  V EYVP    R ++        +P         Q
Sbjct: 35  LYHPNIVAL----LDSGEAPPGLLFAVFEYVP---GRTLREVLAADGALPAGETGRLMLQ 87

Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVN-----PHTHQLKLCDFGSAKVLVKGEPNI---- 114
           +  ALA  HN  G+ HRD+KPQN++V+     PH    K+ DFG   +L           
Sbjct: 88  VLDALACAHNQ-GIVHRDLKPQNIMVSQTGVRPHA---KVLDFGIGTLLPGVRDADVATL 143

Query: 115 ----SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 161
                 + +  Y APE + G    T   D+++ G +  E L GQ +  G S
Sbjct: 144 TRTTEVLGTPTYCAPEQLRGEPV-TPNSDLYAWGLIFLECLTGQRVVQGAS 193

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 56.2 bits (135), Expect = 4e-09
 Identities = 60/221 (27%), Positives = 98/221 (44%), Gaps = 38/221 (17%)

Query: 47  KMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-K 105
           K   R+P    + Y  ++  A+  +H  +   HRDIKP N+L++ + H ++L DFGS  K
Sbjct: 94  KFEDRLPEDMARFYLAEMVIAIDSVHQ-LHYVHRDIKPDNILMDMNGH-IRLADFGSCLK 151

Query: 106 VLVKGEPNISY-ICSRYYRAPELIF----GATEYTAAIDIWSAGCVLAELLLGQPLFPGE 160
           ++  G    S  + +  Y +PE++     G  +Y    D WS G  + E+L G+  F  E
Sbjct: 152 LMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE 211

Query: 161 SGVDQLVEIIKVLGTPTREEIKCMNPNYTE-FKFP-QIKAHPWHKIFQKRMPPEAVDLVS 218
           S V+   +I+                N+ E F+FP Q+            +  +A DL+ 
Sbjct: 212 SLVETYGKIM----------------NHKERFQFPAQV----------TDVSEDAKDLIR 245

Query: 219 RLL-QYSPNLRSTALEAL-IHPFFDELRDPNTRLPNGRFLP 257
           RL+      L    +E    HPFF  +   N R     ++P
Sbjct: 246 RLICSREHRLGQNGIEDFKQHPFFTGIDWDNIRNCEAPYIP 286

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 55.4 bits (133), Expect = 8e-09
 Identities = 48/165 (29%), Positives = 80/165 (48%), Gaps = 13/165 (7%)

Query: 7   PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 66
           P +  L  CF +    D LY   V+EYV       + +  +   R    +   Y  +I  
Sbjct: 61  PFLTQLHSCFQTM---DRLYF--VMEYVNGGD---LMYQIQQVGRFKEPHAVFYAAEIAI 112

Query: 67  ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNISYICSRYYRAP 125
            L ++H+  G+ +RD+K  N++++   H +K+ DFG  K  +  G    ++  +  Y AP
Sbjct: 113 GLFFLHSK-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKENMWDGVTTKTFCGTPDYIAP 170

Query: 126 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 170
           E+I     Y  ++D W+ G +L E+L GQ  F GE   D+L + I
Sbjct: 171 EII-AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQSI 213

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 54.7 bits (131), Expect = 9e-09
 Identities = 67/246 (27%), Positives = 104/246 (42%), Gaps = 45/246 (18%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M+   H N+V+    F S   +D+L++ +  E+      + I H         + YV   
Sbjct: 60  MKDCKHSNIVAY---FGSYLRRDKLWICM--EFCGGGSLQDIYHVTGPLSESQIAYVS-- 112

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICS 119
             +  + L Y+H+  G  HRDIK  N+L+  + H +KL DFG SA++        S+I +
Sbjct: 113 -RETLQGLYYLHSK-GKMHRDIKGANILLTDNGH-VKLADFGVSAQITATIAKRKSFIGT 169

Query: 120 RYYRAPELIFGATE----YTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLG 174
            Y+ APE+   A E    Y    DIW+ G    EL  L  P+F         +  ++ L 
Sbjct: 170 PYWMAPEV--AAVERKGGYNQLCDIWAVGITAIELAELQPPMFD--------LHPMRALF 219

Query: 175 TPTREEIKCMNPNYTEFKFPQIKAH-PWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
             T+          + F+ P++K    W   F           V   L  +P  R TA +
Sbjct: 220 LMTK----------SNFQPPKLKDKMKWSNSFHH--------FVKMALTKNPKKRPTAEK 261

Query: 234 ALIHPF 239
            L HPF
Sbjct: 262 LLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 54.6 bits (131), Expect = 1e-08
 Identities = 63/240 (26%), Positives = 95/240 (39%), Gaps = 40/240 (16%)

Query: 5   DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQI 64
           DHPN+V L   F+      E  L +++E+        +    +     P I  ++   Q 
Sbjct: 60  DHPNIVKLLDAFYY-----ENNLWILIEFCAGGAVDAVMLELERPLTEPQI--RVVCKQT 112

Query: 65  CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYR 123
             AL Y+H    + HRD+K  N+L       +KL DFG SAK     +   S+I + Y+ 
Sbjct: 113 LEALNYLHEN-KIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQRRDSFIGTPYWM 170

Query: 124 APELIFGATE----YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
           APE++   T     Y    D+WS G  L E+   +P                    P  E
Sbjct: 171 APEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEP--------------------PHHE 210

Query: 180 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
               +NP     K    K+ P       R   E  D + + L+ + + R T  + L HPF
Sbjct: 211 ----LNPMRVLLKIA--KSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPF 264

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 46/165 (27%), Positives = 79/165 (47%), Gaps = 16/165 (9%)

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K    +    +
Sbjct: 184 YSFQVAKGMEFLASRKCI-HRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGDA 241

Query: 120 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGT 175
           R    + APE IF    YT   D+WS G +L E+  LG   +PG       V+I +    
Sbjct: 242 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFCR 293

Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 220
             +E  +   P+YT  +  Q     WH    +R  P   +LV  L
Sbjct: 294 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQR--PTFSELVEHL 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 54.2 bits (130), Expect = 2e-08
 Identities = 48/192 (25%), Positives = 93/192 (48%), Gaps = 16/192 (8%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHH-YKMSQR-MPLIYVK 58
           +  ++ P +V+L + F S T     +L LV+  +       +K+H Y + +R + +  V 
Sbjct: 47  LEKVNSPFIVNLAYAFESKT-----HLCLVMSLMNGGD---LKYHIYNVGERGLEMERVI 98

Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 118
            Y  QI   + ++H ++ + +RD+KP+N+L++      +L D G A  L  G+       
Sbjct: 99  HYSAQITCGILHLH-SMDIVYRDMKPENVLLDDQG-NCRLSDLGLAVELKDGKTITQRAG 156

Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 178
           +  Y APE I     Y+  +D ++ GC + E++ G+  F       + V   ++      
Sbjct: 157 TNGYMAPE-ILKEEPYSYPVDWFAMGCSIYEMVAGRTPF---KDHKEKVAKEELKRRTLE 212

Query: 179 EEIKCMNPNYTE 190
           +E+K  + N+TE
Sbjct: 213 DEVKFEHQNFTE 224

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 53.9 bits (129), Expect = 2e-08
 Identities = 47/159 (29%), Positives = 72/159 (45%), Gaps = 8/159 (5%)

Query: 3   LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYF 61
           L +HPNVV     F+   +     L LVLE     +V  ++K      QR+    +    
Sbjct: 75  LPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYIL 134

Query: 62  YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSR 120
           Y     L ++HN   + HRD+K  N+L+      +KL DFG SA++        + + + 
Sbjct: 135 YGALLGLQHLHNN-RIIHRDVKGNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGTP 192

Query: 121 YYRAPELIFGATEYT----AAIDIWSAGCVLAELLLGQP 155
           ++ APE+I    +Y     A  D+WS G    EL  G P
Sbjct: 193 FWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDP 231

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 53.9 bits (129), Expect = 3e-08
 Identities = 43/168 (25%), Positives = 79/168 (47%), Gaps = 15/168 (8%)

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           Y +Q+ R + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K    +    +
Sbjct: 179 YSFQVARGMEFLASRKCI-HRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGSA 236

Query: 120 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGT 175
           R    + APE IF    YT   D+WS G +L E+  LG   +PG       V+I +    
Sbjct: 237 RLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPG-------VQINEEFCQ 288

Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMP-PEAVDLVSRLLQ 222
             ++  +   P     +  +I    W    ++R      V+++  LLQ
Sbjct: 289 RLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 53.2 bits (127), Expect = 3e-08
 Identities = 39/133 (29%), Positives = 70/133 (52%), Gaps = 9/133 (6%)

Query: 64  ICR----ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYIC 118
           +CR    AL ++H+   V HRDIK  N+L+      +KL DFG  A++  +     + + 
Sbjct: 121 VCRECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVG 178

Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 178
           + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   GTP  
Sbjct: 179 TPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPEL 236

Query: 179 EEIKCMNPNYTEF 191
           +  + ++  + +F
Sbjct: 237 QNPEKLSAIFRDF 249

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 53.5 bits (128), Expect = 4e-08
 Identities = 72/266 (27%), Positives = 106/266 (39%), Gaps = 75/266 (28%)

Query: 16  FFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 73
           F+S  +K  LYL  ++E++P  + +  ++K      +       + Y  +   A+  IH 
Sbjct: 67  FYSFQDKRNLYL--IMEFLPGGDMMTLLMKKDTLSEEA-----TQFYIAETVLAIDAIHQ 119

Query: 74  TIGVCHRDIKPQNLLVNPHTHQLKLCDFG------------------------------- 102
            +G  HRDIKP NLL++   H +KL DFG                               
Sbjct: 120 -LGFIHRDIKPDNLLLDAKGH-VKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177

Query: 103 ---SAKVLVKGEPNISY--ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 157
               A+   K    ++Y  + +  Y APE +F  T Y    D WS G ++ E+L+G P F
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPE-VFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236

Query: 158 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLV 217
             E              TP     K MN   T   FP     P   I +K     A DL+
Sbjct: 237 CSE--------------TPQETYRKVMNWKET-LVFP-----PEVPISEK-----AKDLI 271

Query: 218 SRLLQYSPN-LRSTALEALI-HPFFD 241
            R    S N + S  +E +  HPFF+
Sbjct: 272 LRFCTDSENRIGSNGVEEIKSHPFFE 297

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 53.4 bits (128), Expect = 4e-08
 Identities = 37/95 (38%), Positives = 52/95 (54%), Gaps = 16/95 (16%)

Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 122
           Q+  A+ YIH   G+ HRDIK +N+LVN     + L DFG+A    +G    S+    +Y
Sbjct: 268 QLLSAIDYIHGE-GIIHRDIKTENVLVNG-PEDICLGDFGAA-CFARG----SWSTPFHY 320

Query: 123 --------RAPELIFGATEYTAAIDIWSAGCVLAE 149
                    APE++ G   YT ++DIWSAG V+ E
Sbjct: 321 GIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 52.8 bits (126), Expect = 5e-08
 Identities = 49/178 (27%), Positives = 77/178 (43%), Gaps = 32/178 (17%)

Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-YICSRY 121
           +I + L Y+H+   + HRDIK  N+L++ H  ++KL DFG A  L   +   + ++ + +
Sbjct: 109 EILKGLDYLHSEKKI-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNTFVGTPF 166

Query: 122 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 181
           + APE+I   + Y +  DIWS G    EL  G+P                    P  E  
Sbjct: 167 WMAPEVI-KQSAYDSKADIWSLGITAIELAKGEP--------------------PHSE-- 203

Query: 182 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
             ++P    F  P+         + K +     + V   L   P+ R TA E L H F
Sbjct: 204 --LHPMKVLFLIPKNNPPTLEGNYSKPLK----EFVEACLNKEPSFRPTAKELLKHKF 255

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 51.4 bits (123), Expect = 1e-07
 Identities = 63/241 (26%), Positives = 97/241 (40%), Gaps = 55/241 (22%)

Query: 7   PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 66
           PN+V L     S   +D ++L  VL++        +  H      +P   VK +  ++  
Sbjct: 45  PNMVCLHKYIVS---EDSVFL--VLQHAEGGK---LWSHISKFLNIPEECVKRWAAEMVV 96

Query: 67  ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-SYICSRYYRAP 125
           AL  +H    VC RD+ P N+L++   H ++L  F       + E +         Y AP
Sbjct: 97  ALDALHREGIVC-RDLNPNNILLDDRGH-IQLTYFSR---WSEVEDSCDGEAVENMYCAP 151

Query: 126 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE-SGVDQLVEIIKVLGTPTREEIKCM 184
           E + G +E T A D WS G +L ELL G+ L     SG++                    
Sbjct: 152 E-VGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINT------------------- 191

Query: 185 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI-----HPF 239
              +T    P+             +  EA  L+ +LLQ++P  R  A  A +     HPF
Sbjct: 192 ---HTTLNIPEW------------VSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPF 236

Query: 240 F 240
           F
Sbjct: 237 F 237

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 51.1 bits (122), Expect = 2e-07
 Identities = 55/238 (23%), Positives = 103/238 (43%), Gaps = 39/238 (16%)

Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFY 62
           LDHP +V     F    E+D   +  + EY     +   ++      + +    V  +F 
Sbjct: 59  LDHPAIVKFHASFL---ERDAFCI--ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFI 113

Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNISYICSRY 121
           Q+   + Y+H    + HRD+K +N+ +    + LK+ DFG +++L+   +   ++  + Y
Sbjct: 114 QLLLGVHYMHQR-RILHRDLKAKNIFLK--NNLLKIGDFGVSRLLMGSCDLATTFTGTPY 170

Query: 122 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 181
           Y +PE +     Y +  DIWS GC+L E+      F G+   + L  +++++  PT    
Sbjct: 171 YMSPEAL-KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ---NFLSVVLRIVEGPT---- 222

Query: 182 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
               P+  E                     +   ++  +L   P+LR +A E L +PF
Sbjct: 223 ----PSLPE-----------------TYSRQLNSIMQSMLNKDPSLRPSAAEILRNPF 259

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 50.8 bits (121), Expect = 2e-07
 Identities = 38/101 (37%), Positives = 52/101 (51%), Gaps = 13/101 (12%)

Query: 64  ICR----ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYIC 118
           +CR     LAY+H + G  HRDIK  N+L+  +   +KL DFG +AK+        S+I 
Sbjct: 111 VCRETLQGLAYLH-SKGKMHRDIKGANILLTDNG-DVKLADFGVAAKITATIAKRKSFIG 168

Query: 119 SRYYRAPELIFGATE----YTAAIDIWSAGCVLAELLLGQP 155
           + Y+ APE+   A E    Y    DIW+ G    EL   QP
Sbjct: 169 TPYWMAPEV--AAVEKNGGYNQLCDIWAVGITAIELAELQP 207

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 50.4 bits (120), Expect = 3e-07
 Identities = 50/195 (25%), Positives = 72/195 (36%), Gaps = 52/195 (26%)

Query: 56  YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNI 114
           Y+     +I + L Y+H+   + HRDIK  N+L++     +KL DFG A  L   +    
Sbjct: 102 YIATILREILKGLDYLHSERKI-HRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRN 159

Query: 115 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 174
           +++ + ++ APE+I   + Y    DIWS G    EL  G+P                   
Sbjct: 160 TFVGTPFWMAPEVI-KQSAYDFKADIWSLGITAIELAKGEP------------------- 199

Query: 175 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIF--QKRMPPEA--------VDLVSRLLQYS 224
                              P    HP   +F   K  PP           + V   L   
Sbjct: 200 -------------------PNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKD 240

Query: 225 PNLRSTALEALIHPF 239
           P  R TA E L H F
Sbjct: 241 PRFRPTAKELLKHKF 255

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 50.6 bits (121), Expect = 3e-07
 Identities = 34/108 (31%), Positives = 53/108 (49%), Gaps = 19/108 (17%)

Query: 62  YQICRALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK-------VLVKGEP 112
            Q+ + + ++   N I   HRD+  +N+L+       K+CDFG A+        +VKG  
Sbjct: 219 SQVAQGMDFLASKNCI---HRDVAARNVLLT-DGRVAKICDFGLARDIMNDSNYVVKGNA 274

Query: 113 NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 159
            +       + APE IF    YT   D+WS G +L E+  LG+  +PG
Sbjct: 275 RLPV----KWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGKSPYPG 317

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 50.6 bits (121), Expect = 4e-07
 Identities = 34/105 (32%), Positives = 57/105 (54%), Gaps = 9/105 (8%)

Query: 14  HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYK-MSQRMPLIYVKLYFYQICRALAYIH 72
           H ++S    + +YL  V+EY+     + + H Y    + M + Y+     ++  AL Y+H
Sbjct: 68  HLYYSLQSANNVYL--VMEYLIGGDVKSLLHIYGYFDEEMAVKYIS----EVALALDYLH 121

Query: 73  NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
              G+ HRD+KP N+L++   H +KL DFG +KV +  E N+  I
Sbjct: 122 RH-GIIHRDLKPDNMLISNEGH-IKLTDFGLSKVTLNRELNMMDI 164

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 50.0 bits (119), Expect = 4e-07
 Identities = 30/99 (30%), Positives = 54/99 (54%), Gaps = 3/99 (3%)

Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 118
            Y  ++C  L  +     + +RD+KP+N+L++   H +++ D G A  + +GE     + 
Sbjct: 106 FYAAELCCGLEDLQRE-RIVYRDLKPENILLDDRGH-IRISDLGLAVQIPEGETVRGRVG 163

Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 157
           +  Y APE+I    +YT + D W  GC++ E++ GQ  F
Sbjct: 164 TVGYMAPEVI-NNEKYTFSPDWWGLGCLIYEMIQGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 50.0 bits (119), Expect = 5e-07
 Identities = 49/184 (26%), Positives = 75/184 (40%), Gaps = 48/184 (26%)

Query: 16  FFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 73
           F+S  +K  LYL  ++E++P  + +  ++K      +       + Y  +   A+  IH 
Sbjct: 67  FYSFQDKLNLYL--IMEFLPGGDMMTLLMKKDTLTEEE-----TQFYIAETVLAIDSIHQ 119

Query: 74  TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------------------- 113
            +G  HRDIKP NLL++   H +KL DFG    L K                        
Sbjct: 120 -LGFIHRDIKPDNLLLDSKGH-VKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177

Query: 114 ----------------ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 157
                            S + +  Y APE +F  T Y    D WS G ++ E+L+G P F
Sbjct: 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPE-VFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236

Query: 158 PGES 161
             E+
Sbjct: 237 CSET 240

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 49.2 bits (117), Expect = 7e-07
 Identities = 49/163 (30%), Positives = 79/163 (48%), Gaps = 28/163 (17%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-----ETVHRVIKHHYKMSQRMPLI 55
           +R L H N+V  K      TE     + L++E++P     E + R  K+   + Q++   
Sbjct: 60  LRNLYHENIVKYKGI---CTEDGGNGIKLIMEFLPSGSLKEYLPRN-KNKINLKQQLK-- 113

Query: 56  YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS 115
               Y  QIC+ + Y+ +   V HRD+  +N+LV    HQ+K+ DFG  K +   E +  
Sbjct: 114 ----YAVQICKGMDYLGSRQYV-HRDLAARNVLVE-SEHQVKIGDFGLTKAI---ETDKE 164

Query: 116 YICSR-------YYRAPELIFGATEYTAAIDIWSAGCVLAELL 151
           Y   +       ++ APE +  +  Y A+ D+WS G  L ELL
Sbjct: 165 YYTVKDDLDSPVFWYAPECLIQSKFYIAS-DVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 49.2 bits (117), Expect = 7e-07
 Identities = 37/99 (37%), Positives = 53/99 (53%), Gaps = 9/99 (9%)

Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK--GEPNISYICSR 120
           +I R LA++H    V HRDIK QN+L+  +  ++KL DFG +  L +  G  N ++I + 
Sbjct: 129 EILRGLAHLH-AHKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDRTVGRRN-TFIGTP 185

Query: 121 YYRAPELIF----GATEYTAAIDIWSAGCVLAELLLGQP 155
           Y+ APE+I         Y    DIWS G    E+  G P
Sbjct: 186 YWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAP 224

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 49.5 bits (118), Expect = 8e-07
 Identities = 36/106 (33%), Positives = 59/106 (55%), Gaps = 6/106 (5%)

Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNIS 115
           L F Q+  A+ ++H+   + HRDIK  N+L+  +   +KL DFG +K+    V  +   +
Sbjct: 147 LLFIQVLLAVHHVHSK-HMIHRDIKSANILLCSNG-LVKLGDFGFSKMYAATVSDDVGRT 204

Query: 116 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 161
           +  + YY APE I+    Y+   D++S G +L ELL  +  F GE+
Sbjct: 205 FCGTPYYVAPE-IWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN 249

Length = 496

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 49.1 bits (117), Expect = 1e-06
 Identities = 47/168 (27%), Positives = 77/168 (45%), Gaps = 22/168 (13%)

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           Y +Q+ R + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K   +  Y+  
Sbjct: 178 YSFQVARGMEFLASRKCI-HRDLAARNILLS-ENNVVKICDFGLARDIYK---DPDYVRK 232

Query: 120 RYYR------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKV 172
              R      APE IF    YT   D+WS G +L E+  LG   +PG       V+I + 
Sbjct: 233 GDARLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPG-------VQIDEE 284

Query: 173 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 220
                +E  +   P Y   +   I    WH   + R  P   +LV  L
Sbjct: 285 FCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDR--PTFSELVEIL 330

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 48.6 bits (116), Expect = 1e-06
 Identities = 33/102 (32%), Positives = 56/102 (54%), Gaps = 7/102 (6%)

Query: 62  YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY 121
           YQ+ + +A++ +   + HRD+  +N+L+  H   +K+CDFG A+ ++     +    +R 
Sbjct: 148 YQVAKGMAFLASKNCI-HRDLAARNVLLT-HGKIVKICDFGLARDIMNDSNYVVKGNARL 205

Query: 122 ---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 159
              + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 206 PVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPG 246

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 48.2 bits (114), Expect = 1e-06
 Identities = 51/183 (27%), Positives = 79/183 (43%), Gaps = 36/183 (19%)

Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK--GEPNISYICSR 120
           +I R L+++H    V HRDIK QN+L+  +  ++KL DFG +  L +  G  N ++I + 
Sbjct: 119 EILRGLSHLHQH-KVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDRTVGRRN-TFIGTP 175

Query: 121 YYRAPELIF----GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
           Y+ APE+I         Y    D+WS G    E+  G P       +  L  I +     
Sbjct: 176 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR----- 230

Query: 177 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 236
                   NP       P++K+  W K FQ          +   L  + + R T  + + 
Sbjct: 231 --------NPA------PRLKSKKWSKKFQS--------FIESCLVKNHSQRPTTEQLMK 268

Query: 237 HPF 239
           HPF
Sbjct: 269 HPF 271

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 48.4 bits (115), Expect = 2e-06
 Identities = 36/108 (33%), Positives = 55/108 (50%), Gaps = 19/108 (17%)

Query: 62  YQICRALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK-------VLVKGEP 112
           YQ+ + ++++   N I   HRD+  +N+L+  H    K+CDFG A+        +VKG  
Sbjct: 221 YQVAKGMSFLASKNCI---HRDLAARNILLT-HGRITKICDFGLARDIRNDSNYVVKGNA 276

Query: 113 NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 159
            +       + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 277 RLPV----KWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSSPYPG 319

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 47.7 bits (114), Expect = 2e-06
 Identities = 39/172 (22%), Positives = 69/172 (40%), Gaps = 35/172 (20%)

Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 122
           +I   +AY+       HRD+  +N +V      +K+ DFG  +       +I    + YY
Sbjct: 127 EIADGMAYLAAK-KFVHRDLAARNCMVA-EDLTVKIGDFGMTR-------DIYE--TDYY 175

Query: 123 R------------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEI 169
           R            APE +     +T   D+WS G VL E+  L +  + G S  +++++ 
Sbjct: 176 RKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMATLAEQPYQGLSN-EEVLKF 233

Query: 170 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLL 221
           +   G     E  C +      +        W   +  +M P  +++VS L 
Sbjct: 234 VIDGGHLDLPE-NCPDKLLELMR------MCWQ--YNPKMRPTFLEIVSSLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 48.5 bits (115), Expect = 2e-06
 Identities = 34/116 (29%), Positives = 59/116 (50%), Gaps = 7/116 (6%)

Query: 48  MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 107
            S+ +  + +  + YQ+ R + ++ +   V HRD+  +N+L+      +K+CDFG A+ +
Sbjct: 230 GSEGLTTLDLLSFTYQVARGMEFLASKNCV-HRDLAARNVLLA-QGKIVKICDFGLARDI 287

Query: 108 VKGEPNIS---YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 159
           +     +S         + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 288 MHDSNYVSKGSTFLPVKWMAPESIFDNL-YTTLSDVWSYGILLWEIFSLGGTPYPG 342

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 47.0 bits (112), Expect = 4e-06
 Identities = 39/123 (31%), Positives = 63/123 (51%), Gaps = 26/123 (21%)

Query: 62  YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY 121
           YQ+ R + ++ +   + HRD+  +N+LV    H +K+ DFG A+       +I +I   Y
Sbjct: 139 YQVARGMEFLASKKCI-HRDLAARNVLVT-EDHVMKIADFGLAR-------DIHHI--DY 187

Query: 122 YR------------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVE 168
           YR            APE +F    YT   D+WS G +L E+  LG   +PG   V++L +
Sbjct: 188 YRKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIP-VEELFK 245

Query: 169 IIK 171
           ++K
Sbjct: 246 LLK 248

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 46.4 bits (110), Expect = 5e-06
 Identities = 43/157 (27%), Positives = 78/157 (49%), Gaps = 18/157 (11%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           M   DHPN++ L+     T  K  +   +V EY+   ++   ++ H     +  +I +  
Sbjct: 59  MGQFDHPNIIHLEGVV--TKSKPVM---IVTEYMENGSLDAFLRKH---DGQFTVIQLVG 110

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
               I   + Y+ + +G  HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y   
Sbjct: 111 MLRGIASGMKYLSD-MGYVHRDLAARNILVNSNL-VCKVSDFGLSRVL-EDDPEAAYTTR 167

Query: 120 R-----YYRAPELIFGATEYTAAIDIWSAGCVLAELL 151
                  + APE I    ++T+A D+WS G V+ E++
Sbjct: 168 GGKIPIRWTAPEAI-AYRKFTSASDVWSYGIVMWEVM 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 46.3 bits (110), Expect = 5e-06
 Identities = 38/159 (23%), Positives = 72/159 (45%), Gaps = 26/159 (16%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE----TVHRVIKHHYKMSQRMPLIY 56
           M  L HPN+V L   +   T++  +++  V EY+         R  K        + +  
Sbjct: 53  MMKLSHPNLVQL---YGVCTKQRPIFI--VTEYMANGCLLNYLRERKGKLGTEWLLDMCS 107

Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
                  +C A+ Y+ +  G  HRD+  +N LV    + +K+ DFG A+ ++  +    Y
Sbjct: 108 ------DVCEAMEYLESN-GFIHRDLAARNCLVG-EDNVVKVSDFGLARYVLDDQ----Y 155

Query: 117 ICSRYYR-----APELIFGATEYTAAIDIWSAGCVLAEL 150
             S+  +     AP  +F  + +++  D+WS G ++ E+
Sbjct: 156 TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 46.2 bits (109), Expect = 8e-06
 Identities = 48/174 (27%), Positives = 79/174 (45%), Gaps = 24/174 (13%)

Query: 62  YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY 121
           YQ+ R + Y+ +   + HRD+  +N+LV    + +K+ DFG    L +   NI Y     
Sbjct: 144 YQVARGMEYLASQKCI-HRDLAARNVLVT-ENNVMKIADFG----LARDVNNIDYYKKTT 197

Query: 122 -------YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVL 173
                  + APE +F    YT   D+WS G ++ E+  LG   +PG   V++L +++K  
Sbjct: 198 NGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELFKLLKE- 254

Query: 174 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMP-PEAVDLVSRLLQYSPN 226
           G    +   C N  Y   +        WH I   R    + V+ + R+L  + N
Sbjct: 255 GHRMDKPANCTNELYMMMR------DCWHAIPSHRPTFKQLVEDLDRILTLTTN 302

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 46.5 bits (110), Expect = 8e-06
 Identities = 36/133 (27%), Positives = 57/133 (42%), Gaps = 36/133 (27%)

Query: 110 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEI 169
           G PN        Y APE++   T YT   D WS G +L E+L+GQP F  ++ ++  +++
Sbjct: 210 GTPN--------YIAPEVLL-RTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKV 260

Query: 170 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL-- 227
           I    +                          H   Q ++ PEA DL+ +L +   +   
Sbjct: 261 INWQTS-------------------------LHIPPQAKLSPEASDLIIKLCRGPEDRLG 295

Query: 228 RSTALEALIHPFF 240
           ++ A E   HPFF
Sbjct: 296 KNGADEIKAHPFF 308

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 45.3 bits (107), Expect = 2e-05
 Identities = 30/104 (28%), Positives = 55/104 (52%), Gaps = 7/104 (6%)

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           + +QI R + Y+   + + HRD+  +N+LV     ++K+ DFG ++ + + +  +     
Sbjct: 132 FAWQISRGMQYL-AEMKLVHRDLAARNVLV-AEGRKMKISDFGLSRDVYEEDSYVKRSKG 189

Query: 120 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 159
           R    + A E +F    YT   D+WS G +L E++ LG   +PG
Sbjct: 190 RIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 232

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 45.0 bits (106), Expect = 2e-05
 Identities = 30/93 (32%), Positives = 52/93 (55%), Gaps = 9/93 (9%)

Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR--- 120
           I   + Y+ + +   HRD+  +N+LVN    + K+ DFG ++VL + +P  +Y  S    
Sbjct: 116 IAAGMKYLSD-MNYVHRDLAARNILVN-SNLECKVSDFGLSRVL-EDDPEGTYTTSGGKI 172

Query: 121 --YYRAPELIFGATEYTAAIDIWSAGCVLAELL 151
              + APE I    ++T+A D+WS G V+ E++
Sbjct: 173 PIRWTAPEAI-AYRKFTSASDVWSFGIVMWEVM 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 44.8 bits (106), Expect = 2e-05
 Identities = 49/168 (29%), Positives = 73/168 (43%), Gaps = 28/168 (16%)

Query: 5   DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQI 64
           DHPN+V L        +K  +Y+  V+E VP     ++    K   R+ +  +       
Sbjct: 50  DHPNIVKL---IGVCVQKQPIYI--VMELVPGG--SLLTFLRKKKNRLTVKKLLQMSLDA 102

Query: 65  CRALAYIH--NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 122
              + Y+   N I   HRD+  +N LV    + LK+ DFG    + + E    Y  S   
Sbjct: 103 AAGMEYLESKNCI---HRDLAARNCLVG-ENNVLKISDFG----MSREEEGGIYTVSDGL 154

Query: 123 R-------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGES 161
           +       APE L +G   YT+  D+WS G +L E   LG   +PG S
Sbjct: 155 KQIPIKWTAPEALNYG--RYTSESDVWSYGILLWETFSLGDTPYPGMS 200

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 44.6 bits (105), Expect = 3e-05
 Identities = 48/175 (27%), Positives = 78/175 (44%), Gaps = 17/175 (9%)

Query: 54  LIYVKL--YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 111
           L Y+ L  + YQ+   + ++ +   V HRD+  +N+L+      +K+CDFG A+ +++  
Sbjct: 236 LSYMDLVGFSYQVANGMEFLASKNCV-HRDLAARNVLIC-EGKLVKICDFGLARDIMRDS 293

Query: 112 PNIS---YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLV 167
             IS         + APE IF    YT   D+WS G +L E+  LG   +P     +Q  
Sbjct: 294 NYISKGSTFLPLKWMAPESIFNNL-YTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFY 352

Query: 168 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMP-PEAVDLVSRLL 221
             IK          +   P +   +  +I    W + F+ R    + V LV  LL
Sbjct: 353 NAIK-------RGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 44.1 bits (104), Expect = 4e-05
 Identities = 48/170 (28%), Positives = 80/170 (47%), Gaps = 29/170 (17%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL- 59
           M+ L HP +V L    ++   ++ +Y+  + EY+    +  +    K  + + L   KL 
Sbjct: 55  MKQLQHPRLVRL----YAVVTQEPIYI--ITEYM---ENGSLVDFLKTPEGIKLTINKLI 105

Query: 60  -YFYQICRALAYIH--NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
               QI   +A+I   N I   HRD++  N+LV+  T   K+ DFG A+++   E    Y
Sbjct: 106 DMAAQIAEGMAFIERKNYI---HRDLRAANILVS-ETLCCKIADFGLARLIEDNE----Y 157

Query: 117 ICSR------YYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 159
                      + APE I   T +T   D+WS G +L E++  G+  +PG
Sbjct: 158 TAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTYGRIPYPG 206

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 43.9 bits (104), Expect = 4e-05
 Identities = 34/112 (30%), Positives = 53/112 (47%), Gaps = 9/112 (8%)

Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY- 121
           QI + ++Y+     + HRD+  +N+LV    H +K+ DFG AK+L   E        +  
Sbjct: 117 QIAKGMSYLEEK-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLDVDEKEYHAEGGKVP 174

Query: 122 --YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD--QLVE 168
             + A E I     YT   D+WS G  + EL+  G   + G   V+   L+E
Sbjct: 175 IKWMALESIL-HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE 225

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 43.5 bits (103), Expect = 5e-05
 Identities = 43/181 (23%), Positives = 78/181 (43%), Gaps = 29/181 (16%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-----ETVHRVIKHHYKMSQRMPLI 55
           M  LDH N++ L     +        L +V E  P     + + +    H+       + 
Sbjct: 50  MHSLDHENLIRLYGVVLTHP------LMMVTELAPLGSLLDRLRKDALGHF------LIS 97

Query: 56  YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS 115
            +  Y  QI   + Y+ +   + HRD+  +N+L+     ++K+ DFG  + L + E +  
Sbjct: 98  TLCDYAVQIANGMRYLESKRFI-HRDLAARNILL-ASDDKVKIGDFGLMRALPQNEDH-- 153

Query: 116 YICSRYYR------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVE 168
           Y+   + +      APE +   T ++ A D+W  G  L E+   G+  + G SG   L +
Sbjct: 154 YVMEEHLKVPFAWCAPESLRTRT-FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKK 212

Query: 169 I 169
           I
Sbjct: 213 I 213

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 43.5 bits (102), Expect = 6e-05
 Identities = 49/179 (27%), Positives = 83/179 (46%), Gaps = 34/179 (18%)

Query: 62  YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY 121
           YQ+ R + Y+ +   + HRD+  +N+LV    + +K+ DFG A+       +I +I   Y
Sbjct: 147 YQVARGMEYLASKKCI-HRDLAARNVLVT-EDNVMKIADFGLAR-------DIHHI--DY 195

Query: 122 YR------------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVE 168
           Y+            APE +F    YT   D+WS G +L E+  LG   +PG   V++L +
Sbjct: 196 YKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEELFK 253

Query: 169 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMP-PEAVDLVSRLLQYSPN 226
           ++K  G    +   C N  Y   +        WH +  +R    + V+ + R+L  + N
Sbjct: 254 LLKE-GHRMDKPSNCTNELYMMMR------DCWHAVPSQRPTFKQLVEDLDRILALTSN 305

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 43.2 bits (102), Expect = 6e-05
 Identities = 47/183 (25%), Positives = 87/183 (47%), Gaps = 34/183 (18%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYL-------NLVLEYVPETVHRVIKHHYKMSQRMP 53
           M+ L HP ++ L   +   T ++ +Y+         +LEY+     R +K    + Q   
Sbjct: 55  MKKLRHPKLIQL---YAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALK----LPQ--- 104

Query: 54  LIYVKLYFYQICRALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 111
           LI +     Q+   +AY+   N I   HRD+  +N+LV  + +  K+ DFG A+V+ +  
Sbjct: 105 LIDMAA---QVASGMAYLEAQNYI---HRDLAARNVLVGEN-NICKVADFGLARVIKEDI 157

Query: 112 PNISYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESG--VDQ 165
              +   +++   + APE       ++   D+WS G +L E++  G+  +PG +   V Q
Sbjct: 158 YE-AREGAKFPIKWTAPEAAL-YNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQ 215

Query: 166 LVE 168
            V+
Sbjct: 216 QVD 218

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 43.5 bits (102), Expect = 6e-05
 Identities = 43/173 (24%), Positives = 77/173 (44%), Gaps = 23/173 (13%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR-------MP 53
           M+  DHPNV+ L      T E +     +V+  +P   H  + H + +  R       +P
Sbjct: 54  MKEFDHPNVMRLIGVCLQTVESEGYPSPVVI--LPFMKHGDL-HSFLLYSRLGDCPQYLP 110

Query: 54  LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 113
              +  +   I   + Y+ ++    HRD+  +N ++N + + + + DFG +K +  G+  
Sbjct: 111 TQMLVKFMTDIASGMEYL-SSKSFIHRDLAARNCMLNENMN-VCVADFGLSKKIYNGD-- 166

Query: 114 ISYICSRYYRAPELIFGATE------YTAAIDIWSAGCVLAELLL-GQPLFPG 159
             Y   R  + P + + A E      YT   D+WS G  + E+   GQ  +PG
Sbjct: 167 -YYRQGRIAKMP-VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG 217

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 44.0 bits (104), Expect = 6e-05
 Identities = 35/112 (31%), Positives = 56/112 (50%), Gaps = 26/112 (23%)

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV----------LVKG 110
           F++IC  + Y+H+  GV HRD+KP N+L+      + L D+G+A            +   
Sbjct: 119 FHKICATIEYVHSK-GVLHRDLKPDNILLGLFGEVVIL-DWGAAIFKKLEEEDLLDIDVD 176

Query: 111 EPNISY---------ICSRYYRAPELIFG--ATEYTAAIDIWSAGCVLAELL 151
           E NI Y         + +  Y APE + G  A+E T   DI++ G +L ++L
Sbjct: 177 ERNICYSSMTIPGKIVGTPDYMAPERLLGVPASEST---DIYALGVILYQML 225

Length = 932

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 43.2 bits (102), Expect = 6e-05
 Identities = 30/104 (28%), Positives = 45/104 (43%), Gaps = 30/104 (28%)

Query: 62  YQICRALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
            QI   + Y+  H+     HRD+  +N LV      +K+ DFG ++ +   +        
Sbjct: 131 IQIAAGMEYLSSHH---FVHRDLAARNCLVGEG-LTVKISDFGLSRDIYSAD-------- 178

Query: 120 RYYR------------APELI-FGATEYTAAIDIWSAGCVLAEL 150
            YYR             PE I +G  ++T   DIWS G VL E+
Sbjct: 179 -YYRVQSKSLLPVRWMPPEAILYG--KFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 43.5 bits (102), Expect = 6e-05
 Identities = 37/118 (31%), Positives = 60/118 (50%), Gaps = 16/118 (13%)

Query: 62  YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY 121
           YQ+ R + Y+ +   + HRD+  +N+LV    + +K+ DFG    L +   NI Y     
Sbjct: 141 YQVARGMEYLASQKCI-HRDLAARNVLVT-EDNVMKIADFG----LARDVHNIDYYKKTT 194

Query: 122 -------YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIK 171
                  + APE +F    YT   D+WS G +L E+  LG   +PG   V++L +++K
Sbjct: 195 NGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIP-VEELFKLLK 250

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 42.9 bits (101), Expect = 8e-05
 Identities = 46/179 (25%), Positives = 86/179 (48%), Gaps = 26/179 (14%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVK 58
           M  L HP +V L   +   T++  LY+  V E++     ++ + +   K+S+ M L   +
Sbjct: 53  MMKLSHPKLVQL---YGVCTQQKPLYI--VTEFMENGCLLNYLRQRQGKLSKDMLLSMCQ 107

Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 118
                +C  + Y+       HRD+  +N LV+  T  +K+ DFG  + ++  E    Y  
Sbjct: 108 ----DVCEGMEYLERN-SFIHRDLAARNCLVS-STGVVKVSDFGMTRYVLDDE----YTS 157

Query: 119 SR------YYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEII 170
           S        +  PE +F  ++Y++  D+WS G ++ E+   G+  F  +S   ++VE+I
Sbjct: 158 SSGAKFPVKWSPPE-VFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY-EVVEMI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 42.8 bits (100), Expect = 1e-04
 Identities = 31/90 (34%), Positives = 44/90 (48%), Gaps = 10/90 (11%)

Query: 47  KMSQRMP-----LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF 101
           K+   MP     +  +K    Q+   L  +H  IG+ HRDIKP+NLLV     Q+K+ DF
Sbjct: 296 KIPDNMPQDKRDINVIKGVMRQVLTGLRKLH-RIGIVHRDIKPENLLVTVDG-QVKIIDF 353

Query: 102 GSAKVLVKG---EPNISYICSRYYRAPELI 128
           G+A  +  G    P    +  RY    EL+
Sbjct: 354 GAAVDMCTGINFNPLYGMLDPRYSPPEELV 383

Length = 507

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 42.8 bits (100), Expect = 1e-04
 Identities = 50/186 (26%), Positives = 82/186 (44%), Gaps = 11/186 (5%)

Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY--ICSR 120
           Q+  A+ YIH+   + HRDIK +N+ +N    ++ L DFG+A    K      Y  + + 
Sbjct: 275 QLLCAVEYIHDKK-LIHRDIKLENIFLNCDG-KIVLGDFGTAMPFEKEREAFDYGWVGTV 332

Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD---QLVEIIKVLGTPT 177
              +PE++ G   Y    DIWS G +L ++L       G+ G     QL++II  L    
Sbjct: 333 ATNSPEILAGDG-YCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCD 391

Query: 178 RE--EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDL-VSRLLQYSPNLRSTALEA 234
            E  +  C   +Y +        H    + +    P   +  + ++L +  +LR  A E 
Sbjct: 392 EEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAEL 451

Query: 235 LIHPFF 240
           L  P F
Sbjct: 452 LALPLF 457

Length = 501

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 42.1 bits (99), Expect = 1e-04
 Identities = 28/93 (30%), Positives = 51/93 (54%), Gaps = 4/93 (4%)

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-SYIC 118
           Y  QI   L ++H    + +RD+KP+N+L++   + +++ D G A  L  G+     Y  
Sbjct: 102 YTAQIISGLEHLHQR-RIIYRDLKPENVLLDNDGN-VRISDLGLAVELKDGQSKTKGYAG 159

Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELL 151
           +  + APEL+ G  EY  ++D ++ G  L E++
Sbjct: 160 TPGFMAPELLQG-EEYDFSVDYFALGVTLYEMI 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 42.0 bits (99), Expect = 1e-04
 Identities = 41/173 (23%), Positives = 73/173 (42%), Gaps = 36/173 (20%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYL------NLVL-----EYVPETVHRVIKHHYKMS 49
           +  L H N++ + H      E   +        NL L             + +       
Sbjct: 62  LYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQ---- 117

Query: 50  QRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 109
               L+++ +   QI   ++Y+H   GV H+DI  +N +++    Q+K+ D   ++ L  
Sbjct: 118 ---QLVHMAI---QIACGMSYLHK-RGVIHKDIAARNCVID-EELQVKITDNALSRDLFP 169

Query: 110 GEPNISYIC-----SRYYR--APELIFGATEYTAAIDIWSAGCVLAELL-LGQ 154
            +    Y C     +R  +  A E +    EY++A D+WS G +L EL+ LGQ
Sbjct: 170 MD----YHCLGDNENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQ 217

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 41.5 bits (98), Expect = 2e-04
 Identities = 42/175 (24%), Positives = 77/175 (44%), Gaps = 38/175 (21%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYV-----------PETVHRVIKHHYKMS 49
           M+ L H  +V L   +   +E++ +Y+  V EY+            E     +     M+
Sbjct: 55  MKKLRHDKLVQL---YAVCSEEEPIYI--VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMA 109

Query: 50  QRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 109
                        QI   +AY+ +     HRD+  +N+LV  +    K+ DFG A+++  
Sbjct: 110 A------------QIAEGMAYLESR-NYIHRDLAARNILVGEN-LVCKIADFGLARLIED 155

Query: 110 GEPNISYICSRY---YRAPELI-FGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 159
            E   +   +++   + APE   +G   +T   D+WS G +L E++  G+  +PG
Sbjct: 156 DE-YTAREGAKFPIKWTAPEAANYG--RFTIKSDVWSFGILLTEIVTYGRVPYPG 207

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 41.5 bits (97), Expect = 3e-04
 Identities = 28/89 (31%), Positives = 48/89 (53%), Gaps = 11/89 (12%)

Query: 16  FFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 73
           ++S  +KD LY   V++Y+P  + +  +I+         P    + Y  ++  A+  +H 
Sbjct: 67  YYSFQDKDNLYF--VMDYIPGGDMMSLLIRMGI-----FPEDLARFYIAELTCAVESVHK 119

Query: 74  TIGVCHRDIKPQNLLVNPHTHQLKLCDFG 102
            +G  HRDIKP N+L++   H +KL DFG
Sbjct: 120 -MGFIHRDIKPDNILIDRDGH-IKLTDFG 146

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 41.0 bits (96), Expect = 3e-04
 Identities = 35/157 (22%), Positives = 74/157 (47%), Gaps = 22/157 (14%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE----TVHRVIKHHYKMSQRMPLIY 56
           M  L H  +V L   +   T++  +Y+  V EY+         R     ++ SQ + +  
Sbjct: 53  MMKLSHEKLVQL---YGVCTKQRPIYI--VTEYMSNGCLLNYLREHGKRFQPSQLLEMCK 107

Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
                  +C  +AY+ +     HRD+  +N LV+     +K+ DFG ++ ++  E   S 
Sbjct: 108 ------DVCEGMAYLESK-QFIHRDLAARNCLVDDQG-CVKVSDFGLSRYVLDDE-YTSS 158

Query: 117 ICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAEL 150
           + S++   +  PE +   +++++  D+W+ G ++ E+
Sbjct: 159 VGSKFPVRWSPPE-VLLYSKFSSKSDVWAFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 41.5 bits (97), Expect = 3e-04
 Identities = 70/299 (23%), Positives = 116/299 (38%), Gaps = 79/299 (26%)

Query: 2   RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHR-VIKHHYKMSQRMPLIYVKLY 60
           +L +HPN+V  +  F +  E     L +V  ++     + +I  H+     M  + +   
Sbjct: 54  KLFNHPNIVPYRATFIADNE-----LWVVTSFMAYGSAKDLICTHF--MDGMSELAIAYI 106

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVN-----------------PHTHQLKLC-DFG 102
              + +AL YIH+ +G  HR +K  ++L++                  H  +L++  DF 
Sbjct: 107 LQGVLKALDYIHH-MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFP 165

Query: 103 --SAKVLVKGEPNISYICSRYYRAPELIFGATE-YTAAIDIWSAGCVLAELLLGQPLFPG 159
             S KVL    P +S         PE++    + Y A  DI+S G    EL  G   F  
Sbjct: 166 KYSVKVL----PWLS---------PEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212

Query: 160 ESGVDQLVEIIKVLGT------------------PTR--------EEIKCMNPNYTEFKF 193
                 L+E  K+ GT                  P+R        E      P  +    
Sbjct: 213 MPATQMLLE--KLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSN--- 267

Query: 194 PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL-RDPNTRLP 251
            +  +HP+++ F     P     V + LQ +P+ R +A   L H FF ++ R  +  LP
Sbjct: 268 GESSSHPYNRTFS----PHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEALP 322

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 41.0 bits (96), Expect = 4e-04
 Identities = 26/79 (32%), Positives = 43/79 (54%), Gaps = 8/79 (10%)

Query: 79  HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR------YYRAPELIFGAT 132
           HRD+  +N+LVN +    K+ DFG ++ L     + +Y  S        + APE I    
Sbjct: 129 HRDLAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAI-AYR 186

Query: 133 EYTAAIDIWSAGCVLAELL 151
           ++T+A D+WS G V+ E++
Sbjct: 187 KFTSASDVWSYGIVMWEVM 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 41.1 bits (96), Expect = 4e-04
 Identities = 35/118 (29%), Positives = 61/118 (51%), Gaps = 16/118 (13%)

Query: 62  YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY 121
           YQ+ R + Y+ +   + HRD+  +N+LV    + +K+ DFG    L +G  +I Y     
Sbjct: 141 YQVARGMEYLESRRCI-HRDLAARNVLVT-EDNVMKIADFG----LARGVHDIDYYKKTS 194

Query: 122 -------YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIK 171
                  + APE +F    YT   D+WS G ++ E+  LG   +PG   V++L ++++
Sbjct: 195 NGRLPVKWMAPEALFDRV-YTHQSDVWSFGILMWEIFTLGGSPYPGIP-VEELFKLLR 250

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 40.5 bits (95), Expect = 5e-04
 Identities = 57/232 (24%), Positives = 100/232 (43%), Gaps = 33/232 (14%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M+   HPNV+SL           E    +VL Y+    H  +++  +     P +   + 
Sbjct: 50  MKDFSHPNVLSL----LGICLPSEGSPLVVLPYM---KHGDLRNFIRSETHNPTVKDLIG 102

Query: 61  F-YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           F  Q+ + + Y+ +   V HRD+  +N +++  +  +K+ DFG A+ +   E    Y   
Sbjct: 103 FGLQVAKGMEYLASKKFV-HRDLAARNCMLD-ESFTVKVADFGLARDIYDKE----YYSV 156

Query: 120 RYYRAPEL--IFGATE------YTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEII 170
             +   +L   + A E      +T   D+WS G +L EL+  G P +P     D  V ++
Sbjct: 157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLL 216

Query: 171 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQ 222
           +  G    +   C +P Y      ++    WH   +  M P   +LVSR+ Q
Sbjct: 217 Q--GRRLLQPEYCPDPLY------EVMLSCWHP--KPEMRPTFSELVSRIEQ 258

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 40.7 bits (95), Expect = 5e-04
 Identities = 55/240 (22%), Positives = 95/240 (39%), Gaps = 45/240 (18%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQ------RMPL 54
           M+  DHPNV+ L      +  K  L + +V+  +P   H  +     MS+       +PL
Sbjct: 55  MKEFDHPNVIKLIGVSLRSRAKGRLPIPMVI--LPFMKHGDLHTFLLMSRIGEEPFTLPL 112

Query: 55  IYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLC--DFGSAKVLVKGEP 112
             +  +   I   + Y+ +     HRD+  +N ++N     + +C  DFG +K +  G+ 
Sbjct: 113 QTLVRFMIDIASGMEYLSSK-NFIHRDLAARNCMLN---ENMTVCVADFGLSKKIYSGD- 167

Query: 113 NISYICSRYYR---APELIFG--ATE------YTAAIDIWSAGCVLAELL-LGQPLFPGE 160
                   YYR   A +L     A E      YT   D+W+ G  + E++  GQ  + G 
Sbjct: 168 --------YYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV 219

Query: 161 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 220
              +    +IK  G   ++   C+   Y      ++    W    + R  P    L  +L
Sbjct: 220 ENSEIYNYLIK--GNRLKQPPDCLEDVY------ELMCQCWSPEPKCR--PSFQHLRDQL 269

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 39.6 bits (93), Expect = 8e-04
 Identities = 29/94 (30%), Positives = 49/94 (52%), Gaps = 12/94 (12%)

Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY------I 117
           I   + Y+   +   HRD+  +N+LVN +    K+ DFG ++ L   +   +Y      I
Sbjct: 115 IASGMKYLSE-MNYVHRDLAARNILVNSNL-VCKVSDFGLSRRL--EDSEATYTTKGGKI 170

Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL 151
             R+  APE I    ++T+A D+WS G V+ E++
Sbjct: 171 PIRW-TAPEAI-AYRKFTSASDVWSFGIVMWEVM 202

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 39.9 bits (93), Expect = 9e-04
 Identities = 29/102 (28%), Positives = 48/102 (47%), Gaps = 24/102 (23%)

Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 122
           QI   + Y+ +++   HRD+  +N LV  +   +K+ DFG ++ L  G+         YY
Sbjct: 146 QIASGMKYL-SSLNFVHRDLATRNCLVGENLT-IKIADFGMSRNLYAGD---------YY 194

Query: 123 R------------APELIFGATEYTAAIDIWSAGCVLAELLL 152
           R            A E I    ++T A D+W+ G  L E+L+
Sbjct: 195 RIQGRAVLPIRWMAWECIL-MGKFTTASDVWAFGVTLWEILM 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 39.4 bits (92), Expect = 0.001
 Identities = 44/169 (26%), Positives = 80/169 (47%), Gaps = 26/169 (15%)

Query: 1   MRLLDHPNVVSL------KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPL 54
           M+ + HPN+V L      +  F+  TE    Y NL L+Y+ E             Q +  
Sbjct: 56  MKEIKHPNLVQLLGVCTREPPFYIITEF-MTYGNL-LDYLREC----------NRQEVNA 103

Query: 55  IYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 114
           + +     QI  A+ Y+       HRD+  +N LV  + H +K+ DFG ++ L+ G+   
Sbjct: 104 VVLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGEN-HLVKVADFGLSR-LMTGDTYT 160

Query: 115 SYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAEL-LLGQPLFPG 159
           ++  +++   + APE +    +++   D+W+ G +L E+   G   +PG
Sbjct: 161 AHAGAKFPIKWTAPESL-AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 208

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 39.3 bits (92), Expect = 0.001
 Identities = 44/174 (25%), Positives = 68/174 (39%), Gaps = 43/174 (24%)

Query: 1   MRLLDHPNVVSL-------KHCFFSTTEKDELY-LNLVL-EYVPETVHRVIKHHYKMSQR 51
           +  L  PN+  L               E  E   LN  L ++V ET    +  + K    
Sbjct: 73  LSRLSDPNIARLLGVCTVDPPLCM-IMEYMENGDLNQFLQKHVAETSG--LACNSKSLSF 129

Query: 52  MPLIYVKLYFYQICRALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 109
             L+Y+     QI   + Y+   N +   HRD+  +N LV    + +K+ DFG ++ L  
Sbjct: 130 STLLYMAT---QIASGMRYLESLNFV---HRDLATRNCLVGK-NYTIKIADFGMSRNL-- 180

Query: 110 GEPNISYICSRYY----RAP--------ELIFGATEYTAAIDIWSAGCVLAELL 151
                 Y    YY    RAP        E +    ++T   D+W+ G  L E+L
Sbjct: 181 ------YSSD-YYRVQGRAPLPIRWMAWESVLL-GKFTTKSDVWAFGVTLWEIL 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 39.2 bits (91), Expect = 0.001
 Identities = 50/201 (24%), Positives = 82/201 (40%), Gaps = 61/201 (30%)

Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 122
           +I   +AY+ N     HRD+  +N +V  H   +K+ DFG  + + + +         YY
Sbjct: 127 EIADGMAYL-NAKKFVHRDLAARNCMV-AHDFTVKIGDFGMTRDIYETD---------YY 175

Query: 123 R------------APELIFGATEYTAAIDIWSAGCVLAEL--LLGQPLFPGESGVDQLVE 168
           R            APE +     +T + D+WS G VL E+  L  QP + G S  +Q+++
Sbjct: 176 RKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQP-YQGLSN-EQVLK 232

Query: 169 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 228
            +             M+  Y +         P         P    DL+    Q++P +R
Sbjct: 233 FV-------------MDGGYLD--------QP------DNCPERVTDLMRMCWQFNPKMR 265

Query: 229 STALEAL------IHPFFDEL 243
            T LE +      +HP F E+
Sbjct: 266 PTFLEIVNLLKDDLHPSFPEV 286

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 39.3 bits (91), Expect = 0.002
 Identities = 44/165 (26%), Positives = 76/165 (46%), Gaps = 26/165 (15%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-----ETVHRVIKHHYKMSQRMPLI 55
           M  +DHP++V L     S T      + LV + +P     + VH   +H   +  ++ L 
Sbjct: 63  MASMDHPHLVRLLGVCLSPT------IQLVTQLMPHGCLLDYVH---EHKDNIGSQLLLN 113

Query: 56  YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS 115
           +      QI + + Y+     + HRD+  +N+LV    H +K+ DFG A++L   E   +
Sbjct: 114 WC----VQIAKGMMYLEER-RLVHRDLAARNVLVKSPNH-VKITDFGLARLLEGDEKEYN 167

Query: 116 YICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELLL--GQP 155
               +    + A E I    ++T   D+WS G  + EL+   G+P
Sbjct: 168 ADGGKMPIKWMALECIH-YRKFTHQSDVWSYGVTIWELMTFGGKP 211

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 38.1 bits (88), Expect = 0.003
 Identities = 31/102 (30%), Positives = 54/102 (52%), Gaps = 10/102 (9%)

Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY- 121
           Q+   +AYI   +   HRD++  N+LV       K+ DFG A+ L++     +   +++ 
Sbjct: 110 QVAAGMAYIER-MNYIHRDLRSANILVG-DGLVCKIADFGLAR-LIEDNEYTARQGAKFP 166

Query: 122 --YRAPEL-IFGATEYTAAIDIWSAGCVLAELLL-GQPLFPG 159
             + APE  ++G   +T   D+WS G +L EL+  G+  +PG
Sbjct: 167 IKWTAPEAALYG--RFTIKSDVWSFGILLTELVTKGRVPYPG 206

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 37.7 bits (87), Expect = 0.004
 Identities = 48/171 (28%), Positives = 76/171 (44%), Gaps = 31/171 (18%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE----TVHRVIKHHYKMSQRMPLIY 56
           ++  DHPN+V L       T++  +Y+  V+E VP     +  R  K   K  Q +    
Sbjct: 46  LKQYDHPNIVKL---IGVCTQRQPIYI--VMELVPGGDFLSFLRKKKDELKTKQLVK--- 97

Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
              +       +AY+ +     HRD+  +N LV    + LK+ DFG    + + E +  Y
Sbjct: 98  ---FALDAAAGMAYLESK-NCIHRDLAARNCLVG-ENNVLKISDFG----MSRQEDDGIY 148

Query: 117 ICSRY------YRAPE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 159
             S        + APE L +G   Y++  D+WS G +L E   LG   +PG
Sbjct: 149 SSSGLKQIPIKWTAPEALNYG--RYSSESDVWSYGILLWETFSLGVCPYPG 197

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 38.1 bits (88), Expect = 0.004
 Identities = 42/157 (26%), Positives = 67/157 (42%), Gaps = 20/157 (12%)

Query: 1   MRLLDHPNVVSLKH-CFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           M  +D+P+V  L   C  ST +     +    +L+YV E    +   +           +
Sbjct: 63  MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQY-----------L 111

Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
             +  QI + + Y+     V HRD+  +N+LV    H +K+ DFG AK+L   E      
Sbjct: 112 LNWCVQIAKGMNYLEERRLV-HRDLAARNVLVKTPQH-VKITDFGLAKLLGADEKEYHAE 169

Query: 118 CSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL 151
             +    + A E I     YT   D+WS G  + EL+
Sbjct: 170 GGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	292
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
PLN00181	793	protein SPA1-RELATED; Provisional	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.97
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.97
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.97
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.97
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.97
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.97
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.97
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.96
KOG3653	534	consensus Transforming growth factor beta/activin	99.96
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.95
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.95
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.95
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.95
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.94
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.93
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.93
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.92
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.92
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.91
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.87
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.87
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.84
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.83
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.82
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.82
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.82
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.81
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.79
PRK12274	218	serine/threonine protein kinase; Provisional	99.76
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.75
PRK09188	365	serine/threonine protein kinase; Provisional	99.73
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.7
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.68
PRK10345	210	hypothetical protein; Provisional	99.61
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.59
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.59
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.58
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.57
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.52
KOG1243	690	consensus Protein kinase [General function predict	99.5
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.43
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.36
PRK14879	211	serine/threonine protein kinase; Provisional	99.35
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.34
smart00090	237	RIO RIO-like kinase.	99.32
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.3
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.28
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.18
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.11
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.09
COG4248	637	Uncharacterized protein with protein kinase and he	99.07
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.07
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.99
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	98.92
KOG3087	229	consensus Serine/threonine protein kinase [General	98.84
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.81
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	98.79
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.75
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.66
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	98.61
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	98.58
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.55
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.38
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.35
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.2
PRK09902	216	hypothetical protein; Provisional	98.16
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.96
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	97.93
COG0478	304	RIO-like serine/threonine protein kinase fused to	97.73
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.68
COG0661	517	AarF Predicted unusual protein kinase [General fun	97.66
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.6
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.56
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.55
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	97.01
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	96.61
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	96.47
PLN02876	822	acyl-CoA dehydrogenase	95.33
KOG2268	465	consensus Serine/threonine protein kinase [Signal	94.98
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	94.88
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	94.87
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	94.68
PRK05231	319	homoserine kinase; Provisional	94.63
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	94.43
PRK10271	188	thiK thiamine kinase; Provisional	94.19
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	94.09
PF01636	239	APH: Phosphotransferase enzyme family This family	93.74
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	93.57
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	93.11
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	92.75
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	92.66
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	92.52
PLN02236	344	choline kinase	92.5
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	92.32
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	92.13
COG2334	331	Putative homoserine kinase type II (protein kinase	92.0
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	91.89
PHA03111	444	Ser/Thr kinase; Provisional	91.62
smart00587	196	CHK ZnF_C4 abd HLH domain containing kinases domai	91.34
KOG2270	520	consensus Serine/threonine protein kinase involved	91.28
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	89.96
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	89.1
PRK06148	1013	hypothetical protein; Provisional	87.83
PRK06149	972	hypothetical protein; Provisional	87.76
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	87.35
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	86.97
PRK12396	409	5-methylribose kinase; Reviewed	86.96
PRK09550	401	mtnK methylthioribose kinase; Reviewed	86.9
PRK11768	325	serine/threonine protein kinase; Provisional	86.73
KOG2464	246	consensus Serine/threonine kinase (haspin family)	85.65
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	85.16

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.6e-63  Score=409.05  Aligned_cols=285  Identities=75%  Similarity=1.240  Sum_probs=269.3

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      |+.++|||||++..+|....+.+..+..+||||++.+|.+.++.......+++...++-|++||+.||.|||++ ||+||
T Consensus        71 m~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~-~IcHR  149 (364)
T KOG0658|consen   71 MRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH-GICHR  149 (364)
T ss_pred             HHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc-CcccC
Confidence            56889999999999998777666788999999999999999998766678899999999999999999999986 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE  160 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  160 (292)
                      ||||+|+|+|.+.+.+||||||.|+....+++..++.+|++|+|||++.|...|+.+.|+||.||+++||+.|++.|+|+
T Consensus       150 DIKPqNlLvD~~tg~LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~  229 (364)
T KOG0658|consen  150 DIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGD  229 (364)
T ss_pred             CCChheEEEcCCCCeEEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCC
Confidence            99999999999977999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCCc
Q 022799          161 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  240 (292)
Q Consensus       161 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~~  240 (292)
                      +..+++..|++.+|.|+.+++.++++++....++......|...+....++++.+|+.++|+++|.+|.++.|++.||||
T Consensus       230 s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fF  309 (364)
T KOG0658|consen  230 SSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFF  309 (364)
T ss_pred             CHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhh
Confidence            99999999999999999999999999999999999999999888889999999999999999999999999999999999


Q ss_pred             cccCCCCCCCCCCCCCCCCCCCChhccCCCCHHHHhhhchHHHHhhh
Q 022799          241 DELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQC  287 (292)
Q Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (292)
                      +.+++++..++++...|++++|++. ..+...+.+..+.+++..+..
T Consensus       310 delr~~~~~l~~g~~lp~lf~f~~~-e~~~~~~~~~~l~p~~~~~~~  355 (364)
T KOG0658|consen  310 DELRDPNTKLPNGRPLPPLFNFKRA-ELGISPELVNVLIPEHLREQE  355 (364)
T ss_pred             HHhhCcCccCcCCCcCCCccCchHH-HhccchHHHHhhccHhhhhhc
Confidence            9999999999999999999999977 677789999999998877654

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-54  Score=357.33  Aligned_cols=271  Identities=38%  Similarity=0.671  Sum_probs=231.3

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      |+.++|+||+.+++++..+....-..+|+|+|+|+.+|.+++..    ++.++...++.+++||+.||+|+|+. ||+||
T Consensus        75 Lr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elMetDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHSA-nViHR  149 (359)
T KOG0660|consen   75 LRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELMETDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHSA-NVIHR  149 (359)
T ss_pred             HHHhcCCCcceEEeecccccccccceeEEehhHHhhHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhcc-ccccc
Confidence            46789999999999987644455567999999999999999985    35599999999999999999999987 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCcccccc---CCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVK---GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF  157 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf  157 (292)
                      |+||+|++++.+. .+||||||+|+....   ....+.++.|.+|+|||++.....|+.+.||||+|||++||++|++.|
T Consensus       150 DLKPsNll~n~~c-~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplF  228 (359)
T KOG0660|consen  150 DLKPSNLLLNADC-DLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLF  228 (359)
T ss_pred             ccchhheeeccCC-CEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCC
Confidence            9999999999988 799999999998753   333356788999999999988888999999999999999999999999


Q ss_pred             CCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC-cc--ccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHH
Q 022799          158 PGESGVDQLVEIIKVLGTPTREEIKCMNPNY-TE--FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA  234 (292)
Q Consensus       158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~  234 (292)
                      +|.+..+++..|.+.+|.|+.+.+..+.... ..  ...+..+..++...|+ +.++.+.||+.+||++||.+|+|++|+
T Consensus       229 pG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eA  307 (359)
T KOG0660|consen  229 PGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEA  307 (359)
T ss_pred             CCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHH
Confidence            9999999999999999999999988875332 11  2567777888888885 899999999999999999999999999


Q ss_pred             hcCCCccccCCCCCCCCCCCCCCCCCCCChhccCCCCHHHHhhhchHHHHh
Q 022799          235 LIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARK  285 (292)
Q Consensus       235 l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (292)
                      |+|||++.+.++.++......   +..   .+.. .+.+.+++++++...+
T Consensus       308 L~hPYl~~~hdp~dEP~~~~~---~~~---~~~~-~~~~~~r~~i~~e~~~  351 (359)
T KOG0660|consen  308 LAHPYLAPYHDPEDEPVCQPI---FDS---FEHE-LTEEELRELIYKEILD  351 (359)
T ss_pred             hcChhhhhhcCCccCCCCCCC---Ccc---cccc-ccHHHHHHHHHHHHHh
Confidence            999999999988766433221   111   3344 7899999998887543

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-53  Score=363.10  Aligned_cols=234  Identities=36%  Similarity=0.697  Sum_probs=209.8

Q ss_pred             CCCCC-CCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLD-HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~-HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++|+ |||||++.+++.+.+.    .+|+|||||+.+|+++++.+   ...+++..++.|++||+.||+|+|.+ |+.|
T Consensus        62 L~kln~hpniikL~Evi~d~~~----~L~fVfE~Md~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~-GfFH  133 (538)
T KOG0661|consen   62 LRKLNPHPNIIKLKEVIRDNDR----ILYFVFEFMDCNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKH-GFFH  133 (538)
T ss_pred             HHhcCCCCcchhhHHHhhccCc----eEeeeHHhhhhhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhc-Cccc
Confidence            46788 9999999999955331    69999999999999999876   57899999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      ||+||+|||+.... .|||+|||+|+.+.+..+.+.++.|++|+|||++.....|+.+.|+||+|||++|+.+-++.|+|
T Consensus       134 RDlKPENiLi~~~~-~iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG  212 (538)
T KOG0661|consen  134 RDLKPENILISGND-VIKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPG  212 (538)
T ss_pred             ccCChhheEecccc-eeEecccccccccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCC
Confidence            99999999999655 69999999999999888889999999999999999888899999999999999999999999999


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhc--CCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCM--NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      .++.+++.+|.+.+|.|..+.|...  ......+.+|.....++...++. .++++.++|.+||.+||.+||||+++|+|
T Consensus       213 ~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  213 ASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             CcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            9999999999999999998776542  12233457777777777777765 99999999999999999999999999999


Q ss_pred             CCccccC
Q 022799          238 PFFDELR  244 (292)
Q Consensus       238 p~~~~~~  244 (292)
                      |||+.-.
T Consensus       292 pffq~~~  298 (538)
T KOG0661|consen  292 PFFQVGR  298 (538)
T ss_pred             ccccccc
Confidence            9998643

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=4.8e-53  Score=341.01  Aligned_cols=233  Identities=37%  Similarity=0.711  Sum_probs=205.3

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      |++|+|||+|.++++|     .....++||+|||+-++.+.++..   ...++...++.+++|++.|+.|+|++ +++||
T Consensus        55 LKqLkH~NLVnLiEVF-----rrkrklhLVFE~~dhTvL~eLe~~---p~G~~~~~vk~~l~Q~l~ai~~cHk~-n~IHR  125 (396)
T KOG0593|consen   55 LKQLKHENLVNLIEVF-----RRKRKLHLVFEYCDHTVLHELERY---PNGVPSELVKKYLYQLLKAIHFCHKN-NCIHR  125 (396)
T ss_pred             HHhcccchHHHHHHHH-----HhcceeEEEeeecchHHHHHHHhc---cCCCCHHHHHHHHHHHHHHhhhhhhc-Ceecc
Confidence            5789999999999999     666669999999999888888765   56789999999999999999999998 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccc-cCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLV-KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      ||||+|||++.++ .+||||||+|+... .++..+.++.|++|+|||++.|...|+..+||||+||++.||++|.+.|+|
T Consensus       126 DIKPENILit~~g-vvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG  204 (396)
T KOG0593|consen  126 DIKPENILITQNG-VVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPG  204 (396)
T ss_pred             cCChhheEEecCC-cEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCC
Confidence            9999999999998 89999999999887 556667788999999999999988899999999999999999999999999


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHh--hcCCCCccccCCCCCCC-CchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIK--CMNPNYTEFKFPQIKAH-PWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      .++.+++..|.+.+|........  ..++.|-...+|..... +.+..+ ++++.-+.||+++||..||.+|++-+++|.
T Consensus       205 ~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~-p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  205 RSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKY-PKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             cchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhc-ccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            99999999999999998876544  33566666666665443 344444 568889999999999999999999999999


Q ss_pred             CCCccccC
Q 022799          237 HPFFDELR  244 (292)
Q Consensus       237 hp~~~~~~  244 (292)
                      ||||+++.
T Consensus       284 H~yFd~~~  291 (396)
T KOG0593|consen  284 HPYFDGFI  291 (396)
T ss_pred             ChHHHHHH
Confidence            99997654

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=5.1e-52  Score=329.42  Aligned_cols=231  Identities=39%  Similarity=0.754  Sum_probs=202.6

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      |+.++||||+.++++|     .....+.||+||++.+|...++..   ...++...++.|+.+++.|++|||++ .|+||
T Consensus        55 Lqel~h~nIi~LiD~F-----~~~~~l~lVfEfm~tdLe~vIkd~---~i~l~pa~iK~y~~m~LkGl~y~H~~-~IlHR  125 (318)
T KOG0659|consen   55 LQELKHPNIIELIDVF-----PHKSNLSLVFEFMPTDLEVVIKDK---NIILSPADIKSYMLMTLKGLAYCHSK-WILHR  125 (318)
T ss_pred             HHHccCcchhhhhhhc-----cCCCceEEEEEeccccHHHHhccc---ccccCHHHHHHHHHHHHHHHHHHHhh-hhhcc
Confidence            5788999999999999     444458999999999999999864   56799999999999999999999998 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCCccc-ccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      ||||.|+|++++| .+||+|||+|+.+.+.....+ .+.|++|+|||++.|.+.|+..+|+||+|||+.||+.|.+.|+|
T Consensus       126 DlKPnNLLis~~g-~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG  204 (318)
T KOG0659|consen  126 DLKPNNLLISSDG-QLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPG  204 (318)
T ss_pred             cCCccceEEcCCC-cEEeecccchhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCC
Confidence            9999999999999 899999999998866544433 37899999999999999999999999999999999999999999


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcC--CCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      .++.+++..|++.+|+|..+.|..+.  ++|.++.  ..+..+....| +..++++.||+.+||.+||.+|+|+.|+|+|
T Consensus       205 ~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~--~~P~~~~~~lf-~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  205 DSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQ--QFPKPPLNNLF-PAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             CchHHHHHHHHHHcCCCCcccCccccccccHHHHh--cCCCCcccccc-ccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            99999999999999999999998774  4554443  33333444444 4578889999999999999999999999999


Q ss_pred             CCccccC
Q 022799          238 PFFDELR  244 (292)
Q Consensus       238 p~~~~~~  244 (292)
                      +||++.-
T Consensus       282 ~yf~~~P  288 (318)
T KOG0659|consen  282 PYFKSLP  288 (318)
T ss_pred             hhhhcCC
Confidence            9999743

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.4e-53  Score=353.15  Aligned_cols=210  Identities=35%  Similarity=0.522  Sum_probs=171.6

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++|+|||||+++++|.     ...+.||||||++ |+|.+.+-.    ++.+.+...+.+++|++.|+.|||+. ||+|
T Consensus       230 LkkL~HP~IV~~~d~f~-----~~ds~YmVlE~v~GGeLfd~vv~----nk~l~ed~~K~~f~Qll~avkYLH~~-GI~H  299 (475)
T KOG0615|consen  230 LKKLSHPNIVRIKDFFE-----VPDSSYMVLEYVEGGELFDKVVA----NKYLREDLGKLLFKQLLTAVKYLHSQ-GIIH  299 (475)
T ss_pred             HHhcCCCCEEEEeeeee-----cCCceEEEEEEecCccHHHHHHh----ccccccchhHHHHHHHHHHHHHHHHc-Cccc
Confidence            67899999999999994     4444899999999 688887765    47788899999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCC--CCcEEEeecCCccccccCCCcccccccccccCCccccCC--CCCCchhHhhhhhHHHHHHHhCCC
Q 022799           80 RDIKPQNLLVNPH--THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA--TEYTAAIDIWSAGCVLAELLLGQP  155 (292)
Q Consensus        80 ~dlkp~Nill~~~--~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwslG~il~el~~g~~  155 (292)
                      |||||+|||++.+  ...+||+|||+|+.........+.+|||.|.|||++.+.  ..+..++|+||+||++|-+++|.+
T Consensus       300 RDiKPeNILl~~~~e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~p  379 (475)
T KOG0615|consen  300 RDIKPENILLSNDAEDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYP  379 (475)
T ss_pred             ccCCcceEEeccCCcceEEEecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCC
Confidence            9999999999765  226899999999998877777889999999999999654  234558999999999999999999


Q ss_pred             CCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHh
Q 022799          156 LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL  235 (292)
Q Consensus       156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l  235 (292)
                      ||.+......+.+.+....                +.+        .......++.++++||.+||..||++|||++|+|
T Consensus       380 PFS~~~~~~sl~eQI~~G~----------------y~f--------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL  435 (475)
T KOG0615|consen  380 PFSEEYTDPSLKEQILKGR----------------YAF--------GPLQWDRISEEALDLINWMLVVDPENRPSADEAL  435 (475)
T ss_pred             CcccccCCccHHHHHhcCc----------------ccc--------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHh
Confidence            9976654432322222110                000        0011146899999999999999999999999999


Q ss_pred             cCCCccccC
Q 022799          236 IHPFFDELR  244 (292)
Q Consensus       236 ~hp~~~~~~  244 (292)
                      +||||+...
T Consensus       436 ~hpW~~~~~  444 (475)
T KOG0615|consen  436 NHPWFKDAP  444 (475)
T ss_pred             cChhhhccc
Confidence            999999754

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.2e-51  Score=358.87  Aligned_cols=204  Identities=32%  Similarity=0.548  Sum_probs=182.1

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      ++|+|||||+++++|     +|..++|||+|+|. ++|..++++    .+.++|.+++.+++||+.||.|||++ +|+||
T Consensus        73 r~L~HpnIV~f~~~F-----EDs~nVYivLELC~~~sL~el~Kr----rk~ltEpEary~l~QIv~GlkYLH~~-~IiHR  142 (592)
T KOG0575|consen   73 RSLKHPNIVQFYHFF-----EDSNNVYIVLELCHRGSLMELLKR----RKPLTEPEARYFLRQIVEGLKYLHSL-GIIHR  142 (592)
T ss_pred             HhcCCCcEEeeeeEe-----ecCCceEEEEEecCCccHHHHHHh----cCCCCcHHHHHHHHHHHHHHHHHHhc-Cceec
Confidence            579999999999999     77778999999999 899998885    47899999999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccC-CCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      |||..|++++++. .|||+|||+|..+... +...+.+|||.|.|||++.. ..++..+||||+||++|-|++|++||..
T Consensus       143 DLKLGNlfL~~~~-~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k-~gHsfEvDiWSlGcvmYtLL~G~PPFet  220 (592)
T KOG0575|consen  143 DLKLGNLFLNENM-NVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNK-SGHSFEVDIWSLGCVMYTLLVGRPPFET  220 (592)
T ss_pred             ccchhheeecCcC-cEEecccceeeeecCcccccceecCCCcccChhHhcc-CCCCCchhhhhhhhHHHhhhhCCCCccc
Confidence            9999999999988 7999999999988644 67789999999999999974 5699999999999999999999999998


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCC
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF  239 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~  239 (292)
                      .+-.+.+.+|...                 ++.            +|..+|.+++|||.+||..||.+|||++++|.|+|
T Consensus       221 k~vkety~~Ik~~-----------------~Y~------------~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~F  271 (592)
T KOG0575|consen  221 KTVKETYNKIKLN-----------------EYS------------MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPF  271 (592)
T ss_pred             chHHHHHHHHHhc-----------------Ccc------------cccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHh
Confidence            8888888777653                 222            33579999999999999999999999999999999


Q ss_pred             ccccCCC
Q 022799          240 FDELRDP  246 (292)
Q Consensus       240 ~~~~~~~  246 (292)
                      |++--.+
T Consensus       272 f~~g~~p  278 (592)
T KOG0575|consen  272 FKSGFTP  278 (592)
T ss_pred             hhCCCcC
Confidence            9654333

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=3.6e-50  Score=361.31  Aligned_cols=284  Identities=51%  Similarity=0.972  Sum_probs=240.2

Q ss_pred             CCCCCCCCeeeeceeeeccC---CCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCc
Q 022799            1 MRLLDHPNVVSLKHCFFSTT---EKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGV   77 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~---~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i   77 (292)
                      |+.++|||||+++++|....   .....++++||||+++++.+++.........+++..++.++.||+.||.|||++ ||
T Consensus       113 l~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~-~I  191 (440)
T PTZ00036        113 MKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK-FI  191 (440)
T ss_pred             HHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CE
Confidence            46789999999998875432   133457889999999999888876555567899999999999999999999988 99


Q ss_pred             cccCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCC
Q 022799           78 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF  157 (292)
Q Consensus        78 ~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf  157 (292)
                      +||||||+||+++.++..+||+|||+++............||+.|+|||++.+...++.++|+||+||++|+|++|.+||
T Consensus       192 iHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf  271 (440)
T PTZ00036        192 CHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIF  271 (440)
T ss_pred             ecCCcCHHHEEEcCCCCceeeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            99999999999987765799999999987755555556788999999999877666899999999999999999999999


Q ss_pred             CCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          158 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      .+.+..+.+.++.+.++.|..+.+..+.+.+....++......+...++...++++++||.+||++||.+|+|+.|+++|
T Consensus       272 ~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        272 SGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             CCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence            99999999999999999999999888888887777887777777777888899999999999999999999999999999


Q ss_pred             CCccccCCCCCCCCCC-CCCCCCCCCChhccCCCCHHHHhhhchHHHHh
Q 022799          238 PFFDELRDPNTRLPNG-RFLPPLFNFKPHELKGVPVDMLVKLIPEHARK  285 (292)
Q Consensus       238 p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (292)
                      |||+++.+.....+.. ...|.+++|...+...+..+.....+++....
T Consensus       352 p~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  400 (440)
T PTZ00036        352 PFFDDLRDPCIKLPKYIDKLPDLFNFCDAEIKEMSDACRRKIIPKCTYE  400 (440)
T ss_pred             hhHHhhhcccccCCCCCCCCCCCcCCCHHHHhhCCHHHHHHHhhHHHHH
Confidence            9999987654443321 34577888888888888888877776654433

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-51  Score=338.51  Aligned_cols=210  Identities=31%  Similarity=0.572  Sum_probs=174.3

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||+||++|++|+...+    .++++||||+ |+|..++..    .++++|.....++.+|+.||.|||+..+|+|
T Consensus       131 l~~~~spyIV~~ygaF~~~~~----~isI~mEYMDgGSLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIH  202 (364)
T KOG0581|consen  131 LRSCQSPYIVGFYGAFYSNGE----EISICMEYMDGGSLDDILKR----VGRIPEPVLGKIARAVLRGLSYLHEERKIIH  202 (364)
T ss_pred             HhhCCCCCeeeEeEEEEeCCc----eEEeehhhcCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhccCeee
Confidence            357799999999999966442    3899999999 799888875    3789999999999999999999996449999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      |||||+|||++..| .|||||||.++...+. ...+++||..|||||.+.+.. |+.++||||||+.++|+++|+.||..
T Consensus       203 RDIKPsNlLvNskG-eVKicDFGVS~~lvnS-~a~tfvGT~~YMsPERi~g~~-Ys~~sDIWSLGLsllE~a~GrfP~~~  279 (364)
T KOG0581|consen  203 RDIKPSNLLVNSKG-EVKICDFGVSGILVNS-IANTFVGTSAYMSPERISGES-YSVKSDIWSLGLSLLELAIGRFPYPP  279 (364)
T ss_pred             ccCCHHHeeeccCC-CEEeccccccHHhhhh-hcccccccccccChhhhcCCc-CCcccceecccHHHHHHhhCCCCCCC
Confidence            99999999999988 8999999999987665 667899999999999998764 99999999999999999999999976


Q ss_pred             C--CcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccC-CChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          160 E--SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKR-MPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       160 ~--~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      .  .....+..+......|++                         .+|.. +|+++++||..||++||++|+|+.|+++
T Consensus       280 ~~~~~~~~~~Ll~~Iv~~ppP-------------------------~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  280 PNPPYLDIFELLCAIVDEPPP-------------------------RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             cCCCCCCHHHHHHHHhcCCCC-------------------------CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            4  122222222222222221                         12233 8999999999999999999999999999


Q ss_pred             CCCccccCCC
Q 022799          237 HPFFDELRDP  246 (292)
Q Consensus       237 hp~~~~~~~~  246 (292)
                      |||++.....
T Consensus       335 Hpfi~~~~~~  344 (364)
T KOG0581|consen  335 HPFIKKFEDP  344 (364)
T ss_pred             CHHHhhcccc
Confidence            9999976543

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.2e-50  Score=330.97  Aligned_cols=236  Identities=34%  Similarity=0.595  Sum_probs=206.6

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      |.+++|||||.+.++.+..+ .+  .+|||||||+.+|..++.+-   .+++...+++.++.|++.|++|||.+ .|+||
T Consensus       129 Ll~~~H~NIV~vkEVVvG~~-~d--~iy~VMe~~EhDLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~-wilHR  201 (419)
T KOG0663|consen  129 LLKARHPNIVEVKEVVVGSN-MD--KIYIVMEYVEHDLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDN-WILHR  201 (419)
T ss_pred             HHhcCCCCeeeeEEEEeccc-cc--eeeeeHHHHHhhHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhc-eeEec
Confidence            35678999999999875433 22  38999999999999999864   47899999999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCC-cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      |||++|+|++..| .+||+|||+|+.+.+... .+..+.|.+|+|||++.|.+.|++++|+||+|||+.||+++.+.|+|
T Consensus       202 DLK~SNLLm~~~G-~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G  280 (419)
T KOG0663|consen  202 DLKTSNLLLSHKG-ILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPG  280 (419)
T ss_pred             ccchhheeeccCC-cEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCC
Confidence            9999999999888 799999999999866543 34567799999999999999999999999999999999999999999


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcC--CCCccccCCCCCCCCchhhhccC-CChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEFKFPQIKAHPWHKIFQKR-MPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      ....+++.+|++.+|.|+...|.+..  +....+.++......+...|... ++....+|+.++|.+||.+|.||+++|.
T Consensus       281 ~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  281 KSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             CchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence            99999999999999999999988763  22334567777666777777654 7799999999999999999999999999


Q ss_pred             CCCccccC
Q 022799          237 HPFFDELR  244 (292)
Q Consensus       237 hp~~~~~~  244 (292)
                      |+||.+..
T Consensus       361 h~~F~e~P  368 (419)
T KOG0663|consen  361 HEYFRETP  368 (419)
T ss_pred             ccccccCC
Confidence            99999743

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-50  Score=349.33  Aligned_cols=206  Identities=33%  Similarity=0.603  Sum_probs=183.8

Q ss_pred             CCCC-CCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcc
Q 022799            1 MRLL-DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVC   78 (292)
Q Consensus         1 L~~l-~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~   78 (292)
                      |.+| .||.|++|+..|     +|+..+|+|+||++ |+|.++|...    +.+++..++.|+.||+.||+|||++ |||
T Consensus       127 l~~L~~hPgivkLy~TF-----QD~~sLYFvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~~-GII  196 (604)
T KOG0592|consen  127 LTQLSGHPGIVKLYFTF-----QDEESLYFVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHSN-GII  196 (604)
T ss_pred             HHHhhCCCCeEEEEEEe-----ecccceEEEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHhc-Cce
Confidence            3456 899999999999     67777999999999 8999999875    7799999999999999999999998 999


Q ss_pred             ccCCCCCcEEEeCCCCcEEEeecCCccccccCCC--------------cccccccccccCCccccCCCCCCchhHhhhhh
Q 022799           79 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP--------------NISYICSRYYRAPELIFGATEYTAAIDIWSAG  144 (292)
Q Consensus        79 H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~--------------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG  144 (292)
                      ||||||+|||++.|+ .++|+|||.|+.+.....              ..+++||-.|.+||++... ..+..+|+|+||
T Consensus       197 HRDlKPENILLd~dm-hikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~-~~~~~sDiWAlG  274 (604)
T KOG0592|consen  197 HRDLKPENILLDKDG-HIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDS-PAGPSSDLWALG  274 (604)
T ss_pred             eccCChhheeEcCCC-cEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCC-CCCcccchHHHH
Confidence            999999999999999 699999999997643211              1458999999999999654 489999999999


Q ss_pred             HHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccC
Q 022799          145 CVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYS  224 (292)
Q Consensus       145 ~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  224 (292)
                      ||+|.|+.|.+||.+.++..++++|+...                 +            .|++++++.++|||+++|..|
T Consensus       275 CilyQmlaG~PPFra~NeyliFqkI~~l~-----------------y------------~fp~~fp~~a~dLv~KLLv~d  325 (604)
T KOG0592|consen  275 CILYQMLAGQPPFRAANEYLIFQKIQALD-----------------Y------------EFPEGFPEDARDLIKKLLVRD  325 (604)
T ss_pred             HHHHHHhcCCCCCccccHHHHHHHHHHhc-----------------c------------cCCCCCCHHHHHHHHHHHccC
Confidence            99999999999999999999999998752                 1            245789999999999999999


Q ss_pred             CCCcccHHHHhcCCCccccCCCC
Q 022799          225 PNLRSTALEALIHPFFDELRDPN  247 (292)
Q Consensus       225 p~~R~t~~e~l~hp~~~~~~~~~  247 (292)
                      |++|+|+.+|.+||||.++++.+
T Consensus       326 p~~Rlt~~qIk~HpFF~~Vdw~n  348 (604)
T KOG0592|consen  326 PSDRLTSQQIKAHPFFEGVDWEN  348 (604)
T ss_pred             ccccccHHHHhhCcccccCChhh
Confidence            99999999999999999998865

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-50  Score=335.94  Aligned_cols=216  Identities=32%  Similarity=0.544  Sum_probs=183.7

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |..++||+||+++..|     ++...+|+|+||+. |.|...+++    .+.+++..++.|+.+|+.||.|||++ ||+|
T Consensus        79 L~~v~hPFiv~l~ysF-----Qt~~kLylVld~~~GGeLf~hL~~----eg~F~E~~arfYlaEi~lAL~~LH~~-gIiy  148 (357)
T KOG0598|consen   79 LSKIKHPFIVKLIYSF-----QTEEKLYLVLDYLNGGELFYHLQR----EGRFSEDRARFYLAEIVLALGYLHSK-GIIY  148 (357)
T ss_pred             HHhCCCCcEeeeEEec-----ccCCeEEEEEeccCCccHHHHHHh----cCCcchhHHHHHHHHHHHHHHHHHhC-Ceee
Confidence            4568999999999999     66667999999999 588888876    58899999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccc-cCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLV-KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      |||||+|||++.+|| ++|+|||+++... .+....+.+||+.|||||++.+. .|+..+|+||||+++|+|++|.+||.
T Consensus       149 RDlKPENILLd~~GH-i~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~-gy~~~vDWWsLGillYeML~G~pPF~  226 (357)
T KOG0598|consen  149 RDLKPENILLDEQGH-IKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGK-GYDKAVDWWSLGILLYEMLTGKPPFY  226 (357)
T ss_pred             ccCCHHHeeecCCCc-EEEeccccchhcccCCCccccccCCccccChHHHhcC-CCCcccchHhHHHHHHHHhhCCCCCc
Confidence            999999999999995 9999999999553 34556678999999999999876 59999999999999999999999999


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcc----cHHHH
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS----TALEA  234 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~----t~~e~  234 (292)
                      +.+......+|.+.-.                            ...+.-++.+++++|+++|.+||++|.    ++.++
T Consensus       227 ~~~~~~~~~~I~~~k~----------------------------~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~i  278 (357)
T KOG0598|consen  227 AEDVKKMYDKILKGKL----------------------------PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEI  278 (357)
T ss_pred             CccHHHHHHHHhcCcC----------------------------CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHh
Confidence            9998888777766310                            001134899999999999999999995    68999


Q ss_pred             hcCCCccccCCCCCCCCCCCCCCC
Q 022799          235 LIHPFFDELRDPNTRLPNGRFLPP  258 (292)
Q Consensus       235 l~hp~~~~~~~~~~~~~~~~~~~~  258 (292)
                      .+||||.++++.  .+..+...||
T Consensus       279 k~HpfF~~inW~--~l~~k~l~Pp  300 (357)
T KOG0598|consen  279 KRHPFFKGINWE--KLLAKKLSPP  300 (357)
T ss_pred             hcCcccccCCHH--HHHhcCCCCC
Confidence            999999999864  3344444444

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.5e-50  Score=342.71  Aligned_cols=233  Identities=37%  Similarity=0.646  Sum_probs=197.5

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      |++|+||||+++.+...+.   ....+|||+|||+-+|..++.+.   .-.+++.+++.|+.|++.||+|||++ ||+||
T Consensus       170 Lr~l~HpNIikL~eivt~~---~~~siYlVFeYMdhDL~GLl~~p---~vkft~~qIKc~mkQLl~Gl~~cH~~-gvlHR  242 (560)
T KOG0600|consen  170 LRRLDHPNIIKLEEIVTSK---LSGSIYLVFEYMDHDLSGLLSSP---GVKFTEPQIKCYMKQLLEGLEYCHSR-GVLHR  242 (560)
T ss_pred             HHhcCCCcccceeeEEEec---CCceEEEEEecccchhhhhhcCC---CcccChHHHHHHHHHHHHHHHHHhhc-Ceeec
Confidence            6789999999999987554   23459999999999999988752   45799999999999999999999998 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCC--CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      |||.+|||||.+| .+||+|||+|+.+....  ..+..+.|.+|+|||++.|...|+.++|+||+||||.||++|++.|+
T Consensus       243 DIK~SNiLidn~G-~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~  321 (560)
T KOG0600|consen  243 DIKGSNILIDNNG-VLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQ  321 (560)
T ss_pred             cccccceEEcCCC-CEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcC
Confidence            9999999999998 89999999999765443  45667889999999999999999999999999999999999999999


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcC-CCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMN-PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      |.++.+++..|++..|.|++..|.... +.+..+.....-.+.+.+.+ ..+++.+.+|+.+||+.||.+|.||.++|.|
T Consensus       322 G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~-~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s  400 (560)
T KOG0600|consen  322 GRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETF-KDFPASALDLLEKLLSLDPDKRGTASSALQS  400 (560)
T ss_pred             CccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHh-ccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence            999999999999999999999887221 22222211111122233333 5789999999999999999999999999999


Q ss_pred             CCccc
Q 022799          238 PFFDE  242 (292)
Q Consensus       238 p~~~~  242 (292)
                      +||..
T Consensus       401 eyF~t  405 (560)
T KOG0600|consen  401 EYFTT  405 (560)
T ss_pred             ccccc
Confidence            99954

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-50  Score=322.64  Aligned_cols=203  Identities=31%  Similarity=0.518  Sum_probs=181.9

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.+.||+++++.+.|     .+..++||||||++ |.|..++++    .+++++..+++|+.||+.||+|||+. +|++
T Consensus        98 L~~v~~PFlv~l~~t~-----~d~~~lymvmeyv~GGElFS~Lrk----~~rF~e~~arFYAAeivlAleylH~~-~iiY  167 (355)
T KOG0616|consen   98 LKAVSHPFLVKLYGTF-----KDNSNLYMVMEYVPGGELFSYLRK----SGRFSEPHARFYAAEIVLALEYLHSL-DIIY  167 (355)
T ss_pred             HhhccCceeEEEEEee-----ccCCeEEEEEeccCCccHHHHHHh----cCCCCchhHHHHHHHHHHHHHHHHhc-Ceee
Confidence            5678999999999999     77778999999999 688888876    58899999999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      ||+||+|||+|++| .+||+|||+|+....  ...+.+|||.|+|||++.+. .|+.++|+||||+++|||+.|.+||.+
T Consensus       168 RDLKPENiLlD~~G-~iKitDFGFAK~v~~--rT~TlCGTPeYLAPEii~sk-~ynkavDWWalGVLIYEMlaG~pPF~~  243 (355)
T KOG0616|consen  168 RDLKPENLLLDQNG-HIKITDFGFAKRVSG--RTWTLCGTPEYLAPEIIQSK-GYNKAVDWWALGVLIYEMLAGYPPFYD  243 (355)
T ss_pred             ccCChHHeeeccCC-cEEEEeccceEEecC--cEEEecCCccccChHHhhcC-CCCcchhHHHHHHHHHHHHcCCCCCcC
Confidence            99999999999999 599999999998743  47788999999999999765 599999999999999999999999999


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcc-----cHHHH
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEA  234 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----t~~e~  234 (292)
                      .+...++.+|.+.                 +..            +|..++++++|||+++|+.|-.+|.     ...+|
T Consensus       244 ~~~~~iY~KI~~~-----------------~v~------------fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dI  294 (355)
T KOG0616|consen  244 DNPIQIYEKILEG-----------------KVK------------FPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDI  294 (355)
T ss_pred             CChHHHHHHHHhC-----------------ccc------------CCcccCHHHHHHHHHHHhhhhHhhhcCcCCCcccc
Confidence            9999999988873                 222            3456899999999999999999993     57899


Q ss_pred             hcCCCccccCCC
Q 022799          235 LIHPFFDELRDP  246 (292)
Q Consensus       235 l~hp~~~~~~~~  246 (292)
                      .+||||+++.+.
T Consensus       295 k~H~wF~~v~W~  306 (355)
T KOG0616|consen  295 KNHPWFKGVDWE  306 (355)
T ss_pred             ccCcccccccHH
Confidence            999999998764

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.8e-48  Score=321.32  Aligned_cols=243  Identities=36%  Similarity=0.719  Sum_probs=203.4

Q ss_pred             CCCCCCCC-eeeeceeeeccCC-CCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcc
Q 022799            1 MRLLDHPN-VVSLKHCFFSTTE-KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVC   78 (292)
Q Consensus         1 L~~l~Hpn-Iv~~~~~~~~~~~-~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~   78 (292)
                      |+.|+|+| ||.+++++.+... .....+++|+||++-+|.+++.........++...++.+++||+.||+|||++ ||+
T Consensus        64 lk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~-~Il  142 (323)
T KOG0594|consen   64 LKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH-GIL  142 (323)
T ss_pred             HHHhCCCcceEEEEeeeeecccccccceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC-Cee
Confidence            46789999 9999999865442 23346899999999999999987643335677789999999999999999998 999


Q ss_pred             ccCCCCCcEEEeCCCCcEEEeecCCccccccC-CCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCC
Q 022799           79 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF  157 (292)
Q Consensus        79 H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf  157 (292)
                      ||||||+||+++++| .+||+|||+|+...-. ......++|.+|+|||++.|...|+...|+||+|||++||++++..|
T Consensus       143 HRDLKPQNlLi~~~G-~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LF  221 (323)
T KOG0594|consen  143 HRDLKPQNLLISSSG-VLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLF  221 (323)
T ss_pred             cccCCcceEEECCCC-cEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCC
Confidence            999999999999988 7999999999876533 33556788999999999999988999999999999999999999999


Q ss_pred             CCCCcHHHHHHHHHHhCCCCHHHHhhcC--CCCccccCCCCC-CCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHH
Q 022799          158 PGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEFKFPQIK-AHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA  234 (292)
Q Consensus       158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~--~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~  234 (292)
                      +|.++.+++.+|.+.+|+|..+.|....  +++.. .++... ...+.... +..+++..|++.+||+.+|.+|.|++.+
T Consensus       222 pG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~-~f~~~~~~~~l~~~~-~~~~~~~~dll~~~L~y~p~~R~Sa~~a  299 (323)
T KOG0594|consen  222 PGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKA-PFPKWPGPKDLSSIL-PKLDPDGIELLSKLLQYDPAKRISAKGA  299 (323)
T ss_pred             CCCcHHHHHHHHHHHcCCCCccCCCCccccccccc-cCcCCCCccchHHhc-cccCccHHHHHHHHhccCcccCcCHHHH
Confidence            9999999999999999999999887663  23322 333333 33333333 3455799999999999999999999999


Q ss_pred             hcCCCccccCCCC
Q 022799          235 LIHPFFDELRDPN  247 (292)
Q Consensus       235 l~hp~~~~~~~~~  247 (292)
                      |.||||+.+....
T Consensus       300 l~h~yf~~~~~~~  312 (323)
T KOG0594|consen  300 LTHPYFSELPEKS  312 (323)
T ss_pred             hcChhhcccccch
Confidence            9999999876543

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-48  Score=343.51  Aligned_cols=207  Identities=33%  Similarity=0.568  Sum_probs=184.8

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.+.||||+++++++     ++..++|+|+||++ |.|.+++..    .+++++.+++++++||+.|+.|+|.. +|+|
T Consensus        66 MkLi~HpnVl~LydVw-----e~~~~lylvlEyv~gGELFdylv~----kG~l~e~eaa~ff~QIi~gv~yCH~~-~icH  135 (786)
T KOG0588|consen   66 MKLIEHPNVLRLYDVW-----ENKQHLYLVLEYVPGGELFDYLVR----KGPLPEREAAHFFRQILDGVSYCHAF-NICH  135 (786)
T ss_pred             HHHhcCCCeeeeeeee-----ccCceEEEEEEecCCchhHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHhhh-ccee
Confidence            6889999999999999     66667999999998 799998876    48899999999999999999999975 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      ||+||+|+|++..+ +|||+|||+|..-..+....+.||+|.|.+||++.|.++.+.++||||+|||||.|++|+.||.+
T Consensus       136 RDLKpENlLLd~~~-nIKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD  214 (786)
T KOG0588|consen  136 RDLKPENLLLDVKN-NIKIADFGMASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD  214 (786)
T ss_pred             ccCCchhhhhhccc-CEeeeccceeecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC
Confidence            99999999999988 69999999999877788888899999999999999998889999999999999999999999987


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCC
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF  239 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~  239 (292)
                      ++-...+.++.+.                 .+.+|            ..+|+++++||++||..||++|+|.+||++|||
T Consensus       215 dNir~LLlKV~~G-----------------~f~MP------------s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~  265 (786)
T KOG0588|consen  215 DNIRVLLLKVQRG-----------------VFEMP------------SNISSEAQDLLRRMLDVDPSTRITTEEILKHPF  265 (786)
T ss_pred             ccHHHHHHHHHcC-----------------cccCC------------CcCCHHHHHHHHHHhccCccccccHHHHhhCch
Confidence            7766666665542                 22222            569999999999999999999999999999999


Q ss_pred             ccccCCCC
Q 022799          240 FDELRDPN  247 (292)
Q Consensus       240 ~~~~~~~~  247 (292)
                      +..+....
T Consensus       266 l~g~~~~~  273 (786)
T KOG0588|consen  266 LSGYTSLP  273 (786)
T ss_pred             hhcCCCCC
Confidence            99876544

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-48  Score=305.12  Aligned_cols=205  Identities=34%  Similarity=0.550  Sum_probs=175.0

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeecccC-CHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      +.|+|||||++.+.+     +...+.|||+|++.| +|...+-.+    ...++..+..++.||++||.|+|.+ ||+||
T Consensus        65 ~~LqHP~IvrL~~ti-----~~~~~~ylvFe~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~n-~IvHR  134 (355)
T KOG0033|consen   65 RKLQHPNIVRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHSN-GIVHR  134 (355)
T ss_pred             HhcCCCcEeehhhhh-----cccceeEEEEecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHhc-Cceec
Confidence            468999999999998     777889999999994 776555432    3478889999999999999999998 99999


Q ss_pred             CCCCCcEEEeC--CCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           81 DIKPQNLLVNP--HTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        81 dlkp~Nill~~--~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      |+||+|+++.+  .+..+||+|||+|.....+..-...+|||.|||||++... .|+..+|+|+.|+|+|-|+.|.+||.
T Consensus       135 DvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrkd-py~kpvDiW~cGViLfiLL~G~~PF~  213 (355)
T KOG0033|consen  135 DLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFW  213 (355)
T ss_pred             cCChhheeeeeccCCCceeecccceEEEeCCccccccccCCCcccCHHHhhcC-CCCCcchhhhhhHHHHHHHhCCCCCC
Confidence            99999999943  3447999999999998877777788999999999999665 49999999999999999999999999


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCC
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  238 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp  238 (292)
                      +.+....+.+|++..                 ++++.   +.|     +++++++++|+++||..||++|+|+.|+|+||
T Consensus       214 ~~~~~rlye~I~~g~-----------------yd~~~---~~w-----~~is~~Ak~LvrrML~~dP~kRIta~EAL~Hp  268 (355)
T KOG0033|consen  214 DEDQHRLYEQIKAGA-----------------YDYPS---PEW-----DTVTPEAKSLIRRMLTVNPKKRITADEALKHP  268 (355)
T ss_pred             CccHHHHHHHHhccc-----------------cCCCC---ccc-----CcCCHHHHHHHHHHhccChhhhccHHHHhCCc
Confidence            988888888777631                 22221   111     56899999999999999999999999999999


Q ss_pred             Cccc
Q 022799          239 FFDE  242 (292)
Q Consensus       239 ~~~~  242 (292)
                      |+.+
T Consensus       269 Wi~~  272 (355)
T KOG0033|consen  269 WICN  272 (355)
T ss_pred             hhcc
Confidence            9976

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.4e-47  Score=330.44  Aligned_cols=219  Identities=34%  Similarity=0.569  Sum_probs=183.1

Q ss_pred             CCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccC
Q 022799            3 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRD   81 (292)
Q Consensus         3 ~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~d   81 (292)
                      ..++|+||+++-.|     ++..++||||||++ |++..++.+    .+.+++..+++|+.+++.|++.+|+. |+||||
T Consensus       197 ~~ds~~vVKLyYsF-----QD~~~LYLiMEylPGGD~mTLL~~----~~~L~e~~arfYiaE~vlAI~~iH~~-gyIHRD  266 (550)
T KOG0605|consen  197 EVDSPWVVKLYYSF-----QDKEYLYLIMEYLPGGDMMTLLMR----KDTLTEDWARFYIAETVLAIESIHQL-GYIHRD  266 (550)
T ss_pred             hcCCCcEEEEEEEe-----cCCCeeEEEEEecCCccHHHHHHh----cCcCchHHHHHHHHHHHHHHHHHHHc-Cccccc
Confidence            45789999999999     88888999999999 699998886    47899999999999999999999987 999999


Q ss_pred             CCCCcEEEeCCCCcEEEeecCCcccccc------------------------CCC------------------------c
Q 022799           82 IKPQNLLVNPHTHQLKLCDFGSAKVLVK------------------------GEP------------------------N  113 (292)
Q Consensus        82 lkp~Nill~~~~~~ikl~Dfg~a~~~~~------------------------~~~------------------------~  113 (292)
                      |||+|+|||..|| +||+|||++.....                        ...                        .
T Consensus       267 IKPdNlLiD~~GH-iKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a  345 (550)
T KOG0605|consen  267 IKPDNLLIDAKGH-IKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLA  345 (550)
T ss_pred             CChhheeecCCCC-EeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhh
Confidence            9999999999995 99999999854211                        000                        0


Q ss_pred             ccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccC
Q 022799          114 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  193 (292)
Q Consensus       114 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  193 (292)
                      ...+|||.|+|||++.+.. |+..+|+||||||+|||+.|.+||.+.++.+...+|+.--.               .+.+
T Consensus       346 ~StVGTPDYiAPEVll~kg-Y~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~---------------~l~f  409 (550)
T KOG0605|consen  346 YSTVGTPDYIAPEVLLGKG-YGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRE---------------TLKF  409 (550)
T ss_pred             hcccCCccccchHHHhcCC-CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhh---------------hccC
Confidence            1468999999999998865 99999999999999999999999999999999999876311               1112


Q ss_pred             CCCCCCCchhhhccCCChhHHHHHHHHhccCCCCccc---HHHHhcCCCccccCCCCCCCCCCCCCCCC
Q 022799          194 PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST---ALEALIHPFFDELRDPNTRLPNGRFLPPL  259 (292)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t---~~e~l~hp~~~~~~~~~~~~~~~~~~~~~  259 (292)
                      |..          ..++++++|||.+||+ ||.+|..   ++||.+||||+++++..-+....++.|.+
T Consensus       410 P~~----------~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~l~~~~apfvP~v  467 (550)
T KOG0605|consen  410 PEE----------VDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWDHLREMPAPFVPQV  467 (550)
T ss_pred             CCc----------CcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcchhhcCCCCCCCCC
Confidence            211          3578999999999999 9999975   89999999999999876555445555544

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.8e-49  Score=314.99  Aligned_cols=205  Identities=31%  Similarity=0.529  Sum_probs=172.3

Q ss_pred             CCCCCCCCeeeece-eeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh--cCC
Q 022799            1 MRLLDHPNVVSLKH-CFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN--TIG   76 (292)
Q Consensus         1 L~~l~HpnIv~~~~-~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~--~~~   76 (292)
                      |++|+|||||++++ .|.    ++...++||||||+ |+|.+.+++..+....+++..+++++.|++.||.++|+  . .
T Consensus        72 LkQL~HpNIVqYy~~~f~----~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~-r  146 (375)
T KOG0591|consen   72 LKQLNHPNIVQYYAHSFI----EDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIP-R  146 (375)
T ss_pred             HHhcCCchHHHHHHHhhh----ccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcccc-c
Confidence            57999999999988 442    23334889999999 89999999999888999999999999999999999997  3 4


Q ss_pred             --ccccCCCCCcEEEeCCCCcEEEeecCCccccccCCC-cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhC
Q 022799           77 --VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG  153 (292)
Q Consensus        77 --i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g  153 (292)
                        |+||||||.||+++.+| .+||+|||+++.+.+... ..+.+|||+||+||++.+.+ |+.+|||||+||++|||+.-
T Consensus       147 ~~VmHRDIKPaNIFl~~~g-vvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~-Y~~kSDiWslGCllyEMcaL  224 (375)
T KOG0591|consen  147 GTVMHRDIKPANIFLTANG-VVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESG-YNFKSDIWSLGCLLYEMCAL  224 (375)
T ss_pred             cceeeccCcchheEEcCCC-ceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCC-CCcchhHHHHHHHHHHHHhc
Confidence              89999999999999988 799999999998865543 34679999999999998765 99999999999999999999


Q ss_pred             CCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHH
Q 022799          154 QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE  233 (292)
Q Consensus       154 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e  233 (292)
                      ++||.|++-.+...+|.+. ..|+..                          ...+|.++..+|..|+..||..||+.  
T Consensus       225 ~~PF~g~n~~~L~~KI~qg-d~~~~p--------------------------~~~YS~~l~~li~~ci~vd~~~RP~t--  275 (375)
T KOG0591|consen  225 QSPFYGDNLLSLCKKIEQG-DYPPLP--------------------------DEHYSTDLRELINMCIAVDPEQRPDT--  275 (375)
T ss_pred             CCCcccccHHHHHHHHHcC-CCCCCc--------------------------HHHhhhHHHHHHHHHccCCcccCCCc--
Confidence            9999999766666666553 222110                          03578999999999999999999986  


Q ss_pred             HhcCCCccccC
Q 022799          234 ALIHPFFDELR  244 (292)
Q Consensus       234 ~l~hp~~~~~~  244 (292)
                         +|++.++.
T Consensus       276 ---~~~v~di~  283 (375)
T KOG0591|consen  276 ---VPYVQDIQ  283 (375)
T ss_pred             ---chHHHHHH
Confidence               56665554

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.9e-48  Score=308.25  Aligned_cols=207  Identities=29%  Similarity=0.500  Sum_probs=180.7

Q ss_pred             CCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCC
Q 022799            4 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDI   82 (292)
Q Consensus         4 l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dl   82 (292)
                      ..||||+++.++|     +.+.++++|+|.|+ |.|.+++..    .-.+++...+.+++|+++|++|||.+ +|+||||
T Consensus        80 ~GHP~II~l~D~y-----es~sF~FlVFdl~prGELFDyLts----~VtlSEK~tR~iMrqlfegVeylHa~-~IVHRDL  149 (411)
T KOG0599|consen   80 MGHPYIIDLQDVY-----ESDAFVFLVFDLMPRGELFDYLTS----KVTLSEKETRRIMRQLFEGVEYLHAR-NIVHRDL  149 (411)
T ss_pred             cCCCcEEEeeeec-----cCcchhhhhhhhcccchHHHHhhh----heeecHHHHHHHHHHHHHHHHHHHHh-hhhhccc
Confidence            4799999999999     77778999999999 999999976    35799999999999999999999987 9999999


Q ss_pred             CCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccC-----CCCCCchhHhhhhhHHHHHHHhCCCCC
Q 022799           83 KPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG-----ATEYTAAIDIWSAGCVLAELLLGQPLF  157 (292)
Q Consensus        83 kp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DvwslG~il~el~~g~~pf  157 (292)
                      ||+|||++.+. ++||+|||++..+..++.....+|||.|+|||++..     .+.|+..+|+||+|+|+|.|+.|.+||
T Consensus       150 KpENILlddn~-~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPF  228 (411)
T KOG0599|consen  150 KPENILLDDNM-NIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPF  228 (411)
T ss_pred             Chhheeecccc-ceEEeccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCch
Confidence            99999999887 899999999999999988889999999999999853     356899999999999999999999999


Q ss_pred             CCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          158 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      ......-.+..|++.--....++                    |     .++|...+|||.+||+.||.+|+|++|+|+|
T Consensus       229 wHRkQmlMLR~ImeGkyqF~spe--------------------W-----adis~~~KdLIsrlLqVdp~~Ritake~LaH  283 (411)
T KOG0599|consen  229 WHRKQMLMLRMIMEGKYQFRSPE--------------------W-----ADISATVKDLISRLLQVDPTKRITAKEALAH  283 (411)
T ss_pred             hHHHHHHHHHHHHhcccccCCcc--------------------h-----hhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence            87776666666665322111111                    1     4689999999999999999999999999999


Q ss_pred             CCccccCCC
Q 022799          238 PFFDELRDP  246 (292)
Q Consensus       238 p~~~~~~~~  246 (292)
                      |||..+...
T Consensus       284 pff~q~~~~  292 (411)
T KOG0599|consen  284 PFFIQIAQQ  292 (411)
T ss_pred             hHHHHHHHh
Confidence            999876543

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-47  Score=330.75  Aligned_cols=202  Identities=34%  Similarity=0.544  Sum_probs=175.3

Q ss_pred             CCCCC-CCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcc
Q 022799            1 MRLLD-HPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVC   78 (292)
Q Consensus         1 L~~l~-HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~   78 (292)
                      |+++. ||||+++++++...     ..+++|||||. |+|.+.+.+    .+++.+..++++++|++.|++|||++ ||+
T Consensus        73 ~~~~~~HpnI~~l~ev~~t~-----~~~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~-gi~  142 (370)
T KOG0583|consen   73 LRRLRSHPNIIRLLEVFATP-----TKIYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSR-GIV  142 (370)
T ss_pred             HHHhccCCCEeEEEEEEecC-----CeEEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhC-CEe
Confidence            35677 99999999999443     34999999999 599999886    47899999999999999999999988 999


Q ss_pred             ccCCCCCcEEEeCC-CCcEEEeecCCcccc-ccCCCcccccccccccCCccccCCC-CCCchhHhhhhhHHHHHHHhCCC
Q 022799           79 HRDIKPQNLLVNPH-THQLKLCDFGSAKVL-VKGEPNISYICSRYYRAPELIFGAT-EYTAAIDIWSAGCVLAELLLGQP  155 (292)
Q Consensus        79 H~dlkp~Nill~~~-~~~ikl~Dfg~a~~~-~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwslG~il~el~~g~~  155 (292)
                      ||||||+|||++.+ + ++||+|||++... ..+....+.+||+.|+|||++.+.. .-+.++|+||+|+++|.|++|..
T Consensus       143 HRDLK~ENilld~~~~-~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~  221 (370)
T KOG0583|consen  143 HRDLKPENILLDGNEG-NLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRL  221 (370)
T ss_pred             eCCCCHHHEEecCCCC-CEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCC
Confidence            99999999999998 6 8999999999987 4566778899999999999998766 45789999999999999999999


Q ss_pred             CCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCC-ChhHHHHHHHHhccCCCCcccHHHH
Q 022799          156 LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRM-PPEAVDLVSRLLQYSPNLRSTALEA  234 (292)
Q Consensus       156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~li~~~l~~dp~~R~t~~e~  234 (292)
                      ||.+.+......+|.+.                 .+.            ++..+ |+++++||.+||..||.+|+|+.++
T Consensus       222 PF~d~~~~~l~~ki~~~-----------------~~~------------~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i  272 (370)
T KOG0583|consen  222 PFDDSNVPNLYRKIRKG-----------------EFK------------IPSYLLSPEARSLIEKMLVPDPSTRITLLEI  272 (370)
T ss_pred             CCCCccHHHHHHHHhcC-----------------Ccc------------CCCCcCCHHHHHHHHHHcCCCcccCCCHHHH
Confidence            99987766666664431                 111            22446 9999999999999999999999999


Q ss_pred             hcCCCccc
Q 022799          235 LIHPFFDE  242 (292)
Q Consensus       235 l~hp~~~~  242 (292)
                      ++||||+.
T Consensus       273 ~~h~w~~~  280 (370)
T KOG0583|consen  273 LEHPWFQK  280 (370)
T ss_pred             hhChhhcc
Confidence            99999996

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-47  Score=329.72  Aligned_cols=203  Identities=31%  Similarity=0.539  Sum_probs=176.6

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+..+|+|||++++.|...++     +|+||||++ |+|.+++..     ..++|.++..++++++.||+|||.+ ||+|
T Consensus       324 m~~~~H~NiVnfl~Sylv~de-----LWVVMEym~ggsLTDvVt~-----~~~~E~qIA~Icre~l~aL~fLH~~-gIiH  392 (550)
T KOG0578|consen  324 MRDLHHPNIVNFLDSYLVGDE-----LWVVMEYMEGGSLTDVVTK-----TRMTEGQIAAICREILQGLKFLHAR-GIIH  392 (550)
T ss_pred             HHhccchHHHHHHHHhcccce-----eEEEEeecCCCchhhhhhc-----ccccHHHHHHHHHHHHHHHHHHHhc-ceee
Confidence            577899999999999966544     999999999 688888764     5599999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCC-CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      ||||.+|||++.+| .+||+|||++..+.... ...+.+|||+|||||++.. ..|++++||||||++..||+-|++||.
T Consensus       393 rDIKSDnILL~~~g-~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtr-k~YG~KVDIWSLGIMaIEMveGEPPYl  470 (550)
T KOG0578|consen  393 RDIKSDNILLTMDG-SVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTR-KPYGPKVDIWSLGIMAIEMVEGEPPYL  470 (550)
T ss_pred             eccccceeEeccCC-cEEEeeeeeeeccccccCccccccCCCCccchhhhhh-cccCccccchhhhhHHHHHhcCCCCcc
Confidence            99999999999998 79999999998876554 5567899999999999955 459999999999999999999999999


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCC
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  238 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp  238 (292)
                      .+++...++.|... |.|...                         .+..+|+.++|||.+||+.|+.+|++|.|+|.||
T Consensus       471 nE~PlrAlyLIa~n-g~P~lk-------------------------~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~Hp  524 (550)
T KOG0578|consen  471 NENPLRALYLIATN-GTPKLK-------------------------NPEKLSPELKDFLDRCLVVDVEQRASAKELLEHP  524 (550)
T ss_pred             CCChHHHHHHHhhc-CCCCcC-------------------------CccccCHHHHHHHHHHhhcchhcCCCHHHHhcCh
Confidence            98888877776542 222211                         2257999999999999999999999999999999


Q ss_pred             Cccc
Q 022799          239 FFDE  242 (292)
Q Consensus       239 ~~~~  242 (292)
                      ||+-
T Consensus       525 Fl~~  528 (550)
T KOG0578|consen  525 FLKM  528 (550)
T ss_pred             hhhh
Confidence            9954

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-47  Score=335.97  Aligned_cols=211  Identities=29%  Similarity=0.540  Sum_probs=180.2

Q ss_pred             CCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCC
Q 022799            5 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKP   84 (292)
Q Consensus         5 ~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlkp   84 (292)
                      +||++++++.+|     +...++|.||||+.|+.  .+.  ......+++..++.|++.|+.||+|||++ ||||||||.
T Consensus       427 ~HPFL~~L~~~f-----QT~~~l~fvmey~~Ggd--m~~--~~~~~~F~e~rarfyaAev~l~L~fLH~~-~IIYRDlKL  496 (694)
T KOG0694|consen  427 RHPFLVNLFSCF-----QTKEHLFFVMEYVAGGD--LMH--HIHTDVFSEPRARFYAAEVVLGLQFLHEN-GIIYRDLKL  496 (694)
T ss_pred             cCCeEeeccccc-----ccCCeEEEEEEecCCCc--EEE--EEecccccHHHHHHHHHHHHHHHHHHHhc-Cceeeecch
Confidence            699999999999     66667999999999643  111  11257899999999999999999999998 999999999


Q ss_pred             CcEEEeCCCCcEEEeecCCccccc-cCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCCCcH
Q 022799           85 QNLLVNPHTHQLKLCDFGSAKVLV-KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV  163 (292)
Q Consensus        85 ~Nill~~~~~~ikl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~  163 (292)
                      +|||+|.+| .+||+|||+++... .+....+++|||.|+|||++.+.. |+.++|+|||||++|||+.|..||+|+++.
T Consensus       497 dNiLLD~eG-h~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~-Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe  574 (694)
T KOG0694|consen  497 DNLLLDTEG-HVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQS-YTRAVDWWGLGVLLYEMLVGESPFPGDDEE  574 (694)
T ss_pred             hheEEcccC-cEEecccccccccCCCCCccccccCChhhcChhhhccCc-ccchhhHHHHHHHHHHHHcCCCCCCCCCHH
Confidence            999999999 59999999999764 556678899999999999998765 999999999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCccc-----HHHHhcCC
Q 022799          164 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----ALEALIHP  238 (292)
Q Consensus       164 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t-----~~e~l~hp  238 (292)
                      ++...|...                 +.            .+|..+|.++.++|+++|.+||.+|..     +++|..||
T Consensus       575 e~FdsI~~d-----------------~~------------~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hp  625 (694)
T KOG0694|consen  575 EVFDSIVND-----------------EV------------RYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHP  625 (694)
T ss_pred             HHHHHHhcC-----------------CC------------CCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCC
Confidence            988888752                 11            233569999999999999999999986     57899999


Q ss_pred             CccccCCCCCCCCCCCCCCC
Q 022799          239 FFDELRDPNTRLPNGRFLPP  258 (292)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~  258 (292)
                      ||+.+++  +.+.++...||
T Consensus       626 FFr~i~w--~~L~~r~i~PP  643 (694)
T KOG0694|consen  626 FFRSIDW--DDLLNRRIKPP  643 (694)
T ss_pred             ccccCCH--HHHhhccCCCC
Confidence            9999985  34445555554

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.6e-46  Score=310.28  Aligned_cols=226  Identities=31%  Similarity=0.498  Sum_probs=188.6

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||.++.+|..|     +.+.+.|++||||+ |+|..+.+.+  .++.+++..+++|+.+|+.||+|||-. |||+
T Consensus       131 L~~lDHPFlPTLYa~f-----et~~~~cl~meyCpGGdL~~LrqkQ--p~~~fse~~aRFYaAEvl~ALEYLHml-GivY  202 (459)
T KOG0610|consen  131 LSLLDHPFLPTLYASF-----ETDKYSCLVMEYCPGGDLHSLRQKQ--PGKRFSESAARFYAAEVLLALEYLHML-GIVY  202 (459)
T ss_pred             HHhcCCCccchhhhee-----eccceeEEEEecCCCccHHHHHhhC--CCCccchhhHHHHHHHHHHHHHHHHhh-ceee
Confidence            5679999999999999     77778999999999 6888877654  367899999999999999999999965 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCcccccc---------------------------------C-C--------------
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVK---------------------------------G-E--------------  111 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~---------------------------------~-~--------------  111 (292)
                      |||||+|||+.++|| |.|+||.++.....                                 . .              
T Consensus       203 RDLKPENILvredGH-IMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p  281 (459)
T KOG0610|consen  203 RDLKPENILVREDGH-IMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLP  281 (459)
T ss_pred             ccCCcceeEEecCCc-EEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccch
Confidence            999999999999995 99999998653200                                 0 0              


Q ss_pred             ---------CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHh
Q 022799          112 ---------PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK  182 (292)
Q Consensus       112 ---------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  182 (292)
                               ....++||-.|.|||++.|.. .+.++|+|+||+.+|||+.|..||.|.+..+.+.+|+..          
T Consensus       282 ~~~aep~~~RSnSFVGThEYlAPEvI~G~G-HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~----------  350 (459)
T KOG0610|consen  282 ELVAEPTGARSNSFVGTHEYLAPEVIRGEG-HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQ----------  350 (459)
T ss_pred             hhhcCCCCccccccccccccccceeeecCC-CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcC----------
Confidence                     012457899999999998765 899999999999999999999999999999999888753          


Q ss_pred             hcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCccc----HHHHhcCCCccccCCCCCCCCCCCCCCC
Q 022799          183 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST----ALEALIHPFFDELRDPNTRLPNGRFLPP  258 (292)
Q Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t----~~e~l~hp~~~~~~~~~~~~~~~~~~~~  258 (292)
                             ...++..          +.++..++|||+++|.+||++|..    |.||.+||||++++|+-.+...++.+|.
T Consensus       351 -------~l~Fp~~----------~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~  413 (459)
T KOG0610|consen  351 -------PLKFPEE----------PEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIPK  413 (459)
T ss_pred             -------CCcCCCC----------CcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChhheeccCCCcCCC
Confidence                   2222222          357889999999999999999998    9999999999999987656555555665


Q ss_pred             CCCCC
Q 022799          259 LFNFK  263 (292)
Q Consensus       259 ~~~~~  263 (292)
                      ..+..
T Consensus       414 ~~d~~  418 (459)
T KOG0610|consen  414 PVDGG  418 (459)
T ss_pred             ccccC
Confidence            55544

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.5e-45  Score=313.18  Aligned_cols=229  Identities=35%  Similarity=0.695  Sum_probs=188.7

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      |++++||||+++++++     .+..+.++||||++++|.+++...   ...+++..++.++.||+.||.|||++ ||+||
T Consensus        57 l~~l~h~niv~~~~~~-----~~~~~~~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~  127 (288)
T cd07871          57 LKNLKHANIVTLHDII-----HTERCLTLVFEYLDSDLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKR-KILHR  127 (288)
T ss_pred             HHhCCCCCEeeEEEEE-----cCCCeEEEEEeCCCcCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CcccC
Confidence            4578999999999998     444568999999999998887643   34578999999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCC-CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      ||||+||+++.++ .+||+|||+++...... ......+|+.|+|||++.+...++.++|+||+||++|+|++|..||.+
T Consensus       128 dlkp~Nil~~~~~-~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~  206 (288)
T cd07871         128 DLKPQNLLINEKG-ELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPG  206 (288)
T ss_pred             CCCHHHEEECCCC-CEEECcCcceeeccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999888 79999999987643222 223456799999999987766689999999999999999999999999


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCC--CCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNP--NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      .+..+.+..+.+..+.|+.+.+.....  .+....++.....++... ...++++++|||++||++||.+|+|++|+++|
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         207 STVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINH-APRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             CCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHh-CCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            999999999999999999888766532  222333333333333222 24678999999999999999999999999999


Q ss_pred             CCc
Q 022799          238 PFF  240 (292)
Q Consensus       238 p~~  240 (292)
                      |||
T Consensus       286 p~f  288 (288)
T cd07871         286 SYF  288 (288)
T ss_pred             CCC
Confidence            998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-46  Score=311.45  Aligned_cols=205  Identities=32%  Similarity=0.564  Sum_probs=176.8

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++|||||+++++.     +.+.++|||||||+ |+|..++.++    +++++..++.++.||+.||++||++ +|+|
T Consensus        63 Lkel~H~nIV~l~d~~-----~~~~~i~lVMEyC~gGDLs~yi~~~----~~l~e~t~r~Fm~QLA~alq~L~~~-~IiH  132 (429)
T KOG0595|consen   63 LKELKHPNIVRLLDCI-----EDDDFIYLVMEYCNGGDLSDYIRRR----GRLPEATARHFMQQLASALQFLHEN-NIIH  132 (429)
T ss_pred             HHhcCCcceeeEEEEE-----ecCCeEEEEEEeCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-Ceee
Confidence            5789999999999999     55557999999999 7999999874    6899999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCC--C---CcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCC
Q 022799           80 RDIKPQNLLVNPH--T---HQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ  154 (292)
Q Consensus        80 ~dlkp~Nill~~~--~---~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~  154 (292)
                      |||||+|||++..  .   ..+||+|||+|+...++....+.+|+|.|||||++... .|+.|+|+||+|+|+|+|++|.
T Consensus       133 RDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~-~YdAKADLWSiG~Ilyq~l~g~  211 (429)
T KOG0595|consen  133 RDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGSMAETLCGSPLYMAPEVIMSQ-QYDAKADLWSIGTILYQCLTGK  211 (429)
T ss_pred             ccCCcceEEeccCCCCCCCceEEecccchhhhCCchhHHHHhhCCccccCHHHHHhc-cccchhhHHHHHHHHHHHHhCC
Confidence            9999999999764  1   36899999999999888888889999999999999654 4999999999999999999999


Q ss_pred             CCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHH
Q 022799          155 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA  234 (292)
Q Consensus       155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~  234 (292)
                      +||...+..+.+..+.+.-...                          ..++..+++...+++...|..+|..|.+..+-
T Consensus       212 ~Pf~a~t~~eL~~~~~k~~~~~--------------------------~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~  265 (429)
T KOG0595|consen  212 PPFDAETPKELLLYIKKGNEIV--------------------------PVLPAELSNPLRELLISLLQRNPKDRISFEDF  265 (429)
T ss_pred             CCccccCHHHHHHHHhcccccc--------------------------CchhhhccCchhhhhhHHHhcCccccCchHHh
Confidence            9999888877766444321111                          11224577888899999999999999999999


Q ss_pred             hcCCCccc
Q 022799          235 LIHPFFDE  242 (292)
Q Consensus       235 l~hp~~~~  242 (292)
                      +.|++...
T Consensus       266 ~~~~~l~~  273 (429)
T KOG0595|consen  266 FDHPFLAA  273 (429)
T ss_pred             hhhhhccc
Confidence            99998865

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-46  Score=312.62  Aligned_cols=209  Identities=33%  Similarity=0.545  Sum_probs=166.5

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++|||||++++......+   ..+++.|||+. |+|.+.+.+.   ++++++..++.+.+||++||.|||++ ||+|
T Consensus        68 L~~l~~p~IV~~~G~~~~~~~---~~~~i~mEy~~~GsL~~~~~~~---g~~l~E~~v~~ytr~iL~GL~ylHs~-g~vH  140 (313)
T KOG0198|consen   68 LSRLNHPNIVQYYGSSSSREN---DEYNIFMEYAPGGSLSDLIKRY---GGKLPEPLVRRYTRQILEGLAYLHSK-GIVH  140 (313)
T ss_pred             HHhCCCCCEEeeCCccccccC---eeeEeeeeccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CEec
Confidence            467889999999996432221   46889999999 7999999874   23799999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeC-CCCcEEEeecCCcccccc----CCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCC
Q 022799           80 RDIKPQNLLVNP-HTHQLKLCDFGSAKVLVK----GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ  154 (292)
Q Consensus        80 ~dlkp~Nill~~-~~~~ikl~Dfg~a~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~  154 (292)
                      |||||+|||++. ++ .+||+|||.++....    ........||+.|||||++......+.++|+||+||++.||+||.
T Consensus       141 ~DiK~~NiLl~~~~~-~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~  219 (313)
T KOG0198|consen  141 CDIKPANILLDPSNG-DVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGK  219 (313)
T ss_pred             cCcccceEEEeCCCC-eEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCC
Confidence            999999999998 46 799999999987653    122345789999999999974322345999999999999999999


Q ss_pred             CCCCCC-CcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHH
Q 022799          155 PLFPGE-SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE  233 (292)
Q Consensus       155 ~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e  233 (292)
                      .||... ...+.+..+...-                  ..|         .+|..+|+++++||.+|+.+||++||||++
T Consensus       220 ~PW~~~~~~~~~~~~ig~~~------------------~~P---------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~e  272 (313)
T KOG0198|consen  220 PPWSEFFEEAEALLLIGRED------------------SLP---------EIPDSLSDEAKDFLRKCFKRDPEKRPTAEE  272 (313)
T ss_pred             CcchhhcchHHHHHHHhccC------------------CCC---------CCCcccCHHHHHHHHHHhhcCcccCcCHHH
Confidence            999763 2222222222110                  001         244679999999999999999999999999


Q ss_pred             HhcCCCccccC
Q 022799          234 ALIHPFFDELR  244 (292)
Q Consensus       234 ~l~hp~~~~~~  244 (292)
                      +|.|||...-.
T Consensus       273 LL~hpf~~~~~  283 (313)
T KOG0198|consen  273 LLEHPFLKQNS  283 (313)
T ss_pred             HhhChhhhccc
Confidence            99999997643

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=4.2e-45  Score=322.49  Aligned_cols=226  Identities=35%  Similarity=0.596  Sum_probs=185.3

Q ss_pred             CeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcE
Q 022799            8 NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNL   87 (292)
Q Consensus         8 nIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlkp~Ni   87 (292)
                      |||+++++|     ....++|||+|.++.+|+++++.+..  .+++...++.++.||+.||.+||+. ||||+||||+||
T Consensus       249 n~Vrm~d~F-----~fr~HlciVfELL~~NLYellK~n~f--~Glsl~~ir~~~~Qil~~L~~L~~l-~IIHcDLKPENI  320 (586)
T KOG0667|consen  249 NIVRMLDYF-----YFRNHLCIVFELLSTNLYELLKNNKF--RGLSLPLVRKFAQQILTALLFLHEL-GIIHCDLKPENI  320 (586)
T ss_pred             eEEEeeecc-----ccccceeeeehhhhhhHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCChhhe
Confidence            799999999     66677999999999999999986543  4599999999999999999999987 999999999999


Q ss_pred             EEeC-CCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCCCcHHHH
Q 022799           88 LVNP-HTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQL  166 (292)
Q Consensus        88 ll~~-~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~  166 (292)
                      |+.. +...|||+|||.|....  ....+++-++.|+|||++.|.+ |+.+.||||||||++||++|.+.|+|.++.+++
T Consensus       321 LL~~~~r~~vKVIDFGSSc~~~--q~vytYiQSRfYRAPEVILGlp-Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl  397 (586)
T KOG0667|consen  321 LLKDPKRSRIKVIDFGSSCFES--QRVYTYIQSRFYRAPEVILGLP-YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQL  397 (586)
T ss_pred             eeccCCcCceeEEecccccccC--CcceeeeeccccccchhhccCC-CCCccceeehhhhHHhHhcCccccCCCCHHHHH
Confidence            9943 33379999999998753  3344778899999999999876 999999999999999999999999999999999


Q ss_pred             HHHHHHhCCCCHHHHhhcCCCCccccC----CC-----------------------------C-CCCCchhhhccCCChh
Q 022799          167 VEIIKVLGTPTREEIKCMNPNYTEFKF----PQ-----------------------------I-KAHPWHKIFQKRMPPE  212 (292)
Q Consensus       167 ~~i~~~~~~~~~~~~~~~~~~~~~~~~----~~-----------------------------~-~~~~~~~~~~~~~~~~  212 (292)
                      ..|++.+|.|+...+.........++-    +.                             . ...++...+.......
T Consensus       398 ~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~  477 (586)
T KOG0667|consen  398 ARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKL  477 (586)
T ss_pred             HHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHH
Confidence            999999999999887544322111110    00                             0 1112222222233457


Q ss_pred             HHHHHHHHhccCCCCcccHHHHhcCCCccccC
Q 022799          213 AVDLVSRLLQYSPNLRSTALEALIHPFFDELR  244 (292)
Q Consensus       213 ~~~li~~~l~~dp~~R~t~~e~l~hp~~~~~~  244 (292)
                      +.|||++||.+||.+|+|+.++|+||||....
T Consensus       478 F~dflk~~L~~dP~~R~tp~qal~Hpfl~~~~  509 (586)
T KOG0667|consen  478 FIDFLKRCLEWDPAERITPAQALNHPFLTGTS  509 (586)
T ss_pred             HHHHHHHHhccCchhcCCHHHHhcCccccccc
Confidence            89999999999999999999999999999543

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.5e-44  Score=312.71  Aligned_cols=240  Identities=40%  Similarity=0.732  Sum_probs=188.8

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      |+.++||||+++++++......+...+|+||||++++|.+.+..    ...+++..++.++.||+.||.|||++ ||+||
T Consensus        53 l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~  127 (338)
T cd07859          53 LRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTA-NVFHR  127 (338)
T ss_pred             HHhCCCCCEeeecceEeccCCCCCceEEEEEecCCCCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHC-CeecC
Confidence            45789999999999886554444456899999999999888865    35689999999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCC----cccccccccccCCccccCC-CCCCchhHhhhhhHHHHHHHhCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP----NISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLLGQP  155 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~  155 (292)
                      ||||+||+++.++ .+||+|||+++.......    .....||+.|+|||++.+. ..++.++|+||+||++|+|++|+.
T Consensus       128 dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~  206 (338)
T cd07859         128 DLKPKNILANADC-KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP  206 (338)
T ss_pred             CCCHHHeEECCCC-cEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCC
Confidence            9999999999988 799999999976432221    1235689999999998542 458999999999999999999999


Q ss_pred             CCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc-c--cCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHH
Q 022799          156 LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE-F--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAL  232 (292)
Q Consensus       156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~  232 (292)
                      ||.+.+....+..+....+.|+.+.+..+...... .  .............+ +.+++.+.++|.+||..||++|||++
T Consensus       207 pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~  285 (338)
T cd07859         207 LFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKF-PNADPLALRLLERLLAFDPKDRPTAE  285 (338)
T ss_pred             CCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhc-CCCChHHHHHHHHHcCcCcccCCCHH
Confidence            99998888888888888888887765543221100 0  00011111112222 35788999999999999999999999


Q ss_pred             HHhcCCCccccCCCC
Q 022799          233 EALIHPFFDELRDPN  247 (292)
Q Consensus       233 e~l~hp~~~~~~~~~  247 (292)
                      ++++||||+++....
T Consensus       286 e~l~hp~f~~~~~~~  300 (338)
T cd07859         286 EALADPYFKGLAKVE  300 (338)
T ss_pred             HHhcCchhhhcCccc
Confidence            999999999876543

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=5.4e-44  Score=307.12  Aligned_cols=234  Identities=33%  Similarity=0.604  Sum_probs=180.2

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      |+.++||||+++++++     .+....++||||++++|.+.+...   ...+++..++.++.||+.||.|||++ ||+||
T Consensus        57 l~~l~h~niv~~~~~~-----~~~~~~~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~  127 (303)
T cd07869          57 LKGLKHANIVLLHDII-----HTKETLTLVFEYVHTDLCQYMDKH---PGGLHPENVKLFLFQLLRGLSYIHQR-YILHR  127 (303)
T ss_pred             HhhCCCCCcCeEEEEE-----ecCCeEEEEEECCCcCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecC
Confidence            4678999999999998     444569999999999998887643   35688999999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccC-CCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      ||||+||+++.++ .+||+|||++...... .......+|+.|+|||++.+...++.++|+||+||++|+|++|..||.+
T Consensus       128 dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  206 (303)
T cd07869         128 DLKPQNLLISDTG-ELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPG  206 (303)
T ss_pred             CCCHHHEEECCCC-CEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999888 7999999998754322 1223456799999999987666689999999999999999999999987


Q ss_pred             CCc-HHHHHHHHHHhCCCCHHHHhhcCC--CCccccCCCCCCCCchhhhc-cCCChhHHHHHHHHhccCCCCcccHHHHh
Q 022799          160 ESG-VDQLVEIIKVLGTPTREEIKCMNP--NYTEFKFPQIKAHPWHKIFQ-KRMPPEAVDLVSRLLQYSPNLRSTALEAL  235 (292)
Q Consensus       160 ~~~-~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~dp~~R~t~~e~l  235 (292)
                      ..+ .+.+..+....+.+....+.....  .+....+.......+...++ ..+++++.+||.+||+.||++|+|+.+++
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l  286 (303)
T cd07869         207 MKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAAL  286 (303)
T ss_pred             CccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHh
Confidence            544 456667777777776655443221  11111111111111111111 23568899999999999999999999999


Q ss_pred             cCCCccccC
Q 022799          236 IHPFFDELR  244 (292)
Q Consensus       236 ~hp~~~~~~  244 (292)
                      +||||+++.
T Consensus       287 ~h~~f~~~~  295 (303)
T cd07869         287 SHEYFSDLP  295 (303)
T ss_pred             cCcccccCC
Confidence            999999764

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=6.3e-44  Score=304.69  Aligned_cols=232  Identities=34%  Similarity=0.588  Sum_probs=185.1

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccC
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRD   81 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~d   81 (292)
                      +.++||||+++++++..........+++||||++++|.+++....  ...+++..+..++.||+.||.|||++ ||+|||
T Consensus        59 ~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~-~iiH~d  135 (290)
T cd07862          59 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH-RVVHRD  135 (290)
T ss_pred             cccCCCCcceEEEEEecccCCCCCcEEEEEccCCCCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCC
Confidence            346899999999988544333455689999999999998886532  34589999999999999999999988 999999


Q ss_pred             CCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCCC
Q 022799           82 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES  161 (292)
Q Consensus        82 lkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~  161 (292)
                      |||+||+++.++ .+||+|||++.............||+.|+|||.+.+. .++.++|+||+||++|+|++|.+||.+.+
T Consensus       136 lkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~~f~~~~  213 (290)
T cd07862         136 LKPQNILVTSSG-QIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSS  213 (290)
T ss_pred             CCHHHEEEcCCC-CEEEccccceEeccCCcccccccccccccChHHHhCC-CCCCccchHHHHHHHHHHHcCCCCcCCCC
Confidence            999999999888 7999999999876544444456789999999998654 48999999999999999999999999999


Q ss_pred             cHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCCc
Q 022799          162 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  240 (292)
Q Consensus       162 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~~  240 (292)
                      ..+.+.++....+.|..+.+..... .....+.......... +.+.+++.++++|.+||+.||++|||+.++++||||
T Consensus       214 ~~~~~~~i~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         214 DVDQLGKILDVIGLPGEEDWPRDVA-LPRQAFHSKSAQPIEK-FVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             HHHHHHHHHHHhCCCChhhchhhhc-ccchhccCCCCCCHHH-HccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence            9999999998888777655432210 1111111111122222 224688999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.8e-45  Score=318.70  Aligned_cols=202  Identities=33%  Similarity=0.545  Sum_probs=174.8

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      |+.|+|||||.+++.|     +...++|+|+|||.|+|.+++..    .+.++|+.++.+++|++.||.|||+. +|.||
T Consensus        55 ~r~lkHpniv~m~esf-----Et~~~~~vVte~a~g~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs~-rilhr  124 (808)
T KOG0597|consen   55 LRSLKHPNIVEMLESF-----ETSAHLWVVTEYAVGDLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHSN-RILHR  124 (808)
T ss_pred             HHhcCCcchhhHHHhh-----cccceEEEEehhhhhhHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhc-Ccccc
Confidence            4679999999999999     55556999999999999999986    58899999999999999999999998 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCC-cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      |+||.|||++..+ .+|+||||+|+.+..+.. ....-|||.|||||++.+. .|+..+|+||+|||+|||.+|++||..
T Consensus       125 d~kPqniLl~~~~-~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~-pyd~~sDlWslGcilYE~~~G~PPF~a  202 (808)
T KOG0597|consen  125 DMKPQNILLEKGG-TLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQ-PYDHTSDLWSLGCILYELYVGQPPFYA  202 (808)
T ss_pred             cCCcceeeecCCC-ceeechhhhhhhcccCceeeeeccCcccccCHHHHcCC-CccchhhHHHHHHHHHHHhcCCCCchH
Confidence            9999999999988 799999999998865543 3445799999999999765 599999999999999999999999987


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCC
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF  239 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~  239 (292)
                      ..-......|...-                 ..            .|..++.++..||+.+|.+||.+|.|..+++.|||
T Consensus       203 ~si~~Lv~~I~~d~-----------------v~------------~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF  253 (808)
T KOG0597|consen  203 RSITQLVKSILKDP-----------------VK------------PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPF  253 (808)
T ss_pred             HHHHHHHHHHhcCC-----------------CC------------CcccccHHHHHHHHHHhhcChhhcccHHHHhcChH
Confidence            76555555554311                 01            12468999999999999999999999999999999


Q ss_pred             cccc
Q 022799          240 FDEL  243 (292)
Q Consensus       240 ~~~~  243 (292)
                      +++-
T Consensus       254 ~k~~  257 (808)
T KOG0597|consen  254 WKGK  257 (808)
T ss_pred             Hhhh
Confidence            9863

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-45  Score=296.50  Aligned_cols=272  Identities=31%  Similarity=0.558  Sum_probs=211.9

Q ss_pred             CCCCCCCCeeeeceeeeccCC-CCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTE-KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~-~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |..++|+||++++.+|..... ......|+|||+++.+|...+.      ..++...+..+++|+++|++|||+. ||+|
T Consensus        69 ~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs~-~Iih  141 (369)
T KOG0665|consen   69 MKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMDANLCQVIL------MELDHETISYILYQMLCGIKHLHSA-GIIH  141 (369)
T ss_pred             hhhhcccceeeeeeccCccccHHHHHhHHHHHHhhhhHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHhc-ceee
Confidence            456799999999999853322 2234588999999999999886      3367788999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      |||||+||++..+. .+||+|||+|+.-...-..+.++.|++|+|||++.|.. |.+.+||||+||++.||++|+..|+|
T Consensus       142 RdLkPsnivv~~~~-~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g  219 (369)
T KOG0665|consen  142 RDLKPSNIVVNSDC-TLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPG  219 (369)
T ss_pred             cccCcccceecchh-heeeccchhhcccCcccccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecC
Confidence            99999999999988 79999999998765444556778899999999998877 99999999999999999999999999


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccc--cCCCCCCCCchhhhcc-----------CCChhHHHHHHHHhccCCC
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF--KFPQIKAHPWHKIFQK-----------RMPPEAVDLVSRLLQYSPN  226 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~-----------~~~~~~~~li~~~l~~dp~  226 (292)
                      .+..++..++.+.+|.|.....+.+.+....+  ..+++....+...|+.           .-+..++|++.+||..||+
T Consensus       220 ~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe  299 (369)
T KOG0665|consen  220 KDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPE  299 (369)
T ss_pred             chHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChh
Confidence            99999999999999999999888776543322  3334444444444432           2345789999999999999


Q ss_pred             CcccHHHHhcCCCccccCCCCCCCCCCCCCCCCCCCChhccCCCCHHHHhhhchHHHHh
Q 022799          227 LRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARK  285 (292)
Q Consensus       227 ~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (292)
                      +|.+++++|+||||+ +.-...+...+ . |+.+. +-.+....+++.|++.+-+..+.
T Consensus       300 ~Risv~daL~HPY~~-vw~~~~ev~ap-~-pe~~d-~~~d~~~~t~~e~ke~If~ev~~  354 (369)
T KOG0665|consen  300 KRISVDDALRHPYIK-VWYDPDEVEAP-P-PEIYD-KQLDEREHTIEEWKELIFKEVQR  354 (369)
T ss_pred             hcccHHHHhcCCeee-eecccccccCC-C-Cchhh-hhcccccCCHHHHHHHHHHHHHh
Confidence            999999999999998 33222222221 1 12111 22345555688888877766554

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-44  Score=270.06  Aligned_cols=233  Identities=35%  Similarity=0.649  Sum_probs=199.9

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      |+.|+|.|||+++++..     .+..+-+|+|||+.+|.++....   ++.+..+.++.++.|++.||.|+|++ ++.||
T Consensus        55 lkelkhknivrl~dvlh-----sdkkltlvfe~cdqdlkkyfdsl---ng~~d~~~~rsfmlqllrgl~fchsh-nvlhr  125 (292)
T KOG0662|consen   55 LKELKHKNIVRLHDVLH-----SDKKLTLVFEFCDQDLKKYFDSL---NGDLDPEIVRSFMLQLLRGLGFCHSH-NVLHR  125 (292)
T ss_pred             HHHhhhcceeehhhhhc-----cCceeEEeHHHhhHHHHHHHHhc---CCcCCHHHHHHHHHHHHhhhhhhhhh-hhhhc
Confidence            46789999999999883     33448899999999999888764   67899999999999999999999998 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCCc-ccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFP  158 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~  158 (292)
                      |+||.|++++.+| .+|++|||+++.+.-.-.+ ...+.|.+|++|.++.|.+-|+.+.|+||.|||+.|+.. |++.|+
T Consensus       126 dlkpqnllin~ng-elkladfglarafgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfp  204 (292)
T KOG0662|consen  126 DLKPQNLLINRNG-ELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP  204 (292)
T ss_pred             cCCcceEEeccCC-cEEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCC
Confidence            9999999999999 7999999999877443322 344679999999999999999999999999999999995 889999


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCC-CCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA-HPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      |.+-.+++.+|+..+|.|+.+.|..+..--....+|.+.. ..|.... ++++...+|+++++|.-+|.+|++++++++|
T Consensus       205 g~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqiv-p~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  205 GNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIV-PKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             CCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHh-hhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence            9999999999999999999999988754333334444433 3455544 5788899999999999999999999999999


Q ss_pred             CCccccC
Q 022799          238 PFFDELR  244 (292)
Q Consensus       238 p~~~~~~  244 (292)
                      |||.+..
T Consensus       284 pyf~d~s  290 (292)
T KOG0662|consen  284 PYFSDFS  290 (292)
T ss_pred             ccccccC
Confidence            9998753

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-44  Score=302.27  Aligned_cols=218  Identities=26%  Similarity=0.455  Sum_probs=176.9

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||++++.+|....+     +|+||.||. |++.+++.....  ..++|..+..++++++.||.|||.+ |.||
T Consensus        78 msl~~HPNIv~~~~sFvv~~~-----LWvVmpfMa~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~~-G~IH  149 (516)
T KOG0582|consen   78 MSLIDHPNIVTYHCSFVVDSE-----LWVVMPFMAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLHQN-GHIH  149 (516)
T ss_pred             hhhcCCCCcceEEEEEEecce-----eEEeehhhcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHhc-Ccee
Confidence            678999999999999955444     999999999 899999987754  4599999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCC-Cc----ccccccccccCCccc-cCCCCCCchhHhhhhhHHHHHHHhC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PN----ISYICSRYYRAPELI-FGATEYTAAIDIWSAGCVLAELLLG  153 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-~~----~~~~gt~~y~aPE~~-~~~~~~~~~~DvwslG~il~el~~g  153 (292)
                      ||||+.|||++.+| .|||+|||.+..+.... ..    .+.+||++|||||++ .....|+.|+||||+|++..||.+|
T Consensus       150 RdvKAgnILi~~dG-~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G  228 (516)
T KOG0582|consen  150 RDVKAGNILIDSDG-TVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHG  228 (516)
T ss_pred             cccccccEEEcCCC-cEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcC
Confidence            99999999999999 79999999866543322 11    456899999999995 3446699999999999999999999


Q ss_pred             CCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHH
Q 022799          154 QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE  233 (292)
Q Consensus       154 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e  233 (292)
                      +.||...-+.+.+...++  +.|+.......  .+               .-.+.++..++++|..||++||++||||++
T Consensus       229 ~aPf~k~pPmkvLl~tLq--n~pp~~~t~~~--~~---------------d~~k~~~ksf~e~i~~CL~kDP~kRptAsk  289 (516)
T KOG0582|consen  229 HAPFSKYPPMKVLLLTLQ--NDPPTLLTSGL--DK---------------DEDKKFSKSFREMIALCLVKDPSKRPTASK  289 (516)
T ss_pred             CCCcccCChHHHHHHHhc--CCCCCcccccC--Ch---------------HHhhhhcHHHHHHHHHHhhcCcccCCCHHH
Confidence            999988777766654333  33332111000  00               011457889999999999999999999999


Q ss_pred             HhcCCCccccCCC
Q 022799          234 ALIHPFFDELRDP  246 (292)
Q Consensus       234 ~l~hp~~~~~~~~  246 (292)
                      +|+|+||+.....
T Consensus       290 Llkh~FFk~~k~~  302 (516)
T KOG0582|consen  290 LLKHAFFKKAKSK  302 (516)
T ss_pred             HhccHHHhhccch
Confidence            9999999986643

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-44  Score=307.64  Aligned_cols=207  Identities=30%  Similarity=0.480  Sum_probs=170.2

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++|.|||||+++++.-++.   ...+|||+|||. |.+...    ......+++.++++|+++++.||+|||.+ ||+|
T Consensus       162 lKkl~H~nVV~LiEvLDDP~---s~~~YlVley~s~G~v~w~----p~d~~els~~~Ar~ylrDvv~GLEYLH~Q-giiH  233 (576)
T KOG0585|consen  162 LKKLHHPNVVKLIEVLDDPE---SDKLYLVLEYCSKGEVKWC----PPDKPELSEQQARKYLRDVVLGLEYLHYQ-GIIH  233 (576)
T ss_pred             HHhcCCcCeeEEEEeecCcc---cCceEEEEEeccCCccccC----CCCcccccHHHHHHHHHHHHHHHHHHHhc-Ceec
Confidence            68899999999999984433   345999999999 553322    11123389999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccC------CCcccccccccccCCccccCC---CCCCchhHhhhhhHHHHHH
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG------EPNISYICSRYYRAPELIFGA---TEYTAAIDIWSAGCVLAEL  150 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~------~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DvwslG~il~el  150 (292)
                      |||||+|+|++++| .+||+|||.+.....+      ......+|||.|+|||...+.   ...+.+.|+||+||++|.|
T Consensus       234 RDIKPsNLLl~~~g-~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCl  312 (576)
T KOG0585|consen  234 RDIKPSNLLLSSDG-TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCL  312 (576)
T ss_pred             cccchhheEEcCCC-cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHh
Confidence            99999999999998 7999999998766222      122346899999999998773   3357899999999999999


Q ss_pred             HhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCccc
Q 022799          151 LLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST  230 (292)
Q Consensus       151 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t  230 (292)
                      +.|+.||.++...+...+|...                 ...+|..          +.+.++++|||.+||++||.+|++
T Consensus       313 lfG~~PF~~~~~~~l~~KIvn~-----------------pL~fP~~----------pe~~e~~kDli~~lL~KdP~~Ri~  365 (576)
T KOG0585|consen  313 LFGQLPFFDDFELELFDKIVND-----------------PLEFPEN----------PEINEDLKDLIKRLLEKDPEQRIT  365 (576)
T ss_pred             hhccCCcccchHHHHHHHHhcC-----------------cccCCCc----------ccccHHHHHHHHHHhhcChhheee
Confidence            9999999999988888888762                 2222221          357889999999999999999999


Q ss_pred             HHHHhcCCCcccc
Q 022799          231 ALEALIHPFFDEL  243 (292)
Q Consensus       231 ~~e~l~hp~~~~~  243 (292)
                      +.++..|||...-
T Consensus       366 l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  366 LPDIKLHPWVTRD  378 (576)
T ss_pred             hhhheecceeccC
Confidence            9999999999864

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-44  Score=307.46  Aligned_cols=208  Identities=29%  Similarity=0.479  Sum_probs=185.9

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++|||||++|++.     ....-+|||+|+-+ |+|.++|..+   ...+.+..+++|+.||+.|+.|+|.- .+||
T Consensus        71 MKLVQHpNiVRLYEVi-----DTQTKlyLiLELGD~GDl~DyImKH---e~Gl~E~La~kYF~QI~~AI~YCHqL-HVVH  141 (864)
T KOG4717|consen   71 MKLVQHPNIVRLYEVI-----DTQTKLYLILELGDGGDLFDYIMKH---EEGLNEDLAKKYFAQIVHAISYCHQL-HVVH  141 (864)
T ss_pred             HHHhcCcCeeeeeehh-----cccceEEEEEEecCCchHHHHHHhh---hccccHHHHHHHHHHHHHHHHHHhhh-hhhc
Confidence            6778999999999998     44445999999998 6999999875   57799999999999999999999964 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      |||||+|+.+-+.-+-|||+|||++..+..++...+.+|+..|.|||++.|.....+++||||||||+|.|++|++||..
T Consensus       142 RDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqe  221 (864)
T KOG4717|consen  142 RDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQE  221 (864)
T ss_pred             ccCCcceeEEeeecCceEeeeccccccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccc
Confidence            99999999876555589999999999999999999999999999999999998778999999999999999999999999


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCC
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF  239 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~  239 (292)
                      .++.+.+-.|+.+                 ++.            +|..+|.+++|||..||+.||.+|.+.++|..++|
T Consensus       222 ANDSETLTmImDC-----------------KYt------------vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~W  272 (864)
T KOG4717|consen  222 ANDSETLTMIMDC-----------------KYT------------VPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSW  272 (864)
T ss_pred             ccchhhhhhhhcc-----------------ccc------------CchhhhHHHHHHHHHHHhcCchhhccHHHHhcccc
Confidence            9998888888764                 222            33568999999999999999999999999999999


Q ss_pred             ccccCCC
Q 022799          240 FDELRDP  246 (292)
Q Consensus       240 ~~~~~~~  246 (292)
                      ++.++..
T Consensus       273 lq~~D~~  279 (864)
T KOG4717|consen  273 LQAGDRG  279 (864)
T ss_pred             ccCCCCC
Confidence            9987654

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-44  Score=288.23  Aligned_cols=211  Identities=29%  Similarity=0.452  Sum_probs=172.9

Q ss_pred             CCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCC
Q 022799            5 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIK   83 (292)
Q Consensus         5 ~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlk   83 (292)
                      .|||||+++++|...- ++..++.+|||.++ |.|...++.+.  +..++|.++..|+.||..|+.|||+. +|.|||||
T Consensus       113 ~h~~iV~IidVyeNs~-~~rkcLLiVmE~meGGeLfsriq~~g--~~afTErea~eI~~qI~~Av~~lH~~-nIAHRDlK  188 (400)
T KOG0604|consen  113 GHPHIVSIIDVYENSY-QGRKCLLIVMECMEGGELFSRIQDRG--DQAFTEREASEIMKQIGLAVRYLHSM-NIAHRDLK  188 (400)
T ss_pred             CCCceEEeehhhhhhc-cCceeeEeeeecccchHHHHHHHHcc--cccchHHHHHHHHHHHHHHHHHHHhc-chhhccCC
Confidence            6999999999985544 45667889999999 68888887652  46799999999999999999999987 99999999


Q ss_pred             CCcEEEeCC--CCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCCC
Q 022799           84 PQNLLVNPH--THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES  161 (292)
Q Consensus        84 p~Nill~~~--~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~  161 (292)
                      |+|+|....  ...+||+|||+|+.........+.+.||+|.|||++ |...|+...|+||+||++|-|++|.+||.+..
T Consensus       189 pENLLyt~t~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevl-g~eKydkscdmwSlgVimYIlLCGyPPFYS~h  267 (400)
T KOG0604|consen  189 PENLLYTTTSPNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH  267 (400)
T ss_pred             hhheeeecCCCCcceEecccccccccCCCccccCCcccccccCHHHh-CchhcCCCCCccchhHHHHHhhcCCCcccccC
Confidence            999998543  236999999999987766667778899999999999 66679999999999999999999999998766


Q ss_pred             cHHHH----HHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          162 GVDQL----VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       162 ~~~~~----~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      ...+-    .+|.......+.++                    |     ..+|++++|+|+++|..+|++|.|+.+++.|
T Consensus       268 g~aispgMk~rI~~gqy~FP~pE--------------------W-----s~VSe~aKdlIR~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  268 GLAISPGMKRRIRTGQYEFPEPE--------------------W-----SCVSEAAKDLIRKLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             CccCChhHHhHhhccCccCCChh--------------------H-----hHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence            53322    22222111111222                    2     3479999999999999999999999999999


Q ss_pred             CCccccCC
Q 022799          238 PFFDELRD  245 (292)
Q Consensus       238 p~~~~~~~  245 (292)
                      ||+.....
T Consensus       323 pwi~~~~~  330 (400)
T KOG0604|consen  323 PWINQYEA  330 (400)
T ss_pred             chhccccc
Confidence            99987553

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=9.3e-44  Score=309.01  Aligned_cols=202  Identities=28%  Similarity=0.459  Sum_probs=168.1

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++     .+...+|+||||+. |+|.+.+..    ...+++..++.++.||+.||.|||++ ||+|
T Consensus        72 l~~l~hp~iv~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH  141 (329)
T PTZ00263         72 LMELSHPFIVNMMCSF-----QDENRVYFLLEFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSK-DIIY  141 (329)
T ss_pred             HHhCCCCCCCcEEEEE-----EcCCEEEEEEcCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-Ceee
Confidence            4578999999999998     44456999999998 688888765    36789999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      |||||+||+++.++ .+||+|||++......  .....||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+
T Consensus       142 ~dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~  217 (329)
T PTZ00263        142 RDLKPENLLLDNKG-HVKVTDFGFAKKVPDR--TFTLCGTPEYLAPEVIQSK-GHGKAVDWWTMGVLLYEFIAGYPPFFD  217 (329)
T ss_pred             cCCCHHHEEECCCC-CEEEeeccCceEcCCC--cceecCChhhcCHHHHcCC-CCCCcceeechHHHHHHHHcCCCCCCC
Confidence            99999999999888 7999999999866332  3346789999999999665 489999999999999999999999988


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCccc-----HHHH
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----ALEA  234 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t-----~~e~  234 (292)
                      .+.......+...                 ..            .++..++..+++||.+||+.||.+|++     ++++
T Consensus       218 ~~~~~~~~~i~~~-----------------~~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l  268 (329)
T PTZ00263        218 DTPFRIYEKILAG-----------------RL------------KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADV  268 (329)
T ss_pred             CCHHHHHHHHhcC-----------------Cc------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHH
Confidence            7765544443321                 00            012347889999999999999999987     7999


Q ss_pred             hcCCCccccCC
Q 022799          235 LIHPFFDELRD  245 (292)
Q Consensus       235 l~hp~~~~~~~  245 (292)
                      ++||||++..+
T Consensus       269 l~hp~f~~~~~  279 (329)
T PTZ00263        269 KNHPYFHGANW  279 (329)
T ss_pred             hcCCccCCCCH
Confidence            99999987543

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=4.1e-43  Score=302.45  Aligned_cols=234  Identities=36%  Similarity=0.698  Sum_probs=189.6

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      |++++||||+++++++.     .+...++||||++++|.+.+...   ...+++..++.++.||+.||.|||++ ||+||
T Consensus        58 l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~-~ivH~  128 (309)
T cd07872          58 LKDLKHANIVTLHDIVH-----TDKSLTLVFEYLDKDLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRR-KVLHR  128 (309)
T ss_pred             HHhCCCCCcceEEEEEe-----eCCeEEEEEeCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecC
Confidence            35789999999999983     34458999999999988877643   34588999999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCC-CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      ||||+||+++.++ .+||+|||++....... ......+|+.|+|||.+.+...++.++|+||+||++|+|++|..||.+
T Consensus       129 dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~  207 (309)
T cd07872         129 DLKPQNLLINERG-ELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPG  207 (309)
T ss_pred             CCCHHHEEECCCC-CEEECccccceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999888 79999999987643222 223346789999999987666689999999999999999999999999


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCC--CccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPN--YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      .+..+.+..+.+..+.+..+.+......  +....++......+... .+.++++++++|.+||..||.+|+|+.|+++|
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  286 (309)
T cd07872         208 STVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINH-APRLDTEGIELLTKFLQYESKKRISAEEAMKH  286 (309)
T ss_pred             CChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhh-ccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence            9988999999999999988877654322  12223333222222221 24688999999999999999999999999999


Q ss_pred             CCccccCC
Q 022799          238 PFFDELRD  245 (292)
Q Consensus       238 p~~~~~~~  245 (292)
                      |||+.+..
T Consensus       287 ~~~~~~~~  294 (309)
T cd07872         287 AYFRSLGT  294 (309)
T ss_pred             hhhhhccc
Confidence            99998653

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=7.8e-43  Score=306.79  Aligned_cols=237  Identities=32%  Similarity=0.594  Sum_probs=183.0

Q ss_pred             CCCCCCCCeeeeceeeeccCC-CCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTE-KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~-~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++..... .....+|+||||++++|.+.+.      ..+++..+..++.||+.||.|||++ ||+|
T Consensus        74 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~-~ivH  146 (359)
T cd07876          74 LKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIH------MELDHERMSYLLYQMLCGIKHLHSA-GIIH  146 (359)
T ss_pred             HHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCcCHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhC-Cccc
Confidence            357899999999998854332 1223578999999998877764      3478889999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      |||||+||+++.++ .+||+|||+++............||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+
T Consensus       147 rDlkp~NIl~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~  224 (359)
T cd07876         147 RDLKPSNIVVKSDC-TLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELVKGSVIFQG  224 (359)
T ss_pred             CCCCHHHEEECCCC-CEEEecCCCccccccCccCCCCcccCCCCCchhccCC-CCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence            99999999999888 7999999999765444444456789999999999764 489999999999999999999999999


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccc--cCCCCCCCCch-----------hhhccCCChhHHHHHHHHhccCCC
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF--KFPQIKAHPWH-----------KIFQKRMPPEAVDLVSRLLQYSPN  226 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~-----------~~~~~~~~~~~~~li~~~l~~dp~  226 (292)
                      .+..+....+.+..+.|..+...........+  ..+......+.           .......++.+++||.+||..||+
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~  304 (359)
T cd07876         225 TDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPD  304 (359)
T ss_pred             CCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcc
Confidence            98888888888888888766543321110000  00000000000           011123578899999999999999


Q ss_pred             CcccHHHHhcCCCccccCCC
Q 022799          227 LRSTALEALIHPFFDELRDP  246 (292)
Q Consensus       227 ~R~t~~e~l~hp~~~~~~~~  246 (292)
                      +|||+.|+|+||||.....+
T Consensus       305 ~R~t~~e~l~hp~~~~~~~~  324 (359)
T cd07876         305 KRISVDEALRHPYITVWYDP  324 (359)
T ss_pred             cCCCHHHHhcCchhhhhcCc
Confidence            99999999999999865443

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=5.9e-43  Score=298.26  Aligned_cols=229  Identities=39%  Similarity=0.739  Sum_probs=180.3

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      |+.++||||+++++++     .+...+|+||||+++++.+.+...   ...+++..++.++.||+.||.|||+. ||+||
T Consensus        54 l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~  124 (287)
T cd07848          54 LRTLKQENIVELKEAF-----RRRGKLYLVFEYVEKNMLELLEEM---PNGVPPEKVRSYIYQLIKAIHWCHKN-DIVHR  124 (287)
T ss_pred             HHhCCCccccchhhhE-----ecCCEEEEEEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecC
Confidence            4678999999999998     444568999999997766665432   35689999999999999999999987 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCC--CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      ||||+||+++.++ .+||+|||++.......  ......||+.|+|||++.+.. ++.++|+||+||++|+|++|+.||.
T Consensus       125 dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~pf~  202 (287)
T cd07848         125 DIKPENLLISHND-VLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP-YGKAVDMWSVGCILGELSDGQPLFP  202 (287)
T ss_pred             CCCHHHEEEcCCC-cEEEeeccCcccccccccccccccccccccCCcHHHcCCC-CCCchhHHhHHHHHHHHHhCCCCCC
Confidence            9999999999888 79999999998764322  223456899999999997654 8999999999999999999999999


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcC--CCCccccCCCC-CCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHh
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEFKFPQI-KAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL  235 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~--~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l  235 (292)
                      +.+..+....+.+..+..+.+.+....  +.+.....+.. ....+.......+|.++.+||++||++||++|||+++++
T Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l  282 (287)
T cd07848         203 GESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCL  282 (287)
T ss_pred             CCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHh
Confidence            988888888887777777665544321  11111111111 111222233345789999999999999999999999999


Q ss_pred             cCCCc
Q 022799          236 IHPFF  240 (292)
Q Consensus       236 ~hp~~  240 (292)
                      +||||
T Consensus       283 ~hp~f  287 (287)
T cd07848         283 NHPAF  287 (287)
T ss_pred             cCCCC
Confidence            99998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.1e-42  Score=306.41  Aligned_cols=238  Identities=32%  Similarity=0.594  Sum_probs=186.4

Q ss_pred             CCCCCCCCeeeeceeeeccCC-CCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTE-KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~-~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++..... .+...+|+||||++++|.+.+.      ..+++..+..++.|++.||.|||++ ||+|
T Consensus        77 l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH  149 (364)
T cd07875          77 MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA-GIIH  149 (364)
T ss_pred             HHhcCCCCccccceeecccccccccCeEEEEEeCCCCCHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhC-Ceec
Confidence            356899999999998754321 2334589999999999888775      2478889999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      |||||+||+++.++ .+||+|||+++............+|+.|+|||++.+. .++.++|+||+||++|+|++|..||.+
T Consensus       150 ~Dlkp~NIll~~~~-~~kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~  227 (364)
T cd07875         150 RDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPG  227 (364)
T ss_pred             CCCCHHHEEECCCC-cEEEEeCCCccccCCCCcccCCcccCCcCCHHHHhCC-CCCchhhHHhHHHHHHHHHhCCCCCCC
Confidence            99999999999888 7999999999876544444456789999999999764 489999999999999999999999999


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccc--cCCCCCC-----------CCchhhhccCCChhHHHHHHHHhccCCC
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF--KFPQIKA-----------HPWHKIFQKRMPPEAVDLVSRLLQYSPN  226 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~-----------~~~~~~~~~~~~~~~~~li~~~l~~dp~  226 (292)
                      .+..+...++.+..+.|..+.+..+.+....+  ..+....           .++........+..+++||.+||+.||+
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~  307 (364)
T cd07875         228 TDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDAS  307 (364)
T ss_pred             CCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcc
Confidence            99999999999999988876655443221110  0111000           1111111223467899999999999999


Q ss_pred             CcccHHHHhcCCCccccCCCC
Q 022799          227 LRSTALEALIHPFFDELRDPN  247 (292)
Q Consensus       227 ~R~t~~e~l~hp~~~~~~~~~  247 (292)
                      +|||+.++|+||||....++.
T Consensus       308 ~R~t~~e~L~hp~~~~~~~~~  328 (364)
T cd07875         308 KRISVDEALQHPYINVWYDPS  328 (364)
T ss_pred             cCCCHHHHhcCcccccccCcc
Confidence            999999999999998765543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.2e-42  Score=296.34  Aligned_cols=232  Identities=30%  Similarity=0.552  Sum_probs=184.4

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccC
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRD   81 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~d   81 (292)
                      +.++||||+++++++..........+++||||++++|.+++....  ...+++..++.++.||+.||.|||++ |++|||
T Consensus        57 ~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~d  133 (288)
T cd07863          57 EAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFLHAN-CIVHRD  133 (288)
T ss_pred             hhcCCCCeeeeeeeeccccCCCCceEEEEEcccccCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCC
Confidence            346899999999988654444456689999999999988876431  24589999999999999999999988 999999


Q ss_pred             CCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCCC
Q 022799           82 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES  161 (292)
Q Consensus        82 lkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~  161 (292)
                      |||+||+++.++ .+||+|||++.............+|..|+|||++.+. .++.++|+||+||++|+|++|.+||.+..
T Consensus       134 ikp~Nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~~f~~~~  211 (288)
T cd07863         134 LKPENILVTSGG-QVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNS  211 (288)
T ss_pred             CCHHHEEECCCC-CEEECccCccccccCcccCCCccccccccCchHhhCC-CCCCcchhhhHHHHHHHHHhCCcCcCCCC
Confidence            999999999888 7999999999876544444456789999999999664 48999999999999999999999999988


Q ss_pred             cHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCCc
Q 022799          162 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  240 (292)
Q Consensus       162 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~~  240 (292)
                      ..+.+.++....+.+....+..... .....+.......+.. ..+.++..+.++|.+||+.||.+|||+.+++.||||
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         212 EADQLGKIFDLIGLPPEDDWPRDVT-LPRGAFSPRGPRPVQS-VVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             HHHHHHHHHHHhCCCChhhCccccc-ccccccCCCCCCchHH-hCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            8888888888888777655432110 0011111111122222 224678899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.4e-42  Score=304.73  Aligned_cols=237  Identities=33%  Similarity=0.602  Sum_probs=185.5

Q ss_pred             CCCCCCCCeeeeceeeeccCC-CCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTE-KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~-~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++..... ......|+||||+++++.+.+.      ..+++..+..++.|++.||.|||++ ||+|
T Consensus        70 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~-givH  142 (355)
T cd07874          70 MKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA-GIIH  142 (355)
T ss_pred             HHHhCCCchhceeeeeeccccccccceeEEEhhhhcccHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhC-Cccc
Confidence            356899999999998854332 2234578999999998887764      3478889999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      |||||+||+++.++ .+||+|||+++............||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+
T Consensus       143 rDikp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~  220 (355)
T cd07874         143 RDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPG  220 (355)
T ss_pred             CCCChHHEEECCCC-CEEEeeCcccccCCCccccCCccccCCccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            99999999999888 7999999999876544444556789999999999664 489999999999999999999999999


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCC----------ccccCCCCC---CCCchhhhccCCChhHHHHHHHHhccCCC
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNY----------TEFKFPQIK---AHPWHKIFQKRMPPEAVDLVSRLLQYSPN  226 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~dp~  226 (292)
                      .+..+....+.+.++.+..+.+....+..          ....++...   ..+.....+...+..+++||.+||..||+
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~  300 (355)
T cd07874         221 RDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA  300 (355)
T ss_pred             CCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCch
Confidence            99888888888888888776654433221          111111100   00111112234567899999999999999


Q ss_pred             CcccHHHHhcCCCccccCCC
Q 022799          227 LRSTALEALIHPFFDELRDP  246 (292)
Q Consensus       227 ~R~t~~e~l~hp~~~~~~~~  246 (292)
                      +|||+.|+++||||+...++
T Consensus       301 ~Rps~~ell~hp~~~~~~~~  320 (355)
T cd07874         301 KRISVDEALQHPYINVWYDP  320 (355)
T ss_pred             hcCCHHHHhcCcchhcccCh
Confidence            99999999999999865443

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2.3e-43  Score=307.48  Aligned_cols=202  Identities=29%  Similarity=0.468  Sum_probs=169.9

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++     .+..++|+||||+. |+|.+++..    ...+++..++.++.||+.||.|||++ ||+|
T Consensus        85 l~~l~hp~Iv~~~~~~-----~~~~~~~lv~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH  154 (340)
T PTZ00426         85 LNYINHPFCVNLYGSF-----KDESYLYLVLEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSL-NIVY  154 (340)
T ss_pred             HHhCCCCCCcceEEEE-----EeCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEc
Confidence            3568999999999998     44456999999997 689888875    35789999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      |||||+|||++.++ .++|+|||++.....  ......||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+
T Consensus       155 rDLkp~NILl~~~~-~ikL~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~  230 (340)
T PTZ00426        155 RDLKPENLLLDKDG-FIKMTDFGFAKVVDT--RTYTLCGTPEYIAPEILLNV-GHGKAADWWTLGIFIYEILVGCPPFYA  230 (340)
T ss_pred             cCCCHHHEEECCCC-CEEEecCCCCeecCC--CcceecCChhhcCHHHHhCC-CCCccccccchhhHHHHHhcCCCCCCC
Confidence            99999999999888 799999999986533  23456789999999999664 489999999999999999999999988


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcc-----cHHHH
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEA  234 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----t~~e~  234 (292)
                      .+.......+....                 .            .++..+++.+.++|++||..||.+|+     |++++
T Consensus       231 ~~~~~~~~~i~~~~-----------------~------------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~  281 (340)
T PTZ00426        231 NEPLLIYQKILEGI-----------------I------------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNV  281 (340)
T ss_pred             CCHHHHHHHHhcCC-----------------C------------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHH
Confidence            77665555543310                 0            12245788999999999999999995     89999


Q ss_pred             hcCCCccccCC
Q 022799          235 LIHPFFDELRD  245 (292)
Q Consensus       235 l~hp~~~~~~~  245 (292)
                      ++||||+++.+
T Consensus       282 ~~hp~f~~~~~  292 (340)
T PTZ00426        282 KEHPWFGNIDW  292 (340)
T ss_pred             HcCCCcCCCCH
Confidence            99999998764

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.6e-42  Score=299.80  Aligned_cols=235  Identities=33%  Similarity=0.585  Sum_probs=176.4

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhh-----cCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYK-----MSQRMPLIYVKLYFYQICRALAYIHNTI   75 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~-----~~~~~~~~~~~~~~~qil~al~~LH~~~   75 (292)
                      |++++||||++++++|...   ....+|+||||++++|..++.....     ....+++..++.++.||+.||.|||++ 
T Consensus        52 l~~l~h~niv~~~~~~~~~---~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-  127 (317)
T cd07868          52 LRELKHPNVISLQKVFLSH---ADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN-  127 (317)
T ss_pred             HHhcCCCCCcceeeeEecC---CCcEEEEEEeccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC-
Confidence            4678999999999988542   2345889999999999888764321     123589999999999999999999988 


Q ss_pred             CccccCCCCCcEEEe----CCCCcEEEeecCCccccccCC----CcccccccccccCCccccCCCCCCchhHhhhhhHHH
Q 022799           76 GVCHRDIKPQNLLVN----PHTHQLKLCDFGSAKVLVKGE----PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVL  147 (292)
Q Consensus        76 ~i~H~dlkp~Nill~----~~~~~ikl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il  147 (292)
                      ||+||||||+||+++    .++ .+||+|||+++......    ......||+.|+|||++.+...++.++|+||+||++
T Consensus       128 ~ivHrDlkp~Nil~~~~~~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il  206 (317)
T cd07868         128 WVLHRDLKPANILVMGEGPERG-RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIF  206 (317)
T ss_pred             CEEcCCCCHHHEEEecCCCCcC-cEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHH
Confidence            999999999999994    334 79999999998654322    123457899999999997766689999999999999


Q ss_pred             HHHHhCCCCCCCCCc---------HHHHHHHHHHhCCCCHHHHhhcCCCCc------ccc---CCCCCCCCchhhhccCC
Q 022799          148 AELLLGQPLFPGESG---------VDQLVEIIKVLGTPTREEIKCMNPNYT------EFK---FPQIKAHPWHKIFQKRM  209 (292)
Q Consensus       148 ~el~~g~~pf~~~~~---------~~~~~~i~~~~~~~~~~~~~~~~~~~~------~~~---~~~~~~~~~~~~~~~~~  209 (292)
                      |+|++|.+||.+...         .+++.++....+.|....+.....-..      .+.   ..........+......
T Consensus       207 ~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (317)
T cd07868         207 AELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKP  286 (317)
T ss_pred             HHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCC
Confidence            999999999975432         366778888888888776654321100      000   00000000001111234


Q ss_pred             ChhHHHHHHHHhccCCCCcccHHHHhcCCCc
Q 022799          210 PPEAVDLVSRLLQYSPNLRSTALEALIHPFF  240 (292)
Q Consensus       210 ~~~~~~li~~~l~~dp~~R~t~~e~l~hp~~  240 (292)
                      +..+.+||++||++||.+|+|++|+|+||||
T Consensus       287 ~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         287 DSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             ChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            6679999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=3.9e-43  Score=304.36  Aligned_cols=204  Identities=27%  Similarity=0.449  Sum_probs=168.4

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++     .+..++|+||||++ |+|.+.+..    ...+++..++.++.||+.||+|||++ ||+|
T Consensus        49 l~~l~hp~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~-~ivH  118 (323)
T cd05571          49 LQNTRHPFLTALKYSF-----QTHDRLCFVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSC-DVVY  118 (323)
T ss_pred             HHhCCCCCCCCEEEEE-----EcCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEe
Confidence            3578999999999988     44456999999998 688777764    36789999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCcccccc-CCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      |||||+||+++.++ .+||+|||+++.... ........||+.|+|||++.+. .++.++|+||+||++|+|++|..||.
T Consensus       119 rDlkp~NIll~~~~-~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~  196 (323)
T cd05571         119 RDLKLENLMLDKDG-HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFY  196 (323)
T ss_pred             CCCCHHHEEECCCC-CEEEeeCCCCcccccCCCcccceecCccccChhhhcCC-CCCccccCcccchhhhhhhcCCCCCC
Confidence            99999999999888 799999999875422 2233446789999999999664 48999999999999999999999998


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcc-----cHHH
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALE  233 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----t~~e  233 (292)
                      +.+.......+...                 ..            .++..+++++.+||++||..||++|+     ++.+
T Consensus       197 ~~~~~~~~~~~~~~-----------------~~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~  247 (323)
T cd05571         197 NQDHEKLFELILME-----------------EI------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKE  247 (323)
T ss_pred             CCCHHHHHHHHHcC-----------------CC------------CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHH
Confidence            76655444333221                 00            12346899999999999999999999     8999


Q ss_pred             HhcCCCccccCC
Q 022799          234 ALIHPFFDELRD  245 (292)
Q Consensus       234 ~l~hp~~~~~~~  245 (292)
                      +++||||+++.+
T Consensus       248 ll~h~~f~~~~~  259 (323)
T cd05571         248 IMEHRFFASINW  259 (323)
T ss_pred             HHcCCCcCCCCH
Confidence            999999998654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=3.1e-42  Score=295.92  Aligned_cols=235  Identities=34%  Similarity=0.665  Sum_probs=187.7

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      |+.++||||+++++++     .+....++||||++++|..++...   ...+++..++.++.||+.||.|||++ ||+|+
T Consensus        58 l~~l~h~nI~~~~~~~-----~~~~~~~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~-~i~H~  128 (301)
T cd07873          58 LKDLKHANIVTLHDII-----HTEKSLTLVFEYLDKDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRR-KVLHR  128 (301)
T ss_pred             HHhcCCCCcceEEEEE-----ecCCeEEEEEeccccCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCC
Confidence            3578999999999998     444468999999999998887653   35688999999999999999999987 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCC-CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      ||||+||+++.++ .++|+|||++....... ......+++.|+|||.+.+...++.++|+||+||++|+|++|..||.+
T Consensus       129 dlkp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~  207 (301)
T cd07873         129 DLKPQNLLINERG-ELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPG  207 (301)
T ss_pred             CCCHHHEEECCCC-cEEECcCcchhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999888 79999999987643222 122345688999999987766688999999999999999999999999


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCC--CCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNP--NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      .+..+....+....+.+....+.....  .+.....+....... ......+++++++||.+||+.||.+|||++++++|
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h  286 (301)
T cd07873         208 STVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCL-HNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH  286 (301)
T ss_pred             CCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccH-HhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            888888888888888887766654321  111222222211111 11224688999999999999999999999999999


Q ss_pred             CCccccCCC
Q 022799          238 PFFDELRDP  246 (292)
Q Consensus       238 p~~~~~~~~  246 (292)
                      |||+.+...
T Consensus       287 ~~f~~~~~~  295 (301)
T cd07873         287 PYFHCLGER  295 (301)
T ss_pred             cccccccch
Confidence            999987643

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.8e-42  Score=300.65  Aligned_cols=237  Identities=35%  Similarity=0.681  Sum_probs=188.0

Q ss_pred             CCCCCCCCeeeeceeeeccCC-CCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTE-KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~-~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++..... ......|++||+++++|.+++.     ...+++..++.++.||+.||.|||++ ||+|
T Consensus        68 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH  141 (343)
T cd07878          68 LKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSA-GIIH  141 (343)
T ss_pred             HHhcCCCchhhhhhhhcccccccccCcEEEEeecCCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-Ceec
Confidence            467899999999998753321 2224578999999999887765     35699999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      |||||+||+++.++ .+||+|||+++....  ......||+.|+|||++.+...++.++|+||+||++|+|++|..||.+
T Consensus       142 rdikp~Nil~~~~~-~~kl~Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  218 (343)
T cd07878         142 RDLKPSNVAVNEDC-ELRILDFGLARQADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG  218 (343)
T ss_pred             ccCChhhEEECCCC-CEEEcCCccceecCC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            99999999999888 799999999986533  234457899999999997755689999999999999999999999999


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccc---cCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF---KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      .+..+.+..+.+..+.+..+....+.......   ..+......+...+ ...++.+.+||.+||..||.+|||+.++++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         219 NDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIF-RGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             CCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhc-cCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            88888888888888888776655433221110   11111111222222 356788999999999999999999999999


Q ss_pred             CCCccccCCCC
Q 022799          237 HPFFDELRDPN  247 (292)
Q Consensus       237 hp~~~~~~~~~  247 (292)
                      ||||.....+.
T Consensus       298 hp~~~~~~~~~  308 (343)
T cd07878         298 HPYFSQYHDPE  308 (343)
T ss_pred             CcchhccCCCc
Confidence            99999876554

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.3e-42  Score=306.71  Aligned_cols=238  Identities=37%  Similarity=0.606  Sum_probs=187.0

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      |+.++||||+++++++...........|+||||+.++|.+.+..    ...+++..++.++.||+.||.|||++ ||+||
T Consensus        53 l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivH~  127 (372)
T cd07853          53 LCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHSA-GILHR  127 (372)
T ss_pred             HHhCCCCCcCCHhheecCCCccccceEEEEeeccccCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCC
Confidence            35689999999999985443222236899999999998887764    46789999999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCC--CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      ||||+||+++.++ .+||+|||++.......  ......+|+.|+|||.+.+...++.++|+||+||++|+|++|+.||.
T Consensus       128 dlkp~Nili~~~~-~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~  206 (372)
T cd07853         128 DIKPGNLLVNSNC-VLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQ  206 (372)
T ss_pred             CCChHHEEECCCC-CEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCC
Confidence            9999999999888 79999999987653322  12234678999999999776668999999999999999999999999


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCC-CCCCchh--hhccCCChhHHHHHHHHhccCCCCcccHHHHh
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI-KAHPWHK--IFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL  235 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l  235 (292)
                      +.+..+++..+.+.++.++.+.+............... .......  .+....++++.+||.+||+.||.+|||+.+++
T Consensus       207 ~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l  286 (372)
T cd07853         207 AQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADAL  286 (372)
T ss_pred             CCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHh
Confidence            99999999999999999887765432211110000000 0000010  12245688999999999999999999999999


Q ss_pred             cCCCccccC
Q 022799          236 IHPFFDELR  244 (292)
Q Consensus       236 ~hp~~~~~~  244 (292)
                      +||||+...
T Consensus       287 ~hp~~~~~~  295 (372)
T cd07853         287 AHPYLDEGR  295 (372)
T ss_pred             cCHhhCCCc
Confidence            999998743

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=3.2e-43  Score=285.22  Aligned_cols=237  Identities=39%  Similarity=0.667  Sum_probs=190.4

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKM-SQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~-~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      ++.++||||+.+..+|.+.    +..++|++||.+-+|..+|..++.. ...++...++.+++||+.|+.|||++ -|+|
T Consensus        81 ~REl~h~nvi~Lv~Vfl~~----d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N-WvlH  155 (438)
T KOG0666|consen   81 LRELKHPNVISLVKVFLSH----DKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN-WVLH  155 (438)
T ss_pred             HHHhcCCcchhHHHHHhcc----CceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh-heee
Confidence            3678999999999999653    3459999999999999999866443 35689999999999999999999998 8999


Q ss_pred             cCCCCCcEEEeCC----CCcEEEeecCCccccccCCC----cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHH
Q 022799           80 RDIKPQNLLVNPH----THQLKLCDFGSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL  151 (292)
Q Consensus        80 ~dlkp~Nill~~~----~~~ikl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~  151 (292)
                      |||||.||++..+    | .|||+|||+++.+.+.-.    ....+.|.+|+|||++.|...|+.+.|+||+|||+.||+
T Consensus       156 RDLKPaNIlvmgdgperG-~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElL  234 (438)
T KOG0666|consen  156 RDLKPANILVMGDGPERG-RVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELL  234 (438)
T ss_pred             ccCCcceEEEeccCCccC-eeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHH
Confidence            9999999999877    5 899999999998754322    234567999999999999999999999999999999999


Q ss_pred             hCCCCCCCCC---------cHHHHHHHHHHhCCCCHHHHhhcC--CCCcc----ccCCCCCCCCchhhhc--cCCChhHH
Q 022799          152 LGQPLFPGES---------GVDQLVEIIKVLGTPTREEIKCMN--PNYTE----FKFPQIKAHPWHKIFQ--KRMPPEAV  214 (292)
Q Consensus       152 ~g~~pf~~~~---------~~~~~~~i~~~~~~~~~~~~~~~~--~~~~~----~~~~~~~~~~~~~~~~--~~~~~~~~  214 (292)
                      |-.+.|.+..         ..+++.+|++.+|.|+...|..+.  |++..    +.........+...+.  ..-++...
T Consensus       235 tl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~  314 (438)
T KOG0666|consen  235 TLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSAL  314 (438)
T ss_pred             ccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHH
Confidence            9999997642         357899999999999999887663  33210    1111111111111111  22356699


Q ss_pred             HHHHHHhccCCCCcccHHHHhcCCCcccc
Q 022799          215 DLVSRLLQYSPNLRSTALEALIHPFFDEL  243 (292)
Q Consensus       215 ~li~~~l~~dp~~R~t~~e~l~hp~~~~~  243 (292)
                      +|+.+||.+||.+|+|++++|+|+||..-
T Consensus       315 ~LL~klL~yDP~kRIta~qAleh~yF~~d  343 (438)
T KOG0666|consen  315 DLLQKLLTYDPIKRITAEQALEHPYFTED  343 (438)
T ss_pred             HHHHHHhccCchhhccHHHHhcccccccC
Confidence            99999999999999999999999999864

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.6e-43  Score=273.73  Aligned_cols=202  Identities=32%  Similarity=0.475  Sum_probs=177.4

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      +.|+||||++++++|     -+...+||++||.. |.+...++...  ..++++..+..|+.|++.||.|+|.+ +++||
T Consensus        77 s~L~hpnilrlY~~f-----hd~~riyLilEya~~gel~k~L~~~~--~~~f~e~~~a~Yi~q~A~Al~y~h~k-~VIhR  148 (281)
T KOG0580|consen   77 SHLRHPNILRLYGYF-----HDSKRIYLILEYAPRGELYKDLQEGR--MKRFDEQRAATYIKQLANALLYCHLK-RVIHR  148 (281)
T ss_pred             cccCCccHHhhhhhe-----eccceeEEEEEecCCchHHHHHHhcc--cccccccchhHHHHHHHHHHHHhccC-CcccC
Confidence            468999999999999     55556999999998 89998887432  46799999999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE  160 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  160 (292)
                      ||||+|+|++..+ .+||+|||.+.... .....+.+||..|.+||+..+. .++..+|+|++|++.||++.|.+||.+.
T Consensus       149 diKpenlLlg~~~-~lkiAdfGwsV~~p-~~kR~tlcgt~dyl~pEmv~~~-~hd~~Vd~w~lgvl~yeflvg~ppFes~  225 (281)
T KOG0580|consen  149 DIKPENLLLGSAG-ELKIADFGWSVHAP-SNKRKTLCGTLDYLPPEMVEGR-GHDKFVDLWSLGVLCYEFLVGLPPFESQ  225 (281)
T ss_pred             CCCHHHhccCCCC-CeeccCCCceeecC-CCCceeeecccccCCHhhcCCC-CccchhhHHHHHHHHHHHHhcCCchhhh
Confidence            9999999999988 79999999987654 4456678999999999999765 4899999999999999999999999999


Q ss_pred             CcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCCc
Q 022799          161 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  240 (292)
Q Consensus       161 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~~  240 (292)
                      +..+.+++|.+.-                 .            .+|..++..++|+|.+||.++|.+|.+..|++.|||+
T Consensus       226 ~~~etYkrI~k~~-----------------~------------~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI  276 (281)
T KOG0580|consen  226 SHSETYKRIRKVD-----------------L------------KFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWI  276 (281)
T ss_pred             hhHHHHHHHHHcc-----------------c------------cCCcccChhHHHHHHHHhccCccccccHHHHhhhHHH
Confidence            8888888877641                 1            2336789999999999999999999999999999999


Q ss_pred             ccc
Q 022799          241 DEL  243 (292)
Q Consensus       241 ~~~  243 (292)
                      ...
T Consensus       277 ~a~  279 (281)
T KOG0580|consen  277 VAN  279 (281)
T ss_pred             Hhc
Confidence            753

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-42  Score=297.40  Aligned_cols=203  Identities=28%  Similarity=0.445  Sum_probs=170.1

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++     .+..++|+||||++ |+|.+++..    .+.+++..++.++.||+.||.|||++ ||+|
T Consensus        55 l~~l~hp~iv~~~~~~-----~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H  124 (291)
T cd05612          55 LKEVSHPFIIRLFWTE-----HDQRFLYMLMEYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSK-EIVY  124 (291)
T ss_pred             HHhCCCCcHhhhHhhh-----ccCCeEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-Ceee
Confidence            4678999999999988     45556999999998 689888875    35689999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      |||||+||+++.++ .+||+|||++......  .....||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+
T Consensus       125 ~dlkp~NIli~~~~-~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~l~~g~~pf~~  200 (291)
T cd05612         125 RDLKPENILLDKEG-HIKLTDFGFAKKLRDR--TWTLCGTPEYLAPEVIQSK-GHNKAVDWWALGILIYEMLVGYPPFFD  200 (291)
T ss_pred             cCCCHHHeEECCCC-CEEEEecCcchhccCC--cccccCChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            99999999999888 7999999999866332  2345789999999998654 489999999999999999999999988


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCccc-----HHHH
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----ALEA  234 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t-----~~e~  234 (292)
                      .+.......+....                 .            .++..+++.++++|++||+.||.+|++     ++++
T Consensus       201 ~~~~~~~~~i~~~~-----------------~------------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~  251 (291)
T cd05612         201 DNPFGIYEKILAGK-----------------L------------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDV  251 (291)
T ss_pred             CCHHHHHHHHHhCC-----------------c------------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHH
Confidence            77665555544310                 0            122457889999999999999999995     9999


Q ss_pred             hcCCCccccCCC
Q 022799          235 LIHPFFDELRDP  246 (292)
Q Consensus       235 l~hp~~~~~~~~  246 (292)
                      ++||||+.+.+.
T Consensus       252 l~h~~~~~~~~~  263 (291)
T cd05612         252 KNHRWFKSVDWD  263 (291)
T ss_pred             hcCccccCCCHH
Confidence            999999986643

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-42  Score=298.74  Aligned_cols=203  Identities=32%  Similarity=0.531  Sum_probs=167.6

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++     .+....|+||||++ |+|.+++..    ...+++..++.++.||+.||.|||++ ||+|
T Consensus        47 l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H  116 (312)
T cd05585          47 LAQVNCPFIVPLKFSF-----QSPEKLYLVLAFINGGELFHHLQR----EGRFDLSRARFYTAELLCALENLHKF-NVIY  116 (312)
T ss_pred             HHhCCCCcEeceeeEE-----ecCCeEEEEEcCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEe
Confidence            3578999999999988     44456899999998 688888865    35689999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccC-CCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      |||||+||+++.++ .++|+|||+++..... .......||+.|+|||++.+. .++.++|+||+||++|+|++|..||.
T Consensus       117 rDlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~  194 (312)
T cd05585         117 RDLKPENILLDYQG-HIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGH-GYTKAVDWWTLGVLLYEMLTGLPPFY  194 (312)
T ss_pred             CCCCHHHeEECCCC-cEEEEECcccccCccCCCccccccCCcccCCHHHHcCC-CCCCccceechhHHHHHHHhCCCCcC
Confidence            99999999999888 7999999998754222 223345789999999999664 48999999999999999999999998


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcc---cHHHHh
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS---TALEAL  235 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~---t~~e~l  235 (292)
                      +.+.......+...                 .            ..++..++++++++|.+||..||.+|+   ++.+++
T Consensus       195 ~~~~~~~~~~~~~~-----------------~------------~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l  245 (312)
T cd05585         195 DENVNEMYRKILQE-----------------P------------LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIK  245 (312)
T ss_pred             CCCHHHHHHHHHcC-----------------C------------CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence            77665544443321                 0            012246789999999999999999997   589999


Q ss_pred             cCCCccccC
Q 022799          236 IHPFFDELR  244 (292)
Q Consensus       236 ~hp~~~~~~  244 (292)
                      .||||+...
T Consensus       246 ~hp~~~~~~  254 (312)
T cd05585         246 NHPFFSQLS  254 (312)
T ss_pred             cCCCcCCCC
Confidence            999999864

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7e-43  Score=300.98  Aligned_cols=207  Identities=31%  Similarity=0.503  Sum_probs=182.4

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      ++++.|||||.+++.|+    .++.++||||+||+ |++.+.+....  +..+++..+..|+.|++.|+.|||++ +|+|
T Consensus        57 is~~~hP~iv~y~ds~~----~~~~~l~Ivm~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~-~iLH  129 (426)
T KOG0589|consen   57 LSKLLHPNIVEYKDSFE----EDGQLLCIVMEYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN-RVLH  129 (426)
T ss_pred             HHhccCCCeeeeccchh----cCCceEEEEEeecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh-hhhc
Confidence            36799999999999994    33345999999999 69988887654  56799999999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCC-CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      ||||+.||+++.++ .|+|+|||+|+...... ...+.+|||.|++||++.+. .|+.++|+|||||++|||++-+++|.
T Consensus       130 RDlK~~Nifltk~~-~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~-pYn~KSDiWsLGC~~yEm~~lk~aF~  207 (426)
T KOG0589|consen  130 RDLKCANIFLTKDK-KVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDI-PYNEKSDIWSLGCCLYEMCTLKPAFK  207 (426)
T ss_pred             ccchhhhhhccccC-ceeecchhhhhhcCCchhhhheecCCCcccCHHHhCCC-CCCccCcchhhcchHHHHHhcccccC
Confidence            99999999999998 68999999999987665 56778999999999999765 49999999999999999999999999


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCC
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  238 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp  238 (292)
                      +.+-.....+|.+....|                            ++..++.+++.+|+.||..+|..||++.++|.+|
T Consensus       208 a~~m~~Li~ki~~~~~~P----------------------------lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P  259 (426)
T KOG0589|consen  208 ASNMSELILKINRGLYSP----------------------------LPSMYSSELRSLVKSMLRKNPEHRPSALELLRRP  259 (426)
T ss_pred             ccchHHHHHHHhhccCCC----------------------------CCccccHHHHHHHHHHhhcCCccCCCHHHHhhCh
Confidence            999888888888765333                            2357899999999999999999999999999999


Q ss_pred             CccccC
Q 022799          239 FFDELR  244 (292)
Q Consensus       239 ~~~~~~  244 (292)
                      ......
T Consensus       260 ~l~~~~  265 (426)
T KOG0589|consen  260 HLLRYL  265 (426)
T ss_pred             hhhhHH
Confidence            887543

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-42  Score=296.85  Aligned_cols=202  Identities=29%  Similarity=0.451  Sum_probs=168.1

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCC-cc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG-VC   78 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~-i~   78 (292)
                      |++++|||||++++++..+..    .+++||||++ |+|.+++...  ....++...+..++.||+.|+.|||++ + ||
T Consensus        93 l~~l~HpNIV~f~G~~~~~~~----~~~iVtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~-~~iI  165 (362)
T KOG0192|consen   93 LSRLRHPNIVQFYGACTSPPG----SLCIVTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE-GPII  165 (362)
T ss_pred             HHhCCCCCeeeEEEEEcCCCC----ceEEEEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC-CCee
Confidence            467999999999999844331    4899999999 7999998763  246799999999999999999999998 9 99


Q ss_pred             ccCCCCCcEEEeCCCCcEEEeecCCccccccC-CCcccccccccccCCccccC-CCCCCchhHhhhhhHHHHHHHhCCCC
Q 022799           79 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNISYICSRYYRAPELIFG-ATEYTAAIDIWSAGCVLAELLLGQPL  156 (292)
Q Consensus        79 H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DvwslG~il~el~~g~~p  156 (292)
                      ||||||+|||++.+...+||+|||+++..... .......||+.|||||++.+ ...|+.++||||+|+++|||+||..|
T Consensus       166 HrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~P  245 (362)
T KOG0192|consen  166 HRDLKSDNILVDLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIP  245 (362)
T ss_pred             ecccChhhEEEcCCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCC
Confidence            99999999999988546999999999876544 23334689999999999974 34599999999999999999999999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      |.+.........+.....+|.                           ++..+++.+.++|.+||..||.+||+..+++.
T Consensus       246 f~~~~~~~~~~~v~~~~~Rp~---------------------------~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  246 FEDLAPVQVASAVVVGGLRPP---------------------------IPKECPPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             CCCCCHHHHHHHHHhcCCCCC---------------------------CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence            999888665555554322222                           22458899999999999999999999998863

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-42  Score=300.30  Aligned_cols=208  Identities=34%  Similarity=0.585  Sum_probs=176.1

Q ss_pred             CCCCC-CCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcc
Q 022799            1 MRLLD-HPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVC   78 (292)
Q Consensus         1 L~~l~-HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~   78 (292)
                      |+++. |||||+++++|     ++...+++|||+|. |.|.+.+...     .+++..+..++.||+.|+.|||+. ||+
T Consensus        89 l~~l~~hpniv~l~~~~-----e~~~~~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~-gvv  157 (382)
T KOG0032|consen   89 LQQLSGHPNIVQLKDAF-----EDPDSVYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL-GVV  157 (382)
T ss_pred             HHhccCCCCEEEEEEEE-----EcCCeEEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC-Cce
Confidence            46777 99999999999     44445999999999 6888888754     399999999999999999999987 999


Q ss_pred             ccCCCCCcEEEeCCC---CcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCC
Q 022799           79 HRDIKPQNLLVNPHT---HQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQP  155 (292)
Q Consensus        79 H~dlkp~Nill~~~~---~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~  155 (292)
                      ||||||+|+|+....   +.+|++|||++.....+......+||+.|+|||++.+ ..|+..+|+||+|+++|.|++|.+
T Consensus       158 HrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~  236 (382)
T KOG0032|consen  158 HRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVP  236 (382)
T ss_pred             eccCCHHHeeeccccCCCCcEEEeeCCCceEccCCceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCC
Confidence            999999999995432   3799999999999877666778899999999999954 459999999999999999999999


Q ss_pred             CCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHh
Q 022799          156 LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL  235 (292)
Q Consensus       156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l  235 (292)
                      ||.+.+.......+...-.            .+        ....|     +.++..++++|++||..||.+|+|+.++|
T Consensus       237 PF~~~~~~~~~~~i~~~~~------------~f--------~~~~w-----~~is~~akd~i~~ll~~dp~~R~ta~~~L  291 (382)
T KOG0032|consen  237 PFWGETEFEIFLAILRGDF------------DF--------TSEPW-----DDISESAKDFIRKLLEFDPRKRLTAAQAL  291 (382)
T ss_pred             CCcCCChhHHHHHHHcCCC------------CC--------CCCCc-----cccCHHHHHHHHHhcccCcccCCCHHHHh
Confidence            9999988777776554311            11        11111     46899999999999999999999999999


Q ss_pred             cCCCccccCC
Q 022799          236 IHPFFDELRD  245 (292)
Q Consensus       236 ~hp~~~~~~~  245 (292)
                      +|||+++...
T Consensus       292 ~HpWi~~~~~  301 (382)
T KOG0032|consen  292 QHPWIKSIGE  301 (382)
T ss_pred             cCccccCCcc
Confidence            9999987643

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.5e-42  Score=294.25  Aligned_cols=211  Identities=23%  Similarity=0.361  Sum_probs=169.2

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++     .+..+.++||||++ |+|...+...  ....+++..+..++.|++.||.|||++ ||+|
T Consensus        54 l~~l~~~~iv~~~~~~-----~~~~~~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~-~iiH  125 (285)
T cd05631          54 LEKVNSRFVVSLAYAY-----ETKDALCLVLTIMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRE-RIVY  125 (285)
T ss_pred             HHhcCCCcEEEEEEEE-----ccCCeEEEEEEecCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhC-CEEe
Confidence            3568999999999988     44446999999998 6887776532  134689999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      |||||+||+++.++ .++|+|||++.............||+.|+|||++.+. .++.++|+||+||++|+|++|+.||.+
T Consensus       126 ~dikp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~  203 (285)
T cd05631         126 RDLKPENILLDDRG-HIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNE-KYTFSPDWWGLGCLIYEMIQGQSPFRK  203 (285)
T ss_pred             CCCCHHHEEECCCC-CEEEeeCCCcEEcCCCCeecCCCCCCCccCHhhhcCC-CCCcccCchhHHHHHHHHHhCCCCCCC
Confidence            99999999999887 7999999999876444444456789999999999764 589999999999999999999999987


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCccc-----HHHH
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----ALEA  234 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t-----~~e~  234 (292)
                      .+.......+......+.                         ..++..+++++.+||++||..||.+|++     ++++
T Consensus       204 ~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~  258 (285)
T cd05631         204 RKERVKREEVDRRVKEDQ-------------------------EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGV  258 (285)
T ss_pred             CCcchhHHHHHHHhhccc-------------------------ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHH
Confidence            654332222222111100                         0122468899999999999999999997     8999


Q ss_pred             hcCCCccccCCC
Q 022799          235 LIHPFFDELRDP  246 (292)
Q Consensus       235 l~hp~~~~~~~~  246 (292)
                      ++||||+++++.
T Consensus       259 ~~h~~~~~~~~~  270 (285)
T cd05631         259 KQHPIFKNINFK  270 (285)
T ss_pred             hcCHhhcCCCHH
Confidence            999999987643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.2e-41  Score=289.69  Aligned_cols=229  Identities=34%  Similarity=0.585  Sum_probs=179.2

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      |++++||||+++++++     .+...+++|+||++++|.+.+...   ...+++..++.++.||+.||.|||++ ||+||
T Consensus        53 l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~-~i~H~  123 (284)
T cd07839          53 LKELKHKNIVRLYDVL-----HSDKKLTLVFEYCDQDLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSH-NVLHR  123 (284)
T ss_pred             HHhcCCCCeeeHHHHh-----ccCCceEEEEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CEecC
Confidence            3568999999999998     444568999999999988877643   35689999999999999999999987 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCC-cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCC-CC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPL-FP  158 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~p-f~  158 (292)
                      ||||+||+++.++ .++|+|||.+........ .....+++.|+|||.+.+...++.++|+||+||++|+|++|..| |.
T Consensus       124 dl~~~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~  202 (284)
T cd07839         124 DLKPQNLLINKNG-ELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP  202 (284)
T ss_pred             CCCHHHEEEcCCC-cEEECccchhhccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcC
Confidence            9999999999887 799999999876533222 22345688999999987766679999999999999999998877 45


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCC-CchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH-PWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      +.+..+.+..+.+..+.+....+............+..... .|.. ..+.++++++++|.+||..||.+|||+++++.|
T Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h  281 (284)
T cd07839         203 GNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVN-VVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH  281 (284)
T ss_pred             CCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhh-hcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence            66666777788888887776655433211111111111111 1111 224688999999999999999999999999999


Q ss_pred             CCc
Q 022799          238 PFF  240 (292)
Q Consensus       238 p~~  240 (292)
                      |||
T Consensus       282 ~~f  284 (284)
T cd07839         282 PYF  284 (284)
T ss_pred             CCC
Confidence            998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.3e-42  Score=303.46  Aligned_cols=231  Identities=25%  Similarity=0.372  Sum_probs=173.5

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      |++|+|||||+++++|     ......++|||++.++|...+..    ...+++..++.++.||+.||.|||++ ||+||
T Consensus       137 l~~l~HpnIv~~~~~~-----~~~~~~~lv~e~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~-~IvHr  206 (391)
T PHA03212        137 LRAINHPSIIQLKGTF-----TYNKFTCLILPRYKTDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHEN-RIIHR  206 (391)
T ss_pred             HHhCCCCCCCCEeEEE-----EECCeeEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccC
Confidence            4678999999999998     33445899999999998888765    35688999999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccC--CCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      ||||+||+++.++ .+||+|||+++.....  .......||+.|+|||++.+. .++.++|+||+||++|+|++|..||.
T Consensus       207 DiKP~NIll~~~~-~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~  284 (391)
T PHA03212        207 DIKAENIFINHPG-DVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARD-PYGPAVDIWSAGIVLFEMATCHDSLF  284 (391)
T ss_pred             CCChHhEEEcCCC-CEEEEeCCcccccccccccccccccCccCCCChhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence            9999999999888 7999999998653221  222345789999999999664 58999999999999999999998775


Q ss_pred             CCC-------cHHHHHHHHHHhCCCCHHHHhhcCCC----C----ccccCCCCCCCCchhhhccCCChhHHHHHHHHhcc
Q 022799          159 GES-------GVDQLVEIIKVLGTPTREEIKCMNPN----Y----TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQY  223 (292)
Q Consensus       159 ~~~-------~~~~~~~i~~~~~~~~~~~~~~~~~~----~----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  223 (292)
                      +..       ...++..+....+.++.+........    +    ............|...  ..++.++.+||.+||++
T Consensus       285 ~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~Li~~mL~~  362 (391)
T PHA03212        285 EKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNL--YELPIDLEYLICKMLAF  362 (391)
T ss_pred             CcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHH--hhhhhhHHHHHHHHhcC
Confidence            432       34566677777766553321000000    0    0000000001111111  24677899999999999


Q ss_pred             CCCCcccHHHHhcCCCccccCC
Q 022799          224 SPNLRSTALEALIHPFFDELRD  245 (292)
Q Consensus       224 dp~~R~t~~e~l~hp~~~~~~~  245 (292)
                      ||.+|||++|+|+||||+++..
T Consensus       363 dP~~Rpta~elL~hp~f~~~~~  384 (391)
T PHA03212        363 DAHHRPSAEALLDFAAFQDIPD  384 (391)
T ss_pred             ChhhCCCHHHHhcChhhccCCC
Confidence            9999999999999999987643

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=3.6e-42  Score=297.95  Aligned_cols=201  Identities=29%  Similarity=0.506  Sum_probs=166.8

Q ss_pred             CCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCC
Q 022799            4 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDI   82 (292)
Q Consensus         4 l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dl   82 (292)
                      .+||||+++++++     .+...+|+||||++ |+|...+..    ...+++..+..++.|++.||.|||++ ||+||||
T Consensus        53 ~~h~~iv~~~~~~-----~~~~~~~iv~Ey~~~g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~-~ivH~dl  122 (320)
T cd05590          53 RNHPFLTQLYCCF-----QTPDRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDK-GIIYRDL  122 (320)
T ss_pred             cCCCchhceeeEE-----EcCCEEEEEEcCCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCC
Confidence            4799999999998     44445899999998 688877764    35789999999999999999999988 9999999


Q ss_pred             CCCcEEEeCCCCcEEEeecCCcccccc-CCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCCC
Q 022799           83 KPQNLLVNPHTHQLKLCDFGSAKVLVK-GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES  161 (292)
Q Consensus        83 kp~Nill~~~~~~ikl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~  161 (292)
                      ||+||+++.++ .++|+|||+++.... ........||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+.+
T Consensus       123 kp~NIli~~~~-~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~  200 (320)
T cd05590         123 KLDNVLLDHEG-HCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEM-LYGPSVDWWAMGVLLYEMLCGHAPFEAEN  200 (320)
T ss_pred             CHHHeEECCCC-cEEEeeCCCCeecCcCCCcccccccCccccCHHHHcCC-CCCCccchhhhHHHHHHHhhCCCCCCCCC
Confidence            99999999888 799999999875422 2223445789999999999654 48999999999999999999999998877


Q ss_pred             cHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccH------HHHh
Q 022799          162 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA------LEAL  235 (292)
Q Consensus       162 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~------~e~l  235 (292)
                      ..+....+....                 .            .++..++.++.++|++||+.||.+|+++      ++++
T Consensus       201 ~~~~~~~i~~~~-----------------~------------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~  251 (320)
T cd05590         201 EDDLFEAILNDE-----------------V------------VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAIL  251 (320)
T ss_pred             HHHHHHHHhcCC-----------------C------------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHH
Confidence            666555443210                 0            0124578899999999999999999998      9999


Q ss_pred             cCCCccccCC
Q 022799          236 IHPFFDELRD  245 (292)
Q Consensus       236 ~hp~~~~~~~  245 (292)
                      +||||+.+.+
T Consensus       252 ~h~~f~~~~~  261 (320)
T cd05590         252 RHPFFKELDW  261 (320)
T ss_pred             cCCCcCCCCH
Confidence            9999998754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-43  Score=322.88  Aligned_cols=252  Identities=29%  Similarity=0.474  Sum_probs=200.8

Q ss_pred             CCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCC
Q 022799            4 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDI   82 (292)
Q Consensus         4 l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dl   82 (292)
                      .+.+-||++...|     +|+.++|+||||++ |+|..++..+    .++++..+++|+..|+.||.-||+- |+|||||
T Consensus       132 ~ns~Wiv~LhyAF-----QD~~~LYlVMdY~pGGDlltLlSk~----~~~pE~~ArFY~aEiVlAldslH~m-gyVHRDi  201 (1317)
T KOG0612|consen  132 GNSEWIVQLHYAF-----QDERYLYLVMDYMPGGDLLTLLSKF----DRLPEDWARFYTAEIVLALDSLHSM-GYVHRDI  201 (1317)
T ss_pred             CCcHHHHHHHHHh-----cCccceEEEEecccCchHHHHHhhc----CCChHHHHHHHHHHHHHHHHHHHhc-cceeccC
Confidence            3456689998888     88889999999998 6999999875    3899999999999999999999976 9999999


Q ss_pred             CCCcEEEeCCCCcEEEeecCCccccccCCC--cccccccccccCCccccC----CCCCCchhHhhhhhHHHHHHHhCCCC
Q 022799           83 KPQNLLVNPHTHQLKLCDFGSAKVLVKGEP--NISYICSRYYRAPELIFG----ATEYTAAIDIWSAGCVLAELLLGQPL  156 (292)
Q Consensus        83 kp~Nill~~~~~~ikl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslG~il~el~~g~~p  156 (292)
                      ||+|||++.+|| |||+|||.+-.+..++.  ....+|||.|.|||++..    ...|++.+|+||+||++|||+.|..|
T Consensus       202 KPDNvLld~~GH-ikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TP  280 (1317)
T KOG0612|consen  202 KPDNVLLDKSGH-IKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETP  280 (1317)
T ss_pred             CcceeEecccCc-EeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCc
Confidence            999999999995 99999999988754432  345689999999999843    24589999999999999999999999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCccc---HHH
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST---ALE  233 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t---~~e  233 (292)
                      |++++-.+.+.+|+..-               ..+.+|..          ..+|+++++||+++++ +|..|.+   +++
T Consensus       281 FYadslveTY~KIm~hk---------------~~l~FP~~----------~~VSeeakdLI~~ll~-~~e~RLgrngied  334 (1317)
T KOG0612|consen  281 FYADSLVETYGKIMNHK---------------ESLSFPDE----------TDVSEEAKDLIEALLC-DREVRLGRNGIED  334 (1317)
T ss_pred             chHHHHHHHHHHHhchh---------------hhcCCCcc----------cccCHHHHHHHHHHhc-ChhhhcccccHHH
Confidence            99999999999988741               11223311          3589999999999887 8888888   999


Q ss_pred             HhcCCCccccCCCCCCCCCCCCCCCC------CCCChhccCCCCHHHHhhhchHHH-HhhhhhcCC
Q 022799          234 ALIHPFFDELRDPNTRLPNGRFLPPL------FNFKPHELKGVPVDMLVKLIPEHA-RKQCAFLGL  292 (292)
Q Consensus       234 ~l~hp~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  292 (292)
                      +.+||||.++.|...+-..++++|.+      .||...+-.....+..+...+... +++-.|.||
T Consensus       335 ik~HpFF~g~~W~~iR~~~pP~vPevssd~DTsnFd~~~dd~~~~e~~p~~~~~~f~Gn~LPFIGf  400 (1317)
T KOG0612|consen  335 IKNHPFFEGIDWDNIRESVPPVVPEVSSDDDTSNFDVDEDDLRDAETFPPRIPKAFSGNHLPFIGF  400 (1317)
T ss_pred             HHhCccccCCChhhhhhcCCCCCCcCCCCCccccccccccccchhhccCCCCCCCCcCCcCCeeee
Confidence            99999999999876666665666555      444333333334444444444433 666677776

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=5.8e-42  Score=297.59  Aligned_cols=204  Identities=27%  Similarity=0.430  Sum_probs=166.9

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++     .+...+|+||||++ |+|...+..    ...+++..++.++.||+.||.|||++ ||+|
T Consensus        49 l~~l~hp~iv~~~~~~-----~~~~~~~lv~Ey~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivH  118 (328)
T cd05593          49 LKNTRHPFLTSLKYSF-----QTKDRLCFVMEYVNGGELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSG-KIVY  118 (328)
T ss_pred             HHhCCCCCCcceEEEE-----EcCCEEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEe
Confidence            4678999999999988     44456999999998 688777654    35689999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccC-CCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      |||||+||+++.++ .+||+|||+++..... .......||+.|+|||++.+. .++.++|+||+||++|+|++|..||.
T Consensus       119 rDikp~NIll~~~~-~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~Pf~  196 (328)
T cd05593         119 RDLKLENLMLDKDG-HIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFY  196 (328)
T ss_pred             cccCHHHeEECCCC-cEEEecCcCCccCCCcccccccccCCcCccChhhhcCC-CCCccCCccccchHHHHHhhCCCCCC
Confidence            99999999999888 7999999998754222 222345789999999999654 48999999999999999999999998


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcc-----cHHH
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALE  233 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----t~~e  233 (292)
                      +.+.......+...                 ..            .++..+++++.++|++||..||++|+     ++.+
T Consensus       197 ~~~~~~~~~~~~~~-----------------~~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~  247 (328)
T cd05593         197 NQDHEKLFELILME-----------------DI------------KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKE  247 (328)
T ss_pred             CCCHHHHHHHhccC-----------------Cc------------cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHH
Confidence            76654443332210                 00            12346889999999999999999997     8999


Q ss_pred             HhcCCCccccCC
Q 022799          234 ALIHPFFDELRD  245 (292)
Q Consensus       234 ~l~hp~~~~~~~  245 (292)
                      +++||||.+..+
T Consensus       248 il~h~~~~~~~~  259 (328)
T cd05593         248 IMRHSFFTGVNW  259 (328)
T ss_pred             HhcCCCcCCCCH
Confidence            999999987643

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=7.4e-42  Score=296.34  Aligned_cols=204  Identities=27%  Similarity=0.436  Sum_probs=167.7

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||++++++|     .....+|+||||++ |+|...+..    ...+++..++.++.||+.||.|||++ ||+|
T Consensus        49 l~~l~hp~i~~~~~~~-----~~~~~~~lv~E~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH  118 (323)
T cd05595          49 LQNTRHPFLTALKYAF-----QTHDRLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR-DVVY  118 (323)
T ss_pred             HHhCCCCCCcceeeEE-----ecCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEe
Confidence            4578999999999998     44446999999998 688777654    35789999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccC-CCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      |||||+||+++.++ .+||+|||++...... .......||+.|+|||++.+. .++.++|+||+||++|+|++|..||.
T Consensus       119 ~Dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~g~~Pf~  196 (323)
T cd05595         119 RDIKLENLMLDKDG-HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFY  196 (323)
T ss_pred             cCCCHHHEEEcCCC-CEEecccHHhccccCCCCccccccCCcCcCCcccccCC-CCCchhchhhhHHHHHHHHhCCCCCC
Confidence            99999999999888 7999999998753222 222345789999999999654 48999999999999999999999998


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcc-----cHHH
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALE  233 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----t~~e  233 (292)
                      +.+.......+...                 ..            .++..+++++.++|.+||..||.+|+     ++.+
T Consensus       197 ~~~~~~~~~~~~~~-----------------~~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~  247 (323)
T cd05595         197 NQDHERLFELILME-----------------EI------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKE  247 (323)
T ss_pred             CCCHHHHHHHHhcC-----------------CC------------CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHH
Confidence            77665544443321                 00            12246889999999999999999998     8999


Q ss_pred             HhcCCCccccCC
Q 022799          234 ALIHPFFDELRD  245 (292)
Q Consensus       234 ~l~hp~~~~~~~  245 (292)
                      +++||||.+..+
T Consensus       248 ~l~h~~~~~~~~  259 (323)
T cd05595         248 VMEHRFFLSINW  259 (323)
T ss_pred             HHcCCCcCCCCH
Confidence            999999987653

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=3.1e-41  Score=291.59  Aligned_cols=235  Identities=32%  Similarity=0.575  Sum_probs=174.5

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhh-----cCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYK-----MSQRMPLIYVKLYFYQICRALAYIHNTI   75 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~-----~~~~~~~~~~~~~~~qil~al~~LH~~~   75 (292)
                      |+.++||||+++++++...   +...+++||||++++|.+++.....     ....+++..++.++.||+.||.|||++ 
T Consensus        52 l~~l~h~niv~~~~~~~~~---~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~-  127 (317)
T cd07867          52 LRELKHPNVIALQKVFLSH---SDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN-  127 (317)
T ss_pred             HHhCCCCCeeeEEEEEecc---CCCeEEEEEeeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC-
Confidence            4578999999999988543   2345889999999999888764321     123588999999999999999999988 


Q ss_pred             CccccCCCCCcEEEe----CCCCcEEEeecCCccccccCCC----cccccccccccCCccccCCCCCCchhHhhhhhHHH
Q 022799           76 GVCHRDIKPQNLLVN----PHTHQLKLCDFGSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVL  147 (292)
Q Consensus        76 ~i~H~dlkp~Nill~----~~~~~ikl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il  147 (292)
                      ||+||||||+||++.    .++ .+||+|||+++.......    .....+|+.|+|||++.+...++.++|+||+||++
T Consensus       128 ~ivH~Dlkp~Nil~~~~~~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il  206 (317)
T cd07867         128 WVLHRDLKPANILVMGEGPERG-RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIF  206 (317)
T ss_pred             CEEcCCCCHHHEEEccCCCCCC-cEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHH
Confidence            999999999999993    334 799999999986543221    22356799999999997766689999999999999


Q ss_pred             HHHHhCCCCCCCCCc---------HHHHHHHHHHhCCCCHHHHhhcCCC--Cccc----cCCCCCCCCc---hhhhccCC
Q 022799          148 AELLLGQPLFPGESG---------VDQLVEIIKVLGTPTREEIKCMNPN--YTEF----KFPQIKAHPW---HKIFQKRM  209 (292)
Q Consensus       148 ~el~~g~~pf~~~~~---------~~~~~~i~~~~~~~~~~~~~~~~~~--~~~~----~~~~~~~~~~---~~~~~~~~  209 (292)
                      |+|+||.+||.....         ..++.++...++.+..+.+......  +...    ..........   ........
T Consensus       207 ~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  286 (317)
T cd07867         207 AELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKP  286 (317)
T ss_pred             HHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCC
Confidence            999999999975432         3556677777787776665443211  1100    0000000000   01111234


Q ss_pred             ChhHHHHHHHHhccCCCCcccHHHHhcCCCc
Q 022799          210 PPEAVDLVSRLLQYSPNLRSTALEALIHPFF  240 (292)
Q Consensus       210 ~~~~~~li~~~l~~dp~~R~t~~e~l~hp~~  240 (292)
                      +..+.+||.+||+.||.+|||++|+|+||||
T Consensus       287 ~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         287 DSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             ChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            6779999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.5e-41  Score=288.66  Aligned_cols=213  Identities=23%  Similarity=0.349  Sum_probs=168.5

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++.+++     .....+|+||||++ |+|...+.........+++..+..++.||+.||.|||++ ||+|
T Consensus        47 l~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H  120 (280)
T cd05608          47 LAKVHSRFIVSLAYAF-----QTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR-RIIY  120 (280)
T ss_pred             HHhCCCCcEeeeeEEE-----cCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC-Cccc
Confidence            4578999999999988     44455899999998 688877754433456799999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCC-cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      |||||+||+++.++ .++|+|||.+........ .....||+.|+|||.+.+. .++.++|+||+||++|+|++|+.||.
T Consensus       121 ~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~  198 (280)
T cd05608         121 RDLKPENVLLDNDG-NVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGE-EYDFSVDYFALGVTLYEMIAARGPFR  198 (280)
T ss_pred             CCCCHHHEEECCCC-CEEEeeCccceecCCCCccccccCCCcCccCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCC
Confidence            99999999999877 799999999976544322 2335689999999999765 48999999999999999999999997


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcc-----cHHH
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALE  233 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----t~~e  233 (292)
                      ..........+.......+                         ..++..+++.+.+++.+||+.||++|+     |+++
T Consensus       199 ~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~  253 (280)
T cd05608         199 ARGEKVENKELKQRILNDS-------------------------VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDG  253 (280)
T ss_pred             CCCcchhHHHHHHhhcccC-------------------------CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHH
Confidence            6543222222221110000                         012245889999999999999999999     8899


Q ss_pred             HhcCCCccccCCC
Q 022799          234 ALIHPFFDELRDP  246 (292)
Q Consensus       234 ~l~hp~~~~~~~~  246 (292)
                      +++||||+++.+.
T Consensus       254 ~l~h~~~~~~~~~  266 (280)
T cd05608         254 LRTHPLFRDLNWR  266 (280)
T ss_pred             HhcChhhhcCCHh
Confidence            9999999986543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=3.1e-41  Score=287.21  Aligned_cols=230  Identities=35%  Similarity=0.650  Sum_probs=179.7

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      |++++||||+++++++.     ++.++|+||||++++|.+++..... ...+++..++.++.||+.||.|||++ |++||
T Consensus        53 l~~l~h~~i~~~~~~~~-----~~~~~~~v~e~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~  125 (285)
T cd07861          53 LKELQHPNIVCLQDVLM-----QESRLYLIFEFLSMDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSR-RVLHR  125 (285)
T ss_pred             HHhcCCCCEeeeEEEEe-----eCCeEEEEEecCCCCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhC-Ceeec
Confidence            35689999999999983     4445899999999999888765322 35689999999999999999999987 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCC-cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      ||||+||+++.++ .++|+|||++........ .....+++.|+|||.+.+...++.++|+||+||++|+|++|+.||.+
T Consensus       126 dl~p~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~  204 (285)
T cd07861         126 DLKPQNLLIDNKG-VIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHG  204 (285)
T ss_pred             CCCHHHEEEcCCC-cEEECcccceeecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            9999999999888 799999999875432211 12335688899999987666678999999999999999999999999


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccc--cCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      ....+....+.+..+.+....+...... ..+  ..+........ .....++++++++|++||+.||++|||+.++++|
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         205 DSEIDQLFRIFRILGTPTEDVWPGVTSL-PDYKNTFPKWKKGSLR-SAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             CCHHHHHHHHHHHhCCCChhhhhcchhh-HHHHhhccccCcchhH-HhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            8888888888887777766554332110 000  01111111111 1124589999999999999999999999999999


Q ss_pred             CCc
Q 022799          238 PFF  240 (292)
Q Consensus       238 p~~  240 (292)
                      |||
T Consensus       283 ~~~  285 (285)
T cd07861         283 PYF  285 (285)
T ss_pred             CCC
Confidence            997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.7e-42  Score=286.11  Aligned_cols=200  Identities=25%  Similarity=0.462  Sum_probs=177.5

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.|+||||++++++|     ++..-+.|||||.. |.|++++..    .+.+++.+++.+++||++|+.|+|.+ +++|
T Consensus       107 MSsLNHPhII~IyEVF-----ENkdKIvivMEYaS~GeLYDYiSe----r~~LsErEaRhfFRQIvSAVhYCHkn-rVvH  176 (668)
T KOG0611|consen  107 MSSLNHPHIIQIYEVF-----ENKDKIVIVMEYASGGELYDYISE----RGSLSEREARHFFRQIVSAVHYCHKN-RVVH  176 (668)
T ss_pred             HhhcCCCceeehhhhh-----cCCceEEEEEEecCCccHHHHHHH----hccccHHHHHHHHHHHHHHHHHHhhc-ccee
Confidence            6789999999999999     44445999999998 799999987    47799999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      ||||.+|||+|.++ ++||+|||++..+..+.-..+++|+|-|.+||++.|.+.-++.+|.||||+++|-|+.|..||.|
T Consensus       177 RDLKLENILLD~N~-NiKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG  255 (668)
T KOG0611|consen  177 RDLKLENILLDQNN-NIKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG  255 (668)
T ss_pred             cccchhheeecCCC-CeeeeccchhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC
Confidence            99999999999998 89999999999988888888999999999999998887678999999999999999999999999


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCC
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF  239 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~  239 (292)
                      .+....+.+|....              |.                .+.-+.++.-||+.||..||.+|.|++++-+|=|
T Consensus       256 ~Dhk~lvrQIs~Ga--------------Yr----------------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW  305 (668)
T KOG0611|consen  256 RDHKRLVRQISRGA--------------YR----------------EPETPSDASGLIRWMLMVNPERRATIEDIASHWW  305 (668)
T ss_pred             chHHHHHHHhhccc--------------cc----------------CCCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence            88766666654421              11                1346788999999999999999999999999977


Q ss_pred             cc
Q 022799          240 FD  241 (292)
Q Consensus       240 ~~  241 (292)
                      .+
T Consensus       306 vN  307 (668)
T KOG0611|consen  306 VN  307 (668)
T ss_pred             ee
Confidence            64

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-42  Score=301.08  Aligned_cols=208  Identities=34%  Similarity=0.553  Sum_probs=170.4

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++     .+..++|+||||+. ++|.+++...    ..+++..++.++.||+.||.|||++ ||+|
T Consensus        55 l~~~~~~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~-giiH  124 (350)
T cd05573          55 LADADSPWIVKLYYSF-----QDEEHLYLVMEYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKL-GFIH  124 (350)
T ss_pred             HHhcCCCCccchhhhe-----ecCCeEEEEEcCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-Ceec
Confidence            3567899999999988     45556999999997 6998888753    6789999999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCC------------------------------CcccccccccccCCcccc
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE------------------------------PNISYICSRYYRAPELIF  129 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~------------------------------~~~~~~gt~~y~aPE~~~  129 (292)
                      |||||+||+++.++ .++|+|||++.......                              ......||+.|+|||++.
T Consensus       125 ~Dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  203 (350)
T cd05573         125 RDIKPDNILIDADG-HIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLR  203 (350)
T ss_pred             cCCCHHHeEECCCC-CEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHc
Confidence            99999999999988 79999999987654332                              123456899999999997


Q ss_pred             CCCCCCchhHhhhhhHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCC
Q 022799          130 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRM  209 (292)
Q Consensus       130 ~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  209 (292)
                      +. .++.++|+|||||++|+|++|..||.+.+......++......               ...+.          ...+
T Consensus       204 ~~-~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~---------------~~~p~----------~~~~  257 (350)
T cd05573         204 GT-PYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKES---------------LRFPP----------DPPV  257 (350)
T ss_pred             CC-CCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCc---------------ccCCC----------CCCC
Confidence            65 5899999999999999999999999887766555554431000               00111          0236


Q ss_pred             ChhHHHHHHHHhccCCCCccc-HHHHhcCCCccccCCC
Q 022799          210 PPEAVDLVSRLLQYSPNLRST-ALEALIHPFFDELRDP  246 (292)
Q Consensus       210 ~~~~~~li~~~l~~dp~~R~t-~~e~l~hp~~~~~~~~  246 (292)
                      ++++.++|.+||. ||.+|++ ++++++||||+++.+.
T Consensus       258 ~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~~~  294 (350)
T cd05573         258 SPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDWE  294 (350)
T ss_pred             CHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCCHH
Confidence            8999999999998 9999999 9999999999987654

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.8e-41  Score=293.04  Aligned_cols=202  Identities=27%  Similarity=0.466  Sum_probs=165.3

Q ss_pred             CCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccC
Q 022799            3 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRD   81 (292)
Q Consensus         3 ~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~d   81 (292)
                      .++||||+++++++     .+..++|+||||+. |+|...+..    ...+++..+..++.||+.||+|||++ ||+|||
T Consensus        52 ~~~~~~i~~~~~~~-----~~~~~~~lv~E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivHrD  121 (316)
T cd05620          52 AWENPFLTHLYCTF-----QTKEHLFFVMEFLNGGDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSK-GIIYRD  121 (316)
T ss_pred             ccCCCCccCeeEEE-----EeCCEEEEEECCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecC
Confidence            35899999999998     44556999999998 688887764    35789999999999999999999988 999999


Q ss_pred             CCCCcEEEeCCCCcEEEeecCCcccccc-CCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCC
Q 022799           82 IKPQNLLVNPHTHQLKLCDFGSAKVLVK-GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE  160 (292)
Q Consensus        82 lkp~Nill~~~~~~ikl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  160 (292)
                      |||+||+++.++ .++|+|||+++.... ........||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+.
T Consensus       122 lkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~Pf~~~  199 (316)
T cd05620         122 LKLDNVMLDRDG-HIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGL-KYTFSVDWWSFGVLLYEMLIGQSPFHGD  199 (316)
T ss_pred             CCHHHeEECCCC-CEEeCccCCCeecccCCCceeccCCCcCccCHHHHcCC-CCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence            999999999888 799999999875322 2223446789999999999664 4899999999999999999999999877


Q ss_pred             CcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccH-HHHhcCCC
Q 022799          161 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA-LEALIHPF  239 (292)
Q Consensus       161 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~-~e~l~hp~  239 (292)
                      +.......+...  .          +                 .++..++.+++++|.+||..||++|+++ +++++|||
T Consensus       200 ~~~~~~~~~~~~--~----------~-----------------~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~  250 (316)
T cd05620         200 DEDELFESIRVD--T----------P-----------------HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPF  250 (316)
T ss_pred             CHHHHHHHHHhC--C----------C-----------------CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCC
Confidence            665444433210  0          0                 0123478899999999999999999997 58889999


Q ss_pred             ccccCC
Q 022799          240 FDELRD  245 (292)
Q Consensus       240 ~~~~~~  245 (292)
                      |+.+..
T Consensus       251 f~~~~~  256 (316)
T cd05620         251 FKTINW  256 (316)
T ss_pred             cCCCCH
Confidence            998754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.7e-41  Score=293.02  Aligned_cols=202  Identities=27%  Similarity=0.481  Sum_probs=167.1

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      +.++||||+++++++     .+...+|+||||++ ++|...+.     ...+++..++.++.||+.||.|||++ ||+||
T Consensus        57 ~~l~hp~i~~~~~~~-----~~~~~~~lv~E~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~~-~ivHr  125 (324)
T cd05589          57 NSERHPFLVNLFACF-----QTEDHVCFVMEYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLHEN-KIVYR  125 (324)
T ss_pred             cccCCCChhceeeEE-----EcCCEEEEEEcCCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEec
Confidence            567899999999998     44446999999998 57776664     35689999999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCcccccc-CCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVK-GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      ||||+||+++.++ .+||+|||+++.... ........||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+
T Consensus       126 dlkp~Nill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~G~~pf~~  203 (324)
T cd05589         126 DLKLDNLLLDTEG-FVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIYEMLVGESPFPG  203 (324)
T ss_pred             CCCHHHeEECCCC-cEEeCcccCCccCCCCCCcccccccCccccCHhHhcCC-CCCcccchhhHHHHHHHHHhCCCCCCC
Confidence            9999999999988 799999999875322 2223456789999999999664 489999999999999999999999988


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcc-----cHHHH
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEA  234 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----t~~e~  234 (292)
                      .+..+....+....                 .            .++..+++.+.++|.+||..||.+||     ++.++
T Consensus       204 ~~~~~~~~~i~~~~-----------------~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l  254 (324)
T cd05589         204 DDEEEVFDSIVNDE-----------------V------------RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDV  254 (324)
T ss_pred             CCHHHHHHHHHhCC-----------------C------------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHH
Confidence            77666555443310                 0            12245789999999999999999999     79999


Q ss_pred             hcCCCccccCC
Q 022799          235 LIHPFFDELRD  245 (292)
Q Consensus       235 l~hp~~~~~~~  245 (292)
                      ++||||+++..
T Consensus       255 ~~~~~f~~~~~  265 (324)
T cd05589         255 KKQPFFRDINW  265 (324)
T ss_pred             hhCCCcCCCCH
Confidence            99999988653

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2.5e-41  Score=292.41  Aligned_cols=200  Identities=29%  Similarity=0.495  Sum_probs=165.2

Q ss_pred             CCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCC
Q 022799            5 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIK   83 (292)
Q Consensus         5 ~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlk   83 (292)
                      +||||+++++++     .+...+|+||||++ |+|...+..    ...+++..+..++.||+.||.|||++ ||+|||||
T Consensus        54 ~h~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~-~ivH~dlk  123 (318)
T cd05570          54 KHPFLTQLHSCF-----QTKDRLFFVMEYVNGGDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHER-GIIYRDLK  123 (318)
T ss_pred             CCCCccceeeEE-----EcCCEEEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEccCCC
Confidence            799999999998     44446999999998 688777764    35799999999999999999999988 99999999


Q ss_pred             CCcEEEeCCCCcEEEeecCCcccccc-CCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCCCc
Q 022799           84 PQNLLVNPHTHQLKLCDFGSAKVLVK-GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG  162 (292)
Q Consensus        84 p~Nill~~~~~~ikl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~  162 (292)
                      |+||+++.++ .++|+|||++..... ........||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+.+.
T Consensus       124 p~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslGvil~~l~~G~~pf~~~~~  201 (318)
T cd05570         124 LDNVLLDSEG-HIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQ-PYGPAVDWWALGVLLYEMLAGQSPFEGDDE  201 (318)
T ss_pred             HHHeEECCCC-cEEecccCCCeecCcCCCcccceecCccccCHHHhcCC-CCCcchhhhhHHHHHHHHhhCCCCCCCCCH
Confidence            9999999888 799999999865322 2223345689999999999765 489999999999999999999999987765


Q ss_pred             HHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccH-----HHHhcC
Q 022799          163 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA-----LEALIH  237 (292)
Q Consensus       163 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~-----~e~l~h  237 (292)
                      ......+...                 .            ..++..++..+.+||++||..||.+|||+     .+++.|
T Consensus       202 ~~~~~~i~~~-----------------~------------~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         202 DELFQSILED-----------------E------------VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             HHHHHHHHcC-----------------C------------CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence            5544433221                 0            01224578999999999999999999999     999999


Q ss_pred             CCccccCC
Q 022799          238 PFFDELRD  245 (292)
Q Consensus       238 p~~~~~~~  245 (292)
                      |||+.+.+
T Consensus       253 ~~~~~~~~  260 (318)
T cd05570         253 PFFREIDW  260 (318)
T ss_pred             CCcCCCCH
Confidence            99998754

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.2e-41  Score=293.45  Aligned_cols=203  Identities=29%  Similarity=0.496  Sum_probs=167.6

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||++++++|     ..+..+|+||||++ ++|.+.+..    .+.+++..++.++.||+.||.|||++ ||+|
T Consensus        54 l~~l~hp~iv~~~~~~-----~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH  123 (323)
T cd05584          54 LEAVKHPFIVDLIYAF-----QTGGKLYLILEYLSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQ-GIIY  123 (323)
T ss_pred             HHhCCCCchhceeeEE-----ecCCeEEEEEeCCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-Ceec
Confidence            4678999999999998     44446899999998 588887764    35688999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccC-CCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      |||||+||+++.++ .+||+|||+++..... .......||+.|+|||++.+. .++.++|+||+||++|+|++|..||.
T Consensus       124 ~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~pf~  201 (323)
T cd05584         124 RDLKPENILLDAQG-HVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRS-GHGKAVDWWSLGALMYDMLTGAPPFT  201 (323)
T ss_pred             CCCCHHHeEECCCC-CEEEeeCcCCeecccCCCcccccCCCccccChhhccCC-CCCCcceecccHHHHHHHhcCCCCCC
Confidence            99999999999888 7999999998754222 223345789999999999664 48899999999999999999999998


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcc-----cHHH
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALE  233 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----t~~e  233 (292)
                      +.+.......+....                 .            .++..+++++.++|++||..||++|+     ++.+
T Consensus       202 ~~~~~~~~~~~~~~~-----------------~------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~  252 (323)
T cd05584         202 AENRKKTIDKILKGK-----------------L------------NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAE  252 (323)
T ss_pred             CCCHHHHHHHHHcCC-----------------C------------CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHH
Confidence            877655554443210                 0            12245789999999999999999999     8999


Q ss_pred             HhcCCCccccC
Q 022799          234 ALIHPFFDELR  244 (292)
Q Consensus       234 ~l~hp~~~~~~  244 (292)
                      +++||||+...
T Consensus       253 l~~h~~~~~~~  263 (323)
T cd05584         253 VQSHPFFRHVN  263 (323)
T ss_pred             HhcCCCcCCCC
Confidence            99999998754

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-40  Score=289.36  Aligned_cols=269  Identities=35%  Similarity=0.664  Sum_probs=201.6

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      |++++||||+++++++...........++|+||++++|.+.+.     ...+++..++.++.|++.||.|||++ ||+||
T Consensus        57 l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~-~ivH~  130 (336)
T cd07849          57 LRRFKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHSA-NVLHR  130 (336)
T ss_pred             HHhCCCCCcCchhheeecccccccceEEEEehhcccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-Ceecc
Confidence            3578899999999987544434445689999999999887775     35689999999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCC----cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPL  156 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~p  156 (292)
                      ||||+||+++.++ .++|+|||++........    .....||+.|+|||.+.+...++.++|+||+||++|+|++|+.|
T Consensus       131 dlkp~Nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~  209 (336)
T cd07849         131 DLKPSNLLLNTNC-DLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPL  209 (336)
T ss_pred             CCCHHHEEECCCC-CEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            9999999999888 799999999876533221    12346789999999876655689999999999999999999999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccc---cCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHH
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF---KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE  233 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e  233 (292)
                      |.+.+.......+...++.++.+.+..+.......   ..+.....++... .+..++++.++|.+||+.||++|||+.+
T Consensus       210 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~dP~~Rpt~~e  288 (336)
T cd07849         210 FPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKL-FPNADPKALDLLDKMLTFNPHKRITVEE  288 (336)
T ss_pred             CCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHH-hcccCcHHHHHHHHHcCCChhhCcCHHH
Confidence            99888888888888888888877665443211110   0111111122211 2456889999999999999999999999


Q ss_pred             HhcCCCccccCCCCCCCCCCCCCCCCCCCChhccCCCCHHHHhhhchH
Q 022799          234 ALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPE  281 (292)
Q Consensus       234 ~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (292)
                      +++||||+.+.++......    ++.+.|+-+....++.+.+++++-+
T Consensus       289 ~l~hp~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~  332 (336)
T cd07849         289 ALAHPYLEQYHDPSDEPVA----EEPFPFDFELFDDLPKEKLKELIFE  332 (336)
T ss_pred             HhcCccccccCCCCCcccC----CCCCChhhccccccCHHHHHHHHHH
Confidence            9999999988765332221    1222344445555556666655443

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.5e-41  Score=294.43  Aligned_cols=203  Identities=28%  Similarity=0.472  Sum_probs=167.5

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      +.++||||+++++++     .+...+|+||||+. |+|...+..    ...+++..++.++.||+.||.|||++ ||+||
T Consensus        51 ~~l~hp~iv~~~~~~-----~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-givH~  120 (323)
T cd05575          51 KNVKHPFLVGLHYSF-----QTADKLYFVLDYVNGGELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSL-NIIYR  120 (323)
T ss_pred             hhCCCCCCCCeeEEE-----EeCCEEEEEEcCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeC
Confidence            568999999999988     44445899999998 688887764    46789999999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccC-CCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      ||||+||+++.++ .+||+|||++...... .......||+.|+|||++.+. .++.++|+|||||++|+|++|..||.+
T Consensus       121 dikp~NIll~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~  198 (323)
T cd05575         121 DLKPENILLDSQG-HVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYS  198 (323)
T ss_pred             CCCHHHeEECCCC-cEEEeccCCCcccccCCCccccccCChhhcChhhhcCC-CCCccccccccchhhhhhhcCCCCCCC
Confidence            9999999999888 7999999998754222 223345789999999999664 489999999999999999999999988


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccH----HHHh
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA----LEAL  235 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~----~e~l  235 (292)
                      .+..+....+...   +              .            .+++.+++.+.++|++||+.||.+|+++    .+++
T Consensus       199 ~~~~~~~~~i~~~---~--------------~------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il  249 (323)
T cd05575         199 RDTAEMYDNILNK---P--------------L------------RLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIK  249 (323)
T ss_pred             CCHHHHHHHHHcC---C--------------C------------CCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHH
Confidence            7665554444321   0              0            0124578999999999999999999987    6999


Q ss_pred             cCCCccccCC
Q 022799          236 IHPFFDELRD  245 (292)
Q Consensus       236 ~hp~~~~~~~  245 (292)
                      +||||.++.+
T Consensus       250 ~~~~~~~~~~  259 (323)
T cd05575         250 NHVFFSSINW  259 (323)
T ss_pred             cCCCcCCCCH
Confidence            9999987654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.3e-41  Score=297.88  Aligned_cols=208  Identities=28%  Similarity=0.443  Sum_probs=166.3

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++     .+..++|+||||++ |+|.+++..    .+.+++..++.++.|++.||.|||++ ||+|
T Consensus        55 l~~~~~~~iv~~~~~~-----~~~~~~~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~-givH  124 (363)
T cd05628          55 LVEADSLWVVKMFYSF-----QDKLNLYLIMEFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQL-GFIH  124 (363)
T ss_pred             HHhCCCCCcceEEEEE-----ecCCeEEEEEcCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEe
Confidence            3568999999999998     55556999999998 688888865    36799999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCC------------------------------------Cccccccccccc
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE------------------------------------PNISYICSRYYR  123 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~------------------------------------~~~~~~gt~~y~  123 (292)
                      |||||+|||++.++ .+||+|||+++......                                    .....+||+.|+
T Consensus       125 rDlKp~NILi~~~~-~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~  203 (363)
T cd05628         125 RDIKPDNLLLDSKG-HVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYI  203 (363)
T ss_pred             cCCCHHHeEECCCC-CEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCcccc
Confidence            99999999999888 79999999987542211                                    012357899999


Q ss_pred             CCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchh
Q 022799          124 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHK  203 (292)
Q Consensus       124 aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  203 (292)
                      |||++.+. .++.++|+||+||++|+|++|..||.+.+..+...++......               ..++..       
T Consensus       204 aPE~~~~~-~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~---------------~~~p~~-------  260 (363)
T cd05628         204 APEVFMQT-GYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKET---------------LIFPPE-------  260 (363)
T ss_pred             CHHHHcCC-CCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCc---------------ccCCCc-------
Confidence            99999764 4899999999999999999999999888776666555431100               001100       


Q ss_pred             hhccCCChhHHHHHHHHhccCCCC---cccHHHHhcCCCccccCCC
Q 022799          204 IFQKRMPPEAVDLVSRLLQYSPNL---RSTALEALIHPFFDELRDP  246 (292)
Q Consensus       204 ~~~~~~~~~~~~li~~~l~~dp~~---R~t~~e~l~hp~~~~~~~~  246 (292)
                         ..++++++++|.+|+. +|.+   ||+++++++||||+++.+.
T Consensus       261 ---~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~~~  302 (363)
T cd05628         261 ---VPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVDWE  302 (363)
T ss_pred             ---CCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCCHH
Confidence               2378899999999876 5544   5899999999999987653

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-41  Score=294.82  Aligned_cols=210  Identities=29%  Similarity=0.473  Sum_probs=170.8

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++     .+..+.|+||||++ |+|.+++..    ...+++..++.++.||+.||.|||++ ||+|
T Consensus        55 l~~~~h~~iv~~~~~~-----~~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~-~ivH  124 (333)
T cd05600          55 LTTTKSEWLVKLLYAF-----QDDEYLYLAMEYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHEL-GYIH  124 (333)
T ss_pred             HHhCCCCCCccEEEEE-----EcCCEEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-Cccc
Confidence            3567899999999998     44556999999998 699888865    35789999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      |||||+||+++.++ .+||+|||++.....  ......||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+
T Consensus       125 ~dlkp~Nil~~~~~-~~kL~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~  200 (333)
T cd05600         125 RDLKPENFLIDASG-HIKLTDFGLSKGIVT--YANSVVGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSG  200 (333)
T ss_pred             cCCCHHHEEECCCC-CEEEEeCcCCccccc--ccCCcccCccccChhHhcCC-CCCCccceecchHHHhhhhhCCCCCCC
Confidence            99999999999888 799999999976533  33456789999999999765 589999999999999999999999988


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCC
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF  239 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~  239 (292)
                      .+..+....+.......               ..+....      ....+++++.++|.+||..+|.+|+++.++++|||
T Consensus       201 ~~~~~~~~~i~~~~~~~---------------~~~~~~~------~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~  259 (333)
T cd05600         201 STPNETWENLKYWKETL---------------QRPVYDD------PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPF  259 (333)
T ss_pred             CCHHHHHHHHHhccccc---------------cCCCCCc------cccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcc
Confidence            77666555443311000               0000000      00257899999999999999999999999999999


Q ss_pred             ccccCC
Q 022799          240 FDELRD  245 (292)
Q Consensus       240 ~~~~~~  245 (292)
                      |+++..
T Consensus       260 ~~~~~~  265 (333)
T cd05600         260 FKEVDW  265 (333)
T ss_pred             cCCCCH
Confidence            998654

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=3.8e-41  Score=291.08  Aligned_cols=202  Identities=29%  Similarity=0.486  Sum_probs=166.1

Q ss_pred             CCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccC
Q 022799            3 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRD   81 (292)
Q Consensus         3 ~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~d   81 (292)
                      ..+||||+++++++     ....++|+||||++ |+|...+..    ...+++..++.++.||+.||.|||++ ||+|||
T Consensus        52 ~~~hp~i~~~~~~~-----~~~~~~~lv~e~~~gg~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~-~ivH~d  121 (316)
T cd05592          52 AWEHPFLTHLFCTF-----QTKEHLFFVMEYLNGGDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKK-GIIYRD  121 (316)
T ss_pred             ccCCCCccceeeEE-----EcCCEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CEEeCC
Confidence            35899999999988     44456999999998 688877764    35789999999999999999999998 999999


Q ss_pred             CCCCcEEEeCCCCcEEEeecCCccccccC-CCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCC
Q 022799           82 IKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE  160 (292)
Q Consensus        82 lkp~Nill~~~~~~ikl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  160 (292)
                      |||+||+++.++ .+||+|||++...... .......||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+.
T Consensus       122 lkp~Nill~~~~-~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~Pf~~~  199 (316)
T cd05592         122 LKLDNVLLDKDG-HIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQ-KYNESVDWWSFGVLLYEMLIGQSPFHGE  199 (316)
T ss_pred             CCHHHeEECCCC-CEEEccCcCCeECCCCCCccccccCCccccCHHHHcCC-CCCCcccchhHHHHHHHHHhCCCCCCCC
Confidence            999999999888 7999999998764322 223345789999999999765 4899999999999999999999999887


Q ss_pred             CcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccH-HHHhcCCC
Q 022799          161 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA-LEALIHPF  239 (292)
Q Consensus       161 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~-~e~l~hp~  239 (292)
                      +..+....+...  .                           ..++..++.++.++|.+||..||++|+++ .+++.|||
T Consensus       200 ~~~~~~~~i~~~--~---------------------------~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~  250 (316)
T cd05592         200 DEDELFDSILND--R---------------------------PHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPF  250 (316)
T ss_pred             CHHHHHHHHHcC--C---------------------------CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcc
Confidence            765554443321  0                           01224578899999999999999999986 58889999


Q ss_pred             ccccCC
Q 022799          240 FDELRD  245 (292)
Q Consensus       240 ~~~~~~  245 (292)
                      |+.+.+
T Consensus       251 ~~~~~~  256 (316)
T cd05592         251 FRGIDW  256 (316)
T ss_pred             cCCCCH
Confidence            998653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.1e-41  Score=295.59  Aligned_cols=204  Identities=28%  Similarity=0.451  Sum_probs=166.5

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCcc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN-TIGVC   78 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~-~~~i~   78 (292)
                      |+.++||||+++++++     .+...+|+||||++ |+|...+..    ...+++..++.++.||+.||.|||+ + ||+
T Consensus        49 l~~~~hp~i~~~~~~~-----~~~~~~~lv~E~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~-~iv  118 (325)
T cd05594          49 LQNSRHPFLTALKYSF-----QTHDRLCFVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEK-NVV  118 (325)
T ss_pred             HHhCCCCCCCceEEEE-----EcCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcC-CEE
Confidence            3567999999999988     44456999999998 688777654    3578999999999999999999997 5 999


Q ss_pred             ccCCCCCcEEEeCCCCcEEEeecCCcccccc-CCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCC
Q 022799           79 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF  157 (292)
Q Consensus        79 H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf  157 (292)
                      ||||||+||+++.++ .+||+|||+++.... ........||+.|+|||++.+. .++.++|+||+||++|+|++|..||
T Consensus       119 HrDikp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tG~~Pf  196 (325)
T cd05594         119 YRDLKLENLMLDKDG-HIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPF  196 (325)
T ss_pred             ecCCCCCeEEECCCC-CEEEecCCCCeecCCCCcccccccCCcccCCHHHHccC-CCCCccccccccceeeeeccCCCCC
Confidence            999999999999888 799999999875422 2223345789999999999664 4899999999999999999999999


Q ss_pred             CCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcc-----cHH
Q 022799          158 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TAL  232 (292)
Q Consensus       158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----t~~  232 (292)
                      .+.+.......+...                 ..            .++..+++++.++|.+||..||++|+     ++.
T Consensus       197 ~~~~~~~~~~~i~~~-----------------~~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~  247 (325)
T cd05594         197 YNQDHEKLFELILME-----------------EI------------RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAK  247 (325)
T ss_pred             CCCCHHHHHHHHhcC-----------------CC------------CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHH
Confidence            877655444333211                 00            12245789999999999999999997     899


Q ss_pred             HHhcCCCccccCC
Q 022799          233 EALIHPFFDELRD  245 (292)
Q Consensus       233 e~l~hp~~~~~~~  245 (292)
                      ++++||||.++.+
T Consensus       248 ~il~h~~~~~~~~  260 (325)
T cd05594         248 EIMQHKFFAGIVW  260 (325)
T ss_pred             HHhcCCCcCCCCH
Confidence            9999999997654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4e-41  Score=295.57  Aligned_cols=232  Identities=23%  Similarity=0.381  Sum_probs=168.0

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      |++++||||+++++++.     .....++|||++.++|.+++...   ...+++..+..++.||+.||.|||++ ||+||
T Consensus       111 l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHr  181 (357)
T PHA03209        111 LQNVNHPSVIRMKDTLV-----SGAITCMVLPHYSSDLYTYLTKR---SRPLPIDQALIIEKQILEGLRYLHAQ-RIIHR  181 (357)
T ss_pred             HHhCCCCCCcChhheEE-----eCCeeEEEEEccCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecC
Confidence            46789999999999984     34458899999999998887653   46789999999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCC-CC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF-PG  159 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf-~~  159 (292)
                      ||||+||+++.++ .++|+|||.++............||+.|+|||++.+. .++.++|+||+||++|+|+++..++ ..
T Consensus       182 Dlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvvl~ell~~~~~~f~~  259 (357)
T PHA03209        182 DVKTENIFINDVD-QVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARD-KYNSKADIWSAGIVLFEMLAYPSTIFED  259 (357)
T ss_pred             CCCHHHEEECCCC-CEEEecCccccccccCcccccccccccccCCeecCCC-CCCchhhHHHHHHHHHHHHHcCCccccC
Confidence            9999999999888 7999999999764433334456789999999999665 4899999999999999999865444 33


Q ss_pred             CCc---------HHHHHHHHHHhCCCCHHHHhhcCCCCc--cccCCCCCCC---CchhhhccCCChhHHHHHHHHhccCC
Q 022799          160 ESG---------VDQLVEIIKVLGTPTREEIKCMNPNYT--EFKFPQIKAH---PWHKIFQKRMPPEAVDLVSRLLQYSP  225 (292)
Q Consensus       160 ~~~---------~~~~~~i~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~dp  225 (292)
                      ...         ...+..++...+..+............  ...+......   .+...-...++.++.+||.+||+.||
T Consensus       260 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP  339 (357)
T PHA03209        260 PPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDA  339 (357)
T ss_pred             CCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCc
Confidence            211         233444444444332221100000000  0000000000   00111113578889999999999999


Q ss_pred             CCcccHHHHhcCCCcccc
Q 022799          226 NLRSTALEALIHPFFDEL  243 (292)
Q Consensus       226 ~~R~t~~e~l~hp~~~~~  243 (292)
                      .+|||+.|+|+||||+++
T Consensus       340 ~~Rpta~e~l~hp~f~~~  357 (357)
T PHA03209        340 AMRPSAEEILNYPMFAQL  357 (357)
T ss_pred             ccCcCHHHHhcCchhccC
Confidence            999999999999999863

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.3e-40  Score=290.35  Aligned_cols=270  Identities=35%  Similarity=0.648  Sum_probs=203.7

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      |+.++||||+++++++...........|+||||++++|.+.+..    ...+++..+..++.|++.||.|||++ |++||
T Consensus        58 l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~-~i~H~  132 (337)
T cd07858          58 LRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHSA-NVLHR  132 (337)
T ss_pred             HHhcCCCCccchHHheecccccccCcEEEEEeCCCCCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC-CEecC
Confidence            35679999999999875544333345899999999999888764    35799999999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccC-CCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      ||||+||+++.++ .++|+|||++...... .......++..|+|||.+.+...++.++|+||+||++|+|++|..||.+
T Consensus       133 dlkp~Nil~~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  211 (337)
T cd07858         133 DLKPSNLLLNANC-DLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPG  211 (337)
T ss_pred             CCCHHHEEEcCCC-CEEECcCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCC
Confidence            9999999999887 7999999999866433 2223456788999999886544589999999999999999999999998


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCC-ccc--cCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNY-TEF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      .+.......+....+.+..+.+....... ..+  ..+......... ..+.+++++.++|++||..||++|||+.++++
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~  290 (337)
T cd07858         212 KDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALA  290 (337)
T ss_pred             CChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHc
Confidence            88888888888888888776654322111 000  011111111111 22468999999999999999999999999999


Q ss_pred             CCCccccCCCCCCCCCCCCCCCCCCCChhccCCCCHHHHhhhchHH
Q 022799          237 HPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEH  282 (292)
Q Consensus       237 hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (292)
                      ||||+.+..+......    +..+.|+ .+..+.+.+.+++++..+
T Consensus       291 h~~~~~~~~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~~~~~~  331 (337)
T cd07858         291 HPYLASLHDPSDEPVC----QTPFSFD-FEEDALTEEDIKELIYNE  331 (337)
T ss_pred             CcchhhhcCcccCccC----CCccchh-hhhhhcCHHHHHHHHHHH
Confidence            9999998766543221    2233343 334446777777776554

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=4.2e-41  Score=291.45  Aligned_cols=201  Identities=28%  Similarity=0.484  Sum_probs=167.3

Q ss_pred             CCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCC
Q 022799            4 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDI   82 (292)
Q Consensus         4 l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dl   82 (292)
                      .+||||+++++++     .+...+|+||||++ |+|...+..    ...+++..++.++.||+.||.|||++ ||+||||
T Consensus        53 ~~hp~i~~~~~~~-----~~~~~~~lv~E~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDi  122 (321)
T cd05591          53 AKHPFLTALHCCF-----QTKDRLFFVMEYVNGGDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRH-GVIYRDL  122 (321)
T ss_pred             cCCCCccceeeEE-----EcCCeEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCC
Confidence            4799999999999     44445999999998 688877764    35689999999999999999999988 9999999


Q ss_pred             CCCcEEEeCCCCcEEEeecCCccccccC-CCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCCC
Q 022799           83 KPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES  161 (292)
Q Consensus        83 kp~Nill~~~~~~ikl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~  161 (292)
                      ||+||+++.++ .++|+|||++...... .......||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+.+
T Consensus       123 kp~Nill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~  200 (321)
T cd05591         123 KLDNILLDAEG-HCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQEL-EYGPSVDWWALGVLMYEMMAGQPPFEADN  200 (321)
T ss_pred             CHHHeEECCCC-CEEEeecccceecccCCccccccccCccccCHHHHcCC-CCCCccceechhHHHHHHhcCCCCCCCCC
Confidence            99999999988 7999999998754222 223345689999999998654 48999999999999999999999999887


Q ss_pred             cHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcc-------cHHHH
Q 022799          162 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-------TALEA  234 (292)
Q Consensus       162 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-------t~~e~  234 (292)
                      ..+....+....                 .            .++..+++++.++|.+||..||++|+       ++.++
T Consensus       201 ~~~~~~~i~~~~-----------------~------------~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~  251 (321)
T cd05591         201 EDDLFESILHDD-----------------V------------LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAI  251 (321)
T ss_pred             HHHHHHHHHcCC-----------------C------------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHH
Confidence            766665544310                 0            01234788999999999999999999       99999


Q ss_pred             hcCCCccccCC
Q 022799          235 LIHPFFDELRD  245 (292)
Q Consensus       235 l~hp~~~~~~~  245 (292)
                      ++||||..+.+
T Consensus       252 ~~hp~~~~~~~  262 (321)
T cd05591         252 KQHPFFKEIDW  262 (321)
T ss_pred             hcCCccCCCCH
Confidence            99999988654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=3.8e-41  Score=296.73  Aligned_cols=207  Identities=29%  Similarity=0.499  Sum_probs=166.6

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      +.++||||+++++++     .++.++|+||||++ |+|.+++..     ..+++..++.++.||+.||+|||++ ||+||
T Consensus        98 ~~~~hp~iv~~~~~~-----~~~~~~~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~-~IvHr  166 (370)
T cd05621          98 AFANSPWVVQLFCAF-----QDDKYLYMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSM-GLIHR  166 (370)
T ss_pred             HhCCCCCEeeEEEEE-----EcCCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC-CeEec
Confidence            567999999999998     45556999999998 699888863     4588999999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCC--cccccccccccCCccccCCC---CCCchhHhhhhhHHHHHHHhCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP--NISYICSRYYRAPELIFGAT---EYTAAIDIWSAGCVLAELLLGQP  155 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~~DvwslG~il~el~~g~~  155 (292)
                      ||||+||+++.++ .+||+|||++........  .....||+.|+|||++.+..   .++.++|+||+||++|+|++|..
T Consensus       167 DLKp~NILl~~~~-~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~  245 (370)
T cd05621         167 DVKPDNMLLDKHG-HLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDT  245 (370)
T ss_pred             CCCHHHEEECCCC-CEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCC
Confidence            9999999999888 799999999987643221  23567999999999986532   37889999999999999999999


Q ss_pred             CCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCC--cccHHH
Q 022799          156 LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL--RSTALE  233 (292)
Q Consensus       156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--R~t~~e  233 (292)
                      ||.+.+......++......               ..++.          ...++..++++|.+||..++.+  |+|+.+
T Consensus       246 Pf~~~~~~~~~~~i~~~~~~---------------~~~p~----------~~~~s~~~~~li~~~L~~~~~r~~R~~~~e  300 (370)
T cd05621         246 PFYADSLVGTYSKIMDHKNS---------------LNFPE----------DVEISKHAKNLICAFLTDREVRLGRNGVEE  300 (370)
T ss_pred             CCCCCCHHHHHHHHHhCCcc---------------cCCCC----------cccCCHHHHHHHHHHccCchhccCCCCHHH
Confidence            99888776665555432110               01110          0246899999999999855544  889999


Q ss_pred             HhcCCCccccCC
Q 022799          234 ALIHPFFDELRD  245 (292)
Q Consensus       234 ~l~hp~~~~~~~  245 (292)
                      +++||||+...+
T Consensus       301 ~l~hp~~~~~~~  312 (370)
T cd05621         301 IKQHPFFKNDQW  312 (370)
T ss_pred             HhcCcccCCCCc
Confidence            999999987543

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-41  Score=298.95  Aligned_cols=207  Identities=31%  Similarity=0.502  Sum_probs=164.5

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||++++++|     .+..++|+||||++ |+|.+++..    ...+++..++.++.|++.||+|||+. ||+|
T Consensus        55 l~~l~hp~iv~~~~~~-----~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~-givH  124 (377)
T cd05629          55 LAESDSPWVVSLYYSF-----QDAQYLYLIMEFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKL-GFIH  124 (377)
T ss_pred             HHhCCCCCcceEEEEE-----EcCCeeEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-Ceec
Confidence            3568999999999998     45556999999997 699888865    36789999999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCC------------------------------------------------
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE------------------------------------------------  111 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~------------------------------------------------  111 (292)
                      |||||+||+++.++ .++|+|||+++......                                                
T Consensus       125 rDlkp~NIll~~~~-~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  203 (377)
T cd05629         125 RDIKPDNILIDRGG-HIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRL  203 (377)
T ss_pred             cCCCHHHEEECCCC-CEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccc
Confidence            99999999999888 79999999986321100                                                


Q ss_pred             CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccc
Q 022799          112 PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  191 (292)
Q Consensus       112 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  191 (292)
                      .....+||+.|+|||++.+. .++.++|+||+||++|||++|..||.+.+..+....+.....               ..
T Consensus       204 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---------------~~  267 (377)
T cd05629         204 MAYSTVGTPDYIAPEIFLQQ-GYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRE---------------TL  267 (377)
T ss_pred             cccccCCCccccCHHHHccC-CCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCC---------------cc
Confidence            00124689999999999654 489999999999999999999999988776655555443100               00


Q ss_pred             cCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCc---ccHHHHhcCCCccccCC
Q 022799          192 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR---STALEALIHPFFDELRD  245 (292)
Q Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R---~t~~e~l~hp~~~~~~~  245 (292)
                      .++.          ...++.++++||.+||. +|.+|   +|+.+++.||||+++.+
T Consensus       268 ~~p~----------~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~~  313 (377)
T cd05629         268 YFPD----------DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGVDW  313 (377)
T ss_pred             CCCC----------CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCCCH
Confidence            1110          02478899999999998 77765   59999999999997654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=7.7e-41  Score=304.00  Aligned_cols=207  Identities=30%  Similarity=0.412  Sum_probs=171.2

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++|||||++++++     ....++|+||||++ |+|.+.+.........+++..+..++.||+.||.|||++ ||+|
T Consensus       119 l~~l~Hpniv~~~~~~-----~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~ivH  192 (478)
T PTZ00267        119 LAACDHFGIVKHFDDF-----KSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR-KMMH  192 (478)
T ss_pred             HHhCCCCCEeEEEEEE-----EECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC-CEEE
Confidence            4678999999999998     44446999999998 799988876544456789999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCC---CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPL  156 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~p  156 (292)
                      |||||+||+++.++ .+||+|||+++......   .....+||+.|+|||++.+. .++.++|+||+||++|+|++|..|
T Consensus       193 rDlkp~NIll~~~~-~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~P  270 (478)
T PTZ00267        193 RDLKSANIFLMPTG-IIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERK-RYSKKADMWSLGVILYELLTLHRP  270 (478)
T ss_pred             CCcCHHhEEECCCC-cEEEEeCcCceecCCccccccccccCCCccccCHhHhCCC-CCCcHHhHHHHHHHHHHHHhCCCC
Confidence            99999999999888 79999999998764332   12345689999999998654 589999999999999999999999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      |.+.+..+.+..+......                            .++..+++++.++|.+||..||++||++++++.
T Consensus       271 f~~~~~~~~~~~~~~~~~~----------------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        271 FKGPSQREIMQQVLYGKYD----------------------------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             CCCCCHHHHHHHHHhCCCC----------------------------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            9887766555544331000                            012357889999999999999999999999999


Q ss_pred             CCCcccc
Q 022799          237 HPFFDEL  243 (292)
Q Consensus       237 hp~~~~~  243 (292)
                      |+|++.+
T Consensus       323 ~~~~~~~  329 (478)
T PTZ00267        323 TEFLKYV  329 (478)
T ss_pred             CHHHHHH
Confidence            9998653

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-41  Score=298.40  Aligned_cols=207  Identities=32%  Similarity=0.527  Sum_probs=166.7

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||++++++|     .+..++|+||||+. |+|.+++..    .+.+++..++.++.||+.||.|||++ ||+|
T Consensus        55 l~~l~h~~iv~~~~~~-----~~~~~~~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~-~ivH  124 (364)
T cd05599          55 LAEADNPWVVKLYYSF-----QDENYLYLIMEYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKL-GYIH  124 (364)
T ss_pred             HHhCCCCCCcceEEEE-----EcCCeEEEEECCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEe
Confidence            4568999999999998     45556999999998 688888765    35689999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCC---------------------------------------Ccccccccc
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE---------------------------------------PNISYICSR  120 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~---------------------------------------~~~~~~gt~  120 (292)
                      |||||+||+++.++ .++|+|||++.......                                       .....+||+
T Consensus       125 ~Dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  203 (364)
T cd05599         125 RDIKPDNLLLDAKG-HIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTP  203 (364)
T ss_pred             ccCCHHHeEECCCC-CEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCc
Confidence            99999999999988 79999999987542211                                       011246899


Q ss_pred             cccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCC
Q 022799          121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHP  200 (292)
Q Consensus       121 ~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  200 (292)
                      .|+|||++.+. .++.++|+||+||++|+|++|..||.+.+..+....+.....               ....+.     
T Consensus       204 ~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~---------------~~~~~~-----  262 (364)
T cd05599         204 DYIAPEVFLQT-GYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKE---------------TLQFPD-----  262 (364)
T ss_pred             cccCHHHHcCC-CCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCC---------------ccCCCC-----
Confidence            99999998654 589999999999999999999999988776655544432100               000010     


Q ss_pred             chhhhccCCChhHHHHHHHHhccCCCCccc---HHHHhcCCCccccCC
Q 022799          201 WHKIFQKRMPPEAVDLVSRLLQYSPNLRST---ALEALIHPFFDELRD  245 (292)
Q Consensus       201 ~~~~~~~~~~~~~~~li~~~l~~dp~~R~t---~~e~l~hp~~~~~~~  245 (292)
                           ...++++++++|.+||. +|.+|++   +.++++||||+.+.+
T Consensus       263 -----~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~~  304 (364)
T cd05599         263 -----EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDW  304 (364)
T ss_pred             -----CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCCH
Confidence                 02478999999999997 9999998   999999999998754

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=4.7e-40  Score=298.48  Aligned_cols=231  Identities=21%  Similarity=0.369  Sum_probs=174.2

Q ss_pred             CCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCC
Q 022799            4 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIK   83 (292)
Q Consensus         4 l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlk   83 (292)
                      ..|++|++++++|..    +..++|+|||+++++|.+++..    ...+++..++.++.||+.||.|||++.||+|||||
T Consensus       188 ~~~~~i~~i~~~~~~----~~~~~~iv~~~~g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlK  259 (467)
T PTZ00284        188 ADRFPLMKIQRYFQN----ETGHMCIVMPKYGPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLK  259 (467)
T ss_pred             ccCcceeeeEEEEEc----CCceEEEEEeccCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCC
Confidence            356779999988742    2336899999999999888865    35789999999999999999999973499999999


Q ss_pred             CCcEEEeCCCC---------------cEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHH
Q 022799           84 PQNLLVNPHTH---------------QLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLA  148 (292)
Q Consensus        84 p~Nill~~~~~---------------~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~  148 (292)
                      |+|||++.++.               .+||+|||.+...  .......+||+.|+|||++.+. .++.++|||||||++|
T Consensus       260 P~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~--~~~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvil~  336 (467)
T PTZ00284        260 PENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDE--RHSRTAIVSTRHYRSPEVVLGL-GWMYSTDMWSMGCIIY  336 (467)
T ss_pred             HHHEEEecCCcccccccccccCCCCceEEECCCCccccC--ccccccccCCccccCcHHhhcC-CCCcHHHHHHHHHHHH
Confidence            99999986542               4899999987643  2223456899999999999765 4899999999999999


Q ss_pred             HHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC-Cccc-c-----CCCCCCCCchhh-----h-ccCCChhHHH
Q 022799          149 ELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN-YTEF-K-----FPQIKAHPWHKI-----F-QKRMPPEAVD  215 (292)
Q Consensus       149 el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~~~~-~-----~~~~~~~~~~~~-----~-~~~~~~~~~~  215 (292)
                      ||++|+.||.+.+..+.+..+.+.++.++.+........ ...+ .     .+......+...     + ....++.+.|
T Consensus       337 elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  416 (467)
T PTZ00284        337 ELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCD  416 (467)
T ss_pred             HHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHH
Confidence            999999999999888888888888888776543211000 0000 0     000000000000     0 0012467889


Q ss_pred             HHHHHhccCCCCcccHHHHhcCCCccccCC
Q 022799          216 LVSRLLQYSPNLRSTALEALIHPFFDELRD  245 (292)
Q Consensus       216 li~~~l~~dp~~R~t~~e~l~hp~~~~~~~  245 (292)
                      ||.+||++||.+|+|++|+|+||||..+..
T Consensus       417 li~~mL~~dP~~R~ta~e~L~Hp~~~~~~~  446 (467)
T PTZ00284        417 LIYGLLHYDRQKRLNARQMTTHPYVLKYYP  446 (467)
T ss_pred             HHHHhCCcChhhCCCHHHHhcCccccccCC
Confidence            999999999999999999999999998654

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=9.3e-41  Score=288.56  Aligned_cols=202  Identities=28%  Similarity=0.510  Sum_probs=165.4

Q ss_pred             CCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccC
Q 022799            3 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRD   81 (292)
Q Consensus         3 ~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~d   81 (292)
                      .++||||+++++++.     +...+++||||++ |+|.+.+..    ...+++..+..++.|++.||.|||++ ||+|||
T Consensus        52 ~~~hp~iv~~~~~~~-----~~~~~~lv~ey~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~-~ivHrd  121 (316)
T cd05619          52 AWEHPFLTHLYCTFQ-----TKENLFFVMEYLNGGDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSK-GIVYRD  121 (316)
T ss_pred             ccCCCcCcceEEEEE-----eCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEeCC
Confidence            358999999999983     3445899999998 698888764    35689999999999999999999988 999999


Q ss_pred             CCCCcEEEeCCCCcEEEeecCCccccccC-CCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCC
Q 022799           82 IKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE  160 (292)
Q Consensus        82 lkp~Nill~~~~~~ikl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  160 (292)
                      |||+||+++.++ .++|+|||++...... .......||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+.
T Consensus       122 ikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~  199 (316)
T cd05619         122 LKLDNILLDTDG-HIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQ-KYNTSVDWWSFGVLLYEMLIGQSPFHGH  199 (316)
T ss_pred             CCHHHEEECCCC-CEEEccCCcceECCCCCCceeeecCCccccCHHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCC
Confidence            999999999888 7999999998754222 223445789999999999664 4899999999999999999999999877


Q ss_pred             CcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHH-HHhcCCC
Q 022799          161 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAL-EALIHPF  239 (292)
Q Consensus       161 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~-e~l~hp~  239 (292)
                      +..+....+...            .+                 .++..++.+++++|.+||..||++|+++. +++.|||
T Consensus       200 ~~~~~~~~i~~~------------~~-----------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~  250 (316)
T cd05619         200 DEEELFQSIRMD------------NP-----------------CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPF  250 (316)
T ss_pred             CHHHHHHHHHhC------------CC-----------------CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcc
Confidence            655444433210            00                 01234788999999999999999999996 8999999


Q ss_pred             ccccCC
Q 022799          240 FDELRD  245 (292)
Q Consensus       240 ~~~~~~  245 (292)
                      |+.+.+
T Consensus       251 ~~~~~~  256 (316)
T cd05619         251 FREIDW  256 (316)
T ss_pred             cCCCCH
Confidence            998764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=5.2e-41  Score=292.21  Aligned_cols=208  Identities=31%  Similarity=0.458  Sum_probs=164.5

Q ss_pred             CCC-CCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            2 RLL-DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         2 ~~l-~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      +.+ +||||+++++++     .....+++||||++ |+|.+.+..    ...+++..++.++.||+.||.|||++ ||+|
T Consensus        59 ~~l~~~~~i~~~~~~~-----~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH  128 (332)
T cd05614          59 EHVRQSPFLVTLHYAF-----QTEAKLHLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKL-GIVY  128 (332)
T ss_pred             HhccCCCCcccEEEEE-----ecCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcEe
Confidence            345 599999999988     44456899999998 688888764    35689999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCC--CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF  157 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf  157 (292)
                      |||||+|||++.++ .+||+|||+++......  ......||+.|+|||++.+...++.++|+||+||++|+|++|..||
T Consensus       129 rDlkp~Nili~~~~-~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf  207 (332)
T cd05614         129 RDIKLENILLDSEG-HVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPF  207 (332)
T ss_pred             cCCCHHHeEECCCC-CEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCC
Confidence            99999999999888 79999999987653322  2234578999999999976555789999999999999999999999


Q ss_pred             CCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcc-----cHH
Q 022799          158 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TAL  232 (292)
Q Consensus       158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----t~~  232 (292)
                      ...........+......        ..                 ..++..+++.+.++|.+||..||++|+     +++
T Consensus       208 ~~~~~~~~~~~~~~~~~~--------~~-----------------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~  262 (332)
T cd05614         208 TLEGERNTQSEVSRRILK--------CD-----------------PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGAS  262 (332)
T ss_pred             CCCCCCCCHHHHHHHHhc--------CC-----------------CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHH
Confidence            754322111111111000        00                 012245789999999999999999999     889


Q ss_pred             HHhcCCCccccCC
Q 022799          233 EALIHPFFDELRD  245 (292)
Q Consensus       233 e~l~hp~~~~~~~  245 (292)
                      ++++||||++..+
T Consensus       263 ~~l~h~~~~~~~~  275 (332)
T cd05614         263 EIKEHPFFKGLDW  275 (332)
T ss_pred             HHHcCCCcCCCCH
Confidence            9999999997653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=4.5e-40  Score=288.63  Aligned_cols=265  Identities=30%  Similarity=0.574  Sum_probs=195.0

Q ss_pred             CCCCCCCCeeeeceeeeccCC-CCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTE-KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~-~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||++++++|..... .+..+.|+||||++++|.+.+..      .+++..+..++.|++.||.|||++ |++|
T Consensus        69 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~-gi~H  141 (353)
T cd07850          69 MKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSA-GIIH  141 (353)
T ss_pred             HHhcCCCCCcceeeeeccCCCccccCcEEEEEeccCCCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC-Ceee
Confidence            357899999999998854332 22345789999999998887753      288899999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      |||||+||+++.++ .++|+|||.++............+++.|+|||.+.+. .++.++|+||+||++|+|++|..||.+
T Consensus       142 ~dlkp~Nil~~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~  219 (353)
T cd07850         142 RDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGTVLFPG  219 (353)
T ss_pred             CCCCHHHEEECCCC-CEEEccCccceeCCCCCCCCCCcccccccCHHHHhCC-CCCCchhhHhHHHHHHHHHHCCCCCCC
Confidence            99999999999988 7999999999876544333445678999999999664 489999999999999999999999999


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccc--cCCCCCCCCchhhh------------ccCCChhHHHHHHHHhccCC
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF--KFPQIKAHPWHKIF------------QKRMPPEAVDLVSRLLQYSP  225 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~------------~~~~~~~~~~li~~~l~~dp  225 (292)
                      .+......++...++.|+.+...........+  ..+......+...+            +...++.++++|.+||+.||
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  299 (353)
T cd07850         220 TDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDP  299 (353)
T ss_pred             CCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCCh
Confidence            88888889999999988876544432211111  00000011111111            12356789999999999999


Q ss_pred             CCcccHHHHhcCCCccccCCCCCCCCCCCCCCCCCCCChhccCCCCHHHHhhh
Q 022799          226 NLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKL  278 (292)
Q Consensus       226 ~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (292)
                      ++|||+.++|.||||+...++....   ...|...+.. .+..+...+.++..
T Consensus       300 ~~R~t~~eiL~~~~~~~~~~~~~~~---~~~~~~~~~~-~~~~~~~~~~~~~~  348 (353)
T cd07850         300 EKRISVDDALQHPYINVWYDPSEVE---APPPAPYDHS-IDEREHTVEEWKEL  348 (353)
T ss_pred             hhCcCHHHHhcChhHhhccCCccCC---CCCCCccccc-cccccccHHHHHHH
Confidence            9999999999999998644432211   1123333322 23345556666653

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=8.2e-41  Score=296.14  Aligned_cols=208  Identities=31%  Similarity=0.524  Sum_probs=163.5

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++     .+..++|+||||++ |+|.+++..    ...+++..++.++.||+.||.|||+. ||+|
T Consensus        55 l~~l~h~~iv~l~~~~-----~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~-givH  124 (381)
T cd05626          55 LAEADNEWVVKLYYSF-----QDKDNLYFVMDYIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKM-GFIH  124 (381)
T ss_pred             HHhcCCCCeeeeEEEE-----ecCCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-Ceee
Confidence            4578999999999998     44456999999998 688888865    35689999999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCC------------------------------------------------
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE------------------------------------------------  111 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~------------------------------------------------  111 (292)
                      |||||+||+++.++ .++|+|||++.......                                                
T Consensus       125 rDlKp~Nili~~~~-~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  203 (381)
T cd05626         125 RDIKPDNILIDLDG-HIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRC  203 (381)
T ss_pred             cCCcHHHEEECCCC-CEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhcccccccccc
Confidence            99999999999887 79999999875321000                                                


Q ss_pred             CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccc
Q 022799          112 PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  191 (292)
Q Consensus       112 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  191 (292)
                      .....+||+.|+|||++.+. .++.++|+||+||++|||++|..||.+.+..+....+......               .
T Consensus       204 ~~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------~  267 (381)
T cd05626         204 LAHSLVGTPNYIAPEVLLRK-GYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENT---------------L  267 (381)
T ss_pred             ccccccCCccccCHHHHcCC-CCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccc---------------c
Confidence            01234789999999999664 4899999999999999999999999887765544444321000               0


Q ss_pred             cCCCCCCCCchhhhccCCChhHHHHHHHHhccC--CCCcccHHHHhcCCCccccCC
Q 022799          192 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYS--PNLRSTALEALIHPFFDELRD  245 (292)
Q Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d--p~~R~t~~e~l~hp~~~~~~~  245 (292)
                      ..+.          ...+++++++||.+|+..+  +..|++++++++||||+++.+
T Consensus       268 ~~~~----------~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~  313 (381)
T cd05626         268 HIPP----------QVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDF  313 (381)
T ss_pred             CCCC----------CCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCCh
Confidence            0000          1257899999999976554  445999999999999998754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-41  Score=293.21  Aligned_cols=201  Identities=28%  Similarity=0.509  Sum_probs=164.9

Q ss_pred             CCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCC
Q 022799            5 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIK   83 (292)
Q Consensus         5 ~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlk   83 (292)
                      +||||+++++++     .+...+|+||||+. |+|.+.+..    ...+++..++.++.||+.||.|||++ ||+|||||
T Consensus        54 ~~p~i~~~~~~~-----~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~-~ivHrDlk  123 (330)
T cd05586          54 ESPFIVGLKFSF-----QTDSDLYLVTDYMSGGELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKY-DIVYRDLK  123 (330)
T ss_pred             CCCcCcceEEEE-----ecCCeEEEEEcCCCCChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCC
Confidence            799999999998     44445999999998 688877764    46789999999999999999999988 99999999


Q ss_pred             CCcEEEeCCCCcEEEeecCCcccccc-CCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCCCc
Q 022799           84 PQNLLVNPHTHQLKLCDFGSAKVLVK-GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG  162 (292)
Q Consensus        84 p~Nill~~~~~~ikl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~  162 (292)
                      |+||+++.++ .++|+|||++..... ........||+.|+|||++.+...++.++|+||+||++|+|++|..||.+.+.
T Consensus       124 p~Nili~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~  202 (330)
T cd05586         124 PENILLDATG-HIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT  202 (330)
T ss_pred             HHHeEECCCC-CEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH
Confidence            9999999888 799999999875422 22334567899999999987665689999999999999999999999988765


Q ss_pred             HHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcc----cHHHHhcCC
Q 022799          163 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS----TALEALIHP  238 (292)
Q Consensus       163 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~----t~~e~l~hp  238 (292)
                      .+....+...                 ...++           ...+++++.++|++||..||.+|+    ++.++++||
T Consensus       203 ~~~~~~i~~~-----------------~~~~~-----------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~  254 (330)
T cd05586         203 QQMYRNIAFG-----------------KVRFP-----------KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHP  254 (330)
T ss_pred             HHHHHHHHcC-----------------CCCCC-----------CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCc
Confidence            5544433221                 00011           024688999999999999999998    799999999


Q ss_pred             CccccC
Q 022799          239 FFDELR  244 (292)
Q Consensus       239 ~~~~~~  244 (292)
                      ||.+..
T Consensus       255 ~~~~~~  260 (330)
T cd05586         255 FFADID  260 (330)
T ss_pred             cccCCC
Confidence            998754

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=5.9e-41  Score=295.70  Aligned_cols=208  Identities=28%  Similarity=0.479  Sum_probs=168.9

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++     .+..++|+||||++ |+|.+++..     ..+++..+..++.||+.||.|||++ ||+|
T Consensus        97 l~~~~h~~iv~~~~~~-----~~~~~~~lv~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~-~ivH  165 (370)
T cd05596          97 MAHANSEWIVQLHYAF-----QDDKYLYMVMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSM-GFIH  165 (370)
T ss_pred             HHhCCCCCcceEEEEE-----ecCCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC-Ceec
Confidence            4578999999999988     55556999999998 688888753     4588999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCC--CcccccccccccCCccccCCC---CCCchhHhhhhhHHHHHHHhCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE--PNISYICSRYYRAPELIFGAT---EYTAAIDIWSAGCVLAELLLGQ  154 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~---~~~~~~DvwslG~il~el~~g~  154 (292)
                      |||||+|||++.++ .+||+|||++.......  ......||+.|+|||++.+..   .++.++|+||+||++|+|++|.
T Consensus       166 rDLkp~NILl~~~~-~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~  244 (370)
T cd05596         166 RDVKPDNMLLDKSG-HLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD  244 (370)
T ss_pred             cCCCHHHEEEcCCC-CEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCC
Confidence            99999999999888 79999999997654322  123457899999999986532   3789999999999999999999


Q ss_pred             CCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCC--cccHH
Q 022799          155 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL--RSTAL  232 (292)
Q Consensus       155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--R~t~~  232 (292)
                      .||.+.+......++.....               ...++.          ...+|.++++||++||..+|.+  |+|++
T Consensus       245 ~Pf~~~~~~~~~~~i~~~~~---------------~~~~~~----------~~~~s~~~~~li~~~L~~~p~r~~R~s~~  299 (370)
T cd05596         245 TPFYADSLVGTYSKIMDHKN---------------SLTFPD----------DIEISKQAKDLICAFLTDREVRLGRNGVD  299 (370)
T ss_pred             CCcCCCCHHHHHHHHHcCCC---------------cCCCCC----------cCCCCHHHHHHHHHHccChhhccCCCCHH
Confidence            99998876665555543110               001111          0247899999999999999988  99999


Q ss_pred             HHhcCCCccccCC
Q 022799          233 EALIHPFFDELRD  245 (292)
Q Consensus       233 e~l~hp~~~~~~~  245 (292)
                      ++++||||+...+
T Consensus       300 ell~h~~~~~~~~  312 (370)
T cd05596         300 EIKSHPFFKNDQW  312 (370)
T ss_pred             HHhcCcccCCCCh
Confidence            9999999987543

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=3.6e-40  Score=281.98  Aligned_cols=231  Identities=37%  Similarity=0.646  Sum_probs=184.3

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccC
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRD   81 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~d   81 (292)
                      ++++||||+++++++....   ..+.|+||||++++|.+++...   ...+++..++.++.||+.||+|||++ |++|+|
T Consensus        59 ~~l~h~ni~~~~~~~~~~~---~~~~~lv~e~~~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~-~i~H~d  131 (293)
T cd07843          59 LKLQHPNIVTVKEVVVGSN---LDKIYMVMEYVEHDLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDN-WILHRD  131 (293)
T ss_pred             HhcCCCCEEEEEEEEEecC---CCcEEEEehhcCcCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC-Ceeecc
Confidence            5688999999999875431   2458999999999998888653   23689999999999999999999988 999999


Q ss_pred             CCCCcEEEeCCCCcEEEeecCCccccccC-CCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCC
Q 022799           82 IKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE  160 (292)
Q Consensus        82 lkp~Nill~~~~~~ikl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  160 (292)
                      |||+||+++.++ .++|+|||.+...... .......+++.|+|||.+.+...++.++|+||+||++|+|++|..||.+.
T Consensus       132 l~p~nili~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~  210 (293)
T cd07843         132 LKTSNLLLNNRG-ILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGK  210 (293)
T ss_pred             CCHHHEEECCCC-cEEEeecCceeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            999999999887 7999999998876443 22234567889999999876655789999999999999999999999999


Q ss_pred             CcHHHHHHHHHHhCCCCHHHHhhcCC--CCccccCCCCCCCCchhhhccC-CChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          161 SGVDQLVEIIKVLGTPTREEIKCMNP--NYTEFKFPQIKAHPWHKIFQKR-MPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       161 ~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      ...+...++....+.|....+.....  ..............+...++.. +++.+.++|++||+.||++|||+.|++.|
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         211 SEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             ChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence            88888889999888888776654321  0111111111122223334333 68899999999999999999999999999


Q ss_pred             CCc
Q 022799          238 PFF  240 (292)
Q Consensus       238 p~~  240 (292)
                      |||
T Consensus       291 ~~f  293 (293)
T cd07843         291 PYF  293 (293)
T ss_pred             CCC
Confidence            998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=5.2e-41  Score=297.56  Aligned_cols=207  Identities=30%  Similarity=0.510  Sum_probs=164.7

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||++++++|     .+..++|+|||||+ |+|.+++..    .+.+++..++.++.||+.||+|||++ ||+|
T Consensus        55 l~~~~h~~iv~~~~~~-----~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~-~ivH  124 (382)
T cd05625          55 LAEADNEWVVRLYYSF-----QDKDNLYFVMDYIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKM-GFIH  124 (382)
T ss_pred             HHhCCCCcCCeEEEEE-----EeCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-Ceec
Confidence            3578999999999998     44456999999998 688888765    35689999999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccC------------------------------------------------C
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG------------------------------------------------E  111 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~------------------------------------------------~  111 (292)
                      |||||+|||++.++ .+||+|||++......                                                .
T Consensus       125 rDlKp~NILl~~~g-~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  203 (382)
T cd05625         125 RDIKPDNILIDRDG-HIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRC  203 (382)
T ss_pred             CCCCHHHEEECCCC-CEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccc
Confidence            99999999999888 7999999987532100                                                0


Q ss_pred             CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccc
Q 022799          112 PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  191 (292)
Q Consensus       112 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  191 (292)
                      .....+||+.|+|||++.+. .++.++|+||+||++|||++|..||.+.+..+...++......               .
T Consensus       204 ~~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------~  267 (382)
T cd05625         204 LAHSLVGTPNYIAPEVLLRT-GYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTS---------------L  267 (382)
T ss_pred             cccccccCcccCCHHHhcCC-CCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCC---------------c
Confidence            01134689999999999664 4899999999999999999999999887766555444321000               0


Q ss_pred             cCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCccc---HHHHhcCCCccccCC
Q 022799          192 KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST---ALEALIHPFFDELRD  245 (292)
Q Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t---~~e~l~hp~~~~~~~  245 (292)
                      ..+          ....+++++.++|.+|+ .+|.+|++   ++++++||||+.+..
T Consensus       268 ~~p----------~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~  313 (382)
T cd05625         268 HIP----------PQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTIDF  313 (382)
T ss_pred             CCC----------CcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCcCh
Confidence            000          01357899999999976 59999997   999999999998654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.2e-41  Score=292.86  Aligned_cols=204  Identities=28%  Similarity=0.461  Sum_probs=168.9

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++     .+...+|+||||++ |+|.+.+..    ...+++..++.++.||+.||.|||++ ||+|
T Consensus        52 l~~l~h~niv~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H  121 (318)
T cd05582          52 LAEVNHPFIVKLHYAF-----QTEGKLYLILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL-GIIY  121 (318)
T ss_pred             HHhCCCCCcccEEEEE-----EcCCEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CEec
Confidence            4678999999999998     44456899999998 688887754    35689999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccC-CCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      |||||+||+++.++ .++|+|||++...... .......||+.|+|||.+.+. .++.++|+||+||++|+|++|..||.
T Consensus       122 ~dlkp~Nil~~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~  199 (318)
T cd05582         122 RDLKPENILLDEEG-HIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGSLPFQ  199 (318)
T ss_pred             CCCCHHHeEECCCC-cEEEeeccCCcccCCCCCceecccCChhhcCHHHHcCC-CCCCccceeccceEeeeeccCCCCCC
Confidence            99999999999888 7999999998765433 223345789999999999654 47899999999999999999999998


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCccc-----HHH
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----ALE  233 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t-----~~e  233 (292)
                      +.+..+....+.+..                 .            .++..+++++.++|++||+.||++|+|     +.+
T Consensus       200 ~~~~~~~~~~i~~~~-----------------~------------~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~  250 (318)
T cd05582         200 GKDRKETMTMILKAK-----------------L------------GMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEE  250 (318)
T ss_pred             CCCHHHHHHHHHcCC-----------------C------------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHH
Confidence            877655554443210                 0            022457899999999999999999999     788


Q ss_pred             HhcCCCccccCC
Q 022799          234 ALIHPFFDELRD  245 (292)
Q Consensus       234 ~l~hp~~~~~~~  245 (292)
                      ++.||||+.+.+
T Consensus       251 ~~~~~~~~~~~~  262 (318)
T cd05582         251 IKRHPFFSTIDW  262 (318)
T ss_pred             HhCCCCcCCCCH
Confidence            999999987643

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=5e-40  Score=279.81  Aligned_cols=230  Identities=40%  Similarity=0.795  Sum_probs=186.4

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      +++++||||+++++++     .+..+.++||||++++|.+.+...   ...+++..++.++.||+.||.|||++ |++|+
T Consensus        53 l~~~~~~~i~~~~~~~-----~~~~~~~~v~e~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~  123 (286)
T cd07832          53 LQACQHPYVVKLLDVF-----PHGSGFVLVMEYMPSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHAN-GIMHR  123 (286)
T ss_pred             HHhCCCCCCcceeeEE-----ecCCeeEEEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecC
Confidence            3567899999999998     445568999999988999888653   35689999999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCC--cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      ||||+||+++.++ .++|+|||.+........  .....++..|+|||.+.+...++.++|+||+||++|+|++|.++|.
T Consensus       124 dl~p~ni~~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~  202 (286)
T cd07832         124 DLKPANLLISADG-VLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFP  202 (286)
T ss_pred             CcCHHHEEEcCCC-cEEEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcC
Confidence            9999999999877 799999999886644321  2345678999999998766667999999999999999999999999


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCC--CCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNP--NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      +......+..+....+.+....+.....  .+....++......+...+ ++.+..+.++|.+||..||++|||++++++
T Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         203 GENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIF-PDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             CCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhC-CCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            8888888899999888888766654321  1222223333222333322 456799999999999999999999999999


Q ss_pred             CCCcc
Q 022799          237 HPFFD  241 (292)
Q Consensus       237 hp~~~  241 (292)
                      ||||.
T Consensus       282 h~~~~  286 (286)
T cd07832         282 HPYFT  286 (286)
T ss_pred             CcCcC
Confidence            99984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.5e-40  Score=287.59  Aligned_cols=269  Identities=38%  Similarity=0.688  Sum_probs=208.1

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      |+.++||||+++++++..........+|+||||++++|.+.+..    ...+++..++.++.||+.||.|||++ ||+||
T Consensus        53 l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~-gi~H~  127 (330)
T cd07834          53 LRHLRHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSA-NVIHR  127 (330)
T ss_pred             HHhcCCcchhhhhhhhcccCcccccceEEEecchhhhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhC-CeecC
Confidence            35688999999999885544223346899999999988888764    34789999999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCC----CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE----PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPL  156 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~p  156 (292)
                      ||||+||+++.++ .++|+|||.+.......    ......+++.|+|||.+.+...++.++|+||+||++|+|++|..|
T Consensus       128 dlkp~nili~~~~-~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~p  206 (330)
T cd07834         128 DLKPSNILVNSNC-DLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPL  206 (330)
T ss_pred             CCCHHHEEEcCCC-CEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCC
Confidence            9999999999987 79999999998765443    133456788999999997764689999999999999999999999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC-ccc--cCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHH
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNY-TEF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE  233 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e  233 (292)
                      |.+.+..+....+....+.++.+.+....... ..+  ..+.....++... .+.++.++.++|.+||+++|++|||+++
T Consensus       207 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~  285 (330)
T cd07834         207 FPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKL-FPGASPEAIDLLEKMLVFDPKKRITADE  285 (330)
T ss_pred             cCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHh-cccCCHHHHHHHHHHccCChhhCCCHHH
Confidence            99999989899999988888876654221111 111  0111112222222 2457899999999999999999999999


Q ss_pred             HhcCCCccccCCCCCCCCCCCCCCCCCCCChhccCCCCHHHHhhhch
Q 022799          234 ALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIP  280 (292)
Q Consensus       234 ~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (292)
                      ++.||||+++..+....+.    ...+++.+.+-+.++.+.+++.+.
T Consensus       286 ll~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~  328 (330)
T cd07834         286 ALAHPYLAQLHDPEDEPVA----KPPFDFDFFDDDELTEEELKELIY  328 (330)
T ss_pred             HHhCccHHhhcccccCCCC----CCcccccccchhhcCHHHHhHHhh
Confidence            9999999998876544332    233455556667777777766553

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=9.9e-41  Score=290.03  Aligned_cols=201  Identities=26%  Similarity=0.495  Sum_probs=160.9

Q ss_pred             CCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCC
Q 022799            5 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIK   83 (292)
Q Consensus         5 ~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlk   83 (292)
                      +||||++++++|     .+...+|+||||++ |+|...+..    .+++++..++.++.||+.||.|||++ ||+|||||
T Consensus        54 ~hp~Iv~~~~~~-----~~~~~~~lv~e~~~~g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlk  123 (329)
T cd05588          54 NHPFLVGLHSCF-----QTESRLFFVIEFVSGGDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHER-GIIYRDLK  123 (329)
T ss_pred             CCCCCCceEEEE-----EcCCEEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCC
Confidence            799999999998     44456999999998 688777754    36799999999999999999999988 99999999


Q ss_pred             CCcEEEeCCCCcEEEeecCCccccc-cCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCCCc
Q 022799           84 PQNLLVNPHTHQLKLCDFGSAKVLV-KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG  162 (292)
Q Consensus        84 p~Nill~~~~~~ikl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~  162 (292)
                      |+||+++.++ .+||+|||+++... .........||+.|+|||++.+. .++.++|+||+||++|+|++|..||.....
T Consensus       124 p~Nili~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~Pf~~~~~  201 (329)
T cd05588         124 LDNVLLDAEG-HIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGM  201 (329)
T ss_pred             HHHeEECCCC-CEEECcCccccccccCCCccccccCCccccCHHHHcCC-CCCCccceechHHHHHHHHHCCCCcccccc
Confidence            9999999888 79999999987532 22333456789999999999764 489999999999999999999999963211


Q ss_pred             --------HHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCccc----
Q 022799          163 --------VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST----  230 (292)
Q Consensus       163 --------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t----  230 (292)
                              .+...+.+..              .  .            ..++..++..+.++|++||..||.+|+|    
T Consensus       202 ~~~~~~~~~~~~~~~~~~--------------~--~------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~  253 (329)
T cd05588         202 SDNPDQNTEDYLFQVILE--------------K--Q------------IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQ  253 (329)
T ss_pred             cccccccchHHHHHHHHc--------------C--C------------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCC
Confidence                    1111111100              0  0            0123467899999999999999999987    


Q ss_pred             --HHHHhcCCCccccCC
Q 022799          231 --ALEALIHPFFDELRD  245 (292)
Q Consensus       231 --~~e~l~hp~~~~~~~  245 (292)
                        ++++++||||..+.+
T Consensus       254 ~~~~~i~~hp~~~~~~~  270 (329)
T cd05588         254 TGFRDIKSHPFFRNIDW  270 (329)
T ss_pred             CCHHHHhcCCCCCCCCH
Confidence              789999999987654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=8.4e-40  Score=281.81  Aligned_cols=236  Identities=35%  Similarity=0.569  Sum_probs=185.1

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      |++++||||+++++++....   ...+++||||++++|.+++...   ...+++..+..++.||+.||.|||+. |++||
T Consensus        60 l~~l~h~~i~~~~~~~~~~~---~~~~~lv~e~~~~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~  132 (309)
T cd07845          60 LLNLRHPNIVELKEVVVGKH---LDSIFLVMEYCEQDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHEN-FIIHR  132 (309)
T ss_pred             HHhCCCCCCcceEEEEecCC---CCeEEEEEecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC-CeecC
Confidence            35789999999999885322   2347899999999988887653   35689999999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCC-CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      ||||+||+++.++ .++|+|||.+....... ......+++.|+|||.+.+...++.++|+||+||++|+|++|..||.+
T Consensus       133 dl~p~nil~~~~~-~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~  211 (309)
T cd07845         133 DLKVSNLLLTDKG-CLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPG  211 (309)
T ss_pred             CCCHHHEEECCCC-CEEECccceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999887 79999999998764332 222334578899999987766689999999999999999999999999


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCC--CCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNP--NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      .+..+.+..+....+.+....+.....  ....+..+......+...+ ...++++.++|.+||..||++|||+.++++|
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         212 KSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKF-PWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             CCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhc-cccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            999999999999888887765543311  1111111111111111111 2368899999999999999999999999999


Q ss_pred             CCccccCC
Q 022799          238 PFFDELRD  245 (292)
Q Consensus       238 p~~~~~~~  245 (292)
                      |||++..-
T Consensus       291 ~~f~~~~~  298 (309)
T cd07845         291 SYFKEKPL  298 (309)
T ss_pred             hhhccCCC
Confidence            99986443

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=3.7e-41  Score=292.85  Aligned_cols=210  Identities=26%  Similarity=0.455  Sum_probs=169.6

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++     .+..++|+||||++ |+|.+++...   ...+++..++.++.||+.||.|||+. ||+|
T Consensus        55 ~~~~~~~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~-~i~H  125 (330)
T cd05601          55 LSISNSPWIPQLQYAF-----QDKDNLYLVMEYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQM-GYVH  125 (330)
T ss_pred             HHhCCCCCCcceeeEE-----ecCCeEEEEECCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEc
Confidence            3567999999999988     44456999999997 6998888753   35789999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCc--ccccccccccCCccccC-----CCCCCchhHhhhhhHHHHHHHh
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN--ISYICSRYYRAPELIFG-----ATEYTAAIDIWSAGCVLAELLL  152 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~~-----~~~~~~~~DvwslG~il~el~~  152 (292)
                      |||||+||+++.++ .+||+|||++.........  ....||+.|+|||++.+     ...++.++|+||+||++|+|++
T Consensus       126 ~Dlkp~NIll~~~~-~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~  204 (330)
T cd05601         126 RDIKPENVLIDRTG-HIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIY  204 (330)
T ss_pred             ccCchHheEECCCC-CEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeecc
Confidence            99999999999888 7999999999876433322  23468999999999863     3447899999999999999999


Q ss_pred             CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHH
Q 022799          153 GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAL  232 (292)
Q Consensus       153 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~  232 (292)
                      |..||.+.+....+.++.....               ...++.          ...+++++.+||.+||. +|.+|+|++
T Consensus       205 g~~Pf~~~~~~~~~~~i~~~~~---------------~~~~~~----------~~~~~~~~~~li~~ll~-~p~~R~t~~  258 (330)
T cd05601         205 GRSPFHEGTSAKTYNNIMNFQR---------------FLKFPE----------DPKVSSDFLDLIQSLLC-GQKERLGYE  258 (330)
T ss_pred             CCCCCCCCCHHHHHHHHHcCCC---------------ccCCCC----------CCCCCHHHHHHHHHHcc-ChhhCCCHH
Confidence            9999988776665555443200               001110          13578999999999998 999999999


Q ss_pred             HHhcCCCccccCCC
Q 022799          233 EALIHPFFDELRDP  246 (292)
Q Consensus       233 e~l~hp~~~~~~~~  246 (292)
                      ++++||||+.+.+.
T Consensus       259 ~l~~h~~~~~~~~~  272 (330)
T cd05601         259 GLCCHPFFSKIDWN  272 (330)
T ss_pred             HHhCCCCcCCCCHH
Confidence            99999999986643

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=8e-40  Score=278.03  Aligned_cols=229  Identities=38%  Similarity=0.685  Sum_probs=180.2

Q ss_pred             CCC-CCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLL-DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l-~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      +++ +||||+++++++.+.   ....+++||||+++++.+.+...   ...+++..++.++.|++.||.|||++ |++||
T Consensus        52 ~~l~~h~~i~~~~~~~~~~---~~~~~~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~-~i~H~  124 (282)
T cd07831          52 RRLSPHPNILRLIEVLFDR---KTGRLALVFELMDMNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRN-GIFHR  124 (282)
T ss_pred             hhcCCCCCccceEEEEecC---CCCcEEEEEecCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC-Cceec
Confidence            344 599999999998543   11358999999999988887653   35689999999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE  160 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  160 (292)
                      ||+|+||+++. + .++|+|||.+.............+++.|+|||.+.+...++.++|+||+||++|+|++|..||.+.
T Consensus       125 dl~p~ni~l~~-~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~  202 (282)
T cd07831         125 DIKPENILIKD-D-ILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGT  202 (282)
T ss_pred             ccCHHHEEEcC-C-CeEEEecccccccccCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCC
Confidence            99999999998 6 799999999987654444444567899999998755555789999999999999999999999999


Q ss_pred             CcHHHHHHHHHHhCCCCHHHHhhcCCC-CccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCC
Q 022799          161 SGVDQLVEIIKVLGTPTREEIKCMNPN-YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF  239 (292)
Q Consensus       161 ~~~~~~~~i~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~  239 (292)
                      +..+....+....+.+........... ...+.++........ .....++..+.++|.+||..||++|||+.+++.|||
T Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~  281 (282)
T cd07831         203 NELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLR-KLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY  281 (282)
T ss_pred             CHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHH-HHcccccHHHHHHHHHHhccCcccccCHHHHhhCCC
Confidence            888888888888887776543322111 111122221111111 122467899999999999999999999999999999


Q ss_pred             c
Q 022799          240 F  240 (292)
Q Consensus       240 ~  240 (292)
                      |
T Consensus       282 ~  282 (282)
T cd07831         282 F  282 (282)
T ss_pred             C
Confidence            7

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.5e-40  Score=287.81  Aligned_cols=228  Identities=25%  Similarity=0.470  Sum_probs=166.3

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++.     +...+++||||++ |+|.+++..    ...+++..+..++.|++.||.|||++.+|+|
T Consensus        57 l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH  127 (331)
T cd06649          57 LHECNSPYIVGFYGAFY-----SDGEISICMEHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKHQIMH  127 (331)
T ss_pred             HHHCCCCCCCeEEEEEE-----ECCEEEEEeecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEc
Confidence            46789999999999984     3345899999998 699888865    3568999999999999999999998536999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      |||||+||+++.++ .++|+|||++...... ......||+.|+|||.+.+. .++.++|+||+||++|+|++|+.||..
T Consensus       128 ~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~-~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~  204 (331)
T cd06649         128 RDVKPSNILVNSRG-EIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVELAIGRYPIPP  204 (331)
T ss_pred             CCCChhhEEEcCCC-cEEEccCccccccccc-ccccCCCCcCcCCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence            99999999999888 7999999998765332 23345789999999999665 489999999999999999999999977


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHh----hcCCCC----ccc---cCCCCCC------------CCchhhhccCCChhHHHH
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIK----CMNPNY----TEF---KFPQIKA------------HPWHKIFQKRMPPEAVDL  216 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~----~~~~~~----~~~---~~~~~~~------------~~~~~~~~~~~~~~~~~l  216 (292)
                      .+..+...    .++.+......    ...+..    ...   .......            ......-...+++++++|
T Consensus       205 ~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  280 (331)
T cd06649         205 PDAKELEA----IFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEF  280 (331)
T ss_pred             CCHHHHHH----HhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHH
Confidence            65443221    22221110000    000000    000   0000000            000000012468899999


Q ss_pred             HHHHhccCCCCcccHHHHhcCCCccccC
Q 022799          217 VSRLLQYSPNLRSTALEALIHPFFDELR  244 (292)
Q Consensus       217 i~~~l~~dp~~R~t~~e~l~hp~~~~~~  244 (292)
                      |.+||.+||++|||+.++++||||+...
T Consensus       281 i~~~L~~~P~~Rpt~~ell~h~~~~~~~  308 (331)
T cd06649         281 VNKCLIKNPAERADLKMLMNHTFIKRSE  308 (331)
T ss_pred             HHHHccCCcccCCCHHHHhcChHHhhcc
Confidence            9999999999999999999999998643

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=7.7e-41  Score=290.29  Aligned_cols=203  Identities=27%  Similarity=0.459  Sum_probs=167.2

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      +.++||||+++++++     .+...+|+||||++ |+|.+.+..    ...+++..++.++.||+.||.|||++ ||+||
T Consensus        51 ~~~~h~~Iv~~~~~~-----~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~-giiHr  120 (325)
T cd05602          51 KNVKHPFLVGLHFSF-----QTADKLYFVLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL-NIVYR  120 (325)
T ss_pred             HhCCCCCCCceeEEE-----EcCCeEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEec
Confidence            568999999999998     44445899999998 588887764    35688999999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCcccccc-CCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVK-GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      ||||+||+++.++ .++|+|||+++.... ........||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+
T Consensus       121 Dlkp~Nili~~~~-~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~  198 (325)
T cd05602         121 DLKPENILLDSQG-HIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYS  198 (325)
T ss_pred             CCCHHHeEECCCC-CEEEccCCCCcccccCCCCcccccCCccccCHHHHcCC-CCCCccccccccHHHHHHhcCCCCCCC
Confidence            9999999999888 799999999875422 2223455789999999999664 489999999999999999999999988


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHH----HHh
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAL----EAL  235 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~----e~l  235 (292)
                      .+..+....+...   +              .            .+++.+++.+.++|.+||+.||.+|+++.    +++
T Consensus       199 ~~~~~~~~~i~~~---~--------------~------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~  249 (325)
T cd05602         199 RNTAEMYDNILNK---P--------------L------------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIK  249 (325)
T ss_pred             CCHHHHHHHHHhC---C--------------c------------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHh
Confidence            7766655544331   0              0            01246889999999999999999999865    899


Q ss_pred             cCCCccccCC
Q 022799          236 IHPFFDELRD  245 (292)
Q Consensus       236 ~hp~~~~~~~  245 (292)
                      +|+||..+.+
T Consensus       250 ~~~~~~~~~~  259 (325)
T cd05602         250 NHIFFSPINW  259 (325)
T ss_pred             cCcccCCCCH
Confidence            9999987653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.9e-40  Score=294.68  Aligned_cols=231  Identities=23%  Similarity=0.353  Sum_probs=174.2

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      |++++|||||+++++|     ......|+|||++.++|.+++..    ...+++..+..++.||+.||.|||++ ||+||
T Consensus       140 l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~~~~l~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~-givHr  209 (392)
T PHA03207        140 LKTISHRAIINLIHAY-----RWKSTVCMVMPKYKCDLFTYVDR----SGPLPLEQAITIQRRLLEALAYLHGR-GIIHR  209 (392)
T ss_pred             HHhcCCCCccceeeeE-----eeCCEEEEEehhcCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-Ccccc
Confidence            4678999999999988     44456899999999999888843    46799999999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCC---cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF  157 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf  157 (292)
                      ||||+||+++.++ .++|+|||++........   .....||+.|+|||++.+. .++.++|+||+||++|+|++|..||
T Consensus       210 Dlkp~Nill~~~~-~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf  287 (392)
T PHA03207        210 DVKTENIFLDEPE-NAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALD-PYCAKTDIWSAGLVLFEMSVKNVTL  287 (392)
T ss_pred             CCCHHHEEEcCCC-CEEEccCccccccCcccccccccccccccCccCHhHhcCC-CCCchhhHHHHHHHHHHHHHCCCCC
Confidence            9999999999888 799999999876543322   2245789999999999654 4899999999999999999999999


Q ss_pred             CCCC---cHHHHHHHHHHhCCCCHHHHhhcCCC----CccccCCCCCCCCchhh-hccCCChhHHHHHHHHhccCCCCcc
Q 022799          158 PGES---GVDQLVEIIKVLGTPTREEIKCMNPN----YTEFKFPQIKAHPWHKI-FQKRMPPEAVDLVSRLLQYSPNLRS  229 (292)
Q Consensus       158 ~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dp~~R~  229 (292)
                      .+..   ....+..+.+.++..+.+........    +..+............. ....++.++.++|++||..||.+||
T Consensus       288 ~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rp  367 (392)
T PHA03207        288 FGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRP  367 (392)
T ss_pred             CCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCC
Confidence            7654   34566667766655443211100000    00000000000011111 1134678899999999999999999


Q ss_pred             cHHHHhcCCCcccc
Q 022799          230 TALEALIHPFFDEL  243 (292)
Q Consensus       230 t~~e~l~hp~~~~~  243 (292)
                      |+.++|+||||...
T Consensus       368 sa~e~l~~p~f~~~  381 (392)
T PHA03207        368 SAQDILSLPLFTKE  381 (392)
T ss_pred             CHHHHhhCchhhcc
Confidence            99999999999864

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=6e-40  Score=280.71  Aligned_cols=237  Identities=35%  Similarity=0.630  Sum_probs=183.0

Q ss_pred             CC-CCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            3 LL-DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKM-SQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         3 ~l-~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~-~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      .+ +||||+++++++......+....|+||||++++|.+++...... ...+++..++.++.||+.||.|||++ ||+||
T Consensus        56 ~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~-~i~H~  134 (295)
T cd07837          56 MLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH-GVMHR  134 (295)
T ss_pred             HccCCCCccceeeeEeecCCCCCceEEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC-Ceeec
Confidence            45 47999999998865444344568999999999998888654332 35689999999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCC-CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      ||+|+||+++.+...++|+|||.+....... ......+++.|+|||.+.+...++.++|+||+||++|+|++|..||.+
T Consensus       135 dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~  214 (295)
T cd07837         135 DLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPG  214 (295)
T ss_pred             CCChHHEEEecCCCeEEEeecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Confidence            9999999999833489999999987653221 112235688899999987656689999999999999999999999999


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCC
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF  239 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~  239 (292)
                      .+......++.+..+.++...+............+......... ..+.+++.+.+||.+||..||.+|||+++++.|||
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~  293 (295)
T cd07837         215 DSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSR-AVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY  293 (295)
T ss_pred             CCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHH-hccccCHHHHHHHHHHccCChhhcCCHHHHhcCCC
Confidence            98888888888888877766543322111111122211111111 12468899999999999999999999999999999


Q ss_pred             cc
Q 022799          240 FD  241 (292)
Q Consensus       240 ~~  241 (292)
                      |+
T Consensus       294 ~~  295 (295)
T cd07837         294 FD  295 (295)
T ss_pred             cC
Confidence            85

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=8e-40  Score=280.40  Aligned_cols=235  Identities=38%  Similarity=0.671  Sum_probs=185.4

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      |+.++||||+++++++     .+..+.++||||+.++|.+++...   ...+++..+..++.||+.||.|||++ |++|+
T Consensus        56 l~~~~h~~i~~~~~~~-----~~~~~~~lv~e~~~~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~~-~i~H~  126 (298)
T cd07841          56 LQELKHPNIIGLLDVF-----GHKSNINLVFEFMETDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHSN-WILHR  126 (298)
T ss_pred             HhhcCCCCChhhhhee-----ecCCEEEEEEcccCCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhC-Ceeec
Confidence            4578999999999998     344568999999988999988753   13689999999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCC-CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      ||+|+||+++.++ .++|+|||++....... ......+++.|+|||.+.+...++.++|+||+||++|+|++|.++|.+
T Consensus       127 dl~p~nill~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~  205 (298)
T cd07841         127 DLKPNNLLIASDG-VLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPG  205 (298)
T ss_pred             CCChhhEEEcCCC-CEEEccceeeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccC
Confidence            9999999999888 79999999998764432 222345678899999986656689999999999999999999999998


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCC
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF  239 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~  239 (292)
                      .+..+.+.++....+.+....+..................+... .....+..+.++|.+||..||++|||+.+++.|||
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~  284 (298)
T cd07841         206 DSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQ-IFPAASDDALDLLQRLLTLNPNKRITARQALEHPY  284 (298)
T ss_pred             CccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhh-hcccccHHHHHHHHHHhcCCcccCcCHHHHhhCcc
Confidence            88888888888888777766554322111111111111111111 12456889999999999999999999999999999


Q ss_pred             ccccCCC
Q 022799          240 FDELRDP  246 (292)
Q Consensus       240 ~~~~~~~  246 (292)
                      |++...+
T Consensus       285 ~~~~~~~  291 (298)
T cd07841         285 FSNDPAP  291 (298)
T ss_pred             ccCCCCC
Confidence            9986544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.9e-40  Score=281.59  Aligned_cols=212  Identities=23%  Similarity=0.354  Sum_probs=166.1

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++     .+..++|+||||++ ++|.+.+...  ....+++..+..++.||+.||+|||+. ||+|
T Consensus        47 l~~l~hp~i~~~~~~~-----~~~~~~~lv~e~~~g~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH  118 (277)
T cd05607          47 LEKVNSPFIVNLAYAF-----ESKTHLCLVMSLMNGGDLKYHIYNV--GERGLEMERVIHYSAQITCGILHLHSM-DIVY  118 (277)
T ss_pred             HHhcCCCcEEEEEEEE-----ecCCeEEEEEecCCCCCHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHC-CEEE
Confidence            4578999999999988     44556999999998 6887777543  134588889999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      |||||+||+++.++ .++|+|||++.............||+.|+|||++.+.. ++.++|+||+||++|+|++|..||.+
T Consensus       119 ~dikp~Nili~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p~~~  196 (277)
T cd05607         119 RDMKPENVLLDDQG-NCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFKD  196 (277)
T ss_pred             ccCChHhEEEcCCC-CEEEeeceeeeecCCCceeeccCCCCCccCHHHHccCC-CCCchhHHHHHHHHHHHHhCCCCCCC
Confidence            99999999999887 79999999988765444444457899999999997655 89999999999999999999999976


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccH----HHHh
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA----LEAL  235 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~----~e~l  235 (292)
                      .........+......          .   ....           ....++++++++|.+||..||.+||++    ++++
T Consensus       197 ~~~~~~~~~~~~~~~~----------~---~~~~-----------~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~  252 (277)
T cd05607         197 HKEKVAKEELKRRTLE----------D---EVKF-----------EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPR  252 (277)
T ss_pred             CcchhhHHHHHHHhhc----------c---cccc-----------ccccCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence            4332111111111000          0   0000           013578899999999999999999999    7788


Q ss_pred             cCCCccccCCC
Q 022799          236 IHPFFDELRDP  246 (292)
Q Consensus       236 ~hp~~~~~~~~  246 (292)
                      +||||+.+.++
T Consensus       253 ~h~~f~~~~~~  263 (277)
T cd05607         253 KHEFFKTINFP  263 (277)
T ss_pred             cChhhcCCCHH
Confidence            99999987653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=7.7e-41  Score=290.29  Aligned_cols=203  Identities=28%  Similarity=0.475  Sum_probs=166.4

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      +.++||||+++++++     .....+|+||||+. |+|...+..    ...+++..++.++.||+.||.|||++ ||+||
T Consensus        51 ~~~~hp~iv~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~-givH~  120 (325)
T cd05604          51 KNVKHPFLVGLHYSF-----QTTEKLYFVLDFVNGGELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSI-NIVYR  120 (325)
T ss_pred             HhCCCCCCccEEEEE-----ecCCEEEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-Ceeec
Confidence            568999999999988     44445899999998 588777654    46789999999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCcccccc-CCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVK-GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      ||||+||+++.++ .+||+|||+++.... ........||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+
T Consensus       121 Dlkp~NIll~~~~-~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~  198 (325)
T cd05604         121 DLKPENILLDSQG-HVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQ-PYDNTVDWWCLGAVLYEMLYGLPPFYC  198 (325)
T ss_pred             CCCHHHeEECCCC-CEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcCC-CCCCcCccccccceehhhhcCCCCCCC
Confidence            9999999999888 799999999875422 2223445789999999999664 489999999999999999999999988


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccH----HHHh
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA----LEAL  235 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~----~e~l  235 (292)
                      .+..+....+....                 .            .+++..+..+.++|++||..||.+||++    .+++
T Consensus       199 ~~~~~~~~~~~~~~-----------------~------------~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~  249 (325)
T cd05604         199 RDVAEMYDNILHKP-----------------L------------VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQ  249 (325)
T ss_pred             CCHHHHHHHHHcCC-----------------c------------cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHh
Confidence            77655554443210                 0            0124578899999999999999999976    6999


Q ss_pred             cCCCccccCC
Q 022799          236 IHPFFDELRD  245 (292)
Q Consensus       236 ~hp~~~~~~~  245 (292)
                      .||||+...+
T Consensus       250 ~h~~f~~~~~  259 (325)
T cd05604         250 EHPFFESLSW  259 (325)
T ss_pred             cCCCcCCCCH
Confidence            9999997653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.2e-41  Score=266.49  Aligned_cols=237  Identities=30%  Similarity=0.529  Sum_probs=191.6

Q ss_pred             CCCCCCCCeeeeceeeec---cCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCc
Q 022799            1 MRLLDHPNVVSLKHCFFS---TTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGV   77 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~---~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i   77 (292)
                      |..|+|+|++.+++++.+   +...+...+|+||.+|+.+|..++.+.   ..+++..++.+++.+++.||.|+|.. .|
T Consensus        70 L~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~cehDLaGlLsn~---~vr~sls~Ikk~Mk~Lm~GL~~iHr~-ki  145 (376)
T KOG0669|consen   70 LQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEHDLAGLLSNR---KVRFSLSEIKKVMKGLMNGLYYIHRN-KI  145 (376)
T ss_pred             HHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhhhHHHHhcCc---cccccHHHHHHHHHHHHHHHHHHHHh-hH
Confidence            456899999999997753   233455678999999999999988753   36799999999999999999999988 99


Q ss_pred             cccCCCCCcEEEeCCCCcEEEeecCCccccccCCC-----cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh
Q 022799           78 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL  152 (292)
Q Consensus        78 ~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~  152 (292)
                      +|||+|+.|+|++.++ .+||+|||+++.+...+.     .+..+.|.+|++||.+.|.+.|+++.|+|+.|||+.||++
T Consensus       146 lHRDmKaaNvLIt~dg-ilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwt  224 (376)
T KOG0669|consen  146 LHRDMKAANVLITKDG-ILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWT  224 (376)
T ss_pred             HhhcccHhhEEEcCCc-eEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHc
Confidence            9999999999999998 899999999977644322     2345669999999999999999999999999999999999


Q ss_pred             CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC--CCCccccCC---CCCCCCchhhhcc-CCChhHHHHHHHHhccCCC
Q 022799          153 GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEFKFP---QIKAHPWHKIFQK-RMPPEAVDLVSRLLQYSPN  226 (292)
Q Consensus       153 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~--~~~~~~~~~---~~~~~~~~~~~~~-~~~~~~~~li~~~l~~dp~  226 (292)
                      |.+.+.++++..++..|...+|..+.+.|..+.  +-+.....+   .-..+..+....+ .-.+++.||+.++|..||.
T Consensus       225 rspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~  304 (376)
T KOG0669|consen  225 RSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPT  304 (376)
T ss_pred             cCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcc
Confidence            999999999999999999999999988776542  112222111   1111111111110 1246899999999999999


Q ss_pred             CcccHHHHhcCCCccc
Q 022799          227 LRSTALEALIHPFFDE  242 (292)
Q Consensus       227 ~R~t~~e~l~hp~~~~  242 (292)
                      +|++++++++|.||..
T Consensus       305 kR~~ad~alnh~~F~k  320 (376)
T KOG0669|consen  305 KRIDADQALNHDFFWK  320 (376)
T ss_pred             cCcchHhhhchhhhhc
Confidence            9999999999999974

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-42  Score=279.28  Aligned_cols=205  Identities=28%  Similarity=0.451  Sum_probs=175.6

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+..+||.+..+.-.|     +....+|.||||+. |.|.--+.+    ...+++..++.|..+|+.||.|||++ +||+
T Consensus       222 L~~~~HPFLt~LKYsF-----Qt~drlCFVMeyanGGeLf~HLsr----er~FsE~RtRFYGaEIvsAL~YLHs~-~ivY  291 (516)
T KOG0690|consen  222 LQNCRHPFLTSLKYSF-----QTQDRLCFVMEYANGGELFFHLSR----ERVFSEDRTRFYGAEIVSALGYLHSR-NIVY  291 (516)
T ss_pred             HHhccCcHHHHhhhhh-----ccCceEEEEEEEccCceEeeehhh----hhcccchhhhhhhHHHHHHhhhhhhC-Ceee
Confidence            4678999999999888     44445999999998 566555554    56799999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCcccc-ccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      ||+|.+|++++.+| .|||+|||+++.- ..+....+++|||.|+|||++.. ..|+.++|+|.+|+++|||++|+.||.
T Consensus       292 RDlKLENLlLDkDG-HIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleD-nDYgraVDWWG~GVVMYEMmCGRLPFy  369 (516)
T KOG0690|consen  292 RDLKLENLLLDKDG-HIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLED-NDYGRAVDWWGVGVVMYEMMCGRLPFY  369 (516)
T ss_pred             eechhhhheeccCC-ceEeeecccchhcccccceeccccCChhhcCchhhcc-ccccceeehhhhhHHHHHHHhccCccc
Confidence            99999999999999 5999999999864 33455678899999999999955 469999999999999999999999999


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCccc-----HHH
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----ALE  233 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t-----~~e  233 (292)
                      +.+.......|...                 +.            .||..++++++.|+..+|.+||.+|..     +.|
T Consensus       370 n~dh~kLFeLIl~e-----------------d~------------kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakE  420 (516)
T KOG0690|consen  370 NKDHEKLFELILME-----------------DL------------KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKE  420 (516)
T ss_pred             ccchhHHHHHHHhh-----------------hc------------cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHH
Confidence            88877766666542                 11            245689999999999999999999964     889


Q ss_pred             HhcCCCccccCCC
Q 022799          234 ALIHPFFDELRDP  246 (292)
Q Consensus       234 ~l~hp~~~~~~~~  246 (292)
                      +.+|+||.++++.
T Consensus       421 i~~h~FF~~v~W~  433 (516)
T KOG0690|consen  421 IMRHRFFASVDWE  433 (516)
T ss_pred             HHhhhhhccCCHH
Confidence            9999999999864

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=4.4e-40  Score=286.58  Aligned_cols=240  Identities=37%  Similarity=0.711  Sum_probs=190.3

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      |++++||||+++++++.... .+...+++||||++++|.+.+..    ...+++..++.++.||+.||.|||++ ||+||
T Consensus        58 l~~l~h~~iv~~~~~~~~~~-~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~  131 (334)
T cd07855          58 LRHFKHDNIIAIRDILRPPG-ADFKDVYVVMDLMESDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSA-NVIHR  131 (334)
T ss_pred             HHhcCCCCccCHHHhccccC-CCCceEEEEEehhhhhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecC
Confidence            46789999999999875433 34456899999999988887754    35689999999999999999999987 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCC-----cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQP  155 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~  155 (292)
                      ||||+||+++.++ .+||+|||.+........     .....++..|+|||.+.+...++.++|+||+||++|+|++|+.
T Consensus       132 dlkp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~  210 (334)
T cd07855         132 DLKPSNLLVNEDC-ELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQ  210 (334)
T ss_pred             CCCHHHEEEcCCC-cEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCC
Confidence            9999999999988 799999999876533221     1234678899999998665558999999999999999999999


Q ss_pred             CCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc---ccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHH
Q 022799          156 LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE---FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAL  232 (292)
Q Consensus       156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~  232 (292)
                      ||.+.+....+..+....+.|+.+.+.........   ...+......+.. ..+..++++.++|++||+.+|.+|||++
T Consensus       211 pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~  289 (334)
T cd07855         211 LFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSK-IFPKASPEALDLLSQMLQFDPEERITVE  289 (334)
T ss_pred             ccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHH-HcccCCHHHHHHHHHHccCChhhCcCHH
Confidence            99999888888889999998887765433221100   0112222222222 2245789999999999999999999999


Q ss_pred             HHhcCCCccccCCCCC
Q 022799          233 EALIHPFFDELRDPNT  248 (292)
Q Consensus       233 e~l~hp~~~~~~~~~~  248 (292)
                      +++.||||+....+..
T Consensus       290 ~~l~~~~~~~~~~~~~  305 (334)
T cd07855         290 QALQHPFLAQYHDPDD  305 (334)
T ss_pred             HHHhChhhhhccCCcc
Confidence            9999999998766544

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.5e-40  Score=293.15  Aligned_cols=208  Identities=29%  Similarity=0.486  Sum_probs=166.1

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++     .+..++|+||||++ |+|.+++..     ..+++..++.++.||+.||.|||++ ||+|
T Consensus        97 ~~~~~hp~iv~~~~~~-----~~~~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH  165 (371)
T cd05622          97 MAFANSPWVVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM-GFIH  165 (371)
T ss_pred             HHhCCCCCCCeEEEEE-----EcCCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC-CEEe
Confidence            3567999999999998     44556999999998 688888753     4588999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCC--CcccccccccccCCccccCCC---CCCchhHhhhhhHHHHHHHhCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE--PNISYICSRYYRAPELIFGAT---EYTAAIDIWSAGCVLAELLLGQ  154 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~---~~~~~~DvwslG~il~el~~g~  154 (292)
                      |||||+||+++.++ .+||+|||++.......  ......||+.|+|||++.+..   .++.++|+||+||++|+|++|.
T Consensus       166 rDLkp~NIll~~~~-~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~  244 (371)
T cd05622         166 RDVKPDNMLLDKSG-HLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD  244 (371)
T ss_pred             CCCCHHHEEECCCC-CEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCC
Confidence            99999999999888 79999999998664322  123457899999999986532   3789999999999999999999


Q ss_pred             CCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCC--cccHH
Q 022799          155 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL--RSTAL  232 (292)
Q Consensus       155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--R~t~~  232 (292)
                      .||.+.+......++......               ..++.          ...+++.++++|.+||..++.+  |++++
T Consensus       245 ~Pf~~~~~~~~~~~i~~~~~~---------------~~~~~----------~~~~s~~~~~li~~~L~~~~~r~~r~~~~  299 (371)
T cd05622         245 TPFYADSLVGTYSKIMNHKNS---------------LTFPD----------DNDISKEAKNLICAFLTDREVRLGRNGVE  299 (371)
T ss_pred             CCCCCCCHHHHHHHHHcCCCc---------------ccCCC----------cCCCCHHHHHHHHHHcCChhhhcCCCCHH
Confidence            999888776655555432110               01110          1358999999999999844433  78999


Q ss_pred             HHhcCCCccccCC
Q 022799          233 EALIHPFFDELRD  245 (292)
Q Consensus       233 e~l~hp~~~~~~~  245 (292)
                      ++++||||++...
T Consensus       300 ei~~h~~~~~~~~  312 (371)
T cd05622         300 EIKRHLFFKNDQW  312 (371)
T ss_pred             HHhcCcccCCCCh
Confidence            9999999987544

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-40  Score=281.17  Aligned_cols=211  Identities=23%  Similarity=0.355  Sum_probs=169.1

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++     ....++++||||+. |+|...+...  ....+++..+..++.|++.||.|||++ |++|
T Consensus        54 l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH  125 (285)
T cd05605          54 LEKVNSRFVVSLAYAY-----ETKDALCLVLTLMNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRE-RIVY  125 (285)
T ss_pred             HHhcCCCCEeeeeeee-----cCCCeEEEEEeccCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHC-CcEe
Confidence            3578999999999988     44446999999998 6887776542  134689999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      |||||+||+++.++ .++|+|||++.............|++.|+|||.+.+. .++.++|+||+||++|+|++|..||.+
T Consensus       126 ~dlkp~Nil~~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diws~G~~l~el~~g~~pf~~  203 (285)
T cd05605         126 RDLKPENILLDDYG-HIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNE-RYTFSPDWWGLGCLIYEMIEGKSPFRQ  203 (285)
T ss_pred             cCCCHHHEEECCCC-CEEEeeCCCceecCCCCccccccCCCCccCcHHhcCC-CCCccccchhHHHHHHHHHHCCCCCCC
Confidence            99999999999887 7999999999876444433445789999999999654 489999999999999999999999987


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcc-----cHHHH
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEA  234 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----t~~e~  234 (292)
                      .........+........                         ..++..++..+.+||.+||..||.+|+     +++++
T Consensus       204 ~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l  258 (285)
T cd05605         204 RKEKVKREEVERRVKEDQ-------------------------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEV  258 (285)
T ss_pred             CchhhHHHHHHHHhhhcc-------------------------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHH
Confidence            655433333322211000                         011245788999999999999999999     99999


Q ss_pred             hcCCCccccCCC
Q 022799          235 LIHPFFDELRDP  246 (292)
Q Consensus       235 l~hp~~~~~~~~  246 (292)
                      ++||||....+.
T Consensus       259 ~~~~~~~~~~~~  270 (285)
T cd05605         259 KAHPFFRTANFK  270 (285)
T ss_pred             hcCcCccCCCHH
Confidence            999999986544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-41  Score=289.49  Aligned_cols=207  Identities=27%  Similarity=0.471  Sum_probs=187.1

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |..+..|.||++|..|     .+..++|++||-|- |.|+..++.    .+.+.+..+++++..+++|++|||++ |||+
T Consensus       474 m~~~~s~fIvrLYrTf-----rd~kyvYmLmEaClGGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~k-~iIY  543 (732)
T KOG0614|consen  474 MMECRSDFIVRLYRTF-----RDSKYVYMLMEACLGGELWTILRD----RGSFDDYTARFYVACVLEAFEYLHRK-GIIY  543 (732)
T ss_pred             HHhcCchHHHHHHHHh-----ccchhhhhhHHhhcCchhhhhhhh----cCCcccchhhhhHHHHHHHHHHHHhc-Ccee
Confidence            3456789999999999     88889999999986 799999886    47799999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      |||||+|++++.+| -+||.|||+|+.+.++....+++|||.|.|||++.... ++.++|.||||+++|||++|.+||.+
T Consensus       544 RDLKPENllLd~~G-y~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILnKG-HD~avDyWaLGIli~ELL~G~pPFs~  621 (732)
T KOG0614|consen  544 RDLKPENLLLDNRG-YLKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILNKG-HDRAVDYWALGILIYELLTGSPPFSG  621 (732)
T ss_pred             ccCChhheeeccCC-ceEEeehhhHHHhccCCceeeecCCcccccchhhhccC-cchhhHHHHHHHHHHHHHcCCCCCCC
Confidence            99999999999998 79999999999999999999999999999999998754 89999999999999999999999999


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCccc-----HHHH
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----ALEA  234 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t-----~~e~  234 (292)
                      .+++..+..|++.+.               .+.            +|..++..+.+||+++...+|.+|..     +.+|
T Consensus       622 ~dpmktYn~ILkGid---------------~i~------------~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DI  674 (732)
T KOG0614|consen  622 VDPMKTYNLILKGID---------------KIE------------FPRRITKTATDLIKKLCRDNPTERLGYQKGGINDI  674 (732)
T ss_pred             CchHHHHHHHHhhhh---------------hhh------------cccccchhHHHHHHHHHhcCcHhhhccccCChHHH
Confidence            999999999887542               112            34578999999999999999999976     8999


Q ss_pred             hcCCCccccCCC
Q 022799          235 LIHPFFDELRDP  246 (292)
Q Consensus       235 l~hp~~~~~~~~  246 (292)
                      .+|.||.++++.
T Consensus       675 kkH~Wf~gfdwe  686 (732)
T KOG0614|consen  675 KKHRWFEGFDWE  686 (732)
T ss_pred             HhhhhhhcCChh
Confidence            999999998764

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-41  Score=284.12  Aligned_cols=222  Identities=27%  Similarity=0.415  Sum_probs=179.5

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++.|+||.+--.|.+.+.     +|+||..|+ |+|.--|.+..  ...+++..+++|+.+|+.||++||.. +||+
T Consensus       239 L~kV~s~FiVslaYAfeTkd~-----LClVLtlMNGGDLkfHiyn~g--~~gF~e~ra~FYAAEi~cGLehlH~~-~iVY  310 (591)
T KOG0986|consen  239 LEKVSSPFIVSLAYAFETKDA-----LCLVLTLMNGGDLKFHIYNHG--NPGFDEQRARFYAAEIICGLEHLHRR-RIVY  310 (591)
T ss_pred             HHHhccCcEEEEeeeecCCCc-----eEEEEEeecCCceeEEeeccC--CCCCchHHHHHHHHHHHhhHHHHHhc-ceee
Confidence            346788999999888844443     999999999 57765555432  35799999999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      ||+||+|||+|..| .++|+|+|+|..+..+......+||..|||||++.+.. |+.+.|+|||||++|||+.|+.||..
T Consensus       311 RDLKPeNILLDd~G-hvRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~  388 (591)
T KOG0986|consen  311 RDLKPENILLDDHG-HVRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQ  388 (591)
T ss_pred             ccCChhheeeccCC-CeEeeccceEEecCCCCccccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhh
Confidence            99999999999999 59999999999998888888889999999999997655 99999999999999999999999976


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcc-----cHHHH
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEA  234 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----t~~e~  234 (292)
                      .........+-+..-..                         ...++..+|++++++.+.+|++||++|.     ++.++
T Consensus       389 ~KeKvk~eEvdrr~~~~-------------------------~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~ev  443 (591)
T KOG0986|consen  389 RKEKVKREEVDRRTLED-------------------------PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEV  443 (591)
T ss_pred             hhhhhhHHHHHHHHhcc-------------------------hhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchh
Confidence            54433222222211111                         1123467999999999999999999996     58899


Q ss_pred             hcCCCccccCCCCCCCCCCCCCCCC
Q 022799          235 LIHPFFDELRDPNTRLPNGRFLPPL  259 (292)
Q Consensus       235 l~hp~~~~~~~~~~~~~~~~~~~~~  259 (292)
                      .+||||+++++.  ++..+...||+
T Consensus       444 k~HpfFk~lnw~--rleagml~PPf  466 (591)
T KOG0986|consen  444 KEHPFFKDLNWR--RLEAGMLEPPF  466 (591)
T ss_pred             hhCcccccCCHh--HHhccCCCCCC
Confidence            999999998854  45555555554

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-39  Score=277.37  Aligned_cols=229  Identities=36%  Similarity=0.704  Sum_probs=177.9

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      |++++||||+++++++     .+..+.++||||++++|.+++...   ...+++..++.++.|++.||.|||++ ||+||
T Consensus        57 l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~-~i~H~  127 (291)
T cd07844          57 LKDLKHANIVTLHDII-----HTKKTLTLVFEYLDTDLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQR-RVLHR  127 (291)
T ss_pred             HhhCCCcceeeEEEEE-----ecCCeEEEEEecCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC-Ceecc
Confidence            4678999999999998     444569999999999998887653   34689999999999999999999987 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCC-CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      ||||+||+++.++ .++|+|||.+....... ......++..|+|||.+.+...++.++|+||+||++|+|++|..||.+
T Consensus       128 dl~p~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~  206 (291)
T cd07844         128 DLKPQNLLISERG-ELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPG  206 (291)
T ss_pred             cCCHHHEEEcCCC-CEEECccccccccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999888 79999999986542221 112234678899999987655689999999999999999999999977


Q ss_pred             CC-cHHHHHHHHHHhCCCCHHHHhhcCCC--CccccCCCCCCCCchhhhccCCC--hhHHHHHHHHhccCCCCcccHHHH
Q 022799          160 ES-GVDQLVEIIKVLGTPTREEIKCMNPN--YTEFKFPQIKAHPWHKIFQKRMP--PEAVDLVSRLLQYSPNLRSTALEA  234 (292)
Q Consensus       160 ~~-~~~~~~~i~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~--~~~~~li~~~l~~dp~~R~t~~e~  234 (292)
                      .. ..+.+..+.+..+.+....+......  +.....+.....+....+ ..++  .++.++|.+||+.+|.+|||+.++
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~~p~~Rps~~e~  285 (291)
T cd07844         207 STDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHA-PRLDRIPHGEELALKFLQYEPKKRISAAEA  285 (291)
T ss_pred             CccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhC-cCCCCchhHHHHHHHHhccCcccccCHHHH
Confidence            65 55667777788888777665444221  111122111111111111 2344  889999999999999999999999


Q ss_pred             hcCCCc
Q 022799          235 LIHPFF  240 (292)
Q Consensus       235 l~hp~~  240 (292)
                      +.||||
T Consensus       286 l~~~~f  291 (291)
T cd07844         286 MKHPYF  291 (291)
T ss_pred             hcCCCC
Confidence            999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.7e-39  Score=277.84  Aligned_cols=236  Identities=36%  Similarity=0.640  Sum_probs=182.9

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      |++++||||+++++++     .+..+.++||||++++|.+.+....  ...+++..++.++.||+.||+|||++ |++|+
T Consensus        55 l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~-~i~H~  126 (294)
T PLN00009         55 LKEMQHGNIVRLQDVV-----HSEKRLYLVFEYLDLDLKKHMDSSP--DFAKNPRLIKTYLYQILRGIAYCHSH-RVLHR  126 (294)
T ss_pred             HHhccCCCEeeEEEEE-----ecCCeEEEEEecccccHHHHHHhCC--CCCcCHHHHHHHHHHHHHHHHHHHhC-CeeCC
Confidence            3578999999999998     4445699999999988888775431  23467888999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCC-CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      ||+|+||+++.++..+||+|||++....... ......+++.|+|||.+.+...++.++|+||+||++|+|++|..||.+
T Consensus       127 dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~  206 (294)
T PLN00009        127 DLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPG  206 (294)
T ss_pred             CCCcceEEEECCCCEEEEcccccccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            9999999998655579999999997653322 122345688999999986655688999999999999999999999998


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCc-cccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCC
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYT-EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  238 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp  238 (292)
                      ....+...++....+.|....+........ ....+...... .....+.+++++.++|.+||..+|++||++.+++.||
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~  285 (294)
T PLN00009        207 DSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKD-LATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHE  285 (294)
T ss_pred             CCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCC-HHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence            888888888888888887666543211000 00111111111 1112356789999999999999999999999999999


Q ss_pred             CccccCC
Q 022799          239 FFDELRD  245 (292)
Q Consensus       239 ~~~~~~~  245 (292)
                      ||.+++.
T Consensus       286 ~~~~~~~  292 (294)
T PLN00009        286 YFKDLGD  292 (294)
T ss_pred             hHhHHhc
Confidence            9998753

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1e-40  Score=293.45  Aligned_cols=207  Identities=28%  Similarity=0.451  Sum_probs=166.0

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      +.++||||+++++.+     .+..++|+||||++ |+|.+++..    ...+++..++.++.|++.||.|||++ ||+||
T Consensus        56 ~~l~~~~iv~~~~~~-----~~~~~~~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~-givHr  125 (360)
T cd05627          56 VEADGAWVVKMFYSF-----QDKRNLYLIMEFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQL-GFIHR  125 (360)
T ss_pred             HhCCCCCEeeEEEEE-----EcCCEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEcc
Confidence            567999999999998     55556999999998 688888865    36789999999999999999999987 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCC------------------------------------CcccccccccccC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE------------------------------------PNISYICSRYYRA  124 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~------------------------------------~~~~~~gt~~y~a  124 (292)
                      ||||+||+++.++ .++|+|||++.......                                    .....+||+.|+|
T Consensus       126 DLkp~NIli~~~~-~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A  204 (360)
T cd05627         126 DIKPDNLLLDAKG-HVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIA  204 (360)
T ss_pred             CCCHHHEEECCCC-CEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccC
Confidence            9999999999888 79999999986542110                                    0123578999999


Q ss_pred             CccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhh
Q 022799          125 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKI  204 (292)
Q Consensus       125 PE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  204 (292)
                      ||++.+. .++.++|+||+||++|+|++|..||.+.+......++.....               ...++.         
T Consensus       205 PE~~~~~-~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~---------------~~~~p~---------  259 (360)
T cd05627         205 PEVFMQT-GYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKE---------------TLVFPP---------  259 (360)
T ss_pred             HHHHcCC-CCCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCC---------------ceecCC---------
Confidence            9999764 489999999999999999999999988777665555442100               000110         


Q ss_pred             hccCCChhHHHHHHHHhccCCCCcc---cHHHHhcCCCccccCCC
Q 022799          205 FQKRMPPEAVDLVSRLLQYSPNLRS---TALEALIHPFFDELRDP  246 (292)
Q Consensus       205 ~~~~~~~~~~~li~~~l~~dp~~R~---t~~e~l~hp~~~~~~~~  246 (292)
                       ...++++++++|.+|+ .||.+|+   +++++++||||+++++.
T Consensus       260 -~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~~  302 (360)
T cd05627         260 -EVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGVDWG  302 (360)
T ss_pred             -CCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCCCHH
Confidence             0237889999999977 4999998   48999999999987653

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.8e-40  Score=287.53  Aligned_cols=203  Identities=28%  Similarity=0.439  Sum_probs=164.9

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      +.++||||+++++++     .+....|+||||++ |+|...+..    ...+++..++.++.||+.||.|||++ ||+||
T Consensus        51 ~~~~h~~iv~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~-~ivH~  120 (321)
T cd05603          51 KNLKHPFLVGLHYSF-----QTAEKLYFVLDYVNGGELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSL-NIIYR  120 (321)
T ss_pred             HhCCCCCccceeeEE-----EcCCEEEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEec
Confidence            568999999999988     44445899999998 588777654    36689999999999999999999987 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCcccccc-CCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVK-GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      ||||+||+++.++ .+||+|||++..... ........||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+
T Consensus       121 Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~  198 (321)
T cd05603         121 DLKPENILLDSQG-HVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKE-PYDRTVDWWCLGAVLYEMLYGLPPFYS  198 (321)
T ss_pred             cCCHHHeEECCCC-CEEEccCCCCccCCCCCCccccccCCcccCCHHHhcCC-CCCCcCcccccchhhhhhhcCCCCCCC
Confidence            9999999999988 799999999875322 2223345789999999998654 489999999999999999999999988


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccH----HHHh
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA----LEAL  235 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~----~e~l  235 (292)
                      .+.......+...   +                          ..++...+..+.++|.+||+.||.+|+++    .+++
T Consensus       199 ~~~~~~~~~i~~~---~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~  249 (321)
T cd05603         199 RDVSQMYDNILHK---P--------------------------LQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIK  249 (321)
T ss_pred             CCHHHHHHHHhcC---C--------------------------CCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHh
Confidence            7655444433221   0                          01224578899999999999999999875    5999


Q ss_pred             cCCCccccCC
Q 022799          236 IHPFFDELRD  245 (292)
Q Consensus       236 ~hp~~~~~~~  245 (292)
                      +|+||..+.+
T Consensus       250 ~~~~~~~~~~  259 (321)
T cd05603         250 NHVFFSPINW  259 (321)
T ss_pred             CCCCcCCCCH
Confidence            9999987654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=4.1e-40  Score=285.63  Aligned_cols=202  Identities=28%  Similarity=0.460  Sum_probs=164.5

Q ss_pred             CCCC-CCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            3 LLDH-PNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         3 ~l~H-pnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      .+.| ++|+++++++     .+...+|+||||++ |+|.+.+..    ...+++..+..++.||+.||.|||++ ||+||
T Consensus        56 ~~~~~~~i~~~~~~~-----~~~~~~~lv~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~  125 (324)
T cd05587          56 LPGKPPFLTQLHSCF-----QTMDRLYFVMEYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSK-GIIYR  125 (324)
T ss_pred             hcCCCCceeeeEEEE-----EcCCEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEec
Confidence            4555 5688898888     34445899999998 688887764    35689999999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCcccccc-CCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVK-GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      ||||+||+++.++ .++|+|||++..... ........||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+
T Consensus       126 dlkp~Nill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~  203 (324)
T cd05587         126 DLKLDNVMLDAEG-HIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQPPFDG  203 (324)
T ss_pred             CCCHHHeEEcCCC-CEEEeecCcceecCCCCCceeeecCCccccChhhhcCC-CCCcccchhhhHHHHHHHHhCCCCCCC
Confidence            9999999999888 799999999875322 2223345789999999999765 489999999999999999999999988


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccH-----HHH
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA-----LEA  234 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~-----~e~  234 (292)
                      .+..+....+....                             ..++..+++++.++|.+||..||.+|++.     .++
T Consensus       204 ~~~~~~~~~i~~~~-----------------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~  254 (324)
T cd05587         204 EDEDELFQSIMEHN-----------------------------VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDI  254 (324)
T ss_pred             CCHHHHHHHHHcCC-----------------------------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHH
Confidence            77665555543210                             01224578999999999999999999976     899


Q ss_pred             hcCCCccccCC
Q 022799          235 LIHPFFDELRD  245 (292)
Q Consensus       235 l~hp~~~~~~~  245 (292)
                      ++||||+.+++
T Consensus       255 ~~hp~~~~~~~  265 (324)
T cd05587         255 REHAFFRRIDW  265 (324)
T ss_pred             hcCCCcCCCCH
Confidence            99999998754

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.1e-39  Score=277.70  Aligned_cols=230  Identities=36%  Similarity=0.660  Sum_probs=179.9

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      |++++||||+++++++     .+....++||||+.++|..++....  ...+++..+..++.|++.||.|||+. |++|+
T Consensus        53 l~~l~h~~i~~~~~~~-----~~~~~~~~v~e~~~~~l~~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~-~i~H~  124 (284)
T cd07860          53 LKELNHPNIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASP--LSGIPLPLIKSYLFQLLQGLAFCHSH-RVLHR  124 (284)
T ss_pred             HHhcCCCCCcchhhhc-----ccCCcEEEEeeccccCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecC
Confidence            4578999999999988     4444589999999988888776432  35689999999999999999999987 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCC-cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      ||+|+||+++.++ .++|+|||++........ .....+++.|+|||.+.+...++.++|+||+||++|+|+||..||.+
T Consensus       125 ~l~p~nill~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~  203 (284)
T cd07860         125 DLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG  203 (284)
T ss_pred             CCCHHHEEECCCC-CEEEeeccchhhcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            9999999999888 799999999876533221 22335688899999987666578999999999999999999999999


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCC-ccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCC
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNY-TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  238 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp  238 (292)
                      .+..+...++.+..+.+....+......- ....++......... ..+.++++++++|.+||..||++|||+.++++||
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~  282 (284)
T cd07860         204 DSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHP  282 (284)
T ss_pred             CCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCC
Confidence            88888888888888887765443221000 000111111111111 1245788999999999999999999999999999


Q ss_pred             Cc
Q 022799          239 FF  240 (292)
Q Consensus       239 ~~  240 (292)
                      ||
T Consensus       283 ~f  284 (284)
T cd07860         283 FF  284 (284)
T ss_pred             CC
Confidence            98

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=3.3e-40  Score=286.68  Aligned_cols=202  Identities=27%  Similarity=0.504  Sum_probs=160.6

Q ss_pred             CCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCC
Q 022799            4 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDI   82 (292)
Q Consensus         4 l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dl   82 (292)
                      .+||||+++++++     .+...+++||||++ |+|...+..    ...+++..++.++.||+.||.|||++ ||+||||
T Consensus        53 ~~hp~iv~~~~~~-----~~~~~~~lv~E~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~-~ivH~Di  122 (329)
T cd05618          53 SNHPFLVGLHSCF-----QTESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER-GIIYRDL  122 (329)
T ss_pred             CCCCcCCceeeEE-----EeCCEEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCC
Confidence            4899999999998     44445899999998 688777654    36799999999999999999999988 9999999


Q ss_pred             CCCcEEEeCCCCcEEEeecCCcccccc-CCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCCC
Q 022799           83 KPQNLLVNPHTHQLKLCDFGSAKVLVK-GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES  161 (292)
Q Consensus        83 kp~Nill~~~~~~ikl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~  161 (292)
                      ||+||+++.++ .+||+|||+++.... ........||+.|+|||++.+. .++.++|+||+||++|+|++|..||....
T Consensus       123 kp~Nili~~~~-~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~  200 (329)
T cd05618         123 KLDNVLLDSEG-HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVG  200 (329)
T ss_pred             CHHHEEECCCC-CEEEeeCCccccccCCCCccccccCCccccCHHHHcCC-CCCCccceecccHHHHHHhhCCCCCccCC
Confidence            99999999988 799999999875322 2223446789999999999764 48999999999999999999999995311


Q ss_pred             c--------HHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCccc---
Q 022799          162 G--------VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST---  230 (292)
Q Consensus       162 ~--------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t---  230 (292)
                      .        ...+.+....                ..            ..++..++..+.++|++||..||.+|+|   
T Consensus       201 ~~~~~~~~~~~~~~~~i~~----------------~~------------~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~  252 (329)
T cd05618         201 SSDNPDQNTEDYLFQVILE----------------KQ------------IRIPRSLSVKAASVLKSFLNKDPKERLGCHP  252 (329)
T ss_pred             CcCCcccccHHHHHHHHhc----------------CC------------CCCCCCCCHHHHHHHHHHhcCCHHHcCCCCC
Confidence            1        1111111100                00            0133567899999999999999999998   


Q ss_pred             ---HHHHhcCCCccccCC
Q 022799          231 ---ALEALIHPFFDELRD  245 (292)
Q Consensus       231 ---~~e~l~hp~~~~~~~  245 (292)
                         +.++++||||+.+.+
T Consensus       253 ~~~~~~i~~hp~f~~~~~  270 (329)
T cd05618         253 QTGFADIQGHPFFRNVDW  270 (329)
T ss_pred             CCCHHHHhcCCCCCCCCH
Confidence               589999999988654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=5.1e-40  Score=284.93  Aligned_cols=200  Identities=28%  Similarity=0.444  Sum_probs=166.4

Q ss_pred             CCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCC
Q 022799            5 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIK   83 (292)
Q Consensus         5 ~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlk   83 (292)
                      .||+|+++++++     .+...+|+||||++ |+|.+.+..    ...+++..+..++.||+.||.|||++ ||+|||||
T Consensus        59 ~~~~i~~~~~~~-----~~~~~~~lv~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlk  128 (323)
T cd05616          59 KPPFLTQLHSCF-----QTMDRLYFVMEYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSK-GIIYRDLK  128 (323)
T ss_pred             CCCeEeeEEEEE-----ecCCEEEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CEEecCCC
Confidence            689999999998     44446899999998 688887764    35689999999999999999999987 99999999


Q ss_pred             CCcEEEeCCCCcEEEeecCCcccccc-CCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCCCc
Q 022799           84 PQNLLVNPHTHQLKLCDFGSAKVLVK-GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG  162 (292)
Q Consensus        84 p~Nill~~~~~~ikl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~  162 (292)
                      |+||+++.++ .+||+|||+++.... ........||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+.+.
T Consensus       129 p~Nill~~~~-~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~  206 (323)
T cd05616         129 LDNVMLDSEG-HIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDE  206 (323)
T ss_pred             HHHeEECCCC-cEEEccCCCceecCCCCCccccCCCChhhcCHHHhcCC-CCCCccchhchhHHHHHHHhCCCCCCCCCH
Confidence            9999999988 799999999875432 2223345789999999999664 489999999999999999999999988777


Q ss_pred             HHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCccc-----HHHHhcC
Q 022799          163 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----ALEALIH  237 (292)
Q Consensus       163 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t-----~~e~l~h  237 (292)
                      ......+....                 .            .++..+++++.+++.+||+.||.+|++     ..++++|
T Consensus       207 ~~~~~~i~~~~-----------------~------------~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05616         207 DELFQSIMEHN-----------------V------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  257 (323)
T ss_pred             HHHHHHHHhCC-----------------C------------CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence            66655554310                 0            122457899999999999999999997     4899999


Q ss_pred             CCccccCC
Q 022799          238 PFFDELRD  245 (292)
Q Consensus       238 p~~~~~~~  245 (292)
                      |||+.+++
T Consensus       258 ~~~~~~~~  265 (323)
T cd05616         258 AFFRYIDW  265 (323)
T ss_pred             CCcCCCCH
Confidence            99998764

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.2e-40  Score=294.58  Aligned_cols=207  Identities=29%  Similarity=0.473  Sum_probs=164.3

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++.|     .+...+|+||||++ |+|.+++..    .+.+++..++.++.||+.||.|||++ ||+|
T Consensus        55 l~~l~h~~iv~~~~~~-----~~~~~~~lv~E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH  124 (376)
T cd05598          55 LAEADNEWVVKLYYSF-----QDKDNLYFVMDYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKM-GFIH  124 (376)
T ss_pred             HHhCCCCCcceEEEEE-----EcCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEe
Confidence            4578999999999998     44556999999998 689988865    35689999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccC--------------------------------------------CCccc
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG--------------------------------------------EPNIS  115 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~--------------------------------------------~~~~~  115 (292)
                      |||||+||+++.++ .++|+|||++..+...                                            .....
T Consensus       125 rDlkp~Nill~~~~-~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  203 (376)
T cd05598         125 RDIKPDNILIDRDG-HIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHS  203 (376)
T ss_pred             CCCCHHHEEECCCC-CEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccc
Confidence            99999999999888 7999999987432100                                            00113


Q ss_pred             ccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCC
Q 022799          116 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ  195 (292)
Q Consensus       116 ~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (292)
                      .+||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+.+..+....+.....               ....+ 
T Consensus       204 ~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~---------------~~~~~-  266 (376)
T cd05598         204 LVGTPNYIAPEVLLRT-GYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWET---------------TLHIP-  266 (376)
T ss_pred             cCCCccccCHHHHcCC-CCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCc---------------cccCC-
Confidence            4689999999999654 489999999999999999999999988776554444322100               00000 


Q ss_pred             CCCCCchhhhccCCChhHHHHHHHHhccCCCCcc---cHHHHhcCCCccccCC
Q 022799          196 IKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS---TALEALIHPFFDELRD  245 (292)
Q Consensus       196 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~---t~~e~l~hp~~~~~~~  245 (292)
                               ....+++++.++|.+|+ .+|.+|+   |+.++++||||+.+..
T Consensus       267 ---------~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~~~  309 (376)
T cd05598         267 ---------SQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGIDF  309 (376)
T ss_pred             ---------CCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCCCH
Confidence                     01357899999999976 5999999   9999999999998653

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-42  Score=291.60  Aligned_cols=203  Identities=26%  Similarity=0.431  Sum_probs=169.4

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |.++++|||.++|++|..     +..++++||||+ |++.++++.    +..+.+..+..++++++.||.|||.+ +.+|
T Consensus        65 Ls~~~~~~it~yygsyl~-----g~~LwiiMey~~gGsv~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~~-~kiH  134 (467)
T KOG0201|consen   65 LSQCDSPNITEYYGSYLK-----GTKLWIIMEYCGGGSVLDLLKS----GNILDEFEIAVILREVLKGLDYLHSE-KKIH  134 (467)
T ss_pred             HHhcCcchHHhhhhheee-----cccHHHHHHHhcCcchhhhhcc----CCCCccceeeeehHHHHHHhhhhhhc-ceec
Confidence            457899999999999944     444999999999 688888874    45558999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCC-cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      ||||+.||++..+| .+||+|||++........ ..+++|||+|||||++.+ ..|+.++||||||++.+||++|.+|+.
T Consensus       135 rDIKaanil~s~~g-~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~s  212 (467)
T KOG0201|consen  135 RDIKAANILLSESG-DVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPHS  212 (467)
T ss_pred             ccccccceeEeccC-cEEEEecceeeeeechhhccccccccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCCc
Confidence            99999999999987 899999999987755432 378899999999999975 459999999999999999999999998


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCC
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  238 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp  238 (292)
                      ...++..+..|-+                        ....    .+...+|+.+++|+..||.+||+.||+|.++|+|+
T Consensus       213 ~~hPmrvlflIpk------------------------~~PP----~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~  264 (467)
T KOG0201|consen  213 KLHPMRVLFLIPK------------------------SAPP----RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHK  264 (467)
T ss_pred             ccCcceEEEeccC------------------------CCCC----ccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhH
Confidence            7665433333222                        1111    12236789999999999999999999999999999


Q ss_pred             Ccccc
Q 022799          239 FFDEL  243 (292)
Q Consensus       239 ~~~~~  243 (292)
                      |++..
T Consensus       265 FIk~a  269 (467)
T KOG0201|consen  265 FIKRA  269 (467)
T ss_pred             HHHhc
Confidence            99873

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-40  Score=290.72  Aligned_cols=208  Identities=25%  Similarity=0.436  Sum_probs=172.5

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccC-CHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |..++||+||++++.|+-.+.     ++++.|||+| -...++..   .+..+++.++..+++|++.||.|||++ +|||
T Consensus        83 La~CdHP~ivkLl~ayy~enk-----LwiliEFC~GGAVDaimlE---L~r~LtE~QIqvvc~q~ldALn~LHs~-~iIH  153 (1187)
T KOG0579|consen   83 LAECDHPVIVKLLSAYYFENK-----LWILIEFCGGGAVDAIMLE---LGRVLTEDQIQVVCYQVLDALNWLHSQ-NIIH  153 (1187)
T ss_pred             hhcCCChHHHHHHHHHhccCc-----eEEEEeecCCchHhHHHHH---hccccchHHHHHHHHHHHHHHHHHhhc-chhh
Confidence            467899999999998855443     9999999995 55555544   267899999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccc-cCCCcccccccccccCCccccC----CCCCCchhHhhhhhHHHHHHHhCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLV-KGEPNISYICSRYYRAPELIFG----ATEYTAAIDIWSAGCVLAELLLGQ  154 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslG~il~el~~g~  154 (292)
                      ||||..|||++.+| .|+|+|||.+.... ......++.|||+|||||++.+    ...|+.++||||||+++.||..+.
T Consensus       154 RDLKAGNiL~TldG-dirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiE  232 (1187)
T KOG0579|consen  154 RDLKAGNILLTLDG-DIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIE  232 (1187)
T ss_pred             hhccccceEEEecC-cEeeecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccC
Confidence            99999999999999 79999999875442 2234457899999999999853    345999999999999999999999


Q ss_pred             CCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHH
Q 022799          155 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA  234 (292)
Q Consensus       155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~  234 (292)
                      +|....+.+.++.+|.+. ..|+.-                         -|...+..+.||+++||.+||..||+++++
T Consensus       233 PPHhelnpMRVllKiaKS-ePPTLl-------------------------qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaql  286 (1187)
T KOG0579|consen  233 PPHHELNPMRVLLKIAKS-EPPTLL-------------------------QPSHWSRSFSDFLKRCLVKNPRNRPPAAQL  286 (1187)
T ss_pred             CCccccchHHHHHHHhhc-CCCccc-------------------------CcchhhhHHHHHHHHHHhcCCccCCCHHHH
Confidence            999988888888777653 111110                         113567899999999999999999999999


Q ss_pred             hcCCCccccC
Q 022799          235 LIHPFFDELR  244 (292)
Q Consensus       235 l~hp~~~~~~  244 (292)
                      |+|||++++.
T Consensus       287 l~Hpfv~~~~  296 (1187)
T KOG0579|consen  287 LKHPFVQNAP  296 (1187)
T ss_pred             hhCcccccCC
Confidence            9999998654

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.9e-40  Score=293.34  Aligned_cols=229  Identities=27%  Similarity=0.347  Sum_probs=167.6

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      |++|+|||||++++++..     ....++|||++.++|..++...   ...+++..++.++.||+.||.|||++ ||+||
T Consensus       214 L~~L~HpnIv~l~~~~~~-----~~~~~lv~e~~~~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~-gIvHr  284 (461)
T PHA03211        214 LRRLSHPAVLALLDVRVV-----GGLTCLVLPKYRSDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHGE-GIIHR  284 (461)
T ss_pred             HHHCCCCCCCcEEEEEEE-----CCEEEEEEEccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CEEEC
Confidence            467899999999998743     3458899999999998887643   34689999999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCC---cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF  157 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf  157 (292)
                      ||||+|||++.++ .++|+|||+++.......   .....||+.|+|||++.+. .++.++|+|||||++|||++|..++
T Consensus       285 DLKP~NILl~~~~-~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~~~~sDvwSlGviL~El~~g~~~l  362 (461)
T PHA03211        285 DIKTENVLVNGPE-DICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGD-PYTPSVDIWSAGLVIFEAAVHTASL  362 (461)
T ss_pred             cCCHHHEEECCCC-CEEEcccCCceecccccccccccccCCCcCCcCHHHHcCC-CCCchHHHHHHHHHHHHHHHcCCCc
Confidence            9999999999887 799999999976533211   2235689999999999765 4899999999999999999987654


Q ss_pred             CCCC-------cHHHHHHHHHHhCCCCHHHH--------hhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhc
Q 022799          158 PGES-------GVDQLVEIIKVLGTPTREEI--------KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQ  222 (292)
Q Consensus       158 ~~~~-------~~~~~~~i~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  222 (292)
                      ....       ...++.++++..+....+..        ............+......|...  ..++.++.+||.+||+
T Consensus       363 f~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~dli~~mL~  440 (461)
T PHA03211        363 FSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRY--YKLDLDVEYLVCRALT  440 (461)
T ss_pred             ccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhh--ccccchHHHHHHHHcc
Confidence            3321       12445555554433221110        00000000001111111223222  2467799999999999


Q ss_pred             cCCCCcccHHHHhcCCCccc
Q 022799          223 YSPNLRSTALEALIHPFFDE  242 (292)
Q Consensus       223 ~dp~~R~t~~e~l~hp~~~~  242 (292)
                      .||.+|||+.|+|+||||++
T Consensus       441 ~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        441 FDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             cChhhCcCHHHHhhCcccCC
Confidence            99999999999999999974

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-40  Score=286.34  Aligned_cols=210  Identities=28%  Similarity=0.455  Sum_probs=165.8

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      +.++||||+++++++     .+..++|+||||+. |+|.+++...   ...+++..++.++.||+.||+|||++ ||+||
T Consensus        56 ~~~~~~~i~~~~~~~-----~~~~~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~  126 (331)
T cd05597          56 VNGDRRWITNLHYAF-----QDENNLYLVMDYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSVHQL-GYVHR  126 (331)
T ss_pred             HhCCCCCCCceEEEE-----ecCCeEEEEEecCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEEC
Confidence            457899999999998     44556999999997 6998888643   45689999999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCCc--ccccccccccCCccccC----CCCCCchhHhhhhhHHHHHHHhCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN--ISYICSRYYRAPELIFG----ATEYTAAIDIWSAGCVLAELLLGQ  154 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslG~il~el~~g~  154 (292)
                      ||||+||+++.++ .++|+|||++.........  ....||+.|+|||++.+    ...++.++|+||+||++|+|++|.
T Consensus       127 dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~  205 (331)
T cd05597         127 DIKPDNVLLDKNG-HIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE  205 (331)
T ss_pred             CCCHHHEEECCCC-CEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCC
Confidence            9999999999888 7999999998765433221  22468999999999863    234788999999999999999999


Q ss_pred             CCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCC--cccHH
Q 022799          155 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL--RSTAL  232 (292)
Q Consensus       155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--R~t~~  232 (292)
                      .||.+.+..+....+......               ...+.         ....+++.++++|++||+.++.+  |+++.
T Consensus       206 ~Pf~~~~~~~~~~~i~~~~~~---------------~~~~~---------~~~~~~~~~~~li~~ll~~~~~r~~r~~~~  261 (331)
T cd05597         206 TPFYAESLVETYGKIMNHKEH---------------FQFPP---------DVTDVSEEAKDLIRRLICSPETRLGRNGLQ  261 (331)
T ss_pred             CCCCCCCHHHHHHHHHcCCCc---------------ccCCC---------ccCCCCHHHHHHHHHHccCcccccCCCCHH
Confidence            999887766555544321100               00000         01347899999999999765544  78999


Q ss_pred             HHhcCCCccccCC
Q 022799          233 EALIHPFFDELRD  245 (292)
Q Consensus       233 e~l~hp~~~~~~~  245 (292)
                      ++++||||.++++
T Consensus       262 ~~l~hp~~~~~~~  274 (331)
T cd05597         262 DFKDHPFFEGIDW  274 (331)
T ss_pred             HHhcCCCCCCCCH
Confidence            9999999988754

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-40  Score=288.24  Aligned_cols=198  Identities=23%  Similarity=0.404  Sum_probs=169.1

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++|+||||+++.+++     .....+|||||||. |.|.++++.    +..++......|..+|+.|+.|||.+ .|||
T Consensus       166 LRkLkH~NII~FkGVC-----tqsPcyCIiMEfCa~GqL~~VLka----~~~itp~llv~Wsk~IA~GM~YLH~h-KIIH  235 (904)
T KOG4721|consen  166 LRKLKHPNIITFKGVC-----TQSPCYCIIMEFCAQGQLYEVLKA----GRPITPSLLVDWSKGIAGGMNYLHLH-KIIH  235 (904)
T ss_pred             HHhccCcceeeEeeee-----cCCceeEEeeeccccccHHHHHhc----cCccCHHHHHHHHHHhhhhhHHHHHh-hHhh
Confidence            6789999999999999     56667999999999 999999986    56788888889999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      ||||.-||||+-+. .|||+|||.++..........++||..|||||++... ..+.|+||||+||+||||+||..||.+
T Consensus       236 RDLKSPNiLIs~~d-~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrne-PcsEKVDIwSfGVVLWEmLT~EiPYkd  313 (904)
T KOG4721|consen  236 RDLKSPNILISYDD-VVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNE-PCSEKVDIWSFGVVLWEMLTGEIPYKD  313 (904)
T ss_pred             hccCCCceEeeccc-eEEeccccchHhhhhhhhhhhhhhhHhhhCHHHhhcC-CcccccceehhHHHHHHHHhcCCCccc
Confidence            99999999999887 7999999999988777777789999999999999664 589999999999999999999999975


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      -+...++.-                           .....++-..|..++.-++=||+.||.-.|..||++.++|.|
T Consensus       314 VdssAIIwG---------------------------VGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~H  364 (904)
T KOG4721|consen  314 VDSSAIIWG---------------------------VGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLH  364 (904)
T ss_pred             cchheeEEe---------------------------ccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence            543322110                           111122233456788999999999999999999999999988

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=8.6e-40  Score=284.52  Aligned_cols=210  Identities=27%  Similarity=0.449  Sum_probs=166.9

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      +.++||||+++++++     .+...+|+||||+. |+|.+++...   ...+++..++.++.||+.||.|||++ ||+||
T Consensus        56 ~~~~~~~i~~~~~~~-----~~~~~~~lv~ey~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~-~iiHr  126 (332)
T cd05623          56 VNGDNQWITTLHYAF-----QDENNLYLVMDYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQL-HYVHR  126 (332)
T ss_pred             hhCCCCCEeeEEEEE-----ecCCEEEEEEeccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEec
Confidence            467899999999998     44456999999998 7999888653   35689999999999999999999987 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCC--cccccccccccCCccccC----CCCCCchhHhhhhhHHHHHHHhCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP--NISYICSRYYRAPELIFG----ATEYTAAIDIWSAGCVLAELLLGQ  154 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslG~il~el~~g~  154 (292)
                      ||||+||+++.++ .++|+|||++........  .....||+.|+|||++.+    ...++.++|+||+||++|+|++|+
T Consensus       127 Dlkp~Nili~~~~-~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~  205 (332)
T cd05623         127 DIKPDNILMDMNG-HIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGE  205 (332)
T ss_pred             CCCHHHEEECCCC-CEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCC
Confidence            9999999999888 799999999876533222  223578999999999852    345789999999999999999999


Q ss_pred             CCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCC--cccHH
Q 022799          155 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL--RSTAL  232 (292)
Q Consensus       155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--R~t~~  232 (292)
                      .||.+.+..+...++.....               ...++.         ....+++++++||++||+.++.+  |++++
T Consensus       206 ~Pf~~~~~~~~~~~i~~~~~---------------~~~~p~---------~~~~~s~~~~~li~~ll~~~~~r~~r~~~~  261 (332)
T cd05623         206 TPFYAESLVETYGKIMNHKE---------------RFQFPA---------QVTDVSEDAKDLIRRLICSREHRLGQNGIE  261 (332)
T ss_pred             CCCCCCCHHHHHHHHhCCCc---------------cccCCC---------ccccCCHHHHHHHHHHccChhhhcCCCCHH
Confidence            99988776666555543110               000110         01357899999999999765554  68999


Q ss_pred             HHhcCCCccccCC
Q 022799          233 EALIHPFFDELRD  245 (292)
Q Consensus       233 e~l~hp~~~~~~~  245 (292)
                      ++++||||.++.+
T Consensus       262 ~~~~h~~f~~~~~  274 (332)
T cd05623         262 DFKQHPFFTGIDW  274 (332)
T ss_pred             HHhCCCCcCCCCH
Confidence            9999999998764

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.8e-39  Score=281.88  Aligned_cols=201  Identities=26%  Similarity=0.486  Sum_probs=161.3

Q ss_pred             CCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCC
Q 022799            5 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIK   83 (292)
Q Consensus         5 ~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlk   83 (292)
                      +||||+++++++     .+...+|+||||++ |+|...+..    ...+++..++.++.||+.||.|||++ ||+|||||
T Consensus        54 ~~~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~-~ivHrDlk  123 (327)
T cd05617          54 SNPFLVGLHSCF-----QTTSRLFLVIEYVNGGDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHER-GIIYRDLK  123 (327)
T ss_pred             CCCCEeeEEEEE-----EeCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCC
Confidence            699999999998     44445999999998 688877764    35799999999999999999999998 99999999


Q ss_pred             CCcEEEeCCCCcEEEeecCCccccc-cCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCCCc
Q 022799           84 PQNLLVNPHTHQLKLCDFGSAKVLV-KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG  162 (292)
Q Consensus        84 p~Nill~~~~~~ikl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~  162 (292)
                      |+||+++.++ .+||+|||+++... .........||+.|+|||++.+. .++.++|+||+||++|+|++|..||.....
T Consensus       124 p~Nili~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~ell~g~~pf~~~~~  201 (327)
T cd05617         124 LDNVLLDADG-HIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIITD  201 (327)
T ss_pred             HHHEEEeCCC-CEEEeccccceeccCCCCceecccCCcccCCHHHHCCC-CCCchheeehhHHHHHHHHhCCCCCCccCC
Confidence            9999999888 79999999987532 22233456789999999999664 489999999999999999999999964221


Q ss_pred             ------HHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCccc------
Q 022799          163 ------VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST------  230 (292)
Q Consensus       163 ------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t------  230 (292)
                            .+........  .              .            ..++..++..+.++|.+||..||++|++      
T Consensus       202 ~~~~~~~~~~~~~~~~--~--------------~------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~  253 (327)
T cd05617         202 NPDMNTEDYLFQVILE--K--------------P------------IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTG  253 (327)
T ss_pred             CcccccHHHHHHHHHh--C--------------C------------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCC
Confidence                  1122221110  0              0            0123457899999999999999999997      


Q ss_pred             HHHHhcCCCccccCC
Q 022799          231 ALEALIHPFFDELRD  245 (292)
Q Consensus       231 ~~e~l~hp~~~~~~~  245 (292)
                      ++++++||||+.+.+
T Consensus       254 ~~~i~~h~~f~~~~~  268 (327)
T cd05617         254 FSDIKSHTFFRSIDW  268 (327)
T ss_pred             HHHHHcCCCCCCCCH
Confidence            579999999998764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.1e-39  Score=281.50  Aligned_cols=266  Identities=34%  Similarity=0.661  Sum_probs=199.2

Q ss_pred             CCCCCCCCeeeeceeeeccCC-CCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTE-KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~-~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++.+++..... ......++|+||++++|.+++..     .++++..+..++.|++.||.|||+. ||+|
T Consensus        68 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~-gi~H  141 (343)
T cd07851          68 LKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSA-GIIH  141 (343)
T ss_pred             HHhccCCCHHHHHHHhhccccccccccEEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-Ceec
Confidence            356899999999998754332 22345899999999999888863     5689999999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      |||+|+||+++.++ .++|+|||.+......  .....++..|+|||.+.+...++.++|+||+||++|+|++|..||.+
T Consensus       142 ~dlkp~Nill~~~~-~~kL~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~  218 (343)
T cd07851         142 RDLKPSNIAVNEDC-ELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPG  218 (343)
T ss_pred             CCCCHHHeEECCCC-CEEEcccccccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence            99999999999887 7999999998765332  33456788999999986654578999999999999999999999999


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc-c--cCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTE-F--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      ......+..+....+.++...+......... +  ..+......+...+ ..+++.+.++|.+||..||.+|||+.++++
T Consensus       219 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         219 SDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVF-SGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             CChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHh-ccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            8888888888888887776655443322110 0  01111111222222 356899999999999999999999999999


Q ss_pred             CCCccccCCCCCCCCCCCCCCCCCCCChhccCCCCHHHHhhhchHH
Q 022799          237 HPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEH  282 (292)
Q Consensus       237 hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (292)
                      ||||+....+.....     .+.++ ..-+...++.+.++.++..+
T Consensus       298 h~~~~~~~~~~~~~~-----~~~~~-~~~~~~~~~~~~~~~~~~~~  337 (343)
T cd07851         298 HPYLAEYHDPEDEPV-----APPYD-QSFESRDLTVDEWKELVYKE  337 (343)
T ss_pred             CCCccccCCCccccc-----ccccC-cchhhhhcCHHHHHHHhHHH
Confidence            999998765543222     22222 12333445667776665543

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=4e-39  Score=278.18  Aligned_cols=235  Identities=38%  Similarity=0.651  Sum_probs=177.2

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS-QRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~-~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++...   ....+++||||+++++.+.+....... ..+++..++.++.||+.||.|||++ ||+|
T Consensus        56 l~~l~h~~i~~~~~~~~~~---~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~h  131 (316)
T cd07842          56 LRELKHENVVSLVEVFLEH---ADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN-WVLH  131 (316)
T ss_pred             HHhcCCCCccceEEEEeCC---CCceEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC-CEee
Confidence            3568999999999998542   224689999999998888876544333 3789999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeC----CCCcEEEeecCCccccccCCC----cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHH
Q 022799           80 RDIKPQNLLVNP----HTHQLKLCDFGSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL  151 (292)
Q Consensus        80 ~dlkp~Nill~~----~~~~ikl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~  151 (292)
                      |||||+||+++.    ++ .+||+|||++........    .....+|..|+|||.+.+...++.++|+||+||++|+|+
T Consensus       132 ~dlkp~Nil~~~~~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~  210 (316)
T cd07842         132 RDLKPANILVMGEGPERG-VVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELL  210 (316)
T ss_pred             CCCCHHHEEEcCCCCccc-eEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence            999999999998    66 799999999886533221    223467888999998877666899999999999999999


Q ss_pred             hCCCCCCCCCcH---------HHHHHHHHHhCCCCHHHHhhcC--CCCcc----ccCCCCCCCCchhhhcc--CCChhHH
Q 022799          152 LGQPLFPGESGV---------DQLVEIIKVLGTPTREEIKCMN--PNYTE----FKFPQIKAHPWHKIFQK--RMPPEAV  214 (292)
Q Consensus       152 ~g~~pf~~~~~~---------~~~~~i~~~~~~~~~~~~~~~~--~~~~~----~~~~~~~~~~~~~~~~~--~~~~~~~  214 (292)
                      +|..||.+....         ..+..+...++.+....+....  +++..    ..............+..  ..+..+.
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (316)
T cd07842         211 TLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGF  290 (316)
T ss_pred             hcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHH
Confidence            999999765432         3566677777777665443221  11111    00011111111112222  5788999


Q ss_pred             HHHHHHhccCCCCcccHHHHhcCCCc
Q 022799          215 DLVSRLLQYSPNLRSTALEALIHPFF  240 (292)
Q Consensus       215 ~li~~~l~~dp~~R~t~~e~l~hp~~  240 (292)
                      ++|.+||..||++|||+.+++.||||
T Consensus       291 ~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         291 DLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            99999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=8.5e-39  Score=278.60  Aligned_cols=230  Identities=35%  Similarity=0.599  Sum_probs=181.9

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      |+.++||||+++++++     ....+.++||||++|+|.+.+..    ...+++..+..++.|++.||.|||++ |++|+
T Consensus        74 l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~~~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~-~i~H~  143 (335)
T PTZ00024         74 MNEIKHENIMGLVDVY-----VEGDFINLVMDIMASDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKW-YFMHR  143 (335)
T ss_pred             HHhCCCcceeeeeEEE-----ecCCcEEEEEeccccCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-Ceecc
Confidence            3578999999999998     34446899999999999888864    35689999999999999999999987 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccC---------------CCcccccccccccCCccccCCCCCCchhHhhhhhH
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKG---------------EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGC  145 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~  145 (292)
                      ||+|+||+++.++ .++|+|||.+......               .......+++.|+|||.+.+...++.++|+||+||
T Consensus       144 dl~~~nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~  222 (335)
T PTZ00024        144 DLSPANIFINSKG-ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGC  222 (335)
T ss_pred             cccHHHeEECCCC-CEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHH
Confidence            9999999999888 7999999998765411               11122345788999999877656799999999999


Q ss_pred             HHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC--CCccccCCCCCCCCchhhhccCCChhHHHHHHHHhcc
Q 022799          146 VLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP--NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQY  223 (292)
Q Consensus       146 il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  223 (292)
                      ++|+|++|..||.+.+..+.+..+....+.|....+.....  .+..+  .......... .....+.++.++|.+||..
T Consensus       223 ~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~-~~~~~~~~~~~li~~~l~~  299 (335)
T PTZ00024        223 IFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEF--TPRKPKDLKT-IFPNASDDAIDLLQSLLKL  299 (335)
T ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhccccccc--CcCCcccHHH-hCcCCChHHHHHHHHHcCC
Confidence            99999999999999998888888988888887654433211  01110  0001111111 1245688999999999999


Q ss_pred             CCCCcccHHHHhcCCCccccC
Q 022799          224 SPNLRSTALEALIHPFFDELR  244 (292)
Q Consensus       224 dp~~R~t~~e~l~hp~~~~~~  244 (292)
                      +|++|||+++++.||||+...
T Consensus       300 ~P~~R~s~~~~l~~~~~~~~~  320 (335)
T PTZ00024        300 NPLERISAKEALKHEYFKSDP  320 (335)
T ss_pred             CchhccCHHHHhcCcccCCCC
Confidence            999999999999999998643

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=5.6e-39  Score=273.18  Aligned_cols=230  Identities=37%  Similarity=0.683  Sum_probs=183.2

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      |++++||||+++++++.     +....++||||++++|.+++..... ...+++..+..++.|++.||.|||+. |++||
T Consensus        52 l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~h~  124 (284)
T cd07836          52 MKELKHENIVRLHDVIH-----TENKLMLVFEYMDKDLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHEN-RVLHR  124 (284)
T ss_pred             HHhhcCCCEeeeeeeEe-----eCCcEEEEEecCCccHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHC-CeeeC
Confidence            35789999999999984     3445899999999999888865422 34689999999999999999999987 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCC-CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      ||||+||+++.++ .++|+|||.+....... ......++..|++||.+.+...++.++|+||+||++|+|++|..||.+
T Consensus       125 dl~p~ni~~~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~  203 (284)
T cd07836         125 DLKPQNLLINKRG-ELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPG  203 (284)
T ss_pred             CCCHHHEEECCCC-cEEEeecchhhhhcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999887 79999999987553322 122345688899999987766678999999999999999999999999


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc--ccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTE--FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      .+..+...++.+....|....+..+. ....  ...+......... +.+..++.+.++|.+||+.||.+||++.++++|
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         204 TNNEDQLLKIFRIMGTPTESTWPGIS-QLPEYKPTFPRYPPQDLQQ-LFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             CCcHHHHHHHHHHhCCCChhhHHHHh-cCchhcccccCCChHHHHH-HhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            88888888888888888876665443 1111  1122211112211 224578899999999999999999999999999


Q ss_pred             CCc
Q 022799          238 PFF  240 (292)
Q Consensus       238 p~~  240 (292)
                      |||
T Consensus       282 ~~f  284 (284)
T cd07836         282 PWF  284 (284)
T ss_pred             CCC
Confidence            998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.2e-38  Score=271.26  Aligned_cols=229  Identities=36%  Similarity=0.689  Sum_probs=172.3

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      |++++||||+++++++     ......++||||+++++.+.+...   ...+++..++.++.|++.||.|||+. |++||
T Consensus        54 l~~~~h~~i~~~~~~~-----~~~~~~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~~-~i~H~  124 (286)
T cd07847          54 LKQLKHPNLVNLIEVF-----RRKRKLHLVFEYCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHKH-NCIHR  124 (286)
T ss_pred             HHhCCCCCEeeeeeEE-----eeCCEEEEEEeccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC-Cceec
Confidence            3568999999999998     444458999999997554444322   35689999999999999999999987 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCC-CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      ||||+||+++.++ .++|+|||++....... ......++..|+|||.+.+...++.++|+||+||++|+|++|..||.+
T Consensus       125 dl~p~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~  203 (286)
T cd07847         125 DVKPENILITKQG-QIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPG  203 (286)
T ss_pred             CCChhhEEEcCCC-cEEECccccceecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCC
Confidence            9999999999888 79999999998764433 222345788899999987655688999999999999999999999998


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCC--CCccccCCCCCC-CCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNP--NYTEFKFPQIKA-HPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      .+..+....+....+............  -+.....+.... .+....+ +.++..+.+||.+||..||++|||+.+++.
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         204 KSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKF-PNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             CChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHh-ccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            887777766665554433321111100  001111111111 1111112 457899999999999999999999999999


Q ss_pred             CCCc
Q 022799          237 HPFF  240 (292)
Q Consensus       237 hp~~  240 (292)
                      ||||
T Consensus       283 ~~~f  286 (286)
T cd07847         283 HPYF  286 (286)
T ss_pred             CCCC
Confidence            9998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.2e-38  Score=277.36  Aligned_cols=265  Identities=35%  Similarity=0.607  Sum_probs=197.5

Q ss_pred             CC-CCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccC
Q 022799            3 LL-DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRD   81 (292)
Q Consensus         3 ~l-~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~d   81 (292)
                      ++ +||||++++++..... .....+++++||++++|.+.+..    ...+++..++.++.||+.||.|||++ |++|||
T Consensus        57 ~l~~h~~iv~~~~~~~~~~-~~~~~~~~~~e~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~-givH~d  130 (332)
T cd07857          57 HFRGHKNITCLYDMDIVFP-GNFNELYLYEELMEADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSA-NVLHRD  130 (332)
T ss_pred             HhcCCCChheeeeeeeecc-ccCCcEEEEEecccCCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCC
Confidence            44 5999999998754332 22345789999999999888864    46789999999999999999999987 999999


Q ss_pred             CCCCcEEEeCCCCcEEEeecCCccccccCCC-----cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCC
Q 022799           82 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPL  156 (292)
Q Consensus        82 lkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~p  156 (292)
                      |||+||+++.++ .++|+|||.+........     .....||+.|+|||.+.+...++.++|+||+||++|+|++|..|
T Consensus       131 lkp~Nili~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~p  209 (332)
T cd07857         131 LKPGNLLVNADC-ELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPV  209 (332)
T ss_pred             CCHHHeEEcCCC-CEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcC
Confidence            999999999888 799999999976543221     22346889999999886655689999999999999999999999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc-c--cCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHH
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE-F--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE  233 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e  233 (292)
                      |.+.+....+..+....+.++.+.+..+...... +  .........+.. ..+..+..+.++|.+||+.||++|||+.+
T Consensus       210 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~t~~~  288 (332)
T cd07857         210 FKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFES-IFPNANPLALDLLEKLLAFDPTKRISVEE  288 (332)
T ss_pred             CCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHh-hCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence            9998888999999999998887665443221100 0  011111111111 12456889999999999999999999999


Q ss_pred             HhcCCCccccCCCCCCCCCCCCCCCCCCCChhccCCCCHHHHhhhchH
Q 022799          234 ALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPE  281 (292)
Q Consensus       234 ~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (292)
                      ++.|||++..+++.....+.  .+..+.|.    .+-+.+.++.++.+
T Consensus       289 ll~~~~~~~~~~~~~~~~~~--~~~~~~~~----~~~~~~~~~~~~~~  330 (332)
T cd07857         289 ALEHPYLAIWHDPDDEPVCQ--KPFDFSFE----SEDSMEELRDMIIE  330 (332)
T ss_pred             HhcChhhhhhcCcccccccc--ccccCCcc----ccccHHHHHHHHhh
Confidence            99999999887654333322  23333333    23355666665544

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-40  Score=262.86  Aligned_cols=206  Identities=27%  Similarity=0.473  Sum_probs=174.8

Q ss_pred             CCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCC
Q 022799            5 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKP   84 (292)
Q Consensus         5 ~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlkp   84 (292)
                      +.|+||+++++|....+     +++.||.|...+.+++.+-   .++++|..+-++...++.||.||-+++||+|||+||
T Consensus       149 dcpyIV~c~GyFi~n~d-----V~IcMelMs~C~ekLlkri---k~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKP  220 (391)
T KOG0983|consen  149 DCPYIVQCFGYFITNTD-----VFICMELMSTCAEKLLKRI---KGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKP  220 (391)
T ss_pred             CCCeeeeeeeEEeeCch-----HHHHHHHHHHHHHHHHHHh---cCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCc
Confidence            57999999999976554     7789999997777777654   467999999999999999999999999999999999


Q ss_pred             CcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCC--CCCCchhHhhhhhHHHHHHHhCCCCCCC-CC
Q 022799           85 QNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA--TEYTAAIDIWSAGCVLAELLLGQPLFPG-ES  161 (292)
Q Consensus        85 ~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwslG~il~el~~g~~pf~~-~~  161 (292)
                      +|||+|..| +|||||||.+..+.+........|-+.|||||.+.-.  ..|..++||||||+.++||.||..||.+ ..
T Consensus       221 SNILlDe~G-niKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t  299 (391)
T KOG0983|consen  221 SNILLDERG-NIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT  299 (391)
T ss_pred             cceEEccCC-CEEeecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc
Confidence            999999988 8999999999998888888888999999999998533  4589999999999999999999999987 45


Q ss_pred             cHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCCcc
Q 022799          162 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFD  241 (292)
Q Consensus       162 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~~~  241 (292)
                      +.+.+.++.+.  .|+.              ++.          ..++|+++.+|+..||.+|+.+||...++|+|||+.
T Consensus       300 dFe~ltkvln~--ePP~--------------L~~----------~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~  353 (391)
T KOG0983|consen  300 DFEVLTKVLNE--EPPL--------------LPG----------HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIK  353 (391)
T ss_pred             cHHHHHHHHhc--CCCC--------------CCc----------ccCcCHHHHHHHHHHhhcCcccCcchHHHhcCccee
Confidence            66777777662  1111              010          034899999999999999999999999999999998


Q ss_pred             ccCC
Q 022799          242 ELRD  245 (292)
Q Consensus       242 ~~~~  245 (292)
                      .+..
T Consensus       354 ~ye~  357 (391)
T KOG0983|consen  354 RYET  357 (391)
T ss_pred             ecch
Confidence            7653

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.5e-39  Score=281.60  Aligned_cols=227  Identities=24%  Similarity=0.438  Sum_probs=163.7

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||++++++|..     ..++++||||+. |+|.+++..    .+.+++..+..++.|++.||.|||++.+|+|
T Consensus        57 l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH  127 (333)
T cd06650          57 LHECNSPYIVGFYGAFYS-----DGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHKIMH  127 (333)
T ss_pred             HHHCCCCcccceeEEEEE-----CCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEe
Confidence            357899999999999843     345999999998 699888865    3568999999999999999999997547999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      |||||+||+++.++ .+||+|||++...... ......||+.|+|||.+.+. .++.++|+||+||++|+|++|..||..
T Consensus       128 ~dlkp~Nili~~~~-~~kL~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~  204 (333)
T cd06650         128 RDVKPSNILVNSRG-EIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAIGRYPIPP  204 (333)
T ss_pred             cCCChhhEEEcCCC-CEEEeeCCcchhhhhh-ccccCCCCccccCHHHhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            99999999999888 7999999998765332 22345689999999999664 489999999999999999999999976


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhc--CCCCccc------cCCCCCC------------CCchhhh-ccCCChhHHHHHH
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCM--NPNYTEF------KFPQIKA------------HPWHKIF-QKRMPPEAVDLVS  218 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~--~~~~~~~------~~~~~~~------------~~~~~~~-~~~~~~~~~~li~  218 (292)
                      .......    ...+.+........  .+.....      ..+..+.            ......+ ...++.++++||.
T Consensus       205 ~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  280 (333)
T cd06650         205 PDAKELE----LMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVN  280 (333)
T ss_pred             cchhHHH----HHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHH
Confidence            6543221    11111110000000  0000000      0000000            0000000 0136788999999


Q ss_pred             HHhccCCCCcccHHHHhcCCCcccc
Q 022799          219 RLLQYSPNLRSTALEALIHPFFDEL  243 (292)
Q Consensus       219 ~~l~~dp~~R~t~~e~l~hp~~~~~  243 (292)
                      +||++||++|||+.+++.||||+..
T Consensus       281 ~~L~~~P~~Rpt~~ell~h~~~~~~  305 (333)
T cd06650         281 KCLIKNPAERADLKQLMVHAFIKRS  305 (333)
T ss_pred             HhccCCcccCcCHHHHhhCHHHhcC
Confidence            9999999999999999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=5.8e-39  Score=280.41  Aligned_cols=239  Identities=31%  Similarity=0.557  Sum_probs=177.9

Q ss_pred             CCCCCCCCeeeeceeeeccCCC---------CceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHH
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEK---------DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI   71 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~---------~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~L   71 (292)
                      |+.++||||+++++++......         +....|+||||++++|.+.+..     ..+++..++.++.||+.||.||
T Consensus        56 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~L  130 (342)
T cd07854          56 IRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYI  130 (342)
T ss_pred             HHhcCCCcchhhHhhhcccccccccccccccccceEEEEeecccccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHH
Confidence            4578999999999887543211         1235789999999988877752     5689999999999999999999


Q ss_pred             HhcCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCC----CcccccccccccCCccccCCCCCCchhHhhhhhHHH
Q 022799           72 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE----PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVL  147 (292)
Q Consensus        72 H~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il  147 (292)
                      |+. |++||||||+||+++.++..++|+|||.+.......    ......++..|+|||.+.+...++.++|+||+||++
T Consensus       131 H~~-givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil  209 (342)
T cd07854         131 HSA-NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIF  209 (342)
T ss_pred             HhC-CcccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHH
Confidence            987 999999999999998665578999999987653221    112335788999999876655688999999999999


Q ss_pred             HHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccC--CCCCCCCchhhhccCCChhHHHHHHHHhccCC
Q 022799          148 AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF--PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSP  225 (292)
Q Consensus       148 ~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp  225 (292)
                      |+|++|..||.+.+..+....+......+.................  ......+... +.+.++.++.+||.+||+.||
T Consensus       210 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP  288 (342)
T cd07854         210 AEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRD-LLPGVNPEALDFLEQILTFNP  288 (342)
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHH-HccCCCHHHHHHHHHHhCCCc
Confidence            9999999999988887777777666554444322221111100000  0011111112 224688999999999999999


Q ss_pred             CCcccHHHHhcCCCccccCCC
Q 022799          226 NLRSTALEALIHPFFDELRDP  246 (292)
Q Consensus       226 ~~R~t~~e~l~hp~~~~~~~~  246 (292)
                      .+|||+.++++||||+.+..+
T Consensus       289 ~~R~t~~ell~h~~~~~~~~~  309 (342)
T cd07854         289 MDRLTAEEALMHPYMSCYSCP  309 (342)
T ss_pred             hhccCHHHHhCCCccccccCC
Confidence            999999999999999976544

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-39  Score=281.55  Aligned_cols=197  Identities=25%  Similarity=0.371  Sum_probs=165.6

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.|+|+|||++++++..     +..+||||||+. |+|.++++..  .+..+.......++.||++|++||+++ ++||
T Consensus       255 Mk~L~H~~lV~l~gV~~~-----~~piyIVtE~m~~GsLl~yLr~~--~~~~l~~~~Ll~~a~qIaeGM~YLes~-~~IH  326 (468)
T KOG0197|consen  255 MKKLRHEKLVKLYGVCTK-----QEPIYIVTEYMPKGSLLDYLRTR--EGGLLNLPQLLDFAAQIAEGMAYLESK-NYIH  326 (468)
T ss_pred             HHhCcccCeEEEEEEEec-----CCceEEEEEecccCcHHHHhhhc--CCCccchHHHHHHHHHHHHHHHHHHhC-Cccc
Confidence            678999999999999833     224999999999 9999999862  356788999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCccccc--ccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI--CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPL  156 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~p  156 (292)
                      |||...|||++.+. .+||+|||+|+.+.++.......  ....|.|||.+.-. .++.+|||||+|++||||+| |+.|
T Consensus       327 RDLAARNiLV~~~~-~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~-~FS~kSDVWSFGVlL~E~fT~G~~p  404 (468)
T KOG0197|consen  327 RDLAARNILVDEDL-VVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYG-KFSSKSDVWSFGVLLWELFTYGRVP  404 (468)
T ss_pred             hhhhhhheeeccCc-eEEEcccccccccCCCceeecCCCCCCceecCHHHHhhC-CcccccceeehhhhHHHHhccCCCC
Confidence            99999999999988 79999999999654433222211  24569999999654 59999999999999999998 8999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHh
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL  235 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l  235 (292)
                      +.+.+..+.+..+.+....|.                            |..+|+++.++|..||..+|++|||++.+.
T Consensus       405 y~~msn~ev~~~le~GyRlp~----------------------------P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~  455 (468)
T KOG0197|consen  405 YPGMSNEEVLELLERGYRLPR----------------------------PEGCPDEVYELMKSCWHEDPEDRPTFETLR  455 (468)
T ss_pred             CCCCCHHHHHHHHhccCcCCC----------------------------CCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence            999998888887766433222                            257999999999999999999999999765

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-39  Score=273.47  Aligned_cols=229  Identities=41%  Similarity=0.778  Sum_probs=184.7

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      |++++||||+++++++.     +....++||||+++++...+...   ...+++..+..++.|++.||.|||++ |++|+
T Consensus        52 l~~l~~~~i~~~~~~~~-----~~~~~~~v~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~  122 (283)
T cd05118          52 LKELNHPNIIKLLDVFR-----HKGDLYLVFEFMDTDLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSH-GILHR  122 (283)
T ss_pred             HHHhcCCCcchHHHhhc-----cCCCEEEEEeccCCCHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHC-Ceeec
Confidence            35678999999999883     34458999999999988887653   35789999999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCC-CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      ||+|+||+++.++ .++|+|||.+....... ......++..|+|||.+.+...++.++|+||+|+++|+|++|+.||.+
T Consensus       123 dl~p~nili~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~  201 (283)
T cd05118         123 DLKPENLLINTEG-VLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPG  201 (283)
T ss_pred             CcCHHHEEECCCC-cEEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999887 79999999987664433 223345788899999997764689999999999999999999999999


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCC--CCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNP--NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      .+..+...++.+.++.+..+.+.....  ......++......... ..+.++.++.++|.+||..||.+||++.++++|
T Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         202 KSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPK-LFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             CCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHH-hhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            988888888888888887766554432  11122222222222211 224678999999999999999999999999999


Q ss_pred             CCc
Q 022799          238 PFF  240 (292)
Q Consensus       238 p~~  240 (292)
                      |||
T Consensus       281 ~~~  283 (283)
T cd05118         281 PYF  283 (283)
T ss_pred             CCC
Confidence            997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=7.2e-39  Score=277.63  Aligned_cols=200  Identities=27%  Similarity=0.450  Sum_probs=164.5

Q ss_pred             CCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCC
Q 022799            5 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIK   83 (292)
Q Consensus         5 ~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlk   83 (292)
                      +||+|+++++++     .+...+|+||||++ |+|.+.+..    ...+++..+..++.||+.||.|||++ ||+|||||
T Consensus        59 ~~~~i~~~~~~~-----~~~~~~~lv~Ey~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~-~ivHrDik  128 (323)
T cd05615          59 KPPFLTQLHSCF-----QTVDRLYFVMEYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRR-GIIYRDLK  128 (323)
T ss_pred             CCCchhheeeEE-----ecCCEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCC
Confidence            467888999988     44445999999998 688887764    36789999999999999999999988 99999999


Q ss_pred             CCcEEEeCCCCcEEEeecCCccccccCC-CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCCCc
Q 022799           84 PQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG  162 (292)
Q Consensus        84 p~Nill~~~~~~ikl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~  162 (292)
                      |+||+++.++ .++|+|||+++...... ......||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+.+.
T Consensus       129 p~Nill~~~~-~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~  206 (323)
T cd05615         129 LDNVMLDSEG-HIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQ-PYGKSVDWWAYGVLLYEMLAGQPPFDGEDE  206 (323)
T ss_pred             HHHeEECCCC-CEEEeccccccccCCCCccccCccCCccccCHHHHcCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCH
Confidence            9999999888 79999999987543222 22345689999999999654 489999999999999999999999988776


Q ss_pred             HHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCccc-----HHHHhcC
Q 022799          163 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----ALEALIH  237 (292)
Q Consensus       163 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t-----~~e~l~h  237 (292)
                      ......+....                 .            .++..++.++.+++.+||..||.+|++     ..++++|
T Consensus       207 ~~~~~~i~~~~-----------------~------------~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05615         207 DELFQSIMEHN-----------------V------------SYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREH  257 (323)
T ss_pred             HHHHHHHHhCC-----------------C------------CCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcC
Confidence            65555544310                 0            122457889999999999999999997     5799999


Q ss_pred             CCccccCC
Q 022799          238 PFFDELRD  245 (292)
Q Consensus       238 p~~~~~~~  245 (292)
                      |||+.+.+
T Consensus       258 ~~f~~~~~  265 (323)
T cd05615         258 AFFRRIDW  265 (323)
T ss_pred             cccCCCCH
Confidence            99998764

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.2e-38  Score=277.96  Aligned_cols=238  Identities=39%  Similarity=0.755  Sum_probs=186.3

Q ss_pred             CCC-CCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLL-DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l-~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      +++ +||||+++++++..   .+....++||||++++|...+..     ..+++..+..++.||+.||.|||++ ||+||
T Consensus        61 ~~l~~h~ni~~~~~~~~~---~~~~~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~-~i~H~  131 (337)
T cd07852          61 QELGDHPNIVKLLNVIKA---ENDKDIYLVFEYMETDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSG-NVIHR  131 (337)
T ss_pred             HHhcCCCCccceeeeecc---CCCceEEEEecccccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CeecC
Confidence            456 99999999998743   23345889999999998888764     3678888999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCC------CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE------PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ  154 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~  154 (292)
                      ||||+||+++.++ .++|+|||.+.......      ......||..|+|||.+.+...++.++|+||+||++|+|++|+
T Consensus       132 dl~p~nill~~~~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~  210 (337)
T cd07852         132 DLKPSNILLNSDC-RVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK  210 (337)
T ss_pred             CCCHHHEEEcCCC-cEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCC
Confidence            9999999999988 79999999987653322      1223467889999998876666889999999999999999999


Q ss_pred             CCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcccc---CCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccH
Q 022799          155 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK---FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA  231 (292)
Q Consensus       155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~  231 (292)
                      .||.+....+...++....+.+..+.+..+........   ............+ +.++.++.++|.+||+.||++|||+
T Consensus       211 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~~P~~Rps~  289 (337)
T cd07852         211 PLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELL-PKASDDALDLLKKLLVFNPNKRLTA  289 (337)
T ss_pred             CCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhc-cCCCHHHHHHHHHhccCCcccccCH
Confidence            99999888888888888888877665543322111110   1111111112222 3478999999999999999999999


Q ss_pred             HHHhcCCCccccCCCCCCC
Q 022799          232 LEALIHPFFDELRDPNTRL  250 (292)
Q Consensus       232 ~e~l~hp~~~~~~~~~~~~  250 (292)
                      .++++||||+.+..+....
T Consensus       290 ~~il~~~~~~~~~~~~~~~  308 (337)
T cd07852         290 EEALEHPYVAQFHNPSDEP  308 (337)
T ss_pred             HHHhhChhhhhhccCCCCC
Confidence            9999999999987655443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=7.2e-39  Score=272.64  Aligned_cols=201  Identities=20%  Similarity=0.235  Sum_probs=161.8

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++|||||++++++.+.. .+..++++||||++ |+|.+++..    ...+++.....++.|++.||.|||+..+++|
T Consensus        72 l~~l~h~nIv~~~g~~~~~~-~~~~~~~lv~Ey~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~H  146 (283)
T PHA02988         72 LRRIDSNNILKIYGFIIDIV-DDLPRLSLILEYCTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPY  146 (283)
T ss_pred             HHhcCCCCEEEEeeeEEecc-cCCCceEEEEEeCCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcCCCCC
Confidence            56789999999999885422 22345889999999 689988865    3568888999999999999999997448999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCC-CCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      |||||+||+++.++ .+||+|||+++.....  .....||..|+|||++.+. ..++.++|+||+||++|||++|..||.
T Consensus       147 rdlkp~nill~~~~-~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~  223 (283)
T PHA02988        147 KNLTSVSFLVTENY-KLKIICHGLEKILSSP--PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFE  223 (283)
T ss_pred             CcCChhhEEECCCC-cEEEcccchHhhhccc--cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCC
Confidence            99999999999988 7999999998765332  2345688999999998652 458999999999999999999999998


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      +.+..+....+......+                           .++...++.++++|.+||+.||++|||+.+++.
T Consensus       224 ~~~~~~~~~~i~~~~~~~---------------------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        224 NLTTKEIYDLIINKNNSL---------------------------KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             CCCHHHHHHHHHhcCCCC---------------------------CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            776655544443321110                           012357889999999999999999999999984

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-38  Score=270.75  Aligned_cols=229  Identities=35%  Similarity=0.669  Sum_probs=180.1

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      |+.++||||+++++++     .+....+++|||++++|.+++....  ...+++..+..++.|++.||.|||++ |++||
T Consensus        52 l~~l~~~~iv~~~~~~-----~~~~~~~iv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~-~~~H~  123 (283)
T cd07835          52 LKELNHPNIVRLLDVV-----HSENKLYLVFEFLDLDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSH-RVLHR  123 (283)
T ss_pred             HHhcCCCCccCHhhee-----ccCCeEEEEEeccCcCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeCC
Confidence            3567899999999998     4445689999999989988886532  13689999999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCC-CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      ||+|+||+++.++ .++|+|||.+....... ......++..|+|||.+.+...++.++|+||+||++|+|++|..||.+
T Consensus       124 dl~p~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  202 (283)
T cd07835         124 DLKPQNLLIDREG-ALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPG  202 (283)
T ss_pred             CCCHHHEEEcCCC-cEEEeecccccccCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999877 79999999987553222 112335688899999886655578999999999999999999999999


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCC--CCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNP--NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      .+......++.+..+.|....+.....  ++.. .++........ ...+.++..+.++|.+||+.||.+|||+++++.|
T Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         203 DSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKP-TFPKWARQDLS-KVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             CCHHHHHHHHHHHhCCCChHHhhhhhhchhhhh-hcccccccchh-hhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            888888888888888887765533211  1100 11111111111 1235688999999999999999999999999999


Q ss_pred             CCc
Q 022799          238 PFF  240 (292)
Q Consensus       238 p~~  240 (292)
                      |||
T Consensus       281 ~~~  283 (283)
T cd07835         281 PYF  283 (283)
T ss_pred             CCC
Confidence            998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-40  Score=274.34  Aligned_cols=202  Identities=28%  Similarity=0.487  Sum_probs=174.1

Q ss_pred             CCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCC
Q 022799            5 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIK   83 (292)
Q Consensus         5 ~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlk   83 (292)
                      +-|.++++..+|.+.+.     +|.||||+. |+|-..++.    -+++.+..+..|+.+|+-||-+||++ ||++||||
T Consensus       408 kppFL~qlHScFQTmDR-----LyFVMEyvnGGDLMyhiQQ----~GkFKEp~AvFYAaEiaigLFFLh~k-gIiYRDLK  477 (683)
T KOG0696|consen  408 KPPFLVQLHSCFQTMDR-----LYFVMEYVNGGDLMYHIQQ----VGKFKEPVAVFYAAEIAIGLFFLHSK-GIIYRDLK  477 (683)
T ss_pred             CCchHHHHHHHhhhhhh-----eeeEEEEecCchhhhHHHH----hcccCCchhhhhhHHHHHHhhhhhcC-Ceeeeecc
Confidence            45788999999955554     999999999 687766665    37789999999999999999999998 99999999


Q ss_pred             CCcEEEeCCCCcEEEeecCCccccc-cCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCCCc
Q 022799           84 PQNLLVNPHTHQLKLCDFGSAKVLV-KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG  162 (292)
Q Consensus        84 p~Nill~~~~~~ikl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~  162 (292)
                      .+||+++.+| .|||+|||+++... .+....+++|||.|+|||++. ...|+.++|+||+|+++|||+.|++||.|.++
T Consensus       478 LDNvmLd~eG-HiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~-YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE  555 (683)
T KOG0696|consen  478 LDNVMLDSEG-HIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE  555 (683)
T ss_pred             ccceEeccCC-ceEeeecccccccccCCcceeeecCCCcccccceEE-ecccccchhHHHHHHHHHHHHcCCCCCCCCCH
Confidence            9999999999 59999999998643 344556789999999999995 45699999999999999999999999999999


Q ss_pred             HHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCccc-----HHHHhcC
Q 022799          163 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----ALEALIH  237 (292)
Q Consensus       163 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t-----~~e~l~h  237 (292)
                      .+..+.|.+.-                             ..+|+.+|.++.++++.+|.+.|.+|..     -.++-.|
T Consensus       556 ~elF~aI~ehn-----------------------------vsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H  606 (683)
T KOG0696|consen  556 DELFQAIMEHN-----------------------------VSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREH  606 (683)
T ss_pred             HHHHHHHHHcc-----------------------------CcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhC
Confidence            99988888741                             1244679999999999999999999965     3578899


Q ss_pred             CCccccCCCC
Q 022799          238 PFFDELRDPN  247 (292)
Q Consensus       238 p~~~~~~~~~  247 (292)
                      |||+.+++..
T Consensus       607 ~FFR~iDWek  616 (683)
T KOG0696|consen  607 PFFRRIDWEK  616 (683)
T ss_pred             cchhhccHHH
Confidence            9999998653

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.4e-38  Score=273.92  Aligned_cols=235  Identities=29%  Similarity=0.509  Sum_probs=176.7

Q ss_pred             CCCCCCCCeeeeceeeeccCC---CCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTE---KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGV   77 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~---~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i   77 (292)
                      |++++||||+++++++.....   ......++||||++++|.+.+...   ...+++..++.++.||+.||.|||++ |+
T Consensus        65 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~-~i  140 (310)
T cd07865          65 LQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNK---NVKFTLSEIKKVMKMLLNGLYYIHRN-KI  140 (310)
T ss_pred             HHhCCCCCccceEEEEecccccccCCCceEEEEEcCCCcCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC-Ce
Confidence            357899999999998754332   223457999999999988887642   34689999999999999999999988 99


Q ss_pred             cccCCCCCcEEEeCCCCcEEEeecCCccccccCCC-----cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh
Q 022799           78 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL  152 (292)
Q Consensus        78 ~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~  152 (292)
                      +|+||||+||+++.++ .++|+|||.+........     .....++..|+|||.+.+...++.++|+||+|+++|+|++
T Consensus       141 ~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t  219 (310)
T cd07865         141 LHRDMKAANILITKDG-ILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT  219 (310)
T ss_pred             eccCCCHHHEEECCCC-cEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHh
Confidence            9999999999999888 799999999876533221     1234567889999998766557899999999999999999


Q ss_pred             CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCC--CCccccCCCCCCCCchhhh-ccCCChhHHHHHHHHhccCCCCcc
Q 022799          153 GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP--NYTEFKFPQIKAHPWHKIF-QKRMPPEAVDLVSRLLQYSPNLRS  229 (292)
Q Consensus       153 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~dp~~R~  229 (292)
                      |..||.+.+.......+.+..+..+.+.+.....  .+.....+..........+ +...+..+.++|.+||..||.+||
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~  299 (310)
T cd07865         220 RSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRI  299 (310)
T ss_pred             CCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhcc
Confidence            9999998887777777777766665554332210  0111111111111111111 112467889999999999999999


Q ss_pred             cHHHHhcCCCc
Q 022799          230 TALEALIHPFF  240 (292)
Q Consensus       230 t~~e~l~hp~~  240 (292)
                      |++++++||||
T Consensus       300 t~~e~l~h~~f  310 (310)
T cd07865         300 DADTALNHDFF  310 (310)
T ss_pred             CHHHHhcCCCC
Confidence            99999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-38  Score=268.09  Aligned_cols=201  Identities=27%  Similarity=0.484  Sum_probs=162.7

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++     .+....++||||++ ++|.+.+..    ...+++..++.++.|++.||.|||+. |++|
T Consensus        58 l~~l~~~~i~~~~~~~-----~~~~~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~H  127 (263)
T cd06625          58 LKNLQHERIVQYYGCL-----RDDETLSIFMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSN-MIVH  127 (263)
T ss_pred             HHhCCCCCeeeeEEEE-----ccCCeEEEEEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC-Ceec
Confidence            4578999999999998     34446999999998 588888765    35688999999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCc----ccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQP  155 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~  155 (292)
                      |||+|+||+++.++ .++|+|||.+.........    ....++..|+|||.+.+.. ++.++|+||+||++|+|++|..
T Consensus       128 ~dl~p~nilv~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~  205 (263)
T cd06625         128 RDIKGANILRDSAG-NVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG-YGRKADVWSVGCTVVEMLTEKP  205 (263)
T ss_pred             CCCCHHHEEEcCCC-CEEEeecccceeccccccccccccCCCcCccccCcceeccCC-CCchhhhHHHHHHHHHHHhCCC
Confidence            99999999999887 7999999998755322111    2345788999999997654 8999999999999999999999


Q ss_pred             CCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHh
Q 022799          156 LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL  235 (292)
Q Consensus       156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l  235 (292)
                      ||.+.+.......+.....                           ...++..++..+.++|++||..+|.+|||+.+++
T Consensus       206 p~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll  258 (263)
T cd06625         206 PWAEFEAMAAIFKIATQPT---------------------------NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELL  258 (263)
T ss_pred             CccccchHHHHHHHhccCC---------------------------CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHh
Confidence            9977655443333221100                           0012245788999999999999999999999999


Q ss_pred             cCCCc
Q 022799          236 IHPFF  240 (292)
Q Consensus       236 ~hp~~  240 (292)
                      +||||
T Consensus       259 ~~~~~  263 (263)
T cd06625         259 RHFFV  263 (263)
T ss_pred             hCCCC
Confidence            99997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.3e-39  Score=283.27  Aligned_cols=211  Identities=27%  Similarity=0.434  Sum_probs=166.5

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      +.++||||+++++++     .+..+.|+||||+. |+|.+++...   ...+++..++.++.|++.||.|||++ ||+||
T Consensus        56 ~~~~~~~i~~l~~~~-----~~~~~~~lv~Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~-~iiHr  126 (331)
T cd05624          56 VNGDCQWITTLHYAF-----QDENYLYLVMDYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQL-HYVHR  126 (331)
T ss_pred             HhCCCCCEeeEEEEE-----EcCCEEEEEEeCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-Ceeec
Confidence            457899999999998     44556999999998 6999888753   35689999999999999999999987 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCCc--ccccccccccCCccccCC----CCCCchhHhhhhhHHHHHHHhCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN--ISYICSRYYRAPELIFGA----TEYTAAIDIWSAGCVLAELLLGQ  154 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~----~~~~~~~DvwslG~il~el~~g~  154 (292)
                      ||||+||+++.++ .+||+|||++.........  ....||+.|+|||++.+.    ..++.++|+||+||++|+|++|.
T Consensus       127 Dlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~  205 (331)
T cd05624         127 DIKPDNVLLDMNG-HIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE  205 (331)
T ss_pred             cCchHHEEEcCCC-CEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCC
Confidence            9999999999888 7999999998766433222  234689999999998542    34788999999999999999999


Q ss_pred             CCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCC--cccHH
Q 022799          155 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL--RSTAL  232 (292)
Q Consensus       155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--R~t~~  232 (292)
                      .||.+.+..+...++......               ..++.        . ...++++++++|.+||+.++++  |++++
T Consensus       206 ~Pf~~~~~~~~~~~i~~~~~~---------------~~~p~--------~-~~~~~~~~~~li~~ll~~~~~~~~~~~~~  261 (331)
T cd05624         206 TPFYAESLVETYGKIMNHEER---------------FQFPS--------H-ITDVSEEAKDLIQRLICSRERRLGQNGIE  261 (331)
T ss_pred             CCccCCCHHHHHHHHHcCCCc---------------ccCCC--------c-cccCCHHHHHHHHHHccCchhhcCCCCHH
Confidence            999887765555444321100               00110        0 1347899999999999976655  56899


Q ss_pred             HHhcCCCccccCCC
Q 022799          233 EALIHPFFDELRDP  246 (292)
Q Consensus       233 e~l~hp~~~~~~~~  246 (292)
                      ++++||||+.+.+.
T Consensus       262 ~~~~h~~f~~~~~~  275 (331)
T cd05624         262 DFKKHAFFEGIDWE  275 (331)
T ss_pred             HHhcCCCcCCCCHH
Confidence            99999999987653

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=3.4e-38  Score=269.47  Aligned_cols=230  Identities=38%  Similarity=0.681  Sum_probs=173.0

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      |+.++|+||+++++++     .+....|+||||+++++.+.+...   ...+++..++.++.|++.||.|||++ ||+|+
T Consensus        57 l~~l~h~ni~~~~~~~-----~~~~~~~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~  127 (291)
T cd07870          57 LKGLKHANIVLLHDII-----HTKETLTFVFEYMHTDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQ-HILHR  127 (291)
T ss_pred             HHhcCCCCEeEEEEEE-----ecCCeEEEEEecccCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC-CcccC
Confidence            3578999999999998     344468999999998888776542   34578888999999999999999987 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCC-CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      ||||+||+++.++ .++|+|||+++...... ......+++.|+|||.+.+...++.++|+||+||++|+|++|..||.+
T Consensus       128 dlkp~Nil~~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~  206 (291)
T cd07870         128 DLKPQNLLISYLG-ELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPG  206 (291)
T ss_pred             CCChHHEEEcCCC-cEEEeccccccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999888 79999999987543221 123345688999999987655678999999999999999999999976


Q ss_pred             CCc-HHHHHHHHHHhCCCCHHHHhhcC--CCCccccCCCCCCCCchhhhc-cCCChhHHHHHHHHhccCCCCcccHHHHh
Q 022799          160 ESG-VDQLVEIIKVLGTPTREEIKCMN--PNYTEFKFPQIKAHPWHKIFQ-KRMPPEAVDLVSRLLQYSPNLRSTALEAL  235 (292)
Q Consensus       160 ~~~-~~~~~~i~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~dp~~R~t~~e~l  235 (292)
                      ... .+.+.++....+.|....+....  +.+.....+............ -..++.+.+++.+||..||++|||+.+++
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l  286 (291)
T cd07870         207 VSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDAL  286 (291)
T ss_pred             chhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHh
Confidence            543 45566666777777666543321  112111111111111111110 12367899999999999999999999999


Q ss_pred             cCCCc
Q 022799          236 IHPFF  240 (292)
Q Consensus       236 ~hp~~  240 (292)
                      .||||
T Consensus       287 ~h~~~  291 (291)
T cd07870         287 LHPYF  291 (291)
T ss_pred             cCCCC
Confidence            99998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=6.8e-39  Score=302.51  Aligned_cols=215  Identities=30%  Similarity=0.462  Sum_probs=170.4

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhc-----
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT-----   74 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~-----   74 (292)
                      |++|+|||||+++++|....   ...+||||||++ |+|.+++.........+++..++.++.||+.||.|||+.     
T Consensus        66 L~~L~HPNIVrl~d~f~de~---~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~  142 (1021)
T PTZ00266         66 MRELKHKNIVRYIDRFLNKA---NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPN  142 (1021)
T ss_pred             HHHcCCCCcCeEEEEEEecC---CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccc
Confidence            45789999999999885432   235889999998 699999876555456799999999999999999999974     


Q ss_pred             -CCccccCCCCCcEEEeCCC----------------CcEEEeecCCccccccCCCcccccccccccCCccccCC-CCCCc
Q 022799           75 -IGVCHRDIKPQNLLVNPHT----------------HQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA-TEYTA  136 (292)
Q Consensus        75 -~~i~H~dlkp~Nill~~~~----------------~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~  136 (292)
                       .+|+||||||+|||++.+.                ..+||+|||++.............||+.|+|||++.+. ..++.
T Consensus       143 ~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~  222 (1021)
T PTZ00266        143 GERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDD  222 (1021)
T ss_pred             cCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCc
Confidence             1499999999999996421                24899999999876544444456789999999998643 34789


Q ss_pred             hhHhhhhhHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHH
Q 022799          137 AIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDL  216 (292)
Q Consensus       137 ~~DvwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  216 (292)
                      ++||||||||+|+|++|..||...+....+...+...  +.               .+           ....+.++.+|
T Consensus       223 KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~--p~---------------lp-----------i~~~S~eL~dL  274 (1021)
T PTZ00266        223 KSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRG--PD---------------LP-----------IKGKSKELNIL  274 (1021)
T ss_pred             hhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcC--CC---------------CC-----------cCCCCHHHHHH
Confidence            9999999999999999999998766554443332211  00               00           03468899999


Q ss_pred             HHHHhccCCCCcccHHHHhcCCCccccCCC
Q 022799          217 VSRLLQYSPNLRSTALEALIHPFFDELRDP  246 (292)
Q Consensus       217 i~~~l~~dp~~R~t~~e~l~hp~~~~~~~~  246 (292)
                      |.+||..+|.+||++.++|.|||++.+..+
T Consensus       275 I~~~L~~dPeeRPSa~QlL~h~~ik~i~~p  304 (1021)
T PTZ00266        275 IKNLLNLSAKERPSALQCLGYQIIKNVGPP  304 (1021)
T ss_pred             HHHHhcCChhHCcCHHHHhccHHHhhcCCC
Confidence            999999999999999999999999877544

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=4.9e-39  Score=274.00  Aligned_cols=211  Identities=26%  Similarity=0.403  Sum_probs=166.5

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++|+||+++++.+     .+..++|+||||+. ++|.+.+....  ...+++..+..++.|++.||.|||+. ||+|
T Consensus        54 l~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~-~iiH  125 (285)
T cd05630          54 LEKVNSRFVVSLAYAY-----ETKDALCLVLTLMNGGDLKFHIYHMG--EAGFEEGRAVFYAAEICCGLEDLHQE-RIVY  125 (285)
T ss_pred             HHhCCCCCeeeeeEEE-----ecCCEEEEEEEecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC-CEEe
Confidence            4578999999999988     44446999999998 68888775432  34689999999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      |||||+||+++.++ .++|+|||++.............||+.|+|||.+.+. .++.++|+||+||++|+|++|..||.+
T Consensus       126 ~dikp~Nil~~~~~-~~~l~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~Pf~~  203 (285)
T cd05630         126 RDLKPENILLDDHG-HIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQ  203 (285)
T ss_pred             CCCCHHHEEECCCC-CEEEeeccceeecCCCccccCCCCCccccChHHHcCC-CCCCccccHHHHHHHHHHHhCCCCCCC
Confidence            99999999999887 7999999998765444333445789999999999664 489999999999999999999999976


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCccc-----HHHH
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----ALEA  234 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t-----~~e~  234 (292)
                      .................                         ...++..+++++.+||.+||+.||++|+|     ++++
T Consensus       204 ~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~  258 (285)
T cd05630         204 RKKKIKREEVERLVKEV-------------------------QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREV  258 (285)
T ss_pred             CCccchHHHHHhhhhhh-------------------------hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHH
Confidence            54321111111100000                         00122457889999999999999999999     9999


Q ss_pred             hcCCCccccCCC
Q 022799          235 LIHPFFDELRDP  246 (292)
Q Consensus       235 l~hp~~~~~~~~  246 (292)
                      ++||||+.+...
T Consensus       259 ~~h~~~~~~~~~  270 (285)
T cd05630         259 KEHPLFKQINFK  270 (285)
T ss_pred             HcChhhhccCHH
Confidence            999999986543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=3.7e-39  Score=282.82  Aligned_cols=204  Identities=28%  Similarity=0.386  Sum_probs=156.3

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccC-CHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++     .+...+++||||+++ +|...        ....+..+..++.||+.||.|||++ ||+|
T Consensus       126 l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~~~~~L~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH  191 (353)
T PLN00034        126 LRDVNHPNVVKCHDMF-----DHNGEIQVLLEFMDGGSLEGT--------HIADEQFLADVARQILSGIAYLHRR-HIVH  191 (353)
T ss_pred             HHhCCCCCcceeeeEe-----ccCCeEEEEEecCCCCccccc--------ccCCHHHHHHHHHHHHHHHHHHHHC-CEee
Confidence            4678999999999998     444568999999994 65321        3356778889999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCC-CcccccccccccCCccccCC----CCCCchhHhhhhhHHHHHHHhCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGA----TEYTAAIDIWSAGCVLAELLLGQ  154 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~~~DvwslG~il~el~~g~  154 (292)
                      |||||+||+++.++ .+||+|||++....... ......||..|+|||.+...    ...+.++|||||||++|+|++|+
T Consensus       192 rDlkp~NIll~~~~-~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~  270 (353)
T PLN00034        192 RDIKPSNLLINSAK-NVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR  270 (353)
T ss_pred             cCCCHHHEEEcCCC-CEEEcccccceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCC
Confidence            99999999999887 79999999998654322 22345789999999987431    23456899999999999999999


Q ss_pred             CCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHH
Q 022799          155 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA  234 (292)
Q Consensus       155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~  234 (292)
                      .||......+....+.......                         ....+..++.++++||.+||..||++|||+.|+
T Consensus       271 ~pf~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~el  325 (353)
T PLN00034        271 FPFGVGRQGDWASLMCAICMSQ-------------------------PPEAPATASREFRHFISCCLQREPAKRWSAMQL  325 (353)
T ss_pred             CCCCCCCCccHHHHHHHHhccC-------------------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHH
Confidence            9997433222111111100000                         000124578899999999999999999999999


Q ss_pred             hcCCCccccC
Q 022799          235 LIHPFFDELR  244 (292)
Q Consensus       235 l~hp~~~~~~  244 (292)
                      ++||||..-.
T Consensus       326 l~hp~~~~~~  335 (353)
T PLN00034        326 LQHPFILRAQ  335 (353)
T ss_pred             hcCcccccCC
Confidence            9999998753

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=8.8e-39  Score=290.98  Aligned_cols=213  Identities=25%  Similarity=0.363  Sum_probs=172.2

Q ss_pred             CCCCCCCCeeeeceeeeccCC---CCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 022799            1 MRLLDHPNVVSLKHCFFSTTE---KDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG   76 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~---~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~   76 (292)
                      |..++|+||+++++.+.....   .....+++||||++ |+|.+.+.........+++..+..++.|++.||.|||++ |
T Consensus        85 l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~-~  163 (496)
T PTZ00283         85 LLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK-H  163 (496)
T ss_pred             HhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC-C
Confidence            356789999999887754322   12235789999998 799998876555556799999999999999999999988 9


Q ss_pred             ccccCCCCCcEEEeCCCCcEEEeecCCccccccC---CCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhC
Q 022799           77 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG---EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG  153 (292)
Q Consensus        77 i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g  153 (292)
                      |+||||||+||+++.++ .+||+|||+++.....   .......||+.|+|||++.+. .++.++|+||+||++|+|++|
T Consensus       164 IiHrDLKP~NILl~~~~-~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~k~DVwSlGvilyeLltG  241 (496)
T PTZ00283        164 MIHRDIKSANILLCSNG-LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRK-PYSKKADMFSLGVLLYELLTL  241 (496)
T ss_pred             EecCCCCHHHEEEeCCC-CEEEEecccCeeccccccccccccccCCcceeCHHHhCCC-CCCcHHHHHHHHHHHHHHHHC
Confidence            99999999999999888 7999999998765322   122345789999999999764 489999999999999999999


Q ss_pred             CCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHH
Q 022799          154 QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE  233 (292)
Q Consensus       154 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e  233 (292)
                      ..||.+.+..+.+..+.....                            ..++..+++++.++|.+||..||.+||++.+
T Consensus       242 ~~Pf~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~e  293 (496)
T PTZ00283        242 KRPFDGENMEEVMHKTLAGRY----------------------------DPLPPSISPEMQEIVTALLSSDPKRRPSSSK  293 (496)
T ss_pred             CCCCCCCCHHHHHHHHhcCCC----------------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHH
Confidence            999987766555444332100                            0123568899999999999999999999999


Q ss_pred             HhcCCCccccC
Q 022799          234 ALIHPFFDELR  244 (292)
Q Consensus       234 ~l~hp~~~~~~  244 (292)
                      +++|||++.+.
T Consensus       294 ll~~p~~~~~~  304 (496)
T PTZ00283        294 LLNMPICKLFI  304 (496)
T ss_pred             HHhCHHHHHhh
Confidence            99999988653

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.5e-39  Score=293.02  Aligned_cols=231  Identities=23%  Similarity=0.337  Sum_probs=168.3

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhh-hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHY-KMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~-~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++|||||++++++.     +....|+|++++.++|..++.... ..........++.++.||+.||.|||++ ||+|
T Consensus       217 l~~l~HpnIv~l~~~~~-----~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~-gIiH  290 (501)
T PHA03210        217 LGRLNHENILKIEEILR-----SEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK-KLIH  290 (501)
T ss_pred             HHhCCCCCcCcEeEEEE-----ECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC-Ceec
Confidence            45789999999999984     344588999999998888775432 1123345677889999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCC--cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF  157 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf  157 (292)
                      |||||+|||++.++ .+||+|||+++.+.....  .....||+.|+|||++.+. .++.++|+||+||++|||++|..++
T Consensus       291 rDLKP~NILl~~~~-~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~~~~~p  368 (501)
T PHA03210        291 RDIKLENIFLNCDG-KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGD-GYCEITDIWSCGLILLDMLSHDFCP  368 (501)
T ss_pred             CCCCHHHEEECCCC-CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCC
Confidence            99999999999888 799999999987644322  2245789999999999765 4899999999999999999987544


Q ss_pred             CC---CCcHHHHHHHHHHhCCCCHHH-------HhhcCCCCccccCCCCCCCCchhh-hccCCChhHHHHHHHHhccCCC
Q 022799          158 PG---ESGVDQLVEIIKVLGTPTREE-------IKCMNPNYTEFKFPQIKAHPWHKI-FQKRMPPEAVDLVSRLLQYSPN  226 (292)
Q Consensus       158 ~~---~~~~~~~~~i~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dp~  226 (292)
                      .+   .....++.+++..++.+..+.       +..+..    ..+.... ...... ....++.++.++|.+||.+||.
T Consensus       369 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~----~~~~~~~-~~~~~~~~~~~~~~~~~~li~kmL~~DP~  443 (501)
T PHA03210        369 IGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDS----AEIDHAG-HSVPPLIRNLGLPADFEYPLVKMLTFDWH  443 (501)
T ss_pred             ccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhh----hhcccCc-cchhhHHHhcCCChHHHHHHHHHhccCcc
Confidence            32   234455666666554433221       110000    0000000 011111 1135678899999999999999


Q ss_pred             CcccHHHHhcCCCccccC
Q 022799          227 LRSTALEALIHPFFDELR  244 (292)
Q Consensus       227 ~R~t~~e~l~hp~~~~~~  244 (292)
                      +|||+.|+|.||||+...
T Consensus       444 ~Rpsa~elL~hp~f~~~~  461 (501)
T PHA03210        444 LRPGAAELLALPLFSAEE  461 (501)
T ss_pred             cCcCHHHHhhChhhhcCC
Confidence            999999999999998754

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=8.7e-38  Score=271.41  Aligned_cols=260  Identities=35%  Similarity=0.720  Sum_probs=195.9

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      |+.++||||+++.++|....    ...++||||++++|.+++..     .++++..+..++.|+++||.|||+. ||+||
T Consensus        63 l~~l~hpniv~~~~~~~~~~----~~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~-~iiH~  132 (328)
T cd07856          63 LKHLRHENIISLSDIFISPL----EDIYFVTELLGTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSA-GVVHR  132 (328)
T ss_pred             HHhcCCCCeeeEeeeEecCC----CcEEEEeehhccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC-CcccC
Confidence            35789999999999885422    24789999999898877753     4678888999999999999999987 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE  160 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  160 (292)
                      ||+|+||+++.++ .++|+|||.+.....  ......+++.|+|||.+.+...++.++|+||+||++|+|++|..||.+.
T Consensus       133 dl~p~Nili~~~~-~~~l~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~  209 (328)
T cd07856         133 DLKPSNILINENC-DLKICDFGLARIQDP--QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGK  209 (328)
T ss_pred             CCCHHHEeECCCC-CEEeCccccccccCC--CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999999877 799999999875432  2234567889999998866456899999999999999999999999988


Q ss_pred             CcHHHHHHHHHHhCCCCHHHHhhcCCCC-ccc--cCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          161 SGVDQLVEIIKVLGTPTREEIKCMNPNY-TEF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       161 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      ........+.+.++.++.+........- ..+  ..+.....+..... +.++..+.++|.+||+.+|++|||+++++.|
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         210 DHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKF-KNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             CHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHc-CCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            8877788888888888766554321110 000  11111111222222 4578899999999999999999999999999


Q ss_pred             CCccccCCCCCCCCCCCCCCCCCCCChhccCCCCHHHHhhhc
Q 022799          238 PFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI  279 (292)
Q Consensus       238 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (292)
                      |||.....+.....    .-..+++. ..-.+++++.|+-++
T Consensus       289 ~~~~~~~~~~~~~~----~~~~~~~~-~~~~~~~~~~~~~~~  325 (328)
T cd07856         289 PYLAPYHDPTDEPV----AEEKFDWS-FNDADLPVDTWKVMM  325 (328)
T ss_pred             CccccccCCccccC----chhhcCCc-hhcccCCHHHHHHHh
Confidence            99998776543322    12234444 233456788887654

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.5e-38  Score=276.16  Aligned_cols=231  Identities=24%  Similarity=0.419  Sum_probs=163.2

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++..     +...++||||++ |+|.+++..+.  ...+++..++.++.|++.||.|||++ ||+|
T Consensus        53 l~~l~hpniv~~~~~~~~-----~~~~~lv~e~~~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~-~iiH  124 (327)
T cd08227          53 SKLFNHPNIVPYRATFIA-----DNELWVVTSFMAYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHM-GYVH  124 (327)
T ss_pred             HHhcCCCCeeeEEEEEEE-----CCEEEEEEeccCCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC-CEec
Confidence            356899999999999843     345899999998 68888886532  24589999999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCC--------cccccccccccCCccccCC-CCCCchhHhhhhhHHHHHH
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP--------NISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAEL  150 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslG~il~el  150 (292)
                      |||||+||+++.++ .++++||+.+........        .....++..|+|||++.+. ..++.++|+||+||++|+|
T Consensus       125 ~dlkp~Nil~~~~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el  203 (327)
T cd08227         125 RSVKASHILISVDG-KVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACEL  203 (327)
T ss_pred             CCCChhhEEEecCC-cEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHH
Confidence            99999999999888 799999986543321111        1123456779999998653 3588999999999999999


Q ss_pred             HhCCCCCCCCCcHHHHHHHHHHhCCCC---------HHHHhhcCCC-------Ccccc-----CCCCCCCCchhhhccCC
Q 022799          151 LLGQPLFPGESGVDQLVEIIKVLGTPT---------REEIKCMNPN-------YTEFK-----FPQIKAHPWHKIFQKRM  209 (292)
Q Consensus       151 ~~g~~pf~~~~~~~~~~~i~~~~~~~~---------~~~~~~~~~~-------~~~~~-----~~~~~~~~~~~~~~~~~  209 (292)
                      ++|..||.+............  +..+         .+.+. ..+.       .....     .+... ..........+
T Consensus       204 ~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  279 (327)
T cd08227         204 ANGHVPFKDMPATQMLLEKLN--GTVPCLLDTTTIPAEELT-MKPSRSGANSGLGESTTVSTPRPSNG-ESSSHPYNRTF  279 (327)
T ss_pred             HHCCCCCCCcchhHHHHHHhc--CCccccccccchhhhhcc-cCCcccCCcCCCCcccccCCcCcccc-CCccccccccc
Confidence            999999976544332222211  1110         00000 0000       00000     00000 00001122356


Q ss_pred             ChhHHHHHHHHhccCCCCcccHHHHhcCCCccccC
Q 022799          210 PPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  244 (292)
Q Consensus       210 ~~~~~~li~~~l~~dp~~R~t~~e~l~hp~~~~~~  244 (292)
                      ++.+.+||.+||+.||++|||++++++||||+.+.
T Consensus       280 ~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~  314 (327)
T cd08227         280 SPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK  314 (327)
T ss_pred             CHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence            78999999999999999999999999999998764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.1e-38  Score=273.55  Aligned_cols=235  Identities=35%  Similarity=0.676  Sum_probs=182.4

Q ss_pred             CCCCCCCCeeeeceeeeccCC-CCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTE-KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~-~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++..... .....+++||||+..+|....      +..+++..+..++.|++.||.|||++ |++|
T Consensus        68 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~-~i~H  140 (342)
T cd07879          68 LKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHSA-GIIH  140 (342)
T ss_pred             HHhcCCCCccchhheecccccCCCCceEEEEecccccCHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHC-Cccc
Confidence            356899999999998854332 122346899999988776554      24689999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      |||||+||+++.++ .++|+|||+++....  ......+++.|+|||.+.+...++.++|+||+||++|+|++|+.||.+
T Consensus       141 ~dlkp~NIll~~~~-~~kL~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~  217 (342)
T cd07879         141 RDLKPGNLAVNEDC-ELKILDFGLARHADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKG  217 (342)
T ss_pred             CCCCHHHEEECCCC-CEEEeeCCCCcCCCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCC
Confidence            99999999999888 799999999876422  223456788999999986655588999999999999999999999999


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc-c--cCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTE-F--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      .+....+..+....+.+.............. +  ..+......+...+ +..++++.+||.+||+.||.+||++++++.
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~dP~~R~~~~e~l~  296 (342)
T cd07879         218 KDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLF-PKASPQAVDLLEKMLELDVDKRLTATEALE  296 (342)
T ss_pred             CCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHh-cCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            8888888888888777776655443221100 0  11111111122111 357889999999999999999999999999


Q ss_pred             CCCccccCCC
Q 022799          237 HPFFDELRDP  246 (292)
Q Consensus       237 hp~~~~~~~~  246 (292)
                      ||||..+++.
T Consensus       297 h~~f~~~~~~  306 (342)
T cd07879         297 HPYFDSFRDA  306 (342)
T ss_pred             Ccchhhcccc
Confidence            9999998754

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-39  Score=288.37  Aligned_cols=207  Identities=28%  Similarity=0.470  Sum_probs=170.3

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCC--CHHHHHHHHHHHHHHHHHHHhcCCcc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRM--PLIYVKLYFYQICRALAYIHNTIGVC   78 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~--~~~~~~~~~~qil~al~~LH~~~~i~   78 (292)
                      ++|+|.|||++++++     ..+.++-+.||-++ |+|..+++...   +++  .+.++..|..||++||.|||++ .||
T Consensus       627 ~~LrHkNIVrYLGs~-----senGf~kIFMEqVPGGSLSsLLrskW---GPlKDNEstm~fYtkQILeGLkYLHen-~IV  697 (1226)
T KOG4279|consen  627 STLRHKNIVRYLGSV-----SENGFFKIFMEQVPGGSLSSLLRSKW---GPLKDNESTMNFYTKQILEGLKYLHEN-KIV  697 (1226)
T ss_pred             HHHhhHhHHHHhhcc-----CCCCeEEEEeecCCCCcHHHHHHhcc---CCCccchhHHHHHHHHHHHHhhhhhhc-cee
Confidence            468999999999998     66668889999998 69999998753   445  8999999999999999999998 999


Q ss_pred             ccCCCCCcEEEeCCCCcEEEeecCCccccccCC-CcccccccccccCCccccCC-CCCCchhHhhhhhHHHHHHHhCCCC
Q 022799           79 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLLGQPL  156 (292)
Q Consensus        79 H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~p  156 (292)
                      |||||.+|+|++...+.+||+|||.++....-. ..-++.||..|||||++..+ +.|+.++|||||||++.||.||++|
T Consensus       698 HRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPP  777 (1226)
T KOG4279|consen  698 HRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPP  777 (1226)
T ss_pred             eccccCCcEEEeeccceEEecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCC
Confidence            999999999999887799999999998774433 34467899999999999543 5699999999999999999999999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      |........  .+++.                        .....+..+|..+|.+++.||.+|+..||.+||+|.++|.
T Consensus       778 F~ElgspqA--AMFkV------------------------GmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  778 FVELGSPQA--AMFKV------------------------GMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             eeecCChhH--hhhhh------------------------cceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            964322111  11111                        0111223345678999999999999999999999999999


Q ss_pred             CCCcccc
Q 022799          237 HPFFDEL  243 (292)
Q Consensus       237 hp~~~~~  243 (292)
                      .||++.-
T Consensus       832 DpFlq~~  838 (1226)
T KOG4279|consen  832 DPFLQHN  838 (1226)
T ss_pred             CcccccC
Confidence            9999864

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-38  Score=267.43  Aligned_cols=230  Identities=39%  Similarity=0.720  Sum_probs=178.6

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      |+.++||||+++++++..     ....++||||+++++...+...   ...+++..+..++.||+.||.|||++ |++|+
T Consensus        54 l~~l~~~~i~~~~~~~~~-----~~~~~iv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~  124 (288)
T cd07833          54 LRQLRHENIVNLKEAFRR-----KGRLYLVFEYVERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCHSH-NIIHR  124 (288)
T ss_pred             HHhcCCCCeeehhheEEE-----CCEEEEEEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecC
Confidence            357889999999999843     4458999999997766654432   35589999999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCC--CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      ||+|+||+++.++ .++|+|||.+.......  ......++..|+|||++.+...++.++|+||+|+++|+|++|..||.
T Consensus       125 dl~~~ni~~~~~~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~  203 (288)
T cd07833         125 DIKPENILVSESG-VLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFP  203 (288)
T ss_pred             CCCHHHeEECCCC-CEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence            9999999999887 79999999988764443  23345678899999999776468999999999999999999999999


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcC--CCCccccCCCC-CCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHh
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEFKFPQI-KAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL  235 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~--~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l  235 (292)
                      +....+.+..+....+...........  +.+....++.. ....+...++..++.++++||++||..+|++|||+++++
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il  283 (288)
T cd07833         204 GDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELL  283 (288)
T ss_pred             CCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHh
Confidence            888777777777776666554333221  11111111111 111122233445689999999999999999999999999


Q ss_pred             cCCCc
Q 022799          236 IHPFF  240 (292)
Q Consensus       236 ~hp~~  240 (292)
                      +||||
T Consensus       284 ~~~~f  288 (288)
T cd07833         284 QHPYF  288 (288)
T ss_pred             cCCCC
Confidence            99998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-39  Score=281.53  Aligned_cols=192  Identities=34%  Similarity=0.519  Sum_probs=157.6

Q ss_pred             CCCCCeeeeceeeeccCCCCceeEEEEeecccC-CHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCC
Q 022799            4 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDI   82 (292)
Q Consensus         4 l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dl   82 (292)
                      -+||||+++.+++     .+..+.|+|||.+.| .+.+-+..     .+....++..|++||+.|+.|||++ |++||||
T Consensus       373 ~~h~niv~~~~v~-----~~~~~~~~v~e~l~g~ell~ri~~-----~~~~~~e~~~w~~~lv~Av~~LH~~-gvvhRDL  441 (612)
T KOG0603|consen  373 RDHPNIVKSHDVY-----EDGKEIYLVMELLDGGELLRRIRS-----KPEFCSEASQWAAELVSAVDYLHEQ-GVVHRDL  441 (612)
T ss_pred             cCCCcceeeccee-----cCCceeeeeehhccccHHHHHHHh-----cchhHHHHHHHHHHHHHHHHHHHhc-CeeecCC
Confidence            4799999999999     777889999999995 44444433     2333377888999999999999998 9999999


Q ss_pred             CCCcEEE-eCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCCC
Q 022799           83 KPQNLLV-NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES  161 (292)
Q Consensus        83 kp~Nill-~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~  161 (292)
                      ||+|||+ ++.+ .++|+|||.++.....  ..+.+-|..|.|||++. ...|++++|+||||+++|+|++|+.||....
T Consensus       442 kp~NIL~~~~~g-~lrltyFG~a~~~~~~--~~tp~~t~~y~APEvl~-~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P  517 (612)
T KOG0603|consen  442 KPGNILLDGSAG-HLRLTYFGFWSELERS--CDTPALTLQYVAPEVLA-IQEYTEACDWWSLGVLLYEMLTGRTLFAAHP  517 (612)
T ss_pred             ChhheeecCCCC-cEEEEEechhhhCchh--hcccchhhcccChhhhc-cCCCCcchhhHHHHHHHHHHHhCCCccccCC
Confidence            9999999 4666 7999999999876443  44456788999999996 4569999999999999999999999997655


Q ss_pred             cHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCCc
Q 022799          162 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  240 (292)
Q Consensus       162 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~~  240 (292)
                      ..   ..+...++.++                           +...+|..++|||+.||+.||.+|+++++++.||||
T Consensus       518 ~~---~ei~~~i~~~~---------------------------~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  518 AG---IEIHTRIQMPK---------------------------FSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             ch---HHHHHhhcCCc---------------------------cccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence            44   23333333332                           114689999999999999999999999999999999

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-38  Score=267.35  Aligned_cols=229  Identities=39%  Similarity=0.725  Sum_probs=186.7

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      ++.++||||+++++++.     +..+.++||||++++|.+++...   ...+++..+..++.|++.||.|||++ ||+||
T Consensus        52 l~~~~~~~i~~~~~~~~-----~~~~~~~v~e~~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~  122 (282)
T cd07829          52 LKELKHPNIVKLLDVIH-----TERKLYLVFEYCDMDLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYCHSH-RILHR  122 (282)
T ss_pred             HHhcCCCCHHHHHhhhh-----cCCceEEEecCcCcCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHC-CcccC
Confidence            35678999999999983     34568999999999999988763   24689999999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCC-CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      ||+|+||+++.++ .++|+|||.+....... ......++..|+|||.+.+...++.++|+||+||++++|++|..||.+
T Consensus       123 ~l~~~ni~~~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~  201 (282)
T cd07829         123 DLKPQNILINRDG-VLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPG  201 (282)
T ss_pred             CCChheEEEcCCC-CEEEecCCcccccCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999887 79999999987654332 222334577899999987665689999999999999999999999999


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCC-ccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCC
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNY-TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  238 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp  238 (292)
                      .+..+.+.++.+..+.+....+....... ....++..........+ +.++..+.++|++||..||++||++.+++.||
T Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p  280 (282)
T cd07829         202 DSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALKHP  280 (282)
T ss_pred             ccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhc-ccccHHHHHHHHHhhccCcccCCCHHHHhhCc
Confidence            99889999999999999888776543221 22233333333333333 34588999999999999999999999999999


Q ss_pred             Cc
Q 022799          239 FF  240 (292)
Q Consensus       239 ~~  240 (292)
                      ||
T Consensus       281 ~~  282 (282)
T cd07829         281 YF  282 (282)
T ss_pred             CC
Confidence            98

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.3e-38  Score=270.72  Aligned_cols=210  Identities=30%  Similarity=0.482  Sum_probs=165.9

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccC
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRD   81 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~d   81 (292)
                      +.++||||+++++++..     ....|+||||++|+|.+++.........+++..+..++.||+.||.|||++.+++|||
T Consensus        55 ~~~~~~~iv~~~~~~~~-----~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~d  129 (283)
T cd06617          55 RSVDCPYTVTFYGALFR-----EGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRD  129 (283)
T ss_pred             HHcCCCCeeeeeEEEec-----CCcEEEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCC
Confidence            45789999999999843     3348999999999998888765444567999999999999999999999755899999


Q ss_pred             CCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCC---CCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           82 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA---TEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        82 lkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      |||+||+++.++ .+||+|||.+.............++..|+|||.+.+.   ..++.++|+||+||++|+|++|..||.
T Consensus       130 lkp~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~  208 (283)
T cd06617         130 VKPSNVLINRNG-QVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD  208 (283)
T ss_pred             CCHHHEEECCCC-CEEEeecccccccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCC
Confidence            999999999888 7999999998876433333335678899999988542   336889999999999999999999996


Q ss_pred             CC-CcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          159 GE-SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       159 ~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      .. ...+.+..+...   ..        +     ..           ....+|.++.++|.+||..+|.+|||+.+++.|
T Consensus       209 ~~~~~~~~~~~~~~~---~~--------~-----~~-----------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  261 (283)
T cd06617         209 SWKTPFQQLKQVVEE---PS--------P-----QL-----------PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH  261 (283)
T ss_pred             ccccCHHHHHHHHhc---CC--------C-----CC-----------CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            43 222322222210   00        0     00           012478899999999999999999999999999


Q ss_pred             CCccccC
Q 022799          238 PFFDELR  244 (292)
Q Consensus       238 p~~~~~~  244 (292)
                      |||....
T Consensus       262 ~~~~~~~  268 (283)
T cd06617         262 PFFELHL  268 (283)
T ss_pred             chhhhcc
Confidence            9999754

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=4.9e-38  Score=270.72  Aligned_cols=234  Identities=33%  Similarity=0.608  Sum_probs=179.5

Q ss_pred             CCCCCCCCeeeeceeeeccCC---CCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTE---KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGV   77 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~---~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i   77 (292)
                      |+.++||||+++++++.....   .....+++||||+++++...+...   ...+++..++.++.|++.||.|||++ |+
T Consensus        61 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~~l~~~~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~-~i  136 (311)
T cd07866          61 LKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENP---SVKLTESQIKCYMLQLLEGINYLHEN-HI  136 (311)
T ss_pred             HHhcCCCCccchhhheecccccccccCceEEEEEecCCcCHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC-Ce
Confidence            357899999999998754432   234468899999998887777642   35799999999999999999999988 99


Q ss_pred             cccCCCCCcEEEeCCCCcEEEeecCCccccccCCC------------cccccccccccCCccccCCCCCCchhHhhhhhH
Q 022799           78 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP------------NISYICSRYYRAPELIFGATEYTAAIDIWSAGC  145 (292)
Q Consensus        78 ~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~------------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~  145 (292)
                      +|+||||+||+++.++ .++|+|||++........            .....+++.|+|||.+.+...++.++|+||+||
T Consensus       137 ~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~  215 (311)
T cd07866         137 LHRDIKAANILIDNQG-ILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGC  215 (311)
T ss_pred             ecCCCCHHHEEECCCC-CEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHH
Confidence            9999999999999988 799999999876533221            122356788999999866556899999999999


Q ss_pred             HHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC--CCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhcc
Q 022799          146 VLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQY  223 (292)
Q Consensus       146 il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  223 (292)
                      ++|+|++|..||.+.+.......+....+.+....+....  +..................+ ..+++.+.++|.+||..
T Consensus       216 il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~  294 (311)
T cd07866         216 VFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERF-GKLGPEGLDLLSKLLSL  294 (311)
T ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHc-ccCChhHHHHHHHHccc
Confidence            9999999999999998888888888888777665443221  11110000000011111111 34668899999999999


Q ss_pred             CCCCcccHHHHhcCCCc
Q 022799          224 SPNLRSTALEALIHPFF  240 (292)
Q Consensus       224 dp~~R~t~~e~l~hp~~  240 (292)
                      ||.+|||+.+++.||||
T Consensus       295 ~p~~R~t~~ell~~~~f  311 (311)
T cd07866         295 DPYKRLTASDALEHPYF  311 (311)
T ss_pred             CcccCcCHHHHhcCCCC
Confidence            99999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-38  Score=267.65  Aligned_cols=229  Identities=39%  Similarity=0.725  Sum_probs=182.7

Q ss_pred             CCCC-CCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLD-HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~-HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      ++++ ||||+++++++..     ....++||||++|+|.+.+....  ...+++..+..++.|++.||.|||++ |++|+
T Consensus        52 ~~~~~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~-~i~H~  123 (283)
T cd07830          52 RKLNEHPNIVKLKEVFRE-----NDELYFVFEYMEGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH-GFFHR  123 (283)
T ss_pred             HhccCCCCchhHHHHhhc-----CCcEEEEEecCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC-CcccC
Confidence            3566 9999999999843     44589999999999988886532  24689999999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE  160 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  160 (292)
                      ||+|+||+++.++ .++|+|||.+.............++..|+|||.+.+...++.++|+||+|+++++|++|..||.+.
T Consensus       124 dl~~~ni~i~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~  202 (283)
T cd07830         124 DLKPENLLVSGPE-VVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGS  202 (283)
T ss_pred             CCChhhEEEcCCC-CEEEeecccceeccCCCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCC
Confidence            9999999999887 799999999987655444445678889999998866566899999999999999999999999999


Q ss_pred             CcHHHHHHHHHHhCCCCHHHHhhcCCCC--ccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCC
Q 022799          161 SGVDQLVEIIKVLGTPTREEIKCMNPNY--TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  238 (292)
Q Consensus       161 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp  238 (292)
                      ...+...++...++.+....+.......  .....+..........+ ...+..+.++|++||..||++|||+.|++.||
T Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~  281 (283)
T cd07830         203 SEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLI-PNASPEAIDLIKDMLRWDPKKRPTASQALQHP  281 (283)
T ss_pred             ChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHc-ccCCHHHHHHHHHhcccCcccCCCHHHHhhCC
Confidence            9888999998888888766543221111  11112221111122222 23478999999999999999999999999999


Q ss_pred             Cc
Q 022799          239 FF  240 (292)
Q Consensus       239 ~~  240 (292)
                      ||
T Consensus       282 ~~  283 (283)
T cd07830         282 YF  283 (283)
T ss_pred             CC
Confidence            97

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-38  Score=273.35  Aligned_cols=213  Identities=31%  Similarity=0.523  Sum_probs=170.5

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++     .+..+.|+||||+. ++|.+++...  .+..+++..++.++.|++.||.|||+. |++|
T Consensus        55 l~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H  126 (316)
T cd05574          55 LATLDHPFLPTLYASF-----QTETYLCLVMDYCPGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHLL-GIVY  126 (316)
T ss_pred             HHhCCCCCchhheeee-----ecCCEEEEEEEecCCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHHC-Ceec
Confidence            3578899999999988     44556899999998 5998887643  235789999999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCC------------------------------cccccccccccCCcccc
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP------------------------------NISYICSRYYRAPELIF  129 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~------------------------------~~~~~gt~~y~aPE~~~  129 (292)
                      +||||+||+++.++ .++|+|||++........                              .....||..|+|||++.
T Consensus       127 ~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~  205 (316)
T cd05574         127 RDLKPENILLHESG-HIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVIS  205 (316)
T ss_pred             cCCChHHeEEcCCC-CEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHc
Confidence            99999999999887 799999999875422211                              11236788899999997


Q ss_pred             CCCCCCchhHhhhhhHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCC
Q 022799          130 GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRM  209 (292)
Q Consensus       130 ~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  209 (292)
                      +. .++.++|+||+||++|+|++|..||.+.+....+.++....                 ..++.          ...+
T Consensus       206 ~~-~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~-----------------~~~~~----------~~~~  257 (316)
T cd05574         206 GD-GHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKE-----------------VTFPG----------SPPV  257 (316)
T ss_pred             CC-CCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCC-----------------ccCCC----------cccc
Confidence            65 47999999999999999999999998777655554433210                 00000          0236


Q ss_pred             ChhHHHHHHHHhccCCCCccc----HHHHhcCCCccccCCCCCCC
Q 022799          210 PPEAVDLVSRLLQYSPNLRST----ALEALIHPFFDELRDPNTRL  250 (292)
Q Consensus       210 ~~~~~~li~~~l~~dp~~R~t----~~e~l~hp~~~~~~~~~~~~  250 (292)
                      +..+.++|.+||..||++|||    ++++++||||++.+++..+.
T Consensus       258 ~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~~~~  302 (316)
T cd05574         258 SSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIRH  302 (316)
T ss_pred             CHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhhccc
Confidence            889999999999999999999    99999999999987665554

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-37  Score=272.05  Aligned_cols=266  Identities=33%  Similarity=0.646  Sum_probs=194.7

Q ss_pred             CCCCCCCCeeeeceeeeccCCC-CceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~-~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++...... ....+++||||++++|.+++..     ..+++..++.++.||+.||.|||+. ||+|
T Consensus        68 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~-gi~H  141 (343)
T cd07880          68 LKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAA-GIIH  141 (343)
T ss_pred             HHhcCCCCccceeeeecCCccccccceEEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC-Ceec
Confidence            4678999999999988543321 1234689999998888877753     5689999999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      |||||+||+++.++ .++|+|||.+......  .....+++.|+|||.+.+...++.++|+||+||++|+|++|..||.+
T Consensus       142 ~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~  218 (343)
T cd07880         142 RDLKPGNLAVNEDC-ELKILDFGLARQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKG  218 (343)
T ss_pred             CCCCHHHEEEcCCC-CEEEeecccccccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            99999999999887 7999999999765332  23346788999999986644588999999999999999999999998


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc-c--cCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTE-F--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      .+.......+.+..+.++.+....+...... +  ..+....... ..+.+.+++.+.++|.+||+.||++|||+.+++.
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         219 HDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDF-RSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             CCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchH-HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            8877777777777666665544333211100 0  0111111111 1123568889999999999999999999999999


Q ss_pred             CCCccccCCCCCCCCCCCCCCCCCCCChhccCCCCHHHHhhhchHH
Q 022799          237 HPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEH  282 (292)
Q Consensus       237 hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (292)
                      ||||+...........    ++ +. +.-+....+.+.|.++....
T Consensus       298 ~~~~~~~~~~~~~~~~----~~-~~-~~~~~~~~~~~~~~~~~~~~  337 (343)
T cd07880         298 HPYFEEFHDPEDETEA----PP-YD-DSFDEVDQSLEEWKRLTFTE  337 (343)
T ss_pred             CccHhhhcCcccccCC----CC-cc-ccHHhhccchHHHHHHHHHH
Confidence            9999987665332211    11 11 11333444566776665543

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2.4e-38  Score=266.31  Aligned_cols=206  Identities=30%  Similarity=0.536  Sum_probs=166.5

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++.+     .+...+++||||++ ++|.+.+...    ..+++..+..++.||+.||.|||++ |++|
T Consensus        47 l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lH~~-~~~h  116 (262)
T cd05572          47 LEECNHPFIVKLYRTF-----KDKKYIYMLMEYCLGGELWTILRDR----GLFDEYTARFYIACVVLAFEYLHNR-GIIY  116 (262)
T ss_pred             HHhCCCCCEeeeeeeE-----EcCCccEEEEecCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhC-Cccc
Confidence            3568999999999988     44445899999998 6998888652    4589999999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      +||+|+||+++.++ .++|+|||.+.............+++.|++||.+.+. .++.++|+||+|+++|+|++|..||..
T Consensus       117 ~dl~~~nilv~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~  194 (262)
T cd05572         117 RDLKPENLLLDSNG-YVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNK-GYDFSVDYWSLGILLYELLTGRPPFGE  194 (262)
T ss_pred             CCCCHHHEEEcCCC-CEEEeeCCcccccCcccccccccCCcCccChhHhcCC-CCCChhhhhhhHHHHHHHHhCCCCcCC
Confidence            99999999999888 7999999999876554333445678999999998654 489999999999999999999999977


Q ss_pred             CC--cHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCccc-----HH
Q 022799          160 ES--GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----AL  232 (292)
Q Consensus       160 ~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t-----~~  232 (292)
                      ..  .......+.....               .            ..++...++++.++|.+||..||++|++     +.
T Consensus       195 ~~~~~~~~~~~~~~~~~---------------~------------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~  247 (262)
T cd05572         195 DDEDPMEIYNDILKGNG---------------K------------LEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIK  247 (262)
T ss_pred             CCCCHHHHHHHHhccCC---------------C------------CCCCcccCHHHHHHHHHHccCChhhCcCCcccCHH
Confidence            65  3232222221000               0            0122345889999999999999999999     99


Q ss_pred             HHhcCCCccccCC
Q 022799          233 EALIHPFFDELRD  245 (292)
Q Consensus       233 e~l~hp~~~~~~~  245 (292)
                      |+++||||+++++
T Consensus       248 ~l~~~~~~~~~~~  260 (262)
T cd05572         248 DIKKHKWFNGFDW  260 (262)
T ss_pred             HHhcChhhhCCCC
Confidence            9999999998653

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=4.7e-38  Score=267.79  Aligned_cols=230  Identities=36%  Similarity=0.666  Sum_probs=173.4

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      |+.++||||+++++++     .+....++||||+++++.+.+...   ...+++..+..++.||+.||.|||+. |++|+
T Consensus        54 l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~h~  124 (286)
T cd07846          54 LKQLRHENLVNLIEVF-----RRKKRLYLVFEFVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSH-NIIHR  124 (286)
T ss_pred             HHhcCCcchhhHHHhc-----ccCCeEEEEEecCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC-Ccccc
Confidence            3568999999999998     445568999999996544433322   34589999999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCC-cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      ||+|+||+++.++ .++|+|||++........ .....++..|+|||.+.+...++.++|+||+||++|+|++|.+||.+
T Consensus       125 ~l~p~ni~~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~  203 (286)
T cd07846         125 DIKPENILVSQSG-VVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPG  203 (286)
T ss_pred             CCCHHHEEECCCC-cEEEEeeeeeeeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCC
Confidence            9999999999888 799999999876533322 22345788999999987655678999999999999999999999998


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCC--CccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPN--YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      ....+....+....+.............  ......+............+.++..+.+++.+||..+|++||++.++++|
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         204 DSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             CchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence            8877777777776665433221111100  00111111111111111224688999999999999999999999999999


Q ss_pred             CCc
Q 022799          238 PFF  240 (292)
Q Consensus       238 p~~  240 (292)
                      |||
T Consensus       284 ~~~  286 (286)
T cd07846         284 EFF  286 (286)
T ss_pred             CCC
Confidence            998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-38  Score=268.26  Aligned_cols=231  Identities=34%  Similarity=0.630  Sum_probs=179.7

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccC
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRD   81 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~d   81 (292)
                      ++++||||+++++++....   ....++||||++++|.+++...   ...+++..++.++.||+.||.|||++ |++|+|
T Consensus        53 ~~l~~~~i~~~~~~~~~~~---~~~~~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~-~~~h~d  125 (287)
T cd07840          53 QKLRHPNIVRLKEIVTSKG---KGSIYMVFEYMDHDLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSN-GILHRD  125 (287)
T ss_pred             HhccCCCeeeheeeEecCC---CCcEEEEeccccccHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC-Cceecc
Confidence            5678999999999884321   2458999999999988887643   25789999999999999999999987 999999


Q ss_pred             CCCCcEEEeCCCCcEEEeecCCccccccCC--CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           82 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        82 lkp~Nill~~~~~~ikl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      |+|+||+++.++ .++|+|||.+.......  ......++..|+|||.+.+...++.++|+||+||++|+|++|..||.+
T Consensus       126 l~p~nil~~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~  204 (287)
T cd07840         126 IKGSNILINNDG-VLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQG  204 (287)
T ss_pred             CcHHHeEEcCCC-CEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence            999999999988 79999999998764433  123345678899999887665689999999999999999999999999


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCC--CccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPN--YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      .+....+..+.+..+.+....+......  .................+...+++.+.++|++||..||.+||++.+++.|
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         205 STELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             CChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            8888888888888877776655432111  00000000001111122222348999999999999999999999999999


Q ss_pred             CCc
Q 022799          238 PFF  240 (292)
Q Consensus       238 p~~  240 (292)
                      |||
T Consensus       285 ~~~  287 (287)
T cd07840         285 EYF  287 (287)
T ss_pred             cCC
Confidence            997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=3.5e-38  Score=268.71  Aligned_cols=211  Identities=24%  Similarity=0.366  Sum_probs=169.2

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++|+||+++.+++     ..+...|+||||+. ++|.+.+...  ....+++..+..++.|++.||.|||++ ||+|
T Consensus        54 l~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~-~iiH  125 (285)
T cd05632          54 LEKVNSQFVVNLAYAY-----ETKDALCLVLTIMNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHRE-NTVY  125 (285)
T ss_pred             HHHcCCcCceeEEEEE-----ecCCEEEEEEEeccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC-Ceee
Confidence            4578999999999988     34446899999998 5787766532  134699999999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      |||||+||+++.++ .++|+|||++.............|+..|+|||.+.+. .++.++|+||+||++|+|++|..||.+
T Consensus       126 ~dikp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~P~~~  203 (285)
T cd05632         126 RDLKPENILLDDYG-HIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQ-RYTLSPDYWGLGCLIYEMIEGQSPFRG  203 (285)
T ss_pred             cCCCHHHEEECCCC-CEEEecCCcceecCCCCcccCCCCCcCccChHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCC
Confidence            99999999999887 7999999998765443333456789999999999664 489999999999999999999999987


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCccc-----HHHH
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----ALEA  234 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t-----~~e~  234 (292)
                      .........+........                         ..++..++.++.+|+.+||..||++|||     +.++
T Consensus       204 ~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l  258 (285)
T cd05632         204 RKEKVKREEVDRRVLETE-------------------------EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEV  258 (285)
T ss_pred             CCHHHHHHHHHHhhhccc-------------------------cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHH
Confidence            665443333332211110                         0122457889999999999999999999     8999


Q ss_pred             hcCCCccccCCC
Q 022799          235 LIHPFFDELRDP  246 (292)
Q Consensus       235 l~hp~~~~~~~~  246 (292)
                      ++|+||+++...
T Consensus       259 ~~~~~~~~~~~~  270 (285)
T cd05632         259 KRHPFFRNMNFK  270 (285)
T ss_pred             HcChhhhcCCHH
Confidence            999999987544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-39  Score=265.87  Aligned_cols=225  Identities=29%  Similarity=0.553  Sum_probs=176.0

Q ss_pred             eeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEE
Q 022799            9 VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL   88 (292)
Q Consensus         9 Iv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlkp~Nil   88 (292)
                      +|++.++|     +-..+.|+|+|.++-++.+.+..+.  -.+++...++.+++|++.++.+||+. +++|.||||+|||
T Consensus       153 cv~m~~wF-----dyrghiCivfellG~S~~dFlk~N~--y~~fpi~~ir~m~~QL~~sv~fLh~~-kl~HTDLKPENIL  224 (415)
T KOG0671|consen  153 CVQMRDWF-----DYRGHICIVFELLGLSTFDFLKENN--YIPFPIDHIRHMGYQLLESVAFLHDL-KLTHTDLKPENIL  224 (415)
T ss_pred             EEeeehhh-----hccCceEEEEeccChhHHHHhccCC--ccccchHHHHHHHHHHHHHHHHHHhc-ceeecCCChheEE
Confidence            67887878     6666799999999989999998642  25689999999999999999999987 9999999999999


Q ss_pred             EeCC-------------------CCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHH
Q 022799           89 VNPH-------------------THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAE  149 (292)
Q Consensus        89 l~~~-------------------~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~e  149 (292)
                      +.+.                   ...|+++|||.|...  .+...+.+.|..|+|||++.|.+ ++..+||||+|||++|
T Consensus       225 fvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~--~e~hs~iVsTRHYRAPEViLgLG-wS~pCDvWSiGCIL~E  301 (415)
T KOG0671|consen  225 FVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFD--HEHHSTIVSTRHYRAPEVILGLG-WSQPCDVWSIGCILVE  301 (415)
T ss_pred             EeccceEEEeccCCccceeccCCCcceEEEecCCccee--ccCcceeeeccccCCchheeccC-cCCccCceeeeeEEEE
Confidence            7321                   114899999999865  33446778999999999999876 9999999999999999


Q ss_pred             HHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcC-CCCc---cccCCCC-----------CCCCchhhhc--cCCChh
Q 022799          150 LLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN-PNYT---EFKFPQI-----------KAHPWHKIFQ--KRMPPE  212 (292)
Q Consensus       150 l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-~~~~---~~~~~~~-----------~~~~~~~~~~--~~~~~~  212 (292)
                      +.+|...|+...+.++++-+...+|..+...+.... ..+-   ..+++..           ...+......  ...-.+
T Consensus       302 lytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~  381 (415)
T KOG0671|consen  302 LYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQ  381 (415)
T ss_pred             eeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhH
Confidence            999999999999999999999999988877765541 1100   0011100           0011111110  111236


Q ss_pred             HHHHHHHHhccCCCCcccHHHHhcCCCccccC
Q 022799          213 AVDLVSRLLQYSPNLRSTALEALIHPFFDELR  244 (292)
Q Consensus       213 ~~~li~~~l~~dp~~R~t~~e~l~hp~~~~~~  244 (292)
                      +.|||++||.+||.+|+|+.|+|.||||+...
T Consensus       382 LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~~  413 (415)
T KOG0671|consen  382 LFDLLRRMLEFDPARRITLREALSHPFFARLT  413 (415)
T ss_pred             HHHHHHHHHccCccccccHHHHhcCHHhhcCC
Confidence            88999999999999999999999999998753

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-38  Score=258.87  Aligned_cols=211  Identities=28%  Similarity=0.503  Sum_probs=162.9

Q ss_pred             CCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCC
Q 022799            5 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIK   83 (292)
Q Consensus         5 ~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlk   83 (292)
                      .|+||++++++|     +++..+|||||-+. |.|..-|..    ...+++.++..++.+|+.||.|||.+ ||.|||+|
T Consensus       134 gh~nilqLiefF-----Edd~~FYLVfEKm~GGplLshI~~----~~~F~E~EAs~vvkdia~aLdFlH~k-gIAHRDlK  203 (463)
T KOG0607|consen  134 GHKNILQLIEFF-----EDDTRFYLVFEKMRGGPLLSHIQK----RKHFNEREASRVVKDIASALDFLHTK-GIAHRDLK  203 (463)
T ss_pred             CCccHHHHHHHh-----cccceEEEEEecccCchHHHHHHH----hhhccHHHHHHHHHHHHHHHHHHhhc-CcccccCC
Confidence            599999999999     66667999999998 688877765    36799999999999999999999988 99999999


Q ss_pred             CCcEEEeCCC--CcEEEeecCCccccccC--------CCcccccccccccCCcccc----CCCCCCchhHhhhhhHHHHH
Q 022799           84 PQNLLVNPHT--HQLKLCDFGSAKVLVKG--------EPNISYICSRYYRAPELIF----GATEYTAAIDIWSAGCVLAE  149 (292)
Q Consensus        84 p~Nill~~~~--~~ikl~Dfg~a~~~~~~--------~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DvwslG~il~e  149 (292)
                      |+|||-....  ..||||||.++.-+...        ....+.+|+-.|||||++.    ....|+.++|.||||+|+|-
T Consensus       204 PENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYI  283 (463)
T KOG0607|consen  204 PENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYI  283 (463)
T ss_pred             ccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHH
Confidence            9999985432  25899999876543221        1224567888999999872    23458999999999999999


Q ss_pred             HHhCCCCCCCCCcHH----------HH-HHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHH
Q 022799          150 LLLGQPLFPGESGVD----------QL-VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVS  218 (292)
Q Consensus       150 l~~g~~pf~~~~~~~----------~~-~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  218 (292)
                      |++|.+||.|....+          .. ..+++.           +...  .+.+|.   ..|     ..+|.+++|+|+
T Consensus       284 mLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFes-----------IQEG--kYeFPd---kdW-----ahIS~eakdlis  342 (463)
T KOG0607|consen  284 MLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFES-----------IQEG--KYEFPD---KDW-----AHISSEAKDLIS  342 (463)
T ss_pred             HHhCCCCccCccCCcCCccCCCccHHHHHHHHHH-----------Hhcc--CCcCCh---hhh-----HHhhHHHHHHHH
Confidence            999999997654321          11 111111           1111  112221   122     468999999999


Q ss_pred             HHhccCCCCcccHHHHhcCCCccccCCC
Q 022799          219 RLLQYSPNLRSTALEALIHPFFDELRDP  246 (292)
Q Consensus       219 ~~l~~dp~~R~t~~e~l~hp~~~~~~~~  246 (292)
                      ++|..|+.+|.++.++++|||++.....
T Consensus       343 nLlvrda~~rlsa~~vlnhPw~~~~~~e  370 (463)
T KOG0607|consen  343 NLLVRDAKQRLSAAQVLNHPWVQRCAPE  370 (463)
T ss_pred             HHHhccHHhhhhhhhccCCccccccchh
Confidence            9999999999999999999999987654

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-37  Score=264.74  Aligned_cols=232  Identities=33%  Similarity=0.615  Sum_probs=180.9

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccC
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRD   81 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~d   81 (292)
                      +.++||||+++++++......+...++++|||++++|.+++....  ...+++..++.++.|++.||.|||++ |++|+|
T Consensus        56 ~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~-~i~h~~  132 (287)
T cd07838          56 ESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSH-RIVHRD  132 (287)
T ss_pred             hccCCCCcceEEEEEeeccCCCCceeEEEehhcccCHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC-Ceeecc
Confidence            345799999999998665544445689999999999888876532  23589999999999999999999988 999999


Q ss_pred             CCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCCC
Q 022799           82 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES  161 (292)
Q Consensus        82 lkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~  161 (292)
                      |+|+||+++.++ .++|+|||.+.............++..|+|||.+.+. .++.++|+||+||++|+|++|.+||.+.+
T Consensus       133 l~~~nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~s~G~~l~~l~~~~~~~~~~~  210 (287)
T cd07838         133 LKPQNILVTSDG-QVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQS-SYATPVDMWSVGCIFAELFRRRPLFRGTS  210 (287)
T ss_pred             CChhhEEEccCC-CEEEeccCcceeccCCcccccccccccccChHHhccC-CCCCcchhhhHHHHHHHHHhCCCcccCCC
Confidence            999999999987 7999999998876544443445678889999999765 48899999999999999999999999988


Q ss_pred             cHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCCc
Q 022799          162 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  240 (292)
Q Consensus       162 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~~  240 (292)
                      ..+...++.+..+.+....+.... ......++........ ...+.+++.+.++|.+||..||++||++.+++.||||
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         211 EADQLDKIFDVIGLPSEEEWPRNV-SLPRSSFPSYTPRSFK-SFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             hHHHHHHHHHHcCCCChHhcCCCc-ccchhhcccccccchh-hhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence            888888888877665544332111 0001111111111111 1223567899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-39  Score=283.41  Aligned_cols=203  Identities=30%  Similarity=0.480  Sum_probs=174.9

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      |++++|||+|.+.+||.     .+...|||||||-|+-.+++.-+   .+++-+.++..|..+.+.||.|||++ +.|||
T Consensus        80 L~~l~HPntieYkgCyL-----re~TaWLVMEYClGSAsDlleVh---kKplqEvEIAAi~~gaL~gLaYLHS~-~~IHR  150 (948)
T KOG0577|consen   80 LRQLRHPNTIEYKGCYL-----REHTAWLVMEYCLGSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH-NRIHR  150 (948)
T ss_pred             HHhccCCCcccccceee-----ccchHHHHHHHHhccHHHHHHHH---hccchHHHHHHHHHHHHHHHHHHHHh-hHHhh
Confidence            46899999999999994     33348899999999888888765   46799999999999999999999998 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCC--CCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA--TEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      |||..|||++..| .|||+|||.|...   .+..+++|||+|||||++...  +.|+.++||||||++..||..+++|+.
T Consensus       151 DiKAGNILLse~g-~VKLaDFGSAsi~---~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlF  226 (948)
T KOG0577|consen  151 DIKAGNILLSEPG-LVKLADFGSASIM---APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF  226 (948)
T ss_pred             hccccceEecCCC-eeeeccccchhhc---CchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCcc
Confidence            9999999999988 8999999999765   345678999999999998532  458999999999999999999999999


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCC
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  238 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp  238 (292)
                      +.+.+..++.|.+.. .|+.                  ..        ...|..+..|+.+||.+-|.+|||.+++|+|+
T Consensus       227 nMNAMSALYHIAQNe-sPtL------------------qs--------~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~  279 (948)
T KOG0577|consen  227 NMNAMSALYHIAQNE-SPTL------------------QS--------NEWSDYFRNFVDSCLQKIPQERPTSEELLKHR  279 (948)
T ss_pred             CchHHHHHHHHHhcC-CCCC------------------CC--------chhHHHHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence            999999888887631 1111                  11        34678899999999999999999999999999


Q ss_pred             Ccccc
Q 022799          239 FFDEL  243 (292)
Q Consensus       239 ~~~~~  243 (292)
                      |...-
T Consensus       280 fv~R~  284 (948)
T KOG0577|consen  280 FVLRE  284 (948)
T ss_pred             hhccC
Confidence            98753

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=6.7e-38  Score=267.65  Aligned_cols=209  Identities=27%  Similarity=0.409  Sum_probs=164.4

Q ss_pred             CCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCC
Q 022799            5 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIK   83 (292)
Q Consensus         5 ~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlk   83 (292)
                      +||||+++++++...+.......++||||++ ++|.+++.........+++..++.++.|++.||.|||++ |++|||||
T Consensus        77 ~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dlk  155 (291)
T cd06639          77 NHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN-RIIHRDVK  155 (291)
T ss_pred             CCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCC
Confidence            7999999999986554334456889999998 699888875544456789999999999999999999987 99999999


Q ss_pred             CCcEEEeCCCCcEEEeecCCccccccCCC-cccccccccccCCccccCCC----CCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           84 PQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NISYICSRYYRAPELIFGAT----EYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        84 p~Nill~~~~~~ikl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~----~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      |+||+++.++ .++|+|||++........ .....++..|+|||.+....    .++.++|+||+||++|+|++|+.||.
T Consensus       156 p~nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~  234 (291)
T cd06639         156 GNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLF  234 (291)
T ss_pred             HHHEEEcCCC-CEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCC
Confidence            9999999887 799999999876543221 22346788899999875432    26789999999999999999999998


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCC
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  238 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp  238 (292)
                      .......+..+.+.   +.                +..       ..+...+..+.++|.+||..||++||++.++++||
T Consensus       235 ~~~~~~~~~~~~~~---~~----------------~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~  288 (291)
T cd06639         235 DMHPVKTLFKIPRN---PP----------------PTL-------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHP  288 (291)
T ss_pred             CCcHHHHHHHHhcC---CC----------------CCC-------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCc
Confidence            76554443332210   00                000       01134677899999999999999999999999999


Q ss_pred             Ccc
Q 022799          239 FFD  241 (292)
Q Consensus       239 ~~~  241 (292)
                      ||+
T Consensus       289 ~~~  291 (291)
T cd06639         289 FIK  291 (291)
T ss_pred             ccC
Confidence            985

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2e-37  Score=271.06  Aligned_cols=237  Identities=34%  Similarity=0.622  Sum_probs=183.5

Q ss_pred             CCCCCCCCeeeeceeeeccCC-CCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTE-KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~-~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++..... ......|+++++++++|.+++..     ..+++..++.++.|++.||.|||+. ||+|
T Consensus        70 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH  143 (345)
T cd07877          70 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA-DIIH  143 (345)
T ss_pred             HHHcCCCcccceeeeeeecccccccccEEEEehhcccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-Ceee
Confidence            356899999999998753321 22335789999998898877753     4689999999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      |||||+||+++.++ .++|+|||++.....  ......+++.|+|||.+.+...++.++|+||+||++|+|++|..||.+
T Consensus       144 ~dlkp~NIll~~~~-~~kl~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  220 (345)
T cd07877         144 RDLKPSNLAVNEDC-ELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG  220 (345)
T ss_pred             cCCChHHEEEcCCC-CEEEecccccccccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            99999999999888 799999999876532  223456788999999986655688999999999999999999999998


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccc---cCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF---KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      .+....+..+....+.+.......+.......   ..+......+... ....++++.++|.+||..||.+|+|+.++++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  299 (345)
T cd07877         221 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALA  299 (345)
T ss_pred             CCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhh-cCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence            88878888888887777766654433221100   0011111111111 1246889999999999999999999999999


Q ss_pred             CCCccccCCCC
Q 022799          237 HPFFDELRDPN  247 (292)
Q Consensus       237 hp~~~~~~~~~  247 (292)
                      ||||++...+.
T Consensus       300 h~~f~~~~~~~  310 (345)
T cd07877         300 HAYFAQYHDPD  310 (345)
T ss_pred             ChhhhhcCCCC
Confidence            99999876554

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=6.3e-38  Score=266.35  Aligned_cols=206  Identities=27%  Similarity=0.368  Sum_probs=162.3

Q ss_pred             CCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccC
Q 022799            3 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRD   81 (292)
Q Consensus         3 ~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~d   81 (292)
                      ...||||+++++++..     ....++||||++ ++|.+++..    .+.+++..+..++.|++.||.|||++ ||+|||
T Consensus        53 ~~~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~-~ivH~d  122 (279)
T cd05633          53 TGDCPFIVCMTYAFHT-----PDKLCFILDLMNGGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNR-FVVYRD  122 (279)
T ss_pred             hCCCCcEeEEEEEEec-----CCeEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcCCCC
Confidence            3579999999998843     335899999998 688777764    35699999999999999999999988 999999


Q ss_pred             CCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCCC
Q 022799           82 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES  161 (292)
Q Consensus        82 lkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~  161 (292)
                      |||+||+++.++ .++|+|||++....... .....||+.|+|||.+.+...++.++|+||+||++|+|++|..||....
T Consensus       123 ikp~Nil~~~~~-~~~l~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  200 (279)
T cd05633         123 LKPANILLDEHG-HVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHK  200 (279)
T ss_pred             CCHHHEEECCCC-CEEEccCCcceeccccC-ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCC
Confidence            999999999887 79999999987553322 2334689999999998644558899999999999999999999997543


Q ss_pred             cHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcc-----cHHHHhc
Q 022799          162 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEALI  236 (292)
Q Consensus       162 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----t~~e~l~  236 (292)
                      ..... .+.+....                         ....++..++.++.++|.+||..||++|+     |+.++++
T Consensus       201 ~~~~~-~~~~~~~~-------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~  254 (279)
T cd05633         201 TKDKH-EIDRMTLT-------------------------VNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE  254 (279)
T ss_pred             CcCHH-HHHHHhhc-------------------------CCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence            22111 11110000                         00112346789999999999999999999     6999999


Q ss_pred             CCCccccCCC
Q 022799          237 HPFFDELRDP  246 (292)
Q Consensus       237 hp~~~~~~~~  246 (292)
                      ||||+++...
T Consensus       255 h~~~~~~~~~  264 (279)
T cd05633         255 HVFFKGIDWQ  264 (279)
T ss_pred             CccccCCCHh
Confidence            9999987643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-40  Score=264.60  Aligned_cols=207  Identities=25%  Similarity=0.410  Sum_probs=170.9

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++.|++|++|+.|+-..+     +|+|||||+ |+..++++.+   .+++++.++..+++..+.||+|||.. .-+|
T Consensus        82 MQQC~S~yVVKYYGSYFK~sD-----LWIVMEYCGAGSiSDI~R~R---~K~L~E~EIs~iL~~TLKGL~YLH~~-~KIH  152 (502)
T KOG0574|consen   82 MQQCKSKYVVKYYGSYFKHSD-----LWIVMEYCGAGSISDIMRAR---RKPLSEQEISAVLRDTLKGLQYLHDL-KKIH  152 (502)
T ss_pred             HHHcCCchhhhhhhhhccCCc-----eEeehhhcCCCcHHHHHHHh---cCCccHHHHHHHHHHHHhHHHHHHHH-HHHH
Confidence            678999999999999976665     999999999 8999998865   57899999999999999999999986 8999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccC-CCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      ||||..|||++.+| ..||+|||.|....+. ....+..|||.|||||++..- .|..++|+||||+...||..|++||.
T Consensus       153 RDIKAGNILLNT~G-~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EI-GY~~~ADIWSLGITaIEMAEG~PPYs  230 (502)
T KOG0574|consen  153 RDIKAGNILLNTDG-IAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEI-GYDTKADIWSLGITAIEMAEGRPPYS  230 (502)
T ss_pred             hhcccccEEEcccc-hhhhhhccccchhhhhHHhhCccccCcccccHHHHHHh-ccchhhhHhhhcchhhhhhcCCCCcc
Confidence            99999999999999 6999999999876443 234577899999999999654 59999999999999999999999997


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCC
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  238 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp  238 (292)
                      +-.+...+.   -                     .|..+...+..  |...|.++-||+++||.++|++|.||.++++||
T Consensus       231 DIHPMRAIF---M---------------------IPT~PPPTF~K--PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~  284 (502)
T KOG0574|consen  231 DIHPMRAIF---M---------------------IPTKPPPTFKK--PEEWSSEFNDFIRSCLIKKPEERKTALRLCEHT  284 (502)
T ss_pred             cccccceeE---e---------------------ccCCCCCCCCC--hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence            655432111   1                     11111111110  134688999999999999999999999999999


Q ss_pred             CccccC
Q 022799          239 FFDELR  244 (292)
Q Consensus       239 ~~~~~~  244 (292)
                      |+++..
T Consensus       285 FiknA~  290 (502)
T KOG0574|consen  285 FIKNAP  290 (502)
T ss_pred             hhcCCC
Confidence            998744

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=7.7e-38  Score=267.45  Aligned_cols=210  Identities=27%  Similarity=0.426  Sum_probs=163.7

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccC-CHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++.     .+..+++||||++| +|...+...   ...+++..+..++.|++.||.|||++ |++|
T Consensus        63 l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~-~i~H  133 (292)
T cd06644          63 LATCNHPYIVKLLGAFY-----WDGKLWIMIEFCPGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSM-KIIH  133 (292)
T ss_pred             HHhCCCCcEeeeEEEEE-----eCCeEEEEEecCCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcC-Ceee
Confidence            35789999999999883     34458999999994 666665432   35689999999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCC-CcccccccccccCCccccC----CCCCCchhHhhhhhHHHHHHHhCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFG----ATEYTAAIDIWSAGCVLAELLLGQ  154 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslG~il~el~~g~  154 (292)
                      |||||+||+++.++ .++|+|||.+....... ......+++.|+|||.+.+    ...++.++|+||+||++|+|++|.
T Consensus       134 ~dlkp~Nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~  212 (292)
T cd06644         134 RDLKAGNVLLTLDG-DIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE  212 (292)
T ss_pred             cCCCcceEEEcCCC-CEEEccCccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCC
Confidence            99999999999877 79999999886543221 1234467889999999853    234688999999999999999999


Q ss_pred             CCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHH
Q 022799          155 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA  234 (292)
Q Consensus       155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~  234 (292)
                      .||...+......++...   ...           ..            ..+..++.++.++|.+||..||++||+++++
T Consensus       213 ~p~~~~~~~~~~~~~~~~---~~~-----------~~------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i  266 (292)
T cd06644         213 PPHHELNPMRVLLKIAKS---EPP-----------TL------------SQPSKWSMEFRDFLKTALDKHPETRPSAAQL  266 (292)
T ss_pred             CCCccccHHHHHHHHhcC---CCc-----------cC------------CCCcccCHHHHHHHHHHhcCCcccCcCHHHH
Confidence            999776544433332210   000           00            0123578899999999999999999999999


Q ss_pred             hcCCCccccCCC
Q 022799          235 LIHPFFDELRDP  246 (292)
Q Consensus       235 l~hp~~~~~~~~  246 (292)
                      ++||||..+...
T Consensus       267 l~~~~~~~~~~~  278 (292)
T cd06644         267 LEHPFVSSVTSN  278 (292)
T ss_pred             hcCccccccccc
Confidence            999999987654

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.6e-39  Score=283.42  Aligned_cols=206  Identities=27%  Similarity=0.453  Sum_probs=177.3

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.|+||||||++.+..+...     +|+||||+. |.+.+++.+    ++++.+..++.++.|++.|++|||++ +|+|
T Consensus       109 mk~l~HPnIvkl~~v~~t~~~-----lylV~eya~~ge~~~yl~~----~gr~~e~~ar~~F~q~vsaveYcH~k-~ivH  178 (596)
T KOG0586|consen  109 MKSLNHPNIVKLFSVIETEAT-----LYLVMEYASGGELFDYLVK----HGRMKEKEARAKFRQIVSAVEYCHSK-NIVH  178 (596)
T ss_pred             HHhcCCcceeeeeeeeeecce-----eEEEEEeccCchhHHHHHh----cccchhhhhhhhhHHHHHHHHHHhhc-ceec
Confidence            678999999999999855444     999999998 789998886    47788899999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      ||||++||+++.+. ++||+|||++..+..+....+.+|++.|.|||++.|....++.+|+||+|+++|-|+.|..||.+
T Consensus       179 rdLk~eNilL~~~m-nikIaDfgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG  257 (596)
T KOG0586|consen  179 RDLKAENILLDENM-NIKIADFGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDG  257 (596)
T ss_pred             cccchhhccccccc-ceeeeccccceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCC
Confidence            99999999999988 79999999999998888888999999999999999988789999999999999999999999988


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCC
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF  239 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~  239 (292)
                      .+-...-.+.+.                 ..+.            ++--++.++.++|+++|..+|++|++.++++.|.|
T Consensus       258 ~~lk~Lr~rvl~-----------------gk~r------------Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W  308 (596)
T KOG0586|consen  258 QNLKELRPRVLR-----------------GKYR------------IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRW  308 (596)
T ss_pred             cccccccchhee-----------------eeec------------ccceeechhHHHHHHhhccCccccCCHHHhhhhcc
Confidence            764332111111                 0111            22347899999999999999999999999999999


Q ss_pred             ccccCCC
Q 022799          240 FDELRDP  246 (292)
Q Consensus       240 ~~~~~~~  246 (292)
                      .......
T Consensus       309 ~n~~~~~  315 (596)
T KOG0586|consen  309 RNDLLEA  315 (596)
T ss_pred             cchhhhh
Confidence            9876544

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=4.9e-38  Score=268.43  Aligned_cols=202  Identities=31%  Similarity=0.528  Sum_probs=168.1

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++     .+...+++||||++ ++|.+++..    ...+++..+..++.|++.||.|||++ |++|
T Consensus        55 l~~l~h~~i~~~~~~~-----~~~~~~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~~-~i~H  124 (290)
T cd05580          55 LQSIRHPFLVNLYGSF-----QDDSNLYLVMEYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHSL-DIVY  124 (290)
T ss_pred             HHhCCCCCccceeeEE-----EcCCeEEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CEec
Confidence            4578999999999998     44456899999996 799888875    36789999999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      +||+|+||+++.++ .++|+|||++......  .....+++.|+|||.+.+. .++.++|+||+|+++|+|++|..||..
T Consensus       125 ~dl~p~nili~~~~-~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~  200 (290)
T cd05580         125 RDLKPENLLLDSDG-YIKITDFGFAKRVKGR--TYTLCGTPEYLAPEIILSK-GYGKAVDWWALGILIYEMLAGYPPFFD  200 (290)
T ss_pred             CCCCHHHEEECCCC-CEEEeeCCCccccCCC--CCCCCCCccccChhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCC
Confidence            99999999999888 7999999999876443  3345688999999998654 478999999999999999999999987


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcc-----cHHHH
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEA  234 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----t~~e~  234 (292)
                      .+.......+...  .+                           .++..+++.++++|.+||..||.+|+     +++++
T Consensus       201 ~~~~~~~~~~~~~--~~---------------------------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l  251 (290)
T cd05580         201 DNPIQIYEKILEG--KV---------------------------RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDI  251 (290)
T ss_pred             CCHHHHHHHHhcC--Cc---------------------------cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHH
Confidence            6644434333210  00                           12245688999999999999999999     99999


Q ss_pred             hcCCCccccCC
Q 022799          235 LIHPFFDELRD  245 (292)
Q Consensus       235 l~hp~~~~~~~  245 (292)
                      ++||||+.+.+
T Consensus       252 ~~~~~~~~~~~  262 (290)
T cd05580         252 KNHPWFAGIDW  262 (290)
T ss_pred             HcCcccccCCH
Confidence            99999998764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=3.9e-38  Score=271.98  Aligned_cols=235  Identities=21%  Similarity=0.337  Sum_probs=166.7

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++.     +....+++|||++ |+|.+++....  ...+++..++.++.|++.||.|||++ ||+|
T Consensus        53 l~~l~h~~i~~~~~~~~-----~~~~~~~~~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~-~ivH  124 (314)
T cd08216          53 SRQLQHPNILPYVTSFI-----VDSELYVVSPLMAYGSCEDLLKTHF--PEGLPELAIAFILKDVLNALDYIHSK-GFIH  124 (314)
T ss_pred             HHhcCCcchhhhhheee-----cCCeEEEEEeccCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC-Ceec
Confidence            45789999999999984     3445899999999 68888887542  34588999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCC--------cccccccccccCCccccCC-CCCCchhHhhhhhHHHHHH
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP--------NISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAEL  150 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslG~il~el  150 (292)
                      |||||+||+++.++ .++|+|||.+........        .....++..|+|||++.+. ..++.++|+||+||++|+|
T Consensus       125 ~dlk~~Nili~~~~-~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el  203 (314)
T cd08216         125 RSVKASHILLSGDG-KVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACEL  203 (314)
T ss_pred             CCCCcceEEEecCC-ceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHH
Confidence            99999999999887 799999998865532211        1233467789999998653 3478999999999999999


Q ss_pred             HhCCCCCCCCCcHHHHHHHHHHhCCCCHHH----HhhcCCCCccc---cCCCCCCCCchhhhccCCChhHHHHHHHHhcc
Q 022799          151 LLGQPLFPGESGVDQLVEIIKVLGTPTREE----IKCMNPNYTEF---KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQY  223 (292)
Q Consensus       151 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~----~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  223 (292)
                      ++|..||.+............  +......    ...........   .................++.++.+||.+||..
T Consensus       204 ~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  281 (314)
T cd08216         204 ANGHVPFKDMPATQMLLEKVR--GTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQR  281 (314)
T ss_pred             HhCCCCCCCCCHHHHHHHHHh--ccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhc
Confidence            999999987654433222111  1111000    00000000000   00000001111112234567899999999999


Q ss_pred             CCCCcccHHHHhcCCCccccCCC
Q 022799          224 SPNLRSTALEALIHPFFDELRDP  246 (292)
Q Consensus       224 dp~~R~t~~e~l~hp~~~~~~~~  246 (292)
                      ||++|||++++++||||+.++..
T Consensus       282 ~P~~Rpt~~~ll~~p~~~~~~~~  304 (314)
T cd08216         282 DPESRPSASQLLNHSFFKQCKRR  304 (314)
T ss_pred             CCCcCcCHHHHhcCchHhhhccc
Confidence            99999999999999999987643

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-37  Score=262.08  Aligned_cols=203  Identities=34%  Similarity=0.547  Sum_probs=164.1

Q ss_pred             CCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccC
Q 022799            3 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRD   81 (292)
Q Consensus         3 ~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~d   81 (292)
                      ..+||||+++++++     .....+|+||||++ ++|.+++..    ...+++..+..++.|++.||.|||+. |++|||
T Consensus        53 ~~~~~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~-~i~H~d  122 (260)
T cd05611          53 QGESPYVAKLYYSF-----QSKDYLYLVMEYLNGGDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQR-GIIHRD  122 (260)
T ss_pred             cCCCCCeeeeeeeE-----EcCCeEEEEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCC
Confidence            45899999999998     34446899999998 688888865    35689999999999999999999987 999999


Q ss_pred             CCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCCC
Q 022799           82 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES  161 (292)
Q Consensus        82 lkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~  161 (292)
                      |+|+||+++.++ .++|+|||++.....   .....++..|+|||.+.+.. ++.++|+||+|+++|+|++|..||...+
T Consensus       123 l~p~nil~~~~~-~~~l~dfg~~~~~~~---~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~  197 (260)
T cd05611         123 IKPENLLIDQTG-HLKLTDFGLSRNGLE---NKKFVGTPDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAET  197 (260)
T ss_pred             CCHHHeEECCCC-cEEEeecccceeccc---cccCCCCcCccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCCC
Confidence            999999999887 799999999875432   23346788999999987654 8999999999999999999999998776


Q ss_pred             cHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCccc---HHHHhcCC
Q 022799          162 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST---ALEALIHP  238 (292)
Q Consensus       162 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t---~~e~l~hp  238 (292)
                      .......+.....                         .+.......+++.+.++|.+||..||++||+   ++|++.||
T Consensus       198 ~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~  252 (260)
T cd05611         198 PDAVFDNILSRRI-------------------------NWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHP  252 (260)
T ss_pred             HHHHHHHHHhccc-------------------------CCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcCh
Confidence            6544433322100                         0011111357899999999999999999995   57999999


Q ss_pred             CccccCC
Q 022799          239 FFDELRD  245 (292)
Q Consensus       239 ~~~~~~~  245 (292)
                      ||+++++
T Consensus       253 ~~~~~~~  259 (260)
T cd05611         253 FFKSINW  259 (260)
T ss_pred             HhhcCCC
Confidence            9988764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=6.6e-38  Score=265.89  Aligned_cols=211  Identities=27%  Similarity=0.378  Sum_probs=167.5

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++     ......|+||||++ ++|.+.+....  ...+++..+..++.|++.||.|||++ |++|
T Consensus        47 l~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~-~i~H  118 (277)
T cd05577          47 LEKVSSRFIVSLAYAF-----ETKDDLCLVMTLMNGGDLKYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQR-RIVY  118 (277)
T ss_pred             HHhCCCCCEeeeeeEE-----ecCCeEEEEEecCCCCcHHHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhC-Cccc
Confidence            4678999999999988     44445899999998 68888876532  24689999999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      |||+|+||+++.++ .++|+|||.+.............++..|+|||.+.+.. ++.++|+||+||++|+|++|..||.+
T Consensus       119 ~di~p~Nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~  196 (277)
T cd05577         119 RDLKPENVLLDDHG-NVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQ  196 (277)
T ss_pred             CCCCHHHEEECCCC-CEEEccCcchhhhccCCccccccCCCCcCCHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCCCCC
Confidence            99999999999888 79999999987654433334456788899999986654 89999999999999999999999976


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcc-----cHHHH
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEA  234 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----t~~e~  234 (292)
                      .........+.+....                         ....++..+++.+.++|.+||..||++||     ++.++
T Consensus       197 ~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l  251 (277)
T cd05577         197 RKEKVEKEELKRRTLE-------------------------MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEV  251 (277)
T ss_pred             CcccccHHHHHhcccc-------------------------ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHH
Confidence            5432211111111000                         00012245789999999999999999999     99999


Q ss_pred             hcCCCccccCCC
Q 022799          235 LIHPFFDELRDP  246 (292)
Q Consensus       235 l~hp~~~~~~~~  246 (292)
                      ++||||.++++.
T Consensus       252 l~h~~~~~~~~~  263 (277)
T cd05577         252 REHPLFKDLNWR  263 (277)
T ss_pred             HhChhhhcCChh
Confidence            999999987754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=9.3e-38  Score=265.61  Aligned_cols=207  Identities=27%  Similarity=0.411  Sum_probs=163.5

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++.     .....++||||++ ++|...+...   ...+++..+..++.|++.||.|||+. |++|
T Consensus        56 l~~l~h~~ii~~~~~~~-----~~~~~~~v~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~-~i~H  126 (282)
T cd06643          56 LASCDHPNIVKLLDAFY-----YENNLWILIEFCAGGAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHEN-KIIH  126 (282)
T ss_pred             HHHCCCCCeeeEEEEEe-----eCCEEEEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-Ceee
Confidence            35689999999999884     3345899999998 5776665432   35689999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCC-CcccccccccccCCccccC----CCCCCchhHhhhhhHHHHHHHhCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFG----ATEYTAAIDIWSAGCVLAELLLGQ  154 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslG~il~el~~g~  154 (292)
                      |||||+||+++.++ .++|+|||++....... ......+++.|+|||.+..    ...++.++|+||+||++|+|++|.
T Consensus       127 ~dlkp~nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~  205 (282)
T cd06643         127 RDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIE  205 (282)
T ss_pred             cCCCcccEEEccCC-CEEEccccccccccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCC
Confidence            99999999999888 79999999987653321 1233467899999999842    234678999999999999999999


Q ss_pred             CCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHH
Q 022799          155 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA  234 (292)
Q Consensus       155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~  234 (292)
                      .||.+.+.......+.....  +            ..            ..+..++.++.++|.+||..||.+|||++++
T Consensus       206 ~p~~~~~~~~~~~~~~~~~~--~------------~~------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i  259 (282)
T cd06643         206 PPHHELNPMRVLLKIAKSEP--P------------TL------------AQPSRWSSEFKDFLKKCLEKNVDARWTTTQL  259 (282)
T ss_pred             CCccccCHHHHHHHHhhcCC--C------------CC------------CCccccCHHHHHHHHHHccCChhhCcCHHHH
Confidence            99987765554444432110  0            00            0113478899999999999999999999999


Q ss_pred             hcCCCcccc
Q 022799          235 LIHPFFDEL  243 (292)
Q Consensus       235 l~hp~~~~~  243 (292)
                      ++||||+..
T Consensus       260 l~~~~~~~~  268 (282)
T cd06643         260 LQHPFVTVN  268 (282)
T ss_pred             hcCCCEecc
Confidence            999999864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=2.2e-37  Score=265.70  Aligned_cols=234  Identities=31%  Similarity=0.530  Sum_probs=179.1

Q ss_pred             CCCCCCCCeeeeceeeeccCC-----CCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 022799            1 MRLLDHPNVVSLKHCFFSTTE-----KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI   75 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~-----~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~   75 (292)
                      ++.++||||+++++++.+..+     .+..++++|+||+++++...+...   ...+++..++.++.||+.||.|||+. 
T Consensus        60 ~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~-  135 (302)
T cd07864          60 LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKK-  135 (302)
T ss_pred             HHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCccHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence            356899999999998854331     122368999999999888777643   34689999999999999999999988 


Q ss_pred             CccccCCCCCcEEEeCCCCcEEEeecCCccccccCCC--cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhC
Q 022799           76 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG  153 (292)
Q Consensus        76 ~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g  153 (292)
                      ||+|+||+|+||+++.++ .+||+|||.+........  .....++..|+|||.+.+...++.++|+||+||++++|++|
T Consensus       136 ~i~H~dl~p~nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g  214 (302)
T cd07864         136 NFLHRDIKCSNILLNNKG-QIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTK  214 (302)
T ss_pred             CeecCCCCHHHEEECCCC-cEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhC
Confidence            999999999999999888 799999999876543321  12234577899999886655578999999999999999999


Q ss_pred             CCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC--CccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccH
Q 022799          154 QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN--YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA  231 (292)
Q Consensus       154 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~  231 (292)
                      +.||...+..+.+..+.+..+.+....+......  +............+...+ ..++..+.++|.+||..||++|||+
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~  293 (302)
T cd07864         215 KPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTA  293 (302)
T ss_pred             CCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCH
Confidence            9999988888888888888777776554332110  100000000001111111 3578999999999999999999999


Q ss_pred             HHHhcCCCc
Q 022799          232 LEALIHPFF  240 (292)
Q Consensus       232 ~e~l~hp~~  240 (292)
                      .+++.||||
T Consensus       294 ~~il~~~~~  302 (302)
T cd07864         294 EEALNSPWL  302 (302)
T ss_pred             HHHhcCCCC
Confidence            999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.1e-37  Score=263.59  Aligned_cols=205  Identities=26%  Similarity=0.403  Sum_probs=159.9

Q ss_pred             CCCCeeeeceeeeccCCC-CceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCC
Q 022799            5 DHPNVVSLKHCFFSTTEK-DELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDI   82 (292)
Q Consensus         5 ~HpnIv~~~~~~~~~~~~-~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dl   82 (292)
                      +||||+++++++...... ....+++||||++ ++|.+++...  ....+++..+..++.|++.||.|||++ ||+|+||
T Consensus        61 ~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~-~ivh~dl  137 (272)
T cd06637          61 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH-KVIHRDI  137 (272)
T ss_pred             CCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCC
Confidence            699999999988654322 2346889999998 6888887653  134688999999999999999999998 9999999


Q ss_pred             CCCcEEEeCCCCcEEEeecCCccccccC-CCcccccccccccCCccccC----CCCCCchhHhhhhhHHHHHHHhCCCCC
Q 022799           83 KPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNISYICSRYYRAPELIFG----ATEYTAAIDIWSAGCVLAELLLGQPLF  157 (292)
Q Consensus        83 kp~Nill~~~~~~ikl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslG~il~el~~g~~pf  157 (292)
                      ||+||+++.++ .++|+|||++...... .......|+..|+|||++.+    ...++.++|+||+||++|+|++|..||
T Consensus       138 ~~~nili~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~  216 (272)
T cd06637         138 KGQNVLLTENA-EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL  216 (272)
T ss_pred             CHHHEEECCCC-CEEEccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence            99999999888 7999999998765332 12234568899999999853    234788999999999999999999999


Q ss_pred             CCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          158 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      ...........+...   +           .             .......++..+.+||.+||..||.+|||+.+++.|
T Consensus       217 ~~~~~~~~~~~~~~~---~-----------~-------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         217 CDMHPMRALFLIPRN---P-----------A-------------PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             cccCHHHHHHHHhcC---C-----------C-------------CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence            655433222211110   0           0             000113468899999999999999999999999999


Q ss_pred             CCc
Q 022799          238 PFF  240 (292)
Q Consensus       238 p~~  240 (292)
                      |||
T Consensus       270 ~~~  272 (272)
T cd06637         270 PFI  272 (272)
T ss_pred             CCC
Confidence            997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.4e-38  Score=265.56  Aligned_cols=208  Identities=26%  Similarity=0.421  Sum_probs=164.6

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++.+.     .....|+||||++ ++|.+++...   ...+++..++.++.|++.||.|||++ ||+|
T Consensus        56 l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~-~i~h  126 (280)
T cd06611          56 LSECKHPNIVGLYEAYF-----YENKLWILIEFCDGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSH-KVIH  126 (280)
T ss_pred             HHhCCCCceeEEEEEEe-----cCCeEEEEeeccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-Cccc
Confidence            45789999999999984     3445899999998 5888877653   35689999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCC-CcccccccccccCCccccC----CCCCCchhHhhhhhHHHHHHHhCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFG----ATEYTAAIDIWSAGCVLAELLLGQ  154 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslG~il~el~~g~  154 (292)
                      +||+|+||+++.++ .++|+|||.+....... ......+++.|+|||.+..    ...++.++|+||+||++|+|++|.
T Consensus       127 ~dl~p~nili~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~  205 (280)
T cd06611         127 RDLKAGNILLTLDG-DVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQME  205 (280)
T ss_pred             CCCChhhEEECCCC-CEEEccCccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCC
Confidence            99999999999888 79999999886543322 2233467899999999742    233678999999999999999999


Q ss_pred             CCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHH
Q 022799          155 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA  234 (292)
Q Consensus       155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~  234 (292)
                      .||.+.+......++...   ..                +..       ..+..++.++.++|.+||..+|++||++.++
T Consensus       206 ~p~~~~~~~~~~~~~~~~---~~----------------~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i  259 (280)
T cd06611         206 PPHHELNPMRVLLKILKS---EP----------------PTL-------DQPSKWSSSFNDFLKSCLVKDPDDRPTAAEL  259 (280)
T ss_pred             CCcccCCHHHHHHHHhcC---CC----------------CCc-------CCcccCCHHHHHHHHHHhccChhhCcCHHHH
Confidence            999876554433332210   00                000       0113578899999999999999999999999


Q ss_pred             hcCCCccccC
Q 022799          235 LIHPFFDELR  244 (292)
Q Consensus       235 l~hp~~~~~~  244 (292)
                      ++||||.+..
T Consensus       260 l~~~~~~~~~  269 (280)
T cd06611         260 LKHPFVSDQS  269 (280)
T ss_pred             hcChhhcccc
Confidence            9999998763

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.6e-38  Score=266.68  Aligned_cols=206  Identities=36%  Similarity=0.596  Sum_probs=164.1

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeecccC-CHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      ++++||||+++++++..     ....++||||+++ +|.+++..    ...+++..+..++.||+.||.+||++ |++|+
T Consensus        53 ~~l~~~~i~~~~~~~~~-----~~~~~~v~~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~Lh~~-~i~H~  122 (260)
T PF00069_consen   53 RRLRHPNIVQILDVFQD-----DNYLYIVMEYCPGGSLQDYLQK----NKPLSEEEILKIAYQILEALAYLHSK-GIVHR  122 (260)
T ss_dssp             HHHTBTTBCHEEEEEEE-----SSEEEEEEEEETTEBHHHHHHH----HSSBBHHHHHHHHHHHHHHHHHHHHT-TEEES
T ss_pred             ccccccccccccccccc-----cccccccccccccccccccccc----cccccccccccccccccccccccccc-ccccc
Confidence            35689999999999844     4458899999996 99998873    36789999999999999999999998 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCcccc-ccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      ||||+||+++.++ .++|+|||.+... ..........+++.|+|||++.....++.++|+||+|+++|+|++|..||..
T Consensus       123 dikp~NIl~~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~  201 (260)
T PF00069_consen  123 DIKPENILLDENG-EVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEE  201 (260)
T ss_dssp             SBSGGGEEESTTS-EEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTT
T ss_pred             ccccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            9999999999877 7999999998763 2223334567899999999986345589999999999999999999999987


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCC
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF  239 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~  239 (292)
                      ....+....+.+...........                      .....++.+.++|.+||+.||++|||+.++++|||
T Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~  259 (260)
T PF00069_consen  202 SNSDDQLEIIEKILKRPLPSSSQ----------------------QSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPW  259 (260)
T ss_dssp             SSHHHHHHHHHHHHHTHHHHHTT----------------------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGG
T ss_pred             ccchhhhhhhhhccccccccccc----------------------ccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCC
Confidence            74444444443332221111100                      00112479999999999999999999999999999


Q ss_pred             c
Q 022799          240 F  240 (292)
Q Consensus       240 ~  240 (292)
                      |
T Consensus       260 ~  260 (260)
T PF00069_consen  260 F  260 (260)
T ss_dssp             G
T ss_pred             C
Confidence            8

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=9.6e-38  Score=272.32  Aligned_cols=201  Identities=23%  Similarity=0.364  Sum_probs=154.3

Q ss_pred             CCC-CCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhh--------------------------------
Q 022799            2 RLL-DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYK--------------------------------   47 (292)
Q Consensus         2 ~~l-~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~--------------------------------   47 (292)
                      +.+ +||||+++++++...    ...+++||||++ |+|.+++.....                                
T Consensus        65 ~~l~~h~niv~~~~~~~~~----~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  140 (338)
T cd05102          65 IHIGNHLNVVNLLGACTKP----NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAG  140 (338)
T ss_pred             HHhccCcceeeEEeEecCC----CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccc
Confidence            345 899999999987432    224789999998 799988865321                                


Q ss_pred             --------------------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEeCCCCcEEEeec
Q 022799           48 --------------------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  101 (292)
Q Consensus        48 --------------------------~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlkp~Nill~~~~~~ikl~Df  101 (292)
                                                ....+++..+..++.||+.||.|||++ ||+||||||+||+++.++ .+||+||
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDiKp~Nil~~~~~-~~kl~Df  218 (338)
T cd05102         141 QASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASR-KCIHRDLAARNILLSENN-VVKICDF  218 (338)
T ss_pred             cCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHC-CEECCCCccceEEEcCCC-cEEEeec
Confidence                                      013477888999999999999999988 999999999999999887 7999999


Q ss_pred             CCccccccCCC---cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 022799          102 GSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  177 (292)
Q Consensus       102 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~~~i~~~~~~~~  177 (292)
                      |+++.......   .....+++.|+|||++.+. .++.++|+||+||++|||++ |..||.+....+...........  
T Consensus       219 G~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~--  295 (338)
T cd05102         219 GLARDIYKDPDYVRKGSARLPLKWMAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTR--  295 (338)
T ss_pred             ccccccccCcchhcccCCCCCccccCcHHhhcC-CCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCC--
Confidence            99976533221   1223456789999998664 48999999999999999997 99999876543333222221000  


Q ss_pred             HHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          178 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                                   .            ..+...++.+.++|.+||..||.+|||+.++++
T Consensus       296 -------------~------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~  329 (338)
T cd05102         296 -------------M------------RAPENATPEIYRIMLACWQGDPKERPTFSALVE  329 (338)
T ss_pred             -------------C------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                         0            012457889999999999999999999999984

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.8e-37  Score=261.86  Aligned_cols=198  Identities=27%  Similarity=0.434  Sum_probs=158.9

Q ss_pred             CCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCC
Q 022799            5 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIK   83 (292)
Q Consensus         5 ~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlk   83 (292)
                      +||||++++++|..     ....|+||||++ ++|.+++...    ..+++..++.++.||+.||.|||+. |++|||||
T Consensus        67 ~h~~iv~~~~~~~~-----~~~~~iv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~  136 (267)
T PHA03390         67 DNPNFIKLYYSVTT-----LKGHVLIMDYIKDGDLFDLLKKE----GKLSEAEVKKIIRQLVEALNDLHKH-NIIHNDIK  136 (267)
T ss_pred             cCCCEEEEEEEEec-----CCeeEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCC
Confidence            69999999999843     345999999998 6999988753    4789999999999999999999988 99999999


Q ss_pred             CCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCCCcH
Q 022799           84 PQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV  163 (292)
Q Consensus        84 p~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~  163 (292)
                      |+||+++.++..++|+|||.+......   ....++..|+|||.+.+. .++.++|+||+||++|+|++|..||......
T Consensus       137 p~nil~~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~  212 (267)
T PHA03390        137 LENVLYDRAKDRIYLCDYGLCKIIGTP---SCYDGTLDYFSPEKIKGH-NYDVSFDWWAVGVLTYELLTGKHPFKEDEDE  212 (267)
T ss_pred             HHHEEEeCCCCeEEEecCccceecCCC---ccCCCCCcccChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCcc
Confidence            999999987757999999998765322   234678999999999654 4899999999999999999999999755433


Q ss_pred             HHH-HHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCccc-HHHHhcCCCcc
Q 022799          164 DQL-VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-ALEALIHPFFD  241 (292)
Q Consensus       164 ~~~-~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t-~~e~l~hp~~~  241 (292)
                      ... .........+                          ....+.+++.+.++|.+||+.||.+|++ ++++++||||.
T Consensus       213 ~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~  266 (267)
T PHA03390        213 ELDLESLLKRQQKK--------------------------LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK  266 (267)
T ss_pred             hhhHHHHHHhhccc--------------------------CCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence            211 1111110000                          0011358999999999999999999996 59999999997


Q ss_pred             c
Q 022799          242 E  242 (292)
Q Consensus       242 ~  242 (292)
                      +
T Consensus       267 ~  267 (267)
T PHA03390        267 I  267 (267)
T ss_pred             C
Confidence            3

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.8e-38  Score=270.66  Aligned_cols=204  Identities=27%  Similarity=0.492  Sum_probs=157.1

Q ss_pred             CCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCC
Q 022799            5 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKP   84 (292)
Q Consensus         5 ~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlkp   84 (292)
                      .|-+||+++++-     -.+.++||||||-+.+|..++...   ..-++...++.|..||+.|+.+.|.+ ||||.||||
T Consensus       418 g~~~IIqL~DYE-----v~d~~lYmvmE~Gd~DL~kiL~k~---~~~~~~~~lk~ywkqML~aV~~IH~~-gIVHSDLKP  488 (677)
T KOG0596|consen  418 GHDKIIQLYDYE-----VTDGYLYMVMECGDIDLNKILKKK---KSIDPDWFLKFYWKQMLLAVKTIHQH-GIVHSDLKP  488 (677)
T ss_pred             CCceEEEEeeee-----ccCceEEEEeecccccHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHHHh-ceeecCCCc
Confidence            488999999976     446679999999989999999864   23344458999999999999999998 999999999


Q ss_pred             CcEEEeCCCCcEEEeecCCccccccCCCc---ccccccccccCCccccCCC----------CCCchhHhhhhhHHHHHHH
Q 022799           85 QNLLVNPHTHQLKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGAT----------EYTAAIDIWSAGCVLAELL  151 (292)
Q Consensus        85 ~Nill~~~~~~ikl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~----------~~~~~~DvwslG~il~el~  151 (292)
                      .|+|+-. | .+||+|||.|..+..+...   .+.+||+.||+||.+....          ..++++||||||||+|+|+
T Consensus       489 ANFLlVk-G-~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMv  566 (677)
T KOG0596|consen  489 ANFLLVK-G-RLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMV  566 (677)
T ss_pred             ccEEEEe-e-eEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHH
Confidence            9999875 4 6999999999988655432   3568999999999985422          2578999999999999999


Q ss_pred             hCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccH
Q 022799          152 LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA  231 (292)
Q Consensus       152 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~  231 (292)
                      .|++||..-..  ..++ +..+..|..           ++.++...           -..++.++++.||.+||.+|+|.
T Consensus       567 YgktPf~~~~n--~~aK-l~aI~~P~~-----------~Iefp~~~-----------~~~~li~~mK~CL~rdPkkR~si  621 (677)
T KOG0596|consen  567 YGKTPFGQIIN--QIAK-LHAITDPNH-----------EIEFPDIP-----------ENDELIDVMKCCLARDPKKRWSI  621 (677)
T ss_pred             hcCCchHHHHH--HHHH-HHhhcCCCc-----------cccccCCC-----------CchHHHHHHHHHHhcCcccCCCc
Confidence            99999953221  1122 222222211           11222211           11239999999999999999999


Q ss_pred             HHHhcCCCccccC
Q 022799          232 LEALIHPFFDELR  244 (292)
Q Consensus       232 ~e~l~hp~~~~~~  244 (292)
                      .++|+|||.+...
T Consensus       622 ~eLLqhpFl~~~~  634 (677)
T KOG0596|consen  622 PELLQHPFLQIQP  634 (677)
T ss_pred             HHHhcCccccccc
Confidence            9999999998643

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.2e-37  Score=262.69  Aligned_cols=200  Identities=33%  Similarity=0.548  Sum_probs=161.1

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++.     +..+.++||||++ ++|.+++..    ...+++..+..++.|++.||+|||++ |++|
T Consensus        60 l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~-~ivH  129 (267)
T cd06628          60 LKELQHENIVQYLGSSL-----DADHLNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNR-GIIH  129 (267)
T ss_pred             HHhcCCCCeeeEEEEEE-----eCCccEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhc-Cccc
Confidence            35689999999999883     3445889999998 588888865    35688999999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCC-------cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL  152 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~  152 (292)
                      |||+|+||+++.++ .++|+|||.++.......       .....|+..|+|||.+.+. .++.++|+||+||++|+|++
T Consensus       130 ~di~p~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~il~~l~~  207 (267)
T cd06628         130 RDIKGANILVDNKG-GIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQT-SYTRKADIWSLGCLVVEMLT  207 (267)
T ss_pred             ccCCHHHEEEcCCC-CEEecccCCCcccccccccCCccccccccCCCcCccChhHhccC-CCCchhhhHHHHHHHHHHhh
Confidence            99999999999887 799999999876642211       1123578889999998654 47899999999999999999


Q ss_pred             CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHH
Q 022799          153 GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAL  232 (292)
Q Consensus       153 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~  232 (292)
                      |..||.+.+.......+....                   .         ..++..++..+.++|++||+.||.+||++.
T Consensus       208 g~~p~~~~~~~~~~~~~~~~~-------------------~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~  259 (267)
T cd06628         208 GKHPFPDCTQLQAIFKIGENA-------------------S---------PEIPSNISSEAIDFLEKTFEIDHNKRPTAA  259 (267)
T ss_pred             CCCCCCCccHHHHHHHHhccC-------------------C---------CcCCcccCHHHHHHHHHHccCCchhCcCHH
Confidence            999998765444333222100                   0         012245788999999999999999999999


Q ss_pred             HHhcCCCc
Q 022799          233 EALIHPFF  240 (292)
Q Consensus       233 e~l~hp~~  240 (292)
                      ++++||||
T Consensus       260 ~il~~~~~  267 (267)
T cd06628         260 ELLKHPFL  267 (267)
T ss_pred             HHhhCCCC
Confidence            99999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1e-37  Score=263.15  Aligned_cols=204  Identities=25%  Similarity=0.363  Sum_probs=159.3

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++.     +...+++||||++ ++|.+++..    .+.+++..++.++.|++.||.|||+. |++|
T Consensus        60 ~~~l~h~~ii~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H  129 (267)
T cd06645          60 MKDCKHSNIVAYFGSYL-----RRDKLWICMEFCGGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSK-GKMH  129 (267)
T ss_pred             HHhCCCCCeeeEEEEEE-----eCCEEEEEEeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-Ceec
Confidence            35679999999999883     3445899999998 688888764    35789999999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCC-CcccccccccccCCcccc--CCCCCCchhHhhhhhHHHHHHHhCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPL  156 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~--~~~~~~~~~DvwslG~il~el~~g~~p  156 (292)
                      +||||+||+++.++ .++|+|||++....... ......|+..|+|||.+.  ....++.++|+||+||++|+|++|..|
T Consensus       130 ~dlkp~nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p  208 (267)
T cd06645         130 RDIKGANILLTDNG-HVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPP  208 (267)
T ss_pred             CCCCHHHEEECCCC-CEEECcceeeeEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCC
Confidence            99999999999887 79999999987653221 123456899999999874  223478899999999999999999999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      |..................+                 +.     +.  ....++..+.++|.+||..||++|||+++++.
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~-----------------~~-----~~--~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         209 MFDLHPMRALFLMTKSNFQP-----------------PK-----LK--DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             cccccchhhHHhhhccCCCC-----------------Cc-----cc--ccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            97655433322221110000                 00     00  00246788999999999999999999999999


Q ss_pred             CCC
Q 022799          237 HPF  239 (292)
Q Consensus       237 hp~  239 (292)
                      |||
T Consensus       265 ~~~  267 (267)
T cd06645         265 HPF  267 (267)
T ss_pred             CCC
Confidence            998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=2.2e-38  Score=247.20  Aligned_cols=230  Identities=31%  Similarity=0.640  Sum_probs=185.9

Q ss_pred             CCCCeeeeceeeeccCCCCceeEEEEeecccC-CHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCC
Q 022799            5 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIK   83 (292)
Q Consensus         5 ~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlk   83 (292)
                      .||||++++++..++..   ....||+||++. +...+.       +.++.-.++.+++|++.||.|+|+. ||+|||+|
T Consensus        91 gg~NIi~L~DiV~Dp~S---ktpaLiFE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~-GImHRDVK  159 (338)
T KOG0668|consen   91 GGPNIIKLLDIVKDPES---KTPSLIFEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSM-GIMHRDVK  159 (338)
T ss_pred             CCCCeeehhhhhcCccc---cCchhHhhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhc-CcccccCC
Confidence            49999999998855443   336799999995 544443       3477778999999999999999998 99999999


Q ss_pred             CCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCC-CCCCc
Q 022799           84 PQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF-PGESG  162 (292)
Q Consensus        84 p~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf-~~~~~  162 (292)
                      |.|++++.....++|+|+|+|.....+....-.+.+.+|..||++...+.|..+-|+||+||+++.|+..+.|| .|.++
T Consensus       160 PhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN  239 (338)
T KOG0668|consen  160 PHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN  239 (338)
T ss_pred             cceeeechhhceeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCC
Confidence            99999987666899999999999877777677788999999999998888999999999999999999987665 68889


Q ss_pred             HHHHHHHHHHhCCCCHHHH-h----hcCCCCccccCCCCCCCCchhhhcc----CCChhHHHHHHHHhccCCCCcccHHH
Q 022799          163 VDQLVEIIKVLGTPTREEI-K----CMNPNYTEFKFPQIKAHPWHKIFQK----RMPPEAVDLVSRLLQYSPNLRSTALE  233 (292)
Q Consensus       163 ~~~~~~i~~~~~~~~~~~~-~----~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~dp~~R~t~~e  233 (292)
                      .+++.+|.+.+|+...... .    .+++.+.. -.......+|..++++    -.++++.|||.++|.+|..+|+||.|
T Consensus       240 ~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~-i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakE  318 (338)
T KOG0668|consen  240 YDQLVKIAKVLGTDELYAYLNKYQIDLDPQFED-ILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKE  318 (338)
T ss_pred             HHHHHHHHHHhChHHHHHHHHHHccCCChhHhh-HhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHH
Confidence            9999999999987543321 1    11233322 1233445566666543    24699999999999999999999999


Q ss_pred             HhcCCCccccCCC
Q 022799          234 ALIHPFFDELRDP  246 (292)
Q Consensus       234 ~l~hp~~~~~~~~  246 (292)
                      ++.||||..+...
T Consensus       319 am~HpyF~~~~~~  331 (338)
T KOG0668|consen  319 AMAHPYFAPVREA  331 (338)
T ss_pred             HhcCchHHHHHHH
Confidence            9999999987643

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-37  Score=264.07  Aligned_cols=202  Identities=26%  Similarity=0.439  Sum_probs=164.8

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      +.++||||+++++++.     +...+++|+||++ ++|.+.+..     .++++..++.++.|++.|+.|||++ |++|+
T Consensus        54 ~~l~h~~i~~~~~~~~-----~~~~~~~v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~-~i~h~  122 (274)
T cd06609          54 SQCRSPYITKYYGSFL-----KGSKLWIIMEYCGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEE-GKIHR  122 (274)
T ss_pred             HHcCCCCeeeeeEEEE-----ECCeEEEEEEeeCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC-CcccC
Confidence            5678999999999884     3356899999998 588888764     3789999999999999999999987 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccC-CCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      ||+|+||+++.++ .++|+|||.+...... .......+++.|+|||.+.+.. ++.++|+||+||++|+|++|..||.+
T Consensus       123 dl~p~ni~i~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p~~~  200 (274)
T cd06609         123 DIKAANILLSEEG-DVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPLSD  200 (274)
T ss_pred             CCCHHHEEECCCC-CEEEcccccceeecccccccccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCccc
Confidence            9999999999988 7999999999876443 2233456788999999997654 89999999999999999999999977


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhcc-CCChhHHHHHHHHhccCCCCcccHHHHhcCC
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQK-RMPPEAVDLVSRLLQYSPNLRSTALEALIHP  238 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp  238 (292)
                      .+.......+.... .          +                 .++. .+++++.++|.+||..+|++|||++++++||
T Consensus       201 ~~~~~~~~~~~~~~-~----------~-----------------~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~  252 (274)
T cd06609         201 LHPMRVLFLIPKNN-P----------P-----------------SLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHK  252 (274)
T ss_pred             CchHHHHHHhhhcC-C----------C-----------------CCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhCh
Confidence            65444333222210 0          0                 0111 2788999999999999999999999999999


Q ss_pred             CccccC
Q 022799          239 FFDELR  244 (292)
Q Consensus       239 ~~~~~~  244 (292)
                      ||++..
T Consensus       253 ~~~~~~  258 (274)
T cd06609         253 FIKKAK  258 (274)
T ss_pred             hhcCCC
Confidence            998754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=6.2e-38  Score=268.09  Aligned_cols=207  Identities=29%  Similarity=0.484  Sum_probs=164.9

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++.+.     ...+.++||||++ ++|.+++..     ..+++..+..++.||+.||.|||++ ||+|
T Consensus        73 l~~l~h~~ii~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~-~ivH  141 (292)
T cd06658          73 MRDYHHENVVDMYNSYL-----VGDELWVVMEFLEGGALTDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQ-GVIH  141 (292)
T ss_pred             HHhCCCCcHHHHHHhee-----cCCeEEEEEeCCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CEee
Confidence            35689999999999883     3445899999998 577776642     4688999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCC-CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      |||||+||+++.++ .++|+|||++....... ......++..|+|||.+.+. .++.++|+||+|+++|+|++|..||.
T Consensus       142 ~dlkp~Nill~~~~-~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvil~el~~g~~p~~  219 (292)
T cd06658         142 RDIKSDSILLTSDG-RIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMIDGEPPYF  219 (292)
T ss_pred             cCCCHHHEEEcCCC-CEEEccCcchhhcccccccCceeecCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            99999999999887 79999999987543222 12345688999999998654 48999999999999999999999998


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCC
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  238 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp  238 (292)
                      +.+....+..+........                +          ....++..+.++|.+||..||++|||++++++||
T Consensus       220 ~~~~~~~~~~~~~~~~~~~----------------~----------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~  273 (292)
T cd06658         220 NEPPLQAMRRIRDNLPPRV----------------K----------DSHKVSSVLRGFLDLMLVREPSQRATAQELLQHP  273 (292)
T ss_pred             CCCHHHHHHHHHhcCCCcc----------------c----------cccccCHHHHHHHHHHccCChhHCcCHHHHhhCh
Confidence            7766554443322110000                0          0124688999999999999999999999999999


Q ss_pred             CccccCCC
Q 022799          239 FFDELRDP  246 (292)
Q Consensus       239 ~~~~~~~~  246 (292)
                      ||.....+
T Consensus       274 ~~~~~~~~  281 (292)
T cd06658         274 FLKLAGPP  281 (292)
T ss_pred             hhhccCCc
Confidence            99976544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.4e-37  Score=267.98  Aligned_cols=228  Identities=25%  Similarity=0.433  Sum_probs=164.0

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++.     ++.++++||||++ ++|.+++..    ...+++..+..++.|++.||.|||++.+++|
T Consensus        53 l~~l~h~~iv~~~~~~~-----~~~~~~lv~ey~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H  123 (308)
T cd06615          53 LHECNSPYIVGFYGAFY-----SDGEISICMEHMDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREKHKIMH  123 (308)
T ss_pred             HHhCCCCCCCeEEEEEe-----eCCEEEEEeeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEE
Confidence            35689999999999984     4445999999998 699888865    3668999999999999999999997448999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      +||||+||+++.++ .++|+|||++...... ......+++.|+|||.+.+. .++.++|+||+||++|+|++|..||.+
T Consensus       124 ~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~  200 (308)
T cd06615         124 RDVKPSNILVNSRG-EIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGT-HYTVQSDIWSLGLSLVEMAIGRYPIPP  200 (308)
T ss_pred             CCCChHHEEEecCC-cEEEccCCCccccccc-ccccCCCCcCccChhHhcCC-CCCccchHHHHHHHHHHHHhCCCCCCC
Confidence            99999999999887 7999999998765332 22345788999999998654 488999999999999999999999976


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCC-CC-----------CCchhhhc-cCCChhHHHHHHHHhccCCC
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI-KA-----------HPWHKIFQ-KRMPPEAVDLVSRLLQYSPN  226 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-----------~~~~~~~~-~~~~~~~~~li~~~l~~dp~  226 (292)
                      .+.... .....   ...................... ..           .......+ ..++.+++++|.+||..||+
T Consensus       201 ~~~~~~-~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~  276 (308)
T cd06615         201 PDAKEL-EAMFG---RPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPK  276 (308)
T ss_pred             cchhhH-HHhhc---CccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChh
Confidence            653322 22111   1100000000000000000000 00           00000000 13678899999999999999


Q ss_pred             CcccHHHHhcCCCccccC
Q 022799          227 LRSTALEALIHPFFDELR  244 (292)
Q Consensus       227 ~R~t~~e~l~hp~~~~~~  244 (292)
                      +|||+.++++||||.+..
T Consensus       277 ~Rpt~~~ll~~~~~~~~~  294 (308)
T cd06615         277 ERADLKELTKHPFIKRAE  294 (308)
T ss_pred             hCcCHHHHhcChhhhhcc
Confidence            999999999999998643

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.3e-37  Score=260.68  Aligned_cols=203  Identities=29%  Similarity=0.477  Sum_probs=161.8

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      ++.++||||+++++++.     +..+.|+++||++ ++|.+++...   ...+++..+..++.|++.||.|||+. |++|
T Consensus        52 ~~~l~~~~i~~~~~~~~-----~~~~~~l~~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~~l~~lh~~-~i~H  122 (256)
T cd06612          52 LKQCDSPYIVKYYGSYF-----KNTDLWIVMEYCGAGSVSDIMKIT---NKTLTEEEIAAILYQTLKGLEYLHSN-KKIH  122 (256)
T ss_pred             HHhCCCCcEeeeeeeee-----cCCcEEEEEecCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC-Cccc
Confidence            35679999999999984     4456899999999 5888887642   35689999999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCC-CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      +||+|+||+++.++ .++|+|||++....... ......++..|+|||.+.+. .++.++|+||+||++|+|++|..||.
T Consensus       123 ~dl~~~ni~~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~s~G~il~~l~~g~~p~~  200 (256)
T cd06612         123 RDIKAGNILLNEEG-QAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEI-GYNNKADIWSLGITAIEMAEGKPPYS  200 (256)
T ss_pred             CCCCcceEEECCCC-cEEEcccccchhcccCccccccccCCccccCHHHHhcC-CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            99999999999888 79999999988764433 22334578899999998664 58999999999999999999999997


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCC
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  238 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp  238 (292)
                      ..........+...   .                .+.       ...+..++..+.++|.+||..||++|||+.+++.||
T Consensus       201 ~~~~~~~~~~~~~~---~----------------~~~-------~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~  254 (256)
T cd06612         201 DIHPMRAIFMIPNK---P----------------PPT-------LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHP  254 (256)
T ss_pred             CcchhhhhhhhccC---C----------------CCC-------CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCC
Confidence            65443322111100   0                000       001235778999999999999999999999999999


Q ss_pred             Cc
Q 022799          239 FF  240 (292)
Q Consensus       239 ~~  240 (292)
                      ||
T Consensus       255 ~~  256 (256)
T cd06612         255 FI  256 (256)
T ss_pred             CC
Confidence            97

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-37  Score=263.59  Aligned_cols=210  Identities=29%  Similarity=0.438  Sum_probs=164.9

Q ss_pred             CC-CCCCeeeeceeeeccCC-CCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            3 LL-DHPNVVSLKHCFFSTTE-KDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         3 ~l-~HpnIv~~~~~~~~~~~-~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      ++ +||||+++++++..... .+..++++||||++ ++|.+++.........+++..++.++.|++.||.|||++ |++|
T Consensus        58 ~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~-~i~H  136 (275)
T cd06608          58 KYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN-KVIH  136 (275)
T ss_pred             HhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC-Cccc
Confidence            44 79999999999865443 34556899999999 588888876544457799999999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCC-CcccccccccccCCccccCC----CCCCchhHhhhhhHHHHHHHhCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGA----TEYTAAIDIWSAGCVLAELLLGQ  154 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~~~DvwslG~il~el~~g~  154 (292)
                      +||+|+||+++.++ .++|+|||.+....... ......++..|+|||.+.+.    ..++.++|+||+||++|+|++|.
T Consensus       137 ~~l~p~ni~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~  215 (275)
T cd06608         137 RDIKGQNILLTKNA-EVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK  215 (275)
T ss_pred             CCCCHHHEEEccCC-eEEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCC
Confidence            99999999999887 79999999987653322 22345678899999987532    34678899999999999999999


Q ss_pred             CCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHH
Q 022799          155 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA  234 (292)
Q Consensus       155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~  234 (292)
                      .||...........+...   +.                +.     +  ..+..++..++++|.+||..||++|||+.++
T Consensus       216 ~p~~~~~~~~~~~~~~~~---~~----------------~~-----~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~l  269 (275)
T cd06608         216 PPLCDMHPMRALFKIPRN---PP----------------PT-----L--KSPENWSKKFNDFISECLIKNYEQRPFMEEL  269 (275)
T ss_pred             CCccccchHHHHHHhhcc---CC----------------CC-----C--CchhhcCHHHHHHHHHHhhcChhhCcCHHHH
Confidence            999765544443333221   00                00     0  0113468899999999999999999999999


Q ss_pred             hcCCCc
Q 022799          235 LIHPFF  240 (292)
Q Consensus       235 l~hp~~  240 (292)
                      ++|||+
T Consensus       270 l~~~~~  275 (275)
T cd06608         270 LEHPFI  275 (275)
T ss_pred             hcCCCC
Confidence            999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.3e-37  Score=260.79  Aligned_cols=202  Identities=29%  Similarity=0.462  Sum_probs=161.8

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++     .+....++||||+. ++|.+++..    ...+++..+..++.|++.||.|||+. ||+|
T Consensus        56 l~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H  125 (265)
T cd06631          56 LKSLKHVNIVQYLGTC-----LDDNTISIFMEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNN-CVVH  125 (265)
T ss_pred             HHhcCCCCEeeEeeEe-----ecCCeEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-Cccc
Confidence            3578999999999998     44456999999998 588888865    35688999999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccC-------CCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL  152 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~  152 (292)
                      +||+|+||+++.++ .++|+|||.+......       .......++..|+|||.+.+. .++.++|+||+||++|+|++
T Consensus       126 ~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~  203 (265)
T cd06631         126 RDIKGNNVMLMPNG-IIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES-GYGRKSDIWSIGCTVFEMAT  203 (265)
T ss_pred             CCcCHHhEEECCCC-eEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCC-CCcchhhHHHHHHHHHHHHh
Confidence            99999999999887 7999999998764221       111234678899999998654 48899999999999999999


Q ss_pred             CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHH
Q 022799          153 GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAL  232 (292)
Q Consensus       153 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~  232 (292)
                      |..||...+.......+....+.                          ...++..++.++.++|++||..+|++||++.
T Consensus       204 g~~p~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~  257 (265)
T cd06631         204 GKPPLASMDRLAAMFYIGAHRGL--------------------------MPRLPDSFSAAAIDFVTSCLTRDQHERPSAL  257 (265)
T ss_pred             CCCccccCChHHHHHHhhhccCC--------------------------CCCCCCCCCHHHHHHHHHHhcCCcccCCCHH
Confidence            99999765544333222211000                          0012245788999999999999999999999


Q ss_pred             HHhcCCCc
Q 022799          233 EALIHPFF  240 (292)
Q Consensus       233 e~l~hp~~  240 (292)
                      +++.||||
T Consensus       258 ~~l~~~~~  265 (265)
T cd06631         258 QLLRHDFL  265 (265)
T ss_pred             HHhcCCCC
Confidence            99999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2.1e-37  Score=265.36  Aligned_cols=206  Identities=28%  Similarity=0.467  Sum_probs=165.4

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      ++.++||||+++++++     .+...+++|+||+. ++|...+..     ..+++..+..++.|++.||.|||++ |++|
T Consensus        70 l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~-~i~H  138 (296)
T cd06655          70 MKELKNPNIVNFLDSF-----LVGDELFVVMEYLAGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHAN-QVIH  138 (296)
T ss_pred             HHhcCCCceeeeeeeE-----ecCceEEEEEEecCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC-Cccc
Confidence            3578999999999998     34445899999998 588777653     4689999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCC-cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      |||||+||+++.++ .++|+|||++........ .....++..|+|||.+.+. .++.++|+||+||++|+|++|..||.
T Consensus       139 ~dL~p~Nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvil~~lltg~~pf~  216 (296)
T cd06655         139 RDIKSDNVLLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYL  216 (296)
T ss_pred             CCCCHHHEEECCCC-CEEEccCccchhcccccccCCCcCCCccccCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            99999999999887 799999999876543322 2234678899999998654 48899999999999999999999998


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCC
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  238 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp  238 (292)
                      +.+.......+... ..+.                         ...+..+++.+.++|.+||..||.+|||+.+++.||
T Consensus       217 ~~~~~~~~~~~~~~-~~~~-------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~  270 (296)
T cd06655         217 NENPLRALYLIATN-GTPE-------------------------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHP  270 (296)
T ss_pred             CCCHHHHHHHHHhc-CCcc-------------------------cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence            77665444333221 0000                         001145788999999999999999999999999999


Q ss_pred             CccccCC
Q 022799          239 FFDELRD  245 (292)
Q Consensus       239 ~~~~~~~  245 (292)
                      ||+....
T Consensus       271 ~~~~~~~  277 (296)
T cd06655         271 FLKLAKP  277 (296)
T ss_pred             Hhhhccc
Confidence            9987553

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.9e-38  Score=274.96  Aligned_cols=205  Identities=25%  Similarity=0.419  Sum_probs=168.6

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC-Ccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI-GVC   78 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~-~i~   78 (292)
                      |+.|+|||||++++++.+...   ..+.+|+|.+. |+|..|+.++    ++++...++.|++||+.||.|||++. -|+
T Consensus        95 LKsL~H~NIirfy~SW~d~~n---~~in~iTEL~TSGtLr~Y~kk~----~~vn~kaik~W~RQILkGL~yLHs~~PPII  167 (632)
T KOG0584|consen   95 LKSLKHPNIIRFYDSWVDTDN---KTINFITELFTSGTLREYRKKH----RRVNIKAIKSWCRQILKGLVYLHSQDPPII  167 (632)
T ss_pred             HccCCCCceeeeeeheecCCC---ceeeeeeecccCCcHHHHHHHh----ccCCHHHHHHHHHHHHHHhhhhhcCCCCcc
Confidence            678999999999999976553   45789999998 8999999875    67888899999999999999999751 399


Q ss_pred             ccCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           79 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        79 H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      |||||.+||+|+.+.+.|||+|+|+|....... ....+|||.|||||+.-  ..|+..+||||||.++.||+|+..||.
T Consensus       168 HRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~-aksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYs  244 (632)
T KOG0584|consen  168 HRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH-AKSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYS  244 (632)
T ss_pred             ccccccceEEEcCCcCceeecchhHHHHhhccc-cceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChh
Confidence            999999999999988899999999998764433 23479999999999994  469999999999999999999999996


Q ss_pred             CC-CcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          159 GE-SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       159 ~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      .= +...++.++...  ..| ..                        |.+--.+++++||.+||.. .++|+|+.|+|.|
T Consensus       245 EC~n~AQIYKKV~SG--iKP-~s------------------------l~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  245 ECTNPAQIYKKVTSG--IKP-AA------------------------LSKVKDPEVREFIEKCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             hhCCHHHHHHHHHcC--CCH-HH------------------------hhccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence            53 444444444331  111 11                        1122368999999999999 9999999999999


Q ss_pred             CCcccc
Q 022799          238 PFFDEL  243 (292)
Q Consensus       238 p~~~~~  243 (292)
                      |||..-
T Consensus       297 ~Ff~~d  302 (632)
T KOG0584|consen  297 PFFDED  302 (632)
T ss_pred             hhhccc
Confidence            999863

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.3e-37  Score=262.82  Aligned_cols=205  Identities=27%  Similarity=0.383  Sum_probs=163.1

Q ss_pred             CCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccC
Q 022799            3 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRD   81 (292)
Q Consensus         3 ~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~d   81 (292)
                      ...||||+++++++     .+....++||||+. |+|..++..    .+.+++..++.++.|++.||.|||+. +++|||
T Consensus        53 ~~~~~~i~~~~~~~-----~~~~~~~~v~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~-~i~H~d  122 (278)
T cd05606          53 TGDCPFIVCMSYAF-----HTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNR-FVVYRD  122 (278)
T ss_pred             hCCCCcEeeeeeee-----ecCCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CEEcCC
Confidence            35799999999988     44445899999998 588777654    35799999999999999999999987 999999


Q ss_pred             CCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCCC
Q 022799           82 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES  161 (292)
Q Consensus        82 lkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~  161 (292)
                      |||+||+++.++ .++|+|||++....... .....|+..|+|||.+.+...++.++|+||+||++|+|++|..||.+..
T Consensus       123 i~p~nili~~~~-~~kl~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~  200 (278)
T cd05606         123 LKPANILLDEHG-HVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK  200 (278)
T ss_pred             CCHHHEEECCCC-CEEEccCcCccccCccC-CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCC
Confidence            999999999887 79999999987653322 2345789999999998755558999999999999999999999997653


Q ss_pred             cHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcc-----cHHHHhc
Q 022799          162 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEALI  236 (292)
Q Consensus       162 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----t~~e~l~  236 (292)
                      ...... +......                         ....++..++.++.++|.+||..+|++|+     ++.++++
T Consensus       201 ~~~~~~-~~~~~~~-------------------------~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         201 TKDKHE-IDRMTLT-------------------------MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             ccchHH-HHHHhhc-------------------------cCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            221111 0000000                         00012245789999999999999999999     9999999


Q ss_pred             CCCccccCC
Q 022799          237 HPFFDELRD  245 (292)
Q Consensus       237 hp~~~~~~~  245 (292)
                      ||||++..+
T Consensus       255 ~~~~~~~~~  263 (278)
T cd05606         255 HPFFRSLDW  263 (278)
T ss_pred             CccccCCCc
Confidence            999998764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.7e-37  Score=264.35  Aligned_cols=210  Identities=28%  Similarity=0.384  Sum_probs=163.9

Q ss_pred             CC-CCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            3 LL-DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         3 ~l-~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      .+ +||||+++++++......+..++++||||++ ++|.+++.........+++..++.++.|++.||.|||++ +++||
T Consensus        70 ~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~  148 (286)
T cd06638          70 ALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN-KTIHR  148 (286)
T ss_pred             HHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC-Ccccc
Confidence            44 6999999999886544445567899999998 688888765444456789999999999999999999987 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCC-CcccccccccccCCccccCC----CCCCchhHhhhhhHHHHHHHhCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGA----TEYTAAIDIWSAGCVLAELLLGQP  155 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~~~DvwslG~il~el~~g~~  155 (292)
                      ||||+||+++.++ .++|+|||++....... ......|++.|+|||.+.+.    ..++.++|+||+||++|+|++|..
T Consensus       149 dlkp~nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~  227 (286)
T cd06638         149 DVKGNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDP  227 (286)
T ss_pred             CCCHHhEEECCCC-CEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCC
Confidence            9999999999888 69999999987654322 22344688999999987432    347889999999999999999999


Q ss_pred             CCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHh
Q 022799          156 LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL  235 (292)
Q Consensus       156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l  235 (292)
                      ||........+..+...   .                .+.       ...+..++..+.++|.+||..||++|||+.+++
T Consensus       228 p~~~~~~~~~~~~~~~~---~----------------~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell  281 (286)
T cd06638         228 PLADLHPMRALFKIPRN---P----------------PPT-------LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLL  281 (286)
T ss_pred             CCCCCchhHHHhhcccc---C----------------CCc-------ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHh
Confidence            99766543322221110   0                000       001134577899999999999999999999999


Q ss_pred             cCCCc
Q 022799          236 IHPFF  240 (292)
Q Consensus       236 ~hp~~  240 (292)
                      +|+||
T Consensus       282 ~~~~~  286 (286)
T cd06638         282 QHVFI  286 (286)
T ss_pred             hcccC
Confidence            99997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.7e-37  Score=263.90  Aligned_cols=205  Identities=28%  Similarity=0.428  Sum_probs=160.1

Q ss_pred             CCCCeeeeceeeeccCC-CCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCC
Q 022799            5 DHPNVVSLKHCFFSTTE-KDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDI   82 (292)
Q Consensus         5 ~HpnIv~~~~~~~~~~~-~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dl   82 (292)
                      +||||+++++++..... ....++|++|||++ |+|.+++....  ...+++..+..++.||+.||.|||+. ||+|+||
T Consensus        71 ~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~-~ivH~dl  147 (282)
T cd06636          71 HHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAH-KVIHRDI  147 (282)
T ss_pred             CCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCC
Confidence            79999999998864322 23457899999998 58888886532  34588889999999999999999987 9999999


Q ss_pred             CCCcEEEeCCCCcEEEeecCCccccccC-CCcccccccccccCCccccC----CCCCCchhHhhhhhHHHHHHHhCCCCC
Q 022799           83 KPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNISYICSRYYRAPELIFG----ATEYTAAIDIWSAGCVLAELLLGQPLF  157 (292)
Q Consensus        83 kp~Nill~~~~~~ikl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslG~il~el~~g~~pf  157 (292)
                      +|+||+++.++ .++|+|||++...... .......|++.|+|||.+..    ...++.++|+||+||++|+|++|..||
T Consensus       148 ~~~nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~  226 (282)
T cd06636         148 KGQNVLLTENA-EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL  226 (282)
T ss_pred             CHHHEEECCCC-CEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCc
Confidence            99999999888 7999999998765322 12234568899999998753    234788999999999999999999999


Q ss_pred             CCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          158 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      ...........+...   ..                +        ......++.++.++|.+||..||.+|||+.++++|
T Consensus       227 ~~~~~~~~~~~~~~~---~~----------------~--------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         227 CDMHPMRALFLIPRN---PP----------------P--------KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             cccCHHhhhhhHhhC---CC----------------C--------CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence            765443322211110   00                0        00113578899999999999999999999999999


Q ss_pred             CCc
Q 022799          238 PFF  240 (292)
Q Consensus       238 p~~  240 (292)
                      |||
T Consensus       280 ~~~  282 (282)
T cd06636         280 PFI  282 (282)
T ss_pred             CCC
Confidence            997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=4.6e-37  Score=257.59  Aligned_cols=203  Identities=27%  Similarity=0.463  Sum_probs=162.9

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      +++++||||+++++.+..    .+..+|+||||++ ++|.+.+...  ....+++.++..++.|++.|+.+||++ |++|
T Consensus        53 l~~l~~~~i~~~~~~~~~----~~~~~~lv~e~~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~~-~i~H  125 (257)
T cd08223          53 LSQLKHPNIVAYRESWEG----EDGLLYIVMGFCEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHEK-HILH  125 (257)
T ss_pred             HHhCCCCCeeeeeeeecC----CCCEEEEEecccCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC-Ceec
Confidence            356899999999887622    2345889999998 6888887653  234689999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCC-CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      |||||+||+++.++ .++|+|||++....... ......+++.|+|||++.+. .++.++|+||+||++++|++|..||.
T Consensus       126 ~di~p~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~~~~  203 (257)
T cd08223         126 RDLKTQNVFLTRTN-IIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNK-PYNYKSDVWALGCCVYEMATLKHAFN  203 (257)
T ss_pred             cCCCchhEEEecCC-cEEEecccceEEecccCCccccccCCcCccChhHhcCC-CCCchhhhHHHHHHHHHHHcCCCCCC
Confidence            99999999999887 79999999987664322 22344678899999998664 48899999999999999999999998


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCC
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  238 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp  238 (292)
                      +.+.......+.....                   +         ..+..+++.+.++|.+||..||.+|||+.++++||
T Consensus       204 ~~~~~~~~~~~~~~~~-------------------~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~  255 (257)
T cd08223         204 AKDMNSLVYRIIEGKL-------------------P---------PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQP  255 (257)
T ss_pred             CCCHHHHHHHHHhcCC-------------------C---------CCccccCHHHHHHHHHHhccCcccCCCHHHHhcCC
Confidence            7665444433332100                   0         01135788999999999999999999999999999


Q ss_pred             Cc
Q 022799          239 FF  240 (292)
Q Consensus       239 ~~  240 (292)
                      ||
T Consensus       256 ~~  257 (257)
T cd08223         256 YI  257 (257)
T ss_pred             CC
Confidence            97

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2.8e-37  Score=258.71  Aligned_cols=203  Identities=28%  Similarity=0.474  Sum_probs=166.0

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++.+     .+....++||||++ ++|.+++....  ...+++..+..++.|++.||.|||++ |++|
T Consensus        53 l~~~~~~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~-~i~h  124 (256)
T cd08220          53 LKLLSHPNIIEYYENF-----LEDKALMIVMEYAPGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTK-LILH  124 (256)
T ss_pred             HhhCCCCchhheeeeE-----ecCCEEEEEEecCCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC-Ceec
Confidence            4678999999999988     34446899999998 58988886532  34589999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      +||+|+||+++.++..++|+|||.+.............++..|+|||.+.+. .++.++|+||+|+++|+|++|..||.+
T Consensus       125 ~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~~~~~~~~  203 (256)
T cd08220         125 RDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGK-PYNQKSDIWALGCVLYELASLKRAFEA  203 (256)
T ss_pred             CCCCHHHEEEcCCCCEEEEccCCCceecCCCccccccccCCcccCchhccCC-CCCcccchHHHHHHHHHHHhCCCCccc
Confidence            9999999999876657899999999876554444456788999999998654 478999999999999999999999987


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCC
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF  239 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~  239 (292)
                      .+.......+......                            .++..+++++.+++.+||..||++|||+.++++|||
T Consensus       204 ~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~  255 (256)
T cd08220         204 ANLPALVLKIMSGTFA----------------------------PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPI  255 (256)
T ss_pred             CchHHHHHHHHhcCCC----------------------------CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCC
Confidence            6655444333321000                            012357889999999999999999999999999999


Q ss_pred             c
Q 022799          240 F  240 (292)
Q Consensus       240 ~  240 (292)
                      |
T Consensus       256 ~  256 (256)
T cd08220         256 C  256 (256)
T ss_pred             C
Confidence            6

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=3.6e-37  Score=258.04  Aligned_cols=202  Identities=27%  Similarity=0.433  Sum_probs=164.3

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++     .+....++||||+. ++|.+++....  ...+++..+..++.|++.||.|||+. |++|
T Consensus        53 l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~-~i~h  124 (256)
T cd08529          53 LAKLDSSYIIRYYESF-----LDKGKLNIVMEYAENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHSK-KILH  124 (256)
T ss_pred             HHhcCCCCeehheeee-----ccCCEEEEEEEeCCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC-Cccc
Confidence            3578999999999998     44456899999997 69988887532  35688999999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCC-cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      +||+|+||+++.++ .++|+|||.+........ .....+++.|+|||+..+. .++.++|+||+||++++|++|..||.
T Consensus       125 ~dl~~~nili~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~  202 (256)
T cd08529         125 RDIKSLNLFLDAYD-NVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDK-PYNEKSDVWALGVVLYECCTGKHPFD  202 (256)
T ss_pred             CCCCcceEEEeCCC-CEEEcccccceeccCccchhhccccCccccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCC
Confidence            99999999999887 799999999886644322 2234678899999998654 48899999999999999999999998


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCC
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  238 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp  238 (292)
                      ..+.......+.+...                   +         .++..++.++.++|.+||+.+|++||++.++++||
T Consensus       203 ~~~~~~~~~~~~~~~~-------------------~---------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~  254 (256)
T cd08529         203 ANNQGALILKIIRGVF-------------------P---------PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNP  254 (256)
T ss_pred             CCCHHHHHHHHHcCCC-------------------C---------CCccccCHHHHHHHHHHccCCcccCcCHHHHhhCC
Confidence            7765544443332100                   0         01134788999999999999999999999999999


Q ss_pred             Cc
Q 022799          239 FF  240 (292)
Q Consensus       239 ~~  240 (292)
                      |+
T Consensus       255 ~~  256 (256)
T cd08529         255 SL  256 (256)
T ss_pred             CC
Confidence            95

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.4e-37  Score=266.38  Aligned_cols=205  Identities=27%  Similarity=0.436  Sum_probs=163.3

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++.+.     .....|+||||+. ++|.+++..     ..+++..+..++.|++.||.|||+. ||+|
T Consensus        71 l~~~~h~~v~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~-gi~H  139 (296)
T cd06654          71 MRENKNPNIVNYLDSYL-----VGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN-QVIH  139 (296)
T ss_pred             HHhCCCCCEeeEEEEEE-----eCCEEEEeecccCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC-Cccc
Confidence            35679999999999884     3345899999998 688887753     4578899999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCC-cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      |||||+||+++.++ .++|+|||.+........ .....+++.|+|||.+.+. .++.++|+||+||++|+|++|..||.
T Consensus       140 ~dLkp~Nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~~l~~g~~pf~  217 (296)
T cd06654         140 RDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYL  217 (296)
T ss_pred             CCCCHHHEEEcCCC-CEEECccccchhccccccccCcccCCccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCCCC
Confidence            99999999999887 799999999876533221 2234688999999998654 47899999999999999999999998


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCC
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  238 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp  238 (292)
                      ..........+... +.+.                         ...+..++..+.++|.+||..||.+|||+.+++.||
T Consensus       218 ~~~~~~~~~~~~~~-~~~~-------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~  271 (296)
T cd06654         218 NENPLRALYLIATN-GTPE-------------------------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQ  271 (296)
T ss_pred             CCCHHHhHHHHhcC-CCCC-------------------------CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhCh
Confidence            76654333222110 0000                         001245788999999999999999999999999999


Q ss_pred             CccccC
Q 022799          239 FFDELR  244 (292)
Q Consensus       239 ~~~~~~  244 (292)
                      ||...+
T Consensus       272 ~~~~~~  277 (296)
T cd06654         272 FLKIAK  277 (296)
T ss_pred             hhhccC
Confidence            998654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.8e-37  Score=264.25  Aligned_cols=212  Identities=26%  Similarity=0.466  Sum_probs=164.7

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++.     ...++++||||++ ++|..++.... ....+++..+..++.|++.||.|||++.|++|
T Consensus        53 l~~~~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H  126 (286)
T cd06622          53 LHKAVSPYIVDFYGAFF-----IEGAVYMCMEYMDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEHNIIH  126 (286)
T ss_pred             HHhcCCCcHHhhhhhee-----cCCeEEEEEeecCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCEee
Confidence            35689999999999883     4456899999999 58877776421 13478999999999999999999996449999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCC-----CCCchhHhhhhhHHHHHHHhCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT-----EYTAAIDIWSAGCVLAELLLGQ  154 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~DvwslG~il~el~~g~  154 (292)
                      +||||+||+++.++ .++|+|||.+...... ......+++.|+|||.+.+..     .++.++|+||+||++|+|++|.
T Consensus       127 ~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~  204 (286)
T cd06622         127 RDVKPTNVLVNGNG-QVKLCDFGVSGNLVAS-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR  204 (286)
T ss_pred             CCCCHHHEEECCCC-CEEEeecCCcccccCC-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCC
Confidence            99999999999877 7999999998765322 223346788999999985432     2578999999999999999999


Q ss_pred             CCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHH
Q 022799          155 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA  234 (292)
Q Consensus       155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~  234 (292)
                      .||...........+........                         ..++..+++++.++|.+||..+|++||++.++
T Consensus       205 ~pf~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l  259 (286)
T cd06622         205 YPYPPETYANIFAQLSAIVDGDP-------------------------PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQL  259 (286)
T ss_pred             CCCCCcchhhHHHHHHHHhhcCC-------------------------CCCCcccCHHHHHHHHHHcccCcccCCCHHHH
Confidence            99976544333322222111100                         01224578999999999999999999999999


Q ss_pred             hcCCCccccCC
Q 022799          235 LIHPFFDELRD  245 (292)
Q Consensus       235 l~hp~~~~~~~  245 (292)
                      +.||||.....
T Consensus       260 ~~~~~~~~~~~  270 (286)
T cd06622         260 LEHPWLVKYKN  270 (286)
T ss_pred             hcChhhhhccC
Confidence            99999987653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=2.4e-37  Score=263.80  Aligned_cols=211  Identities=25%  Similarity=0.415  Sum_probs=161.3

Q ss_pred             CCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhh-hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCC
Q 022799            5 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHY-KMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIK   83 (292)
Q Consensus         5 ~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~-~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlk   83 (292)
                      +||||+++++++..     ....+++|||+++++.++..... .....+++..+..++.|++.||+|||+..|++|||||
T Consensus        61 ~~~~iv~~~~~~~~-----~~~~~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlk  135 (288)
T cd06616          61 DCPYIVKFYGALFR-----EGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVK  135 (288)
T ss_pred             CCCCEeeeeeEEec-----CCcEEEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCC
Confidence            49999999998843     33478999999987766543221 1246799999999999999999999974499999999


Q ss_pred             CCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCC--CCCCchhHhhhhhHHHHHHHhCCCCCCCCC
Q 022799           84 PQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA--TEYTAAIDIWSAGCVLAELLLGQPLFPGES  161 (292)
Q Consensus        84 p~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwslG~il~el~~g~~pf~~~~  161 (292)
                      |+||+++.++ .++|+|||++.............|+..|+|||.+.+.  ..++.++|+||+||++|+|++|..||....
T Consensus       136 p~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~  214 (288)
T cd06616         136 PSNILLDRNG-NIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN  214 (288)
T ss_pred             HHHEEEccCC-cEEEeecchhHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc
Confidence            9999999887 7999999999766444333445688899999998665  358999999999999999999999997544


Q ss_pred             cHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCCcc
Q 022799          162 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFD  241 (292)
Q Consensus       162 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~~~  241 (292)
                      .  ....+.+......                +..     ....+..++.++.+||.+||..||++|||++++++||||+
T Consensus       215 ~--~~~~~~~~~~~~~----------------~~~-----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~  271 (288)
T cd06616         215 S--VFDQLTQVVKGDP----------------PIL-----SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIK  271 (288)
T ss_pred             h--HHHHHhhhcCCCC----------------CcC-----CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhh
Confidence            1  1122211111000                000     0001134788999999999999999999999999999998


Q ss_pred             ccC
Q 022799          242 ELR  244 (292)
Q Consensus       242 ~~~  244 (292)
                      ...
T Consensus       272 ~~~  274 (288)
T cd06616         272 DYE  274 (288)
T ss_pred             chh
Confidence            754

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2e-37  Score=261.44  Aligned_cols=206  Identities=27%  Similarity=0.500  Sum_probs=162.6

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++     .+...+++||||+. ++|.+++..    ...+++..+..++.||+.||.|||++ |++|
T Consensus        57 l~~l~h~~iv~~~~~~-----~~~~~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~-~i~H  126 (268)
T cd06630          57 MARLNHPHIIRMLGAT-----CEDSHFNLFVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHEN-QIIH  126 (268)
T ss_pred             HHHcCCCceehhhcee-----ccCCeEEEEEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC-Ceec
Confidence            3568999999999998     44456899999999 588888764    35688999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCC-----cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ  154 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~  154 (292)
                      +||+|+||+++.++..++|+|||.+........     .....++..|+|||.+.+. .++.++|+||+||++++|++|.
T Consensus       127 ~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~  205 (268)
T cd06630         127 RDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGE-QYGRSCDVWSVGCVIIEMATAK  205 (268)
T ss_pred             CCCCHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccC-CCCcccchHHHHHHHHHHHhCC
Confidence            999999999987765799999999876643211     1234578899999998654 4889999999999999999999


Q ss_pred             CCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHH
Q 022799          155 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA  234 (292)
Q Consensus       155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~  234 (292)
                      .||...........+.+.....                        ....++..+++++.+++.+||..+|++|||+.++
T Consensus       206 ~p~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~l  261 (268)
T cd06630         206 PPWNAEKHSNHLALIFKIASAT------------------------TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSREL  261 (268)
T ss_pred             CCCCCCCCcchHHHHHHHhccC------------------------CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHH
Confidence            9997554333222222210000                        0001224578899999999999999999999999


Q ss_pred             hcCCCcc
Q 022799          235 LIHPFFD  241 (292)
Q Consensus       235 l~hp~~~  241 (292)
                      ++||||+
T Consensus       262 l~~~~~~  268 (268)
T cd06630         262 LKHPVFR  268 (268)
T ss_pred             hcCcccC
Confidence            9999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=4.9e-37  Score=258.15  Aligned_cols=206  Identities=28%  Similarity=0.470  Sum_probs=167.0

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHH-----hc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH-----NT   74 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH-----~~   74 (292)
                      |+.++||||+++++.+...   +....+++|||++ ++|.+++.........+++..+..++.||+.||.|||     +.
T Consensus        53 l~~l~~~~i~~~~~~~~~~---~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~  129 (265)
T cd08217          53 LRELKHPNIVRYYDRIIDR---SNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN  129 (265)
T ss_pred             HHhcCCCccceeeeeeecC---CCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC
Confidence            4578999999999877542   2345789999998 6999998766555678999999999999999999999     87


Q ss_pred             CCccccCCCCCcEEEeCCCCcEEEeecCCccccccCCC-cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhC
Q 022799           75 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG  153 (292)
Q Consensus        75 ~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g  153 (292)
                       +++|+||+|+||+++.++ .++|+|||.+........ .....+++.|+|||.+.+. .++.++|+||+|+++++|++|
T Consensus       130 -~i~h~dl~p~nili~~~~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g  206 (265)
T cd08217         130 -TVLHRDLKPANIFLDANN-NVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHM-SYDEKSDIWSLGCLIYELCAL  206 (265)
T ss_pred             -cceecCCCHHHEEEecCC-CEEEecccccccccCCcccccccccCCCccChhhhcCC-CCCchhHHHHHHHHHHHHHHC
Confidence             999999999999999887 799999999987654432 3345688999999998664 488999999999999999999


Q ss_pred             CCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHH
Q 022799          154 QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE  233 (292)
Q Consensus       154 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e  233 (292)
                      ..||...+.......+... .                  .         ..++..++..+.+++.+||..+|++|||+.+
T Consensus       207 ~~p~~~~~~~~~~~~~~~~-~------------------~---------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~  258 (265)
T cd08217         207 SPPFTARNQLQLASKIKEG-K------------------F---------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEE  258 (265)
T ss_pred             CCcccCcCHHHHHHHHhcC-C------------------C---------CCCccccCHHHHHHHHHHccCCcccCCCHHH
Confidence            9999876643333222110 0                  0         0122457889999999999999999999999


Q ss_pred             HhcCCCc
Q 022799          234 ALIHPFF  240 (292)
Q Consensus       234 ~l~hp~~  240 (292)
                      +++|||+
T Consensus       259 il~~~~~  265 (265)
T cd08217         259 LLQLPLI  265 (265)
T ss_pred             HhhCCCC
Confidence            9999995

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-37  Score=258.75  Aligned_cols=205  Identities=28%  Similarity=0.412  Sum_probs=161.6

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++     .+...+|++|||++ ++|.+++...   ...+++..+..++.|++.||.|||++ |++|
T Consensus        54 l~~~~h~~i~~~~~~~-----~~~~~~~l~~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~-~i~h  124 (262)
T cd06613          54 LKECRHPNIVAYFGSY-----LRRDKLWIVMEYCGGGSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHET-GKIH  124 (262)
T ss_pred             HHhCCCCChhceEEEE-----EeCCEEEEEEeCCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC-Ccee
Confidence            4678999999999988     33445899999999 5888777642   25689999999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCC-CcccccccccccCCccccCC--CCCCchhHhhhhhHHHHHHHhCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGA--TEYTAAIDIWSAGCVLAELLLGQPL  156 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwslG~il~el~~g~~p  156 (292)
                      +||+|+||+++.++ .++|+|||.+....... ......++..|+|||.+.+.  ..++.++|+||+||++|+|++|..|
T Consensus       125 ~dl~p~ni~i~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p  203 (262)
T cd06613         125 RDIKGANILLTEDG-DVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPP  203 (262)
T ss_pred             cCCChhhEEECCCC-CEEECccccchhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCC
Confidence            99999999999887 79999999987654332 22345678899999998654  2478899999999999999999999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      |.+.+.......+....-.+.                 ..       ......+.++.++|.+||..+|.+|||+.+++.
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~-----------------~~-------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         204 MFDLHPMRALFLISKSNFPPP-----------------KL-------KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             CCCCCHHHHHHHHHhccCCCc-----------------cc-------cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            987665444333222100000                 00       011346788999999999999999999999999


Q ss_pred             CCC
Q 022799          237 HPF  239 (292)
Q Consensus       237 hp~  239 (292)
                      |+|
T Consensus       260 ~~~  262 (262)
T cd06613         260 HPF  262 (262)
T ss_pred             CCC
Confidence            998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.8e-37  Score=260.13  Aligned_cols=209  Identities=27%  Similarity=0.421  Sum_probs=165.4

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++.+     ......++|||+++ ++|.+++..... ...+++..++.++.|++.||.|||+. |++|
T Consensus        53 l~~l~~~~i~~~~~~~-----~~~~~~~iv~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~-~i~h  125 (267)
T cd06610          53 MSQCNHPNVVKYYTSF-----VVGDELWLVMPYLSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN-GQIH  125 (267)
T ss_pred             HHhcCCCCEEEEEEEE-----eeCCEEEEEEeccCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC-Ceec
Confidence            4578999999999988     33445899999998 588888865322 24689999999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCc-----ccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ  154 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~  154 (292)
                      +||+|+||+++.++ .++|+|||++.........     ....|+..|+|||.+.....++.++|+||+||++|+|++|.
T Consensus       126 ~~l~p~ni~~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~  204 (267)
T cd06610         126 RDIKAGNILLGEDG-SVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGA  204 (267)
T ss_pred             CCCCHHhEEEcCCC-CEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCC
Confidence            99999999999887 7999999998766443222     33467889999999876546899999999999999999999


Q ss_pred             CCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHH
Q 022799          155 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA  234 (292)
Q Consensus       155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~  234 (292)
                      .||...+......+....   .+        +.+     +..       .....+++.+.+++.+||..||++|||+.++
T Consensus       205 ~p~~~~~~~~~~~~~~~~---~~--------~~~-----~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l  261 (267)
T cd06610         205 APYSKYPPMKVLMLTLQN---DP--------PSL-----ETG-------ADYKKYSKSFRKMISLCLQKDPSKRPTAEEL  261 (267)
T ss_pred             CCccccChhhhHHHHhcC---CC--------CCc-----CCc-------cccccccHHHHHHHHHHcCCChhhCcCHHHH
Confidence            999876655444433321   00        000     000       0013578899999999999999999999999


Q ss_pred             hcCCCc
Q 022799          235 LIHPFF  240 (292)
Q Consensus       235 l~hp~~  240 (292)
                      +.||||
T Consensus       262 l~~p~~  267 (267)
T cd06610         262 LKHKFF  267 (267)
T ss_pred             hhCCCC
Confidence            999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=5.3e-37  Score=258.78  Aligned_cols=203  Identities=28%  Similarity=0.476  Sum_probs=158.4

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++...   ....++++|||++ ++|.+.+..    ...+++..++.++.|++.||.|||+. |++|
T Consensus        58 l~~l~h~~i~~~~~~~~~~---~~~~~~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~-~i~H  129 (266)
T cd06651          58 LKNLQHERIVQYYGCLRDR---AEKTLTIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSN-MIVH  129 (266)
T ss_pred             HHHcCCCCeeeEEEEEEcC---CCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC-Ceee
Confidence            3568999999999987432   2335789999998 588888865    35688999999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCC----CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE----PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQP  155 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~  155 (292)
                      |||+|+||+++.++ .++|+|||++.......    ......++..|+|||.+.+. .++.++|+||+||++|+|++|..
T Consensus       130 ~~l~p~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~el~~g~~  207 (266)
T cd06651         130 RDIKGANILRDSAG-NVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGE-GYGRKADVWSLGCTVVEMLTEKP  207 (266)
T ss_pred             CCCCHHHEEECCCC-CEEEccCCCccccccccccCCccccCCccccccCHHHhCCC-CCCchhhhHHHHHHHHHHHHCCC
Confidence            99999999999887 79999999987543211    11224578889999998664 48999999999999999999999


Q ss_pred             CCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHh
Q 022799          156 LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL  235 (292)
Q Consensus       156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l  235 (292)
                      ||...........+..   .+.                        ...++..+++.++++| +||..+|++||++++++
T Consensus       208 pf~~~~~~~~~~~~~~---~~~------------------------~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil  259 (266)
T cd06651         208 PWAEYEAMAAIFKIAT---QPT------------------------NPQLPSHISEHARDFL-GCIFVEARHRPSAEELL  259 (266)
T ss_pred             CccccchHHHHHHHhc---CCC------------------------CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHh
Confidence            9976544333322211   000                        0012245688899999 57778999999999999


Q ss_pred             cCCCcc
Q 022799          236 IHPFFD  241 (292)
Q Consensus       236 ~hp~~~  241 (292)
                      +||||+
T Consensus       260 ~hp~~~  265 (266)
T cd06651         260 RHPFAQ  265 (266)
T ss_pred             cCcccc
Confidence            999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=3.1e-37  Score=262.10  Aligned_cols=205  Identities=25%  Similarity=0.485  Sum_probs=157.2

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccC-CHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++..     ....++||||+++ +|..+        ..+++..+..++.|++.||.|||+. ||+|
T Consensus        53 l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~l~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H  118 (279)
T cd06619          53 LYKCDSPYIIGFYGAFFV-----ENRISICTEFMDGGSLDVY--------RKIPEHVLGRIAVAVVKGLTYLWSL-KILH  118 (279)
T ss_pred             HHhCCCCCeeeEEEEEEE-----CCEEEEEEecCCCCChHHh--------hcCCHHHHHHHHHHHHHHHHHHHHC-CEee
Confidence            357899999999999843     3458899999995 55322        3468888999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      +||||+||+++.++ .++|+|||++...... ......+|..|+|||.+.+. .++.++|+||+||++|+|++|..||..
T Consensus       119 ~dlkp~Nill~~~~-~~~l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~  195 (279)
T cd06619         119 RDVKPSNMLVNTRG-QVKLCDFGVSTQLVNS-IAKTYVGTNAYMAPERISGE-QYGIHSDVWSLGISFMELALGRFPYPQ  195 (279)
T ss_pred             CCCCHHHEEECCCC-CEEEeeCCcceecccc-cccCCCCChhhcCceeecCC-CCCCcchHHHHHHHHHHHHhCCCCchh
Confidence            99999999999988 7999999998765332 23345789999999999765 489999999999999999999999965


Q ss_pred             CCcHHH---HHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          160 ESGVDQ---LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       160 ~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      ......   .....+.....          ..     +.        ......++++.++|.+||..||.+||++++++.
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~----------~~-----~~--------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~  252 (279)
T cd06619         196 IQKNQGSLMPLQLLQCIVDE----------DP-----PV--------LPVGQFSEKFVHFITQCMRKQPKERPAPENLMD  252 (279)
T ss_pred             hcccccccchHHHHHHHhcc----------CC-----CC--------CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            321110   00111110000          00     00        001346789999999999999999999999999


Q ss_pred             CCCccccCC
Q 022799          237 HPFFDELRD  245 (292)
Q Consensus       237 hp~~~~~~~  245 (292)
                      ||||...+.
T Consensus       253 ~~~~~~~~~  261 (279)
T cd06619         253 HPFIVQYND  261 (279)
T ss_pred             CcccccccC
Confidence            999987643

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=8.2e-37  Score=256.01  Aligned_cols=202  Identities=34%  Similarity=0.534  Sum_probs=165.3

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++.     +...++++|||++ ++|.+.+....  ...+++..+..++.|++.||.|||+. |++|
T Consensus        53 l~~~~h~~i~~~~~~~~-----~~~~~~~~~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h  124 (256)
T cd08221          53 LSLLQHPNIIAYYNHFM-----DDNTLLIEMEYANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA-GILH  124 (256)
T ss_pred             HHhCCCCCeeEEEeEEe-----cCCeEEEEEEecCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC-Cccc
Confidence            46789999999999994     3445899999998 69998887532  35689999999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCC-CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      +||+|+||+++.++ .+||+|||.+....... ......+++.|+|||.+.+.. ++.++|+||+||++|+|++|..||.
T Consensus       125 ~dl~p~ni~~~~~~-~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~  202 (256)
T cd08221         125 RDIKTLNIFLTKAG-LIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVK-YNFKSDIWALGCVLYELLTLKRTFD  202 (256)
T ss_pred             cCCChHhEEEeCCC-CEEECcCcceEEcccccccccccCCCccccCHhhcCCCC-CCCcchhHHHHHHHHHHHHCCCCCC
Confidence            99999999999888 79999999987653333 223456889999999986654 7899999999999999999999998


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCC
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  238 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp  238 (292)
                      +.+..+....+...  ..+            .              .+..++.++.++|.+||..+|.+||++.++++||
T Consensus       203 ~~~~~~~~~~~~~~--~~~------------~--------------~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         203 ATNPLNLVVKIVQG--NYT------------P--------------VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             CCCHHHHHHHHHcC--CCC------------C--------------CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence            77665555544321  000            0              1135788999999999999999999999999999


Q ss_pred             Cc
Q 022799          239 FF  240 (292)
Q Consensus       239 ~~  240 (292)
                      |+
T Consensus       255 ~l  256 (256)
T cd08221         255 LL  256 (256)
T ss_pred             CC
Confidence            86

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1e-36  Score=262.16  Aligned_cols=207  Identities=32%  Similarity=0.530  Sum_probs=163.3

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++.+     ....++++||||++ ++|.+++..    ...+++..+..++.|++.||.|||++ |++|
T Consensus        55 l~~~~~~~i~~~~~~~-----~~~~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H  124 (305)
T cd05609          55 LTFAENPFVVSMFCSF-----ETKRHLCMVMEYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNY-GIVH  124 (305)
T ss_pred             HHhCCCCCeeeeEEEE-----ecCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-Cccc
Confidence            3568999999999988     44446899999998 588888865    35689999999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCC----------------CcccccccccccCCccccCCCCCCchhHhhhh
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE----------------PNISYICSRYYRAPELIFGATEYTAAIDIWSA  143 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~----------------~~~~~~gt~~y~aPE~~~~~~~~~~~~Dvwsl  143 (292)
                      |||||+||+++.++ .++|+|||.++......                ......++..|+|||.+.+. .++.++|+||+
T Consensus       125 ~dl~p~NIll~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~sl  202 (305)
T cd05609         125 RDLKPDNLLITSMG-HIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ-GYGKPVDWWAM  202 (305)
T ss_pred             cCCchHHEEECCCC-CEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCC-CCCchhhHHHH
Confidence            99999999999887 79999999886321000                00123567889999998654 48999999999


Q ss_pred             hHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhcc
Q 022799          144 GCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQY  223 (292)
Q Consensus       144 G~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  223 (292)
                      ||++|+|++|..||.+....+....+......                 .+.         ....++.++.++|.+||..
T Consensus       203 G~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~-----------------~~~---------~~~~~~~~~~~li~~~l~~  256 (305)
T cd05609         203 GIILYEFLVGCVPFFGDTPEELFGQVISDDIE-----------------WPE---------GDEALPADAQDLISRLLRQ  256 (305)
T ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC-----------------CCC---------ccccCCHHHHHHHHHHhcc
Confidence            99999999999999877655544443321000                 000         0024788999999999999


Q ss_pred             CCCCccc---HHHHhcCCCccccCC
Q 022799          224 SPNLRST---ALEALIHPFFDELRD  245 (292)
Q Consensus       224 dp~~R~t---~~e~l~hp~~~~~~~  245 (292)
                      ||++||+   +.++++||||...+.
T Consensus       257 ~P~~R~~~~~~~~ll~~~~~~~~~~  281 (305)
T cd05609         257 NPLERLGTGGAFEVKQHRFFLGLDW  281 (305)
T ss_pred             ChhhccCccCHHHHHhCccccCCCH
Confidence            9999998   799999999977554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3.4e-37  Score=264.16  Aligned_cols=206  Identities=28%  Similarity=0.443  Sum_probs=163.4

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++     ......++||||++ ++|.+++..     ..+++..+..++.|++.||.|||+. |++|
T Consensus        70 l~~~~h~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~-~i~H  138 (297)
T cd06656          70 MRENKNPNIVNYLDSY-----LVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSN-QVIH  138 (297)
T ss_pred             HHhCCCCCEeeEEEEE-----ecCCEEEEeecccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC-Cccc
Confidence            3568999999999998     44445899999998 688887753     4578899999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCC-cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      |||||+||+++.++ .++|+|||.+........ .....+++.|+|||.+.+ ..++.++|+||+||++|+|++|..||.
T Consensus       139 ~dL~p~Nili~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~  216 (297)
T cd06656         139 RDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYL  216 (297)
T ss_pred             CCCCHHHEEECCCC-CEEECcCccceEccCCccCcCcccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            99999999999887 799999999876533322 223467889999999865 448899999999999999999999997


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCC
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  238 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp  238 (292)
                      +.+.......+.. .+.+.                         ...+..++..++++|.+||..||.+||++.+++.||
T Consensus       217 ~~~~~~~~~~~~~-~~~~~-------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~  270 (297)
T cd06656         217 NENPLRALYLIAT-NGTPE-------------------------LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHP  270 (297)
T ss_pred             CCCcchheeeecc-CCCCC-------------------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence            6554322211110 00000                         001245788999999999999999999999999999


Q ss_pred             CccccCC
Q 022799          239 FFDELRD  245 (292)
Q Consensus       239 ~~~~~~~  245 (292)
                      ||+....
T Consensus       271 ~~~~~~~  277 (297)
T cd06656         271 FLKLAKP  277 (297)
T ss_pred             hhccccc
Confidence            9997654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=9.4e-37  Score=255.65  Aligned_cols=202  Identities=36%  Similarity=0.552  Sum_probs=163.1

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++     .+...+++||||++ ++|.+++..    ...+++..+..++.||+.||.|||+. |++|
T Consensus        56 l~~~~h~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H  125 (258)
T cd06632          56 LSKLQHPNIVQYLGTE-----REEDNLYIFLELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHDR-NTVH  125 (258)
T ss_pred             HHhcCCCCchheeeeE-----ecCCeEEEEEEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-Cccc
Confidence            3568999999999988     44445899999998 588888865    35688999999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      +||+|+||+++.++ .+||+|||.+.............++..|++||.+.....++.++|+||+||++|+|++|..||..
T Consensus       126 ~dl~~~ni~~~~~~-~~kl~d~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~  204 (258)
T cd06632         126 RDIKGANILVDTNG-VVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQ  204 (258)
T ss_pred             CCCCHHHEEECCCC-CEEEccCccceeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCccc
Confidence            99999999999887 79999999987764444334556889999999985543478999999999999999999999976


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCC
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF  239 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~  239 (292)
                      .........+......                           ..++..+++++.+++.+||..+|.+||++.+++.|||
T Consensus       205 ~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~  257 (258)
T cd06632         205 LEGVAAVFKIGRSKEL---------------------------PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPF  257 (258)
T ss_pred             CcHHHHHHHHHhcccC---------------------------CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCC
Confidence            5543333322211000                           0122457889999999999999999999999999999


Q ss_pred             c
Q 022799          240 F  240 (292)
Q Consensus       240 ~  240 (292)
                      +
T Consensus       258 ~  258 (258)
T cd06632         258 V  258 (258)
T ss_pred             C
Confidence            6

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9e-39  Score=298.87  Aligned_cols=205  Identities=29%  Similarity=0.482  Sum_probs=168.5

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      ..|+|||+|+++++-+..+.     ++|.||||. |+|.++++.    +.-.++...+.|..|++.|+.|||++ |||||
T Consensus      1289 E~lnHpNlV~YyGVEvHRek-----v~IFMEyC~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~LH~~-gIVHR 1358 (1509)
T KOG4645|consen 1289 EGLNHPNLVRYYGVEVHREK-----VYIFMEYCEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHEH-GIVHR 1358 (1509)
T ss_pred             HhccCccccccCceeecHHH-----HHHHHHHhccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHhc-Cceec
Confidence            45899999999998754443     789999999 799998886    45577888899999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCC-----CcccccccccccCCccccCCC--CCCchhHhhhhhHHHHHHHhC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-----PNISYICSRYYRAPELIFGAT--EYTAAIDIWSAGCVLAELLLG  153 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~--~~~~~~DvwslG~il~el~~g  153 (292)
                      ||||.||+++.+| .+|++|||.|..+....     ......||+.|||||++.+..  ....+.|||||||++.||+||
T Consensus      1359 DIK~aNI~Ld~~g-~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tG 1437 (1509)
T KOG4645|consen 1359 DIKPANILLDFNG-LIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATG 1437 (1509)
T ss_pred             CCCccceeeecCC-cEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecC
Confidence            9999999999988 89999999999875542     123567999999999997653  467899999999999999999


Q ss_pred             CCCCCC-CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHH
Q 022799          154 QPLFPG-ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAL  232 (292)
Q Consensus       154 ~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~  232 (292)
                      +.||.. ++++.+++++-.. ..|                           .+|..+|++.+|||..||+.||++|.++.
T Consensus      1438 krPW~~~dne~aIMy~V~~g-h~P---------------------------q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~ 1489 (1509)
T KOG4645|consen 1438 KRPWAELDNEWAIMYHVAAG-HKP---------------------------QIPERLSSEGRDFLEHCLEQDPKMRWTAS 1489 (1509)
T ss_pred             CCchhhccchhHHHhHHhcc-CCC---------------------------CCchhhhHhHHHHHHHHHhcCchhhhHHH
Confidence            999975 3455555544321 111                           13456899999999999999999999999


Q ss_pred             HHhcCCCccccCC
Q 022799          233 EALIHPFFDELRD  245 (292)
Q Consensus       233 e~l~hp~~~~~~~  245 (292)
                      |++.|-|-+.-.+
T Consensus      1490 qlle~~f~~~~~d 1502 (1509)
T KOG4645|consen 1490 QLLEHAFGKSCTD 1502 (1509)
T ss_pred             HHHHhhccccccc
Confidence            9999988766443

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2.7e-37  Score=268.45  Aligned_cols=236  Identities=20%  Similarity=0.330  Sum_probs=164.4

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      +.++||||++++++|     ....+.++||||+. +++.+++....  ...+++..+..++.|++.||+|||++ |++||
T Consensus        54 ~~l~h~niv~~~~~~-----~~~~~~~~v~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~-~ivHr  125 (328)
T cd08226          54 HFFRHPNIMTSWTVF-----TTGSWLWVISPFMAYGSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQN-GYIHR  125 (328)
T ss_pred             HhCCCCCcceEeeeE-----ecCCceEEEEecccCCCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC-CeecC
Confidence            458999999999998     44445899999999 68888877542  24589999999999999999999987 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCCc--------ccccccccccCCccccCC-CCCCchhHhhhhhHHHHHHH
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN--------ISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELL  151 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~--------~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~  151 (292)
                      ||||+||+++.++ .++++||+.+.........        ....++..|+|||.+.+. ..++.++|+||+||++|+|+
T Consensus       126 Dlkp~Nill~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~  204 (328)
T cd08226         126 NIKASHILISGDG-LVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELA  204 (328)
T ss_pred             CCCHHHEEEeCCC-cEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHH
Confidence            9999999999887 7999999765432211110        112345679999998654 34789999999999999999


Q ss_pred             hCCCCCCCCCcHHHHHHHHHHhCCCCHH---------HHhhcCCCCcc-----ccC----CCCCCCCchhhhccCCChhH
Q 022799          152 LGQPLFPGESGVDQLVEIIKVLGTPTRE---------EIKCMNPNYTE-----FKF----PQIKAHPWHKIFQKRMPPEA  213 (292)
Q Consensus       152 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~---------~~~~~~~~~~~-----~~~----~~~~~~~~~~~~~~~~~~~~  213 (292)
                      +|..||.+.........+.......+..         .+.........     ...    .......+.......+++.+
T Consensus       205 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (328)
T cd08226         205 TGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAF  284 (328)
T ss_pred             hCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHH
Confidence            9999998766544433332211100000         00000000000     000    00000011111223567889


Q ss_pred             HHHHHHHhccCCCCcccHHHHhcCCCccccCCC
Q 022799          214 VDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  246 (292)
Q Consensus       214 ~~li~~~l~~dp~~R~t~~e~l~hp~~~~~~~~  246 (292)
                      .+||++||+.||++|||++++++||||..+...
T Consensus       285 ~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~  317 (328)
T cd08226         285 QNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQ  317 (328)
T ss_pred             HHHHHHHccCCcccCCCHHHHhhCHHHHHHHHh
Confidence            999999999999999999999999999987653

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=3.9e-37  Score=259.63  Aligned_cols=204  Identities=25%  Similarity=0.371  Sum_probs=157.8

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++.     ....+++||||++ ++|.+.+..    ...+++..+..++.|++.||.|||++ ||+|
T Consensus        60 l~~~~h~~ii~~~~~~~-----~~~~~~iv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H  129 (267)
T cd06646          60 VKECKHCNIVAYFGSYL-----SREKLWICMEYCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSK-GKMH  129 (267)
T ss_pred             HHhcCCCCeeeeeEEEE-----eCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-Cccc
Confidence            35689999999999884     3345899999998 688887754    35689999999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCC-CcccccccccccCCccccC--CCCCCchhHhhhhhHHHHHHHhCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFG--ATEYTAAIDIWSAGCVLAELLLGQPL  156 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslG~il~el~~g~~p  156 (292)
                      |||+|+||+++.++ .++|+|||++....... ......+++.|+|||.+.+  ...++.++|+||+||++|+|++|..|
T Consensus       130 ~dl~p~nill~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p  208 (267)
T cd06646         130 RDIKGANILLTDNG-DVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPP  208 (267)
T ss_pred             cCCCHHHEEECCCC-CEEECcCccceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCC
Confidence            99999999999887 69999999988653322 2234567889999998742  23478899999999999999999999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      |...........+...                 .+..+.     +  .....++..+.++|++||..+|++|||++++++
T Consensus       209 ~~~~~~~~~~~~~~~~-----------------~~~~~~-----~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  264 (267)
T cd06646         209 MFDLHPMRALFLMSKS-----------------NFQPPK-----L--KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLT  264 (267)
T ss_pred             ccccchhhhheeeecC-----------------CCCCCC-----C--ccccccCHHHHHHHHHHhhCChhhCcCHHHHhc
Confidence            8654432221111110                 000000     0  011346889999999999999999999999999


Q ss_pred             CCC
Q 022799          237 HPF  239 (292)
Q Consensus       237 hp~  239 (292)
                      |+|
T Consensus       265 ~l~  267 (267)
T cd06646         265 HLF  267 (267)
T ss_pred             CCC
Confidence            987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-37  Score=282.63  Aligned_cols=201  Identities=28%  Similarity=0.478  Sum_probs=157.4

Q ss_pred             CCCCC-CCCeeeecee-eeccCCCC-ceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 022799            1 MRLLD-HPNVVSLKHC-FFSTTEKD-ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG   76 (292)
Q Consensus         1 L~~l~-HpnIv~~~~~-~~~~~~~~-~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~   76 (292)
                      |++|+ |||||.+++. ........ ..-+.|.||||. |+|.+++..+..  .+|++.++.+|++|+++|+.+||.. .
T Consensus        88 MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~-~  164 (738)
T KOG1989|consen   88 MKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYL-K  164 (738)
T ss_pred             HHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcC-C
Confidence            56776 9999999994 33222222 345779999999 799999986543  4599999999999999999999965 8


Q ss_pred             --ccccCCCCCcEEEeCCCCcEEEeecCCccccccCCCc----------ccccccccccCCcccc--CCCCCCchhHhhh
Q 022799           77 --VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN----------ISYICSRYYRAPELIF--GATEYTAAIDIWS  142 (292)
Q Consensus        77 --i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~----------~~~~gt~~y~aPE~~~--~~~~~~~~~Dvws  142 (292)
                        |||||||-+||||+.++ ..||||||.|.........          .....|+.|+|||++.  +....++|+|||+
T Consensus       165 pPiIHRDLKiENvLls~~g-~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWA  243 (738)
T KOG1989|consen  165 PPIIHRDLKIENVLLSADG-NYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWA  243 (738)
T ss_pred             CccchhhhhhhheEEcCCC-CEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHH
Confidence              99999999999999998 7999999998654322211          1234599999999973  3345899999999


Q ss_pred             hhHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhc
Q 022799          143 AGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQ  222 (292)
Q Consensus       143 lG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  222 (292)
                      |||+||-|+....||.......++.                     ..+.+|..          +.++..+++||+.||+
T Consensus       244 LGclLYkLCy~t~PFe~sg~laIln---------------------g~Y~~P~~----------p~ys~~l~~LI~~mL~  292 (738)
T KOG1989|consen  244 LGCLLYKLCYFTTPFEESGKLAILN---------------------GNYSFPPF----------PNYSDRLKDLIRTMLQ  292 (738)
T ss_pred             HHHHHHHHHHhCCCcCcCcceeEEe---------------------ccccCCCC----------ccHHHHHHHHHHHHhc
Confidence            9999999999999997664332221                     11222221          4689999999999999


Q ss_pred             cCCCCcccHHHHhc
Q 022799          223 YSPNLRSTALEALI  236 (292)
Q Consensus       223 ~dp~~R~t~~e~l~  236 (292)
                      .||.+||++.+++.
T Consensus       293 ~nP~~RPnI~Qv~~  306 (738)
T KOG1989|consen  293 PNPDERPNIYQVLE  306 (738)
T ss_pred             cCcccCCCHHHHHH
Confidence            99999999998874

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.3e-36  Score=257.72  Aligned_cols=218  Identities=25%  Similarity=0.433  Sum_probs=163.2

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||++++++|...   +...+++||||++ ++|.+++.........+++..+..++.||+.||.|||+. |++|
T Consensus        53 l~~l~h~~iv~~~~~~~~~---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~-~i~H  128 (287)
T cd06621          53 NKSCKSPYIVKYYGAFLDE---SSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR-KIIH  128 (287)
T ss_pred             HHhCCCCCeeeeeeEEEcc---CCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-Cccc
Confidence            4678999999999988442   2335789999998 688888765544456789999999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      +||+|+||+++.++ .++|+|||++....... .....++..|+|||.+.+. .++.++|+||+||++|+|++|..||..
T Consensus       129 ~dl~~~nil~~~~~-~~~l~dfg~~~~~~~~~-~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~  205 (287)
T cd06621         129 RDIKPSNILLTRKG-QVKLCDFGVSGELVNSL-AGTFTGTSFYMAPERIQGK-PYSITSDVWSLGLTLLEVAQNRFPFPP  205 (287)
T ss_pred             CCCCHHHEEEecCC-eEEEeeccccccccccc-cccccCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCc
Confidence            99999999999887 79999999987653322 1234568889999998654 589999999999999999999999976


Q ss_pred             CCc--HHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          160 ESG--VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       160 ~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      ...  .... .............            .+....      .....++.+.++|.+||..||++|||+.|++.|
T Consensus       206 ~~~~~~~~~-~~~~~~~~~~~~~------------~~~~~~------~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~  266 (287)
T cd06621         206 EGEPPLGPI-ELLSYIVNMPNPE------------LKDEPG------NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH  266 (287)
T ss_pred             ccCCCCChH-HHHHHHhcCCchh------------hccCCC------CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence            522  0001 1111111100000            000000      001346789999999999999999999999999


Q ss_pred             CCccccC
Q 022799          238 PFFDELR  244 (292)
Q Consensus       238 p~~~~~~  244 (292)
                      |||+...
T Consensus       267 ~~~~~~~  273 (287)
T cd06621         267 PWIKAQM  273 (287)
T ss_pred             ccccccc
Confidence            9997643

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-39  Score=255.67  Aligned_cols=237  Identities=37%  Similarity=0.612  Sum_probs=187.9

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccC
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRD   81 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~d   81 (292)
                      ..++|.|++..+++...+.-.--.-+|+++|.+..+|.+++-.    ...++.+.++.+++||+.||+|||+. ||.|||
T Consensus       107 cfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQSDLHKIIVS----PQ~Ls~DHvKVFlYQILRGLKYLHsA-~ILHRD  181 (449)
T KOG0664|consen  107 SSFRHDNVLSLLDILQPANPSFFQELYVLTELMQSDLHKIIVS----PQALTPDHVKVFVYQILRGLKYLHTA-NILHRD  181 (449)
T ss_pred             HhhccccHHHHHHhcCCCCchHHHHHHHHHHHHHhhhhheecc----CCCCCcchhhhhHHHHHhhhHHHhhc-chhhcc
Confidence            3468999999988764322111112678999999999888865    46789999999999999999999987 999999


Q ss_pred             CCCCcEEEeCCCCcEEEeecCCccccccCCCc--ccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           82 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        82 lkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      |||.|+|++++. .+||||||+++....++..  +..+.|.+|+|||++.|.+.|+.+.||||+|||+.|++.++..|..
T Consensus       182 IKPGNLLVNSNC-vLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQA  260 (449)
T KOG0664|consen  182 IKPGNLLVNSNC-ILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQA  260 (449)
T ss_pred             CCCccEEeccCc-eEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhc
Confidence            999999999988 7999999999876544332  2345689999999999999999999999999999999999999999


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc-ccCCCCCCCCchhhh----ccCCChhHHHHHHHHhccCCCCcccHHHH
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTE-FKFPQIKAHPWHKIF----QKRMPPEAVDLVSRLLQYSPNLRSTALEA  234 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~dp~~R~t~~e~  234 (292)
                      .++.+++..|.+.+|+|+.+.++.-.+.... +.....+..++...+    +..-..+..+++.++|..||++|++.+++
T Consensus       261 q~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A  340 (449)
T KOG0664|consen  261 AGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEA  340 (449)
T ss_pred             cChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhh
Confidence            9999999999999999999987654333221 111122222221111    12334578899999999999999999999


Q ss_pred             hcCCCccccC
Q 022799          235 LIHPFFDELR  244 (292)
Q Consensus       235 l~hp~~~~~~  244 (292)
                      +.|++..+.+
T Consensus       341 ~~~~~~~e~R  350 (449)
T KOG0664|consen  341 LQHRYLEEGR  350 (449)
T ss_pred             cccccccccc
Confidence            9999987654

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=6.9e-37  Score=262.25  Aligned_cols=206  Identities=29%  Similarity=0.500  Sum_probs=164.2

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++.     .....++||||++ ++|...+..     ..+++..+..++.|++.||.|||++ |++|
T Consensus        72 l~~l~hp~i~~~~~~~~-----~~~~~~iv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~-~ivH  140 (297)
T cd06659          72 MRDYQHQNVVEMYKSYL-----VGEELWVLMEFLQGGALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQ-GVIH  140 (297)
T ss_pred             HHhCCCCchhhhhhhee-----eCCeEEEEEecCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC-Ceec
Confidence            35689999999999883     3445899999998 577776542     5688999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCC-cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      |||+|+||+++.++ .++|+|||++........ .....++..|+|||.+.+. .++.++|+||+||++|+|++|..||.
T Consensus       141 ~dl~p~Nill~~~~-~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~  218 (297)
T cd06659         141 RDIKSDSILLTLDG-RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRT-PYGTEVDIWSLGIMVIEMVDGEPPYF  218 (297)
T ss_pred             CCCCHHHeEEccCC-cEEEeechhHhhcccccccccceecCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            99999999999888 799999999875533221 2335688999999999654 48999999999999999999999998


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCC
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  238 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp  238 (292)
                      .......+..+...   +..           ..            .....++..+.++|.+||+.+|.+||+++++++||
T Consensus       219 ~~~~~~~~~~~~~~---~~~-----------~~------------~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~  272 (297)
T cd06659         219 SDSPVQAMKRLRDS---PPP-----------KL------------KNAHKISPVLRDFLERMLTREPQERATAQELLDHP  272 (297)
T ss_pred             CCCHHHHHHHHhcc---CCC-----------Cc------------cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhCh
Confidence            76655544332210   000           00            01135788999999999999999999999999999


Q ss_pred             CccccCC
Q 022799          239 FFDELRD  245 (292)
Q Consensus       239 ~~~~~~~  245 (292)
                      ||.....
T Consensus       273 ~~~~~~~  279 (297)
T cd06659         273 FLLQTGL  279 (297)
T ss_pred             hhccCCC
Confidence            9987543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.6e-36  Score=256.03  Aligned_cols=205  Identities=27%  Similarity=0.484  Sum_probs=157.6

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCC--CHHHHHHHHHHHHHHHHHHHhcCCc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRM--PLIYVKLYFYQICRALAYIHNTIGV   77 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~--~~~~~~~~~~qil~al~~LH~~~~i   77 (292)
                      |+.++||||+++++++     ......++|+||++ ++|.+.+....   ..+  ++..+..++.||+.||.|||++ ||
T Consensus        59 l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~-~i  129 (268)
T cd06624          59 HSYLKHRNIVQYLGSD-----SENGFFKIFMEQVPGGSLSALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHDN-QI  129 (268)
T ss_pred             HHhcCCCCeeeeeeee-----ccCCEEEEEEecCCCCCHHHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHHC-CE
Confidence            3568999999999988     44456899999998 69988887531   234  7888899999999999999988 99


Q ss_pred             cccCCCCCcEEEeCCCCcEEEeecCCccccccCCC-cccccccccccCCccccCC-CCCCchhHhhhhhHHHHHHHhCCC
Q 022799           78 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLLGQP  155 (292)
Q Consensus        78 ~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~  155 (292)
                      +||||||+||+++.+...++|+|||.+........ .....+++.|+|||.+.+. ..++.++|+||+|+++|+|++|..
T Consensus       130 ~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~  209 (268)
T cd06624         130 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKP  209 (268)
T ss_pred             eecCCCHHHEEEcCCCCeEEEecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCC
Confidence            99999999999987444799999999876533222 2234578899999998543 347899999999999999999999


Q ss_pred             CCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHh
Q 022799          156 LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL  235 (292)
Q Consensus       156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l  235 (292)
                      ||.................                          ....++..+++++.+++.+||..+|++|||+.+++
T Consensus       210 p~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll  263 (268)
T cd06624         210 PFIELGEPQAAMFKVGMFK--------------------------IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLL  263 (268)
T ss_pred             CCccccChhhhHhhhhhhc--------------------------cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHH
Confidence            9965432111110000000                          00112345788999999999999999999999999


Q ss_pred             cCCCc
Q 022799          236 IHPFF  240 (292)
Q Consensus       236 ~hp~~  240 (292)
                      .||||
T Consensus       264 ~~~~~  268 (268)
T cd06624         264 QDPFL  268 (268)
T ss_pred             hCCCC
Confidence            99997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.2e-36  Score=259.32  Aligned_cols=206  Identities=29%  Similarity=0.504  Sum_probs=164.9

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++..     ..+.++|+||+. ++|.+++..     .++++..+..++.|++.||.|||++ |++|
T Consensus        70 l~~~~h~~vv~~~~~~~~-----~~~~~~v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~-~i~H  138 (285)
T cd06648          70 MRDYQHPNIVEMYSSYLV-----GDELWVVMEFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ-GVIH  138 (285)
T ss_pred             HHHcCCCChheEEEEEEc-----CCeEEEEEeccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC-Ceec
Confidence            356789999999998843     345899999997 688887764     4688999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCC-CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      |||+|+||+++.++ .++|+|||.+....... ......|++.|+|||.+.+. .++.++|+||+||++|+|++|..||.
T Consensus       139 ~dl~p~Nil~~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGv~l~ell~g~~p~~  216 (285)
T cd06648         139 RDIKSDSILLTSDG-RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMVDGEPPYF  216 (285)
T ss_pred             CCCChhhEEEcCCC-cEEEcccccchhhccCCcccccccCCccccCHHHhcCC-CCCCcccHHHHHHHHHHHHhCCCCCc
Confidence            99999999999887 79999999876543322 12234688999999998664 48999999999999999999999998


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCC
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  238 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp  238 (292)
                      +.+.......+... ..+.                  .       ..+..++..+.++|.+||..+|++|||+.++++||
T Consensus       217 ~~~~~~~~~~~~~~-~~~~------------------~-------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~  270 (285)
T cd06648         217 NEPPLQAMKRIRDN-LPPK------------------L-------KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHP  270 (285)
T ss_pred             CCCHHHHHHHHHhc-CCCC------------------C-------cccccCCHHHHHHHHHHcccChhhCcCHHHHccCc
Confidence            76655444433321 0000                  0       00123788999999999999999999999999999


Q ss_pred             CccccCC
Q 022799          239 FFDELRD  245 (292)
Q Consensus       239 ~~~~~~~  245 (292)
                      ||+...+
T Consensus       271 ~~~~~~~  277 (285)
T cd06648         271 FLAKAGP  277 (285)
T ss_pred             ccccCCC
Confidence            9998664

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=6.7e-37  Score=257.30  Aligned_cols=205  Identities=34%  Similarity=0.601  Sum_probs=164.8

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++     .+....|+||||+. ++|.+++...    ..+++..+..++.||+.||.|||+. |++|
T Consensus        47 l~~~~h~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~-~i~H  116 (265)
T cd05579          47 LSQAQSPYVVKLYYSF-----QGKKNLYLVMEYLPGGDLASLLENV----GSLDEDVARIYIAEIVLALEYLHSN-GIIH  116 (265)
T ss_pred             HHhCCCcchhHHHHhe-----ecCcEEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHc-Ceec
Confidence            3567899999999988     44556899999998 5998888753    4789999999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCC---------CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHH
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE---------PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAEL  150 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el  150 (292)
                      +||+|+||+++.++ .++|+|||++.......         ......++..|+|||...+.. ++.++|+||+|+++|++
T Consensus       117 ~di~~~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~~~l  194 (265)
T cd05579         117 RDLKPDNILIDSNG-HLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEF  194 (265)
T ss_pred             CCCCHHHeEEcCCC-CEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCC-CCcchhhHHHHHHHHHH
Confidence            99999999999988 79999999987643321         112345678899999986654 88999999999999999


Q ss_pred             HhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCccc
Q 022799          151 LLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST  230 (292)
Q Consensus       151 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t  230 (292)
                      ++|..||...........+...  .               ...+.        .  ..++..+.++|.+||+.+|.+|||
T Consensus       195 ~~g~~p~~~~~~~~~~~~~~~~--~---------------~~~~~--------~--~~~~~~~~~~i~~~l~~~p~~Rpt  247 (265)
T cd05579         195 LVGIPPFHGETPEEIFQNILNG--K---------------IEWPE--------D--VEVSDEAIDLISKLLVPDPEKRLG  247 (265)
T ss_pred             HhCCCCCCCCCHHHHHHHHhcC--C---------------cCCCc--------c--ccCCHHHHHHHHHHhcCCHhhcCC
Confidence            9999999877655444333220  0               00000        0  124889999999999999999999


Q ss_pred             H---HHHhcCCCccccC
Q 022799          231 A---LEALIHPFFDELR  244 (292)
Q Consensus       231 ~---~e~l~hp~~~~~~  244 (292)
                      +   .++++||||+++.
T Consensus       248 ~~~~~~~l~~~~~~~~~  264 (265)
T cd05579         248 AKSIEEIKNHPFFKGID  264 (265)
T ss_pred             CccHHHHhcCccccCCC
Confidence            9   9999999999765

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.4e-36  Score=261.50  Aligned_cols=203  Identities=28%  Similarity=0.456  Sum_probs=162.8

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      |+.++||||+++++++..     ....++||||+.|++.+++...   ...+++..+..++.|++.||.|||+. |++||
T Consensus        69 l~~l~h~niv~~~~~~~~-----~~~~~lv~e~~~g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~~-~i~H~  139 (307)
T cd06607          69 LQQLRHPNTIEYKGCYLR-----EHTAWLVMEYCLGSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSH-ERIHR  139 (307)
T ss_pred             HHhCCCCCEEEEEEEEEe-----CCeEEEEHHhhCCCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHHC-Cceec
Confidence            356899999999999843     3348899999999988877643   35689999999999999999999987 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccC--CCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG--ATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      ||+|+||+++.++ .++|+|||++......   ....+++.|+|||.+.+  ...++.++|+||+|+++|+|++|..||.
T Consensus       140 dl~p~nIl~~~~~-~~kL~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~  215 (307)
T cd06607         140 DIKAGNILLTEPG-TVKLADFGSASLVSPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF  215 (307)
T ss_pred             CCCcccEEECCCC-CEEEeecCcceecCCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCC
Confidence            9999999999888 7999999998754322   34567889999998742  3447889999999999999999999998


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCC
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  238 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp  238 (292)
                      +.+.......+...  .+                 +..        .+..++..+.++|.+||..||++||++.+++.||
T Consensus       216 ~~~~~~~~~~~~~~--~~-----------------~~~--------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  268 (307)
T cd06607         216 NMNAMSALYHIAQN--DS-----------------PTL--------SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR  268 (307)
T ss_pred             CccHHHHHHHHhcC--CC-----------------CCC--------CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence            76654443332210  00                 000        0123678899999999999999999999999999


Q ss_pred             Ccccc
Q 022799          239 FFDEL  243 (292)
Q Consensus       239 ~~~~~  243 (292)
                      ||..-
T Consensus       269 ~~~~~  273 (307)
T cd06607         269 FVLRE  273 (307)
T ss_pred             hhccc
Confidence            99863

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.7e-36  Score=254.08  Aligned_cols=202  Identities=28%  Similarity=0.455  Sum_probs=163.8

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      ++.++||||+++++++     .+..+.++||||+. ++|.+.+....  ...+++..+..++.|++.|+.|||++ |++|
T Consensus        53 l~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h  124 (256)
T cd08218          53 LSNMKHPNIVQYQESF-----EENGNLYIVMDYCEGGDLYKKINAQR--GVLFPEDQILDWFVQICLALKHVHDR-KILH  124 (256)
T ss_pred             HHhCCCCCeeeeEeee-----cCCCeEEEEEecCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC-CEec
Confidence            4678999999999998     44556899999998 68888776421  24578999999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCC-cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      +||+|+||+++.++ .++|+|||.+........ .....|++.|+|||.+.+. .++.++|+||+||++++|++|..||.
T Consensus       125 ~~l~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~  202 (256)
T cd08218         125 RDIKSQNIFLTKDG-TIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENR-PYNNKSDIWALGCVLYEMCTLKHAFE  202 (256)
T ss_pred             CCCCHHHEEEcCCC-CEEEeeccceeecCcchhhhhhccCCccccCHHHhCCC-CCCCccchhHHHHHHHHHHcCCCCcc
Confidence            99999999999887 799999999876533221 1234578889999998665 47889999999999999999999998


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCC
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  238 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp  238 (292)
                      ..+..+....+.....                            ...+..++.++.++|.+||..+|.+||++.++++||
T Consensus       203 ~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~  254 (256)
T cd08218         203 AGNMKNLVLKIIRGSY----------------------------PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKN  254 (256)
T ss_pred             CCCHHHHHHHHhcCCC----------------------------CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCc
Confidence            7665555444432100                            001245788999999999999999999999999999


Q ss_pred             Cc
Q 022799          239 FF  240 (292)
Q Consensus       239 ~~  240 (292)
                      ||
T Consensus       255 ~~  256 (256)
T cd08218         255 FI  256 (256)
T ss_pred             CC
Confidence            97

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=2.8e-36  Score=260.36  Aligned_cols=203  Identities=29%  Similarity=0.475  Sum_probs=164.2

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      |+.++||||+++++++.     +....|+||||+.|++.+.+...   ...+++..+..++.||+.||.|||++ |++|+
T Consensus        75 l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~~~~~l~~~l~~~---~~~l~~~~~~~~~~qi~~al~~LH~~-gi~H~  145 (313)
T cd06633          75 LQQLKHPNTIEYKGCYL-----KEHTAWLVMEYCLGSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH-NMIHR  145 (313)
T ss_pred             HHhCCCCCCccEEEEEE-----eCCEEEEEEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecC
Confidence            35789999999999984     34458999999999988877643   35689999999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccC--CCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG--ATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      ||+|+||+++.++ .++|+|||++....   ......|+..|+|||.+.+  ...++.++|+||+||++|+|++|..||.
T Consensus       146 dl~p~nili~~~~-~~kL~dfg~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~  221 (313)
T cd06633         146 DIKAGNILLTEPG-QVKLADFGSASKSS---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF  221 (313)
T ss_pred             CCChhhEEECCCC-CEEEeecCCCcccC---CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            9999999999887 79999999886432   2234568889999999842  2347889999999999999999999998


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCC
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  238 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp  238 (292)
                      +.+.......+... ..+                  .        .....++..+++||.+||+.+|.+||++.++++||
T Consensus       222 ~~~~~~~~~~~~~~-~~~------------------~--------~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~  274 (313)
T cd06633         222 NMNAMSALYHIAQN-DSP------------------T--------LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHD  274 (313)
T ss_pred             CCChHHHHHHHHhc-CCC------------------C--------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence            77665555444321 000                  0        00134677899999999999999999999999999


Q ss_pred             Ccccc
Q 022799          239 FFDEL  243 (292)
Q Consensus       239 ~~~~~  243 (292)
                      ||+..
T Consensus       275 ~~~~~  279 (313)
T cd06633         275 FVRRD  279 (313)
T ss_pred             ccCCC
Confidence            99863

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=6.6e-37  Score=257.77  Aligned_cols=206  Identities=30%  Similarity=0.582  Sum_probs=161.9

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN-TIGVCH   79 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~-~~~i~H   79 (292)
                      +.++||||+++++++.     .....++++||++ ++|.+++...   ...+++..+..++.|++.||.|||+ . |++|
T Consensus        54 ~~~~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~-~i~H  124 (265)
T cd06605          54 HKCNSPYIVGFYGAFY-----NNGDISICMEYMDGGSLDKILKEV---QGRIPERILGKIAVAVLKGLTYLHEKH-KIIH  124 (265)
T ss_pred             HHCCCCchhhhheeee-----cCCEEEEEEEecCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHcCCC-Ceec
Confidence            5678999999999883     3456999999999 6998888753   2678999999999999999999998 6 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      +||||+||+++.++ .++|+|||.+......... ...++..|+|||.+.+. .++.++|+||+||++|+|++|..||..
T Consensus       125 ~dl~~~ni~~~~~~-~~~l~d~g~~~~~~~~~~~-~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~  201 (265)
T cd06605         125 RDVKPSNILVNSRG-QIKLCDFGVSGQLVNSLAK-TFVGTSSYMAPERIQGN-DYSVKSDIWSLGLSLIELATGRFPYPP  201 (265)
T ss_pred             CCCCHHHEEECCCC-CEEEeecccchhhHHHHhh-cccCChhccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCc
Confidence            99999999999877 7999999998765332222 26678899999998665 589999999999999999999999965


Q ss_pred             CCc-HHHHHHHHHH-hCCCCHHHHhhcCCCCccccCCCCCCCCchhhhcc-CCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          160 ESG-VDQLVEIIKV-LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQK-RMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       160 ~~~-~~~~~~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      ... ........+. ...+.                +         .++. .+++++.++|.+||..||.+|||+.+++.
T Consensus       202 ~~~~~~~~~~~~~~~~~~~~----------------~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         202 ENDPPDGIFELLQYIVNEPP----------------P---------RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             cccccccHHHHHHHHhcCCC----------------C---------CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            421 1111111111 11000                0         0011 27889999999999999999999999999


Q ss_pred             CCCccccC
Q 022799          237 HPFFDELR  244 (292)
Q Consensus       237 hp~~~~~~  244 (292)
                      ||||+.+.
T Consensus       257 ~~~~~~~~  264 (265)
T cd06605         257 HPFIKKYE  264 (265)
T ss_pred             Cchhhccc
Confidence            99998753

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.9e-36  Score=257.51  Aligned_cols=201  Identities=22%  Similarity=0.296  Sum_probs=159.4

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhc------------CCCCCHHHHHHHHHHHHHH
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKM------------SQRMPLIYVKLYFYQICRA   67 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~------------~~~~~~~~~~~~~~qil~a   67 (292)
                      |+.++||||+++++++     .+....+++|||++ ++|.+++......            ...+++..+..++.|++.|
T Consensus        62 l~~l~h~~i~~~~~~~-----~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~a  136 (283)
T cd05048          62 MSDLQHPNIVCLLGVC-----TKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAG  136 (283)
T ss_pred             HHhcCCcccceEEEEE-----cCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHH
Confidence            3568999999999988     33445889999998 6999888753211            1457889999999999999


Q ss_pred             HHHHHhcCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCCC---cccccccccccCCccccCCCCCCchhHhhhhh
Q 022799           68 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAG  144 (292)
Q Consensus        68 l~~LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG  144 (292)
                      |.|||++ |++||||||+||+++.++ .++|+|||++........   .....+++.|+|||.+.+. .++.++|+||+|
T Consensus       137 l~~lH~~-~i~H~dlkp~Nil~~~~~-~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~slG  213 (283)
T cd05048         137 MEYLSSH-HFVHRDLAARNCLVGEGL-TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG-KFTTESDIWSFG  213 (283)
T ss_pred             HHHHHhC-CeeccccccceEEEcCCC-cEEECCCcceeeccccccccccCCCcccccccCHHHhccC-cCchhhhHHHHH
Confidence            9999988 999999999999999887 799999999876533221   2233567889999998654 489999999999


Q ss_pred             HHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhcc
Q 022799          145 CVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQY  223 (292)
Q Consensus       145 ~il~el~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  223 (292)
                      |++|||++ |..||.+....+....+.....                   +         ..+..+++++.+|+.+||..
T Consensus       214 ~il~el~~~g~~p~~~~~~~~~~~~i~~~~~-------------------~---------~~~~~~~~~~~~l~~~c~~~  265 (283)
T cd05048         214 VVLWEIFSYGLQPYYGFSNQEVIEMIRSRQL-------------------L---------PCPEDCPARVYALMIECWNE  265 (283)
T ss_pred             HHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc-------------------C---------CCcccCCHHHHHHHHHHccC
Confidence            99999998 9999988766554443332100                   0         01246889999999999999


Q ss_pred             CCCCcccHHHHhcC
Q 022799          224 SPNLRSTALEALIH  237 (292)
Q Consensus       224 dp~~R~t~~e~l~h  237 (292)
                      ||.+||++.+++++
T Consensus       266 ~p~~Rp~~~~i~~~  279 (283)
T cd05048         266 IPARRPRFKDIHTR  279 (283)
T ss_pred             ChhhCcCHHHHHHH
Confidence            99999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.7e-36  Score=259.39  Aligned_cols=206  Identities=19%  Similarity=0.269  Sum_probs=155.4

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhc---------------CCCCCHHHHHHHHHHH
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKM---------------SQRMPLIYVKLYFYQI   64 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~---------------~~~~~~~~~~~~~~qi   64 (292)
                      |+.++||||+++++++..     ....++||||+. |+|.+++......               ...+++..+..++.||
T Consensus        73 l~~l~h~niv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i  147 (304)
T cd05096          73 LSRLKDPNIIRLLGVCVD-----EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQI  147 (304)
T ss_pred             HhhcCCCCeeEEEEEEec-----CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHH
Confidence            467899999999999843     334899999998 6999888653211               1246778899999999


Q ss_pred             HHHHHHHHhcCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCCC---cccccccccccCCccccCCCCCCchhHhh
Q 022799           65 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIW  141 (292)
Q Consensus        65 l~al~~LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Dvw  141 (292)
                      +.||.|||++ ||+||||||+||+++.++ .+||+|||+++.......   .....++..|+|||.+.+. .++.++|+|
T Consensus       148 ~~al~~lH~~-~ivH~dlkp~Nill~~~~-~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~  224 (304)
T cd05096         148 ASGMKYLSSL-NFVHRDLATRNCLVGENL-TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG-KFTTASDVW  224 (304)
T ss_pred             HHHHHHHHHC-CccccCcchhheEEcCCc-cEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC-CCCchhhhH
Confidence            9999999988 999999999999999887 799999999976533321   1123447789999998654 489999999


Q ss_pred             hhhHHHHHHHh--CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHH
Q 022799          142 SAGCVLAELLL--GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSR  219 (292)
Q Consensus       142 slG~il~el~~--g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  219 (292)
                      |+||++|+|++  +..||.+.+..+....+..........           .          ....++.+++.+.++|.+
T Consensus       225 slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-----------~----------~~~~~~~~~~~~~~li~~  283 (304)
T cd05096         225 AFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQ-----------V----------YLFRPPPCPQGLYELMLQ  283 (304)
T ss_pred             HHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhcccc-----------c----------cccCCCCCCHHHHHHHHH
Confidence            99999999986  567887766555444433221100000           0          000124578899999999


Q ss_pred             HhccCCCCcccHHHHh
Q 022799          220 LLQYSPNLRSTALEAL  235 (292)
Q Consensus       220 ~l~~dp~~R~t~~e~l  235 (292)
                      ||..||++|||+.++.
T Consensus       284 cl~~~p~~RPs~~~i~  299 (304)
T cd05096         284 CWSRDCRERPSFSDIH  299 (304)
T ss_pred             HccCCchhCcCHHHHH
Confidence            9999999999999995

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=7.3e-37  Score=259.42  Aligned_cols=203  Identities=26%  Similarity=0.410  Sum_probs=162.1

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++     .+....++||||++ ++|.+++.     ...+++..++.++.|++.|+.|||++ |++|
T Consensus        56 l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~-~ivH  124 (277)
T cd06642          56 LSQCDSPYITRYYGSY-----LKGTKLWIIMEYLGGGSALDLLK-----PGPLEETYIATILREILKGLDYLHSE-RKIH  124 (277)
T ss_pred             HHcCCCCccHhhhccc-----ccCCceEEEEEccCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhcC-Ceec
Confidence            3578999999999998     44445899999999 58877765     25688999999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCC-cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      +||+|+||+++.++ .++|+|||++........ .....++..|+|||.+.+. .++.++|+||+||++|+|++|..||.
T Consensus       125 ~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~  202 (277)
T cd06642         125 RDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS-AYDFKADIWSLGITAIELAKGEPPNS  202 (277)
T ss_pred             cCCChheEEEeCCC-CEEEccccccccccCcchhhhcccCcccccCHHHhCcC-CCchhhhHHHHHHHHHHHHhCCCCCc
Confidence            99999999999887 799999999876543321 1234578889999998654 48999999999999999999999987


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCC
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  238 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp  238 (292)
                      ..........+...                   .         ...+...++.++.++|.+||..+|++|||+.++++||
T Consensus       203 ~~~~~~~~~~~~~~-------------------~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  254 (277)
T cd06642         203 DLHPMRVLFLIPKN-------------------S---------PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHK  254 (277)
T ss_pred             ccchhhHHhhhhcC-------------------C---------CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhH
Confidence            55443322211100                   0         0001234678999999999999999999999999999


Q ss_pred             CccccC
Q 022799          239 FFDELR  244 (292)
Q Consensus       239 ~~~~~~  244 (292)
                      ||....
T Consensus       255 ~~~~~~  260 (277)
T cd06642         255 FITRYT  260 (277)
T ss_pred             HHHHHh
Confidence            998754

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.6e-36  Score=255.23  Aligned_cols=206  Identities=32%  Similarity=0.543  Sum_probs=160.7

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++     .....+++||||+. ++|.+.+...    ..+++..++.++.||+.||.|||++ |++|
T Consensus        62 l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H  131 (272)
T cd06629          62 LKDLDHLNIVQYLGFE-----TTEEYLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSK-GILH  131 (272)
T ss_pred             HHhcCCCCcceEEEEe-----ccCCceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhC-Ceee
Confidence            4578999999999988     33445899999998 6888888653    5789999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCC---CcccccccccccCCccccCCC-CCCchhHhhhhhHHHHHHHhCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGAT-EYTAAIDIWSAGCVLAELLLGQP  155 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwslG~il~el~~g~~  155 (292)
                      |||+|+||+++.++ .++|+|||.+.......   ......++..|+|||.+.+.. .++.++|+||+|+++|++++|..
T Consensus       132 ~dl~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~  210 (272)
T cd06629         132 RDLKADNLLVDADG-ICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR  210 (272)
T ss_pred             cCCChhhEEEcCCC-eEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCC
Confidence            99999999999887 79999999987643221   122345788999999986543 47899999999999999999999


Q ss_pred             CCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHh
Q 022799          156 LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL  235 (292)
Q Consensus       156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l  235 (292)
                      ||...........+......                       ..........++..+.++|.+||..+|.+|||+++++
T Consensus       211 p~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il  267 (272)
T cd06629         211 PWSDEEAIAAMFKLGNKRSA-----------------------PPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELL  267 (272)
T ss_pred             CCcCcchHHHHHHhhccccC-----------------------CcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHh
Confidence            99655443322221110000                       0000111135789999999999999999999999999


Q ss_pred             cCCCc
Q 022799          236 IHPFF  240 (292)
Q Consensus       236 ~hp~~  240 (292)
                      +||||
T Consensus       268 ~~~~~  272 (272)
T cd06629         268 QHPFI  272 (272)
T ss_pred             hCCCC
Confidence            99997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=2e-36  Score=256.78  Aligned_cols=203  Identities=25%  Similarity=0.410  Sum_probs=162.9

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.+.||||+++++++     .+..+.++||||++ ++|.+++..     .++++..+..++.|++.||.|||+. +++|
T Consensus        56 l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~-~ivH  124 (277)
T cd06640          56 LSQCDSPYVTKYYGSY-----LKGTKLWIIMEYLGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSE-KKIH  124 (277)
T ss_pred             HHhCCCCCEeeEEEEE-----EECCEEEEEEecCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC-CccC
Confidence            3568999999999998     44456999999998 588887753     4688899999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCC-cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      +||+|+||+++.++ .++|+|||++........ .....++..|+|||.+.+. .++.++|+||+||++|+|++|..||.
T Consensus       125 ~dl~p~Nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~  202 (277)
T cd06640         125 RDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQS-AYDSKADIWSLGITAIELAKGEPPNS  202 (277)
T ss_pred             cCCChhhEEEcCCC-CEEEcccccceeccCCccccccccCcccccCHhHhccC-CCccHHHHHHHHHHHHHHHHCCCCCC
Confidence            99999999999887 799999999876643332 2234578889999998654 48999999999999999999999997


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCC
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  238 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp  238 (292)
                      +.........+..  +.+                          ..+...++..+.++|.+||..+|++||++.+++.||
T Consensus       203 ~~~~~~~~~~~~~--~~~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  254 (277)
T cd06640         203 DMHPMRVLFLIPK--NNP--------------------------PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHK  254 (277)
T ss_pred             CcChHhHhhhhhc--CCC--------------------------CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhCh
Confidence            6654433222110  000                          011234678899999999999999999999999999


Q ss_pred             CccccC
Q 022799          239 FFDELR  244 (292)
Q Consensus       239 ~~~~~~  244 (292)
                      ||....
T Consensus       255 ~~~~~~  260 (277)
T cd06640         255 FIVKNA  260 (277)
T ss_pred             Hhhhcc
Confidence            998654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.1e-36  Score=255.20  Aligned_cols=197  Identities=19%  Similarity=0.252  Sum_probs=155.2

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++.     .....++||||++ |+|.+++...   ...+++..++.++.||+.||+|||++ |++|
T Consensus        60 l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~-~iiH  130 (266)
T cd05064          60 LGQFDHSNIVRLEGVIT-----RGNTMMIVTEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEM-GYVH  130 (266)
T ss_pred             HhcCCCCCcCeEEEEEe-----cCCCcEEEEEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC-CEee
Confidence            45789999999999883     3345899999998 5888777643   35689999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcc--cccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI--SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPL  156 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~p  156 (292)
                      |||||+||+++.++ .++++|||.+..........  ...++..|+|||.+.+. .++.++|+||+||++|++++ |..|
T Consensus       131 ~dikp~nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~p  208 (266)
T cd05064         131 KGLAAHKVLVNSDL-VCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYH-HFSSASDVWSFGIVMWEVMSYGERP  208 (266)
T ss_pred             ccccHhhEEEcCCC-cEEECCCcccccccccchhcccCCCCceeecCHHHHhhC-CccchhHHHHHHHHHHHHhcCCCCC
Confidence            99999999999888 79999999876542221111  12346789999998654 48999999999999999775 9999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      |.+.+..+....+.+...                  .          ..+..++..+.+++.+||..+|.+|||++++++
T Consensus       209 ~~~~~~~~~~~~~~~~~~------------------~----------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         209 YWDMSGQDVIKAVEDGFR------------------L----------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             cCcCCHHHHHHHHHCCCC------------------C----------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence            987766554444322100                  0          012457889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=9.6e-37  Score=255.95  Aligned_cols=202  Identities=28%  Similarity=0.466  Sum_probs=163.5

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++     .+....++|+||+. ++|.+.+...    ..+++..+..++.||+.||.|||++ |++|
T Consensus        54 l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~-~i~h  123 (258)
T cd05578          54 LQELNHPFLVNLWYSF-----QDEENMYLVVDLLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSK-GIIH  123 (258)
T ss_pred             HHhCCCCChHHHHHhh-----cCCCeEEEEEeCCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhC-Ceec
Confidence            3578999999999988     44556999999998 5888887652    5789999999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      +||+|+||+++.++ .++|+|||.+.............++..|+|||.+.+.. ++.++|+||+|+++|+|++|..||..
T Consensus       124 ~dl~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~  201 (258)
T cd05578         124 RDIKPDNILLDEQG-HVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQG-YSVAVDWWSLGVTAYECLRGKRPYRG  201 (258)
T ss_pred             cCCCHHHeEEcCCC-CEEEeecccccccCCCccccccCCChhhcCHHHHcccC-CCCcccchhhHHHHHHHHhCCCCCCC
Confidence            99999999999988 79999999987765443344556788999999986544 89999999999999999999999987


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccH--HHHhcC
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA--LEALIH  237 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~--~e~l~h  237 (292)
                      .+... ...+.+.....                         ...++...+.++.++|.+||..||.+|+++  .++++|
T Consensus       202 ~~~~~-~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~  255 (258)
T cd05578         202 HSRTI-RDQIRAKQETA-------------------------DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNH  255 (258)
T ss_pred             CCccH-HHHHHHHhccc-------------------------cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcC
Confidence            65421 11111111000                         011224578999999999999999999999  999999


Q ss_pred             CCc
Q 022799          238 PFF  240 (292)
Q Consensus       238 p~~  240 (292)
                      |||
T Consensus       256 ~~~  258 (258)
T cd05578         256 PYF  258 (258)
T ss_pred             CCC
Confidence            998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2.4e-36  Score=258.25  Aligned_cols=206  Identities=30%  Similarity=0.491  Sum_probs=163.8

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++.     ...+.++||||++ ++|.+++..     ..+++..++.++.|++.||.|||++ |++|
T Consensus        71 l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~-givH  139 (292)
T cd06657          71 MRDYQHENVVEMYNSYL-----VGDELWVVMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQ-GVIH  139 (292)
T ss_pred             HHhcCCcchhheeeEEE-----eCCEEEEEEecCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-Ceec
Confidence            35689999999999984     3445899999998 577776542     4688999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCC-cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      +||+|+||+++.++ .++|+|||++........ .....+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||.
T Consensus       140 ~dl~p~Nilv~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~  217 (292)
T cd06657         140 RDIKSDSILLTHDG-RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYF  217 (292)
T ss_pred             CCCCHHHEEECCCC-CEEEcccccceecccccccccccccCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            99999999999887 799999998876533221 223467889999998854 447899999999999999999999998


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCC
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  238 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp  238 (292)
                      +....+....+.....  .         ..     .          ....+++.+.++|.+||..||.+||++.+++.||
T Consensus       218 ~~~~~~~~~~~~~~~~--~---------~~-----~----------~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~  271 (292)
T cd06657         218 NEPPLKAMKMIRDNLP--P---------KL-----K----------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHP  271 (292)
T ss_pred             CCCHHHHHHHHHhhCC--c---------cc-----C----------CcccCCHHHHHHHHHHHhCCcccCcCHHHHhcCh
Confidence            7665544433322110  0         00     0          0134688999999999999999999999999999


Q ss_pred             CccccCC
Q 022799          239 FFDELRD  245 (292)
Q Consensus       239 ~~~~~~~  245 (292)
                      ||.....
T Consensus       272 ~~~~~~~  278 (292)
T cd06657         272 FLAKAGP  278 (292)
T ss_pred             HHhccCC
Confidence            9997653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=4.2e-36  Score=253.09  Aligned_cols=203  Identities=28%  Similarity=0.465  Sum_probs=159.1

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++.+.   ....+++||||++ ++|.+++..    ...+++..+..++.|++.||.|||++ |++|
T Consensus        58 l~~l~h~~i~~~~~~~~~~---~~~~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~H  129 (265)
T cd06652          58 LKNLLHERIVQYYGCLRDP---MERTLSIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHSN-MIVH  129 (265)
T ss_pred             HHhcCCCCeeeEEeEeccC---CCceEEEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC-CEec
Confidence            3578999999999987432   2235789999998 688888764    35578899999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCC----CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE----PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQP  155 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~  155 (292)
                      +||+|+||+++.++ .++|+|||.+.......    ......++..|+|||.+.+. .++.++|+||+||++|+|++|+.
T Consensus       130 ~dl~p~nil~~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~  207 (265)
T cd06652         130 RDIKGANILRDSVG-NVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGE-GYGRKADIWSVGCTVVEMLTEKP  207 (265)
T ss_pred             CCCCHHHEEecCCC-CEEECcCccccccccccccccccccCCCCccccChhhhcCC-CCCcchhHHHHHHHHHHHhhCCC
Confidence            99999999999887 79999999987653211    12234578899999998664 48999999999999999999999


Q ss_pred             CCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHh
Q 022799          156 LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL  235 (292)
Q Consensus       156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l  235 (292)
                      ||.+........++.   ..+.                        ....+..++..+.++|.+|+. +|++||++++++
T Consensus       208 p~~~~~~~~~~~~~~---~~~~------------------------~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il  259 (265)
T cd06652         208 PWAEFEAMAAIFKIA---TQPT------------------------NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELL  259 (265)
T ss_pred             CCCccchHHHHHHHh---cCCC------------------------CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHh
Confidence            997654443332221   1110                        001224567889999999995 999999999999


Q ss_pred             cCCCcc
Q 022799          236 IHPFFD  241 (292)
Q Consensus       236 ~hp~~~  241 (292)
                      +|||+.
T Consensus       260 ~~~~~~  265 (265)
T cd06652         260 RHTFVH  265 (265)
T ss_pred             cCcccC
Confidence            999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=5.6e-36  Score=255.48  Aligned_cols=208  Identities=23%  Similarity=0.308  Sum_probs=161.1

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhc------CCCCCHHHHHHHHHHHHHHHHHHHh
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKM------SQRMPLIYVKLYFYQICRALAYIHN   73 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~------~~~~~~~~~~~~~~qil~al~~LH~   73 (292)
                      |+.++||||+++++++     .+....|+||||+. |+|.+++......      ....+...+..++.|++.||.|||+
T Consensus        63 l~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~  137 (288)
T cd05061          63 MKGFTCHHVVRLLGVV-----SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA  137 (288)
T ss_pred             HHhCCCCCeeeEEEEE-----cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            4578999999999988     33345899999998 7999998753211      1345677889999999999999998


Q ss_pred             cCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCCC---cccccccccccCCccccCCCCCCchhHhhhhhHHHHHH
Q 022799           74 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAEL  150 (292)
Q Consensus        74 ~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el  150 (292)
                      + ||+||||||+||+++.++ .++|+|||+++.......   .....++..|+|||.+.+. .++.++|+||+||++|+|
T Consensus       138 ~-~i~H~dikp~nili~~~~-~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~DvwslG~~l~el  214 (288)
T cd05061         138 K-KFVHRDLAARNCMVAHDF-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTSSDMWSFGVVLWEI  214 (288)
T ss_pred             C-CCcCCCCChheEEEcCCC-cEEECcCCccccccccccccccCCCcccccccCHHHhccC-CCChHhHHHHHHHHHHHH
Confidence            8 999999999999999887 799999999876533221   1122346679999998654 489999999999999999


Q ss_pred             Hh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcc
Q 022799          151 LL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS  229 (292)
Q Consensus       151 ~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~  229 (292)
                      ++ |..||.+....+....+... +.+                           .++...++.+.+++.+||+.||++||
T Consensus       215 ~~~~~~p~~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp  266 (288)
T cd05061         215 TSLAEQPYQGLSNEQVLKFVMDG-GYL---------------------------DQPDNCPERVTDLMRMCWQFNPKMRP  266 (288)
T ss_pred             HhCCCCCCCCCCHHHHHHHHHcC-CCC---------------------------CCCCCCCHHHHHHHHHHcCCChhHCc
Confidence            98 78899776554433332210 000                           01134678999999999999999999


Q ss_pred             cHHHHhc------CCCccccC
Q 022799          230 TALEALI------HPFFDELR  244 (292)
Q Consensus       230 t~~e~l~------hp~~~~~~  244 (292)
                      |+.++++      ||||+++.
T Consensus       267 s~~~ll~~l~~~~~~~~~~~~  287 (288)
T cd05061         267 TFLEIVNLLKDDLHPSFPEVS  287 (288)
T ss_pred             CHHHHHHHHHhhcCCCCCCCC
Confidence            9999986      99998875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-36  Score=267.35  Aligned_cols=218  Identities=29%  Similarity=0.519  Sum_probs=168.7

Q ss_pred             CCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccC
Q 022799            3 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRD   81 (292)
Q Consensus         3 ~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~d   81 (292)
                      .-+.+-||+||..|     +|...+|+||+|++ |++-.++.+    -+-+.|..+++|+.++.+|+++.|.. |+||||
T Consensus       685 EADn~WVVrLyySF-----QDkdnLYFVMdYIPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHkm-GFIHRD  754 (1034)
T KOG0608|consen  685 EADNEWVVRLYYSF-----QDKDNLYFVMDYIPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHKM-GFIHRD  754 (1034)
T ss_pred             hcCCcceEEEEEEe-----ccCCceEEEEeccCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHhc-cceecc
Confidence            44678899999999     66667999999999 688887765    37799999999999999999999976 999999


Q ss_pred             CCCCcEEEeCCCCcEEEeecCCcccc---------ccCC-----------------Cc-----------------ccccc
Q 022799           82 IKPQNLLVNPHTHQLKLCDFGSAKVL---------VKGE-----------------PN-----------------ISYIC  118 (292)
Q Consensus        82 lkp~Nill~~~~~~ikl~Dfg~a~~~---------~~~~-----------------~~-----------------~~~~g  118 (292)
                      |||+|||||.+| .|||+|||++.-+         .++.                 .+                 ...+|
T Consensus       755 iKPDNILIDrdG-HIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvg  833 (1034)
T KOG0608|consen  755 IKPDNILIDRDG-HIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVG  833 (1034)
T ss_pred             cCccceEEccCC-ceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcC
Confidence            999999999999 5999999997532         1100                 00                 13578


Q ss_pred             cccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCC
Q 022799          119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA  198 (292)
Q Consensus       119 t~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  198 (292)
                      |+.|+|||++.. ..|+..+|+||.|||||||+.|++||.++...+...+++.-         ..    +  ..++    
T Consensus       834 t~nyiapevl~r-~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw---------~~----~--l~~~----  893 (1034)
T KOG0608|consen  834 TPNYIAPEVLAR-TGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINW---------RN----F--LHIP----  893 (1034)
T ss_pred             CCcccChHHhcc-cCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeeh---------hh----c--cccc----
Confidence            999999999964 55999999999999999999999999887765544433320         00    0  0000    


Q ss_pred             CCchhhhccCCChhHHHHHHHHhccCCCCccc---HHHHhcCCCccccCCCCCCCCCCCCCCC
Q 022799          199 HPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST---ALEALIHPFFDELRDPNTRLPNGRFLPP  258 (292)
Q Consensus       199 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t---~~e~l~hp~~~~~~~~~~~~~~~~~~~~  258 (292)
                            .-.++|+++.++|.++.+ +++.|..   ++++.+||||+.+++..-+.....++|.
T Consensus       894 ------~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkgIDfsslRkq~ApYIP~  949 (1034)
T KOG0608|consen  894 ------YQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKGIDFSSLRKQRAPYIPR  949 (1034)
T ss_pred             ------cccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccccchHhhhhccCCcCcc
Confidence                  114789999999998655 8888874   7889999999999876544433334443

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.2e-36  Score=266.93  Aligned_cols=200  Identities=22%  Similarity=0.319  Sum_probs=154.5

Q ss_pred             CCC-CCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhh--------------------------------
Q 022799            2 RLL-DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYK--------------------------------   47 (292)
Q Consensus         2 ~~l-~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~--------------------------------   47 (292)
                      +.+ +|||||++++++     .+...+++|||||. |+|.+++.....                                
T Consensus        96 ~~l~~h~nIv~~~~~~-----~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (374)
T cd05106          96 SHLGQHKNIVNLLGAC-----THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSD  170 (374)
T ss_pred             HhhccCCceeeEeeEe-----cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhccccccc
Confidence            456 899999999998     44445899999998 799988864321                                


Q ss_pred             ----------------------------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEeCCC
Q 022799           48 ----------------------------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT   93 (292)
Q Consensus        48 ----------------------------------~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlkp~Nill~~~~   93 (292)
                                                        ...++++..+..++.||+.||.|||++ ||+||||||+||+++.++
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-giiHrDLkp~Nil~~~~~  249 (374)
T cd05106         171 SGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK-NCIHRDVAARNVLLTDGR  249 (374)
T ss_pred             ccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC-CEEeccCchheEEEeCCC
Confidence                                              013478889999999999999999988 999999999999999877


Q ss_pred             CcEEEeecCCccccccCCCc---ccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCCCCCCCCcHHHHHHH
Q 022799           94 HQLKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEI  169 (292)
Q Consensus        94 ~~ikl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~~~i  169 (292)
                       .++|+|||+++........   ....++..|+|||++.+. .++.++|+||+||++|+|++ |..||.+.........+
T Consensus       250 -~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~  327 (374)
T cd05106         250 -VAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKM  327 (374)
T ss_pred             -eEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHH
Confidence             7999999998765333211   122345679999998654 48999999999999999997 99999876544333333


Q ss_pred             HHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          170 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      ......+                           ..+...++++.++|.+||+.||.+|||+.++++
T Consensus       328 ~~~~~~~---------------------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         328 VKRGYQM---------------------------SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             HHcccCc---------------------------cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            3210000                           011346889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=4.1e-36  Score=256.35  Aligned_cols=200  Identities=22%  Similarity=0.291  Sum_probs=157.9

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhh---------cCCCCCHHHHHHHHHHHHHHHHH
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYK---------MSQRMPLIYVKLYFYQICRALAY   70 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~---------~~~~~~~~~~~~~~~qil~al~~   70 (292)
                      |++++||||+++++++     .+..++++||||++ ++|.+++.....         ....+++..+..++.|++.||+|
T Consensus        61 l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~  135 (288)
T cd05093          61 LTNLQHEHIVKFYGVC-----VEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVY  135 (288)
T ss_pred             HHhCCCCCcceEEEEE-----ecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHH
Confidence            4578999999999998     34445899999998 799888875421         12358999999999999999999


Q ss_pred             HHhcCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCCC---cccccccccccCCccccCCCCCCchhHhhhhhHHH
Q 022799           71 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVL  147 (292)
Q Consensus        71 LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il  147 (292)
                      ||++ |++||||||+||+++.++ .++|+|||.+........   .....++..|+|||.+.+. .++.++|+||+||++
T Consensus       136 lH~~-~i~H~dlkp~Nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il  212 (288)
T cd05093         136 LASQ-HFVHRDLATRNCLVGENL-LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVL  212 (288)
T ss_pred             HHhC-CeeecccCcceEEEccCC-cEEeccCCccccccCCceeecCCCCCccccccCHHHhccC-CCCchhhHHHHHHHH
Confidence            9987 999999999999999888 799999999976533221   1223346789999998654 589999999999999


Q ss_pred             HHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCC
Q 022799          148 AELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPN  226 (292)
Q Consensus       148 ~el~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~  226 (292)
                      |+|++ |..||.+....+....+....  ..                          ..+..+++++.+++.+||+.||.
T Consensus       213 ~~l~t~g~~p~~~~~~~~~~~~i~~~~--~~--------------------------~~~~~~~~~l~~li~~~l~~~p~  264 (288)
T cd05093         213 WEIFTYGKQPWYQLSNNEVIECITQGR--VL--------------------------QRPRTCPKEVYDLMLGCWQREPH  264 (288)
T ss_pred             HHHHhCCCCCCCCCCHHHHHHHHHcCC--cC--------------------------CCCCCCCHHHHHHHHHHccCChh
Confidence            99998 899998776655444433210  00                          01134788999999999999999


Q ss_pred             CcccHHHHhc
Q 022799          227 LRSTALEALI  236 (292)
Q Consensus       227 ~R~t~~e~l~  236 (292)
                      +|||+.+++.
T Consensus       265 ~Rpt~~~v~~  274 (288)
T cd05093         265 MRLNIKEIHS  274 (288)
T ss_pred             hCCCHHHHHH
Confidence            9999999963

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=4.9e-36  Score=252.16  Aligned_cols=203  Identities=33%  Similarity=0.531  Sum_probs=164.5

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN-TIGVCH   79 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~-~~~i~H   79 (292)
                      +.++||||+++++++.     .....++||||++ ++|.+++...    ..+++..+..++.|++.|+.|||+ . |++|
T Consensus        54 ~~l~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~-~~~H  123 (264)
T cd06623          54 RSCESPYVVKCYGAFY-----KEGEISIVLEYMDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKR-HIIH  123 (264)
T ss_pred             HhcCCCCeeeEEEEEc-----cCCeEEEEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccC-CCcc
Confidence            4678999999999984     3455899999999 7999888753    678999999999999999999998 7 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcc-cccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      +||+|+||+++.++ .++|+|||.+.......... ...++..|+|||.+.+. .++.++|+||||+++|+|++|..||.
T Consensus       124 ~~l~~~ni~~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~  201 (264)
T cd06623         124 RDIKPSNLLINSKG-EVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGE-SYSYAADIWSLGLTLLECALGKFPFL  201 (264)
T ss_pred             CCCCHHHEEECCCC-CEEEccCccceecccCCCcccceeecccccCHhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCc
Confidence            99999999999888 79999999988764443332 45678899999998654 58999999999999999999999997


Q ss_pred             CCCc---HHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccC-CChhHHHHHHHHhccCCCCcccHHHH
Q 022799          159 GESG---VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKR-MPPEAVDLVSRLLQYSPNLRSTALEA  234 (292)
Q Consensus       159 ~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~dp~~R~t~~e~  234 (292)
                      ....   .+....+..   ...                         ..++.. ++..+.++|.+||..+|++|||+.++
T Consensus       202 ~~~~~~~~~~~~~~~~---~~~-------------------------~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l  253 (264)
T cd06623         202 PPGQPSFFELMQAICD---GPP-------------------------PSLPAEEFSPEFRDFISACLQKDPKKRPSAAEL  253 (264)
T ss_pred             cccccCHHHHHHHHhc---CCC-------------------------CCCCcccCCHHHHHHHHHHccCChhhCCCHHHH
Confidence            6642   222211111   000                         001133 78899999999999999999999999


Q ss_pred             hcCCCccccC
Q 022799          235 LIHPFFDELR  244 (292)
Q Consensus       235 l~hp~~~~~~  244 (292)
                      ++||||+.++
T Consensus       254 l~~~~~~~~~  263 (264)
T cd06623         254 LQHPFIKKAD  263 (264)
T ss_pred             HhCHHHHhcc
Confidence            9999998754

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=3.8e-36  Score=251.91  Aligned_cols=203  Identities=28%  Similarity=0.452  Sum_probs=162.4

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++.+     .+....++|+||+. ++|.+++....  ...+++..+..++.|++.||.|||+. +++|
T Consensus        53 l~~~~h~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~H  124 (257)
T cd08225          53 LAKMKHPNIVTFFASF-----QENGRLFIVMEYCDGGDLMKRINRQR--GVLFSEDQILSWFVQISLGLKHIHDR-KILH  124 (257)
T ss_pred             HHhCCCCChhhhhhee-----ccCCeEEEEEecCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC-Cccc
Confidence            3568999999999988     44456899999998 69988886431  23578999999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCc-ccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      +||||+||+++.++..++|+|||.+......... ....|++.|+|||.+.+. .++.++|+||+||++++|++|..||.
T Consensus       125 ~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~  203 (257)
T cd08225         125 RDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNR-PYNNKTDIWSLGCVLYELCTLKHPFE  203 (257)
T ss_pred             ccCCHHHEEEcCCCCeEEecccccchhccCCcccccccCCCccccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            9999999999887656799999998766433221 234578899999988654 48899999999999999999999997


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCC
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  238 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp  238 (292)
                      +.+..+....+....              .              ....+.++.+++++|.+||..+|++|||+.++++||
T Consensus       204 ~~~~~~~~~~~~~~~--------------~--------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~  255 (257)
T cd08225         204 GNNLHQLVLKICQGY--------------F--------------APISPNFSRDLRSLISQLFKVSPRDRPSITSILKRP  255 (257)
T ss_pred             CccHHHHHHHHhccc--------------C--------------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCC
Confidence            765544333322110              0              001235788999999999999999999999999999


Q ss_pred             Cc
Q 022799          239 FF  240 (292)
Q Consensus       239 ~~  240 (292)
                      ||
T Consensus       256 ~~  257 (257)
T cd08225         256 FL  257 (257)
T ss_pred             CC
Confidence            97

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-38  Score=269.07  Aligned_cols=207  Identities=30%  Similarity=0.529  Sum_probs=172.7

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      |+.+.||.||.+...|.+++.     +++|||-+.|+..+.|....  .+++++...++++.||+.||.|||-+ ||+|+
T Consensus       617 Lq~l~HPGiV~le~M~ET~er-----vFVVMEKl~GDMLEMILSsE--kgRL~er~TkFlvtQIL~ALr~LH~k-nIvHC  688 (888)
T KOG4236|consen  617 LQNLHHPGIVNLECMFETPER-----VFVVMEKLHGDMLEMILSSE--KGRLPERITKFLVTQILVALRYLHFK-NIVHC  688 (888)
T ss_pred             HHhcCCCCeeEEEEeecCCce-----EEEEehhhcchHHHHHHHhh--cccchHHHHHHHHHHHHHHHHHhhhc-ceeec
Confidence            567899999999988855443     89999999999988876543  37899999999999999999999987 99999


Q ss_pred             CCCCCcEEEeCC--CCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           81 DIKPQNLLVNPH--THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        81 dlkp~Nill~~~--~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      ||||+|||+.+.  ..++||||||+|+.+.+..-..+.+|||.|+|||++... .|..+-|+||+|+|+|--++|..||.
T Consensus       689 DLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVLrnk-GyNrSLDMWSVGVIiYVsLSGTFPFN  767 (888)
T KOG4236|consen  689 DLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNK-GYNRSLDMWSVGVIIYVSLSGTFPFN  767 (888)
T ss_pred             cCCchheeeccCCCCCceeeccccceeecchhhhhhhhcCCccccCHHHHhhc-cccccccceeeeEEEEEEecccccCC
Confidence            999999999643  347999999999999887777789999999999999764 59999999999999999999999996


Q ss_pred             CCCc-HHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          159 GESG-VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       159 ~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      .+.+ .+++++-                    .+-   ++..+|     ..+++.+.|||.++|+..-++|.|.+..|.|
T Consensus       768 EdEdIndQIQNA--------------------aFM---yPp~PW-----~eis~~AidlIn~LLqVkm~kRysvdk~lsh  819 (888)
T KOG4236|consen  768 EDEDINDQIQNA--------------------AFM---YPPNPW-----SEISPEAIDLINNLLQVKMRKRYSVDKSLSH  819 (888)
T ss_pred             CccchhHHhhcc--------------------ccc---cCCCch-----hhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence            4432 2222221                    111   122344     3589999999999999999999999999999


Q ss_pred             CCccccC
Q 022799          238 PFFDELR  244 (292)
Q Consensus       238 p~~~~~~  244 (292)
                      ||++++.
T Consensus       820 ~Wlq~yq  826 (888)
T KOG4236|consen  820 PWLQDYQ  826 (888)
T ss_pred             hhhhcch
Confidence            9998754

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-36  Score=254.00  Aligned_cols=201  Identities=28%  Similarity=0.475  Sum_probs=159.7

Q ss_pred             CCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCC
Q 022799            5 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIK   83 (292)
Q Consensus         5 ~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlk   83 (292)
                      .||||+++++++     .+....|+||||++ ++|.+++..     ..+++..+..++.|++.||.|||+. |++|+||+
T Consensus        60 ~~~~vi~~~~~~-----~~~~~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~-~i~H~dl~  128 (277)
T cd06917          60 QPPNITKYYGSY-----LKGPRLWIIMEYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKV-GVIHRDIK  128 (277)
T ss_pred             CCCCeeeEeeee-----eeCCEEEEEEecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCcC
Confidence            599999999988     34445899999998 588887753     4688999999999999999999987 99999999


Q ss_pred             CCcEEEeCCCCcEEEeecCCccccccCCC-cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCCCc
Q 022799           84 PQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG  162 (292)
Q Consensus        84 p~Nill~~~~~~ikl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~  162 (292)
                      |+||+++.++ .++|+|||.+........ .....|+..|+|||.+.+...++.++|+||+||++|+|++|..||.+...
T Consensus       129 p~ni~i~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~  207 (277)
T cd06917         129 AANILVTNTG-NVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA  207 (277)
T ss_pred             HHHEEEcCCC-CEEEccCCceeecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh
Confidence            9999999877 799999999877644322 23346888999999986655578999999999999999999999976543


Q ss_pred             HHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCCccc
Q 022799          163 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  242 (292)
Q Consensus       163 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~~~~  242 (292)
                      ......+...                   ..+..        ....++.++.++|.+||..||++||++.+++.|+||+.
T Consensus       208 ~~~~~~~~~~-------------------~~~~~--------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~  260 (277)
T cd06917         208 FRAMMLIPKS-------------------KPPRL--------EDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKA  260 (277)
T ss_pred             hhhhhccccC-------------------CCCCC--------CcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhc
Confidence            3221111000                   00000        00236789999999999999999999999999999986


Q ss_pred             cC
Q 022799          243 LR  244 (292)
Q Consensus       243 ~~  244 (292)
                      ..
T Consensus       261 ~~  262 (277)
T cd06917         261 HS  262 (277)
T ss_pred             cc
Confidence            54

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.6e-36  Score=251.77  Aligned_cols=190  Identities=29%  Similarity=0.374  Sum_probs=152.2

Q ss_pred             CCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCC
Q 022799            4 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDI   82 (292)
Q Consensus         4 l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dl   82 (292)
                      ..||||+++++++     .+....++||||++ |+|.+++...    ..+++..+..++.|++.||.|||+. |++||||
T Consensus        42 ~~~~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~ql~~~l~~lH~~-~i~H~dl  111 (237)
T cd05576          42 HCVPNMVCLHKYI-----VSEDSVFLVLQHAEGGKLWSHISKF----LNIPEECVKRWAAEMVVALDALHRE-GIVCRDL  111 (237)
T ss_pred             cCCCceeehhhhe-----ecCCeEEEEEecCCCCCHHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCC
Confidence            4699999999988     34445899999998 6898888653    4589999999999999999999987 9999999


Q ss_pred             CCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCCCc
Q 022799           83 KPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG  162 (292)
Q Consensus        83 kp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~  162 (292)
                      ||+||+++.++ .++++|||.+......  .....++..|+|||...+. .++.++|+||+||++|+|++|..|+.....
T Consensus       112 kp~Nil~~~~~-~~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~~~~~~~~  187 (237)
T cd05576         112 NPNNILLDDRG-HIQLTYFSRWSEVEDS--CDGEAVENMYCAPEVGGIS-EETEACDWWSLGAILFELLTGKTLVECHPS  187 (237)
T ss_pred             CHHHEEEcCCC-CEEEecccchhccccc--cccCCcCccccCCcccCCC-CCCchhhHHHHHHHHHHHHHCcchhhcCch
Confidence            99999999988 6999999987665332  2234457789999988544 478999999999999999999987743210


Q ss_pred             HHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccH-----HHHhcC
Q 022799          163 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA-----LEALIH  237 (292)
Q Consensus       163 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~-----~e~l~h  237 (292)
                      .      ..               ....            ..++..+++.++++|.+||+.||++|+|+     +++++|
T Consensus       188 ~------~~---------------~~~~------------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  234 (237)
T cd05576         188 G------IN---------------THTT------------LNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSH  234 (237)
T ss_pred             h------cc---------------cccc------------cCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcC
Confidence            0      00               0000            01234578899999999999999999985     999999


Q ss_pred             CCc
Q 022799          238 PFF  240 (292)
Q Consensus       238 p~~  240 (292)
                      |||
T Consensus       235 ~~~  237 (237)
T cd05576         235 PFF  237 (237)
T ss_pred             CCC
Confidence            997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=5.7e-36  Score=257.90  Aligned_cols=204  Identities=26%  Similarity=0.447  Sum_probs=163.1

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      |+.++||||+++.+++..     ....++||||+.|++.+++...   ...+++..+..++.|++.||.|||++ |++||
T Consensus        69 l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~~-~i~H~  139 (308)
T cd06634          69 LQKLRHPNTIQYRGCYLR-----EHTAWLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH-NMIHR  139 (308)
T ss_pred             HHhCCCCCcccEEEEEEc-----CCeeEEEEEccCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CcccC
Confidence            356899999999999843     3458899999999888877543   34688999999999999999999987 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccC--CCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG--ATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      ||+|+||+++.++ .++|+|||++.....   .....+++.|+|||.+.+  ...++.++|+||+||++|+|++|..||.
T Consensus       140 dl~p~nil~~~~~-~~kl~dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~  215 (308)
T cd06634         140 DVKAGNILLSEPG-LVKLGDFGSASIMAP---ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF  215 (308)
T ss_pred             CCCHHhEEECCCC-cEEECCcccceeecC---cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCc
Confidence            9999999999887 799999999876532   233567889999999742  2347889999999999999999999997


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCC
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  238 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp  238 (292)
                      +.+.......+.+.. .+.                          .....++..+.++|++||..+|.+||+++++++||
T Consensus       216 ~~~~~~~~~~~~~~~-~~~--------------------------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~  268 (308)
T cd06634         216 NMNAMSALYHIAQNE-SPA--------------------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (308)
T ss_pred             cccHHHHHHHHhhcC-CCC--------------------------cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence            665444433332210 000                          00135788899999999999999999999999999


Q ss_pred             CccccC
Q 022799          239 FFDELR  244 (292)
Q Consensus       239 ~~~~~~  244 (292)
                      |+....
T Consensus       269 ~~~~~~  274 (308)
T cd06634         269 FVLRER  274 (308)
T ss_pred             cccccC
Confidence            998743

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=7.4e-36  Score=255.13  Aligned_cols=200  Identities=22%  Similarity=0.294  Sum_probs=157.6

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHH
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYK------------MSQRMPLIYVKLYFYQICRA   67 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~------------~~~~~~~~~~~~~~~qil~a   67 (292)
                      |+.++||||+++++++     .+....++||||++ ++|.+++.....            ....+++..+..++.||+.|
T Consensus        61 l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~a  135 (291)
T cd05094          61 LTNLQHEHIVKFYGVC-----GDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASG  135 (291)
T ss_pred             HhcCCCCCcceEEEEE-----ccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHH
Confidence            3678999999999988     34445899999998 799998875421            12458899999999999999


Q ss_pred             HHHHHhcCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCCC---cccccccccccCCccccCCCCCCchhHhhhhh
Q 022799           68 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAG  144 (292)
Q Consensus        68 l~~LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG  144 (292)
                      |.|||++ ||+||||||+||+++.++ .++|+|||++........   .....++..|+|||.+.+. .++.++|+||+|
T Consensus       136 l~~lH~~-~i~H~dlkp~Nil~~~~~-~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG  212 (291)
T cd05094         136 MVYLASQ-HFVHRDLATRNCLVGANL-LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFG  212 (291)
T ss_pred             HHHHHhC-CeeecccCcceEEEccCC-cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccC-CCCchhhHHHHH
Confidence            9999988 999999999999999888 799999999876533221   2234457889999998664 489999999999


Q ss_pred             HHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhcc
Q 022799          145 CVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQY  223 (292)
Q Consensus       145 ~il~el~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  223 (292)
                      |++|+|++ |..||...+..+....+...  .            .     +         ..+...+..+.+++.+||..
T Consensus       213 ~il~el~t~g~~p~~~~~~~~~~~~~~~~--~------------~-----~---------~~~~~~~~~~~~li~~~l~~  264 (291)
T cd05094         213 VILWEIFTYGKQPWFQLSNTEVIECITQG--R------------V-----L---------ERPRVCPKEVYDIMLGCWQR  264 (291)
T ss_pred             HHHHHHHhCCCCCCCCCCHHHHHHHHhCC--C------------C-----C---------CCCccCCHHHHHHHHHHccc
Confidence            99999998 99999776655443332110  0            0     0         01134688999999999999


Q ss_pred             CCCCcccHHHHhc
Q 022799          224 SPNLRSTALEALI  236 (292)
Q Consensus       224 dp~~R~t~~e~l~  236 (292)
                      ||++|||+.++++
T Consensus       265 ~P~~Rpt~~~v~~  277 (291)
T cd05094         265 EPQQRLNIKEIYK  277 (291)
T ss_pred             ChhhCcCHHHHHH
Confidence            9999999999974

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.2e-35  Score=256.78  Aligned_cols=202  Identities=28%  Similarity=0.448  Sum_probs=163.0

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      |+.++||||+++++++..     ....++||||+.|++.+.+...   ..++++..+..++.|++.||.|||++ |++||
T Consensus        79 l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~g~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~-~i~H~  149 (317)
T cd06635          79 LQRIKHPNSIEYKGCYLR-----EHTAWLVMEYCLGSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH-NMIHR  149 (317)
T ss_pred             HHhCCCCCEEEEEEEEee-----CCeEEEEEeCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccC
Confidence            356899999999999843     3458899999999988877543   35689999999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccC--CCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG--ATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      ||+|+||+++.++ .++|+|||++.....   .....+++.|+|||.+.+  ...++.++|+||+||++|+|++|..||.
T Consensus       150 dL~p~Nil~~~~~-~~kl~dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~  225 (317)
T cd06635         150 DIKAGNILLTEPG-QVKLADFGSASIASP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF  225 (317)
T ss_pred             CCCcccEEECCCC-CEEEecCCCccccCC---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence            9999999999887 799999998865432   234567889999999742  2347889999999999999999999997


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCC
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  238 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp  238 (292)
                      +.+.......+......+                           ......++.++++|.+||..+|.+||++.++++|+
T Consensus       226 ~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~  278 (317)
T cd06635         226 NMNAMSALYHIAQNESPT---------------------------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM  278 (317)
T ss_pred             CccHHHHHHHHHhccCCC---------------------------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence            766555444443311100                           00134678899999999999999999999999999


Q ss_pred             Cccc
Q 022799          239 FFDE  242 (292)
Q Consensus       239 ~~~~  242 (292)
                      |+..
T Consensus       279 ~~~~  282 (317)
T cd06635         279 FVLR  282 (317)
T ss_pred             hhhc
Confidence            9965

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=8.1e-36  Score=253.01  Aligned_cols=201  Identities=20%  Similarity=0.282  Sum_probs=156.0

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhc------CCCCCHHHHHHHHHHHHHHHHHHHh
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKM------SQRMPLIYVKLYFYQICRALAYIHN   73 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~------~~~~~~~~~~~~~~qil~al~~LH~   73 (292)
                      |+.++||||+++++++     .+....++||||++ ++|.+++......      ...++...+..++.|++.||.|||+
T Consensus        63 l~~l~~~~iv~~~~~~-----~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~  137 (277)
T cd05062          63 MKEFNCHHVVRLLGVV-----SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA  137 (277)
T ss_pred             HHhCCCCCeeeEEEEE-----cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH
Confidence            3568999999999988     44445899999998 6999888653221      1235677889999999999999998


Q ss_pred             cCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCCC---cccccccccccCCccccCCCCCCchhHhhhhhHHHHHH
Q 022799           74 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAEL  150 (292)
Q Consensus        74 ~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el  150 (292)
                      . |++||||||+||+++.++ .++|+|||++........   .....+++.|+|||.+.+. .++.++|+|||||++|+|
T Consensus       138 ~-~~vH~dlkp~Nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el  214 (277)
T cd05062         138 N-KFVHRDLAARNCMVAEDF-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEI  214 (277)
T ss_pred             C-CcccCCcchheEEEcCCC-CEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcC-CcCchhHHHHHHHHHHHH
Confidence            7 999999999999999888 799999999876533221   1123446789999998654 489999999999999999


Q ss_pred             Hh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcc
Q 022799          151 LL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS  229 (292)
Q Consensus       151 ~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~  229 (292)
                      ++ |..||.+.+.......+... ..+                           ..+...+..+.+++.+||+.||++||
T Consensus       215 ~~~~~~p~~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp  266 (277)
T cd05062         215 ATLAEQPYQGMSNEQVLRFVMEG-GLL---------------------------DKPDNCPDMLFELMRMCWQYNPKMRP  266 (277)
T ss_pred             HcCCCCCCCCCCHHHHHHHHHcC-CcC---------------------------CCCCCCCHHHHHHHHHHcCCChhhCc
Confidence            99 78899876655444333221 000                           01235678999999999999999999


Q ss_pred             cHHHHhcC
Q 022799          230 TALEALIH  237 (292)
Q Consensus       230 t~~e~l~h  237 (292)
                      |+.+++++
T Consensus       267 s~~e~l~~  274 (277)
T cd05062         267 SFLEIISS  274 (277)
T ss_pred             CHHHHHHH
Confidence            99999853

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=7e-36  Score=251.52  Aligned_cols=195  Identities=19%  Similarity=0.259  Sum_probs=149.3

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++..     ....++||||++ |+|..++...   ...+++..+..++.||+.||.|||++ ||+|
T Consensus        58 l~~l~hp~iv~~~~~~~~-----~~~~~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH  128 (262)
T cd05077          58 MRQVSHKHIVLLYGVCVR-----DVENIMVEEFVEFGPLDLFMHRK---SDVLTTPWKFKVAKQLASALSYLEDK-DLVH  128 (262)
T ss_pred             HHhCCCCCEeeEEEEEec-----CCCCEEEEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhC-CeEC
Confidence            356899999999998843     334789999999 5766665432   35689999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCC------cEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHH-h
Q 022799           80 RDIKPQNLLVNPHTH------QLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-L  152 (292)
Q Consensus        80 ~dlkp~Nill~~~~~------~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~-~  152 (292)
                      |||||+||+++.++.      .++++|||.+......   ....++..|+|||.+.+...++.++|+||+||++|+|+ +
T Consensus       129 ~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~  205 (262)
T cd05077         129 GNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYN  205 (262)
T ss_pred             CCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhC
Confidence            999999999976542      2899999998755322   23457888999998865556899999999999999998 5


Q ss_pred             CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHH
Q 022799          153 GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAL  232 (292)
Q Consensus       153 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~  232 (292)
                      |..||.+....+.. .....              ..     .          .....+.++.++|.+||..||.+||++.
T Consensus       206 ~~~p~~~~~~~~~~-~~~~~--------------~~-----~----------~~~~~~~~~~~li~~cl~~dp~~Rp~~~  255 (262)
T cd05077         206 GEIPLKDKTLAEKE-RFYEG--------------QC-----M----------LVTPSCKELADLMTHCMNYDPNQRPFFR  255 (262)
T ss_pred             CCCCCCCcchhHHH-HHHhc--------------Cc-----c----------CCCCChHHHHHHHHHHcCCChhhCcCHH
Confidence            88888654432211 11100              00     0          0022467899999999999999999999


Q ss_pred             HHhcC
Q 022799          233 EALIH  237 (292)
Q Consensus       233 e~l~h  237 (292)
                      +++++
T Consensus       256 ~il~~  260 (262)
T cd05077         256 AIMRD  260 (262)
T ss_pred             HHHHh
Confidence            99864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1e-35  Score=249.67  Aligned_cols=198  Identities=18%  Similarity=0.314  Sum_probs=156.4

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++.     .....++||||+. |+|.+++...   ...+++..+..++.||+.||.|||++ |++|
T Consensus        53 l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H  123 (256)
T cd05113          53 MMKLSHEKLVQLYGVCT-----KQRPIYIVTEYMSNGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESK-QFIH  123 (256)
T ss_pred             HhcCCCCCeeeEEEEEc-----cCCCcEEEEEcCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC-Ceec
Confidence            46789999999999883     3334899999998 6888887653   23689999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCc--ccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPL  156 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~p  156 (292)
                      +||||+||+++.++ .+||+|||.++........  ....++..|+|||.+.+. .++.++|+||+||++|+|++ |..|
T Consensus       124 ~dl~p~nili~~~~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p  201 (256)
T cd05113         124 RDLAARNCLVDDQG-CVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYS-KFSSKSDVWAFGVLMWEVYSLGKMP  201 (256)
T ss_pred             cccCcceEEEcCCC-CEEECCCccceecCCCceeecCCCccChhhCCHHHHhcC-cccchhHHHHHHHHHHHHhcCCCCC
Confidence            99999999999887 7999999998765333211  112345679999999654 48999999999999999998 9999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      |...+..+....+.+....                            ..+...+..+++++.+||..||.+|||+.+++.
T Consensus       202 ~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~  253 (256)
T cd05113         202 YERFNNSETVEKVSQGLRL----------------------------YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLS  253 (256)
T ss_pred             cCcCCHHHHHHHHhcCCCC----------------------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            9766655444443321100                            011346789999999999999999999999986


Q ss_pred             C
Q 022799          237 H  237 (292)
Q Consensus       237 h  237 (292)
                      +
T Consensus       254 ~  254 (256)
T cd05113         254 S  254 (256)
T ss_pred             h
Confidence            4

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=6e-36  Score=256.29  Aligned_cols=207  Identities=27%  Similarity=0.436  Sum_probs=161.1

Q ss_pred             CCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCC
Q 022799            4 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIK   83 (292)
Q Consensus         4 l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlk   83 (292)
                      ..||||+++++++     .+....|+||||+++++.+++...   ...+++..+..++.||+.||.|||+..||+||||+
T Consensus        71 ~~~~~i~~~~~~~-----~~~~~~~~v~e~~~~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~  142 (296)
T cd06618          71 HDCPYIVKCYGYF-----ITDSDVFICMELMSTCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVK  142 (296)
T ss_pred             cCCCchHhhheee-----ecCCeEEEEeeccCcCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCc
Confidence            3599999999998     444459999999998887776653   35789999999999999999999973499999999


Q ss_pred             CCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCC---CCCCchhHhhhhhHHHHHHHhCCCCCCCC
Q 022799           84 PQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA---TEYTAAIDIWSAGCVLAELLLGQPLFPGE  160 (292)
Q Consensus        84 p~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DvwslG~il~el~~g~~pf~~~  160 (292)
                      |+||+++.++ .++|+|||.+.............++..|+|||.+.+.   ..++.++|+||+|+++|+|++|..||...
T Consensus       143 p~nill~~~~-~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~  221 (296)
T cd06618         143 PSNILLDASG-NVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNC  221 (296)
T ss_pred             HHHEEEcCCC-CEEECccccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcc
Confidence            9999999887 7999999998766444333344578889999998643   23788999999999999999999999653


Q ss_pred             Cc-HHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCC
Q 022799          161 SG-VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF  239 (292)
Q Consensus       161 ~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~  239 (292)
                      .. .+.+..+...   .        .+.     .+          ....++.++.+||.+||..||.+||++++++.|||
T Consensus       222 ~~~~~~~~~~~~~---~--------~~~-----~~----------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~  275 (296)
T cd06618         222 KTEFEVLTKILQE---E--------PPS-----LP----------PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF  275 (296)
T ss_pred             hhHHHHHHHHhcC---C--------CCC-----CC----------CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence            32 2222222110   0        000     00          00236789999999999999999999999999999


Q ss_pred             ccccCC
Q 022799          240 FDELRD  245 (292)
Q Consensus       240 ~~~~~~  245 (292)
                      |.....
T Consensus       276 ~~~~~~  281 (296)
T cd06618         276 IRRYET  281 (296)
T ss_pred             hhccch
Confidence            987543

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-36  Score=246.73  Aligned_cols=212  Identities=27%  Similarity=0.506  Sum_probs=170.5

Q ss_pred             CCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCC
Q 022799            4 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDI   82 (292)
Q Consensus         4 l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dl   82 (292)
                      -+||.+|.+..||     +.+..++.|.||++ |+|.--+++    ..+++++.++.|-.+|+.||.|||++ ||++|||
T Consensus       308 sn~pflvglhscf-----qtesrlffvieyv~ggdlmfhmqr----qrklpeeharfys~ei~lal~flh~r-giiyrdl  377 (593)
T KOG0695|consen  308 SNNPFLVGLHSCF-----QTESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEICLALNFLHER-GIIYRDL  377 (593)
T ss_pred             cCCCeEEehhhhh-----cccceEEEEEEEecCcceeeehhh----hhcCcHHHhhhhhHHHHHHHHHHhhc-Ceeeeec
Confidence            4799999999999     55555899999999 576555554    46799999999999999999999998 9999999


Q ss_pred             CCCcEEEeCCCCcEEEeecCCcccc-ccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC---
Q 022799           83 KPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP---  158 (292)
Q Consensus        83 kp~Nill~~~~~~ikl~Dfg~a~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~---  158 (292)
                      |.+|+|++..| .+||+|+|+++.. ..+....+++|||.|.|||++.|. .|+.++|+|+||++++||+.|+.||.   
T Consensus       378 kldnvlldaeg-hikltdygmcke~l~~gd~tstfcgtpnyiapeilrge-eygfsvdwwalgvlmfemmagrspfdivg  455 (593)
T KOG0695|consen  378 KLDNVLLDAEG-HIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIVG  455 (593)
T ss_pred             cccceEEccCC-ceeecccchhhcCCCCCcccccccCCCcccchhhhccc-ccCceehHHHHHHHHHHHHcCCCCcceec
Confidence            99999999999 5999999999864 445566788999999999999875 49999999999999999999999994   


Q ss_pred             ----CCCcHHHHHHHH-HHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcc----
Q 022799          159 ----GESGVDQLVEII-KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS----  229 (292)
Q Consensus       159 ----~~~~~~~~~~i~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~----  229 (292)
                          ..+..+.+.+++ +.                             +-.+|..+|-.+..+++..|.+||.+|.    
T Consensus       456 m~n~d~ntedylfqvilek-----------------------------qiriprslsvkas~vlkgflnkdp~erlgc~~  506 (593)
T KOG0695|consen  456 MDNPDMNTEDYLFQVILEK-----------------------------QIRIPRSLSVKASHVLKGFLNKDPKERLGCRP  506 (593)
T ss_pred             CCCcccchhHHHHHHHhhh-----------------------------cccccceeehhhHHHHHHhhcCCcHHhcCCCc
Confidence                122233333322 21                             0123456788889999999999999995    


Q ss_pred             --cHHHHhcCCCccccCCCCCCCCCCCCCCC
Q 022799          230 --TALEALIHPFFDELRDPNTRLPNGRFLPP  258 (292)
Q Consensus       230 --t~~e~l~hp~~~~~~~~~~~~~~~~~~~~  258 (292)
                        ...++..|+||+.+++.  .+..++.+||
T Consensus       507 ~~g~~dik~h~ffr~idwd--~leqk~v~pp  535 (593)
T KOG0695|consen  507 QTGFSDIKSHAFFRSIDWD--LLEQKQVLPP  535 (593)
T ss_pred             ccchhhhhcchhhhhCCHH--HHhhcccCCC
Confidence              47899999999988754  3334444444

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=6.6e-36  Score=256.16  Aligned_cols=199  Identities=19%  Similarity=0.280  Sum_probs=154.4

Q ss_pred             CC-CCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHH
Q 022799            3 LL-DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYK------------MSQRMPLIYVKLYFYQICRAL   68 (292)
Q Consensus         3 ~l-~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~------------~~~~~~~~~~~~~~~qil~al   68 (292)
                      ++ +||||+++++++     .+...+++||||++ ++|.+++.....            ....+++..++.++.|++.||
T Consensus        58 ~l~~hp~iv~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al  132 (297)
T cd05089          58 KLGHHPNIINLLGAC-----ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGM  132 (297)
T ss_pred             hhcCCCchhheEEEE-----ccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHH
Confidence            45 799999999988     33445899999998 799998865321            113588999999999999999


Q ss_pred             HHHHhcCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHH
Q 022799           69 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLA  148 (292)
Q Consensus        69 ~~LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~  148 (292)
                      +|||++ ||+||||||+||+++.++ .+||+|||++..............+..|+|||.+.+. .++.++|+|||||++|
T Consensus       133 ~~lH~~-~ivH~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~  209 (297)
T cd05089         133 QYLSEK-QFIHRDLAARNVLVGENL-ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYS-VYTTKSDVWSFGVLLW  209 (297)
T ss_pred             HHHHHC-CcccCcCCcceEEECCCC-eEEECCcCCCccccceeccCCCCcCccccCchhhccC-CCCchhhHHHHHHHHH
Confidence            999987 999999999999999887 7999999998643221111112234569999998654 4899999999999999


Q ss_pred             HHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCC
Q 022799          149 ELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL  227 (292)
Q Consensus       149 el~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~  227 (292)
                      +|++ |..||.+....+....+.....                            ...+..++..+.+||.+||..+|.+
T Consensus       210 el~t~g~~pf~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~  261 (297)
T cd05089         210 EIVSLGGTPYCGMTCAELYEKLPQGYR----------------------------MEKPRNCDDEVYELMRQCWRDRPYE  261 (297)
T ss_pred             HHHcCCCCCCCCCCHHHHHHHHhcCCC----------------------------CCCCCCCCHHHHHHHHHHcCCChhh
Confidence            9997 9999987766554443322100                            0011357889999999999999999


Q ss_pred             cccHHHHhcC
Q 022799          228 RSTALEALIH  237 (292)
Q Consensus       228 R~t~~e~l~h  237 (292)
                      |||++++++.
T Consensus       262 Rp~~~~i~~~  271 (297)
T cd05089         262 RPPFAQISVQ  271 (297)
T ss_pred             CcCHHHHHHH
Confidence            9999999754

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=7.2e-36  Score=254.27  Aligned_cols=210  Identities=28%  Similarity=0.470  Sum_probs=159.5

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      +.++||||+++++++.     +...+++||||++ ++|.+++..    .+.+++..+..++.|++.||.|||+..|++||
T Consensus        58 ~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~  128 (284)
T cd06620          58 HECRSPYIVSFYGAFL-----NENNICMCMEFMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHR  128 (284)
T ss_pred             HHcCCCCcceEeeeEe-----cCCEEEEEEecCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhcCeecc
Confidence            5689999999999984     3456899999998 588777654    35689999999999999999999974499999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE  160 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  160 (292)
                      ||+|+||+++.++ .++|+|||++...... ......|+..|+|||.+.+. .++.++|+||+||++|+|++|..||...
T Consensus       129 dl~p~nil~~~~~-~~~l~d~gl~~~~~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~  205 (284)
T cd06620         129 DIKPSNILVNSRG-QIKLCDFGVSGELINS-IADTFVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFS  205 (284)
T ss_pred             CCCHHHEEECCCC-cEEEccCCcccchhhh-ccCccccCcccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCCCCccc
Confidence            9999999999887 7999999998654322 22345789999999998654 5889999999999999999999999765


Q ss_pred             CcHHH----HHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          161 SGVDQ----LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       161 ~~~~~----~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      ...+.    ...+....    ......   .     .+..        -...++.++.+||.+||..||.+|||++|+++
T Consensus       206 ~~~~~~~~~~~~~~~~~----~~~~~~---~-----~~~~--------~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~  265 (284)
T cd06620         206 NIDDDGQDDPMGILDLL----QQIVQE---P-----PPRL--------PSSDFPEDLRDFVDACLLKDPTERPTPQQLCA  265 (284)
T ss_pred             chhhhhhhhhhHHHHHH----HHHhhc---c-----CCCC--------CchhcCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            43211    00000000    000000   0     0000        00136788999999999999999999999999


Q ss_pred             CCCcccc
Q 022799          237 HPFFDEL  243 (292)
Q Consensus       237 hp~~~~~  243 (292)
                      |+||..-
T Consensus       266 ~~~~~~~  272 (284)
T cd06620         266 MPPFIQA  272 (284)
T ss_pred             Ccccccc
Confidence            9999753

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=5e-36  Score=251.90  Aligned_cols=202  Identities=25%  Similarity=0.490  Sum_probs=161.9

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      +.++||||+++++++.     +....++||||+. ++|.+.+.........+++..+..++.|++.||.|||++ |++|+
T Consensus        57 ~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~h~  130 (260)
T cd08222          57 SKLDHPAIVKFHASFL-----ERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR-RILHR  130 (260)
T ss_pred             HhCCCCcHHHHHHHHh-----cCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc-Ccccc
Confidence            5679999999999883     3334889999998 588888876544567799999999999999999999987 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCC-cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      ||+|+||+++. + .++|+|||.+........ .....+++.|+|||...+. .++.++|+||+|+++|+|++|..||.+
T Consensus       131 ~l~~~nili~~-~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~  207 (260)
T cd08222         131 DLKAKNIFLKN-N-LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQ-GYDSKSDIWSLGCILYEMCCLAHAFEG  207 (260)
T ss_pred             CCChhheEeec-C-CEeecccCceeecCCCcccccCCCCCcCccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            99999999975 4 599999999876533222 2234578899999988554 478899999999999999999999976


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCC
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF  239 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~  239 (292)
                      .........+...   +.                         ..++..++.++.++|.+||..||++||++.++++|||
T Consensus       208 ~~~~~~~~~~~~~---~~-------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  259 (260)
T cd08222         208 QNFLSVVLRIVEG---PT-------------------------PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPF  259 (260)
T ss_pred             ccHHHHHHHHHcC---CC-------------------------CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCC
Confidence            6544433332210   00                         0012457889999999999999999999999999999


Q ss_pred             c
Q 022799          240 F  240 (292)
Q Consensus       240 ~  240 (292)
                      |
T Consensus       260 ~  260 (260)
T cd08222         260 I  260 (260)
T ss_pred             C
Confidence            7

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=8.7e-36  Score=253.03  Aligned_cols=200  Identities=21%  Similarity=0.276  Sum_probs=158.2

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhh----------hcCCCCCHHHHHHHHHHHHHHHH
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHY----------KMSQRMPLIYVKLYFYQICRALA   69 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~----------~~~~~~~~~~~~~~~~qil~al~   69 (292)
                      |+.++||||+++++++..     ....++||||++ ++|.+++....          .....+++..+..++.|++.|+.
T Consensus        62 l~~l~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~  136 (280)
T cd05049          62 LTNFQHENIVKFYGVCTE-----GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMV  136 (280)
T ss_pred             HHhcCCCCchheeeEEec-----CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHH
Confidence            356899999999999843     345899999998 69999887532          12345788899999999999999


Q ss_pred             HHHhcCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCCC---cccccccccccCCccccCCCCCCchhHhhhhhHH
Q 022799           70 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCV  146 (292)
Q Consensus        70 ~LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~i  146 (292)
                      |||++ |++||||||+||+++.++ .++|+|||++........   .....+++.|+|||++.+. .++.++|+||+||+
T Consensus       137 ~lH~~-~i~h~dlkp~nili~~~~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~i  213 (280)
T cd05049         137 YLASQ-HFVHRDLATRNCLVGYDL-VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVV  213 (280)
T ss_pred             HHhhC-CeeccccccceEEEcCCC-eEEECCcccceecccCcceecCCCCcccceecChhhhccC-CcchhhhHHHHHHH
Confidence            99988 999999999999999888 799999999876432221   1233457789999999665 48999999999999


Q ss_pred             HHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCC
Q 022799          147 LAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSP  225 (292)
Q Consensus       147 l~el~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp  225 (292)
                      +|+|++ |..||.+.+..+....+....  .                          ...+..++..+.++|.+||..||
T Consensus       214 l~e~~~~g~~p~~~~~~~~~~~~~~~~~--~--------------------------~~~~~~~~~~~~~li~~~l~~~p  265 (280)
T cd05049         214 LWEIFTYGKQPWYGLSNEEVIECITQGR--L--------------------------LQRPRTCPSEVYDIMLGCWKRDP  265 (280)
T ss_pred             HHHHHhcCCCCCCCCCHHHHHHHHHcCC--c--------------------------CCCCCCCCHHHHHHHHHHcCCCc
Confidence            999998 999998766555444332110  0                          00113578899999999999999


Q ss_pred             CCcccHHHHhc
Q 022799          226 NLRSTALEALI  236 (292)
Q Consensus       226 ~~R~t~~e~l~  236 (292)
                      ++|||+.|+++
T Consensus       266 ~~Rp~~~eil~  276 (280)
T cd05049         266 QQRINIKDIHE  276 (280)
T ss_pred             ccCCCHHHHHH
Confidence            99999999984

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.8e-35  Score=250.71  Aligned_cols=195  Identities=19%  Similarity=0.263  Sum_probs=150.9

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++..     ....++||||++ |+|..++...   .+.+++..+..++.||+.||+|||++ ||+|
T Consensus        70 ~~~l~h~niv~~~~~~~~-----~~~~~lv~ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~-~iiH  140 (274)
T cd05076          70 MSQVSHIHLAFVHGVCVR-----GSENIMVEEFVEHGPLDVCLRKE---KGRVPVAWKITVAQQLASALSYLEDK-NLVH  140 (274)
T ss_pred             HhcCCCCCeeeEEEEEEe-----CCceEEEEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHcC-CccC
Confidence            467899999999999843     335889999999 5777776542   35689999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCC------CcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHH-h
Q 022799           80 RDIKPQNLLVNPHT------HQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-L  152 (292)
Q Consensus        80 ~dlkp~Nill~~~~------~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~-~  152 (292)
                      |||||+||+++..+      ..++++|||.+......   ....++..|+|||.+.+...++.++|+||+||++|+|+ +
T Consensus       141 ~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~  217 (274)
T cd05076         141 GNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFD  217 (274)
T ss_pred             CCCCcccEEEeccCcccCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhC
Confidence            99999999997543      13899999988654222   22356788999998866556899999999999999995 6


Q ss_pred             CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHH
Q 022799          153 GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAL  232 (292)
Q Consensus       153 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~  232 (292)
                      |..||.+....+... .....                 .            .++...++.+.++|.+||..+|++|||+.
T Consensus       218 g~~p~~~~~~~~~~~-~~~~~-----------------~------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~  267 (274)
T cd05076         218 GEVPLKERTPSEKER-FYEKK-----------------H------------RLPEPSCKELATLISQCLTYEPTQRPSFR  267 (274)
T ss_pred             CCCCccccChHHHHH-HHHhc-----------------c------------CCCCCCChHHHHHHHHHcccChhhCcCHH
Confidence            899997665433211 11100                 0            01123467899999999999999999999


Q ss_pred             HHhcC
Q 022799          233 EALIH  237 (292)
Q Consensus       233 e~l~h  237 (292)
                      +++++
T Consensus       268 ~il~~  272 (274)
T cd05076         268 TILRD  272 (274)
T ss_pred             HHHHh
Confidence            99864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.4e-35  Score=248.61  Aligned_cols=197  Identities=20%  Similarity=0.323  Sum_probs=156.4

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++     .+....++||||++ |+|.+.+...   ...+++..+..++.|++.||.|||++ |++|
T Consensus        53 l~~l~h~~i~~~~~~~-----~~~~~~~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H  123 (256)
T cd05114          53 MMKLSHPKLVQLYGVC-----TQQKPLYIVTEFMENGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERN-SFIH  123 (256)
T ss_pred             HHHCCCCCceeEEEEE-----ccCCCEEEEEEcCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC-Cccc
Confidence            4678999999999988     33445899999998 7888887643   24588999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCc--ccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPL  156 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~p  156 (292)
                      |||||+||+++.++ .++|+|||.+.........  ....++..|+|||.+.+. .++.++|+||+|+++|+|++ |..|
T Consensus       124 ~dl~p~ni~i~~~~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~s~G~~l~el~~~g~~p  201 (256)
T cd05114         124 RDLAARNCLVSSTG-VVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFS-KYSSKSDVWSFGVLMWEVFTEGKMP  201 (256)
T ss_pred             cccCcceEEEcCCC-eEEECCCCCccccCCCceeccCCCCCchhhCChhhcccC-ccchhhhhHHHHHHHHHHHcCCCCC
Confidence            99999999999887 7999999998765332211  122345679999998654 58999999999999999999 8999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      |.+.+..+....+.+... +                           ..+...+..+.+++.+||..||.+|||++++++
T Consensus       202 ~~~~~~~~~~~~i~~~~~-~---------------------------~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         202 FEKKSNYEVVEMISRGFR-L---------------------------YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             CCCCCHHHHHHHHHCCCC-C---------------------------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            987776555555433100 0                           011235778999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1e-35  Score=249.90  Aligned_cols=195  Identities=19%  Similarity=0.261  Sum_probs=151.4

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++..     ....++||||++ |+|.+++...   ...+++..+..++.||+.||.|||++ ||+|
T Consensus        53 l~~~~h~~iv~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~-~iiH  123 (258)
T cd05078          53 MSQLSHKHLVLNYGVCVC-----GDESIMVQEYVKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDK-GLTH  123 (258)
T ss_pred             HHhCCCCChhheeeEEEe-----CCCcEEEEecCCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHC-Ceec
Confidence            457899999999999843     334789999998 6888888653   24688999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCc-------EEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh
Q 022799           80 RDIKPQNLLVNPHTHQ-------LKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL  152 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~-------ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~  152 (292)
                      |||||+||+++.++..       ++++|||.+.....   .....++..|+|||.+.+...++.++|+||+||++|+|++
T Consensus       124 ~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~  200 (258)
T cd05078         124 GNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFS  200 (258)
T ss_pred             CCCccceEEEecccccccCCCceEEecccccccccCC---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHc
Confidence            9999999999876532       79999999865532   2234678889999999765568999999999999999999


Q ss_pred             CC-CCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccH
Q 022799          153 GQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA  231 (292)
Q Consensus       153 g~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~  231 (292)
                      |. .||........... ...            .                 ..++...+.++.++|.+||+.||++|||+
T Consensus       201 g~~~~~~~~~~~~~~~~-~~~------------~-----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~  250 (258)
T cd05078         201 GGDKPLSALDSQKKLQF-YED------------R-----------------HQLPAPKWTELANLINQCMDYEPDFRPSF  250 (258)
T ss_pred             CCCCChhhccHHHHHHH-HHc------------c-----------------ccCCCCCcHHHHHHHHHHhccChhhCCCH
Confidence            85 66654443322111 110            0                 00123456789999999999999999999


Q ss_pred             HHHhcC
Q 022799          232 LEALIH  237 (292)
Q Consensus       232 ~e~l~h  237 (292)
                      +++++.
T Consensus       251 ~~il~~  256 (258)
T cd05078         251 RAIIRD  256 (258)
T ss_pred             HHHHHh
Confidence            999853

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=8.6e-36  Score=263.32  Aligned_cols=201  Identities=22%  Similarity=0.319  Sum_probs=154.1

Q ss_pred             CCC-CCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhh--------------------------------
Q 022799            2 RLL-DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYK--------------------------------   47 (292)
Q Consensus         2 ~~l-~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~--------------------------------   47 (292)
                      +.+ +||||+++++++     .+....++|||||+ |+|.+++.....                                
T Consensus        93 ~~l~~HpnIv~l~~~~-----~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  167 (375)
T cd05104          93 SYLGNHINIVNLLGAC-----TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNE  167 (375)
T ss_pred             HHhcCCcceeeeeeee-----ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhh
Confidence            345 799999999998     44445899999998 799888864321                                


Q ss_pred             ---------------------------------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEE
Q 022799           48 ---------------------------------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL   88 (292)
Q Consensus        48 ---------------------------------------~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlkp~Nil   88 (292)
                                                             ....+++..+..++.||+.||.|||++ ||+||||||+||+
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~Nil  246 (375)
T cd05104         168 YMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK-NCIHRDLAARNIL  246 (375)
T ss_pred             hhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCchhhEE
Confidence                                                   012478888999999999999999987 9999999999999


Q ss_pred             EeCCCCcEEEeecCCccccccCCCc---ccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCCCCCCCCcHH
Q 022799           89 VNPHTHQLKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVD  164 (292)
Q Consensus        89 l~~~~~~ikl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~  164 (292)
                      ++.++ .+||+|||+++........   ....++..|+|||.+.+. .++.++|+||+||++|+|++ |..||.+.....
T Consensus       247 l~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~  324 (375)
T cd05104         247 LTHGR-ITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS  324 (375)
T ss_pred             EECCC-cEEEecCccceeccCcccccccCCCCCCcceeChhHhcCC-CCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH
Confidence            99877 7999999999765433211   122345679999999664 48999999999999999998 889997765444


Q ss_pred             HHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          165 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       165 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      ...+.......+                           ..+...+.++.++|.+||..||++|||+.++++.
T Consensus       325 ~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         325 KFYKMIKEGYRM---------------------------LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             HHHHHHHhCccC---------------------------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            333332210000                           0112357899999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1e-35  Score=249.04  Aligned_cols=203  Identities=35%  Similarity=0.565  Sum_probs=165.2

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      +.++|||++++.+.+.     +....++|+||++ ++|.+.+.........+++..+..++.|++.||.+||++ |++|+
T Consensus        54 ~~l~~~~~~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~~H~  127 (258)
T cd08215          54 KKLNHPNIIKYYESFE-----EKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR-KILHR  127 (258)
T ss_pred             HhcCCCChhheEEEEe-----cCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC-CEecc
Confidence            5678999999999884     3356899999998 599988876543357799999999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCC-CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      ||+|+||+++.++ .++|+|||.+....... ......+++.|+|||...+. .++.++|+||+|+++++|++|..||..
T Consensus       128 dl~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~  205 (258)
T cd08215         128 DIKPQNIFLTSNG-LVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNK-PYNYKSDIWSLGCVLYELCTLKHPFEG  205 (258)
T ss_pred             cCChHHeEEcCCC-cEEECCccceeecccCcceecceeeeecccChhHhccC-CCCccccHHHHHHHHHHHHcCCCCCCC
Confidence            9999999999877 79999999987664432 22335678899999998654 488999999999999999999999977


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCC
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF  239 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~  239 (292)
                      .+..+.........              .     +         .++..++..+.+++.+||..+|++|||+.+++.|||
T Consensus       206 ~~~~~~~~~~~~~~--------------~-----~---------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~  257 (258)
T cd08215         206 ENLLELALKILKGQ--------------Y-----P---------PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPF  257 (258)
T ss_pred             CcHHHHHHHHhcCC--------------C-----C---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCC
Confidence            66444333322110              0     0         012357889999999999999999999999999999


Q ss_pred             c
Q 022799          240 F  240 (292)
Q Consensus       240 ~  240 (292)
                      |
T Consensus       258 ~  258 (258)
T cd08215         258 I  258 (258)
T ss_pred             C
Confidence            7

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-35  Score=248.30  Aligned_cols=201  Identities=26%  Similarity=0.372  Sum_probs=161.6

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKM-----SQRMPLIYVKLYFYQICRALAYIHNT   74 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~-----~~~~~~~~~~~~~~qil~al~~LH~~   74 (292)
                      ++.++||||+++++++.     +...+++||||++ ++|.+.+......     ...+++..+..++.|++.||.|||++
T Consensus        50 l~~~~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~  124 (262)
T cd00192          50 MKKLGHPNVVRLLGVCT-----EEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK  124 (262)
T ss_pred             HhhcCCCChheeeeeec-----CCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC
Confidence            35678999999999884     3445899999996 7999988764221     36789999999999999999999987


Q ss_pred             CCccccCCCCCcEEEeCCCCcEEEeecCCccccccCC---CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHH
Q 022799           75 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL  151 (292)
Q Consensus        75 ~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~  151 (292)
                       |++|+||+|+||+++.++ .++|+|||.+.......   ......++..|+|||.+.+. .++.++|+||+||++|+|+
T Consensus       125 -~i~H~di~p~nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~  201 (262)
T cd00192         125 -KFVHRDLAARNCLVGEDL-VVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIF  201 (262)
T ss_pred             -CcccCccCcceEEECCCC-cEEEcccccccccccccccccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHH
Confidence             999999999999999987 79999999998764432   12334568889999998665 5899999999999999999


Q ss_pred             h-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCccc
Q 022799          152 L-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST  230 (292)
Q Consensus       152 ~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t  230 (292)
                      + |..||.+....+....+....                            ....+..+++++.+++.+||..||++|||
T Consensus       202 ~~g~~p~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps  253 (262)
T cd00192         202 TLGATPYPGLSNEEVLEYLRKGY----------------------------RLPKPEYCPDELYELMLSCWQLDPEDRPT  253 (262)
T ss_pred             hcCCCCCCCCCHHHHHHHHHcCC----------------------------CCCCCccCChHHHHHHHHHccCCcccCcC
Confidence            9 699998776554444333200                            00112457899999999999999999999


Q ss_pred             HHHHhcC
Q 022799          231 ALEALIH  237 (292)
Q Consensus       231 ~~e~l~h  237 (292)
                      +.+++++
T Consensus       254 ~~~l~~~  260 (262)
T cd00192         254 FSELVER  260 (262)
T ss_pred             HHHHHHh
Confidence            9999864

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=9e-36  Score=249.64  Aligned_cols=199  Identities=29%  Similarity=0.499  Sum_probs=159.6

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++     .+..++|+||||++ ++|.+.+...  ....+++..+..++.|++.||.|||++ ||+|
T Consensus        52 l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~-~i~H  123 (255)
T cd08219          52 LAKMKHPNIVAFKESF-----EADGHLYIVMEYCDGGDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHEK-RVLH  123 (255)
T ss_pred             HHhCCCCCcceEEEEE-----EECCEEEEEEeeCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhhC-Cccc
Confidence            3568999999999998     44556999999998 6888877642  235688999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCC-CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      +||||+||+++.++ .++++|||.+....... ......+++.|+|||++.+. .++.++|+||+|+++|+|++|..||.
T Consensus       124 ~dl~p~nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~p~~  201 (255)
T cd08219         124 RDIKSKNIFLTQNG-KVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENM-PYNNKSDIWSLGCILYELCTLKHPFQ  201 (255)
T ss_pred             CCCCcceEEECCCC-cEEEcccCcceeecccccccccccCCccccCHHHHccC-CcCchhhhhhhchhheehhhccCCCC
Confidence            99999999999887 79999999987653322 22345688899999998654 48999999999999999999999998


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      ..+.......+....              +.              .++..++..+.++|.+||..||.+|||+.++++-
T Consensus       202 ~~~~~~~~~~~~~~~--------------~~--------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         202 ANSWKNLILKVCQGS--------------YK--------------PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CCCHHHHHHHHhcCC--------------CC--------------CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            766544433332210              00              0123578899999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.4e-35  Score=249.71  Aligned_cols=198  Identities=21%  Similarity=0.342  Sum_probs=156.0

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++     ..+..+++||||++ ++|.+.+....  ...+++..+..++.|++.||.|||++ |++|
T Consensus        56 l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~-~i~H  127 (263)
T cd05052          56 MKEIKHPNLVQLLGVC-----TREPPFYIITEFMTYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEKK-NFIH  127 (263)
T ss_pred             HHhCCCCChhheEEEE-----cCCCCcEEEEEeCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CEee
Confidence            4578999999999988     33445889999997 68988886432  34588899999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcc--cccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI--SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPL  156 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~p  156 (292)
                      |||||+||+++.++ .++|+|||.+..........  ...++..|+|||.+.+. .++.++|+||+||++|+|++ |..|
T Consensus       128 ~dlkp~nil~~~~~-~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p  205 (263)
T cd05052         128 RDLAARNCLVGENH-LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSP  205 (263)
T ss_pred             cccCcceEEEcCCC-cEEeCCCccccccccceeeccCCCCCccccCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCC
Confidence            99999999999887 79999999987664332111  12235679999998654 48999999999999999998 9999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      |.+.+..+....+....                .            ...+..+++++.++|.+||..||++|||+.++++
T Consensus       206 ~~~~~~~~~~~~~~~~~----------------~------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         206 YPGIDLSQVYELLEKGY----------------R------------MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             CCCCCHHHHHHHHHCCC----------------C------------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            98766544433332110                0            0112457899999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.9e-35  Score=247.17  Aligned_cols=197  Identities=21%  Similarity=0.305  Sum_probs=152.3

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++     .+....++||||+. ++|.+++...   ...+++..+..++.|++.||.|||++ |++|
T Consensus        47 l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H  117 (252)
T cd05084          47 LKQYSHPNIVRLIGVC-----TQKQPIYIVMELVQGGDFLTFLRTE---GPRLKVKELIQMVENAAAGMEYLESK-HCIH  117 (252)
T ss_pred             HHhCCCCCcceEEEEE-----cCCCCeEEEEeeccCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC-Cccc
Confidence            4678999999999998     33445899999998 6888887642   34688999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcc---cccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI---SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQP  155 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~  155 (292)
                      |||||+||+++.++ .++|+|||.+..........   ....+..|+|||.+.+. .++.++|+||+||++|+|++ |..
T Consensus       118 ~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~e~~~~~~~  195 (252)
T cd05084         118 RDLAARNCLVTEKN-VLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYG-RYSSESDVWSFGILLWEAFSLGAV  195 (252)
T ss_pred             cccchheEEEcCCC-cEEECccccCcccccccccccCCCCCCceeecCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCC
Confidence            99999999999887 79999999987543221111   11224569999998654 48999999999999999998 888


Q ss_pred             CCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHh
Q 022799          156 LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL  235 (292)
Q Consensus       156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l  235 (292)
                      ||...........+.... .                           ...+...+..+.+++.+||..||++|||+.+++
T Consensus       196 p~~~~~~~~~~~~~~~~~-~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~  247 (252)
T cd05084         196 PYANLSNQQTREAIEQGV-R---------------------------LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVH  247 (252)
T ss_pred             CccccCHHHHHHHHHcCC-C---------------------------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence            886655433222222100 0                           001235688999999999999999999999987


Q ss_pred             c
Q 022799          236 I  236 (292)
Q Consensus       236 ~  236 (292)
                      +
T Consensus       248 ~  248 (252)
T cd05084         248 Q  248 (252)
T ss_pred             H
Confidence            4

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.3e-35  Score=252.87  Aligned_cols=208  Identities=30%  Similarity=0.503  Sum_probs=165.8

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++..     ....++|+||++ ++|.+++....   ..++...+..++.|++.||.|||+. |++|
T Consensus        69 l~~l~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~-gi~H  139 (286)
T cd06614          69 MKDCKHPNIVDYYDSYLV-----GDELWVVMEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ-NVIH  139 (286)
T ss_pred             HHHCCCCCeeEEEEEEEE-----CCEEEEEEeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC-Ceee
Confidence            357899999999999844     345899999999 79999887632   3789999999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCC-CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      +||+|+||+++.++ .++|+|||.+....... ......++..|+|||.+.+. .++.++|+||+||++|+|++|..||.
T Consensus       140 ~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slGvil~~l~~g~~p~~  217 (286)
T cd06614         140 RDIKSDNILLSKDG-SVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRK-DYGPKVDIWSLGIMCIEMAEGEPPYL  217 (286)
T ss_pred             CCCChhhEEEcCCC-CEEECccchhhhhccchhhhccccCCcccCCHhHhcCC-CCCCccccHHHHHHHHHHHhCCCCCC
Confidence            99999999999887 79999999876543322 11234578889999998654 48999999999999999999999998


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCC
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  238 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp  238 (292)
                      +.+.......+... +.+..                         .....++..++++|.+||+.+|.+|||+.+++.|+
T Consensus       218 ~~~~~~~~~~~~~~-~~~~~-------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~  271 (286)
T cd06614         218 REPPLRALFLITTK-GIPPL-------------------------KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHP  271 (286)
T ss_pred             CCCHHHHHHHHHhc-CCCCC-------------------------cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhCh
Confidence            76655443333221 00000                         00123788999999999999999999999999999


Q ss_pred             CccccCC
Q 022799          239 FFDELRD  245 (292)
Q Consensus       239 ~~~~~~~  245 (292)
                      ||+....
T Consensus       272 ~~~~~~~  278 (286)
T cd06614         272 FLKKACP  278 (286)
T ss_pred             HhhccCc
Confidence            9998543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2.1e-35  Score=247.76  Aligned_cols=195  Identities=23%  Similarity=0.337  Sum_probs=154.2

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++     .++ ..++||||++ |+|.+++..    ...+++..+..++.|++.||.|||++ |++|
T Consensus        50 l~~l~h~~i~~~~~~~-----~~~-~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~-~i~H  118 (257)
T cd05116          50 MQQLDNPYIVRMIGIC-----EAE-SWMLVMELAELGPLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEET-NFVH  118 (257)
T ss_pred             HHhCCCCCcceEEEEE-----cCC-CcEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CEee
Confidence            3568999999999876     222 3689999999 688888864    35689999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCc----ccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQ  154 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~  154 (292)
                      |||||+||+++.++ .++|+|||.+.........    ....++..|+|||.+.+ ..++.++|+||+||++|||++ |.
T Consensus       119 ~dlkp~nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~  196 (257)
T cd05116         119 RDLAARNVLLVTQH-YAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQ  196 (257)
T ss_pred             cccchhhEEEcCCC-eEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCC
Confidence            99999999999877 7999999999776433221    11233578999998854 448899999999999999998 99


Q ss_pred             CCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHH
Q 022799          155 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA  234 (292)
Q Consensus       155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~  234 (292)
                      .||.+.+..+....+.+. ..+                           ..+..+++++.++|.+||+.||++||++++|
T Consensus       197 ~p~~~~~~~~~~~~i~~~-~~~---------------------------~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i  248 (257)
T cd05116         197 KPYKGMKGNEVTQMIESG-ERM---------------------------ECPQRCPPEMYDLMKLCWTYGVDERPGFAVV  248 (257)
T ss_pred             CCCCCCCHHHHHHHHHCC-CCC---------------------------CCCCCCCHHHHHHHHHHhccCchhCcCHHHH
Confidence            999876665444433221 000                           0124578999999999999999999999988


Q ss_pred             hc
Q 022799          235 LI  236 (292)
Q Consensus       235 l~  236 (292)
                      ..
T Consensus       249 ~~  250 (257)
T cd05116         249 EL  250 (257)
T ss_pred             HH
Confidence            63

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=7.1e-36  Score=256.70  Aligned_cols=200  Identities=21%  Similarity=0.310  Sum_probs=154.5

Q ss_pred             CCC-CCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHH
Q 022799            2 RLL-DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYK------------MSQRMPLIYVKLYFYQICRA   67 (292)
Q Consensus         2 ~~l-~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~------------~~~~~~~~~~~~~~~qil~a   67 (292)
                      +++ +||||+++++++     ....++++||||++ ++|.+++.....            ....+++..++.++.||+.|
T Consensus        62 ~~l~~h~~iv~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~a  136 (303)
T cd05088          62 CKLGHHPNIINLLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARG  136 (303)
T ss_pred             HHhcCCCCcceEEEEE-----CCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHH
Confidence            356 899999999998     44456899999998 699998865421            12357899999999999999


Q ss_pred             HHHHHhcCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHH
Q 022799           68 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVL  147 (292)
Q Consensus        68 l~~LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il  147 (292)
                      |+|||++ |++||||||+||+++.++ .++|+|||++.............++..|+|||.+.+. .++.++|+||+||++
T Consensus       137 l~~LH~~-gi~H~dlkp~Nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il  213 (303)
T cd05088         137 MDYLSQK-QFIHRDLAARNILVGENY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLL  213 (303)
T ss_pred             HHHHHhC-CccccccchheEEecCCC-cEEeCccccCcccchhhhcccCCCcccccCHHHHhcc-CCcccccchhhhhHH
Confidence            9999987 999999999999999887 7999999998643221111122335679999988554 488999999999999


Q ss_pred             HHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCC
Q 022799          148 AELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPN  226 (292)
Q Consensus       148 ~el~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~  226 (292)
                      |+|+| |..||.+.+..+....+...               . ..            ..+...++++.++|.+||..+|+
T Consensus       214 ~ellt~g~~p~~~~~~~~~~~~~~~~---------------~-~~------------~~~~~~~~~~~~li~~~l~~~p~  265 (303)
T cd05088         214 WEIVSLGGTPYCGMTCAELYEKLPQG---------------Y-RL------------EKPLNCDDEVYDLMRQCWREKPY  265 (303)
T ss_pred             HHHHhcCCCCcccCChHHHHHHHhcC---------------C-cC------------CCCCCCCHHHHHHHHHHcCCChh
Confidence            99998 99999776654433322110               0 00            01134678999999999999999


Q ss_pred             CcccHHHHhcC
Q 022799          227 LRSTALEALIH  237 (292)
Q Consensus       227 ~R~t~~e~l~h  237 (292)
                      +||++++++.+
T Consensus       266 ~Rp~~~~il~~  276 (303)
T cd05088         266 ERPSFAQILVS  276 (303)
T ss_pred             hCcCHHHHHHH
Confidence            99999999875

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=7.9e-36  Score=255.22  Aligned_cols=206  Identities=28%  Similarity=0.456  Sum_probs=162.6

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++..     ....++|+||++ ++|.+++..     ..+++..+..++.|++.||.|||++ |++|
T Consensus        70 l~~l~hp~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~-gi~H  138 (293)
T cd06647          70 MRENKHPNIVNYLDSYLV-----GDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN-QVIH  138 (293)
T ss_pred             HhhcCCCCeeehhheeee-----CCcEEEEEecCCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC-CEee
Confidence            457899999999999843     345899999998 688888763     4578889999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCC-cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      +||+|+||+++.++ .++|+|||++........ .....+++.|+|||.+.+. .++.++|+||+||++|++++|..||.
T Consensus       139 ~dL~p~Nili~~~~-~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~ll~~ll~g~~pf~  216 (293)
T cd06647         139 RDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYL  216 (293)
T ss_pred             ccCCHHHEEEcCCC-CEEEccCcceecccccccccccccCChhhcCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            99999999999887 799999998865533222 2234678889999998654 48899999999999999999999997


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCC
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  238 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp  238 (292)
                      ..+.......+.. .+.+.                       +  ..+..++..++++|.+||..+|.+||++.+++.|+
T Consensus       217 ~~~~~~~~~~~~~-~~~~~-----------------------~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~  270 (293)
T cd06647         217 NENPLRALYLIAT-NGTPE-----------------------L--QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHP  270 (293)
T ss_pred             CCChhhheeehhc-CCCCC-----------------------C--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence            7654332221110 00000                       0  01134678899999999999999999999999999


Q ss_pred             CccccCC
Q 022799          239 FFDELRD  245 (292)
Q Consensus       239 ~~~~~~~  245 (292)
                      ||+..+.
T Consensus       271 ~~~~~~~  277 (293)
T cd06647         271 FLKIAKP  277 (293)
T ss_pred             HHhcCcc
Confidence            9987653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-35  Score=250.29  Aligned_cols=200  Identities=22%  Similarity=0.304  Sum_probs=157.4

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhh------cCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYK------MSQRMPLIYVKLYFYQICRALAYIHN   73 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~------~~~~~~~~~~~~~~~qil~al~~LH~   73 (292)
                      |+.++||||+++++++     .+..+.++||||++ |+|.+++.....      ....+++..+..++.|++.||.|||+
T Consensus        63 l~~~~~~~i~~~~~~~-----~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~  137 (277)
T cd05032          63 MKEFNCHHVVRLLGVV-----STGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA  137 (277)
T ss_pred             HHhCCCCceeEEEEEE-----cCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            3568999999999998     44456899999998 799998865322      12347888999999999999999998


Q ss_pred             cCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCCC---cccccccccccCCccccCCCCCCchhHhhhhhHHHHHH
Q 022799           74 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAEL  150 (292)
Q Consensus        74 ~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el  150 (292)
                      + |++||||||+||+++.++ .++|+|||.++.......   .....++..|+|||.+.+. .++.++|+||+||++|++
T Consensus       138 ~-~i~H~di~p~nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el  214 (277)
T cd05032         138 K-KFVHRDLAARNCMVAEDL-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTKSDVWSFGVVLWEM  214 (277)
T ss_pred             C-CccccccChheEEEcCCC-CEEECCcccchhhccCcccccCCCCCccccccCHHHHhcC-CCCcccchHHHHHHHHHh
Confidence            7 999999999999999988 799999999876543321   1233457789999998654 489999999999999999


Q ss_pred             Hh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcc
Q 022799          151 LL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS  229 (292)
Q Consensus       151 ~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~  229 (292)
                      ++ |..||.+.+..+....+.. ...+                           .++...+..+.++|.+||+.+|++||
T Consensus       215 ~t~g~~p~~~~~~~~~~~~~~~-~~~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp  266 (277)
T cd05032         215 ATLAEQPYQGLSNEEVLKFVID-GGHL---------------------------DLPENCPDKLLELMRMCWQYNPKMRP  266 (277)
T ss_pred             hccCCCCCccCCHHHHHHHHhc-CCCC---------------------------CCCCCCCHHHHHHHHHHcCCChhhCC
Confidence            98 9999987665544333321 0000                           01234688999999999999999999


Q ss_pred             cHHHHhc
Q 022799          230 TALEALI  236 (292)
Q Consensus       230 t~~e~l~  236 (292)
                      |+.++++
T Consensus       267 t~~~l~~  273 (277)
T cd05032         267 TFLEIVS  273 (277)
T ss_pred             CHHHHHH
Confidence            9999985

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2.4e-35  Score=246.81  Aligned_cols=203  Identities=30%  Similarity=0.482  Sum_probs=164.7

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++.+++..     ....++||||++ ++|.+++.........+++..+..++.|++.||.|||+. |++|
T Consensus        53 l~~l~~~~i~~~~~~~~~-----~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~-~i~h  126 (256)
T cd08530          53 LASVNHPNIISYKEAFLD-----GNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ-KILH  126 (256)
T ss_pred             HHhCCCCCchhhhhhhcc-----CCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC-Cccc
Confidence            357889999999998843     355899999997 589988876554456789999999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      +||+|+||+++.++ .++|+|||.+...... ......+++.|+|||.+.+. .++.++|+||+|+++++|++|..||..
T Consensus       127 ~~l~~~ni~~~~~~-~~kl~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~p~~~  203 (256)
T cd08530         127 RDLKSANILLVAND-LVKIGDLGISKVLKKN-MAKTQIGTPHYMAPEVWKGR-PYSYKSDIWSLGCLLYEMATFAPPFEA  203 (256)
T ss_pred             CCCCcceEEEecCC-cEEEeeccchhhhccC-CcccccCCccccCHHHHCCC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            99999999999877 7999999998776444 23335678899999999664 488899999999999999999999987


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCC
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF  239 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~  239 (292)
                      .+.......+...              .+     +         ..+..++.+++++|.+||..+|.+|||+.++++||+
T Consensus       204 ~~~~~~~~~~~~~--------------~~-----~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~  255 (256)
T cd08530         204 RSMQDLRYKVQRG--------------KY-----P---------PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPA  255 (256)
T ss_pred             CCHHHHHHHHhcC--------------CC-----C---------CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCC
Confidence            6654433322210              00     0         011347889999999999999999999999999997


Q ss_pred             c
Q 022799          240 F  240 (292)
Q Consensus       240 ~  240 (292)
                      +
T Consensus       256 ~  256 (256)
T cd08530         256 V  256 (256)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-36  Score=235.79  Aligned_cols=209  Identities=28%  Similarity=0.397  Sum_probs=159.5

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCC--cc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG--VC   78 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~--i~   78 (292)
                      ++++||||+++++.......+.....|++++|.. |+|.+.+......+..+++.++..++.+|+.||++||+. .  .+
T Consensus        73 rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yA  151 (302)
T KOG2345|consen   73 RKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYA  151 (302)
T ss_pred             HhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCccc
Confidence            4679999999998766544445667899999998 899999998777677899999999999999999999987 8  99


Q ss_pred             ccCCCCCcEEEeCCCCcEEEeecCCccccccCCC----------cccccccccccCCccccCC--CCCCchhHhhhhhHH
Q 022799           79 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP----------NISYICSRYYRAPELIFGA--TEYTAAIDIWSAGCV  146 (292)
Q Consensus        79 H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~----------~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwslG~i  146 (292)
                      ||||||.||+++.++ .++|.|||.+....-.-.          .....+|..|+|||++.-.  ...+.++|||||||+
T Consensus       152 H~DiKP~NILls~~~-~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCt  230 (302)
T KOG2345|consen  152 HRDIKPANILLSDSG-LPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCT  230 (302)
T ss_pred             ccCCCcceeEecCCC-ceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHH
Confidence            999999999999877 799999999875421110          0123468899999998433  236889999999999


Q ss_pred             HHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCC
Q 022799          147 LAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPN  226 (292)
Q Consensus       147 l~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~  226 (292)
                      +|.|+.|..||..         +.+..+....   .-.+   ..+.+|..          ..+|+.+.++|+.||+.||.
T Consensus       231 LYa~mf~~sPfe~---------~~~~GgSlaL---Av~n---~q~s~P~~----------~~yse~l~~lik~mlqvdP~  285 (302)
T KOG2345|consen  231 LYAMMFGESPFER---------IYQQGGSLAL---AVQN---AQISIPNS----------SRYSEALHQLIKSMLQVDPN  285 (302)
T ss_pred             HHHHHHcCCcchH---------HhhcCCeEEE---eeec---cccccCCC----------CCccHHHHHHHHHHhcCCcc
Confidence            9999999999941         1111110000   0000   01111111          34899999999999999999


Q ss_pred             CcccHHHHhcC
Q 022799          227 LRSTALEALIH  237 (292)
Q Consensus       227 ~R~t~~e~l~h  237 (292)
                      +||++.+++.+
T Consensus       286 qRP~i~~ll~~  296 (302)
T KOG2345|consen  286 QRPTIPELLSK  296 (302)
T ss_pred             cCCCHHHHHHH
Confidence            99999999864

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=2.3e-35  Score=249.36  Aligned_cols=206  Identities=20%  Similarity=0.284  Sum_probs=157.1

Q ss_pred             CCCCCCCCeeeeceeeeccCC-CCceeEEEEeeccc-CCHHHHHHhhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 022799            1 MRLLDHPNVVSLKHCFFSTTE-KDELYLNLVLEYVP-ETVHRVIKHHYK--MSQRMPLIYVKLYFYQICRALAYIHNTIG   76 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~-~~~~~~~lv~e~~~-g~L~~~l~~~~~--~~~~~~~~~~~~~~~qil~al~~LH~~~~   76 (292)
                      |+.++||||+++++.+..... ......++||||+. |+|.+.+.....  ....+++..+..++.||+.||.|||++ |
T Consensus        54 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~  132 (272)
T cd05075          54 MKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK-S  132 (272)
T ss_pred             HHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC-C
Confidence            357899999999987654332 22335789999998 788887753221  234588999999999999999999988 9


Q ss_pred             ccccCCCCCcEEEeCCCCcEEEeecCCccccccCCC---cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-
Q 022799           77 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-  152 (292)
Q Consensus        77 i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-  152 (292)
                      |+||||||+||+++.++ .++|+|||+++.......   .....+++.|++||...+. .++.++|+||+||++|+|++ 
T Consensus       133 i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~el~~~  210 (272)
T cd05075         133 FIHRDLAARNCMLNENM-NVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADR-VYTTKSDVWSFGVTMWEIATR  210 (272)
T ss_pred             eeccccchhheEEcCCC-CEEECCCCcccccCcccceecCCcccCCcccCCHHHccCC-CcChHHHHHHHHHHHHHHHcC
Confidence            99999999999999887 799999999987643321   1122356789999998654 58999999999999999999 


Q ss_pred             CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHH
Q 022799          153 GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAL  232 (292)
Q Consensus       153 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~  232 (292)
                      |..||.+.........+... ..+                           ..+..++..+.++|.+||+.||.+|||+.
T Consensus       211 g~~p~~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~  262 (272)
T cd05075         211 GQTPYPGVENSEIYDYLRQG-NRL---------------------------KQPPDCLDGLYSLMSSCWLLNPKDRPSFE  262 (272)
T ss_pred             CCCCCCCCCHHHHHHHHHcC-CCC---------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHH
Confidence            88999876554433322210 000                           01245788999999999999999999999


Q ss_pred             HHhcC
Q 022799          233 EALIH  237 (292)
Q Consensus       233 e~l~h  237 (292)
                      +++++
T Consensus       263 ~l~~~  267 (272)
T cd05075         263 TLRCE  267 (272)
T ss_pred             HHHHH
Confidence            99853

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.9e-35  Score=250.76  Aligned_cols=203  Identities=26%  Similarity=0.415  Sum_probs=162.7

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++     .++.+.++||||++ ++|.+++..     ..+++..+..++.|++.|+.+||++ |++|
T Consensus        56 l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h  124 (277)
T cd06641          56 LSQCDSPYVTKYYGSY-----LKDTKLWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE-KKIH  124 (277)
T ss_pred             HHhcCCCCEeEEEEEE-----EeCCeEEEEEEeCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccC-Ceec
Confidence            3578999999999998     44456899999998 588877753     4688999999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCC-cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      +||+|+||+++.++ .++|+|||++........ .....++..|+|||.+.+. .++.++|+||+||++|+|++|..||.
T Consensus       125 ~dl~p~Ni~i~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~  202 (277)
T cd06641         125 RDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPHS  202 (277)
T ss_pred             CCCCHHhEEECCCC-CEEEeecccceecccchhhhccccCCccccChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCC
Confidence            99999999999887 799999999876543221 2234578889999998654 47899999999999999999999997


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCC
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  238 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp  238 (292)
                      ..........+... ..                           ..++..++.++.++|.+||..+|.+||++.++++||
T Consensus       203 ~~~~~~~~~~~~~~-~~---------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~  254 (277)
T cd06641         203 ELHPMKVLFLIPKN-NP---------------------------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK  254 (277)
T ss_pred             ccchHHHHHHHhcC-CC---------------------------CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCH
Confidence            65544333322110 00                           001245788999999999999999999999999999


Q ss_pred             CccccC
Q 022799          239 FFDELR  244 (292)
Q Consensus       239 ~~~~~~  244 (292)
                      ||....
T Consensus       255 ~~~~~~  260 (277)
T cd06641         255 FIVRFA  260 (277)
T ss_pred             HHhhhh
Confidence            998743

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2.8e-35  Score=247.67  Aligned_cols=204  Identities=32%  Similarity=0.542  Sum_probs=158.6

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++     .+...+++|+||++ ++|.+++..    ...+++..+..++.|++.||.|||+. |++|
T Consensus        53 ~~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~-~i~H  122 (264)
T cd06626          53 LELLKHPNLVKYYGVE-----VHREKVYIFMEYCSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSH-GIVH  122 (264)
T ss_pred             HHhCCCCChhheeeeE-----ecCCEEEEEEecCCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHC-Cccc
Confidence            3578999999999987     33445899999998 688888764    34578899999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCc-----ccccccccccCCccccCCC--CCCchhHhhhhhHHHHHHHh
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-----ISYICSRYYRAPELIFGAT--EYTAAIDIWSAGCVLAELLL  152 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~--~~~~~~DvwslG~il~el~~  152 (292)
                      +||+|+||+++.++ .++|+|||.+.........     ....++..|+|||.+.+..  .++.++|+||+||++|+|++
T Consensus       123 ~dl~~~nil~~~~~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~  201 (264)
T cd06626         123 RDIKPANIFLDHNG-VIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMAT  201 (264)
T ss_pred             CCCCHHHEEECCCC-CEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHh
Confidence            99999999999877 7999999998776433221     1245688899999986543  37889999999999999999


Q ss_pred             CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHH
Q 022799          153 GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAL  232 (292)
Q Consensus       153 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~  232 (292)
                      |..||.+............. +.++              ..+.          ...+++.+.++|.+||+.+|.+|||+.
T Consensus       202 g~~pf~~~~~~~~~~~~~~~-~~~~--------------~~~~----------~~~~~~~~~~li~~~l~~~p~~R~~~~  256 (264)
T cd06626         202 GKRPWSELDNEFQIMFHVGA-GHKP--------------PIPD----------SLQLSPEGKDFLDRCLESDPKKRPTAS  256 (264)
T ss_pred             CCCCccCCcchHHHHHHHhc-CCCC--------------CCCc----------ccccCHHHHHHHHHHccCCcccCCCHH
Confidence            99999765332222111111 1000              0000          023588999999999999999999999


Q ss_pred             HHhcCCCc
Q 022799          233 EALIHPFF  240 (292)
Q Consensus       233 e~l~hp~~  240 (292)
                      +++.|||+
T Consensus       257 ~i~~~~~~  264 (264)
T cd06626         257 ELLQHPFV  264 (264)
T ss_pred             HHhcCCCC
Confidence            99999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-35  Score=246.57  Aligned_cols=199  Identities=36%  Similarity=0.605  Sum_probs=163.0

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++.+     .++...++||||++ ++|.+++...    ..+++..+..++.|++.||.|||+. |++|
T Consensus        47 l~~l~h~~i~~~~~~~-----~~~~~~~~v~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lh~~-~~~H  116 (250)
T cd05123          47 LSRINHPFIVKLHYAF-----QTEEKLYLVLEYAPGGELFSHLSKE----GRFSEERARFYAAEIVLALEYLHSL-GIIY  116 (250)
T ss_pred             HHHcCCCcHHHHHHHe-----ecCCeeEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-Ccee
Confidence            3567899999999988     55556999999995 7998888753    4689999999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccC-CCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      +||+|+||+++.++ .++|+|||.+...... .......++..|+|||...+.. .+.++|+||+|+++|++++|..||.
T Consensus       117 ~~l~p~ni~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~~  194 (250)
T cd05123         117 RDLKPENILLDADG-HIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKG-YGKAVDWWSLGVLLYEMLTGKPPFY  194 (250)
T ss_pred             cCCCcceEEEcCCC-cEEEeecCcceecccCCCcccCCcCCccccChHHhCCCC-CCchhhHHHHHHHHHHHHHCCCCCC
Confidence            99999999999888 7999999998776443 2233456788999999986544 7899999999999999999999997


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccH---HHHh
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA---LEAL  235 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~---~e~l  235 (292)
                      ..........+..  .               ..            .++...+..+.++|++||..||++||++   ++++
T Consensus       195 ~~~~~~~~~~~~~--~---------------~~------------~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~  245 (250)
T cd05123         195 AEDRKEIYEKILK--D---------------PL------------RFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIK  245 (250)
T ss_pred             CCCHHHHHHHHhc--C---------------CC------------CCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHH
Confidence            6655333333322  0               00            1224568899999999999999999999   9999


Q ss_pred             cCCCc
Q 022799          236 IHPFF  240 (292)
Q Consensus       236 ~hp~~  240 (292)
                      +||||
T Consensus       246 ~~~~f  250 (250)
T cd05123         246 AHPFF  250 (250)
T ss_pred             hCCCC
Confidence            99998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-35  Score=250.21  Aligned_cols=199  Identities=21%  Similarity=0.312  Sum_probs=152.8

Q ss_pred             CCC-CCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHH
Q 022799            2 RLL-DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYK------------MSQRMPLIYVKLYFYQICRA   67 (292)
Q Consensus         2 ~~l-~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~------------~~~~~~~~~~~~~~~qil~a   67 (292)
                      +++ +||||+++++++     ....+.++||||+. |+|.+++.....            ....+++..+..++.|++.|
T Consensus        50 ~~l~~h~~iv~~~~~~-----~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~a  124 (270)
T cd05047          50 CKLGHHPNIINLLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARG  124 (270)
T ss_pred             HhhccCCCeeeEEEEE-----ecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHH
Confidence            356 799999999998     34445899999998 799998875321            12357899999999999999


Q ss_pred             HHHHHhcCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHH
Q 022799           68 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVL  147 (292)
Q Consensus        68 l~~LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il  147 (292)
                      |+|||++ |++||||||+||+++.++ .++|+|||++..............+..|+|||.+.+ ..++.++|+||+||++
T Consensus       125 l~~lH~~-~i~H~dikp~nili~~~~-~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il  201 (270)
T cd05047         125 MDYLSQK-QFIHRDLAARNILVGENY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLL  201 (270)
T ss_pred             HHHHHHC-CEeecccccceEEEcCCC-eEEECCCCCccccchhhhccCCCCccccCChHHHcc-CCCCchhhHHHHHHHH
Confidence            9999987 999999999999999888 799999999864321111111223567999999855 4589999999999999


Q ss_pred             HHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCC
Q 022799          148 AELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPN  226 (292)
Q Consensus       148 ~el~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~  226 (292)
                      |+|++ |..||.+.+..+....+...                  ...          ..+..++.++.+++.+||..||.
T Consensus       202 ~el~~~g~~pf~~~~~~~~~~~~~~~------------------~~~----------~~~~~~~~~~~~li~~~l~~~p~  253 (270)
T cd05047         202 WEIVSLGGTPYCGMTCAELYEKLPQG------------------YRL----------EKPLNCDDEVYDLMRQCWREKPY  253 (270)
T ss_pred             HHHHcCCCCCccccCHHHHHHHHhCC------------------CCC----------CCCCcCCHHHHHHHHHHcccChh
Confidence            99997 99999776554433332110                  000          01134678999999999999999


Q ss_pred             CcccHHHHhc
Q 022799          227 LRSTALEALI  236 (292)
Q Consensus       227 ~R~t~~e~l~  236 (292)
                      +|||+.+++.
T Consensus       254 ~Rps~~~il~  263 (270)
T cd05047         254 ERPSFAQILV  263 (270)
T ss_pred             hCCCHHHHHH
Confidence            9999999984

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=3e-35  Score=247.32  Aligned_cols=198  Identities=25%  Similarity=0.354  Sum_probs=156.9

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++     .+....+++|||+. ++|.+++...  ....+++..+..++.|++.||.|||++ |++|
T Consensus        55 l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~-~i~H  126 (261)
T cd05072          55 MKTLQHDKLVRLYAVV-----TKEEPIYIITEYMAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERK-NYIH  126 (261)
T ss_pred             HHhCCCCCeeeEEEEE-----cCCCCcEEEEecCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC-Ceec
Confidence            3578999999999988     44445899999997 6999888653  235688889999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCC--cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPL  156 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~p  156 (292)
                      |||||+||+++.++ .++|+|||.+........  .....++..|+|||.+.+. .++.++|+||+||++|+|++ |..|
T Consensus       127 ~dl~p~nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p  204 (261)
T cd05072         127 RDLRAANVLVSESL-MCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLYEIVTYGKIP  204 (261)
T ss_pred             cccchhhEEecCCC-cEEECCCccceecCCCceeccCCCccceecCCHHHhccC-CCChhhhhhhhHHHHHHHHccCCCC
Confidence            99999999999887 799999999976543221  1122346679999998654 48899999999999999998 9999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      |.+....+....+......                  +          ....++.++.+++.+||..+|++|||++++++
T Consensus       205 ~~~~~~~~~~~~~~~~~~~------------------~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         205 YPGMSNSDVMSALQRGYRM------------------P----------RMENCPDELYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             CCCCCHHHHHHHHHcCCCC------------------C----------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            9877665544443321100                  0          11347889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-35  Score=248.80  Aligned_cols=206  Identities=20%  Similarity=0.302  Sum_probs=159.3

Q ss_pred             CCCCCCCCeeeeceeeeccCC-CCceeEEEEeeccc-CCHHHHHHhhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 022799            1 MRLLDHPNVVSLKHCFFSTTE-KDELYLNLVLEYVP-ETVHRVIKHHYK--MSQRMPLIYVKLYFYQICRALAYIHNTIG   76 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~-~~~~~~~lv~e~~~-g~L~~~l~~~~~--~~~~~~~~~~~~~~~qil~al~~LH~~~~   76 (292)
                      |+.++||||+++++++..... .+..+.++||||+. |+|..++.....  ....+++..+..++.|++.||.|||++ |
T Consensus        55 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~-~  133 (273)
T cd05035          55 MKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR-N  133 (273)
T ss_pred             HHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC-C
Confidence            356899999999998755433 33446789999998 799888765432  124689999999999999999999988 9


Q ss_pred             ccccCCCCCcEEEeCCCCcEEEeecCCccccccCCCc---ccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-
Q 022799           77 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-  152 (292)
Q Consensus        77 i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-  152 (292)
                      ++||||||+||+++.++ .+||+|||.++........   ....++..|+|||.+.+ ..++.++|+||+||++|||++ 
T Consensus       134 i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~  211 (273)
T cd05035         134 FIHRDLAARNCMLREDM-TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATR  211 (273)
T ss_pred             eeccccchheEEECCCC-eEEECCccceeeccccccccccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhC
Confidence            99999999999999887 7999999999865433211   11234667999999854 458999999999999999999 


Q ss_pred             CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHH
Q 022799          153 GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAL  232 (292)
Q Consensus       153 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~  232 (292)
                      |..||.+....+....+....                ..            ..+..+++.+.+++.+||..||++|||+.
T Consensus       212 g~~p~~~~~~~~~~~~~~~~~----------------~~------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~  263 (273)
T cd05035         212 GQTPYPGVENHEIYDYLRHGN----------------RL------------KQPEDCLDELYDLMYSCWRADPKDRPTFT  263 (273)
T ss_pred             CCCCCCCCCHHHHHHHHHcCC----------------CC------------CCCcCCCHHHHHHHHHHcCCChhhCcCHH
Confidence            889998766554433332110                00            01245788999999999999999999999


Q ss_pred             HHhcC
Q 022799          233 EALIH  237 (292)
Q Consensus       233 e~l~h  237 (292)
                      +++++
T Consensus       264 e~~~~  268 (273)
T cd05035         264 KLREV  268 (273)
T ss_pred             HHHHH
Confidence            99853

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.3e-35  Score=248.69  Aligned_cols=202  Identities=30%  Similarity=0.448  Sum_probs=157.8

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++..     ....++||||++ ++|.+++.........+++..+..++.|++.||.|||++ |++|
T Consensus        56 l~~l~h~~i~~~~~~~~~-----~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H  129 (267)
T cd08228          56 LKQLNHPNVIKYLDSFIE-----DNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR-RVMH  129 (267)
T ss_pred             HHhCCCcceeeeeeeEEE-----CCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC-CeeC
Confidence            467899999999998843     335889999999 689888875544455689999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCC-cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      +||||+||+++.++ .++|+|||.+........ .....+++.|+|||.+.+. .++.++|+||+|+++|+|++|..||.
T Consensus       130 ~dl~~~nil~~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~  207 (267)
T cd08228         130 RDIKPANVFITATG-VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFY  207 (267)
T ss_pred             CCCCHHHEEEcCCC-CEEECccccceeccchhHHHhcCCCCccccChhhhccC-CCCchhhHHHHHHHHHHHhcCCCCCc
Confidence            99999999999887 799999999876543221 1234678899999998664 47899999999999999999999996


Q ss_pred             CCCcH-HHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          159 GESGV-DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       159 ~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      ..... ..........+.++                          .....++..+.++|.+||..+|++|||+.++++
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~  260 (267)
T cd08228         208 GDKMNLFSLCQKIEQCDYPP--------------------------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ  260 (267)
T ss_pred             cccccHHHHHHHHhcCCCCC--------------------------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence            54321 12222221111111                          001246788999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.5e-35  Score=246.31  Aligned_cols=198  Identities=20%  Similarity=0.333  Sum_probs=155.9

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++     .+..+.++||||++ ++|.+++...   ...+++..+..++.|++.||.|||++ |++|
T Consensus        53 l~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H  123 (256)
T cd05059          53 MMKLSHPNLVQLYGVC-----TKQRPIFIVTEYMANGCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESN-GFIH  123 (256)
T ss_pred             HHhCCCCCEEEEEEEE-----cCCCceEEEEecCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC-Cccc
Confidence            3578999999999988     44445899999997 6898888643   24689999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcc--cccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI--SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPL  156 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~p  156 (292)
                      |||||+||+++.++ .+||+|||.++...+.....  ...++..|+|||.+.+. .++.++|+||+||++|+|++ |..|
T Consensus       124 ~dl~p~ni~i~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~il~~l~~~g~~p  201 (256)
T cd05059         124 RDLAARNCLVGEDN-VVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYS-RFSSKSDVWSFGVLMWEVFSEGKMP  201 (256)
T ss_pred             ccccHhhEEECCCC-cEEECCcccceecccccccccCCCCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHhccCCCC
Confidence            99999999999888 79999999987654322111  11234579999998664 48999999999999999998 8999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      |.+.+..+....+.....                            ...+...+..+.+++.+||..+|++|||+.++++
T Consensus       202 ~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~  253 (256)
T cd05059         202 YERFSNSEVVESVSAGYR----------------------------LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLS  253 (256)
T ss_pred             CCCCCHHHHHHHHHcCCc----------------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            977665544433321100                            0011347889999999999999999999999985


Q ss_pred             C
Q 022799          237 H  237 (292)
Q Consensus       237 h  237 (292)
                      .
T Consensus       254 ~  254 (256)
T cd05059         254 Q  254 (256)
T ss_pred             H
Confidence            3

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=3.3e-35  Score=249.31  Aligned_cols=202  Identities=20%  Similarity=0.318  Sum_probs=155.9

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKM---SQRMPLIYVKLYFYQICRALAYIHNTIG   76 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~---~~~~~~~~~~~~~~qil~al~~LH~~~~   76 (292)
                      |+.++||||+++++++.+     ....++||||+. ++|.+++......   ...+++..+..++.||+.||.|||++ |
T Consensus        63 l~~l~~~~i~~~~~~~~~-----~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~-~  136 (277)
T cd05036          63 MSKFNHQNIVRLIGVSFE-----RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN-H  136 (277)
T ss_pred             HHhCCCCCEeeEEEEEcc-----CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-C
Confidence            357899999999998843     334789999997 6999988754321   13588999999999999999999988 9


Q ss_pred             ccccCCCCCcEEEeCCC--CcEEEeecCCccccccCCCc---ccccccccccCCccccCCCCCCchhHhhhhhHHHHHHH
Q 022799           77 VCHRDIKPQNLLVNPHT--HQLKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL  151 (292)
Q Consensus        77 i~H~dlkp~Nill~~~~--~~ikl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~  151 (292)
                      ++||||||+||+++.++  ..++|+|||+++........   .....+..|+|||.+.+.. ++.++|+||+||++|+|+
T Consensus       137 ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~  215 (277)
T cd05036         137 FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGI-FTSKTDVWSFGVLLWEIF  215 (277)
T ss_pred             EeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCC-cCchhHHHHHHHHHHHHH
Confidence            99999999999998653  25899999999866322111   1222356799999996644 899999999999999999


Q ss_pred             h-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCccc
Q 022799          152 L-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST  230 (292)
Q Consensus       152 ~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t  230 (292)
                      + |..||.+.+..+....+... ..               .            ..+..++..+.+++.+||+.+|++|||
T Consensus       216 ~~g~~pf~~~~~~~~~~~~~~~-~~---------------~------------~~~~~~~~~~~~~i~~cl~~~p~~Rps  267 (277)
T cd05036         216 SLGYMPYPGRTNQEVMEFVTGG-GR---------------L------------DPPKGCPGPVYRIMTDCWQHTPEDRPN  267 (277)
T ss_pred             cCCCCCCCCCCHHHHHHHHHcC-Cc---------------C------------CCCCCCCHHHHHHHHHHcCCCcccCcC
Confidence            7 99999876655433322210 00               0            012457889999999999999999999


Q ss_pred             HHHHhcC
Q 022799          231 ALEALIH  237 (292)
Q Consensus       231 ~~e~l~h  237 (292)
                      +.++++|
T Consensus       268 ~~~vl~~  274 (277)
T cd05036         268 FATILER  274 (277)
T ss_pred             HHHHHHH
Confidence            9999975

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.8e-35  Score=252.89  Aligned_cols=200  Identities=21%  Similarity=0.345  Sum_probs=156.2

Q ss_pred             CCC-CCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhh------------hcCCCCCHHHHHHHHHHHHHH
Q 022799            2 RLL-DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHY------------KMSQRMPLIYVKLYFYQICRA   67 (292)
Q Consensus         2 ~~l-~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~------------~~~~~~~~~~~~~~~~qil~a   67 (292)
                      +++ +||||+++++++     .....+++||||+. |+|..++....            .....+++..+..++.|++.|
T Consensus        70 ~~l~~h~~i~~~~~~~-----~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~a  144 (293)
T cd05053          70 KMIGKHKNIINLLGVC-----TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARG  144 (293)
T ss_pred             HhhcCCCCeeeEEEEE-----cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHH
Confidence            355 799999999988     33445899999998 79998886532            224568899999999999999


Q ss_pred             HHHHHhcCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCCC---cccccccccccCCccccCCCCCCchhHhhhhh
Q 022799           68 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAG  144 (292)
Q Consensus        68 l~~LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG  144 (292)
                      |.|||++ ||+||||||+||+++.++ .++|+|||.++.......   .....++..|+|||.+.+. .++.++|+||+|
T Consensus       145 l~~LH~~-~ivH~dlkp~Nil~~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG  221 (293)
T cd05053         145 MEFLASK-KCIHRDLAARNVLVTEDH-VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFG  221 (293)
T ss_pred             HHHHHHC-CccccccceeeEEEcCCC-eEEeCccccccccccccceeccCCCCCCccccCHHHhccC-CcCcccceeehh
Confidence            9999988 999999999999999887 799999999986543221   1122345679999998554 489999999999


Q ss_pred             HHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhcc
Q 022799          145 CVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQY  223 (292)
Q Consensus       145 ~il~el~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  223 (292)
                      |++|+|++ |..||.+....+....+....                ..            ..+...+..+.+|+.+||..
T Consensus       222 ~il~el~~~g~~p~~~~~~~~~~~~~~~~~----------------~~------------~~~~~~~~~~~~li~~~l~~  273 (293)
T cd05053         222 VLLWEIFTLGGSPYPGIPVEELFKLLKEGY----------------RM------------EKPQNCTQELYHLMRDCWHE  273 (293)
T ss_pred             hHHHHHhcCCCCCCCCCCHHHHHHHHHcCC----------------cC------------CCCCCCCHHHHHHHHHHccc
Confidence            99999997 999998766544433322110                00            01134688999999999999


Q ss_pred             CCCCcccHHHHhcC
Q 022799          224 SPNLRSTALEALIH  237 (292)
Q Consensus       224 dp~~R~t~~e~l~h  237 (292)
                      ||++|||+.+++++
T Consensus       274 ~p~~Rps~~eil~~  287 (293)
T cd05053         274 VPSQRPTFKQLVED  287 (293)
T ss_pred             CcccCcCHHHHHHH
Confidence            99999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2.5e-35  Score=251.65  Aligned_cols=208  Identities=28%  Similarity=0.464  Sum_probs=163.1

Q ss_pred             CCC-CCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            2 RLL-DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         2 ~~l-~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      +++ +||||+++++++     ..+...|+||||++ ++|.+.+..    ...+++..+..++.|++.||.|||+. |++|
T Consensus        59 ~~l~~~~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~-~i~H  128 (290)
T cd05613          59 EHIRQSPFLVTLHYAF-----QTDTKLHLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKL-GIIY  128 (290)
T ss_pred             HhcccCCChhceeeEe-----ecCCeEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC-Ceec
Confidence            345 599999999988     44456899999999 688888765    35688999999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCC--CcccccccccccCCccccCC-CCCCchhHhhhhhHHHHHHHhCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE--PNISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLLGQPL  156 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~p  156 (292)
                      |||+|+||+++.++ .++|+|||++.......  ......|+..|+|||.+.+. ..++.++|+||+||++|+|++|..|
T Consensus       129 ~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p  207 (290)
T cd05613         129 RDIKLENILLDSNG-HVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP  207 (290)
T ss_pred             cCCCHHHeEECCCC-CEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCC
Confidence            99999999999887 79999999987653322  12235678899999998643 2467899999999999999999999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcc-----cH
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TA  231 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----t~  231 (292)
                      |...........+.+.....        .                 ..++..+++.+.+++.+||..||++|+     ++
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~--------~-----------------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~  262 (290)
T cd05613         208 FTVDGEKNSQAEISRRILKS--------E-----------------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDA  262 (290)
T ss_pred             CCcCCccccHHHHHHHhhcc--------C-----------------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCH
Confidence            96543322222222211000        0                 001245788999999999999999997     89


Q ss_pred             HHHhcCCCccccCC
Q 022799          232 LEALIHPFFDELRD  245 (292)
Q Consensus       232 ~e~l~hp~~~~~~~  245 (292)
                      ++++.||||+...+
T Consensus       263 ~~l~~~~~~~~~~~  276 (290)
T cd05613         263 DEIKKHPFFQKINW  276 (290)
T ss_pred             HHHHcCcccccCCH
Confidence            99999999998764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=4.6e-35  Score=245.85  Aligned_cols=196  Identities=22%  Similarity=0.290  Sum_probs=153.9

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++.     .. ..++||||++ ++|.+++...   ...+++..+..++.|++.||.|||++ |++|
T Consensus        49 l~~l~h~~ii~~~~~~~-----~~-~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H  118 (257)
T cd05115          49 MHQLDNPYIVRMIGVCE-----AE-ALMLVMEMASGGPLNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGK-NFVH  118 (257)
T ss_pred             HHhcCCCCeEEEEEEEc-----CC-CeEEEEEeCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhc-Ceee
Confidence            46789999999999872     22 3789999998 6888887642   35689999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCc----ccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQ  154 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~  154 (292)
                      |||||+||+++.++ .+||+|||++.........    ....++..|+|||.+.+. .++.++|+||+||++|++++ |.
T Consensus       119 ~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~  196 (257)
T cd05115         119 RDLAARNVLLVNQH-YAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGITMWEAFSYGQ  196 (257)
T ss_pred             cccchheEEEcCCC-cEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccC-CCCchhhHHHHHHHHHHHhcCCC
Confidence            99999999999877 7999999998765333211    111225679999998654 48999999999999999996 99


Q ss_pred             CCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHH
Q 022799          155 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA  234 (292)
Q Consensus       155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~  234 (292)
                      .||.+....+....+.+.. .                           ..++...++++.++|.+||..||++||++.++
T Consensus       197 ~p~~~~~~~~~~~~~~~~~-~---------------------------~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i  248 (257)
T cd05115         197 KPYKKMKGPEVMSFIEQGK-R---------------------------LDCPAECPPEMYALMKDCWIYKWEDRPNFAKV  248 (257)
T ss_pred             CCcCcCCHHHHHHHHHCCC-C---------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence            9998776655443332210 0                           00124578999999999999999999999998


Q ss_pred             hc
Q 022799          235 LI  236 (292)
Q Consensus       235 l~  236 (292)
                      .+
T Consensus       249 ~~  250 (257)
T cd05115         249 EE  250 (257)
T ss_pred             HH
Confidence            64

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=5.5e-35  Score=245.09  Aligned_cols=198  Identities=23%  Similarity=0.326  Sum_probs=158.8

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++.+..      ...++||||++ ++|.+.+.....  ..+++..+..++.|++.||.|||++ |++|
T Consensus        50 l~~l~h~~iv~~~~~~~~------~~~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H  120 (257)
T cd05040          50 MHSLDHENLIRLYGVVLT------HPLMMVTELAPLGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK-RFIH  120 (257)
T ss_pred             HhhcCCCCccceeEEEcC------CeEEEEEEecCCCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC-Cccc
Confidence            467899999999998843      45889999997 799998876421  4689999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCc----ccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQ  154 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~  154 (292)
                      +||+|+||+++.++ .+||+|||++.........    ....++..|+|||.+.+. .++.++|+||+||++|+|++ |.
T Consensus       121 ~di~p~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Di~slG~~l~el~t~g~  198 (257)
T cd05040         121 RDLAARNILLASDD-KVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTR-TFSHASDVWMFGVTLWEMFTYGE  198 (257)
T ss_pred             cccCcccEEEecCC-EEEeccccccccccccccceecccCCCCCceecCHHHhccc-CcCchhhhHHHHHHHHHHHhCCC
Confidence            99999999999887 7999999998876442211    123456789999998654 48999999999999999998 99


Q ss_pred             CCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHH
Q 022799          155 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA  234 (292)
Q Consensus       155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~  234 (292)
                      .||.+.+..+....+......               .            ..+...+..+.+++.+||..+|++|||+.++
T Consensus       199 ~p~~~~~~~~~~~~~~~~~~~---------------~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~  251 (257)
T cd05040         199 EPWAGLSGSQILKKIDKEGER---------------L------------ERPEACPQDIYNVMLQCWAHNPADRPTFAAL  251 (257)
T ss_pred             CCCCCCCHHHHHHHHHhcCCc---------------C------------CCCccCCHHHHHHHHHHCCCCcccCCCHHHH
Confidence            999877666555544321000               0            0113468899999999999999999999999


Q ss_pred             hc
Q 022799          235 LI  236 (292)
Q Consensus       235 l~  236 (292)
                      ++
T Consensus       252 ~~  253 (257)
T cd05040         252 RE  253 (257)
T ss_pred             HH
Confidence            74

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=3.5e-35  Score=249.84  Aligned_cols=199  Identities=21%  Similarity=0.275  Sum_probs=155.8

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhh------------hcCCCCCHHHHHHHHHHHHHHH
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHY------------KMSQRMPLIYVKLYFYQICRAL   68 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~------------~~~~~~~~~~~~~~~~qil~al   68 (292)
                      +.++||||+++++++.     +....++++||+. ++|.+++....            .....+++..+..++.|++.||
T Consensus        63 ~~l~h~~iv~~~~~~~-----~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL  137 (283)
T cd05091          63 SRLQHPNIVCLLGVVT-----KEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGM  137 (283)
T ss_pred             hcCCCCCcCeEEEEEc-----CCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHH
Confidence            5689999999999883     3334889999998 68888875321            1123578888999999999999


Q ss_pred             HHHHhcCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCCC---cccccccccccCCccccCCCCCCchhHhhhhhH
Q 022799           69 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGC  145 (292)
Q Consensus        69 ~~LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~  145 (292)
                      .|||++ ||+||||||+||+++.++ .+||+|||+++.......   .....+++.|+|||.+.+.. ++.++|+||+||
T Consensus       138 ~~lH~~-gi~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~  214 (283)
T cd05091         138 EFLSSH-HVVHKDLATRNVLVFDKL-NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGK-FSIDSDIWSYGV  214 (283)
T ss_pred             HHHHHc-CccccccchhheEecCCC-ceEecccccccccccchheeeccCccCCccccCHHHHhcCC-CCcchhHHHHHH
Confidence            999988 999999999999999877 799999999876533221   12234567899999986544 899999999999


Q ss_pred             HHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccC
Q 022799          146 VLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYS  224 (292)
Q Consensus       146 il~el~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  224 (292)
                      ++|||++ |..||.+....+....+......                            ..+..++..+.+++.+||+.+
T Consensus       215 ~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~----------------------------~~~~~~~~~~~~li~~cl~~~  266 (283)
T cd05091         215 VLWEVFSYGLQPYCGYSNQDVIEMIRNRQVL----------------------------PCPDDCPAWVYTLMLECWNEF  266 (283)
T ss_pred             HHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC----------------------------CCCCCCCHHHHHHHHHHhCCC
Confidence            9999998 88898876665544443321000                            012467889999999999999


Q ss_pred             CCCcccHHHHhc
Q 022799          225 PNLRSTALEALI  236 (292)
Q Consensus       225 p~~R~t~~e~l~  236 (292)
                      |.+||++.+++.
T Consensus       267 p~~RP~~~~i~~  278 (283)
T cd05091         267 PSRRPRFKDIHS  278 (283)
T ss_pred             cccCCCHHHHHH
Confidence            999999999985

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=4e-35  Score=249.54  Aligned_cols=201  Identities=21%  Similarity=0.322  Sum_probs=156.3

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhh-------------cCCCCCHHHHHHHHHHHHH
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYK-------------MSQRMPLIYVKLYFYQICR   66 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~-------------~~~~~~~~~~~~~~~qil~   66 (292)
                      |+.++||||+++++++.     .....|+||||++ ++|.+++.....             ....+++..+..++.|++.
T Consensus        61 l~~l~h~niv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~  135 (283)
T cd05090          61 MAELHHPNIVCLLGVVT-----QEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAA  135 (283)
T ss_pred             HhhCCCCCeeeEEEEEe-----cCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHH
Confidence            46789999999999883     3344899999998 699888753211             0134788889999999999


Q ss_pred             HHHHHHhcCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCCC---cccccccccccCCccccCCCCCCchhHhhhh
Q 022799           67 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSA  143 (292)
Q Consensus        67 al~~LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Dvwsl  143 (292)
                      ||.|||++ |++||||||+||+++.++ .+||+|||+++.......   .....++..|+|||.+.+. .++.++|+||+
T Consensus       136 al~~lH~~-~i~H~dlkp~nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~sl  212 (283)
T cd05090         136 GMEYLSSH-FFVHKDLAARNILIGEQL-HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG-KFSSDSDIWSF  212 (283)
T ss_pred             HHHHHHhc-CeehhccccceEEEcCCC-cEEeccccccccccCCcceecccCCCccceecChHHhccC-CCCchhhhHHH
Confidence            99999988 999999999999999887 799999999976533221   1223456679999998654 48999999999


Q ss_pred             hHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhc
Q 022799          144 GCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQ  222 (292)
Q Consensus       144 G~il~el~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  222 (292)
                      ||++|+|++ |..||.+.+.......+... ..+                           ..+..+++.+.+++.+||+
T Consensus       213 G~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~~~~~li~~cl~  264 (283)
T cd05090         213 GVVLWEIFSFGLQPYYGFSNQEVIEMVRKR-QLL---------------------------PCSEDCPPRMYSLMTECWQ  264 (283)
T ss_pred             HHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CcC---------------------------CCCCCCCHHHHHHHHHHcc
Confidence            999999998 99999876654443333221 000                           0124578899999999999


Q ss_pred             cCCCCcccHHHHhcC
Q 022799          223 YSPNLRSTALEALIH  237 (292)
Q Consensus       223 ~dp~~R~t~~e~l~h  237 (292)
                      .||.+||++.+++++
T Consensus       265 ~~p~~Rp~~~~i~~~  279 (283)
T cd05090         265 EGPSRRPRFKDIHTR  279 (283)
T ss_pred             cCcccCcCHHHHHHH
Confidence            999999999998754

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=3.9e-35  Score=249.32  Aligned_cols=200  Identities=22%  Similarity=0.316  Sum_probs=156.3

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhh-----------cCCCCCHHHHHHHHHHHHHHH
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYK-----------MSQRMPLIYVKLYFYQICRAL   68 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~-----------~~~~~~~~~~~~~~~qil~al   68 (292)
                      |+.++||||+++++++     .+....+++|||++ ++|.+++.....           ....+++..+..++.||+.|+
T Consensus        61 l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al  135 (280)
T cd05092          61 LTVLQHQHIVRFYGVC-----TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGM  135 (280)
T ss_pred             HhcCCCCCCceEEEEE-----ecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHH
Confidence            3578999999999988     33345899999998 699888875321           113578899999999999999


Q ss_pred             HHHHhcCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCCC---cccccccccccCCccccCCCCCCchhHhhhhhH
Q 022799           69 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGC  145 (292)
Q Consensus        69 ~~LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~  145 (292)
                      .|||++ |++||||||+||+++.++ .++|+|||++........   .....+++.|+|||.+.+. .++.++|+|||||
T Consensus       136 ~~LH~~-~i~H~dlkp~nil~~~~~-~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~  212 (280)
T cd05092         136 VYLASL-HFVHRDLATRNCLVGQGL-VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDIWSFGV  212 (280)
T ss_pred             HHHHHC-CeecccccHhhEEEcCCC-CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccC-CcCchhhHHHHHH
Confidence            999987 999999999999999877 799999999875533221   1223346789999998664 4899999999999


Q ss_pred             HHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccC
Q 022799          146 VLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYS  224 (292)
Q Consensus       146 il~el~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  224 (292)
                      ++|+|++ |..||......+....+.....                            ...+..+++.+.++|.+||+.|
T Consensus       213 il~el~~~g~~p~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~cl~~~  264 (280)
T cd05092         213 VLWEIFTYGKQPWYQLSNTEAIECITQGRE----------------------------LERPRTCPPEVYAIMQGCWQRE  264 (280)
T ss_pred             HHHHHHcCCCCCCccCCHHHHHHHHHcCcc----------------------------CCCCCCCCHHHHHHHHHHccCC
Confidence            9999998 8999977665544433322100                            0011357889999999999999


Q ss_pred             CCCcccHHHHhc
Q 022799          225 PNLRSTALEALI  236 (292)
Q Consensus       225 p~~R~t~~e~l~  236 (292)
                      |.+||++.++++
T Consensus       265 P~~Rp~~~~l~~  276 (280)
T cd05092         265 PQQRMVIKDIHS  276 (280)
T ss_pred             hhhCCCHHHHHH
Confidence            999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=2.9e-35  Score=248.52  Aligned_cols=204  Identities=21%  Similarity=0.301  Sum_probs=153.7

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKM-SQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~-~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      +.++||||+++++.+.     +....++||||++ |+|.+++...... ....++..+..++.||+.||+|||+. ||+|
T Consensus        50 ~~l~h~nii~~~~~~~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH  123 (269)
T cd05042          50 RELNHPNVLQCLGQCI-----ESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA-DFIH  123 (269)
T ss_pred             HhCCCCCcceEEEEEC-----CCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc-CEec
Confidence            5679999999999883     3345899999998 6999988764322 23356778899999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCC---cccccccccccCCccccC------CCCCCchhHhhhhhHHHHHH
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFG------ATEYTAAIDIWSAGCVLAEL  150 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~------~~~~~~~~DvwslG~il~el  150 (292)
                      |||||+||+++.++ .+||+|||++........   .....++..|+|||++..      ...++.++|+||+||++|+|
T Consensus       124 ~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el  202 (269)
T cd05042         124 SDLALRNCQLTADL-SVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL  202 (269)
T ss_pred             ccccHhheEecCCC-cEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHH
Confidence            99999999999988 799999999865422211   122345677999998743      23468899999999999999


Q ss_pred             Hh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcc
Q 022799          151 LL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS  229 (292)
Q Consensus       151 ~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~  229 (292)
                      ++ |..||......+.+..+.......                .+.       ...+..+++...+++..|+ .||++||
T Consensus       203 ~~~~~~p~~~~~~~~~~~~~~~~~~~~----------------~~~-------~~~~~~~~~~~~~~~~~~~-~dp~~Rp  258 (269)
T cd05042         203 FTAADQPYPDLSDEQVLKQVVREQDIK----------------LPK-------PQLDLKYSDRWYEVMQFCW-LDPETRP  258 (269)
T ss_pred             HhCCCCCCCcCCHHHHHHHHhhccCcc----------------CCC-------CcccccCCHHHHHHHHHHh-cCccccc
Confidence            99 788888776655554443321110                000       0112457888999999998 5999999


Q ss_pred             cHHHHhc
Q 022799          230 TALEALI  236 (292)
Q Consensus       230 t~~e~l~  236 (292)
                      |++++++
T Consensus       259 t~~~v~~  265 (269)
T cd05042         259 TAEEVHE  265 (269)
T ss_pred             CHHHHHH
Confidence            9999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=2.6e-35  Score=249.79  Aligned_cols=198  Identities=34%  Similarity=0.621  Sum_probs=162.1

Q ss_pred             CCCC-CCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            2 RLLD-HPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         2 ~~l~-HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      +++. ||||+++++++     .+....++||||+. ++|.+++..    ...+++..+..++.|++.||.+||++ |++|
T Consensus        56 ~~l~~~~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~~-~~~H  125 (280)
T cd05581          56 TRLNGHPGIIKLYYTF-----QDEENLYFVLEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHSK-GIIH  125 (280)
T ss_pred             HhcccCCCchhHHHHh-----cCCceEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-Ceee
Confidence            4566 99999999988     44455899999995 799888875    34799999999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCC---------------------cccccccccccCCccccCCCCCCchh
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---------------------NISYICSRYYRAPELIFGATEYTAAI  138 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~---------------------~~~~~gt~~y~aPE~~~~~~~~~~~~  138 (292)
                      +||+|+||+++.++ .++|+|||++........                     .....++..|+|||...+. .++.++
T Consensus       126 ~dl~~~ni~i~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~  203 (280)
T cd05581         126 RDLKPENILLDKDM-HIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK-PAGKSS  203 (280)
T ss_pred             cCCCHHHeEECCCC-CEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCC-CCChhh
Confidence            99999999999888 799999999876533221                     1223567889999998654 488999


Q ss_pred             HhhhhhHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHH
Q 022799          139 DIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVS  218 (292)
Q Consensus       139 DvwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  218 (292)
                      |+||+||+++++++|..||...+.......+....                             ..++..+++.+.++|.
T Consensus       204 Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~li~  254 (280)
T cd05581         204 DLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLE-----------------------------YSFPPNFPPDAKDLIE  254 (280)
T ss_pred             hHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcC-----------------------------CCCCCccCHHHHHHHH
Confidence            99999999999999999998776544444333210                             0122457889999999


Q ss_pred             HHhccCCCCcccH----HHHhcCCCc
Q 022799          219 RLLQYSPNLRSTA----LEALIHPFF  240 (292)
Q Consensus       219 ~~l~~dp~~R~t~----~e~l~hp~~  240 (292)
                      +||..||++|||+    +++++||||
T Consensus       255 ~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         255 KLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             HHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            9999999999999    999999997

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=3.6e-35  Score=255.80  Aligned_cols=202  Identities=23%  Similarity=0.355  Sum_probs=155.3

Q ss_pred             CCC-CCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhh--------------------------------
Q 022799            2 RLL-DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYK--------------------------------   47 (292)
Q Consensus         2 ~~l-~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~--------------------------------   47 (292)
                      +++ +||||+++++++...    +..++++|||++ ++|.+++.....                                
T Consensus        65 ~~l~~h~niv~~~~~~~~~----~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  140 (337)
T cd05054          65 IHIGHHLNVVNLLGACTKP----GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQ  140 (337)
T ss_pred             HhhccCcchhheeeeEecC----CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccc
Confidence            345 799999999987432    235889999998 699888754321                                


Q ss_pred             -------------------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEeCCCCcEEEeecC
Q 022799           48 -------------------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  102 (292)
Q Consensus        48 -------------------------~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg  102 (292)
                                               ....+++..+..++.||+.||.|||++ ||+||||||+||+++.++ .++|+|||
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~-~ivHrDikp~Nill~~~~-~vkL~DfG  218 (337)
T cd05054         141 SSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASR-KCIHRDLAARNILLSENN-VVKICDFG  218 (337)
T ss_pred             cccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCcceEEEeCCC-cEEEeccc
Confidence                                     013678999999999999999999988 999999999999999887 79999999


Q ss_pred             CccccccCCC---cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 022799          103 SAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR  178 (292)
Q Consensus       103 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~~~i~~~~~~~~~  178 (292)
                      ++..+.....   .....++..|+|||.+.+. .++.++|+||+||++|+|++ |..||.+....+.+...+.....+  
T Consensus       219 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~--  295 (337)
T cd05054         219 LARDIYKDPDYVRKGDARLPLKWMAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM--  295 (337)
T ss_pred             cchhcccCcchhhccCCCCCccccCcHHhcCC-CCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCC--
Confidence            9987533221   1223456789999998665 48999999999999999998 999997754443333322210000  


Q ss_pred             HHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          179 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                                               ..+...++++.+++.+||+.+|++||++.++++|
T Consensus       296 -------------------------~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~  329 (337)
T cd05054         296 -------------------------RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI  329 (337)
T ss_pred             -------------------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                                     0113467899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=6.1e-35  Score=244.32  Aligned_cols=204  Identities=34%  Similarity=0.532  Sum_probs=162.5

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      +++++||||+++++++....   ....++|+||++ ++|.+++...    ..+++..+..++.|++.||.|||+. |++|
T Consensus        53 l~~l~~~~i~~~~~~~~~~~---~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~-~~~h  124 (260)
T cd06606          53 LSSLQHPNIVRYYGSERDEE---KNTLNIFLEYVSGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSN-GIVH  124 (260)
T ss_pred             HHHcCCCCEeeEEEEEecCC---CCeEEEEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-Cccc
Confidence            35788999999999884331   145889999996 6988888753    3789999999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCC---cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPL  156 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~p  156 (292)
                      +||+|+||+++.++ .++|+|||.+........   .....++..|+|||.+.+.. ++.++|+||+|+++|+|++|..|
T Consensus       125 ~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p  202 (260)
T cd06606         125 RDIKGANILVDSDG-VVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE-YGRAADIWSLGCTVIEMATGKPP  202 (260)
T ss_pred             cCCCHHHEEEcCCC-CEEEcccccEEecccccccccccCCCCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCC
Confidence            99999999999877 799999999887655442   34456788999999986654 89999999999999999999999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      |.......  .........                        .....++...+..+.++|.+||..||++||++.+++.
T Consensus       203 ~~~~~~~~--~~~~~~~~~------------------------~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         203 WSELGNPM--AALYKIGSS------------------------GEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             CCCCCchH--HHHHhcccc------------------------CCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            97665211  111111000                        0000122456889999999999999999999999999


Q ss_pred             CCCc
Q 022799          237 HPFF  240 (292)
Q Consensus       237 hp~~  240 (292)
                      ||||
T Consensus       257 ~~~~  260 (260)
T cd06606         257 HPFL  260 (260)
T ss_pred             CCCC
Confidence            9997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=9.6e-35  Score=245.34  Aligned_cols=205  Identities=20%  Similarity=0.271  Sum_probs=154.1

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      ++.++||||+++++.+     .+....|+||||++ |+|.+++..........++..+..++.||+.||.|||++ +++|
T Consensus        49 ~~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~-~i~H  122 (268)
T cd05086          49 YRILQHPNILQCLGQC-----VEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH-NFLH  122 (268)
T ss_pred             HhccCCcchhheEEEe-----cCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC-Ceec
Confidence            3568999999999998     34445899999999 699998875433334567778889999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCC---CcccccccccccCCccccCC------CCCCchhHhhhhhHHHHHH
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGA------TEYTAAIDIWSAGCVLAEL  150 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~~DvwslG~il~el  150 (292)
                      |||||+||+++.++ .++|+|||++.......   ......++..|+|||++.+.      ..++.++|+||+||++|+|
T Consensus       123 ~dikp~nil~~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el  201 (268)
T cd05086         123 SDLALRNCFLTSDL-TVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWEL  201 (268)
T ss_pred             cCCccceEEEcCCc-cEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHH
Confidence            99999999999888 79999999876432111   12234678889999987431      2357899999999999999


Q ss_pred             Hh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcc
Q 022799          151 LL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS  229 (292)
Q Consensus       151 ~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~  229 (292)
                      ++ |..||...+..+.+..+.......                .       ....+...+++.+.+++..|+ .+|.+||
T Consensus       202 ~~~~~~p~~~~~~~~~~~~~~~~~~~~----------------~-------~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp  257 (268)
T cd05086         202 FENAAQPYSHLSDREVLNHVIKDQQVK----------------L-------FKPQLELPYSERWYEVLQFCW-LSPEKRA  257 (268)
T ss_pred             HhCCCCCCCCCCHHHHHHHHHhhcccc----------------c-------CCCccCCCCcHHHHHHHHHHh-hCcccCC
Confidence            97 567887666655555443321100                0       001112346788999999999 6899999


Q ss_pred             cHHHHhc
Q 022799          230 TALEALI  236 (292)
Q Consensus       230 t~~e~l~  236 (292)
                      ++.++++
T Consensus       258 ~~~~i~~  264 (268)
T cd05086         258 TAEEVHR  264 (268)
T ss_pred             CHHHHHH
Confidence            9999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-35  Score=248.83  Aligned_cols=235  Identities=28%  Similarity=0.481  Sum_probs=181.5

Q ss_pred             CCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCC
Q 022799            6 HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQ   85 (292)
Q Consensus         6 HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlkp~   85 (292)
                      -.+||++++.|.... .+..++|||+|+++.+|+.+|....  -..++...++.|++|||.||.|||.++||||.||||+
T Consensus       141 ~~~VV~LlD~FkhsG-pNG~HVCMVfEvLGdnLLklI~~s~--YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPE  217 (590)
T KOG1290|consen  141 KKCVVQLLDHFKHSG-PNGQHVCMVFEVLGDNLLKLIKYSN--YRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPE  217 (590)
T ss_pred             CceeeeeeccceecC-CCCcEEEEEehhhhhHHHHHHHHhC--CCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcc
Confidence            346999999886544 5677999999999999999988643  3568999999999999999999999999999999999


Q ss_pred             cEEEe---------------------------------------------------------------------------
Q 022799           86 NLLVN---------------------------------------------------------------------------   90 (292)
Q Consensus        86 Nill~---------------------------------------------------------------------------   90 (292)
                      |||+.                                                                           
T Consensus       218 NvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~  297 (590)
T KOG1290|consen  218 NVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEE  297 (590)
T ss_pred             eeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccccc
Confidence            99983                                                                           


Q ss_pred             ---------------------------------------CC---------------------------C-----------
Q 022799           91 ---------------------------------------PH---------------------------T-----------   93 (292)
Q Consensus        91 ---------------------------------------~~---------------------------~-----------   93 (292)
                                                             ..                           .           
T Consensus       298 ~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n  377 (590)
T KOG1290|consen  298 PNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASN  377 (590)
T ss_pred             ccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccc
Confidence                                                   00                           0           


Q ss_pred             -------------CcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC-
Q 022799           94 -------------HQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG-  159 (292)
Q Consensus        94 -------------~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~-  159 (292)
                                   -+|||.|||.|.+..  ...+....|+.|+|||++.|.. |++.+||||++|++|||+||..+|.- 
T Consensus       378 ~~v~p~~~~~~~di~vKIaDlGNACW~~--khFT~DIQTRQYRapEVllGsg-Y~~~ADiWS~AC~~FELaTGDyLFePh  454 (590)
T KOG1290|consen  378 PLVNPDIPLPECDIRVKIADLGNACWVH--KHFTEDIQTRQYRAPEVLLGSG-YSTSADIWSTACMAFELATGDYLFEPH  454 (590)
T ss_pred             cccCCCCCCCccceeEEEeeccchhhhh--hhhchhhhhhhccCcceeecCC-CCCchhHHHHHHHHHHhhcCceeecCC
Confidence                         026778888777752  2233445689999999999876 99999999999999999999988842 


Q ss_pred             -----CCcHHHHHHHHHHhCCCCHHHHhhcCCCCcccc-------CCCCCCCCchhh------hccCCChhHHHHHHHHh
Q 022799          160 -----ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK-------FPQIKAHPWHKI------FQKRMPPEAVDLVSRLL  221 (292)
Q Consensus       160 -----~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~------~~~~~~~~~~~li~~~l  221 (292)
                           ..+.++++.|++.+|..+......-.-....+.       .......++...      ++.....++.|||.-||
T Consensus       455 sG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmL  534 (590)
T KOG1290|consen  455 SGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPML  534 (590)
T ss_pred             CCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHH
Confidence                 346789999999999999877654332222221       111122222222      22334568899999999


Q ss_pred             ccCCCCcccHHHHhcCCCccccCCC
Q 022799          222 QYSPNLRSTALEALIHPFFDELRDP  246 (292)
Q Consensus       222 ~~dp~~R~t~~e~l~hp~~~~~~~~  246 (292)
                      +++|.+|+||.++|+|||+..+..+
T Consensus       535 ef~PeKR~tA~~cl~hPwLn~~~~~  559 (590)
T KOG1290|consen  535 EFDPEKRPTAAQCLKHPWLNPVAGP  559 (590)
T ss_pred             hcCccccccHHHHhcCccccCCCCC
Confidence            9999999999999999999976543

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=6.3e-35  Score=243.25  Aligned_cols=202  Identities=29%  Similarity=0.510  Sum_probs=161.7

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++..     ....++++||++ ++|.+++...   ...+++..+..++.|++.||.+||++ |++|
T Consensus        51 l~~l~~~~i~~~~~~~~~-----~~~~~l~~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~-~i~h  121 (253)
T cd05122          51 LKKCKHPNIVKYYGSYLK-----KDELWIVMEFCSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSN-GIIH  121 (253)
T ss_pred             HHhCCCCCEeEEEEEEec-----CCeEEEEEecCCCCcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcC-CEec
Confidence            356889999999998843     345889999999 6888887653   25789999999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      |||+|+||+++.++ .++|+|||.+.............++..|+|||.+.+.. ++.++|+||+|+++|+|++|..||..
T Consensus       122 ~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~  199 (253)
T cd05122         122 RDIKAANILLTSDG-EVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKP-YDYKADIWSLGITAIELAEGKPPYSE  199 (253)
T ss_pred             CCCCHHHEEEccCC-eEEEeeccccccccccccccceecCCcccCHHHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCC
Confidence            99999999999877 79999999988765443234556788999999986654 88999999999999999999999977


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCC
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF  239 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~  239 (292)
                      .+.......+.. ...+.               .+          .+..++..+.++|.+||..||++|||+.+++.|||
T Consensus       200 ~~~~~~~~~~~~-~~~~~---------------~~----------~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         200 LPPMKALFKIAT-NGPPG---------------LR----------NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             CchHHHHHHHHh-cCCCC---------------cC----------cccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence            654433332221 00000               00          00224789999999999999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=8e-35  Score=244.07  Aligned_cols=197  Identities=21%  Similarity=0.310  Sum_probs=155.0

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++...    ....++||||++ ++|.+++....  ...+++..+..++.|++.||.|||++ |++|
T Consensus        53 l~~l~~~~i~~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H  125 (256)
T cd05082          53 MTQLRHSNLVQLLGVIVEE----KGGLYIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEAN-NFVH  125 (256)
T ss_pred             HHhCCCCCeeeEEEEEEcC----CCceEEEEECCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CEec
Confidence            4678999999999876432    234789999998 69998886532  23578899999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFP  158 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~  158 (292)
                      |||||+||+++.++ .+||+|||++.......  ....++..|+|||.+.+. .++.++|+||+||++|+|++ |..||.
T Consensus       126 ~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~~g~~p~~  201 (256)
T cd05082         126 RDLAARNVLVSEDN-VAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYP  201 (256)
T ss_pred             cccchheEEEcCCC-cEEecCCccceeccccC--CCCccceeecCHHHHccC-CCCchhhhHHHHHHHHHHHhCCCCCCC
Confidence            99999999999888 79999999987653322  223446679999998554 58999999999999999997 999997


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      ..+..+....+.+..                            ....+..+++.+.++|.+||..+|++|||+.++++
T Consensus       202 ~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         202 RIPLKDVVPRVEKGY----------------------------KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             CCCHHHHHHHHhcCC----------------------------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            665544333332110                            00112457899999999999999999999999974

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=6.3e-35  Score=259.08  Aligned_cols=156  Identities=24%  Similarity=0.389  Sum_probs=122.1

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCCC---cccccccccccCCcc
Q 022799           51 RMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPEL  127 (292)
Q Consensus        51 ~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~  127 (292)
                      .+++..+..++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+++.......   .....++..|+|||.
T Consensus       233 ~l~~~~~~~~~~qi~~aL~~LH~~-~ivH~dikp~Nill~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~  310 (400)
T cd05105         233 GLTTLDLLSFTYQVARGMEFLASK-NCVHRDLAARNVLLAQGK-IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPES  310 (400)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChHhEEEeCCC-EEEEEeCCcceeccccccccccCCcCCCcceEChhh
Confidence            478888899999999999999987 999999999999999887 799999999876533221   123346778999999


Q ss_pred             ccCCCCCCchhHhhhhhHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhc
Q 022799          128 IFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQ  206 (292)
Q Consensus       128 ~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  206 (292)
                      +.+. .++.++|+||+||++|+|++ |..||.+................+                           ..+
T Consensus       311 ~~~~-~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~---------------------------~~~  362 (400)
T cd05105         311 IFDN-LYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRM---------------------------AKP  362 (400)
T ss_pred             hcCC-CCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCC---------------------------CCC
Confidence            8664 48999999999999999997 999997654433333222210000                           012


Q ss_pred             cCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          207 KRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       207 ~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      ..++.++.++|.+||..||++|||+.++.+
T Consensus       363 ~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         363 DHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             ccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            357889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=5.4e-35  Score=249.62  Aligned_cols=200  Identities=21%  Similarity=0.350  Sum_probs=155.1

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhh--------------------cCCCCCHHHHHH
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYK--------------------MSQRMPLIYVKL   59 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~--------------------~~~~~~~~~~~~   59 (292)
                      |+.++||||+++++.+     ......+++|||+. ++|.+++.....                    ....+++..+..
T Consensus        57 l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  131 (290)
T cd05045          57 LKQVNHPHVIKLYGAC-----SQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLIS  131 (290)
T ss_pred             HhhCCCCCEeeEEEEE-----ecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHH
Confidence            4578999999999988     33344889999999 799888764321                    123578899999


Q ss_pred             HHHHHHHHHHHHHhcCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCCC---cccccccccccCCccccCCCCCCc
Q 022799           60 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTA  136 (292)
Q Consensus        60 ~~~qil~al~~LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~  136 (292)
                      ++.|++.||.|||++ |++||||||+||+++.++ .++|+|||+++.......   .....++..|+|||.+.+. .++.
T Consensus       132 i~~~i~~~l~~LH~~-~ivH~dikp~nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~  208 (290)
T cd05045         132 FAWQISRGMQYLAEM-KLVHRDLAARNVLVAEGR-KMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH-IYTT  208 (290)
T ss_pred             HHHHHHHHHHHHHHC-CeehhhhhhheEEEcCCC-cEEeccccccccccCccchhcccCCCCCccccCHHHHccC-Ccch
Confidence            999999999999987 999999999999999877 799999999876533221   1122346689999988654 4899


Q ss_pred             hhHhhhhhHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHH
Q 022799          137 AIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVD  215 (292)
Q Consensus       137 ~~DvwslG~il~el~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  215 (292)
                      ++|+||+||++|+|++ |..||.+.........+.+..                ..            ..+..++.++.+
T Consensus       209 ~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~----------------~~------------~~~~~~~~~~~~  260 (290)
T cd05045         209 QSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGY----------------RM------------ERPENCSEEMYN  260 (290)
T ss_pred             HhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC----------------CC------------CCCCCCCHHHHH
Confidence            9999999999999998 999997766544333221100                00            012457889999


Q ss_pred             HHHHHhccCCCCcccHHHHhc
Q 022799          216 LVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       216 li~~~l~~dp~~R~t~~e~l~  236 (292)
                      ++.+||+.+|++||++.++++
T Consensus       261 ~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         261 LMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             HHHHHccCCcccCCCHHHHHH
Confidence            999999999999999999974

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.7e-35  Score=245.22  Aligned_cols=198  Identities=22%  Similarity=0.317  Sum_probs=156.2

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++     ......++||||+. ++|.+.+....  ...+++..+..++.|++.||.+||++ |++|
T Consensus        55 l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H  126 (261)
T cd05068          55 MKKLRHPKLIQLYAVC-----TLEEPIYIVTELMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ-NYIH  126 (261)
T ss_pred             HHHCCCCCccceeEEE-----ecCCCeeeeeecccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC-Ceee
Confidence            3568999999999987     33345899999996 79998886532  34689999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcc--cccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI--SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPL  156 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~p  156 (292)
                      |||||+||+++.++ .++|+|||++..........  ....+..|+|||.+.+. .++.++|+||+||++|+|++ |+.|
T Consensus       127 ~dl~p~Nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p  204 (261)
T cd05068         127 RDLAARNVLVGENN-ICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYN-RFSIKSDVWSFGILLTEIVTYGRMP  204 (261)
T ss_pred             ccCCcceEEEcCCC-CEEECCcceEEEccCCcccccCCCcCceeccCccccccC-CCCchhhHHHHHHHHHHHHhcCCCC
Confidence            99999999999888 79999999998764322111  11223579999998654 48999999999999999999 9999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      |.+.+.......+.+....                            ..+...+..+.+++.+||..+|.+||++.+++.
T Consensus       205 ~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         205 YPGMTNAEVLQQVDQGYRM----------------------------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             CCCCCHHHHHHHHHcCCCC----------------------------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            9877655544443321100                            011346889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=4.3e-35  Score=253.33  Aligned_cols=197  Identities=22%  Similarity=0.356  Sum_probs=154.3

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++...      ..++|+||+. |+|.+.+...   ...++...+..++.||+.||+|||++ ||+|
T Consensus        63 l~~l~h~niv~~~g~~~~~------~~~~v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~-~iiH  132 (316)
T cd05108          63 MASVDNPHVCRLLGICLTS------TVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEER-RLVH  132 (316)
T ss_pred             HHhCCCCCCCeEEEEEcCC------CceeeeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhc-Ceec
Confidence            4678999999999987431      2568999998 7998888753   34588889999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCccc---ccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS---YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQP  155 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~---~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~  155 (292)
                      |||||+||+++.++ .+||+|||+++..........   ..++..|+|||.+.+. .++.++|+||+||++|+|++ |..
T Consensus       133 ~dlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slGv~l~el~t~g~~  210 (316)
T cd05108         133 RDLAARNVLVKTPQ-HVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSK  210 (316)
T ss_pred             cccchhheEecCCC-cEEEccccccccccCCCcceeccCCccceeecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCC
Confidence            99999999999887 799999999987644332221   2235679999998654 48999999999999999997 999


Q ss_pred             CCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHh
Q 022799          156 LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL  235 (292)
Q Consensus       156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l  235 (292)
                      ||.+....+. ..+......+                 +          .+..++.++.+++.+||..||.+|||+.+++
T Consensus       211 p~~~~~~~~~-~~~~~~~~~~-----------------~----------~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~  262 (316)
T cd05108         211 PYDGIPASEI-SSILEKGERL-----------------P----------QPPICTIDVYMIMVKCWMIDADSRPKFRELI  262 (316)
T ss_pred             CCCCCCHHHH-HHHHhCCCCC-----------------C----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            9976554332 2222211000                 0          1134678899999999999999999999999


Q ss_pred             cC
Q 022799          236 IH  237 (292)
Q Consensus       236 ~h  237 (292)
                      .+
T Consensus       263 ~~  264 (316)
T cd05108         263 IE  264 (316)
T ss_pred             HH
Confidence            75

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-34  Score=244.62  Aligned_cols=202  Identities=26%  Similarity=0.478  Sum_probs=159.6

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++...   ....++++|||++ ++|.+.+..    ...+++..+..++.|++.||.|||++ |++|
T Consensus        58 l~~l~h~~i~~~~~~~~~~---~~~~~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~-~i~H  129 (264)
T cd06653          58 LKNLRHDRIVQYYGCLRDP---EEKKLSIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSN-MIVH  129 (264)
T ss_pred             HHHcCCCCcceEEEEEEcC---CCCEEEEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC-CEec
Confidence            3578999999999987432   2235789999998 588888764    35688999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccC----CCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG----EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQP  155 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~  155 (292)
                      +||||+||+++.++ .++|+|||++......    .......++..|+|||.+.+. .++.++|+||+||++|+|++|+.
T Consensus       130 ~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~  207 (264)
T cd06653         130 RDIKGANILRDSAG-NVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGE-GYGRKADVWSVACTVVEMLTEKP  207 (264)
T ss_pred             CCCCHHHEEEcCCC-CEEECccccccccccccccCccccccCCcccccCHhhhcCC-CCCccccHHHHHHHHHHHHhCCC
Confidence            99999999999887 7999999998765321    111234578899999998664 48899999999999999999999


Q ss_pred             CCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHh
Q 022799          156 LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL  235 (292)
Q Consensus       156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l  235 (292)
                      ||..........++   ...+..                        ..++..+++.+.++|.+||. +|..||++.+++
T Consensus       208 p~~~~~~~~~~~~~---~~~~~~------------------------~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~  259 (264)
T cd06653         208 PWAEYEAMAAIFKI---ATQPTK------------------------PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLL  259 (264)
T ss_pred             CCCccCHHHHHHHH---HcCCCC------------------------CCCCcccCHHHHHHHHHHhc-CcccCccHHHHh
Confidence            99766544333222   211110                        11335688999999999999 579999999999


Q ss_pred             cCCCc
Q 022799          236 IHPFF  240 (292)
Q Consensus       236 ~hp~~  240 (292)
                      .|||.
T Consensus       260 ~~~~~  264 (264)
T cd06653         260 RHPFV  264 (264)
T ss_pred             cCCCC
Confidence            99983

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=4.2e-35  Score=250.03  Aligned_cols=208  Identities=30%  Similarity=0.465  Sum_probs=160.6

Q ss_pred             CCC-CCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            2 RLL-DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         2 ~~l-~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      +++ +||||+++.+++     ......++||||++ ++|.+.+..    ...+++..++.++.|++.||.|||+. |++|
T Consensus        59 ~~~~~~~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~-~~~H  128 (288)
T cd05583          59 EAVRRCPFLVTLHYAF-----QTDTKLHLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQL-GIIY  128 (288)
T ss_pred             HhccCCcchhhhheee-----ecCCEEEEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHC-Ceec
Confidence            345 599999999988     44456899999998 688888764    35688999999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCC--cccccccccccCCccccCCC-CCCchhHhhhhhHHHHHHHhCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP--NISYICSRYYRAPELIFGAT-EYTAAIDIWSAGCVLAELLLGQPL  156 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwslG~il~el~~g~~p  156 (292)
                      |||+|+||+++.++ .++|+|||++........  .....|+..|+|||.+.+.. ..+.++|+||+|+++|+|++|..|
T Consensus       129 ~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p  207 (288)
T cd05583         129 RDIKLENILLDSEG-HVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP  207 (288)
T ss_pred             cCCCHHHeEECCCC-CEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCC
Confidence            99999999999887 799999999876533322  12345788999999985532 368899999999999999999999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCccc---HHH
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST---ALE  233 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t---~~e  233 (292)
                      |...........+.+....       . .                 ...+..++..+.++|.+||+.||++|||   +.+
T Consensus       208 ~~~~~~~~~~~~~~~~~~~-------~-~-----------------~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~  262 (288)
T cd05583         208 FTVDGEQNSQSEISRRILK-------S-K-----------------PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADE  262 (288)
T ss_pred             cccCcccchHHHHHHHHHc-------c-C-----------------CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHH
Confidence            9654332222222211100       0 0                 0012457889999999999999999998   567


Q ss_pred             HhcCCCccccCC
Q 022799          234 ALIHPFFDELRD  245 (292)
Q Consensus       234 ~l~hp~~~~~~~  245 (292)
                      +++||||+.+.+
T Consensus       263 ~l~~~~~~~~~~  274 (288)
T cd05583         263 IKNHPFFQGIDW  274 (288)
T ss_pred             HhcCcccccCCH
Confidence            799999998765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=8.4e-35  Score=249.91  Aligned_cols=198  Identities=23%  Similarity=0.364  Sum_probs=155.3

Q ss_pred             CCC-CCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            2 RLL-DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         2 ~~l-~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      +++ +||||+++++++     ......++||||+. |+|.+++....  ...+++..+..++.|++.||.|||++ ||+|
T Consensus        93 ~~l~~h~~iv~~~~~~-----~~~~~~~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~-~ivH  164 (302)
T cd05055          93 SHLGNHENIVNLLGAC-----TIGGPILVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASK-NCIH  164 (302)
T ss_pred             HhccCCCCcceEEEEE-----ecCCceEEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC-Ceeh
Confidence            456 799999999988     33345899999998 79998886421  23489999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCC---cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQP  155 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~  155 (292)
                      +||||+||+++.++ .++++|||.++.......   .....++..|+|||.+.+.. ++.++|+||+||++|+|++ |..
T Consensus       165 ~dlkp~Nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~t~g~~  242 (302)
T cd05055         165 RDLAARNVLLTHGK-IVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSN  242 (302)
T ss_pred             hhhccceEEEcCCC-eEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCC-CCcHhHHHHHHHHHHHHHhCCCC
Confidence            99999999999877 799999999876543321   11234567899999986654 8999999999999999998 999


Q ss_pred             CCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHh
Q 022799          156 LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL  235 (292)
Q Consensus       156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l  235 (292)
                      ||.+....+...+.......                           ...+...++.+.+++.+||..+|++|||+.+++
T Consensus       243 p~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell  295 (302)
T cd05055         243 PYPGMPVDSKFYKLIKEGYR---------------------------MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIV  295 (302)
T ss_pred             CcCCCCchHHHHHHHHcCCc---------------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence            99876654444333221000                           001134678999999999999999999999998


Q ss_pred             c
Q 022799          236 I  236 (292)
Q Consensus       236 ~  236 (292)
                      .
T Consensus       296 ~  296 (302)
T cd05055         296 Q  296 (302)
T ss_pred             H
Confidence            4

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.4e-34  Score=244.36  Aligned_cols=201  Identities=22%  Similarity=0.383  Sum_probs=161.0

Q ss_pred             CCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccC
Q 022799            3 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRD   81 (292)
Q Consensus         3 ~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~d   81 (292)
                      .++||||+++++++     .+..+.++||||++ ++|.+++.........+++..++.++.|++.||.|||+..|++|+|
T Consensus        65 ~~~h~~i~~~~~~~-----~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~d  139 (269)
T cd08528          65 QLRHPNIVRYYKTF-----LENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRD  139 (269)
T ss_pred             cCCCCCeeeEEeeE-----ccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecC
Confidence            57899999999988     44456899999998 5888888654444567999999999999999999999633899999


Q ss_pred             CCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCCC
Q 022799           82 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES  161 (292)
Q Consensus        82 lkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~  161 (292)
                      |+|+||+++.++ .++|+|||.+.............++..|++||.+.+. .++.++|+||+|+++|+|++|..||....
T Consensus       140 l~~~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Dv~slG~ll~~l~~g~~p~~~~~  217 (269)
T cd08528         140 LTPNNIMLGEDD-KVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNE-PYGEKADVWAFGCILYQMCTLQPPFYSTN  217 (269)
T ss_pred             CCHHHEEECCCC-cEEEecccceeecccccccccccCcccCcChhhhcCC-CCchHHHHHHHHHHHHHHHhCCCcccccC
Confidence            999999999888 7999999999876544433455678899999999764 48999999999999999999999997665


Q ss_pred             cHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          162 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       162 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      .......+......+.                           ....+++.+.++|.+||..||++||++.|+.++
T Consensus       218 ~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         218 MLSLATKIVEAVYEPL---------------------------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             HHHHHHHHhhccCCcC---------------------------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            5444333322111000                           012467899999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=8.4e-35  Score=245.30  Aligned_cols=198  Identities=23%  Similarity=0.344  Sum_probs=156.1

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++     .+....++||||++ ++|.+++...   ...+++..+..++.|++.||.|||++ ||+|
T Consensus        59 l~~l~h~~i~~~~~~~-----~~~~~~~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~-~i~H  129 (266)
T cd05033          59 MGQFDHPNIIRLEGVV-----TKSRPVMIITEYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEM-NYVH  129 (266)
T ss_pred             HHhCCCCCcceEeEEE-----ecCCceEEEEEcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC-Cccc
Confidence            4578999999999988     33445899999998 6998888653   34789999999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCc-c--cccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-I--SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQP  155 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~-~--~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~  155 (292)
                      +||||+||+++.++ .++|+|||++......... .  ...++..|+|||.+.+. .++.++|+||+||++|+|++ |..
T Consensus       130 ~di~p~nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Dv~slG~~l~~l~~~g~~  207 (266)
T cd05033         130 RDLAARNILVNSNL-VCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSYGER  207 (266)
T ss_pred             CCCCcceEEEcCCC-CEEECccchhhcccccccceeccCCCCCccccChhhhccC-CCccccchHHHHHHHHHHHccCCC
Confidence            99999999999887 7999999999876422111 1  12335679999998654 48999999999999999998 999


Q ss_pred             CCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHh
Q 022799          156 LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL  235 (292)
Q Consensus       156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l  235 (292)
                      ||...........+.+....+                            .+...++.+.+++.+||..+|++||++.+++
T Consensus       208 p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~  259 (266)
T cd05033         208 PYWDMSNQDVIKAVEDGYRLP----------------------------PPMDCPSALYQLMLDCWQKDRNERPTFSQIV  259 (266)
T ss_pred             CCCCCCHHHHHHHHHcCCCCC----------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHH
Confidence            997665544433332210000                            1135788999999999999999999999998


Q ss_pred             cC
Q 022799          236 IH  237 (292)
Q Consensus       236 ~h  237 (292)
                      ++
T Consensus       260 ~~  261 (266)
T cd05033         260 ST  261 (266)
T ss_pred             HH
Confidence            64

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-34  Score=242.48  Aligned_cols=200  Identities=35%  Similarity=0.574  Sum_probs=162.8

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++.     +....++||||++ ++|.+++...    ..+++..+..++.|++.||.+||++ |++|
T Consensus        53 l~~l~~~~i~~~~~~~~-----~~~~~~~v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~-~i~H  122 (254)
T cd06627          53 LKNLKHPNIVKYIGSIE-----TSDSLYIILEYAENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQ-GVIH  122 (254)
T ss_pred             HHhCCCCCccEEEEEEE-----eCCEEEEEEecCCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhC-Cccc
Confidence            35689999999999883     3445899999998 5888887653    6789999999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCC-cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      |||+|+||+++.++ .++|+|||.+........ .....++..|+|||...+.. ++.++|+||+|+++|+|++|..||.
T Consensus       123 ~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~  200 (254)
T cd06627         123 RDIKAANILTTKDG-VVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPPYY  200 (254)
T ss_pred             CCCCHHHEEECCCC-CEEEeccccceecCCCcccccccccchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCC
Confidence            99999999999877 799999999987644332 22346788999999986544 8899999999999999999999997


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCC
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  238 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp  238 (292)
                      ..+.......+...              ..              ..++..++..+.++|.+||..+|++|||+.+++.||
T Consensus       201 ~~~~~~~~~~~~~~--------------~~--------------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~  252 (254)
T cd06627         201 DLNPMAALFRIVQD--------------DH--------------PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHP  252 (254)
T ss_pred             CccHHHHHHHHhcc--------------CC--------------CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCC
Confidence            66544333332210              00              012245788999999999999999999999999999


Q ss_pred             Cc
Q 022799          239 FF  240 (292)
Q Consensus       239 ~~  240 (292)
                      ||
T Consensus       253 ~~  254 (254)
T cd06627         253 WI  254 (254)
T ss_pred             CC
Confidence            97

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=5.5e-35  Score=246.41  Aligned_cols=202  Identities=31%  Similarity=0.479  Sum_probs=156.6

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++.     +....+++|||+. ++|.+++.........+++..+..++.||+.||.|||++ |++|
T Consensus        56 l~~~~h~~i~~~~~~~~-----~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H  129 (267)
T cd08229          56 LKQLNHPNVIKYYASFI-----EDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR-RVMH  129 (267)
T ss_pred             HHHccCCchhhhhheeE-----eCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC-Ceec
Confidence            35689999999999984     3345889999998 589888875444456789999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCC-cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      +||||+||+++.++ .++|+|||.+........ .....++..|+|||.+.+. .++.++|+||+|+++|+|++|..||.
T Consensus       130 ~dl~p~nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~  207 (267)
T cd08229         130 RDIKPANVFITATG-VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFY  207 (267)
T ss_pred             CCCCHHHEEEcCCC-CEEECcchhhhccccCCcccccccCCcCccCHHHhcCC-CccchhhHHHHHHHHHHHHhCCCCcc
Confidence            99999999999887 799999999876543322 2234678899999998654 48899999999999999999999997


Q ss_pred             CCCcH-HHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          159 GESGV-DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       159 ~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      +.... ....+.......                  +.        ..+..+++.++++|.+||..||.+|||+.+++.
T Consensus       208 ~~~~~~~~~~~~~~~~~~------------------~~--------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         208 GDKMNLYSLCKKIEQCDY------------------PP--------LPSDHYSEELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             cccchHHHHhhhhhcCCC------------------CC--------CCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence            65432 111111110000                  00        001347889999999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=8.9e-35  Score=244.35  Aligned_cols=198  Identities=20%  Similarity=0.296  Sum_probs=158.4

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++     .+....++||||++ ++|.+++....  +..+++..+..++.||+.||.|||++ |++|
T Consensus        56 l~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~-~i~h  127 (261)
T cd05148          56 LKRLRHKHLISLFAVC-----SVGEPVYIITELMEKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYLEEQ-NSIH  127 (261)
T ss_pred             HhcCCCcchhheeeeE-----ecCCCeEEEEeecccCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC-Ceec
Confidence            4678999999999988     34445899999998 69999887532  35689999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCC-cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLF  157 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf  157 (292)
                      +||+|+||+++.++ .++|+|||.+........ .....++..|+|||.+.+. .++.++|+||+||++|+|++ |..||
T Consensus       128 ~dl~~~nilv~~~~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~~l~~l~~~g~~p~  205 (261)
T cd05148         128 RDLAARNILVGEDL-VCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHG-TFSTKSDVWSFGILLYEMFTYGQVPY  205 (261)
T ss_pred             cccCcceEEEcCCc-eEEEccccchhhcCCccccccCCCCceEecCHHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCC
Confidence            99999999999888 799999999876533221 1122346679999998654 58999999999999999998 89999


Q ss_pred             CCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          158 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      .+.+..+....+......                            ..+..+++.+.++|.+||..||.+|||+.++++
T Consensus       206 ~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         206 PGMNNHEVYDQITAGYRM----------------------------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             CcCCHHHHHHHHHhCCcC----------------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            877655555544321100                            012457889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.2e-34  Score=250.33  Aligned_cols=199  Identities=21%  Similarity=0.334  Sum_probs=154.7

Q ss_pred             CCC-CCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHH
Q 022799            2 RLL-DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYK------------MSQRMPLIYVKLYFYQICRA   67 (292)
Q Consensus         2 ~~l-~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~------------~~~~~~~~~~~~~~~qil~a   67 (292)
                      +++ +||||+++++++     .+..++++||||+. |+|.+++.....            ....+++..+..++.||+.|
T Consensus        72 ~~l~~h~~iv~~~~~~-----~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~a  146 (314)
T cd05099          72 KLIGKHKNIINLLGVC-----TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARG  146 (314)
T ss_pred             HhccCCCCeeeEEEEE-----ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHH
Confidence            345 699999999988     34445899999998 799999876421            12458888999999999999


Q ss_pred             HHHHHhcCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCCC---cccccccccccCCccccCCCCCCchhHhhhhh
Q 022799           68 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAG  144 (292)
Q Consensus        68 l~~LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG  144 (292)
                      |.|||++ |++||||||+||+++.++ .+||+|||.++.......   .....++..|+|||.+.+. .++.++|+||+|
T Consensus       147 L~~lH~~-gi~H~dlkp~Nill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG  223 (314)
T cd05099         147 MEYLESR-RCIHRDLAARNVLVTEDN-VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDR-VYTHQSDVWSFG  223 (314)
T ss_pred             HHHHHHC-CeeeccccceeEEEcCCC-cEEEccccccccccccccccccccCCCCccccCHHHHccC-CcCccchhhHHH
Confidence            9999987 999999999999999887 799999999976533211   1112234579999998654 589999999999


Q ss_pred             HHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhcc
Q 022799          145 CVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQY  223 (292)
Q Consensus       145 ~il~el~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  223 (292)
                      |++|+|++ |..||.+....+....+....                ..            ..+..++.++.+++.+||..
T Consensus       224 ~~l~el~~~g~~p~~~~~~~~~~~~~~~~~----------------~~------------~~~~~~~~~l~~li~~cl~~  275 (314)
T cd05099         224 ILMWEIFTLGGSPYPGIPVEELFKLLREGH----------------RM------------DKPSNCTHELYMLMRECWHA  275 (314)
T ss_pred             HHHHHHHhCCCCCCCCCCHHHHHHHHHcCC----------------CC------------CCCCCCCHHHHHHHHHHcCC
Confidence            99999999 889997766544443332100                00            01235688999999999999


Q ss_pred             CCCCcccHHHHhc
Q 022799          224 SPNLRSTALEALI  236 (292)
Q Consensus       224 dp~~R~t~~e~l~  236 (292)
                      ||++|||+.++++
T Consensus       276 ~p~~Rps~~~ll~  288 (314)
T cd05099         276 VPTQRPTFKQLVE  288 (314)
T ss_pred             CcccCcCHHHHHH
Confidence            9999999999984

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=8.9e-35  Score=250.32  Aligned_cols=199  Identities=21%  Similarity=0.324  Sum_probs=153.5

Q ss_pred             CC-CCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHH
Q 022799            3 LL-DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYK------------MSQRMPLIYVKLYFYQICRAL   68 (292)
Q Consensus         3 ~l-~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~------------~~~~~~~~~~~~~~~qil~al   68 (292)
                      .+ +||||+++++++     .+....|+||||++ |+|.+++.....            ....++...+..++.|++.||
T Consensus        79 ~l~~h~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL  153 (307)
T cd05098          79 MIGKHKNIINLLGAC-----TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGM  153 (307)
T ss_pred             HhcCCCCEeeEEEEE-----ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHH
Confidence            45 799999999988     33445899999998 699999875422            123588899999999999999


Q ss_pred             HHHHhcCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCCCc---ccccccccccCCccccCCCCCCchhHhhhhhH
Q 022799           69 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGC  145 (292)
Q Consensus        69 ~~LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~  145 (292)
                      +|||++ |++||||||+||+++.++ .++|+|||.+.........   ....+++.|+|||.+.+. .++.++|+||+||
T Consensus       154 ~~lH~~-gi~H~dlkp~Nill~~~~-~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~  230 (307)
T cd05098         154 EYLASK-KCIHRDLAARNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGV  230 (307)
T ss_pred             HHHHHC-CcccccccHHheEEcCCC-cEEECCCcccccccccchhhccccCCCccceeChHHhccC-CCCcHHHHHHHHH
Confidence            999987 999999999999999887 7999999998765332211   112235679999998664 4899999999999


Q ss_pred             HHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccC
Q 022799          146 VLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYS  224 (292)
Q Consensus       146 il~el~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  224 (292)
                      ++|+|++ |..||.+....+....+ .....                           ...+...+.++.++|.+||..+
T Consensus       231 ~l~el~~~g~~p~~~~~~~~~~~~~-~~~~~---------------------------~~~~~~~~~~~~~li~~~l~~~  282 (307)
T cd05098         231 LLWEIFTLGGSPYPGVPVEELFKLL-KEGHR---------------------------MDKPSNCTNELYMMMRDCWHAV  282 (307)
T ss_pred             HHHHHHcCCCCCCCcCCHHHHHHHH-HcCCC---------------------------CCCCCcCCHHHHHHHHHHcccC
Confidence            9999998 88888765543332222 21000                           0012357889999999999999


Q ss_pred             CCCcccHHHHhcC
Q 022799          225 PNLRSTALEALIH  237 (292)
Q Consensus       225 p~~R~t~~e~l~h  237 (292)
                      |.+|||+.+++++
T Consensus       283 p~~Rps~~evl~~  295 (307)
T cd05098         283 PSQRPTFKQLVED  295 (307)
T ss_pred             hhhCcCHHHHHHH
Confidence            9999999999853

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=9.8e-35  Score=249.70  Aligned_cols=200  Identities=20%  Similarity=0.330  Sum_probs=155.7

Q ss_pred             CCC-CCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHH
Q 022799            2 RLL-DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYK------------MSQRMPLIYVKLYFYQICRA   67 (292)
Q Consensus         2 ~~l-~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~------------~~~~~~~~~~~~~~~qil~a   67 (292)
                      +.+ +||||+++++++     .+....++||||+. |+|.+++.....            ....++...+..++.||+.|
T Consensus        75 ~~l~~h~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~a  149 (304)
T cd05101          75 KMIGKHKNIINLLGAC-----TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARG  149 (304)
T ss_pred             HhhccCCCchheeEEE-----ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHH
Confidence            456 799999999988     34445899999998 699998875422            12357788899999999999


Q ss_pred             HHHHHhcCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCCC---cccccccccccCCccccCCCCCCchhHhhhhh
Q 022799           68 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAG  144 (292)
Q Consensus        68 l~~LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG  144 (292)
                      |.|||++ |++||||||+||+++.++ .+||+|||.++.......   .....+++.|+|||.+.+. .++.++|+||+|
T Consensus       150 l~~LH~~-givH~dlkp~Nili~~~~-~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG  226 (304)
T cd05101         150 MEYLASQ-KCIHRDLAARNVLVTENN-VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFG  226 (304)
T ss_pred             HHHHHHC-CeeecccccceEEEcCCC-cEEECCCccceecccccccccccCCCCCceeeCchhhccC-CCCchhhHHHHH
Confidence            9999988 999999999999999887 799999999986643221   1122346789999998664 489999999999


Q ss_pred             HHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhcc
Q 022799          145 CVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQY  223 (292)
Q Consensus       145 ~il~el~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  223 (292)
                      |++|+|++ |..||.+....+....+.... .               .            ..+..++..++++|.+||..
T Consensus       227 ~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~---------------~------------~~~~~~~~~~~~li~~cl~~  278 (304)
T cd05101         227 VLMWEIFTLGGSPYPGIPVEELFKLLKEGH-R---------------M------------DKPANCTNELYMMMRDCWHA  278 (304)
T ss_pred             HHHHHHHcCCCCCcccCCHHHHHHHHHcCC-c---------------C------------CCCCCCCHHHHHHHHHHccc
Confidence            99999998 788887765544433322100 0               0            01135788999999999999


Q ss_pred             CCCCcccHHHHhcC
Q 022799          224 SPNLRSTALEALIH  237 (292)
Q Consensus       224 dp~~R~t~~e~l~h  237 (292)
                      +|.+|||+.++++.
T Consensus       279 ~p~~Rps~~e~l~~  292 (304)
T cd05101         279 IPSHRPTFKQLVED  292 (304)
T ss_pred             ChhhCCCHHHHHHH
Confidence            99999999999853

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2.1e-34  Score=244.74  Aligned_cols=196  Identities=20%  Similarity=0.294  Sum_probs=153.0

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      ++.++||||+++++++.     +. ..++++||+. |+|.+++...   ...+++..+..++.||+.||.|||++ |++|
T Consensus        63 l~~l~h~~iv~~~~~~~-----~~-~~~~i~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~-~iiH  132 (279)
T cd05111          63 MGSLDHAYIVRLLGICP-----GA-SLQLVTQLSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEEH-RMVH  132 (279)
T ss_pred             HhcCCCCCcceEEEEEC-----CC-ccEEEEEeCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC-CEec
Confidence            35789999999999862     22 2678999998 7999988653   35689999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCC---cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQP  155 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~  155 (292)
                      |||||+||+++.++ .+||+|||.++.......   .....++..|+|||.+.+. .++.++|+||+||++|||++ |..
T Consensus       133 ~dlkp~nili~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~el~t~g~~  210 (279)
T cd05111         133 RNLAARNILLKSDS-IVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFG-RYTHQSDVWSYGVTVWEMMSYGAE  210 (279)
T ss_pred             cccCcceEEEcCCC-cEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCC
Confidence            99999999999887 799999999976533321   1223456789999998654 48999999999999999998 999


Q ss_pred             CCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHh
Q 022799          156 LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL  235 (292)
Q Consensus       156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l  235 (292)
                      ||.+...... ..+......++                           .+...+.++.+++.+|+..||++|||+.+++
T Consensus       211 p~~~~~~~~~-~~~~~~~~~~~---------------------------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~  262 (279)
T cd05111         211 PYAGMRPHEV-PDLLEKGERLA---------------------------QPQICTIDVYMVMVKCWMIDENVRPTFKELA  262 (279)
T ss_pred             CCCCCCHHHH-HHHHHCCCcCC---------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHH
Confidence            9977654332 22222111000                           0123567899999999999999999999997


Q ss_pred             c
Q 022799          236 I  236 (292)
Q Consensus       236 ~  236 (292)
                      +
T Consensus       263 ~  263 (279)
T cd05111         263 N  263 (279)
T ss_pred             H
Confidence            5

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-36  Score=241.75  Aligned_cols=217  Identities=24%  Similarity=0.344  Sum_probs=170.3

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhh-hhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHH-YKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~-~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.-+.||||++++..+...+     .|+-||.|+-+|..+...- ......++|....++....+.||.||-+.+.|+|
T Consensus       117 mks~~cp~IVkfyGa~F~EGd-----cWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIH  191 (361)
T KOG1006|consen  117 MKSSNCPNIVKFYGALFSEGD-----CWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIH  191 (361)
T ss_pred             HhhcCCcHHHHHhhhhhcCCc-----eeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhh
Confidence            345678999999998865443     7899999998877665432 2235679999999999999999999999889999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCC-CCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT-EYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      ||+||+|||++..| .+||||||.+......-..+...|-..|||||.+.... .|..+||+||||+++||+.||..|+.
T Consensus       192 RDvKPSNILldr~G-~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr  270 (361)
T KOG1006|consen  192 RDVKPSNILLDRHG-DVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYR  270 (361)
T ss_pred             ccCChhheEEecCC-CEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcc
Confidence            99999999999988 79999999998776655555667888999999996554 38999999999999999999999997


Q ss_pred             CCCcHHHHHHHHHHh-CCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          159 GESGVDQLVEIIKVL-GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      +-+.  ++.++.... |.|+.-..            +.         -.-+++..+..+|..||.+|-+.||..++++++
T Consensus       271 ~w~s--vfeql~~Vv~gdpp~l~~------------~~---------~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  271 KWDS--VFEQLCQVVIGDPPILLF------------DK---------ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             hHHH--HHHHHHHHHcCCCCeecC------------cc---------cccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            5432  333333322 22221100            00         002478999999999999999999999999999


Q ss_pred             CCccccCCC
Q 022799          238 PFFDELRDP  246 (292)
Q Consensus       238 p~~~~~~~~  246 (292)
                      ||++.+...
T Consensus       328 ~fyr~y~~~  336 (361)
T KOG1006|consen  328 PFYRMYAVE  336 (361)
T ss_pred             chhhhhhhc
Confidence            999976543

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.3e-34  Score=247.86  Aligned_cols=207  Identities=18%  Similarity=0.263  Sum_probs=157.6

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhh-------cCCCCCHHHHHHHHHHHHHHHHHHH
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYK-------MSQRMPLIYVKLYFYQICRALAYIH   72 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~-------~~~~~~~~~~~~~~~qil~al~~LH   72 (292)
                      |++++||||+++++++     .++...++||||+. ++|.+++.....       ....+++..+..++.|++.||.|||
T Consensus        73 l~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH  147 (296)
T cd05051          73 LSRLSDPNIARLLGVC-----TVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE  147 (296)
T ss_pred             HHhcCCCCEeEEEEEE-----ecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            4678999999999988     33345899999998 689888875421       1126899999999999999999999


Q ss_pred             hcCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCCC---cccccccccccCCccccCCCCCCchhHhhhhhHHHHH
Q 022799           73 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAE  149 (292)
Q Consensus        73 ~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~e  149 (292)
                      ++ |++||||||+||+++.++ .++|+|||.+........   .....+++.|+|||.+.+. .++.++|+||+||++|+
T Consensus       148 ~~-~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~e  224 (296)
T cd05051         148 SL-NFVHRDLATRNCLVGKNY-TIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG-KFTTKSDVWAFGVTLWE  224 (296)
T ss_pred             Hc-CccccccchhceeecCCC-ceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC-CCCccchhhhhHHHHHH
Confidence            87 999999999999999887 799999999876533221   1233457789999998654 48999999999999999


Q ss_pred             HHh--CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCC
Q 022799          150 LLL--GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL  227 (292)
Q Consensus       150 l~~--g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~  227 (292)
                      |++  +..||......+.+............               ..      ....+..++.++.+++.+||+.||.+
T Consensus       225 l~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~---------------~~------~~~~~~~~~~~l~~li~~cl~~~p~~  283 (296)
T cd05051         225 ILTLCREQPYEHLTDQQVIENAGHFFRDDGR---------------QI------YLPRPPNCPKDIYELMLECWRRDEED  283 (296)
T ss_pred             HHhcCCCCCCCCcChHHHHHHHHhccccccc---------------cc------cCCCccCCCHHHHHHHHHHhccChhc
Confidence            998  67888766555544443322110000               00      00012356789999999999999999


Q ss_pred             cccHHHHhc
Q 022799          228 RSTALEALI  236 (292)
Q Consensus       228 R~t~~e~l~  236 (292)
                      |||+.+++.
T Consensus       284 Rpt~~el~~  292 (296)
T cd05051         284 RPTFREIHL  292 (296)
T ss_pred             CCCHHHHHH
Confidence            999999963

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.5e-34  Score=246.01  Aligned_cols=211  Identities=25%  Similarity=0.365  Sum_probs=153.7

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++...   +...+++||||++ ++|.+++..     ..+++..++.++.|++.||.|||++ ||+|
T Consensus        60 l~~l~h~~i~~~~~~~~~~---~~~~~~lv~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~-~i~H  130 (283)
T cd05080          60 LKTLYHENIVKYKGCCSEQ---GGKGLQLIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQ-HYIH  130 (283)
T ss_pred             HHhCCCCCEeeEEEEEecC---CCceEEEEecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHC-Ceec
Confidence            4678999999999987432   2335889999998 688888764     4589999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCc----ccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQP  155 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~  155 (292)
                      |||||+||+++.++ .++|+|||++.........    ....++..|+|||.+.+. .++.++|+||+||++|+|++|..
T Consensus       131 ~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~el~tg~~  208 (283)
T cd05080         131 RDLAARNVLLDNDR-LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKEN-KFSYASDVWSFGVTLYELLTHCD  208 (283)
T ss_pred             cccChheEEEcCCC-cEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhccc-CCCcccccHHHHHHHHHHHhCCC
Confidence            99999999999887 7999999999876433221    122346679999998654 48999999999999999999999


Q ss_pred             CCCCCCcHHHHHHHHHH-hCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHH
Q 022799          156 LFPGESGVDQLVEIIKV-LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA  234 (292)
Q Consensus       156 pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~  234 (292)
                      ||......  ....... .+......+...            .........+..++..+.+++.+||..||++|||++++
T Consensus       209 p~~~~~~~--~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i  274 (283)
T cd05080         209 SKQSPPKK--FEEMIGPKQGQMTVVRLIEL------------LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSL  274 (283)
T ss_pred             CCCCCcch--hhhhhcccccccchhhhhhh------------hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHH
Confidence            98654321  1111100 000000000000            00000011234578899999999999999999999999


Q ss_pred             hc
Q 022799          235 LI  236 (292)
Q Consensus       235 l~  236 (292)
                      +.
T Consensus       275 ~~  276 (283)
T cd05080         275 IP  276 (283)
T ss_pred             HH
Confidence            84

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.3e-34  Score=242.89  Aligned_cols=197  Identities=21%  Similarity=0.326  Sum_probs=155.4

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++.+++     .+....++||||++ ++|.+++...   ...+++..+..++.|++.|+.|||+. |++|
T Consensus        60 l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~-~i~H  130 (268)
T cd05063          60 MGQFSHHNIIRLEGVV-----TKFKPAMIITEYMENGALDKYLRDH---DGEFSSYQLVGMLRGIAAGMKYLSDM-NYVH  130 (268)
T ss_pred             HhcCCCCCeeEEEEEE-----ccCCCcEEEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-Ceec
Confidence            4678999999999988     33445899999998 6888887642   35688999999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcc----cccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI----SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQ  154 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~  154 (292)
                      |||||+||+++.++ .++|+|||++..........    ....+..|+|||.+.+. .++.++|+||+||++|+|++ |.
T Consensus       131 ~dlkp~Nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~il~ell~~g~  208 (268)
T cd05063         131 RDLAARNILVNSNL-ECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSFGE  208 (268)
T ss_pred             cccchhhEEEcCCC-cEEECCCccceecccccccceeccCCCcCceecCHHHhhcC-CcChHhHHHHHHHHHHHHHhCCC
Confidence            99999999999887 79999999987654322111    11224569999998654 48999999999999999997 99


Q ss_pred             CCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHH
Q 022799          155 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA  234 (292)
Q Consensus       155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~  234 (292)
                      .||...+..+....+......|                            .+...+..+.+++.+||..+|++||++.++
T Consensus       209 ~p~~~~~~~~~~~~i~~~~~~~----------------------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i  260 (268)
T cd05063         209 RPYWDMSNHEVMKAINDGFRLP----------------------------APMDCPSAVYQLMLQCWQQDRARRPRFVDI  260 (268)
T ss_pred             CCCCcCCHHHHHHHHhcCCCCC----------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence            9998776655444443211000                            013468899999999999999999999999


Q ss_pred             hc
Q 022799          235 LI  236 (292)
Q Consensus       235 l~  236 (292)
                      ++
T Consensus       261 ~~  262 (268)
T cd05063         261 VN  262 (268)
T ss_pred             HH
Confidence            74

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.7e-34  Score=243.86  Aligned_cols=205  Identities=19%  Similarity=0.249  Sum_probs=151.9

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCcc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKM-SQRMPLIYVKLYFYQICRALAYIHNTIGVC   78 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~-~~~~~~~~~~~~~~qil~al~~LH~~~~i~   78 (292)
                      |++++||||+++++++     .+....++||||++ |+|.+++...... ....+...+..++.|++.|+.|||+. |++
T Consensus        49 l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~i~  122 (269)
T cd05087          49 YRSLQHSNLLQCLGQC-----TEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN-NFI  122 (269)
T ss_pred             HHhCCCCCEeeEEEEE-----cCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC-CEe
Confidence            3578999999999988     33445889999998 7998888754321 23466778888999999999999988 999


Q ss_pred             ccCCCCCcEEEeCCCCcEEEeecCCccccccCCC---cccccccccccCCccccCCC------CCCchhHhhhhhHHHHH
Q 022799           79 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGAT------EYTAAIDIWSAGCVLAE  149 (292)
Q Consensus        79 H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~------~~~~~~DvwslG~il~e  149 (292)
                      |+||||+||+++.++ .++|+|||.+........   .....++..|+|||++.+..      .++.++|+||+||++|+
T Consensus       123 H~dlkp~nil~~~~~-~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~e  201 (269)
T cd05087         123 HSDLALRNCLLTADL-TVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWE  201 (269)
T ss_pred             ccccCcceEEEcCCC-cEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHH
Confidence            999999999999877 799999999875432221   12235678899999985321      35789999999999999


Q ss_pred             HHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCc
Q 022799          150 LLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR  228 (292)
Q Consensus       150 l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R  228 (292)
                      |++ |..||......+...........                ..+.       ..+....++.+.+++.+|+ .+|++|
T Consensus       202 l~~~g~~p~~~~~~~~~~~~~~~~~~~----------------~~~~-------~~~~~~~~~~~~~l~~~c~-~~P~~R  257 (269)
T cd05087         202 LFELGSQPYRHLSDEQVLTYTVREQQL----------------KLPK-------PRLKLPLSDRWYEVMQFCW-LQPEQR  257 (269)
T ss_pred             HHhCCCCCCCCCChHHHHHHHhhcccC----------------CCCC-------CccCCCCChHHHHHHHHHh-cCcccC
Confidence            996 99999776554433222211000                0000       0011246788999999998 689999


Q ss_pred             ccHHHHhc
Q 022799          229 STALEALI  236 (292)
Q Consensus       229 ~t~~e~l~  236 (292)
                      ||+++++.
T Consensus       258 pt~~~l~~  265 (269)
T cd05087         258 PSAEEVHL  265 (269)
T ss_pred             CCHHHHHH
Confidence            99999974

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2.3e-34  Score=242.94  Aligned_cols=201  Identities=20%  Similarity=0.315  Sum_probs=155.9

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKM---SQRMPLIYVKLYFYQICRALAYIHNTIG   76 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~---~~~~~~~~~~~~~~qil~al~~LH~~~~   76 (292)
                      |+.++||||+++++++.     +....++||||++ ++|.+++......   ...+++..+..++.|++.||.|||++ +
T Consensus        53 l~~l~h~~i~~~~~~~~-----~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~  126 (269)
T cd05044          53 MSNFNHPNIVKLLGVCL-----LNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM-H  126 (269)
T ss_pred             HHhcCCCCeeeEeeeec-----CCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC-C
Confidence            46789999999999883     3335899999998 6999988754321   24578899999999999999999987 9


Q ss_pred             ccccCCCCCcEEEeCCC----CcEEEeecCCccccccCCC---cccccccccccCCccccCCCCCCchhHhhhhhHHHHH
Q 022799           77 VCHRDIKPQNLLVNPHT----HQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAE  149 (292)
Q Consensus        77 i~H~dlkp~Nill~~~~----~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~e  149 (292)
                      ++|+||||+||+++.++    ..++|+|||++........   .....++..|+|||.+.+. .++.++|+|||||++|+
T Consensus       127 i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~e  205 (269)
T cd05044         127 FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDG-KFTTQSDVWSFGVLMWE  205 (269)
T ss_pred             cccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccC-CcccchhHHHHHHHHHH
Confidence            99999999999998754    2599999999876533221   1123456789999998654 48999999999999999


Q ss_pred             HHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCc
Q 022799          150 LLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR  228 (292)
Q Consensus       150 l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R  228 (292)
                      |++ |..||...+..+....+... ..               .            ..+..+++.+.++|.+||..+|.+|
T Consensus       206 llt~g~~p~~~~~~~~~~~~~~~~-~~---------------~------------~~~~~~~~~~~~li~~~l~~~p~~R  257 (269)
T cd05044         206 ILTLGQQPYPALNNQEVLQHVTAG-GR---------------L------------QKPENCPDKIYQLMTNCWAQDPSER  257 (269)
T ss_pred             HHHcCCCCCcccCHHHHHHHHhcC-Cc---------------c------------CCcccchHHHHHHHHHHcCCCcccC
Confidence            998 99999876655443332210 00               0            0113578899999999999999999


Q ss_pred             ccHHHHhc
Q 022799          229 STALEALI  236 (292)
Q Consensus       229 ~t~~e~l~  236 (292)
                      |+++++++
T Consensus       258 p~~~~i~~  265 (269)
T cd05044         258 PTFDRIQE  265 (269)
T ss_pred             CCHHHHHH
Confidence            99999874

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-34  Score=241.77  Aligned_cols=195  Identities=26%  Similarity=0.362  Sum_probs=153.9

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++.     .. ..++||||++ |+|.+++...    ..+++..+..++.|++.||.|||+. |++|
T Consensus        50 l~~l~h~~iv~~~~~~~-----~~-~~~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh~~-~i~H  118 (257)
T cd05060          50 MAQLDHPCIVRLIGVCK-----GE-PLMLVMELAPLGPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESK-HFVH  118 (257)
T ss_pred             HHhcCCCCeeeEEEEEc-----CC-ceEEEEEeCCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhc-Ceec
Confidence            46789999999999762     22 3689999998 6999888753    4689999999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcc----cccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI----SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQ  154 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~  154 (292)
                      +||||+||+++.++ .++|+|||.++.........    ...++..|+|||.+.+. .++.++|+||+||++|+|++ |.
T Consensus       119 ~di~p~nili~~~~-~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~~g~  196 (257)
T cd05060         119 RDLAARNVLLVNRH-QAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYG-KFSSKSDVWSYGVTLWEAFSYGA  196 (257)
T ss_pred             cCcccceEEEcCCC-cEEeccccccceeecCCcccccccCccccccccCHHHhcCC-CCCccchHHHHHHHHHHHHcCCC
Confidence            99999999999888 79999999998664433211    11224579999998654 48999999999999999998 99


Q ss_pred             CCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHH
Q 022799          155 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA  234 (292)
Q Consensus       155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~  234 (292)
                      .||...+..+....+... ..                           ...+..++..++++|.+||..+|++||++.++
T Consensus       197 ~p~~~~~~~~~~~~~~~~-~~---------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l  248 (257)
T cd05060         197 KPYGEMKGAEVIAMLESG-ER---------------------------LPRPEECPQEIYSIMLSCWKYRPEDRPTFSEL  248 (257)
T ss_pred             CCcccCCHHHHHHHHHcC-Cc---------------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHH
Confidence            999776654433332211 00                           00124578899999999999999999999998


Q ss_pred             hc
Q 022799          235 LI  236 (292)
Q Consensus       235 l~  236 (292)
                      ++
T Consensus       249 ~~  250 (257)
T cd05060         249 ES  250 (257)
T ss_pred             HH
Confidence            74

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.3e-34  Score=244.34  Aligned_cols=197  Identities=25%  Similarity=0.376  Sum_probs=155.3

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++     .+....++||||++ ++|.+++...   ...+++..+..++.|++.||.|||+. |++|
T Consensus        59 l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~h  129 (267)
T cd05066          59 MGQFDHPNIIHLEGVV-----TKSKPVMIVTEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDM-GYVH  129 (267)
T ss_pred             HHhCCCCCcceEEEEE-----ecCCccEEEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CEee
Confidence            3578999999999988     33345899999998 6888888643   34688999999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcc----cccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI----SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQ  154 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~  154 (292)
                      |||||+||+++.++ .++|+|||.+..........    ...++..|+|||.+.+. .++.++|+||+||++|++++ |.
T Consensus       130 ~dlkp~nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~ell~~g~  207 (267)
T cd05066         130 RDLAARNILVNSNL-VCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGE  207 (267)
T ss_pred             hhhchhcEEECCCC-eEEeCCCCcccccccccceeeecCCCccceeecCHhHhccC-ccCchhhhHHHHHHHHHHhcCCC
Confidence            99999999999887 79999999998764332211    11224679999999654 48999999999999999886 99


Q ss_pred             CCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHH
Q 022799          155 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA  234 (292)
Q Consensus       155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~  234 (292)
                      .||.+....+....+.+...                  .+          .+...++.+.+++.+||+.+|.+||++.++
T Consensus       208 ~p~~~~~~~~~~~~~~~~~~------------------~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i  259 (267)
T cd05066         208 RPYWEMSNQDVIKAIEEGYR------------------LP----------APMDCPAALHQLMLDCWQKDRNERPKFEQI  259 (267)
T ss_pred             CCcccCCHHHHHHHHhCCCc------------------CC----------CCCCCCHHHHHHHHHHcccCchhCCCHHHH
Confidence            99977665544443332110                  00          113468899999999999999999999998


Q ss_pred             hc
Q 022799          235 LI  236 (292)
Q Consensus       235 l~  236 (292)
                      ++
T Consensus       260 ~~  261 (267)
T cd05066         260 VS  261 (267)
T ss_pred             HH
Confidence            74

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2.8e-34  Score=241.50  Aligned_cols=198  Identities=22%  Similarity=0.352  Sum_probs=150.8

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++...    +...++||||+. |+|.+++...   ....++..+..++.|++.||.|||+. |++|
T Consensus        50 l~~l~h~~iv~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H  121 (262)
T cd05058          50 MKDFSHPNVLSLLGICLPS----EGSPLVVLPYMKHGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASK-KFVH  121 (262)
T ss_pred             HccCCCCCcceEEEEeecC----CCCcEEEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC-Cccc
Confidence            4678999999999966432    224779999998 7998888643   23467777888999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCC-----CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-C
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-----PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-G  153 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g  153 (292)
                      |||||+||+++.++ .++|+|||+++......     ......++..|+|||.+.+. .++.++|+||+||++|+|++ |
T Consensus       122 ~dlk~~nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~  199 (262)
T cd05058         122 RDLAARNCMLDESF-TVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRG  199 (262)
T ss_pred             cccCcceEEEcCCC-cEEECCccccccccCCcceeecccccCcCCccccChhHhccC-ccchHHHHHHHHHHHHHHHcCC
Confidence            99999999999887 79999999987653221     11123456789999998654 48999999999999999999 5


Q ss_pred             CCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHH
Q 022799          154 QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE  233 (292)
Q Consensus       154 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e  233 (292)
                      .+||...+..+....+... ..+                           ..+..+++.+.+++.+||..+|++||++.+
T Consensus       200 ~~~~~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~  251 (262)
T cd05058         200 APPYPDVDSFDITVYLLQG-RRL---------------------------LQPEYCPDPLYEVMLSCWHPKPEMRPTFSE  251 (262)
T ss_pred             CCCCCCCCHHHHHHHHhcC-CCC---------------------------CCCCcCCHHHHHHHHHHcCCChhhCCCHHH
Confidence            6677665544433222110 000                           011346789999999999999999999999


Q ss_pred             Hhc
Q 022799          234 ALI  236 (292)
Q Consensus       234 ~l~  236 (292)
                      ++.
T Consensus       252 il~  254 (262)
T cd05058         252 LVS  254 (262)
T ss_pred             HHH
Confidence            985

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.8e-34  Score=243.71  Aligned_cols=197  Identities=22%  Similarity=0.355  Sum_probs=154.4

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++     .+....++||||++ ++|.+++...   .+.+++..+..++.|++.||.|||++ |++|
T Consensus        59 l~~l~h~ni~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~-g~~H  129 (269)
T cd05065          59 MGQFDHPNIIHLEGVV-----TKSRPVMIITEFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEM-NYVH  129 (269)
T ss_pred             HHhCCCcCcceEEEEE-----CCCCceEEEEecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHC-CEee
Confidence            3578999999999988     44445889999998 5888887643   35688999999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCccc---cc---ccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS---YI---CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-  152 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~---~~---gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-  152 (292)
                      +||||+||+++.++ .++|+|||++...........   ..   .+..|+|||.+.+. .++.++|+||+||++|||++ 
T Consensus       130 ~dl~p~nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~e~l~~  207 (269)
T cd05065         130 RDLAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSY  207 (269)
T ss_pred             cccChheEEEcCCC-cEEECCCccccccccCccccccccccCCCcceeecCHhHhccC-cccchhhhhhhHHHHHHHhcC
Confidence            99999999999877 799999999876533222111   11   13479999998654 48999999999999999886 


Q ss_pred             CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHH
Q 022799          153 GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAL  232 (292)
Q Consensus       153 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~  232 (292)
                      |..||.+.+..+....+......+                            .+..++..+.+++.+||..+|++||++.
T Consensus       208 g~~p~~~~~~~~~~~~i~~~~~~~----------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~  259 (269)
T cd05065         208 GERPYWDMSNQDVINAIEQDYRLP----------------------------PPMDCPTALHQLMLDCWQKDRNARPKFG  259 (269)
T ss_pred             CCCCCCCCCHHHHHHHHHcCCcCC----------------------------CcccCCHHHHHHHHHHcCCChhhCcCHH
Confidence            999997766554444432211000                            1135688999999999999999999999


Q ss_pred             HHhc
Q 022799          233 EALI  236 (292)
Q Consensus       233 e~l~  236 (292)
                      +++.
T Consensus       260 ~i~~  263 (269)
T cd05065         260 QIVS  263 (269)
T ss_pred             HHHH
Confidence            9985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2.3e-34  Score=240.30  Aligned_cols=197  Identities=22%  Similarity=0.355  Sum_probs=154.1

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++.     +....++||||++ ++|.+++...   ...+++..+..++.|++.||.|||++ |++|
T Consensus        46 l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~~~H  116 (250)
T cd05085          46 LKQYDHPNIVKLIGVCT-----QRQPIYIVMELVPGGDFLSFLRKK---KDELKTKQLVKFALDAAAGMAYLESK-NCIH  116 (250)
T ss_pred             HHhCCCCCcCeEEEEEe-----cCCccEEEEECCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC-Ceee
Confidence            35689999999999883     3345899999998 6888877643   34578999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCc--ccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPL  156 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~p  156 (292)
                      |||||+||+++.++ .++|+|||++.........  ....++..|+|||.+.+. .++.++|+||+|+++|++++ |..|
T Consensus       117 ~dl~p~nili~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~~~~~g~~p  194 (250)
T cd05085         117 RDLAARNCLVGENN-VLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYG-RYSSESDVWSYGILLWETFSLGVCP  194 (250)
T ss_pred             cccChheEEEcCCC-eEEECCCccceeccccccccCCCCCCcccccCHHHhccC-CCCchhHHHHHHHHHHHHhcCCCCC
Confidence            99999999999887 7999999998754322111  112335679999998654 48999999999999999998 9999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      |.+.........+....                .            ...+..++..+.+++.+||..+|++||++.++++
T Consensus       195 ~~~~~~~~~~~~~~~~~----------------~------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  246 (250)
T cd05085         195 YPGMTNQQAREQVEKGY----------------R------------MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK  246 (250)
T ss_pred             CCCCCHHHHHHHHHcCC----------------C------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            98766544333332110                0            0012357889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=4.3e-35  Score=246.33  Aligned_cols=197  Identities=26%  Similarity=0.391  Sum_probs=151.5

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      ++++||||+++++++....     ..++||||+. |+|.+++...  ....++......++.||+.||.|||++ +++|+
T Consensus        56 ~~l~h~ni~~~~g~~~~~~-----~~~lv~e~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~-~iiH~  127 (259)
T PF07714_consen   56 RKLRHPNIVKLYGFCIENE-----PLFLVMEYCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSN-NIIHG  127 (259)
T ss_dssp             HTHSBTTBE-EEEEEESSS-----SEEEEEE--TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHT-TEEES
T ss_pred             ccccccccccccccccccc-----ccccccccccccccccccccc--ccccccccccccccccccccccccccc-ccccc
Confidence            4679999999999986322     2889999998 7999999864  235689999999999999999999998 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCCc---ccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPL  156 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~p  156 (292)
                      +|+++||+++.++ .+||+|||++.........   ....+...|+|||.+.+.. ++.++||||||+++||+++ |..|
T Consensus       128 ~l~~~nill~~~~-~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~l~ei~~~~~~p  205 (259)
T PF07714_consen  128 NLSPSNILLDSNG-QVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGE-YTKKSDVYSFGMLLYEILTLGKFP  205 (259)
T ss_dssp             T-SGGGEEEETTT-EEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSE-ESHHHHHHHHHHHHHHHHTTSSGT
T ss_pred             ccccccccccccc-ccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccccccc
Confidence            9999999999988 8999999999876322221   2234567899999996654 8999999999999999999 7899


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      |.+.+..+....+.+. ..                           ...+..++..+.++|.+||..||.+|||+.++++
T Consensus       206 ~~~~~~~~~~~~~~~~-~~---------------------------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  206 FSDYDNEEIIEKLKQG-QR---------------------------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             TTTSCHHHHHHHHHTT-EE---------------------------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             cccccccccccccccc-cc---------------------------ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            9877666555554221 00                           0112457899999999999999999999999874

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=2.9e-34  Score=241.62  Aligned_cols=196  Identities=24%  Similarity=0.344  Sum_probs=153.7

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      +.++||||+++++++     .+ ...++||||++ |+|.+++...  ....+++..+..++.|++.||.|||++ |++||
T Consensus        56 ~~l~~~~i~~~~~~~-----~~-~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~-~i~H~  126 (262)
T cd05071          56 KKLRHEKLVQLYAVV-----SE-EPIYIVTEYMSKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERM-NYVHR  126 (262)
T ss_pred             HhCCCCCcceEEEEE-----CC-CCcEEEEEcCCCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHC-Ccccc
Confidence            568999999999876     22 23689999998 6999888643  134578899999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCCc--ccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLF  157 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf  157 (292)
                      ||||+||+++.++ .++|+|||.+.........  ....++..|+|||...+. .++.++|+||+||++|+|++ |..||
T Consensus       127 dl~p~Nill~~~~-~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~ellt~g~~p~  204 (262)
T cd05071         127 DLRAANILVGENL-VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPY  204 (262)
T ss_pred             ccCcccEEEcCCC-cEEeccCCceeeccccccccccCCcccceecCHhHhccC-CCCchhhHHHHHHHHHHHHcCCCCCC
Confidence            9999999999887 7999999999765433221  123356679999988554 48999999999999999999 88899


Q ss_pred             CCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          158 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      .+....+....+......                            ..+..++..+.++|.+||+.||++||++.++++
T Consensus       205 ~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         205 PGMVNREVLDQVERGYRM----------------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             CCCChHHHHHHHhcCCCC----------------------------CCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            876655444333221000                            011357889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=2.2e-34  Score=244.46  Aligned_cols=195  Identities=19%  Similarity=0.287  Sum_probs=152.4

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      +.++||||+++++++...      ..+++|||++ |+|.+.+...   ...+++..+..++.||+.||.|||++ |++||
T Consensus        64 ~~~~~~~i~~~~~~~~~~------~~~l~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~-~iiH~  133 (279)
T cd05109          64 AGVGSPYVCRLLGICLTS------TVQLVTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEV-RLVHR  133 (279)
T ss_pred             HhcCCCCCceEEEEEcCC------CcEEEEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC-Ceecc
Confidence            567899999999987421      2678999998 7998887643   35689999999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCCcc---cccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI---SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPL  156 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~p  156 (292)
                      ||||+||+++.++ .+||+|||+++.........   ...+++.|+|||...+. .++.++|+||+||++|||++ |..|
T Consensus       134 dlkp~Nil~~~~~-~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p  211 (279)
T cd05109         134 DLAARNVLVKSPN-HVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHR-RFTHQSDVWSYGVTVWELMTFGAKP  211 (279)
T ss_pred             ccccceEEEcCCC-cEEECCCCceeecccccceeecCCCccchhhCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCC
Confidence            9999999998877 69999999998764332211   12345679999998654 48999999999999999998 8899


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      |......... ........++                           .+...+.++.+++.+||..||++||++.+++.
T Consensus       212 ~~~~~~~~~~-~~~~~~~~~~---------------------------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         212 YDGIPAREIP-DLLEKGERLP---------------------------QPPICTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             CCCCCHHHHH-HHHHCCCcCC---------------------------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            8765543322 2222111100                           11346889999999999999999999999984

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=3.4e-34  Score=240.87  Aligned_cols=197  Identities=24%  Similarity=0.338  Sum_probs=154.8

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++     .+. ..++||||+. ++|.+++...  ....+++..+..++.|++.||.|||+. |++|
T Consensus        55 l~~l~h~~i~~~~~~~-----~~~-~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~-~i~H  125 (260)
T cd05069          55 MKKLRHDKLVPLYAVV-----SEE-PIYIVTEFMGKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERM-NYIH  125 (260)
T ss_pred             HHhCCCCCeeeEEEEE-----cCC-CcEEEEEcCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC-CEee
Confidence            4578999999999876     222 3689999998 5999888653  134578899999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCc--ccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPL  156 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~p  156 (292)
                      +||||+||+++.++ .++|+|||.+.........  ....++..|+|||...+. .++.++|+||+||++|+|++ |..|
T Consensus       126 ~dl~~~Nill~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~~l~el~t~g~~p  203 (260)
T cd05069         126 RDLRAANILVGDNL-VCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVP  203 (260)
T ss_pred             cccCcceEEEcCCC-eEEECCCccceEccCCcccccCCCccchhhCCHHHhccC-CcChHHHHHHHHHHHHHHHhCCCCC
Confidence            99999999999887 7999999999765332211  122346679999988654 48999999999999999999 8999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      |.+....+....+..... +                           ..+...+..+.+++.+||..||++||+++++++
T Consensus       204 ~~~~~~~~~~~~~~~~~~-~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         204 YPGMVNREVLEQVERGYR-M---------------------------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             CCCCCHHHHHHHHHcCCC-C---------------------------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            987766554443322100 0                           012357889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=5.6e-36  Score=257.52  Aligned_cols=226  Identities=35%  Similarity=0.573  Sum_probs=178.1

Q ss_pred             CeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcE
Q 022799            8 NVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNL   87 (292)
Q Consensus         8 nIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlkp~Ni   87 (292)
                      |+++++-.|     ....++|||+|-+.-+|.+++..+.. .-.+....++.|+.|+..||..|-. +||+|.||||+||
T Consensus       495 Hclrl~r~F-----~hknHLClVFE~LslNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~-c~vlHaDIKPDNi  567 (752)
T KOG0670|consen  495 HCLRLFRHF-----KHKNHLCLVFEPLSLNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKK-CGVLHADIKPDNI  567 (752)
T ss_pred             HHHHHHHHh-----hhcceeEEEehhhhchHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHh-cCeeecccCccce
Confidence            577888777     66677999999999999999986533 4568888999999999999999985 5999999999999


Q ss_pred             EEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCCCcHHHHH
Q 022799           88 LVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV  167 (292)
Q Consensus        88 ll~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~  167 (292)
                      |++.....+||||||.|......+ .+.+..+..|.|||++.|.+ |+...|+||+||++|||.||+..|+|.++.+.+.
T Consensus       568 LVNE~k~iLKLCDfGSA~~~~ene-itPYLVSRFYRaPEIiLG~~-yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLr  645 (752)
T KOG0670|consen  568 LVNESKNILKLCDFGSASFASENE-ITPYLVSRFYRAPEIILGLP-YDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLR  645 (752)
T ss_pred             EeccCcceeeeccCcccccccccc-ccHHHHHHhccCcceeecCc-ccCCccceeeceeeEEeeccceecCCCCcHHHHH
Confidence            999877789999999998765443 34556688899999999876 9999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCHHHHhhcCC---CCcc-ccCC-----------------CCCC-CCchhhhcc--CCC-------hhHHHH
Q 022799          168 EIIKVLGTPTREEIKCMNP---NYTE-FKFP-----------------QIKA-HPWHKIFQK--RMP-------PEAVDL  216 (292)
Q Consensus       168 ~i~~~~~~~~~~~~~~~~~---~~~~-~~~~-----------------~~~~-~~~~~~~~~--~~~-------~~~~~l  216 (292)
                      ..+..-|..+..++....-   -|.. ..+-                 .... ..+.+.+..  .++       ..+++|
T Consensus       646 l~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdL  725 (752)
T KOG0670|consen  646 LFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDL  725 (752)
T ss_pred             HHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHH
Confidence            9999888888776643210   0100 0000                 0000 111111111  122       478999


Q ss_pred             HHHHhccCCCCcccHHHHhcCCCccc
Q 022799          217 VSRLLQYSPNLRSTALEALIHPFFDE  242 (292)
Q Consensus       217 i~~~l~~dp~~R~t~~e~l~hp~~~~  242 (292)
                      |.+||..||++|.|..++|.||||..
T Consensus       726 Ldkml~LdP~KRit~nqAL~HpFi~~  751 (752)
T KOG0670|consen  726 LDKMLILDPEKRITVNQALKHPFITE  751 (752)
T ss_pred             HHHHhccChhhcCCHHHHhcCCcccC
Confidence            99999999999999999999999974

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.8e-34  Score=239.28  Aligned_cols=196  Identities=24%  Similarity=0.370  Sum_probs=155.1

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++..     ....++||||++ ++|.+++....  ...+++..+..++.|++.||.|||++ |++|
T Consensus        54 l~~l~~~~i~~~~~~~~~-----~~~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~~-~i~H  125 (256)
T cd05039          54 MTTLRHPNLVQLLGVVLQ-----GNPLYIVTEYMAKGSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEEK-NFVH  125 (256)
T ss_pred             HHhcCCcceeeeEEEEcC-----CCCeEEEEEecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC-Cccc
Confidence            357899999999998843     344899999998 69998886531  23689999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFP  158 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~  158 (292)
                      +||||+||+++.++ .++|+|||.++......  .....+..|+|||.+.+. .++.++|+||+||++|+|++ |..||.
T Consensus       126 ~di~p~Nili~~~~-~~~l~d~g~~~~~~~~~--~~~~~~~~~~ape~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~  201 (256)
T cd05039         126 RDLAARNVLVSEDL-VAKVSDFGLAKEASQGQ--DSGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYP  201 (256)
T ss_pred             hhcccceEEEeCCC-CEEEccccccccccccc--ccCCCcccccCchhhcCC-cCCcHHHHHHHHHHHHHHHhcCCCCCC
Confidence            99999999999888 79999999998763222  123345679999998654 48899999999999999997 999997


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      .....+....+...               +             ....+..+++.+.++|.+||..+|++|||++++++
T Consensus       202 ~~~~~~~~~~~~~~---------------~-------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         202 RIPLKDVVPHVEKG---------------Y-------------RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             CCCHHHHHHHHhcC---------------C-------------CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            66544433222210               0             00012457889999999999999999999999984

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=3.5e-34  Score=241.39  Aligned_cols=203  Identities=33%  Similarity=0.516  Sum_probs=157.0

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++|+||+++++++..     ....++||||++ ++|.+++.........+++..+..++.|++.||.|||+. |++|
T Consensus        56 l~~~~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h  129 (267)
T cd08224          56 LKQLDHPNVIKYLASFIE-----NNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK-RIMH  129 (267)
T ss_pred             HHhCCCCCeeeeeeeeec-----CCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC-CEec
Confidence            357899999999999843     345899999998 699988876544456689999999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCC-CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      |||+|+||+++.++ .++|+|||.+....... ......+++.|+|||.+.+. .++.++|+||+||++|+|++|..||.
T Consensus       130 ~dl~p~nil~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~  207 (267)
T cd08224         130 RDIKPANVFITATG-VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFY  207 (267)
T ss_pred             CCcChhhEEECCCC-cEEEeccceeeeccCCCcccceecCCccccCHHHhccC-CCCchhcHHHHHHHHHHHHHCCCCcc
Confidence            99999999999888 79999999987654332 12334678899999998654 48999999999999999999999996


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      .....  .....+.....               ..+.        .....++..+.++|.+||..+|++|||+.++++
T Consensus       208 ~~~~~--~~~~~~~~~~~---------------~~~~--------~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         208 GDKMN--LYSLCKKIEKC---------------DYPP--------LPADHYSEELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             cCCcc--HHHHHhhhhcC---------------CCCC--------CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            54321  11111110000               0000        001246789999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=4.2e-34  Score=240.22  Aligned_cols=196  Identities=23%  Similarity=0.337  Sum_probs=154.1

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++.     + ...+++|||++ ++|.+++...  ....+++..+..++.|++.||.|||++ |++|
T Consensus        55 l~~l~~~~i~~~~~~~~-----~-~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~-~i~H  125 (260)
T cd05070          55 MKKLRHDKLVQLYAVVS-----E-EPIYIVTEYMSKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERM-NYIH  125 (260)
T ss_pred             HHhcCCCceEEEEeEEC-----C-CCcEEEEEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC-Cccc
Confidence            46789999999998762     1 12689999998 6998888643  134589999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCc--ccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPL  156 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~p  156 (292)
                      |||||+||+++.++ .++|+|||.+.........  ....++..|+|||.+.+. .++.++|+||+||++|+|++ |..|
T Consensus       126 ~di~p~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p  203 (260)
T cd05070         126 RDLRSANILVGDGL-VCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVP  203 (260)
T ss_pred             CCCccceEEEeCCc-eEEeCCceeeeeccCcccccccCCCCCccccChHHHhcC-CCcchhhhHHHHHHHHHHHhcCCCC
Confidence            99999999999887 7999999999765432211  112345679999998654 48999999999999999999 8999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHh
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL  235 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l  235 (292)
                      |.+.+..+....+......                            ..+...+..+.+++.+||..||++|||+.++.
T Consensus       204 ~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~  254 (260)
T cd05070         204 YPGMNNREVLEQVERGYRM----------------------------PCPQDCPISLHELMLQCWKKDPEERPTFEYLQ  254 (260)
T ss_pred             CCCCCHHHHHHHHHcCCCC----------------------------CCCCcCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence            9877655544443321000                            01135788999999999999999999999887

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.9e-34  Score=239.06  Aligned_cols=197  Identities=24%  Similarity=0.352  Sum_probs=153.6

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      +++++||||+++++++.     +....++||||++ ++|.+++...   ...+++..+..++.|++.||.|||++ |++|
T Consensus        46 l~~l~~~~i~~~~~~~~-----~~~~~~~v~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~-~i~h  116 (251)
T cd05041          46 LKQYDHPNIVKLIGVCV-----QKQPIYIVMELVPGGSLLTFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESK-NCIH  116 (251)
T ss_pred             HHhCCCCCeEEEEEEEe-----cCCCeEEEEEcCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CEeh
Confidence            35789999999999883     3445899999997 6888887643   34678889999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCc---ccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQP  155 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~  155 (292)
                      |||+|+||+++.++ .++|+|||.+.........   ....++..|+|||.+.+. .++.++|+||+||++|+|++ |..
T Consensus       117 ~di~p~nili~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~i~~~l~t~~~~  194 (251)
T cd05041         117 RDLAARNCLVGENN-VLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYG-RYTSESDVWSYGILLWETFSLGDT  194 (251)
T ss_pred             hhcCcceEEEcCCC-cEEEeeccccccccCCcceeccccCcceeccCChHhhccC-CCCcchhHHHHHHHHHHHHhccCC
Confidence            99999999999888 7999999998765322111   112235669999998654 48999999999999999999 888


Q ss_pred             CCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHh
Q 022799          156 LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL  235 (292)
Q Consensus       156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l  235 (292)
                      ||.+.........+.....                            ...+..++..+.+++.+||..+|.+|||+.+++
T Consensus       195 p~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell  246 (251)
T cd05041         195 PYPGMSNQQTRERIESGYR----------------------------MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIY  246 (251)
T ss_pred             CCccCCHHHHHHHHhcCCC----------------------------CCCCccCCHHHHHHHHHHhccChhhCcCHHHHH
Confidence            8877654433332211000                            001235788999999999999999999999998


Q ss_pred             c
Q 022799          236 I  236 (292)
Q Consensus       236 ~  236 (292)
                      +
T Consensus       247 ~  247 (251)
T cd05041         247 N  247 (251)
T ss_pred             H
Confidence            5

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=3.1e-34  Score=249.84  Aligned_cols=200  Identities=20%  Similarity=0.324  Sum_probs=155.2

Q ss_pred             CCC-CCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHH
Q 022799            2 RLL-DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYK------------MSQRMPLIYVKLYFYQICRA   67 (292)
Q Consensus         2 ~~l-~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~------------~~~~~~~~~~~~~~~qil~a   67 (292)
                      +++ +||||+++++++     .+...++++|||++ |+|.+++.....            ....++...+..++.|++.|
T Consensus        72 ~~l~~h~~iv~~~~~~-----~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~a  146 (334)
T cd05100          72 KMIGKHKNIINLLGAC-----TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARG  146 (334)
T ss_pred             HhhcCCCCeeeeeEEE-----ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHH
Confidence            456 799999999988     33445899999998 699998875321            12357788899999999999


Q ss_pred             HHHHHhcCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCCCc---ccccccccccCCccccCCCCCCchhHhhhhh
Q 022799           68 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAG  144 (292)
Q Consensus        68 l~~LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG  144 (292)
                      |.|||++ |++||||||+||+++.++ .+||+|||+++........   ....++..|+|||.+.+. .++.++|+||+|
T Consensus       147 l~~LH~~-givH~dlkp~Nill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG  223 (334)
T cd05100         147 MEYLASQ-KCIHRDLAARNVLVTEDN-VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFG  223 (334)
T ss_pred             HHHHHHC-CeeccccccceEEEcCCC-cEEECCcccceecccccccccccCCCcCceEcCHHHhccC-CcCchhhhHHHH
Confidence            9999988 999999999999999887 7999999998765332211   112235679999998654 489999999999


Q ss_pred             HHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhcc
Q 022799          145 CVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQY  223 (292)
Q Consensus       145 ~il~el~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  223 (292)
                      |++|+|++ |..||.+....+....+.....                .            ..+..++..+.+++.+||..
T Consensus       224 ~il~el~~~g~~p~~~~~~~~~~~~~~~~~~----------------~------------~~~~~~~~~l~~li~~cl~~  275 (334)
T cd05100         224 VLLWEIFTLGGSPYPGIPVEELFKLLKEGHR----------------M------------DKPANCTHELYMIMRECWHA  275 (334)
T ss_pred             HHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC----------------C------------CCCCCCCHHHHHHHHHHccc
Confidence            99999998 8899987665444333321000                0            01135688999999999999


Q ss_pred             CCCCcccHHHHhcC
Q 022799          224 SPNLRSTALEALIH  237 (292)
Q Consensus       224 dp~~R~t~~e~l~h  237 (292)
                      +|.+|||+.+++++
T Consensus       276 ~p~~Rps~~ell~~  289 (334)
T cd05100         276 VPSQRPTFKQLVED  289 (334)
T ss_pred             ChhhCcCHHHHHHH
Confidence            99999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.4e-34  Score=240.14  Aligned_cols=197  Identities=25%  Similarity=0.364  Sum_probs=157.0

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++     ......++||||++ ++|.+++....  +..+++..+..++.|++.|+.|||++ |++|
T Consensus        55 l~~l~h~~i~~~~~~~-----~~~~~~~~v~e~~~~~~L~~~i~~~~--~~~~~~~~~~~~~~~i~~al~~lh~~-~i~h  126 (261)
T cd05034          55 MKKLRHDKLVQLYAVC-----SEEEPIYIVTEYMSKGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLESR-NYIH  126 (261)
T ss_pred             HhhCCCCCEeeeeeee-----ecCCceEEEEeccCCCCHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhC-Cccc
Confidence            4678999999999987     33345899999998 69988886531  34689999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCc--ccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPL  156 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~p  156 (292)
                      +||||+||+++.++ .++|+|||.+.........  ....++..|+|||.+.+. .++.++|+||+||++|+|++ |+.|
T Consensus       127 ~di~p~nili~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p  204 (261)
T cd05034         127 RDLAARNILVGENL-VCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYG-RFTIKSDVWSFGILLTEIVTYGRVP  204 (261)
T ss_pred             CCcchheEEEcCCC-CEEECccccceeccchhhhhhhccCCCccccCHHHhccC-CcCchhHHHHHHHHHHHHHhCCCCC
Confidence            99999999999888 7999999998765432111  122345679999998654 48999999999999999998 9999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHh
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL  235 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l  235 (292)
                      |.+.+.......+......+                            .+...+.++.+++.+||..+|.+||++++++
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~  255 (261)
T cd05034         205 YPGMTNREVLEQVERGYRMP----------------------------RPPNCPEELYDLMLQCWDKDPEERPTFEYLQ  255 (261)
T ss_pred             CCCCCHHHHHHHHHcCCCCC----------------------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHH
Confidence            98776665555543311100                            1134678999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=8.3e-34  Score=242.84  Aligned_cols=206  Identities=19%  Similarity=0.201  Sum_probs=153.1

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccC
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRD   81 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~d   81 (292)
                      +.+.|+||++++++..... ....+.++++|++..++.+.+...    ...++..+..++.|++.||.|||++ ||+|||
T Consensus        78 ~~~~h~~i~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~-~iiHrD  151 (294)
T PHA02882         78 HNIDHLGIPKYYGCGSFKR-CRMYYRFILLEKLVENTKEIFKRI----KCKNKKLIKNIMKDMLTTLEYIHEH-GISHGD  151 (294)
T ss_pred             ccCCCCCCCcEEEeeeEec-CCceEEEEEEehhccCHHHHHHhh----ccCCHHHHHHHHHHHHHHHHHHHhC-CeecCC
Confidence            4578999999998764332 223456789999887777766542    3457888999999999999999988 999999


Q ss_pred             CCCCcEEEeCCCCcEEEeecCCccccccCC--------CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhC
Q 022799           82 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGE--------PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG  153 (292)
Q Consensus        82 lkp~Nill~~~~~~ikl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g  153 (292)
                      |||+||+++.++ .++|+|||+|+......        ......||+.|+|||+..+. .++.++|+||+||++|+|++|
T Consensus       152 iKp~Nill~~~~-~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~-~~~~~~DiwSlG~~l~el~~g  229 (294)
T PHA02882        152 IKPENIMVDGNN-RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGA-CVTRRGDLESLGYCMLKWAGI  229 (294)
T ss_pred             CCHHHEEEcCCC-cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHhC
Confidence            999999999877 79999999997653221        11234689999999998664 489999999999999999999


Q ss_pred             CCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHH
Q 022799          154 QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE  233 (292)
Q Consensus       154 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e  233 (292)
                      ..||.+...........+.      +.+..+...  ..             .....++.+.++++.|+..+|++||+..+
T Consensus       230 ~~P~~~~~~~~~~~~~~~~------~~~~~~~~~--~~-------------~~~~~~~~~~~~~~~~~~~~~~~rp~~~~  288 (294)
T PHA02882        230 KLPWKGFGHNGNLIHAAKC------DFIKRLHEG--KI-------------KIKNANKFIYDFIECVTKLSYEEKPDYDA  288 (294)
T ss_pred             CCCCCccccchHHHHHhHH------HHHHHhhhh--hh-------------ccCCCCHHHHHHHHHHHhCCCCCCCCHHH
Confidence            9999876433222221111      000000000  00             01346789999999999999999999999


Q ss_pred             Hhc
Q 022799          234 ALI  236 (292)
Q Consensus       234 ~l~  236 (292)
                      +++
T Consensus       289 l~~  291 (294)
T PHA02882        289 LIK  291 (294)
T ss_pred             HHH
Confidence            874

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=4.6e-34  Score=244.62  Aligned_cols=207  Identities=19%  Similarity=0.274  Sum_probs=154.9

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhc-------CCCCCHHHHHHHHHHHHHHHHHHH
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKM-------SQRMPLIYVKLYFYQICRALAYIH   72 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~-------~~~~~~~~~~~~~~qil~al~~LH   72 (292)
                      |+.++||||+++++++..     ....++||||++ ++|.+++......       ...+++..+..++.|++.||+|||
T Consensus        73 l~~l~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH  147 (296)
T cd05095          73 MSRLKDPNIIRLLAVCIT-----SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS  147 (296)
T ss_pred             HHhCCCCCcceEEEEEec-----CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH
Confidence            457899999999998843     334899999998 6999888754221       134778889999999999999999


Q ss_pred             hcCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCCC---cccccccccccCCccccCCCCCCchhHhhhhhHHHHH
Q 022799           73 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAE  149 (292)
Q Consensus        73 ~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~e  149 (292)
                      ++ |++||||||+||+++.++ .++|+|||++........   .....++..|++||...+. .++.++|+||+||++||
T Consensus       148 ~~-~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~DiwSlG~~l~e  224 (296)
T cd05095         148 SL-NFVHRDLATRNCLVGKNY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG-KFTTASDVWAFGVTLWE  224 (296)
T ss_pred             HC-CeecccCChheEEEcCCC-CEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC-CccchhhhhHHHHHHHH
Confidence            88 999999999999999877 799999999876533321   1122335789999987654 48999999999999999


Q ss_pred             HHh--CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCC
Q 022799          150 LLL--GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL  227 (292)
Q Consensus       150 l~~--g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~  227 (292)
                      |++  |..||...+..+..........        ..   ......+          .+..+++.+.+|+.+||..||.+
T Consensus       225 l~~~~~~~p~~~~~~~~~~~~~~~~~~--------~~---~~~~~~~----------~~~~~~~~~~~li~~cl~~~p~~  283 (296)
T cd05095         225 ILTLCKEQPYSQLSDEQVIENTGEFFR--------DQ---GRQVYLP----------KPALCPDSLYKLMLSCWRRNAKE  283 (296)
T ss_pred             HHHhCCCCCccccChHHHHHHHHHHHh--------hc---cccccCC----------CCCCCCHHHHHHHHHHcCCCccc
Confidence            998  7788876665544433222110        00   0000000          11346789999999999999999


Q ss_pred             cccHHHHhc
Q 022799          228 RSTALEALI  236 (292)
Q Consensus       228 R~t~~e~l~  236 (292)
                      |||+.++++
T Consensus       284 Rp~~~~i~~  292 (296)
T cd05095         284 RPSFQEIHA  292 (296)
T ss_pred             CCCHHHHHH
Confidence            999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=4e-34  Score=243.97  Aligned_cols=200  Identities=22%  Similarity=0.300  Sum_probs=154.8

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhh------------------cCCCCCHHHHHHHH
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYK------------------MSQRMPLIYVKLYF   61 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~------------------~~~~~~~~~~~~~~   61 (292)
                      |+.++||||+++++++     .+....++||||++ |+|.+++.....                  ....+++..+..++
T Consensus        62 l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  136 (288)
T cd05050          62 MAEFDHPNIVKLLGVC-----AVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIA  136 (288)
T ss_pred             HHhcCCCchheEEEEE-----cCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHH
Confidence            3568999999999988     33445899999998 699998874321                  11247788899999


Q ss_pred             HHHHHHHHHHHhcCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCCC---cccccccccccCCccccCCCCCCchh
Q 022799           62 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAI  138 (292)
Q Consensus        62 ~qil~al~~LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~  138 (292)
                      .|++.||.|||++ |++||||||+||+++.++ .++|+|||.+........   .....++..|+|||.+.+. .++.++
T Consensus       137 ~~i~~aL~~lH~~-~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~  213 (288)
T cd05050         137 KQVAAGMAYLSER-KFVHRDLATRNCLVGENM-VVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN-RYTTES  213 (288)
T ss_pred             HHHHHHHHHHHhC-CeecccccHhheEecCCC-ceEECccccceecccCccccccCCCccChhhcCHHHHhcC-CCCchh
Confidence            9999999999988 999999999999999888 799999999876533221   1122346679999998654 489999


Q ss_pred             HhhhhhHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHH
Q 022799          139 DIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLV  217 (292)
Q Consensus       139 DvwslG~il~el~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  217 (292)
                      |+||+||++|+|++ |..||.+....+....+....                   ..         ..+..++..+.++|
T Consensus       214 Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~-------------------~~---------~~~~~~~~~l~~li  265 (288)
T cd05050         214 DVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGN-------------------VL---------SCPDNCPLELYNLM  265 (288)
T ss_pred             HHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-------------------CC---------CCCCCCCHHHHHHH
Confidence            99999999999997 888997766554443332110                   00         01135688999999


Q ss_pred             HHHhccCCCCcccHHHHhc
Q 022799          218 SRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       218 ~~~l~~dp~~R~t~~e~l~  236 (292)
                      .+||+.||++|||+.|+++
T Consensus       266 ~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         266 RLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             HHHcccCcccCCCHHHHHH
Confidence            9999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.4e-34  Score=262.54  Aligned_cols=199  Identities=23%  Similarity=0.322  Sum_probs=164.0

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhc------CC----CCCHHHHHHHHHHHHHHHH
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKM------SQ----RMPLIYVKLYFYQICRALA   69 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~------~~----~~~~~~~~~~~~qil~al~   69 (292)
                      |..|+|||||++++++..     +.-+|||+|||. |||.+++......      +.    +++..+...++.||+.|++
T Consensus       543 la~l~H~nIVrLlGVC~~-----~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~  617 (774)
T KOG1026|consen  543 LAELQHPNIVRLLGVCRE-----GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGME  617 (774)
T ss_pred             HHhccCCCeEEEEEEEcc-----CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHH
Confidence            457899999999999943     344999999999 9999999765321      22    2788899999999999999


Q ss_pred             HHHhcCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCCCcc---cccccccccCCccccCCCCCCchhHhhhhhHH
Q 022799           70 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI---SYICSRYYRAPELIFGATEYTAAIDIWSAGCV  146 (292)
Q Consensus        70 ~LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~i  146 (292)
                      ||-++ .+|||||...|+||+++. .|||+|||+++.+-+.+...   ...-..+|||||.+.-+ .|+.+|||||+||+
T Consensus       618 YLs~~-~FVHRDLATRNCLVge~l-~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~-kFTteSDVWs~GVv  694 (774)
T KOG1026|consen  618 YLSSH-HFVHRDLATRNCLVGENL-VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYG-KFTTESDVWSFGVV  694 (774)
T ss_pred             HHHhC-cccccchhhhhceeccce-EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcC-cccchhhhhhhhhh
Confidence            99987 999999999999999988 79999999998764433221   11235689999999654 59999999999999


Q ss_pred             HHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCC
Q 022799          147 LAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSP  225 (292)
Q Consensus       147 l~el~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp  225 (292)
                      +||+++ |.-||.+..+.+++..+.+.--                +            .-|.++|.++.+||..||+.+|
T Consensus       695 LWEIFsyG~QPy~glSn~EVIe~i~~g~l----------------L------------~~Pe~CP~~vY~LM~~CW~~~P  746 (774)
T KOG1026|consen  695 LWEIFSYGKQPYYGLSNQEVIECIRAGQL----------------L------------SCPENCPTEVYSLMLECWNENP  746 (774)
T ss_pred             hhhhhccccCcccccchHHHHHHHHcCCc----------------c------------cCCCCCCHHHHHHHHHHhhcCc
Confidence            999997 8999999998888877654210                0            1236799999999999999999


Q ss_pred             CCcccHHHHh
Q 022799          226 NLRSTALEAL  235 (292)
Q Consensus       226 ~~R~t~~e~l  235 (292)
                      ++||+++||-
T Consensus       747 ~~RPsF~eI~  756 (774)
T KOG1026|consen  747 KRRPSFKEIH  756 (774)
T ss_pred             ccCCCHHHHH
Confidence            9999999984

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=5.4e-34  Score=241.46  Aligned_cols=202  Identities=20%  Similarity=0.293  Sum_probs=157.0

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcC-----CCCCHHHHHHHHHHHHHHHHHHHhc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMS-----QRMPLIYVKLYFYQICRALAYIHNT   74 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~-----~~~~~~~~~~~~~qil~al~~LH~~   74 (292)
                      |++++||||+++++++     .+....++||||++ |+|.+++.......     ..+++..+..++.|++.||.|||++
T Consensus        62 l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~  136 (275)
T cd05046          62 FRKLSHKNVVRLLGLC-----REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA  136 (275)
T ss_pred             HHhcCCcceeeeEEEE-----CCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc
Confidence            4578999999999988     44455899999998 79999887543211     2689999999999999999999988


Q ss_pred             CCccccCCCCCcEEEeCCCCcEEEeecCCccccccCC--CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh
Q 022799           75 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL  152 (292)
Q Consensus        75 ~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~  152 (292)
                       ||+||||||+||+++.++ .++++|||++.......  ......++..|+|||.+.+. .++.++|+||+||++|+|++
T Consensus       137 -~i~H~dlkp~Nili~~~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~  213 (275)
T cd05046         137 -RFVHRDLAARNCLVSSQR-EVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQED-DFSTKSDVWSFGVLMWEVFT  213 (275)
T ss_pred             -CcccCcCccceEEEeCCC-cEEEcccccccccCcccccccCCceeEEeecChhhhccC-CCCchhhHHHHHHHHHHHHh
Confidence             999999999999999888 79999999986543221  11233557789999988654 47899999999999999998


Q ss_pred             -CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccH
Q 022799          153 -GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA  231 (292)
Q Consensus       153 -g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~  231 (292)
                       |..||.+.........+...                 ....          ..+..++..+.+++.+||..||.+|||+
T Consensus       214 ~~~~p~~~~~~~~~~~~~~~~-----------------~~~~----------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~  266 (275)
T cd05046         214 QGELPFYGLSDEEVLNRLQAG-----------------KLEL----------PVPEGCPSRLYKLMTRCWAVNPKDRPSF  266 (275)
T ss_pred             CCCCCccccchHHHHHHHHcC-----------------CcCC----------CCCCCCCHHHHHHHHHHcCCCcccCCCH
Confidence             78899765554433332210                 0000          0113578899999999999999999999


Q ss_pred             HHHhcC
Q 022799          232 LEALIH  237 (292)
Q Consensus       232 ~e~l~h  237 (292)
                      .+++..
T Consensus       267 ~~~l~~  272 (275)
T cd05046         267 SELVSA  272 (275)
T ss_pred             HHHHHH
Confidence            999853

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=2.8e-34  Score=270.24  Aligned_cols=203  Identities=23%  Similarity=0.390  Sum_probs=153.3

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhc-------CCCCCHHHHHHHHHHHHHHHHHHH
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKM-------SQRMPLIYVKLYFYQICRALAYIH   72 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~-------~~~~~~~~~~~~~~qil~al~~LH   72 (292)
                      |+.++||||+++++++     .+....|+||||++ |+|.+++......       ....+...+..++.||+.||+|||
T Consensus        56 Ls~L~HPNIVkl~~v~-----~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH  130 (932)
T PRK13184         56 AADLIHPGIVPVYSIC-----SDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH  130 (932)
T ss_pred             HHhCCCcCcCeEEEEE-----eeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH
Confidence            3578999999999988     44445899999998 6998888653211       234566778889999999999999


Q ss_pred             hcCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCC-------------------CcccccccccccCCccccCCCC
Q 022799           73 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-------------------PNISYICSRYYRAPELIFGATE  133 (292)
Q Consensus        73 ~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-------------------~~~~~~gt~~y~aPE~~~~~~~  133 (292)
                      ++ ||+||||||+||+++.++ .++|+|||+++......                   .....+||+.|+|||.+.+. .
T Consensus       131 s~-GIIHRDLKPeNILLd~dg-~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~-~  207 (932)
T PRK13184        131 SK-GVLHRDLKPDNILLGLFG-EVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV-P  207 (932)
T ss_pred             HC-CccccCCchheEEEcCCC-CEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC-C
Confidence            88 999999999999999888 79999999997652110                   01124689999999998665 4


Q ss_pred             CCchhHhhhhhHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhH
Q 022799          134 YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEA  213 (292)
Q Consensus       134 ~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  213 (292)
                      ++.++|+||+||++|+|++|..||.+.........  .....|..              .     .+     ...+++.+
T Consensus       208 ~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~--~~i~~P~~--------------~-----~p-----~~~iP~~L  261 (932)
T PRK13184        208 ASESTDIYALGVILYQMLTLSFPYRRKKGRKISYR--DVILSPIE--------------V-----AP-----YREIPPFL  261 (932)
T ss_pred             CCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhh--hhccChhh--------------c-----cc-----cccCCHHH
Confidence            89999999999999999999999977544332211  11000000              0     00     03578899


Q ss_pred             HHHHHHHhccCCCCcccHHHHhcC
Q 022799          214 VDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       214 ~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      .+++.+||..||++|++..+.+.+
T Consensus       262 ~~LI~rcL~~DP~kR~ss~eeLl~  285 (932)
T PRK13184        262 SQIAMKALAVDPAERYSSVQELKQ  285 (932)
T ss_pred             HHHHHHHccCChhhCcCHHHHHHH
Confidence            999999999999999887665543

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=6.7e-34  Score=238.36  Aligned_cols=198  Identities=19%  Similarity=0.339  Sum_probs=154.7

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++     ......++||||+. ++|.+++...   ...+++..+..++.|++.|+.|||++ |++|
T Consensus        53 l~~l~~~~i~~~~~~~-----~~~~~~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~h  123 (256)
T cd05112          53 MMKLSHPKLVQLYGVC-----TERSPICLVFEFMEHGCLSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLESS-NVIH  123 (256)
T ss_pred             HHhCCCCCeeeEEEEE-----ccCCceEEEEEcCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC-Cccc
Confidence            3578999999999988     44445899999998 6888777643   34578899999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCc--ccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPL  156 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~p  156 (292)
                      +||||+||+++.++ .++|+|||.+.........  ....++..|+|||.+.+. .++.++|+||+||++|+|++ |..|
T Consensus       124 ~dl~p~ni~i~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p  201 (256)
T cd05112         124 RDLAARNCLVGENQ-VVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFS-KYSSKSDVWSFGVLMWEVFSEGKTP  201 (256)
T ss_pred             cccccceEEEcCCC-eEEECCCcceeecccCcccccCCCccchhhcCHhHhccC-CcChHHHHHHHHHHHHHHHcCCCCC
Confidence            99999999999877 7999999998765332211  122345679999998654 48999999999999999998 9999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      |...........+.+...                            ...+...+..+.+++.+||..+|++|||+.++++
T Consensus       202 ~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~  253 (256)
T cd05112         202 YENRSNSEVVETINAGFR----------------------------LYKPRLASQSVYELMQHCWKERPEDRPSFSLLLH  253 (256)
T ss_pred             CCcCCHHHHHHHHhCCCC----------------------------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            977665444433321100                            0011336789999999999999999999999985


Q ss_pred             C
Q 022799          237 H  237 (292)
Q Consensus       237 h  237 (292)
                      .
T Consensus       254 ~  254 (256)
T cd05112         254 Q  254 (256)
T ss_pred             h
Confidence            3

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=5e-34  Score=241.09  Aligned_cols=196  Identities=28%  Similarity=0.411  Sum_probs=154.7

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++.     +. ..++||||++ ++|.+++...   ...+++..+..++.|++.||.|||+. |++|
T Consensus        61 l~~~~h~~i~~~~~~~~-----~~-~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~-~~~H  130 (270)
T cd05056          61 MRQFDHPHIVKLIGVIT-----EN-PVWIVMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESK-RFVH  130 (270)
T ss_pred             HHhCCCCchhceeEEEc-----CC-CcEEEEEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC-Ceec
Confidence            35789999999999873     22 2679999998 7999988653   24589999999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcc--cccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI--SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPL  156 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~p  156 (292)
                      +||||+||+++.++ .++|+|||+++.........  ...++..|+|||.+.+. .++.++|+||+||++|+|++ |..|
T Consensus       131 ~dl~p~nili~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p  208 (270)
T cd05056         131 RDIAARNVLVSSPD-CVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMLGVKP  208 (270)
T ss_pred             cccChheEEEecCC-CeEEccCceeeecccccceecCCCCccccccChhhhccC-CCCchhhhHHHHHHHHHHHHcCCCC
Confidence            99999999999887 79999999987654332111  12234679999998554 58999999999999999996 9999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      |.+....+....+......                            ..+..++..+.++|.+|+..+|++|||+.+++.
T Consensus       209 f~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~  260 (270)
T cd05056         209 FQGVKNNDVIGRIENGERL----------------------------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA  260 (270)
T ss_pred             CCCCCHHHHHHHHHcCCcC----------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            9877665554443221000                            012457889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=7e-34  Score=243.38  Aligned_cols=207  Identities=20%  Similarity=0.272  Sum_probs=155.4

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhh--------cCCCCCHHHHHHHHHHHHHHHHHH
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYK--------MSQRMPLIYVKLYFYQICRALAYI   71 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~--------~~~~~~~~~~~~~~~qil~al~~L   71 (292)
                      |++++||||+++++++.     .....++||||+. ++|.+++.....        ....+++..+..++.|++.||.||
T Consensus        71 l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l  145 (295)
T cd05097          71 MSRLKNPNIIRLLGVCV-----SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL  145 (295)
T ss_pred             HHhCCCCCcCeEEEEEc-----CCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHH
Confidence            46789999999999983     3345899999998 699888854311        012367888999999999999999


Q ss_pred             HhcCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCCC---cccccccccccCCccccCCCCCCchhHhhhhhHHHH
Q 022799           72 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLA  148 (292)
Q Consensus        72 H~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~  148 (292)
                      |++ |++||||||+||+++.++ .+||+|||++........   .....++..|+|||.+.+. .++.++|+|||||++|
T Consensus       146 H~~-~i~H~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~~l~  222 (295)
T cd05097         146 ASL-NFVHRDLATRNCLVGNHY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG-KFTTASDVWAFGVTLW  222 (295)
T ss_pred             Hhc-CeeccccChhhEEEcCCC-cEEecccccccccccCcceeccCcCcCceeecChhhhccC-CcCchhhHHHHHHHHH
Confidence            988 999999999999999877 799999999876533221   1122346789999998654 4899999999999999


Q ss_pred             HHHh--CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCC
Q 022799          149 ELLL--GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPN  226 (292)
Q Consensus       149 el~~--g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~  226 (292)
                      +|++  +..||...+..+....+.+.......       ..+              ...++..++.+.+++.+||..||+
T Consensus       223 el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~-------~~~--------------~~~~~~~~~~l~~li~~~l~~~p~  281 (295)
T cd05097         223 EMFTLCKEQPYSLLSDEQVIENTGEFFRNQGR-------QIY--------------LSQTPLCPSPVFKLMMRCWSRDIK  281 (295)
T ss_pred             HHHHcCCCCCCcccChHHHHHHHHHhhhhccc-------ccc--------------CCCCCCCCHHHHHHHHHHcCCCch
Confidence            9998  66788776655544443332110000       000              001134688999999999999999


Q ss_pred             CcccHHHHhc
Q 022799          227 LRSTALEALI  236 (292)
Q Consensus       227 ~R~t~~e~l~  236 (292)
                      +|||++++++
T Consensus       282 ~RPs~~~i~~  291 (295)
T cd05097         282 DRPTFNKIHH  291 (295)
T ss_pred             hCcCHHHHHH
Confidence            9999999974

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=5.7e-34  Score=241.99  Aligned_cols=201  Identities=19%  Similarity=0.259  Sum_probs=155.8

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhc----CCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKM----SQRMPLIYVKLYFYQICRALAYIHNTI   75 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~----~~~~~~~~~~~~~~qil~al~~LH~~~   75 (292)
                      |+.++||||+++++++...    ....++++||++ ++|.+++......    ...+++..+..++.|++.||.|||++ 
T Consensus        62 l~~l~h~ni~~~~~~~~~~----~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-  136 (280)
T cd05043          62 LYGLSHQNILPILHVCIED----GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR-  136 (280)
T ss_pred             HHhCCCCCCCeEEEEEecC----CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC-
Confidence            4578999999999976432    234789999998 7998888654322    14689999999999999999999987 


Q ss_pred             CccccCCCCCcEEEeCCCCcEEEeecCCccccccCCCc---ccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh
Q 022799           76 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL  152 (292)
Q Consensus        76 ~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~  152 (292)
                      |++||||||+||+++.++ .+||+|||+++.+......   ....++..|+|||.+.+. .++.++|+||+||++|++++
T Consensus       137 ~i~H~di~p~nil~~~~~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~~  214 (280)
T cd05043         137 GVIHKDIAARNCVIDEEL-QVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNK-EYSSASDVWSFGVLLWELMT  214 (280)
T ss_pred             CEeecccCHhhEEEcCCC-cEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcC-CCCchhhHHHhHHHHHHHhc
Confidence            999999999999999887 7999999999765332211   123346679999998654 48999999999999999998


Q ss_pred             -CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccH
Q 022799          153 -GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA  231 (292)
Q Consensus       153 -g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~  231 (292)
                       |..||.+.+..+....+....                  ..+          .+..+++++.+++.+||..||++|||+
T Consensus       215 ~g~~p~~~~~~~~~~~~~~~~~------------------~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~  266 (280)
T cd05043         215 LGQTPYVEIDPFEMAAYLKDGY------------------RLA----------QPINCPDELFAVMACCWALDPEERPSF  266 (280)
T ss_pred             CCCCCcCcCCHHHHHHHHHcCC------------------CCC----------CCCcCCHHHHHHHHHHcCCChhhCCCH
Confidence             999998766544332222100                  000          013467899999999999999999999


Q ss_pred             HHHhc
Q 022799          232 LEALI  236 (292)
Q Consensus       232 ~e~l~  236 (292)
                      .++++
T Consensus       267 ~~~~~  271 (280)
T cd05043         267 SQLVQ  271 (280)
T ss_pred             HHHHH
Confidence            99984

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=6.8e-34  Score=238.19  Aligned_cols=198  Identities=27%  Similarity=0.398  Sum_probs=156.7

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++..     ....+++|||+. ++|.+.+.....  ..+++..+..++.|++.||.+||++ |++|
T Consensus        55 l~~l~~~~i~~~~~~~~~-----~~~~~~i~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~-~~~h  126 (258)
T smart00219       55 MRKLDHPNIVKLLGVCTE-----EEPLMIVMEYMEGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLESK-NFIH  126 (258)
T ss_pred             HHhcCCCchheEEEEEcC-----CCeeEEEEeccCCCCHHHHHHhhhh--ccCCHHHHHHHHHHHHHHHHHHhcC-Ceee
Confidence            356799999999998843     345899999998 699888865321  2289999999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcc--cccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI--SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPL  156 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~p  156 (292)
                      +||+|+||+++.++ .++|+|||.+..........  ...+++.|+|||.+.+ ..++.++|+||+||++|+|++ |..|
T Consensus       127 ~dl~~~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p  204 (258)
T smart00219      127 RDLAARNCLVGENL-VVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESP  204 (258)
T ss_pred             cccccceEEEccCC-eEEEcccCCceecccccccccccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCC
Confidence            99999999999888 79999999998764432211  1236788999999854 458999999999999999998 7888


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      |.+.+.......+.....                            ...+...+.++.+++.+||..||++|||+.++++
T Consensus       205 ~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      205 YPGMSNEEVLEYLKKGYR----------------------------LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             CCCCCHHHHHHHHhcCCC----------------------------CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence            877665554444332100                            0011347889999999999999999999999985

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=5.3e-34  Score=267.98  Aligned_cols=93  Identities=30%  Similarity=0.507  Sum_probs=82.1

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      +.++||||+++++++     .+..++|+||||+. ++|.+++..    .+.+++..++.++.||+.||.|||++ ||+||
T Consensus        59 ~~l~hp~Iv~~~~~~-----~~~~~~~lVmEy~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~-gIiHr  128 (669)
T cd05610          59 ALSKSPFIVHLYYSL-----QSANNVYLVMEYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRH-GIIHR  128 (669)
T ss_pred             HhcCCCCcCeEEEEE-----EECCEEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CEEeC
Confidence            567999999999888     44456999999997 699888864    35688999999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCcc
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAK  105 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~  105 (292)
                      ||||+|||++.++ .++|+|||+++
T Consensus       129 DLKP~NILl~~~g-~vkL~DFGls~  152 (669)
T cd05610         129 DLKPDNMLISNEG-HIKLTDFGLSK  152 (669)
T ss_pred             CccHHHEEEcCCC-CEEEEeCCCCc
Confidence            9999999999888 79999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.2e-33  Score=237.12  Aligned_cols=193  Identities=22%  Similarity=0.244  Sum_probs=149.1

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++.. .     ..++||||++ |+|.+++...   ...+++..+..++.||+.||.|||++ ||+|
T Consensus        55 l~~l~h~~i~~~~~~~~~-~-----~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H  124 (259)
T cd05037          55 MSQLSHKHLVKLYGVCVR-D-----ENIMVEEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLEDK-KLVH  124 (259)
T ss_pred             HHcCCCcchhheeeEEec-C-----CcEEEEEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhC-Ceec
Confidence            467899999999998744 2     2689999998 6888887753   23688999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCC------cEEEeecCCccccccCCCcccccccccccCCccccCC-CCCCchhHhhhhhHHHHHHHh
Q 022799           80 RDIKPQNLLVNPHTH------QLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLL  152 (292)
Q Consensus        80 ~dlkp~Nill~~~~~------~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~  152 (292)
                      |||||+||+++.++.      .++|+|||++.....   .....++..|+|||.+.+. ..++.++|+||+||++|+|++
T Consensus       125 ~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~  201 (259)
T cd05037         125 GNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICS  201 (259)
T ss_pred             ccCccceEEEecCccccCCceeEEeCCCCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHh
Confidence            999999999987652      499999999876533   2234567789999998665 358999999999999999999


Q ss_pred             -CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccH
Q 022799          153 -GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA  231 (292)
Q Consensus       153 -g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~  231 (292)
                       |..||...+..........    ..                          ..+......+.++|.+||..+|.+|||+
T Consensus       202 ~~~~p~~~~~~~~~~~~~~~----~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~  251 (259)
T cd05037         202 NGEEPLSTLSSSEKERFYQD----QH--------------------------RLPMPDCAELANLINQCWTYDPTKRPSF  251 (259)
T ss_pred             CCCCCcccCCchhHHHHHhc----CC--------------------------CCCCCCchHHHHHHHHHhccChhhCCCH
Confidence             5777765542221111100    00                          0001123789999999999999999999


Q ss_pred             HHHhc
Q 022799          232 LEALI  236 (292)
Q Consensus       232 ~e~l~  236 (292)
                      .++++
T Consensus       252 ~~il~  256 (259)
T cd05037         252 RAILR  256 (259)
T ss_pred             HHHHH
Confidence            99985

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.1e-33  Score=237.01  Aligned_cols=195  Identities=21%  Similarity=0.315  Sum_probs=152.9

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++..     + ..++||||+. ++|.+++....  ...+++..+..++.|++.||.|||++ |++|
T Consensus        53 l~~~~~~~i~~~~~~~~~-----~-~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~-~~~H  123 (254)
T cd05083          53 MTKLHHKNLVRLLGVILH-----N-GLYIVMELMSKGNLVNFLRTRG--RALVSVIQLLQFSLDVAEGMEYLESK-KLVH  123 (254)
T ss_pred             HHhCCCCCcCeEEEEEcC-----C-CcEEEEECCCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhC-Ceec
Confidence            357899999999998732     1 1689999998 69999887531  24588999999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFP  158 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~  158 (292)
                      |||||+||+++.++ .++|+|||.+......  ......+..|+|||.+.+. .++.++|+||+||++|+|++ |..||.
T Consensus       124 ~dl~p~nili~~~~-~~kl~Dfg~~~~~~~~--~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~  199 (254)
T cd05083         124 RDLAARNILVSEDG-VAKVSDFGLARVGSMG--VDNSKLPVKWTAPEALKHK-KFSSKSDVWSYGVLLWEVFSYGRAPYP  199 (254)
T ss_pred             cccCcceEEEcCCC-cEEECCCccceecccc--CCCCCCCceecCHHHhccC-CcCchhhHHHHHHHHHHHHhCCCCCCc
Confidence            99999999999888 7999999998764322  1222345679999998654 48999999999999999997 999998


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      +.+..+....+.+..                ..            ..+..++..+.+++.+||..+|.+||++++++.
T Consensus       200 ~~~~~~~~~~~~~~~----------------~~------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         200 KMSLKEVKECVEKGY----------------RM------------EPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             cCCHHHHHHHHhCCC----------------CC------------CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            766544333222100                00            011357889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-33  Score=240.20  Aligned_cols=196  Identities=24%  Similarity=0.332  Sum_probs=154.7

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++..      ...++||||+. |+|.+.+...   ...+++..+..++.||+.||.|||+. |++|
T Consensus        63 l~~l~h~~i~~~~~~~~~------~~~~~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~-~i~H  132 (279)
T cd05057          63 MASVDHPHVVRLLGICLS------SQVQLITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEEK-RLVH  132 (279)
T ss_pred             HHhCCCCCcceEEEEEec------CceEEEEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC-CEEe
Confidence            457899999999998853      24889999998 7998888653   34589999999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCccc---ccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS---YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQP  155 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~---~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~  155 (292)
                      |||||+||+++.++ .++|+|||.++..........   ..++..|+|||.+... .++.++|+||+||++|++++ |..
T Consensus       133 ~di~p~nil~~~~~-~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~~~g~~  210 (279)
T cd05057         133 RDLAARNVLVKTPQ-HVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHR-IYTHKSDVWSYGVTVWELMTFGAK  210 (279)
T ss_pred             cccCcceEEEcCCC-eEEECCCcccccccCcccceecCCCcccccccCHHHhhcC-CcCchhhHHHHHHHHHHHhcCCCC
Confidence            99999999999887 799999999987643322211   1235679999988543 48999999999999999998 999


Q ss_pred             CCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHh
Q 022799          156 LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL  235 (292)
Q Consensus       156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l  235 (292)
                      ||.+....+....+... ...                           ..+...+.++.+++.+||..||.+|||+.+++
T Consensus       211 p~~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~  262 (279)
T cd05057         211 PYEGIPAVEIPDLLEKG-ERL---------------------------PQPPICTIDVYMVLVKCWMIDAESRPTFKELI  262 (279)
T ss_pred             CCCCCCHHHHHHHHhCC-CCC---------------------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHH
Confidence            99876654443333211 000                           01134678899999999999999999999987


Q ss_pred             c
Q 022799          236 I  236 (292)
Q Consensus       236 ~  236 (292)
                      +
T Consensus       263 ~  263 (279)
T cd05057         263 N  263 (279)
T ss_pred             H
Confidence            3

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.4e-33  Score=240.05  Aligned_cols=213  Identities=24%  Similarity=0.371  Sum_probs=151.4

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++....   ...+++||||++ ++|.+++...   ...+++..+..++.|++.||.|||++ |++|
T Consensus        59 l~~l~h~~iv~~~~~~~~~~---~~~~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~-~i~H  131 (284)
T cd05081          59 LKSLQHDNIVKYKGVCYSAG---RRNLRLVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSK-RYVH  131 (284)
T ss_pred             HHhCCCCCeeEEEEEEccCC---CCceEEEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC-Ccee
Confidence            45789999999999775432   234889999997 7999888643   34588999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCc----ccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQP  155 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~  155 (292)
                      |||||+||+++.++ .++|+|||++.........    ....++..|+|||.+.+. .++.++|+||+||++|||++|..
T Consensus       132 ~dlkp~nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~  209 (284)
T cd05081         132 RDLATRNILVESEN-RVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYSD  209 (284)
T ss_pred             ccCCHhhEEECCCC-eEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccC-CcChHHHHHHHHHHHHHHhhcCC
Confidence            99999999999888 7999999999865432211    111234569999998654 48999999999999999999887


Q ss_pred             CCCCCCcHHHHHHHHHHhC-CCCHHHH-hhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHH
Q 022799          156 LFPGESGVDQLVEIIKVLG-TPTREEI-KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE  233 (292)
Q Consensus       156 pf~~~~~~~~~~~i~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e  233 (292)
                      ++...... ....+..... ......+ ......   ..          ...+..++.++.++|.+||..+|++|||+.+
T Consensus       210 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~---~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~e  275 (284)
T cd05081         210 KSCSPPAE-FMRMMGNDKQGQMIVYHLIELLKNN---GR----------LPAPPGCPAEIYAIMKECWNNDPSQRPSFSE  275 (284)
T ss_pred             cCCCcchh-hhhhcccccccccchHHHHHHHhcC---Cc----------CCCCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence            66433211 0000000000 0000000 000000   00          0012457889999999999999999999999


Q ss_pred             Hhc
Q 022799          234 ALI  236 (292)
Q Consensus       234 ~l~  236 (292)
                      +++
T Consensus       276 i~~  278 (284)
T cd05081         276 LAL  278 (284)
T ss_pred             HHH
Confidence            975

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.5e-33  Score=236.90  Aligned_cols=197  Identities=23%  Similarity=0.333  Sum_probs=154.7

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++.     + ...+++|||+. ++|.+.+...  .+..+++..+..++.|++.||+|||+. |++|
T Consensus        55 l~~l~h~~i~~~~~~~~-----~-~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~-~i~H  125 (260)
T cd05067          55 MKQLQHPRLVRLYAVVT-----Q-EPIYIITEYMENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIERK-NYIH  125 (260)
T ss_pred             HHhcCCcCeeeEEEEEc-----c-CCcEEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcC-Ceec
Confidence            46789999999998762     1 23789999997 6998887643  235688999999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCc--ccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPL  156 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~p  156 (292)
                      |||||+||+++.++ .++|+|||.+.........  ....++..|+|||.+.+. .++.++|+||+|+++|+|++ |..|
T Consensus       126 ~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~el~~~g~~p  203 (260)
T cd05067         126 RDLRAANILVSETL-CCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTYGRIP  203 (260)
T ss_pred             ccccHHhEEEcCCC-CEEEccCcceeecCCCCcccccCCcccccccCHHHhccC-CcCcccchHHHHHHHHHHHhCCCCC
Confidence            99999999999887 7999999998765422211  122346789999998554 48899999999999999998 9999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      |.+.+..+....+......                            ..+...+.++.++|.+||..+|++|||++++++
T Consensus       204 ~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         204 YPGMTNPEVIQNLERGYRM----------------------------PRPDNCPEELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             CCCCChHHHHHHHHcCCCC----------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            9877655544433221100                            011346789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-34  Score=253.58  Aligned_cols=197  Identities=25%  Similarity=0.359  Sum_probs=161.1

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++|||||+++|+...     ...+++|||+|. |+|.++++..   .+.++..+...++.+.+.||+|||++ +++|
T Consensus       215 Mr~l~H~NVVr~yGVa~~-----~~Pl~ivmEl~~gGsL~~~L~k~---~~~v~~~ek~~~~~~AA~Gl~YLh~k-~~IH  285 (474)
T KOG0194|consen  215 MRQLNHPNVVRFYGVAVL-----EEPLMLVMELCNGGSLDDYLKKN---KKSLPTLEKLRFCYDAARGLEYLHSK-NCIH  285 (474)
T ss_pred             HHhCCCCCEEEEEEEEcC-----CCccEEEEEecCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHhHHHHHHHC-CCcc
Confidence            578999999999998843     334999999999 6999999874   23689999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcc-cccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLF  157 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf  157 (292)
                      |||-..|+|++.++ .+||+|||+++......... ..--...|+|||.+... .|+.++||||+||++||+.+ |..||
T Consensus       286 RDIAARNcL~~~~~-~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py  363 (474)
T KOG0194|consen  286 RDIAARNCLYSKKG-VVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPY  363 (474)
T ss_pred             hhHhHHHheecCCC-eEEeCccccccCCcceeeccccccCcceecChhhhccC-ccccccchhheeeeEEeeeccCCCCC
Confidence            99999999999877 58999999987643211111 11235679999999655 69999999999999999998 78899


Q ss_pred             CCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHh
Q 022799          158 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL  235 (292)
Q Consensus       158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l  235 (292)
                      .+....+...++.......                           ..+...+..+..++.+|+..||++|+|+.++.
T Consensus       364 ~g~~~~~v~~kI~~~~~r~---------------------------~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~  414 (474)
T KOG0194|consen  364 PGMKNYEVKAKIVKNGYRM---------------------------PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIK  414 (474)
T ss_pred             CCCCHHHHHHHHHhcCccC---------------------------CCCCCCHHHHHHHHHHhccCChhhccCHHHHH
Confidence            9999888777774421111                           12245788999999999999999999999887

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-34  Score=253.67  Aligned_cols=195  Identities=30%  Similarity=0.495  Sum_probs=163.0

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++|||||++++++.+..      .|+|||.+. |.|..+++.+   ...++......|++||+.||.|||++ .+||
T Consensus       445 MrnfdHphIikLIGv~~e~P------~WivmEL~~~GELr~yLq~n---k~sL~l~tL~ly~~Qi~talaYLeSk-rfVH  514 (974)
T KOG4257|consen  445 MRNFDHPHIIKLIGVCVEQP------MWIVMELAPLGELREYLQQN---KDSLPLRTLTLYCYQICTALAYLESK-RFVH  514 (974)
T ss_pred             HHhCCCcchhheeeeeeccc------eeEEEecccchhHHHHHHhc---cccchHHHHHHHHHHHHHHHHHHHhh-chhh
Confidence            68899999999999984322      789999999 9999999875   45688899999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccc--cccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC--SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPL  156 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~p  156 (292)
                      |||...|||+.+.. .|||+|||+++.+..........|  ...|||||.+ +-+.++.++|||.||+.+||++. |..|
T Consensus       515 RDIAaRNiLVsSp~-CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESI-NfRrFTtASDVWMFgVCmWEIl~lGvkP  592 (974)
T KOG4257|consen  515 RDIAARNILVSSPQ-CVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESI-NFRRFTTASDVWMFGVCMWEILSLGVKP  592 (974)
T ss_pred             hhhhhhheeecCcc-eeeecccchhhhccccchhhccccccceeecCcccc-chhcccchhhHHHHHHHHHHHHHhcCCc
Confidence            99999999999877 699999999999866554333333  4569999998 44569999999999999999985 9999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHh
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL  235 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l  235 (292)
                      |.|-.+.+.+..+.+....|                            .|+++|+.+..|+.+||.++|.+||++.++.
T Consensus       593 fqgvkNsDVI~~iEnGeRlP----------------------------~P~nCPp~LYslmskcWayeP~kRPrftei~  643 (974)
T KOG4257|consen  593 FQGVKNSDVIGHIENGERLP----------------------------CPPNCPPALYSLMSKCWAYEPSKRPRFTEIK  643 (974)
T ss_pred             cccccccceEEEecCCCCCC----------------------------CCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence            99987777665554422111                            2368999999999999999999999987764

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2.1e-33  Score=249.21  Aligned_cols=157  Identities=22%  Similarity=0.356  Sum_probs=123.1

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCCC---cccccccccccCCcc
Q 022799           51 RMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPEL  127 (292)
Q Consensus        51 ~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~  127 (292)
                      .+++..+..++.||+.||.|||+. |++||||||+||+++.++ .++|+|||+++.......   .....+++.|+|||.
T Consensus       235 ~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrdlkp~NiLl~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~  312 (401)
T cd05107         235 ALSYMDLVGFSYQVANGMEFLASK-NCVHRDLAARNVLICEGK-LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPES  312 (401)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhcC-CcCcccCCcceEEEeCCC-EEEEEecCcceecccccccccCCCcCCCCceeChHH
Confidence            367778889999999999999987 999999999999999877 799999999976532221   123456788999999


Q ss_pred             ccCCCCCCchhHhhhhhHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhc
Q 022799          128 IFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQ  206 (292)
Q Consensus       128 ~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  206 (292)
                      +.+. .++.++|+||+||++|||++ |..||......+.....+.....+                           ..+
T Consensus       313 ~~~~-~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~---------------------------~~p  364 (401)
T cd05107         313 IFNN-LYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRM---------------------------AKP  364 (401)
T ss_pred             hcCC-CCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCC---------------------------CCC
Confidence            9654 48999999999999999998 889997665544433332210000                           012


Q ss_pred             cCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          207 KRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       207 ~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      ..++.++.+++.+||..+|.+||++.++++.
T Consensus       365 ~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         365 AHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             CCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            4578899999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2e-33  Score=236.21  Aligned_cols=197  Identities=24%  Similarity=0.359  Sum_probs=154.5

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++|+||+++++++..      ...+++|||++ ++|.+++....  ...+++..+..++.|++.||.|||++ |++|
T Consensus        55 l~~l~~~~i~~~~~~~~~------~~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~-~i~H  125 (260)
T cd05073          55 MKTLQHDKLVKLHAVVTK------EPIYIITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR-NYIH  125 (260)
T ss_pred             HHhcCCCCcceEEEEEcC------CCeEEEEEeCCCCcHHHHHHhCC--ccccCHHHHHHHHHHHHHHHHHHHhC-Cccc
Confidence            467899999999998733      34789999998 69998886532  34578888999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCc--ccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPL  156 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~p  156 (292)
                      +||||+||+++.++ .++|+|||.+.........  ....++..|+|||.+.+. .++.++|+||+||++|++++ |..|
T Consensus       126 ~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p  203 (260)
T cd05073         126 RDLRAANILVSASL-VCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIP  203 (260)
T ss_pred             cccCcceEEEcCCC-cEEECCCcceeeccCCCcccccCCcccccccCHhHhccC-CcCccccchHHHHHHHHHHhcCCCC
Confidence            99999999999887 7999999998765332211  122345679999998654 48999999999999999998 9999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      |.+.+..+....+.....                  .          ..+...+.++.+++.+||..+|++||++.++++
T Consensus       204 ~~~~~~~~~~~~~~~~~~------------------~----------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         204 YPGMSNPEVIRALERGYR------------------M----------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             CCCCCHHHHHHHHhCCCC------------------C----------CCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence            987665544433322100                  0          011357889999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1.2e-33  Score=259.78  Aligned_cols=213  Identities=23%  Similarity=0.281  Sum_probs=142.8

Q ss_pred             CceeEEEEeeccc-CCHHHHHHhhhh----------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCC
Q 022799           23 DELYLNLVLEYVP-ETVHRVIKHHYK----------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQ   85 (292)
Q Consensus        23 ~~~~~~lv~e~~~-g~L~~~l~~~~~----------------~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlkp~   85 (292)
                      +...+++||||++ ++|.+++.....                .........+..++.||+.||.|||++ ||+||||||+
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~-gIiHRDLKP~  284 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST-GIVHRDVKPQ  284 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC-CEEeCcCCHH
Confidence            3445889999998 688888764210                001122345778999999999999988 9999999999


Q ss_pred             cEEEeCCCCcEEEeecCCccccccCC--CcccccccccccCCccccCCC---------------------CCCchhHhhh
Q 022799           86 NLLVNPHTHQLKLCDFGSAKVLVKGE--PNISYICSRYYRAPELIFGAT---------------------EYTAAIDIWS  142 (292)
Q Consensus        86 Nill~~~~~~ikl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~---------------------~~~~~~Dvws  142 (292)
                      |||++.+...+||+|||+++......  ......+|+.|+|||.+....                     .++.++||||
T Consensus       285 NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS  364 (566)
T PLN03225        285 NIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS  364 (566)
T ss_pred             HEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence            99998654479999999997653322  223567899999999653221                     1345679999


Q ss_pred             hhHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhc
Q 022799          143 AGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQ  222 (292)
Q Consensus       143 lG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  222 (292)
                      +||++|||+++..+  .......+.+++...+...........+....    .  ...... .....+....+||.+||+
T Consensus       365 lGviL~el~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~----~--~~~~~~-~~d~~~~~~~dLi~~mL~  435 (566)
T PLN03225        365 AGLIFLQMAFPNLR--SDSNLIQFNRQLKRNDYDLVAWRKLVEPRASP----D--LRRGFE-VLDLDGGAGWELLKSMMR  435 (566)
T ss_pred             HHHHHHHHHhCcCC--CchHHHHHHHHHHhcCCcHHHHHHhhccccch----h--hhhhhh-hccccchHHHHHHHHHcc
Confidence            99999999987644  44444455555544433322211111111000    0  000000 001234567799999999


Q ss_pred             cCCCCcccHHHHhcCCCccccCC
Q 022799          223 YSPNLRSTALEALIHPFFDELRD  245 (292)
Q Consensus       223 ~dp~~R~t~~e~l~hp~~~~~~~  245 (292)
                      +||++|||+.++|+||||++...
T Consensus       436 ~dP~kR~ta~e~L~Hpff~~~~~  458 (566)
T PLN03225        436 FKGRQRISAKAALAHPYFDREGL  458 (566)
T ss_pred             CCcccCCCHHHHhCCcCcCCCCc
Confidence            99999999999999999987554

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.3e-33  Score=240.39  Aligned_cols=210  Identities=22%  Similarity=0.379  Sum_probs=152.3

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++...   +....++||||++ ++|.+++...   ...+++..+..++.||+.||.|||++ |++|
T Consensus        60 l~~l~h~~i~~~~~~~~~~---~~~~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~-gi~H  132 (284)
T cd05079          60 LRNLYHENIVKYKGICTED---GGNGIKLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSR-QYVH  132 (284)
T ss_pred             HHhCCCCCeeeeeeEEecC---CCCceEEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC-Ceee
Confidence            4578999999999987432   2245889999997 6898887643   24588999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCc----ccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQP  155 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~  155 (292)
                      |||||+||+++.++ .++|+|||++.........    ....++..|+|||.+.+. .++.++|+||+||++|+|+++..
T Consensus       133 ~dlkp~Nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~ellt~~~  210 (284)
T cd05079         133 RDLAARNVLVESEH-QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQS-KFYIASDVWSFGVTLYELLTYCD  210 (284)
T ss_pred             cccchheEEEcCCC-CEEECCCccccccccCccceeecCCCCCCccccCHHHhccC-CCCccccchhhhhhhhhhhcCCC
Confidence            99999999999887 7999999998866433221    123456779999998654 48899999999999999999876


Q ss_pred             CCCCCCcHHHHHHHHHHhCCCCHH-----HHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCccc
Q 022799          156 LFPGESGVDQLVEIIKVLGTPTRE-----EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST  230 (292)
Q Consensus       156 pf~~~~~~~~~~~i~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t  230 (292)
                      |+.....  ..   .+..+....+     ........             .....+..++..+.+||.+||+.||.+|||
T Consensus       211 ~~~~~~~--~~---~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt  272 (284)
T cd05079         211 SESSPMT--LF---LKMIGPTHGQMTVTRLVRVLEEG-------------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTT  272 (284)
T ss_pred             CCccccc--hh---hhhcccccccccHHHHHHHHHcC-------------ccCCCCCCCCHHHHHHHHHHccCCcccCcC
Confidence            6532211  00   0111100000     00000000             000012457899999999999999999999


Q ss_pred             HHHHhcC
Q 022799          231 ALEALIH  237 (292)
Q Consensus       231 ~~e~l~h  237 (292)
                      +.+++++
T Consensus       273 ~~~il~~  279 (284)
T cd05079         273 FQNLIEG  279 (284)
T ss_pred             HHHHHHH
Confidence            9999853

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2.5e-33  Score=240.94  Aligned_cols=197  Identities=21%  Similarity=0.333  Sum_probs=152.3

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      ++.++||||+++++++...      ..++++||++ |+|.+.+...   ...+++..+..++.|++.||.|||++ ||+|
T Consensus        63 ~~~l~h~niv~~~~~~~~~------~~~~v~e~~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~-~ivH  132 (303)
T cd05110          63 MASMDHPHLVRLLGVCLSP------TIQLVTQLMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEER-RLVH  132 (303)
T ss_pred             HHhCCCCCcccEEEEEcCC------CceeeehhcCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhhc-Ceec
Confidence            3578999999999987421      2568999998 7898887643   34588999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCc---ccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQP  155 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~  155 (292)
                      |||||+||+++.++ .+||+|||+++........   ....++..|+|||.+.+. .++.++|+||+||++|+|++ |..
T Consensus       133 ~dikp~Nill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~el~t~g~~  210 (303)
T cd05110         133 RDLAARNVLVKSPN-HVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYR-KFTHQSDVWSYGVTIWELMTFGGK  210 (303)
T ss_pred             cccccceeeecCCC-ceEEccccccccccCcccccccCCCccccccCCHHHhccC-CCChHHHHHHHHHHHHHHHhCCCC
Confidence            99999999998877 7999999999865433221   123346789999998654 48999999999999999997 889


Q ss_pred             CCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHh
Q 022799          156 LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL  235 (292)
Q Consensus       156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l  235 (292)
                      ||.+..... ...+......+                 +          .+...+.++.+++.+|+..+|++||++++++
T Consensus       211 p~~~~~~~~-~~~~~~~~~~~-----------------~----------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~  262 (303)
T cd05110         211 PYDGIPTRE-IPDLLEKGERL-----------------P----------QPPICTIDVYMVMVKCWMIDADSRPKFKELA  262 (303)
T ss_pred             CCCCCCHHH-HHHHHHCCCCC-----------------C----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence            997654332 22222211000                 0          0134678899999999999999999999987


Q ss_pred             cC
Q 022799          236 IH  237 (292)
Q Consensus       236 ~h  237 (292)
                      +.
T Consensus       263 ~~  264 (303)
T cd05110         263 AE  264 (303)
T ss_pred             HH
Confidence            63

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-34  Score=256.74  Aligned_cols=210  Identities=29%  Similarity=0.428  Sum_probs=173.2

Q ss_pred             CCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccC
Q 022799            3 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRD   81 (292)
Q Consensus         3 ~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~d   81 (292)
                      ...|||++.++++|.-.....+..+|||||||+ |+.-+++++..  +.++.|..+..|++.++.|+.+||.+ .++|||
T Consensus        72 ~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n-kviHRD  148 (953)
T KOG0587|consen   72 YSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN-KVIHRD  148 (953)
T ss_pred             ccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc-ceeeec
Confidence            457999999999987555455567999999999 68888887665  78899999999999999999999987 999999


Q ss_pred             CCCCcEEEeCCCCcEEEeecCCccccccC-CCcccccccccccCCccccCCC----CCCchhHhhhhhHHHHHHHhCCCC
Q 022799           82 IKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNISYICSRYYRAPELIFGAT----EYTAAIDIWSAGCVLAELLLGQPL  156 (292)
Q Consensus        82 lkp~Nill~~~~~~ikl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~----~~~~~~DvwslG~il~el~~g~~p  156 (292)
                      ||-.|||++.++ .|||+|||++...... ....+.+|||.|||||++...+    .|+..+|+||||++..||.-|.+|
T Consensus       149 ikG~NiLLT~e~-~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PP  227 (953)
T KOG0587|consen  149 IKGQNVLLTENA-EVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPP  227 (953)
T ss_pred             ccCceEEEeccC-cEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCC
Confidence            999999999998 6999999998776443 3456778999999999996543    367789999999999999999999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      +.+..+...+..|.+   .|+.                       ...-+..-++++.+||..||.+|-.+||+..++|.
T Consensus       228 l~DmHPmraLF~IpR---NPPP-----------------------kLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  228 LCDMHPMRALFLIPR---NPPP-----------------------KLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             ccCcchhhhhccCCC---CCCc-----------------------cccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            987776554433322   1111                       01112456889999999999999999999999999


Q ss_pred             CCCccc
Q 022799          237 HPFFDE  242 (292)
Q Consensus       237 hp~~~~  242 (292)
                      |||+..
T Consensus       282 hpFi~e  287 (953)
T KOG0587|consen  282 HPFITE  287 (953)
T ss_pred             CCcccc
Confidence            999973

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=3.4e-33  Score=244.13  Aligned_cols=202  Identities=23%  Similarity=0.346  Sum_probs=151.7

Q ss_pred             CCC-CCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhh--------------------------------
Q 022799            2 RLL-DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYK--------------------------------   47 (292)
Q Consensus         2 ~~l-~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~--------------------------------   47 (292)
                      +++ +||||+++++++...    ...+++||||++ |+|.+++.....                                
T Consensus        65 ~~l~~h~niv~~~~~~~~~----~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  140 (343)
T cd05103          65 IHIGHHLNVVNLLGACTKP----GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDS  140 (343)
T ss_pred             HhccCCccHhhhcceeecC----CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccc
Confidence            445 689999999977432    234789999999 799888864311                                


Q ss_pred             -------------------------------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEeCCCCcE
Q 022799           48 -------------------------------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQL   96 (292)
Q Consensus        48 -------------------------------~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlkp~Nill~~~~~~i   96 (292)
                                                     ....++...+..++.||+.||.|||++ ||+||||||+||+++.++ .+
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~i~H~dikp~Nil~~~~~-~~  218 (343)
T cd05103         141 ITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR-KCIHRDLAARNILLSENN-VV  218 (343)
T ss_pred             cccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCccCeEEEcCCC-cE
Confidence                                           012467888899999999999999998 999999999999999887 79


Q ss_pred             EEeecCCccccccCCC---cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCCCCCCCCcHHHHHHHHHH
Q 022799           97 KLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKV  172 (292)
Q Consensus        97 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~~~i~~~  172 (292)
                      +|+|||++........   .....++..|+|||.+.+. .++.++|+||+||++|+|++ |..||.+.............
T Consensus       219 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~  297 (343)
T cd05103         219 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE  297 (343)
T ss_pred             EEEecccccccccCcchhhcCCCCCCcceECcHHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhc
Confidence            9999999876532221   1122345679999998654 48999999999999999997 89999765433322222211


Q ss_pred             hCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          173 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      ...+                           ..+...++++.+++.+||..||++|||+.++++|
T Consensus       298 ~~~~---------------------------~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         298 GTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             cCCC---------------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            0000                           0112367889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=6.1e-33  Score=234.69  Aligned_cols=205  Identities=20%  Similarity=0.317  Sum_probs=155.0

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCc-eeEEEEeeccc-CCHHHHHHhhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDE-LYLNLVLEYVP-ETVHRVIKHHYK--MSQRMPLIYVKLYFYQICRALAYIHNTIG   76 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~-~~~~lv~e~~~-g~L~~~l~~~~~--~~~~~~~~~~~~~~~qil~al~~LH~~~~   76 (292)
                      |+.++||||+++++++......+. ...++++||+. |+|.+++.....  ....++...+..++.||+.||+|||++ |
T Consensus        55 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~-~  133 (273)
T cd05074          55 MKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK-N  133 (273)
T ss_pred             HhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-C
Confidence            467899999999998755433222 23578899998 788877653221  123578889999999999999999988 9


Q ss_pred             ccccCCCCCcEEEeCCCCcEEEeecCCccccccCCC---cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-
Q 022799           77 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-  152 (292)
Q Consensus        77 i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-  152 (292)
                      |+||||||+||+++.++ .++|+|||.++.......   .....+++.|++||.+.+. .++.++|+||+||++|+|++ 
T Consensus       134 i~H~dikp~nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~sDi~slG~il~el~~~  211 (273)
T cd05074         134 FIHRDLAARNCMLNENM-TVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADN-VYTTHSDVWAFGVTMWEIMTR  211 (273)
T ss_pred             EeecccchhhEEEcCCC-CEEECcccccccccCCcceecCCCccCchhhcCHhHHhcC-ccchhhhhHHHHHHHHHHhhC
Confidence            99999999999999877 799999999886533221   1223446789999998554 48899999999999999999 


Q ss_pred             CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHH
Q 022799          153 GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAL  232 (292)
Q Consensus       153 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~  232 (292)
                      |..||.+.+..+....+... ..               .            ..+...+..+.+++.+||..+|++|||+.
T Consensus       212 g~~p~~~~~~~~~~~~~~~~-~~---------------~------------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~  263 (273)
T cd05074         212 GQTPYAGVENSEIYNYLIKG-NR---------------L------------KQPPDCLEDVYELMCQCWSPEPKCRPSFQ  263 (273)
T ss_pred             CCCCCCCCCHHHHHHHHHcC-Cc---------------C------------CCCCCCCHHHHHHHHHHcCCChhhCcCHH
Confidence            88999776654433333211 00               0            01134678999999999999999999999


Q ss_pred             HHhc
Q 022799          233 EALI  236 (292)
Q Consensus       233 e~l~  236 (292)
                      +++.
T Consensus       264 ~~~~  267 (273)
T cd05074         264 HLRD  267 (273)
T ss_pred             HHHH
Confidence            9985

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-34  Score=251.24  Aligned_cols=201  Identities=18%  Similarity=0.259  Sum_probs=156.1

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccC-CHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++=+|-||+=+.+++     .... +.||+.+|+| +|+..+...   ..++.....+.|+.||+.|+.|||.+ +|||
T Consensus       442 lkkTRH~NIlLFMG~~-----~~p~-~AIiTqwCeGsSLY~hlHv~---etkfdm~~~idIAqQiaqGM~YLHAK-~IIH  511 (678)
T KOG0193|consen  442 LKKTRHENILLFMGAC-----MNPP-LAIITQWCEGSSLYTHLHVQ---ETKFDMNTTIDIAQQIAQGMDYLHAK-NIIH  511 (678)
T ss_pred             Hhhcchhhheeeehhh-----cCCc-eeeeehhccCchhhhhccch---hhhhhHHHHHHHHHHHHHhhhhhhhh-hhhh
Confidence            3556899999999988     3333 3799999997 888887643   35688999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccc---cCCCcccccccccccCCccccCC--CCCCchhHhhhhhHHHHHHHhCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLV---KGEPNISYICSRYYRAPELIFGA--TEYTAAIDIWSAGCVLAELLLGQ  154 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwslG~il~el~~g~  154 (292)
                      ||||..||++.+++ .|||+|||++..-.   .........|...|||||++...  ..|++.+||||+||++|||++|.
T Consensus       512 rDLKSnNIFl~~~~-kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~  590 (678)
T KOG0193|consen  512 RDLKSNNIFLHEDL-KVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGE  590 (678)
T ss_pred             hhccccceEEccCC-cEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCc
Confidence            99999999999887 79999999985431   11222334577789999999643  34899999999999999999999


Q ss_pred             CCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHH
Q 022799          155 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA  234 (292)
Q Consensus       155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~  234 (292)
                      .||...+...++..+-+....|...                        ....+.++++++|+..||.+++++||.+.++
T Consensus       591 lPysi~~~dqIifmVGrG~l~pd~s------------------------~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~i  646 (678)
T KOG0193|consen  591 LPYSIQNRDQIIFMVGRGYLMPDLS------------------------KIRSNCPKAMKRLLSDCWKFDREERPLFPQL  646 (678)
T ss_pred             CCcCCCChhheEEEecccccCccch------------------------hhhccCHHHHHHHHHHHHhcCcccCccHHHH
Confidence            9998554443333222211111111                        1124678899999999999999999999998


Q ss_pred             hc
Q 022799          235 LI  236 (292)
Q Consensus       235 l~  236 (292)
                      |.
T Consensus       647 l~  648 (678)
T KOG0193|consen  647 LS  648 (678)
T ss_pred             HH
Confidence            85

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-33  Score=263.13  Aligned_cols=200  Identities=20%  Similarity=0.355  Sum_probs=163.8

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYK---MSQRMPLIYVKLYFYQICRALAYIHNTIG   76 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~---~~~~~~~~~~~~~~~qil~al~~LH~~~~   76 (292)
                      |+.++|||||+++++..+...     .++++|||. |+|..++++.+.   ....++......++.||+.|++||+++ +
T Consensus       749 m~~f~HpNiv~liGv~l~~~~-----~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~-~  822 (1025)
T KOG1095|consen  749 MSKFDHPNIVSLIGVCLDSGP-----PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK-H  822 (1025)
T ss_pred             HhcCCCcceeeEEEeecCCCC-----cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC-C
Confidence            678999999999999966333     889999999 799999986422   245688899999999999999999998 9


Q ss_pred             ccccCCCCCcEEEeCCCCcEEEeecCCccccccCCCcc---cccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-
Q 022799           77 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI---SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-  152 (292)
Q Consensus        77 i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-  152 (292)
                      +|||||...|+|++... .+||+|||+|+.+...+...   ...-...|||||.+... .++.++|||||||++||++| 
T Consensus       823 fvHRDLAaRNCLL~~~r-~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~-iFtskSDvWsFGVllWEifsl  900 (1025)
T KOG1095|consen  823 FVHRDLAARNCLLDERR-VVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDG-IFTSKSDVWSFGVLLWEIFSL  900 (1025)
T ss_pred             CcCcchhhhheeecccC-cEEEcccchhHhhhhchheeccCccccceecCCHHHHhhc-ccccccchhhhHHHHHHHHhC
Confidence            99999999999999987 79999999999553332211   11124579999999764 59999999999999999998 


Q ss_pred             CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHH
Q 022799          153 GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAL  232 (292)
Q Consensus       153 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~  232 (292)
                      |..||.+.++.+++....+....+                            -|..++..+.++|..||+.+|++||++.
T Consensus       901 G~~PY~~~~n~~v~~~~~~ggRL~----------------------------~P~~CP~~ly~lM~~CW~~~pe~RP~F~  952 (1025)
T KOG1095|consen  901 GATPYPSRSNFEVLLDVLEGGRLD----------------------------PPSYCPEKLYQLMLQCWKHDPEDRPSFR  952 (1025)
T ss_pred             CCCCCCCcchHHHHHHHHhCCccC----------------------------CCCCCChHHHHHHHHHccCChhhCccHH
Confidence            899999988887776554421111                            1246899999999999999999999999


Q ss_pred             HHhc
Q 022799          233 EALI  236 (292)
Q Consensus       233 e~l~  236 (292)
                      .+++
T Consensus       953 ~i~~  956 (1025)
T KOG1095|consen  953 TIVE  956 (1025)
T ss_pred             HHHh
Confidence            9986

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-34  Score=254.73  Aligned_cols=156  Identities=28%  Similarity=0.409  Sum_probs=131.7

Q ss_pred             CCCCCCCCeeeeceeeeccCC-CCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTE-KDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVC   78 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~-~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~   78 (292)
                      |++|+|||||+++++-.+... --.....+|||||. |+|+.++..-. ...++++.+.+.++..+..||.|||++ ||+
T Consensus        65 lkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PE-N~~GLpE~e~l~lL~d~~~al~~LrEn-~Iv  142 (732)
T KOG4250|consen   65 LKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPE-NAYGLPESEFLDLLSDLVSALRHLREN-GIV  142 (732)
T ss_pred             HHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcc-cccCCCHHHHHHHHHHHHHHHHHHHHc-Cce
Confidence            578999999999887432220 00234679999999 79999887533 357899999999999999999999998 999


Q ss_pred             ccCCCCCcEEEe--CCCC-cEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCC
Q 022799           79 HRDIKPQNLLVN--PHTH-QLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQP  155 (292)
Q Consensus        79 H~dlkp~Nill~--~~~~-~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~  155 (292)
                      ||||||.||++-  .+|. .-||+|||.|+...++....+.+||+.|.+||+.-.++.|+..+|.||+||++|+++||..
T Consensus       143 HRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~l  222 (732)
T KOG4250|consen  143 HRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGEL  222 (732)
T ss_pred             eccCCCCcEEEeecCCCceEEeeecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCC
Confidence            999999999973  3332 4699999999999988888899999999999999655679999999999999999999999


Q ss_pred             CCC
Q 022799          156 LFP  158 (292)
Q Consensus       156 pf~  158 (292)
                      ||.
T Consensus       223 PF~  225 (732)
T KOG4250|consen  223 PFI  225 (732)
T ss_pred             CCC
Confidence            985

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-33  Score=241.50  Aligned_cols=213  Identities=26%  Similarity=0.326  Sum_probs=152.3

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCC--c
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG--V   77 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~--i   77 (292)
                      |.+++|||+|++++++.+..+    ..+||+||+. |+|.+.+......  .+++....+|+.+++.||+|||+...  |
T Consensus       125 ls~l~H~Nlv~LlGyC~e~~~----~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~i  198 (361)
T KOG1187|consen  125 LSRLRHPNLVKLLGYCLEGGE----HRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPI  198 (361)
T ss_pred             HhcCCCcCcccEEEEEecCCc----eEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCE
Confidence            467899999999999954331    4889999999 8999988754221  78999999999999999999998654  9


Q ss_pred             cccCCCCCcEEEeCCCCcEEEeecCCcccccc-CCCcccc-cccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCC
Q 022799           78 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-GEPNISY-ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQP  155 (292)
Q Consensus        78 ~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~-~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~  155 (292)
                      +|||||++|||+|.+. ..||+|||+|+.... .....+. .||..|++||.... ...+.++||||+|+++.|++||+.
T Consensus       199 iHrDiKssNILLD~~~-~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~  276 (361)
T KOG1187|consen  199 IHRDIKSSNILLDEDF-NAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRK  276 (361)
T ss_pred             ecCCCCHHHeeECCCC-CEEccCccCcccCCccccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCc
Confidence            9999999999999988 799999999976543 3322233 78999999999965 348999999999999999999998


Q ss_pred             CCCCCC---cHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhcc-CCChhHHHHHHHHhccCCCCcccH
Q 022799          156 LFPGES---GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQK-RMPPEAVDLVSRLLQYSPNLRSTA  231 (292)
Q Consensus       156 pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~dp~~R~t~  231 (292)
                      +.....   ...........+.......+  +.+....            ..++. ..-..+..+..+|+..+|.+||++
T Consensus       277 ~~d~~~~~~~~~l~~w~~~~~~~~~~~ei--iD~~l~~------------~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m  342 (361)
T KOG1187|consen  277 AVDQSRPRGELSLVEWAKPLLEEGKLREI--VDPRLKE------------GEYPDEKEVKKLAELALRCLRPDPKERPTM  342 (361)
T ss_pred             ccCCCCCcccccHHHHHHHHHHCcchhhe--eCCCccC------------CCCChHHHHHHHHHHHHHHcCcCCCcCcCH
Confidence            776432   11111111111111100000  0111000            00000 011235567789999999999999


Q ss_pred             HHHh
Q 022799          232 LEAL  235 (292)
Q Consensus       232 ~e~l  235 (292)
                      .+++
T Consensus       343 ~~Vv  346 (361)
T KOG1187|consen  343 SQVV  346 (361)
T ss_pred             HHHH
Confidence            9975

>PLN00181 protein SPA1-RELATED; Provisional

Probab=100.00  E-value=1.5e-33  Score=270.52  Aligned_cols=207  Identities=19%  Similarity=0.225  Sum_probs=150.1

Q ss_pred             CCCCC-CCeeeeceeeeccC--CCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcc
Q 022799            2 RLLDH-PNVVSLKHCFFSTT--EKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVC   78 (292)
Q Consensus         2 ~~l~H-pnIv~~~~~~~~~~--~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~   78 (292)
                      +.++| +||+++++.|....  ..+...++.+|||++++|.+++...   ...+++..+..+++||+.||.|||++ ||+
T Consensus        27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~-gIv  102 (793)
T PLN00181         27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNP---DRSVDAFECFHVFRQIVEIVNAAHSQ-GIV  102 (793)
T ss_pred             chhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcc---cccccHHHHHHHHHHHHHHHHHHHhC-Cee
Confidence            56778 78999999873222  1122357789999999999998642   35689999999999999999999988 999


Q ss_pred             ccCCCCCcEEEeCCC------------------CcEEEeecCCccccccCC-----------------Cccccccccccc
Q 022799           79 HRDIKPQNLLVNPHT------------------HQLKLCDFGSAKVLVKGE-----------------PNISYICSRYYR  123 (292)
Q Consensus        79 H~dlkp~Nill~~~~------------------~~ikl~Dfg~a~~~~~~~-----------------~~~~~~gt~~y~  123 (292)
                      ||||||+|||++..+                  ..+|++|||+++......                 ......||+.|+
T Consensus       103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~  182 (793)
T PLN00181        103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT  182 (793)
T ss_pred             eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence            999999999995422                  246777777765421100                 011235789999


Q ss_pred             CCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchh
Q 022799          124 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHK  203 (292)
Q Consensus       124 aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  203 (292)
                      |||++.+.. ++.++||||+||++|||++|..|+....  .....+.... .|+.                         
T Consensus       183 APE~~~~~~-~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~-~~~~-------------------------  233 (793)
T PLN00181        183 SPEEDNGSS-SNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV-LPPQ-------------------------  233 (793)
T ss_pred             ChhhhccCC-CCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh-cChh-------------------------
Confidence            999987654 8999999999999999999988865321  1111111110 0000                         


Q ss_pred             hhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCCcccc
Q 022799          204 IFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  243 (292)
Q Consensus       204 ~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~~~~~  243 (292)
                       . ....+...+++.+||..||.+||++.++++||||...
T Consensus       234 -~-~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~  271 (793)
T PLN00181        234 -I-LLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP  271 (793)
T ss_pred             -h-hhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence             0 0123456789999999999999999999999999864

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-34  Score=256.55  Aligned_cols=201  Identities=31%  Similarity=0.437  Sum_probs=152.0

Q ss_pred             CCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCC
Q 022799            5 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKP   84 (292)
Q Consensus         5 ~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlkp   84 (292)
                      +|||||++++.-     ++..+.|+..|.|..+|.+++...............+.++.|++.||++||+- +||||||||
T Consensus       561 ~H~NviRyyc~E-----~d~qF~YIalELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl-~iVHRDLkP  634 (903)
T KOG1027|consen  561 EHPNVIRYYCSE-----QDRQFLYIALELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL-KIVHRDLKP  634 (903)
T ss_pred             CCCceEEEEeec-----cCCceEEEEehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc-ccccccCCC
Confidence            699999998765     78889999999999999999986411111111135678899999999999985 999999999


Q ss_pred             CcEEEeC---CC-CcEEEeecCCccccccCCC----cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhC-CC
Q 022799           85 QNLLVNP---HT-HQLKLCDFGSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG-QP  155 (292)
Q Consensus        85 ~Nill~~---~~-~~ikl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g-~~  155 (292)
                      .||||+.   ++ .+++|+|||+++....+..    ..+..||-.|+|||++.+.. -+.++|++|+||++|+.++| .+
T Consensus       635 QNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~H  713 (903)
T KOG1027|consen  635 QNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSH  713 (903)
T ss_pred             ceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCcc
Confidence            9999976   33 3689999999998865543    33456899999999997654 57799999999999999985 89


Q ss_pred             CCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHh
Q 022799          156 LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL  235 (292)
Q Consensus       156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l  235 (292)
                      ||.+.-.  .-.+|...              .+.-..+.            +....++.|||.+|+..+|..||+|.++|
T Consensus       714 pFGd~~~--R~~NIl~~--------------~~~L~~L~------------~~~d~eA~dLI~~ml~~dP~~RPsa~~VL  765 (903)
T KOG1027|consen  714 PFGDSLE--RQANILTG--------------NYTLVHLE------------PLPDCEAKDLISRMLNPDPQLRPSATDVL  765 (903)
T ss_pred             CCCchHH--hhhhhhcC--------------ccceeeec------------cCchHHHHHHHHHhcCCCcccCCCHHHHh
Confidence            9954321  11222221              00000000            11122899999999999999999999999


Q ss_pred             cCCCc
Q 022799          236 IHPFF  240 (292)
Q Consensus       236 ~hp~~  240 (292)
                      .||+|
T Consensus       766 ~HPlF  770 (903)
T KOG1027|consen  766 NHPLF  770 (903)
T ss_pred             CCCcc
Confidence            99998

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.4e-32  Score=227.46  Aligned_cols=202  Identities=39%  Similarity=0.653  Sum_probs=161.4

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeecccC-CHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      ++++|+||+++++++..     ....++++||+++ +|.+++...    ..++...+..++.+++.++.+||+. |++|+
T Consensus        42 ~~l~~~~i~~~~~~~~~-----~~~~~l~~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~  111 (244)
T smart00220       42 KKLKHPNIVRLYDVFED-----EDKLYLVMEYCDGGDLFDLLKKR----GRLSEDEARFYARQILSALEYLHSN-GIIHR  111 (244)
T ss_pred             HhCCCCcHHHHHhheee-----CCEEEEEEeCCCCCCHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHc-CeecC
Confidence            56799999999998843     3458999999995 998888653    3388999999999999999999987 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE  160 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  160 (292)
                      ||+|+||+++.++ .++|+|||.+.............++..|++||.+.+. .++.++|+||+|++++++++|..||...
T Consensus       112 ~i~~~ni~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~-~~~~~~Di~slG~~l~~l~~~~~p~~~~  189 (244)
T smart00220      112 DLKPENILLDEDG-HVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVLLGK-GYGKAVDVWSLGVILYELLTGKPPFPGD  189 (244)
T ss_pred             CcCHHHeEECCCC-cEEEccccceeeeccccccccccCCcCCCCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999999887 7999999999877554444556778899999998644 4788999999999999999999999774


Q ss_pred             CcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCCc
Q 022799          161 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  240 (292)
Q Consensus       161 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~~  240 (292)
                      .......+..........                         .....++.++.+++.+||..+|++||++.++++||||
T Consensus       190 ~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~  244 (244)
T smart00220      190 DQLLELFKKIGKPKPPFP-------------------------PPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF  244 (244)
T ss_pred             CcHHHHHHHHhccCCCCc-------------------------cccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence            333333332221100000                         0001177899999999999999999999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=8e-33  Score=212.89  Aligned_cols=164  Identities=26%  Similarity=0.439  Sum_probs=139.4

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccC
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRD   81 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~d   81 (292)
                      +-...|.+|.+++.++.     +..+++.||.++.+|..+...-.+.++.++|..+-+++..++.||.|||+++.++|||
T Consensus       100 r~~~CPf~V~FyGa~~r-----egdvwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRD  174 (282)
T KOG0984|consen  100 RTVDCPFTVHFYGALFR-----EGDVWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRD  174 (282)
T ss_pred             cCCCCCeEEEeehhhhc-----cccEEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhcc
Confidence            45578999999998843     3348999999999999888887888899999999999999999999999999999999


Q ss_pred             CCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccC---CCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           82 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG---ATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        82 lkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      +||+|||++.+| ++|+||||.+....+.-..+-..|-..|||||.+..   ...|+.++|+||||+.+.||.+++.||.
T Consensus       175 vKPsNiLIn~~G-qVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~  253 (282)
T KOG0984|consen  175 VKPSNILINYDG-QVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYE  253 (282)
T ss_pred             CCcceEEEccCC-cEEEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccc
Confidence            999999999999 799999999987765544444577788999999843   2358999999999999999999999997


Q ss_pred             C-CCcHHHHHHHHH
Q 022799          159 G-ESGVDQLVEIIK  171 (292)
Q Consensus       159 ~-~~~~~~~~~i~~  171 (292)
                      . .++.+++.++.+
T Consensus       254 ~w~tpF~qLkqvVe  267 (282)
T KOG0984|consen  254 SWGTPFQQLKQVVE  267 (282)
T ss_pred             ccCCHHHHHHHHhc
Confidence            4 455666655544

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-32  Score=233.67  Aligned_cols=210  Identities=25%  Similarity=0.387  Sum_probs=160.2

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeecccC-CHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhc-CCccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT-IGVCH   79 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~-~~i~H   79 (292)
                      +.|+||.||++|++|.-..    ..+|.|+|||+| +|.-++..    ++-+++.+++.|+.||+.||.||.+. .-|+|
T Consensus       522 KeLDHpRIVKlYDyfslDt----dsFCTVLEYceGNDLDFYLKQ----hklmSEKEARSIiMQiVnAL~YLNEikpPIIH  593 (775)
T KOG1151|consen  522 KELDHPRIVKLYDYFSLDT----DSFCTVLEYCEGNDLDFYLKQ----HKLMSEKEARSIIMQIVNALKYLNEIKPPIIH  593 (775)
T ss_pred             hccCcceeeeeeeeeeecc----ccceeeeeecCCCchhHHHHh----hhhhhHHHHHHHHHHHHHHHHHHhccCCCeee
Confidence            4689999999999884222    238999999997 66666665    46789999999999999999999963 25999


Q ss_pred             cCCCCCcEEEeCC--CCcEEEeecCCccccccCCCc--------ccccccccccCCccccC---CCCCCchhHhhhhhHH
Q 022799           80 RDIKPQNLLVNPH--THQLKLCDFGSAKVLVKGEPN--------ISYICSRYYRAPELIFG---ATEYTAAIDIWSAGCV  146 (292)
Q Consensus        80 ~dlkp~Nill~~~--~~~ikl~Dfg~a~~~~~~~~~--------~~~~gt~~y~aPE~~~~---~~~~~~~~DvwslG~i  146 (292)
                      -||||.|||+...  .+.|||+|||+++.+......        ....||.+|++||.+.-   -+..+.++||||+|||
T Consensus       594 YDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVI  673 (775)
T KOG1151|consen  594 YDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVI  673 (775)
T ss_pred             eccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehh
Confidence            9999999998432  236999999999987554322        23568999999998743   2457899999999999


Q ss_pred             HHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCC
Q 022799          147 LAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPN  226 (292)
Q Consensus       147 l~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~  226 (292)
                      ||.++.|+.||..+...   +.|++...-.          ...+..+|.-          +-+++++++||++||++-.+
T Consensus       674 FyQClYGrKPFGhnqsQ---QdILqeNTIl----------kAtEVqFP~K----------PvVsseAkaFIRRCLaYRKe  730 (775)
T KOG1151|consen  674 FYQCLYGRKPFGHNQSQ---QDILQENTIL----------KATEVQFPPK----------PVVSSEAKAFIRRCLAYRKE  730 (775)
T ss_pred             hhhhhccCCCCCCchhH---HHHHhhhchh----------cceeccCCCC----------CccCHHHHHHHHHHHHhhhh
Confidence            99999999999654322   1222210000          0112222221          45899999999999999999


Q ss_pred             CcccHHHHhcCCCccc
Q 022799          227 LRSTALEALIHPFFDE  242 (292)
Q Consensus       227 ~R~t~~e~l~hp~~~~  242 (292)
                      +|....++-.||+|..
T Consensus       731 DR~DV~qLA~dpyllP  746 (775)
T KOG1151|consen  731 DRIDVQQLACDPYLLP  746 (775)
T ss_pred             hhhhHHHHccCccccc
Confidence            9999999999999975

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.2e-32  Score=231.46  Aligned_cols=213  Identities=24%  Similarity=0.374  Sum_probs=152.2

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++..   .+..+.++||||++ ++|.+++...   ...+++..+..++.|++.||.|||++ |++|
T Consensus        60 l~~l~~~~i~~~~~~~~~---~~~~~~~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~-~i~H  132 (284)
T cd05038          60 LRTLDHENIVKYKGVCEK---PGGRSLRLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQ-RYIH  132 (284)
T ss_pred             HHhCCCCChheEEeeeec---CCCCceEEEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhC-Ceec
Confidence            357899999999988733   22445889999998 6998888653   23589999999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCc----ccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQP  155 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~  155 (292)
                      +||||+||+++.++ .++|+|||.+.........    ....++..|+|||.+.+. .++.++|+||+||++++|++|..
T Consensus       133 ~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~el~tg~~  210 (284)
T cd05038         133 RDLAARNILVESED-LVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTS-KFSSASDVWSFGVTLYELFTYGD  210 (284)
T ss_pred             CCCCHHhEEEcCCC-CEEEcccccccccccCCcceeccCCCCCcccccCcHHHccC-CCCcccchHHHhhhhheeeccCC
Confidence            99999999999887 7999999999876422211    112345569999998654 48899999999999999999999


Q ss_pred             CCCCCCcHHHHHHHHH-HhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHH
Q 022799          156 LFPGESGVDQLVEIIK-VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA  234 (292)
Q Consensus       156 pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~  234 (292)
                      |+.........  +.. ..+......+.........  .          ..+..++..+.+++.+||..+|.+|||+.++
T Consensus       211 p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~--~----------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei  276 (284)
T cd05038         211 PSQSPPAEFLR--MIGIAQGQMIVTRLLELLKEGER--L----------PRPPSCPDEVYDLMKLCWEAEPQDRPSFADL  276 (284)
T ss_pred             Ccccccchhcc--ccccccccccHHHHHHHHHcCCc--C----------CCCccCCHHHHHHHHHHhccChhhCCCHHHH
Confidence            88653221100  000 0000000000000000000  0          0113467889999999999999999999999


Q ss_pred             hc
Q 022799          235 LI  236 (292)
Q Consensus       235 l~  236 (292)
                      ++
T Consensus       277 ~~  278 (284)
T cd05038         277 IL  278 (284)
T ss_pred             HH
Confidence            84

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1e-31  Score=235.86  Aligned_cols=196  Identities=21%  Similarity=0.365  Sum_probs=157.8

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++|||+|++++++     ..+.-+|||+|||. |+|.++++....  ..++......++.||..|++||..+ ++||
T Consensus       317 MKeikHpNLVqLLGVC-----T~EpPFYIiTEfM~yGNLLdYLRecnr--~ev~avvLlyMAtQIsSaMeYLEkk-nFIH  388 (1157)
T KOG4278|consen  317 MKEIKHPNLVQLLGVC-----THEPPFYIITEFMCYGNLLDYLRECNR--SEVPAVVLLYMATQISSAMEYLEKK-NFIH  388 (1157)
T ss_pred             HHhhcCccHHHHhhhh-----ccCCCeEEEEecccCccHHHHHHHhch--hhcchhHHHHHHHHHHHHHHHHHHh-hhhh
Confidence            6889999999999999     55555899999998 999999986432  3466667778889999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccc---cccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC---SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQP  155 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~g---t~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~  155 (292)
                      |||...|+|+.++. .||++|||+++.+..+. .+...|   ...|.|||-+.= ..++.++|||+||+++||+.| |..
T Consensus       389 RDLAARNCLVgEnh-iVKvADFGLsRlMtgDT-YTAHAGAKFPIKWTAPEsLAy-NtFSiKSDVWAFGVLLWEIATYGMs  465 (1157)
T KOG4278|consen  389 RDLAARNCLVGENH-IVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAY-NTFSIKSDVWAFGVLLWEIATYGMS  465 (1157)
T ss_pred             hhhhhhhccccccc-eEEeeccchhhhhcCCc-eecccCccCcccccCcccccc-cccccchhhHHHHHHHHHHHhcCCC
Confidence            99999999999876 89999999999875432 223334   456999999843 448999999999999999998 889


Q ss_pred             CCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHh
Q 022799          156 LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL  235 (292)
Q Consensus       156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l  235 (292)
                      ||+|-+...++..+.+.+                .++.            |.++++.+.+||+.||.++|++||++.|+-
T Consensus       466 PYPGidlSqVY~LLEkgy----------------RM~~------------PeGCPpkVYeLMraCW~WsPsDRPsFaeiH  517 (1157)
T KOG4278|consen  466 PYPGIDLSQVYGLLEKGY----------------RMDG------------PEGCPPKVYELMRACWNWSPSDRPSFAEIH  517 (1157)
T ss_pred             CCCCccHHHHHHHHhccc----------------cccC------------CCCCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence            999877654444333211                1111            257999999999999999999999988873

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.97  E-value=2.3e-32  Score=245.01  Aligned_cols=197  Identities=23%  Similarity=0.379  Sum_probs=169.8

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |-+++||||+++.++.     ....-++||+|||+ |+|+.+++.+   .+.++..+...+++.|+.|++||-+. |.||
T Consensus       684 MGQFdHPNIIrLEGVV-----Tks~PvMIiTEyMENGsLDsFLR~~---DGqftviQLVgMLrGIAsGMkYLsdm-~YVH  754 (996)
T KOG0196|consen  684 MGQFDHPNIIRLEGVV-----TKSKPVMIITEYMENGSLDSFLRQN---DGQFTVIQLVGMLRGIASGMKYLSDM-NYVH  754 (996)
T ss_pred             cccCCCCcEEEEEEEE-----ecCceeEEEhhhhhCCcHHHHHhhc---CCceEeehHHHHHHHHHHHhHHHhhc-Cchh
Confidence            5688999999999987     44445899999999 8999999875   46688889999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCC-ccccc-c--cccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NISYI-C--SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQ  154 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~-~~~~~-g--t~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~  154 (292)
                      |||...|||++++- .+|++|||+++...++.. ..+.. |  ..+|.|||.+. .+.++.+||+||+|+++||.++ |.
T Consensus       755 RDLAARNILVNsnL-vCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa-~RKFTsASDVWSyGIVmWEVmSyGE  832 (996)
T KOG0196|consen  755 RDLAARNILVNSNL-VCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIA-YRKFTSASDVWSYGIVMWEVMSYGE  832 (996)
T ss_pred             hhhhhhheeeccce-EEEeccccceeecccCCCccccccCCccceeecChhHhh-hcccCchhhccccceEEEEecccCC
Confidence            99999999999998 799999999998765542 22222 2  46799999995 4559999999999999999885 99


Q ss_pred             CCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHH
Q 022799          155 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA  234 (292)
Q Consensus       155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~  234 (292)
                      .||-+.++.+++..|.+.+..|+.                            .++|..+..|+..||++|-.+||.+.+|
T Consensus       833 RPYWdmSNQdVIkaIe~gyRLPpP----------------------------mDCP~aL~qLMldCWqkdR~~RP~F~qi  884 (996)
T KOG0196|consen  833 RPYWDMSNQDVIKAIEQGYRLPPP----------------------------MDCPAALYQLMLDCWQKDRNRRPKFAQI  884 (996)
T ss_pred             CcccccchHHHHHHHHhccCCCCC----------------------------CCCcHHHHHHHHHHHHHHhhcCCCHHHH
Confidence            999999999999999887666653                            5689999999999999999999999998


Q ss_pred             hc
Q 022799          235 LI  236 (292)
Q Consensus       235 l~  236 (292)
                      ++
T Consensus       885 V~  886 (996)
T KOG0196|consen  885 VS  886 (996)
T ss_pred             HH
Confidence            75

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.97  E-value=7e-31  Score=221.30  Aligned_cols=228  Identities=31%  Similarity=0.521  Sum_probs=165.9

Q ss_pred             CCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCC
Q 022799            5 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIK   83 (292)
Q Consensus         5 ~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlk   83 (292)
                      .+.||+++.+++     ..+....+||||.+ ....++...       ++..+++.|++.++.||.++|.+ ||||||||
T Consensus        93 G~~ni~~~~~~~-----rnnd~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~-GIvHRDiK  159 (418)
T KOG1167|consen   93 GSDNIIKLNGCF-----RNNDQVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKN-GIVHRDIK  159 (418)
T ss_pred             cchhhhcchhhh-----ccCCeeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhcc-CccccCCC
Confidence            578999999999     55555899999999 566666543       67889999999999999999987 99999999


Q ss_pred             CCcEEEeCCCCcEEEeecCCccccccC---------------------------------------------CCcccccc
Q 022799           84 PQNLLVNPHTHQLKLCDFGSAKVLVKG---------------------------------------------EPNISYIC  118 (292)
Q Consensus        84 p~Nill~~~~~~ikl~Dfg~a~~~~~~---------------------------------------------~~~~~~~g  118 (292)
                      |+|++.+.....-.|.|||+|......                                             .......|
T Consensus       160 psNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAG  239 (418)
T KOG1167|consen  160 PSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAG  239 (418)
T ss_pred             ccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCC
Confidence            999999887777899999998721000                                             00013568


Q ss_pred             cccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC-CCCcHHHHHHHHHHhCCCCHHHHhhcCCC----------
Q 022799          119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP-GESGVDQLVEIIKVLGTPTREEIKCMNPN----------  187 (292)
Q Consensus       119 t~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~~----------  187 (292)
                      |+.|+|||++...+.-++++|+||.|+|+..++++..||. ..++.+.+.++...+|...-.........          
T Consensus       240 T~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~  319 (418)
T KOG1167|consen  240 TPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIP  319 (418)
T ss_pred             CCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeecccccc
Confidence            9999999999887778999999999999999999998875 44555555666555554332221111110          


Q ss_pred             --------CccccCCC-CCCC---CchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCCccccCC
Q 022799          188 --------YTEFKFPQ-IKAH---PWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  245 (292)
Q Consensus       188 --------~~~~~~~~-~~~~---~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~~~~~~~  245 (292)
                              +....... ...+   -+........+..+.||+.+||..||.+|+||+++|+||||.....
T Consensus       320 ~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~  389 (418)
T KOG1167|consen  320 TIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADR  389 (418)
T ss_pred             ccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhh
Confidence                    11110000 0000   1112222445679999999999999999999999999999996543

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.97  E-value=3e-31  Score=231.21  Aligned_cols=205  Identities=20%  Similarity=0.283  Sum_probs=161.7

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |.+|+|||||.+++++...+.     +|+||||++ |+|.+++..+...  .+.-.....++.||+.|++||.+- ++||
T Consensus       589 LsqLkhPNIveLvGVC~~DeP-----icmI~EYmEnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLes~-nfVH  660 (807)
T KOG1094|consen  589 LSRLKHPNIVELLGVCVQDDP-----LCMITEYMENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLESL-NFVH  660 (807)
T ss_pred             HhccCCCCeeEEEeeeecCCc-----hHHHHHHHhcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHHhh-chhh
Confidence            578999999999999965443     899999999 9999999875321  123344556899999999999975 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCc---ccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh--CC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL--GQ  154 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~--g~  154 (292)
                      |||.+.|+|++.+. .+||+|||+++..-+++..   ...+-..+|||+|.+.-.+ ++.++|+|++|+++||+++  ..
T Consensus       661 rd~a~rNcLv~~e~-~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgk-FttaSDvWafgvTlwE~~~~C~e  738 (807)
T KOG1094|consen  661 RDLATRNCLVDGEF-TIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEVFMLCRE  738 (807)
T ss_pred             ccccccceeecCcc-cEEecCcccccccccCCceeeecceeeeeeehhHHHHHhcc-ccchhhhhhhHHHHHHHHHHHhh
Confidence            99999999999998 7999999999876444322   2234467899999987654 9999999999999999874  77


Q ss_pred             CCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHH
Q 022799          155 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA  234 (292)
Q Consensus       155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~  234 (292)
                      .||....+.+...+.-..+..+......                     .-|+-++..+.++|-+|+..|-.+||+.+++
T Consensus       739 ~Py~~lt~e~vven~~~~~~~~~~~~~l---------------------~~P~~cp~~lyelml~Cw~~es~~RPsFe~l  797 (807)
T KOG1094|consen  739 QPYSQLTDEQVVENAGEFFRDQGRQVVL---------------------SRPPACPQGLYELMLRCWRRESEQRPSFEQL  797 (807)
T ss_pred             CchhhhhHHHHHHhhhhhcCCCCcceec---------------------cCCCcCcHHHHHHHHHHhchhhhcCCCHHHH
Confidence            8998877777766655554444322111                     1124578899999999999999999999998


Q ss_pred             hc
Q 022799          235 LI  236 (292)
Q Consensus       235 l~  236 (292)
                      -.
T Consensus       798 h~  799 (807)
T KOG1094|consen  798 HL  799 (807)
T ss_pred             HH
Confidence            53

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=2.3e-30  Score=233.08  Aligned_cols=217  Identities=22%  Similarity=0.296  Sum_probs=143.9

Q ss_pred             CeeeeceeeeccCC---CCceeEEEEeeccc-CCHHHHHHhhhh--------------------cCCCCCHHHHHHHHHH
Q 022799            8 NVVSLKHCFFSTTE---KDELYLNLVLEYVP-ETVHRVIKHHYK--------------------MSQRMPLIYVKLYFYQ   63 (292)
Q Consensus         8 nIv~~~~~~~~~~~---~~~~~~~lv~e~~~-g~L~~~l~~~~~--------------------~~~~~~~~~~~~~~~q   63 (292)
                      +++++++++.....   ......+|||||++ ++|.+++.....                    ....+++..++.++.|
T Consensus       238 ~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~q  317 (507)
T PLN03224        238 SCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQ  317 (507)
T ss_pred             hhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHH
Confidence            34666666543211   11234789999999 699888764210                    0123466788999999


Q ss_pred             HHHHHHHHHhcCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccc--cccccccCCccccCCCC--------
Q 022799           64 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY--ICSRYYRAPELIFGATE--------  133 (292)
Q Consensus        64 il~al~~LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~--~gt~~y~aPE~~~~~~~--------  133 (292)
                      ++.||.|||++ +|+||||||+||+++.++ .+||+|||++............  .+|+.|+|||.+.....        
T Consensus       318 l~~aL~~lH~~-~ivHrDLKp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~  395 (507)
T PLN03224        318 VLTGLRKLHRI-GIVHRDIKPENLLVTVDG-QVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPA  395 (507)
T ss_pred             HHHHHHHHHHC-CeecCCCchHhEEECCCC-cEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccchhh
Confidence            99999999987 999999999999999887 7999999999765433222222  34789999998753211        


Q ss_pred             -----------C--CchhHhhhhhHHHHHHHhCCC-CCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCC
Q 022799          134 -----------Y--TAAIDIWSAGCVLAELLLGQP-LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH  199 (292)
Q Consensus       134 -----------~--~~~~DvwslG~il~el~~g~~-pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  199 (292)
                                 +  ..+.|+||+||++++|++|.. ||.+.....   ...+.... ....|......  .+.++     
T Consensus       396 ~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~---~~~~~~~~-~~~~~r~~~~~--~~~~~-----  464 (507)
T PLN03224        396 MAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFN---TELRQYDN-DLNRWRMYKGQ--KYDFS-----  464 (507)
T ss_pred             hhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhh---hHHhhccc-hHHHHHhhccc--CCCcc-----
Confidence                       1  134799999999999999875 664322111   00110000 00001100000  00111     


Q ss_pred             CchhhhccCCChhHHHHHHHHhccCC---CCcccHHHHhcCCCccc
Q 022799          200 PWHKIFQKRMPPEAVDLVSRLLQYSP---NLRSTALEALIHPFFDE  242 (292)
Q Consensus       200 ~~~~~~~~~~~~~~~~li~~~l~~dp---~~R~t~~e~l~hp~~~~  242 (292)
                           .....++..+||+.+||..+|   .+|+|++|+|+||||..
T Consensus       465 -----~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        465 -----LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             -----cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence                 114578999999999999876   68999999999999963

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.97  E-value=1.1e-30  Score=243.76  Aligned_cols=185  Identities=31%  Similarity=0.463  Sum_probs=136.2

Q ss_pred             ceeEEEEeecccCCHHHHHHhhhhcCCCC--CHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEeCCCCcEEEeec
Q 022799           24 ELYLNLVLEYVPETVHRVIKHHYKMSQRM--PLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  101 (292)
Q Consensus        24 ~~~~~lv~e~~~g~L~~~l~~~~~~~~~~--~~~~~~~~~~qil~al~~LH~~~~i~H~dlkp~Nill~~~~~~ikl~Df  101 (292)
                      ...+||=||||+.++.+.+.+.    +.+  ....++.+++||++||.|+|+. |||||||||.||+++++. .|||+||
T Consensus       668 ~~~LYIQMEyCE~~ll~~iI~~----N~~~~~~d~~wrLFreIlEGLaYIH~~-giIHRDLKP~NIFLd~~~-~VKIGDF  741 (1351)
T KOG1035|consen  668 PLILYIQMEYCEKTLLRDIIRR----NHFNSQRDEAWRLFREILEGLAYIHDQ-GIIHRDLKPRNIFLDSRN-SVKIGDF  741 (1351)
T ss_pred             ceEEEEEHhhhhhhHHHHHHHh----cccchhhHHHHHHHHHHHHHHHHHHhC-ceeeccCCcceeEEcCCC-Ceeeccc
Confidence            3679999999996555544432    222  4678999999999999999998 999999999999999888 7999999


Q ss_pred             CCccccc-------------------cCCCcccccccccccCCccccCCC--CCCchhHhhhhhHHHHHHHhCCCCCCCC
Q 022799          102 GSAKVLV-------------------KGEPNISYICSRYYRAPELIFGAT--EYTAAIDIWSAGCVLAELLLGQPLFPGE  160 (292)
Q Consensus       102 g~a~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DvwslG~il~el~~g~~pf~~~  160 (292)
                      |+|....                   +....+..+||--|+|||++.+..  .|+.|+|+||||+||+||+.   ||...
T Consensus       742 GLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts  818 (1351)
T KOG1035|consen  742 GLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTS  818 (1351)
T ss_pred             ccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCch
Confidence            9998721                   011234578999999999997665  59999999999999999985   46433


Q ss_pred             CcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCCc
Q 022799          161 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  240 (292)
Q Consensus       161 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~~  240 (292)
                      .+..  . ++..+..+.               .|..      .-|..+--+.-..+|+.||..||++||||.|+|++.||
T Consensus       819 MERa--~-iL~~LR~g~---------------iP~~------~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~ll  874 (1351)
T KOG1035|consen  819 MERA--S-ILTNLRKGS---------------IPEP------ADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELL  874 (1351)
T ss_pred             HHHH--H-HHHhcccCC---------------CCCC------cccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCC
Confidence            2221  1 111111110               0100      11112233456889999999999999999999999998


Q ss_pred             c
Q 022799          241 D  241 (292)
Q Consensus       241 ~  241 (292)
                      -
T Consensus       875 p  875 (1351)
T KOG1035|consen  875 P  875 (1351)
T ss_pred             C
Confidence            6

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=6.1e-31  Score=233.43  Aligned_cols=201  Identities=22%  Similarity=0.335  Sum_probs=165.0

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |-+|+|||++++|++..+.      -+.||||++. |+|.+.+..  .....+.......|+.||+.|+.||.++ +.||
T Consensus       165 M~~L~H~hliRLyGvVl~q------p~mMV~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLesk-rlvH  235 (1039)
T KOG0199|consen  165 MLKLQHPHLIRLYGVVLDQ------PAMMVFELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESK-RLVH  235 (1039)
T ss_pred             HHhccCcceeEEeeeeccc------hhhHHhhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhh-hhhh
Confidence            5679999999999988431      2679999999 899988876  2356788999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccc----cccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC----SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQ  154 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~g----t~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~  154 (292)
                      |||...|+++-... .|||+|||+.+....++..+...+    .-.|+|||.+.-. .++.++|+|++||++|||++ |+
T Consensus       236 RDLAARNlllaspr-tVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~-kFShaSDvWmyGVTiWEMFtyGE  313 (1039)
T KOG0199|consen  236 RDLAARNLLLASPR-TVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHR-KFSHASDVWMYGVTIWEMFTYGE  313 (1039)
T ss_pred             hhhhhhhheecccc-eeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccc-cccccchhhhhhhhHHhhhccCC
Confidence            99999999998766 799999999998866665543322    3359999999654 59999999999999999998 88


Q ss_pred             CCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHH
Q 022799          155 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA  234 (292)
Q Consensus       155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~  234 (292)
                      .||.|-....++.+|-+....+                            -++.+|+++.++++.||..+|.+|||+..|
T Consensus       314 ePW~G~~g~qIL~~iD~~erLp----------------------------RPk~csedIY~imk~cWah~paDRptFsai  365 (1039)
T KOG0199|consen  314 EPWVGCRGIQILKNIDAGERLP----------------------------RPKYCSEDIYQIMKNCWAHNPADRPTFSAI  365 (1039)
T ss_pred             CCCCCCCHHHHHHhccccccCC----------------------------CCCCChHHHHHHHHHhccCCccccccHHHH
Confidence            9999999888877765321111                            124689999999999999999999999988


Q ss_pred             hcCCCc
Q 022799          235 LIHPFF  240 (292)
Q Consensus       235 l~hp~~  240 (292)
                      .+.-+.
T Consensus       366 r~~~~l  371 (1039)
T KOG0199|consen  366 REDLVL  371 (1039)
T ss_pred             HHhHHH
Confidence            654333

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.97  E-value=3.5e-30  Score=203.90  Aligned_cols=167  Identities=22%  Similarity=0.222  Sum_probs=126.2

Q ss_pred             CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCCCccc
Q 022799           36 ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS  115 (292)
Q Consensus        36 g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~  115 (292)
                      |+|.+++..+   +..+++..++.++.||+.||.|||++ +      ||+||+++.++ .+++  ||.+......    .
T Consensus         1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~-~------kp~Nil~~~~~-~~~~--fG~~~~~~~~----~   63 (176)
T smart00750        1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQ-A------KSGNILLTWDG-LLKL--DGSVAFKTPE----Q   63 (176)
T ss_pred             CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhc-C------CcccEeEcCcc-ceee--ccceEeeccc----c
Confidence            6788888753   45699999999999999999999987 6      99999999888 6888  9998765332    2


Q ss_pred             ccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCCHHHHhhcCCCCccccCC
Q 022799          116 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQ-LVEIIKVLGTPTREEIKCMNPNYTEFKFP  194 (292)
Q Consensus       116 ~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  194 (292)
                      ..||+.|+|||++.+. .++.++||||+||++|||++|..||........ +..+........                +
T Consensus        64 ~~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------------~  126 (176)
T smart00750       64 SRVDPYFMAPEVIQGQ-SYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADD----------------P  126 (176)
T ss_pred             CCCcccccChHHhcCC-CCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCC----------------c
Confidence            3688999999999765 489999999999999999999999976543322 222222110000                0


Q ss_pred             CCCCCCchhhhccCCCh--hHHHHHHHHhccCCCCcccHHHHhcCCCccc
Q 022799          195 QIKAHPWHKIFQKRMPP--EAVDLVSRLLQYSPNLRSTALEALIHPFFDE  242 (292)
Q Consensus       195 ~~~~~~~~~~~~~~~~~--~~~~li~~~l~~dp~~R~t~~e~l~hp~~~~  242 (292)
                      .  ...    .+..++.  .++++|.+||..||.+||++.+++.|+|+..
T Consensus       127 ~--~~~----~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      127 R--DRS----NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             c--ccc----cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence            0  000    0012333  6999999999999999999999999998763

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.97  E-value=4.7e-30  Score=252.11  Aligned_cols=205  Identities=23%  Similarity=0.324  Sum_probs=143.0

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hcCC
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH---NTIG   76 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH---~~~~   76 (292)
                      |++++|||||++++++..     ....++||||++ |+|.+++.       .+++..+..++.||+.||+|||   +. +
T Consensus       737 l~~l~HpnIv~~~~~~~~-----~~~~~lv~Ey~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~-~  803 (968)
T PLN00113        737 MGKLQHPNIVKLIGLCRS-----EKGAYLIHEYIEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSP-A  803 (968)
T ss_pred             HhhCCCCCcceEEEEEEc-----CCCCEEEEeCCCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCC-C
Confidence            467899999999999843     334889999998 79988885       2788889999999999999999   55 9


Q ss_pred             ccccCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCC
Q 022799           77 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPL  156 (292)
Q Consensus        77 i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~p  156 (292)
                      |+||||||+||+++.++ ..++. ||.......   .....+|+.|+|||.+.+. .++.++||||+||++|||++|+.|
T Consensus       804 iiH~dlkp~Nil~~~~~-~~~~~-~~~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~el~tg~~p  877 (968)
T PLN00113        804 VVVGNLSPEKIIIDGKD-EPHLR-LSLPGLLCT---DTKCFISSAYVAPETRETK-DITEKSDIYGFGLILIELLTGKSP  877 (968)
T ss_pred             eecCCCCHHhEEECCCC-ceEEE-ecccccccc---CCCccccccccCcccccCC-CCCcccchhhHHHHHHHHHhCCCC
Confidence            99999999999998876 45654 555433211   1234678999999998654 489999999999999999999999


Q ss_pred             CCCCCcH-HHHHHHHHH-hCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHH
Q 022799          157 FPGESGV-DQLVEIIKV-LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA  234 (292)
Q Consensus       157 f~~~~~~-~~~~~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~  234 (292)
                      |...... ....+..+. ........          +.-+.....   ...+.....++.+++.+||+.||++|||+.++
T Consensus       878 ~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~---~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~ev  944 (968)
T PLN00113        878 ADAEFGVHGSIVEWARYCYSDCHLDM----------WIDPSIRGD---VSVNQNEIVEVMNLALHCTATDPTARPCANDV  944 (968)
T ss_pred             CCcccCCCCcHHHHHHHhcCccchhh----------eeCccccCC---CCccHHHHHHHHHHHHhhCcCCchhCcCHHHH
Confidence            8532211 111111111 00000000          000000000   00001123467889999999999999999999


Q ss_pred             hcC
Q 022799          235 LIH  237 (292)
Q Consensus       235 l~h  237 (292)
                      ++.
T Consensus       945 l~~  947 (968)
T PLN00113        945 LKT  947 (968)
T ss_pred             HHH
Confidence            854

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=8e-29  Score=230.00  Aligned_cols=197  Identities=23%  Similarity=0.391  Sum_probs=153.7

Q ss_pred             CCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhh---hc-------C--CCCCHHHHHHHHHHHHHHHHH
Q 022799            4 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHY---KM-------S--QRMPLIYVKLYFYQICRALAY   70 (292)
Q Consensus         4 l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~---~~-------~--~~~~~~~~~~~~~qil~al~~   70 (292)
                      .+||||+.+++++..     ...+++|+||+. |+|.++++..+   ..       .  ..++......+++||+.|++|
T Consensus       359 g~H~niv~llG~~t~-----~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~  433 (609)
T KOG0200|consen  359 GKHPNIVNLLGACTQ-----DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEY  433 (609)
T ss_pred             cCCcchhhheeeecc-----CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHH
Confidence            369999999998843     445889999999 99999998765   11       1  138889999999999999999


Q ss_pred             HHhcCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCCCccc--ccc--cccccCCccccCCCCCCchhHhhhhhHH
Q 022799           71 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS--YIC--SRYYRAPELIFGATEYTAAIDIWSAGCV  146 (292)
Q Consensus        71 LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~--~~g--t~~y~aPE~~~~~~~~~~~~DvwslG~i  146 (292)
                      |+++ .++||||-..|||+..+. .+||+|||+|+..........  ..+  ...|||||.+.. ..|+.++||||+|++
T Consensus       434 L~~~-~~vHRDLAaRNVLi~~~~-~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~  510 (609)
T KOG0200|consen  434 LASV-PCVHRDLAARNVLITKNK-VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGIL  510 (609)
T ss_pred             HhhC-CccchhhhhhhEEecCCC-EEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHH
Confidence            9998 999999999999999887 799999999986544332211  112  334999999976 569999999999999


Q ss_pred             HHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCC
Q 022799          147 LAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSP  225 (292)
Q Consensus       147 l~el~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp  225 (292)
                      +||+.+ |..||++-.....+.+.++.....               .            -|..+++++.++++.||..+|
T Consensus       511 L~EifsLG~~PYp~~~~~~~l~~~l~~G~r~---------------~------------~P~~c~~eiY~iM~~CW~~~p  563 (609)
T KOG0200|consen  511 LWEIFTLGGTPYPGIPPTEELLEFLKEGNRM---------------E------------QPEHCSDEIYDLMKSCWNADP  563 (609)
T ss_pred             HHHHhhCCCCCCCCCCcHHHHHHHHhcCCCC---------------C------------CCCCCCHHHHHHHHHHhCCCc
Confidence            999998 889998744222222222211110               1            124579999999999999999


Q ss_pred             CCcccHHHHh
Q 022799          226 NLRSTALEAL  235 (292)
Q Consensus       226 ~~R~t~~e~l  235 (292)
                      .+||+..++.
T Consensus       564 ~~RP~F~~~~  573 (609)
T KOG0200|consen  564 EDRPTFSECV  573 (609)
T ss_pred             ccCCCHHHHH
Confidence            9999999887

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=1e-28  Score=210.88  Aligned_cols=218  Identities=25%  Similarity=0.288  Sum_probs=157.9

Q ss_pred             CCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh--------
Q 022799            3 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN--------   73 (292)
Q Consensus         3 ~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~--------   73 (292)
                      .++|+||++++..-. ..+.+..-++||++|.+ |+|.+++..     ..+++.....++..++.||+|||+        
T Consensus       260 ~m~h~nIl~Fi~~ek-r~t~~~~eywLVt~fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~  333 (534)
T KOG3653|consen  260 GMKHENILQFIGAEK-RGTADRMEYWLVTEFHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHH  333 (534)
T ss_pred             CccchhHHHhhchhc-cCCccccceeEEeeeccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCC
Confidence            579999999987532 22223446899999999 999999985     578999999999999999999997        


Q ss_pred             cCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCCCc---ccccccccccCCccccCCCCCC-----chhHhhhhhH
Q 022799           74 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYT-----AAIDIWSAGC  145 (292)
Q Consensus        74 ~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~-----~~~DvwslG~  145 (292)
                      +..|+|||||..|||+.+|+ +..|+|||+|..+..+...   ...+||.+|||||++.|..++.     .+.||||+|.
T Consensus       334 Kp~IaHRDlkSkNVLvK~Dl-TccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgL  412 (534)
T KOG3653|consen  334 KPPIAHRDLKSKNVLVKNDL-TCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGL  412 (534)
T ss_pred             CCccccccccccceEEccCC-cEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHH
Confidence            23699999999999999999 7999999999987654332   3468999999999997765554     4799999999


Q ss_pred             HHHHHHhCCCCCC-CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccC
Q 022799          146 VLAELLLGQPLFP-GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYS  224 (292)
Q Consensus       146 il~el~~g~~pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  224 (292)
                      ++|||+++..-+. +..+.-++.--.+....|+.+.+...--.  +..+|.. ...|...   .....+++.+..||..|
T Consensus       413 VLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~--kK~RP~~-p~~W~~h---~~~~~l~et~EeCWDhD  486 (534)
T KOG3653|consen  413 VLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVR--KKQRPKI-PDAWRKH---AGMAVLCETIEECWDHD  486 (534)
T ss_pred             HHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHh--hccCCCC-hhhhhcC---ccHHHHHHHHHHHcCCc
Confidence            9999999775543 33332222222344445555554432100  0011111 1112221   24567899999999999


Q ss_pred             CCCcccHHH
Q 022799          225 PNLRSTALE  233 (292)
Q Consensus       225 p~~R~t~~e  233 (292)
                      |+.|.||.=
T Consensus       487 aeARLTA~C  495 (534)
T KOG3653|consen  487 AEARLTAGC  495 (534)
T ss_pred             hhhhhhhHH
Confidence            999999753

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.96  E-value=1.8e-29  Score=223.08  Aligned_cols=207  Identities=26%  Similarity=0.387  Sum_probs=167.1

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++|||||.+++.|.-.+.     +++.||||+ |+|.++-.    ..+.+++.++..+.+..+.|+.|||+. |-+|
T Consensus        66 ~~dc~h~nivay~gsylr~dk-----lwicMEycgggslQdiy~----~TgplselqiayvcRetl~gl~ylhs~-gk~h  135 (829)
T KOG0576|consen   66 LRDCRHPNIVAYFGSYLRRDK-----LWICMEYCGGGSLQDIYH----VTGPLSELQIAYVCRETLQGLKYLHSQ-GKIH  135 (829)
T ss_pred             eecCCCcChHHHHhhhhhhcC-----cEEEEEecCCCcccceee----ecccchhHHHHHHHhhhhccchhhhcC-Cccc
Confidence            467899999999999854433     899999999 56655433    268899999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccC-CCcccccccccccCCcccc--CCCCCCchhHhhhhhHHHHHHHhCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNISYICSRYYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPL  156 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DvwslG~il~el~~g~~p  156 (292)
                      ||||-.||+++..| .+|+.|||.+..+... .....+.||++|||||+..  ....|...+|+|++|+...|+..-++|
T Consensus       136 RdiKGanilltd~g-DvklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpp  214 (829)
T KOG0576|consen  136 RDIKGANILLTDEG-DVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPP  214 (829)
T ss_pred             ccccccceeecccC-ceeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCc
Confidence            99999999999888 7999999998765332 2345678999999999862  223589999999999999999988888


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      .....+...+..+.+....|+.-                 .       -+..-++.+-+|++.+|.++|.+|||++.+|.
T Consensus       215 lfdlhpmr~l~LmTkS~~qpp~l-----------------k-------Dk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  215 LFDLHPMRALFLMTKSGFQPPTL-----------------K-------DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             ccccchHHHHHHhhccCCCCCcc-----------------c-------CCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            87777766666655543333211                 0       01345778999999999999999999999999


Q ss_pred             CCCccc
Q 022799          237 HPFFDE  242 (292)
Q Consensus       237 hp~~~~  242 (292)
                      |||...
T Consensus       271 h~fvs~  276 (829)
T KOG0576|consen  271 HPFVSQ  276 (829)
T ss_pred             ceeecc
Confidence            999864

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.95  E-value=7.5e-29  Score=216.09  Aligned_cols=143  Identities=30%  Similarity=0.482  Sum_probs=128.9

Q ss_pred             CCCCeeeeceeeeccCCCCceeEEEEeeccc-C-CHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCC
Q 022799            5 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-E-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDI   82 (292)
Q Consensus         5 ~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g-~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dl   82 (292)
                      .|+||+|++++|     +++.++||+||-.+ | +|.++|..    ...++|.+++.+++||+.|+++||+. ||+||||
T Consensus       627 sH~NIlKlLdfF-----Eddd~yyl~te~hg~gIDLFd~IE~----kp~m~E~eAk~IFkQV~agi~hlh~~-~ivhrdi  696 (772)
T KOG1152|consen  627 SHENILKLLDFF-----EDDDYYYLETEVHGEGIDLFDFIEF----KPRMDEPEAKLIFKQVVAGIKHLHDQ-GIVHRDI  696 (772)
T ss_pred             Cccchhhhhhee-----ecCCeeEEEecCCCCCcchhhhhhc----cCccchHHHHHHHHHHHhcccccccc-Cceeccc
Confidence            399999999999     77788999999988 5 88999886    47799999999999999999999998 9999999


Q ss_pred             CCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           83 KPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        83 kp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      |-+|+.++++| .+||+|||.|....++ +...++||..|.|||++.|.+..+..-|||++|+++|.++....||.+
T Consensus       697 kdenvivd~~g-~~klidfgsaa~~ksg-pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  697 KDENVIVDSNG-FVKLIDFGSAAYTKSG-PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             ccccEEEecCC-eEEEeeccchhhhcCC-CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            99999999999 6999999999766443 456789999999999998877778899999999999999999999864

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.95  E-value=5.1e-28  Score=218.27  Aligned_cols=196  Identities=24%  Similarity=0.340  Sum_probs=157.8

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |..|+|||+++++++.....      +.||++|++ |+|.++++.+   ...+.......|.+||++|+.|||++ +++|
T Consensus       752 masldHpnl~RLLgvc~~s~------~qlvtq~mP~G~LlDyvr~h---r~~igsq~lLnw~~QIAkgM~YLe~q-rlVH  821 (1177)
T KOG1025|consen  752 MASLDHPNLLRLLGVCMLST------LQLVTQLMPLGCLLDYVREH---RDNIGSQDLLNWCYQIAKGMKYLEEQ-RLVH  821 (1177)
T ss_pred             HhcCCCchHHHHhhhcccch------HHHHHHhcccchHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhc-chhh
Confidence            67899999999999884322      679999999 8999999875   45688889999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccc---cccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC---SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQP  155 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~g---t~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~  155 (292)
                      |||-..|||+.+-. .+||+|||+++.....+......+   .+.|||=|.+.- ..|+.++||||+||.+||++| |..
T Consensus       822 rdLaaRNVLVksP~-hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~-~~~thqSDVWsfGVtiWElmTFGa~  899 (1177)
T KOG1025|consen  822 RDLAARNVLVKSPN-HVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELMTFGAK  899 (1177)
T ss_pred             hhhhhhheeecCCC-eEEEEecchhhccCcccccccccccccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCC
Confidence            99999999999877 599999999998766554433322   456899888855 459999999999999999997 999


Q ss_pred             CCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHh
Q 022799          156 LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL  235 (292)
Q Consensus       156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l  235 (292)
                      |+.+....++-.. ++.-.+                 ++          =|+..+-++.-++.+||..|+..||+++++-
T Consensus       900 Py~gi~~~eI~dl-le~geR-----------------Ls----------qPpiCtiDVy~~mvkCwmid~~~rp~fkel~  951 (1177)
T KOG1025|consen  900 PYDGIPAEEIPDL-LEKGER-----------------LS----------QPPICTIDVYMVMVKCWMIDADSRPTFKELA  951 (1177)
T ss_pred             ccCCCCHHHhhHH-Hhcccc-----------------CC----------CCCCccHHHHHHHHHHhccCcccCccHHHHH
Confidence            9987765443222 221100                 11          1246788999999999999999999999875


Q ss_pred             c
Q 022799          236 I  236 (292)
Q Consensus       236 ~  236 (292)
                      .
T Consensus       952 ~  952 (1177)
T KOG1025|consen  952 E  952 (1177)
T ss_pred             H
Confidence            3

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.4e-27  Score=201.16  Aligned_cols=209  Identities=22%  Similarity=0.241  Sum_probs=149.1

Q ss_pred             CCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-------c
Q 022799            3 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN-------T   74 (292)
Q Consensus         3 ~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~-------~   74 (292)
                      .|+|+||+.+++.=.. ++..-..++||++|.+ |+|.+++.+     ..++...+.+++..+++||.+||.       +
T Consensus       261 mLRHENILgFIaaD~~-~~gs~TQLwLvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgK  334 (513)
T KOG2052|consen  261 MLRHENILGFIAADNK-DNGSWTQLWLVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGK  334 (513)
T ss_pred             Hhccchhhhhhhcccc-CCCceEEEEEeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCC
Confidence            4799999999875322 2244567999999999 999999985     678999999999999999999995       3


Q ss_pred             CCccccCCCCCcEEEeCCCCcEEEeecCCccccccCC-----CcccccccccccCCccccCCCCC-----CchhHhhhhh
Q 022799           75 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-----PNISYICSRYYRAPELIFGATEY-----TAAIDIWSAG  144 (292)
Q Consensus        75 ~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-----~~~~DvwslG  144 (292)
                      ..|.|||||..|||+.+++ .+.|+|+|+|....+..     ..+..+||.+|||||++...-..     -..+||||+|
T Consensus       335 PaIAHRDlKSKNILVKkn~-~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafg  413 (513)
T KOG2052|consen  335 PAIAHRDLKSKNILVKKNG-TCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFG  413 (513)
T ss_pred             chhhccccccccEEEccCC-cEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHH
Confidence            3699999999999999999 79999999998765442     23567999999999999654221     1358999999


Q ss_pred             HHHHHHHhC----------CCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHH
Q 022799          145 CVLAELLLG----------QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAV  214 (292)
Q Consensus       145 ~il~el~~g----------~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  214 (292)
                      .++||++.+          .+||.+-.+.+           |+-+++.   .......+.......|++   ...-..+.
T Consensus       414 LVlWEiarRc~~ggi~eey~~Pyyd~Vp~D-----------Ps~eeMr---kVVCv~~~RP~ipnrW~s---~~~l~~m~  476 (513)
T KOG2052|consen  414 LVLWEIARRCESGGIVEEYQLPYYDVVPSD-----------PSFEEMR---KVVCVQKLRPNIPNRWKS---DPALRVMA  476 (513)
T ss_pred             HHHHHHHHHhhcCCEehhhcCCcccCCCCC-----------CCHHHHh---cceeecccCCCCCccccc---CHHHHHHH
Confidence            999999853          35665432211           1111111   111111111112222322   11223567


Q ss_pred             HHHHHHhccCCCCcccHHHHh
Q 022799          215 DLVSRLLQYSPNLRSTALEAL  235 (292)
Q Consensus       215 ~li~~~l~~dp~~R~t~~e~l  235 (292)
                      .+|+.||..||.-|.||--+.
T Consensus       477 klMkeCW~~Np~aRltALriK  497 (513)
T KOG2052|consen  477 KLMKECWYANPAARLTALRIK  497 (513)
T ss_pred             HHHHHhhcCCchhhhHHHHHH
Confidence            889999999999999987665

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=2.7e-28  Score=224.17  Aligned_cols=214  Identities=25%  Similarity=0.396  Sum_probs=163.6

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccC
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRD   81 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~d   81 (292)
                      ..|.||||+..+..+.....     ..-+||||+++|...+..    ...+....+..++.|++.|++|+|+. ||.|||
T Consensus       376 ~~l~h~~~~e~l~~~~~~~~-----~~~~mE~~~~Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~~-Giahrd  445 (601)
T KOG0590|consen  376 SSLSHPNIIETLDIVQEIDG-----ILQSMEYCPYDLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHSM-GLAHRD  445 (601)
T ss_pred             ccccCCchhhhHHHHhhccc-----chhhhhcccHHHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHhc-Cceecc
Confidence            35799999888877644332     333499999988888875    24688889999999999999999987 999999


Q ss_pred             CCCCcEEEeCCCCcEEEeecCCccccccCCC-----cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCC
Q 022799           82 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPL  156 (292)
Q Consensus        82 lkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~p  156 (292)
                      +|++|+++..++ .+||+|||.+......-.     ....+|+..|+|||++.+........|+||.|+++..|++|+.|
T Consensus       446 lK~enll~~~~g-~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~  524 (601)
T KOG0590|consen  446 LKLENLLVTENG-ILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFP  524 (601)
T ss_pred             CccccEEEecCC-ceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCc
Confidence            999999999988 899999999876533222     24567899999999998877667789999999999999999999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      |......+....-.                .+...    .....-...+...++...+.+|.+||+.||.+|.|+++|++
T Consensus       525 Wk~a~~~~~~~~~~----------------~~~~~----~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  525 WKVAKKSDNSFKTN----------------NYSDQ----RNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             cccccccccchhhh----------------ccccc----cccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            97554333221000                00000    00000011122467889999999999999999999999999


Q ss_pred             CCCccccCCC
Q 022799          237 HPFFDELRDP  246 (292)
Q Consensus       237 hp~~~~~~~~  246 (292)
                      .+||+.+...
T Consensus       585 d~W~~~i~~c  594 (601)
T KOG0590|consen  585 DEWIRSIECC  594 (601)
T ss_pred             ChHhhhcceE
Confidence            9999987643

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.6e-27  Score=190.70  Aligned_cols=203  Identities=23%  Similarity=0.328  Sum_probs=147.0

Q ss_pred             CCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCC
Q 022799            5 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIK   83 (292)
Q Consensus         5 ~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlk   83 (292)
                      .|.||+.-|++-+++.+    +++.++||++ |+|..-+..     ..+.|...+.++.|+++|+.|+|++ ++||||||
T Consensus        79 ~H~hIi~tY~vaFqt~d----~YvF~qE~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHsk-nlVHRdlK  148 (378)
T KOG1345|consen   79 PHQHIIDTYEVAFQTSD----AYVFVQEFAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSK-NLVHRDLK  148 (378)
T ss_pred             cchhhhHHHHHHhhcCc----eEEEeeccCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhcc-chhhcccc
Confidence            58899999887655443    6789999999 898877653     5688899999999999999999999 99999999


Q ss_pred             CCcEEE-eCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCC----CCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           84 PQNLLV-NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT----EYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        84 p~Nill-~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      .+|||+ +.|..+|||||||.++..+..  ....-.+..|.+||......    ...+.+|+|.+|+++|.++||..||+
T Consensus       149 ~eNiLif~~df~rvKlcDFG~t~k~g~t--V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQ  226 (378)
T KOG1345|consen  149 AENILIFDADFYRVKLCDFGLTRKVGTT--VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQ  226 (378)
T ss_pred             cceEEEecCCccEEEeeecccccccCce--ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcch
Confidence            999998 555558999999998765322  11222356699999874321    24678999999999999999999997


Q ss_pred             CCCcHHH-HHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCc---ccHHHH
Q 022799          159 GESGVDQ-LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR---STALEA  234 (292)
Q Consensus       159 ~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R---~t~~e~  234 (292)
                      ...-.+. +.+.++-.+...        +             .....| ..+++.+..+.++-|..++++|   -++...
T Consensus       227 ka~~~d~~Y~~~~~w~~rk~--------~-------------~~P~~F-~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~  284 (378)
T KOG1345|consen  227 KASIMDKPYWEWEQWLKRKN--------P-------------ALPKKF-NPFSEKALRLFKKSLTPRFKDRCKIWTAKKM  284 (378)
T ss_pred             hhhccCchHHHHHHHhcccC--------c-------------cCchhh-cccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence            4432221 122222111110        0             011112 3478999999999999999999   455555


Q ss_pred             hcCCCcc
Q 022799          235 LIHPFFD  241 (292)
Q Consensus       235 l~hp~~~  241 (292)
                      ...-|..
T Consensus       285 rk~~w~E  291 (378)
T KOG1345|consen  285 RKCLWKE  291 (378)
T ss_pred             HHHHHHH
Confidence            5555654

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.93  E-value=2.5e-25  Score=179.77  Aligned_cols=168  Identities=36%  Similarity=0.620  Sum_probs=140.7

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++|++|+++++++..     ....+++|||++ ++|.+++...   ...++...+..++.+++.++.+||+. |++|
T Consensus        45 ~~~l~~~~i~~~~~~~~~-----~~~~~~~~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~-~~~H  115 (215)
T cd00180          45 LKKLNHPNIVKLYGVFED-----ENHLYLVMEYCEGGSLKDLLKEN---EGKLSEDEILRILLQILEGLEYLHSN-GIIH  115 (215)
T ss_pred             HHhcCCCCeeeEeeeeec-----CCeEEEEEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC-Ceec
Confidence            356889999999998843     345889999999 7998888753   14688999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeC-CCCcEEEeecCCccccccCC-CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCC
Q 022799           80 RDIKPQNLLVNP-HTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF  157 (292)
Q Consensus        80 ~dlkp~Nill~~-~~~~ikl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf  157 (292)
                      +||+|.||+++. ++ .++|+|||.+....... ......+...|++||.......++.++|+|++|++++++       
T Consensus       116 ~dl~~~ni~~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------  187 (215)
T cd00180         116 RDLKPENILLDSDNG-KVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------  187 (215)
T ss_pred             cCCCHhhEEEeCCCC-cEEEecCCceEEccCCcchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------
Confidence            999999999998 56 79999999987653332 123345678899999986543578999999999999999       


Q ss_pred             CCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          158 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                                                                           ..+.+++.+|+..||++||++.+++++
T Consensus       188 -----------------------------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 -----------------------------------------------------PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             -----------------------------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence                                                                 156899999999999999999999987


Q ss_pred             C
Q 022799          238 P  238 (292)
Q Consensus       238 p  238 (292)
                      +
T Consensus       215 ~  215 (215)
T cd00180         215 L  215 (215)
T ss_pred             C
Confidence            5

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.93  E-value=5.5e-25  Score=184.32  Aligned_cols=199  Identities=20%  Similarity=0.254  Sum_probs=153.5

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhc----CCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKM----SQRMPLIYVKLYFYQICRALAYIHNTIG   76 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~----~~~~~~~~~~~~~~qil~al~~LH~~~~   76 (292)
                      ..+.|||+..+.++..+.    ....++++.+.+ |+|..++...+..    .+.++..+...++.|++.|++|||++ |
T Consensus       342 y~~sH~nll~V~~V~ie~----~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~-~  416 (563)
T KOG1024|consen  342 YGASHPNLLSVLGVSIED----YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH-G  416 (563)
T ss_pred             hcCcCCCccceeEEEeec----cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc-C
Confidence            346899999999877542    224678889999 9999998743321    23466677788999999999999987 9


Q ss_pred             ccccCCCCCcEEEeCCCCcEEEeecCCccccccCCCcc---cccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-
Q 022799           77 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI---SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-  152 (292)
Q Consensus        77 i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-  152 (292)
                      ++|.||...|.+++..- ++||+|=.+++.....+...   .......||+||.+... .|+.++|+||||+++|||+| 
T Consensus       417 ViHkDiAaRNCvIdd~L-qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~-~yssasDvWsfGVllWELmtl  494 (563)
T KOG1024|consen  417 VIHKDIAARNCVIDDQL-QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNS-HYSSASDVWSFGVLLWELMTL  494 (563)
T ss_pred             cccchhhhhcceehhhe-eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhh-hhcchhhhHHHHHHHHHHHhc
Confidence            99999999999999877 89999999888765443221   11225569999999654 59999999999999999998 


Q ss_pred             CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHH
Q 022799          153 GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAL  232 (292)
Q Consensus       153 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~  232 (292)
                      |+.|+..-++.+...-+.+.                  +...+          |-++|.++..++..||..+|++||+.+
T Consensus       495 g~~PyaeIDPfEm~~ylkdG------------------yRlaQ----------P~NCPDeLf~vMacCWallpeeRPsf~  546 (563)
T KOG1024|consen  495 GKLPYAEIDPFEMEHYLKDG------------------YRLAQ----------PFNCPDELFTVMACCWALLPEERPSFS  546 (563)
T ss_pred             CCCCccccCHHHHHHHHhcc------------------ceecC----------CCCCcHHHHHHHHHHHhcCcccCCCHH
Confidence            88999776665543333221                  11111          136899999999999999999999999


Q ss_pred             HHh
Q 022799          233 EAL  235 (292)
Q Consensus       233 e~l  235 (292)
                      ++.
T Consensus       547 Qlv  549 (563)
T KOG1024|consen  547 QLV  549 (563)
T ss_pred             HHH
Confidence            986

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=2e-24  Score=181.57  Aligned_cols=200  Identities=24%  Similarity=0.359  Sum_probs=146.0

Q ss_pred             CCCCCeeeeceeeeccC----------------------CCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHH
Q 022799            4 LDHPNVVSLKHCFFSTT----------------------EKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF   61 (292)
Q Consensus         4 l~HpnIv~~~~~~~~~~----------------------~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~   61 (292)
                      -+|||||++...|.+..                      -.....+|+||..++.+|.+++..     ...+....+.++
T Consensus       273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~-----~~~s~r~~~~~l  347 (598)
T KOG4158|consen  273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWT-----RHRSYRTGRVIL  347 (598)
T ss_pred             CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhc-----CCCchHHHHHHH
Confidence            47999999998874322                      123557899999999999999874     556778889999


Q ss_pred             HHHHHHHHHHHhcCCccccCCCCCcEEEeC--CC-CcEEEeecCCccccccCC-------CcccccccccccCCccccCC
Q 022799           62 YQICRALAYIHNTIGVCHRDIKPQNLLVNP--HT-HQLKLCDFGSAKVLVKGE-------PNISYICSRYYRAPELIFGA  131 (292)
Q Consensus        62 ~qil~al~~LH~~~~i~H~dlkp~Nill~~--~~-~~ikl~Dfg~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~  131 (292)
                      .|+++|+.|||.+ ||.|||+|.+|||+.-  |+ ..++++|||.+-......       ......|.-..||||+....
T Consensus       348 aQlLEav~hL~~h-gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~  426 (598)
T KOG4158|consen  348 AQLLEAVTHLHKH-GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV  426 (598)
T ss_pred             HHHHHHHHHHHHc-cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence            9999999999987 9999999999999843  22 268999999875432211       11223456678999998543


Q ss_pred             CC-----CCchhHhhhhhHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhc
Q 022799          132 TE-----YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQ  206 (292)
Q Consensus       132 ~~-----~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  206 (292)
                      +.     .-.++|.|+.|.+.||+++...||.+......-.+                  .|.+-..|         ..+
T Consensus       427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r------------------~Yqe~qLP---------alp  479 (598)
T KOG4158|consen  427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTR------------------TYQESQLP---------ALP  479 (598)
T ss_pred             CCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechh------------------hhhhhhCC---------CCc
Confidence            32     12479999999999999999999987443221111                  11111111         134


Q ss_pred             cCCChhHHHHHHHHhccCCCCcccH---HHHhc
Q 022799          207 KRMPPEAVDLVSRLLQYSPNLRSTA---LEALI  236 (292)
Q Consensus       207 ~~~~~~~~~li~~~l~~dp~~R~t~---~e~l~  236 (292)
                      ..+++.+++++..+|+.||++|+++   ..+++
T Consensus       480 ~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  480 SRVPPVARQLVFDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             ccCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence            5789999999999999999999984   45554

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.92  E-value=2.8e-24  Score=176.03  Aligned_cols=156  Identities=35%  Similarity=0.592  Sum_probs=127.5

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeecccC-CHHHHHHhhhhcCCC-CCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQR-MPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~-~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      +.++|+||+++++++.     .....++++||+++ +|.+.+...    .. +++..+..++.|++.++.+||++ |++|
T Consensus        52 ~~~~~~~i~~~~~~~~-----~~~~~~~v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h  121 (225)
T smart00221       52 KKLKHPNIVKLYGVFE-----DPEPLYLVMEYCEGGDLFDYLRKK----GGKLSEEEARFYLRQILEALEYLHSL-GIVH  121 (225)
T ss_pred             HhCCCCChhhheeeee-----cCCceEEEEeccCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhC-Ceec
Confidence            4578999999999873     33458899999995 998888753    23 78899999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCC--CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF  157 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf  157 (292)
                      +|++|.||+++.++ .++|+|||.+.......  ......++..|++||...+...++.++|+|++|+++++|++|+.||
T Consensus       122 ~di~~~ni~v~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf  200 (225)
T smart00221      122 RDLKPENILLGMDG-LVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPF  200 (225)
T ss_pred             CCCCHHHEEEcCCC-CEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCc
Confidence            99999999999877 79999999988764432  2344567888999999843345788999999999999999999999


Q ss_pred             CC-CCcHHHHHH
Q 022799          158 PG-ESGVDQLVE  168 (292)
Q Consensus       158 ~~-~~~~~~~~~  168 (292)
                      .+ .+....+.+
T Consensus       201 ~~~~~~~~~~~~  212 (225)
T smart00221      201 SGEGEFTSLLSD  212 (225)
T ss_pred             cccchhHHHHHH
Confidence            77 444433333

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.91  E-value=1.1e-24  Score=192.60  Aligned_cols=192  Identities=29%  Similarity=0.413  Sum_probs=159.0

Q ss_pred             CCCCeeeeceeeeccCCCCceeEEEEeecccC-CHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCC
Q 022799            5 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIK   83 (292)
Q Consensus         5 ~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlk   83 (292)
                      .||.+|++...|.+     +...++++++..| .+..-+.    ....+.+..++.+...++.|++++|+. ||+|||+|
T Consensus        55 ~~~f~v~lhyafqt-----~~kl~l~ld~~rgg~lft~l~----~~~~f~~~~~~~~~aelaLald~lh~l-~iiyrd~k  124 (612)
T KOG0603|consen   55 NTPFLVKLHYAFQT-----DGKLYLILDFLRGGDLFTRLS----KEVMFDELDVAFYLAELALALDHLHKL-GIAYRDYK  124 (612)
T ss_pred             CCCceeeeeeeecc-----ccchhHhhhhcccchhhhccc----cCCchHHHHHHHHHHHHHHHHhhcchh-HHHHhccc
Confidence            49999999998843     4448899999985 6544443    256688889999999999999999976 99999999


Q ss_pred             CCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCCCcH
Q 022799           84 PQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV  163 (292)
Q Consensus        84 p~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~  163 (292)
                      ++||+++.+| .+++.|||.++.....+..   +||..|||||++.   .....+|+||+|+++++|+||..||.+    
T Consensus       125 ~enilld~~G-hi~~tdfglske~v~~~~~---cgt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----  193 (612)
T KOG0603|consen  125 LENVLLLLEG-HIKLTDFGLSKEAVKEKIA---CGTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----  193 (612)
T ss_pred             ccceeecccC-ccccCCchhhhHhHhhhhc---ccchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----
Confidence            9999999999 5999999999876554433   8999999999995   367899999999999999999999987    


Q ss_pred             HHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCccc-----HHHHhcCC
Q 022799          164 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----ALEALIHP  238 (292)
Q Consensus       164 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t-----~~e~l~hp  238 (292)
                      +....|.+.--                             ..|..++..+++++..++..+|.+|..     +.++++|+
T Consensus       194 ~~~~~Il~~~~-----------------------------~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~  244 (612)
T KOG0603|consen  194 DTMKRILKAEL-----------------------------EMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHE  244 (612)
T ss_pred             HHHHHHhhhcc-----------------------------CCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccc
Confidence            55555555210                             122457889999999999999999975     57999999


Q ss_pred             CccccCCC
Q 022799          239 FFDELRDP  246 (292)
Q Consensus       239 ~~~~~~~~  246 (292)
                      ||+.+++.
T Consensus       245 f~~~i~~~  252 (612)
T KOG0603|consen  245 FFQSIDWN  252 (612)
T ss_pred             hheeeeHh
Confidence            99998865

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.87  E-value=5e-21  Score=164.79  Aligned_cols=216  Identities=35%  Similarity=0.525  Sum_probs=159.5

Q ss_pred             CCCCCC-CeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            2 RLLDHP-NVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         2 ~~l~Hp-nIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      +.+.|+ +|+++.+++     ......+++++++. +++.+.+...... ..+....+..++.|++.++.|+|+. |++|
T Consensus        52 ~~~~~~~~i~~~~~~~-----~~~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~-~~~h  124 (384)
T COG0515          52 ASLNHPPNIVKLYDFF-----QDEGSLYLVMEYVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK-GIIH  124 (384)
T ss_pred             HHccCCcceeeEEEEE-----ecCCEEEEEEecCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC-Ceec
Confidence            356777 799999998     22333789999999 5766555432111 3689999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCC-------CcccccccccccCCccccCC--CCCCchhHhhhhhHHHHHH
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-------PNISYICSRYYRAPELIFGA--TEYTAAIDIWSAGCVLAEL  150 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwslG~il~el  150 (292)
                      ||+||+||+++..+..++++|||.+.......       ......||..|++||.+.+.  ..++...|+||+|++++++
T Consensus       125 rd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~  204 (384)
T COG0515         125 RDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYEL  204 (384)
T ss_pred             cCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHH
Confidence            99999999999876459999999987554332       23566889999999999763  4589999999999999999


Q ss_pred             HhCCCCCCCCCc---HHHHHHHHHHhCCC-CHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCC
Q 022799          151 LLGQPLFPGESG---VDQLVEIIKVLGTP-TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPN  226 (292)
Q Consensus       151 ~~g~~pf~~~~~---~~~~~~i~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~  226 (292)
                      ++|..||.....   .............+ ...              .....      ........+.+++.+++..+|.
T Consensus       205 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~------~~~~~~~~~~~~~~~~~~~~~~  264 (384)
T COG0515         205 LTGLPPFEGEKNSSATSQTLKIILELPTPSLAS--------------PLSPS------NPELISKAASDLLKKLLAKDPK  264 (384)
T ss_pred             HhCCCCCCCCCccccHHHHHHHHHhcCCccccc--------------ccCcc------ccchhhHHHHHHHHHHHhcCch
Confidence            999999877664   33444443332222 000              00000      0011235789999999999999


Q ss_pred             CcccHHHHhcCCCccccC
Q 022799          227 LRSTALEALIHPFFDELR  244 (292)
Q Consensus       227 ~R~t~~e~l~hp~~~~~~  244 (292)
                      .|.+..+...+++.....
T Consensus       265 ~r~~~~~~~~~~~~~~~~  282 (384)
T COG0515         265 NRLSSSSDLSHDLLAHLK  282 (384)
T ss_pred             hcCCHHHHhhchHhhCcc
Confidence            999999998887666543

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.87  E-value=1.6e-22  Score=187.64  Aligned_cols=154  Identities=34%  Similarity=0.525  Sum_probs=126.6

Q ss_pred             HHHHHHHHHhcCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCC----------------CcccccccccccCCcc
Q 022799           64 ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE----------------PNISYICSRYYRAPEL  127 (292)
Q Consensus        64 il~al~~LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~----------------~~~~~~gt~~y~aPE~  127 (292)
                      ++.+++|||+. ||+|||+||+|++|+.-| .+|++|||+.+.....-                .....+|||.|.|||+
T Consensus       152 mvla~Eylh~y-givhrdlkpdnllIT~mG-hiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeV  229 (1205)
T KOG0606|consen  152 MVLAVEYLHSY-GIVHRDLKPDNLLITSMG-HIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEV  229 (1205)
T ss_pred             hhHHhHhhccC-CeecCCCCCCcceeeecc-cccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhh
Confidence            37799999975 999999999999999988 69999999987642110                0124589999999999


Q ss_pred             ccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhcc
Q 022799          128 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQK  207 (292)
Q Consensus       128 ~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  207 (292)
                      +..+ .|+..+|+|++|+|+|+.+.|.+||.++...+.+...+.....-+++                          ..
T Consensus       230 ilrq-gygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~--------------------------de  282 (1205)
T KOG0606|consen  230 ILRQ-GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEE--------------------------DE  282 (1205)
T ss_pred             hhhh-ccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccccc--------------------------Cc
Confidence            9754 59999999999999999999999999999988887766532211111                          14


Q ss_pred             CCChhHHHHHHHHhccCCCCcc---cHHHHhcCCCccccCCC
Q 022799          208 RMPPEAVDLVSRLLQYSPNLRS---TALEALIHPFFDELRDP  246 (292)
Q Consensus       208 ~~~~~~~~li~~~l~~dp~~R~---t~~e~l~hp~~~~~~~~  246 (292)
                      .++++++++|.++|..+|..|.   .+.++..|+||+.+++.
T Consensus       283 a~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~  324 (1205)
T KOG0606|consen  283 ALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK  324 (1205)
T ss_pred             CCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence            5789999999999999999995   47788899999999876

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.84  E-value=1.9e-21  Score=181.11  Aligned_cols=196  Identities=31%  Similarity=0.457  Sum_probs=140.0

Q ss_pred             CCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCC
Q 022799            3 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDI   82 (292)
Q Consensus         3 ~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dl   82 (292)
                      .++|||++.+.-+.     ..+...|||-+|+..+|++.+..+    .-+.+.+.+.|+.|++.||.-+|.. ||+||||
T Consensus        77 l~~~pn~lPfqk~~-----~t~kAAylvRqyvkhnLyDRlSTR----PFL~~iEKkWiaFQLL~al~qcH~~-gVcHGDI  146 (1431)
T KOG1240|consen   77 LMKAPNCLPFQKVL-----VTDKAAYLVRQYVKHNLYDRLSTR----PFLVLIEKKWIAFQLLKALSQCHKL-GVCHGDI  146 (1431)
T ss_pred             hhcCCcccchHHHH-----HhhHHHHHHHHHHhhhhhhhhccc----hHHHHHHHHHHHHHHHHHHHHHHHc-Ccccccc
Confidence            46899999987664     334457799999999999888653    4467778889999999999999976 9999999


Q ss_pred             CCCcEEEeCCCCcEEEeecCCcccccc--CC-C-ccccccc----ccccCCccccCCC----------CCCchhHhhhhh
Q 022799           83 KPQNLLVNPHTHQLKLCDFGSAKVLVK--GE-P-NISYICS----RYYRAPELIFGAT----------EYTAAIDIWSAG  144 (292)
Q Consensus        83 kp~Nill~~~~~~ikl~Dfg~a~~~~~--~~-~-~~~~~gt----~~y~aPE~~~~~~----------~~~~~~DvwslG  144 (292)
                      |.+|||+++=. .+.|+||..-+..--  +. . ...+..|    ..|.|||.+....          ..+++-||||+|
T Consensus       147 KsENILiTSWN-W~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~G  225 (1431)
T KOG1240|consen  147 KSENILITSWN-WLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAG  225 (1431)
T ss_pred             ccceEEEeeec-hhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhh
Confidence            99999998755 799999986554311  11 1 1112223    2499999885421          157889999999


Q ss_pred             HHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhcc
Q 022799          145 CVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQY  223 (292)
Q Consensus       145 ~il~el~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  223 (292)
                      |+++||++ |++||.    ..++....... .-..++                       .+..--+..++.+|..|++.
T Consensus       226 CViaELf~Eg~PlF~----LSQL~aYr~~~-~~~~e~-----------------------~Le~Ied~~~Rnlil~Mi~r  277 (1431)
T KOG1240|consen  226 CVIAELFLEGRPLFT----LSQLLAYRSGN-ADDPEQ-----------------------LLEKIEDVSLRNLILSMIQR  277 (1431)
T ss_pred             HHHHHHHhcCCCccc----HHHHHhHhccC-ccCHHH-----------------------HHHhCcCccHHHHHHHHHcc
Confidence            99999997 788883    22222221110 111111                       01112345789999999999


Q ss_pred             CCCCcccHHHHhcC
Q 022799          224 SPNLRSTALEALIH  237 (292)
Q Consensus       224 dp~~R~t~~e~l~h  237 (292)
                      ||++|.+|++.|+.
T Consensus       278 dPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  278 DPSKRLSAEDYLQK  291 (1431)
T ss_pred             CchhccCHHHHHHh
Confidence            99999999999875

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.83  E-value=1.8e-19  Score=155.94  Aligned_cols=199  Identities=21%  Similarity=0.175  Sum_probs=146.0

Q ss_pred             CCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCc
Q 022799            7 PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQN   86 (292)
Q Consensus         7 pnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlkp~N   86 (292)
                      +++.++++...    ....+-++||+.++.+|.++.....  .+.++..++..++.|++.+|++||+. |++||||||+|
T Consensus        80 ~~~~~~~~~G~----~~~~~~~iVM~l~G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~-G~iHRDiKp~N  152 (322)
T KOG1164|consen   80 SHFPKLLDHGR----STEDFNFIVMSLLGPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK-GFIHRDIKPEN  152 (322)
T ss_pred             CCCCEEEEecc----CCCceeEEEEeccCccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc-CcccCCcCHHH
Confidence            46777776652    2445688999999999999876543  57899999999999999999999987 99999999999


Q ss_pred             EEEeCCC----CcEEEeecCCcc--ccccCC--------C-cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHH
Q 022799           87 LLVNPHT----HQLKLCDFGSAK--VLVKGE--------P-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL  151 (292)
Q Consensus        87 ill~~~~----~~ikl~Dfg~a~--~~~~~~--------~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~  151 (292)
                      +++....    ..+.|.|||+++  ......        . .....||..|.++..-.+. ..+.+.|+||++.++.++.
T Consensus       153 ~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~-e~~r~DDles~~Y~l~el~  231 (322)
T KOG1164|consen  153 FVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGI-EQGRRDDLESLFYMLLELL  231 (322)
T ss_pred             eeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCC-ccCCchhhhhHHHHHHHHh
Confidence            9997543    469999999998  321111        1 1234599999999988665 4899999999999999999


Q ss_pred             hCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccH
Q 022799          152 LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA  231 (292)
Q Consensus       152 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~  231 (292)
                      .|..||.+........+..+......               ...         +....+..+.++...+-..+...+|..
T Consensus       232 ~g~LPW~~~~~~~~~~~~~~~~~~~~---------------~~~---------~~~~~~~~~~~~~~~~~~~~~~~~Pdy  287 (322)
T KOG1164|consen  232 KGSLPWEALEMTDLKSKFEKDPRKLL---------------TDR---------FGDLKPEEFAKILEYIDSLDYEDKPDY  287 (322)
T ss_pred             cCCCCCccccccchHHHHHHHhhhhc---------------ccc---------ccCCChHHHHHHHHHhhccCCcCCCCH
Confidence            99999977654333222222110000               000         112345677888888877899999987


Q ss_pred             HHHhcC
Q 022799          232 LEALIH  237 (292)
Q Consensus       232 ~e~l~h  237 (292)
                      ..+...
T Consensus       288 ~~~~~~  293 (322)
T KOG1164|consen  288 EKLAEL  293 (322)
T ss_pred             HHHHHH
Confidence            776543

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.82  E-value=5.2e-21  Score=159.38  Aligned_cols=166  Identities=26%  Similarity=0.329  Sum_probs=106.9

Q ss_pred             eEEEEeecccCCHHHHHHhhhhcCCC---CCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEeCCCCcEEEeecC
Q 022799           26 YLNLVLEYVPETVHRVIKHHYKMSQR---MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  102 (292)
Q Consensus        26 ~~~lv~e~~~g~L~~~l~~~~~~~~~---~~~~~~~~~~~qil~al~~LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg  102 (292)
                      ..+++|+-+.++|.+++..-......   +.......+..|++..+++||+. |++|+||+|+|++++.+| .+.|+||+
T Consensus       113 n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~-GlVHgdi~~~nfll~~~G-~v~Lg~F~  190 (288)
T PF14531_consen  113 NRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY-GLVHGDIKPENFLLDQDG-GVFLGDFS  190 (288)
T ss_dssp             SEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT-TEEEST-SGGGEEE-TTS--EEE--GG
T ss_pred             hhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc-ceEecccceeeEEEcCCC-CEEEcChH
Confidence            35789999999998876643222222   22223334558999999999987 999999999999999998 79999998


Q ss_pred             CccccccCCCcccccccccccCCccccCC-------CCCCchhHhhhhhHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Q 022799          103 SAKVLVKGEPNISYICSRYYRAPELIFGA-------TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT  175 (292)
Q Consensus       103 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~  175 (292)
                      ...........  ...+..|.+||.....       ..++.+.|.|+||+++|.|+++..||........          
T Consensus       191 ~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~----------  258 (288)
T PF14531_consen  191 SLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEAD----------  258 (288)
T ss_dssp             GEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGST----------
T ss_pred             HHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCcccc----------
Confidence            87654322111  3345779999987432       2378899999999999999999999975432110          


Q ss_pred             CCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCc
Q 022799          176 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR  228 (292)
Q Consensus       176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R  228 (292)
                                   ..+.+..         - .++|+.+++||..+|.+||.+|
T Consensus       259 -------------~~~~f~~---------C-~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  259 -------------PEWDFSR---------C-RDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             -------------SGGGGTT---------S-S---HHHHHHHHHHT-SSGGGS
T ss_pred             -------------ccccchh---------c-CCcCHHHHHHHHHHccCCcccC
Confidence                         0001111         1 2589999999999999999988

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.82  E-value=5.8e-21  Score=166.24  Aligned_cols=179  Identities=30%  Similarity=0.497  Sum_probs=133.6

Q ss_pred             ceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEeCCCCcEEEeecC
Q 022799           24 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  102 (292)
Q Consensus        24 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg  102 (292)
                      ..++|+.|++|. ++|.+++.+... ....+...+..++.|+..|++|   + |.+|+|+||.||+...+. .+||.|||
T Consensus       328 ~~~lyI~Mn~c~~~tledWl~rr~~-~e~~s~s~~~~~~~q~~~~~~y---k-~~ihrdlkp~nif~~~d~-q~kIgDFg  401 (516)
T KOG1033|consen  328 KVYLYIQMNLCEKETLEDWLRRRRT-GEERSLSLMLDIFKQIAPAVEY---K-GLIHRDLKPSNIFFSDDD-QLKIGDFG  401 (516)
T ss_pred             ccchhhhhhhhhhhhHHHHhhCCCc-ccccchhHHHHHHHhhccchhh---c-cchhhhccccccccccch-hhhhhhhh
Confidence            346899999999 799999875433 4556778899999999999999   6 999999999999998877 79999999


Q ss_pred             CccccccCC-------CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhC-CCCCCCCCcHHHHHHHHHHhC
Q 022799          103 SAKVLVKGE-------PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG-QPLFPGESGVDQLVEIIKVLG  174 (292)
Q Consensus       103 ~a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g-~~pf~~~~~~~~~~~i~~~~~  174 (292)
                      +........       ..+..+||..||+||.+.+.. |+.++|+||||+|++|++.- ...|....    ..       
T Consensus       402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~-y~~kvdIyaLGlil~EL~~~f~T~~er~~----t~-------  469 (516)
T KOG1033|consen  402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQ-YSEKVDIYALGLILAELLIQFSTQFERIA----TL-------  469 (516)
T ss_pred             heeecccCCcccchhhhhhhcccccccCCHHHHhhhh-hhhhcchhhHHHHHHHHHHHhccHHHHHH----hh-------
Confidence            987665544       345678999999999998765 99999999999999999972 22221100    00       


Q ss_pred             CCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCCc
Q 022799          175 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  240 (292)
Q Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~~  240 (292)
                                         ...+...+.+.+..+ -+.-.+|+..||...|.+||++.+.-.|+|.
T Consensus       470 -------------------~d~r~g~ip~~~~~d-~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  470 -------------------TDIRDGIIPPEFLQD-YPEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             -------------------hhhhcCCCChHHhhc-CcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence                               011111111111112 2345799999999999999988877777664

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.82  E-value=7.7e-20  Score=161.70  Aligned_cols=204  Identities=25%  Similarity=0.382  Sum_probs=150.2

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.+.|.|+.++++.....     ...++|.+||. |+|.+.+...   ...++......++++|+.||.|||......|
T Consensus         1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~~---~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~h   72 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSNE---DIKLDYFFILSFIRDISKGLAYLHNSPIGYH   72 (484)
T ss_pred             CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhcc---ccCccHHHHHHHHHHHHHHHHHHhcCcceee
Confidence            7899999999999998654     34889999999 9999999863   4567888889999999999999997633499


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccC---CCcccccccccccCCccccCCCC------CCchhHhhhhhHHHHHH
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG---EPNISYICSRYYRAPELIFGATE------YTAAIDIWSAGCVLAEL  150 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~------~~~~~DvwslG~il~el  150 (292)
                      +.++..|.+++... .+||+|||+.......   .......-..-|.|||++.+...      .+.+.|+||+|++++|+
T Consensus        73 g~l~s~nClvd~~w-~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei  151 (484)
T KOG1023|consen   73 GALKSSNCLVDSRW-VLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEI  151 (484)
T ss_pred             eeeccccceeeeeE-EEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHH
Confidence            99999999999988 8999999998765321   11111112345899999966311      36679999999999999


Q ss_pred             HhCCCCCCCCCc----HHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCC
Q 022799          151 LLGQPLFPGESG----VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPN  226 (292)
Q Consensus       151 ~~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~  226 (292)
                      ++...||.....    .+.+..+.+....+.               .|...      .. ....+++..+++.||..+|.
T Consensus       152 ~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~---------------rP~i~------~~-~e~~~~l~~l~~~cw~e~P~  209 (484)
T KOG1023|consen  152 LFRSGPFDLRNLVEDPDEIILRVKKGGSNPF---------------RPSIE------LL-NELPPELLLLVARCWEEIPE  209 (484)
T ss_pred             HhccCccccccccCChHHHHHHHHhcCCCCc---------------Ccchh------hh-hhcchHHHHHHHHhcccChh
Confidence            999999975322    123333222011111               11100      00 13556899999999999999


Q ss_pred             CcccHHHHh
Q 022799          227 LRSTALEAL  235 (292)
Q Consensus       227 ~R~t~~e~l  235 (292)
                      +||+++++-
T Consensus       210 ~rPs~~~i~  218 (484)
T KOG1023|consen  210 KRPSIEQIR  218 (484)
T ss_pred             hCccHHHHH
Confidence            999999886

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.81  E-value=1.1e-19  Score=146.27  Aligned_cols=194  Identities=16%  Similarity=0.247  Sum_probs=145.0

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.+.||||+.+++.+     +...++.++..|++ |+|+.++....  +-..+..++..++.+|+.|+.|||+---++-
T Consensus       241 lrifshpnilpvlgac-----nsppnlv~isq~mp~gslynvlhe~t--~vvvd~sqav~faldiargmaflhslep~ip  313 (448)
T KOG0195|consen  241 LRIFSHPNILPVLGAC-----NSPPNLVIISQYMPFGSLYNVLHEQT--SVVVDHSQAVRFALDIARGMAFLHSLEPMIP  313 (448)
T ss_pred             eeeecCCchhhhhhhc-----cCCCCceEeeeeccchHHHHHHhcCc--cEEEecchHHHHHHHHHhhHHHHhhcchhhh
Confidence            4567899999999999     44455999999999 99999886532  2346677888999999999999997534444


Q ss_pred             c-CCCCCcEEEeCCCCcEEE--eecCCccccccCCCcccccccccccCCccccCCCC--CCchhHhhhhhHHHHHHHhCC
Q 022799           80 R-DIKPQNLLVNPHTHQLKL--CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE--YTAAIDIWSAGCVLAELLLGQ  154 (292)
Q Consensus        80 ~-dlkp~Nill~~~~~~ikl--~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DvwslG~il~el~~g~  154 (292)
                      | .+....++++.+. ..+|  +|-.++..      .......|.||+||.+...+.  .-.++|+||+++++||+.|+.
T Consensus       314 r~~lns~hvmidedl-tarismad~kfsfq------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~tre  386 (448)
T KOG0195|consen  314 RFYLNSKHVMIDEDL-TARISMADTKFSFQ------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTRE  386 (448)
T ss_pred             hhhcccceEEecchh-hhheecccceeeee------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccc
Confidence            4 5788889998876 4444  44333321      122345788999999965432  245799999999999999999


Q ss_pred             CCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHH
Q 022799          155 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA  234 (292)
Q Consensus       155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~  234 (292)
                      +||..-.+.+.-.++.-                           +.+...+|++++..+..|+.-|+.-||.+||..+.+
T Consensus       387 vpfadlspmecgmkial---------------------------eglrv~ippgis~hm~klm~icmnedpgkrpkfdmi  439 (448)
T KOG0195|consen  387 VPFADLSPMECGMKIAL---------------------------EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMI  439 (448)
T ss_pred             cccccCCchhhhhhhhh---------------------------ccccccCCCCccHHHHHHHHHHhcCCCCcCCCccee
Confidence            99987776654443321                           112234568899999999999999999999998876


Q ss_pred             h
Q 022799          235 L  235 (292)
Q Consensus       235 l  235 (292)
                      +
T Consensus       440 v  440 (448)
T KOG0195|consen  440 V  440 (448)
T ss_pred             h
Confidence            5

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.79  E-value=2.5e-18  Score=141.94  Aligned_cols=148  Identities=20%  Similarity=0.290  Sum_probs=123.0

Q ss_pred             CCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCC
Q 022799            5 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKP   84 (292)
Q Consensus         5 ~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlkp   84 (292)
                      ..++|..++-+-     +...+-.||+|+++.+|.+++...   +.+++..++..++.|++.-++++|++ .+|+|||||
T Consensus        82 g~~GIP~vYYFG-----qeG~~NiLVidLLGPSLEDLFD~C---gR~FSvKTV~miA~Qmi~rie~vH~k-~LIYRDIKP  152 (449)
T KOG1165|consen   82 GTEGIPQVYYFG-----QEGKYNILVIDLLGPSLEDLFDLC---GRRFSVKTVAMIAKQMITRIEYVHEK-DLIYRDIKP  152 (449)
T ss_pred             CCCCCCceeeec-----cccchhhhhhhhhCcCHHHHHHHh---cCcccHHhHHHHHHHHHHHHHHHHhc-ceeecccCc
Confidence            356677776544     555667799999999999988764   67899999999999999999999998 999999999


Q ss_pred             CcEEEeCC----CCcEEEeecCCccccccCCC--------cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh
Q 022799           85 QNLLVNPH----THQLKLCDFGSAKVLVKGEP--------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL  152 (292)
Q Consensus        85 ~Nill~~~----~~~ikl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~  152 (292)
                      +|+||...    ...|.++|||+|+.+.+...        .....||-.||+=-.-.|.+ -+...|+=|||-+|.+.+.
T Consensus       153 dNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrE-QSRRDDLEaLGHvFmYFLR  231 (449)
T KOG1165|consen  153 DNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLR  231 (449)
T ss_pred             cceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccch-hhhhhhHHHhhhhhhhhcc
Confidence            99999543    23589999999998755432        23557899999988887765 7899999999999999999


Q ss_pred             CCCCCCCCCc
Q 022799          153 GQPLFPGESG  162 (292)
Q Consensus       153 g~~pf~~~~~  162 (292)
                      |..||.|...
T Consensus       232 GsLPWQGLKA  241 (449)
T KOG1165|consen  232 GSLPWQGLKA  241 (449)
T ss_pred             CCCccccccC
Confidence            9999987644

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.76  E-value=3.9e-18  Score=135.43  Aligned_cols=139  Identities=19%  Similarity=0.130  Sum_probs=99.8

Q ss_pred             CCCCC-CCCeeeeceeeeccCCCCceeEEEEeecccC-CHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcc
Q 022799            1 MRLLD-HPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVC   78 (292)
Q Consensus         1 L~~l~-HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~   78 (292)
                      |++|. |++|.+++++.     .    .+++|||+.| +|......           ....++.|++.+|.++|++ ||+
T Consensus        55 L~~L~~~~~vP~ll~~~-----~----~~lvmeyI~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~-GIv  113 (218)
T PRK12274         55 LRQLDGLPRTPRLLHWD-----G----RHLDRSYLAGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRC-GVA  113 (218)
T ss_pred             HHhcCCCCCCCEEEEEc-----C----EEEEEeeecCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHC-cCc
Confidence            35664 57888887742     2    6899999997 55432210           1134678999999999988 999


Q ss_pred             ccCC-CCCcEEEeCCCCcEEEeecCCccccccCCCc----c----------cccccccccCCccccCCCCCC-chhHhhh
Q 022799           79 HRDI-KPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN----I----------SYICSRYYRAPELIFGATEYT-AAIDIWS  142 (292)
Q Consensus        79 H~dl-kp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~----~----------~~~gt~~y~aPE~~~~~~~~~-~~~Dvws  142 (292)
                      |||| ||+||+++.++ .++|+|||++.........    .          ..-.++.|++|+...-....+ ...++.+
T Consensus       114 HrDL~kp~NILv~~~g-~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~  192 (218)
T PRK12274        114 HNDLAKEANWLVQEDG-SPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFA  192 (218)
T ss_pred             cCCCCCcceEEEcCCC-CEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHH
Confidence            9999 79999999877 7999999999855433211    0          112367777887543332334 5678889


Q ss_pred             hhHHHHHHHhCCCCCCCCC
Q 022799          143 AGCVLAELLLGQPLFPGES  161 (292)
Q Consensus       143 lG~il~el~~g~~pf~~~~  161 (292)
                      .|+.+|.++|+..++.+++
T Consensus       193 ~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        193 TGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             hcchHHHHHhccCCccccC
Confidence            9999999999998886554

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.75  E-value=1.7e-17  Score=131.37  Aligned_cols=143  Identities=23%  Similarity=0.307  Sum_probs=114.6

Q ss_pred             CCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEeCC--CCcEEEe
Q 022799           22 KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH--THQLKLC   99 (292)
Q Consensus        22 ~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlkp~Nill~~~--~~~ikl~   99 (292)
                      .+..+-.+||+.++.+|.+++.-.   +..++..++...+-|++.-++|+|.+ +++||||||+|+|+.-+  ..++-++
T Consensus        81 ~e~~ynvlVMdLLGPsLEdLfnfC---~R~ftmkTvLMLaDQml~RiEyvH~r-~fiHRDIKPdNFLMGlgrh~~kl~LI  156 (341)
T KOG1163|consen   81 TEKDYNVLVMDLLGPSLEDLFNFC---SRRFTMKTVLMLADQMLSRIEYVHLR-NFIHRDIKPDNFLMGLGRHCNKLYLI  156 (341)
T ss_pred             cccccceeeeeccCccHHHHHHHH---hhhhhHHhHHHHHHHHHHHHHHHHhh-ccccccCCccceeeccccccceEEEE
Confidence            444567799999999999887653   56799999999999999999999988 99999999999998543  3368899


Q ss_pred             ecCCccccccCC--------CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCCCcHHHHHHH
Q 022799          100 DFGSAKVLVKGE--------PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEI  169 (292)
Q Consensus       100 Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~i  169 (292)
                      |||+|+.+.+..        ......||..|.+--...+.. -+...|+=|+|.++..+..|..||++.......++.
T Consensus       157 DFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~e-qSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKy  233 (341)
T KOG1163|consen  157 DFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIE-QSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKY  233 (341)
T ss_pred             eccchhhhccccccccCccccCCccceeeeehhhhhhhhhh-hhhhhhhhhhcceeeeeecCCCcccccchhhHHHHH
Confidence            999999874432        123457899998876665543 578899999999999999999999987665544443

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.73  E-value=3.3e-18  Score=148.46  Aligned_cols=108  Identities=24%  Similarity=0.338  Sum_probs=80.3

Q ss_pred             CCCCCCCCeee-eceeeeccCCCCceeEEEEeecccC-CHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcc
Q 022799            1 MRLLDHPNVVS-LKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVC   78 (292)
Q Consensus         1 L~~l~HpnIv~-~~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~   78 (292)
                      |++++|+||+. +++.    .     ..|+||||++| +|. .+.       ...   ...++.|++.||.|||++ ||+
T Consensus        75 L~~L~h~~iv~~l~~~----~-----~~~LVmE~~~G~~L~-~~~-------~~~---~~~~~~~i~~aL~~lH~~-gIi  133 (365)
T PRK09188         75 LKTVRGIGVVPQLLAT----G-----KDGLVRGWTEGVPLH-LAR-------PHG---DPAWFRSAHRALRDLHRA-GIT  133 (365)
T ss_pred             HHhccCCCCCcEEEEc----C-----CcEEEEEccCCCCHH-HhC-------ccc---hHHHHHHHHHHHHHHHHC-CCe
Confidence            46789999985 4331    1     26899999985 554 221       011   146788999999999988 999


Q ss_pred             ccCC-CCCcEEEeCCCCcEEEeecCCccccccCCCc---------ccccccccccCCccccC
Q 022799           79 HRDI-KPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN---------ISYICSRYYRAPELIFG  130 (292)
Q Consensus        79 H~dl-kp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~---------~~~~gt~~y~aPE~~~~  130 (292)
                      |||| ||+||+++.++ .++|+|||+|+........         .+..+++.|.|||.+..
T Consensus       134 HrDL~KP~NILv~~~~-~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        134 HNDLAKPQNWLMGPDG-EAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             eCCCCCcceEEEcCCC-CEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            9999 99999998877 7999999999876443211         23456788999998854

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.70  E-value=2.6e-18  Score=158.43  Aligned_cols=205  Identities=27%  Similarity=0.380  Sum_probs=156.4

Q ss_pred             CCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHH-hcCCccccCCC
Q 022799            6 HPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH-NTIGVCHRDIK   83 (292)
Q Consensus         6 HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH-~~~~i~H~dlk   83 (292)
                      |+|++++++..     .+..+.+++++|.. +++...+..  ......+...+..++.|+..++.|+| .. ++.|+|+|
T Consensus        80 h~n~~~~~~~~-----~~~~~~~~~~~~s~g~~~f~~i~~--~~~~~~~~~~~~~~~~ql~s~l~~~H~~~-~~~h~~ik  151 (601)
T KOG0590|consen   80 HSNTVHMIEPS-----SSPRSYLLSLSYSDGGSLFSKISH--PDSTGTSSSSASRYLPQLNSGLSYLHPEN-GVTHRDIK  151 (601)
T ss_pred             cccccccCCcc-----CCCcccccccCccccccccccccc--CCccCCCCcchhhhhhhhccCccccCccc-ccccCCCC
Confidence            99999999987     55556889999987 466666521  11225667778899999999999999 76 99999999


Q ss_pred             CCcEEEeCCCCcEEEeecCCcccccc-CCC---cccccc-cccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           84 PQNLLVNPHTHQLKLCDFGSAKVLVK-GEP---NISYIC-SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        84 p~Nill~~~~~~ikl~Dfg~a~~~~~-~~~---~~~~~g-t~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      |+|.+++..+..+++.|||+|..... ...   ....+| ++.|+|||...+....++..|+||+|+++.-+++|..|+.
T Consensus       152 P~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~  231 (601)
T KOG0590|consen  152 PSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWD  231 (601)
T ss_pred             CccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcc
Confidence            99999987763599999999987755 222   234577 9999999999876567899999999999999999999986


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCC
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  238 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp  238 (292)
                      ........                     +.  .+.... ..........++....+++.+++..+|+.|.+.+++..+|
T Consensus       232 ~~~~~~~~---------------------~~--~~~~~~-~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~  287 (601)
T KOG0590|consen  232 FPSRKDGR---------------------YS--SWKSNK-GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDN  287 (601)
T ss_pred             cccccccc---------------------ce--eecccc-cccccCccccCChhhhhcccccccCCchhccccccccccc
Confidence            54432200                     00  000000 0000111146889999999999999999999999999999


Q ss_pred             Cccc
Q 022799          239 FFDE  242 (292)
Q Consensus       239 ~~~~  242 (292)
                      |+..
T Consensus       288 ~~~~  291 (601)
T KOG0590|consen  288 WLSS  291 (601)
T ss_pred             cccc
Confidence            9988

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.68  E-value=2.6e-17  Score=133.35  Aligned_cols=123  Identities=14%  Similarity=0.213  Sum_probs=87.5

Q ss_pred             CCCCCCCeeeeceeeeccCCC---CceeEEEEeecccC-CHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEK---DELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGV   77 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~---~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i   77 (292)
                      .++.||+|..+.+++......   -....+|||||++| +|.+...        +++    ....+++.++..+|++ |+
T Consensus        90 ~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~-gi  156 (232)
T PRK10359         90 DRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH-GM  156 (232)
T ss_pred             HHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc-CC
Confidence            457899999998886543211   12347899999997 7765521        233    2355999999999988 99


Q ss_pred             cccCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHH
Q 022799           78 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL  151 (292)
Q Consensus        78 ~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~  151 (292)
                      +|||+||+||+++.++  ++|+|||.............           ++.. ..+..++|+||||+.+..+.
T Consensus       157 ~H~Dikp~Nili~~~g--i~liDfg~~~~~~e~~a~d~-----------~vle-r~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        157 VSGDPHKGNFIVSKNG--LRIIDLSGKRCTAQRKAKDR-----------IDLE-RHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             ccCCCChHHEEEeCCC--EEEEECCCcccccchhhHHH-----------HHHH-hHhcccccccceeEeehHHH
Confidence            9999999999999876  99999998765422211111           2223 23668899999999876554

>PRK10345 hypothetical protein; Provisional

Probab=99.61  E-value=1.8e-15  Score=122.01  Aligned_cols=91  Identities=14%  Similarity=0.188  Sum_probs=68.3

Q ss_pred             CCCCeeeeceeeeccCCCCceeEEEEeeccc---CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHH-HHHHhcCCcccc
Q 022799            5 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP---ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRAL-AYIHNTIGVCHR   80 (292)
Q Consensus         5 ~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~---g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al-~~LH~~~~i~H~   80 (292)
                      +||||+++++++.+..+ ....+.+||||++   |+|.+++.+     ..+++.  ..++.|++.++ +|||++ +|+||
T Consensus        59 ~h~nIvr~yg~~et~~g-~g~v~~~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~~-~Ivhr  129 (210)
T PRK10345         59 DWSGIPRYYGTVETDCG-TGYVYDVIADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLDN-RIVTM  129 (210)
T ss_pred             CCcccceeeEEEEeCCC-CeEEEEEEecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHHC-CEeec
Confidence            68999999999855321 1222447999954   699999964     235555  35688888888 999998 99999


Q ss_pred             CCCCCcEEEeCC---CCcEEEeecCCc
Q 022799           81 DIKPQNLLVNPH---THQLKLCDFGSA  104 (292)
Q Consensus        81 dlkp~Nill~~~---~~~ikl~Dfg~a  104 (292)
                      ||||+||+++..   ...++|+||+.+
T Consensus       130 DlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345        130 ELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             CCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            999999999742   226999995444

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.59  E-value=1.5e-15  Score=121.19  Aligned_cols=74  Identities=15%  Similarity=0.225  Sum_probs=60.9

Q ss_pred             EEEEeecccC-CHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHH-HhcCCccccCCCCCcEEEeCCCCcEEEeecCCc
Q 022799           27 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI-HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  104 (292)
Q Consensus        27 ~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~L-H~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a  104 (292)
                      .++||||++| ++......    ...+++..+..++.|++.+|.++ |+. ||+||||||+||+++. + .++|+|||+|
T Consensus        92 ~~iVmE~i~g~~l~~~~~~----~~~~~~~~~~~i~~qi~~~L~~l~H~~-giiHrDlkP~NIli~~-~-~v~LiDFG~a  164 (190)
T cd05147          92 HVLVMEFIGDDGWAAPRLK----DAPLSESKARELYLQVIQIMRILYQDC-RLVHADLSEYNLLYHD-G-KLYIIDVSQS  164 (190)
T ss_pred             CEEEEEEeCCCCCcchhhh----cCCCCHHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEEEC-C-cEEEEEcccc
Confidence            3799999996 43333222    35688999999999999999999 677 9999999999999984 4 6999999998


Q ss_pred             ccc
Q 022799          105 KVL  107 (292)
Q Consensus       105 ~~~  107 (292)
                      ...
T Consensus       165 ~~~  167 (190)
T cd05147         165 VEH  167 (190)
T ss_pred             ccC
Confidence            654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.59  E-value=1.4e-15  Score=142.18  Aligned_cols=214  Identities=29%  Similarity=0.389  Sum_probs=159.3

Q ss_pred             CCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCC
Q 022799            6 HPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKP   84 (292)
Q Consensus         6 HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlkp   84 (292)
                      ||.++...-.+..     ....+|+++|++ ++|...+.+    .+..+..-++.++..+..++++||+. .+.|+|++|
T Consensus       863 ~P~v~~~~~s~~~-----rsP~~L~~~~~~~~~~~Skl~~----~~~~saepaRs~i~~~vqs~e~L~s~-~r~h~~~~p  932 (1205)
T KOG0606|consen  863 SPAVVRSFPSFPC-----RSPLPLVGHYLNGGDLPSKLHN----SGCLSAEPARSPILERVQSLESLHSS-LRKHRDLKP  932 (1205)
T ss_pred             CCceecccCCCCC-----CCCcchhhHHhccCCchhhhhc----CCCcccccccchhHHHHhhhhccccc-hhhcccccc
Confidence            4555555433322     223789999998 588777765    34567777888888999999999975 699999999


Q ss_pred             CcEEEeCCCCcEEEeecCCccccccC--------------------------------CCcccccccccccCCccccCCC
Q 022799           85 QNLLVNPHTHQLKLCDFGSAKVLVKG--------------------------------EPNISYICSRYYRAPELIFGAT  132 (292)
Q Consensus        85 ~Nill~~~~~~ikl~Dfg~a~~~~~~--------------------------------~~~~~~~gt~~y~aPE~~~~~~  132 (292)
                      .|++...++ ..+++|||........                                .......+|+.|.+||++.+..
T Consensus       933 ~~~l~~~~g-h~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~ 1011 (1205)
T KOG0606|consen  933 DSLLIAYDG-HRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR 1011 (1205)
T ss_pred             cchhhcccC-CcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc
Confidence            999999888 5899999843322100                                0012346799999999998865


Q ss_pred             CCCchhHhhhhhHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChh
Q 022799          133 EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPE  212 (292)
Q Consensus       133 ~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  212 (292)
                       .+..+|+|+.|++++|.++|.+||...........|....-                         +|.. -+...+..
T Consensus      1012 -hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~-------------------------~~p~-g~~~~s~~ 1064 (1205)
T KOG0606|consen 1012 -HGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFENILNRDI-------------------------PWPE-GPEEGSYE 1064 (1205)
T ss_pred             -CCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhccccCCC-------------------------CCCC-CccccChh
Confidence             78899999999999999999999998887776655544211                         1110 11357889


Q ss_pred             HHHHHHHHhccCCCCcccHH---HHhcCCCccccCCCCCCCCCCCCCC
Q 022799          213 AVDLVSRLLQYSPNLRSTAL---EALIHPFFDELRDPNTRLPNGRFLP  257 (292)
Q Consensus       213 ~~~li~~~l~~dp~~R~t~~---e~l~hp~~~~~~~~~~~~~~~~~~~  257 (292)
                      +++++.+.|..+|.+|..+.   ++-.|+||+++.+.........++|
T Consensus      1065 aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~l~~q~~~~~p 1112 (1205)
T KOG0606|consen 1065 AQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWENLALQKAEFVP 1112 (1205)
T ss_pred             hhhhhhhhhccCchhccCcccccccccCCccCCCCccccccccCccCC
Confidence            99999999999999999877   8889999999887665544444443

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.58  E-value=3.6e-15  Score=141.17  Aligned_cols=122  Identities=26%  Similarity=0.384  Sum_probs=103.2

Q ss_pred             EEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEeC------CCCcEEEe
Q 022799           27 LNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP------HTHQLKLC   99 (292)
Q Consensus        27 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlkp~Nill~~------~~~~ikl~   99 (292)
                      -+||+||.+ |+|.+++..    .+.+++..+..+..|++.-++.||.. +|||+||||+|++|..      +..-++|+
T Consensus       769 S~lv~ey~~~Gtlld~~N~----~~~m~e~lv~~~~~qml~ive~lH~~-~IIHgDiKPDNfll~~~~~~~~~~~~l~lI  843 (974)
T KOG1166|consen  769 SVLVSEYSPYGTLLDLINT----NKVMDEYLVMFFSCQMLRIVEHLHAM-GIIHGDIKPDNFLLRREICADSDSKGLYLI  843 (974)
T ss_pred             ceeeeeccccccHHHhhcc----CCCCCchhhhHHHHHHHHHHHHHHhc-ceecccCCcceeEeecccCCCCcccceEEE
Confidence            568999999 999999984    57789999999999999999999987 9999999999999842      22359999


Q ss_pred             ecCCccccccCC---CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCC
Q 022799          100 DFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ  154 (292)
Q Consensus       100 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~  154 (292)
                      |||.+..+.--.   .....++|-.+-.+|+..|.. ++.++|.|.++.+++-|+.|+
T Consensus       844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grp-WtYq~DyfGlAa~~h~mLFG~  900 (974)
T KOG1166|consen  844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRP-WTYQIDYFGLAATVHVMLFGK  900 (974)
T ss_pred             ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCC-CchhhhhHHHHHHHHHHHHHH
Confidence            999987653322   334456788899999997754 999999999999999999997

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.57  E-value=5e-15  Score=118.50  Aligned_cols=74  Identities=16%  Similarity=0.212  Sum_probs=61.0

Q ss_pred             EEEEeecccCC-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCccccCCCCCcEEEeCCCCcEEEeecCCc
Q 022799           27 LNLVLEYVPET-VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN-TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  104 (292)
Q Consensus        27 ~~lv~e~~~g~-L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~-~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a  104 (292)
                      .++||||++|. +......    ...++...+..++.|++.++.++|+ + ||+||||||+||+++ ++ .++|+|||++
T Consensus        92 ~~lVmE~~~g~~~~~~~l~----~~~~~~~~~~~i~~~l~~~l~~lH~~~-givHrDlkP~NIll~-~~-~~~liDFG~a  164 (190)
T cd05145          92 NVLVMEFIGDDGSPAPRLK----DVPLEEEEAEELYEQVVEQMRRLYQEA-GLVHGDLSEYNILYH-DG-KPYIIDVSQA  164 (190)
T ss_pred             CEEEEEEecCCCchhhhhh----hccCCHHHHHHHHHHHHHHHHHHHHhC-CEecCCCChhhEEEE-CC-CEEEEEcccc
Confidence            37999999964 3332221    2457788899999999999999998 7 999999999999998 55 7999999999


Q ss_pred             ccc
Q 022799          105 KVL  107 (292)
Q Consensus       105 ~~~  107 (292)
                      ...
T Consensus       165 ~~~  167 (190)
T cd05145         165 VEL  167 (190)
T ss_pred             eec
Confidence            765

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.52  E-value=9.6e-15  Score=120.87  Aligned_cols=208  Identities=20%  Similarity=0.244  Sum_probs=144.5

Q ss_pred             CCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhc-CCcccc
Q 022799            3 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT-IGVCHR   80 (292)
Q Consensus         3 ~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~-~~i~H~   80 (292)
                      ++.|.|||+++.++.+....+.....+++||+. |++..++++-.+....+.....++|+-||+.||.|||+. .-|+|+
T Consensus       123 qlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppiihg  202 (458)
T KOG1266|consen  123 QLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHG  202 (458)
T ss_pred             HHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccC
Confidence            457999999999886655555666778999999 899999988777778899999999999999999999963 149999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCc--cccc---cCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSA--KVLV---KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQP  155 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a--~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~  155 (292)
                      ++..+.|++..++ -||+.--.-.  ....   .........+-++|.+||.=.. ...+..+|||++|....+|..+..
T Consensus       203 nlTc~tifiq~ng-LIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~-tn~~~a~dIy~fgmcAlemailEi  280 (458)
T KOG1266|consen  203 NLTCDTIFIQHNG-LIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTT-TNTTGASDIYKFGMCALEMAILEI  280 (458)
T ss_pred             CcchhheeecCCc-eEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcc-cccccchhhhhhhHHHHHHHHhee
Confidence            9999999999777 5776421111  0000   0001112345678999986432 335778999999998999998875


Q ss_pred             CCC-CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCC-ChhHHHHHHHHhccCCCCcccHHH
Q 022799          156 LFP-GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRM-PPEAVDLVSRLLQYSPNLRSTALE  233 (292)
Q Consensus       156 pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~li~~~l~~dp~~R~t~~e  233 (292)
                      --. +......-..+....                                 -.+ ..--++++.+||.-.|..||++.+
T Consensus       281 q~tnseS~~~~ee~ia~~i---------------------------------~~len~lqr~~i~kcl~~eP~~rp~ar~  327 (458)
T KOG1266|consen  281 QSTNSESKVEVEENIANVI---------------------------------IGLENGLQRGSITKCLEGEPNGRPDARL  327 (458)
T ss_pred             ccCCCcceeehhhhhhhhe---------------------------------eeccCccccCcCcccccCCCCCCcchhh
Confidence            322 111111001111100                                 001 122357899999999999999999


Q ss_pred             HhcCCCccccCC
Q 022799          234 ALIHPFFDELRD  245 (292)
Q Consensus       234 ~l~hp~~~~~~~  245 (292)
                      ++.||..-++..
T Consensus       328 llfHpllfeVhs  339 (458)
T KOG1266|consen  328 LLFHPLLFEVHS  339 (458)
T ss_pred             hhcCceeeecch
Confidence            999998766543

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.50  E-value=2e-13  Score=122.83  Aligned_cols=136  Identities=26%  Similarity=0.379  Sum_probs=101.7

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      |+.++||||+++++++     +.+..+|||+|.+. .|..++..       +....+..-++||+.||.|||+..+++|+
T Consensus        63 lKtlRHP~Il~yL~t~-----e~~~~~ylvTErV~-Pl~~~lk~-------l~~~~v~~Gl~qIl~AL~FL~~d~~lvHg  129 (690)
T KOG1243|consen   63 LKTLRHPNILSYLDTT-----EEEGTLYLVTERVR-PLETVLKE-------LGKEEVCLGLFQILAALSFLNDDCNLVHG  129 (690)
T ss_pred             hhhccCchhhhhhhhh-----cccCceEEEeeccc-cHHHHHHH-------hHHHHHHHHHHHHHHHHHHHhccCCeeec
Confidence            5779999999999998     44446999999987 33345544       23567788899999999999977799999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCC-cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG  153 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g  153 (292)
                      +|.-+.|+++..| ..||++|.++........ ......--.|..|+.....   .-..|.|.|||++++++.|
T Consensus       130 Nv~~~SVfVn~~G-eWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s---~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  130 NVCKDSVFVNESG-EWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPS---EWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             cEeeeeEEEcCCC-cEEEeeeEEEeccccCCcccccchhhhcccChhhcCcc---ccchhhhhHHHHHHHHhCc
Confidence            9999999999988 799999988755422221 1111112236667655222   2457999999999999999

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.43  E-value=2.7e-13  Score=120.59  Aligned_cols=198  Identities=24%  Similarity=0.230  Sum_probs=151.8

Q ss_pred             CCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHH----HHHHHHhcCCcccc
Q 022799            5 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR----ALAYIHNTIGVCHR   80 (292)
Q Consensus         5 ~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~----al~~LH~~~~i~H~   80 (292)
                      .|+|.++.+..+     .+....++-+|+|+.+|..+....   ..-++...++..+.+...    ||.++|+. +++|-
T Consensus       176 ~~~~~v~~~~~~-----e~~~~lfiqtE~~~~sl~~~~~~~---~~~~p~~~l~~~~~~~~~~~~~al~~~hs~-~~~~~  246 (524)
T KOG0601|consen  176 SHENPVRDSPAW-----EGSGILFIQTELCGESLQSYCHTP---CNFLPDNLLWNSLRDWLSRDVTALSHLHSN-NIVHD  246 (524)
T ss_pred             ccccccccCccc-----ccCCcceeeeccccchhHHhhhcc---cccCCchhhhhHHhhhhhcccccccccCCC-ccccc
Confidence            488888876666     555558899999998887776542   345888899999999999    99999998 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCCcc------cccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI------SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ  154 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~  154 (292)
                      |+||+||++..+....+++|||+...+.......      ...|...|++||...+  -++...|++++|-++.+..++.
T Consensus       247 ~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~  324 (524)
T KOG0601|consen  247 DLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGS  324 (524)
T ss_pred             ccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhc
Confidence            9999999999884479999999998876554221      1245667999999855  4799999999999999999988


Q ss_pred             CCCCCC--CcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHH
Q 022799          155 PLFPGE--SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAL  232 (292)
Q Consensus       155 ~pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~  232 (292)
                      .++...  ..+.++....                              .+..+-...+..+...+..|+..+|..|+++.
T Consensus       325 ~~~~~g~~~~W~~~r~~~------------------------------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q  374 (524)
T KOG0601|consen  325 HLPSVGKNSSWSQLRQGY------------------------------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQ  374 (524)
T ss_pred             ccccCCCCCCcccccccc------------------------------CchhhhcCcchhhhhHHHHhcCcchhhhhHHH
Confidence            776543  2222211110                              11111134566777799999999999999999


Q ss_pred             HHhcCCCcccc
Q 022799          233 EALIHPFFDEL  243 (292)
Q Consensus       233 e~l~hp~~~~~  243 (292)
                      .+++|+++...
T Consensus       375 ~~~~l~~i~s~  385 (524)
T KOG0601|consen  375 ILTALNVIHSK  385 (524)
T ss_pred             HHhccccccch
Confidence            99999998753

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.36  E-value=1.8e-12  Score=107.26  Aligned_cols=92  Identities=16%  Similarity=0.271  Sum_probs=66.2

Q ss_pred             CCCCCCe--eeeceeeeccCCCCceeEEEEeecccC--CHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcc
Q 022799            3 LLDHPNV--VSLKHCFFSTTEKDELYLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVC   78 (292)
Q Consensus         3 ~l~HpnI--v~~~~~~~~~~~~~~~~~~lv~e~~~g--~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~   78 (292)
                      +|.|++|  ++.+++..... ......++|||+++|  +|.+.+..     ..+++..    +.||+.+|.+||++ ||+
T Consensus        96 ~L~~~gi~vP~pl~~~~~~~-~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~~----~~~i~~~l~~lH~~-GI~  164 (239)
T PRK01723         96 QLYEAGLPVPRPIAARVVRH-GLFYRADILIERIEGARDLVALLQE-----APLSEEQ----WQAIGQLIARFHDA-GVY  164 (239)
T ss_pred             HHHhCCCCCceeEeeeeeec-CcceeeeEEEEecCCCCCHHHHHhc-----CCCCHHH----HHHHHHHHHHHHHC-CCC
Confidence            4566664  55655432211 111123599999985  77777653     3455443    56899999999988 999


Q ss_pred             ccCCCCCcEEEeCCCCcEEEeecCCccc
Q 022799           79 HRDIKPQNLLVNPHTHQLKLCDFGSAKV  106 (292)
Q Consensus        79 H~dlkp~Nill~~~~~~ikl~Dfg~a~~  106 (292)
                      ||||||+|||++.++ .++|+|||.+..
T Consensus       165 HrDlkp~NILv~~~~-~v~LIDfg~~~~  191 (239)
T PRK01723        165 HADLNAHNILLDPDG-KFWLIDFDRGEL  191 (239)
T ss_pred             CCCCCchhEEEcCCC-CEEEEECCCccc
Confidence            999999999999877 799999998864

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.35  E-value=1.7e-12  Score=105.52  Aligned_cols=88  Identities=20%  Similarity=0.348  Sum_probs=68.1

Q ss_pred             CCCCCCeeeeceeeeccCCCCceeEEEEeecccC-CHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccC
Q 022799            3 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRD   81 (292)
Q Consensus         3 ~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~d   81 (292)
                      .+.|++|.....++....     ..++||||++| +|.+.+...    .   . ....++.+++.+|.++|++ |++|+|
T Consensus        55 ~l~~~~i~~p~~~~~~~~-----~~~lv~e~~~G~~L~~~~~~~----~---~-~~~~i~~~i~~~l~~lH~~-~i~H~D  120 (211)
T PRK14879         55 RARKAGVNVPAVYFVDPE-----NFIIVMEYIEGEPLKDLINSN----G---M-EELELSREIGRLVGKLHSA-GIIHGD  120 (211)
T ss_pred             HHHHCCCCCCeEEEEeCC-----CCEEEEEEeCCcCHHHHHHhc----c---H-HHHHHHHHHHHHHHHHHhC-CcccCC
Confidence            356777665555443222     36799999985 888777532    1   1 6788899999999999987 999999


Q ss_pred             CCCCcEEEeCCCCcEEEeecCCccc
Q 022799           82 IKPQNLLVNPHTHQLKLCDFGSAKV  106 (292)
Q Consensus        82 lkp~Nill~~~~~~ikl~Dfg~a~~  106 (292)
                      ++|.||+++ ++ .++|+|||.+..
T Consensus       121 l~p~Nil~~-~~-~~~liDf~~a~~  143 (211)
T PRK14879        121 LTTSNMILS-GG-KIYLIDFGLAEF  143 (211)
T ss_pred             CCcccEEEE-CC-CEEEEECCcccC
Confidence            999999999 45 699999998865

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.34  E-value=2e-12  Score=119.51  Aligned_cols=86  Identities=21%  Similarity=0.327  Sum_probs=68.2

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++|++|+....+.....     ..++||||++ ++|.+.+.            ....++.|++.+|.+||+. |++|
T Consensus       390 l~~l~~~~i~~p~~~~~~~~-----~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~-giiH  451 (535)
T PRK09605        390 LSEARRAGVPTPVIYDVDPE-----EKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA-GIVH  451 (535)
T ss_pred             HHhhcccCCCeeEEEEEeCC-----CCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC-CCcc
Confidence            34678999887665543322     2679999998 58877664            2456888999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccc
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKV  106 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~  106 (292)
                      |||||+||+++ ++ .++|+|||+++.
T Consensus       452 rDlkp~NILl~-~~-~~~liDFGla~~  476 (535)
T PRK09605        452 GDLTTSNFIVR-DD-RLYLIDFGLGKY  476 (535)
T ss_pred             CCCChHHEEEE-CC-cEEEEeCccccc
Confidence            99999999994 44 699999999865

>smart00090 RIO RIO-like kinase

Probab=99.32  E-value=2.8e-12  Score=105.84  Aligned_cols=74  Identities=16%  Similarity=0.178  Sum_probs=59.8

Q ss_pred             EEEEeecccC-CHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCC-ccccCCCCCcEEEeCCCCcEEEeecCCc
Q 022799           27 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG-VCHRDIKPQNLLVNPHTHQLKLCDFGSA  104 (292)
Q Consensus        27 ~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~-i~H~dlkp~Nill~~~~~~ikl~Dfg~a  104 (292)
                      .++||||++| +|......    ........+..++.||+.++.+||++ | ++||||||+||+++ ++ .++|+|||.+
T Consensus       123 ~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~-g~iiH~Dikp~NIli~-~~-~i~LiDFg~a  195 (237)
T smart00090      123 NVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYKE-GELVHGDLSEYNILVH-DG-KVVIIDVSQS  195 (237)
T ss_pred             ceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHhc-CCEEeCCCChhhEEEE-CC-CEEEEEChhh
Confidence            4799999997 44443321    23456667789999999999999988 9 99999999999999 55 7999999988


Q ss_pred             ccc
Q 022799          105 KVL  107 (292)
Q Consensus       105 ~~~  107 (292)
                      ...
T Consensus       196 ~~~  198 (237)
T smart00090      196 VEL  198 (237)
T ss_pred             hcc
Confidence            643

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.30  E-value=1e-12  Score=118.77  Aligned_cols=159  Identities=23%  Similarity=0.356  Sum_probs=114.8

Q ss_pred             HHHHHHHHHHHHhcCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCCC--------cccc--cccccccCCccccC
Q 022799           61 FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP--------NISY--ICSRYYRAPELIFG  130 (292)
Q Consensus        61 ~~qil~al~~LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~--------~~~~--~gt~~y~aPE~~~~  130 (292)
                      +.+++.|+.|+|.+.++||++|.|++|.++..+ ..||+.|+++........        ....  .-...|.|||++.+
T Consensus       105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~-~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  105 LGNVADGLAFLHRSAKVVHGNIQPEAIVVNANG-DWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hhcccchhhhhccCcceeecccchhheeeccCc-ceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            345678999999988999999999999999988 799999998765533211        0111  12456999999976


Q ss_pred             CCCCCchhHhhhhhHHHHHHH-hCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCC
Q 022799          131 ATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRM  209 (292)
Q Consensus       131 ~~~~~~~~DvwslG~il~el~-~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  209 (292)
                       ...+.++|++|+||++|.+. .|...+.+.+.......-....+             ....            ..+.++
T Consensus       184 -~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~-------------~~~~------------~~s~~~  237 (700)
T KOG2137|consen  184 -TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLN-------------AGAF------------GYSNNL  237 (700)
T ss_pred             -ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccc-------------cccc------------cccccC
Confidence             44789999999999999998 56655544432221111111000             0000            112568


Q ss_pred             ChhHHHHHHHHhccCCCCcccHHHHhcCCCccccCCC
Q 022799          210 PPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  246 (292)
Q Consensus       210 ~~~~~~li~~~l~~dp~~R~t~~e~l~hp~~~~~~~~  246 (292)
                      ++++++=|.++|..++..||++.+++..|||++..-.
T Consensus       238 p~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~~~  274 (700)
T KOG2137|consen  238 PSELRESLKKLLNGDSAVRPTLDLLLSIPFFSDPGLK  274 (700)
T ss_pred             cHHHHHHHHHHhcCCcccCcchhhhhcccccCCchhh
Confidence            9999999999999999999999999999999975543

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.28  E-value=5.6e-12  Score=101.54  Aligned_cols=66  Identities=29%  Similarity=0.541  Sum_probs=55.1

Q ss_pred             EEEEeecccC-CHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEeCCCCcEEEeecCCcc
Q 022799           27 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  105 (292)
Q Consensus        27 ~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~  105 (292)
                      .++||||++| +|.+.+...    ..       .++.|++.+|.+||+. |++|+|++|.||+++ ++ .++++|||.+.
T Consensus        72 ~~lv~e~~~g~~l~~~~~~~----~~-------~~~~~i~~~l~~lH~~-gi~H~Dl~~~Nil~~-~~-~~~liDfg~a~  137 (199)
T TIGR03724        72 KTIVMEYIEGKPLKDVIEEG----ND-------ELLREIGRLVGKLHKA-GIVHGDLTTSNIIVR-DD-KLYLIDFGLGK  137 (199)
T ss_pred             CEEEEEEECCccHHHHHhhc----HH-------HHHHHHHHHHHHHHHC-CeecCCCCcceEEEE-CC-cEEEEECCCCc
Confidence            5799999985 777766431    10       7788999999999987 999999999999999 55 79999999886


Q ss_pred             c
Q 022799          106 V  106 (292)
Q Consensus       106 ~  106 (292)
                      .
T Consensus       138 ~  138 (199)
T TIGR03724       138 Y  138 (199)
T ss_pred             C
Confidence            5

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.18  E-value=5.3e-11  Score=95.87  Aligned_cols=69  Identities=20%  Similarity=0.284  Sum_probs=56.5

Q ss_pred             EEEEeecccC-CHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEeCCCCcEEEeecCCcc
Q 022799           27 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  105 (292)
Q Consensus        27 ~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~  105 (292)
                      .++||||++| +|.....          ......++.+++.++.++|+. |++||||+|+||+++.++ .++|+|||.+.
T Consensus       106 ~~lv~e~~~g~~L~~~~~----------~~~~~~~~~~i~~~l~~lh~~-gi~H~Dl~p~Nill~~~~-~~~liDfg~~~  173 (198)
T cd05144         106 HAVVMEYIDGVELYRVRV----------LEDPEEVLDEILEEIVKAYKH-GIIHGDLSEFNILVDDDE-KIYIIDWPQMV  173 (198)
T ss_pred             ceEEEEEeCCcchhhccc----------cccHHHHHHHHHHHHHHHHHC-CCCcCCCCcccEEEcCCC-cEEEEECCccc
Confidence            5799999996 5544321          023567888999999999987 999999999999999877 79999999986


Q ss_pred             cc
Q 022799          106 VL  107 (292)
Q Consensus       106 ~~  107 (292)
                      ..
T Consensus       174 ~~  175 (198)
T cd05144         174 ST  175 (198)
T ss_pred             cC
Confidence            54

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.11  E-value=1.3e-09  Score=95.93  Aligned_cols=179  Identities=21%  Similarity=0.274  Sum_probs=125.4

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc--CCHHHHHHhhh-----------hcCCCCCHHHHHHHHHHHHHHH
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHY-----------KMSQRMPLIYVKLYFYQICRAL   68 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~--g~L~~~l~~~~-----------~~~~~~~~~~~~~~~~qil~al   68 (292)
                      +++.|+|||++.++|.+.. -++..+++|++|.+  ++|.++.....           ..+.+.++..++.|+.|+..||
T Consensus       328 kkl~h~NvV~frevf~t~t-F~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL  406 (655)
T KOG3741|consen  328 KKLCHTNVVPFREVFLTYT-FGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAAL  406 (655)
T ss_pred             HHhccCceeehhhhhhhhc-cCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHH
Confidence            5678999999999997433 56677999999998  58877654321           1234578999999999999999


Q ss_pred             HHHHhcCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHH
Q 022799           69 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLA  148 (292)
Q Consensus        69 ~~LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~  148 (292)
                      .++|+. |..-+-|.+.+|+++.+. +|+|+.-|.......+.           .  |.+.+    -.+-|.=.||.+++
T Consensus       407 ~sIHss-GLAck~L~~~kIlv~G~~-RIriS~C~i~Dvl~~d~-----------~--~~le~----~Qq~D~~~lG~ll~  467 (655)
T KOG3741|consen  407 YSIHSS-GLACKTLDLKKILVTGKM-RIRISGCGIMDVLQEDP-----------T--EPLES----QQQNDLRDLGLLLL  467 (655)
T ss_pred             HHHHhc-CceeecccHhHeEeeCcc-eEEEecccceeeecCCC-----------C--cchhH----HhhhhHHHHHHHHH
Confidence            999987 999999999999999876 78888766554432222           0  11211    24568889999999


Q ss_pred             HHHhCCCC-CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCC
Q 022799          149 ELLLGQPL-FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL  227 (292)
Q Consensus       149 el~~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~  227 (292)
                      .|.||..- +..+.....  .+ +.                                +...++.+++++|..+...++++
T Consensus       468 aLAt~~~ns~~~d~~~~s--~~-~~--------------------------------I~~~yS~D~rn~v~yl~s~~~~~  512 (655)
T KOG3741|consen  468 ALATGTENSNRTDSTQSS--HL-TR--------------------------------ITTTYSTDLRNVVEYLESLNFRE  512 (655)
T ss_pred             HHhhcccccccccchHHH--HH-HH--------------------------------hhhhhhHHHHHHHHHHHhcCccc
Confidence            99999632 111111111  11 10                                11457788888888888888875


Q ss_pred             cccHHHHhc
Q 022799          228 RSTALEALI  236 (292)
Q Consensus       228 R~t~~e~l~  236 (292)
                       -++.+++.
T Consensus       513 -ksI~~llp  520 (655)
T KOG3741|consen  513 -KSIQDLLP  520 (655)
T ss_pred             -ccHHHHHH
Confidence             45665553

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.09  E-value=2.6e-10  Score=90.82  Aligned_cols=72  Identities=21%  Similarity=0.300  Sum_probs=56.0

Q ss_pred             EEEEeecccC-CHH-HHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCccccCCCCCcEEEeCCCCcEEEeecCC
Q 022799           27 LNLVLEYVPE-TVH-RVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN-TIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  103 (292)
Q Consensus        27 ~~lv~e~~~g-~L~-~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~-~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~  103 (292)
                      .++||||++| ++. ..+....     . ...++.++.+++.++.++|. . ||+|+||||+||+++ ++ .++|+|||.
T Consensus        90 ~~lv~e~~~g~~~~~~~l~~~~-----~-~~~~~~~~~~~~~~l~~lh~~~-~ivH~Dl~p~Nili~-~~-~~~liDfg~  160 (187)
T cd05119          90 HVLVMEFIGGDGIPAPRLKDVR-----L-LEDPEELYDQILELMRKLYREA-GLVHGDLSEYNILVD-DG-KVYIIDVPQ  160 (187)
T ss_pred             CEEEEEEeCCCCccChhhhhhh-----h-cccHHHHHHHHHHHHHHHhhcc-CcCcCCCChhhEEEE-CC-cEEEEECcc
Confidence            5799999996 221 1122110     1 15678899999999999998 6 999999999999999 55 799999999


Q ss_pred             cccc
Q 022799          104 AKVL  107 (292)
Q Consensus       104 a~~~  107 (292)
                      +...
T Consensus       161 a~~~  164 (187)
T cd05119         161 AVEI  164 (187)
T ss_pred             cccc
Confidence            8654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.07  E-value=5.1e-09  Score=90.33  Aligned_cols=196  Identities=18%  Similarity=0.256  Sum_probs=125.4

Q ss_pred             EEEEeecccC--CHHHHHH--hhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEeCCCCcEEEeecC
Q 022799           27 LNLVLEYVPE--TVHRVIK--HHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG  102 (292)
Q Consensus        27 ~~lv~e~~~g--~L~~~l~--~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg  102 (292)
                      +.+.|..+.|  .+..+..  .++.......+.....+++.++.+..-||++ |.+-+|+.++|+|++.++ .++|.|-.
T Consensus        85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~-Gh~vGDVn~~~~lVsd~~-~V~LVdsD  162 (637)
T COG4248          85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH-GHVVGDVNQNSFLVSDDS-KVVLVDSD  162 (637)
T ss_pred             eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc-CCcccccCccceeeecCc-eEEEEccc
Confidence            7788988875  4444432  2223345578889999999999999999987 999999999999999887 68888754


Q ss_pred             CccccccCCCcccccccccccCCcccc-C---CCCCCchhHhhhhhHHHHHHHhC-CCCCCCCCcHHHHHHHHHHhCCCC
Q 022799          103 SAKVLVKGEPNISYICSRYYRAPELIF-G---ATEYTAAIDIWSAGCVLAELLLG-QPLFPGESGVDQLVEIIKVLGTPT  177 (292)
Q Consensus       103 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-~---~~~~~~~~DvwslG~il~el~~g-~~pf~~~~~~~~~~~i~~~~~~~~  177 (292)
                      .-....++......+|...|.+||.-. +   .-.-+...|.|.||+++|+++.| ++||.|--..       .....|-
T Consensus       163 sfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~-------~~ap~p~  235 (637)
T COG4248         163 SFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLI-------SDAPNPL  235 (637)
T ss_pred             ceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCccccc-------CCCCCcc
Confidence            333223333444567899999999863 1   11246789999999999999986 8999763210       0000011


Q ss_pred             HHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccC--CCCcccHH
Q 022799          178 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYS--PNLRSTAL  232 (292)
Q Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d--p~~R~t~~  232 (292)
                      +..+....-.|.....+..+..+....+ ..+++++..+..+|+...  +.-|||++
T Consensus       236 E~~Ia~g~f~ya~~~~~g~~p~P~~~P~-~~Lpp~vqAlF~qaF~~~~~~~~RP~a~  291 (637)
T COG4248         236 ETDIAHGRFAYASDQRRGLKPPPRSIPL-SMLPPDVQALFQQAFTESGVATPRPTAK  291 (637)
T ss_pred             hhhhhcceeeechhccCCCCCCCCCCCh-hhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence            1111111111111111222211111111 357899999999999753  45799875

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.07  E-value=1.1e-10  Score=89.20  Aligned_cols=83  Identities=22%  Similarity=0.290  Sum_probs=62.8

Q ss_pred             CCeeeeceeeeccCCCCceeEEEEeecccCC-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhc--CCccccCCC
Q 022799            7 PNVVSLKHCFFSTTEKDELYLNLVLEYVPET-VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT--IGVCHRDIK   83 (292)
Q Consensus         7 pnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~-L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~--~~i~H~dlk   83 (292)
                      +++.+++..+     ......+++|||++|. +..+           +......++.+++.++..+|..  .+++|+|++
T Consensus        53 ~~~p~~~~~~-----~~~~~~~~v~e~~~g~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~  116 (155)
T cd05120          53 LPVPKVLASG-----ESDGWSYLLMEWIEGETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLH  116 (155)
T ss_pred             CCCCeEEEEc-----CCCCccEEEEEecCCeecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCC
Confidence            4777777665     2223488999999863 3221           3345567788999999999963  169999999


Q ss_pred             CCcEEEeCCCCcEEEeecCCccc
Q 022799           84 PQNLLVNPHTHQLKLCDFGSAKV  106 (292)
Q Consensus        84 p~Nill~~~~~~ikl~Dfg~a~~  106 (292)
                      |+||+++..+ .++++|||.+..
T Consensus       117 ~~Nil~~~~~-~~~l~Df~~~~~  138 (155)
T cd05120         117 PGNILVDDGK-ILGIIDWEYAGY  138 (155)
T ss_pred             cceEEEECCc-EEEEEecccccC
Confidence            9999999866 799999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.99  E-value=1.6e-10  Score=103.25  Aligned_cols=194  Identities=21%  Similarity=0.172  Sum_probs=135.6

Q ss_pred             CCCCeeeeceeeeccCCCCceeEEEEeecccC-CHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCC
Q 022799            5 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIK   83 (292)
Q Consensus         5 ~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlk   83 (292)
                      .|.+++..+..|....     ..|+=.|||++ ++......    ...+.+...+....|++.++.++|+. .++|+|++
T Consensus       324 ~~~~~~g~~~~W~~~r-----~~~ip~e~~~~~s~~l~~~~----~~~~d~~~~~~~~~q~~~~l~~i~s~-~~~~~d~~  393 (524)
T KOG0601|consen  324 SHLPSVGKNSSWSQLR-----QGYIPLEFCEGGSSSLRSVT----SQMLDEDPRLRLTAQILTALNVIHSK-LFVHLDVK  393 (524)
T ss_pred             cccccCCCCCCccccc-----cccCchhhhcCcchhhhhHH----HHhcCcchhhhhHHHHHhccccccch-hhhccccc
Confidence            5888888888774433     36688999974 44333321    24467778889999999999999987 99999999


Q ss_pred             CCcEEEeCCCCcEEEeecCCccccccCCCccccccccccc-CCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCCCc
Q 022799           84 PQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR-APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG  162 (292)
Q Consensus        84 p~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~-aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~  162 (292)
                      |+||++..++...++.|||.+..+.-  .......+..+. ..|++.....+..+.|++|+|..+.+.+++.+.-.....
T Consensus       394 psni~i~~~~~~~~~~~~~~~t~~~~--~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~  471 (524)
T KOG0601|consen  394 PSNILISNDGFFSKLGDFGCWTRLAF--SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ  471 (524)
T ss_pred             ccceeeccchhhhhccccccccccce--ecccccccccccccchhhccccccccccccccccccccccccCcccCccccc
Confidence            99999988655789999998864211  111222333444 366666666789999999999999999998854432221


Q ss_pred             HHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCCccc
Q 022799          163 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  242 (292)
Q Consensus       163 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~~~~  242 (292)
                      ..   .+...                   ..+          ..+..+.++..+.+.+...++..|+.+.++..|.-|..
T Consensus       472 ~~---~i~~~-------------------~~p----------~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~  519 (524)
T KOG0601|consen  472 SL---TIRSG-------------------DTP----------NLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR  519 (524)
T ss_pred             ce---eeecc-------------------ccc----------CCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence            11   01000                   000          01234467888999999999999999999988876654

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=98.92  E-value=3.8e-09  Score=84.01  Aligned_cols=73  Identities=16%  Similarity=0.271  Sum_probs=56.0

Q ss_pred             EEEEeecccCC-HH-HHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHH-HhcCCccccCCCCCcEEEeCCCCcEEEeecCC
Q 022799           27 LNLVLEYVPET-VH-RVIKHHYKMSQRMPLIYVKLYFYQICRALAYI-HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  103 (292)
Q Consensus        27 ~~lv~e~~~g~-L~-~~l~~~~~~~~~~~~~~~~~~~~qil~al~~L-H~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~  103 (292)
                      -++||||++++ +. ..+.     ...++...+..++.|++.+|..| |+. |++|+||++.||+++. + .+.|+|||.
T Consensus        99 ~~lvME~Ig~~~~~~~~Lk-----d~~~~~~~~~~i~~~i~~~l~~l~H~~-glVHGDLs~~NIL~~~-~-~v~iIDF~q  170 (197)
T cd05146          99 HVLVMSFIGDDQVPAPKLK-----DAKLNDEEMKNAYYQVLSMMKQLYKEC-NLVHADLSEYNMLWHD-G-KVWFIDVSQ  170 (197)
T ss_pred             CEEEEEEcCCCCccchhhh-----ccccCHHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEEC-C-cEEEEECCC
Confidence            56899999863 21 1222     12345556777889999999998 876 9999999999999974 4 599999998


Q ss_pred             cccc
Q 022799          104 AKVL  107 (292)
Q Consensus       104 a~~~  107 (292)
                      +...
T Consensus       171 av~~  174 (197)
T cd05146         171 SVEP  174 (197)
T ss_pred             ceeC
Confidence            8654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.84  E-value=1.6e-08  Score=78.09  Aligned_cols=77  Identities=21%  Similarity=0.322  Sum_probs=60.5

Q ss_pred             EEEEeecccC--CHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEeCCCCcE--EEeecC
Q 022799           27 LNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQL--KLCDFG  102 (292)
Q Consensus        27 ~~lv~e~~~g--~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlkp~Nill~~~~~~i--kl~Dfg  102 (292)
                      -+|+|||++|  ++.+++.....  ..........++.+|-+.+.-||.+ +|+|+||..+||++.+++.++  .++|||
T Consensus        85 ~~i~ME~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~n-diiHGDLTTSNill~~~~~~~~~~lIdfg  161 (229)
T KOG3087|consen   85 GQIYMEFIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHDN-DIIHGDLTTSNILLRSDGNQITPILIDFG  161 (229)
T ss_pred             CeEEEEeccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhhC-CeecccccccceEEecCCCcCceEEEeec
Confidence            4589999998  88888876532  2222223367888899999999998 999999999999998877655  899999


Q ss_pred             Cccc
Q 022799          103 SAKV  106 (292)
Q Consensus       103 ~a~~  106 (292)
                      ++..
T Consensus       162 ls~~  165 (229)
T KOG3087|consen  162 LSSV  165 (229)
T ss_pred             chhc
Confidence            9854

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.81  E-value=2.1e-08  Score=77.59  Aligned_cols=66  Identities=18%  Similarity=0.420  Sum_probs=51.8

Q ss_pred             EEEEeecccCC-HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEeCCCCcEEEeecCCcc
Q 022799           27 LNLVLEYVPET-VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  105 (292)
Q Consensus        27 ~~lv~e~~~g~-L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~  105 (292)
                      ..|+|||++|. |.+.+...       .    ..++..+-.-+.-||.+ ||+|+||.++||+++.++  +.++|||++.
T Consensus        74 ~~I~me~I~G~~lkd~l~~~-------~----~~~~r~vG~~vg~lH~~-givHGDLTtsNiIl~~~~--i~~IDfGLg~  139 (204)
T COG3642          74 GLIVMEYIEGELLKDALEEA-------R----PDLLREVGRLVGKLHKA-GIVHGDLTTSNIILSGGR--IYFIDFGLGE  139 (204)
T ss_pred             CEEEEEEeCChhHHHHHHhc-------c----hHHHHHHHHHHHHHHhc-CeecCCCccceEEEeCCc--EEEEECCccc
Confidence            45899999984 44466542       1    34555677778889987 999999999999998754  9999999986


Q ss_pred             c
Q 022799          106 V  106 (292)
Q Consensus       106 ~  106 (292)
                      .
T Consensus       140 ~  140 (204)
T COG3642         140 F  140 (204)
T ss_pred             c
Confidence            4

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=98.79  E-value=1.6e-08  Score=90.91  Aligned_cols=74  Identities=20%  Similarity=0.300  Sum_probs=53.4

Q ss_pred             EEEEeecccC-CHHHHHHhhhhcCCCCCHHHHHHHHHHHHH-HHHHHHhcCCccccCCCCCcEEEeCCCCcEEEeecCCc
Q 022799           27 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICR-ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  104 (292)
Q Consensus        27 ~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~qil~-al~~LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a  104 (292)
                      .+|||||++| +|.+......   ....   ...++.+++. .+..+|.. |++|+|+||.||+++.++ .++++|||++
T Consensus       233 ~vLvmE~i~G~~L~~~~~~~~---~~~~---~~~ia~~~~~~~l~ql~~~-g~~H~D~hPgNilv~~~g-~i~liDfG~~  304 (437)
T TIGR01982       233 RVLTMEWIDGIPLSDIAALDE---AGLD---RKALAENLARSFLNQVLRD-GFFHADLHPGNIFVLKDG-KIIALDFGIV  304 (437)
T ss_pred             ceEEEEeECCcccccHHHHHh---cCCC---HHHHHHHHHHHHHHHHHhC-CceeCCCCcccEEECCCC-cEEEEeCCCe
Confidence            5799999985 6666543211   1122   2234445554 46778877 999999999999998887 7999999998


Q ss_pred             cccc
Q 022799          105 KVLV  108 (292)
Q Consensus       105 ~~~~  108 (292)
                      ....
T Consensus       305 ~~l~  308 (437)
T TIGR01982       305 GRLS  308 (437)
T ss_pred             eECC
Confidence            7653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.75  E-value=8e-08  Score=80.58  Aligned_cols=77  Identities=13%  Similarity=0.179  Sum_probs=62.1

Q ss_pred             eEEEEeecccC--CHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEeCC------CCcEE
Q 022799           26 YLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH------THQLK   97 (292)
Q Consensus        26 ~~~lv~e~~~g--~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlkp~Nill~~~------~~~ik   97 (292)
                      .-++|||++++  +|.+++....  ....+......++.+++..+.-||++ ||+|+|+++.|||++.+      ...+.
T Consensus       109 ~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~-Gi~HgDL~~~NiLl~~~~~~~~~~~~~~  185 (268)
T PRK15123        109 TSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAA-GINHRDCYICHFLLHLPFPGREEDLKLS  185 (268)
T ss_pred             eeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC-cCccCCCChhhEEEeccccCCCCCceEE
Confidence            36799999996  6888775321  23456677889999999999999988 99999999999999752      23689


Q ss_pred             EeecCCcc
Q 022799           98 LCDFGSAK  105 (292)
Q Consensus        98 l~Dfg~a~  105 (292)
                      ++||+.+.
T Consensus       186 LIDl~r~~  193 (268)
T PRK15123        186 VIDLHRAQ  193 (268)
T ss_pred             EEECCccc
Confidence            99999875

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.66  E-value=2e-07  Score=75.39  Aligned_cols=77  Identities=21%  Similarity=0.448  Sum_probs=62.8

Q ss_pred             eeEEEEeecccC--CHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEeCCC--CcEEEee
Q 022799           25 LYLNLVLEYVPE--TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT--HQLKLCD  100 (292)
Q Consensus        25 ~~~~lv~e~~~g--~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlkp~Nill~~~~--~~ikl~D  100 (292)
                      ...++|+|+++|  +|.+++...    ...+......++.+++..+.-||++ ||+|+|+++.|||++.++  ..+.++|
T Consensus        90 ~~s~lite~l~~~~~L~~~~~~~----~~~~~~~~~~ll~~l~~~i~~lH~~-gi~H~Dl~~~NILv~~~~~~~~~~lID  164 (206)
T PF06293_consen   90 YRSYLITEALPGAQDLRDLLQQW----EQLDPSQRRELLRALARLIAKLHDA-GIYHGDLNPSNILVDPDDGQYRFYLID  164 (206)
T ss_pred             eeEEEEEEeCCCcccHHHHHHhh----cccchhhHHHHHHHHHHHHHHHHHC-cCCCCCCCcccEEEeCCCCceeEEEEc
Confidence            346799999986  788887753    2256667788999999999999988 999999999999998764  2588999


Q ss_pred             cCCccc
Q 022799          101 FGSAKV  106 (292)
Q Consensus       101 fg~a~~  106 (292)
                      |+.++.
T Consensus       165 ld~~~~  170 (206)
T PF06293_consen  165 LDRMRF  170 (206)
T ss_pred             chhcee
Confidence            987754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=98.61  E-value=5.4e-08  Score=88.91  Aligned_cols=75  Identities=25%  Similarity=0.330  Sum_probs=52.1

Q ss_pred             EEEEeecccC-CHHHHH--HhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEeCCC---CcEEEee
Q 022799           27 LNLVLEYVPE-TVHRVI--KHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT---HQLKLCD  100 (292)
Q Consensus        27 ~~lv~e~~~g-~L~~~l--~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlkp~Nill~~~~---~~ikl~D  100 (292)
                      .+|||||++| .+.+.-  .........+.+..+..++.|++.       . |++|+|+||.||+++.++   .+++++|
T Consensus       236 ~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif~-------~-GffHaDpHPGNIlv~~~g~~~~~i~llD  307 (537)
T PRK04750        236 TVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVFR-------D-GFFHADMHPGNIFVSYDPPENPRYIALD  307 (537)
T ss_pred             ceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHHh-------C-CeeeCCCChHHeEEecCCCCCCeEEEEe
Confidence            5799999996 665532  211000113555556666666653       5 999999999999998765   2699999


Q ss_pred             cCCcccccc
Q 022799          101 FGSAKVLVK  109 (292)
Q Consensus       101 fg~a~~~~~  109 (292)
                      ||++.....
T Consensus       308 FGivg~l~~  316 (537)
T PRK04750        308 FGIVGSLNK  316 (537)
T ss_pred             cceEEECCH
Confidence            999877633

>cd05151 ChoK Choline Kinase (ChoK)

Probab=98.58  E-value=8e-08  Score=75.10  Aligned_cols=64  Identities=23%  Similarity=0.387  Sum_probs=48.7

Q ss_pred             EEEEeecccC-CHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCc-----cccCCCCCcEEEeCCCCcEEEee
Q 022799           27 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGV-----CHRDIKPQNLLVNPHTHQLKLCD  100 (292)
Q Consensus        27 ~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i-----~H~dlkp~Nill~~~~~~ikl~D  100 (292)
                      .++||||++| ++...        .    ......+.+++.+|..||+. ++     +|+|++|.||+++ ++ .++++|
T Consensus        66 ~~lv~e~i~G~~l~~~--------~----~~~~~~~~~l~~~l~~LH~~-~~~~~~~~HgD~~~~Nil~~-~~-~~~liD  130 (170)
T cd05151          66 GVLITEFIEGSELLTE--------D----FSDPENLEKIAKLLKKLHSS-PLPDLVPCHNDLLPGNFLLD-DG-RLWLID  130 (170)
T ss_pred             CeEEEEecCCCccccc--------c----ccCHHHHHHHHHHHHHHhCC-CCCCceeecCCCCcCcEEEE-CC-eEEEEe
Confidence            3689999997 43221        0    11234567899999999976 75     9999999999999 44 699999


Q ss_pred             cCCcc
Q 022799          101 FGSAK  105 (292)
Q Consensus       101 fg~a~  105 (292)
                      ||.+.
T Consensus       131 f~~a~  135 (170)
T cd05151         131 WEYAG  135 (170)
T ss_pred             ccccc
Confidence            99875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.55  E-value=8e-08  Score=76.11  Aligned_cols=73  Identities=23%  Similarity=0.334  Sum_probs=47.1

Q ss_pred             EEEEeeccc--CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHH-HHhcCCccccCCCCCcEEEeCCCCcEEEeecCC
Q 022799           27 LNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAY-IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  103 (292)
Q Consensus        27 ~~lv~e~~~--g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~-LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~  103 (292)
                      -+|||||++  |.....+...     .++......++.+++..+.. +|+. ||+|+|+++.||+++.+  .+.++|||.
T Consensus        81 ~~ivME~I~~~G~~~~~l~~~-----~~~~~~~~~~~~~il~~~~~~~~~~-givHGDLs~~NIlv~~~--~~~iIDf~q  152 (188)
T PF01163_consen   81 NVIVMEYIGEDGVPLPRLKDV-----DLSPEEPKELLEEILEEIIKMLHKA-GIVHGDLSEYNILVDDG--KVYIIDFGQ  152 (188)
T ss_dssp             TEEEEE--EETTEEGGCHHHC-----GGGGSTHHHHHHHHHHHHHHHHHCT-TEEESS-STTSEEEETT--CEEE--GTT
T ss_pred             CEEEEEecCCCccchhhHHhc-----cccchhHHHHHHHHHHHHHHHHHhc-CceecCCChhhEEeecc--eEEEEecCc
Confidence            459999999  6333333321     11123456677788886555 5666 99999999999999976  599999998


Q ss_pred             cccc
Q 022799          104 AKVL  107 (292)
Q Consensus       104 a~~~  107 (292)
                      +...
T Consensus       153 av~~  156 (188)
T PF01163_consen  153 AVDS  156 (188)
T ss_dssp             EEET
T ss_pred             ceec
Confidence            8654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.38  E-value=7e-07  Score=86.03  Aligned_cols=198  Identities=20%  Similarity=0.297  Sum_probs=128.1

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeecccC-CHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      ....|+|++.++.+-.+....+ ....+..++|.+ ++...+++    ....+...++.+..++++|+.++|+. ...|.
T Consensus       237 ~k~~~~n~~~~~~~~le~~~~g-~~~~v~~~~~s~~~~~~~~q~----v~~i~~~~~r~~~~~~~~GL~~~h~~-~l~~v  310 (1351)
T KOG1035|consen  237 SKIAHDNLGGYFVYGLERLFRG-IVLDVLQEICSKVELRSLLQS----VGSIPLETLRILHQKLLEGLAYLHSL-SLEHV  310 (1351)
T ss_pred             HhhccccccceeEEeehhhcch-HHHHHHHhhcCccchHHHHhh----ccccCHHHHHHHHHHHhhhHHHHHHh-cccee
Confidence            4578999999987664433222 122344567773 66666665    46789999999999999999999976 55555


Q ss_pred             CCCCC---cEEEeCCCCcEEEe--ecCCccccccCCCcccccccccccCCccccCCC-CCCchhHhhhhhHHHHHHHhCC
Q 022799           81 DIKPQ---NLLVNPHTHQLKLC--DFGSAKVLVKGEPNISYICSRYYRAPELIFGAT-EYTAAIDIWSAGCVLAELLLGQ  154 (292)
Q Consensus        81 dlkp~---Nill~~~~~~ikl~--Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwslG~il~el~~g~  154 (292)
                      -+..+   +-..+.++ .+.++  ||+..+.............+..+.++|...... ..+...|+|.+|.....+..|.
T Consensus       311 ~L~~s~~~~~~~~~e~-~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~  389 (1351)
T KOG1035|consen  311 VLSASSSKESTVDGEG-VVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGE  389 (1351)
T ss_pred             EEecccccccccCccc-eeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcC
Confidence            44444   22233333 34555  888777664444333344456677888774432 1234479999999999998876


Q ss_pred             CCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHH
Q 022799          155 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA  234 (292)
Q Consensus       155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~  234 (292)
                      .+-....   .....                                   .+........+.+.+|+.-++++|+++.++
T Consensus       390 ~i~~~~~---~~~~~-----------------------------------l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~l  431 (1351)
T KOG1035|consen  390 DISEKSA---VPVSL-----------------------------------LDVLSTSELLDALPKCLDEDSEERLSALEL  431 (1351)
T ss_pred             ccccccc---chhhh-----------------------------------hccccchhhhhhhhhhcchhhhhccchhhh
Confidence            4421110   00000                                   001112267899999999999999999999


Q ss_pred             hcCCCccccC
Q 022799          235 LIHPFFDELR  244 (292)
Q Consensus       235 l~hp~~~~~~  244 (292)
                      +.|+|.+.-.
T Consensus       432 l~~~f~~~~~  441 (1351)
T KOG1035|consen  432 LTHPFLRFPT  441 (1351)
T ss_pred             hhchhccccc
Confidence            9999987543

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.35  E-value=1.3e-06  Score=70.12  Aligned_cols=64  Identities=22%  Similarity=0.401  Sum_probs=48.2

Q ss_pred             EEEEeecccC-CHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEeCCCCcEEEeecCCcc
Q 022799           27 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  105 (292)
Q Consensus        27 ~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~  105 (292)
                      .+|+|||++| .|.+...        +++.    +.-.+.+++.-||+. |+.|+|.+|.|++++.++  ++++||+..+
T Consensus       118 ~~ll~EYIeG~~l~d~~~--------i~e~----~~~ki~~~ikqlH~~-G~~HGD~hpgNFlv~~~~--i~iID~~~k~  182 (229)
T PF06176_consen  118 YVLLMEYIEGVELNDIED--------IDED----LAEKIVEAIKQLHKH-GFYHGDPHPGNFLVSNNG--IRIIDTQGKR  182 (229)
T ss_pred             EEEEEEEecCeecccchh--------cCHH----HHHHHHHHHHHHHHc-CCccCCCCcCcEEEECCc--EEEEECcccc
Confidence            5689999997 4433321        2222    334677889999987 999999999999999655  9999997654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.20  E-value=3.1e-07  Score=83.34  Aligned_cols=200  Identities=21%  Similarity=0.240  Sum_probs=127.6

Q ss_pred             CCCCCCCC-eeeeceeeeccCCCCceeEEEEeecccCC--HHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCc
Q 022799            1 MRLLDHPN-VVSLKHCFFSTTEKDELYLNLVLEYVPET--VHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGV   77 (292)
Q Consensus         1 L~~l~Hpn-Iv~~~~~~~~~~~~~~~~~~lv~e~~~g~--L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i   77 (292)
                      |.+++||| .+..++-+     +.+.+.+++++++++.  ....+..   ....+..-+.....+.-..++++||+. --
T Consensus       287 LdK~n~P~~~v~~~~d~-----~~E~~~~i~~~i~s~~rs~~~~~~~---se~~~~~~~~~~~~r~et~~l~~l~~~-~~  357 (829)
T KOG0576|consen  287 LDKVNNPNPVVRYLEDY-----DGEDYLWIPMRICSTGRSSALEMTV---SEIALEQYQFAYPLRKETRPLAELHSS-YK  357 (829)
T ss_pred             HHHccCCCCcccccccC-----CcccccchhhhhhcCCccccccCCh---hhHhhhhhhhhhhhhhhcccccccccc-cc
Confidence            45789999 55555544     6666788999999843  1111100   011122233444556667889999965 45


Q ss_pred             cccCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCC
Q 022799           78 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF  157 (292)
Q Consensus        78 ~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf  157 (292)
                      +|+|    ||+..+.  ..+..||+............+..+|+.++|||+..+.. +....|.|++|.--.+|.-|.+|-
T Consensus       358 ~~~d----~~l~s~~--~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~~-~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  358 VHRD----NILGSEE--EVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQENT-IDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             cCcc----ccccccc--ccccccccCCcccCcccccccCCCCCCCCCchhhcccc-cccCCCccCCCcchhhcCCCCCCC
Confidence            8888    8877764  48999999987775554556678899999999886654 788999999998777787777765


Q ss_pred             CCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCC-CCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          158 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA-HPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      ...-..      ....+..         +     ..+.... ..|..       ..-.++...|+...|..|+....++.
T Consensus       431 ~~P~~~------~~~~g~~---------p-----~s~~L~~~~aw~~-------~~~~~~~~~~~~g~P~~pkv~mgacf  483 (829)
T KOG0576|consen  431 SSPPAV------LPMIGNG---------P-----NSPMLTDKSAWSP-------VFHRDFPAPCLNGLPPTPKVHMGACF  483 (829)
T ss_pred             CCCccc------cCCCCCC---------C-----CccccchhhhcCc-------ccccCCcccccCCCCCCCcchhhHHH
Confidence            431100      0000000         0     0000000 11111       11125778899999999999999999


Q ss_pred             CCCcccc
Q 022799          237 HPFFDEL  243 (292)
Q Consensus       237 hp~~~~~  243 (292)
                      |.+|...
T Consensus       484 sKvfngC  490 (829)
T KOG0576|consen  484 SKVFNGC  490 (829)
T ss_pred             HHHhccC
Confidence            9999864

>PRK09902 hypothetical protein; Provisional

Probab=98.16  E-value=1.4e-05  Score=64.02  Aligned_cols=80  Identities=13%  Similarity=0.082  Sum_probs=63.5

Q ss_pred             ceeEEEEeeccc--CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEeCCCC-cEEEee
Q 022799           24 ELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH-QLKLCD  100 (292)
Q Consensus        24 ~~~~~lv~e~~~--g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlkp~Nill~~~~~-~ikl~D  100 (292)
                      ...-+||+|-++  .+|.+++....  ..+.+......++.+++..+.-||+. |+.|+|+.+.||+++.++. .++++|
T Consensus        97 ~~rA~LVTe~L~g~~~L~~~l~~~~--~~~~~~~~k~~il~~va~~ia~LH~~-Gv~Hgdly~khIll~~~g~~~v~lID  173 (216)
T PRK09902         97 EWRALLVTEDMAGFISIADWYAQHA--VSPYSDEVRQAMLKAVALAFKKMHSV-NRQHGCCYVRHIYVKTEGKAEAGFLD  173 (216)
T ss_pred             ceEEEEEEEeCCCCccHHHHHhcCC--cCCcchHHHHHHHHHHHHHHHHHHHC-CCcCCCCCHhheeecCCCCeeEEEEE
Confidence            445679999888  48888875421  13456777788999999999999988 9999999999999986552 499999


Q ss_pred             cCCccc
Q 022799          101 FGSAKV  106 (292)
Q Consensus       101 fg~a~~  106 (292)
                      |..++.
T Consensus       174 lEk~r~  179 (216)
T PRK09902        174 LEKSRR  179 (216)
T ss_pred             hhccch
Confidence            987654

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.96  E-value=9.6e-06  Score=72.37  Aligned_cols=166  Identities=20%  Similarity=0.283  Sum_probs=105.4

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      |+.+.|+|..+++++-....+    ...+|||+++.+|.++...+.     +.   +.    +++       .+ |+.|-
T Consensus        36 lktl~~~~l~~yl~~~r~~~~----r~IVV~e~~~~Sled~~~~~~-----l~---~~----s~~-------~~-~~~~~   91 (725)
T KOG1093|consen   36 LKSLQHDNLCQYLDFSRGKHE----RVIVVMEHYTMSLEDILKTGN-----LK---DE----SLL-------AH-GVLHL   91 (725)
T ss_pred             HHhhcCccceeeEeeecCccc----eEEEEehhhccchHHHHHhcc-----cc---hh----hhc-------cc-cccee
Confidence            456789999999887533222    277899999999999887531     11   00    111       12 33332


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE  160 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  160 (292)
                      .             .+..+| .++              |. |  |-      ..++++||||+|.++.++.-|...+...
T Consensus        92 ~-------------~~~~td-~~~--------------t~-~--~~------~~~pKsdVwsl~~i~~el~L~~~l~~~~  134 (725)
T KOG1093|consen   92 N-------------IIYITD-HFL--------------TK-Y--PS------PIGPKSDVWSLGFIILELYLGISLEAEL  134 (725)
T ss_pred             h-------------hhhccc-ccc--------------cc-C--CC------CCCcchhhhhHHHHHHHHHHhhHHHHHH
Confidence            2             233344 000              00 1  11      1225999999999999999999888766


Q ss_pred             CcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCCc
Q 022799          161 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  240 (292)
Q Consensus       161 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~~  240 (292)
                      ...+.+..+.+....+.....-.+                 ...+...++..+.+++.+|+...|+.||...+..+++-|
T Consensus       135 ~~s~~l~~i~k~~~~d~~~~~~a~-----------------e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~  197 (725)
T KOG1093|consen  135 TESEYLEILLKYYTDDQELLSTAM-----------------EHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSF  197 (725)
T ss_pred             HHHHHHHHHHHhccCchhHHHHHH-----------------HHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccH
Confidence            666666555554433332211110                 012224577888999999999999999999999999999


Q ss_pred             cccC
Q 022799          241 DELR  244 (292)
Q Consensus       241 ~~~~  244 (292)
                      ..+.
T Consensus       198 ~ev~  201 (725)
T KOG1093|consen  198 TEVY  201 (725)
T ss_pred             HHHH
Confidence            8764

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=97.93  E-value=2.4e-05  Score=63.73  Aligned_cols=31  Identities=26%  Similarity=0.499  Sum_probs=25.3

Q ss_pred             CccccCCCCCcEEEeCC-CCcEEEeecCCccc
Q 022799           76 GVCHRDIKPQNLLVNPH-THQLKLCDFGSAKV  106 (292)
Q Consensus        76 ~i~H~dlkp~Nill~~~-~~~ikl~Dfg~a~~  106 (292)
                      .++|+|+++.||+++.+ +..+.|+||+.+..
T Consensus       175 ~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         175 GLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             EEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence            57999999999999873 22578999998753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=97.73  E-value=5.8e-05  Score=62.31  Aligned_cols=71  Identities=18%  Similarity=0.250  Sum_probs=49.8

Q ss_pred             eEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEeCCCCcEEEeecCCcc
Q 022799           26 YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  105 (292)
Q Consensus        26 ~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~  105 (292)
                      ...+|||+++|....-+        +++...+..++..|++-+.-+-.. |++|+|+++-||+++.+| .+.++||-.+.
T Consensus       181 RHaVvMe~ieG~eL~~~--------r~~~en~~~il~~il~~~~~~~~~-GiVHGDlSefNIlV~~dg-~~~vIDwPQ~v  250 (304)
T COG0478         181 RHAVVMEYIEGVELYRL--------RLDVENPDEILDKILEEVRKAYRR-GIVHGDLSEFNILVTEDG-DIVVIDWPQAV  250 (304)
T ss_pred             cceeeeehcccceeecc--------cCcccCHHHHHHHHHHHHHHHHHc-CccccCCchheEEEecCC-CEEEEeCcccc
Confidence            35799999998322111        112333455556666666655545 999999999999999998 69999997664


Q ss_pred             c
Q 022799          106 V  106 (292)
Q Consensus       106 ~  106 (292)
                      .
T Consensus       251 ~  251 (304)
T COG0478         251 P  251 (304)
T ss_pred             c
Confidence            3

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.68  E-value=0.00027  Score=64.49  Aligned_cols=74  Identities=24%  Similarity=0.312  Sum_probs=50.2

Q ss_pred             EEEEeecccC---CHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEeC---CCCcEEEee
Q 022799           27 LNLVLEYVPE---TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP---HTHQLKLCD  100 (292)
Q Consensus        27 ~~lv~e~~~g---~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlkp~Nill~~---~~~~ikl~D  100 (292)
                      -+|+||||+|   +-.+.+..     ..++...+...+.+...-.-+-  . |++|+|-+|.||++..   .+..+.+.|
T Consensus       277 RVLtME~~~G~~i~Dl~~i~~-----~gi~~~~i~~~l~~~~~~qIf~--~-GffHaDPHPGNilv~~~~~~~~~ivllD  348 (538)
T KOG1235|consen  277 RVLTMEYVDGIKINDLDAIDK-----RGISPHDILNKLVEAYLEQIFK--T-GFFHADPHPGNILVRPNPEGDEEIVLLD  348 (538)
T ss_pred             eEEEEEecCCccCCCHHHHHH-----cCCCHHHHHHHHHHHHHHHHHh--c-CCccCCCCCCcEEEecCCCCCccEEEEc
Confidence            6799999996   22234443     3455555555444444333333  4 9999999999999984   345899999


Q ss_pred             cCCccccc
Q 022799          101 FGSAKVLV  108 (292)
Q Consensus       101 fg~a~~~~  108 (292)
                      ||+...+.
T Consensus       349 hGl~~~is  356 (538)
T KOG1235|consen  349 HGLYAVIS  356 (538)
T ss_pred             cccccccc
Confidence            99987653

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=97.66  E-value=0.00018  Score=65.77  Aligned_cols=76  Identities=20%  Similarity=0.271  Sum_probs=48.8

Q ss_pred             EEEEeecccC-CHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEeCCCCcEEEeecCCcc
Q 022799           27 LNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  105 (292)
Q Consensus        27 ~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~  105 (292)
                      -.|+|||++| .+.+.....   ....+...+...+.++.---- + .. |++|.|.+|.||+++.++ .+.+.|||...
T Consensus       241 ~VLtmE~i~Gi~i~d~~~l~---~~g~d~k~ia~~~~~~f~~q~-~-~d-gffHaDpHpGNi~v~~~g-~i~~lDfGi~g  313 (517)
T COG0661         241 RVLTMEWIDGIKISDIAALK---SAGIDRKELAELLVRAFLRQL-L-RD-GFFHADPHPGNILVRSDG-RIVLLDFGIVG  313 (517)
T ss_pred             cEEEEEeeCCEecccHHHHH---hcCCCHHHHHHHHHHHHHHHH-H-hc-CccccCCCccceEEecCC-cEEEEcCccee
Confidence            5699999997 554443221   133443333332222221111 1 24 999999999999999998 79999999987


Q ss_pred             cccc
Q 022799          106 VLVK  109 (292)
Q Consensus       106 ~~~~  109 (292)
                      .+..
T Consensus       314 ~l~~  317 (517)
T COG0661         314 RLDP  317 (517)
T ss_pred             cCCH
Confidence            6643

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.60  E-value=0.00012  Score=58.27  Aligned_cols=90  Identities=22%  Similarity=0.193  Sum_probs=67.5

Q ss_pred             CCCC-CCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHH---HHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---c
Q 022799            3 LLDH-PNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRV---IKHHYKMSQRMPLIYVKLYFYQICRALAYIHN---T   74 (292)
Q Consensus         3 ~l~H-pnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~---l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~---~   74 (292)
                      .+.+ +++.+++|++     .    ..+|+||.+ +++...   +..    -...++.....++.+++..+.+|+.   .
T Consensus        15 ~l~~~~~~pk~lG~C-----G----~~~v~E~~~~~~~~~~~~~l~~----~~~~~w~~R~~iA~~lL~~l~~l~~~~~~   81 (188)
T PF12260_consen   15 LLQGSEPFPKLLGSC-----G----RFYVVEYVGAGSLYGIYRPLSQ----FLQSPWEQRAKIALQLLELLEELDHGPLG   81 (188)
T ss_pred             HcCCCCCCCCeeeEC-----C----CEEEEEeecCcccccccccccc----ccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            3444 5899999987     4    346889998 454321   111    1235788899999999999999985   3


Q ss_pred             CCccccCCCCCcEEEeCCCCcEEEeecCCcccc
Q 022799           75 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL  107 (292)
Q Consensus        75 ~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~  107 (292)
                       .+.-.|++++|+-++.++ ++|++|...+...
T Consensus        82 -~~~lcDv~~~nfgv~~~~-~lk~iDld~v~~~  112 (188)
T PF12260_consen   82 -FFYLCDVSPDNFGVNDDG-RLKLIDLDDVFVE  112 (188)
T ss_pred             -cEEEeecchHHeEEeCCC-cEEEEechhcchh
Confidence             467789999999999887 7999999876543

Proteins in this uncharacterised family are described as transmembrane proteins.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.56  E-value=0.00018  Score=58.86  Aligned_cols=74  Identities=18%  Similarity=0.270  Sum_probs=54.7

Q ss_pred             EEEEeecccCCH--HHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEeCCCCcEEEeecCCc
Q 022799           27 LNLVLEYVPETV--HRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  104 (292)
Q Consensus        27 ~~lv~e~~~g~L--~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a  104 (292)
                      -.|||||++...  .-.+.     .-.+...++..+..+++..+.-|-..+|+||+||+.-|||+. ++ .+.|+|||.|
T Consensus       141 nVLvMEfIg~~g~pAP~Lk-----Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~-~p~iID~~Qa  213 (268)
T COG1718         141 NVLVMEFIGDDGLPAPRLK-----DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DG-EPYIIDVSQA  213 (268)
T ss_pred             CeEEEEeccCCCCCCCCcc-----cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CC-eEEEEECccc
Confidence            469999998431  11111     122333367888889999999888745999999999999999 45 5999999988


Q ss_pred             ccc
Q 022799          105 KVL  107 (292)
Q Consensus       105 ~~~  107 (292)
                      ...
T Consensus       214 V~~  216 (268)
T COG1718         214 VTI  216 (268)
T ss_pred             ccc
Confidence            654

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.55  E-value=2.5e-05  Score=77.79  Aligned_cols=207  Identities=16%  Similarity=0.011  Sum_probs=131.5

Q ss_pred             CCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCC----c
Q 022799            3 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG----V   77 (292)
Q Consensus         3 ~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~----i   77 (292)
                      ...|++++....-....   ...-.+.+++||. |.+...+.........+....+.....+.+.+..-+|+.-+    -
T Consensus      1285 ~~~h~~~~~~p~rI~ps---~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~ 1361 (2724)
T KOG1826|consen 1285 EAKHYLTEVDPLRIPPS---ESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTN 1361 (2724)
T ss_pred             hhhceeeecccccCCCC---CChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccc
Confidence            45788888776543221   1222557899998 78888887665545555555554444444666666664323    5


Q ss_pred             cccCCCCCcEEEeCCCCcEEEeecCCcc-ccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCC
Q 022799           78 CHRDIKPQNLLVNPHTHQLKLCDFGSAK-VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPL  156 (292)
Q Consensus        78 ~H~dlkp~Nill~~~~~~ikl~Dfg~a~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~p  156 (292)
                      +|+++|+-|.++..+- .+++.++|+++ ...........++++.|+.|++... -.++.++|+|..|+.+|....|..+
T Consensus      1362 v~~~Lkf~lpmIVtny-~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~-ik~t~rsdilr~s~~ly~rs~~n~~ 1439 (2724)
T KOG1826|consen 1362 VSKSLKFTLPMIVTNY-NVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNE-IKFTKRSDILRRSLSLYLRSDGNAY 1439 (2724)
T ss_pred             hhhhhhhhccceecCC-cccccccccccccCchHhhhhhhhCCHHHHHHHHHHH-HhhhhHHHHHHHHHHHHHHhcccHH
Confidence            7899999999998776 79999999998 3222222345577889999998743 3478889999999999999988877


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      |.     ...+...+           +.-.+.....            .+.-.|.+.-.....+|-+.-..||.-...+.
T Consensus      1440 fi-----~flq~~Lk-----------giidn~tf~s------------Ie~l~pgdaNve~~~~Ll~K~~~rp~q~isls 1491 (2724)
T KOG1826|consen 1440 FI-----FFLQPALK-----------GIIDNHTFFS------------IEKLKPGDANVEALHRLLWKYMERPGQYISLS 1491 (2724)
T ss_pred             HH-----HHHHHHHc-----------Cccccccccc------------ccccCCCcccHHHHHHHHHHhhhcchhhhhcc
Confidence            62     11111111           1111111111            11123444555555566666678899888888


Q ss_pred             CCCccc
Q 022799          237 HPFFDE  242 (292)
Q Consensus       237 hp~~~~  242 (292)
                      .+.|..
T Consensus      1492 ~d~~a~ 1497 (2724)
T KOG1826|consen 1492 RDHFAV 1497 (2724)
T ss_pred             cccccc
Confidence            777753

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=97.01  E-value=0.0027  Score=54.93  Aligned_cols=76  Identities=17%  Similarity=0.296  Sum_probs=61.5

Q ss_pred             CCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEeCCCCcEEEeec
Q 022799           22 KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  101 (292)
Q Consensus        22 ~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlkp~Nill~~~~~~ikl~Df  101 (292)
                      .+..+.|++|++-++++...        .....+++..++++.+.-+.-+..++..=||++..+||+++ +| +|.|+||
T Consensus       296 de~~y~yl~~kdhgt~is~i--------k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~G-nvtLIDf  365 (488)
T COG5072         296 DETLYLYLHFKDHGTPISII--------KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EG-NVTLIDF  365 (488)
T ss_pred             CCceEEEEEEecCCceeeee--------ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cC-ceEEEEe
Confidence            45668899999988765432        22345678889999988888888888899999999999999 67 7999999


Q ss_pred             CCcccc
Q 022799          102 GSAKVL  107 (292)
Q Consensus       102 g~a~~~  107 (292)
                      -+++.-
T Consensus       366 klsRl~  371 (488)
T COG5072         366 KLSRLS  371 (488)
T ss_pred             eeeecc
Confidence            999843

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=96.61  E-value=0.011  Score=48.45  Aligned_cols=28  Identities=21%  Similarity=0.247  Sum_probs=24.4

Q ss_pred             CccccCCCCCcEEEeCCCCcEEEeecCCcc
Q 022799           76 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  105 (292)
Q Consensus        76 ~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~  105 (292)
                      .++|+|+.|.||+++.++  +.++||+.+.
T Consensus       154 ~~~HgD~~~~Nii~~~~~--~~iIDwe~a~  181 (226)
T TIGR02172       154 TCLHGDFQIGNLITSGKG--TYWIDLGDFG  181 (226)
T ss_pred             ceEecCCCCCcEEEcCCC--cEEEechhcC
Confidence            578999999999998755  8999998774

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=96.47  E-value=0.032  Score=44.72  Aligned_cols=82  Identities=20%  Similarity=0.320  Sum_probs=54.2

Q ss_pred             CCCCCeeeeceeeeccCCCCceeEEEEeeccc---C----CHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 022799            4 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP---E----TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG   76 (292)
Q Consensus         4 l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~---g----~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~   76 (292)
                      ..+.+|.++++...+.-+     ..+|+|.+.   |    +|.+++.+     +.++. ....   .+-.-..||-++ +
T Consensus        74 ~~~~~i~r~~G~veT~~G-----~Glv~e~I~d~dG~~s~TL~~~l~~-----~~~~~-~~~~---~L~~f~~~l~~~-~  138 (199)
T PF10707_consen   74 VDWSHIPRFYGFVETNLG-----LGLVVELIRDADGNISPTLEDYLKE-----GGLTE-ELRQ---ALDEFKRYLLDH-H  138 (199)
T ss_pred             CcccccccEeEEEecCCc-----eEEEEEEEECCCCCcCccHHHHHHc-----CCccH-HHHH---HHHHHHHHHHHc-C
Confidence            457789999998744333     677888763   3    66666643     44555 3332   333456677777 9


Q ss_pred             ccccCCCCCcEEEeCC--CC-cEEEee
Q 022799           77 VCHRDIKPQNLLVNPH--TH-QLKLCD  100 (292)
Q Consensus        77 i~H~dlkp~Nill~~~--~~-~ikl~D  100 (292)
                      |+.+|++|.||++...  +. .+.|+|
T Consensus       139 Iv~~dl~~~NIv~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  139 IVIRDLNPHNIVVQRRDSGEFRLVLID  165 (199)
T ss_pred             CeecCCCcccEEEEecCCCceEEEEEe
Confidence            9999999999999543  22 467776

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PLN02876 acyl-CoA dehydrogenase

Probab=95.33  E-value=0.032  Score=54.75  Aligned_cols=31  Identities=23%  Similarity=0.539  Sum_probs=24.6

Q ss_pred             CccccCCCCCcEEEeCC-CCcEEEeecCCccc
Q 022799           76 GVCHRDIKPQNLLVNPH-THQLKLCDFGSAKV  106 (292)
Q Consensus        76 ~i~H~dlkp~Nill~~~-~~~ikl~Dfg~a~~  106 (292)
                      .++|+|+++.|++++.+ +..+-|.||.++..
T Consensus       226 ~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~  257 (822)
T PLN02876        226 GIVHGDFRIDNLVFHPTEDRVIGILDWELSTL  257 (822)
T ss_pred             ceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence            59999999999999853 32357899998764

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=94.98  E-value=0.022  Score=48.79  Aligned_cols=69  Identities=17%  Similarity=0.242  Sum_probs=48.7

Q ss_pred             eeEEEEeecccC-CHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEeCCCCcEEEeecCC
Q 022799           25 LYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  103 (292)
Q Consensus        25 ~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~  103 (292)
                      ...|+|||++.| .|...-.       ..   -+..+...++.-+.-|..+ |+||+|+.-=||+++.++ .++++||-.
T Consensus       181 ~RH~Vvmelv~g~Pl~~v~~-------v~---d~~~ly~~lm~~Iv~la~~-GlIHgDFNEFNimv~dd~-~i~vIDFPQ  248 (465)
T KOG2268|consen  181 NRHCVVMELVDGYPLRQVRH-------VE---DPPTLYDDLMGLIVRLANH-GLIHGDFNEFNIMVKDDD-KIVVIDFPQ  248 (465)
T ss_pred             cceeeHHHhhcccceeeeee-------cC---ChHHHHHHHHHHHHHHHHc-CceecccchheeEEecCC-CEEEeechH
Confidence            347899999987 5433321       11   1334444556666777777 999999999999999877 699999965


Q ss_pred             cc
Q 022799          104 AK  105 (292)
Q Consensus       104 a~  105 (292)
                      ..
T Consensus       249 mv  250 (465)
T KOG2268|consen  249 MV  250 (465)
T ss_pred             hh
Confidence            43

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=94.88  E-value=0.042  Score=45.17  Aligned_cols=29  Identities=28%  Similarity=0.536  Sum_probs=25.3

Q ss_pred             CccccCCCCCcEEEeC-CCCcEEEeecCCcc
Q 022799           76 GVCHRDIKPQNLLVNP-HTHQLKLCDFGSAK  105 (292)
Q Consensus        76 ~i~H~dlkp~Nill~~-~~~~ikl~Dfg~a~  105 (292)
                      +++|+|+.+.||+++. ++ .+.++||..|.
T Consensus       171 ~l~H~Dl~~~Nil~~~~~~-~~~lIDwe~a~  200 (235)
T cd05157         171 VFCHNDLLSGNIIYNEEKN-SVKFIDYEYAG  200 (235)
T ss_pred             EEEcCCCCcCcEEEeCCCC-CEEEEEcccCC
Confidence            6999999999999997 34 69999998774

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=94.87  E-value=0.06  Score=46.15  Aligned_cols=30  Identities=33%  Similarity=0.566  Sum_probs=25.7

Q ss_pred             CCccccCCCCCcEEEeCC----CCcEEEeecCCcc
Q 022799           75 IGVCHRDIKPQNLLVNPH----THQLKLCDFGSAK  105 (292)
Q Consensus        75 ~~i~H~dlkp~Nill~~~----~~~ikl~Dfg~a~  105 (292)
                      .+++|+|+.+.||+++.+    + .+.++||..|.
T Consensus       179 ~~lcH~Dl~~~Nil~~~~~~~~~-~i~lIDwEya~  212 (302)
T cd05156         179 VVFCHNDLQEGNILLLNPSSETK-KLVLIDFEYAS  212 (302)
T ss_pred             ceEEecCCCcCeEEecCCCCCCC-cEEEEeeCCCC
Confidence            378999999999999874    5 69999998774

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=94.68  E-value=0.068  Score=45.98  Aligned_cols=30  Identities=33%  Similarity=0.416  Sum_probs=25.9

Q ss_pred             CCccccCCCCCcEEEeCCCCcEEEeecCCcc
Q 022799           75 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  105 (292)
Q Consensus        75 ~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~  105 (292)
                      .+++|+|+++.|++++.++ .+.|+||+.+.
T Consensus       187 ~~l~HgD~~~~Nvl~~~~~-~~~vIDfd~~~  216 (307)
T TIGR00938       187 RGVIHADLFPDNVLFDGDS-VKGVIDFYFAC  216 (307)
T ss_pred             CccCCCCCCcCcEEEECCc-eEEEeeccccc
Confidence            3899999999999999876 56899998763

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK05231 homoserine kinase; Provisional

Probab=94.63  E-value=0.029  Score=48.49  Aligned_cols=29  Identities=31%  Similarity=0.327  Sum_probs=24.7

Q ss_pred             CccccCCCCCcEEEeCCCCcEEEeecCCcc
Q 022799           76 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  105 (292)
Q Consensus        76 ~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~  105 (292)
                      |++|+|+.|.||+++.+. ..-|+||+.+.
T Consensus       188 ~liHgD~~~~Nil~~~~~-~~~iIDf~~~~  216 (319)
T PRK05231        188 GVIHADLFRDNVLFEGDR-LSGFIDFYFAC  216 (319)
T ss_pred             ccCCCCCCCCcEEEECCc-eEEEEeccccc
Confidence            899999999999998654 45799999774

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=94.43  E-value=0.1  Score=44.79  Aligned_cols=29  Identities=28%  Similarity=0.582  Sum_probs=24.7

Q ss_pred             CCccccCCCCCcEEEeCCCCcEEEeecCCcc
Q 022799           75 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  105 (292)
Q Consensus        75 ~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~  105 (292)
                      .+++|+|+.+.||+++. + .+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~-~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-N-EVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-C-cEEEEECcccc
Confidence            38999999999999987 4 58999998653

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PRK10271 thiK thiamine kinase; Provisional

Probab=94.19  E-value=0.046  Score=43.23  Aligned_cols=29  Identities=28%  Similarity=0.350  Sum_probs=24.8

Q ss_pred             CccccCCCCCcEEEeCCCCcEEEeecCCccc
Q 022799           76 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  106 (292)
Q Consensus        76 ~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~  106 (292)
                      ..+|+|+.|.|++++.++  ++++||+.+..
T Consensus        78 ~p~H~D~~~~N~~~~~~~--~~lIDwe~a~~  106 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG--LRLIDWEYAGD  106 (188)
T ss_pred             eeecCCCCCccEEEECCC--EEEEeCCcccC
Confidence            458999999999998765  89999998854

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=94.09  E-value=0.044  Score=45.15  Aligned_cols=29  Identities=34%  Similarity=0.441  Sum_probs=24.1

Q ss_pred             CccccCCCCCcEEEeCCCCcEEEeecCCcc
Q 022799           76 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  105 (292)
Q Consensus        76 ~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~  105 (292)
                      +++|+|+.+.||+++.++ ..-|+||+.+.
T Consensus       165 ~l~HGD~~~~Nvlv~~~~-i~giIDw~~a~  193 (235)
T cd05155         165 VWFHGDLAPGNLLVQDGR-LSAVIDFGCLG  193 (235)
T ss_pred             eEEeCCCCCCcEEEECCC-EEEEEeCcccC
Confidence            689999999999998654 45699999764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=93.74  E-value=0.038  Score=45.02  Aligned_cols=29  Identities=31%  Similarity=0.582  Sum_probs=19.8

Q ss_pred             CccccCCCCCcEEEe-CCCCcEEEeecCCcc
Q 022799           76 GVCHRDIKPQNLLVN-PHTHQLKLCDFGSAK  105 (292)
Q Consensus        76 ~i~H~dlkp~Nill~-~~~~~ikl~Dfg~a~  105 (292)
                      .++|+|+.|.||+++ .++ .+-|+||+.+.
T Consensus       167 ~~~HgD~~~~Nil~~~~~~-~i~iID~e~a~  196 (239)
T PF01636_consen  167 VLIHGDLHPGNILVDPSDG-RIGIIDFEDAG  196 (239)
T ss_dssp             EEE-SS-SGGGEEEESSTT-EEEE--GTT-E
T ss_pred             EEEEeccccccceeeeccc-eeEEEecccce
Confidence            699999999999999 444 56799998764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=93.57  E-value=0.056  Score=46.14  Aligned_cols=29  Identities=31%  Similarity=0.341  Sum_probs=25.1

Q ss_pred             CccccCCCCCcEEEeCCCCcEEEeecCCcc
Q 022799           76 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  105 (292)
Q Consensus        76 ~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~  105 (292)
                      +++|+|+.|.|++++.++ .+.|+||+.+.
T Consensus       176 ~l~HgD~~~~Nil~~~~~-~~~iIDfe~a~  204 (296)
T cd05153         176 GVIHADLFRDNVLFDGDE-LSGVIDFYFAC  204 (296)
T ss_pred             cCCccCcCcccEEEeCCc-eEEEeehhhhc
Confidence            799999999999999865 46899998764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=93.11  E-value=0.17  Score=42.62  Aligned_cols=49  Identities=29%  Similarity=0.466  Sum_probs=34.5

Q ss_pred             HHHHHHHHHHHHHHHHhc-CCccccCCCCCcEEEeCCCCcEEEeecCCccc
Q 022799           57 VKLYFYQICRALAYIHNT-IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  106 (292)
Q Consensus        57 ~~~~~~qil~al~~LH~~-~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~  106 (292)
                      ....+..+-.++.-.+.. .-++|+|+.|+|++.+..+ .++|+||..|..
T Consensus       134 ~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~-~l~LIDWEyAg~  183 (269)
T COG0510         134 LRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKG-GLFLIDWEYAGL  183 (269)
T ss_pred             HHHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCC-cEEEEecccCCC
Confidence            333444444555555522 2489999999999999866 699999988754

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=92.75  E-value=0.097  Score=43.30  Aligned_cols=29  Identities=28%  Similarity=0.351  Sum_probs=25.0

Q ss_pred             CccccCCCCCcEEEeCCCCcEEEeecCCcc
Q 022799           76 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  105 (292)
Q Consensus        76 ~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~  105 (292)
                      .++|+|+.|.||+++.++ .+.|+||+.+.
T Consensus       164 ~l~HgD~~~~Nil~~~~~-~~~iIDwe~a~  192 (244)
T cd05150         164 VVTHGDACLPNIIVDPGK-FSGFIDLGRLG  192 (244)
T ss_pred             EEECCCCCCccEEEeCCc-EEEEEEccccc
Confidence            589999999999999865 57899998764

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>TIGR02721 ycfN_thiK thiamine kinase

Probab=92.66  E-value=0.089  Score=43.91  Aligned_cols=29  Identities=38%  Similarity=0.518  Sum_probs=25.2

Q ss_pred             CccccCCCCCcEEEeCCCCcEEEeecCCccc
Q 022799           76 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  106 (292)
Q Consensus        76 ~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~  106 (292)
                      .++|+|+.|.||+++.++  +.++||..+..
T Consensus       147 ~l~H~Dl~~~Nil~~~~~--~~lIDwE~a~~  175 (256)
T TIGR02721       147 APLHMDVHAYNLVVTPQG--LKLIDWEYASD  175 (256)
T ss_pred             eeecCCCCcCcEEEeCCC--CEEEeccccCc
Confidence            589999999999999766  78999988754

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=92.52  E-value=0.11  Score=41.90  Aligned_cols=30  Identities=40%  Similarity=0.717  Sum_probs=19.8

Q ss_pred             CccccCCCCCcEEE-eCCCCcEEEeecCCccc
Q 022799           76 GVCHRDIKPQNLLV-NPHTHQLKLCDFGSAKV  106 (292)
Q Consensus        76 ~i~H~dlkp~Nill-~~~~~~ikl~Dfg~a~~  106 (292)
                      .++|+|+.+.||++ +.++ .++++||..|..
T Consensus       144 v~cHnDl~~~Nil~~~~~~-~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDG-EVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSS-CEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCC-eEEEecHHHHhh
Confidence            68999999999999 5555 799999988754

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PLN02236 choline kinase

Probab=92.50  E-value=0.2  Score=43.90  Aligned_cols=31  Identities=26%  Similarity=0.645  Sum_probs=25.9

Q ss_pred             CccccCCCCCcEEEeCCCCcEEEeecCCccc
Q 022799           76 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  106 (292)
Q Consensus        76 ~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~  106 (292)
                      .++|+|+++.||+++.+...+.++||..+..
T Consensus       201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        201 GFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             eEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            6899999999999986433799999988753

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=92.32  E-value=0.26  Score=42.47  Aligned_cols=29  Identities=14%  Similarity=0.192  Sum_probs=25.9

Q ss_pred             CccccCCCCCcEEEeCCCCcEEEeecCCcc
Q 022799           76 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  105 (292)
Q Consensus        76 ~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~  105 (292)
                      +++|+|+.++|++++.++ .+.++||..+.
T Consensus       197 ~lcHgD~~~~Nvl~~~~~-~~~iIDfd~~~  225 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETR-GGYFINFEKAS  225 (309)
T ss_pred             eeeCCCCcHHhEEEcCCC-CEEEEEhhhcc
Confidence            799999999999998877 68999998774

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=92.13  E-value=0.15  Score=41.46  Aligned_cols=39  Identities=26%  Similarity=0.336  Sum_probs=32.7

Q ss_pred             HHHHHHHH-hcCCccccCCCCCcEEEeCCCCcEEEeecCCc
Q 022799           65 CRALAYIH-NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  104 (292)
Q Consensus        65 l~al~~LH-~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a  104 (292)
                      +.+|...| ++.+.+|+|..|+||+-++.| .+||.|-+.-
T Consensus       151 i~~L~~fH~~~~~~lHGD~np~NiM~D~~G-~lKlVDP~~L  190 (308)
T PF07387_consen  151 IKDLMDFHSENQHCLHGDCNPDNIMCDKFG-YLKLVDPVCL  190 (308)
T ss_pred             HHHHHHhhccCCCeecCCCChhheeecCCC-CEEecChhhh
Confidence            56788888 455799999999999999998 7999997643

The function of this family is unknown.

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=92.00  E-value=0.25  Score=42.91  Aligned_cols=29  Identities=31%  Similarity=0.551  Sum_probs=24.6

Q ss_pred             ccccCCCCCcEEEeCCCCcEEEeecCCcc
Q 022799           77 VCHRDIKPQNLLVNPHTHQLKLCDFGSAK  105 (292)
Q Consensus        77 i~H~dlkp~Nill~~~~~~ikl~Dfg~a~  105 (292)
                      +||+|+.|+||+++.+...+.+.||+-+.
T Consensus       199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             eeecCCCccceeEcCCCCeeeEEEccccc
Confidence            99999999999999765227899998764

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=91.89  E-value=0.13  Score=43.66  Aligned_cols=31  Identities=29%  Similarity=0.517  Sum_probs=25.0

Q ss_pred             CccccCCCCCcEEEeCCCCcEEEeecCCccc
Q 022799           76 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  106 (292)
Q Consensus        76 ~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~  106 (292)
                      .++|+|+++.||+++.++...-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            5899999999999987552356999998753

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PHA03111 Ser/Thr kinase; Provisional

Probab=91.62  E-value=0.51  Score=40.77  Aligned_cols=63  Identities=21%  Similarity=0.330  Sum_probs=36.5

Q ss_pred             EEEeecccCCHHHHHH-hhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---cCCccccCCCCCcEEEe
Q 022799           28 NLVLEYVPETVHRVIK-HHYKMSQRMPLIYVKLYFYQICRALAYIHN---TIGVCHRDIKPQNLLVN   90 (292)
Q Consensus        28 ~lv~e~~~g~L~~~l~-~~~~~~~~~~~~~~~~~~~qil~al~~LH~---~~~i~H~dlkp~Nill~   90 (292)
                      .+|++.+.++-.++-. .....+-..-.+.++.++.||+.-.-..-+   ..+.+|-||||+|||+-
T Consensus       251 IIIfPLArcSadkv~~~~~~e~GF~s~~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiF  317 (444)
T PHA03111        251 IIIFPLARCSADKVTEENAAELGFKSLVEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIF  317 (444)
T ss_pred             EEEEehhhcccccCCHHHHHHcCCccHHHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEe
Confidence            3788876533222211 111112233456788889998765433311   12799999999999983

>smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain

Probab=91.34  E-value=0.18  Score=40.37  Aligned_cols=30  Identities=20%  Similarity=0.337  Sum_probs=24.6

Q ss_pred             CccccCCCCCcEEEeCCCC----cEEEeecCCcc
Q 022799           76 GVCHRDIKPQNLLVNPHTH----QLKLCDFGSAK  105 (292)
Q Consensus        76 ~i~H~dlkp~Nill~~~~~----~ikl~Dfg~a~  105 (292)
                      .++|||+.+.|+++..++.    .+.+.||..+.
T Consensus       121 vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~  154 (196)
T smart00587      121 VLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH  154 (196)
T ss_pred             EEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence            7899999999999975431    48899998774

subfamily of choline kinases

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=91.28  E-value=0.45  Score=41.82  Aligned_cols=73  Identities=18%  Similarity=0.236  Sum_probs=56.3

Q ss_pred             EEEEeecccCCH--HHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEeCCCCcEEEeecCCc
Q 022799           27 LNLVLEYVPETV--HRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  104 (292)
Q Consensus        27 ~~lv~e~~~g~L--~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a  104 (292)
                      .+|||++++++-  .-.+.     ...++...+..+-.|++.-+.-|-..+++||.||+--|+|+-. | .+.++|.+.+
T Consensus       239 hVLVM~FlGrdgw~aPkLK-----d~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyhd-G-~lyiIDVSQS  311 (520)
T KOG2270|consen  239 HVLVMEFLGRDGWAAPKLK-----DASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHD-G-KLYIIDVSQS  311 (520)
T ss_pred             ceEeeeeccCCCCcCcccc-----cccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEEC-C-EEEEEEcccc
Confidence            569999998421  11222     3456777888888899988888887889999999999999874 4 5999998877


Q ss_pred             cc
Q 022799          105 KV  106 (292)
Q Consensus       105 ~~  106 (292)
                      ..
T Consensus       312 VE  313 (520)
T KOG2270|consen  312 VE  313 (520)
T ss_pred             cc
Confidence            54

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=89.96  E-value=0.25  Score=42.99  Aligned_cols=30  Identities=27%  Similarity=0.435  Sum_probs=25.3

Q ss_pred             ccccCCCCCcEEEeCCCCcEEEeecCCccc
Q 022799           77 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  106 (292)
Q Consensus        77 i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~  106 (292)
                      .+|.|+.+.||+++.++..++++||..|..
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            799999999999975543799999998753

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=89.10  E-value=0.6  Score=37.46  Aligned_cols=80  Identities=25%  Similarity=0.399  Sum_probs=51.6

Q ss_pred             CCCCCCCe--eeeceeeeccC-------------CCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHH
Q 022799            2 RLLDHPNV--VSLKHCFFSTT-------------EKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR   66 (292)
Q Consensus         2 ~~l~HpnI--v~~~~~~~~~~-------------~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~   66 (292)
                      +.+.+.++  |+++++..-..             ........||.||+...-            .+....    +.+|+.
T Consensus       112 ke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~~~----~~~~~~  175 (207)
T PF13095_consen  112 KEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQIRD----IPQMLR  175 (207)
T ss_pred             HhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccchhH----HHHHHH
Confidence            34455566  77777653221             012234567888876431            122222    447888


Q ss_pred             HHHHHHhcCCccccCCCCCcEEEeCCCCcEEEeecCCc
Q 022799           67 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA  104 (292)
Q Consensus        67 al~~LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a  104 (292)
                      -+..+|.. ||+-+|+++.|..   +|   +|+|||.+
T Consensus       176 dl~~~~k~-gI~~~Dv~~~ny~---~G---~lvDfs~~  206 (207)
T PF13095_consen  176 DLKILHKL-GIVPRDVKPRNYR---GG---KLVDFSSS  206 (207)
T ss_pred             HHHHHHHC-CeeeccCcccccc---CC---EEEecccC
Confidence            89999976 9999999999975   33   89999864

>PRK06148 hypothetical protein; Provisional

Probab=87.83  E-value=0.79  Score=46.22  Aligned_cols=31  Identities=35%  Similarity=0.460  Sum_probs=25.2

Q ss_pred             CccccCCCCCcEEEeCCC--CcEEEeecCCccc
Q 022799           76 GVCHRDIKPQNLLVNPHT--HQLKLCDFGSAKV  106 (292)
Q Consensus        76 ~i~H~dlkp~Nill~~~~--~~ikl~Dfg~a~~  106 (292)
                      ++||+|+.+.||+++.++  ...-|+|||-+..
T Consensus       204 ~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        204 QVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             ceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            899999999999998764  2344999998754

>PRK06149 hypothetical protein; Provisional

Probab=87.76  E-value=0.78  Score=46.09  Aligned_cols=31  Identities=23%  Similarity=0.297  Sum_probs=24.8

Q ss_pred             CccccCCCCCcEEEeCCC----CcEEEeecCCccc
Q 022799           76 GVCHRDIKPQNLLVNPHT----HQLKLCDFGSAKV  106 (292)
Q Consensus        76 ~i~H~dlkp~Nill~~~~----~~ikl~Dfg~a~~  106 (292)
                      |+||+|++++||+++.+.    ...-|+|||-+..
T Consensus       209 g~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~~~  243 (972)
T PRK06149        209 QAVHLDITDDNVVGSRDADGRWQPDGVIDFGDLVR  243 (972)
T ss_pred             cccCCCCCcccEEEcCCCCCCcceeEEEEcccchh
Confidence            899999999999998652    1247899997653

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=87.35  E-value=0.8  Score=39.80  Aligned_cols=61  Identities=21%  Similarity=0.384  Sum_probs=34.7

Q ss_pred             EEeecccCCHHHHHHhh-hhcCCCCCHHHHHHHHHHHHHHHH---HHHhcCCccccCCCCCcEEE
Q 022799           29 LVLEYVPETVHRVIKHH-YKMSQRMPLIYVKLYFYQICRALA---YIHNTIGVCHRDIKPQNLLV   89 (292)
Q Consensus        29 lv~e~~~g~L~~~l~~~-~~~~~~~~~~~~~~~~~qil~al~---~LH~~~~i~H~dlkp~Nill   89 (292)
                      +|++.+-++-.++-... ...+-..-...++.++.||+.-.-   .|-...+.+|-||||+|||+
T Consensus       248 IIfPLA~~Sadkv~~~~~~e~GF~s~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILi  312 (434)
T PF05445_consen  248 IIFPLARCSADKVTESNAAELGFKSNVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILI  312 (434)
T ss_pred             EEEehhhcchhhcCHHHHHhcCchhHHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEE
Confidence            78887654322221111 111222345567888888765331   12112279999999999998

; GO: 0004672 protein kinase activity, 0005524 ATP binding

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=86.97  E-value=0.57  Score=40.44  Aligned_cols=30  Identities=27%  Similarity=0.513  Sum_probs=26.6

Q ss_pred             CccccCCCCCcEEEeCCCCcEEEeecCCccc
Q 022799           76 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  106 (292)
Q Consensus        76 ~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~  106 (292)
                      .++|+|+.+.|++++.++ .+-+.||+.+..
T Consensus       199 ~lvHGD~~~gNlii~~~~-~~gVlDwe~~~l  228 (321)
T COG3173         199 VLVHGDYRPGNLIIDPGR-PTGVLDWELATL  228 (321)
T ss_pred             eeeeCCcccCCEEEeCCC-eeEEEecccccc
Confidence            489999999999999887 489999998864

>PRK12396 5-methylribose kinase; Reviewed

Probab=86.96  E-value=0.58  Score=41.65  Aligned_cols=35  Identities=20%  Similarity=0.297  Sum_probs=27.2

Q ss_pred             HHHhcCCccccCCCCCcEEEeCCCCcEEEeecCCccc
Q 022799           70 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  106 (292)
Q Consensus        70 ~LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~  106 (292)
                      |+-+.-..+|||++|.||+++.++  +|++|..+|..
T Consensus       222 F~~~~~aLlHGDlHtGSI~v~~~~--~kvIDpEFAfy  256 (409)
T PRK12396        222 FMTNAQALIHGDLHTGSVFVKNDS--TKVIDPEFAFY  256 (409)
T ss_pred             HHhcchhhccCcCCCCCEEecCCc--eEEEccccccc
Confidence            333333789999999999999865  89999877643

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=86.90  E-value=0.58  Score=41.81  Aligned_cols=29  Identities=21%  Similarity=0.235  Sum_probs=25.0

Q ss_pred             CccccCCCCCcEEEeCCCCcEEEeecCCccc
Q 022799           76 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  106 (292)
Q Consensus        76 ~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~  106 (292)
                      .++|||+.+.||++..++  ++++||-++..
T Consensus       224 ~l~HgDl~~gni~~~~~~--~~viD~E~a~~  252 (401)
T PRK09550        224 ALLHGDLHTGSIFVTEEE--TKVIDPEFAFY  252 (401)
T ss_pred             ceeeccCCcccEEeeCCC--cEEEecccccc
Confidence            689999999999998764  89999987653

>PRK11768 serine/threonine protein kinase; Provisional

Probab=86.73  E-value=0.41  Score=41.60  Aligned_cols=27  Identities=26%  Similarity=0.350  Sum_probs=22.9

Q ss_pred             CccccCCCCCcEEEeCCCCcEEEeecCCcc
Q 022799           76 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  105 (292)
Q Consensus        76 ~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~  105 (292)
                      +++|+|+.+.||+++ ++  +.++||+.+.
T Consensus       197 ~liHgD~h~~NvL~~-d~--~~iIDFDd~~  223 (325)
T PRK11768        197 LRLHGDCHPGNILWR-DG--PHFVDLDDAR  223 (325)
T ss_pred             cceecCCCchhcccc-CC--cEEEeCCCCC
Confidence            789999999999995 33  7899998763

>KOG2464 consensus Serine/threonine kinase (haspin family) [Cell cycle control, cell division, chromosome partitioning]

Probab=85.65  E-value=2.9  Score=34.77  Aligned_cols=42  Identities=24%  Similarity=0.355  Sum_probs=37.4

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEeCCC
Q 022799           52 MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHT   93 (292)
Q Consensus        52 ~~~~~~~~~~~qil~al~~LH~~~~i~H~dlkp~Nill~~~~   93 (292)
                      .+..++..++.|+...+.-..++.++.|||+.+.||+++..+
T Consensus       134 ~~~~~~~si~~q~~~~l~i~~~~~~~~hrdl~~gnili~k~~  175 (246)
T KOG2464|consen  134 ESKNQALSIFWQLVLSLAIAEKSLGFEHRDLHLGNILIKKTG  175 (246)
T ss_pred             ccHHHHHHHHHHHHHHHHHhhhhhcccccccCcCcEEEeccc
Confidence            466788899999999999999988999999999999998754

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=85.16  E-value=0.6  Score=41.02  Aligned_cols=29  Identities=24%  Similarity=0.289  Sum_probs=24.7

Q ss_pred             CccccCCCCCcEEEeCCCCcEEEeecCCccc
Q 022799           76 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  106 (292)
Q Consensus        76 ~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~  106 (292)
                      .++|||+.+.||+++.++  ++++|+.++..
T Consensus       193 ~llHGDl~~gNi~~~~~~--~~~iD~e~~~~  221 (370)
T TIGR01767       193 TLLHGDLHSGSIFVSEHE--TKVIDPEFAFY  221 (370)
T ss_pred             eeeeccCCcccEEEcCCC--CEEEcCccccc
Confidence            789999999999998755  78999987653

This enzyme is involved in the methionine salvage pathway in certain bacteria.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	292
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-119
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-119
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-119
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-119
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-119
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-119
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-119
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-118
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-118
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-118
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-118
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-118
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-117
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-117
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-117
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-117
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-117
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-117
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-116
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-116
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-115
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-113
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		6e-81
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		2e-75
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		7e-41
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-39
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		4e-39
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		8e-39
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		8e-39
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		9e-39
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		9e-39
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-38
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-38
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-38
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-38
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-38
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-38
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-38
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-38
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-38
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-38
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-38
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-38
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-38
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-38
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-38
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-38
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		5e-38
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-38
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		8e-38
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		8e-38
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		9e-38
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-36
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-36
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-36
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-36
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-36
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		4e-36
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		8e-36
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-35
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-35
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-35
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-35
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-35
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-35
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-35
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-35
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-35
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-35
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-35
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-35
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-35
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-35
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-35
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-35
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-35
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-35
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-35
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		3e-35
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-35
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-35
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-35
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-35
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		3e-35
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		3e-35
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-35
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-35
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		4e-35
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-35
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		7e-35
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		7e-35
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		7e-35
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		8e-35
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-34
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-34
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-34
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-34
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-34
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-34
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-34
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-34
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-34
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-34
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		4e-34
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		5e-34
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		5e-34
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		6e-34
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		8e-34
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		9e-34
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		9e-34
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		9e-34
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		9e-34
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-33
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-33
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-33
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-33
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-33
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-33
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-33
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-33
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-33
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-33
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-33
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-33
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-33
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-33
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-33
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-33
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-33
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-33
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-33
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-33
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-33
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-33
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-33
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-33
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-33
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-33
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-33
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-33
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-33
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-33
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-33
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-33
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-33
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-33
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-33
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-33
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-33
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-33
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		4e-33
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		4e-33
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		5e-33
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		7e-33
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-32
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-32
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-32
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-32
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-32
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-32
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-32
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		4e-32
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		1e-31
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		2e-31
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-31
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		7e-31
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		9e-31
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		9e-31
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		9e-31
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		1e-30
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		2e-30
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		2e-30
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-30
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-30
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		2e-30
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		2e-30
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		2e-30
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		2e-30
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		2e-30
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		3e-30
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-30
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		9e-30
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-29
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		1e-29
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-29
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-29
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		2e-29
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		3e-29
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		3e-29
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		4e-29
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-29
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		4e-29
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		5e-29
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		7e-29
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		8e-29
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		9e-29
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		9e-29
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		9e-29
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		1e-28
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		1e-28
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-28
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		1e-28
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		1e-28
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		1e-28
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		1e-28
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		1e-28
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		1e-28
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		1e-28
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		1e-28
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		1e-28
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-28
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-28
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		2e-28
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-28
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-28
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-28
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		2e-28
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-28
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-28
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-28
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-28
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-28
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		2e-28
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-28
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-28
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		7e-28
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-27
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-27
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-27
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		7e-27
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-26
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		3e-26
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		1e-25
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		5e-25
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		6e-25
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-24
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-23
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-23
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-23
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-23
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		3e-22
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		4e-22
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-21
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		3e-21
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		1e-20
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		1e-20
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		2e-19
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		3e-19
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		7e-19
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		7e-19
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		8e-19
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		8e-19
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		8e-19
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-18
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-18
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-18
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		7e-18
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		8e-18
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		9e-18
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		9e-18
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-17
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-17
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-17
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		2e-17
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-17
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-17
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		4e-17
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		4e-17
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		5e-17
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		6e-17
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-16
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-16
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-16
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-16
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-16
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-16
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-16
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-16
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-16
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		3e-16
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-16
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-16
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-16
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		3e-16
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-16
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-16
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-16
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		4e-16
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		4e-16
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		4e-16
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		5e-16
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		5e-16
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		5e-16
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		5e-16
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		5e-16
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		6e-16
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		6e-16
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		6e-16
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		6e-16
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		7e-16
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		7e-16
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		8e-16
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		9e-16
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		9e-16
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		9e-16
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		1e-15
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-15
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-15
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-15
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-15
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-15
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-15
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-15
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		1e-15
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-15
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-15
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-15
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-15
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-15
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-15
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-15
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-15
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-15
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		3e-15
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		3e-15
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-15
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-15
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-15
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-15
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-15
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		3e-15
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-15
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-15
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-15
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-15
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-15
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		4e-15
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		4e-15
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		4e-15
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		5e-15
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		5e-15
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		5e-15
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		5e-15
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		5e-15
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		6e-15
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-14
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-14
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-14
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-14
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-14
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-14
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		4e-14
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-14
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		6e-14
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		7e-14
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		8e-14
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-14
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		9e-14
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		9e-14
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		9e-14
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		9e-14
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-13
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-13
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-13
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-13
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-13
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-13
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-13
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-13
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-13
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-13
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-13
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-13
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-13
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-13
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-13
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-13
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-13
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-13
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-13
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-13
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-13
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-13
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		3e-13
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		3e-13
3soa_A	444	Full-Length Human Camkii Length = 444		3e-13
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-13
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		3e-13
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		4e-13
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-13
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		4e-13
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		4e-13
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		4e-13
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		4e-13
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		4e-13
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		4e-13
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		5e-13
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		5e-13
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		5e-13
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		6e-13
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		6e-13
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		7e-13
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		7e-13
3g51_A	325	Structural Diversity Of The Active Conformation Of		7e-13
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		7e-13
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		7e-13
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		8e-13
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		8e-13
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		8e-13
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		8e-13
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		8e-13
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		8e-13
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		8e-13
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		8e-13
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		9e-13
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		9e-13
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		9e-13
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-12
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		1e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-12
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-12
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-12
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-12
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-12
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-12
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-12
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-12
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-12
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-12
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-12
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-12
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-12
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-12
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-12
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-12
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-12
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-12
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		3e-12
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-12
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		3e-12
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		4e-12
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		4e-12
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		4e-12
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		5e-12
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		5e-12
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		6e-12
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		6e-12
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		7e-12
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		7e-12
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		8e-12
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		8e-12
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		8e-12
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		8e-12
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		9e-12
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		9e-12
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		9e-12
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		9e-12
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		9e-12
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-11
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-11
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-11
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-11
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-11
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-11
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-11
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-11
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-11
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-11
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-11
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-11
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-11
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-11
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-11
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-11
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-11
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-11
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-11
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-11
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-11
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		1e-11
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		1e-11
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		1e-11
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-11
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-11
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		1e-11
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		1e-11
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-11
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-11
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		1e-11
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		1e-11
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-11
2oza_A	356	Structure Of P38alpha Complex Length = 356		2e-11
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		2e-11
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		2e-11
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-11
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		2e-11
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-11
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-11
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-11
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-11
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-11
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		2e-11
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-11
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-11
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-11
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-11
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-11
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-11
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-11
4ae6_A	343	Structure And Function Of The Human Sperm-specific		3e-11
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		3e-11
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		3e-11
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		3e-11
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		3e-11
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-11
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-11
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-11
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-11
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		4e-11
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		4e-11
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		4e-11
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		4e-11
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		4e-11
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-11
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		5e-11
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		5e-11
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		5e-11
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		5e-11
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		6e-11
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		6e-11
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		6e-11
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		6e-11
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		6e-11
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		6e-11
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		6e-11
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		6e-11
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		6e-11
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		7e-11
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		8e-11
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		8e-11
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		8e-11
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		8e-11
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		8e-11
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		9e-11
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		9e-11
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-10
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-10
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-10
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-10
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-10
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-10
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-10
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-10
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-10
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-10
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-10
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-10
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-10
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-10
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-10
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-10
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-10
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-10
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-10
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-10
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		2e-10
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-10
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-10
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-10
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-10
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		2e-10
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		2e-10
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		2e-10
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		2e-10
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-10
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-10
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-10
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-10
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-10
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-10
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		2e-10
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-10
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-10
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		2e-10
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-10
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-10
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-10
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		3e-10
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-10
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		3e-10
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		3e-10
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-10
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		3e-10
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-10
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-10
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-10
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-10
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		3e-10
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		3e-10
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		4e-10
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		4e-10
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		4e-10
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		4e-10
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		4e-10
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		5e-10
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		5e-10
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		6e-10
3kk9_A	282	Camkii Substrate Complex B Length = 282		7e-10
3kk8_A	284	Camkii Substrate Complex A Length = 284		8e-10
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		8e-10
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		8e-10
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		8e-10
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		8e-10
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-09
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		1e-09
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-09
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-09
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		1e-09
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-09
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-09
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-09
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		3e-09
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		3e-09
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-09
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-09
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		3e-09
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-09
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		4e-09
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		5e-09
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-09
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		5e-09
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		5e-09
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		6e-09
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		6e-09
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		6e-09
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		8e-09
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		8e-09
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		8e-09
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		8e-09
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		9e-09
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		9e-09
3a7f_A	303	Human Mst3 Kinase Length = 303		9e-09
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		9e-09
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-08
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		1e-08
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-08
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-08
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-08
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-08
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-08
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-08
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-08
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-08
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-08
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-08
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-08
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-08
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-08
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-08
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-08
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-08
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		4e-08
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		4e-08
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		4e-08
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		4e-08
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-08
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		5e-08
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		5e-08
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		5e-08
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		6e-08
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		6e-08
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		7e-08
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		7e-08
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		7e-08
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		7e-08
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		7e-08
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-07
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-07
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-07
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-07
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-07
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-07
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-07
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		3e-07
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		3e-07
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		3e-07
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		3e-07
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-07
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-07
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		3e-07
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		4e-07
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		4e-07
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-07
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		4e-07
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		4e-07
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		4e-07
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		4e-07
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		4e-07
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-07
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		4e-07
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		4e-07
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-07
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		4e-07
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		4e-07
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-07
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		5e-07
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		5e-07
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		5e-07
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-07
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		5e-07
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		5e-07
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		5e-07
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		5e-07
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		5e-07
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		5e-07
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		5e-07
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-07
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		6e-07
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		6e-07
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		6e-07
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		6e-07
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		7e-07
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		7e-07
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		7e-07
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		7e-07
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		7e-07
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-07
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		7e-07
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		8e-07
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		9e-07
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-06
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-06
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-06
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-06
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-06
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-06
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-06
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-06
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-06
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-06
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-06
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-06
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-06
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-06
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-06
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		3e-06
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-06
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		3e-06
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		4e-06
3gni_B	389	Structure Of Strad And Mo25 Length = 389		4e-06
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-06
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		4e-06
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		4e-06
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		4e-06
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		5e-06
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-06
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		5e-06
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-06
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		5e-06
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		5e-06
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		5e-06
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		5e-06
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-06
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		5e-06
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		6e-06
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-05
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-05
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-05
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-05
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		2e-05
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		3e-05
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-05
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		3e-05
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-05
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		3e-05
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-05
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-05
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		4e-05
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		4e-05
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-05
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		5e-05
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		6e-05
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		6e-05
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		6e-05
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		7e-05
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		7e-05
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		7e-05
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		7e-05
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		7e-05
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		8e-05
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		8e-05
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-04
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		1e-04
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-04
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-04
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-04
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-04
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-04
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-04
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		3e-04
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-04
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-04
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		3e-04
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		5e-04
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		6e-04
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		6e-04
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		6e-04
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		7e-04
4h58_A	275	Braf In Complex With Compound 3 Length = 275		7e-04
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		7e-04
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		7e-04
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		7e-04
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		8e-04

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  424 bits (1091), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 203/289 (70%), Positives = 239/289 (82%), Gaps = 3/289 (1%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL 59
           MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +  Q +P+IYVKL
Sbjct: 101 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 160
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           Y YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+SYICS
Sbjct: 161 YMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS 219
Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
           RYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE
Sbjct: 220 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 279
Query: 180 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
           +I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  R T LEA  H F
Sbjct: 280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339
Query: 240 FDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCA 288
           FDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR Q A
Sbjct: 340 FDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHARIQAA 387

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  424 bits (1091), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 203/289 (70%), Positives = 239/289 (82%), Gaps = 3/289 (1%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL 59
           MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +  Q +P+IYVKL
Sbjct: 95  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 154
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           Y YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+SYICS
Sbjct: 155 YMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS 213
Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
           RYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE
Sbjct: 214 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 273
Query: 180 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
           +I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  R T LEA  H F
Sbjct: 274 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 333
Query: 240 FDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCA 288
           FDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR Q A
Sbjct: 334 FDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHARIQAA 381

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  424 bits (1091), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 203/289 (70%), Positives = 239/289 (82%), Gaps = 3/289 (1%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL 59
           MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +  Q +P+IYVKL
Sbjct: 146 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 205
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           Y YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+SYICS
Sbjct: 206 YMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS 264
Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
           RYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE
Sbjct: 265 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 324
Query: 180 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
           +I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  R T LEA  H F
Sbjct: 325 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 384
Query: 240 FDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCA 288
           FDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR Q A
Sbjct: 385 FDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHARIQAA 432

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  424 bits (1091), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 203/289 (70%), Positives = 239/289 (82%), Gaps = 3/289 (1%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL 59
           MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +  Q +P+IYVKL
Sbjct: 105 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 164
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           Y YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+SYICS
Sbjct: 165 YMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS 223
Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
           RYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE
Sbjct: 224 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 283
Query: 180 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
           +I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  R T LEA  H F
Sbjct: 284 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 343
Query: 240 FDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCA 288
           FDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR Q A
Sbjct: 344 FDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHARIQAA 391

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  424 bits (1091), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 203/289 (70%), Positives = 239/289 (82%), Gaps = 3/289 (1%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL 59
           MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +  Q +P+IYVKL
Sbjct: 103 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 162
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           Y YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+SYICS
Sbjct: 163 YMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS 221
Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
           RYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE
Sbjct: 222 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 281
Query: 180 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
           +I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  R T LEA  H F
Sbjct: 282 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 341
Query: 240 FDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCA 288
           FDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR Q A
Sbjct: 342 FDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHARIQAA 389

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  424 bits (1090), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 203/289 (70%), Positives = 239/289 (82%), Gaps = 3/289 (1%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL 59
           MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +  Q +P+IYVKL
Sbjct: 72  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 131
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           Y YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+SYICS
Sbjct: 132 YMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS 190
Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
           RYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE
Sbjct: 191 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 250
Query: 180 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
           +I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  R T LEA  H F
Sbjct: 251 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 310
Query: 240 FDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCA 288
           FDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR Q A
Sbjct: 311 FDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHARIQAA 358

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  422 bits (1086), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 203/289 (70%), Positives = 239/289 (82%), Gaps = 3/289 (1%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL 59
           MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +  Q +P+IYVKL
Sbjct: 80  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 139
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           Y YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+SYICS
Sbjct: 140 YMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS 198
Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
           RYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE
Sbjct: 199 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 258
Query: 180 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
           +I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  R T LEA  H F
Sbjct: 259 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 318
Query: 240 FDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCA 288
           FDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR Q A
Sbjct: 319 FDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHARIQAA 366

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  422 bits (1084), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 202/289 (69%), Positives = 238/289 (82%), Gaps = 3/289 (1%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL 59
           MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +  Q +P+IYVKL
Sbjct: 101 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 160
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           Y YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+S ICS
Sbjct: 161 YMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICS 219
Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
           RYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE
Sbjct: 220 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 279
Query: 180 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
           +I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  R T LEA  H F
Sbjct: 280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339
Query: 240 FDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCA 288
           FDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR Q A
Sbjct: 340 FDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHARIQAA 387

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  420 bits (1079), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 202/289 (69%), Positives = 238/289 (82%), Gaps = 3/289 (1%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL 59
           MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +  Q +P+IYVKL
Sbjct: 79  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 138
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           Y YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+S ICS
Sbjct: 139 YMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICS 197
Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
           RYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE
Sbjct: 198 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 257
Query: 180 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
           +I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  R T LEA  H F
Sbjct: 258 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 317
Query: 240 FDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCA 288
           FDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR Q A
Sbjct: 318 FDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHARIQAA 365

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  420 bits (1079), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 202/289 (69%), Positives = 238/289 (82%), Gaps = 3/289 (1%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL 59
           MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +  Q +P+IYVKL
Sbjct: 79  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 138
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           Y YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+S ICS
Sbjct: 139 YMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICS 197
Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
           RYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE
Sbjct: 198 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 257
Query: 180 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
           +I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  R T LEA  H F
Sbjct: 258 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 317
Query: 240 FDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCA 288
           FDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR Q A
Sbjct: 318 FDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHARIQAA 365

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  420 bits (1079), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 202/289 (69%), Positives = 238/289 (82%), Gaps = 3/289 (1%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL 59
           MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +  Q +P+IYVKL
Sbjct: 75  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 134
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           Y YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+S ICS
Sbjct: 135 YMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICS 193
Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
           RYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE
Sbjct: 194 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 253
Query: 180 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
           +I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  R T LEA  H F
Sbjct: 254 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 313
Query: 240 FDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCA 288
           FDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR Q A
Sbjct: 314 FDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHARIQAA 361

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  419 bits (1078), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 202/289 (69%), Positives = 238/289 (82%), Gaps = 3/289 (1%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL 59
           MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +  Q +P+IYVKL
Sbjct: 86  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 145
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           Y YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+S ICS
Sbjct: 146 YMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICS 204
Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
           RYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE
Sbjct: 205 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 264
Query: 180 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
           +I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  R T LEA  H F
Sbjct: 265 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 324
Query: 240 FDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCA 288
           FDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR Q A
Sbjct: 325 FDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHARIQAA 372

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score =  419 bits (1076), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 201/285 (70%), Positives = 237/285 (83%), Gaps = 3/285 (1%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL 59
           MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +  Q +P+IYVKL
Sbjct: 67  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 126
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           Y YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+SYICS
Sbjct: 127 YMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS 185
Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
           RYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 245
Query: 180 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
           +I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  R T LEA  H F
Sbjct: 246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 305
Query: 240 FDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHAR 284
           FDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR
Sbjct: 306 FDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHAR 349

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score =  419 bits (1076), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 201/285 (70%), Positives = 237/285 (83%), Gaps = 3/285 (1%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL 59
           MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +  Q +P+IYVKL
Sbjct: 67  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 126
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           Y YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+SYICS
Sbjct: 127 YMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS 185
Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
           RYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 245
Query: 180 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
           +I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  R T LEA  H F
Sbjct: 246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 305
Query: 240 FDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHAR 284
           FDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR
Sbjct: 306 FDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHAR 349

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score =  418 bits (1074), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 201/288 (69%), Positives = 237/288 (82%), Gaps = 3/288 (1%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL 59
           MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +  Q +P+IYVKL
Sbjct: 67  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 126
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           Y YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+SYICS
Sbjct: 127 YMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS 185
Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
           RYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 245
Query: 180 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
           +I+ MNPNYTEF FPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  R T LEA  H F
Sbjct: 246 QIREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 305
Query: 240 FDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQC 287
           FDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR Q 
Sbjct: 306 FDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHARIQA 352

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  417 bits (1071), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 201/288 (69%), Positives = 237/288 (82%), Gaps = 3/288 (1%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL 59
           MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +  Q +P+IYVKL
Sbjct: 67  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 126
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           Y YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+S ICS
Sbjct: 127 YMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICS 185
Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
           RYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 245
Query: 180 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
           +I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  R T LEA  H F
Sbjct: 246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 305
Query: 240 FDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQC 287
           FDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR Q 
Sbjct: 306 FDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHARIQA 352

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score =  416 bits (1069), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 200/285 (70%), Positives = 236/285 (82%), Gaps = 3/285 (1%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL 59
           MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +  Q +P+IYVKL
Sbjct: 67  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 126
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           Y YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+S ICS
Sbjct: 127 YMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICS 185
Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
           RYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 245
Query: 180 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
           +I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  R T LEA  H F
Sbjct: 246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 305
Query: 240 FDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHAR 284
           FDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR
Sbjct: 306 FDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHAR 349

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  416 bits (1068), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 200/285 (70%), Positives = 236/285 (82%), Gaps = 3/285 (1%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL 59
           MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +  Q +P+IYVKL
Sbjct: 71  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 130
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           Y YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+S ICS
Sbjct: 131 YMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICS 189
Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
           RYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE
Sbjct: 190 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 249
Query: 180 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
           +I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  R T LEA  H F
Sbjct: 250 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 309
Query: 240 FDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHAR 284
           FDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR
Sbjct: 310 FDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHAR 353

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score =  416 bits (1068), Expect = e-116,   Method: Compositional matrix adjust.
 Identities = 200/285 (70%), Positives = 236/285 (82%), Gaps = 3/285 (1%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL 59
           MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +  Q +P+IYVKL
Sbjct: 68  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 127
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           Y YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+S ICS
Sbjct: 128 YMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICS 186
Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
           RYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE
Sbjct: 187 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 246
Query: 180 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
           +I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  R T LEA  H F
Sbjct: 247 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 306
Query: 240 FDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHAR 284
           FDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR
Sbjct: 307 FDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHAR 350

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score =  413 bits (1061), Expect = e-116,   Method: Compositional matrix adjust.
 Identities = 199/285 (69%), Positives = 235/285 (82%), Gaps = 3/285 (1%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL 59
           MR LDH N+V L++ F+S+ EK D +YLNLVL+YVPETV+RV +H+ +  Q +P+IYVKL
Sbjct: 67  MRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 126
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           Y YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+S ICS
Sbjct: 127 YMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICS 185
Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
           RYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 245
Query: 180 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
           +I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  R T LEA  H F
Sbjct: 246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 305
Query: 240 FDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHAR 284
           FDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR
Sbjct: 306 FDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHAR 349

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  412 bits (1059), Expect = e-115,   Method: Compositional matrix adjust.
 Identities = 198/285 (69%), Positives = 234/285 (82%), Gaps = 3/285 (1%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL 59
           MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVP TV+RV +H+ +  Q +P+IYVKL
Sbjct: 67  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKL 126
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           Y YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+S ICS
Sbjct: 127 YMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICS 185
Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
           RYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 245
Query: 180 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
           +I+ MNPNYTEF FPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  R T LEA  H F
Sbjct: 246 QIREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 305
Query: 240 FDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHAR 284
           FDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR
Sbjct: 306 FDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHAR 349

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score =  403 bits (1036), Expect = e-113,   Method: Compositional matrix adjust.
 Identities = 189/293 (64%), Positives = 237/293 (80%), Gaps = 3/293 (1%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL 59
           MR++ HPNVV LK  F+S  +K DE++LNLVLEYVPETV+R  +H+ K+ Q MP++ +KL
Sbjct: 86  MRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKL 145
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           Y YQ+ R+LAYIH +IG+CHRDIKPQNLL++P +  LKL DFGSAK+L+ GEPN+S ICS
Sbjct: 146 YMYQLLRSLAYIH-SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICS 204
Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
           RYYRAPELIFGAT YT  IDIWS GCV+AEL+ GQPLFPGESG+DQLVEIIKVLGTP+RE
Sbjct: 205 RYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSRE 264
Query: 180 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
           +IK MNPNY E KFPQI+ HP+ K+F+ R PP+A+DL+SRLL+Y+P+ R TA+EAL HPF
Sbjct: 265 QIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPF 324
Query: 240 FDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLGL 292
           FDELR    R+PNGR LPPLFN+   EL   P D++ +L+P+HA  +    G+
Sbjct: 325 FDELRTGEARMPNGRELPPLFNWTKEELSVRP-DLISRLVPQHAEAELLSRGI 376

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score =  296 bits (759), Expect = 6e-81,   Method: Compositional matrix adjust.
 Identities = 142/324 (43%), Positives = 214/324 (66%), Gaps = 43/324 (13%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKD---------------------------------ELYL 27
           M++LDH N++ L   F++T +++                                   YL
Sbjct: 54  MKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYL 113
Query: 28  NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNL 87
           N+++EYVP+T+H+V+K   +  + +P+  + +Y YQ+ RA+ +IH ++G+CHRDIKPQNL
Sbjct: 114 NVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH-SLGICHRDIKPQNL 172
Query: 88  LVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVL 147
           LVN   + LKLCDFGSAK L+  EP+++ ICSR+YRAPEL+ GATEYT +ID+WS GCV 
Sbjct: 173 LVNSKDNTLKLCDFGSAKKLIPSEPSVAXICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232
Query: 148 AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQK 207
            EL+LG+PLF GE+ +DQLV II+++GTPT+E++  MNP+YTE +FP +KA  W KI  +
Sbjct: 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPE 292
Query: 208 RMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP-------NTRLPNG--RFLPP 258
             P  A+DL+ ++L+Y P+LR    EA+ HPFFD LR+        N+  P+G  + +P 
Sbjct: 293 GTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQ 352
Query: 259 LFNFKPHELKGVPVDMLVKLIPEH 282
           LFNF P+EL  +P ++L +++P++
Sbjct: 353 LFNFSPYELSIIPGNVLNRILPKN 376

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score =  279 bits (713), Expect = 2e-75,   Method: Compositional matrix adjust.
 Identities = 136/286 (47%), Positives = 194/286 (67%), Gaps = 7/286 (2%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKD--ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 58
           + +L HPN+V L+  F++  E+D  ++YLN+V+EYVP+T+HR  +++Y+     P I +K
Sbjct: 73  LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIK 132
Query: 59  LYFYQICRALAYIH-NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           ++ +Q+ R++  +H  ++ VCHRDIKP N+LVN     LKLCDFGSAK L   EPN++YI
Sbjct: 133 VFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYI 192
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
           CSRYYRAPELIFG   YT A+DIWS GC+ AE++LG+P+F G++   QL EI++VLG P+
Sbjct: 193 CSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS 252
Query: 178 REEIKCMNPNYTEFKFPQIKAHPWHKIFQK---RMPPEAVDLVSRLLQYSPNLRSTALEA 234
           RE ++ +NP++T+      K  PW  +F     +   EA DL+S LLQY P  R    EA
Sbjct: 253 REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEA 312
Query: 235 LIHPFFDELRDPNTRLPNGRFLP-PLFNFKPHELKGVPVDMLVKLI 279
           L HP+FDEL DP T+LPN + LP  LF F P+E++ +      KL+
Sbjct: 313 LCHPYFDELHDPATKLPNNKDLPEDLFRFLPNEIEVMSEAQKAKLV 358

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score =  164 bits (414), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 89/250 (35%), Positives = 149/250 (59%), Gaps = 17/250 (6%)
Query: 6   HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 65
           H NV+ ++    ++T +    + +V + +   +++++K     SQ++   ++  + YQI 
Sbjct: 100 HENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLK-----SQQLSNDHICYFLYQIL 154
Query: 66  RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY----ICSRY 121
           R L YIH+   V HRD+KP NLL+N  T  LK+CDFG A++      +  +    + +R+
Sbjct: 155 RGLKYIHSA-NVLHRDLKPSNLLINT-TCDLKICDFGLARIADPEHDHTGFLTEXVATRW 212
Query: 122 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 181
           YRAPE++  +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++
Sbjct: 213 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 272
Query: 182 KCM----NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 237
            C+      NY +   P      W K+F K    +A+DL+ R+L ++PN R T  EAL H
Sbjct: 273 NCIINMKARNYLQ-SLPSKTKVAWAKLFPKS-DSKALDLLDRMLTFNPNKRITVEEALAH 330
Query: 238 PFFDELRDPN 247
           P+ ++  DP 
Sbjct: 331 PYLEQYYDPT 340

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score =  159 bits (401), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 96/272 (35%), Positives = 154/272 (56%), Gaps = 26/272 (9%)
Query: 23  DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDI 82
           +E+Y+  + E +   +HRVI      +Q +   +++ + YQ  RA+  +H +  V HRD+
Sbjct: 87  NEVYI--IQELMQTDLHRVIS-----TQMLSDDHIQYFIYQTLRAVKVLHGS-NVIHRDL 138
Query: 83  KPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-----------YICSRYYRAPELIFGA 131
           KP NLL+N +   LK+CDFG A+++ +   + S           Y+ +R+YRAPE++  +
Sbjct: 139 KPSNLLINSNC-DLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRAPEVMLTS 197
Query: 132 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP-TREEIKCM-NPNYT 189
            +Y+ A+D+WS GC+LAEL L +P+FPG     QL+ I  ++GTP +  +++C+ +P   
Sbjct: 198 AKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAR 257
Query: 190 EF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 247
           E+    P   A P  K+F  R+ P+ +DL+ R+L + P  R TA EAL HP+     DPN
Sbjct: 258 EYIKSLPMYPAAPLEKMF-PRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPN 316
Query: 248 TRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI 279
              P G  +PP F    H  + +    L KLI
Sbjct: 317 DE-PEGEPIPPSFFEFDHYKEALTTKDLKKLI 347

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score =  158 bits (399), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 96/272 (35%), Positives = 155/272 (56%), Gaps = 26/272 (9%)
Query: 23  DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDI 82
           +E+Y+  + E +   +HRVI      +Q +   +++ + YQ  RA+  +H +  V HRD+
Sbjct: 87  NEVYI--IQELMQTDLHRVIS-----TQMLSDDHIQYFIYQTLRAVKVLHGS-NVIHRDL 138
Query: 83  KPQNLLVNPHTHQLKLCDFGSAKVLVKG-----EPN------ISYICSRYYRAPELIFGA 131
           KP NLL+N +   LK+CDFG A+++ +      EP       + ++ +R+YRAPE++  +
Sbjct: 139 KPSNLLINSNC-DLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTS 197
Query: 132 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP-TREEIKCM-NPNYT 189
            +Y+ A+D+WS GC+LAEL L +P+FPG     QL+ I  ++GTP +  +++C+ +P   
Sbjct: 198 AKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAR 257
Query: 190 EF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 247
           E+    P   A P  K+F  R+ P+ +DL+ R+L + P  R TA EAL HP+     DPN
Sbjct: 258 EYIKSLPMYPAAPLEKMF-PRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPN 316
Query: 248 TRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI 279
              P G  +PP F    H  + +    L KLI
Sbjct: 317 DE-PEGEPIPPSFFEFDHYKEALTTKDLKKLI 347

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score =  157 bits (396), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 97/296 (32%), Positives = 165/296 (55%), Gaps = 29/296 (9%)
Query: 6   HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 65
           H N++ +     + T +    + +V + +   +++++K     +Q +   ++  + YQI 
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQIL 138
Query: 66  RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYIC 118
           R L YIH+   V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ 
Sbjct: 139 RGLKYIHSA-NVLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVA 193
Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 178
           +R+YRAPE++  +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 253
Query: 179 EEIKCM----NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 234
           E++ C+      NY     P     PW+++F      +A+DL+ ++L ++P+ R    +A
Sbjct: 254 EDLNCIINLKARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQA 311
Query: 235 LIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI-PEHARKQCAF 289
           L HP+ ++  DP+    +       F F   EL  +P + L +LI  E AR Q  +
Sbjct: 312 LAHPYLEQYYDPS----DEPIAEAPFKFD-MELDDLPKEKLKELIFEETARFQPGY 362

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score =  157 bits (396), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 86/253 (33%), Positives = 147/253 (58%), Gaps = 23/253 (9%)
Query: 6   HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 65
           H N++ +     + T +    + LV   +   +++++K     +Q +   ++  + YQI 
Sbjct: 100 HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK-----TQHLSNDHICYFLYQIL 154
Query: 66  RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYIC 118
           R L YIH+   V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ 
Sbjct: 155 RGLKYIHSA-NVLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVA 209
Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 178
           +R+YRAPE++  +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 269
Query: 179 EEIKCM----NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 234
           E++ C+      NY     P     PW+++F      +A+DL+ ++L ++P+ R    +A
Sbjct: 270 EDLNCIINLKARNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKRIEVEQA 327
Query: 235 LIHPFFDELRDPN 247
           L HP+ ++  DP+
Sbjct: 328 LAHPYLEQYYDPS 340

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score =  157 bits (396), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 97/296 (32%), Positives = 165/296 (55%), Gaps = 29/296 (9%)
Query: 6   HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 65
           H N++ +     + T +    + +V + +   +++++K     +Q +   ++  + YQI 
Sbjct: 80  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQIL 134
Query: 66  RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYIC 118
           R L YIH+   V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ 
Sbjct: 135 RGLKYIHSA-NVLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVA 189
Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 178
           +R+YRAPE++  +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 249
Query: 179 EEIKCM----NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 234
           E++ C+      NY     P     PW+++F      +A+DL+ ++L ++P+ R    +A
Sbjct: 250 EDLNCIINLKARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQA 307
Query: 235 LIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI-PEHARKQCAF 289
           L HP+ ++  DP+    +       F F   EL  +P + L +LI  E AR Q  +
Sbjct: 308 LAHPYLEQYYDPS----DEPIAEAPFKFD-MELDDLPKEKLKELIFEETARFQPGY 358

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score =  157 bits (396), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 97/296 (32%), Positives = 165/296 (55%), Gaps = 29/296 (9%)
Query: 6   HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 65
           H N++ +     + T +    + +V + +   +++++K     +Q +   ++  + YQI 
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQIL 138
Query: 66  RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYIC 118
           R L YIH+   V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ 
Sbjct: 139 RGLKYIHSA-NVLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVA 193
Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 178
           +R+YRAPE++  +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 253
Query: 179 EEIKCM----NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 234
           E++ C+      NY     P     PW+++F      +A+DL+ ++L ++P+ R    +A
Sbjct: 254 EDLNCIINLKARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQA 311
Query: 235 LIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI-PEHARKQCAF 289
           L HP+ ++  DP+    +       F F   EL  +P + L +LI  E AR Q  +
Sbjct: 312 LAHPYLEQYYDPS----DEPIAEAPFKFD-MELDDLPKEKLKELIFEETARFQPGY 362

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 97/296 (32%), Positives = 165/296 (55%), Gaps = 29/296 (9%)
Query: 6   HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 65
           H N++ +     + T +    + +V + +   +++++K     +Q +   ++  + YQI 
Sbjct: 88  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQIL 142
Query: 66  RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYIC 118
           R L YIH+   V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ 
Sbjct: 143 RGLKYIHSA-NVLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVA 197
Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 178
           +R+YRAPE++  +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++
Sbjct: 198 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 257
Query: 179 EEIKCM----NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 234
           E++ C+      NY     P     PW+++F      +A+DL+ ++L ++P+ R    +A
Sbjct: 258 EDLNCIINLKARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQA 315
Query: 235 LIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI-PEHARKQCAF 289
           L HP+ ++  DP+    +       F F   EL  +P + L +LI  E AR Q  +
Sbjct: 316 LAHPYLEQYYDPS----DEPIAEAPFKFD-MELDDLPKEKLKELIFEETARFQPGY 366

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 97/296 (32%), Positives = 165/296 (55%), Gaps = 29/296 (9%)
Query: 6   HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 65
           H N++ +     + T +    + +V + +   +++++K     +Q +   ++  + YQI 
Sbjct: 80  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQIL 134
Query: 66  RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYIC 118
           R L YIH+   V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ 
Sbjct: 135 RGLKYIHSA-NVLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVA 189
Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 178
           +R+YRAPE++  +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 249
Query: 179 EEIKCM----NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 234
           E++ C+      NY     P     PW+++F      +A+DL+ ++L ++P+ R    +A
Sbjct: 250 EDLNCIINLKARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQA 307
Query: 235 LIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI-PEHARKQCAF 289
           L HP+ ++  DP+    +       F F   EL  +P + L +LI  E AR Q  +
Sbjct: 308 LAHPYLEQYYDPS----DEPIAEAPFKFD-MELDDLPKEKLKELIFEETARFQPGY 358

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 97/296 (32%), Positives = 165/296 (55%), Gaps = 29/296 (9%)
Query: 6   HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 65
           H N++ +     + T +    + +V + +   +++++K     +Q +   ++  + YQI 
Sbjct: 100 HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQIL 154
Query: 66  RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYIC 118
           R L YIH+   V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ 
Sbjct: 155 RGLKYIHSA-NVLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVA 209
Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 178
           +R+YRAPE++  +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 269
Query: 179 EEIKCM----NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 234
           E++ C+      NY     P     PW+++F      +A+DL+ ++L ++P+ R    +A
Sbjct: 270 EDLNCIINLKARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQA 327
Query: 235 LIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI-PEHARKQCAF 289
           L HP+ ++  DP+    +       F F   EL  +P + L +LI  E AR Q  +
Sbjct: 328 LAHPYLEQYYDPS----DEPIAEAPFKFD-MELDDLPKEKLKELIFEETARFQPGY 378

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 97/296 (32%), Positives = 165/296 (55%), Gaps = 29/296 (9%)
Query: 6   HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 65
           H N++ +     + T +    + +V + +   +++++K     +Q +   ++  + YQI 
Sbjct: 85  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQIL 139
Query: 66  RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYIC 118
           R L YIH+   V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ 
Sbjct: 140 RGLKYIHSA-NVLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVA 194
Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 178
           +R+YRAPE++  +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++
Sbjct: 195 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 254
Query: 179 EEIKCM----NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 234
           E++ C+      NY     P     PW+++F      +A+DL+ ++L ++P+ R    +A
Sbjct: 255 EDLNCIINLKARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQA 312
Query: 235 LIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI-PEHARKQCAF 289
           L HP+ ++  DP+    +       F F   EL  +P + L +LI  E AR Q  +
Sbjct: 313 LAHPYLEQYYDPS----DEPIAEAPFKFD-MELDDLPKEKLKELIFEETARFQPGY 363

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 97/296 (32%), Positives = 165/296 (55%), Gaps = 29/296 (9%)
Query: 6   HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 65
           H N++ +     + T +    + +V + +   +++++K     +Q +   ++  + YQI 
Sbjct: 86  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQIL 140
Query: 66  RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYIC 118
           R L YIH+   V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ 
Sbjct: 141 RGLKYIHSA-NVLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVA 195
Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 178
           +R+YRAPE++  +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++
Sbjct: 196 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 255
Query: 179 EEIKCM----NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 234
           E++ C+      NY     P     PW+++F      +A+DL+ ++L ++P+ R    +A
Sbjct: 256 EDLNCIINLKARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQA 313
Query: 235 LIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI-PEHARKQCAF 289
           L HP+ ++  DP+    +       F F   EL  +P + L +LI  E AR Q  +
Sbjct: 314 LAHPYLEQYYDPS----DEPIAEAPFKFD-MELDDLPKEKLKELIFEETARFQPGY 364

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 97/296 (32%), Positives = 165/296 (55%), Gaps = 29/296 (9%)
Query: 6   HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 65
           H N++ +     + T +    + +V + +   +++++K     +Q +   ++  + YQI 
Sbjct: 77  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQIL 131
Query: 66  RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYIC 118
           R L YIH+   V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ 
Sbjct: 132 RGLKYIHSA-NVLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVA 186
Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 178
           +R+YRAPE++  +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++
Sbjct: 187 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 246
Query: 179 EEIKCM----NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 234
           E++ C+      NY     P     PW+++F      +A+DL+ ++L ++P+ R    +A
Sbjct: 247 EDLNCIINLKARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQA 304
Query: 235 LIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI-PEHARKQCAF 289
           L HP+ ++  DP+    +       F F   EL  +P + L +LI  E AR Q  +
Sbjct: 305 LAHPYLEQYYDPS----DEPIAEAPFKFD-MELDDLPKEKLKELIFEETARFQPGY 355

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 97/296 (32%), Positives = 165/296 (55%), Gaps = 29/296 (9%)
Query: 6   HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 65
           H N++ +     + T +    + +V + +   +++++K     +Q +   ++  + YQI 
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQIL 138
Query: 66  RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYIC 118
           R L YIH+   V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ 
Sbjct: 139 RGLKYIHSA-NVLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVA 193
Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 178
           +R+YRAPE++  +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 253
Query: 179 EEIKCM----NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 234
           E++ C+      NY     P     PW+++F      +A+DL+ ++L ++P+ R    +A
Sbjct: 254 EDLNCIINLKARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQA 311
Query: 235 LIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI-PEHARKQCAF 289
           L HP+ ++  DP+    +       F F   EL  +P + L +LI  E AR Q  +
Sbjct: 312 LAHPYLEQYYDPS----DEPIAEAPFKFD-MELDDLPKEKLKELIFEETARFQPGY 362

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 97/296 (32%), Positives = 165/296 (55%), Gaps = 29/296 (9%)
Query: 6   HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 65
           H N++ +     + T +    + +V + +   +++++K     +Q +   ++  + YQI 
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQIL 138
Query: 66  RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYIC 118
           R L YIH+   V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ 
Sbjct: 139 RGLKYIHSA-NVLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVA 193
Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 178
           +R+YRAPE++  +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 253
Query: 179 EEIKCM----NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 234
           E++ C+      NY     P     PW+++F      +A+DL+ ++L ++P+ R    +A
Sbjct: 254 EDLNCIINLKARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQA 311
Query: 235 LIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI-PEHARKQCAF 289
           L HP+ ++  DP+    +       F F   EL  +P + L +LI  E AR Q  +
Sbjct: 312 LAHPYLEQYYDPS----DEPIAEAPFKFD-MELDDLPKEKLKELIFEETARFQPGY 362

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 97/296 (32%), Positives = 165/296 (55%), Gaps = 29/296 (9%)
Query: 6   HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 65
           H N++ +     + T +    + +V + +   +++++K     +Q +   ++  + YQI 
Sbjct: 78  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQIL 132
Query: 66  RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYIC 118
           R L YIH+   V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ 
Sbjct: 133 RGLKYIHSA-NVLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVA 187
Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 178
           +R+YRAPE++  +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++
Sbjct: 188 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 247
Query: 179 EEIKCM----NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 234
           E++ C+      NY     P     PW+++F      +A+DL+ ++L ++P+ R    +A
Sbjct: 248 EDLNCIINLKARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQA 305
Query: 235 LIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI-PEHARKQCAF 289
           L HP+ ++  DP+    +       F F   EL  +P + L +LI  E AR Q  +
Sbjct: 306 LAHPYLEQYYDPS----DEPIAEAPFKFD-MELDDLPKEKLKELIFEETARFQPGY 356

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 95/272 (34%), Positives = 153/272 (56%), Gaps = 26/272 (9%)
Query: 23  DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDI 82
           +E+Y+  + E +   +HRVI      +Q +   +++ + YQ  RA+  +H +  V HRD+
Sbjct: 87  NEVYI--IQELMQTDLHRVIS-----TQMLSDDHIQYFIYQTLRAVKVLHGS-NVIHRDL 138
Query: 83  KPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-----------YICSRYYRAPELIFGA 131
           KP NLL+N +   LK+CDFG A+++ +   + S            + +R+YRAPE++  +
Sbjct: 139 KPSNLLINSNC-DLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRAPEVMLTS 197
Query: 132 TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP-TREEIKCM-NPNYT 189
            +Y+ A+D+WS GC+LAEL L +P+FPG     QL+ I  ++GTP +  +++C+ +P   
Sbjct: 198 AKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAR 257
Query: 190 EF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 247
           E+    P   A P  K+F  R+ P+ +DL+ R+L + P  R TA EAL HP+     DPN
Sbjct: 258 EYIKSLPMYPAAPLEKMF-PRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPN 316
Query: 248 TRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI 279
              P G  +PP F    H  + +    L KLI
Sbjct: 317 DE-PEGEPIPPSFFEFDHYKEALTTKDLKKLI 347

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 97/296 (32%), Positives = 165/296 (55%), Gaps = 29/296 (9%)
Query: 6   HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 65
           H N++ +     + T +    + +V + +   +++++K     +Q +   ++  + YQI 
Sbjct: 82  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQIL 136
Query: 66  RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYIC 118
           R L YIH+   V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ 
Sbjct: 137 RGLKYIHSA-NVLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVA 191
Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 178
           +R+YRAPE++  +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 251
Query: 179 EEIKCM----NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 234
           E++ C+      NY     P     PW+++F      +A+DL+ ++L ++P+ R    +A
Sbjct: 252 EDLNCIINLKARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQA 309
Query: 235 LIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI-PEHARKQCAF 289
           L HP+ ++  DP+    +       F F   EL  +P + L +LI  E AR Q  +
Sbjct: 310 LAHPYLEQYYDPS----DEPIAEAPFKFD-MELDDLPKEKLKELIFEETARFQPGY 360

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 97/296 (32%), Positives = 165/296 (55%), Gaps = 29/296 (9%)
Query: 6   HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 65
           H N++ +     + T +    + +V + +   +++++K     +Q +   ++  + YQI 
Sbjct: 80  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQIL 134
Query: 66  RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYIC 118
           R L YIH+   V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ 
Sbjct: 135 RGLKYIHSA-NVLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVA 189
Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 178
           +R+YRAPE++  +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 249
Query: 179 EEIKCM----NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 234
           E++ C+      NY     P     PW+++F      +A+DL+ ++L ++P+ R    +A
Sbjct: 250 EDLNCIINLKARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQA 307
Query: 235 LIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI-PEHARKQCAF 289
           L HP+ ++  DP+    +       F F   EL  +P + L +LI  E AR Q  +
Sbjct: 308 LAHPYLEQYYDPS----DEPIAEAPFKFD-MELDDLPKEKLKELIFEETARFQPGY 358

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  155 bits (391), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 93/252 (36%), Positives = 143/252 (56%), Gaps = 19/252 (7%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ L HPN+VSL     S     E  L LV E++ + + +V+  +    Q      +K+Y
Sbjct: 73  LKELHHPNIVSLIDVIHS-----ERCLTLVFEFMEKDLKKVLDENKTGLQDSQ---IKIY 124
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---I 117
            YQ+ R +A+ H    + HRD+KPQNLL+N     LKL DFG A+    G P  SY   +
Sbjct: 125 LYQLLRGVAHCHQH-RILHRDLKPQNLLINSDG-ALKLADFGLARAF--GIPVRSYTHEV 180
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            + +YRAP+++ G+ +Y+ ++DIWS GC+ AE++ G+PLFPG +  DQL +I  +LGTP 
Sbjct: 181 VTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPN 240
Query: 178 REEIKCMN--PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 235
             E   +   P + +  F   +  PW  I       E +DL+S +L + PN R +A +A+
Sbjct: 241 PREWPQVQELPLWKQRTFQVFEKKPWSSIIPG-FCQEGIDLLSNMLCFDPNKRISARDAM 299
Query: 236 IHPFFDELRDPN 247
            HP+F +L DP 
Sbjct: 300 NHPYFKDL-DPQ 310

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  155 bits (391), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 95/295 (32%), Positives = 162/295 (54%), Gaps = 27/295 (9%)
Query: 6   HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 65
           H N++ +     + T +    + +V + +   +++++K     +Q +   ++  + YQI 
Sbjct: 82  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQIL 136
Query: 66  RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYIC 118
           R L YIH+   V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ 
Sbjct: 137 RGLKYIHSA-NVLHRDLKPSNLLLNT-TSDLKICDFGLARV---ADPDHDHTGFLTEYVA 191
Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 178
           +R+YRAPE++  +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 251
Query: 179 EEIKC---MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 235
           E++ C   +         P     PW+++F      +A+DL+ ++L ++P+ R    +AL
Sbjct: 252 EDLNCGINLKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQAL 310
Query: 236 IHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI-PEHARKQCAF 289
            HP+  +  DP+    +       F F   EL  +P + L +LI  E AR Q  +
Sbjct: 311 AHPYLAQYYDPS----DEPIAEAPFKFD-MELDDLPKEKLKELIFEETARFQPGY 360

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score =  155 bits (391), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 97/296 (32%), Positives = 164/296 (55%), Gaps = 29/296 (9%)
Query: 6   HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 65
           H N++ +     + T +    + +V + +   +++++K     +Q +   ++  + YQI 
Sbjct: 78  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQIL 132
Query: 66  RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYIC 118
           R L YIH+   V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ 
Sbjct: 133 RGLKYIHSA-NVLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVA 187
Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 178
           +R+YRAPE++  +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P +
Sbjct: 188 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQ 247
Query: 179 EEIKCM----NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 234
           E++ C+      NY     P     PW+++F      +A+DL+ ++L ++P+ R    +A
Sbjct: 248 EDLNCIINLKARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQA 305
Query: 235 LIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI-PEHARKQCAF 289
           L HP+ ++  DP+    +       F F   EL  +P + L +LI  E AR Q  +
Sbjct: 306 LAHPYLEQYYDPS----DEPIAEAPFKFD-MELDDLPKEKLKELIFEETARFQPGY 356

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  154 bits (390), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 93/252 (36%), Positives = 143/252 (56%), Gaps = 19/252 (7%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ L HPN+VSL     S     E  L LV E++ + + +V+  +    Q      +K+Y
Sbjct: 73  LKELHHPNIVSLIDVIHS-----ERCLTLVFEFMEKDLKKVLDENKTGLQDSQ---IKIY 124
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---I 117
            YQ+ R +A+ H    + HRD+KPQNLL+N     LKL DFG A+    G P  SY   +
Sbjct: 125 LYQLLRGVAHCHQH-RILHRDLKPQNLLINSDG-ALKLADFGLARAF--GIPVRSYTHEV 180
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            + +YRAP+++ G+ +Y+ ++DIWS GC+ AE++ G+PLFPG +  DQL +I  +LGTP 
Sbjct: 181 VTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPN 240
Query: 178 REEIKCMN--PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 235
             E   +   P + +  F   +  PW  I       E +DL+S +L + PN R +A +A+
Sbjct: 241 PREWPQVQELPLWKQRTFQVFEKKPWSSIIPG-FCQEGIDLLSNMLCFDPNKRISARDAM 299
Query: 236 IHPFFDELRDPN 247
            HP+F +L DP 
Sbjct: 300 NHPYFKDL-DPQ 310

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  154 bits (390), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 97/296 (32%), Positives = 164/296 (55%), Gaps = 29/296 (9%)
Query: 6   HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 65
           H N++ +     + T +    + +V + +   +++++K      Q +   ++  + YQI 
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----CQHLSNDHICYFLYQIL 138
Query: 66  RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYIC 118
           R L YIH+   V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ 
Sbjct: 139 RGLKYIHSA-NVLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVA 193
Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 178
           +R+YRAPE++  +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 253
Query: 179 EEIKCM----NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 234
           E++ C+      NY     P     PW+++F      +A+DL+ ++L ++P+ R    +A
Sbjct: 254 EDLNCIINLKARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQA 311
Query: 235 LIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI-PEHARKQCAF 289
           L HP+ ++  DP+    +       F F   EL  +P + L +LI  E AR Q  +
Sbjct: 312 LAHPYLEQYYDPS----DEPIAEAPFKFD-MELDDLPKEKLKELIFEETARFQPGY 362

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  154 bits (390), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 97/296 (32%), Positives = 164/296 (55%), Gaps = 29/296 (9%)
Query: 6   HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 65
           H N++ +     + T +    + +V + +   +++++K     +Q +   ++  + YQI 
Sbjct: 82  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQIL 136
Query: 66  RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYIC 118
           R L YIH+   V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ 
Sbjct: 137 RGLKYIHSA-NVLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVA 191
Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 178
           +R+YRAPE++  +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 251
Query: 179 EEIKCM----NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 234
           E++ C+      NY     P     PW+++F      +A+DL+ ++L ++P+ R    +A
Sbjct: 252 EDLNCIINLKARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQA 309
Query: 235 LIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI-PEHARKQCAF 289
           L HP+  +  DP+    +       F F   EL  +P + L +LI  E AR Q  +
Sbjct: 310 LAHPYLAQYYDPS----DEPIAEAPFKFD-MELDDLPKEKLKELIFEETARFQPGY 360

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  154 bits (388), Expect = 8e-38,   Method: Compositional matrix adjust.
 Identities = 95/293 (32%), Positives = 163/293 (55%), Gaps = 23/293 (7%)
Query: 6   HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 65
           H N++ +     + T +    + +V + +   +++++K     +Q +   ++  + YQI 
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQIL 138
Query: 66  RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY----ICSRY 121
           R L YIH+   V HRD+KP NLL+N  T  LK+CDFG A+V      +  +    + +R+
Sbjct: 139 RGLKYIHSA-NVLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLXEXVATRW 196
Query: 122 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 181
           YRAPE++  +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 256
Query: 182 KCM----NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 237
            C+      NY     P     PW+++F      +A+DL+ ++L ++P+ R    +AL H
Sbjct: 257 NCIINLKARNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKRIEVEQALAH 314
Query: 238 PFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI-PEHARKQCAF 289
           P+ ++  DP+    +       F F   EL  +P + L +LI  E AR Q  +
Sbjct: 315 PYLEQYYDPS----DEPIAEAPFKFD-MELDDLPKEKLKELIFEETARFQPGY 362

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  154 bits (388), Expect = 8e-38,   Method: Compositional matrix adjust.
 Identities = 95/293 (32%), Positives = 163/293 (55%), Gaps = 23/293 (7%)
Query: 6   HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 65
           H N++ +     + T +    + +V + +   +++++K     +Q +   ++  + YQI 
Sbjct: 85  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQIL 139
Query: 66  RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY----ICSRY 121
           R L YIH+   V HRD+KP NLL+N  T  LK+CDFG A+V      +  +    + +R+
Sbjct: 140 RGLKYIHSA-NVLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLXEXVATRW 197
Query: 122 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 181
           YRAPE++  +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++E++
Sbjct: 198 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 257
Query: 182 KCM----NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 237
            C+      NY     P     PW+++F      +A+DL+ ++L ++P+ R    +AL H
Sbjct: 258 NCIINLKARNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKRIEVEQALAH 315
Query: 238 PFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI-PEHARKQCAF 289
           P+ ++  DP+    +       F F   EL  +P + L +LI  E AR Q  +
Sbjct: 316 PYLEQYYDPS----DEPIAEAPFKFD-MELDDLPKEKLKELIFEETARFQPGY 363

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score =  153 bits (387), Expect = 9e-38,   Method: Compositional matrix adjust.
 Identities = 97/296 (32%), Positives = 163/296 (55%), Gaps = 29/296 (9%)
Query: 6   HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 65
           H N++ +     + T +    + +V + +   +++++K     +Q +   ++  + YQI 
Sbjct: 80  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQIL 134
Query: 66  RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYIC 118
           R L YIH+   V HRD+KP NLL+N  T  LK+CDFG A+V    +P+         Y+ 
Sbjct: 135 RGLKYIHSA-NVLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVA 189
Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 178
           +R+YRAPE++  +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 249
Query: 179 EE----IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 234
           E+    I     NY     P     PW+++F      +A+DL+ ++L ++P+ R    +A
Sbjct: 250 EDLNXIINLKARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQA 307
Query: 235 LIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI-PEHARKQCAF 289
           L HP+ ++  DP+    +       F F   EL  +P + L +LI  E AR Q  +
Sbjct: 308 LAHPYLEQYYDPS----DEPIAEAPFKFD-MELDDLPKEKLKELIFEETARFQPGY 358

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score =  150 bits (378), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 84/251 (33%), Positives = 135/251 (53%), Gaps = 15/251 (5%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL 59
           ++ + H NV+ L   F   +     Y   LV+ ++   + +++   +   +      ++ 
Sbjct: 95  LKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEK------IQY 148
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
             YQ+ + L YIH+  GV HRD+KP NL VN    +LK+ DFG A+          Y+ +
Sbjct: 149 LVYQMLKGLKYIHSA-GVVHRDLKPGNLAVNEDC-ELKILDFGLARH--ADAEMTGYVVT 204
Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
           R+YRAPE+I     Y   +DIWS GC++AE+L G+ LF G+  +DQL +I+KV G P  E
Sbjct: 205 RWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE 264
Query: 180 EIKCMNPNYTEF---KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 236
            ++ +N    +      PQ     + ++F  R  P+A DL+ ++L+   + R TA +AL 
Sbjct: 265 FVQKLNDKAAKSYIQSLPQTPRKDFTQLF-PRASPQAADLLEKMLELDVDKRLTAAQALT 323
Query: 237 HPFFDELRDPN 247
           HPFF+  RDP 
Sbjct: 324 HPFFEPFRDPE 334

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score =  149 bits (377), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 96/296 (32%), Positives = 162/296 (54%), Gaps = 29/296 (9%)
Query: 6   HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 65
           H N++ +     + T +    + +V + +   +++++K     +Q +   ++  + YQI 
Sbjct: 80  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQIL 134
Query: 66  RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------ISYIC 118
           R L YIH+   V HRD+KP NLL+N  T  LK+ DFG A+V    +P+         Y+ 
Sbjct: 135 RGLKYIHSA-NVLHRDLKPSNLLLNT-TXDLKIXDFGLARV---ADPDHDHTGFLTEYVA 189
Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 178
           +R+YRAPE++  +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P++
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 249
Query: 179 EE----IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 234
           E+    I     NY     P     PW+++F      +A+DL+ ++L ++P+ R    +A
Sbjct: 250 EDLNXIINLKARNYL-LSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQA 307
Query: 235 LIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI-PEHARKQCAF 289
           L HP+ ++  DP+    +       F F   EL  +P + L +LI  E AR Q  +
Sbjct: 308 LAHPYLEQYYDPS----DEPIAEAPFKFD-MELDDLPKEKLKELIFEETARFQPGY 358

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score =  149 bits (376), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 88/285 (30%), Positives = 150/285 (52%), Gaps = 50/285 (17%)
Query: 3   LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 62
           L  H N+V+L +   +  ++D   + LV +Y+   +H VI+ +      +  ++ +   Y
Sbjct: 65  LSGHENIVNLLNVLRADNDRD---VYLVFDYMETDLHAVIRANI-----LEPVHKQYVVY 116
Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV---KGEPNI----- 114
           Q+ + + Y+H+  G+ HRD+KP N+L+N   H +K+ DFG ++  V   +   NI     
Sbjct: 117 QLIKVIKYLHSG-GLLHRDMKPSNILLNAECH-VKVADFGLSRSFVNIRRVTNNIPLSIN 174
Query: 115 --------------SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 160
                          Y+ +R+YRAPE++ G+T+YT  ID+WS GC+L E+L G+P+FPG 
Sbjct: 175 ENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234
Query: 161 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH-------------PWHKIFQK 207
           S ++QL  II V+  P+ E+++ +   + +     +K                W  +  K
Sbjct: 235 STMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLK 294
Query: 208 RMPP-----EAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 247
             P      EA+DL+ +LLQ++PN R +A +AL HPF     +PN
Sbjct: 295 INPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPN 339

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  149 bits (375), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 94/250 (37%), Positives = 135/250 (54%), Gaps = 22/250 (8%)
Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 63
           L HPN++ L   F   +      ++LV +++   +  +IK +   S  +   ++K Y   
Sbjct: 69  LSHPNIIGLLDAFGHKSN-----ISLVFDFMETDLEVIIKDN---SLVLTPSHIKAYMLM 120
Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSR 120
             + L Y+H    + HRD+KP NLL++     LKL DFG AK    G PN +Y   + +R
Sbjct: 121 TLQGLEYLHQHW-ILHRDLKPNNLLLD-ENGVLKLADFGLAKSF--GSPNRAYXHQVVTR 176
Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 180
           +YRAPEL+FGA  Y   +D+W+ GC+LAELLL  P  PG+S +DQL  I + LGTPT E+
Sbjct: 177 WYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQ 236
Query: 181 I--KCMNPNYTEFK-FPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 237
               C  P+Y  FK FP I   P H IF      + +DL+  L  ++P  R TA +AL  
Sbjct: 237 WPDMCSLPDYVTFKSFPGI---PLHHIFSA-AGDDLLDLIQGLFLFNPCARITATQALKM 292
Query: 238 PFFDELRDPN 247
            +F     P 
Sbjct: 293 KYFSNRPGPT 302

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score =  149 bits (375), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 85/251 (33%), Positives = 135/251 (53%), Gaps = 15/251 (5%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL 59
           ++ + H NV+ L   F   +     Y   LV+ ++   + +++   +   +   L+Y   
Sbjct: 77  LKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVY--- 133
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
              Q+ + L YIH+  GV HRD+KP NL VN    +LK+ DFG A+          Y+ +
Sbjct: 134 ---QMLKGLKYIHSA-GVVHRDLKPGNLAVNEDC-ELKILDFGLARH--ADAEMTGYVVT 186
Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
           R+YRAPE+I     Y   +DIWS GC++AE+L G+ LF G+  +DQL +I+KV G P  E
Sbjct: 187 RWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE 246
Query: 180 EIKCMNPNYTEF---KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 236
            ++ +N    +      PQ     + ++F  R  P+A DL+ ++L+   + R TA +AL 
Sbjct: 247 FVQKLNDKAAKSYIQSLPQTPRKDFTQLF-PRASPQAADLLEKMLELDVDKRLTAAQALT 305
Query: 237 HPFFDELRDPN 247
           HPFF+  RDP 
Sbjct: 306 HPFFEPFRDPE 316

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score =  148 bits (373), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 86/251 (34%), Positives = 138/251 (54%), Gaps = 14/251 (5%)
Query: 1   MRLLDHPNVVSLKHCFF-STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL 59
           ++ L H NV+ L   F  +T+ +D   + LV   +   ++ ++K     SQ +   +V+ 
Sbjct: 81  LKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVK-----SQALSDEHVQF 135
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
             YQ+ R L YIH+  G+ HRD+KP N+ VN  + +L++ DFG A+     E    Y+ +
Sbjct: 136 LVYQLLRGLKYIHSA-GIIHRDLKPSNVAVNEDS-ELRILDFGLARQ--ADEEMTGYVAT 191
Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
           R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++V+GTP+ E
Sbjct: 192 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPE 251
Query: 180 EIKCMNPNYTEF---KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 236
            +  ++  +        P +       IF +   P A+DL+ R+L    + R +A EAL 
Sbjct: 252 VLAKISSEHARTYIQSLPPMPQKDLSSIF-RGANPLAIDLLGRMLVLDSDQRVSAAEALA 310
Query: 237 HPFFDELRDPN 247
           H +F +  DP 
Sbjct: 311 HAYFSQYHDPE 321

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score =  147 bits (370), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 88/251 (35%), Positives = 138/251 (54%), Gaps = 16/251 (6%)
Query: 6   HPNVVSLKHCFFSTTEKDEL-YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQI 64
           H N++++K     T    E   + +VL+ +   +H++I      SQ + L +V+ + YQ+
Sbjct: 112 HDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHS----SQPLTLEHVRYFLYQL 167
Query: 65  CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-----ISYICS 119
            R L Y+H+   V HRD+KP NLLVN +  +LK+ DFG A+ L             Y+ +
Sbjct: 168 LRGLKYMHSA-QVIHRDLKPSNLLVNENC-ELKIGDFGMARGLCTSPAEHQYFMTEYVAT 225
Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
           R+YRAPEL+    EYT AID+WS GC+  E+L  + LFPG++ V QL  I+ VLGTP+  
Sbjct: 226 RWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA 285
Query: 180 EIKCMNPNYTEF---KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 236
            I+ +            P  +  PW  ++      +A+ L+ R+L++ P+ R +A  AL 
Sbjct: 286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPG-ADRQALSLLGRMLRFEPSARISAAAALR 344
Query: 237 HPFFDELRDPN 247
           HPF  +  DP+
Sbjct: 345 HPFLAKYHDPD 355

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score =  146 bits (369), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 88/251 (35%), Positives = 138/251 (54%), Gaps = 16/251 (6%)
Query: 6   HPNVVSLKHCFFSTTEKDEL-YLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQI 64
           H N++++K     T    E   + +VL+ +   +H++I      SQ + L +V+ + YQ+
Sbjct: 113 HDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHS----SQPLTLEHVRYFLYQL 168
Query: 65  CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-----ISYICS 119
            R L Y+H+   V HRD+KP NLLVN +  +LK+ DFG A+ L             Y+ +
Sbjct: 169 LRGLKYMHSA-QVIHRDLKPSNLLVNENC-ELKIGDFGMARGLCTSPAEHQYFMTEYVAT 226
Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
           R+YRAPEL+    EYT AID+WS GC+  E+L  + LFPG++ V QL  I+ VLGTP+  
Sbjct: 227 RWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA 286
Query: 180 EIKCMNPNYTEF---KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 236
            I+ +            P  +  PW  ++      +A+ L+ R+L++ P+ R +A  AL 
Sbjct: 287 VIQAVGAERVRAYIQSLPPRQPVPWETVYPG-ADRQALSLLGRMLRFEPSARISAAAALR 345
Query: 237 HPFFDELRDPN 247
           HPF  +  DP+
Sbjct: 346 HPFLAKYHDPD 356

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  146 bits (368), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 92/253 (36%), Positives = 142/253 (56%), Gaps = 22/253 (8%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ L+HPN+V L     +   +++LYL  V E+V + + + +         +PLI  K Y
Sbjct: 59  LKELNHPNIVKLLDVIHT---ENKLYL--VFEHVDQDLKKFMDASALTGIPLPLI--KSY 111
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---I 117
            +Q+ + LA+ H+   V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   +
Sbjct: 112 LFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEV 167
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            + +YRAPE++ G   Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP 
Sbjct: 168 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD 227
Query: 178 REEIKCMNPNYTEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALE 233
               + + P  T     +     W  + F K +PP   +   L+S++L Y PN R +A  
Sbjct: 228 ----EVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKA 283
Query: 234 ALIHPFFDELRDP 246
           AL HPFF ++  P
Sbjct: 284 ALAHPFFQDVTKP 296

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  146 bits (368), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 96/260 (36%), Positives = 144/260 (55%), Gaps = 36/260 (13%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVK 58
           ++ L+HPN+V L     +   +++LYL      V E VH+ +K     S    +PL  +K
Sbjct: 55  LKELNHPNIVKLLDVIHT---ENKLYL------VFEHVHQDLKTFMDASALTGIPLPLIK 105
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-- 116
            Y +Q+ + LA+ H+   V HRD+KPQNLL+N     +KL DFG A+    G P  +Y  
Sbjct: 106 SYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTH 161
Query: 117 -ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
            + + +YRAPE++ G   Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGT
Sbjct: 162 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT 221
Query: 176 PTREEIKCMNPNYTEF-----KFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPN 226
           P     + + P  T        FP+     W  + F K +PP   +   L+S++L Y PN
Sbjct: 222 PD----EVVWPGVTSMPDYKPSFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPN 272
Query: 227 LRSTALEALIHPFFDELRDP 246
            R +A  AL HPFF ++  P
Sbjct: 273 KRISAKAALAHPFFQDVTKP 292

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  145 bits (367), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 95/260 (36%), Positives = 144/260 (55%), Gaps = 36/260 (13%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVK 58
           ++ L+HPN+V L     +   +++LYL      V E +H+ +K     S    +PL  +K
Sbjct: 56  LKELNHPNIVKLLDVIHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIK 106
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-- 116
            Y +Q+ + LA+ H+   V HRD+KPQNLL+N     +KL DFG A+    G P  +Y  
Sbjct: 107 SYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTH 162
Query: 117 -ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
            + + +YRAPE++ G   Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGT
Sbjct: 163 EVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT 222
Query: 176 PTREEIKCMNPNYTEF-----KFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPN 226
           P     + + P  T        FP+     W  + F K +PP   +   L+S++L Y PN
Sbjct: 223 PD----EVVWPGVTSMPDYKPSFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPN 273
Query: 227 LRSTALEALIHPFFDELRDP 246
            R +A  AL HPFF ++  P
Sbjct: 274 KRISAKAALAHPFFQDVTKP 293

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  145 bits (366), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 89/257 (34%), Positives = 143/257 (55%), Gaps = 18/257 (7%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ L H N+V+L       TEK    L LV EY+ + + + +         + +  VKL+
Sbjct: 54  LKDLKHANIVTLHDIIH--TEKS---LTLVFEYLDKDLKQYLD---DCGNIINMHNVKLF 105
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---I 117
            +Q+ R LAY H    V HRD+KPQNLL+N    +LKL DFG A+   K  P  +Y   +
Sbjct: 106 LFQLLRGLAYCHRQ-KVLHRDLKPQNLLINERG-ELKLADFGLARA--KSIPTKTYDNEV 161
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            + +YR P+++ G+T+Y+  ID+W  GC+  E+  G+PLFPG +  +QL  I ++LGTPT
Sbjct: 162 VTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPT 221
Query: 178 REEIKCM--NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 235
            E    +  N  +  + +P+ +A         R+  +  DL+++LLQ+    R +A +A+
Sbjct: 222 EETWPGILSNEEFKTYNYPKYRAEALLS-HAPRLDSDGADLLTKLLQFEGRNRISAEDAM 280
Query: 236 IHPFFDELRDPNTRLPN 252
            HPFF  L +   +LP+
Sbjct: 281 KHPFFLSLGERIHKLPD 297

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score =  145 bits (366), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 85/251 (33%), Positives = 137/251 (54%), Gaps = 14/251 (5%)
Query: 1   MRLLDHPNVVSLKHCFF-STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL 59
           ++ L H NV+ L   F  +T+ +D   + LV   +   ++ ++K      Q +   +V+ 
Sbjct: 81  LKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVK-----CQALSDEHVQF 135
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
             YQ+ R L YIH+  G+ HRD+KP N+ VN  + +L++ DFG A+     E    Y+ +
Sbjct: 136 LVYQLLRGLKYIHSA-GIIHRDLKPSNVAVNEDS-ELRILDFGLARQ--ADEEMTGYVAT 191
Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
           R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++V+GTP+ E
Sbjct: 192 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPE 251
Query: 180 EIKCMNPNYTEF---KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 236
            +  ++  +        P +       IF +   P A+DL+ R+L    + R +A EAL 
Sbjct: 252 VLAKISSEHARTYIQSLPPMPQKDLSSIF-RGANPLAIDLLGRMLVLDSDQRVSAAEALA 310
Query: 237 HPFFDELRDPN 247
           H +F +  DP 
Sbjct: 311 HAYFSQYHDPE 321

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  145 bits (366), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 93/255 (36%), Positives = 142/255 (55%), Gaps = 26/255 (10%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVK 58
           ++ L+HPN+V L     +   +++LYL      V E +H+ +K     S    +PL  +K
Sbjct: 63  LKELNHPNIVKLLDVIHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIK 113
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-- 116
            Y +Q+ + LA+ H+   V HRD+KPQNLL+N     +KL DFG A+    G P  +Y  
Sbjct: 114 SYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTH 169
Query: 117 -ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
            + + +YRAPE++ G   Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGT
Sbjct: 170 EVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT 229
Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTA 231
           P     + + P  T     +     W  + F K +PP   +   L+S++L Y PN R +A
Sbjct: 230 PD----EVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 285
Query: 232 LEALIHPFFDELRDP 246
             AL HPFF ++  P
Sbjct: 286 KAALAHPFFQDVTKP 300

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  145 bits (366), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 93/255 (36%), Positives = 142/255 (55%), Gaps = 26/255 (10%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVK 58
           ++ L+HPN+V L     +   +++LYL      V E +H+ +K     S    +PL  +K
Sbjct: 56  LKELNHPNIVKLLDVIHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIK 106
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-- 116
            Y +Q+ + LA+ H+   V HRD+KPQNLL+N     +KL DFG A+    G P  +Y  
Sbjct: 107 SYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXH 162
Query: 117 -ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
            + + +YRAPE++ G   Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGT
Sbjct: 163 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT 222
Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTA 231
           P     + + P  T     +     W  + F K +PP   +   L+S++L Y PN R +A
Sbjct: 223 PD----EVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 278
Query: 232 LEALIHPFFDELRDP 246
             AL HPFF ++  P
Sbjct: 279 KAALAHPFFQDVTKP 293

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  145 bits (366), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 95/260 (36%), Positives = 144/260 (55%), Gaps = 36/260 (13%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVK 58
           ++ L+HPN+V L     +   +++LYL      V E +H+ +K     S    +PL  +K
Sbjct: 56  LKELNHPNIVKLLDVIHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIK 106
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-- 116
            Y +Q+ + LA+ H+   V HRD+KPQNLL+N     +KL DFG A+    G P  +Y  
Sbjct: 107 SYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXH 162
Query: 117 -ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
            + + +YRAPE++ G   Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGT
Sbjct: 163 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT 222
Query: 176 PTREEIKCMNPNYTEF-----KFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPN 226
           P     + + P  T        FP+     W  + F K +PP   +   L+S++L Y PN
Sbjct: 223 PD----EVVWPGVTSMPDYKPSFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPN 273
Query: 227 LRSTALEALIHPFFDELRDP 246
            R +A  AL HPFF ++  P
Sbjct: 274 KRISAKAALAHPFFQDVTKP 293

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  145 bits (366), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 93/255 (36%), Positives = 142/255 (55%), Gaps = 26/255 (10%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVK 58
           ++ L+HPN+V L     +   +++LYL      V E +H+ +K     S    +PL  +K
Sbjct: 55  LKELNHPNIVKLLDVIHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIK 105
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-- 116
            Y +Q+ + LA+ H+   V HRD+KPQNLL+N     +KL DFG A+    G P  +Y  
Sbjct: 106 SYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXH 161
Query: 117 -ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
            + + +YRAPE++ G   Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGT
Sbjct: 162 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT 221
Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTA 231
           P     + + P  T     +     W  + F K +PP   +   L+S++L Y PN R +A
Sbjct: 222 PD----EVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 277
Query: 232 LEALIHPFFDELRDP 246
             AL HPFF ++  P
Sbjct: 278 KAALAHPFFQDVTKP 292

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  145 bits (366), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 93/255 (36%), Positives = 142/255 (55%), Gaps = 26/255 (10%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVK 58
           ++ L+HPN+V L     +   +++LYL      V E +H+ +K     S    +PL  +K
Sbjct: 58  LKELNHPNIVKLLDVIHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIK 108
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-- 116
            Y +Q+ + LA+ H+   V HRD+KPQNLL+N     +KL DFG A+    G P  +Y  
Sbjct: 109 SYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXH 164
Query: 117 -ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
            + + +YRAPE++ G   Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGT
Sbjct: 165 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT 224
Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTA 231
           P     + + P  T     +     W  + F K +PP   +   L+S++L Y PN R +A
Sbjct: 225 PD----EVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 280
Query: 232 LEALIHPFFDELRDP 246
             AL HPFF ++  P
Sbjct: 281 KAALAHPFFQDVTKP 295

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  145 bits (366), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 93/255 (36%), Positives = 142/255 (55%), Gaps = 26/255 (10%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVK 58
           ++ L+HPN+V L     +   +++LYL      V E +H+ +K     S    +PL  +K
Sbjct: 55  LKELNHPNIVKLLDVIHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIK 105
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-- 116
            Y +Q+ + LA+ H+   V HRD+KPQNLL+N     +KL DFG A+    G P  +Y  
Sbjct: 106 SYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTH 161
Query: 117 -ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
            + + +YRAPE++ G   Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGT
Sbjct: 162 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT 221
Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTA 231
           P     + + P  T     +     W  + F K +PP   +   L+S++L Y PN R +A
Sbjct: 222 PD----EVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 277
Query: 232 LEALIHPFFDELRDP 246
             AL HPFF ++  P
Sbjct: 278 KAALAHPFFQDVTKP 292

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  145 bits (366), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 93/255 (36%), Positives = 142/255 (55%), Gaps = 26/255 (10%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVK 58
           ++ L+HPN+V L     +   +++LYL      V E +H+ +K     S    +PL  +K
Sbjct: 56  LKELNHPNIVKLLDVIHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIK 106
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-- 116
            Y +Q+ + LA+ H+   V HRD+KPQNLL+N     +KL DFG A+    G P  +Y  
Sbjct: 107 SYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTH 162
Query: 117 -ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
            + + +YRAPE++ G   Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGT
Sbjct: 163 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT 222
Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTA 231
           P     + + P  T     +     W  + F K +PP   +   L+S++L Y PN R +A
Sbjct: 223 PD----EVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 278
Query: 232 LEALIHPFFDELRDP 246
             AL HPFF ++  P
Sbjct: 279 KAALAHPFFQDVTKP 293

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  145 bits (366), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 93/255 (36%), Positives = 142/255 (55%), Gaps = 26/255 (10%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVK 58
           ++ L+HPN+V L     +   +++LYL      V E +H+ +K     S    +PL  +K
Sbjct: 55  LKELNHPNIVKLLDVIHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIK 105
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-- 116
            Y +Q+ + LA+ H+   V HRD+KPQNLL+N     +KL DFG A+    G P  +Y  
Sbjct: 106 SYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTH 161
Query: 117 -ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
            + + +YRAPE++ G   Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGT
Sbjct: 162 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT 221
Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTA 231
           P     + + P  T     +     W  + F K +PP   +   L+S++L Y PN R +A
Sbjct: 222 PD----EVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 277
Query: 232 LEALIHPFFDELRDP 246
             AL HPFF ++  P
Sbjct: 278 KAALAHPFFQDVTKP 292

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  145 bits (366), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 93/255 (36%), Positives = 142/255 (55%), Gaps = 26/255 (10%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVK 58
           ++ L+HPN+V L     +   +++LYL      V E +H+ +K     S    +PL  +K
Sbjct: 56  LKELNHPNIVKLLDVIHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIK 106
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-- 116
            Y +Q+ + LA+ H+   V HRD+KPQNLL+N     +KL DFG A+    G P  +Y  
Sbjct: 107 SYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXH 162
Query: 117 -ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
            + + +YRAPE++ G   Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGT
Sbjct: 163 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT 222
Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTA 231
           P     + + P  T     +     W  + F K +PP   +   L+S++L Y PN R +A
Sbjct: 223 PD----EVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 278
Query: 232 LEALIHPFFDELRDP 246
             AL HPFF ++  P
Sbjct: 279 KAALAHPFFQDVTKP 293

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  145 bits (365), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 93/255 (36%), Positives = 142/255 (55%), Gaps = 26/255 (10%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVK 58
           ++ L+HPN+V L     +   +++LYL      V E +H+ +K     S    +PL  +K
Sbjct: 56  LKELNHPNIVKLLDVIHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIK 106
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-- 116
            Y +Q+ + LA+ H+   V HRD+KPQNLL+N     +KL DFG A+    G P  +Y  
Sbjct: 107 SYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTH 162
Query: 117 -ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
            + + +YRAPE++ G   Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGT
Sbjct: 163 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT 222
Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTA 231
           P     + + P  T     +     W  + F K +PP   +   L+S++L Y PN R +A
Sbjct: 223 PD----EVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 278
Query: 232 LEALIHPFFDELRDP 246
             AL HPFF ++  P
Sbjct: 279 KAALAHPFFQDVTKP 293

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  145 bits (365), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 93/255 (36%), Positives = 142/255 (55%), Gaps = 26/255 (10%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVK 58
           ++ L+HPN+V L     +   +++LYL      V E +H+ +K     S    +PL  +K
Sbjct: 55  LKELNHPNIVKLLDVIHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIK 105
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-- 116
            Y +Q+ + LA+ H+   V HRD+KPQNLL+N     +KL DFG A+    G P  +Y  
Sbjct: 106 SYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTH 161
Query: 117 -ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
            + + +YRAPE++ G   Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGT
Sbjct: 162 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT 221
Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTA 231
           P     + + P  T     +     W  + F K +PP   +   L+S++L Y PN R +A
Sbjct: 222 PD----EVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 277
Query: 232 LEALIHPFFDELRDP 246
             AL HPFF ++  P
Sbjct: 278 KAALAHPFFQDVTKP 292

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  145 bits (365), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 93/255 (36%), Positives = 142/255 (55%), Gaps = 26/255 (10%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVK 58
           ++ L+HPN+V L     +   +++LYL      V E +H+ +K     S    +PL  +K
Sbjct: 59  LKELNHPNIVKLLDVIHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIK 109
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-- 116
            Y +Q+ + LA+ H+   V HRD+KPQNLL+N     +KL DFG A+    G P  +Y  
Sbjct: 110 SYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXH 165
Query: 117 -ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
            + + +YRAPE++ G   Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGT
Sbjct: 166 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT 225
Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTA 231
           P     + + P  T     +     W  + F K +PP   +   L+S++L Y PN R +A
Sbjct: 226 PD----EVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 281
Query: 232 LEALIHPFFDELRDP 246
             AL HPFF ++  P
Sbjct: 282 KAALAHPFFQDVTKP 296

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  145 bits (365), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 93/255 (36%), Positives = 142/255 (55%), Gaps = 26/255 (10%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVK 58
           ++ L+HPN+V L     +   +++LYL      V E +H+ +K     S    +PL  +K
Sbjct: 58  LKELNHPNIVKLLDVIHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIK 108
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-- 116
            Y +Q+ + LA+ H+   V HRD+KPQNLL+N     +KL DFG A+    G P  +Y  
Sbjct: 109 SYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXH 164
Query: 117 -ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
            + + +YRAPE++ G   Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGT
Sbjct: 165 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT 224
Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTA 231
           P     + + P  T     +     W  + F K +PP   +   L+S++L Y PN R +A
Sbjct: 225 PD----EVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 280
Query: 232 LEALIHPFFDELRDP 246
             AL HPFF ++  P
Sbjct: 281 KAALAHPFFQDVTKP 295

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  145 bits (365), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 93/255 (36%), Positives = 142/255 (55%), Gaps = 26/255 (10%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVK 58
           ++ L+HPN+V L     +   +++LYL      V E +H+ +K     S    +PL  +K
Sbjct: 63  LKELNHPNIVKLLDVIHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIK 113
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-- 116
            Y +Q+ + LA+ H+   V HRD+KPQNLL+N     +KL DFG A+    G P  +Y  
Sbjct: 114 SYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTH 169
Query: 117 -ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
            + + +YRAPE++ G   Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGT
Sbjct: 170 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT 229
Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTA 231
           P     + + P  T     +     W  + F K +PP   +   L+S++L Y PN R +A
Sbjct: 230 PD----EVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 285
Query: 232 LEALIHPFFDELRDP 246
             AL HPFF ++  P
Sbjct: 286 KAALAHPFFQDVTKP 300

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  145 bits (365), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 93/255 (36%), Positives = 142/255 (55%), Gaps = 26/255 (10%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVK 58
           ++ L+HPN+V L     +   +++LYL      V E +H+ +K     S    +PL  +K
Sbjct: 55  LKELNHPNIVKLLDVIHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIK 105
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-- 116
            Y +Q+ + LA+ H+   V HRD+KPQNLL+N     +KL DFG A+    G P  +Y  
Sbjct: 106 SYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXH 161
Query: 117 -ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
            + + +YRAPE++ G   Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGT
Sbjct: 162 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT 221
Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTA 231
           P     + + P  T     +     W  + F K +PP   +   L+S++L Y PN R +A
Sbjct: 222 PD----EVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 277
Query: 232 LEALIHPFFDELRDP 246
             AL HPFF ++  P
Sbjct: 278 KAALAHPFFQDVTKP 292

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  145 bits (365), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 93/255 (36%), Positives = 142/255 (55%), Gaps = 26/255 (10%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVK 58
           ++ L+HPN+V L     +   +++LYL      V E +H+ +K     S    +PL  +K
Sbjct: 60  LKELNHPNIVKLLDVIHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIK 110
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-- 116
            Y +Q+ + LA+ H+   V HRD+KPQNLL+N     +KL DFG A+    G P  +Y  
Sbjct: 111 SYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXH 166
Query: 117 -ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
            + + +YRAPE++ G   Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGT
Sbjct: 167 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT 226
Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTA 231
           P     + + P  T     +     W  + F K +PP   +   L+S++L Y PN R +A
Sbjct: 227 PD----EVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 282
Query: 232 LEALIHPFFDELRDP 246
             AL HPFF ++  P
Sbjct: 283 KAALAHPFFQDVTKP 297

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  145 bits (365), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 93/255 (36%), Positives = 142/255 (55%), Gaps = 26/255 (10%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVK 58
           ++ L+HPN+V L     +   +++LYL      V E +H+ +K     S    +PL  +K
Sbjct: 57  LKELNHPNIVKLLDVIHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIK 107
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-- 116
            Y +Q+ + LA+ H+   V HRD+KPQNLL+N     +KL DFG A+    G P  +Y  
Sbjct: 108 SYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXH 163
Query: 117 -ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
            + + +YRAPE++ G   Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGT
Sbjct: 164 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT 223
Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTA 231
           P     + + P  T     +     W  + F K +PP   +   L+S++L Y PN R +A
Sbjct: 224 PD----EVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 279
Query: 232 LEALIHPFFDELRDP 246
             AL HPFF ++  P
Sbjct: 280 KAALAHPFFQDVTKP 294

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  145 bits (365), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 93/255 (36%), Positives = 142/255 (55%), Gaps = 26/255 (10%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVK 58
           ++ L+HPN+V L     +   +++LYL      V E +H+ +K     S    +PL  +K
Sbjct: 57  LKELNHPNIVKLLDVIHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIK 107
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-- 116
            Y +Q+ + LA+ H+   V HRD+KPQNLL+N     +KL DFG A+    G P  +Y  
Sbjct: 108 SYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXH 163
Query: 117 -ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
            + + +YRAPE++ G   Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGT
Sbjct: 164 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT 223
Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTA 231
           P     + + P  T     +     W  + F K +PP   +   L+S++L Y PN R +A
Sbjct: 224 PD----EVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 279
Query: 232 LEALIHPFFDELRDP 246
             AL HPFF ++  P
Sbjct: 280 KAALAHPFFQDVTKP 294

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  145 bits (365), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 93/255 (36%), Positives = 142/255 (55%), Gaps = 26/255 (10%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVK 58
           ++ L+HPN+V L     +   +++LYL      V E +H+ +K     S    +PL  +K
Sbjct: 56  LKELNHPNIVKLLDVIHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIK 106
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-- 116
            Y +Q+ + LA+ H+   V HRD+KPQNLL+N     +KL DFG A+    G P  +Y  
Sbjct: 107 SYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTH 162
Query: 117 -ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
            + + +YRAPE++ G   Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGT
Sbjct: 163 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT 222
Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTA 231
           P     + + P  T     +     W  + F K +PP   +   L+S++L Y PN R +A
Sbjct: 223 PD----EVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 278
Query: 232 LEALIHPFFDELRDP 246
             AL HPFF ++  P
Sbjct: 279 KAALAHPFFQDVTKP 293

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  145 bits (365), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 93/255 (36%), Positives = 142/255 (55%), Gaps = 26/255 (10%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVK 58
           ++ L+HPN+V L     +   +++LYL      V E +H+ +K     S    +PL  +K
Sbjct: 57  LKELNHPNIVKLLDVIHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIK 107
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-- 116
            Y +Q+ + LA+ H+   V HRD+KPQNLL+N     +KL DFG A+    G P  +Y  
Sbjct: 108 SYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTH 163
Query: 117 -ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
            + + +YRAPE++ G   Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGT
Sbjct: 164 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT 223
Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTA 231
           P     + + P  T     +     W  + F K +PP   +   L+S++L Y PN R +A
Sbjct: 224 PD----EVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 279
Query: 232 LEALIHPFFDELRDP 246
             AL HPFF ++  P
Sbjct: 280 KAALAHPFFQDVTKP 294

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  145 bits (365), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 93/255 (36%), Positives = 142/255 (55%), Gaps = 26/255 (10%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVK 58
           ++ L+HPN+V L     +   +++LYL      V E +H+ +K     S    +PL  +K
Sbjct: 60  LKELNHPNIVKLLDVIHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIK 110
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-- 116
            Y +Q+ + LA+ H+   V HRD+KPQNLL+N     +KL DFG A+    G P  +Y  
Sbjct: 111 SYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTH 166
Query: 117 -ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
            + + +YRAPE++ G   Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGT
Sbjct: 167 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT 226
Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTA 231
           P     + + P  T     +     W  + F K +PP   +   L+S++L Y PN R +A
Sbjct: 227 PD----EVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 282
Query: 232 LEALIHPFFDELRDP 246
             AL HPFF ++  P
Sbjct: 283 KAALAHPFFQDVTKP 297

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  145 bits (365), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 93/255 (36%), Positives = 142/255 (55%), Gaps = 26/255 (10%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVK 58
           ++ L+HPN+V L     +   +++LYL      V E +H+ +K     S    +PL  +K
Sbjct: 59  LKELNHPNIVKLLDVIHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIK 109
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-- 116
            Y +Q+ + LA+ H+   V HRD+KPQNLL+N     +KL DFG A+    G P  +Y  
Sbjct: 110 SYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXH 165
Query: 117 -ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
            + + +YRAPE++ G   Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGT
Sbjct: 166 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT 225
Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTA 231
           P     + + P  T     +     W  + F K +PP   +   L+S++L Y PN R +A
Sbjct: 226 PD----EVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 281
Query: 232 LEALIHPFFDELRDP 246
             AL HPFF ++  P
Sbjct: 282 KAALAHPFFQDVTKP 296

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  144 bits (364), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 93/255 (36%), Positives = 142/255 (55%), Gaps = 26/255 (10%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVK 58
           ++ L+HPN+V L     +   +++LYL      V E +H+ +K     S    +PL  +K
Sbjct: 59  LKELNHPNIVKLLDVIHT---ENKLYL------VFEFLHQDLKTFMDASALTGIPLPLIK 109
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-- 116
            Y +Q+ + LA+ H+   V HRD+KPQNLL+N     +KL DFG A+    G P  +Y  
Sbjct: 110 SYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXH 165
Query: 117 -ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
            + + +YRAPE++ G   Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGT
Sbjct: 166 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT 225
Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTA 231
           P     + + P  T     +     W  + F K +PP   +   L+S++L Y PN R +A
Sbjct: 226 PD----EVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 281
Query: 232 LEALIHPFFDELRDP 246
             AL HPFF ++  P
Sbjct: 282 KAALAHPFFQDVTKP 296

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  144 bits (363), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 92/255 (36%), Positives = 142/255 (55%), Gaps = 26/255 (10%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVK 58
           ++ L+HPN+V L     +   +++LYL      V E +H+ +K     S    +PL  +K
Sbjct: 56  LKELNHPNIVKLLDVIHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIK 106
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-- 116
            Y +Q+ + L++ H+   V HRD+KPQNLL+N     +KL DFG A+    G P  +Y  
Sbjct: 107 SYLFQLLQGLSFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTH 162
Query: 117 -ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
            + + +YRAPE++ G   Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGT
Sbjct: 163 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT 222
Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTA 231
           P     + + P  T     +     W  + F K +PP   +   L+S++L Y PN R +A
Sbjct: 223 PD----EVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 278
Query: 232 LEALIHPFFDELRDP 246
             AL HPFF ++  P
Sbjct: 279 KAALAHPFFQDVTKP 293

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  144 bits (362), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 92/255 (36%), Positives = 142/255 (55%), Gaps = 26/255 (10%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVK 58
           ++ L+HPN+V L     +   +++LYL      V E +H+ +K     S    +PL  +K
Sbjct: 58  LKELNHPNIVKLLDVIHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIK 108
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-- 116
            Y +Q+ + LA+ H+   V HRD+KP+NLL+N     +KL DFG A+    G P  +Y  
Sbjct: 109 SYLFQLLQGLAFCHSH-RVLHRDLKPENLLINTEG-AIKLADFGLARAF--GVPVRTYXH 164
Query: 117 -ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
            + + +YRAPE++ G   Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGT
Sbjct: 165 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT 224
Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTA 231
           P     + + P  T     +     W  + F K +PP   +   L+S++L Y PN R +A
Sbjct: 225 PD----EVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 280
Query: 232 LEALIHPFFDELRDP 246
             AL HPFF ++  P
Sbjct: 281 KAALAHPFFQDVTKP 295

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  144 bits (362), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 92/255 (36%), Positives = 142/255 (55%), Gaps = 26/255 (10%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVK 58
           ++ L+HPN+V L     +   +++LYL      V E +H+ +K     S    +PL  +K
Sbjct: 57  LKELNHPNIVKLLDVIHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIK 107
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-- 116
            Y +Q+ + LA+ H+   V HRD+KP+NLL+N     +KL DFG A+    G P  +Y  
Sbjct: 108 SYLFQLLQGLAFCHSH-RVLHRDLKPENLLINTEG-AIKLADFGLARAF--GVPVRTYXH 163
Query: 117 -ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
            + + +YRAPE++ G   Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGT
Sbjct: 164 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT 223
Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTA 231
           P     + + P  T     +     W  + F K +PP   +   L+S++L Y PN R +A
Sbjct: 224 PD----EVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 279
Query: 232 LEALIHPFFDELRDP 246
             AL HPFF ++  P
Sbjct: 280 KAALAHPFFQDVTKP 294

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score =  144 bits (362), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 85/251 (33%), Positives = 136/251 (54%), Gaps = 14/251 (5%)
Query: 1   MRLLDHPNVVSLKHCFF-STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL 59
           ++ L H NV+ L   F  +T+ +D   + LV   +   ++ ++K      Q +   +V+ 
Sbjct: 73  LKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVK-----CQALSDEHVQF 127
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
             YQ+ R L YIH+  G+ HRD+KP N+ VN    +L++ DFG A+     E    Y+ +
Sbjct: 128 LVYQLLRGLKYIHSA-GIIHRDLKPSNVAVNEDC-ELRILDFGLARQ--ADEEMTGYVAT 183
Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
           R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++V+GTP+ E
Sbjct: 184 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPE 243
Query: 180 EIKCMNPNYTEF---KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 236
            +  ++  +        P +       IF +   P A+DL+ R+L    + R +A EAL 
Sbjct: 244 VLAKISSEHARTYIQSLPPMPQKDLSSIF-RGANPLAIDLLGRMLVLDSDQRVSAAEALA 302
Query: 237 HPFFDELRDPN 247
           H +F +  DP 
Sbjct: 303 HAYFSQYHDPE 313

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  144 bits (362), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 92/255 (36%), Positives = 142/255 (55%), Gaps = 26/255 (10%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVK 58
           ++ L+HPN+V L     +   +++LYL      V E +H+ +K     S    +PL  +K
Sbjct: 56  LKELNHPNIVKLLDVIHT---ENKLYL------VFEFLHQDLKDFMDASALTGIPLPLIK 106
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-- 116
            Y +Q+ + LA+ H+   V HRD+KP+NLL+N     +KL DFG A+    G P  +Y  
Sbjct: 107 SYLFQLLQGLAFCHSH-RVLHRDLKPENLLINTEG-AIKLADFGLARAF--GVPVRTYXH 162
Query: 117 -ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
            + + +YRAPE++ G   Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGT
Sbjct: 163 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT 222
Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTA 231
           P     + + P  T     +     W  + F K +PP   +   L+S++L Y PN R +A
Sbjct: 223 PD----EVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 278
Query: 232 LEALIHPFFDELRDP 246
             AL HPFF ++  P
Sbjct: 279 KAALAHPFFQDVTKP 293

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  143 bits (361), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 88/250 (35%), Positives = 134/250 (53%), Gaps = 25/250 (10%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ L H N+V L     +        L LV E++ + + +++         +  +  K +
Sbjct: 54  LKELKHSNIVKLYDVIHTKKR-----LVLVFEHLDQDLKKLLD---VCEGGLESVTAKSF 105
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---I 117
             Q+   +AY H+   V HRD+KPQNLL+N    +LK+ DFG A+    G P   Y   I
Sbjct: 106 LLQLLNGIAYCHDR-RVLHRDLKPQNLLIN-REGELKIADFGLARAF--GIPVRKYTHEI 161
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            + +YRAP+++ G+ +Y+  IDIWS GC+ AE++ G PLFPG S  DQL+ I ++LGTP 
Sbjct: 162 VTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPN 221
Query: 178 REEIKCMNPNYTEF-----KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAL 232
            +      PN TE       F   +  PW   F K +    +DL+S++L+  PN R TA 
Sbjct: 222 SKNW----PNVTELPKYDPNFTVYEPLPWES-FLKGLDESGIDLLSKMLKLDPNQRITAK 276
Query: 233 EALIHPFFDE 242
           +AL H +F E
Sbjct: 277 QALEHAYFKE 286

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  143 bits (360), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 94/256 (36%), Positives = 142/256 (55%), Gaps = 36/256 (14%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS--QRMPLIYVK 58
           ++ L+HPN+V L     +   +++LYL      V E +H+ +K     S    +PL  +K
Sbjct: 56  LKELNHPNIVKLLDVIHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIK 106
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-- 116
            Y +Q+ + LA+ H+   V HRD+KPQNLL+N     +KL DFG A+    G P  +Y  
Sbjct: 107 SYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXH 162
Query: 117 -ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
            + + +YRAPE++ G   Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGT
Sbjct: 163 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT 222
Query: 176 PTREEIKCMNPNYTEF-----KFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPN 226
           P     + + P  T        FP+     W  + F K +PP   +   L+S++L Y PN
Sbjct: 223 PD----EVVWPGVTSMPDYKPSFPK-----WARQDFSKVVPPLDEDGRSLLSQMLHYDPN 273
Query: 227 LRSTALEALIHPFFDE 242
            R +A  AL HPFF +
Sbjct: 274 KRISAKAALAHPFFQD 289

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  143 bits (360), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 91/253 (35%), Positives = 140/253 (55%), Gaps = 22/253 (8%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ L+HPN+V L     +   +++LYL  V E++   +   +         +PLI  K Y
Sbjct: 59  LKELNHPNIVKLLDVIHT---ENKLYL--VFEFLSMDLKDFMDASALTGIPLPLI--KSY 111
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---I 117
            +Q+ + LA+ H+   V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   +
Sbjct: 112 LFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEV 167
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            + +YRAPE++ G   Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP 
Sbjct: 168 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD 227
Query: 178 REEIKCMNPNYTEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALE 233
               + + P  T     +     W  + F K +PP   +   L+S++L Y PN R +A  
Sbjct: 228 ----EVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKA 283
Query: 234 ALIHPFFDELRDP 246
           AL HPFF ++  P
Sbjct: 284 ALAHPFFQDVTKP 296

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  142 bits (359), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 88/252 (34%), Positives = 135/252 (53%), Gaps = 16/252 (6%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL 59
           ++ + H NV+ L   F   T  +E   + LV   +   ++ ++K      Q++   +V+ 
Sbjct: 104 LKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQF 158
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
             YQI R L YIH+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+ +
Sbjct: 159 LIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVAT 214
Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
           R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   ++QL +I+++ GTP   
Sbjct: 215 RWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPAS 274
Query: 180 EIKCM----NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 235
            I  M      NY     PQ+    +  +F     P AVDL+ ++L    + R TA EAL
Sbjct: 275 VISRMPSHEARNYIN-SLPQMPKRNFADVFIG-ANPLAVDLLEKMLVLDTDKRITASEAL 332
Query: 236 IHPFFDELRDPN 247
            HP+F +  DP+
Sbjct: 333 AHPYFSQYHDPD 344

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 90/253 (35%), Positives = 141/253 (55%), Gaps = 22/253 (8%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ L+HPN+V L     +   +++LYL  V E++   + + +         +PLI  K Y
Sbjct: 57  LKELNHPNIVKLLDVIHT---ENKLYL--VFEFLSMDLKKFMDASALTGIPLPLI--KSY 109
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---I 117
            +Q+ + LA+ H+   V HRD+KP+NLL+N     +KL DFG A+    G P  +Y   +
Sbjct: 110 LFQLLQGLAFCHSH-RVLHRDLKPENLLINTEG-AIKLADFGLARAF--GVPVRTYXHEV 165
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            + +YRAPE++ G   Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP 
Sbjct: 166 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD 225
Query: 178 REEIKCMNPNYTEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALE 233
               + + P  T     +     W  + F K +PP   +   L+S++L Y PN R +A  
Sbjct: 226 ----EVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKA 281
Query: 234 ALIHPFFDELRDP 246
           AL HPFF ++  P
Sbjct: 282 ALAHPFFQDVTKP 294

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 91/253 (35%), Positives = 140/253 (55%), Gaps = 22/253 (8%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ L+HPN+V L     +   +++LYL  V E++   +   +         +PLI  K Y
Sbjct: 58  LKELNHPNIVKLLDVIHT---ENKLYL--VFEFLSMDLKDFMDASALTGIPLPLI--KSY 110
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---I 117
            +Q+ + LA+ H+   V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   +
Sbjct: 111 LFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEV 166
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            + +YRAPE++ G   Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP 
Sbjct: 167 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD 226
Query: 178 REEIKCMNPNYTEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALE 233
               + + P  T     +     W  + F K +PP   +   L+S++L Y PN R +A  
Sbjct: 227 ----EVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKA 282
Query: 234 ALIHPFFDELRDP 246
           AL HPFF ++  P
Sbjct: 283 ALAHPFFQDVTKP 295

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 87/250 (34%), Positives = 134/250 (53%), Gaps = 25/250 (10%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ L H N+V L     +        L LV E++ + + +++         +  +  K +
Sbjct: 54  LKELKHSNIVKLYDVIHTKKR-----LVLVFEHLDQDLKKLLD---VCEGGLESVTAKSF 105
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---I 117
             Q+   +AY H+   V HRD+KPQNLL+N    +LK+ DFG A+    G P   Y   +
Sbjct: 106 LLQLLNGIAYCHDR-RVLHRDLKPQNLLIN-REGELKIADFGLARAF--GIPVRKYTHEV 161
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            + +YRAP+++ G+ +Y+  IDIWS GC+ AE++ G PLFPG S  DQL+ I ++LGTP 
Sbjct: 162 VTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPN 221
Query: 178 REEIKCMNPNYTEF-----KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAL 232
            +      PN TE       F   +  PW   F K +    +DL+S++L+  PN R TA 
Sbjct: 222 SKNW----PNVTELPKYDPNFTVYEPLPWES-FLKGLDESGIDLLSKMLKLDPNQRITAK 276
Query: 233 EALIHPFFDE 242
           +AL H +F E
Sbjct: 277 QALEHAYFKE 286

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 90/253 (35%), Positives = 141/253 (55%), Gaps = 22/253 (8%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ L+HPN+V L     +   +++LYL  V E++   + + +         +PLI  K Y
Sbjct: 59  LKELNHPNIVKLLDVIHT---ENKLYL--VFEFLSMDLKKFMDASALTGIPLPLI--KSY 111
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---I 117
            +Q+ + LA+ H+   V HRD+KP+NLL+N     +KL DFG A+    G P  +Y   +
Sbjct: 112 LFQLLQGLAFCHSH-RVLHRDLKPENLLINTEG-AIKLADFGLARAF--GVPVRTYXHEV 167
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            + +YRAPE++ G   Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP 
Sbjct: 168 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD 227
Query: 178 REEIKCMNPNYTEFKFPQIKAHPW-HKIFQKRMPP---EAVDLVSRLLQYSPNLRSTALE 233
               + + P  T     +     W  + F K +PP   +   L+S++L Y PN R +A  
Sbjct: 228 ----EVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKA 283
Query: 234 ALIHPFFDELRDP 246
           AL HPFF ++  P
Sbjct: 284 ALAHPFFQDVTKP 296

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 87/250 (34%), Positives = 134/250 (53%), Gaps = 25/250 (10%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ L H N+V L     +        L LV E++ + + +++         +  +  K +
Sbjct: 54  LKELKHSNIVKLYDVIHTKKR-----LVLVFEHLDQDLKKLLD---VCEGGLESVTAKSF 105
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---I 117
             Q+   +AY H+   V HRD+KPQNLL+N    +LK+ DFG A+    G P   Y   +
Sbjct: 106 LLQLLNGIAYCHDR-RVLHRDLKPQNLLIN-REGELKIADFGLARAF--GIPVRKYTHEV 161
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            + +YRAP+++ G+ +Y+  IDIWS GC+ AE++ G PLFPG S  DQL+ I ++LGTP 
Sbjct: 162 VTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPN 221
Query: 178 REEIKCMNPNYTEF-----KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAL 232
            +      PN TE       F   +  PW   F K +    +DL+S++L+  PN R TA 
Sbjct: 222 SKNW----PNVTELPKYDPNFTVYEPLPWES-FLKGLDESGIDLLSKMLKLDPNQRITAK 276
Query: 233 EALIHPFFDE 242
           +AL H +F E
Sbjct: 277 QALEHAYFKE 286

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score =  142 bits (358), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 88/254 (34%), Positives = 140/254 (55%), Gaps = 20/254 (7%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++ + H NV+ L   F    S  E +++YL  V   +   ++ ++K      Q++   +V
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHV 127
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           +   YQI R L YIH+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+
Sbjct: 128 QFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYV 183
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +R+YRAPE++  A  Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP 
Sbjct: 184 ATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 243
Query: 178 REEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
            E +K ++     NY +    Q+    +  +F     P AVDL+ ++L    + R TA +
Sbjct: 244 AELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQ 301
Query: 234 ALIHPFFDELRDPN 247
           AL H +F +  DP+
Sbjct: 302 ALAHAYFAQYHDPD 315

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score =  141 bits (355), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 140/254 (55%), Gaps = 20/254 (7%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++ + H NV+ L   F    S  E +++YL  V   +   ++ ++K     SQ++   +V
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----SQKLTDDHV 127
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           +   YQI R L YIH+   + HRD+KP NL VN  + +LK+ DFG  +     +    Y+
Sbjct: 128 QFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDS-ELKILDFGLCRH--TDDEMTGYV 183
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP 
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 243
Query: 178 REEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
            E +K ++     NY +    Q+    +  +F     P AVDL+ ++L    + R TA +
Sbjct: 244 AELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQ 301
Query: 234 ALIHPFFDELRDPN 247
           AL H +F +  DP+
Sbjct: 302 ALAHAYFAQYHDPD 315

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score =  141 bits (355), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 140/254 (55%), Gaps = 20/254 (7%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++ + H NV+ L   F    S  E +++YL  V   +   ++ ++K      Q++   +V
Sbjct: 81  LKHMKHENVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHV 133
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           +   YQI R L YIH+   + HRD+KP NL VN  + +LK+ DFG A+     +    Y+
Sbjct: 134 QFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDS-ELKILDFGLARH--TDDEMTGYV 189
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP 
Sbjct: 190 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 249
Query: 178 REEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
            E +K ++     NY +    Q+    +  +F     P AVDL+ ++L    + R TA +
Sbjct: 250 AELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQ 307
Query: 234 ALIHPFFDELRDPN 247
           AL H +F +  DP+
Sbjct: 308 ALAHAYFAQYHDPD 321

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  141 bits (355), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 140/254 (55%), Gaps = 20/254 (7%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++ + H NV+ L   F    S  E +++YL  V   +   ++ ++K      Q++   +V
Sbjct: 77  LKHMKHENVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHV 129
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           +   YQI R L YIH+   + HRD+KP NL VN  + +LK+ DFG A+     +    Y+
Sbjct: 130 QFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDS-ELKILDFGLARH--TDDEMTGYV 185
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP 
Sbjct: 186 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 245
Query: 178 REEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
            E +K ++     NY +    Q+    +  +F     P AVDL+ ++L    + R TA +
Sbjct: 246 AELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQ 303
Query: 234 ALIHPFFDELRDPN 247
           AL H +F +  DP+
Sbjct: 304 ALAHAYFAQYHDPD 317

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  140 bits (354), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 139/254 (54%), Gaps = 20/254 (7%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++ + H NV+ L   F    S  E +++YL  V   +   ++ ++K      Q++   +V
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----XQKLTDDHV 127
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           +   YQI R L YIH+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+
Sbjct: 128 QFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVN-EDXELKILDFGLARH--TDDEMTGYV 183
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP 
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 243
Query: 178 REEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
            E +K ++     NY +    Q+    +  +F     P AVDL+ ++L    + R TA +
Sbjct: 244 AELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQ 301
Query: 234 ALIHPFFDELRDPN 247
           AL H +F +  DP+
Sbjct: 302 ALAHAYFAQYHDPD 315

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score =  140 bits (353), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 139/254 (54%), Gaps = 20/254 (7%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++ + H NV+ L   F    S  E +++YL  V   +   ++ ++K      Q++   +V
Sbjct: 86  LKHMKHENVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHV 138
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           +   YQI R L YIH+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+
Sbjct: 139 QFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVN-EDXELKILDFGLARH--TDDEMTGYV 194
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP 
Sbjct: 195 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 254
Query: 178 REEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
            E +K ++     NY +    Q+    +  +F     P AVDL+ ++L    + R TA +
Sbjct: 255 AELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQ 312
Query: 234 ALIHPFFDELRDPN 247
           AL H +F +  DP+
Sbjct: 313 ALAHAYFAQYHDPD 326

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score =  140 bits (353), Expect = 9e-34,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 139/254 (54%), Gaps = 20/254 (7%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++ + H NV+ L   F    S  E +++YL  V   +   ++ ++K      Q++   +V
Sbjct: 80  LKHMKHENVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHV 132
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           +   YQI R L YIH+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+
Sbjct: 133 QFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVN-EDXELKILDFGLARH--TDDEMTGYV 188
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP 
Sbjct: 189 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 248
Query: 178 REEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
            E +K ++     NY +    Q+    +  +F     P AVDL+ ++L    + R TA +
Sbjct: 249 AELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQ 306
Query: 234 ALIHPFFDELRDPN 247
           AL H +F +  DP+
Sbjct: 307 ALAHAYFAQYHDPD 320

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score =  140 bits (353), Expect = 9e-34,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 139/254 (54%), Gaps = 20/254 (7%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++ + H NV+ L   F    S  E +++YL  V   +   ++ ++K      Q++   +V
Sbjct: 80  LKHMKHENVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHV 132
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           +   YQI R L YIH+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+
Sbjct: 133 QFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVN-EDXELKILDFGLARH--TDDEMTGYV 188
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP 
Sbjct: 189 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 248
Query: 178 REEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
            E +K ++     NY +    Q+    +  +F     P AVDL+ ++L    + R TA +
Sbjct: 249 AELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQ 306
Query: 234 ALIHPFFDELRDPN 247
           AL H +F +  DP+
Sbjct: 307 ALAHAYFAQYHDPD 320

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  140 bits (353), Expect = 9e-34,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 139/254 (54%), Gaps = 20/254 (7%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++ + H NV+ L   F    S  E +++YL  V   +   ++ ++K      Q++   +V
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----XQKLTDDHV 127
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           +   YQI R L YIH+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+
Sbjct: 128 QFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYV 183
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP 
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 243
Query: 178 REEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
            E +K ++     NY +    Q+    +  +F     P AVDL+ ++L    + R TA +
Sbjct: 244 AELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQ 301
Query: 234 ALIHPFFDELRDPN 247
           AL H +F +  DP+
Sbjct: 302 ALAHAYFAQYHDPD 315

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score =  140 bits (353), Expect = 9e-34,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 139/254 (54%), Gaps = 20/254 (7%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++ + H NV+ L   F    S  E +++YL  V   +   ++ ++K      Q++   +V
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHV 134
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           +   YQI R L YIH+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+
Sbjct: 135 QFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TADEMTGYV 190
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP 
Sbjct: 191 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 250
Query: 178 REEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
            E +K ++     NY +    Q+    +  +F     P AVDL+ ++L    + R TA +
Sbjct: 251 AELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQ 308
Query: 234 ALIHPFFDELRDPN 247
           AL H +F +  DP+
Sbjct: 309 ALAHAYFAQYHDPD 322

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score =  140 bits (352), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 139/254 (54%), Gaps = 20/254 (7%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++ + H NV+ L   F    S  E +++YL  V   +   ++ ++K      Q++   +V
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHV 134
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           +   YQI R L YIH+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+
Sbjct: 135 QFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TADEMTGYV 190
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP 
Sbjct: 191 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 250
Query: 178 REEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
            E +K ++     NY +    Q+    +  +F     P AVDL+ ++L    + R TA +
Sbjct: 251 AELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQ 308
Query: 234 ALIHPFFDELRDPN 247
           AL H +F +  DP+
Sbjct: 309 ALAHAYFAQYHDPD 322

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score =  140 bits (352), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 139/254 (54%), Gaps = 20/254 (7%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++ + H NV+ L   F    S  E +++YL  V   +   ++ ++K      Q++   +V
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHV 134
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           +   YQI R L YIH+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+
Sbjct: 135 QFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TADEMTGYV 190
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP 
Sbjct: 191 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 250
Query: 178 REEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
            E +K ++     NY +    Q+    +  +F     P AVDL+ ++L    + R TA +
Sbjct: 251 AELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQ 308
Query: 234 ALIHPFFDELRDPN 247
           AL H +F +  DP+
Sbjct: 309 ALAHAYFAQYHDPD 322

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score =  140 bits (352), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 139/254 (54%), Gaps = 20/254 (7%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++ + H NV+ L   F    S  E +++YL  V   +   ++ ++K      Q++   +V
Sbjct: 81  LKHMKHENVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHV 133
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           +   YQI R L YIH+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+
Sbjct: 134 QFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYV 189
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP 
Sbjct: 190 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 249
Query: 178 REEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
            E +K ++     NY +    Q+    +  +F     P AVDL+ ++L    + R TA +
Sbjct: 250 AELLKKISSESARNYIQ-SLAQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQ 307
Query: 234 ALIHPFFDELRDPN 247
           AL H +F +  DP+
Sbjct: 308 ALAHAYFAQYHDPD 321

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score =  140 bits (352), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 139/254 (54%), Gaps = 20/254 (7%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++ + H NV+ L   F    S  E +++YL  V   +   ++ ++K      Q++   +V
Sbjct: 81  LKHMKHENVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHV 133
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           +   YQI R L YIH+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+
Sbjct: 134 QFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYV 189
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP 
Sbjct: 190 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 249
Query: 178 REEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
            E +K ++     NY +    Q+    +  +F     P AVDL+ ++L    + R TA +
Sbjct: 250 AELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQ 307
Query: 234 ALIHPFFDELRDPN 247
           AL H +F +  DP+
Sbjct: 308 ALAHAYFAQYHDPD 321

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score =  140 bits (352), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 139/254 (54%), Gaps = 20/254 (7%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++ + H NV+ L   F    S  E +++YL  V   +   ++ ++K      Q++   +V
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHV 127
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           +   YQI R L YIH+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+
Sbjct: 128 QFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYV 183
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP 
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 243
Query: 178 REEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
            E +K ++     NY +    Q+    +  +F     P AVDL+ ++L    + R TA +
Sbjct: 244 AELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQ 301
Query: 234 ALIHPFFDELRDPN 247
           AL H +F +  DP+
Sbjct: 302 ALAHAYFAQYHDPD 315

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score =  140 bits (352), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 139/254 (54%), Gaps = 20/254 (7%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++ + H NV+ L   F    S  E +++YL  V   +   ++ ++K      Q++   +V
Sbjct: 87  LKHMKHENVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHV 139
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           +   YQI R L YIH+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+
Sbjct: 140 QFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYV 195
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP 
Sbjct: 196 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 255
Query: 178 REEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
            E +K ++     NY +    Q+    +  +F     P AVDL+ ++L    + R TA +
Sbjct: 256 AELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQ 313
Query: 234 ALIHPFFDELRDPN 247
           AL H +F +  DP+
Sbjct: 314 ALAHAYFAQYHDPD 327

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score =  140 bits (352), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 139/254 (54%), Gaps = 20/254 (7%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++ + H NV+ L   F    S  E +++YL  V   +   ++ ++K      Q++   +V
Sbjct: 86  LKHMKHENVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHV 138
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           +   YQI R L YIH+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+
Sbjct: 139 QFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYV 194
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP 
Sbjct: 195 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 254
Query: 178 REEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
            E +K ++     NY +    Q+    +  +F     P AVDL+ ++L    + R TA +
Sbjct: 255 AELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQ 312
Query: 234 ALIHPFFDELRDPN 247
           AL H +F +  DP+
Sbjct: 313 ALAHAYFAQYHDPD 326

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score =  140 bits (352), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 139/254 (54%), Gaps = 20/254 (7%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++ + H NV+ L   F    S  E +++YL  V   +   ++ ++K      Q++   +V
Sbjct: 87  LKHMKHENVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHV 139
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           +   YQI R L YIH+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+
Sbjct: 140 QFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYV 195
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP 
Sbjct: 196 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 255
Query: 178 REEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
            E +K ++     NY +    Q+    +  +F     P AVDL+ ++L    + R TA +
Sbjct: 256 AELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQ 313
Query: 234 ALIHPFFDELRDPN 247
           AL H +F +  DP+
Sbjct: 314 ALAHAYFAQYHDPD 327

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score =  139 bits (351), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 139/254 (54%), Gaps = 20/254 (7%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++ + H NV+ L   F    S  E +++YL  V   +   ++ ++K      Q++   +V
Sbjct: 81  LKHMKHENVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHV 133
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           +   YQI R L YIH+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+
Sbjct: 134 QFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYV 189
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP 
Sbjct: 190 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 249
Query: 178 REEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
            E +K ++     NY +    Q+    +  +F     P AVDL+ ++L    + R TA +
Sbjct: 250 AELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQ 307
Query: 234 ALIHPFFDELRDPN 247
           AL H +F +  DP+
Sbjct: 308 ALAHAYFAQYHDPD 321

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score =  139 bits (351), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 139/254 (54%), Gaps = 20/254 (7%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++ + H NV+ L   F    S  E +++YL  V   +   ++ ++K      Q++   +V
Sbjct: 95  LKHMKHENVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHV 147
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           +   YQI R L YIH+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+
Sbjct: 148 QFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYV 203
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP 
Sbjct: 204 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 263
Query: 178 REEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
            E +K ++     NY +    Q+    +  +F     P AVDL+ ++L    + R TA +
Sbjct: 264 AELLKKISSESARNYIQ-SLAQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQ 321
Query: 234 ALIHPFFDELRDPN 247
           AL H +F +  DP+
Sbjct: 322 ALAHAYFAQYHDPD 335

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score =  139 bits (351), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 139/254 (54%), Gaps = 20/254 (7%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++ + H NV+ L   F    S  E +++YL  V   +   ++ ++K      Q++   +V
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHV 123
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           +   YQI R L YIH+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+
Sbjct: 124 QFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYV 179
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP 
Sbjct: 180 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 239
Query: 178 REEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
            E +K ++     NY +    Q+    +  +F     P AVDL+ ++L    + R TA +
Sbjct: 240 AELLKKISSESARNYIQ-SLAQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQ 297
Query: 234 ALIHPFFDELRDPN 247
           AL H +F +  DP+
Sbjct: 298 ALAHAYFAQYHDPD 311

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score =  139 bits (351), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 139/254 (54%), Gaps = 20/254 (7%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++ + H NV+ L   F    S  E +++YL  V   +   ++ ++K      Q++   +V
Sbjct: 73  LKHMKHENVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHV 125
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           +   YQI R L YIH+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+
Sbjct: 126 QFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYV 181
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP 
Sbjct: 182 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 241
Query: 178 REEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
            E +K ++     NY +    Q+    +  +F     P AVDL+ ++L    + R TA +
Sbjct: 242 AELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQ 299
Query: 234 ALIHPFFDELRDPN 247
           AL H +F +  DP+
Sbjct: 300 ALAHAYFAQYHDPD 313

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score =  139 bits (351), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 139/254 (54%), Gaps = 20/254 (7%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++ + H NV+ L   F    S  E +++YL  V   +   ++ ++K      Q++   +V
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHV 127
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           +   YQI R L YIH+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+
Sbjct: 128 QFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYV 183
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP 
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 243
Query: 178 REEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
            E +K ++     NY +    Q+    +  +F     P AVDL+ ++L    + R TA +
Sbjct: 244 AELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQ 301
Query: 234 ALIHPFFDELRDPN 247
           AL H +F +  DP+
Sbjct: 302 ALAHAYFAQYHDPD 315

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score =  139 bits (351), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 139/254 (54%), Gaps = 20/254 (7%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++ + H NV+ L   F    S  E +++YL  V   +   ++ ++K      Q++   +V
Sbjct: 80  LKHMKHENVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHV 132
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           +   YQI R L YIH+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+
Sbjct: 133 QFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYV 188
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP 
Sbjct: 189 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 248
Query: 178 REEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
            E +K ++     NY +    Q+    +  +F     P AVDL+ ++L    + R TA +
Sbjct: 249 AELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQ 306
Query: 234 ALIHPFFDELRDPN 247
           AL H +F +  DP+
Sbjct: 307 ALAHAYFAQYHDPD 320

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score =  139 bits (351), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 139/254 (54%), Gaps = 20/254 (7%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++ + H NV+ L   F    S  E +++YL  V   +   ++ ++K      Q++   +V
Sbjct: 98  LKHMKHENVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHV 150
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           +   YQI R L YIH+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+
Sbjct: 151 QFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYV 206
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP 
Sbjct: 207 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 266
Query: 178 REEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
            E +K ++     NY +    Q+    +  +F     P AVDL+ ++L    + R TA +
Sbjct: 267 AELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQ 324
Query: 234 ALIHPFFDELRDPN 247
           AL H +F +  DP+
Sbjct: 325 ALAHAYFAQYHDPD 338

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score =  139 bits (351), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 139/254 (54%), Gaps = 20/254 (7%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++ + H NV+ L   F    S  E +++YL  V   +   ++ ++K      Q++   +V
Sbjct: 72  LKHMKHENVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHV 124
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           +   YQI R L YIH+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+
Sbjct: 125 QFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYV 180
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP 
Sbjct: 181 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 240
Query: 178 REEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
            E +K ++     NY +    Q+    +  +F     P AVDL+ ++L    + R TA +
Sbjct: 241 AELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQ 298
Query: 234 ALIHPFFDELRDPN 247
           AL H +F +  DP+
Sbjct: 299 ALAHAYFAQYHDPD 312

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score =  139 bits (351), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 139/254 (54%), Gaps = 20/254 (7%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++ + H NV+ L   F    S  E +++YL  V   +   ++ ++K      Q++   +V
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHV 127
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           +   YQI R L YIH+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+
Sbjct: 128 QFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYV 183
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP 
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 243
Query: 178 REEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
            E +K ++     NY +    Q+    +  +F     P AVDL+ ++L    + R TA +
Sbjct: 244 AELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQ 301
Query: 234 ALIHPFFDELRDPN 247
           AL H +F +  DP+
Sbjct: 302 ALAHAYFAQYHDPD 315

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score =  139 bits (351), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 139/254 (54%), Gaps = 20/254 (7%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++ + H NV+ L   F    S  E +++YL  V   +   ++ ++K      Q++   +V
Sbjct: 95  LKHMKHENVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHV 147
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           +   YQI R L YIH+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+
Sbjct: 148 QFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYV 203
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP 
Sbjct: 204 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 263
Query: 178 REEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
            E +K ++     NY +    Q+    +  +F     P AVDL+ ++L    + R TA +
Sbjct: 264 AELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQ 321
Query: 234 ALIHPFFDELRDPN 247
           AL H +F +  DP+
Sbjct: 322 ALAHAYFAQYHDPD 335

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score =  139 bits (351), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 139/254 (54%), Gaps = 20/254 (7%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++ + H NV+ L   F    S  E +++YL  V   +   ++ ++K      Q++   +V
Sbjct: 94  LKHMKHENVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHV 146
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           +   YQI R L YIH+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+
Sbjct: 147 QFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYV 202
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP 
Sbjct: 203 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 262
Query: 178 REEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
            E +K ++     NY +    Q+    +  +F     P AVDL+ ++L    + R TA +
Sbjct: 263 AELLKKISSESARNYIQ-SLAQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQ 320
Query: 234 ALIHPFFDELRDPN 247
           AL H +F +  DP+
Sbjct: 321 ALAHAYFAQYHDPD 334

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score =  139 bits (351), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 139/254 (54%), Gaps = 20/254 (7%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++ + H NV+ L   F    S  E +++YL  V   +   ++ ++K      Q++   +V
Sbjct: 85  LKHMKHENVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHV 137
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           +   YQI R L YIH+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+
Sbjct: 138 QFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYV 193
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP 
Sbjct: 194 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 253
Query: 178 REEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
            E +K ++     NY +    Q+    +  +F     P AVDL+ ++L    + R TA +
Sbjct: 254 AELLKKISSESARNYIQ-SLAQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQ 311
Query: 234 ALIHPFFDELRDPN 247
           AL H +F +  DP+
Sbjct: 312 ALAHAYFAQYHDPD 325

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score =  139 bits (351), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 139/254 (54%), Gaps = 20/254 (7%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++ + H NV+ L   F    S  E +++YL  V   +   ++ ++K      Q++   +V
Sbjct: 87  LKHMKHENVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHV 139
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           +   YQI R L YIH+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+
Sbjct: 140 QFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYV 195
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP 
Sbjct: 196 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 255
Query: 178 REEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
            E +K ++     NY +    Q+    +  +F     P AVDL+ ++L    + R TA +
Sbjct: 256 AELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQ 313
Query: 234 ALIHPFFDELRDPN 247
           AL H +F +  DP+
Sbjct: 314 ALAHAYFAQYHDPD 327

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score =  139 bits (351), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 139/254 (54%), Gaps = 20/254 (7%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++ + H NV+ L   F    S  E +++YL  V   +   ++ ++K      Q++   +V
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHV 127
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           +   YQI R L YIH+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+
Sbjct: 128 QFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYV 183
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP 
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 243
Query: 178 REEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
            E +K ++     NY +    Q+    +  +F     P AVDL+ ++L    + R TA +
Sbjct: 244 AELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQ 301
Query: 234 ALIHPFFDELRDPN 247
           AL H +F +  DP+
Sbjct: 302 ALAHAYFAQYHDPD 315

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score =  139 bits (351), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 139/254 (54%), Gaps = 20/254 (7%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++ + H NV+ L   F    S  E +++YL  V   +   ++ ++K      Q++   +V
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHV 127
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           +   YQI R L YIH+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+
Sbjct: 128 QFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYV 183
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP 
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 243
Query: 178 REEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
            E +K ++     NY +    Q+    +  +F     P AVDL+ ++L    + R TA +
Sbjct: 244 AELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQ 301
Query: 234 ALIHPFFDELRDPN 247
           AL H +F +  DP+
Sbjct: 302 ALAHAYFAQYHDPD 315

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score =  139 bits (351), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 139/254 (54%), Gaps = 20/254 (7%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++ + H NV+ L   F    S  E +++YL  V   +   ++ ++K      Q++   +V
Sbjct: 72  LKHMKHENVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHV 124
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           +   YQI R L YIH+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+
Sbjct: 125 QFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYV 180
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP 
Sbjct: 181 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 240
Query: 178 REEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
            E +K ++     NY +    Q+    +  +F     P AVDL+ ++L    + R TA +
Sbjct: 241 AELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQ 298
Query: 234 ALIHPFFDELRDPN 247
           AL H +F +  DP+
Sbjct: 299 ALAHAYFAQYHDPD 312

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score =  139 bits (351), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 139/254 (54%), Gaps = 20/254 (7%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++ + H NV+ L   F    S  E +++YL  V   +   ++ ++K      Q++   +V
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHV 127
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           +   YQI R L YIH+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+
Sbjct: 128 QFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYV 183
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP 
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 243
Query: 178 REEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
            E +K ++     NY +    Q+    +  +F     P AVDL+ ++L    + R TA +
Sbjct: 244 AELLKKISSESARNYIQ-SLAQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQ 301
Query: 234 ALIHPFFDELRDPN 247
           AL H +F +  DP+
Sbjct: 302 ALAHAYFAQYHDPD 315

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score =  139 bits (351), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 139/254 (54%), Gaps = 20/254 (7%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++ + H NV+ L   F    S  E +++YL  V   +   ++ ++K      Q++   +V
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHV 127
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           +   YQI R L YIH+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+
Sbjct: 128 QFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYV 183
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP 
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 243
Query: 178 REEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
            E +K ++     NY +    Q+    +  +F     P AVDL+ ++L    + R TA +
Sbjct: 244 AELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQ 301
Query: 234 ALIHPFFDELRDPN 247
           AL H +F +  DP+
Sbjct: 302 ALAHAYFAQYHDPD 315

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score =  139 bits (351), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 139/254 (54%), Gaps = 20/254 (7%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++ + H NV+ L   F    S  E +++YL  V   +   ++ ++K      Q++   +V
Sbjct: 77  LKHMKHENVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHV 129
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           +   YQI R L YIH+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+
Sbjct: 130 QFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYV 185
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP 
Sbjct: 186 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 245
Query: 178 REEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
            E +K ++     NY +    Q+    +  +F     P AVDL+ ++L    + R TA +
Sbjct: 246 AELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQ 303
Query: 234 ALIHPFFDELRDPN 247
           AL H +F +  DP+
Sbjct: 304 ALAHAYFAQYHDPD 317

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score =  139 bits (351), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 139/254 (54%), Gaps = 20/254 (7%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++ + H NV+ L   F    S  E +++YL  V   +   ++ ++K      Q++   +V
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHV 123
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           +   YQI R L YIH+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+
Sbjct: 124 QFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYV 179
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP 
Sbjct: 180 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 239
Query: 178 REEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
            E +K ++     NY +    Q+    +  +F     P AVDL+ ++L    + R TA +
Sbjct: 240 AELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQ 297
Query: 234 ALIHPFFDELRDPN 247
           AL H +F +  DP+
Sbjct: 298 ALAHAYFAQYHDPD 311

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score =  139 bits (351), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 139/254 (54%), Gaps = 20/254 (7%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++ + H NV+ L   F    S  E +++YL  V   +   ++ ++K      Q++   +V
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHV 127
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           +   YQI R L YIH+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+
Sbjct: 128 QFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYV 183
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP 
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 243
Query: 178 REEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
            E +K ++     NY +    Q+    +  +F     P AVDL+ ++L    + R TA +
Sbjct: 244 AELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQ 301
Query: 234 ALIHPFFDELRDPN 247
           AL H +F +  DP+
Sbjct: 302 ALAHAYFAQYHDPD 315

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score =  139 bits (351), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 139/254 (54%), Gaps = 20/254 (7%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++ + H NV+ L   F    S  E +++YL  V   +   ++ ++K      Q++   +V
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHV 134
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           +   YQI R L YIH+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+
Sbjct: 135 QFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYV 190
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP 
Sbjct: 191 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 250
Query: 178 REEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
            E +K ++     NY +    Q+    +  +F     P AVDL+ ++L    + R TA +
Sbjct: 251 AELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQ 308
Query: 234 ALIHPFFDELRDPN 247
           AL H +F +  DP+
Sbjct: 309 ALAHAYFAQYHDPD 322

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score =  139 bits (351), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 139/254 (54%), Gaps = 20/254 (7%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++ + H NV+ L   F    S  E +++YL  V   +   ++ ++K      Q++   +V
Sbjct: 94  LKHMKHENVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHV 146
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           +   YQI R L YIH+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+
Sbjct: 147 QFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYV 202
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP 
Sbjct: 203 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 262
Query: 178 REEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
            E +K ++     NY +    Q+    +  +F     P AVDL+ ++L    + R TA +
Sbjct: 263 AELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQ 320
Query: 234 ALIHPFFDELRDPN 247
           AL H +F +  DP+
Sbjct: 321 ALAHAYFAQYHDPD 334

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 139/254 (54%), Gaps = 20/254 (7%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++ + H NV+ L   F    S  E +++YL  V   +   ++ ++K      Q++   +V
Sbjct: 98  LKHMKHENVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHV 150
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           +   YQI R L YIH+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+
Sbjct: 151 QFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMXGYV 206
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP 
Sbjct: 207 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 266
Query: 178 REEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
            E +K ++     NY +    Q+    +  +F     P AVDL+ ++L    + R TA +
Sbjct: 267 AELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQ 324
Query: 234 ALIHPFFDELRDPN 247
           AL H +F +  DP+
Sbjct: 325 ALAHAYFAQYHDPD 338

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 139/254 (54%), Gaps = 20/254 (7%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++ + H NV+ L   F    S  E +++YL  V   +   ++ ++K      Q++   +V
Sbjct: 80  LKHMKHENVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHV 132
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           +   YQI R L YIH+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+
Sbjct: 133 QFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYV 188
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP 
Sbjct: 189 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 248
Query: 178 REEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
            E +K ++     NY +    Q+    +  +F     P AVDL+ ++L    + R TA +
Sbjct: 249 AELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQ 306
Query: 234 ALIHPFFDELRDPN 247
           AL H +F +  DP+
Sbjct: 307 ALAHAYFAQYHDPD 320

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 139/254 (54%), Gaps = 20/254 (7%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++ + H NV+ L   F    S  E +++YL  V   +   ++ ++K      Q++   +V
Sbjct: 74  LKHMKHENVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHV 126
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           +   YQI R L YIH+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+
Sbjct: 127 QFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYV 182
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP 
Sbjct: 183 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 242
Query: 178 REEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
            E +K ++     NY +    Q+    +  +F     P AVDL+ ++L    + R TA +
Sbjct: 243 AELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQ 300
Query: 234 ALIHPFFDELRDPN 247
           AL H +F +  DP+
Sbjct: 301 ALAHAYFAQYHDPD 314

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 139/254 (54%), Gaps = 20/254 (7%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++ + H NV+ L   F    S  E +++YL  V   +   ++ ++K      Q++   +V
Sbjct: 77  LKHMKHENVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHV 129
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           +   YQI R L YIH+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+
Sbjct: 130 QFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYV 185
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP 
Sbjct: 186 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 245
Query: 178 REEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
            E +K ++     NY +    Q+    +  +F     P AVDL+ ++L    + R TA +
Sbjct: 246 AELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQ 303
Query: 234 ALIHPFFDELRDPN 247
           AL H +F +  DP+
Sbjct: 304 ALAHAYFAQYHDPD 317

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score =  139 bits (350), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 85/245 (34%), Positives = 129/245 (52%), Gaps = 16/245 (6%)
Query: 6   HPNVVSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQI 64
           H NV+ L   F      D+     LV+ ++   + +++KH      R     ++   YQ+
Sbjct: 83  HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDR-----IQFLVYQM 137
Query: 65  CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 124
            + L YIH   G+ HRD+KP NL VN    +LK+ DFG A+           + +R+YRA
Sbjct: 138 LKGLRYIH-AAGIIHRDLKPGNLAVNEDC-ELKILDFGLARQ--ADSEMXGXVVTRWYRA 193
Query: 125 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 184
           PE+I     YT  +DIWS GC++AE++ G+ LF G   +DQL EI+KV GTP  E ++ +
Sbjct: 194 PEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 253
Query: 185 NP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
                 NY +   P+++   +  I      P AV+L+ ++L      R TA EAL HP+F
Sbjct: 254 QSDEAKNYMK-GLPELEKKDFASILTN-ASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 311
Query: 241 DELRD 245
           + L D
Sbjct: 312 ESLHD 316

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score =  139 bits (350), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 87/254 (34%), Positives = 139/254 (54%), Gaps = 20/254 (7%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++ + H NV+ L   F    S  E +++YL  V   +   ++ ++K      Q++   +V
Sbjct: 77  LKHMKHENVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHV 129
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           +   YQI R L YIH+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+
Sbjct: 130 QFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYV 185
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP 
Sbjct: 186 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 245
Query: 178 REEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
            E +K ++     NY +    Q+    +  +F     P AVDL+ ++L    + R TA +
Sbjct: 246 AELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQ 303
Query: 234 ALIHPFFDELRDPN 247
           AL H +F +  DP+
Sbjct: 304 ALAHAYFAQYHDPD 317

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  138 bits (348), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 86/254 (33%), Positives = 139/254 (54%), Gaps = 20/254 (7%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++ + H NV+ L   F    S  E +++YL  V   +   ++ ++K      Q++   +V
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHV 127
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           +   YQI R L YIH+   + HRD+KP NL VN    +LK+ D+G A+     +    Y+
Sbjct: 128 QFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDYGLARH--TDDEMTGYV 183
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP 
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 243
Query: 178 REEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
            E +K ++     NY +    Q+    +  +F     P AVDL+ ++L    + R TA +
Sbjct: 244 AELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQ 301
Query: 234 ALIHPFFDELRDPN 247
           AL H +F +  DP+
Sbjct: 302 ALAHAYFAQYHDPD 315

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score =  138 bits (347), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 86/254 (33%), Positives = 139/254 (54%), Gaps = 20/254 (7%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++ + H NV+ L   F    S  E +++YL  V   +   ++ ++K      Q++   +V
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHV 123
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           +   YQI R L YIH+   + HRD+KP NL VN    +LK+ DFG A+     +    ++
Sbjct: 124 QFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMAGFV 179
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP 
Sbjct: 180 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 239
Query: 178 REEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
            E +K ++     NY +    Q+    +  +F     P AVDL+ ++L    + R TA +
Sbjct: 240 AELLKKISSESARNYIQ-SLAQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQ 297
Query: 234 ALIHPFFDELRDPN 247
           AL H +F +  DP+
Sbjct: 298 ALAHAYFAQYHDPD 311

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score =  138 bits (347), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 86/254 (33%), Positives = 139/254 (54%), Gaps = 20/254 (7%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++ + H NV+ L   F    S  E +++YL  V   +   ++ ++K      Q++   +V
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHV 127
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           +   YQI R L YIH+   + HRD+KP NL VN    +LK+ DFG A+     +    ++
Sbjct: 128 QFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMAGFV 183
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP 
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 243
Query: 178 REEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
            E +K ++     NY +    Q+    +  +F     P AVDL+ ++L    + R TA +
Sbjct: 244 AELLKKISSESARNYIQ-SLAQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQ 301
Query: 234 ALIHPFFDELRDPN 247
           AL H +F +  DP+
Sbjct: 302 ALAHAYFAQYHDPD 315

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score =  137 bits (346), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 86/254 (33%), Positives = 139/254 (54%), Gaps = 20/254 (7%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++ + H NV+ L   F    S  E +++YL  V   +   ++ ++K      Q++   +V
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHV 127
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           +   YQI R L YIH+   + HRD+KP NL VN    +LK+ DFG A+     +    ++
Sbjct: 128 QFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMAGFV 183
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP 
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 243
Query: 178 REEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
            E +K ++     NY +    Q+    +  +F     P AVDL+ ++L    + R TA +
Sbjct: 244 AELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQ 301
Query: 234 ALIHPFFDELRDPN 247
           AL H +F +  DP+
Sbjct: 302 ALAHAYFAQYHDPD 315

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score =  137 bits (345), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 86/254 (33%), Positives = 138/254 (54%), Gaps = 20/254 (7%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++ + H NV+ L   F    S  E +++YL  V   +   ++ ++K       ++   +V
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CAKLTDDHV 123
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           +   YQI R L YIH+   + HRD+KP NL VN    +LK+ DFG A+     +    Y+
Sbjct: 124 QFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYV 179
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP 
Sbjct: 180 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 239
Query: 178 REEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
            E +K ++     NY +    Q+    +  +F     P AVDL+ ++L    + R TA +
Sbjct: 240 AELLKKISSESARNYIQ-SLAQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQ 297
Query: 234 ALIHPFFDELRDPN 247
           AL H +F +  DP+
Sbjct: 298 ALAHAYFAQYHDPD 311

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 86/254 (33%), Positives = 138/254 (54%), Gaps = 20/254 (7%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++ + H NV+ L   F    S  E +++YL  V   +   ++ ++K      Q++   +V
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHV 127
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           +   YQI R L YIH+   + HRD+KP NL VN    +LK+  FG A+     +    Y+
Sbjct: 128 QFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILGFGLARH--TDDEMTGYV 183
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP 
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 243
Query: 178 REEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
            E +K ++     NY +    Q+    +  +F     P AVDL+ ++L    + R TA +
Sbjct: 244 AELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQ 301
Query: 234 ALIHPFFDELRDPN 247
           AL H +F +  DP+
Sbjct: 302 ALAHAYFAQYHDPD 315

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score =  136 bits (343), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 86/254 (33%), Positives = 138/254 (54%), Gaps = 20/254 (7%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++ + H NV+ L   F    S  E +++YL  V   +   ++ ++K      Q++   +V
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHV 127
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           +   YQI R L YIH+   + HRD+KP NL VN    +LK+ DFG A+     +     +
Sbjct: 128 QFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGXV 183
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP 
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 243
Query: 178 REEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
            E +K ++     NY +    Q+    +  +F     P AVDL+ ++L    + R TA +
Sbjct: 244 AELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQ 301
Query: 234 ALIHPFFDELRDPN 247
           AL H +F +  DP+
Sbjct: 302 ALAHAYFAQYHDPD 315

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  136 bits (343), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 86/254 (33%), Positives = 138/254 (54%), Gaps = 20/254 (7%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++ + H NV+ L   F    S  E +++YL  V   +   ++ ++K      Q++   +V
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHV 127
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           +   YQI R L YIH+   + HRD+KP NL VN    +LK+ D G A+     +    Y+
Sbjct: 128 QFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDAGLARH--TDDEMTGYV 183
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP 
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 243
Query: 178 REEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
            E +K ++     NY +    Q+    +  +F     P AVDL+ ++L    + R TA +
Sbjct: 244 AELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQ 301
Query: 234 ALIHPFFDELRDPN 247
           AL H +F +  DP+
Sbjct: 302 ALAHAYFAQYHDPD 315

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score =  136 bits (343), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 86/254 (33%), Positives = 138/254 (54%), Gaps = 20/254 (7%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++ + H NV+ L   F    S  E +++YL  V   +   ++ ++K      Q++   +V
Sbjct: 95  LKHMKHENVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHV 147
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           +   YQI R L YIH+   + HRD+KP NL VN    +LK+ DFG A+     +     +
Sbjct: 148 QFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMXGXV 203
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP 
Sbjct: 204 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 263
Query: 178 REEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
            E +K ++     NY +    Q+    +  +F     P AVDL+ ++L    + R TA +
Sbjct: 264 AELLKKISSESARNYIQ-SLAQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQ 321
Query: 234 ALIHPFFDELRDPN 247
           AL H +F +  DP+
Sbjct: 322 ALAHAYFAQYHDPD 335

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  136 bits (342), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 86/254 (33%), Positives = 138/254 (54%), Gaps = 20/254 (7%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++ + H NV+ L   F    S  E +++YL  V   +   ++ ++K      Q++   +V
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHV 127
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           +   YQI R L YIH+   + HRD+KP NL VN    +LK+ D G A+     +    Y+
Sbjct: 128 QFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDGGLARH--TDDEMTGYV 183
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP 
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 243
Query: 178 REEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
            E +K ++     NY +    Q+    +  +F     P AVDL+ ++L    + R TA +
Sbjct: 244 AELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQ 301
Query: 234 ALIHPFFDELRDPN 247
           AL H +F +  DP+
Sbjct: 302 ALAHAYFAQYHDPD 315

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  136 bits (342), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 86/254 (33%), Positives = 138/254 (54%), Gaps = 20/254 (7%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++ + H NV+ L   F    S  E +++YL  V   +   ++ ++K      Q++   +V
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHV 127
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           +   YQI R L YIH+   + HRD+KP NL VN    +LK+ D G A+     +    Y+
Sbjct: 128 QFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDRGLARH--TDDEMTGYV 183
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP 
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 243
Query: 178 REEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
            E +K ++     NY +    Q+    +  +F     P AVDL+ ++L    + R TA +
Sbjct: 244 AELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQ 301
Query: 234 ALIHPFFDELRDPN 247
           AL H +F +  DP+
Sbjct: 302 ALAHAYFAQYHDPD 315

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score =  135 bits (341), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 86/254 (33%), Positives = 138/254 (54%), Gaps = 20/254 (7%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++ + H NV+ L   F    S  E +++YL  V   +   ++ ++K      Q++   +V
Sbjct: 75  LKHMKHENVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHV 127
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           +   YQI R L YIH+   + HRD+KP NL VN    +LK+ DF  A+     +    Y+
Sbjct: 128 QFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFYLARH--TDDEMTGYV 183
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP 
Sbjct: 184 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 243
Query: 178 REEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
            E +K ++     NY +    Q+    +  +F     P AVDL+ ++L    + R TA +
Sbjct: 244 AELLKKISSESARNYIQ-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQ 301
Query: 234 ALIHPFFDELRDPN 247
           AL H +F +  DP+
Sbjct: 302 ALAHAYFAQYHDPD 315

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  135 bits (339), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 83/244 (34%), Positives = 131/244 (53%), Gaps = 15/244 (6%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ L H N+V+L        +K   YL  V E+V    H ++         +    V+ Y
Sbjct: 78  LKQLRHENLVNLLEV---CKKKKRWYL--VFEFVD---HTILDDLELFPNGLDYQVVQKY 129
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-GEPNISYICS 119
            +QI   + + H+   + HRDIKP+N+LV+  +  +KLCDFG A+ L   GE     + +
Sbjct: 130 LFQIINGIGFCHSH-NIIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVYDDEVAT 187
Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT--PT 177
           R+YRAPEL+ G  +Y  A+D+W+ GC++ E+ +G+PLFPG+S +DQL  I+  LG   P 
Sbjct: 188 RWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPR 247
Query: 178 REEIKCMNPNYTEFKFPQIKA-HPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 236
            +E+   NP +   + P+IK   P  + + K +    +DL  + L   P+ R    E L 
Sbjct: 248 HQELFNKNPVFAGVRLPEIKEREPLERRYPK-LSEVVIDLAKKCLHIDPDKRPFCAELLH 306
Query: 237 HPFF 240
           H FF
Sbjct: 307 HDFF 310

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score =  133 bits (334), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 80/255 (31%), Positives = 135/255 (52%), Gaps = 17/255 (6%)
Query: 1   MRLLDH---PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI-- 55
           +RLL+H   PN++ L+  F    E     L LV E +   + +VI       QR+ +   
Sbjct: 80  IRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIH-----DQRIVISPQ 134
Query: 56  YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS 115
           +++ + Y I   L  +H   GV HRD+ P N+L+    + + +CDF  A+          
Sbjct: 135 HIQYFMYHILLGLHVLHEA-GVVHRDLHPGNILL-ADNNDITICDFNLAREDTADANKTH 192
Query: 116 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
           Y+  R+YRAPEL+     +T  +D+WSAGCV+AE+   + LF G +  +QL +I++V+GT
Sbjct: 193 YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGT 252
Query: 176 PTREEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 231
           P  E++   +     +Y       + A  W  +      P A+DL++++L+++P  R + 
Sbjct: 253 PKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPT-ADPVALDLIAKMLEFNPQRRIST 311
Query: 232 LEALIHPFFDELRDP 246
            +AL HP+F+ L DP
Sbjct: 312 EQALRHPYFESLFDP 326

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 80/255 (31%), Positives = 135/255 (52%), Gaps = 17/255 (6%)
Query: 1   MRLLDH---PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI-- 55
           +RLL+H   PN++ L+  F    E     L LV E +   + +VI       QR+ +   
Sbjct: 80  IRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIH-----DQRIVISPQ 134
Query: 56  YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS 115
           +++ + Y I   L  +H   GV HRD+ P N+L+    + + +CDF  A+          
Sbjct: 135 HIQYFMYHILLGLHVLHEA-GVVHRDLHPGNILL-ADNNDITICDFNLAREDTADANKTH 192
Query: 116 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
           Y+  R+YRAPEL+     +T  +D+WSAGCV+AE+   + LF G +  +QL +I++V+GT
Sbjct: 193 YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGT 252
Query: 176 PTREEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 231
           P  E++   +     +Y       + A  W  +      P A+DL++++L+++P  R + 
Sbjct: 253 PKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPT-ADPVALDLIAKMLEFNPQRRIST 311
Query: 232 LEALIHPFFDELRDP 246
            +AL HP+F+ L DP
Sbjct: 312 EQALRHPYFESLFDP 326

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 87/256 (33%), Positives = 140/256 (54%), Gaps = 27/256 (10%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHY--KMSQRMPLIYVK 58
           M+ L H N+V L     +     E  L LV E++   + + +         + + L  VK
Sbjct: 57  MKELKHENIVRLYDVIHT-----ENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVK 111
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-- 116
            + +Q+ + LA+ H    + HRD+KPQNLL+N    QLKL DFG A+    G P  ++  
Sbjct: 112 YFQWQLLQGLAFCHEN-KILHRDLKPQNLLINKRG-QLKLGDFGLARAF--GIPVNTFSS 167
Query: 117 -ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
            + + +YRAP+++ G+  Y+ +IDIWS GC+LAE++ G+PLFPG +  +QL  I  ++GT
Sbjct: 168 EVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGT 227
Query: 176 PTREEIKCMNPNYTEF-KF-PQIKAHPWHKIFQKRMP-------PEAVDLVSRLLQYSPN 226
           P     + + P+ T+  K+ P I+  P   + Q   P          +D +  LLQ +P+
Sbjct: 228 PN----ESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPD 283
Query: 227 LRSTALEALIHPFFDE 242
           +R +A +AL HP+F E
Sbjct: 284 MRLSAKQALHHPWFAE 299

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  130 bits (327), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 88/256 (34%), Positives = 133/256 (51%), Gaps = 28/256 (10%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ L H N+V L     S  +     L LV E+  + +    K+    +  +    VK +
Sbjct: 55  LKELKHKNIVRLHDVLHSDKK-----LTLVFEFCDQDLK---KYFDSCNGDLDPEIVKSF 106
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---I 117
            +Q+ + L + H+   V HRD+KPQNLL+N    +LKL +FG A+    G P   Y   +
Sbjct: 107 LFQLLKGLGFCHSR-NVLHRDLKPQNLLIN-RNGELKLANFGLARAF--GIPVRCYSAEV 162
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTP 176
            + +YR P+++FGA  Y+ +ID+WSAGC+ AEL   G+PLFPG    DQL  I ++LGTP
Sbjct: 163 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP 222
Query: 177 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQK------RMPPEAVDLVSRLLQYSPNLRST 230
           T E+   M       K P  K +P +           ++     DL+  LL+ +P  R +
Sbjct: 223 TEEQWPSMT------KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS 276
Query: 231 ALEALIHPFFDELRDP 246
           A EAL HP+F +   P
Sbjct: 277 AEEALQHPYFSDFCPP 292

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  130 bits (327), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 91/252 (36%), Positives = 136/252 (53%), Gaps = 21/252 (8%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR-MPLIYVKL 59
           ++ L HPN+V+L   F     + +  L+LV EY   TV     H     QR +P   VK 
Sbjct: 56  LKQLKHPNLVNLLEVF-----RRKRRLHLVFEYCDHTV----LHELDRYQRGVPEHLVKS 106
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY--- 116
             +Q  +A+ + H      HRD+KP+N+L+  H+  +KLCDFG A++L    P+  Y   
Sbjct: 107 ITWQTLQAVNFCHKH-NCIHRDVKPENILITKHS-VIKLCDFGFARLLTG--PSDYYDDE 162
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT- 175
           + +R+YR+PEL+ G T+Y   +D+W+ GCV AELL G PL+PG+S VDQL  I K LG  
Sbjct: 163 VATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDL 222
Query: 176 -PTREEIKCMNPNYTEFKFPQIK-AHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
            P  +++   N  ++  K P  +   P    F     P A+ L+   L   P  R T  +
Sbjct: 223 IPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYP-ALGLLKGCLHMDPTERLTCEQ 281
Query: 234 ALIHPFFDELRD 245
            L HP+F+ +R+
Sbjct: 282 LLHHPYFENIRE 293

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score =  130 bits (327), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 82/257 (31%), Positives = 134/257 (52%), Gaps = 31/257 (12%)
Query: 3   LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFY 62
           L+  PN+V L         K     +L+ EYV  T  +V      +   +    ++ Y Y
Sbjct: 82  LMGGPNIVKLLDIVRDQHSKTP---SLIFEYVNNTDFKV------LYPTLTDYDIRYYIY 132
Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 122
           ++ +AL Y H+  G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY+
Sbjct: 133 ELLKALDYCHSQ-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYF 191
Query: 123 RAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI 181
           + PEL+    +Y  ++D+WS GC+ A ++   +P F G    DQLV+I KVLGT      
Sbjct: 192 KGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTD----- 246
Query: 182 KCMNPNYTEFKF---PQIKA-------HPWHKIF----QKRMPPEAVDLVSRLLQYSPNL 227
             +N    +++    PQ++A        PW K      Q  + PEA+D + +LL+Y    
Sbjct: 247 -GLNVYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQE 305
Query: 228 RSTALEALIHPFFDELR 244
           R TALEA+ HP+F ++R
Sbjct: 306 RLTALEAMTHPYFQQVR 322

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  130 bits (327), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 87/253 (34%), Positives = 131/253 (51%), Gaps = 28/253 (11%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ L H N+V L     S  +     L LV E+  + +    K+    +  +    VK +
Sbjct: 55  LKELKHKNIVRLHDVLHSDKK-----LTLVFEFCDQDLK---KYFDSCNGDLDPEIVKSF 106
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---I 117
            +Q+ + L + H+   V HRD+KPQNLL+N    +LKL DFG A+    G P   Y   +
Sbjct: 107 LFQLLKGLGFCHSR-NVLHRDLKPQNLLIN-RNGELKLADFGLARAF--GIPVRCYSAEV 162
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTP 176
            + +YR P+++FGA  Y+ +ID+WSAGC+ AEL    +PLFPG    DQL  I ++LGTP
Sbjct: 163 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTP 222
Query: 177 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQK------RMPPEAVDLVSRLLQYSPNLRST 230
           T E+   M       K P  K +P +           ++     DL+  LL+ +P  R +
Sbjct: 223 TEEQWPSMT------KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS 276
Query: 231 ALEALIHPFFDEL 243
           A EAL HP+F + 
Sbjct: 277 AEEALQHPYFSDF 289

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score =  129 bits (325), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 76/232 (32%), Positives = 126/232 (54%), Gaps = 28/232 (12%)
Query: 28  NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNL 87
           +L+ EYV  T  +V      +   +    ++ Y Y++ +AL Y H+  G+ HRD+KP N+
Sbjct: 125 SLIFEYVNNTDFKV------LYPTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNV 177
Query: 88  LVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVL 147
           +++    +L+L D+G A+    G+     + SRY++ PEL+    +Y  ++D+WS GC+ 
Sbjct: 178 MIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 237
Query: 148 AELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF---PQIKA----- 198
           A ++   +P F G    DQLV+I KVLGT        +N    +++    PQ++A     
Sbjct: 238 AGMIFRKEPFFYGHDNHDQLVKIAKVLGT------DGLNAYLNKYRIELDPQLEALVGRH 291
Query: 199 --HPWHKIF----QKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 244
              PW K      Q  + PEA+D + +LL+Y    R TALEA+ HP+F ++R
Sbjct: 292 SRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQVR 343

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 76/232 (32%), Positives = 126/232 (54%), Gaps = 28/232 (12%)
Query: 28  NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNL 87
           +L+ EYV  T  +V      +   +    ++ Y Y++ +AL Y H+  G+ HRD+KP N+
Sbjct: 104 SLIFEYVNNTDFKV------LYPTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNV 156
Query: 88  LVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVL 147
           +++    +L+L D+G A+    G+     + SRY++ PEL+    +Y  ++D+WS GC+ 
Sbjct: 157 MIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 216
Query: 148 AELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF---PQIKA----- 198
           A ++   +P F G    DQLV+I KVLGT        +N    +++    PQ++A     
Sbjct: 217 AGMIFRKEPFFYGHDNHDQLVKIAKVLGTD------GLNVYLNKYRIELDPQLEALVGRH 270
Query: 199 --HPWHKIF----QKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 244
              PW K      Q  + PEA+D + +LL+Y    R TALEA+ HP+F ++R
Sbjct: 271 SRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQVR 322

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 76/232 (32%), Positives = 126/232 (54%), Gaps = 28/232 (12%)
Query: 28  NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNL 87
           +L+ EYV  T  +V      +   +    ++ Y Y++ +AL Y H+  G+ HRD+KP N+
Sbjct: 104 SLIFEYVNNTDFKV------LYPTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNV 156
Query: 88  LVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVL 147
           +++    +L+L D+G A+    G+     + SRY++ PEL+    +Y  ++D+WS GC+ 
Sbjct: 157 MIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 216
Query: 148 AELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF---PQIKA----- 198
           A ++   +P F G    DQLV+I KVLGT        +N    +++    PQ++A     
Sbjct: 217 AGMIFRKEPFFYGHDNHDQLVKIAKVLGTD------GLNVYLNKYRIELDPQLEALVGRH 270
Query: 199 --HPWHKIF----QKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 244
              PW K      Q  + PEA+D + +LL+Y    R TALEA+ HP+F ++R
Sbjct: 271 SRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQVR 322

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  129 bits (324), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 84/267 (31%), Positives = 140/267 (52%), Gaps = 35/267 (13%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIK---HHYKMSQRMPL 54
           M++++H N++ L + F    S  E  ++Y+  V+E +   + +VI+    H +MS     
Sbjct: 77  MKVVNHKNIIGLLNVFTPQKSLEEFQDVYI--VMELMDANLSQVIQMELDHERMS----- 129
Query: 55  IYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 114
                  YQ+   + ++H+  G+ HRD+KP N++V      LK+ DFG A+         
Sbjct: 130 ----YLLYQMLVGIKHLHSA-GIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMT 183
Query: 115 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 174
            Y+ +RYYRAPE+I G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LG
Sbjct: 184 PYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLG 242
Query: 175 TPTREEIKCMNP---NYTEFKFPQIKAHPWHKIF-----------QKRMPPEAVDLVSRL 220
           TP+ E +K + P    Y E + P+   + + K+F            K    +A DL+S++
Sbjct: 243 TPSPEFMKKLQPTVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKM 301
Query: 221 LQYSPNLRSTALEALIHPFFDELRDPN 247
           L    + R +  EAL HP+ +   DP+
Sbjct: 302 LVIDASKRISVDEALQHPYINVWYDPS 328

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score =  129 bits (324), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 76/232 (32%), Positives = 126/232 (54%), Gaps = 28/232 (12%)
Query: 28  NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNL 87
           +L+ EYV  T  +V      +   +    ++ Y Y++ +AL Y H+  G+ HRD+KP N+
Sbjct: 104 SLIFEYVNNTDFKV------LYPTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNV 156
Query: 88  LVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVL 147
           +++    +L+L D+G A+    G+     + SRY++ PEL+    +Y  ++D+WS GC+ 
Sbjct: 157 MIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 216
Query: 148 AELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF---PQIKA----- 198
           A ++   +P F G    DQLV+I KVLGT        +N    +++    PQ++A     
Sbjct: 217 AGMIFRKEPFFYGHDNHDQLVKIAKVLGTD------GLNVYLNKYRIELDPQLEALVGRH 270
Query: 199 --HPWHKIF----QKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 244
              PW K      Q  + PEA+D + +LL+Y    R TALEA+ HP+F ++R
Sbjct: 271 SRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQVR 322

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score =  129 bits (324), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 76/232 (32%), Positives = 126/232 (54%), Gaps = 28/232 (12%)
Query: 28  NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNL 87
           +L+ EYV  T  +V      +   +    ++ Y Y++ +AL Y H+  G+ HRD+KP N+
Sbjct: 105 SLIFEYVNNTDFKV------LYPTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNV 157
Query: 88  LVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVL 147
           +++    +L+L D+G A+    G+     + SRY++ PEL+    +Y  ++D+WS GC+ 
Sbjct: 158 MIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 217
Query: 148 AELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF---PQIKA----- 198
           A ++   +P F G    DQLV+I KVLGT        +N    +++    PQ++A     
Sbjct: 218 AGMIFRKEPFFYGHDNHDQLVKIAKVLGTD------GLNVYLNKYRIELDPQLEALVGRH 271
Query: 199 --HPWHKIF----QKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 244
              PW K      Q  + PEA+D + +LL+Y    R TALEA+ HP+F ++R
Sbjct: 272 SRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQVR 323

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score =  129 bits (324), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 76/232 (32%), Positives = 126/232 (54%), Gaps = 28/232 (12%)
Query: 28  NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNL 87
           +L+ EYV  T  +V      +   +    ++ Y Y++ +AL Y H+  G+ HRD+KP N+
Sbjct: 105 SLIFEYVNNTDFKV------LYPTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNV 157
Query: 88  LVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVL 147
           +++    +L+L D+G A+    G+     + SRY++ PEL+    +Y  ++D+WS GC+ 
Sbjct: 158 MIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 217
Query: 148 AELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF---PQIKA----- 198
           A ++   +P F G    DQLV+I KVLGT        +N    +++    PQ++A     
Sbjct: 218 AGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG------LNVYLNKYRIELDPQLEALVGRH 271
Query: 199 --HPWHKIF----QKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 244
              PW K      Q  + PEA+D + +LL+Y    R TALEA+ HP+F ++R
Sbjct: 272 SRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQVR 323

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score =  129 bits (324), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 76/232 (32%), Positives = 126/232 (54%), Gaps = 28/232 (12%)
Query: 28  NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNL 87
           +L+ EYV  T  +V      +   +    ++ Y Y++ +AL Y H+  G+ HRD+KP N+
Sbjct: 104 SLIFEYVNNTDFKV------LYPTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNV 156
Query: 88  LVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVL 147
           +++    +L+L D+G A+    G+     + SRY++ PEL+    +Y  ++D+WS GC+ 
Sbjct: 157 MIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 216
Query: 148 AELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF---PQIKA----- 198
           A ++   +P F G    DQLV+I KVLGT        +N    +++    PQ++A     
Sbjct: 217 AGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG------LNVYLNKYRIELDPQLEALVGRH 270
Query: 199 --HPWHKIF----QKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 244
              PW K      Q  + PEA+D + +LL+Y    R TALEA+ HP+F ++R
Sbjct: 271 SRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQVR 322

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score =  129 bits (324), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 76/232 (32%), Positives = 126/232 (54%), Gaps = 28/232 (12%)
Query: 28  NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNL 87
           +L+ EYV  T  +V      +   +    ++ Y Y++ +AL Y H+  G+ HRD+KP N+
Sbjct: 104 SLIFEYVNNTDFKV------LYPTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNV 156
Query: 88  LVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVL 147
           +++    +L+L D+G A+    G+     + SRY++ PEL+    +Y  ++D+WS GC+ 
Sbjct: 157 MIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 216
Query: 148 AELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF---PQIKA----- 198
           A ++   +P F G    DQLV+I KVLGT        +N    +++    PQ++A     
Sbjct: 217 AGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG------LNVYLNKYRIELDPQLEALVGRH 270
Query: 199 --HPWHKIF----QKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 244
              PW K      Q  + PEA+D + +LL+Y    R TALEA+ HP+F ++R
Sbjct: 271 SRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQVR 322

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score =  129 bits (324), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 77/243 (31%), Positives = 127/243 (52%), Gaps = 28/243 (11%)
Query: 28  NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNL 87
           +L+ EYV  T  +V      +   +    ++ Y Y++ +AL Y H+  G+ HRD+KP N+
Sbjct: 106 SLIFEYVNNTDFKV------LYPTLTDYDIRYYIYELLKALDYCHSQ-GIMHRDVKPHNV 158
Query: 88  LVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVL 147
           +++    +L+L D+G A+    G+     + SRY++ PEL+    +Y  ++D+WS GC+ 
Sbjct: 159 MIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMF 218
Query: 148 AELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF---PQIKA----- 198
           A ++   +P F G    DQLV+I KVLGT        +N    +++    PQ++A     
Sbjct: 219 AGMIFRKEPFFYGHDNHDQLVKIAKVLGTDG------LNVYLNKYRIELDPQLEALVGRH 272
Query: 199 --HPWHKIF----QKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPN 252
              PW K      Q  + PEA+D + +LL+Y    R TALEA+ HP+F ++R        
Sbjct: 273 SRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQVRAAENSRTR 332
Query: 253 GRF 255
             F
Sbjct: 333 AEF 335

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score =  128 bits (322), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 88/266 (33%), Positives = 140/266 (52%), Gaps = 44/266 (16%)
Query: 1   MRLLDHPNVV-----------SLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS 49
           +R LDH N+V            L     S TE + +Y+  V EY+   +  V+       
Sbjct: 62  IRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYI--VQEYMETDLANVL------- 112
Query: 50  QRMPLI--YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 107
           ++ PL+  + +L+ YQ+ R L YIH+   V HRD+KP NL +N     LK+ DFG A+++
Sbjct: 113 EQGPLLEEHARLFMYQLLRGLKYIHSA-NVLHRDLKPANLFINTEDLVLKIGDFGLARIM 171
Query: 108 VKGEPNISY-------ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 160
              +P+ S+       + +++YR+P L+     YT AID+W+AGC+ AE+L G+ LF G 
Sbjct: 172 ---DPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGA 228
Query: 161 SGVDQL---VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPP---EAV 214
             ++Q+   +E I V+    R+E+  + P Y      +      HK   + +P    EAV
Sbjct: 229 HELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEP-----HKPLTQLLPGISREAV 283
Query: 215 DLVSRLLQYSPNLRSTALEALIHPFF 240
           D + ++L +SP  R TA EAL HP+ 
Sbjct: 284 DFLEQILTFSPMDRLTAEEALSHPYM 309

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  128 bits (321), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 84/267 (31%), Positives = 140/267 (52%), Gaps = 35/267 (13%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIK---HHYKMSQRMPL 54
           M++++H N++ L + F    S  E  ++Y+  V+E +   + +VI+    H +MS     
Sbjct: 77  MKVVNHKNIIGLLNVFTPQKSLEEFQDVYI--VMELMDANLSQVIQMELDHERMS----- 129
Query: 55  IYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 114
                  YQ+   + ++H+  G+ HRD+KP N++V      LK+ DFG A+         
Sbjct: 130 ----YLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMT 183
Query: 115 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 174
            Y+ +RYYRAPE+I G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LG
Sbjct: 184 PYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLG 242
Query: 175 TPTREEIKCMNP---NYTEFKFPQIKAHPWHKIF-----------QKRMPPEAVDLVSRL 220
           TP+ E +K + P    Y E + P+   + + K+F            K    +A DL+S++
Sbjct: 243 TPSPEFMKKLQPTVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKM 301
Query: 221 LQYSPNLRSTALEALIHPFFDELRDPN 247
           L    + R +  EAL HP+ +   DP+
Sbjct: 302 LVIDASKRISVDEALQHPYINVWYDPS 328

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  127 bits (318), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 84/267 (31%), Positives = 139/267 (52%), Gaps = 35/267 (13%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIK---HHYKMSQRMPL 54
           M+ ++H N++ L + F    S  E  ++Y+  V+E +   + +VI+    H +MS     
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYI--VMELMDANLSQVIQMELDHERMS----- 129
Query: 55  IYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 114
                  YQ+   + ++H+  G+ HRD+KP N++V      LK+ DFG A+         
Sbjct: 130 ----YLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMT 183
Query: 115 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 174
            Y+ +RYYRAPE+I G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LG
Sbjct: 184 PYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLG 242
Query: 175 TPTREEIKCMNP---NYTEFKFPQIKAHPWHKIF-----------QKRMPPEAVDLVSRL 220
           TP+ E +K + P    Y E + P+   + + K+F            K    +A DL+S++
Sbjct: 243 TPSPEFMKKLQPTVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKM 301
Query: 221 LQYSPNLRSTALEALIHPFFDELRDPN 247
           L    + R +  EAL HP+ +   DP+
Sbjct: 302 LVIDASKRISVDEALQHPYINVWYDPS 328

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  126 bits (317), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 83/267 (31%), Positives = 139/267 (52%), Gaps = 35/267 (13%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIK---HHYKMSQRMPL 54
           M++++H N++ L + F    S  E  ++Y+  V+E +   + +VI+    H +MS     
Sbjct: 77  MKVVNHKNIIGLLNVFTPQKSLEEFQDVYI--VMELMDANLSQVIQMELDHERMS----- 129
Query: 55  IYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 114
                  YQ+   + ++H+  G+ HRD+KP N++V      LK+ DFG A+         
Sbjct: 130 ----YLLYQMLVGIKHLHSA-GIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMT 183
Query: 115 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 174
            Y+ +RYYRAPE+I G   Y   +DIWS G ++ E++ G  LFPG   +DQ  ++I+ LG
Sbjct: 184 PYVVTRYYRAPEVILGMG-YKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLG 242
Query: 175 TPTREEIKCMNP---NYTEFKFPQIKAHPWHKIF-----------QKRMPPEAVDLVSRL 220
           TP+ E +K + P    Y E + P+   + + K+F            K    +A DL+S++
Sbjct: 243 TPSPEFMKKLQPTVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKM 301
Query: 221 LQYSPNLRSTALEALIHPFFDELRDPN 247
           L    + R +  EAL HP+ +   DP+
Sbjct: 302 LVIDASKRISVDEALQHPYINVWYDPS 328

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score =  126 bits (316), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 86/260 (33%), Positives = 135/260 (51%), Gaps = 23/260 (8%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL 59
           ++ ++H N++SL + F      +E   + LV+E +   + +VI H     +RM  +    
Sbjct: 77  LKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-HMELDHERMSYL---- 131
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
             YQ+   + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +
Sbjct: 132 -LYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNFMMTPYVVT 188
Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
           RYYRAPE+I G   Y A +DIWS GC++ EL+ G  +F G   +DQ  ++I+ LGTP+ E
Sbjct: 189 RYYRAPEVILGMG-YAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAE 247
Query: 180 EIKCMNP---NYTEF--KFPQIKAH--------PWHKIFQKRMPPEAVDLVSRLLQYSPN 226
            +  + P   NY E   K+P IK          P      K    +A DL+S++L   P+
Sbjct: 248 FMAALQPTVRNYVENRPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPD 307
Query: 227 LRSTALEALIHPFFDELRDP 246
            R +  EAL HP+     DP
Sbjct: 308 KRISVDEALRHPYITVWYDP 327

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  126 bits (316), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 84/267 (31%), Positives = 139/267 (52%), Gaps = 35/267 (13%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIK---HHYKMSQRMPL 54
           M+ ++H N++ L + F    S  E  ++Y+  V+E +   + +VI+    H +MS     
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYI--VMELMDANLSQVIQMELDHERMS----- 129
Query: 55  IYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 114
                  YQ+   + ++H+  G+ HRD+KP N++V      LK+ DFG A+         
Sbjct: 130 ----YLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMT 183
Query: 115 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 174
            Y+ +RYYRAPE+I G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LG
Sbjct: 184 PYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLG 242
Query: 175 TPTREEIKCMNP---NYTEFKFPQIKAHPWHKIF-----------QKRMPPEAVDLVSRL 220
           TP+ E +K + P    Y E + P+   + + K+F            K    +A DL+S++
Sbjct: 243 TPSPEFMKKLQPTVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKM 301
Query: 221 LQYSPNLRSTALEALIHPFFDELRDPN 247
           L    + R +  EAL HP+ +   DP+
Sbjct: 302 LVIDASKRISVDEALQHPYINVWYDPS 328

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 83/267 (31%), Positives = 139/267 (52%), Gaps = 35/267 (13%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIK---HHYKMSQRMPL 54
           M++++H N++ L + F    S  E  ++Y+  V+E +   + +VI+    H +MS     
Sbjct: 77  MKVVNHKNIIGLLNVFTPQKSLEEFQDVYI--VMELMDANLSQVIQMELDHERMS----- 129
Query: 55  IYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 114
                  YQ+   + ++H+  G+ HRD+KP N++V      LK+ DFG A+         
Sbjct: 130 ----YLLYQMLVGIKHLHSA-GIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMT 183
Query: 115 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 174
            Y+ +RYYRAPE+I G   Y   +DIWS G ++ E++ G  LFPG   +DQ  ++I+ LG
Sbjct: 184 PYVVTRYYRAPEVILGMG-YKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLG 242
Query: 175 TPTREEIKCMNP---NYTEFKFPQIKAHPWHKIF-----------QKRMPPEAVDLVSRL 220
           TP+ E +K + P    Y E + P+   + + K+F            K    +A DL+S++
Sbjct: 243 TPSPEFMKKLQPTVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKM 301
Query: 221 LQYSPNLRSTALEALIHPFFDELRDPN 247
           L    + R +  EAL HP+ +   DP+
Sbjct: 302 LVIDASKRISVDEALQHPYINVWYDPS 328

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 84/263 (31%), Positives = 134/263 (50%), Gaps = 29/263 (11%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIY 56
           M+ ++H N++SL + F      +E   + LV+E +   + +VI+    H +MS       
Sbjct: 77  MKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMS------- 129
Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
                YQ+   + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y
Sbjct: 130 --YLLYQMLXGIKHLHSA-GIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPY 185
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
           + +RYYRAPE+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP
Sbjct: 186 VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 244
Query: 177 TREEIKCMNP---NYTE-------FKFPQI---KAHPWHKIFQKRMPPEAVDLVSRLLQY 223
             E +K + P   NY E         FP++      P      K    +A DL+S++L  
Sbjct: 245 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 304
Query: 224 SPNLRSTALEALIHPFFDELRDP 246
            P  R +  +AL HP+ +   DP
Sbjct: 305 DPAKRISVDDALQHPYINVWYDP 327

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score =  125 bits (314), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 84/263 (31%), Positives = 134/263 (50%), Gaps = 29/263 (11%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIY 56
           M+ ++H N++SL + F      +E   + LV+E +   + +VI+    H +MS       
Sbjct: 70  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMS------- 122
Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
                YQ+   + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y
Sbjct: 123 --YLLYQMLXGIKHLHSA-GIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPY 178
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
           + +RYYRAPE+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP
Sbjct: 179 VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237
Query: 177 TREEIKCMNP---NYTE-------FKFPQI---KAHPWHKIFQKRMPPEAVDLVSRLLQY 223
             E +K + P   NY E         FP++      P      K    +A DL+S++L  
Sbjct: 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 297
Query: 224 SPNLRSTALEALIHPFFDELRDP 246
            P  R +  +AL HP+ +   DP
Sbjct: 298 DPAKRISVDDALQHPYINVWYDP 320

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score =  125 bits (314), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 84/263 (31%), Positives = 134/263 (50%), Gaps = 29/263 (11%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIY 56
           M+ ++H N++SL + F      +E   + LV+E +   + +VI+    H +MS       
Sbjct: 77  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMS------- 129
Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
                YQ+   + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y
Sbjct: 130 --YLLYQMLXGIKHLHSA-GIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPY 185
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
           + +RYYRAPE+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP
Sbjct: 186 VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 244
Query: 177 TREEIKCMNP---NYTE-------FKFPQI---KAHPWHKIFQKRMPPEAVDLVSRLLQY 223
             E +K + P   NY E         FP++      P      K    +A DL+S++L  
Sbjct: 245 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 304
Query: 224 SPNLRSTALEALIHPFFDELRDP 246
            P  R +  +AL HP+ +   DP
Sbjct: 305 DPAKRISVDDALQHPYINVWYDP 327

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  125 bits (313), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 89/263 (33%), Positives = 138/263 (52%), Gaps = 13/263 (4%)
Query: 1   MRLLDHPNVVSL-KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQ-RMPLIYVK 58
           +   +HPNVV L   C  S T++ E  L LV E+V + +   +    K+ +  +P   +K
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDR-ETKLTLVFEHVDQDLTTYLD---KVPEPGVPTETIK 123
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 118
              +Q+ R L ++H+   V HRD+KPQN+LV   + Q+KL DFG A++        S + 
Sbjct: 124 DMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVV 181
Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 178
           + +YRAPE++  ++ Y   +D+WS GC+ AE+   +PLF G S VDQL +I+ V+G P  
Sbjct: 182 TLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 240
Query: 179 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 238
           E+    +       F    A P  K F   +     DL+ + L ++P  R +A  AL HP
Sbjct: 241 EDWP-RDVALPRQAFHSKSAQPIEK-FVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP 298
Query: 239 FFDELRDPNTRLPNGRFLPPLFN 261
           +F +L      L +   LPP  N
Sbjct: 299 YFQDLERCKENLDS--HLPPSQN 319

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  125 bits (313), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 84/267 (31%), Positives = 139/267 (52%), Gaps = 35/267 (13%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIK---HHYKMSQRMPL 54
           M+ ++H N++ L + F    S  E  ++Y+  V+E +   + +VI+    H +MS     
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYI--VMELMDANLCQVIQMELDHERMS----- 129
Query: 55  IYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 114
                  YQ+   + ++H+  G+ HRD+KP N++V      LK+ DFG A+         
Sbjct: 130 ----YLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMT 183
Query: 115 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 174
            Y+ +RYYRAPE+I G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LG
Sbjct: 184 PYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLG 242
Query: 175 TPTREEIKCMNP---NYTEFKFPQIKAHPWHKIF-----------QKRMPPEAVDLVSRL 220
           TP+ E +K + P    Y E + P+   + + K+F            K    +A DL+S++
Sbjct: 243 TPSPEFMKKLQPTVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKM 301
Query: 221 LQYSPNLRSTALEALIHPFFDELRDPN 247
           L    + R +  EAL HP+ +   DP+
Sbjct: 302 LVIDASKRISVDEALQHPYINVWYDPS 328

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  124 bits (312), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 84/245 (34%), Positives = 132/245 (53%), Gaps = 11/245 (4%)
Query: 1   MRLLDHPNVVSL-KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQ-RMPLIYVK 58
           +   +HPNVV L   C  S T++ E  L LV E+V + +   +    K+ +  +P   +K
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDR-ETKLTLVFEHVDQDLTTYLD---KVPEPGVPTETIK 123
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 118
              +Q+ R L ++H+   V HRD+KPQN+LV   + Q+KL DFG A++        S + 
Sbjct: 124 DMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVV 181
Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 178
           + +YRAPE++  ++ Y   +D+WS GC+ AE+   +PLF G S VDQL +I+ V+G P  
Sbjct: 182 TLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 240
Query: 179 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 238
           E+    +       F    A P  K F   +     DL+ + L ++P  R +A  AL HP
Sbjct: 241 EDWP-RDVALPRQAFHSKSAQPIEK-FVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP 298
Query: 239 FFDEL 243
           +F +L
Sbjct: 299 YFQDL 303

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score =  124 bits (312), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 83/260 (31%), Positives = 134/260 (51%), Gaps = 23/260 (8%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL 59
           M+ ++H N++SL + F      +E   + LV+E +   + +VI+      +RM  +    
Sbjct: 77  MKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELD-HERMSYL---- 131
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
             YQ+   + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +
Sbjct: 132 -LYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPYVVT 188
Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
           RYYRAPE+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E
Sbjct: 189 RYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 247
Query: 180 EIKCMNP---NYTE-------FKFPQI---KAHPWHKIFQKRMPPEAVDLVSRLLQYSPN 226
            +K + P   NY E         FP++      P      K    +A DL+S++L   P 
Sbjct: 248 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 307
Query: 227 LRSTALEALIHPFFDELRDP 246
            R +  +AL HP+ +   DP
Sbjct: 308 KRISVDDALQHPYINVWYDP 327

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score =  124 bits (311), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 74/223 (33%), Positives = 120/223 (53%), Gaps = 20/223 (8%)
Query: 29  LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL 88
           LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y H ++G+ HRD+KP N+L
Sbjct: 111 LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVL 163
Query: 89  VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLA 148
           ++    +L+L D+G A+    G+     + SRY++ PEL+     Y  ++D+WS GC+LA
Sbjct: 164 IDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 223
Query: 149 ELLL-GQPLFPGESGVDQLVEIIKVLGTP------TREEIKCMNPNYTEFKFPQIKAHPW 201
            ++   +P F G    DQLV I KVLGT        +  I+ ++P + +    +     W
Sbjct: 224 SMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE-LDPRFNDI-LGRHSRKRW 281
Query: 202 ----HKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
               H   Q  + PEA+D + +LL+Y    R TA EA+ HP+F
Sbjct: 282 ERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score =  124 bits (310), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 73/223 (32%), Positives = 120/223 (53%), Gaps = 20/223 (8%)
Query: 29  LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL 88
           LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y H ++G+ HRD+KP N++
Sbjct: 111 LVFEHVNNTDFK------QLRQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVM 163
Query: 89  VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLA 148
           ++    +L+L D+G A+    G+     + SRY++ PEL+     Y  ++D+WS GC+LA
Sbjct: 164 IDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 223
Query: 149 ELLL-GQPLFPGESGVDQLVEIIKVLGTP------TREEIKCMNPNYTEFKFPQIKAHPW 201
            ++   +P F G    DQLV I KVLGT        +  I+ ++P + +    +     W
Sbjct: 224 SMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE-LDPRFNDI-LGRHSRKRW 281
Query: 202 ----HKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
               H   Q  + PEA+D + +LL+Y    R TA EA+ HP+F
Sbjct: 282 ERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score =  124 bits (310), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 136/265 (51%), Gaps = 31/265 (11%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIY 56
           M+ ++H N++ L + F      +E   + +V+E +   + +VI+    H +MS       
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS------- 129
Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
                YQ+   + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y
Sbjct: 130 --YLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPY 185
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
           + +RYYRAPE+I G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LGTP
Sbjct: 186 VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP 244
Query: 177 TREEIKCMNP---NYTEFKFPQIKAHPWHKIF-----------QKRMPPEAVDLVSRLLQ 222
             E +K + P    Y E + P+   + + K+F            K    +A DL+S++L 
Sbjct: 245 CPEFMKKLQPTVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLV 303
Query: 223 YSPNLRSTALEALIHPFFDELRDPN 247
              + R +  EAL HP+ +   DP+
Sbjct: 304 IDASKRISVDEALQHPYINVWYDPS 328

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score =  123 bits (309), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 73/223 (32%), Positives = 120/223 (53%), Gaps = 20/223 (8%)
Query: 29  LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL 88
           LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y H ++G+ HRD+KP N++
Sbjct: 111 LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVM 163
Query: 89  VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLA 148
           ++    +L+L D+G A+    G+     + SRY++ PEL+     Y  ++D+WS GC+LA
Sbjct: 164 IDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 223
Query: 149 ELLL-GQPLFPGESGVDQLVEIIKVLGTP------TREEIKCMNPNYTEFKFPQIKAHPW 201
            ++   +P F G    DQLV I KVLGT        +  I+ ++P + +    +     W
Sbjct: 224 SMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE-LDPRFNDI-LGRHSRKRW 281
Query: 202 ----HKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
               H   Q  + PEA+D + +LL+Y    R TA EA+ HP+F
Sbjct: 282 ERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score =  123 bits (309), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 138/264 (52%), Gaps = 29/264 (10%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           M+ ++H N++ L + F    S  E  ++Y+  V+E +   + +VI+      +RM  +  
Sbjct: 78  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYI--VMELMDANLCQVIQMELD-HERMSYL-- 132
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
               YQ+   + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+
Sbjct: 133 ---LYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYV 187
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +RYYRAPE+I G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LGTP 
Sbjct: 188 VTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 246
Query: 178 REEIKCMNP---NYTEFKFPQIKAHPWHKIF-----------QKRMPPEAVDLVSRLLQY 223
            E +K + P    Y E + P+   + + K+F            K    +A DL+S++L  
Sbjct: 247 PEFMKKLQPTVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVI 305
Query: 224 SPNLRSTALEALIHPFFDELRDPN 247
             + R +  EAL HP+ +   DP+
Sbjct: 306 DASKRISVDEALQHPYINVWYDPS 329

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 73/223 (32%), Positives = 120/223 (53%), Gaps = 20/223 (8%)
Query: 29  LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL 88
           LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y H ++G+ HRD+KP N++
Sbjct: 111 LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVM 163
Query: 89  VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLA 148
           ++    +L+L D+G A+    G+     + SRY++ PEL+     Y  ++D+WS GC+LA
Sbjct: 164 IDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 223
Query: 149 ELLL-GQPLFPGESGVDQLVEIIKVLGTP------TREEIKCMNPNYTEFKFPQIKAHPW 201
            ++   +P F G    DQLV I KVLGT        +  I+ ++P + +    +     W
Sbjct: 224 SMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE-LDPRFNDI-LGRHSRKRW 281
Query: 202 ----HKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
               H   Q  + PEA+D + +LL+Y    R TA EA+ HP+F
Sbjct: 282 ERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 73/223 (32%), Positives = 120/223 (53%), Gaps = 20/223 (8%)
Query: 29  LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL 88
           LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y H ++G+ HRD+KP N++
Sbjct: 111 LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVM 163
Query: 89  VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLA 148
           ++    +L+L D+G A+    G+     + SRY++ PEL+     Y  ++D+WS GC+LA
Sbjct: 164 IDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 223
Query: 149 ELLL-GQPLFPGESGVDQLVEIIKVLGTP------TREEIKCMNPNYTEFKFPQIKAHPW 201
            ++   +P F G    DQLV I KVLGT        +  I+ ++P + +    +     W
Sbjct: 224 SMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE-LDPRFNDI-LGRHSRKRW 281
Query: 202 ----HKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
               H   Q  + PEA+D + +LL+Y    R TA EA+ HP+F
Sbjct: 282 ERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 81/265 (30%), Positives = 137/265 (51%), Gaps = 31/265 (11%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIY 56
           M+ ++H N++ L + F      +E   + +V+E +   + +VI+    H +MS       
Sbjct: 79  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS------- 131
Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
                YQ+   + ++H+  G+ HRD+KP N++V      LK+ DFG A+        + +
Sbjct: 132 --YLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMVPF 187
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
           + +RYYRAPE+I G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LGTP
Sbjct: 188 VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP 246
Query: 177 TREEIKCMNP---NYTEFKFPQIKAHPWHKIF-----------QKRMPPEAVDLVSRLLQ 222
             E +K + P    Y E + P+   + + K+F            K    +A DL+S++L 
Sbjct: 247 CPEFMKKLQPTVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLV 305
Query: 223 YSPNLRSTALEALIHPFFDELRDPN 247
              + R +  EAL HP+ +   DP+
Sbjct: 306 IDASKRISVDEALQHPYINVWYDPS 330

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 73/223 (32%), Positives = 120/223 (53%), Gaps = 20/223 (8%)
Query: 29  LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL 88
           LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y H ++G+ HRD+KP N++
Sbjct: 111 LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVM 163
Query: 89  VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLA 148
           ++    +L+L D+G A+    G+     + SRY++ PEL+     Y  ++D+WS GC+LA
Sbjct: 164 IDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 223
Query: 149 ELLL-GQPLFPGESGVDQLVEIIKVLGTP------TREEIKCMNPNYTEFKFPQIKAHPW 201
            ++   +P F G    DQLV I KVLGT        +  I+ ++P + +    +     W
Sbjct: 224 SMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE-LDPRFNDI-LGRHSRKRW 281
Query: 202 ----HKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
               H   Q  + PEA+D + +LL+Y    R TA EA+ HP+F
Sbjct: 282 ERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 73/223 (32%), Positives = 120/223 (53%), Gaps = 20/223 (8%)
Query: 29  LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL 88
           LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y H ++G+ HRD+KP N++
Sbjct: 110 LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVM 162
Query: 89  VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLA 148
           ++    +L+L D+G A+    G+     + SRY++ PEL+     Y  ++D+WS GC+LA
Sbjct: 163 IDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 222
Query: 149 ELLL-GQPLFPGESGVDQLVEIIKVLGTP------TREEIKCMNPNYTEFKFPQIKAHPW 201
            ++   +P F G    DQLV I KVLGT        +  I+ ++P + +    +     W
Sbjct: 223 SMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE-LDPRFNDI-LGRHSRKRW 280
Query: 202 ----HKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
               H   Q  + PEA+D + +LL+Y    R TA EA+ HP+F
Sbjct: 281 ERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 73/223 (32%), Positives = 120/223 (53%), Gaps = 20/223 (8%)
Query: 29  LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL 88
           LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y H ++G+ HRD+KP N++
Sbjct: 111 LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVM 163
Query: 89  VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLA 148
           ++    +L+L D+G A+    G+     + SRY++ PEL+     Y  ++D+WS GC+LA
Sbjct: 164 IDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 223
Query: 149 ELLL-GQPLFPGESGVDQLVEIIKVLGTP------TREEIKCMNPNYTEFKFPQIKAHPW 201
            ++   +P F G    DQLV I KVLGT        +  I+ ++P + +    +     W
Sbjct: 224 SMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE-LDPRFNDI-LGRHSRKRW 281
Query: 202 ----HKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
               H   Q  + PEA+D + +LL+Y    R TA EA+ HP+F
Sbjct: 282 ERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 73/223 (32%), Positives = 120/223 (53%), Gaps = 20/223 (8%)
Query: 29  LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL 88
           LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y H ++G+ HRD+KP N++
Sbjct: 109 LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVM 161
Query: 89  VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLA 148
           ++    +L+L D+G A+    G+     + SRY++ PEL+     Y  ++D+WS GC+LA
Sbjct: 162 IDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 221
Query: 149 ELLL-GQPLFPGESGVDQLVEIIKVLGTP------TREEIKCMNPNYTEFKFPQIKAHPW 201
            ++   +P F G    DQLV I KVLGT        +  I+ ++P + +    +     W
Sbjct: 222 SMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE-LDPRFNDI-LGRHSRKRW 279
Query: 202 ----HKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
               H   Q  + PEA+D + +LL+Y    R TA EA+ HP+F
Sbjct: 280 ERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 322

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 73/223 (32%), Positives = 120/223 (53%), Gaps = 20/223 (8%)
Query: 29  LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL 88
           LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y H ++G+ HRD+KP N++
Sbjct: 111 LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVM 163
Query: 89  VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLA 148
           ++    +L+L D+G A+    G+     + SRY++ PEL+     Y  ++D+WS GC+LA
Sbjct: 164 IDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 223
Query: 149 ELLL-GQPLFPGESGVDQLVEIIKVLGTP------TREEIKCMNPNYTEFKFPQIKAHPW 201
            ++   +P F G    DQLV I KVLGT        +  I+ ++P + +    +     W
Sbjct: 224 SMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE-LDPRFNDI-LGRHSRKRW 281
Query: 202 ----HKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
               H   Q  + PEA+D + +LL+Y    R TA EA+ HP+F
Sbjct: 282 ERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 73/223 (32%), Positives = 120/223 (53%), Gaps = 20/223 (8%)
Query: 29  LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL 88
           LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y H ++G+ HRD+KP N++
Sbjct: 110 LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVM 162
Query: 89  VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLA 148
           ++    +L+L D+G A+    G+     + SRY++ PEL+     Y  ++D+WS GC+LA
Sbjct: 163 IDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 222
Query: 149 ELLL-GQPLFPGESGVDQLVEIIKVLGTP------TREEIKCMNPNYTEFKFPQIKAHPW 201
            ++   +P F G    DQLV I KVLGT        +  I+ ++P + +    +     W
Sbjct: 223 SMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE-LDPRFNDI-LGRHSRKRW 280
Query: 202 ----HKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
               H   Q  + PEA+D + +LL+Y    R TA EA+ HP+F
Sbjct: 281 ERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 73/223 (32%), Positives = 120/223 (53%), Gaps = 20/223 (8%)
Query: 29  LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL 88
           LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y H ++G+ HRD+KP N++
Sbjct: 111 LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVM 163
Query: 89  VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLA 148
           ++    +L+L D+G A+    G+     + SRY++ PEL+     Y  ++D+WS GC+LA
Sbjct: 164 IDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 223
Query: 149 ELLL-GQPLFPGESGVDQLVEIIKVLGTP------TREEIKCMNPNYTEFKFPQIKAHPW 201
            ++   +P F G    DQLV I KVLGT        +  I+ ++P + +    +     W
Sbjct: 224 SMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE-LDPRFNDI-LGRHSRKRW 281
Query: 202 ----HKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
               H   Q  + PEA+D + +LL+Y    R TA EA+ HP+F
Sbjct: 282 ERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score =  123 bits (308), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 73/223 (32%), Positives = 120/223 (53%), Gaps = 20/223 (8%)
Query: 29  LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL 88
           LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y H ++G+ HRD+KP N++
Sbjct: 116 LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVM 168
Query: 89  VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLA 148
           ++    +L+L D+G A+    G+     + SRY++ PEL+     Y  ++D+WS GC+LA
Sbjct: 169 IDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 228
Query: 149 ELLL-GQPLFPGESGVDQLVEIIKVLGTP------TREEIKCMNPNYTEFKFPQIKAHPW 201
            ++   +P F G    DQLV I KVLGT        +  I+ ++P + +    +     W
Sbjct: 229 SMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE-LDPRFNDI-LGRHSRKRW 286
Query: 202 ----HKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
               H   Q  + PEA+D + +LL+Y    R TA EA+ HP+F
Sbjct: 287 ERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 329

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score =  123 bits (308), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 73/223 (32%), Positives = 120/223 (53%), Gaps = 20/223 (8%)
Query: 29  LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL 88
           LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y H ++G+ HRD+KP N++
Sbjct: 111 LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVM 163
Query: 89  VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLA 148
           ++    +L+L D+G A+    G+     + SRY++ PEL+     Y  ++D+WS GC+LA
Sbjct: 164 IDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 223
Query: 149 ELLL-GQPLFPGESGVDQLVEIIKVLGTP------TREEIKCMNPNYTEFKFPQIKAHPW 201
            ++   +P F G    DQLV I KVLGT        +  I+ ++P + +    +     W
Sbjct: 224 SMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE-LDPRFNDI-LGRHSRKRW 281
Query: 202 ----HKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
               H   Q  + PEA+D + +LL+Y    R TA EA+ HP+F
Sbjct: 282 ERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 84/263 (31%), Positives = 134/263 (50%), Gaps = 29/263 (11%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIY 56
           M+ ++H N++SL + F      +E   + LV+E +   + +VI+    H +MS       
Sbjct: 78  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS------- 130
Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
                YQ+   + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y
Sbjct: 131 --YLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPY 186
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
           + +RYYRAPE+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP
Sbjct: 187 VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 245
Query: 177 TREEIKCMNP---NYTE-------FKFPQI---KAHPWHKIFQKRMPPEAVDLVSRLLQY 223
             E +K + P   NY E         FP++      P      K    +A DL+S++L  
Sbjct: 246 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 305
Query: 224 SPNLRSTALEALIHPFFDELRDP 246
            P  R +  +AL HP+ +   DP
Sbjct: 306 DPAKRISVDDALQHPYINVWYDP 328

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 84/263 (31%), Positives = 134/263 (50%), Gaps = 29/263 (11%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIY 56
           M+ ++H N++SL + F      +E   + LV+E +   + +VI+    H +MS       
Sbjct: 71  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS------- 123
Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
                YQ+   + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y
Sbjct: 124 --YLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPY 179
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
           + +RYYRAPE+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP
Sbjct: 180 VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 238
Query: 177 TREEIKCMNP---NYTE-------FKFPQI---KAHPWHKIFQKRMPPEAVDLVSRLLQY 223
             E +K + P   NY E         FP++      P      K    +A DL+S++L  
Sbjct: 239 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 298
Query: 224 SPNLRSTALEALIHPFFDELRDP 246
            P  R +  +AL HP+ +   DP
Sbjct: 299 DPAKRISVDDALQHPYINVWYDP 321

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 73/223 (32%), Positives = 120/223 (53%), Gaps = 20/223 (8%)
Query: 29  LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL 88
           LV E+V  T  +      ++ Q +    ++ Y Y+I +AL Y H ++G+ HRD+KP N++
Sbjct: 111 LVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVM 163
Query: 89  VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLA 148
           ++    +L+L D+G A+    G+     + SRY++ PEL+     Y  ++D+WS GC+LA
Sbjct: 164 IDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 223
Query: 149 ELLL-GQPLFPGESGVDQLVEIIKVLGTP------TREEIKCMNPNYTEFKFPQIKAHPW 201
            ++   +P F G    DQLV I KVLGT        +  I+ ++P + +    +     W
Sbjct: 224 SMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE-LDPRFNDI-LGRHSRKRW 281
Query: 202 ----HKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
               H   Q  + PEA+D + +LL+Y    R TA EA+ HP+F
Sbjct: 282 ERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 84/263 (31%), Positives = 134/263 (50%), Gaps = 29/263 (11%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIY 56
           M+ ++H N++SL + F      +E   + LV+E +   + +VI+    H +MS       
Sbjct: 77  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS------- 129
Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
                YQ+   + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y
Sbjct: 130 --YLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPY 185
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
           + +RYYRAPE+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP
Sbjct: 186 VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 244
Query: 177 TREEIKCMNP---NYTE-------FKFPQI---KAHPWHKIFQKRMPPEAVDLVSRLLQY 223
             E +K + P   NY E         FP++      P      K    +A DL+S++L  
Sbjct: 245 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 304
Query: 224 SPNLRSTALEALIHPFFDELRDP 246
            P  R +  +AL HP+ +   DP
Sbjct: 305 DPAKRISVDDALQHPYINVWYDP 327

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 84/263 (31%), Positives = 134/263 (50%), Gaps = 29/263 (11%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIY 56
           M+ ++H N++SL + F      +E   + LV+E +   + +VI+    H +MS       
Sbjct: 77  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS------- 129
Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
                YQ+   + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y
Sbjct: 130 --YLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPY 185
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
           + +RYYRAPE+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP
Sbjct: 186 VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 244
Query: 177 TREEIKCMNP---NYTE-------FKFPQI---KAHPWHKIFQKRMPPEAVDLVSRLLQY 223
             E +K + P   NY E         FP++      P      K    +A DL+S++L  
Sbjct: 245 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 304
Query: 224 SPNLRSTALEALIHPFFDELRDP 246
            P  R +  +AL HP+ +   DP
Sbjct: 305 DPAKRISVDDALQHPYINVWYDP 327

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 83/242 (34%), Positives = 130/242 (53%), Gaps = 11/242 (4%)
Query: 1   MRLLDHPNVVSL-KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQ-RMPLIYVK 58
           +   +HPNVV L   C  S T++ E  L LV E+V + +   +    K+ +  +P   +K
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDR-ETKLTLVFEHVDQDLTTYLD---KVPEPGVPTETIK 123
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 118
              +Q+ R L ++H+   V HRD+KPQN+LV   + Q+KL DFG A++        S + 
Sbjct: 124 DMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVV 181
Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 178
           + +YRAPE++  ++ Y   +D+WS GC+ AE+   +PLF G S VDQL +I+ V+G P  
Sbjct: 182 TLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 240
Query: 179 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 238
           E+    +       F    A P  K F   +     DL+ + L ++P  R +A  AL HP
Sbjct: 241 EDWP-RDVALPRQAFHSKSAQPIEK-FVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP 298
Query: 239 FF 240
           +F
Sbjct: 299 YF 300

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 119/225 (52%), Gaps = 24/225 (10%)
Query: 29  LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL 88
           LV EY+  T  +      ++ Q +    ++ Y Y++ +AL Y H+  G+ HRD+KP N++
Sbjct: 117 LVFEYINNTDFK------QLYQILTDFDIRFYMYELLKALDYCHSK-GIMHRDVKPHNVM 169
Query: 89  VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLA 148
           ++    +L+L D+G A+     +     + SRY++ PEL+     Y  ++D+WS GC+LA
Sbjct: 170 IDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 229
Query: 149 ELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKC--------MNPNYTEFKFPQIKAH 199
            ++   +P F G+   DQLV I KVLGT   EE+          ++P++ +    Q    
Sbjct: 230 SMIFRREPFFHGQDNYDQLVRIAKVLGT---EELYGYLKKYHIDLDPHFNDI-LGQHSRK 285
Query: 200 PWHKIFQKR----MPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
            W           + PEA+DL+ +LL+Y    R TA EA+ HP+F
Sbjct: 286 RWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYF 330

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 84/263 (31%), Positives = 134/263 (50%), Gaps = 29/263 (11%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIY 56
           M+ ++H N++SL + F      +E   + LV+E +   + +VI+    H +MS       
Sbjct: 70  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS------- 122
Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
                YQ+   + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y
Sbjct: 123 --YLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPY 178
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
           + +RYYRAPE+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP
Sbjct: 179 VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237
Query: 177 TREEIKCMNP---NYTE-------FKFPQI---KAHPWHKIFQKRMPPEAVDLVSRLLQY 223
             E +K + P   NY E         FP++      P      K    +A DL+S++L  
Sbjct: 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 297
Query: 224 SPNLRSTALEALIHPFFDELRDP 246
            P  R +  +AL HP+ +   DP
Sbjct: 298 DPAKRISVDDALQHPYINVWYDP 320

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 83/260 (31%), Positives = 134/260 (51%), Gaps = 23/260 (8%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL 59
           M+ ++H N++SL + F      +E   + LV+E +   + +VI+      +RM  +    
Sbjct: 71  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-HERMSYL---- 125
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
             YQ+   + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +
Sbjct: 126 -LYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVT 182
Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
           RYYRAPE+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E
Sbjct: 183 RYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 241
Query: 180 EIKCMNP---NYTE-------FKFPQI---KAHPWHKIFQKRMPPEAVDLVSRLLQYSPN 226
            +K + P   NY E         FP++      P      K    +A DL+S++L   P 
Sbjct: 242 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 301
Query: 227 LRSTALEALIHPFFDELRDP 246
            R +  +AL HP+ +   DP
Sbjct: 302 KRISVDDALQHPYINVWYDP 321

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 84/263 (31%), Positives = 134/263 (50%), Gaps = 29/263 (11%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIY 56
           M+ ++H N++SL + F      +E   + LV+E +   + +VI+    H +MS       
Sbjct: 78  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS------- 130
Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
                YQ+   + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y
Sbjct: 131 --YLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPY 186
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
           + +RYYRAPE+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP
Sbjct: 187 VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 245
Query: 177 TREEIKCMNP---NYTE-------FKFPQI---KAHPWHKIFQKRMPPEAVDLVSRLLQY 223
             E +K + P   NY E         FP++      P      K    +A DL+S++L  
Sbjct: 246 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 305
Query: 224 SPNLRSTALEALIHPFFDELRDP 246
            P  R +  +AL HP+ +   DP
Sbjct: 306 DPAKRISVDDALQHPYINVWYDP 328

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 83/260 (31%), Positives = 134/260 (51%), Gaps = 23/260 (8%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL 59
           M+ ++H N++SL + F      +E   + LV+E +   + +VI+      +RM  +    
Sbjct: 115 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-HERMSYL---- 169
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
             YQ+   + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +
Sbjct: 170 -LYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVT 226
Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
           RYYRAPE+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E
Sbjct: 227 RYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 285
Query: 180 EIKCMNP---NYTE-------FKFPQI---KAHPWHKIFQKRMPPEAVDLVSRLLQYSPN 226
            +K + P   NY E         FP++      P      K    +A DL+S++L   P 
Sbjct: 286 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 345
Query: 227 LRSTALEALIHPFFDELRDP 246
            R +  +AL HP+ +   DP
Sbjct: 346 KRISVDDALQHPYINVWYDP 365

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 84/263 (31%), Positives = 134/263 (50%), Gaps = 29/263 (11%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIY 56
           M+ ++H N++SL + F      +E   + LV+E +   + +VI+    H +MS       
Sbjct: 76  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS------- 128
Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
                YQ+   + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y
Sbjct: 129 --YLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPY 184
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
           + +RYYRAPE+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP
Sbjct: 185 VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 243
Query: 177 TREEIKCMNP---NYTE-------FKFPQI---KAHPWHKIFQKRMPPEAVDLVSRLLQY 223
             E +K + P   NY E         FP++      P      K    +A DL+S++L  
Sbjct: 244 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 303
Query: 224 SPNLRSTALEALIHPFFDELRDP 246
            P  R +  +AL HP+ +   DP
Sbjct: 304 DPAKRISVDDALQHPYINVWYDP 326

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score =  122 bits (306), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 119/225 (52%), Gaps = 24/225 (10%)
Query: 29  LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL 88
           LV EY+  T  +      ++ Q +    ++ Y Y++ +AL Y H+  G+ HRD+KP N++
Sbjct: 112 LVFEYINNTDFK------QLYQILTDFDIRFYMYELLKALDYCHSK-GIMHRDVKPHNVM 164
Query: 89  VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLA 148
           ++    +L+L D+G A+     +     + SRY++ PEL+     Y  ++D+WS GC+LA
Sbjct: 165 IDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 224
Query: 149 ELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKC--------MNPNYTEFKFPQIKAH 199
            ++   +P F G+   DQLV I KVLGT   EE+          ++P++ +    Q    
Sbjct: 225 SMIFRREPFFHGQDNYDQLVRIAKVLGT---EELYGYLKKYHIDLDPHFNDI-LGQHSRK 280
Query: 200 PWHKIFQKR----MPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
            W           + PEA+DL+ +LL+Y    R TA EA+ HP+F
Sbjct: 281 RWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYF 325

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score =  122 bits (306), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 84/263 (31%), Positives = 134/263 (50%), Gaps = 29/263 (11%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIY 56
           M+ ++H N++SL + F      +E   + LV+E +   + +VI+    H +MS       
Sbjct: 115 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS------- 167
Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
                YQ+   + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y
Sbjct: 168 --YLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPY 223
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
           + +RYYRAPE+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP
Sbjct: 224 VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 282
Query: 177 TREEIKCMNP---NYTE-------FKFPQI---KAHPWHKIFQKRMPPEAVDLVSRLLQY 223
             E +K + P   NY E         FP++      P      K    +A DL+S++L  
Sbjct: 283 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 342
Query: 224 SPNLRSTALEALIHPFFDELRDP 246
            P  R +  +AL HP+ +   DP
Sbjct: 343 DPAKRISVDDALQHPYINVWYDP 365

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score =  122 bits (305), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 83/260 (31%), Positives = 133/260 (51%), Gaps = 23/260 (8%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL 59
           ++ ++H N++SL + F      +E   + LV+E +   + +VI H     +RM  +    
Sbjct: 75  LKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-HMELDHERMSYL---- 129
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
             YQ+   + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +
Sbjct: 130 -LYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTASTNFMMTPYVVT 186
Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
           RYYRAPE+I G   Y   +DIWS GC++ EL+ G  +F G   +DQ  ++I+ LGTP+ E
Sbjct: 187 RYYRAPEVILGMG-YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAE 245
Query: 180 EIKCMNP---NYTEFK--FPQIKAH--------PWHKIFQKRMPPEAVDLVSRLLQYSPN 226
            +  + P   NY E +  +P I           P      K    +A DL+S++L   P+
Sbjct: 246 FMAALQPTVRNYVENRPAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPD 305
Query: 227 LRSTALEALIHPFFDELRDP 246
            R +  EAL HP+     DP
Sbjct: 306 KRISVDEALRHPYITVWYDP 325

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score =  120 bits (302), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 81/255 (31%), Positives = 132/255 (51%), Gaps = 23/255 (9%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL 59
           M+ ++H N++SL + F      +E   + LV+E +   + +VI+      +RM  +    
Sbjct: 77  MKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-HERMSYL---- 131
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
             YQ+   + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +
Sbjct: 132 -LYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPYVVT 188
Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
           RYYRAPE+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E
Sbjct: 189 RYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 247
Query: 180 EIKCMNP---NYTE-------FKFPQI---KAHPWHKIFQKRMPPEAVDLVSRLLQYSPN 226
            +K + P   NY E         FP++      P      K    +A DL+S++L   P 
Sbjct: 248 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 307
Query: 227 LRSTALEALIHPFFD 241
            R +  +AL HP+ +
Sbjct: 308 KRISVDDALQHPYIN 322

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score =  120 bits (300), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 81/265 (30%), Positives = 136/265 (51%), Gaps = 31/265 (11%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIK---HHYKMSQRMPLIY 56
           M+ ++H N++ L + F      +E   + +V+E +   + +VI+    H +MS       
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS------- 129
Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
                YQ+   + ++H+  G+ HRD+KP N++V      LK+ DFG A+           
Sbjct: 130 --YLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPE 185
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
           + +RYYRAPE+I G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LGTP
Sbjct: 186 VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP 244
Query: 177 TREEIKCMNP---NYTEFKFPQIKAHPWHKIFQKRMPP-----------EAVDLVSRLLQ 222
             E +K + P    Y E + P+   + + K+F   + P           +A DL+S++L 
Sbjct: 245 CPEFMKKLQPTVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNALKASQARDLLSKMLV 303
Query: 223 YSPNLRSTALEALIHPFFDELRDPN 247
              + R +  EAL HP+ +   DP+
Sbjct: 304 IDASKRISVDEALQHPYINVWYDPS 328

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score =  119 bits (299), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 79/262 (30%), Positives = 136/262 (51%), Gaps = 25/262 (9%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL 59
           M+ ++H N++ L + F      +E   + +V+E +   + +VI+      +RM  +    
Sbjct: 71  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELD-HERMSYL---- 125
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
             YQ+   + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +
Sbjct: 126 -LYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVT 182
Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
           RYYRAPE+I G   Y   +D+WS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E
Sbjct: 183 RYYRAPEVILGMG-YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPE 241
Query: 180 EIKCMNP---NYTEFKFPQIKAHPWHKIF-----------QKRMPPEAVDLVSRLLQYSP 225
            +K + P    Y E + P+   + + K+F            K    +A DL+S++L    
Sbjct: 242 FMKKLQPTVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 300
Query: 226 NLRSTALEALIHPFFDELRDPN 247
           + R +  EAL HP+ +   DP+
Sbjct: 301 SKRISVDEALQHPYINVWYDPS 322

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score =  119 bits (299), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 79/262 (30%), Positives = 136/262 (51%), Gaps = 25/262 (9%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELY-LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL 59
           M+ ++H N++ L + F      +E   + +V+E +   + +VI+      +RM  +    
Sbjct: 82  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELD-HERMSYL---- 136
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
             YQ+   + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+ +
Sbjct: 137 -LYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVT 193
Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
           RYYRAPE+I G   Y   +D+WS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E
Sbjct: 194 RYYRAPEVILGMG-YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPE 252
Query: 180 EIKCMNP---NYTEFKFPQIKAHPWHKIF-----------QKRMPPEAVDLVSRLLQYSP 225
            +K + P    Y E + P+   + + K+F            K    +A DL+S++L    
Sbjct: 253 FMKKLQPTVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 311
Query: 226 NLRSTALEALIHPFFDELRDPN 247
           + R +  EAL HP+ +   DP+
Sbjct: 312 SKRISVDEALQHPYINVWYDPS 333

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score =  117 bits (293), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 77/249 (30%), Positives = 132/249 (53%), Gaps = 22/249 (8%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ L H N++ LK             L+L+ EY    + + +  +  +S R+    +K +
Sbjct: 87  LKELQHRNIIELKSVIHHNHR-----LHLIFEYAENDLKKYMDKNPDVSMRV----IKSF 137
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVN----PHTHQLKLCDFGSAKVLVKGEPNISY 116
            YQ+   + + H+     HRD+KPQNLL++      T  LK+ DFG A+    G P   +
Sbjct: 138 LYQLINGVNFCHSR-RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF--GIPIRQF 194
Query: 117 ---ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL 173
              I + +YR PE++ G+  Y+ ++DIWS  C+ AE+L+  PLFPG+S +DQL +I +VL
Sbjct: 195 THEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVL 254
Query: 174 GTPTREEIKCMN--PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 231
           G P       +   P++ +  FP+ +     ++    +  E +DL++ +L+  P  R +A
Sbjct: 255 GLPDDTTWPGVTALPDWKQ-SFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISA 313
Query: 232 LEALIHPFF 240
             AL HP+F
Sbjct: 314 KNALEHPYF 322

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score =  116 bits (291), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 82/267 (30%), Positives = 137/267 (51%), Gaps = 35/267 (13%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIK---HHYKMSQRMPL 54
           M+ ++H N++ L + F    S  E  ++Y+  V+E +   + +VI+    H +MS     
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYI--VMELMDANLCQVIQMELDHERMS----- 129
Query: 55  IYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 114
                  YQ+   + ++H+  G+ HRD+KP N++V      LK+ DFG A+         
Sbjct: 130 ----YLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMME 183
Query: 115 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 174
             + +RYYRAPE+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LG
Sbjct: 184 PEVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLG 242
Query: 175 TPTREEIKCMNP---NYTEFKFPQIKAHPWHKIF-----------QKRMPPEAVDLVSRL 220
           TP    +K + P   NY E + P+   + + K+F            K    +A DL+S++
Sbjct: 243 TPCPAFMKKLQPTVRNYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKM 301
Query: 221 LQYSPNLRSTALEALIHPFFDELRDPN 247
           L    + R +  EAL HP+ +   DP+
Sbjct: 302 LVIDASKRISVDEALQHPYINVWYDPS 328

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score =  115 bits (288), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 81/267 (30%), Positives = 137/267 (51%), Gaps = 35/267 (13%)
Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIK---HHYKMSQRMPL 54
           M+ ++H N++ L + F    S  E  ++Y+  V+E +   + +VI+    H +MS     
Sbjct: 77  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYI--VMELMDANLCQVIQMELDHERMS----- 129
Query: 55  IYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 114
                  YQ+   + ++H+  G+ HRD+KP N++V      LK+ DFG A+         
Sbjct: 130 ----YLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMME 183
Query: 115 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 174
             + +RYYRAPE+I G   Y   +D+WS GC++ E++  + LFPG   +DQ  ++I+ LG
Sbjct: 184 PEVVTRYYRAPEVILGMG-YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLG 242
Query: 175 TPTREEIKCMNP---NYTEFKFPQIKAHPWHKIF-----------QKRMPPEAVDLVSRL 220
           TP  E +K + P    Y E + P+   + + K+F            K    +A DL+S++
Sbjct: 243 TPCPEFMKKLQPTVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKM 301
Query: 221 LQYSPNLRSTALEALIHPFFDELRDPN 247
           L    + R +  EAL HP+ +   DP+
Sbjct: 302 LVIDASKRISVDEALQHPYINVWYDPS 328

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score =  113 bits (282), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 92/279 (32%), Positives = 137/279 (49%), Gaps = 42/279 (15%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHY-----KMSQRMPLI 55
           +R L HPNV+SL+  F S  ++    + L+ +Y    +  +IK H      K   ++P  
Sbjct: 72  LRELKHPNVISLQKVFLSHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRG 128
Query: 56  YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVL---VK 109
            VK   YQI   + Y+H    V HRD+KP N+LV    P   ++K+ D G A++    +K
Sbjct: 129 MVKSLLYQILDGIHYLHANW-VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 187
Query: 110 GEPNIS-YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV----- 163
              ++   + + +YRAPEL+ GA  YT AIDIW+ GC+ AELL  +P+F           
Sbjct: 188 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN 247
Query: 164 ----DQLVEIIKVLGTPTR---EEIKCMNPNYTEFKFPQ---------IKAHPWHKIFQK 207
               DQL  I  V+G P     E+IK M  + T  K  +         IK    HK+   
Sbjct: 248 PYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKV--- 304
Query: 208 RMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP 246
           +   +A  L+ +LL   P  R T+ +A+  P+F  L DP
Sbjct: 305 KPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF--LEDP 341

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score =  111 bits (277), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 86/279 (30%), Positives = 137/279 (49%), Gaps = 69/279 (24%)
Query: 23  DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDI 82
           DELY+  VLE     + ++ K    +++     ++K   Y +     +IH + G+ HRD+
Sbjct: 103 DELYI--VLEIADSDLKKLFKTPIFLTEE----HIKTILYNLLLGENFIHES-GIIHRDL 155
Query: 83  KPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNI----------------------SYICS 119
           KP N L+N     +K+CDFG A+ +  + + NI                      S++ +
Sbjct: 156 KPANCLLNQDC-SVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVT 214
Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQ----------PLFPG--------- 159
           R+YRAPELI     YT +IDIWS GC+ AELL + Q          PLFPG         
Sbjct: 215 RWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPD 274
Query: 160 --------ESGVDQLVEIIKVLGTPTREEIKCMN-PNYTEFKFPQIKAHPWHK---IFQK 207
                   +S  DQL  I  ++GTPT +++K +N P   ++    IK  P  K   + QK
Sbjct: 275 RNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKY----IKLFPHRKPINLKQK 330
Query: 208 --RMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 244
              +  + ++L+  +L+++PN R T  +AL HP+  ++R
Sbjct: 331 YPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVR 369

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score =  111 bits (277), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 85/284 (29%), Positives = 127/284 (44%), Gaps = 71/284 (25%)
Query: 23  DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDI 82
           DELY+  VLE       ++ +    +++    +++K   Y +   + Y+H + G+ HRD+
Sbjct: 130 DELYV--VLEIADSDFKKLFRTPVYLTE----LHIKTLLYNLLVGVKYVH-SAGILHRDL 182
Query: 83  KPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS--------------------------- 115
           KP N LVN     +K+CDFG A+ +   E   S                           
Sbjct: 183 KPANCLVNQDC-SVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLT 241
Query: 116 -YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-----------LGQPLFPGES-- 161
            ++ +R+YRAPELI     YT AID+WS GC+ AELL              PLFPG S  
Sbjct: 242 GHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCF 301
Query: 162 ------------------GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHK 203
                               DQL  I  +LGTP+ E+I+ +     + ++ +I       
Sbjct: 302 PLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAK-RYIRIFPKREGT 360
Query: 204 IFQKRMPPEAVD---LVSRLLQYSPNLRSTALEALIHPFFDELR 244
              +R P  + D   L+ R+L ++PN R T  E L HPFF E+R
Sbjct: 361 DLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR 404

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 84/284 (29%), Positives = 129/284 (45%), Gaps = 70/284 (24%)
Query: 23  DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDI 82
           DELY+  VLE     + ++ K    ++++    +VK   Y +     +IH + G+ HRD+
Sbjct: 105 DELYI--VLEIADSDLKKLFKTPIFLTEQ----HVKTILYNLLLGEKFIHES-GIIHRDL 157
Query: 83  KPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI---------------------------S 115
           KP N L+N     +K+CDFG A+  +  + +I                           S
Sbjct: 158 KPANCLLNQDC-SVKICDFGLART-INSDKDIHIVNDLEEKEENEEPGPHNKNLKKQLTS 215
Query: 116 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-----------PLFPG----- 159
           ++ +R+YRAPELI     YT +IDIWS GC+ AELL              PLFPG     
Sbjct: 216 HVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKSHINNPTNRFPLFPGSSCFP 275
Query: 160 ------------ESGVDQLVEIIKVLGTPTREEIKCMNPN----YTEFKFPQIKAHPWHK 203
                       +S  DQL  I  V+GTP  E++KC+       Y +  FP        K
Sbjct: 276 LSPDHNSKKVHEKSNRDQLNIIFNVIGTPPEEDLKCITKQEVIKYIKL-FPTRDGIDLSK 334
Query: 204 IFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN 247
            +   +  E +DL+  +L+++   R T  +AL HP+  ++R  N
Sbjct: 335 KYSS-ISKEGIDLLESMLRFNAQKRITIDKALSHPYLKDVRKEN 377

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 116/240 (48%), Gaps = 7/240 (2%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           +   +HPNVV L     ++    E+ + LV E+V + +   +         +P   +K  
Sbjct: 68  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG--LPAETIKDL 125
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
             Q  R L ++H    + HRD+KP+N+LV      +KL DFG A++          + + 
Sbjct: 126 MRQFLRGLDFLHANC-IVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALTPVVVTL 183
Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 180
           +YRAPE++  +T Y   +D+WS GC+ AE+   +PLF G S  DQL +I  ++G P  ++
Sbjct: 184 WYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 242
Query: 181 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
               + +     FP     P   +  + M      L+  +L ++P+ R +A  AL H + 
Sbjct: 243 WP-RDVSLPRGAFPPRGPRPVQSVVPE-MEESGAQLLLEMLTFNPHKRISAFRALQHSYL 300

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 116/240 (48%), Gaps = 7/240 (2%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           +   +HPNVV L     ++    E+ + LV E+V + +   +         +P   +K  
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG--LPAETIKDL 117
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
             Q  R L ++H    + HRD+KP+N+LV      +KL DFG A++          + + 
Sbjct: 118 MRQFLRGLDFLHANC-IVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALFPVVVTL 175
Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 180
           +YRAPE++  +T Y   +D+WS GC+ AE+   +PLF G S  DQL +I  ++G P  ++
Sbjct: 176 WYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 234
Query: 181 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
               + +     FP     P   +  + M      L+  +L ++P+ R +A  AL H + 
Sbjct: 235 WP-RDVSLPRGAFPPRGPRPVQSVVPE-MEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 116/240 (48%), Gaps = 7/240 (2%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           +   +HPNVV L     ++    E+ + LV E+V + +   +         +P   +K  
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG--LPAETIKDL 117
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
             Q  R L ++H    + HRD+KP+N+LV      +KL DFG A++          + + 
Sbjct: 118 MRQFLRGLDFLHANC-IVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALAPVVVTL 175
Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 180
           +YRAPE++  +T Y   +D+WS GC+ AE+   +PLF G S  DQL +I  ++G P  ++
Sbjct: 176 WYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 234
Query: 181 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
               + +     FP     P   +  + M      L+  +L ++P+ R +A  AL H + 
Sbjct: 235 WP-RDVSLPRGAFPPRGPRPVQSVVPE-MEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  105 bits (262), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 116/240 (48%), Gaps = 7/240 (2%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           +   +HPNVV L     ++    E+ + LV E+V + +   +         +P   +K  
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG--LPAETIKDL 117
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
             Q  R L ++H    + HRD+KP+N+LV      +KL DFG A++          + + 
Sbjct: 118 MRQFLRGLDFLHANC-IVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALDPVVVTL 175
Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 180
           +YRAPE++  +T Y   +D+WS GC+ AE+   +PLF G S  DQL +I  ++G P  ++
Sbjct: 176 WYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 234
Query: 181 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
               + +     FP     P   +  + M      L+  +L ++P+ R +A  AL H + 
Sbjct: 235 WP-RDVSLPRGAFPPRGPRPVQSVVPE-MEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score =  102 bits (253), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 135/274 (49%), Gaps = 45/274 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           +R  D  N +++ H   + T ++  ++ +  E +   ++ +IK +      +PL  V+ +
Sbjct: 150 LRKQDKDNTMNVIHMLENFTFRN--HICMTFELLSMNLYELIKKNKFQGFSLPL--VRKF 205
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ-LKLCDFGSAKVLVKGEPNISYICS 119
            + I + L  +H    + H D+KP+N+L+       +K+ DFGS+    + +   + I S
Sbjct: 206 AHSILQCLDALHKNR-IIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYTXIQS 262
Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
           R+YRAPE+I GA  Y   ID+WS GC+LAELL G PL PGE   DQL  +I++LG P++ 
Sbjct: 263 RFYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQ- 320
Query: 180 EIKCMNPNYTEFKFPQIKAHPWH------------------KIFQKRMPPEA-------- 213
             K ++ +     F   K +P +                  +  + R PPE+        
Sbjct: 321 --KLLDASKRAKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALK 378
Query: 214 -------VDLVSRLLQYSPNLRSTALEALIHPFF 240
                  +D + + L++ P +R T  +AL HP+ 
Sbjct: 379 GCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWL 412

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score =  101 bits (252), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 135/274 (49%), Gaps = 45/274 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           +R  D  N +++ H   + T ++  ++ +  E +   ++ +IK +      +PL  V+ +
Sbjct: 150 LRKQDKDNTMNVIHMLENFTFRN--HICMTFELLSMNLYELIKKNKFQGFSLPL--VRKF 205
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ-LKLCDFGSAKVLVKGEPNISYICS 119
            + I + L  +H    + H D+KP+N+L+       +K+ DFGS+    + +   + I S
Sbjct: 206 AHSILQCLDALHKNR-IIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYTXIQS 262
Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
           R+YRAPE+I GA  Y   ID+WS GC+LAELL G PL PGE   DQL  +I++LG P++ 
Sbjct: 263 RFYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQ- 320
Query: 180 EIKCMNPNYTEFKFPQIKAHPWH------------------KIFQKRMPPEA-------- 213
             K ++ +     F   K +P +                  +  + R PPE+        
Sbjct: 321 --KLLDASKRAKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALK 378
Query: 214 -------VDLVSRLLQYSPNLRSTALEALIHPFF 240
                  +D + + L++ P +R T  +AL HP+ 
Sbjct: 379 GCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWL 412

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 133/274 (48%), Gaps = 45/274 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           +R  D  N +++ H   + T ++  ++ +  E +   ++ +IK +      +PL  V+ +
Sbjct: 150 LRKQDKDNTMNVIHMLENFTFRN--HICMTFELLSMNLYELIKKNKFQGFSLPL--VRKF 205
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ-LKLCDFGSAKVLVKGEPNISYICS 119
            + I + L  +H    + H D+KP+N+L+       +K+ DFGS+    + +     I S
Sbjct: 206 AHSILQCLDALHKNR-IIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYXXIQS 262
Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
           R+YRAPE+I GA  Y   ID+WS GC+LAELL G PL PGE   DQL  +I++LG P + 
Sbjct: 263 RFYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPXQ- 320
Query: 180 EIKCMNPNYTEFKFPQIKAHPWH------------------KIFQKRMPPEA-------- 213
             K ++ +     F   K +P +                  +  + R PPE+        
Sbjct: 321 --KLLDASKRAKNFVSXKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALK 378
Query: 214 -------VDLVSRLLQYSPNLRSTALEALIHPFF 240
                  +D + + L++ P +R T  +AL HP+ 
Sbjct: 379 GCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWL 412

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 105/225 (46%), Gaps = 44/225 (19%)
Query: 63  QICRALAYIHN-TIGVCHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
           Q+C AL ++    + + H D+KP+N LL NP    +K+ DFGS+  L  G+     I SR
Sbjct: 146 QMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIYQXIQSR 203
Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 180
           +YR+PE++ G   Y  AID+WS GC+L E+  G+PLF G + VDQ+ +I++VLG P    
Sbjct: 204 FYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPP-AH 261
Query: 181 IKCMNPNYTEFKFPQIKAHPWH----KIFQKRMPPEAV---------------------- 214
           I    P   +F F ++    W+    K  ++   P                         
Sbjct: 262 ILDQAPKARKF-FEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGES 320
Query: 215 -----------DLVSRLLQYSPNLRSTALEALIHPFFDELRDPNT 248
                      DL+ R+L Y P  R     AL H FF +  D  T
Sbjct: 321 GHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADEGT 365

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 71/222 (31%), Positives = 104/222 (46%), Gaps = 44/222 (19%)
Query: 63  QICRALAYIHN-TIGVCHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
           Q+C AL ++    + + H D+KP+N LL NP    +K+ DFGS+  L  G+     I SR
Sbjct: 165 QMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIYQXIQSR 222
Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 180
           +YR+PE++ G   Y  AID+WS GC+L E+  G+PLF G + VDQ+ +I++VLG P    
Sbjct: 223 FYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPP-AH 280
Query: 181 IKCMNPNYTEFKFPQIKAHPWH----KIFQKRMPPEAV---------------------- 214
           I    P   +F F ++    W+    K  ++   P                         
Sbjct: 281 ILDQAPKARKF-FEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGES 339
Query: 215 -----------DLVSRLLQYSPNLRSTALEALIHPFFDELRD 245
                      DL+ R+L Y P  R     AL H FF +  D
Sbjct: 340 GHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTAD 381

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 71/222 (31%), Positives = 104/222 (46%), Gaps = 44/222 (19%)
Query: 63  QICRALAYIHN-TIGVCHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
           Q+C AL ++    + + H D+KP+N LL NP    +K+ DFGS+  L  G+     I SR
Sbjct: 165 QMCTALLFLATPELSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQL--GQRIYQXIQSR 222
Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 180
           +YR+PE++ G   Y  AID+WS GC+L E+  G+PLF G + VDQ+ +I++VLG P    
Sbjct: 223 FYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPP-AH 280
Query: 181 IKCMNPNYTEFKFPQIKAHPWH----KIFQKRMPPEAV---------------------- 214
           I    P   +F F ++    W+    K  ++   P                         
Sbjct: 281 ILDQAPKARKF-FEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGES 339
Query: 215 -----------DLVSRLLQYSPNLRSTALEALIHPFFDELRD 245
                      DL+ R+L Y P  R     AL H FF +  D
Sbjct: 340 GHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTAD 381

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 92.4 bits (228), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 83/291 (28%), Positives = 137/291 (47%), Gaps = 46/291 (15%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++LLDH          F+    + +++ +V E + E +  +IK +    + +PLIYVK  
Sbjct: 89  LKLLDH----------FNHKGPNGVHVVMVFEVLGENLLALIKKY--EHRGIPLIYVKQI 136
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVN-----PHTHQLKLCDFGSAKVLVKGEPNIS 115
             Q+   L Y+H   G+ H DIKP+N+L+       +  Q+K+ D G+A      E   +
Sbjct: 137 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDEHYTN 194
Query: 116 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG------VDQLVEI 169
            I +R YR+PE++ GA  +    DIWS  C++ EL+ G  LF  + G       D + +I
Sbjct: 195 SIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 253
Query: 170 IKVLG------------TPTREEIKCMNPNYTEFKFPQIKAHPWHKI-FQKRMPPEAVDL 216
           I++LG            T T    + +  N ++ KF  ++     K  F K    E  D 
Sbjct: 254 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 313
Query: 217 VSRLLQYSPNLRSTALEALIHPFF------DELRDPNTRL-PNGRFLPPLF 260
           +S +LQ  P  R+ A   + HP+       +E+R P+  L  +G  +P  F
Sbjct: 314 LSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWF 364

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 83/291 (28%), Positives = 137/291 (47%), Gaps = 46/291 (15%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++LLDH          F+    + +++ +V E + E +  +IK +    + +PLIYVK  
Sbjct: 89  LKLLDH----------FNHKGPNGVHVVMVFEVLGENLLALIKKY--EHRGIPLIYVKQI 136
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVN-----PHTHQLKLCDFGSAKVLVKGEPNIS 115
             Q+   L Y+H   G+ H DIKP+N+L+       +  Q+K+ D G+A      E   +
Sbjct: 137 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDEHYTN 194
Query: 116 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG------VDQLVEI 169
            I +R YR+PE++ GA  +    DIWS  C++ EL+ G  LF  + G       D + +I
Sbjct: 195 SIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 253
Query: 170 IKVLG------------TPTREEIKCMNPNYTEFKFPQIKAHPWHKI-FQKRMPPEAVDL 216
           I++LG            T T    + +  N ++ KF  ++     K  F K    E  D 
Sbjct: 254 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 313
Query: 217 VSRLLQYSPNLRSTALEALIHPFF------DELRDPNTRL-PNGRFLPPLF 260
           +S +LQ  P  R+ A   + HP+       +E+R P+  L  +G  +P  F
Sbjct: 314 LSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWF 364

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 90.9 bits (224), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 122/248 (49%), Gaps = 42/248 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ L+HP ++ +K+ F    + ++ Y+ L L    E   +V+ +     +R+     KLY
Sbjct: 69  LKKLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLY 119
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNI-SYI 117
           FYQ+  A+ Y+H   G+ HRD+KP+N+L++       +K+ DFG +K+L  GE ++   +
Sbjct: 120 FYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTL 176
Query: 118 CSR-YYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 174
           C    Y APE++   G   Y  A+D WS G +L   L G P F        L        
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL-------- 228
Query: 175 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 234
              +++I     N+     P++    W ++ +K     A+DLV +LL   P  R T  EA
Sbjct: 229 ---KDQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLLVVDPKARFTTEEA 272
Query: 235 LIHPFFDE 242
           L HP+  +
Sbjct: 273 LRHPWLQD 280

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 90.9 bits (224), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 122/248 (49%), Gaps = 42/248 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ L+HP ++ +K+ F    + ++ Y+ L L    E   +V+ +     +R+     KLY
Sbjct: 75  LKKLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLY 125
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNI-SYI 117
           FYQ+  A+ Y+H   G+ HRD+KP+N+L++       +K+ DFG +K+L  GE ++   +
Sbjct: 126 FYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTL 182
Query: 118 CSR-YYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 174
           C    Y APE++   G   Y  A+D WS G +L   L G P F        L        
Sbjct: 183 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL-------- 234
Query: 175 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 234
              +++I     N+     P++    W ++ +K     A+DLV +LL   P  R T  EA
Sbjct: 235 ---KDQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLLVVDPKARFTTEEA 278
Query: 235 LIHPFFDE 242
           L HP+  +
Sbjct: 279 LRHPWLQD 286

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 90.9 bits (224), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 122/248 (49%), Gaps = 42/248 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ L+HP ++ +K+ F    + ++ Y+ L L    E   +V+ +     +R+     KLY
Sbjct: 69  LKKLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLY 119
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNI-SYI 117
           FYQ+  A+ Y+H   G+ HRD+KP+N+L++       +K+ DFG +K+L  GE ++   +
Sbjct: 120 FYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTL 176
Query: 118 CSR-YYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 174
           C    Y APE++   G   Y  A+D WS G +L   L G P F        L        
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL-------- 228
Query: 175 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 234
              +++I     N+     P++    W ++ +K     A+DLV +LL   P  R T  EA
Sbjct: 229 ---KDQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLLVVDPKARFTTEEA 272
Query: 235 LIHPFFDE 242
           L HP+  +
Sbjct: 273 LRHPWLQD 280

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 90.9 bits (224), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 122/248 (49%), Gaps = 42/248 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ L+HP ++ +K+ F    + ++ Y+ L L    E   +V+ +     +R+     KLY
Sbjct: 69  LKKLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLY 119
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNI-SYI 117
           FYQ+  A+ Y+H   G+ HRD+KP+N+L++       +K+ DFG +K+L  GE ++   +
Sbjct: 120 FYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTL 176
Query: 118 CSR-YYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 174
           C    Y APE++   G   Y  A+D WS G +L   L G P F        L        
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL-------- 228
Query: 175 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 234
              +++I     N+     P++    W ++ +K     A+DLV +LL   P  R T  EA
Sbjct: 229 ---KDQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLLVVDPKARFTTEEA 272
Query: 235 LIHPFFDE 242
           L HP+  +
Sbjct: 273 LRHPWLQD 280

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 90.9 bits (224), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 122/248 (49%), Gaps = 42/248 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ L+HP ++ +K+ F    + ++ Y+ L L    E   +V+ +     +R+     KLY
Sbjct: 68  LKKLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLY 118
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNI-SYI 117
           FYQ+  A+ Y+H   G+ HRD+KP+N+L++       +K+ DFG +K+L  GE ++   +
Sbjct: 119 FYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTL 175
Query: 118 CSR-YYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 174
           C    Y APE++   G   Y  A+D WS G +L   L G P F        L        
Sbjct: 176 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL-------- 227
Query: 175 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 234
              +++I     N+     P++    W ++ +K     A+DLV +LL   P  R T  EA
Sbjct: 228 ---KDQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLLVVDPKARFTTEEA 271
Query: 235 LIHPFFDE 242
           L HP+  +
Sbjct: 272 LRHPWLQD 279

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 122/248 (49%), Gaps = 42/248 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ L+HP ++ +K+ F    + ++ Y+ L L    E   +V+ +     +R+     KLY
Sbjct: 208 LKKLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLY 258
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNI-SYI 117
           FYQ+  A+ Y+H   G+ HRD+KP+N+L++       +K+ DFG +K+L  GE ++   +
Sbjct: 259 FYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTL 315
Query: 118 CSR-YYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 174
           C    Y APE++   G   Y  A+D WS G +L   L G P F        L        
Sbjct: 316 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL-------- 367
Query: 175 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 234
              +++I     N+     P++    W ++ +K     A+DLV +LL   P  R T  EA
Sbjct: 368 ---KDQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLLVVDPKARFTTEEA 411
Query: 235 LIHPFFDE 242
           L HP+  +
Sbjct: 412 LRHPWLQD 419

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/248 (29%), Positives = 122/248 (49%), Gaps = 42/248 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ L+HP ++ +K+ F    + ++ Y+ L L    E   +V+ +     +R+     KLY
Sbjct: 194 LKKLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLY 244
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNI-SYI 117
           FYQ+  A+ Y+H   G+ HRD+KP+N+L++       +K+ DFG +K+L  GE ++   +
Sbjct: 245 FYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTL 301
Query: 118 CSR-YYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 174
           C    Y APE++   G   Y  A+D WS G +L   L G P F        L        
Sbjct: 302 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL-------- 353
Query: 175 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 234
              +++I     N+     P++    W ++ +K     A+DLV +LL   P  R T  EA
Sbjct: 354 ---KDQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLLVVDPKARFTTEEA 397
Query: 235 LIHPFFDE 242
           L HP+  +
Sbjct: 398 LRHPWLQD 405

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 79/264 (29%), Positives = 127/264 (48%), Gaps = 43/264 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLE-YVPETVHRVIKHHYKMSQRMPLIYVKL 59
           ++LLDHPN++ L + FF    +D+    LV+E Y    +   I H  K ++    + +K 
Sbjct: 90  LKLLDHPNIMKL-YDFF----EDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIK- 143
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYI 117
              Q+   + Y+H    + HRD+KP+NLL+        +K+ DFG + V    +     +
Sbjct: 144 ---QVLSGVTYLHKH-NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL 199
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            + YY APE++    +Y    D+WS G +L  LL G P F G++  DQ  EI++      
Sbjct: 200 GTAYYIAPEVL--RKKYDEKCDVWSIGVILFILLAGYPPFGGQT--DQ--EILR------ 247
Query: 178 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 237
               K     YT F  P+     W     K +   A DL+ ++LQ+    R +A +AL H
Sbjct: 248 ----KVEKGKYT-FDSPE-----W-----KNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292
Query: 238 PFFDELRDPNTRLPNGRFLPPLFN 261
           P+  E+    ++  +G  LP L N
Sbjct: 293 PWIKEM---CSKKESGIELPSLAN 313

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 107/227 (47%), Gaps = 43/227 (18%)
Query: 54  LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL---------------------VNPH 92
           L +++   YQIC+++ ++H+   + H D+KP+N+L                     +NP 
Sbjct: 117 LDHIRKMAYQICKSVNFLHSN-KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINP- 174
Query: 93  THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL 152
              +K+ DFGSA      E + + + +R+YRAPE+I  A  ++   D+WS GC+L E  L
Sbjct: 175 --DIKVVDFGSATY--DDEHHSTLVSTRHYRAPEVIL-ALGWSQPCDVWSIGCILIEYYL 229
Query: 153 GQPLFPGESGVDQLVEIIKVLG---------TPTREEIKCMNPNYTEFKFPQIKAHPWHK 203
           G  +FP     + L  + ++LG         T  R+       ++ E            K
Sbjct: 230 GFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACK 289
Query: 204 IFQKRMPPEAV------DLVSRLLQYSPNLRSTALEALIHPFFDELR 244
             ++ M  + V      DL+ ++L+Y P  R T  EAL HPFFD L+
Sbjct: 290 PLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLK 336

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 87.4 bits (215), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 71/254 (27%), Positives = 120/254 (47%), Gaps = 22/254 (8%)
Query: 1   MRLLDHPNVVSLKHCFFSTTE-----KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 55
           ++LL H NVV+L     +        K  +YL  V ++    +  ++ +   +  +  L 
Sbjct: 70  LQLLKHENVVNLIEICRTKASPYNRCKGSIYL--VFDFCEHDLAGLLSN---VLVKFTLS 124
Query: 56  YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV---KGEP 112
            +K     +   L YIH    + HRD+K  N+L+      LKL DFG A+        +P
Sbjct: 125 EIKRVMQMLLNGLYYIHRN-KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQP 182
Query: 113 N--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 170
           N   + + + +YR PEL+ G  +Y   ID+W AGC++AE+    P+  G +   QL  I 
Sbjct: 183 NRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 242
Query: 171 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMP----PEAVDLVSRLLQYSPN 226
           ++ G+ T E    ++ NY  ++  ++      K+  +       P A+DL+ +LL   P 
Sbjct: 243 QLCGSITPEVWPNVD-NYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPA 301
Query: 227 LRSTALEALIHPFF 240
            R  + +AL H FF
Sbjct: 302 QRIDSDDALNHDFF 315

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 87.4 bits (215), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 71/254 (27%), Positives = 120/254 (47%), Gaps = 22/254 (8%)
Query: 1   MRLLDHPNVVSLKHCFFSTTE-----KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 55
           ++LL H NVV+L     +        K  +YL  V ++    +  ++ +   +  +  L 
Sbjct: 71  LQLLKHENVVNLIEICRTKASPYNRCKGSIYL--VFDFCEHDLAGLLSN---VLVKFTLS 125
Query: 56  YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV---KGEP 112
            +K     +   L YIH    + HRD+K  N+L+      LKL DFG A+        +P
Sbjct: 126 EIKRVMQMLLNGLYYIHRN-KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQP 183
Query: 113 N--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 170
           N   + + + +YR PEL+ G  +Y   ID+W AGC++AE+    P+  G +   QL  I 
Sbjct: 184 NRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 243
Query: 171 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMP----PEAVDLVSRLLQYSPN 226
           ++ G+ T E    ++ NY  ++  ++      K+  +       P A+DL+ +LL   P 
Sbjct: 244 QLCGSITPEVWPNVD-NYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPA 302
Query: 227 LRSTALEALIHPFF 240
            R  + +AL H FF
Sbjct: 303 QRIDSDDALNHDFF 316

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 87.4 bits (215), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 71/254 (27%), Positives = 120/254 (47%), Gaps = 22/254 (8%)
Query: 1   MRLLDHPNVVSLKHCFFSTTE-----KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 55
           ++LL H NVV+L     +        K  +YL  V ++    +  ++ +   +  +  L 
Sbjct: 71  LQLLKHENVVNLIEICRTKASPYNRCKGSIYL--VFDFCEHDLAGLLSN---VLVKFTLS 125
Query: 56  YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV---KGEP 112
            +K     +   L YIH    + HRD+K  N+L+      LKL DFG A+        +P
Sbjct: 126 EIKRVMQMLLNGLYYIHRN-KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQP 183
Query: 113 N--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 170
           N   + + + +YR PEL+ G  +Y   ID+W AGC++AE+    P+  G +   QL  I 
Sbjct: 184 NRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 243
Query: 171 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMP----PEAVDLVSRLLQYSPN 226
           ++ G+ T E    ++ NY  ++  ++      K+  +       P A+DL+ +LL   P 
Sbjct: 244 QLCGSITPEVWPNVD-NYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPA 302
Query: 227 LRSTALEALIHPFF 240
            R  + +AL H FF
Sbjct: 303 QRIDSDDALNHDFF 316

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/245 (30%), Positives = 116/245 (47%), Gaps = 40/245 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVI-KHHYKMSQRMPLIYVKL 59
           M+ LDHPN++ L   F   T+   +YL + L    E   RV+ K  ++ S    ++    
Sbjct: 77  MKSLDHPNIIRLYETFEDNTD---IYLVMELCTGGELFERVVHKRVFRESDAARIMK--- 130
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLL--VNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
               +  A+AY H  + V HRD+KP+N L   +     LKL DFG A     G+   + +
Sbjct: 131 ---DVLSAVAYCHK-LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV 186
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            + YY +P+++ G   Y    D WSAG ++  LL G P F   +  + +++I +  GT  
Sbjct: 187 GTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIRE--GT-- 240
Query: 178 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 237
                        F FP+     W  +      P+A  L+ RLL  SP  R T+L+AL H
Sbjct: 241 -------------FTFPE---KDWLNV-----SPQAESLIRRLLTKSPKQRITSLQALEH 279
Query: 238 PFFDE 242
            +F++
Sbjct: 280 EWFEK 284

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/254 (27%), Positives = 120/254 (47%), Gaps = 22/254 (8%)
Query: 1   MRLLDHPNVVSLKHCFFSTTE-----KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI 55
           ++LL H NVV+L     +        K  +YL  V ++    +  ++ +   +  +  L 
Sbjct: 71  LQLLKHENVVNLIEICRTKASPYNRCKASIYL--VFDFCEHDLAGLLSN---VLVKFTLS 125
Query: 56  YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV---KGEP 112
            +K     +   L YIH    + HRD+K  N+L+      LKL DFG A+        +P
Sbjct: 126 EIKRVMQMLLNGLYYIHRN-KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQP 183
Query: 113 N--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 170
           N   + + + +YR PEL+ G  +Y   ID+W AGC++AE+    P+  G +   QL  I 
Sbjct: 184 NRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 243
Query: 171 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMP----PEAVDLVSRLLQYSPN 226
           ++ G+ T E    ++ NY  ++  ++      K+  +       P A+DL+ +LL   P 
Sbjct: 244 QLCGSITPEVWPNVD-NYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPA 302
Query: 227 LRSTALEALIHPFF 240
            R  + +AL H FF
Sbjct: 303 QRIDSDDALNHDFF 316

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/245 (30%), Positives = 116/245 (47%), Gaps = 40/245 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVI-KHHYKMSQRMPLIYVKL 59
           M+ LDHPN++ L   F   T+   +YL + L    E   RV+ K  ++ S    ++    
Sbjct: 60  MKSLDHPNIIRLYETFEDNTD---IYLVMELCTGGELFERVVHKRVFRESDAARIMK--- 113
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLL--VNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
               +  A+AY H  + V HRD+KP+N L   +     LKL DFG A     G+   + +
Sbjct: 114 ---DVLSAVAYCHK-LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV 169
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            + YY +P+++ G   Y    D WSAG ++  LL G P F   +  + +++I +  GT  
Sbjct: 170 GTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIRE--GT-- 223
Query: 178 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 237
                        F FP+     W  +      P+A  L+ RLL  SP  R T+L+AL H
Sbjct: 224 -------------FTFPE---KDWLNV-----SPQAESLIRRLLTKSPKQRITSLQALEH 262
Query: 238 PFFDE 242
            +F++
Sbjct: 263 EWFEK 267

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 106/227 (46%), Gaps = 43/227 (18%)
Query: 54  LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL---------------------VNPH 92
           L +++   YQIC+++ ++H+   + H D+KP+N+L                     +NP 
Sbjct: 117 LDHIRKMAYQICKSVNFLHSN-KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINP- 174
Query: 93  THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL 152
              +K+ DFGSA      E + + +  R+YRAPE+I  A  ++   D+WS GC+L E  L
Sbjct: 175 --DIKVVDFGSATY--DDEHHSTLVXXRHYRAPEVIL-ALGWSQPCDVWSIGCILIEYYL 229
Query: 153 GQPLFPGESGVDQLVEIIKVLG---------TPTREEIKCMNPNYTEFKFPQIKAHPWHK 203
           G  +FP     + L  + ++LG         T  R+       ++ E            K
Sbjct: 230 GFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACK 289
Query: 204 IFQKRMPPEAV------DLVSRLLQYSPNLRSTALEALIHPFFDELR 244
             ++ M  + V      DL+ ++L+Y P  R T  EAL HPFFD L+
Sbjct: 290 PLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLK 336

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 110/243 (45%), Gaps = 42/243 (17%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVK 58
           ++ LDHPN++ L   F     +D+ Y  LV E     E    +I       +R   +   
Sbjct: 80  LKQLDHPNIMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIISR-----KRFSEVDAA 129
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISY 116
               Q+   + Y+H    + HRD+KP+NLL+   +    +++ DFG +      +     
Sbjct: 130 RIIRQVLSGITYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK 188
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
           I + YY APE++ G   Y    D+WS G +L  LL G P F G +  D L ++ K     
Sbjct: 189 IGTAYYIAPEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK----- 241
Query: 177 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 236
                      YT F+ PQ     W     K++   A DL+ ++L Y P++R +A +AL 
Sbjct: 242 ---------GKYT-FELPQ-----W-----KKVSESAKDLIRKMLTYVPSMRISARDALD 281
Query: 237 HPF 239
           H +
Sbjct: 282 HEW 284

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 110/243 (45%), Gaps = 42/243 (17%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVK 58
           ++ LDHPN++ L   F     +D+ Y  LV E     E    +I       +R   +   
Sbjct: 104 LKQLDHPNIMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIISR-----KRFSEVDAA 153
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISY 116
               Q+   + Y+H    + HRD+KP+NLL+   +    +++ DFG +      +     
Sbjct: 154 RIIRQVLSGITYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK 212
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
           I + YY APE++ G   Y    D+WS G +L  LL G P F G +  D L ++ K     
Sbjct: 213 IGTAYYIAPEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK----- 265
Query: 177 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 236
                      YT F+ PQ     W     K++   A DL+ ++L Y P++R +A +AL 
Sbjct: 266 ---------GKYT-FELPQ-----W-----KKVSESAKDLIRKMLTYVPSMRISARDALD 305
Query: 237 HPF 239
           H +
Sbjct: 306 HEW 308

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 110/243 (45%), Gaps = 42/243 (17%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVK 58
           ++ LDHPN++ L   F     +D+ Y  LV E     E    +I       +R   +   
Sbjct: 103 LKQLDHPNIMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIISR-----KRFSEVDAA 152
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISY 116
               Q+   + Y+H    + HRD+KP+NLL+   +    +++ DFG +      +     
Sbjct: 153 RIIRQVLSGITYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK 211
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
           I + YY APE++ G   Y    D+WS G +L  LL G P F G +  D L ++ K     
Sbjct: 212 IGTAYYIAPEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK----- 264
Query: 177 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 236
                      YT F+ PQ     W     K++   A DL+ ++L Y P++R +A +AL 
Sbjct: 265 ---------GKYT-FELPQ-----W-----KKVSESAKDLIRKMLTYVPSMRISARDALD 304
Query: 237 HPF 239
           H +
Sbjct: 305 HEW 307

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 110/243 (45%), Gaps = 42/243 (17%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVK 58
           ++ LDHPN++ L   F     +D+ Y  LV E     E    +I       +R   +   
Sbjct: 86  LKQLDHPNIMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIISR-----KRFSEVDAA 135
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISY 116
               Q+   + Y+H    + HRD+KP+NLL+   +    +++ DFG +      +     
Sbjct: 136 RIIRQVLSGITYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK 194
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
           I + YY APE++ G   Y    D+WS G +L  LL G P F G +  D L ++ K     
Sbjct: 195 IGTAYYIAPEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK----- 247
Query: 177 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 236
                      YT F+ PQ     W     K++   A DL+ ++L Y P++R +A +AL 
Sbjct: 248 ---------GKYT-FELPQ-----W-----KKVSESAKDLIRKMLTYVPSMRISARDALD 287
Query: 237 HPF 239
           H +
Sbjct: 288 HEW 290

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 84.7 bits (208), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 71/237 (29%), Positives = 109/237 (45%), Gaps = 43/237 (18%)
Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFY 62
           L HPN++ L   F  +T      + L+LEY P  TV+R ++   K  ++    Y+     
Sbjct: 65  LRHPNILRLYGYFHDSTR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---- 115
Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 122
           ++  AL+Y H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y
Sbjct: 116 ELANALSYCHSK-KVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRAALCGTLDY 172
Query: 123 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 182
             PE+I G   +   +D+WS G +  E L+G+P F   +  D    I +V          
Sbjct: 173 LPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRV---------- 221
Query: 183 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
                  EF FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 222 -------EFTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 62/190 (32%), Positives = 92/190 (48%), Gaps = 33/190 (17%)
Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNISYICSR- 120
           QI  AL Y+HN  G+CHRDIKP+N L + + + ++KL DFG +K   K      Y  +  
Sbjct: 176 QIFSALHYLHNQ-GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTK 234
Query: 121 ----YYRAPELIFGATE-YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
               Y+ APE++    E Y    D WSAG +L  LL+G   FPG +  D + +++     
Sbjct: 235 AGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLN---- 290
Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 235
              +++   NPNY                    + P A DL+S LL  + + R  A+ AL
Sbjct: 291 ---KKLCFENPNYN------------------VLSPLARDLLSNLLNRNVDERFDAMRAL 329
Query: 236 IHPFFDELRD 245
            HP+  +  D
Sbjct: 330 QHPWISQFSD 339

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 81/241 (33%), Positives = 115/241 (47%), Gaps = 42/241 (17%)
Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYF 61
           L HPN++ LK  F + TE     ++LVLE V   E   R+++  Y  S+R     VK   
Sbjct: 105 LSHPNIIKLKEIFETPTE-----ISLVLELVTGGELFDRIVEKGY-YSERDAADAVK--- 155
Query: 62  YQICRALAYIHNTIGVCHRDIKPQNLL-VNPHTHQ-LKLCDFGSAKVLVKGEPNISYICS 119
            QI  A+AY+H   G+ HRD+KP+NLL   P     LK+ DFG +K+ V+ +  +  +C 
Sbjct: 156 -QILEAVAYLHEN-GIVHRDLKPENLLYATPAPDAPLKIADFGLSKI-VEHQVLMKTVCG 212
Query: 120 R-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 178
              Y APE++ G   Y   +D+WS G +   LL G   F  E G DQ +          R
Sbjct: 213 TPGYCAPEILRGCA-YGPEVDMWSVGIITYILLCGFEPFYDERG-DQFM---------FR 261
Query: 179 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 238
             + C      E+ F      PW       +   A DLV +L+   P  R T  +AL HP
Sbjct: 262 RILNC------EYYF----ISPWW----DEVSLNAKDLVRKLIVLDPKKRLTTFQALQHP 307
Query: 239 F 239
           +
Sbjct: 308 W 308

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/237 (29%), Positives = 108/237 (45%), Gaps = 43/237 (18%)
Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFY 62
           L HPN++ L   F   T      + L+LEY P  TV+R ++   K  ++    Y+     
Sbjct: 68  LRHPNILRLYGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---- 118
Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 122
           ++  AL+Y H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y
Sbjct: 119 ELANALSYCHSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDY 175
Query: 123 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 182
             PE+I G   +   +D+WS G +  E L+G+P F   +  +    I +V          
Sbjct: 176 LPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------- 224
Query: 183 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
                  EF FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 225 -------EFTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/237 (29%), Positives = 108/237 (45%), Gaps = 43/237 (18%)
Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFY 62
           L HPN++ L   F   T      + L+LEY P  TV+R ++   K  ++    Y+     
Sbjct: 91  LRHPNILRLYGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---- 141
Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 122
           ++  AL+Y H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y
Sbjct: 142 ELANALSYCHSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDY 198
Query: 123 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 182
             PE+I G   +   +D+WS G +  E L+G+P F   +  +    I +V          
Sbjct: 199 LPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------- 247
Query: 183 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
                  EF FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 248 -------EFTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 285

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 72/261 (27%), Positives = 114/261 (43%), Gaps = 41/261 (15%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ LDHPN++ L   F    +    Y+   L    E    +IK   + S+      +K  
Sbjct: 75  LKKLDHPNIMKL---FEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIK-- 128
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYIC 118
             Q+   + Y+H    + HRD+KP+N+L+        +K+ DFG +    +       I 
Sbjct: 129 --QVFSGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIG 185
Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 178
           + YY APE++ G   Y    D+WSAG +L  LL G P F G++  D L            
Sbjct: 186 TAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL------------ 231
Query: 179 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 238
              K +      F  PQ     W  I       +A DL+ ++L + P+LR TA + L HP
Sbjct: 232 ---KRVETGKYAFDLPQ-----WRTI-----SDDAKDLIRKMLTFHPSLRITATQCLEHP 278
Query: 239 FFDELRDPNTRLPNGRFLPPL 259
           +   ++  ++  P    LP L
Sbjct: 279 W---IQKYSSETPTISDLPSL 296

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/241 (28%), Positives = 106/241 (43%), Gaps = 38/241 (15%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ LDHPN++ L   F    +    Y+   L    E    +IK   + S+      +K  
Sbjct: 75  LKKLDHPNIMKL---FEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIK-- 128
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYIC 118
             Q+   + Y+H    + HRD+KP+N+L+        +K+ DFG +    +       I 
Sbjct: 129 --QVFSGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIG 185
Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 178
           + YY APE++ G   Y    D+WSAG +L  LL G P F G++  D L            
Sbjct: 186 TAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL------------ 231
Query: 179 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 238
              K +      F  PQ     W  I       +A DL+ ++L + P+LR TA + L HP
Sbjct: 232 ---KRVETGKYAFDLPQ-----WRTI-----SDDAKDLIRKMLTFHPSLRITATQCLEHP 278
Query: 239 F 239
           +
Sbjct: 279 W 279

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 70/237 (29%), Positives = 108/237 (45%), Gaps = 43/237 (18%)
Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFY 62
           L HPN++ L   F   T      + L+LEY P  TV+R ++   K  ++    Y+     
Sbjct: 64  LRHPNILRLYGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---- 114
Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 122
           ++  AL+Y H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y
Sbjct: 115 ELANALSYCHSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDY 171
Query: 123 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 182
             PE+I G   +   +D+WS G +  E L+G+P F   +  +    I +V          
Sbjct: 172 LPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------- 220
Query: 183 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
                  EF FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 221 -------EFTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 258

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/241 (28%), Positives = 106/241 (43%), Gaps = 38/241 (15%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ LDHPN++ L   F    +    Y+   L    E    +IK   + S+      +K  
Sbjct: 75  LKKLDHPNIMKL---FEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIK-- 128
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYIC 118
             Q+   + Y+H    + HRD+KP+N+L+        +K+ DFG +    +       I 
Sbjct: 129 --QVFSGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIG 185
Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 178
           + YY APE++ G   Y    D+WSAG +L  LL G P F G++  D L            
Sbjct: 186 TAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL------------ 231
Query: 179 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 238
              K +      F  PQ     W  I       +A DL+ ++L + P+LR TA + L HP
Sbjct: 232 ---KRVETGKYAFDLPQ-----WRTI-----SDDAKDLIRKMLTFHPSLRITATQCLEHP 278
Query: 239 F 239
           +
Sbjct: 279 W 279

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 70/237 (29%), Positives = 108/237 (45%), Gaps = 43/237 (18%)
Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFY 62
           L HPN++ L   F   T      + L+LEY P  TV+R ++   K  ++    Y+     
Sbjct: 82  LRHPNILRLYGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---- 132
Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 122
           ++  AL+Y H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y
Sbjct: 133 ELANALSYCHSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDY 189
Query: 123 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 182
             PE+I G   +   +D+WS G +  E L+G+P F   +  +    I +V          
Sbjct: 190 LPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------- 238
Query: 183 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
                  EF FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 239 -------EFTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 276

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 70/237 (29%), Positives = 108/237 (45%), Gaps = 43/237 (18%)
Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFY 62
           L HPN++ L   F   T      + L+LEY P  TV+R ++   K  ++    Y+     
Sbjct: 68  LRHPNILRLYGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---- 118
Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 122
           ++  AL+Y H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y
Sbjct: 119 ELANALSYCHSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDY 175
Query: 123 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 182
             PE+I G   +   +D+WS G +  E L+G+P F   +  +    I +V          
Sbjct: 176 LPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------- 224
Query: 183 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
                  EF FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 225 -------EFTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 70/237 (29%), Positives = 108/237 (45%), Gaps = 43/237 (18%)
Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFY 62
           L HPN++ L   F   T      + L+LEY P  TV+R ++   K  ++    Y+     
Sbjct: 70  LRHPNILRLYGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---- 120
Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 122
           ++  AL+Y H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y
Sbjct: 121 ELANALSYCHSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDY 177
Query: 123 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 182
             PE+I G   +   +D+WS G +  E L+G+P F   +  +    I +V          
Sbjct: 178 LPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------- 226
Query: 183 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
                  EF FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 227 -------EFTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 264

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 70/237 (29%), Positives = 108/237 (45%), Gaps = 43/237 (18%)
Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFY 62
           L HPN++ L   F   T      + L+LEY P  TV+R ++   K  ++    Y+     
Sbjct: 62  LRHPNILRLYGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---- 112
Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 122
           ++  AL+Y H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y
Sbjct: 113 ELANALSYCHSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDY 169
Query: 123 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 182
             PE+I G   +   +D+WS G +  E L+G+P F   +  +    I +V          
Sbjct: 170 LPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------- 218
Query: 183 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
                  EF FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 219 -------EFTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 256

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 70/237 (29%), Positives = 108/237 (45%), Gaps = 43/237 (18%)
Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFY 62
           L HPN++ L   F   T      + L+LEY P  TV+R ++   K  ++    Y+     
Sbjct: 69  LRHPNILRLYGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---- 119
Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 122
           ++  AL+Y H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y
Sbjct: 120 ELANALSYCHSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDY 176
Query: 123 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 182
             PE+I G   +   +D+WS G +  E L+G+P F   +  +    I +V          
Sbjct: 177 LPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------- 225
Query: 183 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
                  EF FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 226 -------EFTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 263

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 70/237 (29%), Positives = 108/237 (45%), Gaps = 43/237 (18%)
Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFY 62
           L HPN++ L   F   T      + L+LEY P  TV+R ++   K  ++    Y+     
Sbjct: 65  LRHPNILRLYGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---- 115
Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 122
           ++  AL+Y H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y
Sbjct: 116 ELANALSYCHSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDY 172
Query: 123 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 182
             PE+I G   +   +D+WS G +  E L+G+P F   +  +    I +V          
Sbjct: 173 LPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------- 221
Query: 183 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
                  EF FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 222 -------EFTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 70/237 (29%), Positives = 108/237 (45%), Gaps = 43/237 (18%)
Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFY 62
           L HPN++ L   F   T      + L+LEY P  TV+R ++   K  ++    Y+     
Sbjct: 65  LRHPNILRLYGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---- 115
Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 122
           ++  AL+Y H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y
Sbjct: 116 ELANALSYCHSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRAALCGTLDY 172
Query: 123 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 182
             PE+I G   +   +D+WS G +  E L+G+P F   +  +    I +V          
Sbjct: 173 LPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------- 221
Query: 183 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
                  EF FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 222 -------EFTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 70/237 (29%), Positives = 107/237 (45%), Gaps = 43/237 (18%)
Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFY 62
           L HPN++ L   F   T      + L+LEY P  TV+R ++   K  ++    Y+     
Sbjct: 70  LRHPNILRLYGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---- 120
Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 122
           ++  AL+Y H+   V HRDIKP+NLL+     +LK+ DFG + V            +  Y
Sbjct: 121 ELANALSYCHSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTDLCGTLDY 177
Query: 123 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 182
             PE+I G   +   +D+WS G +  E L+G+P F   +  +    I +V          
Sbjct: 178 LPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------- 226
Query: 183 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
                  EF FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 227 -------EFTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 264

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 70/237 (29%), Positives = 107/237 (45%), Gaps = 43/237 (18%)
Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFY 62
           L HPN++ L   F   T      + L+LEY P  TV+R ++   K  ++    Y+     
Sbjct: 65  LRHPNILRLYGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---- 115
Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 122
           ++  AL+Y H+   V HRDIKP+NLL+     +LK+ DFG + V            +  Y
Sbjct: 116 ELANALSYCHSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTDLCGTLDY 172
Query: 123 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 182
             PE+I G   +   +D+WS G +  E L+G+P F   +  +    I +V          
Sbjct: 173 LPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------- 221
Query: 183 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
                  EF FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 222 -------EFTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 106/243 (43%), Gaps = 42/243 (17%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVK 58
           ++ LDHPN+  L   F     +D+ Y  LV E     E    +I       +R   +   
Sbjct: 80  LKQLDHPNIXKLYEFF-----EDKGYFYLVGEVYTGGELFDEIISR-----KRFSEVDAA 129
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISY 116
               Q+   + Y H    + HRD+KP+NLL+   +    +++ DFG +      +     
Sbjct: 130 RIIRQVLSGITYXHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDK 188
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
           I + YY APE++ G   Y    D+WS G +L  LL G P F G +  D L ++ K     
Sbjct: 189 IGTAYYIAPEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK----- 241
Query: 177 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 236
                      YT F+ PQ     W     K++   A DL+ + L Y P+ R +A +AL 
Sbjct: 242 ---------GKYT-FELPQ-----W-----KKVSESAKDLIRKXLTYVPSXRISARDALD 281
Query: 237 HPF 239
           H +
Sbjct: 282 HEW 284

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 70/237 (29%), Positives = 107/237 (45%), Gaps = 43/237 (18%)
Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFY 62
           L HPN++ L   F   T      + L+LEY P  TV+R ++   K  ++    Y+     
Sbjct: 66  LRHPNILRLYGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---- 116
Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 122
           ++  AL+Y H+   V HRDIKP+NLL+     +LK+ DFG + V            +  Y
Sbjct: 117 ELANALSYCHSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTDLCGTLDY 173
Query: 123 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 182
             PE+I G   +   +D+WS G +  E L+G+P F   +  +    I +V          
Sbjct: 174 LPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------- 222
Query: 183 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
                  EF FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 223 -------EFTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 260

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 70/237 (29%), Positives = 108/237 (45%), Gaps = 43/237 (18%)
Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFY 62
           L HPN++ L   F   T      + L+LEY P  TV+R ++   K  ++    Y+     
Sbjct: 68  LRHPNILRLYGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---- 118
Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 122
           ++  AL+Y H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y
Sbjct: 119 ELANALSYCHSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRAALCGTLDY 175
Query: 123 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 182
             PE+I G   +   +D+WS G +  E L+G+P F   +  +    I +V          
Sbjct: 176 LPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------- 224
Query: 183 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
                  EF FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 225 -------EFTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 70/237 (29%), Positives = 107/237 (45%), Gaps = 43/237 (18%)
Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFY 62
           L HPN++ L   F   T      + L+LEY P  TV+R ++   K  ++    Y+     
Sbjct: 65  LRHPNILRLYGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---- 115
Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 122
           ++  AL+Y H+   V HRDIKP+NLL+     +LK+ DFG + V            +  Y
Sbjct: 116 ELANALSYCHSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTDLCGTLDY 172
Query: 123 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 182
             PE+I G   +   +D+WS G +  E L+G+P F   +  +    I +V          
Sbjct: 173 LPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------- 221
Query: 183 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
                  EF FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 222 -------EFTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 70/237 (29%), Positives = 107/237 (45%), Gaps = 43/237 (18%)
Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFY 62
           L HPN++ L   F   T      + L+LEY P  TV+R ++   K  ++    Y+     
Sbjct: 65  LRHPNILRLYGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---- 115
Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 122
           ++  AL+Y H+   V HRDIKP+NLL+     +LK+ DFG + V            +  Y
Sbjct: 116 ELANALSYCHSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTXLCGTLDY 172
Query: 123 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 182
             PE+I G   +   +D+WS G +  E L+G+P F   +  +    I +V          
Sbjct: 173 LPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------- 221
Query: 183 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
                  EF FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 222 -------EFTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 70/237 (29%), Positives = 107/237 (45%), Gaps = 43/237 (18%)
Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFY 62
           L HPN++ L   F   T      + L+LEY P  TV+R ++   K  ++    Y+     
Sbjct: 65  LRHPNILRLYGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---- 115
Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 122
           ++  AL+Y H+   V HRDIKP+NLL+     +LK+ DFG + V            +  Y
Sbjct: 116 ELANALSYCHSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTELCGTLDY 172
Query: 123 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 182
             PE+I G   +   +D+WS G +  E L+G+P F   +  +    I +V          
Sbjct: 173 LPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------- 221
Query: 183 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
                  EF FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 222 -------EFTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 70/237 (29%), Positives = 108/237 (45%), Gaps = 43/237 (18%)
Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFY 62
           L HPN++ L   F   T      + L+LEY P  TV+R ++   K  ++    Y+     
Sbjct: 66  LRHPNILRLYGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---- 116
Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 122
           ++  AL+Y H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y
Sbjct: 117 ELANALSYCHSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRDTLCGTLDY 173
Query: 123 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 182
             PE+I G   +   +D+WS G +  E L+G+P F   +  +    I +V          
Sbjct: 174 LPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------- 222
Query: 183 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
                  EF FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 223 -------EFTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 260

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 70/237 (29%), Positives = 107/237 (45%), Gaps = 43/237 (18%)
Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFY 62
           L HPN++ L   F   T      + L+LEY P  TV+R ++   K  ++    Y+     
Sbjct: 70  LRHPNILRLYGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---- 120
Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 122
           ++  AL+Y H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y
Sbjct: 121 ELANALSYCHSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDY 177
Query: 123 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 182
             PE I G   +   +D+WS G +  E L+G+P F   +  +    I +V          
Sbjct: 178 LPPEXIEGRX-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------- 226
Query: 183 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
                  EF FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 227 -------EFTFPDF------------VTEGARDLISRLLKHNPSQRPXLREVLEHPW 264

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 70/237 (29%), Positives = 107/237 (45%), Gaps = 43/237 (18%)
Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFY 62
           L HPN++ L   F   T      + L+LEY P  TV+R ++   K  ++    Y+     
Sbjct: 65  LRHPNILRLYGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---- 115
Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 122
           ++  AL+Y H+   V HRDIKP+NLL+     +LK+ DFG + V            +  Y
Sbjct: 116 ELANALSYCHSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRXXLCGTLDY 172
Query: 123 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 182
             PE+I G   +   +D+WS G +  E L+G+P F   +  +    I +V          
Sbjct: 173 LPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------- 221
Query: 183 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
                  EF FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 222 -------EFTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 259

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 70/237 (29%), Positives = 107/237 (45%), Gaps = 43/237 (18%)
Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFY 62
           L HPN++ L   F   T      + L+LEY P  TV+R ++   K  ++    Y+     
Sbjct: 68  LRHPNILRLYGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---- 118
Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 122
           ++  AL+Y H+   V HRDIKP+NLL+     +LK+ DFG + V            +  Y
Sbjct: 119 ELANALSYCHSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRXXLCGTLDY 175
Query: 123 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 182
             PE+I G   +   +D+WS G +  E L+G+P F   +  +    I +V          
Sbjct: 176 LPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------- 224
Query: 183 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
                  EF FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 225 -------EFTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 70/237 (29%), Positives = 107/237 (45%), Gaps = 43/237 (18%)
Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFY 62
           L HPN++ L   F   T      + L+LEY P  TV+R ++   K  ++    Y+     
Sbjct: 91  LRHPNILRLYGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---- 141
Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 122
           ++  AL+Y H+   V HRDIKP+NLL+     +LK+ DFG + V            +  Y
Sbjct: 142 ELANALSYCHSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRDDLCGTLDY 198
Query: 123 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 182
             PE+I G   +   +D+WS G +  E L+G+P F   +  +    I +V          
Sbjct: 199 LPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------- 247
Query: 183 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
                  EF FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 248 -------EFTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 285

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 70/237 (29%), Positives = 107/237 (45%), Gaps = 43/237 (18%)
Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFY 62
           L HPN++ L   F   T      + L+LEY P  TV+R ++   K  ++    Y+     
Sbjct: 67  LRHPNILRLYGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---- 117
Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 122
           ++  AL+Y H+   V HRDIKP+NLL+     +LK+ DFG + V            +  Y
Sbjct: 118 ELANALSYCHSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRXXLCGTLDY 174
Query: 123 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 182
             PE+I G   +   +D+WS G +  E L+G+P F   +  +    I +V          
Sbjct: 175 LPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------- 223
Query: 183 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
                  EF FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 224 -------EFTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 261

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 78/260 (30%), Positives = 125/260 (48%), Gaps = 57/260 (21%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M  LDHP  V L   +F+  + ++LY  L      E    ++K+  K+         + Y
Sbjct: 87  MSRLDHPFFVKL---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFY 138
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYI 117
             +I  AL Y+H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K     S++
Sbjct: 139 TAEIVSALEYLHGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFV 196
Query: 118 CSRYYRAPELIFGATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVL 173
            +  Y +PEL+   TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+ 
Sbjct: 197 GTAQYVSPELL---TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL- 250
Query: 174 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL--LQYSPNLRSTA 231
                           E+ FP+       K F     P+A DLV +L  L  +  L    
Sbjct: 251 ----------------EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEE 282
Query: 232 LEAL----IHPFFDELRDPN 247
           +E       HPFF+ +   N
Sbjct: 283 MEGYGPLKAHPFFESVTWEN 302

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 70/237 (29%), Positives = 107/237 (45%), Gaps = 43/237 (18%)
Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFY 62
           L HPN++ L   F   T      + L+LEY P  TV+R ++   K  ++    Y+     
Sbjct: 68  LRHPNILRLYGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---- 118
Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 122
           ++  AL+Y H+   V HRDIKP+NLL+     +LK+ DFG + V            +  Y
Sbjct: 119 ELANALSYCHSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRDDLCGTLDY 175
Query: 123 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 182
             PE+I G   +   +D+WS G +  E L+G+P F   +  +    I +V          
Sbjct: 176 LPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------- 224
Query: 183 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
                  EF FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 225 -------EFTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 78/260 (30%), Positives = 125/260 (48%), Gaps = 57/260 (21%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M  LDHP  V L   +F+  + ++LY  L      E    ++K+  K+         + Y
Sbjct: 83  MSRLDHPFFVKL---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFY 134
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYI 117
             +I  AL Y+H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K     S++
Sbjct: 135 TAEIVSALEYLHGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFV 192
Query: 118 CSRYYRAPELIFGATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVL 173
            +  Y +PEL+   TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+ 
Sbjct: 193 GTAQYVSPELL---TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL- 246
Query: 174 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL--LQYSPNLRSTA 231
                           E+ FP+       K F     P+A DLV +L  L  +  L    
Sbjct: 247 ----------------EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEE 278
Query: 232 LEAL----IHPFFDELRDPN 247
           +E       HPFF+ +   N
Sbjct: 279 MEGYGPLKAHPFFESVTWEN 298

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 71/244 (29%), Positives = 109/244 (44%), Gaps = 57/244 (23%)
Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFY 62
           L HPN++ L   F   T      + L+LEY P  TV+R ++   K  ++    Y+     
Sbjct: 66  LRHPNILRLYGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---- 116
Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-------SAKVLVKGEPNIS 115
           ++  AL+Y H+   V HRDIKP+NLL+     +LK+ DFG       S +  + G  +  
Sbjct: 117 ELANALSYCHSK-RVIHRDIKPENLLLGS-AGELKIADFGWSCHAPSSRRTTLSGTLD-- 172
Query: 116 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
                 Y  PE+I G   +   +D+WS G +  E L+G+P F   +  +    I +V   
Sbjct: 173 ------YLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--- 222
Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 235
                         EF FP              +   A DL+SRLL+++P+ R    E L
Sbjct: 223 --------------EFTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVL 256
Query: 236 IHPF 239
            HP+
Sbjct: 257 EHPW 260

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 105/227 (46%), Gaps = 37/227 (16%)
Query: 50  QRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV---------NPHTH------ 94
           Q  PL +V+   YQ+C AL ++H    + H D+KP+N+L          N H        
Sbjct: 118 QPYPLPHVRHMAYQLCHALRFLHEN-QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSV 176
Query: 95  ---QLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL 151
               +++ DFGSA      E + + + +R+YR PE+I     +    D+WS GC+L E  
Sbjct: 177 KNTSIRVADFGSATF--DHEHHTTIVATRHYRPPEVIL-ELGWAQPCDVWSIGCILFEYY 233
Query: 152 LGQPLFPGESGVDQLVEIIKVLG-------TPTREEIK------CMNPNYTEFKFPQIKA 198
            G  LF      + LV + K+LG         TR++          + N ++ ++ +   
Sbjct: 234 RGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENC 293
Query: 199 HPWHK-IFQKRMPP-EAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 243
            P    + Q  +   +  DL+ R+L++ P  R T  EAL+HPFF  L
Sbjct: 294 KPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGL 340

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 105/227 (46%), Gaps = 37/227 (16%)
Query: 50  QRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV---------NPHTH------ 94
           Q  PL +V+   YQ+C AL ++H    + H D+KP+N+L          N H        
Sbjct: 127 QPYPLPHVRHMAYQLCHALRFLHEN-QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSV 185
Query: 95  ---QLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL 151
               +++ DFGSA      E + + + +R+YR PE+I     +    D+WS GC+L E  
Sbjct: 186 KNTSIRVADFGSATF--DHEHHTTIVATRHYRPPEVIL-ELGWAQPCDVWSIGCILFEYY 242
Query: 152 LGQPLFPGESGVDQLVEIIKVLG-------TPTREEIK------CMNPNYTEFKFPQIKA 198
            G  LF      + LV + K+LG         TR++          + N ++ ++ +   
Sbjct: 243 RGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENC 302
Query: 199 HPWHK-IFQKRMPP-EAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 243
            P    + Q  +   +  DL+ R+L++ P  R T  EAL+HPFF  L
Sbjct: 303 KPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGL 349

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 80.5 bits (197), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 70/247 (28%), Positives = 118/247 (47%), Gaps = 41/247 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVK 58
           ++ LDHPN++ +   F     +D   + +V+E     E + R++    +  + +   YV 
Sbjct: 74  LKSLDHPNIIKIFEVF-----EDYHNMYIVMETCEGGELLERIVSAQAR-GKALSEGYVA 127
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLL---VNPHTHQLKLCDFGSAKVLVKGEPNIS 115
               Q+  ALAY H+   V H+D+KP+N+L    +PH+  +K+ DFG A++    E + +
Sbjct: 128 ELMKQMMNALAYFHSQ-HVVHKDLKPENILFQDTSPHS-PIKIIDFGLAELFKSDEHSTN 185
Query: 116 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
              +  Y APE+     + T   DIWSAG V+  LL G   F G S    L E+      
Sbjct: 186 AAGTALYMAPEVF--KRDVTFKCDIWSAGVVMYFLLTGCLPFTGTS----LEEV------ 233
Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 235
             +++     PNY       ++  P        + P+AVDL+ ++L   P  R +A + L
Sbjct: 234 --QQKATYKEPNYA------VECRP--------LTPQAVDLLKQMLTKDPERRPSAAQVL 277
Query: 236 IHPFFDE 242
            H +F +
Sbjct: 278 HHEWFKQ 284

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 105/227 (46%), Gaps = 37/227 (16%)
Query: 50  QRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV---------NPHTH------ 94
           Q  PL +V+   YQ+C AL ++H    + H D+KP+N+L          N H        
Sbjct: 150 QPYPLPHVRHMAYQLCHALRFLHEN-QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSV 208
Query: 95  ---QLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL 151
               +++ DFGSA      E + + + +R+YR PE+I     +    D+WS GC+L E  
Sbjct: 209 KNTSIRVADFGSATF--DHEHHTTIVATRHYRPPEVIL-ELGWAQPCDVWSIGCILFEYY 265
Query: 152 LGQPLFPGESGVDQLVEIIKVLG-------TPTREEIK------CMNPNYTEFKFPQIKA 198
            G  LF      + LV + K+LG         TR++          + N ++ ++ +   
Sbjct: 266 RGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENC 325
Query: 199 HPWHK-IFQKRMPP-EAVDLVSRLLQYSPNLRSTALEALIHPFFDEL 243
            P    + Q  +   +  DL+ R+L++ P  R T  EAL+HPFF  L
Sbjct: 326 KPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGL 372

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 108/237 (45%), Gaps = 43/237 (18%)
Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFY 62
           L HPN++ L   F   T      + L+LEY P  TV+R ++   K  ++    Y+     
Sbjct: 68  LRHPNILRLYGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---- 118
Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 122
           ++  AL+Y H+   V HRDIKP+NLL+     +LK+ +FG + V        +   +  Y
Sbjct: 119 ELANALSYCHSK-RVIHRDIKPENLLLGS-AGELKIANFGWS-VHAPSSRRTTLCGTLDY 175
Query: 123 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 182
             PE+I G   +   +D+WS G +  E L+G+P F   +  +    I +V          
Sbjct: 176 LPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------- 224
Query: 183 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
                  EF FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 225 -------EFTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 78/260 (30%), Positives = 123/260 (47%), Gaps = 57/260 (21%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M  LDHP  V L  CF    + ++LY  L      E    ++K+  K+         + Y
Sbjct: 91  MSRLDHPFFVKLYFCF---QDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFY 142
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYI 117
             +I  AL Y+H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++
Sbjct: 143 TAEIVSALEYLHGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFV 200
Query: 118 CSRYYRAPELIFGATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVL 173
            +  Y +PEL+   TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+ 
Sbjct: 201 GTAQYVSPELL---TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL- 254
Query: 174 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL--LQYSPNLRSTA 231
                           E+ FP+       K F     P+A DLV +L  L  +  L    
Sbjct: 255 ----------------EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEE 286
Query: 232 LEAL----IHPFFDELRDPN 247
           +E       HPFF+ +   N
Sbjct: 287 MEGYGPLKAHPFFESVTWEN 306

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 108/237 (45%), Gaps = 43/237 (18%)
Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFY 62
           L HPN++ L   F   T      + L+LEY P  TV+R ++   +  ++    Y+     
Sbjct: 69  LRHPNILRLYGYFHDATR-----VYLILEYAPLGTVYRELQKLSRFDEQRTATYIT---- 119
Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 122
           ++  AL+Y H+   V HRDIKP+NLL+  +  +LK+ DFG + V        +   +  Y
Sbjct: 120 ELANALSYCHSK-RVIHRDIKPENLLLGSNG-ELKIADFGWS-VHAPSSRRTTLCGTLDY 176
Query: 123 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 182
             PE+I G   +   +D+WS G +  E L+G P F   +  +    I +V          
Sbjct: 177 LPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRV---------- 225
Query: 183 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
                  EF FP              +   A DL+SRLL+++ + R T  E L HP+
Sbjct: 226 -------EFTFPDF------------VTEGARDLISRLLKHNASQRLTLAEVLEHPW 263

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 108/237 (45%), Gaps = 43/237 (18%)
Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFY 62
           L HPN++ L   F   T      + L+LEY P  TV+R ++   K  ++    Y+     
Sbjct: 67  LRHPNILRLYGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT---- 117
Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 122
           ++  AL+Y H+   V HRDIKP+NLL+     +LK+ +FG + V        +   +  Y
Sbjct: 118 ELANALSYCHSK-RVIHRDIKPENLLLGS-AGELKIANFGWS-VHAPSSRRTTLCGTLDY 174
Query: 123 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 182
             PE+I G   +   +D+WS G +  E L+G+P F   +  +    I +V          
Sbjct: 175 LPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------- 223
Query: 183 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
                  EF FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 224 -------EFTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 261

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/162 (35%), Positives = 81/162 (50%), Gaps = 10/162 (6%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           ++ L+HPNV+     F    E     LN+VLE      + R+IKH  K  + +P   V  
Sbjct: 86  LKQLNHPNVIKYYASFIEDNE-----LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWK 140
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNISYIC 118
           YF Q+C AL ++H+   V HRDIKP N+ +   T  +KL D G  +    K     S + 
Sbjct: 141 YFVQLCSALEHMHSR-RVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVG 198
Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 160
           + YY +PE I     Y    DIWS GC+L E+   Q  F G+
Sbjct: 199 TPYYMSPERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/239 (28%), Positives = 107/239 (44%), Gaps = 42/239 (17%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVK 58
           ++ LDHPN++ L   F     +D+ Y  LV E+    E   ++I  H K  +      +K
Sbjct: 100 LKSLDHPNIIKLFDVF-----EDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMK 153
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNISY 116
               QI   + Y+H    + HRDIKP+N+L+        +K+ DFG +    K       
Sbjct: 154 ----QILSGICYLHKH-NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDR 208
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
           + + YY APE++    +Y    D+WS G ++  LL G P F G++  D + ++ K     
Sbjct: 209 LGTAYYIAPEVL--KKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK----- 261
Query: 177 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 235
                      Y +F       + W     K +  EA +L+  +L Y  N R TA EAL
Sbjct: 262 --------GKYYFDF-------NDW-----KNISDEAKELIKLMLTYDYNKRCTAEEAL 300

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 77/260 (29%), Positives = 125/260 (48%), Gaps = 57/260 (21%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M  LDHP  V L   +F+  + ++LY  L      E    ++K+  K+         + Y
Sbjct: 84  MSRLDHPFFVKL---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFY 135
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYI 117
             +I  AL Y+H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K     +++
Sbjct: 136 TAEIVSALEYLHGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANAFV 193
Query: 118 CSRYYRAPELIFGATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVL 173
            +  Y +PEL+   TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+ 
Sbjct: 194 GTAQYVSPELL---TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL- 247
Query: 174 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL--LQYSPNLRSTA 231
                           E+ FP+       K F     P+A DLV +L  L  +  L    
Sbjct: 248 ----------------EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEE 279
Query: 232 LEAL----IHPFFDELRDPN 247
           +E       HPFF+ +   N
Sbjct: 280 MEGYGPLKAHPFFESVTWEN 299

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 53  PLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQL---------------- 96
           P+  V+   +Q+C+A+ ++H+   + H D+KP+N+L     ++L                
Sbjct: 135 PIHQVRHMAFQLCQAVKFLHDN-KLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKST 193
Query: 97  --KLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ 154
             ++ DFGSA      E + + + +R+YRAPE+I     ++   D+WS GC++ E  +G 
Sbjct: 194 AVRVVDFGSATF--DHEHHSTIVSTRHYRAPEVIL-ELGWSQPCDVWSIGCIIFEYYVGF 250
Query: 155 PLFPGESGVDQLVEIIKVLG-TPTREEIKC------------MNPNYTEFKFPQIKAHPW 201
            LF      + L  + ++LG  P+R   K              + N +  ++ +    P 
Sbjct: 251 TLFQTHDNREHLAMMERILGPIPSRMIRKTRKQKYFYRGRLDWDENTSAGRYVRENCKPL 310
Query: 202 HKIFQKRMPP--EAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 244
            +          +  DL+  +L+Y P  R T  EAL HPFF  LR
Sbjct: 311 RRYLTSEAEEHHQLFDLIESMLEYEPAKRLTLGEALQHPFFARLR 355

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 77/260 (29%), Positives = 124/260 (47%), Gaps = 57/260 (21%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M  LDHP  V L   +F+  + ++LY  L      E    ++K+  K+         + Y
Sbjct: 86  MSRLDHPFFVKL---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFY 137
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYI 117
             +I  AL Y+H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++
Sbjct: 138 TAEIVSALEYLHGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFV 195
Query: 118 CSRYYRAPELIFGATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVL 173
            +  Y +PEL+   TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+ 
Sbjct: 196 GTAQYVSPELL---TEKSAXKSSDLWALGCIIYQLVAGLP--PFRAGNEGLIFAKIIKL- 249
Query: 174 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL--LQYSPNLRSTA 231
                           E+ FP+       K F     P+A DLV +L  L  +  L    
Sbjct: 250 ----------------EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEE 281
Query: 232 LEAL----IHPFFDELRDPN 247
           +E       HPFF+ +   N
Sbjct: 282 MEGYGPLKAHPFFESVTWEN 301

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/260 (30%), Positives = 125/260 (48%), Gaps = 57/260 (21%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M  LDHP  V L   +F+  + ++LY  L   Y       ++K+  K+         + Y
Sbjct: 86  MSRLDHPFFVKL---YFTFQDDEKLYFGL--SYAKNGC--LLKYIRKIGS-FDETCTRFY 137
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYI 117
             +I  AL Y+H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K     S++
Sbjct: 138 TAEIVSALEYLHGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFV 195
Query: 118 CSRYYRAPELIFGATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVL 173
            +  Y +PEL+   TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+ 
Sbjct: 196 GTAQYVSPELL---TEKSASKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL- 249
Query: 174 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL--LQYSPNLRSTA 231
                           E+ FP+       K F     P+A DLV +L  L  +  L    
Sbjct: 250 ----------------EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEE 281
Query: 232 LEAL----IHPFFDELRDPN 247
           +E       HPFF+ +   N
Sbjct: 282 MEGYGPLKAHPFFESVTWEN 301

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/260 (29%), Positives = 124/260 (47%), Gaps = 57/260 (21%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M  LDHP  V L   +F+  + ++LY  L      E    ++K+  K+         + Y
Sbjct: 86  MSRLDHPFFVKL---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFY 137
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYI 117
             +I  AL Y+H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++
Sbjct: 138 TAEIVSALEYLHGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFV 195
Query: 118 CSRYYRAPELIFGATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVL 173
            +  Y +PEL+   TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+ 
Sbjct: 196 GTAQYVSPELL---TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEGLIFAKIIKL- 249
Query: 174 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL--LQYSPNLRSTA 231
                           E+ FP+       K F     P+A DLV +L  L  +  L    
Sbjct: 250 ----------------EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEE 281
Query: 232 LEAL----IHPFFDELRDPN 247
           +E       HPFF+ +   N
Sbjct: 282 MEGYGPLKAHPFFESVTWEN 301

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 108/237 (45%), Gaps = 43/237 (18%)
Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFY 62
           L HPN++ L   F   T      + L+LEY P  TV+R ++   +  ++    Y+     
Sbjct: 69  LRHPNILRLYGYFHDATR-----VYLILEYAPLGTVYRELQKLSRFDEQRTATYIT---- 119
Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 122
           ++  AL+Y H+   V HRDIKP+NLL+  +  +LK+ DFG + V        +   +  Y
Sbjct: 120 ELANALSYCHSK-RVIHRDIKPENLLLGSNG-ELKIADFGWS-VHAPSSRRDTLCGTLDY 176
Query: 123 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 182
             PE+I G   +   +D+WS G +  E L+G P F   +  +    I +V          
Sbjct: 177 LPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRV---------- 225
Query: 183 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
                  EF FP              +   A DL+SRLL+++ + R T  E L HP+
Sbjct: 226 -------EFTFPDF------------VTEGARDLISRLLKHNASQRLTLAEVLEHPW 263

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 82/151 (54%), Gaps = 13/151 (8%)
Query: 5   DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQ 63
           + P +V     F+S  E     +++ +E++   ++ +V+K     ++R+P   +      
Sbjct: 72  NSPYIVGFYGAFYSDGE-----ISICMEHMDGGSLDQVLKE----AKRIPEEILGKVSIA 122
Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 123
           + R LAY+     + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y 
Sbjct: 123 VLRGLAYLREKHQIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYM 180
Query: 124 APELIFGATEYTAAIDIWSAGCVLAELLLGQ 154
           APE + G T Y+   DIWS G  L EL +G+
Sbjct: 181 APERLQG-THYSVQSDIWSMGLSLVELAVGR 210

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 107/237 (45%), Gaps = 43/237 (18%)
Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFY 62
           L HPN++ L   F   T      + L+LEY P   V++ ++   K  ++    Y+     
Sbjct: 70  LRHPNILRLYGYFHDATR-----VYLILEYAPRGEVYKELQKLSKFDEQRTATYIT---- 120
Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 122
           ++  AL+Y H+   V HRDIKP+NLL+     +LK+ DFG + V        +   +  Y
Sbjct: 121 ELANALSYCHSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDY 177
Query: 123 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 182
             PE+I G   +   +D+WS G +  E L+G+P F   +  +    I +V          
Sbjct: 178 LPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------- 226
Query: 183 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
                  EF FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 227 -------EFTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 264

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/260 (29%), Positives = 124/260 (47%), Gaps = 57/260 (21%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M  LDHP  V L   +F+  + ++LY  L      E    ++K+  K+         + Y
Sbjct: 84  MSRLDHPFFVKL---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFY 135
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYI 117
             +I  AL Y+H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++
Sbjct: 136 TAEIVSALEYLHGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFV 193
Query: 118 CSRYYRAPELIFGATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVL 173
            +  Y +PEL+   TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+ 
Sbjct: 194 GTAQYVSPELL---TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL- 247
Query: 174 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL--LQYSPNLRSTA 231
                           E+ FP+       K F     P+A DLV +L  L  +  L    
Sbjct: 248 ----------------EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEE 279
Query: 232 LEAL----IHPFFDELRDPN 247
           +E       HPFF+ +   N
Sbjct: 280 MEGYGPLKAHPFFESVTWEN 299

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/260 (29%), Positives = 124/260 (47%), Gaps = 57/260 (21%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M  LDHP  V L   +F+  + ++LY  L      E    ++K+  K+         + Y
Sbjct: 84  MSRLDHPFFVKL---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFY 135
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYI 117
             +I  AL Y+H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++
Sbjct: 136 TAEIVSALEYLHGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFV 193
Query: 118 CSRYYRAPELIFGATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVL 173
            +  Y +PEL+   TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+ 
Sbjct: 194 GTAQYVSPELL---TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL- 247
Query: 174 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL--LQYSPNLRSTA 231
                           E+ FP+       K F     P+A DLV +L  L  +  L    
Sbjct: 248 ----------------EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEE 279
Query: 232 LEAL----IHPFFDELRDPN 247
           +E       HPFF+ +   N
Sbjct: 280 MEGYGPLKAHPFFESVTWEN 299

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 77/260 (29%), Positives = 124/260 (47%), Gaps = 57/260 (21%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M  LDHP  V L   +F+  + ++LY  L      E    ++K+  K+         + Y
Sbjct: 84  MSRLDHPFFVKL---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFY 135
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYI 117
             +I  AL Y+H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++
Sbjct: 136 TAEIVSALEYLHGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFV 193
Query: 118 CSRYYRAPELIFGATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVL 173
            +  Y +PEL+   TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+ 
Sbjct: 194 GTAQYVSPELL---TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL- 247
Query: 174 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL--LQYSPNLRSTA 231
                           E+ FP+       K F     P+A DLV +L  L  +  L    
Sbjct: 248 ----------------EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEE 279
Query: 232 LEAL----IHPFFDELRDPN 247
           +E       HPFF+ +   N
Sbjct: 280 MEGYGPLKAHPFFESVTWEN 299

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 112/282 (39%), Gaps = 57/282 (20%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           MR +D P  V+     F      E  + + +E +  ++ +  K      Q +P   +   
Sbjct: 104 MRTVDCPFTVTFYGALFR-----EGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKI 158
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
              I +AL ++H+ + V HRD+KP N+L+N    Q+K+CDFG +  LV           +
Sbjct: 159 AVSIVKALEHLHSKLSVIHRDVKPSNVLINA-LGQVKMCDFGISGYLVDSVAKTIDAGCK 217
Query: 121 YYRAPELI---FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            Y APE I        Y+   DIWS G  + EL + +  FP +S            GTP 
Sbjct: 218 PYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR--FPYDS-----------WGTPF 264
Query: 178 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 237
           ++               Q+   P  ++   +   E VD  S+ L+ +   R T  E + H
Sbjct: 265 QQ-------------LKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 311
Query: 238 PFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI 279
           PF                      F  HE KG  V   VKLI
Sbjct: 312 PF----------------------FTLHESKGTDVASFVKLI 331

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 77/260 (29%), Positives = 124/260 (47%), Gaps = 57/260 (21%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M  LDHP  V L   +F+  + ++LY  L      E    ++K+  K+         + Y
Sbjct: 86  MSRLDHPFFVKL---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFY 137
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYI 117
             +I  AL Y+H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++
Sbjct: 138 TAEIVSALEYLHGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFV 195
Query: 118 CSRYYRAPELIFGATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVL 173
            +  Y +PEL+   TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+ 
Sbjct: 196 GTAQYVSPELL---TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL- 249
Query: 174 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL--LQYSPNLRSTA 231
                           E+ FP+       K F     P+A DLV +L  L  +  L    
Sbjct: 250 ----------------EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEE 281
Query: 232 LEAL----IHPFFDELRDPN 247
           +E       HPFF+ +   N
Sbjct: 282 MEGYGPLKAHPFFESVTWEN 301

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 72/244 (29%), Positives = 111/244 (45%), Gaps = 40/244 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ + H N+V+L+  + STT     YL + L    E   R+++      +   L+     
Sbjct: 60  LKKIKHENIVTLEDIYESTTH---YYLVMQLVSGGELFDRILERGVYTEKDASLV----- 111
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNISYIC 118
             Q+  A+ Y+H   G+ HRD+KP+NLL + P  + ++ + DFG +K+   G   +S  C
Sbjct: 112 IQQVLSAVKYLHEN-GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG--IMSTAC 168
Query: 119 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
               Y APE +     Y+ A+D WS G +   LL G P F  E+   +L E IK      
Sbjct: 169 GTPGYVAPE-VLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE-SKLFEKIK------ 220
Query: 178 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 237
                     Y EF+ P          F   +   A D +  LL+  PN R T  +AL H
Sbjct: 221 --------EGYYEFESP----------FWDDISESAKDFICHLLEKDPNERYTCEKALSH 262
Query: 238 PFFD 241
           P+ D
Sbjct: 263 PWID 266

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 77/260 (29%), Positives = 124/260 (47%), Gaps = 57/260 (21%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M  LDHP  V L   +F+  + ++LY  L      E    ++K+  K+         + Y
Sbjct: 86  MSRLDHPFFVKL---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFY 137
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYI 117
             +I  AL Y+H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++
Sbjct: 138 TAEIVSALEYLHGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFV 195
Query: 118 CSRYYRAPELIFGATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVL 173
            +  Y +PEL+   TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+ 
Sbjct: 196 GTAQYVSPELL---TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL- 249
Query: 174 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL--LQYSPNLRSTA 231
                           E+ FP+       K F     P+A DLV +L  L  +  L    
Sbjct: 250 ----------------EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEE 281
Query: 232 LEAL----IHPFFDELRDPN 247
           +E       HPFF+ +   N
Sbjct: 282 MEGYGPLKAHPFFESVTWEN 301

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 77/260 (29%), Positives = 124/260 (47%), Gaps = 57/260 (21%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M  LDHP  V L   +F+  + ++LY  L      E    ++K+  K+         + Y
Sbjct: 86  MSRLDHPFFVKL---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFY 137
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYI 117
             +I  AL Y+H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++
Sbjct: 138 TAEIVSALEYLHGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFV 195
Query: 118 CSRYYRAPELIFGATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVL 173
            +  Y +PEL+   TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+ 
Sbjct: 196 GTAQYVSPELL---TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL- 249
Query: 174 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL--LQYSPNLRSTA 231
                           E+ FP+       K F     P+A DLV +L  L  +  L    
Sbjct: 250 ----------------EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEE 281
Query: 232 LEAL----IHPFFDELRDPN 247
           +E       HPFF+ +   N
Sbjct: 282 MEGYGPLKAHPFFESVTWEN 301

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 77/260 (29%), Positives = 124/260 (47%), Gaps = 57/260 (21%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M  LDHP  V L   +F+  + ++LY  L      E    ++K+  K+         + Y
Sbjct: 87  MSRLDHPFFVKL---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFY 138
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYI 117
             +I  AL Y+H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++
Sbjct: 139 TAEIVSALEYLHGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFV 196
Query: 118 CSRYYRAPELIFGATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVL 173
            +  Y +PEL+   TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+ 
Sbjct: 197 GTAQYVSPELL---TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL- 250
Query: 174 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL--LQYSPNLRSTA 231
                           E+ FP+       K F     P+A DLV +L  L  +  L    
Sbjct: 251 ----------------EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEE 282
Query: 232 LEAL----IHPFFDELRDPN 247
           +E       HPFF+ +   N
Sbjct: 283 MEGYGPLKAHPFFESVTWEN 302

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 110/241 (45%), Gaps = 38/241 (15%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ LDHPN++ L   F    +K   YL + +    E    +I     + Q+   +   + 
Sbjct: 75  LKQLDHPNIMKLYEFF---EDKRNYYLVMEVYRGGELFDEII-----LRQKFSEVDAAVI 126
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYIC 118
             Q+     Y+H    + HRD+KP+NLL+   +    +K+ DFG +     G      + 
Sbjct: 127 MKQVLSGTTYLHKH-NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLG 185
Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 178
           + YY APE++    +Y    D+WS G +L  LL G P F G++  DQ  EI+K +    +
Sbjct: 186 TAYYIAPEVL--RKKYDEKCDVWSCGVILYILLCGYPPFGGQT--DQ--EILKRV---EK 236
Query: 179 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 238
            +     P++T+                  +  EA  LV  +L Y P+ R +A EAL HP
Sbjct: 237 GKFSFDPPDWTQ------------------VSDEAKQLVKLMLTYEPSKRISAEEALNHP 278
Query: 239 F 239
           +
Sbjct: 279 W 279

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 77/260 (29%), Positives = 124/260 (47%), Gaps = 57/260 (21%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M  LDHP  V L   +F+  + ++LY  L      E    ++K+  K+         + Y
Sbjct: 83  MSRLDHPFFVKL---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFY 134
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYI 117
             +I  AL Y+H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++
Sbjct: 135 TAEIVSALEYLHGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFV 192
Query: 118 CSRYYRAPELIFGATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVL 173
            +  Y +PEL+   TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+ 
Sbjct: 193 GTAQYVSPELL---TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL- 246
Query: 174 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL--LQYSPNLRSTA 231
                           E+ FP+       K F     P+A DLV +L  L  +  L    
Sbjct: 247 ----------------EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEE 278
Query: 232 LEAL----IHPFFDELRDPN 247
           +E       HPFF+ +   N
Sbjct: 279 MEGYGPLKAHPFFESVTWEN 298

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 77/260 (29%), Positives = 124/260 (47%), Gaps = 57/260 (21%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M  LDHP  V L   +F+  + ++LY  L      E    ++K+  K+         + Y
Sbjct: 61  MSRLDHPFFVKL---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFY 112
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYI 117
             +I  AL Y+H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++
Sbjct: 113 TAEIVSALEYLHGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFV 170
Query: 118 CSRYYRAPELIFGATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVL 173
            +  Y +PEL+   TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+ 
Sbjct: 171 GTAQYVSPELL---TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL- 224
Query: 174 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL--LQYSPNLRSTA 231
                           E+ FP+       K F     P+A DLV +L  L  +  L    
Sbjct: 225 ----------------EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEE 256
Query: 232 LEAL----IHPFFDELRDPN 247
           +E       HPFF+ +   N
Sbjct: 257 MEGYGPLKAHPFFESVTWEN 276

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 77/260 (29%), Positives = 124/260 (47%), Gaps = 57/260 (21%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M  LDHP  V L   +F+  + ++LY  L      E    ++K+  K+         + Y
Sbjct: 62  MSRLDHPFFVKL---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFY 113
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYI 117
             +I  AL Y+H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++
Sbjct: 114 TAEIVSALEYLHGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFV 171
Query: 118 CSRYYRAPELIFGATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVL 173
            +  Y +PEL+   TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+ 
Sbjct: 172 GTAQYVSPELL---TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL- 225
Query: 174 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL--LQYSPNLRSTA 231
                           E+ FP+       K F     P+A DLV +L  L  +  L    
Sbjct: 226 ----------------EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEE 257
Query: 232 LEAL----IHPFFDELRDPN 247
           +E       HPFF+ +   N
Sbjct: 258 MEGYGPLKAHPFFESVTWEN 277

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 77/260 (29%), Positives = 124/260 (47%), Gaps = 57/260 (21%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M  LDHP  V L   +F+  + ++LY  L      E    ++K+  K+         + Y
Sbjct: 68  MSRLDHPFFVKL---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFY 119
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYI 117
             +I  AL Y+H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++
Sbjct: 120 TAEIVSALEYLHGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFV 177
Query: 118 CSRYYRAPELIFGATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVL 173
            +  Y +PEL+   TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+ 
Sbjct: 178 GTAQYVSPELL---TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL- 231
Query: 174 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL--LQYSPNLRSTA 231
                           E+ FP+       K F     P+A DLV +L  L  +  L    
Sbjct: 232 ----------------EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEE 263
Query: 232 LEAL----IHPFFDELRDPN 247
           +E       HPFF+ +   N
Sbjct: 264 MEGYGPLKAHPFFESVTWEN 283

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 77/260 (29%), Positives = 124/260 (47%), Gaps = 57/260 (21%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M  LDHP  V L   +F+  + ++LY  L      E    ++K+  K+         + Y
Sbjct: 63  MSRLDHPFFVKL---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFY 114
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYI 117
             +I  AL Y+H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++
Sbjct: 115 TAEIVSALEYLHGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFV 172
Query: 118 CSRYYRAPELIFGATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVL 173
            +  Y +PEL+   TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+ 
Sbjct: 173 GTAQYVSPELL---TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL- 226
Query: 174 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL--LQYSPNLRSTA 231
                           E+ FP+       K F     P+A DLV +L  L  +  L    
Sbjct: 227 ----------------EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEE 258
Query: 232 LEAL----IHPFFDELRDPN 247
           +E       HPFF+ +   N
Sbjct: 259 MEGYGPLKAHPFFESVTWEN 278

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 77/260 (29%), Positives = 124/260 (47%), Gaps = 57/260 (21%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M  LDHP  V L   +F+  + ++LY  L      E    ++K+  K+         + Y
Sbjct: 64  MSRLDHPFFVKL---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFY 115
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYI 117
             +I  AL Y+H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++
Sbjct: 116 TAEIVSALEYLHGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFV 173
Query: 118 CSRYYRAPELIFGATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVL 173
            +  Y +PEL+   TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+ 
Sbjct: 174 GTAQYVSPELL---TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL- 227
Query: 174 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL--LQYSPNLRSTA 231
                           E+ FP+       K F     P+A DLV +L  L  +  L    
Sbjct: 228 ----------------EYDFPE-------KFF-----PKARDLVEKLLVLDATKRLGCEE 259
Query: 232 LEAL----IHPFFDELRDPN 247
           +E       HPFF+ +   N
Sbjct: 260 MEGYGPLKAHPFFESVTWEN 279

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 110/241 (45%), Gaps = 38/241 (15%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ LDHPN++ L   F    +K   YL + +    E    +I     + Q+   +   + 
Sbjct: 58  LKQLDHPNIMKLYEFF---EDKRNYYLVMEVYRGGELFDEII-----LRQKFSEVDAAVI 109
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYIC 118
             Q+     Y+H    + HRD+KP+NLL+   +    +K+ DFG +     G      + 
Sbjct: 110 MKQVLSGTTYLHKH-NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLG 168
Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 178
           + YY APE++    +Y    D+WS G +L  LL G P F G++  DQ  EI+K +    +
Sbjct: 169 TAYYIAPEVL--RKKYDEKCDVWSCGVILYILLCGYPPFGGQT--DQ--EILKRV---EK 219
Query: 179 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 238
            +     P++T+                  +  EA  LV  +L Y P+ R +A EAL HP
Sbjct: 220 GKFSFDPPDWTQ------------------VSDEAKQLVKLMLTYEPSKRISAEEALNHP 261
Query: 239 F 239
           +
Sbjct: 262 W 262

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 106/237 (44%), Gaps = 43/237 (18%)
Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFY 62
           L HPN++ L   F   T      + L+LEY P   V++ ++   K  ++    Y+     
Sbjct: 70  LRHPNILRLYGYFHDATR-----VYLILEYAPRGEVYKELQKLSKFDEQRTATYIT---- 120
Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 122
           ++  AL+Y H+   V HRDIKP+NLL+     +LK+ DFG + V            +  Y
Sbjct: 121 ELANALSYCHSK-RVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRXXLXGTLDY 177
Query: 123 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 182
             PE+I G   +   +D+WS G +  E L+G+P F   +  +    I +V          
Sbjct: 178 LPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------- 226
Query: 183 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
                  EF FP              +   A DL+SRLL+++P+ R    E L HP+
Sbjct: 227 -------EFTFPDF------------VTEGARDLISRLLKHNPSQRPMLREVLEHPW 264

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 78.2 bits (191), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 81/186 (43%), Gaps = 29/186 (15%)
Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NIS 115
           +  Y  QI   L Y+H+   + HRDIK  N+L+N ++  LK+ DFG++K L    P   +
Sbjct: 124 IGFYTKQILEGLKYLHDNQ-IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET 182
Query: 116 YICSRYYRAPELIF-GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 174
           +  +  Y APE+I  G   Y  A DIWS GC + E+  G+P F                 
Sbjct: 183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF----------------- 225
Query: 175 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 234
                  +   P    FK    K HP      + M  EA   + +  +  P+ R+ A + 
Sbjct: 226 ------YELGEPQAAMFKVGMFKVHPE---IPESMSAEAKAFILKCFEPDPDKRACANDL 276
Query: 235 LIHPFF 240
           L+  F 
Sbjct: 277 LVDEFL 282

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 115/283 (40%), Gaps = 59/283 (20%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           MR +D P  V+     F   +     + + +E +  ++ +  K      Q +P   +   
Sbjct: 60  MRTVDCPFTVTFYGALFREGD-----VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKI 114
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNISYICS 119
              I +AL ++H+ + V HRD+KP N+L+N    Q+K+CDFG +  LV     +I   C 
Sbjct: 115 AVSIVKALEHLHSKLSVIHRDVKPSNVLINA-LGQVKMCDFGISGYLVDDVAKDIDAGC- 172
Query: 120 RYYRAPELI---FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
           + Y APE I        Y+   DIWS G  + EL + +  FP +S            GTP
Sbjct: 173 KPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR--FPYDS-----------WGTP 219
Query: 177 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 236
            ++               Q+   P  ++   +   E VD  S+ L+ +   R T  E + 
Sbjct: 220 FQQ-------------LKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266
Query: 237 HPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI 279
           HPF                      F  HE KG  V   VKLI
Sbjct: 267 HPF----------------------FTLHESKGTDVASFVKLI 287

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 53/161 (32%), Positives = 84/161 (52%), Gaps = 11/161 (6%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           +RLL HP+++ L     S   KDE+ +  V+EY    +   I    KMS++      + +
Sbjct: 58  LRLLRHPHIIKLYDVIKS---KDEIIM--VIEYAGNELFDYIVQRDKMSEQE----ARRF 108
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
           F QI  A+ Y H    + HRD+KP+NLL++ H + +K+ DFG + ++  G    +   S 
Sbjct: 109 FQQIISAVEYCHRH-KIVHRDLKPENLLLDEHLN-VKIADFGLSNIMTDGNFLKTSCGSP 166
Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 161
            Y APE+I G       +D+WS G +L  +L  +  F  ES
Sbjct: 167 NYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES 207

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 81/186 (43%), Gaps = 29/186 (15%)
Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NIS 115
           +  Y  QI   L Y+H+   + HRDIK  N+L+N ++  LK+ DFG++K L    P   +
Sbjct: 110 IGFYTKQILEGLKYLHDNQ-IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET 168
Query: 116 YICSRYYRAPELIF-GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 174
           +  +  Y APE+I  G   Y  A DIWS GC + E+  G+P F                 
Sbjct: 169 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF----------------- 211
Query: 175 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 234
                  +   P    FK    K HP      + M  EA   + +  +  P+ R+ A + 
Sbjct: 212 ------YELGEPQAAMFKVGMFKVHPE---IPESMSAEAKAFILKCFEPDPDKRACANDL 262
Query: 235 LIHPFF 240
           L+  F 
Sbjct: 263 LVDEFL 268

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 53/161 (32%), Positives = 84/161 (52%), Gaps = 11/161 (6%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           +RLL HP+++ L     S   KDE+ +  V+EY    +   I    KMS++      + +
Sbjct: 68  LRLLRHPHIIKLYDVIKS---KDEIIM--VIEYAGNELFDYIVQRDKMSEQ----EARRF 118
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
           F QI  A+ Y H    + HRD+KP+NLL++ H + +K+ DFG + ++  G    +   S 
Sbjct: 119 FQQIISAVEYCHRH-KIVHRDLKPENLLLDEHLN-VKIADFGLSNIMTDGNFLKTSCGSP 176
Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 161
            Y APE+I G       +D+WS G +L  +L  +  F  ES
Sbjct: 177 NYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES 217

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 53/161 (32%), Positives = 84/161 (52%), Gaps = 11/161 (6%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           +RLL HP+++ L     S   KDE+ +  V+EY    +   I    KMS++      + +
Sbjct: 62  LRLLRHPHIIKLYDVIKS---KDEIIM--VIEYAGNELFDYIVQRDKMSEQE----ARRF 112
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
           F QI  A+ Y H    + HRD+KP+NLL++ H + +K+ DFG + ++  G    +   S 
Sbjct: 113 FQQIISAVEYCHRH-KIVHRDLKPENLLLDEHLN-VKIADFGLSNIMTDGNFLKTSCGSP 170
Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 161
            Y APE+I G       +D+WS G +L  +L  +  F  ES
Sbjct: 171 NYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES 211

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 53/161 (32%), Positives = 84/161 (52%), Gaps = 11/161 (6%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           +RLL HP+++ L     S   KDE+ +  V+EY    +   I    KMS++      + +
Sbjct: 67  LRLLRHPHIIKLYDVIKS---KDEIIM--VIEYAGNELFDYIVQRDKMSEQE----ARRF 117
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
           F QI  A+ Y H    + HRD+KP+NLL++ H + +K+ DFG + ++  G    +   S 
Sbjct: 118 FQQIISAVEYCHRH-KIVHRDLKPENLLLDEHLN-VKIADFGLSNIMTDGNFLKTSCGSP 175
Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 161
            Y APE+I G       +D+WS G +L  +L  +  F  ES
Sbjct: 176 NYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES 216

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/260 (28%), Positives = 121/260 (46%), Gaps = 57/260 (21%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M  LDHP  V L   +F+  + ++LY  L      E    ++K+  K+         + Y
Sbjct: 89  MSRLDHPFFVKL---YFTFQDDEKLYFGLSYAKNGE----LLKYIRKIGS-FDETCTRFY 140
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYI 117
             +I  AL Y+H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++
Sbjct: 141 TAEIVSALEYLHGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFV 198
Query: 118 CSRYYRAPELIFGATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLV--EIIKVL 173
            +  Y +PEL+   TE +A  + D+W+ GC++ +L+ G P  P  +G + L+  +IIK+ 
Sbjct: 199 GTAQYVSPELL---TEKSACKSSDLWALGCIIYQLVAGLP--PFRAGNEYLIFQKIIKL- 252
Query: 174 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL--LQYSPNLRSTA 231
                           E+ FP                P+A DLV +L  L  +  L    
Sbjct: 253 ----------------EYDFPAA------------FFPKARDLVEKLLVLDATKRLGCEE 284
Query: 232 LEAL----IHPFFDELRDPN 247
           +E       HPFF+ +   N
Sbjct: 285 MEGYGPLKAHPFFESVTWEN 304

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 113/260 (43%), Gaps = 43/260 (16%)
Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 63
           LD+P+VV   H FF    +D+ ++ +VLE       R +   +K  + +     + +  Q
Sbjct: 99  LDNPHVVGF-HGFF----EDDDFVYVVLEIC---RRRSLLELHKRRKAVTEPEARYFMRQ 150
Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYY 122
             + + Y+HN   V HRD+K  NL +N     +K+ DFG + K+   GE   +   +  Y
Sbjct: 151 TIQGVQYLHNN-RVIHRDLKLGNLFLNDDM-DVKIGDFGLATKIEFDGERKKTLCGTPNY 208
Query: 123 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 182
            APE +     ++  +DIWS GC+L  LL+G+P F                      E  
Sbjct: 209 IAPE-VLCKKGHSFEVDIWSLGCILYTLLVGKPPF----------------------ETS 245
Query: 183 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 242
           C+   Y   K  +    P H      + P A  L+ R+L   P LR +  E L   FF  
Sbjct: 246 CLKETYIRIKKNEYSV-PRH------INPVASALIRRMLHADPTLRPSVAELLTDEFFTS 298
Query: 243 LRDPNTRLPNGRF-LPPLFN 261
              P  RLP     +PP F+
Sbjct: 299 GYAP-MRLPTSCLTVPPRFS 317

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 112/260 (43%), Gaps = 43/260 (16%)
Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 63
           LD+P+VV   H FF    +D+ ++ +VLE       R +   +K  + +     + +  Q
Sbjct: 83  LDNPHVVGF-HGFF----EDDDFVYVVLEIC---RRRSLLELHKRRKAVTEPEARYFMRQ 134
Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYY 122
             + + Y+HN   V HRD+K  NL +N     +K+ DFG + K+   GE       +  Y
Sbjct: 135 TIQGVQYLHNN-RVIHRDLKLGNLFLNDDM-DVKIGDFGLATKIEFDGERKKDLCGTPNY 192
Query: 123 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 182
            APE +     ++  +DIWS GC+L  LL+G+P F                      E  
Sbjct: 193 IAPE-VLCKKGHSFEVDIWSLGCILYTLLVGKPPF----------------------ETS 229
Query: 183 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 242
           C+   Y   K  +    P H      + P A  L+ R+L   P LR +  E L   FF  
Sbjct: 230 CLKETYIRIKKNEYSV-PRH------INPVASALIRRMLHADPTLRPSVAELLTDEFFTS 282
Query: 243 LRDPNTRLPNGRF-LPPLFN 261
              P  RLP     +PP F+
Sbjct: 283 GYAP-MRLPTSCLTVPPRFS 301

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 112/260 (43%), Gaps = 43/260 (16%)
Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 63
           LD+P+VV   H FF    +D+ ++ +VLE       R +   +K  + +     + +  Q
Sbjct: 99  LDNPHVVGF-HGFF----EDDDFVYVVLEIC---RRRSLLELHKRRKAVTEPEARYFMRQ 150
Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYY 122
             + + Y+HN   V HRD+K  NL +N     +K+ DFG + K+   GE       +  Y
Sbjct: 151 TIQGVQYLHNN-RVIHRDLKLGNLFLNDDM-DVKIGDFGLATKIEFDGERKKDLCGTPNY 208
Query: 123 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 182
            APE +     ++  +DIWS GC+L  LL+G+P F                      E  
Sbjct: 209 IAPE-VLCKKGHSFEVDIWSLGCILYTLLVGKPPF----------------------ETS 245
Query: 183 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 242
           C+   Y   K  +    P H      + P A  L+ R+L   P LR +  E L   FF  
Sbjct: 246 CLKETYIRIKKNEYSV-PRH------INPVASALIRRMLHADPTLRPSVAELLTDEFFTS 298
Query: 243 LRDPNTRLPNGRF-LPPLFN 261
              P  RLP     +PP F+
Sbjct: 299 GYAP-MRLPTSCLTVPPRFS 317

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/259 (25%), Positives = 112/259 (43%), Gaps = 40/259 (15%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVK 58
           M  L HP +++L   F     +D+  + L+LE++   E   R+    YKMS+   + Y++
Sbjct: 102 MNQLHHPKLINLHDAF-----EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMR 156
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLV-NPHTHQLKLCDFGSAKVLVKGEPNISYI 117
               Q C  L ++H    + H DIKP+N++        +K+ DFG A  L   E      
Sbjct: 157 ----QACEGLKHMHEH-SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT 211
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +  + APE++          D+W+ G +   LL G   F GE  ++ L           
Sbjct: 212 ATAEFAAPEIV-DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL----------- 259
Query: 178 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 237
            + +K  +  + E  F  +              PEA D +  LLQ  P  R T  +AL H
Sbjct: 260 -QNVKRCDWEFDEDAFSSVS-------------PEAKDFIKNLLQKEPRKRLTVHDALEH 305
Query: 238 PFF-DELRDPNTRLPNGRF 255
           P+   +  +  +R+P+ R+
Sbjct: 306 PWLKGDHSNLTSRIPSSRY 324

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 112/260 (43%), Gaps = 43/260 (16%)
Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 63
           LD+P+VV   H FF    +D+ ++ +VLE       R +   +K  + +     + +  Q
Sbjct: 99  LDNPHVVGF-HGFF----EDDDFVYVVLEIC---RRRSLLELHKRRKAVTEPEARYFMRQ 150
Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYY 122
             + + Y+HN   V HRD+K  NL +N     +K+ DFG + K+   GE       +  Y
Sbjct: 151 TIQGVQYLHNN-RVIHRDLKLGNLFLNDDM-DVKIGDFGLATKIEFDGERKKXLCGTPNY 208
Query: 123 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 182
            APE +     ++  +DIWS GC+L  LL+G+P F                      E  
Sbjct: 209 IAPE-VLCKKGHSFEVDIWSLGCILYTLLVGKPPF----------------------ETS 245
Query: 183 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 242
           C+   Y   K  +    P H      + P A  L+ R+L   P LR +  E L   FF  
Sbjct: 246 CLKETYIRIKKNEYSV-PRH------INPVASALIRRMLHADPTLRPSVAELLTDEFFTS 298
Query: 243 LRDPNTRLPNGRF-LPPLFN 261
              P  RLP     +PP F+
Sbjct: 299 GYAP-MRLPTSCLTVPPRFS 317

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/245 (27%), Positives = 109/245 (44%), Gaps = 39/245 (15%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVK 58
           M  LDH N++ L   F S  +     + LV+EYV   E   R+I   Y +++   ++++K
Sbjct: 140 MNQLDHANLIQLYDAFESKND-----IVLVMEYVDGGELFDRIIDESYNLTELDTILFMK 194
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLL-VNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
               QIC  + ++H    + H D+KP+N+L VN    Q+K+ DFG A+     E      
Sbjct: 195 ----QICEGIRHMHQMY-ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF 249
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +  + APE++      +   D+WS G +   LL G   F G++  + L  I+       
Sbjct: 250 GTPEFLAPEVV-NYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLE 308
Query: 178 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 237
            EE                        FQ  +  EA + +S+LL    + R +A EAL H
Sbjct: 309 DEE------------------------FQD-ISEEAKEFISKLLIKEKSWRISASEALKH 343
Query: 238 PFFDE 242
           P+  +
Sbjct: 344 PWLSD 348

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 105/241 (43%), Gaps = 37/241 (15%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           +R + H N+V+L+  + S    + LYL + L    E   R+++  +   +    +     
Sbjct: 74  LRKIKHENIVALEDIYESP---NHLYLVMQLVSGGELFDRIVEKGFYTEKDASTL----- 125
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKL--CDFGSAKVLVKGEPNISYIC 118
             Q+  A+ Y+H  +G+ HRD+KP+NLL      + K+   DFG +K+  KG+   +   
Sbjct: 126 IRQVLDAVYYLHR-MGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACG 184
Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 178
           +  Y APE +     Y+ A+D WS G +   LL G P F  E+      +I+K       
Sbjct: 185 TPGYVAPE-VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKA------ 237
Query: 179 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 238
                      EF  P      W  I        A D +  L++  PN R T  +A  HP
Sbjct: 238 ---------EYEFDSPY-----WDDI-----SDSAKDFIRNLMEKDPNKRYTCEQAARHP 278
Query: 239 F 239
           +
Sbjct: 279 W 279

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 73/243 (30%), Positives = 108/243 (44%), Gaps = 40/243 (16%)
Query: 2   RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 61
           RLL HPN+V L     S +E+   YL   L    E    ++   Y               
Sbjct: 76  RLLKHPNIVRLHD---SISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHC-----I 127
Query: 62  YQICRALAYIHNTIGVCHRDIKPQNLLVNP--HTHQLKLCDFGSAKVLVKGEPN--ISYI 117
            QI  A+ + H  +GV HRD+KP+NLL+        +KL DFG A + V+GE      + 
Sbjct: 128 QQILEAVLHCHQ-MGVVHRDLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQQAWFGFA 185
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +  Y +PE +     Y   +D+W+ G +L  LL+G P F  E    +L + IK      
Sbjct: 186 GTPGYLSPE-VLRKDPYGKPVDLWACGVILYILLVGYPPFWDED-QHRLYQQIKA----- 238
Query: 178 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 237
                        + FP   +  W  +      PEA DL++++L  +P+ R TA EAL H
Sbjct: 239 -----------GAYDFP---SPEWDTV-----TPEAKDLINKMLTINPSKRITAAEALKH 279
Query: 238 PFF 240
           P+ 
Sbjct: 280 PWI 282

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 86/167 (51%), Gaps = 13/167 (7%)
Query: 5   DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQ 63
           + P +V     F+S  E     +++ +E++   ++ +V+K     + R+P   +      
Sbjct: 81  NSPYIVGFYGAFYSDGE-----ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIA 131
Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 123
           + + L Y+     + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y 
Sbjct: 132 VIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYM 189
Query: 124 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 170
           +PE + G T Y+   DIWS G  L E+ +G+      SG   + E++
Sbjct: 190 SPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELL 235

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 114/268 (42%), Gaps = 43/268 (16%)
Query: 2   RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 61
           R L H +VV   H FF    +D  ++ +VLE       R +   +K  + +     + Y 
Sbjct: 72  RSLAHQHVVGF-HGFF----EDNDFVFVVLELC---RRRSLLELHKRRKALTEPEARYYL 123
Query: 62  YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISYICSR 120
            QI     Y+H    V HRD+K  NL +N    ++K+ DFG A KV   GE   +   + 
Sbjct: 124 RQIVLGCQYLHRN-RVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGERKKTLCGTP 181
Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 180
            Y APE +     ++  +D+WS GC++  LL+G+P F                      E
Sbjct: 182 NYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKPPF----------------------E 218
Query: 181 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
             C+   Y      +IK + +     K + P A  L+ ++LQ  P  R T  E L   FF
Sbjct: 219 TSCLKETYL-----RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFF 271
Query: 241 DELRDPNTRLP-NGRFLPPLFNFKPHEL 267
                P  RLP     +PP F+  P  L
Sbjct: 272 TSGYIP-ARLPITCLTIPPXFSIAPSSL 298

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 80/151 (52%), Gaps = 13/151 (8%)
Query: 5   DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQ 63
           + P +V     F+S  E     +++ +E++   ++ +V+K     + R+P   +      
Sbjct: 89  NSPYIVGFYGAFYSDGE-----ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIA 139
Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 123
           + + L Y+     + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y 
Sbjct: 140 VIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYM 197
Query: 124 APELIFGATEYTAAIDIWSAGCVLAELLLGQ 154
           +PE + G T Y+   DIWS G  L E+ +G+
Sbjct: 198 SPERLQG-THYSVQSDIWSMGLSLVEMAVGR 227

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 80/151 (52%), Gaps = 13/151 (8%)
Query: 5   DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQ 63
           + P +V     F+S  E     +++ +E++   ++ +V+K     + R+P   +      
Sbjct: 124 NSPYIVGFYGAFYSDGE-----ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIA 174
Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 123
           + + L Y+     + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y 
Sbjct: 175 VIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYM 232
Query: 124 APELIFGATEYTAAIDIWSAGCVLAELLLGQ 154
           +PE + G T Y+   DIWS G  L E+ +G+
Sbjct: 233 SPERLQG-THYSVQSDIWSMGLSLVEMAVGR 262

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 113/252 (44%), Gaps = 39/252 (15%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           MR   H NVV + + +      DEL++  V+E++       I  H +M++      +   
Sbjct: 71  MRDYQHENVVEMYNSYLVG---DELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAV 121
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
              + +AL+ +H   GV HRDIK  ++L+  H  ++KL DFG    + K  P    +   
Sbjct: 122 CLAVLQALSVLHAQ-GVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGT 179
Query: 121 -YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
            Y+ APELI     Y   +DIWS G ++ E++ G+P +  E               P  +
Sbjct: 180 PYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLK 223
Query: 180 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
            +K +  N      P++K    HK+      P     + RLL   P  R+TA E L HPF
Sbjct: 224 AMKMIRDNLP----PRLKN--LHKV-----SPSLKGFLDRLLVRDPAQRATAAELLKHPF 272
Query: 240 FDELRDPNTRLP 251
             +   P + +P
Sbjct: 273 LAKAGPPASIVP 284

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 113/252 (44%), Gaps = 39/252 (15%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           MR   H NVV + + +      DEL++  V+E++       I  H +M++      +   
Sbjct: 125 MRDYQHENVVEMYNSYLVG---DELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAV 175
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
              + +AL+ +H   GV HRDIK  ++L+  H  ++KL DFG    + K  P    +   
Sbjct: 176 CLAVLQALSVLHAQ-GVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGT 233
Query: 121 -YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
            Y+ APELI     Y   +DIWS G ++ E++ G+P +  E               P  +
Sbjct: 234 PYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLK 277
Query: 180 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
            +K +  N      P++K    HK+      P     + RLL   P  R+TA E L HPF
Sbjct: 278 AMKMIRDNLP----PRLKN--LHKV-----SPSLKGFLDRLLVRDPAQRATAAELLKHPF 326
Query: 240 FDELRDPNTRLP 251
             +   P + +P
Sbjct: 327 LAKAGPPASIVP 338

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 113/252 (44%), Gaps = 39/252 (15%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           MR   H NVV + + +      DEL++  V+E++       I  H +M++      +   
Sbjct: 82  MRDYQHENVVEMYNSYLVG---DELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAV 132
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
              + +AL+ +H   GV HRDIK  ++L+  H  ++KL DFG    + K  P    +   
Sbjct: 133 CLAVLQALSVLHAQ-GVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGT 190
Query: 121 -YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
            Y+ APELI     Y   +DIWS G ++ E++ G+P +  E               P  +
Sbjct: 191 PYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLK 234
Query: 180 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
            +K +  N      P++K    HK+      P     + RLL   P  R+TA E L HPF
Sbjct: 235 AMKMIRDNLP----PRLKN--LHKV-----SPSLKGFLDRLLVRDPAQRATAAELLKHPF 283
Query: 240 FDELRDPNTRLP 251
             +   P + +P
Sbjct: 284 LAKAGPPASIVP 295

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 114/268 (42%), Gaps = 43/268 (16%)
Query: 2   RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 61
           R L H +VV   H FF    +D  ++ +VLE       R +   +K  + +     + Y 
Sbjct: 72  RSLAHQHVVGF-HGFF----EDNDFVFVVLELC---RRRSLLELHKRRKALTEPEARYYL 123
Query: 62  YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSR 120
            QI     Y+H    V HRD+K  NL +N    ++K+ DFG + KV   GE   +   + 
Sbjct: 124 RQIVLGCQYLHRN-RVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGERKKTLCGTP 181
Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 180
            Y APE +     ++  +D+WS GC++  LL+G+P F                      E
Sbjct: 182 NYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKPPF----------------------E 218
Query: 181 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
             C+   Y      +IK + +     K + P A  L+ ++LQ  P  R T  E L   FF
Sbjct: 219 TSCLKETYL-----RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFF 271
Query: 241 DELRDPNTRLP-NGRFLPPLFNFKPHEL 267
                P  RLP     +PP F+  P  L
Sbjct: 272 TSGYIP-ARLPITCLTIPPRFSIAPSSL 298

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 113/252 (44%), Gaps = 39/252 (15%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           MR   H NVV + + +      DEL++  V+E++       I  H +M++      +   
Sbjct: 75  MRDYQHENVVEMYNSYLVG---DELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAV 125
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
              + +AL+ +H   GV HRDIK  ++L+  H  ++KL DFG    + K  P    +   
Sbjct: 126 CLAVLQALSVLHAQ-GVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGT 183
Query: 121 -YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
            Y+ APELI     Y   +DIWS G ++ E++ G+P +  E               P  +
Sbjct: 184 PYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLK 227
Query: 180 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
            +K +  N      P++K    HK+      P     + RLL   P  R+TA E L HPF
Sbjct: 228 AMKMIRDNLP----PRLKN--LHKV-----SPSLKGFLDRLLVRDPAQRATAAELLKHPF 276
Query: 240 FDELRDPNTRLP 251
             +   P + +P
Sbjct: 277 LAKAGPPASIVP 288

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 113/252 (44%), Gaps = 39/252 (15%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           MR   H NVV + + +      DEL++  V+E++       I  H +M++      +   
Sbjct: 80  MRDYQHENVVEMYNSYLVG---DELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAV 130
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
              + +AL+ +H   GV HRDIK  ++L+  H  ++KL DFG    + K  P    +   
Sbjct: 131 CLAVLQALSVLHAQ-GVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGT 188
Query: 121 -YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
            Y+ APELI     Y   +DIWS G ++ E++ G+P +  E               P  +
Sbjct: 189 PYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLK 232
Query: 180 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
            +K +  N      P++K    HK+      P     + RLL   P  R+TA E L HPF
Sbjct: 233 AMKMIRDNLP----PRLKN--LHKV-----SPSLKGFLDRLLVRDPAQRATAAELLKHPF 281
Query: 240 FDELRDPNTRLP 251
             +   P + +P
Sbjct: 282 LAKAGPPASIVP 293

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 114/268 (42%), Gaps = 43/268 (16%)
Query: 2   RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 61
           R L H +VV   H FF    +D  ++ +VLE       R +   +K  + +     + Y 
Sbjct: 76  RSLAHQHVVGF-HGFF----EDNDFVFVVLELC---RRRSLLELHKRRKALTEPEARYYL 127
Query: 62  YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSR 120
            QI     Y+H    V HRD+K  NL +N    ++K+ DFG + KV   GE   +   + 
Sbjct: 128 RQIVLGCQYLHRN-RVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGERKKTLCGTP 185
Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 180
            Y APE +     ++  +D+WS GC++  LL+G+P F                      E
Sbjct: 186 NYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKPPF----------------------E 222
Query: 181 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
             C+   Y      +IK + +     K + P A  L+ ++LQ  P  R T  E L   FF
Sbjct: 223 TSCLKETYL-----RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFF 275
Query: 241 DELRDPNTRLP-NGRFLPPLFNFKPHEL 267
                P  RLP     +PP F+  P  L
Sbjct: 276 TSGYIP-ARLPITCLTIPPRFSIAPSSL 302

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 80/151 (52%), Gaps = 13/151 (8%)
Query: 5   DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQ 63
           + P +V     F+S  E     +++ +E++   ++ +V+K     + R+P   +      
Sbjct: 62  NSPYIVGFYGAFYSDGE-----ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIA 112
Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 123
           + + L Y+     + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y 
Sbjct: 113 VIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYM 170
Query: 124 APELIFGATEYTAAIDIWSAGCVLAELLLGQ 154
           +PE + G T Y+   DIWS G  L E+ +G+
Sbjct: 171 SPERLQG-THYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 80/151 (52%), Gaps = 13/151 (8%)
Query: 5   DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQ 63
           + P +V     F+S  E     +++ +E++   ++ +V+K     + R+P   +      
Sbjct: 62  NSPYIVGFYGAFYSDGE-----ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIA 112
Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 123
           + + L Y+     + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y 
Sbjct: 113 VIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYM 170
Query: 124 APELIFGATEYTAAIDIWSAGCVLAELLLGQ 154
           +PE + G T Y+   DIWS G  L E+ +G+
Sbjct: 171 SPERLQG-THYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 80/151 (52%), Gaps = 13/151 (8%)
Query: 5   DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQ 63
           + P +V     F+S  E     +++ +E++   ++ +V+K     + R+P   +      
Sbjct: 62  NSPYIVGFYGAFYSDGE-----ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIA 112
Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 123
           + + L Y+     + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y 
Sbjct: 113 VIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYM 170
Query: 124 APELIFGATEYTAAIDIWSAGCVLAELLLGQ 154
           +PE + G T Y+   DIWS G  L E+ +G+
Sbjct: 171 SPERLQG-THYSVQSDIWSMGLSLVEMAVGR 200

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 80/151 (52%), Gaps = 13/151 (8%)
Query: 5   DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQ 63
           + P +V     F+S  E     +++ +E++   ++ +V+K     + R+P   +      
Sbjct: 62  NSPYIVGFYGAFYSDGE-----ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIA 112
Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 123
           + + L Y+     + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y 
Sbjct: 113 VIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYM 170
Query: 124 APELIFGATEYTAAIDIWSAGCVLAELLLGQ 154
           +PE + G T Y+   DIWS G  L E+ +G+
Sbjct: 171 SPERLQG-THYSVQSDIWSMGLSLVEMAVGR 200

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 80/151 (52%), Gaps = 13/151 (8%)
Query: 5   DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQ 63
           + P +V     F+S  E     +++ +E++   ++ +V+K     + R+P   +      
Sbjct: 62  NSPYIVGFYGAFYSDGE-----ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIA 112
Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 123
           + + L Y+     + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y 
Sbjct: 113 VIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYM 170
Query: 124 APELIFGATEYTAAIDIWSAGCVLAELLLGQ 154
           +PE + G T Y+   DIWS G  L E+ +G+
Sbjct: 171 SPERLQG-THYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/262 (25%), Positives = 115/262 (43%), Gaps = 45/262 (17%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVK 58
           M +L HP +V+L   F     +D+  + ++ E++   E   +V   H KMS+   + Y++
Sbjct: 208 MSVLRHPTLVNLHDAF-----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR 262
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLL-VNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
               Q+C+ L ++H      H D+KP+N++     +++LKL DFG    L   +      
Sbjct: 263 ----QVCKGLCHMHEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT 317
Query: 118 CSRYYRAPELIFG--ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
            +  + APE+  G     YT   D+WS G +   LL G   F GE+  + L         
Sbjct: 318 GTAEFAAPEVAEGKPVGYYT---DMWSVGVLSYILLSGLSPFGGENDDETL--------- 365
Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 235
                +K  + N  +  F  I               +  D + +LL   PN R T  +AL
Sbjct: 366 ---RNVKSCDWNMDDSAFSGISE-------------DGKDFIRKLLLADPNTRMTIHQAL 409
Query: 236 IHPFFDELRDP--NTRLPNGRF 255
            HP+      P  ++++P+ R+
Sbjct: 410 EHPWLTPGNAPGRDSQIPSSRY 431

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/252 (28%), Positives = 113/252 (44%), Gaps = 39/252 (15%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           MR   H NVV + + +      DEL++  V+E++       I  H +M++      +   
Sbjct: 202 MRDYQHENVVEMYNSYLVG---DELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAV 252
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
              + +AL+ +H   GV HRDIK  ++L+  H  ++KL DFG    + K  P    +   
Sbjct: 253 CLAVLQALSVLHAQ-GVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGT 310
Query: 121 -YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
            Y+ APELI     Y   +DIWS G ++ E++ G+P +  E               P  +
Sbjct: 311 PYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLK 354
Query: 180 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
            +K +  N      P++K    HK+      P     + RLL   P  R+TA E L HPF
Sbjct: 355 AMKMIRDNLP----PRLKN--LHKVS-----PSLKGFLDRLLVRDPAQRATAAELLKHPF 403
Query: 240 FDELRDPNTRLP 251
             +   P + +P
Sbjct: 404 LAKAGPPASIVP 415

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/163 (32%), Positives = 79/163 (48%), Gaps = 14/163 (8%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVK 58
           M++L+HPN+V L    F   E  E  L LV+EY    E    ++ H      RM     +
Sbjct: 68  MKILNHPNIVKL----FEVIET-EKTLYLVMEYASGGEVFDYLVAHG-----RMKEKEAR 117
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 118
             F QI  A+ Y H    + HRD+K +NLL++   + +K+ DFG +     G    ++  
Sbjct: 118 AKFRQIVSAVQYCHQKY-IVHRDLKAENLLLDGDMN-IKIADFGFSNEFTVGNKLDTFCG 175
Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 161
           S  Y APEL  G       +D+WS G +L  L+ G   F G++
Sbjct: 176 SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/163 (31%), Positives = 80/163 (49%), Gaps = 14/163 (8%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVK 58
           M++L+HPN+V L    F   E ++  L LV+EY    E    ++ H      RM     +
Sbjct: 67  MKVLNHPNIVKL----FEVIETEKT-LYLVMEYASGGEVFDYLVAHG-----RMKEKEAR 116
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 118
             F QI  A+ Y H    + HRD+K +NLL++   + +K+ DFG +     G    ++  
Sbjct: 117 AKFRQIVSAVQYCHQKF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDTFCG 174
Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 161
           S  Y APEL  G       +D+WS G +L  L+ G   F G++
Sbjct: 175 SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/163 (31%), Positives = 80/163 (49%), Gaps = 14/163 (8%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVK 58
           M++L+HPN+V L    F   E ++  L LV+EY    E    ++ H      RM     +
Sbjct: 67  MKVLNHPNIVKL----FEVIETEKT-LYLVMEYASGGEVFDYLVAHG-----RMKEKEAR 116
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 118
             F QI  A+ Y H    + HRD+K +NLL++   + +K+ DFG +     G    ++  
Sbjct: 117 AKFRQIVSAVQYCHQKF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDTFCG 174
Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 161
           S  Y APEL  G       +D+WS G +L  L+ G   F G++
Sbjct: 175 SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/163 (31%), Positives = 80/163 (49%), Gaps = 14/163 (8%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVK 58
           M++L+HPN+V L    F   E ++  L LV+EY    E    ++ H      RM     +
Sbjct: 67  MKVLNHPNIVKL----FEVIETEKT-LYLVMEYASGGEVFDYLVAHG-----RMKEKEAR 116
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 118
             F QI  A+ Y H    + HRD+K +NLL++   + +K+ DFG +     G    ++  
Sbjct: 117 AKFRQIVSAVQYCHQKF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDTFCG 174
Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 161
           S  Y APEL  G       +D+WS G +L  L+ G   F G++
Sbjct: 175 SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/262 (25%), Positives = 115/262 (43%), Gaps = 45/262 (17%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVK 58
           M +L HP +V+L   F     +D+  + ++ E++   E   +V   H KMS+   + Y++
Sbjct: 102 MSVLRHPTLVNLHDAF-----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR 156
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLL-VNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
               Q+C+ L ++H      H D+KP+N++     +++LKL DFG    L   +      
Sbjct: 157 ----QVCKGLCHMHEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT 211
Query: 118 CSRYYRAPELIFG--ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
            +  + APE+  G     YT   D+WS G +   LL G   F GE+  + L         
Sbjct: 212 GTAEFAAPEVAEGKPVGYYT---DMWSVGVLSYILLSGLSPFGGENDDETL--------- 259
Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 235
                +K  + N  +  F  I               +  D + +LL   PN R T  +AL
Sbjct: 260 ---RNVKSCDWNMDDSAFSGISE-------------DGKDFIRKLLLADPNTRMTIHQAL 303
Query: 236 IHPFFDELRDP--NTRLPNGRF 255
            HP+      P  ++++P+ R+
Sbjct: 304 EHPWLTPGNAPGRDSQIPSSRY 325

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/162 (32%), Positives = 81/162 (50%), Gaps = 14/162 (8%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVK 58
           ++L  HP+++ L     + T+       +V+EYV   E    + KH      R+  +  +
Sbjct: 65  LKLFRHPHIIKLYQVISTPTD-----FFMVMEYVSGGELFDYICKH-----GRVEEMEAR 114
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 118
             F QI  A+ Y H  + V HRD+KP+N+L++ H +  K+ DFG + ++  GE   +   
Sbjct: 115 RLFQQILSAVDYCHRHM-VVHRDLKPENVLLDAHMNA-KIADFGLSNMMSDGEFLRTSCG 172
Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 160
           S  Y APE+I G       +DIWS G +L  LL G   F  E
Sbjct: 173 SPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE 214

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/249 (28%), Positives = 112/249 (44%), Gaps = 42/249 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           +R   HPN+++LK  +    +   +YL   L    E + ++++  +  S+R         
Sbjct: 75  LRYGQHPNIITLKDVY---DDGKHVYLVTELMRGGELLDKILRQKF-FSER----EASFV 126
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLV-----NPHTHQLKLCDFGSAKVLVKGEPNIS 115
            + I + + Y+H+  GV HRD+KP N+L      NP    L++CDFG AK L      + 
Sbjct: 127 LHTIGKTVEYLHSQ-GVVHRDLKPSNILYVDESGNPEC--LRICDFGFAKQLRAENGLLM 183
Query: 116 YIC-SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG-QPLFPGESGVDQLVEIIKVL 173
             C +  + APE +     Y    DIWS G +L  +L G  P   G S  D   EI+  +
Sbjct: 184 TPCYTANFVAPE-VLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPS--DTPEEILTRI 240
Query: 174 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
           G+                KF  +    W+ + +      A DLVS++L   P+ R TA +
Sbjct: 241 GSG---------------KFT-LSGGNWNTVSET-----AKDLVSKMLHVDPHQRLTAKQ 279
Query: 234 ALIHPFFDE 242
            L HP+  +
Sbjct: 280 VLQHPWVTQ 288

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/249 (27%), Positives = 111/249 (44%), Gaps = 42/249 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           +R   HPN+++LK  +    +   +YL   L    E + ++++  +   +    +     
Sbjct: 75  LRYGQHPNIITLKDVY---DDGKHVYLVTELMRGGELLDKILRQKFFSEREASFV----- 126
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLV-----NPHTHQLKLCDFGSAKVLVKGEPNIS 115
            + I + + Y+H+  GV HRD+KP N+L      NP    L++CDFG AK L      + 
Sbjct: 127 LHTIGKTVEYLHSQ-GVVHRDLKPSNILYVDESGNPEC--LRICDFGFAKQLRAENGLLM 183
Query: 116 YIC-SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG-QPLFPGESGVDQLVEIIKVL 173
             C +  + APE +     Y    DIWS G +L  +L G  P   G S  D   EI+  +
Sbjct: 184 TPCYTANFVAPE-VLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPS--DTPEEILTRI 240
Query: 174 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
           G+                KF  +    W+ + +      A DLVS++L   P+ R TA +
Sbjct: 241 GSG---------------KFT-LSGGNWNTVSET-----AKDLVSKMLHVDPHQRLTAKQ 279
Query: 234 ALIHPFFDE 242
            L HP+  +
Sbjct: 280 VLQHPWVTQ 288

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/162 (32%), Positives = 80/162 (49%), Gaps = 14/162 (8%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVK 58
           ++L  HP+++ L     + T+       +V+EYV   E    + KH      R+  +  +
Sbjct: 65  LKLFRHPHIIKLYQVISTPTD-----FFMVMEYVSGGELFDYICKH-----GRVEEMEAR 114
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 118
             F QI  A+ Y H  + V HRD+KP+N+L++ H +  K+ DFG + ++  GE       
Sbjct: 115 RLFQQILSAVDYCHRHM-VVHRDLKPENVLLDAHMNA-KIADFGLSNMMSDGEFLRDSCG 172
Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 160
           S  Y APE+I G       +DIWS G +L  LL G   F  E
Sbjct: 173 SPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE 214

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/163 (31%), Positives = 79/163 (48%), Gaps = 14/163 (8%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVK 58
           M++L+HPN+V L    F   E ++  L LV+EY    E    ++ H      RM     +
Sbjct: 67  MKVLNHPNIVKL----FEVIETEKT-LYLVMEYASGGEVFDYLVAHG-----RMKEKEAR 116
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 118
             F QI  A+ Y H    + HRD+K +NLL++   + +K+ DFG +     G     +  
Sbjct: 117 AKFRQIVSAVQYCHQKF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDEFCG 174
Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 161
           S  Y APEL  G       +D+WS G +L  L+ G   F G++
Sbjct: 175 SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 113/268 (42%), Gaps = 43/268 (16%)
Query: 2   RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 61
           R L H +VV   H FF    +D  ++ +VLE       R +   +K  + +     + Y 
Sbjct: 96  RSLAHQHVVGF-HGFF----EDNDFVFVVLELC---RRRSLLELHKRRKALTEPEARYYL 147
Query: 62  YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSR 120
            QI     Y+H    V HRD+K  NL +N    ++K+ DFG + KV   GE       + 
Sbjct: 148 RQIVLGCQYLHRN-RVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTP 205
Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 180
            Y APE +     ++  +D+WS GC++  LL+G+P F                      E
Sbjct: 206 NYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKPPF----------------------E 242
Query: 181 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
             C+   Y      +IK + +     K + P A  L+ ++LQ  P  R T  E L   FF
Sbjct: 243 TSCLKETYL-----RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFF 295
Query: 241 DELRDPNTRLP-NGRFLPPLFNFKPHEL 267
                P  RLP     +PP F+  P  L
Sbjct: 296 TSGYIP-ARLPITCLTIPPRFSIAPSSL 322

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 113/268 (42%), Gaps = 43/268 (16%)
Query: 2   RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 61
           R L H +VV   H FF    +D  ++ +VLE       R +   +K  + +     + Y 
Sbjct: 94  RSLAHQHVVGF-HGFF----EDNDFVFVVLELC---RRRSLLELHKRRKALTEPEARYYL 145
Query: 62  YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSR 120
            QI     Y+H    V HRD+K  NL +N    ++K+ DFG + KV   GE       + 
Sbjct: 146 RQIVLGCQYLHRN-RVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGERKKVLCGTP 203
Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 180
            Y APE +     ++  +D+WS GC++  LL+G+P F                      E
Sbjct: 204 NYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKPPF----------------------E 240
Query: 181 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
             C+   Y      +IK + +     K + P A  L+ ++LQ  P  R T  E L   FF
Sbjct: 241 TSCLKETYL-----RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFF 293
Query: 241 DELRDPNTRLP-NGRFLPPLFNFKPHEL 267
                P  RLP     +PP F+  P  L
Sbjct: 294 TSGYIP-ARLPITCLTIPPRFSIAPSSL 320

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/244 (29%), Positives = 103/244 (42%), Gaps = 60/244 (24%)
Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK----------V 106
           V+ Y   + +AL  IH   G+ HRD+KP N L N    +  L DFG A+           
Sbjct: 119 VREYMLNLFKALKRIHQ-FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLK 177
Query: 107 LVKGEP-------NISYIC-SRY-----------YRAPELIFGATEYTAAIDIWSAGCVL 147
            V+ E        N   IC SR            +RAPE++      T AID+WSAG + 
Sbjct: 178 FVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIF 237
Query: 148 AELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIK-----------------------C 183
             LL G+ P +     +  L +I+ + G  +RE I+                       C
Sbjct: 238 LSLLSGRYPFYKASDDLTALAQIMTIRG--SRETIQAAKTFGKSILCSKEVPAQDLRKLC 295
Query: 184 MNPNYTEFKFPQ----IKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
                 +   P+    I+ H  +      +P EA DL+ +LL  +P  R TA EAL+HPF
Sbjct: 296 ERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPF 355
Query: 240 FDEL 243
           F ++
Sbjct: 356 FKDM 359

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 72/243 (29%), Positives = 108/243 (44%), Gaps = 40/243 (16%)
Query: 2   RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 61
           RLL HPN+V L     S +E+   YL   L    E    ++   Y               
Sbjct: 65  RLLKHPNIVRLHD---SISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHC-----I 116
Query: 62  YQICRALAYIHNTIGVCHRDIKPQNLLVNPH--THQLKLCDFGSAKVLVKGEPN--ISYI 117
            QI  A+ + H  +GV HR++KP+NLL+        +KL DFG A + V+GE      + 
Sbjct: 117 QQILEAVLHCHQ-MGVVHRNLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQQAWFGFA 174
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +  Y +PE +     Y   +D+W+ G +L  LL+G P F  E    +L + IK      
Sbjct: 175 GTPGYLSPE-VLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ-HRLYQQIKA----- 227
Query: 178 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 237
                        + FP  +   W  +      PEA DL++++L  +P+ R TA EAL H
Sbjct: 228 -----------GAYDFPSPE---WDTV-----TPEAKDLINKMLTINPSKRITAAEALKH 268
Query: 238 PFF 240
           P+ 
Sbjct: 269 PWI 271

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 107/255 (41%), Gaps = 58/255 (22%)
Query: 2   RLLDHPNVVSLKHCF---------FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRM 52
           ++  HPN++ LK  +         F   +K EL+     +Y+ E V    K   K+ + +
Sbjct: 79  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELF-----DYLTEKVTLSEKETRKIMRAL 133
Query: 53  PLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 112
             +   L+              + + HRD+KP+N+L++   + +KL DFG +  L  GE 
Sbjct: 134 LEVICALH-------------KLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEK 179
Query: 113 NISYICSRYYRAPELIFGATE-----YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV 167
             S   +  Y APE+I  +       Y   +D+WS G ++  LL G P F     +  L 
Sbjct: 180 LRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR 239
Query: 168 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL 227
            I              M+ NY +F  P+     W             DLVSR L   P  
Sbjct: 240 MI--------------MSGNY-QFGSPE-----WDD-----YSDTVKDLVSRFLVVQPQK 274
Query: 228 RSTALEALIHPFFDE 242
           R TA EAL HPFF +
Sbjct: 275 RYTAEEALAHPFFQQ 289

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 115/255 (45%), Gaps = 49/255 (19%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVK 58
           +R   HPN+++LK  +      D  Y+ +V E +   E + ++++  +   +    +   
Sbjct: 70  LRYGQHPNIITLKDVY-----DDGKYVYVVTELMKGGELLDKILRQKFFSEREASAV--- 121
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLV-----NPHTHQLKLCDFGSAKVLVKGEPN 113
              + I + + Y+H   GV HRD+KP N+L      NP +  +++CDFG AK L      
Sbjct: 122 --LFTITKTVEYLHAQ-GVVHRDLKPSNILYVDESGNPES--IRICDFGFAKQLRAENGL 176
Query: 114 ISYIC-SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG-QPLFPGESGVDQLVEIIK 171
           +   C +  + APE +     Y AA DIWS G +L  +L G  P   G    D   EI+ 
Sbjct: 177 LMTPCYTANFVAPE-VLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD--DTPEEILA 233
Query: 172 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 231
            +G+                KF  +    W+ +        A DLVS++L   P+ R TA
Sbjct: 234 RIGSG---------------KF-SLSGGYWNSV-----SDTAKDLVSKMLHVDPHQRLTA 272
Query: 232 LEALIHPF---FDEL 243
              L HP+   +D+L
Sbjct: 273 ALVLRHPWIVHWDQL 287

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 80/163 (49%), Gaps = 14/163 (8%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVK 58
           M++L+HPN+V L    F   E ++  L LV+EY    E    ++ H +   +       +
Sbjct: 60  MKVLNHPNIVKL----FEVIETEKT-LYLVMEYASGGEVFDYLVAHGWMKEKE-----AR 109
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 118
             F QI  A+ Y H    + HRD+K +NLL++   + +K+ DFG +     G    ++  
Sbjct: 110 AKFRQIVSAVQYCHQKF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDTFCG 167
Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 161
           S  Y APEL  G       +D+WS G +L  L+ G   F G++
Sbjct: 168 SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 210

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 80/163 (49%), Gaps = 14/163 (8%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVK 58
           M++L+HPN+V L    F   E ++  L LV+EY    E    ++ H      RM     +
Sbjct: 67  MKVLNHPNIVKL----FEVIETEKT-LYLVMEYASGGEVFDYLVAHG-----RMKEKEAR 116
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 118
             F QI  A+ Y H    + HRD+K +NLL++   + +K+ DFG +     G    ++  
Sbjct: 117 AKFRQIVSAVQYCHQKF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDAFCG 174
Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 161
           +  Y APEL  G       +D+WS G +L  L+ G   F G++
Sbjct: 175 APPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 102/238 (42%), Gaps = 37/238 (15%)
Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 63
           + HPN+V+L   + S      LYL + L    E   R+++  +   +    +      +Q
Sbjct: 73  IKHPNIVALDDIYESGGH---LYLIMQLVSGGELFDRIVEKGFYTERDASRL-----IFQ 124
Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNP--HTHQLKLCDFGSAKVLVKGEPNISYICSRY 121
           +  A+ Y+H+ +G+ HRD+KP+NLL        ++ + DFG +K+   G    +   +  
Sbjct: 125 VLDAVKYLHD-LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPG 183
Query: 122 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 181
           Y APE +     Y+ A+D WS G +   LL G P F  E+      +I+K          
Sbjct: 184 YVAPE-VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA--------- 233
Query: 182 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
                   EF  P      W  I        A D +  L++  P  R T  +AL HP+
Sbjct: 234 ------EYEFDSPY-----WDDI-----SDSAKDFIRHLMEKDPEKRFTCEQALQHPW 275

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 53/164 (32%), Positives = 83/164 (50%), Gaps = 11/164 (6%)
Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 63
           L+HP +V++     + T    L   +V+EYV     R I H          I V      
Sbjct: 69  LNHPAIVAVYDTGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGPMTPKRAIEV---IAD 124
Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI----SYICS 119
            C+AL + H   G+ HRD+KP N+L++  T+ +K+ DFG A+ +     ++    + I +
Sbjct: 125 ACQALNFSHQN-GIIHRDVKPANILISA-TNAVKVVDFGIARAIADSGNSVXQTAAVIGT 182
Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 163
             Y +PE   G +   A  D++S GCVL E+L G+P F G+S V
Sbjct: 183 AQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 101/237 (42%), Gaps = 37/237 (15%)
Query: 6   HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 65
           HPN+V+L   + S      LYL + L    E   R+++  +   +    +      +Q+ 
Sbjct: 75  HPNIVALDDIYESGGH---LYLIMQLVSGGELFDRIVEKGFYTERDASRL-----IFQVL 126
Query: 66  RALAYIHNTIGVCHRDIKPQNLLVNP--HTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 123
            A+ Y+H+ +G+ HRD+KP+NLL        ++ + DFG +K+   G    +   +  Y 
Sbjct: 127 DAVKYLHD-LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYV 185
Query: 124 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 183
           APE +     Y+ A+D WS G +   LL G P F  E+      +I+K            
Sbjct: 186 APE-VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA----------- 233
Query: 184 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
                 EF  P      W  I        A D +  L++  P  R T  +AL HP+ 
Sbjct: 234 ----EYEFDSPY-----WDDI-----SDSAKDFIRHLMEKDPEKRFTCEQALQHPWI 276

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/166 (34%), Positives = 90/166 (54%), Gaps = 21/166 (12%)
Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFY 62
           L H N+VS+        E+D+ Y  LV+EY+   T+   I+ H  +S    + +      
Sbjct: 68  LSHQNIVSM----IDVDEEDDCYY-LVMEYIEGPTLSEYIESHGPLSVDTAINFTN---- 118
Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS----YIC 118
           QI   + + H+ + + HRDIKPQN+L++ +   LK+ DFG AK L   E +++     + 
Sbjct: 119 QILDGIKHAHD-MRIVHRDIKPQNILIDSN-KTLKIFDFGIAKAL--SETSLTQTNHVLG 174
Query: 119 SRYYRAPELIFG-ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 163
           +  Y +PE   G AT+     DI+S G VL E+L+G+P F GE+ V
Sbjct: 175 TVQYFSPEQAKGEATD--ECTDIYSIGIVLYEMLVGEPPFNGETAV 218

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 102/238 (42%), Gaps = 37/238 (15%)
Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 63
           + HPN+V+L   + S      LYL + L    E   R+++  +   +    +      +Q
Sbjct: 73  IKHPNIVALDDIYESGGH---LYLIMQLVSGGELFDRIVEKGFYTERDASRL-----IFQ 124
Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNP--HTHQLKLCDFGSAKVLVKGEPNISYICSRY 121
           +  A+ Y+H+ +G+ HRD+KP+NLL        ++ + DFG +K+   G    +   +  
Sbjct: 125 VLDAVKYLHD-LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPG 183
Query: 122 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 181
           Y APE +     Y+ A+D WS G +   LL G P F  E+      +I+K          
Sbjct: 184 YVAPE-VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA--------- 233
Query: 182 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
                   EF  P      W  I        A D +  L++  P  R T  +AL HP+
Sbjct: 234 ------EYEFDSPY-----WDDI-----SDSAKDFIRHLMEKDPEKRFTCEQALQHPW 275

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 102/238 (42%), Gaps = 37/238 (15%)
Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 63
           + HPN+V+L   + S      LYL + L    E   R+++  +   +    +      +Q
Sbjct: 73  IKHPNIVALDDIYESGGH---LYLIMQLVSGGELFDRIVEKGFYTERDASRL-----IFQ 124
Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNP--HTHQLKLCDFGSAKVLVKGEPNISYICSRY 121
           +  A+ Y+H+ +G+ HRD+KP+NLL        ++ + DFG +K+   G    +   +  
Sbjct: 125 VLDAVKYLHD-LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPG 183
Query: 122 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 181
           Y APE +     Y+ A+D WS G +   LL G P F  E+      +I+K          
Sbjct: 184 YVAPE-VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA--------- 233
Query: 182 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
                   EF  P      W  I        A D +  L++  P  R T  +AL HP+
Sbjct: 234 ------EYEFDSPY-----WDDI-----SDSAKDFIRHLMEKDPEKRFTCEQALQHPW 275

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 68/248 (27%), Positives = 114/248 (45%), Gaps = 45/248 (18%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVK 58
           + +  H N++ L   F S  E     L ++ E++   +   R+    +++++R  + YV 
Sbjct: 55  LNIARHRNILHLHESFESMEE-----LVMIFEFISGLDIFERINTSAFELNEREIVSYV- 108
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEP-NISY 116
              +Q+C AL ++H+   + H DI+P+N++     +  +K+ +FG A+ L  G+   + +
Sbjct: 109 ---HQVCEALQFLHSH-NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF 164
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
               YY APE +      + A D+WS G ++  LL G   F  E+   Q++E I      
Sbjct: 165 TAPEYY-APE-VHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-QQIIENI------ 215
Query: 177 TREEIKCMNPNYT--EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 234
                  MN  YT  E  F +I               EA+D V RLL      R TA EA
Sbjct: 216 -------MNAEYTFDEEAFKEI-------------SIEAMDFVDRLLVKERKSRMTASEA 255
Query: 235 LIHPFFDE 242
           L HP+  +
Sbjct: 256 LQHPWLKQ 263

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 52/163 (31%), Positives = 79/163 (48%), Gaps = 14/163 (8%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVK 58
           M++L+HPN+V L    F   E  E  L L++EY    E    ++ H      RM     +
Sbjct: 65  MKILNHPNIVKL----FEVIET-EKTLYLIMEYASGGEVFDYLVAHG-----RMKEKEAR 114
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 118
             F QI  A+ Y H    + HRD+K +NLL++   + +K+ DFG +     G    ++  
Sbjct: 115 SKFRQIVSAVQYCHQK-RIVHRDLKAENLLLDADMN-IKIADFGFSNEFTVGGKLDTFCG 172
Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 161
           S  Y APEL  G       +D+WS G +L  L+ G   F G++
Sbjct: 173 SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 215

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 112/265 (42%), Gaps = 43/265 (16%)
Query: 2   RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 61
           R L H +VV   H FF    +D  ++ +VLE       R +   +K  + +     + Y 
Sbjct: 70  RSLAHQHVVGF-HGFF----EDNDFVFVVLELCR---RRSLLELHKRRKALTEPEARYYL 121
Query: 62  YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISYICSR 120
            QI     Y+H    V HRD+K  NL +N    ++K+ DFG A KV   GE       + 
Sbjct: 122 RQIVLGCQYLHRN-RVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGERKKVLCGTP 179
Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 180
            Y APE +     ++  +D+WS GC++  LL+G+P F                      E
Sbjct: 180 NYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKPPF----------------------E 216
Query: 181 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
             C+   Y      +IK + +     K + P A  L+ ++LQ  P  R T  E L   FF
Sbjct: 217 TSCLKETYL-----RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLNDEFF 269
Query: 241 DELRDPNTRLP-NGRFLPPLFNFKP 264
                P  RLP     +PP F+  P
Sbjct: 270 TSGYIP-ARLPITCLTIPPRFSIAP 293

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/175 (32%), Positives = 91/175 (52%), Gaps = 16/175 (9%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M   + P VV L  C F    +D+ YL +V+EY+P      +  +Y + ++    + K Y
Sbjct: 129 MAFANSPWVVQL-FCAF----QDDKYLYMVMEYMPGGDLVNLMSNYDVPEK----WAKFY 179
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNI-SYIC 118
             ++  AL  IH ++G+ HRD+KP N+L++ H H LKL DFG+  K+   G  +  + + 
Sbjct: 180 TAEVVLALDAIH-SMGLIHRDVKPDNMLLDKHGH-LKLADFGTCMKMDETGMVHCDTAVG 237
Query: 119 SRYYRAPELI---FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 170
           +  Y +PE++    G   Y    D WS G  L E+L+G   F  +S V    +I+
Sbjct: 238 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 292

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 83/160 (51%), Gaps = 11/160 (6%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++LL HP+++ L     + T+     + +V+EY    +   I    +M++       + +
Sbjct: 63  LKLLRHPHIIKLYDVITTPTD-----IVMVIEYAGGELFDYIVEKKRMTEDEG----RRF 113
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
           F QI  A+ Y H    + HRD+KP+NLL++ + + +K+ DFG + ++  G    +   S 
Sbjct: 114 FQQIICAIEYCHRH-KIVHRDLKPENLLLDDNLN-VKIADFGLSNIMTDGNFLKTSCGSP 171
Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 160
            Y APE+I G       +D+WS G VL  +L+G+  F  E
Sbjct: 172 NYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE 211

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 109/238 (45%), Gaps = 42/238 (17%)
Query: 5   DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQI 64
           +HP +V L  CF     + E  L  V+EYV       +  H +  +++P  + + Y  +I
Sbjct: 79  NHPFLVGLHSCF-----QTESRLFFVIEYVNGGD---LMFHMQRQRKLPEEHARFYSAEI 130
Query: 65  CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYR 123
             AL Y+H   G+ +RD+K  N+L++   H +KL D+G  K  ++     S  C    Y 
Sbjct: 131 SLALNYLHER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSXFCGTPNYI 188
Query: 124 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLF--------PGESGVDQLVEII--KVL 173
           APE++ G  +Y  ++D W+ G ++ E++ G+  F        P ++  D L ++I  K +
Sbjct: 189 APEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 247
Query: 174 GTPTREEIKC-------MNPNYTE-------FKFPQIKAHP------WHKIFQKRMPP 211
             P    +K        +N +  E         F  I+ HP      W  + QK++ P
Sbjct: 248 RIPRSMSVKAASVLKSFLNKDPKERLGCLPQTGFADIQGHPFFRNVDWDMMEQKQVVP 305

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 83/164 (50%), Gaps = 11/164 (6%)
Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 63
           L+HP +V++     + T    L   +V+EYV     R I H          I V      
Sbjct: 69  LNHPAIVAVYDTGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGPMTPKRAIEV---IAD 124
Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS----YICS 119
            C+AL + H   G+ HRD+KP N++++  T+ +K+ DFG A+ +     +++     I +
Sbjct: 125 ACQALNFSHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 163
             Y +PE   G +   A  D++S GCVL E+L G+P F G+S V
Sbjct: 183 AQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 92/177 (51%), Gaps = 17/177 (9%)
Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY--VKLYF 61
           ++HP +V L + F     + E  L L+L+++     R      ++S+ +      VK Y 
Sbjct: 83  VNHPFIVKLHYAF-----QTEGKLYLILDFL-----RGGDLFTRLSKEVMFTEEDVKFYL 132
Query: 62  YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY 121
            ++  AL ++H ++G+ +RD+KP+N+L++   H +KL DFG +K  +  E      C   
Sbjct: 133 AELALALDHLH-SLGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTV 190
Query: 122 -YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV-LGTP 176
            Y APE++     +T + D WS G ++ E+L G   F G+   + +  I+K  LG P
Sbjct: 191 EYMAPEVV-NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 246

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 69/245 (28%), Positives = 112/245 (45%), Gaps = 43/245 (17%)
Query: 7   PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 66
           P +V+L + F + T+     L+L+L+Y+       +  H    +R     V++Y  +I  
Sbjct: 119 PFLVTLHYAFQTETK-----LHLILDYINGGE---LFTHLSQRERFTEHEVQIYVGEIVL 170
Query: 67  ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-ICSRY-YRA 124
           AL ++H  +G+ +RDIK +N+L++ + H + L DFG +K  V  E   +Y  C    Y A
Sbjct: 171 ALEHLHK-LGIIYRDIKLENILLDSNGHVV-LTDFGLSKEFVADETERAYDFCGTIEYMA 228
Query: 125 PELIFGA-TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 183
           P+++ G  + +  A+D WS G ++ ELL G   F  +   +   EI       +R  +K 
Sbjct: 229 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI-------SRRILKS 281
Query: 184 MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHP 238
             P      +PQ             M   A DL+ RLL   P  R       A E   H 
Sbjct: 282 EPP------YPQ------------EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323
Query: 239 FFDEL 243
           FF ++
Sbjct: 324 FFQKI 328

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 79/151 (52%), Gaps = 13/151 (8%)
Query: 5   DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQ 63
           + P +V     F+S  E     +++ +E++   ++ +V+K     + R+P   +      
Sbjct: 65  NSPYIVGFYGAFYSDGE-----ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIA 115
Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 123
           + + L Y+     + HRD+KP N+LVN    ++KLCDFG +  L+    N  ++ +R Y 
Sbjct: 116 VIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDEMAN-EFVGTRSYM 173
Query: 124 APELIFGATEYTAAIDIWSAGCVLAELLLGQ 154
           +PE + G T Y+   DIWS G  L E+ +G+
Sbjct: 174 SPERLQG-THYSVQSDIWSMGLSLVEMAVGR 203

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 109/282 (38%), Gaps = 59/282 (20%)
Query: 2   RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 61
           R +D P  V+     F   +     + +  E    ++ +  K      Q +P   +    
Sbjct: 88  RTVDCPFTVTFYGALFREGD-----VWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIA 142
Query: 62  YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNISYICSR 120
             I +AL ++H+ + V HRD+KP N+L+N    Q+K CDFG +  LV     +I   C +
Sbjct: 143 VSIVKALEHLHSKLSVIHRDVKPSNVLINA-LGQVKXCDFGISGYLVDDVAKDIDAGC-K 200
Query: 121 YYRAPELI---FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            Y APE I        Y+   DIWS G    EL + +  FP +S            GTP 
Sbjct: 201 PYXAPERINPELNQKGYSVKSDIWSLGITXIELAILR--FPYDS-----------WGTPF 247
Query: 178 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 237
           ++               Q+   P  ++   +   E VD  S+ L+ +   R T  E   H
Sbjct: 248 QQ-------------LKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELXQH 294
Query: 238 PFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI 279
           PF                      F  HE KG  V   VKLI
Sbjct: 295 PF----------------------FTLHESKGTDVASFVKLI 314

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 113/238 (47%), Gaps = 42/238 (17%)
Query: 5   DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQI 64
           +HP +V L  CF     + E  L  V+EYV       +  H +  +++P  + + Y  +I
Sbjct: 111 NHPFLVGLHSCF-----QTESRLFFVIEYVNGGD---LMFHMQRQRKLPEEHARFYSAEI 162
Query: 65  CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-GEPNISYICSRYYR 123
             AL Y+H   G+ +RD+K  N+L++   H +KL D+G  K  ++ G+   ++  +  Y 
Sbjct: 163 SLALNYLHER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYI 220
Query: 124 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLF--------PGESGVDQLVEII--KVL 173
           APE++ G  +Y  ++D W+ G ++ E++ G+  F        P ++  D L ++I  K +
Sbjct: 221 APEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 279
Query: 174 GTPTREEIKC-------MNPN-------YTEFKFPQIKAHP------WHKIFQKRMPP 211
             P    +K        +N +       + +  F  I+ HP      W  + QK++ P
Sbjct: 280 RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVP 337

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 78/151 (51%), Gaps = 9/151 (5%)
Query: 12  LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 71
           L H F +   K+ L+   V+EY+       + +H +   +  L     Y  +I   L ++
Sbjct: 80  LTHMFCTFQTKENLFF--VMEYLNGGD---LMYHIQSCHKFDLSRATFYAAEIILGLQFL 134
Query: 72  HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFG 130
           H+  G+ +RD+K  N+L++   H +K+ DFG  K  + G+   +  C    Y APE++ G
Sbjct: 135 HSK-GIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLG 192
Query: 131 ATEYTAAIDIWSAGCVLAELLLGQPLFPGES 161
             +Y  ++D WS G +L E+L+GQ  F G+ 
Sbjct: 193 -QKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 222

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 120/260 (46%), Gaps = 55/260 (21%)
Query: 5   DHPNVVSLKHCFFSTTEKDELYL-----NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL 59
           DHPNV+     + S T    LY+     NL L+ + E+ + V   + K+ +    I +  
Sbjct: 85  DHPNVI---RYYCSETTDRFLYIALELCNLNLQDLVESKN-VSDENLKLQKEYNPISL-- 138
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH------------QLKLCDFGSAKVL 107
              QI   +A++H ++ + HRD+KPQN+LV+  +             ++ + DFG  K L
Sbjct: 139 -LRQIASGVAHLH-SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL 196
Query: 108 VKGEPNISY-----ICSRYYRAPELIFGATE--YTAAIDIWSAGCVLAELLLGQPLFPGE 160
             G+            +  +RAPEL+  +T+   T +IDI+S GCV    +L +   P  
Sbjct: 197 DSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFY-YILSKGKHPFG 255
Query: 161 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 220
               +   II+  G  + +E+KC++                     + +  EA DL+S++
Sbjct: 256 DKYSRESNIIR--GIFSLDEMKCLH--------------------DRSLIAEATDLISQM 293
Query: 221 LQYSPNLRSTALEALIHPFF 240
           + + P  R TA++ L HP F
Sbjct: 294 IDHDPLKRPTAMKVLRHPLF 313

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 51/162 (31%), Positives = 82/162 (50%), Gaps = 11/162 (6%)
Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 63
           L+HP +V++     + T    L   +V+EYV     R I H          I V      
Sbjct: 69  LNHPAIVAVYDTGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGPMTPKRAIEV---IAD 124
Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS----YICS 119
            C+AL + H   G+ HRD+KP N++++  T+ +K+ DFG A+ +     +++     I +
Sbjct: 125 ACQALNFSHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 161
             Y +PE   G +   A  D++S GCVL E+L G+P F G+S
Sbjct: 183 AQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDS 223

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 83/164 (50%), Gaps = 11/164 (6%)
Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 63
           L+HP +V++     + T    L   +V+EYV     R I H          I V      
Sbjct: 69  LNHPAIVAVYDTGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGPMTPKRAIEV---IAD 124
Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS----YICS 119
            C+AL + H   G+ HRD+KP N++++  T+ +K+ DFG A+ +     +++     I +
Sbjct: 125 ACQALNFSHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 163
             Y +PE   G +   A  D++S GCVL E+L G+P F G+S V
Sbjct: 183 AQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 110/238 (46%), Gaps = 42/238 (17%)
Query: 5   DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQI 64
           +HP +V L  CF     + E  L  V+EYV       +  H +  +++P  + + Y  +I
Sbjct: 64  NHPFLVGLHSCF-----QTESRLFFVIEYVNGGD---LMFHMQRQRKLPEEHARFYSAEI 115
Query: 65  CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYR 123
             AL Y+H   G+ +RD+K  N+L++   H +KL D+G  K  ++     S  C    Y 
Sbjct: 116 SLALNYLHER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSXFCGTPNYI 173
Query: 124 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLF--------PGESGVDQLVEII--KVL 173
           APE++ G  +Y  ++D W+ G ++ E++ G+  F        P ++  D L ++I  K +
Sbjct: 174 APEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 232
Query: 174 GTPTREEIKC-------MNPN-------YTEFKFPQIKAHP------WHKIFQKRMPP 211
             P    +K        +N +       + +  F  I+ HP      W  + QK++ P
Sbjct: 233 RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVP 290

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 120/260 (46%), Gaps = 55/260 (21%)
Query: 5   DHPNVVSLKHCFFSTTEKDELYL-----NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL 59
           DHPNV+     + S T    LY+     NL L+ + E+ + V   + K+ +    I +  
Sbjct: 85  DHPNVI---RYYCSETTDRFLYIALELCNLNLQDLVESKN-VSDENLKLQKEYNPISL-- 138
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH------------QLKLCDFGSAKVL 107
              QI   +A++H ++ + HRD+KPQN+LV+  +             ++ + DFG  K L
Sbjct: 139 -LRQIASGVAHLH-SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL 196
Query: 108 VKGEPNISY-----ICSRYYRAPELIFGATE--YTAAIDIWSAGCVLAELLLGQPLFPGE 160
             G+            +  +RAPEL+  +T+   T +IDI+S GCV    +L +   P  
Sbjct: 197 DSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFY-YILSKGKHPFG 255
Query: 161 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 220
               +   II+  G  + +E+KC++                     + +  EA DL+S++
Sbjct: 256 DKYSRESNIIR--GIFSLDEMKCLH--------------------DRSLIAEATDLISQM 293
Query: 221 LQYSPNLRSTALEALIHPFF 240
           + + P  R TA++ L HP F
Sbjct: 294 IDHDPLKRPTAMKVLRHPLF 313

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 110/238 (46%), Gaps = 42/238 (17%)
Query: 5   DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQI 64
           +HP +V L  CF     + E  L  V+EYV       +  H +  +++P  + + Y  +I
Sbjct: 68  NHPFLVGLHSCF-----QTESRLFFVIEYVNGGD---LMFHMQRQRKLPEEHARFYSAEI 119
Query: 65  CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYR 123
             AL Y+H   G+ +RD+K  N+L++   H +KL D+G  K  ++     S  C    Y 
Sbjct: 120 SLALNYLHER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSXFCGTPNYI 177
Query: 124 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLF--------PGESGVDQLVEII--KVL 173
           APE++ G  +Y  ++D W+ G ++ E++ G+  F        P ++  D L ++I  K +
Sbjct: 178 APEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 236
Query: 174 GTPTREEIKC-------MNPN-------YTEFKFPQIKAHP------WHKIFQKRMPP 211
             P    +K        +N +       + +  F  I+ HP      W  + QK++ P
Sbjct: 237 RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVP 294

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 70/255 (27%), Positives = 106/255 (41%), Gaps = 58/255 (22%)
Query: 2   RLLDHPNVVSLKHCF---------FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRM 52
           ++  HPN++ LK  +         F   +K EL+     +Y+ E V    K   K+ + +
Sbjct: 66  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELF-----DYLTEKVTLSEKETRKIMRAL 120
Query: 53  PLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 112
             +   L+              + + HRD+KP+N+L++   + +KL DFG +  L  GE 
Sbjct: 121 LEVICALH-------------KLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEK 166
Query: 113 NISYICSRYYRAPELIFGATE-----YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV 167
                 +  Y APE+I  +       Y   +D+WS G ++  LL G P F     +  L 
Sbjct: 167 LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR 226
Query: 168 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL 227
            I              M+ NY +F  P+     W             DLVSR L   P  
Sbjct: 227 MI--------------MSGNY-QFGSPE-----WDD-----YSDTVKDLVSRFLVVQPQK 261
Query: 228 RSTALEALIHPFFDE 242
           R TA EAL HPFF +
Sbjct: 262 RYTAEEALAHPFFQQ 276

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 96/204 (47%), Gaps = 43/204 (21%)
Query: 47  KMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV 106
           + SQR P    K Y  ++C AL Y+H+   + +RD+KP+N+L++ + H +K+ DFG AK 
Sbjct: 98  RKSQRFPNPVAKFYAAEVCLALEYLHSK-DIIYRDLKPENILLDKNGH-IKITDFGFAKY 155
Query: 107 LVKGEPNISY-ICSR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD 164
           +    P+++Y +C    Y APE++     Y  +ID WS G ++ E+L G   F   + + 
Sbjct: 156 V----PDVTYXLCGTPDYIAPEVV-STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK 210
Query: 165 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLL--- 221
              +I+                   E +FP                 +  DL+SRL+   
Sbjct: 211 TYEKILNA-----------------ELRFPPF------------FNEDVKDLLSRLITRD 241
Query: 222 --QYSPNLRSTALEALIHPFFDEL 243
             Q   NL++   +   HP+F E+
Sbjct: 242 LSQRLGNLQNGTEDVKNHPWFKEV 265

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 100/231 (43%), Gaps = 41/231 (17%)
Query: 6   HPNVVSLKHCFFSTTEKDELYLNLVLEYV--PETVHRVIKHHYKMSQRMPLIYVKLYFYQ 63
           HPN+V L   F      D+L+  LV+E +   E   R+ K  +        I  KL    
Sbjct: 65  HPNIVKLHEVFH-----DQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKL---- 115
Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQL--KLCDFGSAKVLVKGEPNISYIC-SR 120
              A++++H+ +GV HRD+KP+NLL       L  K+ DFG A++       +   C + 
Sbjct: 116 -VSAVSHMHD-VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTL 173
Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES---GVDQLVEIIKVLGTPT 177
           +Y APEL+     Y  + D+WS G +L  +L GQ  F            VEI+K +    
Sbjct: 174 HYAAPELL-NQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKI---- 228
Query: 178 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 228
                       +F F   +   W  + Q     EA DL+  LL   PN R
Sbjct: 229 ---------KKGDFSF---EGEAWKNVSQ-----EAKDLIQGLLTVDPNKR 262

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 83/164 (50%), Gaps = 11/164 (6%)
Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 63
           L+HP +V++     + T    L   +V+EYV     R I H          I V      
Sbjct: 69  LNHPAIVAVYATGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGPMTPKRAIEV---IAD 124
Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS----YICS 119
            C+AL + H   G+ HRD+KP N++++  T+ +K+ DFG A+ +     +++     I +
Sbjct: 125 ACQALNFSHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 163
             Y +PE   G +   A  D++S GCVL E+L G+P F G+S V
Sbjct: 183 AQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 92/177 (51%), Gaps = 17/177 (9%)
Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY--VKLYF 61
           ++HP +V L + F     + E  L L+L+++     R      ++S+ +      VK Y 
Sbjct: 83  VNHPFIVKLHYAF-----QTEGKLYLILDFL-----RGGDLFTRLSKEVMFTEEDVKFYL 132
Query: 62  YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY 121
            ++  AL ++H ++G+ +RD+KP+N+L++   H +KL DFG +K  +  E      C   
Sbjct: 133 AELALALDHLH-SLGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTV 190
Query: 122 -YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV-LGTP 176
            Y APE++     +T + D WS G ++ E+L G   F G+   + +  I+K  LG P
Sbjct: 191 EYMAPEVV-NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 246

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/244 (26%), Positives = 104/244 (42%), Gaps = 41/244 (16%)
Query: 2   RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKL 59
           R L HPN+V  K    + T     +L +++EY    E   R+       + R      + 
Sbjct: 71  RSLRHPNIVRFKEVILTPT-----HLAIIMEYASGGELYERICN-----AGRFSEDEARF 120
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNISYIC 118
           +F Q+   ++Y H ++ +CHRD+K +N L++     +LK+CDFG +K  V      S + 
Sbjct: 121 FFQQLLSGVSYCH-SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 179
Query: 119 SRYYRAPELIFGATEYTAAI-DIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTP 176
           +  Y APE++    EY   I D+WS G  L  +L+G  P    E   D    I ++L   
Sbjct: 180 TPAYIAPEVLL-RQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILS-- 236
Query: 177 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 236
                        ++  P             R+ PE   L+SR+    P  R +  E   
Sbjct: 237 ------------VKYSIPD----------DIRISPECCHLISRIFVADPATRISIPEIKT 274
Query: 237 HPFF 240
           H +F
Sbjct: 275 HSWF 278

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/255 (28%), Positives = 109/255 (42%), Gaps = 58/255 (22%)
Query: 2   RLLDHPNVVSLKHCF---------FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRM 52
           ++  HPN++ LK  +         F   +K EL+     +Y+ E V         +S++ 
Sbjct: 79  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELF-----DYLTEKV--------TLSEKE 125
Query: 53  PLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 112
               ++     IC AL    + + + HRD+KP+N+L++   + +KL DFG +  L  GE 
Sbjct: 126 TRKIMRALLEVIC-AL----HKLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEK 179
Query: 113 NISYICSRYYRAPELIFGATE-----YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV 167
                 +  Y APE+I  +       Y   +D+WS G ++  LL G P F     +  L 
Sbjct: 180 LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR 239
Query: 168 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL 227
            I              M+ NY +F  P+     W             DLVSR L   P  
Sbjct: 240 MI--------------MSGNY-QFGSPE-----WDD-----YSDTVKDLVSRFLVVQPQK 274
Query: 228 RSTALEALIHPFFDE 242
           R TA EAL HPFF +
Sbjct: 275 RYTAEEALAHPFFQQ 289

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 92/177 (51%), Gaps = 17/177 (9%)
Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY--VKLYF 61
           ++HP +V L + F     + E  L L+L+++     R      ++S+ +      VK Y 
Sbjct: 84  VNHPFIVKLHYAF-----QTEGKLYLILDFL-----RGGDLFTRLSKEVMFTEEDVKFYL 133
Query: 62  YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY 121
            ++  AL ++H ++G+ +RD+KP+N+L++   H +KL DFG +K  +  E      C   
Sbjct: 134 AELALALDHLH-SLGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTV 191
Query: 122 -YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV-LGTP 176
            Y APE++     +T + D WS G ++ E+L G   F G+   + +  I+K  LG P
Sbjct: 192 EYMAPEVV-NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 247

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 78/151 (51%), Gaps = 9/151 (5%)
Query: 12  LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI 71
           L H F +   K+ L+   V+EY+       + +H +   +  L     Y  +I   L ++
Sbjct: 81  LTHMFCTFQTKENLFF--VMEYLNGGD---LMYHIQSCHKFDLSRATFYAAEIILGLQFL 135
Query: 72  HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFG 130
           H+  G+ +RD+K  N+L++   H +K+ DFG  K  + G+   +  C    Y APE++ G
Sbjct: 136 HSK-GIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLG 193
Query: 131 ATEYTAAIDIWSAGCVLAELLLGQPLFPGES 161
             +Y  ++D WS G +L E+L+GQ  F G+ 
Sbjct: 194 -QKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 223

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 85/163 (52%), Gaps = 13/163 (7%)
Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYK-MSQRMPLIYVKLYFY 62
           L+HP +V++     + T    L   +V+EYV     R I H    M+ +  +  +     
Sbjct: 86  LNHPAIVAVYDTGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIA---- 140
Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS----YIC 118
             C+AL + H   G+ HRD+KP N++++  T+ +K+ DFG A+ +     +++     I 
Sbjct: 141 DACQALNFSHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVTQTAAVIG 198
Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 161
           +  Y +PE   G +   A  D++S GCVL E+L G+P F G+S
Sbjct: 199 TAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDS 240

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 79/163 (48%), Gaps = 14/163 (8%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVK 58
           M++L+HPN+V L    F   E  E  L L++EY    E    ++ H      RM     +
Sbjct: 68  MKILNHPNIVKL----FEVIET-EKTLYLIMEYASGGEVFDYLVAHG-----RMKEKEAR 117
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 118
             F QI  A+ Y H    + HRD+K +NLL++   + +K+ DFG +     G    ++  
Sbjct: 118 SKFRQIVSAVQYCHQK-RIVHRDLKAENLLLDADMN-IKIADFGFSNEFTVGGKLDAFCG 175
Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 161
           +  Y APEL  G       +D+WS G +L  L+ G   F G++
Sbjct: 176 APPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 104/227 (45%), Gaps = 39/227 (17%)
Query: 44  HHYKMSQR-MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG 102
           H Y M Q   P      Y  +IC  L  +H    + +RD+KP+N+L++ H H +++ D G
Sbjct: 274 HIYHMGQAGFPEARAVFYAAEICCGLEDLHRER-IVYRDLKPENILLDDHGH-IRISDLG 331
Query: 103 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG 162
            A  + +G+     + +  Y APE++     YT + D W+ GC+L E++ GQ  F     
Sbjct: 332 LAVHVPEGQTIKGRVGTVGYMAPEVV-KNERYTFSPDWWALGCLLYEMIAGQSPF----- 385
Query: 163 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQ 222
             Q  + IK      REE++ +           +K  P  + + +R  P+A  L S+LL 
Sbjct: 386 -QQRKKKIK------REEVERL-----------VKEVP--EEYSERFSPQARSLCSQLLC 425
Query: 223 YSPNLR-----STALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKP 264
             P  R      +A E   HP F +L     RL  G   PP   FKP
Sbjct: 426 KDPAERLGCRGGSAREVKEHPLFKKLN--FKRLGAGMLEPP---FKP 467

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 114/259 (44%), Gaps = 51/259 (19%)
Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFY 62
           L HPN++ + + F      D   + L+LE+ P   +++ ++ H +  ++    +++    
Sbjct: 71  LRHPNILRMYNYFH-----DRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFME---- 121
Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 122
           ++  AL Y H    V HRDIKP+NLL+  +  +LK+ DFG + V            +  Y
Sbjct: 122 ELADALHYCHER-KVIHRDIKPENLLMG-YKGELKIADFGWS-VHAPSLRRRXMCGTLDY 178
Query: 123 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 182
             PE+I G T +   +D+W AG +  E L+G P F   S  +    I+ V          
Sbjct: 179 LPPEMIEGKT-HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV---------- 227
Query: 183 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 242
                  + KFP              +   + DL+S+LL+Y P  R      + HP+   
Sbjct: 228 -------DLKFPPF------------LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWV-- 266
Query: 243 LRDPNTRLPNGRFLPPLFN 261
               N+R    R LPP++ 
Sbjct: 267 --KANSR----RVLPPVYQ 279

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 88/176 (50%), Gaps = 18/176 (10%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M   + P VV L + F     +D+ YL +V+EY+P      +  +Y +    P  + + Y
Sbjct: 128 MAFANSPWVVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMSNYDV----PEKWARFY 178
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI---SYI 117
             ++  AL  IH ++G  HRD+KP N+L++   H LKL DFG+   + K E  +   + +
Sbjct: 179 TAEVVLALDAIH-SMGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNK-EGMVRCDTAV 235
Query: 118 CSRYYRAPELI---FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 170
            +  Y +PE++    G   Y    D WS G  L E+L+G   F  +S V    +I+
Sbjct: 236 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 291

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 88/176 (50%), Gaps = 18/176 (10%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M   + P VV L + F     +D+ YL +V+EY+P      +  +Y +    P  + + Y
Sbjct: 128 MAFANSPWVVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMSNYDV----PEKWARFY 178
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI---SYI 117
             ++  AL  IH ++G  HRD+KP N+L++   H LKL DFG+   + K E  +   + +
Sbjct: 179 TAEVVLALDAIH-SMGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNK-EGMVRCDTAV 235
Query: 118 CSRYYRAPELI---FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 170
            +  Y +PE++    G   Y    D WS G  L E+L+G   F  +S V    +I+
Sbjct: 236 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 291

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 88/176 (50%), Gaps = 18/176 (10%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M   + P VV L + F     +D+ YL +V+EY+P      +  +Y +    P  + + Y
Sbjct: 123 MAFANSPWVVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMSNYDV----PEKWARFY 173
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI---SYI 117
             ++  AL  IH ++G  HRD+KP N+L++   H LKL DFG+   + K E  +   + +
Sbjct: 174 TAEVVLALDAIH-SMGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNK-EGMVRCDTAV 230
Query: 118 CSRYYRAPELI---FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 170
            +  Y +PE++    G   Y    D WS G  L E+L+G   F  +S V    +I+
Sbjct: 231 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 286

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 114/259 (44%), Gaps = 51/259 (19%)
Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFY 62
           L HPN++ + + F      D   + L+LE+ P   +++ ++ H +  ++    +++    
Sbjct: 72  LRHPNILRMYNYFH-----DRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFME---- 122
Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 122
           ++  AL Y H    V HRDIKP+NLL+  +  +LK+ DFG + V            +  Y
Sbjct: 123 ELADALHYCHER-KVIHRDIKPENLLMG-YKGELKIADFGWS-VHAPSLRRRXMCGTLDY 179
Query: 123 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 182
             PE+I G T +   +D+W AG +  E L+G P F   S  +    I+ V          
Sbjct: 180 LPPEMIEGKT-HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV---------- 228
Query: 183 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 242
                  + KFP              +   + DL+S+LL+Y P  R      + HP+   
Sbjct: 229 -------DLKFPPF------------LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWV-- 267
Query: 243 LRDPNTRLPNGRFLPPLFN 261
               N+R    R LPP++ 
Sbjct: 268 --KANSR----RVLPPVYQ 280

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 104/227 (45%), Gaps = 39/227 (17%)
Query: 44  HHYKMSQR-MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG 102
           H Y M Q   P      Y  +IC  L  +H    + +RD+KP+N+L++ H H +++ D G
Sbjct: 274 HIYHMGQAGFPEARAVFYAAEICCGLEDLHRER-IVYRDLKPENILLDDHGH-IRISDLG 331
Query: 103 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG 162
            A  + +G+     + +  Y APE++     YT + D W+ GC+L E++ GQ  F     
Sbjct: 332 LAVHVPEGQTIKGRVGTVGYMAPEVV-KNERYTFSPDWWALGCLLYEMIAGQSPF----- 385
Query: 163 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQ 222
             Q  + IK      REE++ +           +K  P  + + +R  P+A  L S+LL 
Sbjct: 386 -QQRKKKIK------REEVERL-----------VKEVP--EEYSERFSPQARSLCSQLLC 425
Query: 223 YSPNLR-----STALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKP 264
             P  R      +A E   HP F +L     RL  G   PP   FKP
Sbjct: 426 KDPAERLGCRGGSAREVKEHPLFKKLN--FKRLGAGMLEPP---FKP 467

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/243 (28%), Positives = 107/243 (44%), Gaps = 40/243 (16%)
Query: 2   RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 61
           RLL HPN+V L     S +E+   YL   L    E    ++   Y               
Sbjct: 58  RLLKHPNIVRLHD---SISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHC-----I 109
Query: 62  YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPN--ISYI 117
            QI  ++ + H   G+ HRD+KP+NLL+   +    +KL DFG A + V+G+      + 
Sbjct: 110 QQILESVNHCHLN-GIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFGFA 167
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +  Y +PE +     Y   +D+W+ G +L  LL+G P F  E    +L + IK      
Sbjct: 168 GTPGYLSPE-VLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQ-HRLYQQIKA----- 220
Query: 178 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 237
                        + FP   +  W  +      PEA DL++++L  +P  R TA EAL H
Sbjct: 221 -----------GAYDFP---SPEWDTV-----TPEAKDLINKMLTINPAKRITASEALKH 261
Query: 238 PFF 240
           P+ 
Sbjct: 262 PWI 264

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/243 (28%), Positives = 107/243 (44%), Gaps = 40/243 (16%)
Query: 2   RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 61
           RLL HPN+V L     S +E+   YL   L    E    ++   Y               
Sbjct: 58  RLLKHPNIVRLHD---SISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHC-----I 109
Query: 62  YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPN--ISYI 117
            QI  ++ + H   G+ HRD+KP+NLL+   +    +KL DFG A + V+G+      + 
Sbjct: 110 QQILESVNHCHLN-GIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFGFA 167
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +  Y +PE +     Y   +D+W+ G +L  LL+G P F  E    +L + IK      
Sbjct: 168 GTPGYLSPE-VLRKDPYGKPVDMWACGVILYILLVGYPPFWDED-QHRLYQQIKA----- 220
Query: 178 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 237
                        + FP   +  W  +      PEA DL++++L  +P  R TA EAL H
Sbjct: 221 -----------GAYDFP---SPEWDTV-----TPEAKDLINKMLTINPAKRITASEALKH 261
Query: 238 PFF 240
           P+ 
Sbjct: 262 PWI 264

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 112/255 (43%), Gaps = 49/255 (19%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVK 58
           +R   HPN+++LK  +      D  Y+ +V E     E + ++++  +   +    +   
Sbjct: 70  LRYGQHPNIITLKDVY-----DDGKYVYVVTELXKGGELLDKILRQKFFSEREASAV--- 121
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLV-----NPHTHQLKLCDFGSAKVLVKGEPN 113
              + I + + Y+H   GV HRD+KP N+L      NP +  +++CDFG AK L      
Sbjct: 122 --LFTITKTVEYLHAQ-GVVHRDLKPSNILYVDESGNPES--IRICDFGFAKQLRAENGL 176
Query: 114 ISYIC-SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG-QPLFPGESGVDQLVEIIK 171
           +   C +  + APE +     Y AA DIWS G +L   L G  P   G    D   EI+ 
Sbjct: 177 LXTPCYTANFVAPE-VLERQGYDAACDIWSLGVLLYTXLTGYTPFANGPD--DTPEEILA 233
Query: 172 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 231
            +G+                KF  +    W+ +        A DLVS+ L   P+ R TA
Sbjct: 234 RIGSG---------------KF-SLSGGYWNSV-----SDTAKDLVSKXLHVDPHQRLTA 272
Query: 232 LEALIHPF---FDEL 243
              L HP+   +D+L
Sbjct: 273 ALVLRHPWIVHWDQL 287

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 85/183 (46%), Gaps = 32/183 (17%)
Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 123
           +  A++++H    + HRD+KP+N+L++ +  Q++L DFG +  L  GE       +  Y 
Sbjct: 209 LLEAVSFLHAN-NIVHRDLKPENILLDDNM-QIRLSDFGFSCHLEPGEKLRELCGTPGYL 266
Query: 124 APELIFGATE-----YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 178
           APE++  + +     Y   +D+W+ G +L  LL G P F     +  L  I         
Sbjct: 267 APEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI--------- 317
Query: 179 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 238
                M   Y +F  P+     W             DL+SRLLQ  P  R TA +AL HP
Sbjct: 318 -----MEGQY-QFSSPE-----WDD-----RSSTVKDLISRLLQVDPEARLTAEQALQHP 361
Query: 239 FFD 241
           FF+
Sbjct: 362 FFE 364

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 74/155 (47%), Gaps = 14/155 (9%)
Query: 2   RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKL 59
           R L HPN+V  K    + T     +L +V+EY    E   R+       + R      + 
Sbjct: 70  RSLRHPNIVRFKEVILTPT-----HLAIVMEYASGGELFERICN-----AGRFSEDEARF 119
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNISYIC 118
           +F Q+   ++Y H  + VCHRD+K +N L++     +LK+CDFG +K  V      S + 
Sbjct: 120 FFQQLISGVSYCH-AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 178
Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG 153
           +  Y APE++          D+WS G  L  +L+G
Sbjct: 179 TPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 74/155 (47%), Gaps = 14/155 (9%)
Query: 2   RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKL 59
           R L HPN+V  K    + T     +L +V+EY    E   R+       + R      + 
Sbjct: 69  RSLRHPNIVRFKEVILTPT-----HLAIVMEYASGGELFERICN-----AGRFSEDEARF 118
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNISYIC 118
           +F Q+   ++Y H  + VCHRD+K +N L++     +LK+CDFG +K  V      S + 
Sbjct: 119 FFQQLISGVSYCH-AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 177
Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG 153
           +  Y APE++          D+WS G  L  +L+G
Sbjct: 178 TPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 212

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 71/262 (27%), Positives = 112/262 (42%), Gaps = 59/262 (22%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           MR   H NVV +   + S    DEL++  V+E++       I  H +M++      +   
Sbjct: 96  MRDYHHDNVVDM---YSSYLVGDELWV--VMEFLEGGALTDIVTHTRMNEEQ----IATV 146
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
              + RAL+Y+HN  GV HRDIK  ++L+     ++KL DFG    + K  P    +   
Sbjct: 147 CLSVLRALSYLHNQ-GVIHRDIKSDSILLTSDG-RIKLSDFGFCAQVSKEVPKRKXLVGT 204
Query: 121 -YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
            Y+ APE+I     Y   +DIWS G ++ E++ G+P +                      
Sbjct: 205 PYWMAPEVI-SRLPYGTEVDIWSLGIMVIEMIDGEPPY---------------------- 241
Query: 180 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDL--VSRLLQ--------YSPNLRS 229
                      F  P ++A    +  +  +PP   DL  VS +L+          P+ R+
Sbjct: 242 -----------FNEPPLQA---MRRIRDSLPPRVKDLHKVSSVLRGFLDLMLVREPSQRA 287
Query: 230 TALEALIHPFFDELRDPNTRLP 251
           TA E L HPF      P+  +P
Sbjct: 288 TAQELLGHPFLKLAGPPSCIVP 309

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 110/233 (47%), Gaps = 33/233 (14%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M+ L+HP +V+L + F     +DE  + +V++ +   +   +++H + +       VKL+
Sbjct: 69  MQGLEHPFLVNLWYSF-----QDEEDMFMVVDLL---LGGDLRYHLQQNVHFKEETVKLF 120
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
             ++  AL Y+ N   + HRD+KP N+L++ H H + + DF  A +L +     +   ++
Sbjct: 121 ICELVMALDYLQNQ-RIIHRDMKPDNILLDEHGH-VHITDFNIAAMLPRETQITTMAGTK 178
Query: 121 YYRAPELIFG--ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP-- 176
            Y APE+        Y+ A+D WS G    ELL G+  +   S      EI+    T   
Sbjct: 179 PYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS-KEIVHTFETTVV 237
Query: 177 ------TREEI----KCMNPN----YTEF----KFPQIKAHPWHKIFQKRMPP 211
                 ++E +    K + PN    +++      FP +    W  +FQKR+ P
Sbjct: 238 TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAVFQKRLIP 290

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 105/244 (43%), Gaps = 43/244 (17%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVK 58
           ++L  HP+++ L     + ++     + +V+EYV   E    + K     + R+     +
Sbjct: 70  LKLFRHPHIIKLYQVISTPSD-----IFMVMEYVSGGELFDYICK-----NGRLDEKESR 119
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 118
             F QI   + Y H  + V HRD+KP+N+L++ H +  K+ DFG + ++  GE       
Sbjct: 120 RLFQQILSGVDYCHRHM-VVHRDLKPENVLLDAHMNA-KIADFGLSNMMSDGEFLRXSCG 177
Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 178
           S  Y APE+I G       +DIWS+G +L  LL G   F  +               PT 
Sbjct: 178 SPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH-------------VPTL 224
Query: 179 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 238
            +  C    YT    PQ             + P  + L+  +LQ  P  R+T  +   H 
Sbjct: 225 FKKICDGIFYT----PQY------------LNPSVISLLKHMLQVDPMKRATIKDIREHE 268
Query: 239 FFDE 242
           +F +
Sbjct: 269 WFKQ 272

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 91/177 (51%), Gaps = 17/177 (9%)
Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY--VKLYF 61
           ++HP VV L + F     + E  L L+L+++     R      ++S+ +      VK Y 
Sbjct: 87  VNHPFVVKLHYAF-----QTEGKLYLILDFL-----RGGDLFTRLSKEVMFTEEDVKFYL 136
Query: 62  YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY 121
            ++   L ++H ++G+ +RD+KP+N+L++   H +KL DFG +K  +  E      C   
Sbjct: 137 AELALGLDHLH-SLGIIYRDLKPENILLDEEGH-IKLTDFGLSKEAIDHEKKAYSFCGTV 194
Query: 122 -YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV-LGTP 176
            Y APE++     ++ + D WS G ++ E+L G   F G+   + +  I+K  LG P
Sbjct: 195 EYMAPEVV-NRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMP 250

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/264 (24%), Positives = 116/264 (43%), Gaps = 59/264 (22%)
Query: 5   DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY---- 60
           DHPNV+      +  +E  + +L + LE     +  +++      + + L   K Y    
Sbjct: 67  DHPNVIR-----YYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKL--QKEYNPIS 119
Query: 61  -FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH------------QLKLCDFGSAKVL 107
              QI   +A++H ++ + HRD+KPQN+LV+  +             ++ + DFG  K L
Sbjct: 120 LLRQIASGVAHLH-SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL 178
Query: 108 VKGEPNISY-----ICSRYYRAPELIFGATEY------TAAIDIWSAGCVLAELLLGQPL 156
             G+ +          +  +RAPEL+  +         T +IDI+S GCV    +L +  
Sbjct: 179 DSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFY-YILSKGK 237
Query: 157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDL 216
            P      +   II+  G  + +E+KC++                     + +  EA DL
Sbjct: 238 HPFGDKYSRESNIIR--GIFSLDEMKCLH--------------------DRSLIAEATDL 275
Query: 217 VSRLLQYSPNLRSTALEALIHPFF 240
           +S+++ + P  R TA++ L HP F
Sbjct: 276 ISQMIDHDPLKRPTAMKVLRHPLF 299

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/193 (32%), Positives = 88/193 (45%), Gaps = 31/193 (16%)
Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNP--HTHQLKLCDF--GSAKVLVKG-----EPNI 114
           +  AL ++H T G+ HRD+KP+N+L         +K+CDF  GS   L         P +
Sbjct: 120 VAAALDFLH-TKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPEL 178
Query: 115 SYIC-SRYYRAPELI----FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD---QL 166
           +  C S  Y APE++      AT Y    D+WS G VL  +L G P F G  G D     
Sbjct: 179 TTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDR 238
Query: 167 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPN 226
            E+ +V      E I+       +++FP      W  I       EA DL+S+LL     
Sbjct: 239 GEVCRVCQNKLFESIQ-----EGKYEFPD---KDWAHI-----SSEAKDLISKLLVRDAK 285
Query: 227 LRSTALEALIHPF 239
            R +A + L HP+
Sbjct: 286 QRLSAAQVLQHPW 298

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 69/258 (26%), Positives = 116/258 (44%), Gaps = 30/258 (11%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           +R L H NV+ L    ++  EK ++Y+  V+EY    +  ++       +R P+     Y
Sbjct: 60  LRRLRHKNVIQLVDVLYNE-EKQKMYM--VMEYCVCGMQEMLDS--VPEKRFPVCQAHGY 114
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL---VKGEPNISYI 117
           F Q+   L Y+H+  G+ H+DIKP NLL+      LK+   G A+ L      +   +  
Sbjct: 115 FCQLIDGLEYLHSQ-GIVHKDIKPGNLLLT-TGGTLKISALGVAEALHPFAADDTCRTSQ 172
Query: 118 CSRYYRAPELIFGATEYTA-AIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV---- 172
            S  ++ PE+  G   ++   +DIWSAG  L  +  G   F G++ + +L E I      
Sbjct: 173 GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-IYKLFENIGKGSYA 231
Query: 173 ----LGTPTREEIKCM---NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSP 225
                G P  + +K M    P    F   QI+ H W   F+K+ PP    +    +  SP
Sbjct: 232 IPGDCGPPLSDLLKGMLEYEPA-KRFSIRQIRQHSW---FRKKHPPAEAPVP---IPPSP 284
Query: 226 NLRSTALEALIHPFFDEL 243
           + +       + P+ ++L
Sbjct: 285 DTKDRWRSMTVVPYLEDL 302

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 93/200 (46%), Gaps = 27/200 (13%)
Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQL---KLCDFG-SAKVLVKGE------PN 113
           +  AL ++HN  G+ HRD+KP+N+L   H +Q+   K+CDFG  + + + G+      P 
Sbjct: 120 VASALDFLHNK-GIAHRDLKPENILCE-HPNQVSPVKICDFGLGSGIKLNGDCSPISTPE 177
Query: 114 ISYIC-SRYYRAPELIFGATE----YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE 168
           +   C S  Y APE++   +E    Y    D+WS G +L  LL G P F G  G D   +
Sbjct: 178 LLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWD 237
Query: 169 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 228
             +    P  + +   +    +++FP      W  I        A DL+S+LL      R
Sbjct: 238 --RGEACPACQNMLFESIQEGKYEFPD---KDWAHI-----SCAAKDLISKLLVRDAKQR 287
Query: 229 STALEALIHPFFDELRDPNT 248
            +A + L HP+       NT
Sbjct: 288 LSAAQVLQHPWVQGCAPENT 307

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 99/230 (43%), Gaps = 53/230 (23%)
Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN------------------------PH 92
           +KLY  +I +AL Y+   + + H D+KP+N+L++                          
Sbjct: 139 IKLYCIEILKALNYLRK-MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTK 197
Query: 93  THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL 152
           +  +KL DFG A    K + + S I +R YRAPE+I     +  + D+WS GCVLAEL  
Sbjct: 198 STGIKLIDFGCATF--KSDYHGSIINTRQYRAPEVILNLG-WDVSSDMWSFGCVLAELYT 254
Query: 153 GQPLFPGESGVDQLVEIIKVL----------GTPTREEIKCMNPNYTEFKFPQ------- 195
           G  LF     ++ L  +  ++           T T    K +N +  +  +P+       
Sbjct: 255 GSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGS-KYVNKDELKLAWPENASSINS 313
Query: 196 ----IKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFD 241
                K  P +KI +  +     D +  +LQ  P LR +  E L H F +
Sbjct: 314 IKHVKKCLPLYKIIKHEL---FCDFLYSILQIDPTLRPSPAELLKHKFLE 360

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 83/177 (46%), Gaps = 29/177 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-------------------DELYLNLVLEYVPETVHRV 41
           M++LD   VV LK    +  EK                   D   L +V+EYVP      
Sbjct: 71  MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGE--- 127
Query: 42  IKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF 101
           +  H +   R    + + Y  QI     Y+H ++ + +RD+KP+NLL++   + +K+ DF
Sbjct: 128 MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IKVADF 185
Query: 102 GSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 157
           G AK  VKG      +C    Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 186 GFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 86/182 (47%), Gaps = 31/182 (17%)
Query: 52  MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--K 109
           MP    + +F+Q+   + Y+H  IG+ HRDIKP+NLL++   + LK+ DFG A V     
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNN 158
Query: 110 GEPNISYICSRY-YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE 168
            E  ++ +C    Y APEL+     +   +D+WS G VL  +L G+   P +   D   E
Sbjct: 159 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE 216
Query: 169 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 228
                              Y+++K  +   +PW KI    +      L+ ++L  +P+ R
Sbjct: 217 -------------------YSDWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSAR 252
Query: 229 ST 230
            T
Sbjct: 253 IT 254

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 86/182 (47%), Gaps = 31/182 (17%)
Query: 52  MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--K 109
           MP    + +F+Q+   + Y+H  IG+ HRDIKP+NLL++   + LK+ DFG A V     
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNN 158
Query: 110 GEPNISYICSRY-YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE 168
            E  ++ +C    Y APEL+     +   +D+WS G VL  +L G+   P +   D   E
Sbjct: 159 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE 216
Query: 169 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 228
                              Y+++K  +   +PW KI    +      L+ ++L  +P+ R
Sbjct: 217 -------------------YSDWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSAR 252
Query: 229 ST 230
            T
Sbjct: 253 IT 254

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 86/182 (47%), Gaps = 31/182 (17%)
Query: 52  MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--K 109
           MP    + +F+Q+   + Y+H  IG+ HRDIKP+NLL++   + LK+ DFG A V     
Sbjct: 102 MPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNN 159
Query: 110 GEPNISYICSRY-YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE 168
            E  ++ +C    Y APEL+     +   +D+WS G VL  +L G+   P +   D   E
Sbjct: 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE 217
Query: 169 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 228
                              Y+++K  +   +PW KI    +      L+ ++L  +P+ R
Sbjct: 218 -------------------YSDWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSAR 253
Query: 229 ST 230
            T
Sbjct: 254 IT 255

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 81/163 (49%), Gaps = 8/163 (4%)
Query: 1   MRLLDHPNVVSLKHC--FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 58
           M+ L+HPNVVS +           ++L L L +EY      R   + ++    +    ++
Sbjct: 67  MKKLNHPNVVSAREVPDGLQKLAPNDLPL-LAMEYCEGGDLRKYLNQFENCCGLKEGPIR 125
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQL--KLCDFGSAKVLVKGEPNISY 116
                I  AL Y+H    + HRD+KP+N+++ P   +L  K+ D G AK L +GE    +
Sbjct: 126 TLLSDISSALRYLHEN-RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF 184
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG-QPLFP 158
           + +  Y APEL+    +YT  +D WS G +  E + G +P  P
Sbjct: 185 VGTLQYLAPELL-EQKKYTVTVDYWSFGTLAFECITGFRPFLP 226

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 81/163 (49%), Gaps = 8/163 (4%)
Query: 1   MRLLDHPNVVSLKHC--FFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 58
           M+ L+HPNVVS +           ++L L L +EY      R   + ++    +    ++
Sbjct: 66  MKKLNHPNVVSAREVPDGLQKLAPNDLPL-LAMEYCEGGDLRKYLNQFENCCGLKEGPIR 124
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQL--KLCDFGSAKVLVKGEPNISY 116
                I  AL Y+H    + HRD+KP+N+++ P   +L  K+ D G AK L +GE    +
Sbjct: 125 TLLSDISSALRYLHEN-RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF 183
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG-QPLFP 158
           + +  Y APEL+    +YT  +D WS G +  E + G +P  P
Sbjct: 184 VGTLQYLAPELL-EQKKYTVTVDYWSFGTLAFECITGFRPFLP 225

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 71/242 (29%), Positives = 106/242 (43%), Gaps = 40/242 (16%)
Query: 2   RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 61
           RLL H N+V L     S +E+   YL   L    E    ++   Y               
Sbjct: 58  RLLKHSNIVRLHD---SISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHC-----I 109
Query: 62  YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPN--ISYI 117
            QI  A+ + H  +GV HRD+KP+NLL+        +KL DFG A + V+G+      + 
Sbjct: 110 QQILEAVLHCHQ-MGVVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGDQQAWFGFA 167
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +  Y +PE +     Y   +DIW+ G +L  LL+G P F  E    +L + IK      
Sbjct: 168 GTPGYLSPE-VLRKEAYGKPVDIWACGVILYILLVGYPPFWDEDQ-HKLYQQIKA----- 220
Query: 178 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 237
                        + FP   +  W  +      PEA +L++++L  +P  R TA EAL H
Sbjct: 221 -----------GAYDFP---SPEWDTV-----TPEAKNLINQMLTINPAKRITAHEALKH 261
Query: 238 PF 239
           P+
Sbjct: 262 PW 263

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 80/163 (49%), Gaps = 23/163 (14%)
Query: 66  RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAP 125
           +AL ++   + + HRDIKP N+L++  +  +KLCDFG +  LV           R Y AP
Sbjct: 136 KALNHLKENLKIIHRDIKPSNILLD-RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAP 194
Query: 126 ELIFGATE---YTAAIDIWSAGCVLAELLLGQPLFPGESGV-DQLVEIIKVLGTP---TR 178
           E I  +     Y    D+WS G  L EL  G+  +P  + V DQL +++K  G P   + 
Sbjct: 195 ERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK--GDPPQLSN 252
Query: 179 EEIKCMNPNYTEF-------------KFPQIKAHPWHKIFQKR 208
            E +  +P++  F             K+ ++  HP+  ++++R
Sbjct: 253 SEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEER 295

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 86/182 (47%), Gaps = 31/182 (17%)
Query: 52  MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--K 109
           MP    + +F+Q+   + Y+H  IG+ HRDIKP+NLL++   + LK+ DFG A V     
Sbjct: 100 MPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNN 157
Query: 110 GEPNISYICSRY-YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE 168
            E  ++ +C    Y APEL+     +   +D+WS G VL  +L G+   P +   D   E
Sbjct: 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE 215
Query: 169 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 228
                              Y+++K  +   +PW KI    +      L+ ++L  +P+ R
Sbjct: 216 -------------------YSDWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSAR 251
Query: 229 ST 230
            T
Sbjct: 252 IT 253

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 86/182 (47%), Gaps = 31/182 (17%)
Query: 52  MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--K 109
           MP    + +F+Q+   + Y+H  IG+ HRDIKP+NLL++   + LK+ DFG A V     
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNN 158
Query: 110 GEPNISYICSRY-YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE 168
            E  ++ +C    Y APEL+     +   +D+WS G VL  +L G+   P +   D   E
Sbjct: 159 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE 216
Query: 169 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 228
                              Y+++K  +   +PW KI    +      L+ ++L  +P+ R
Sbjct: 217 -------------------YSDWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSAR 252
Query: 229 ST 230
            T
Sbjct: 253 IT 254

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 107/242 (44%), Gaps = 40/242 (16%)
Query: 2   RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 61
           RLL HPN+V L     S +E+   YL   L    E    ++   Y               
Sbjct: 85  RLLKHPNIVRLHD---SISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHC-----I 136
Query: 62  YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPN--ISYI 117
           +QI  ++ +IH    + HRD+KP+NLL+        +KL DFG A + V+GE      + 
Sbjct: 137 HQILESVNHIHQH-DIVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGEQQAWFGFA 194
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +  Y +PE +     Y   +DIW+ G +L  LL+G P F  E    +L + IK      
Sbjct: 195 GTPGYLSPE-VLRKDPYGKPVDIWACGVILYILLVGYPPFWDEDQ-HKLYQQIKA----- 247
Query: 178 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 237
                        + FP   +  W  +      PEA +L++++L  +P  R TA +AL H
Sbjct: 248 -----------GAYDFP---SPEWDTV-----TPEAKNLINQMLTINPAKRITADQALKH 288
Query: 238 PF 239
           P+
Sbjct: 289 PW 290

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 86/182 (47%), Gaps = 31/182 (17%)
Query: 52  MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--K 109
           MP    + +F+Q+   + Y+H  IG+ HRDIKP+NLL++   + LK+ DFG A V     
Sbjct: 102 MPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNN 159
Query: 110 GEPNISYICSRY-YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE 168
            E  ++ +C    Y APEL+     +   +D+WS G VL  +L G+   P +   D   E
Sbjct: 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE 217
Query: 169 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 228
                              Y+++K  +   +PW KI    +      L+ ++L  +P+ R
Sbjct: 218 -------------------YSDWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSAR 253
Query: 229 ST 230
            T
Sbjct: 254 IT 255

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 86/182 (47%), Gaps = 31/182 (17%)
Query: 52  MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--K 109
           MP    + +F+Q+   + Y+H  IG+ HRDIKP+NLL++   + LK+ DFG A V     
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNN 158
Query: 110 GEPNISYICSRY-YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE 168
            E  ++ +C    Y APEL+     +   +D+WS G VL  +L G+   P +   D   E
Sbjct: 159 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE 216
Query: 169 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 228
                              Y+++K  +   +PW KI    +      L+ ++L  +P+ R
Sbjct: 217 -------------------YSDWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSAR 252
Query: 229 ST 230
            T
Sbjct: 253 IT 254

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 86/182 (47%), Gaps = 31/182 (17%)
Query: 52  MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--K 109
           MP    + +F+Q+   + Y+H  IG+ HRDIKP+NLL++   + LK+ DFG A V     
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNN 158
Query: 110 GEPNISYICSRY-YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE 168
            E  ++ +C    Y APEL+     +   +D+WS G VL  +L G+   P +   D   E
Sbjct: 159 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE 216
Query: 169 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 228
                              Y+++K  +   +PW KI    +      L+ ++L  +P+ R
Sbjct: 217 -------------------YSDWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSAR 252
Query: 229 ST 230
            T
Sbjct: 253 IT 254

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 83/158 (52%), Gaps = 15/158 (9%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ ++ P +V L++ F     KD   L +V+EYVP      +  H +   R    + + Y
Sbjct: 95  LQAVNFPFLVKLEYSF-----KDNSNLYMVMEYVPGGE---MFSHLRRIGRFSEPHARFY 146
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
             QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C  
Sbjct: 147 AAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGT 201
Query: 121 -YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 157
             Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 202 PEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 86/188 (45%), Gaps = 38/188 (20%)
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV-KGEPNISYI 117
            Y  +I  AL ++H   G+ +RD+KP+N+++N H   +KL DFG  K  +  G    ++ 
Sbjct: 125 FYLAEISMALGHLHQK-GIIYRDLKPENIMLN-HQGHVKLTDFGLCKESIHDGTVTHTFC 182
Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +  Y APE++   + +  A+D WS G ++ ++L G P F GE+    + +I+K      
Sbjct: 183 GTIEYMAPEILM-RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC----- 236
Query: 178 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STAL 232
               K   P Y                    +  EA DL+ +LL+ +   R       A 
Sbjct: 237 ----KLNLPPY--------------------LTQEARDLLKKLLKRNAASRLGAGPGDAG 272
Query: 233 EALIHPFF 240
           E   HPFF
Sbjct: 273 EVQAHPFF 280

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 86/182 (47%), Gaps = 31/182 (17%)
Query: 52  MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--K 109
           MP    + +F+Q+   + Y+H  IG+ HRDIKP+NLL++   + LK+ DFG A V     
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNN 158
Query: 110 GEPNISYICSRY-YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE 168
            E  ++ +C    Y APEL+     +   +D+WS G VL  +L G+   P +   D   E
Sbjct: 159 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE 216
Query: 169 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 228
                              Y+++K  +   +PW KI    +      L+ ++L  +P+ R
Sbjct: 217 -------------------YSDWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSAR 252
Query: 229 ST 230
            T
Sbjct: 253 IT 254

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 86/182 (47%), Gaps = 31/182 (17%)
Query: 52  MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--K 109
           MP    + +F+Q+   + Y+H  IG+ HRDIKP+NLL++   + LK+ DFG A V     
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNN 158
Query: 110 GEPNISYICSRY-YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE 168
            E  ++ +C    Y APEL+     +   +D+WS G VL  +L G+   P +   D   E
Sbjct: 159 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE 216
Query: 169 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 228
                              Y+++K  +   +PW KI    +      L+ ++L  +P+ R
Sbjct: 217 -------------------YSDWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSAR 252
Query: 229 ST 230
            T
Sbjct: 253 IT 254

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 86/182 (47%), Gaps = 31/182 (17%)
Query: 52  MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--K 109
           MP    + +F+Q+   + Y+H  IG+ HRDIKP+NLL++   + LK+ DFG A V     
Sbjct: 102 MPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNN 159
Query: 110 GEPNISYICSRY-YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE 168
            E  ++ +C    Y APEL+     +   +D+WS G VL  +L G+   P +   D   E
Sbjct: 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE 217
Query: 169 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 228
                              Y+++K  +   +PW KI    +      L+ ++L  +P+ R
Sbjct: 218 -------------------YSDWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSAR 253
Query: 229 ST 230
            T
Sbjct: 254 IT 255

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 83/158 (52%), Gaps = 15/158 (9%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ ++ P +V L++ F     KD   L +V+EYVP      +  H +   R    + + Y
Sbjct: 95  LQAVNFPFLVKLEYSF-----KDNSNLYMVMEYVPGGE---MFSHLRRIGRFSEPHARFY 146
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
             QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C  
Sbjct: 147 AAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGT 201
Query: 121 -YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 157
             Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 202 PEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 86/182 (47%), Gaps = 31/182 (17%)
Query: 52  MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--K 109
           MP    + +F+Q+   + Y+H  IG+ HRDIKP+NLL++   + LK+ DFG A V     
Sbjct: 102 MPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNN 159
Query: 110 GEPNISYICSRY-YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE 168
            E  ++ +C    Y APEL+     +   +D+WS G VL  +L G+   P +   D   E
Sbjct: 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE 217
Query: 169 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 228
                              Y+++K  +   +PW KI    +      L+ ++L  +P+ R
Sbjct: 218 -------------------YSDWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSAR 253
Query: 229 ST 230
            T
Sbjct: 254 IT 255

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 105/241 (43%), Gaps = 45/241 (18%)
Query: 6   HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 65
           HP + +LK+ F  T ++    L  V+EY        +  H    +       + Y  +I 
Sbjct: 69  HPFLTALKYSF-QTHDR----LCFVMEYANGGE---LFFHLSRERVFSEDRARFYGAEIV 120
Query: 66  RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRA 124
            AL Y+H+   V +RD+K +NL+++   H +K+ DFG  K  +K    +   C    Y A
Sbjct: 121 SALDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKXFCGTPEYLA 179
Query: 125 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 184
           PE +    +Y  A+D W  G V+ E++ G+  F  +   ++L E+I +      EEI+  
Sbjct: 180 PE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR-- 229
Query: 185 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPF 239
                               F + + PEA  L+S LL+  P  R       A E + H F
Sbjct: 230 --------------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRF 269
Query: 240 F 240
           F
Sbjct: 270 F 270

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 83/158 (52%), Gaps = 15/158 (9%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ ++ P +V L++ F     KD   L +V+EYVP      +  H +   R    + + Y
Sbjct: 95  LQAVNFPFLVKLEYSF-----KDNSNLYMVMEYVPGGE---MFSHLRRIGRFSEPHARFY 146
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
             QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C  
Sbjct: 147 AAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGT 201
Query: 121 -YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 157
             Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 202 PEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 86/182 (47%), Gaps = 31/182 (17%)
Query: 52  MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--K 109
           MP    + +F+Q+   + Y+H  IG+ HRDIKP+NLL++   + LK+ DFG A V     
Sbjct: 102 MPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNN 159
Query: 110 GEPNISYICSRY-YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE 168
            E  ++ +C    Y APEL+     +   +D+WS G VL  +L G+   P +   D   E
Sbjct: 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE 217
Query: 169 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 228
                              Y+++K  +   +PW KI    +      L+ ++L  +P+ R
Sbjct: 218 -------------------YSDWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSAR 253
Query: 229 ST 230
            T
Sbjct: 254 IT 255

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 86/182 (47%), Gaps = 31/182 (17%)
Query: 52  MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--K 109
           MP    + +F+Q+   + Y+H  IG+ HRDIKP+NLL++   + LK+ DFG A V     
Sbjct: 102 MPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNN 159
Query: 110 GEPNISYICSRY-YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE 168
            E  ++ +C    Y APEL+     +   +D+WS G VL  +L G+   P +   D   E
Sbjct: 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE 217
Query: 169 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 228
                              Y+++K  +   +PW KI    +      L+ ++L  +P+ R
Sbjct: 218 -------------------YSDWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSAR 253
Query: 229 ST 230
            T
Sbjct: 254 IT 255

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 86/182 (47%), Gaps = 31/182 (17%)
Query: 52  MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--K 109
           MP    + +F+Q+   + Y+H  IG+ HRDIKP+NLL++   + LK+ DFG A V     
Sbjct: 102 MPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNN 159
Query: 110 GEPNISYICSRY-YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE 168
            E  ++ +C    Y APEL+     +   +D+WS G VL  +L G+   P +   D   E
Sbjct: 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE 217
Query: 169 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 228
                              Y+++K  +   +PW KI    +      L+ ++L  +P+ R
Sbjct: 218 -------------------YSDWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSAR 253
Query: 229 ST 230
            T
Sbjct: 254 IT 255

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 105/241 (43%), Gaps = 45/241 (18%)
Query: 6   HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 65
           HP + +LK+ F  T ++    L  V+EY        +  H    +       + Y  +I 
Sbjct: 67  HPFLTALKYSF-QTHDR----LCFVMEYANGGE---LFFHLSRERVFSEDRARFYGAEIV 118
Query: 66  RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRA 124
            AL Y+H+   V +RD+K +NL+++   H +K+ DFG  K  +K    +   C    Y A
Sbjct: 119 SALDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKXFCGTPEYLA 177
Query: 125 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 184
           PE +    +Y  A+D W  G V+ E++ G+  F  +   ++L E+I +      EEI+  
Sbjct: 178 PE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR-- 227
Query: 185 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPF 239
                               F + + PEA  L+S LL+  P  R       A E + H F
Sbjct: 228 --------------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRF 267
Query: 240 F 240
           F
Sbjct: 268 F 268

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 86/182 (47%), Gaps = 31/182 (17%)
Query: 52  MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--K 109
           MP    + +F+Q+   + Y+H  IG+ HRDIKP+NLL++   + LK+ DFG A V     
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNN 158
Query: 110 GEPNISYICSRY-YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE 168
            E  ++ +C    Y APEL+     +   +D+WS G VL  +L G+   P +   D   E
Sbjct: 159 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE 216
Query: 169 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 228
                              Y+++K  +   +PW KI    +      L+ ++L  +P+ R
Sbjct: 217 -------------------YSDWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPSAR 252
Query: 229 ST 230
            T
Sbjct: 253 IT 254

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 105/241 (43%), Gaps = 45/241 (18%)
Query: 6   HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 65
           HP + +LK+ F  T ++    L  V+EY        +  H    +       + Y  +I 
Sbjct: 68  HPFLTALKYSF-QTHDR----LCFVMEYANGGE---LFFHLSRERVFSEDRARFYGAEIV 119
Query: 66  RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRA 124
            AL Y+H+   V +RD+K +NL+++   H +K+ DFG  K  +K    +   C    Y A
Sbjct: 120 SALDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKXFCGTPEYLA 178
Query: 125 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 184
           PE +    +Y  A+D W  G V+ E++ G+  F  +   ++L E+I +      EEI+  
Sbjct: 179 PE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR-- 228
Query: 185 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIHPF 239
                               F + + PEA  L+S LL+  P  R       A E + H F
Sbjct: 229 --------------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRF 268
Query: 240 F 240
           F
Sbjct: 269 F 269

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 87/196 (44%), Gaps = 26/196 (13%)
Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRY 121
           I  A+ Y+H +I + HRD+KP+NLL         LKL DFG AK         +   + Y
Sbjct: 131 IGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 189
Query: 122 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 181
           Y APE + G  +Y  + D+WS G ++  LL G P F    G      +    G  TR  +
Sbjct: 190 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM 242
Query: 182 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF-F 240
                   +++FP  +   W ++ +     E   L+  LL+  P  R T  E + HP+  
Sbjct: 243 -------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPWIM 287
Query: 241 DELRDPNTRLPNGRFL 256
              + P T L   R L
Sbjct: 288 QSTKVPQTPLHTSRVL 303

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/264 (24%), Positives = 115/264 (43%), Gaps = 59/264 (22%)
Query: 5   DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY---- 60
           DHPNV+      +  +E  + +L + LE     +  +++      + + L   K Y    
Sbjct: 67  DHPNVIR-----YYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKL--QKEYNPIS 119
Query: 61  -FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH------------QLKLCDFGSAKVL 107
              QI   +A++H ++ + HRD+KPQN+LV+  +             ++ + DFG  K L
Sbjct: 120 LLRQIASGVAHLH-SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL 178
Query: 108 VKGEPNISY-----ICSRYYRAPELIFGATEY------TAAIDIWSAGCVLAELLLGQPL 156
             G+            +  +RAPEL+  +         T +IDI+S GCV    +L +  
Sbjct: 179 DSGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFY-YILSKGK 237
Query: 157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDL 216
            P      +   II+  G  + +E+KC++                     + +  EA DL
Sbjct: 238 HPFGDKYSRESNIIR--GIFSLDEMKCLH--------------------DRSLIAEATDL 275
Query: 217 VSRLLQYSPNLRSTALEALIHPFF 240
           +S+++ + P  R TA++ L HP F
Sbjct: 276 ISQMIDHDPLKRPTAMKVLRHPLF 299

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 87/196 (44%), Gaps = 26/196 (13%)
Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRY 121
           I  A+ Y+H +I + HRD+KP+NLL         LKL DFG AK         +   + Y
Sbjct: 130 IGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 188
Query: 122 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 181
           Y APE + G  +Y  + D+WS G ++  LL G P F    G      +    G  TR  +
Sbjct: 189 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM 241
Query: 182 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF-F 240
                   +++FP  +   W ++ +     E   L+  LL+  P  R T  E + HP+  
Sbjct: 242 -------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPWIM 286
Query: 241 DELRDPNTRLPNGRFL 256
              + P T L   R L
Sbjct: 287 QSTKVPQTPLHTSRVL 302

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 82/177 (46%), Gaps = 29/177 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-------------------DELYLNLVLEYVPETVHRV 41
           M++LD   VV LK    +  EK                   D   L +VLEY P      
Sbjct: 72  MKILDKQKVVKLKQIEHTLNEKRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGE--- 128
Query: 42  IKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF 101
           +  H +   R    + + Y  QI     Y+H ++ + +RD+KP+NLL++   + +K+ DF
Sbjct: 129 MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IKVADF 186
Query: 102 GSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 157
           G AK  VKG      +C    Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 187 GFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 85/190 (44%), Gaps = 37/190 (19%)
Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
            + Y  +I  AL Y+H+   V +RD+K +NL+++   H +K+ DFG  K  +K    +  
Sbjct: 253 ARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKT 311
Query: 117 ICSR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
            C    Y APE +    +Y  A+D W  G V+ E++ G+  F  +   ++L E+I +   
Sbjct: 312 FCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM--- 366
Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----ST 230
                         E +FP+             + PEA  L+S LL+  P  R       
Sbjct: 367 -------------EEIRFPRT------------LGPEAKSLLSGLLKKDPKQRLGGGSED 401
Query: 231 ALEALIHPFF 240
           A E + H FF
Sbjct: 402 AKEIMQHRFF 411

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 87/196 (44%), Gaps = 26/196 (13%)
Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRY 121
           I  A+ Y+H +I + HRD+KP+NLL         LKL DFG AK         +   + Y
Sbjct: 124 IGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 182
Query: 122 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 181
           Y APE + G  +Y  + D+WS G ++  LL G P F    G      +    G  TR  +
Sbjct: 183 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM 235
Query: 182 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF-F 240
                   +++FP  +   W ++ +     E   L+  LL+  P  R T  E + HP+  
Sbjct: 236 -------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPWIM 280
Query: 241 DELRDPNTRLPNGRFL 256
              + P T L   R L
Sbjct: 281 QSTKVPQTPLHTSRVL 296

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 87/196 (44%), Gaps = 26/196 (13%)
Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRY 121
           I  A+ Y+H +I + HRD+KP+NLL         LKL DFG AK         +   + Y
Sbjct: 125 IGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 183
Query: 122 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 181
           Y APE + G  +Y  + D+WS G ++  LL G P F    G      +    G  TR  +
Sbjct: 184 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM 236
Query: 182 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF-F 240
                   +++FP  +   W ++ +     E   L+  LL+  P  R T  E + HP+  
Sbjct: 237 -------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPWIM 281
Query: 241 DELRDPNTRLPNGRFL 256
              + P T L   R L
Sbjct: 282 QSTKVPQTPLHTSRVL 297

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 86/190 (45%), Gaps = 37/190 (19%)
Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
            + Y  +I  AL Y+H+   V +RD+K +NL+++   H +K+ DFG  K  +K    +  
Sbjct: 250 ARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKT 308
Query: 117 ICSR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
            C    Y APE +    +Y  A+D W  G V+ E++ G+  F  +   ++L E+I +   
Sbjct: 309 FCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM--- 363
Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----ST 230
              EEI+                      F + + PEA  L+S LL+  P  R       
Sbjct: 364 ---EEIR----------------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSED 398
Query: 231 ALEALIHPFF 240
           A E + H FF
Sbjct: 399 AKEIMQHRFF 408

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 78/157 (49%), Gaps = 15/157 (9%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ L HPN +  + C+       E    LV+EY   +   +++ H K  Q + +  V   
Sbjct: 108 LQKLRHPNTIQYRGCYLR-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVT-- 160
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
            +   + LAY+H+   + HRD+K  N+L++     +KL DFGSA ++    P   ++ + 
Sbjct: 161 -HGALQGLAYLHSH-NMIHRDVKAGNILLS-EPGLVKLGDFGSASIMA---PANXFVGTP 214
Query: 121 YYRAPELIFGATE--YTAAIDIWSAGCVLAELLLGQP 155
           Y+ APE+I    E  Y   +D+WS G    EL   +P
Sbjct: 215 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 251

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 87/196 (44%), Gaps = 26/196 (13%)
Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRY 121
           I  A+ Y+H +I + HRD+KP+NLL         LKL DFG AK         +   + Y
Sbjct: 126 IGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 184
Query: 122 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 181
           Y APE + G  +Y  + D+WS G ++  LL G P F    G      +    G  TR  +
Sbjct: 185 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM 237
Query: 182 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF-F 240
                   +++FP  +   W ++ +     E   L+  LL+  P  R T  E + HP+  
Sbjct: 238 -------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPWIM 282
Query: 241 DELRDPNTRLPNGRFL 256
              + P T L   R L
Sbjct: 283 QSTKVPQTPLHTSRVL 298

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 87/196 (44%), Gaps = 26/196 (13%)
Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRY 121
           I  A+ Y+H +I + HRD+KP+NLL         LKL DFG AK         +   + Y
Sbjct: 132 IGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 190
Query: 122 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 181
           Y APE + G  +Y  + D+WS G ++  LL G P F    G      +    G  TR  +
Sbjct: 191 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM 243
Query: 182 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF-F 240
                   +++FP  +   W ++ +     E   L+  LL+  P  R T  E + HP+  
Sbjct: 244 -------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPWIM 288
Query: 241 DELRDPNTRLPNGRFL 256
              + P T L   R L
Sbjct: 289 QSTKVPQTPLHTSRVL 304

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 83/188 (44%), Gaps = 38/188 (20%)
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 118
            Y  +I  AL ++H   G+ +RD+KP+N+++N H   +KL DFG  K  +         C
Sbjct: 125 FYLAEISMALGHLHQK-GIIYRDLKPENIMLN-HQGHVKLTDFGLCKESIHDGTVTHXFC 182
Query: 119 SRY-YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
               Y APE++   + +  A+D WS G ++ ++L G P F GE+    + +I+K      
Sbjct: 183 GTIEYMAPEILM-RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC----- 236
Query: 178 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STAL 232
               K   P Y                    +  EA DL+ +LL+ +   R       A 
Sbjct: 237 ----KLNLPPY--------------------LTQEARDLLKKLLKRNAASRLGAGPGDAG 272
Query: 233 EALIHPFF 240
           E   HPFF
Sbjct: 273 EVQAHPFF 280

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 87/196 (44%), Gaps = 26/196 (13%)
Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRY 121
           I  A+ Y+H +I + HRD+KP+NLL         LKL DFG AK         +   + Y
Sbjct: 126 IGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 184
Query: 122 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 181
           Y APE + G  +Y  + D+WS G ++  LL G P F    G    + I   + T  R   
Sbjct: 185 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG----LAISPGMKTRIR--- 236
Query: 182 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF-F 240
                   +++FP  +   W ++ +     E   L+  LL+  P  R T  E + HP+  
Sbjct: 237 ------MGQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPWIM 282
Query: 241 DELRDPNTRLPNGRFL 256
              + P T L   R L
Sbjct: 283 QSTKVPQTPLHTSRVL 298

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 87/196 (44%), Gaps = 26/196 (13%)
Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRY 121
           I  A+ Y+H +I + HRD+KP+NLL         LKL DFG AK         +   + Y
Sbjct: 170 IGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 228
Query: 122 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 181
           Y APE + G  +Y  + D+WS G ++  LL G P F    G    + I   + T  R   
Sbjct: 229 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG----LAISPGMKTRIR--- 280
Query: 182 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF-F 240
                   +++FP  +   W ++ +     E   L+  LL+  P  R T  E + HP+  
Sbjct: 281 ------MGQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPWIM 326
Query: 241 DELRDPNTRLPNGRFL 256
              + P T L   R L
Sbjct: 327 QSTKVPQTPLHTSRVL 342

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 87/196 (44%), Gaps = 26/196 (13%)
Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRY 121
           I  A+ Y+H +I + HRD+KP+NLL         LKL DFG AK         +   + Y
Sbjct: 176 IGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 234
Query: 122 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 181
           Y APE + G  +Y  + D+WS G ++  LL G P F    G    + I   + T  R   
Sbjct: 235 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG----LAISPGMKTRIR--- 286
Query: 182 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF-F 240
                   +++FP  +   W ++ +     E   L+  LL+  P  R T  E + HP+  
Sbjct: 287 ------MGQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPWIM 332
Query: 241 DELRDPNTRLPNGRFL 256
              + P T L   R L
Sbjct: 333 QSTKVPQTPLHTSRVL 348

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 78/157 (49%), Gaps = 15/157 (9%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ L HPN +  + C+       E    LV+EY   +   +++ H K  Q + +  V   
Sbjct: 69  LQKLRHPNTIQYRGCYLR-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVT-- 121
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
            +   + LAY+H+   + HRD+K  N+L++     +KL DFGSA ++    P   ++ + 
Sbjct: 122 -HGALQGLAYLHSH-NMIHRDVKAGNILLS-EPGLVKLGDFGSASIMA---PANXFVGTP 175
Query: 121 YYRAPELIFGATE--YTAAIDIWSAGCVLAELLLGQP 155
           Y+ APE+I    E  Y   +D+WS G    EL   +P
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 212

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 87/196 (44%), Gaps = 26/196 (13%)
Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRY 121
           I  A+ Y+H +I + HRD+KP+NLL         LKL DFG AK         +   + Y
Sbjct: 140 IGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 198
Query: 122 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 181
           Y APE + G  +Y  + D+WS G ++  LL G P F    G      +    G  TR  +
Sbjct: 199 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM 251
Query: 182 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF-F 240
                   +++FP  +   W ++ +     E   L+  LL+  P  R T  E + HP+  
Sbjct: 252 -------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPWIM 296
Query: 241 DELRDPNTRLPNGRFL 256
              + P T L   R L
Sbjct: 297 QSTKVPQTPLHTSRVL 312

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 83/177 (46%), Gaps = 29/177 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-------------------DELYLNLVLEYVPETVHRV 41
           M++LD   VV LK    +  EK                   D   L +V+EY+P      
Sbjct: 71  MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGD--- 127
Query: 42  IKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF 101
           +  H +   R    + + Y  QI     Y+H ++ + +RD+KP+NLL++   + +K+ DF
Sbjct: 128 MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IKVADF 185
Query: 102 GSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 157
           G AK  VKG      +C    Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 186 GFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 83/177 (46%), Gaps = 29/177 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-------------------DELYLNLVLEYVPETVHRV 41
           M++LD   VV LK    +  EK                   D   L +V+EY+P      
Sbjct: 71  MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGD--- 127
Query: 42  IKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF 101
           +  H +   R    + + Y  QI     Y+H ++ + +RD+KP+NLL++   + +K+ DF
Sbjct: 128 MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IKVADF 185
Query: 102 GSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 157
           G AK  VKG      +C    Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 186 GFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/252 (26%), Positives = 111/252 (44%), Gaps = 39/252 (15%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           MR   H NVV +   +    E     L +++E++       I    ++++      +   
Sbjct: 96  MRDYQHFNVVEMYKSYLVGEE-----LWVLMEFLQGGALTDIVSQVRLNEEQ----IATV 146
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
              + +ALAY+H   GV HRDIK  ++L+     ++KL DFG    + K  P    +   
Sbjct: 147 CEAVLQALAYLHAQ-GVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDVPKRKXLVGT 204
Query: 121 -YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
            Y+ APE+I   + Y   +DIWS G ++ E++ G+P +  +S V  +            +
Sbjct: 205 PYWMAPEVI-SRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM------------K 251
Query: 180 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
            ++   P       P++K    HK+      P   D + R+L   P  R+TA E L HPF
Sbjct: 252 RLRDSPP-------PKLKNS--HKV-----SPVLRDFLERMLVRDPQERATAQELLDHPF 297
Query: 240 FDELRDPNTRLP 251
             +   P   +P
Sbjct: 298 LLQTGLPECLVP 309

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 83/177 (46%), Gaps = 29/177 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-------------------DELYLNLVLEYVPETVHRV 41
           M++LD   VV LK    +  EK                   D   L +V+EYVP      
Sbjct: 92  MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGE--- 148
Query: 42  IKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF 101
           +  H +   R    + + Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DF
Sbjct: 149 MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDF 206
Query: 102 GSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 157
           G AK  VKG      +C    Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 207 GFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 83/177 (46%), Gaps = 29/177 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-------------------DELYLNLVLEYVPETVHRV 41
           M++LD   VV LK    +  EK                   D   L +V+EYVP      
Sbjct: 72  MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGE--- 128
Query: 42  IKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF 101
           +  H +   R    + + Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DF
Sbjct: 129 MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDF 186
Query: 102 GSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 157
           G AK  VKG      +C    Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 187 GFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 86/196 (43%), Gaps = 26/196 (13%)
Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRY 121
           I  A+ Y+H +I + HRD+KP+NLL         LKL DFG AK             + Y
Sbjct: 124 IGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPY 182
Query: 122 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 181
           Y APE + G  +Y  + D+WS G ++  LL G P F    G      +    G  TR  +
Sbjct: 183 YVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRM 235
Query: 182 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF-F 240
                   +++FP  +   W ++ +     E   L+  LL+  P  R T  E + HP+  
Sbjct: 236 -------GQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPWIM 280
Query: 241 DELRDPNTRLPNGRFL 256
              + P T L   R L
Sbjct: 281 QSTKVPQTPLHTSRVL 296

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 77/162 (47%), Gaps = 14/162 (8%)
Query: 2   RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKL 59
           ++L+HPN+V L    F   E ++  L LV EY    E    ++ H      R      + 
Sbjct: 68  KVLNHPNIVKL----FEVIETEKT-LYLVXEYASGGEVFDYLVAHG-----RXKEKEARA 117
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
            F QI  A+ Y H    + HRD+K +NLL++   + +K+ DFG +     G    ++  +
Sbjct: 118 KFRQIVSAVQYCHQKF-IVHRDLKAENLLLDADXN-IKIADFGFSNEFTFGNKLDAFCGA 175
Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 161
             Y APEL  G       +D+WS G +L  L+ G   F G++
Sbjct: 176 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 83/177 (46%), Gaps = 29/177 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-------------------DELYLNLVLEYVPETVHRV 41
           M++LD   VV LK    +  EK                   D   L +V+EYVP      
Sbjct: 71  MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGE--- 127
Query: 42  IKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF 101
           +  H +   R    + + Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DF
Sbjct: 128 MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDF 185
Query: 102 GSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 157
           G AK  VKG      +C    Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 186 GFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 83/177 (46%), Gaps = 29/177 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-------------------DELYLNLVLEYVPETVHRV 41
           M++LD   VV LK    +  EK                   D   L +V+EYVP      
Sbjct: 72  MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGE--- 128
Query: 42  IKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF 101
           +  H +   R    + + Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DF
Sbjct: 129 MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDF 186
Query: 102 GSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 157
           G AK  VKG      +C    Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 187 GFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 83/177 (46%), Gaps = 29/177 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-------------------DELYLNLVLEYVPETVHRV 41
           M++LD   VV LK    +  EK                   D   L +V+EYVP      
Sbjct: 72  MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGE--- 128
Query: 42  IKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF 101
           +  H +   R    + + Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DF
Sbjct: 129 MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDF 186
Query: 102 GSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 157
           G AK  VKG      +C    Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 187 GFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 83/177 (46%), Gaps = 29/177 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-------------------DELYLNLVLEYVPETVHRV 41
           M++LD   VV LK    +  EK                   D   L +V+EYVP      
Sbjct: 72  MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGE--- 128
Query: 42  IKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF 101
           +  H +   R    + + Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DF
Sbjct: 129 MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDF 186
Query: 102 GSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 157
           G AK  VKG      +C    Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 187 GFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 83/177 (46%), Gaps = 29/177 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-------------------DELYLNLVLEYVPETVHRV 41
           M++LD   VV LK    +  EK                   D   L +V+EYVP      
Sbjct: 71  MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGE--- 127
Query: 42  IKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF 101
           +  H +   R    + + Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DF
Sbjct: 128 MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDF 185
Query: 102 GSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 157
           G AK  VKG      +C    Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 186 GFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 83/177 (46%), Gaps = 29/177 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-------------------DELYLNLVLEYVPETVHRV 41
           M++LD   VV LK    +  EK                   D   L +V+EYVP      
Sbjct: 71  MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGE--- 127
Query: 42  IKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF 101
           +  H +   R    + + Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DF
Sbjct: 128 MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDF 185
Query: 102 GSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 157
           G AK  VKG      +C    Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 186 GFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 82/158 (51%), Gaps = 15/158 (9%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + + Y
Sbjct: 88  LQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGGE---MFSHLRRIGRFSEPHARFY 139
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
             QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C  
Sbjct: 140 AAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGT 194
Query: 121 -YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 157
             Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 195 PEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 82/158 (51%), Gaps = 15/158 (9%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + + Y
Sbjct: 96  LQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGGE---MFSHLRRIGRFSEPHARFY 147
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
             QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C  
Sbjct: 148 AAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGRTWT--LCGT 202
Query: 121 -YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 157
             Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 203 PEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 73/155 (47%), Gaps = 14/155 (9%)
Query: 2   RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKL 59
           R L HPN+V  K    + T     +L +V+EY    E   R+       + R      + 
Sbjct: 70  RSLRHPNIVRFKEVILTPT-----HLAIVMEYASGGELFERICN-----AGRFSEDEARF 119
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNISYIC 118
           +F Q+   ++Y H  + VCHRD+K +N L++     +LK+C FG +K  V      S + 
Sbjct: 120 FFQQLISGVSYCH-AMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVG 178
Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG 153
           +  Y APE++          D+WS G  L  +L+G
Sbjct: 179 TPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 84/171 (49%), Gaps = 12/171 (7%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           + LLD P  ++  H  F T ++    L  V+EYV       + +H +   +        Y
Sbjct: 73  LALLDKPPFLTQLHSCFQTVDR----LYFVMEYVNGGD---LMYHIQQVGKFKEPQAVFY 125
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV-LVKGEPNISYICS 119
             +I   L ++H   G+ +RD+K  N++++   H +K+ DFG  K  ++ G     +  +
Sbjct: 126 AAEISIGLFFLHKR-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKEHMMDGVTTREFCGT 183
Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 170
             Y APE+I     Y  ++D W+ G +L E+L GQP F GE   D+L + I
Sbjct: 184 PDYIAPEII-AYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED-EDELFQSI 232

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 82/157 (52%), Gaps = 13/157 (8%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ ++ P +V L+  F     KD   L +V+EYVP      +  H +   R    + + Y
Sbjct: 81  LQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVPGGE---MFSHLRRIGRFSEPHARFY 132
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
             QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG    +   + 
Sbjct: 133 AAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR-TWTLCGTP 188
Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 157
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 189 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 224

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 83/177 (46%), Gaps = 29/177 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-------------------DELYLNLVLEYVPETVHRV 41
           M++LD   VV LK    +  EK                   D   L +V+EYVP      
Sbjct: 71  MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGE--- 127
Query: 42  IKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF 101
           +  H +   R    + + Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DF
Sbjct: 128 MFSHLRRIGRFXEPHARFYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDF 185
Query: 102 GSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 157
           G AK  VKG      +C    Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 186 GFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 83/177 (46%), Gaps = 29/177 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-------------------DELYLNLVLEYVPETVHRV 41
           M++LD   VV LK    +  EK                   D   L +V+EYVP      
Sbjct: 72  MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGE--- 128
Query: 42  IKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF 101
           +  H +   R    + + Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DF
Sbjct: 129 MFSHLRRIGRFXEPHARFYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDF 186
Query: 102 GSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 157
           G AK  VKG      +C    Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 187 GFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 83/177 (46%), Gaps = 29/177 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-------------------DELYLNLVLEYVPETVHRV 41
           M++LD   VV LK    +  EK                   D   L +V+EYVP      
Sbjct: 71  MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGE--- 127
Query: 42  IKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF 101
           +  H +   R    + + Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DF
Sbjct: 128 MFSHLRRIGRFXEPHARFYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDF 185
Query: 102 GSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 157
           G AK  VKG      +C    Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 186 GFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 83/177 (46%), Gaps = 29/177 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-------------------DELYLNLVLEYVPETVHRV 41
           M++LD   VV LK    +  EK                   D   L +V+EYVP      
Sbjct: 64  MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGE--- 120
Query: 42  IKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF 101
           +  H +   R    + + Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DF
Sbjct: 121 MFSHLRRIGRFXEPHARFYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDF 178
Query: 102 GSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 157
           G AK  VKG      +C    Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 179 GFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 82/177 (46%), Gaps = 29/177 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-------------------DELYLNLVLEYVPETVHRV 41
           M++LD   VV LK    +  EK                   D   L +V+EY P      
Sbjct: 71  MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGE--- 127
Query: 42  IKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF 101
           +  H +   R    + + Y  QI     Y+H ++ + +RD+KP+NL+++   + +K+ DF
Sbjct: 128 MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IKVTDF 185
Query: 102 GSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 157
           G AK  VKG      +C    Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 186 GFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 82/177 (46%), Gaps = 29/177 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-------------------DELYLNLVLEYVPETVHRV 41
           M++LD   VV LK    +  EK                   D   L +V+EY P      
Sbjct: 72  MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGE--- 128
Query: 42  IKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF 101
           +  H +   R    + + Y  QI     Y+H ++ + +RD+KP+NL+++   + +K+ DF
Sbjct: 129 MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IKVTDF 186
Query: 102 GSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 157
           G AK  VKG      +C    Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 187 GFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 82/177 (46%), Gaps = 29/177 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-------------------DELYLNLVLEYVPETVHRV 41
           M++LD   VV LK    +  EK                   D   L +V+EY P      
Sbjct: 72  MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGE--- 128
Query: 42  IKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF 101
           +  H +   R    + + Y  QI     Y+H ++ + +RD+KP+NL+++   + +K+ DF
Sbjct: 129 MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IKVTDF 186
Query: 102 GSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 157
           G AK  VKG      +C    Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 187 GFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 82/177 (46%), Gaps = 29/177 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-------------------DELYLNLVLEYVPETVHRV 41
           M++LD   VV LK    +  EK                   D   L +V+EY P      
Sbjct: 72  MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGE--- 128
Query: 42  IKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF 101
           +  H +   R    + + Y  QI     Y+H ++ + +RD+KP+NL+++   + +K+ DF
Sbjct: 129 MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IKVTDF 186
Query: 102 GSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 157
           G AK  VKG      +C    Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 187 GFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 117/268 (43%), Gaps = 55/268 (20%)
Query: 6   HPNVVSLKHCFFSTTEKDELYLNLVLEYV--PETVHRVIKHHYKMSQRMPLIYVKLYFYQ 63
           HP + +LK+ F  T ++    L  V+EY    E    + +      +R      + Y  +
Sbjct: 64  HPFLTALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAE 113
Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YY 122
           I  AL Y+H+   V +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y
Sbjct: 114 IVSALEYLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEY 171
Query: 123 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 182
            APE +    +Y  A+D W  G V+ E++ G+  F  +   ++L E+I +      EEI+
Sbjct: 172 LAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR 223
Query: 183 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIH 237
                                 F + + PEA  L++ LL+  P  R     S A E + H
Sbjct: 224 ----------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261
Query: 238 PFFDELRDPNTRLPNGRFLPPLFNFKPH 265
            FF  +   +  +   + LPP   FKP 
Sbjct: 262 RFFLSINWQD--VVQKKLLPP---FKPQ 284

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 81/158 (51%), Gaps = 15/158 (9%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ ++ P +V L+  F     KD   L +V+EY P      +  H +   R    + + Y
Sbjct: 95  LQAVNFPFLVKLEFSF-----KDNSNLYMVMEYAPGGE---MFSHLRRIGRFSEPHARFY 146
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
             QI     Y+H ++ + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C  
Sbjct: 147 AAQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IKVTDFGLAK-RVKGR--TWXLCGT 201
Query: 121 -YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 157
             Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 202 PEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 116/268 (43%), Gaps = 55/268 (20%)
Query: 6   HPNVVSLKHCFFSTTEKDELYLNLVLEYV--PETVHRVIKHHYKMSQRMPLIYVKLYFYQ 63
           HP + +LK+ F  T ++    L  V+EY    E    + +      +R      + Y  +
Sbjct: 69  HPFLTALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAE 118
Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YY 122
           I  AL Y+H+   V +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y
Sbjct: 119 IVSALEYLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEY 176
Query: 123 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 182
            APE +    +Y  A+D W  G V+ E++ G+  F  +   ++L E+I +      EEI+
Sbjct: 177 LAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR 228
Query: 183 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIH 237
                                 F + + PEA  L++ LL+  P  R     S A E + H
Sbjct: 229 ----------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 266
Query: 238 PFFDELRDPNTRLPNGRFLPPLFNFKPH 265
            FF  L      +   + LPP   FKP 
Sbjct: 267 RFF--LSINWQDVVQKKLLPP---FKPQ 289

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 85/184 (46%), Gaps = 35/184 (19%)
Query: 52  MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 111
           MP    + +F+Q+   + Y+H  IG+ HRDIKP+NLL++   + LK+ DFG A V     
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYN- 157
Query: 112 PNISYICSRY-----YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQL 166
            N   + ++      Y APEL+     +   +D+WS G VL  +L G+   P +   D  
Sbjct: 158 -NRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSX 214
Query: 167 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPN 226
            E                   Y+++K  +   +PW KI    +      L+ ++L  +P+
Sbjct: 215 QE-------------------YSDWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPS 250
Query: 227 LRST 230
            R T
Sbjct: 251 ARIT 254

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 92/200 (46%), Gaps = 27/200 (13%)
Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQL---KLCDFG-SAKVLVKGE------PN 113
           +  AL ++HN  G+ HRD+KP+N+L   H +Q+   K+CDF   + + + G+      P 
Sbjct: 120 VASALDFLHNK-GIAHRDLKPENILCE-HPNQVSPVKICDFDLGSGIKLNGDCSPISTPE 177
Query: 114 ISYIC-SRYYRAPELIFGATE----YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE 168
           +   C S  Y APE++   +E    Y    D+WS G +L  LL G P F G  G D   +
Sbjct: 178 LLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWD 237
Query: 169 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 228
             +    P  + +   +    +++FP      W  I        A DL+S+LL      R
Sbjct: 238 --RGEACPACQNMLFESIQEGKYEFPD---KDWAHI-----SCAAKDLISKLLVRDAKQR 287
Query: 229 STALEALIHPFFDELRDPNT 248
            +A + L HP+       NT
Sbjct: 288 LSAAQVLQHPWVQGCAPENT 307

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 82/177 (46%), Gaps = 29/177 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-------------------DELYLNLVLEYVPETVHRV 41
           M++LD   VV LK    +  EK                   D   L +V+EY P      
Sbjct: 72  MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGE--- 128
Query: 42  IKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF 101
           +  H +   R    + + Y  QI     Y+H ++ + +RD+KP+NL+++   + +K+ DF
Sbjct: 129 MFSHLRRIGRFXEPHARFYAAQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IKVTDF 186
Query: 102 GSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 157
           G AK  VKG      +C    Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 187 GFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 82/177 (46%), Gaps = 29/177 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-------------------DELYLNLVLEYVPETVHRV 41
           M++LD   VV LK    +  EK                   D   L +V+EY P      
Sbjct: 71  MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGE--- 127
Query: 42  IKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF 101
           +  H +   R    + + Y  QI     Y+H ++ + +RD+KP+NL+++   + +K+ DF
Sbjct: 128 MFSHLRRIGRFXEPHARFYAAQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IKVTDF 185
Query: 102 GSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 157
           G AK  VKG      +C    Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 186 GFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 117/268 (43%), Gaps = 55/268 (20%)
Query: 6   HPNVVSLKHCFFSTTEKDELYLNLVLEYV--PETVHRVIKHHYKMSQRMPLIYVKLYFYQ 63
           HP + +LK+ F  T ++    L  V+EY    E    + +      +R      + Y  +
Sbjct: 64  HPFLTALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAE 113
Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YY 122
           I  AL Y+H+   V +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y
Sbjct: 114 IVSALEYLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEY 171
Query: 123 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 182
            APE +    +Y  A+D W  G V+ E++ G+  F  +   ++L E+I +      EEI+
Sbjct: 172 LAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR 223
Query: 183 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIH 237
                                 F + + PEA  L++ LL+  P  R     S A E + H
Sbjct: 224 ----------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261
Query: 238 PFFDELRDPNTRLPNGRFLPPLFNFKPH 265
            FF  +   +  +   + LPP   FKP 
Sbjct: 262 RFFLSINWQD--VVQKKLLPP---FKPQ 284

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 117/268 (43%), Gaps = 55/268 (20%)
Query: 6   HPNVVSLKHCFFSTTEKDELYLNLVLEYV--PETVHRVIKHHYKMSQRMPLIYVKLYFYQ 63
           HP + +LK+ F  T ++    L  V+EY    E    + +      +R      + Y  +
Sbjct: 64  HPFLTALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAE 113
Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YY 122
           I  AL Y+H+   V +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y
Sbjct: 114 IVSALEYLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEY 171
Query: 123 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 182
            APE +    +Y  A+D W  G V+ E++ G+  F  +   ++L E+I +      EEI+
Sbjct: 172 LAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR 223
Query: 183 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIH 237
                                 F + + PEA  L++ LL+  P  R     S A E + H
Sbjct: 224 ----------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261
Query: 238 PFFDELRDPNTRLPNGRFLPPLFNFKPH 265
            FF  +   +  +   + LPP   FKP 
Sbjct: 262 RFFLSINWQD--VVQKKLLPP---FKPQ 284

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 85/184 (46%), Gaps = 35/184 (19%)
Query: 52  MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 111
           MP    + +F+Q+   + Y+H  IG+ HRDIKP+NLL++   + LK+ DFG A V     
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYN- 157
Query: 112 PNISYICSRY-----YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQL 166
            N   + ++      Y APEL+     +   +D+WS G VL  +L G+   P +   D  
Sbjct: 158 -NRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSC 214
Query: 167 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPN 226
            E                   Y+++K  +   +PW KI    +      L+ ++L  +P+
Sbjct: 215 QE-------------------YSDWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPS 250
Query: 227 LRST 230
            R T
Sbjct: 251 ARIT 254

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 117/268 (43%), Gaps = 55/268 (20%)
Query: 6   HPNVVSLKHCFFSTTEKDELYLNLVLEYV--PETVHRVIKHHYKMSQRMPLIYVKLYFYQ 63
           HP + +LK+ F  T ++    L  V+EY    E    + +      +R      + Y  +
Sbjct: 64  HPFLTALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAE 113
Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YY 122
           I  AL Y+H+   V +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y
Sbjct: 114 IVSALEYLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEY 171
Query: 123 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 182
            APE +    +Y  A+D W  G V+ E++ G+  F  +   ++L E+I +      EEI+
Sbjct: 172 LAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR 223
Query: 183 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIH 237
                                 F + + PEA  L++ LL+  P  R     S A E + H
Sbjct: 224 ----------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261
Query: 238 PFFDELRDPNTRLPNGRFLPPLFNFKPH 265
            FF  +   +  +   + LPP   FKP 
Sbjct: 262 RFFLSINWQD--VVQKKLLPP---FKPQ 284

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 85/184 (46%), Gaps = 35/184 (19%)
Query: 52  MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 111
           MP    + +F+Q+   + Y+H  IG+ HRDIKP+NLL++   + LK+ DFG A V     
Sbjct: 102 MPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYN- 158
Query: 112 PNISYICSRY-----YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQL 166
            N   + ++      Y APEL+     +   +D+WS G VL  +L G+   P +   D  
Sbjct: 159 -NRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSC 215
Query: 167 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPN 226
            E                   Y+++K  +   +PW KI    +      L+ ++L  +P+
Sbjct: 216 QE-------------------YSDWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPS 251
Query: 227 LRST 230
            R T
Sbjct: 252 ARIT 255

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 117/268 (43%), Gaps = 55/268 (20%)
Query: 6   HPNVVSLKHCFFSTTEKDELYLNLVLEYV--PETVHRVIKHHYKMSQRMPLIYVKLYFYQ 63
           HP + +LK+ F  T ++    L  V+EY    E    + +      +R      + Y  +
Sbjct: 67  HPFLTALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAE 116
Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YY 122
           I  AL Y+H+   V +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y
Sbjct: 117 IVSALEYLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEY 174
Query: 123 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 182
            APE +    +Y  A+D W  G V+ E++ G+  F  +   ++L E+I +      EEI+
Sbjct: 175 LAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR 226
Query: 183 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIH 237
                                 F + + PEA  L++ LL+  P  R     S A E + H
Sbjct: 227 ----------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 264
Query: 238 PFFDELRDPNTRLPNGRFLPPLFNFKPH 265
            FF  +   +  +   + LPP   FKP 
Sbjct: 265 RFFLSINWQD--VVQKKLLPP---FKPQ 287

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 117/268 (43%), Gaps = 55/268 (20%)
Query: 6   HPNVVSLKHCFFSTTEKDELYLNLVLEYV--PETVHRVIKHHYKMSQRMPLIYVKLYFYQ 63
           HP + +LK+ F  T ++    L  V+EY    E    + +      +R      + Y  +
Sbjct: 64  HPFLTALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAE 113
Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YY 122
           I  AL Y+H+   V +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y
Sbjct: 114 IVSALEYLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEY 171
Query: 123 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 182
            APE +    +Y  A+D W  G V+ E++ G+  F  +   ++L E+I +      EEI+
Sbjct: 172 LAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR 223
Query: 183 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIH 237
                                 F + + PEA  L++ LL+  P  R     S A E + H
Sbjct: 224 ----------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261
Query: 238 PFFDELRDPNTRLPNGRFLPPLFNFKPH 265
            FF  +   +  +   + LPP   FKP 
Sbjct: 262 RFFLSINWQD--VVQKKLLPP---FKPQ 284

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 110/241 (45%), Gaps = 36/241 (14%)
Query: 20  TEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQR----MPLIYVKLYFYQICRALAYIHNT 74
           T  DE+Y+  + EY+  +++ +  ++ + + +     +P+  +K     +  + +YIHN 
Sbjct: 113 TNYDEVYI--IYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNE 170
Query: 75  IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 134
             +CHRD+KP N+L++ +  ++KL DFG ++ +V  +   S   +  +  PE     + Y
Sbjct: 171 KNICHRDVKPSNILMDKNG-RVKLSDFGESEYMVDKKIKGSR-GTYEFMPPEFFSNESSY 228
Query: 135 TAA-IDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 193
             A +DIWS G  L  +      F  +     LVE+   + T   E             +
Sbjct: 229 NGAKVDIWSLGICLYVMFYNVVPFSLKIS---LVELFNNIRTKNIE-------------Y 272
Query: 194 PQIKAHPWHKIFQKR-------MPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP 246
           P  + H  + +  K+       +  E +D +   L+ +P  R T+ +AL H +   L D 
Sbjct: 273 PLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEW---LADT 329
Query: 247 N 247
           N
Sbjct: 330 N 330

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 85/184 (46%), Gaps = 35/184 (19%)
Query: 52  MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 111
           MP    + +F+Q+   + Y+H  IG+ HRDIKP+NLL++   + LK+ DFG A V     
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYN- 157
Query: 112 PNISYICSRY-----YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQL 166
            N   + ++      Y APEL+     +   +D+WS G VL  +L G+   P +   D  
Sbjct: 158 -NRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSC 214
Query: 167 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPN 226
            E                   Y+++K  +   +PW KI    +      L+ ++L  +P+
Sbjct: 215 QE-------------------YSDWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPS 250
Query: 227 LRST 230
            R T
Sbjct: 251 ARIT 254

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 85/184 (46%), Gaps = 35/184 (19%)
Query: 52  MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 111
           MP    + +F+Q+   + Y+H  IG+ HRDIKP+NLL++   + LK+ DFG A V     
Sbjct: 101 MPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYN- 157
Query: 112 PNISYICSRY-----YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQL 166
            N   + ++      Y APEL+     +   +D+WS G VL  +L G+   P +   D  
Sbjct: 158 -NRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSC 214
Query: 167 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPN 226
            E                   Y+++K  +   +PW KI    +      L+ ++L  +P+
Sbjct: 215 QE-------------------YSDWKEKKTYLNPWKKIDSAPLA-----LLHKILVENPS 250
Query: 227 LRST 230
            R T
Sbjct: 251 ARIT 254

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 83/196 (42%), Gaps = 26/196 (13%)
Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYICSRY 121
           I  A+ Y+H +I + HRD+KP+NLL         LKL DFG AK         +   + Y
Sbjct: 170 IGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 228
Query: 122 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 181
           Y APE + G  +Y  + D WS G +   LL G P F    G      +    G  TR   
Sbjct: 229 YVAPE-VLGPEKYDKSCDXWSLGVIXYILLCGYPPFYSNHG------LAISPGXKTR--- 278
Query: 182 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFD 241
             +     EF  P+     W ++ +     E   L+  LL+  P  R T  E   HP+  
Sbjct: 279 --IRXGQYEFPNPE-----WSEVSE-----EVKXLIRNLLKTEPTQRXTITEFXNHPWIX 326
Query: 242 E-LRDPNTRLPNGRFL 256
           +  + P T L   R L
Sbjct: 327 QSTKVPQTPLHTSRVL 342

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 72/155 (46%), Gaps = 14/155 (9%)
Query: 2   RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKL 59
           R L HPN+V  K    + T     +L +V+EY    E   R+       + R      + 
Sbjct: 70  RSLRHPNIVRFKEVILTPT-----HLAIVMEYASGGELFERICN-----AGRFSEDEARF 119
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNISYIC 118
           +F Q+   ++Y H  + VCHRD+K +N L++     +LK+C FG +K  V        + 
Sbjct: 120 FFQQLISGVSYCH-AMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVG 178
Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG 153
           +  Y APE++          D+WS G  L  +L+G
Sbjct: 179 TPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 86/192 (44%), Gaps = 28/192 (14%)
Query: 45  HYKMSQRMPLIYVKLYFY--QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG 102
           HY +SQ        + FY  +I   L ++HN   V +RD+KP N+L++ H H +++ D G
Sbjct: 280 HYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF-VVYRDLKPANILLDEHGH-VRISDLG 337
Query: 103 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF----- 157
            A    K +P+ S + +  Y APE++     Y ++ D +S GC+L +LL G   F     
Sbjct: 338 LACDFSKKKPHAS-VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 396
Query: 158 PGESGVDQLVEIIKV-----------------LGTPTREEIKCMNPNYTEFK-FPQIKAH 199
             +  +D++   + V                 L       + C+     E K  P  ++ 
Sbjct: 397 KDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 456
Query: 200 PWHKIFQKRMPP 211
            W  +F ++ PP
Sbjct: 457 DWQMVFLQKYPP 468

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 86/192 (44%), Gaps = 28/192 (14%)
Query: 45  HYKMSQRMPLIYVKLYFY--QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG 102
           HY +SQ        + FY  +I   L ++HN   V +RD+KP N+L++ H H +++ D G
Sbjct: 279 HYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF-VVYRDLKPANILLDEHGH-VRISDLG 336
Query: 103 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF----- 157
            A    K +P+ S + +  Y APE++     Y ++ D +S GC+L +LL G   F     
Sbjct: 337 LACDFSKKKPHAS-VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 395
Query: 158 PGESGVDQLVEIIKV-----------------LGTPTREEIKCMNPNYTEFK-FPQIKAH 199
             +  +D++   + V                 L       + C+     E K  P  ++ 
Sbjct: 396 KDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 455
Query: 200 PWHKIFQKRMPP 211
            W  +F ++ PP
Sbjct: 456 DWQMVFLQKYPP 467

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 86/192 (44%), Gaps = 28/192 (14%)
Query: 45  HYKMSQRMPLIYVKLYFY--QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG 102
           HY +SQ        + FY  +I   L ++HN   V +RD+KP N+L++ H H +++ D G
Sbjct: 280 HYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF-VVYRDLKPANILLDEHGH-VRISDLG 337
Query: 103 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF----- 157
            A    K +P+ S + +  Y APE++     Y ++ D +S GC+L +LL G   F     
Sbjct: 338 LACDFSKKKPHAS-VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 396
Query: 158 PGESGVDQLVEIIKV-----------------LGTPTREEIKCMNPNYTEFK-FPQIKAH 199
             +  +D++   + V                 L       + C+     E K  P  ++ 
Sbjct: 397 KDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 456
Query: 200 PWHKIFQKRMPP 211
            W  +F ++ PP
Sbjct: 457 DWQMVFLQKYPP 468

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 86/192 (44%), Gaps = 28/192 (14%)
Query: 45  HYKMSQRMPLIYVKLYFY--QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG 102
           HY +SQ        + FY  +I   L ++HN   V +RD+KP N+L++ H H +++ D G
Sbjct: 280 HYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF-VVYRDLKPANILLDEHGH-VRISDLG 337
Query: 103 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF----- 157
            A    K +P+ S + +  Y APE++     Y ++ D +S GC+L +LL G   F     
Sbjct: 338 LACDFSKKKPHAS-VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 396
Query: 158 PGESGVDQLVEIIKV-----------------LGTPTREEIKCMNPNYTEFK-FPQIKAH 199
             +  +D++   + V                 L       + C+     E K  P  ++ 
Sbjct: 397 KDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 456
Query: 200 PWHKIFQKRMPP 211
            W  +F ++ PP
Sbjct: 457 DWQMVFLQKYPP 468

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 82/177 (46%), Gaps = 29/177 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-------------------DELYLNLVLEYVPETVHRV 41
           M++LD   VV LK    +  EK                   D   L +V+EY P      
Sbjct: 71  MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGE--- 127
Query: 42  IKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF 101
           +  H +   R    + + Y  QI     Y+H ++ + +RD+KP+NL+++   + +++ DF
Sbjct: 128 MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IQVTDF 185
Query: 102 GSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 157
           G AK  VKG      +C    Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 186 GFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 81/158 (51%), Gaps = 15/158 (9%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ ++ P +V L+  F     KD   L +V+EY P      +  H +   R    + + Y
Sbjct: 95  LQAVNFPFLVKLEFSF-----KDNSNLYMVMEYAPGGE---MFSHLRRIGRFSEPHARFY 146
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
             QI     Y+H ++ + +RD+KP+NL+++   + +++ DFG AK  VKG      +C  
Sbjct: 147 AAQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IQVTDFGLAK-RVKGR--TWXLCGT 201
Query: 121 -YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 157
             Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 202 PEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 102/242 (42%), Gaps = 39/242 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ LDHPNVV L        E D LY+  V E V +     +     +S+       + Y
Sbjct: 90  LKKLDHPNVVKLVEVLDDPNE-DHLYM--VFELVNQGPVMEVPTLKPLSEDQ----ARFY 142
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-YICS 119
           F  + + + Y+H    + HRDIKP NLLV    H +K+ DFG +      +  +S  + +
Sbjct: 143 FQDLIKGIEYLHYQ-KIIHRDIKPSNLLVGEDGH-IKIADFGVSNEFKGSDALLSNTVGT 200
Query: 120 RYYRAPELIFGATEYTA--AIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
             + APE +    +  +  A+D+W+ G  L   + GQ  F                    
Sbjct: 201 PAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF-------------------M 241
Query: 178 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 237
            E I C++         +IK+       Q  +  +  DL++R+L  +P  R    E  +H
Sbjct: 242 DERIMCLHS--------KIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293
Query: 238 PF 239
           P+
Sbjct: 294 PW 295

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 72/155 (46%), Gaps = 14/155 (9%)
Query: 2   RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKL 59
           R L HPN+V  K    + T     +L +V+EY    E   R+       + R      + 
Sbjct: 70  RSLRHPNIVRFKEVILTPT-----HLAIVMEYASGGELFERICN-----AGRFSEDEARF 119
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNISYIC 118
           +F Q+   ++Y H  + V HRD+K +N L++     +LK+ DFG +K  V      S + 
Sbjct: 120 FFQQLISGVSYAH-AMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVG 178
Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG 153
           +  Y APE++          D+WS G  L  +L+G
Sbjct: 179 TPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 79/160 (49%), Gaps = 16/160 (10%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYV--PETVHRVIKHHYKMSQRMPLIYVK 58
           ++ + HP +V L H  F T +K    L  VL+Y+   E  + + +    +  R      +
Sbjct: 93  LKNVKHPFLVGL-HFSFQTADK----LYFVLDYINGGELFYHLQRERCFLEPR-----AR 142
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 118
            Y  +I  AL Y+H ++ + +RD+KP+N+L++   H + L DFG  K  ++     S  C
Sbjct: 143 FYAAEIASALGYLH-SLNIVYRDLKPENILLDSQGH-IVLTDFGLCKENIEHNSTTSTFC 200
Query: 119 SR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 157
               Y APE++     Y   +D W  G VL E+L G P F
Sbjct: 201 GTPEYLAPEVLH-KQPYDRTVDWWCLGAVLYEMLYGLPPF 239

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 82/177 (46%), Gaps = 29/177 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-------------------DELYLNLVLEYVPETVHRV 41
           M++LD   VV LK    +  EK                   D   L +V+EYV       
Sbjct: 71  MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV---AGGE 127
Query: 42  IKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF 101
           +  H +   R    + + Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DF
Sbjct: 128 MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDF 185
Query: 102 GSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 157
           G AK  VKG      +C    Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 186 GFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 82/176 (46%), Gaps = 27/176 (15%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-------------------DELYLNLVLEYVPETVHRV 41
           M++LD   VV LK    +  EK                   D   L +V+EYV       
Sbjct: 92  MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV---AGGE 148
Query: 42  IKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF 101
           +  H +   R    + + Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DF
Sbjct: 149 MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDF 206
Query: 102 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 157
           G AK  VKG    +   +  Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 207 GFAK-RVKG-ATWTLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 76/148 (51%), Gaps = 5/148 (3%)
Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
            + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K      +
Sbjct: 159 ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDF 216
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGT 175
             +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + + +
Sbjct: 217 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSS 276
Query: 176 PTREEIK-CMNPNYTEF-KFPQIKAHPW 201
             +  I+ C+    ++   F +I+ HPW
Sbjct: 277 ECQHLIRWCLALRPSDRPTFEEIQNHPW 304

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 90/180 (50%), Gaps = 8/180 (4%)
Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
            + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K      +
Sbjct: 117 ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDF 174
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGT 175
             +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + + +
Sbjct: 175 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSS 234
Query: 176 PTREEIK-CMNPNYTEF-KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
             +  I+ C+    ++   F +I+ HPW +     +P E  ++    L   P+ ++ ALE
Sbjct: 235 ECQHLIRWCLALRPSDRPTFEEIQNHPWMQ--DVLLPQETAEIHLHSLSPGPS-KAAALE 291

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 82/177 (46%), Gaps = 29/177 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-------------------DELYLNLVLEYVPETVHRV 41
           M++LD   VV LK    +  EK                   D   L +V+EYV       
Sbjct: 72  MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV---AGGE 128
Query: 42  IKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF 101
           +  H +   R    + + Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DF
Sbjct: 129 MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDF 186
Query: 102 GSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 157
           G AK  VKG      +C    Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 187 GFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 76/148 (51%), Gaps = 5/148 (3%)
Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
            + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K      +
Sbjct: 112 ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDF 169
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGT 175
             +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + + +
Sbjct: 170 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSS 229
Query: 176 PTREEIK-CMNPNYTEF-KFPQIKAHPW 201
             +  I+ C+    ++   F +I+ HPW
Sbjct: 230 ECQHLIRWCLALRPSDRPTFEEIQNHPW 257

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 82/177 (46%), Gaps = 29/177 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-------------------DELYLNLVLEYVPETVHRV 41
           M++LD   VV LK    +  EK                   D   L +V+EYV       
Sbjct: 71  MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV---AGGE 127
Query: 42  IKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF 101
           +  H +   R    + + Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DF
Sbjct: 128 MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDF 185
Query: 102 GSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 157
           G AK  VKG      +C    Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 186 GFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 76/148 (51%), Gaps = 5/148 (3%)
Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
            + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K      +
Sbjct: 145 ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDF 202
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGT 175
             +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + + +
Sbjct: 203 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSS 262
Query: 176 PTREEIK-CMNPNYTEF-KFPQIKAHPW 201
             +  I+ C+    ++   F +I+ HPW
Sbjct: 263 ECQHLIRWCLALRPSDRPTFEEIQNHPW 290

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 82/177 (46%), Gaps = 29/177 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-------------------DELYLNLVLEYVPETVHRV 41
           M++LD   VV LK    +  EK                   D   L +V+EYV       
Sbjct: 71  MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV---AGGE 127
Query: 42  IKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF 101
           +  H +   R    + + Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DF
Sbjct: 128 MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDF 185
Query: 102 GSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 157
           G AK  VKG      +C    Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 186 GFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 76/148 (51%), Gaps = 5/148 (3%)
Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
            + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K      +
Sbjct: 144 ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDF 201
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGT 175
             +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + + +
Sbjct: 202 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSS 261
Query: 176 PTREEIK-CMNPNYTEF-KFPQIKAHPW 201
             +  I+ C+    ++   F +I+ HPW
Sbjct: 262 ECQHLIRWCLALRPSDRPTFEEIQNHPW 289

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 82/177 (46%), Gaps = 29/177 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-------------------DELYLNLVLEYVPETVHRV 41
           M++LD   VV LK    +  EK                   D   L +V+EYV       
Sbjct: 71  MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV---AGGE 127
Query: 42  IKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF 101
           +  H +   R    + + Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DF
Sbjct: 128 MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDF 185
Query: 102 GSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 157
           G AK  VKG      +C    Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 186 GFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 82/177 (46%), Gaps = 29/177 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-------------------DELYLNLVLEYVPETVHRV 41
           M++LD   VV LK    +  EK                   D   L +V+EYV       
Sbjct: 71  MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV---AGGE 127
Query: 42  IKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF 101
           +  H +   R    + + Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DF
Sbjct: 128 MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDF 185
Query: 102 GSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 157
           G AK  VKG      +C    Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 186 GFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 76/148 (51%), Gaps = 5/148 (3%)
Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
            + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K      +
Sbjct: 144 ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDF 201
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGT 175
             +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + + +
Sbjct: 202 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSS 261
Query: 176 PTREEIK-CMNPNYTEF-KFPQIKAHPW 201
             +  I+ C+    ++   F +I+ HPW
Sbjct: 262 ECQHLIRWCLALRPSDRPTFEEIQNHPW 289

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 81/167 (48%), Gaps = 13/167 (7%)
Query: 5   DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQI 64
           +HP +  L  C F T ++    L  V+E+V       +  H + S+R      + Y  +I
Sbjct: 82  NHPFLTQL-FCCFQTPDR----LFFVMEFVNGGD---LMFHIQKSRRFDEARARFYAAEI 133
Query: 65  CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK-VLVKGEPNISYICSRYYR 123
             AL ++H+  G+ +RD+K  N+L++ H    KL DFG  K  +  G    ++  +  Y 
Sbjct: 134 ISALMFLHDK-GIIYRDLKLDNVLLD-HEGHCKLADFGMCKEGICNGVTTATFCGTPDYI 191
Query: 124 APELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 170
           APE I     Y  A+D W+ G +L E+L G   F  E+  D L E I
Sbjct: 192 APE-ILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN-EDDLFEAI 236

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 76/148 (51%), Gaps = 5/148 (3%)
Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
            + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K      +
Sbjct: 145 ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDF 202
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGT 175
             +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + + +
Sbjct: 203 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSS 262
Query: 176 PTREEIK-CMNPNYTEF-KFPQIKAHPW 201
             +  I+ C+    ++   F +I+ HPW
Sbjct: 263 ECQHLIRWCLALRPSDRPTFEEIQNHPW 290

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 76/148 (51%), Gaps = 5/148 (3%)
Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
            + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K      +
Sbjct: 115 ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDF 172
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGT 175
             +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + + +
Sbjct: 173 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSS 232
Query: 176 PTREEIK-CMNPNYTEF-KFPQIKAHPW 201
             +  I+ C+    ++   F +I+ HPW
Sbjct: 233 ECQHLIRWCLALRPSDRPTFEEIQNHPW 260

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 82/177 (46%), Gaps = 29/177 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-------------------DELYLNLVLEYVPETVHRV 41
           M++LD   VV LK    +  EK                   D   L +V+EYV       
Sbjct: 71  MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV---AGGE 127
Query: 42  IKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF 101
           +  H +   R    + + Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DF
Sbjct: 128 MFSHLRRIGRFAEPHARFYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDF 185
Query: 102 GSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 157
           G AK  VKG      +C    Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 186 GFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 81/158 (51%), Gaps = 15/158 (9%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ ++ P +V L+  F     KD   L +V+EYV       +  H +   R    + + Y
Sbjct: 82  LQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVAGGE---MFSHLRRIGRFSEPHARFY 133
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
             QI     Y+H ++ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C  
Sbjct: 134 AAQIVLTFEYLH-SLDLIYRDLKPENLLIDEQGY-IQVTDFGFAK-RVKGR--TWXLCGT 188
Query: 121 -YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 157
             Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 189 PEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 225

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 82/177 (46%), Gaps = 29/177 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-------------------DELYLNLVLEYVPETVHRV 41
           M++LD   VV LK    +  EK                   D   L +V+EYV       
Sbjct: 71  MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE--- 127
Query: 42  IKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF 101
           +  H +   R    + + Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DF
Sbjct: 128 MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDF 185
Query: 102 GSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 157
           G AK  VKG      +C    Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 186 GFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 76/148 (51%), Gaps = 5/148 (3%)
Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
            + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K      +
Sbjct: 116 ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDF 173
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGT 175
             +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + + +
Sbjct: 174 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSS 233
Query: 176 PTREEIK-CMNPNYTEF-KFPQIKAHPW 201
             +  I+ C+    ++   F +I+ HPW
Sbjct: 234 ECQHLIRWCLALRPSDRPTFEEIQNHPW 261

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 76/148 (51%), Gaps = 5/148 (3%)
Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
            + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K      +
Sbjct: 112 ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDF 169
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGT 175
             +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + + +
Sbjct: 170 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSS 229
Query: 176 PTREEIK-CMNPNYTEF-KFPQIKAHPW 201
             +  I+ C+    ++   F +I+ HPW
Sbjct: 230 ECQHLIRWCLALRPSDRPTFEEIQNHPW 257

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 76/148 (51%), Gaps = 5/148 (3%)
Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
            + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K      +
Sbjct: 144 ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDF 201
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGT 175
             +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + + +
Sbjct: 202 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSS 261
Query: 176 PTREEIK-CMNPNYTEF-KFPQIKAHPW 201
             +  I+ C+    ++   F +I+ HPW
Sbjct: 262 ECQHLIRWCLALRPSDRPTFEEIQNHPW 289

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 76/148 (51%), Gaps = 5/148 (3%)
Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
            + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K      +
Sbjct: 116 ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDF 173
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGT 175
             +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + + +
Sbjct: 174 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSS 233
Query: 176 PTREEIK-CMNPNYTEF-KFPQIKAHPW 201
             +  I+ C+    ++   F +I+ HPW
Sbjct: 234 ECQHLIRWCLALRPSDRPTFEEIQNHPW 261

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 76/148 (51%), Gaps = 5/148 (3%)
Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
            + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K      +
Sbjct: 117 ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDF 174
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGT 175
             +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + + +
Sbjct: 175 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSS 234
Query: 176 PTREEIK-CMNPNYTEF-KFPQIKAHPW 201
             +  I+ C+    ++   F +I+ HPW
Sbjct: 235 ECQHLIRWCLALRPSDRPTFEEIQNHPW 262

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 84/170 (49%), Gaps = 14/170 (8%)
Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYF 61
           + HPN+V  +  F    E   LY+  V++Y    +   R+      + Q   ++    +F
Sbjct: 80  MKHPNIVQYRESF---EENGSLYI--VMDYCEGGDLFKRINAQKGVLFQEDQILD---WF 131
Query: 62  YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNISYICSR 120
            QIC AL ++H+   + HRDIK QN+ +      ++L DFG A+VL    E   + I + 
Sbjct: 132 VQICLALKHVHDR-KILHRDIKSQNIFLTKDG-TVQLGDFGIARVLNSTVELARACIGTP 189
Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 170
           YY +PE I     Y    DIW+ GCVL EL   +  F   S  + +++II
Sbjct: 190 YYLSPE-ICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKII 238

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 82/177 (46%), Gaps = 29/177 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-------------------DELYLNLVLEYVPETVHRV 41
           M++LD   VV LK    +  EK                   D   L +V+EYV       
Sbjct: 92  MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE--- 148
Query: 42  IKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF 101
           +  H +   R    + + Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DF
Sbjct: 149 MFSHLRRIGRFXEPHARFYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDF 206
Query: 102 GSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 157
           G AK  VKG      +C    Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 207 GFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 81/176 (46%), Gaps = 27/176 (15%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-------------------DELYLNLVLEYVPETVHRV 41
           M++LD   VV LK    +  EK                   D   L +V+EYV       
Sbjct: 71  MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV---AGGE 127
Query: 42  IKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF 101
           +  H +   R    + + Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DF
Sbjct: 128 MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDF 185
Query: 102 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 157
           G AK  VKG        +  Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 186 GFAK-RVKGR-TWXLAGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 82/177 (46%), Gaps = 29/177 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-------------------DELYLNLVLEYVPETVHRV 41
           M++LD   VV LK    +  EK                   D   L +V+EYV       
Sbjct: 66  MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE--- 122
Query: 42  IKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF 101
           +  H +   R    + + Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DF
Sbjct: 123 MFSHLRRIGRFXEPHARFYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDF 180
Query: 102 GSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 157
           G AK  VKG      +C    Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 181 GFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 233

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 82/177 (46%), Gaps = 29/177 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-------------------DELYLNLVLEYVPETVHRV 41
           M++LD   VV LK    +  EK                   D   L +V+EYV       
Sbjct: 71  MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV---AGGE 127
Query: 42  IKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF 101
           +  H +   R    + + Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DF
Sbjct: 128 MFSHLRRIGRFXEPHARFYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDF 185
Query: 102 GSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 157
           G AK  VKG      +C    Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 186 GFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 76/148 (51%), Gaps = 5/148 (3%)
Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
            + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K      +
Sbjct: 159 ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDF 216
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGT 175
             +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + + +
Sbjct: 217 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSS 276
Query: 176 PTREEIK-CMNPNYTEF-KFPQIKAHPW 201
             +  I+ C+    ++   F +I+ HPW
Sbjct: 277 ECQHLIRWCLALRPSDRPTFEEIQNHPW 304

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 76/148 (51%), Gaps = 5/148 (3%)
Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
            + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K      +
Sbjct: 117 ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDF 174
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGT 175
             +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + + +
Sbjct: 175 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSS 234
Query: 176 PTREEIK-CMNPNYTEF-KFPQIKAHPW 201
             +  I+ C+    ++   F +I+ HPW
Sbjct: 235 ECQHLIRWCLALRPSDRPTFEEIQNHPW 262

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 81/176 (46%), Gaps = 27/176 (15%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-------------------DELYLNLVLEYVPETVHRV 41
           M++LD   VV LK    +  EK                   D   L +V+EYV       
Sbjct: 71  MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV---AGGE 127
Query: 42  IKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF 101
           +  H +   R    + + Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DF
Sbjct: 128 MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDF 185
Query: 102 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 157
           G AK  VKG        +  Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 186 GFAK-RVKGR-TWXLXGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 82/177 (46%), Gaps = 29/177 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-------------------DELYLNLVLEYVPETVHRV 41
           M++LD   VV LK    +  EK                   D   L +V+EYV       
Sbjct: 71  MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV---AGGE 127
Query: 42  IKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF 101
           +  H +   R    + + Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DF
Sbjct: 128 MFSHLRRIGRFXEPHARFYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDF 185
Query: 102 GSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 157
           G AK  VKG      +C    Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 186 GFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 55/98 (56%), Gaps = 2/98 (2%)
Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
            + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K      +
Sbjct: 112 ARSFFWQVLEAVRHCHNX-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDF 169
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ 154
             +R Y  PE I     +  +  +WS G +L +++ G 
Sbjct: 170 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 207

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 76/148 (51%), Gaps = 5/148 (3%)
Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
            + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K      +
Sbjct: 151 ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDF 208
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGT 175
             +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + + +
Sbjct: 209 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSS 268
Query: 176 PTREEIK-CMNPNYTEF-KFPQIKAHPW 201
             +  I+ C+    ++   F +I+ HPW
Sbjct: 269 ECQHLIRWCLALRPSDRPTFEEIQNHPW 296

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 76/148 (51%), Gaps = 5/148 (3%)
Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
            + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K      +
Sbjct: 131 ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDF 188
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGT 175
             +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + + +
Sbjct: 189 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSS 248
Query: 176 PTREEIK-CMNPNYTEF-KFPQIKAHPW 201
             +  I+ C+    ++   F +I+ HPW
Sbjct: 249 ECQHLIRWCLALRPSDRPTFEEIQNHPW 276

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 76/148 (51%), Gaps = 5/148 (3%)
Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
            + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K      +
Sbjct: 132 ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDF 189
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGT 175
             +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + + +
Sbjct: 190 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSS 249
Query: 176 PTREEIK-CMNPNYTEF-KFPQIKAHPW 201
             +  I+ C+    ++   F +I+ HPW
Sbjct: 250 ECQHLIRWCLALRPSDRPTFEEIQNHPW 277

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 82/177 (46%), Gaps = 29/177 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-------------------DELYLNLVLEYVPETVHRV 41
           M++LD   VV LK    +  EK                   D   L +V+EYV       
Sbjct: 71  MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV---AGGE 127
Query: 42  IKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF 101
           +  H +   R    + + Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DF
Sbjct: 128 MFSHLRRIGRFXEPHARFYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDF 185
Query: 102 GSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 157
           G AK  VKG      +C    Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 186 GFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 86/171 (50%), Gaps = 22/171 (12%)
Query: 3   LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPET-VHRVIKHHYKMSQRMPLIYVKLYF 61
           +L HPN+++L+          E  L LV+E+     ++RV+       +R+P   +  + 
Sbjct: 62  MLKHPNIIALRGVCLK-----EPNLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWA 111
Query: 62  YQICRALAYIHN--TIGVCHRDIKPQNLLV-------NPHTHQLKLCDFGSAKVLVKGEP 112
            QI R + Y+H+   + + HRD+K  N+L+       +     LK+ DFG A+   +   
Sbjct: 112 VQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR-TT 170
Query: 113 NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 163
            +S   +  + APE+I  A+ ++   D+WS G +L ELL G+  F G  G+
Sbjct: 171 KMSAAGAYAWMAPEVIR-ASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL 220

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 84/165 (50%), Gaps = 16/165 (9%)
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           Y +Q+ R + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K    +    +
Sbjct: 204 YSFQVARGMEFLSSRKCI-HRDLAARNILLS-ENNVVKICDFGLARDIYKNPDYVRKGDT 261
Query: 120 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGT 175
           R    + APE IF    Y+   D+WS G +L E+  LG   +PG       V++ +   +
Sbjct: 262 RLPLKWMAPESIFDKI-YSTKSDVWSYGVLLWEIFSLGGSPYPG-------VQMDEDFCS 313
Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL 220
             RE ++   P Y+  +  QI    WH+  ++R  P   +LV +L
Sbjct: 314 RLREGMRMRAPEYSTPEIYQIMLDCWHRDPKER--PRFAELVEKL 356

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 55/98 (56%), Gaps = 2/98 (2%)
Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
            + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K      +
Sbjct: 139 ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDF 196
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ 154
             +R Y  PE I     +  +  +WS G +L +++ G 
Sbjct: 197 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 234

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 39/99 (39%), Positives = 50/99 (50%), Gaps = 7/99 (7%)
Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 123
           I +AL Y+    GV HRD+KP N+L++    Q+KLCDFG +  LV  +          Y 
Sbjct: 133 IVKALYYLKEKHGVIHRDVKPSNILLDERG-QIKLCDFGISGRLVDDKAKDRSAGCAAYM 191
Query: 124 APELIF----GATEYTAAIDIWSAGCVLAELLLGQPLFP 158
           APE I        +Y    D+WS G  L EL  GQ  FP
Sbjct: 192 APERIDPPDPTKPDYDIRADVWSLGISLVELATGQ--FP 228

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 75/148 (50%), Gaps = 5/148 (3%)
Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
            + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K      +
Sbjct: 144 ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDF 201
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGT 175
             +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + +  
Sbjct: 202 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSX 261
Query: 176 PTREEIK-CMNPNYTEF-KFPQIKAHPW 201
             +  I+ C+    ++   F +I+ HPW
Sbjct: 262 ECQHLIRWCLALRPSDRPTFEEIQNHPW 289

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 75/148 (50%), Gaps = 5/148 (3%)
Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
            + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K      +
Sbjct: 145 ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDF 202
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGT 175
             +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + +  
Sbjct: 203 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSX 262
Query: 176 PTREEIK-CMNPNYTEF-KFPQIKAHPW 201
             +  I+ C+    ++   F +I+ HPW
Sbjct: 263 ECQHLIRWCLALRPSDRPTFEEIQNHPW 290

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 74/257 (28%), Positives = 109/257 (42%), Gaps = 53/257 (20%)
Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYF 61
           L HPN++ L + F+     D   + L+LEY P  E    + K      QR   I      
Sbjct: 80  LHHPNILRLYNYFY-----DRRRIYLILEYAPRGELYKELQKSCTFDEQRTATI-----M 129
Query: 62  YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY 121
            ++  AL Y H    V HRDIKP+NLL+     +LK+ DFG + V        +   +  
Sbjct: 130 EELADALMYCHGK-KVIHRDIKPENLLLG-LKGELKIADFGWS-VHAPSLRRKTMCGTLD 186
Query: 122 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 181
           Y  PE+I G   +   +D+W  G +  ELL+G P F   S  +    I+KV         
Sbjct: 187 YLPPEMIEGRM-HNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKV--------- 236
Query: 182 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFD 241
                   + KFP              +P  A DL+S+LL+++P+ R    +   HP+  
Sbjct: 237 --------DLKFPA------------SVPTGAQDLISKLLRHNPSERLPLAQVSAHPW-- 274
Query: 242 ELRDPNTRLPNGRFLPP 258
                  R  + R LPP
Sbjct: 275 ------VRANSRRVLPP 285

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 82/177 (46%), Gaps = 29/177 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-------------------DELYLNLVLEYVPETVHRV 41
           M++LD   VV LK    +  EK                   D   L +V+EYV       
Sbjct: 71  MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV---AGGE 127
Query: 42  IKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF 101
           +  H +   R    + + Y  QI     Y+H ++ + +RD+KP+NL+++   + +++ DF
Sbjct: 128 MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH-SLDLIYRDLKPENLIIDQQGY-IQVTDF 185
Query: 102 GSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 157
           G AK  VKG      +C    Y APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 186 GFAK-RVKGR--TWXLCGTPEYLAPEIII-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 75/148 (50%), Gaps = 5/148 (3%)
Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
            + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K      +
Sbjct: 145 ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDF 202
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGT 175
             +R Y  PE I     +  +  +WS G +L +++ G  P    E  +   V   + +  
Sbjct: 203 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSX 262
Query: 176 PTREEIK-CMNPNYTEF-KFPQIKAHPW 201
             +  I+ C+    ++   F +I+ HPW
Sbjct: 263 ECQHLIRWCLALRPSDRPTFEEIQNHPW 290

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 55/98 (56%), Gaps = 2/98 (2%)
Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
            + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K      +
Sbjct: 159 ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDF 216
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ 154
             +R Y  PE I     +  +  +WS G +L +++ G 
Sbjct: 217 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 254

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 55/98 (56%), Gaps = 2/98 (2%)
Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
            + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K      +
Sbjct: 164 ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDF 221
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ 154
             +R Y  PE I     +  +  +WS G +L +++ G 
Sbjct: 222 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 259

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 55/98 (56%), Gaps = 2/98 (2%)
Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
            + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K      +
Sbjct: 131 ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDF 188
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ 154
             +R Y  PE I     +  +  +WS G +L +++ G 
Sbjct: 189 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 226

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 55/98 (56%), Gaps = 2/98 (2%)
Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
            + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K      +
Sbjct: 132 ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDF 189
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ 154
             +R Y  PE I     +  +  +WS G +L +++ G 
Sbjct: 190 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 227

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 55/98 (56%), Gaps = 2/98 (2%)
Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
            + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K      +
Sbjct: 132 ARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDF 189
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ 154
             +R Y  PE I     +  +  +WS G +L +++ G 
Sbjct: 190 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 227

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 82/177 (46%), Gaps = 29/177 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-------------------DELYLNLVLEYVPETVHRV 41
           M++LD   VV LK    +  EK                   D   L +V+EYV       
Sbjct: 71  MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV---AGGE 127
Query: 42  IKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF 101
           +  H +   R    + + Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DF
Sbjct: 128 MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDF 185
Query: 102 GSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 157
           G AK  VKG      +C    Y APE+I  +  Y  A+D W+ G ++ ++  G P F
Sbjct: 186 GFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYQMAAGYPPF 238

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 100/241 (41%), Gaps = 39/241 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYV-PETVHRVIKHHYKMSQRMPLIYVKL 59
           M+  D P+VV     +F  T+     L +V+EY    +V  +I+   K      +  +  
Sbjct: 78  MQQCDSPHVVKYYGSYFKNTD-----LWIVMEYCGAGSVSDIIRLRNKTLTEDEIATI-- 130
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
                 + L Y+H    + HRDIK  N+L+N   H  KL DFG A  L       + +  
Sbjct: 131 -LQSTLKGLEYLHFMRKI-HRDIKAGNILLNTEGH-AKLADFGVAGQLTDXMAKRNXVIG 187
Query: 120 R-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 178
             ++ APE+I     Y    DIWS G    E+  G+P +        +  +  +   PT 
Sbjct: 188 TPFWMAPEVI-QEIGYNCVADIWSLGITAIEMAEGKPPYA------DIHPMRAIFMIPT- 239
Query: 179 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 238
                 NP  T F+ P++    W   F         D V + L  SP  R+TA + L HP
Sbjct: 240 ------NPPPT-FRKPEL----WSDNF--------TDFVKQCLVKSPEQRATATQLLQHP 280
Query: 239 F 239
           F
Sbjct: 281 F 281

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/188 (31%), Positives = 85/188 (45%), Gaps = 35/188 (18%)
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNI--- 114
           Y  QI  AL Y H+   + HRD+KP+N+L+    +   +KL DFG A  L  GE  +   
Sbjct: 135 YMRQILEALRYCHDN-NIIHRDVKPENVLLASKENSAPVKLGDFGVAIQL--GESGLVAG 191
Query: 115 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 174
             + + ++ APE++     Y   +D+W  G +L  LL G   F G    ++L E I    
Sbjct: 192 GRVGTPHFMAPEVV-KREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGI---- 244
Query: 175 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 234
              + + K MNP              W  I +      A DLV R+L   P  R T  EA
Sbjct: 245 --IKGKYK-MNP------------RQWSHISES-----AKDLVRRMLMLDPAERITVYEA 284
Query: 235 LIHPFFDE 242
           L HP+  E
Sbjct: 285 LNHPWLKE 292

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/239 (26%), Positives = 99/239 (41%), Gaps = 43/239 (17%)
Query: 22  KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRD 81
           +DE YL LV+EY       ++    K  +R+P    + Y  +I  A+  +H  +G  HRD
Sbjct: 131 QDENYLYLVMEYY--VGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHR-LGYVHRD 187
Query: 82  IKPQNLLVNPHTHQLKLCDFGSA-KVLVKGE-PNISYICSRYYRAPELIFGATEYTAAI- 138
           IKP N+L++   H ++L DFGS  K+   G   ++  + +  Y +PE++           
Sbjct: 188 IKPDNILLDRCGH-IRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGS 246
Query: 139 -----DIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 193
                D W+ G    E+  GQ  F  +S  +   +I+                       
Sbjct: 247 YGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIV----------------------- 283
Query: 194 PQIKAHPWHKIFQKRMPPEAVDLVSRLL--QYSPNLRSTALEALIHPFF-----DELRD 245
              K H    +  + +P EA D + RLL    +   R  A +   HPFF     D LRD
Sbjct: 284 -HYKEHLSLPLVDEGVPEEARDFIQRLLCPPETRLGRGGAGDFRTHPFFFGLDWDGLRD 341

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 102/241 (42%), Gaps = 39/241 (16%)
Query: 2   RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVI-KHHYKMSQRMPLIYVKLY 60
           R L HPN+V L     S  E+   YL   L    E    ++ +  Y  +     I     
Sbjct: 60  RKLQHPNIVRLHD---SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ---- 112
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNISYIC 118
             QI  ++AY H+  G+ HR++KP+NLL+        +KL DFG A  +   E    +  
Sbjct: 113 --QILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAG 169
Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 178
           +  Y +PE +     Y+  +DIW+ G +L  LL+G P F  E    +L   IK       
Sbjct: 170 TPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-HRLYAQIKA------ 221
Query: 179 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 238
                       + +P   +  W  +      PEA  L+  +L  +P  R TA +AL  P
Sbjct: 222 ----------GAYDYP---SPEWDTV-----TPEAKSLIDSMLTVNPKKRITADQALKVP 263
Query: 239 F 239
           +
Sbjct: 264 W 264

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 102/242 (42%), Gaps = 39/242 (16%)
Query: 2   RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVI-KHHYKMSQRMPLIYVKLY 60
           R L HPN+V L     S  E+   YL   L    E    ++ +  Y  +     I     
Sbjct: 59  RKLQHPNIVRLHD---SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ---- 111
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNISYIC 118
             QI  ++AY H+  G+ HR++KP+NLL+        +KL DFG A  +   E    +  
Sbjct: 112 --QILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAG 168
Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 178
           +  Y +PE +     Y+  +DIW+ G +L  LL+G P F  E    +L   IK       
Sbjct: 169 TPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-HRLYAQIKA------ 220
Query: 179 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 238
                       + +P   +  W  +      PEA  L+  +L  +P  R TA +AL  P
Sbjct: 221 ----------GAYDYP---SPEWDTV-----TPEAKSLIDSMLTVNPKKRITADQALKVP 262
Query: 239 FF 240
           + 
Sbjct: 263 WI 264

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 102/242 (42%), Gaps = 39/242 (16%)
Query: 2   RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVI-KHHYKMSQRMPLIYVKLY 60
           R L HPN+V L     S  E+   YL   L    E    ++ +  Y  +     I     
Sbjct: 60  RKLQHPNIVRLHD---SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ---- 112
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNISYIC 118
             QI  ++AY H+  G+ HR++KP+NLL+        +KL DFG A  +   E    +  
Sbjct: 113 --QILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAG 169
Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 178
           +  Y +PE +     Y+  +DIW+ G +L  LL+G P F  E    +L   IK       
Sbjct: 170 TPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-HRLYAQIKA------ 221
Query: 179 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 238
                       + +P   +  W  +      PEA  L+  +L  +P  R TA +AL  P
Sbjct: 222 ----------GAYDYP---SPEWDTV-----TPEAKSLIDSMLTVNPKKRITADQALKVP 263
Query: 239 FF 240
           + 
Sbjct: 264 WI 265

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 63/249 (25%), Positives = 115/249 (46%), Gaps = 46/249 (18%)
Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPET-VHRVIKHHYK-MSQRMPLIYVKLYF 61
           L HP+++ L + F     +D  Y+ LVLE      ++R +K+  K  S+       + + 
Sbjct: 68  LKHPSILELYNYF-----EDSNYVYLVLEMCHNGEMNRYLKNRVKPFSEN----EARHFM 118
Query: 62  YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNISYICSR 120
           +QI   + Y+H+  G+ HRD+   NLL+  +   +K+ DFG A  L +  E + +   + 
Sbjct: 119 HQIITGMLYLHSH-GILHRDLTLSNLLLTRNM-NIKIADFGLATQLKMPHEKHYTLCGTP 176
Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 180
            Y +PE I   + +    D+WS GC+   LL+G+P F  ++  + L +++          
Sbjct: 177 NYISPE-IATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV---------- 225
Query: 181 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
                    +++ P              +  EA DL+ +LL+ +P  R +    L HPF 
Sbjct: 226 -------LADYEMPSF------------LSIEAKDLIHQLLRRNPADRLSLSSVLDHPFM 266
Query: 241 DELRDPNTR 249
              R+ +T+
Sbjct: 267 S--RNSSTK 273

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 85/170 (50%), Gaps = 33/170 (19%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIK---HHYKMSQRMPLIY 56
           MR L+HPNV+     F     KD+  LN + EY+   T+  +IK     Y  SQR+    
Sbjct: 61  MRCLEHPNVLK----FIGVLYKDK-RLNFITEYIKGGTLRGIIKSMDSQYPWSQRVS--- 112
Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV--KGEPN- 113
              +   I   +AY+H ++ + HRD+   N LV  + + + + DFG A+++V  K +P  
Sbjct: 113 ---FAKDIASGMAYLH-SMNIIHRDLNSHNCLVRENKNVV-VADFGLARLMVDEKTQPEG 167
Query: 114 ------------ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL 151
                        + + + Y+ APE+I G + Y   +D++S G VL E++
Sbjct: 168 LRSLKKPDRKKRYTVVGNPYWMAPEMINGRS-YDEKVDVFSFGIVLCEII 216

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 69/244 (28%), Positives = 103/244 (42%), Gaps = 43/244 (17%)
Query: 2   RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVI-KHHYKMSQRMPLIYVKLY 60
           R L HPN+V L     S  E+   YL   L    E    ++ +  Y  +     I     
Sbjct: 83  RKLQHPNIVRLHD---SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ---- 135
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNISYIC 118
             QI  ++AY H+  G+ HR++KP+NLL+        +KL DFG A  +   E    +  
Sbjct: 136 --QILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAG 192
Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQ--LVEIIKVLGTP 176
           +  Y +PE +     Y+  +DIW+ G +L  LL+G P F  E   DQ  L   IK     
Sbjct: 193 TPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDE---DQHRLYAQIKA---- 244
Query: 177 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 236
                         + +P   +  W  +      PEA  L+  +L  +P  R TA +AL 
Sbjct: 245 ------------GAYDYP---SPEWDTV-----TPEAKSLIDSMLTVNPKKRITADQALK 284
Query: 237 HPFF 240
            P+ 
Sbjct: 285 VPWI 288

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 81/177 (45%), Gaps = 29/177 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-------------------DELYLNLVLEYVPETVHRV 41
           M++LD   VV LK    +  EK                   D   L +V+EYV       
Sbjct: 71  MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE--- 127
Query: 42  IKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF 101
           +  H +   R    + + Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DF
Sbjct: 128 MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDF 185
Query: 102 GSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 157
           G AK  VKG      +C    Y AP +I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 186 GFAK-RVKGR--TWXLCGTPEYLAPAIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/134 (31%), Positives = 70/134 (52%), Gaps = 23/134 (17%)
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK-------VLVKGEPN 113
           F QI  AL+YIH+  G+ HRD+KP N+ ++  +  +K+ DFG AK       +L     N
Sbjct: 122 FRQILEALSYIHSQ-GIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 114 I--------SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQ 165
           +        S I +  Y A E++ G   Y   ID++S G +  E+     ++P  +G+++
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM-----IYPFSTGMER 234
Query: 166 LVEIIKVLGTPTRE 179
            V I+K L + + E
Sbjct: 235 -VNILKKLRSVSIE 247

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 75/165 (45%), Gaps = 21/165 (12%)
Query: 2   RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLI--YVKL 59
           +L  HPN+V          E+ +      L        ++++   KM  R PL    V  
Sbjct: 81  KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK 140
Query: 60  YFYQICRALAYIHNTIG-VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 118
            FYQ CRA+ ++H     + HRD+K +NLL++ +   +KLCDFGSA   +   P+ S+  
Sbjct: 141 IFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS-NQGTIKLCDFGSATT-ISHYPDYSWSA 198
Query: 119 SR--------------YYRAPELIFGATEY--TAAIDIWSAGCVL 147
            R               YR PE+I   + +      DIW+ GC+L
Sbjct: 199 QRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCIL 243

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/134 (31%), Positives = 70/134 (52%), Gaps = 23/134 (17%)
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK-------VLVKGEPN 113
           F QI  AL+YIH+  G+ HRD+KP N+ ++  +  +K+ DFG AK       +L     N
Sbjct: 122 FRQILEALSYIHSQ-GIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 114 I--------SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQ 165
           +        S I +  Y A E++ G   Y   ID++S G +  E+     ++P  +G+++
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM-----IYPFSTGMER 234
Query: 166 LVEIIKVLGTPTRE 179
            V I+K L + + E
Sbjct: 235 -VNILKKLRSVSIE 247

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 81/177 (45%), Gaps = 29/177 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEK-------------------DELYLNLVLEYVPETVHRV 41
           M++LD   VV LK    +  EK                   D   L +V+EYV       
Sbjct: 71  MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV---AGGE 127
Query: 42  IKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF 101
           +  H +   R    + + Y  QI     Y+H ++ + +RD+KP+NLL++   + +++ DF
Sbjct: 128 MFSHLRRIGRFSEPHARFYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDF 185
Query: 102 GSAKVLVKGEPNISYICSR-YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF 157
           G AK  VKG      +C      APE+I  +  Y  A+D W+ G ++ E+  G P F
Sbjct: 186 GFAK-RVKGR--TWXLCGTPEALAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 91/197 (46%), Gaps = 29/197 (14%)
Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYIC-SR 120
           I  A+ ++H+   + HRD+KP+NLL         LKL DFG AK   +    +   C + 
Sbjct: 137 IGTAIQFLHSH-NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPCYTP 193
Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 180
           YY APE + G  +Y  + D+WS G ++  LL G P F   +G        + +    +  
Sbjct: 194 YYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTG--------QAISPGMKRR 244
Query: 181 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
           I+       ++ FP  +   W ++ +     +A  L+  LL+  P  R T  + + HP+ 
Sbjct: 245 IR-----LGQYGFPNPE---WSEVSE-----DAKQLIRLLLKTDPTERLTITQFMNHPWI 291
Query: 241 DE-LRDPNTRLPNGRFL 256
           ++ +  P T L   R L
Sbjct: 292 NQSMVVPQTPLHTARVL 308

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 115/261 (44%), Gaps = 40/261 (15%)
Query: 22  KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRD 81
           +DE +L LV++Y       ++    K   ++P    + Y  ++  A+  IH  +   HRD
Sbjct: 144 QDENHLYLVMDYY--VGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQ-LHYVHRD 200
Query: 82  IKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISY-ICSRYYRAPELI----FGATEYT 135
           IKP N+L++ + H ++L DFGS  K+   G    S  + +  Y +PE++     G  +Y 
Sbjct: 201 IKPDNVLLDVNGH-IRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYG 259
Query: 136 AAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE-FKFP 194
              D WS G  + E+L G+  F  ES V+   +I+                N+ E F+FP
Sbjct: 260 PECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM----------------NHEERFQFP 303
Query: 195 QIKAHPWHKIFQKRMPPEAVDLVSRLL-QYSPNLRSTALEAL-IHPFFDELRDPNTRLPN 252
              +H         +  EA DL+ RL+      L    +E    H FF+ L   N R   
Sbjct: 304 ---SHV------TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGLNWENIRNLE 354
Query: 253 GRFLPPLFNFKPHELKGVPVD 273
             ++P + +  P +     VD
Sbjct: 355 APYIPDVSS--PSDTSNFDVD 373

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 91/197 (46%), Gaps = 29/197 (14%)
Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYIC-SR 120
           I  A+ ++H+   + HRD+KP+NLL         LKL DFG AK   +    +   C + 
Sbjct: 118 IGTAIQFLHSH-NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPCYTP 174
Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 180
           YY APE + G  +Y  + D+WS G ++  LL G P F   +G        + +    +  
Sbjct: 175 YYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTG--------QAISPGMKRR 225
Query: 181 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
           I+       ++ FP  +   W ++ +     +A  L+  LL+  P  R T  + + HP+ 
Sbjct: 226 IR-----LGQYGFPNPE---WSEVSE-----DAKQLIRLLLKTDPTERLTITQFMNHPWI 272
Query: 241 DE-LRDPNTRLPNGRFL 256
           ++ +  P T L   R L
Sbjct: 273 NQSMVVPQTPLHTARVL 289

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 115/260 (44%), Gaps = 38/260 (14%)
Query: 22  KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRD 81
           +DE +L LV++Y       ++    K   ++P    + Y  ++  A+  IH  +   HRD
Sbjct: 160 QDENHLYLVMDYY--VGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQ-LHYVHRD 216
Query: 82  IKPQNLLVNPHTHQLKLCDFGSA-KVLVKGEPNISY-ICSRYYRAPELI----FGATEYT 135
           IKP N+L++ + H ++L DFGS  K+   G    S  + +  Y +PE++     G  +Y 
Sbjct: 217 IKPDNVLLDVNGH-IRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYG 275
Query: 136 AAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 195
              D WS G  + E+L G+  F  ES       +++  G       K MN +   F+FP 
Sbjct: 276 PECDWWSLGVCMYEMLYGETPFYAES-------LVETYG-------KIMN-HEERFQFP- 319
Query: 196 IKAHPWHKIFQKRMPPEAVDLVSRLL-QYSPNLRSTALEAL-IHPFFDELRDPNTRLPNG 253
             +H         +  EA DL+ RL+      L    +E    H FF+ L   N R    
Sbjct: 320 --SHV------TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGLNWENIRNLEA 371
Query: 254 RFLPPLFNFKPHELKGVPVD 273
            ++P + +  P +     VD
Sbjct: 372 PYIPDVSS--PSDTSNFDVD 389

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/132 (34%), Positives = 67/132 (50%), Gaps = 15/132 (11%)
Query: 27  LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQN 86
           L LV+EY+P    R     ++   R+    + LY  QIC+ + Y+ +   V HRD+  +N
Sbjct: 85  LRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGSRRCV-HRDLAARN 141
Query: 87  LLVNPHTHQLKLCDFGSAKVL-------VKGEPNISYICSRYYRAPELIFGATEYTAAID 139
           +LV    H +K+ DFG AK+L       V  EP  S I   ++ APE +     ++   D
Sbjct: 142 ILVESEAH-VKIADFGLAKLLPLDKDXXVVREPGQSPI---FWYAPESL-SDNIFSRQSD 196
Query: 140 IWSAGCVLAELL 151
           +WS G VL EL 
Sbjct: 197 VWSFGVVLYELF 208

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 108/268 (40%), Gaps = 75/268 (27%)
Query: 41  VIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQN-------------- 86
           +IK +Y   Q +P+  VK    Q+ + L Y+H+   + H DIKP+N              
Sbjct: 129 IIKSNY---QGLPVRCVKSIIRQVLQGLDYLHSKCKIIHTDIKPENILMCVDDAYVRRMA 185
Query: 87  --------------------------LLVNP------HTHQLKLCDFGSAKVLVKGEPNI 114
                                     LLVNP         ++K+ D G+A  + K     
Sbjct: 186 AEATEWQKAGAPPPSGSAVSTAPAADLLVNPLDPRNADKIRVKIADLGNACWVHK--HFT 243
Query: 115 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG------VDQLVE 168
             I +R YR+ E++ GA  Y+   DIWS  C+  EL  G  LF   SG       D +  
Sbjct: 244 EDIQTRQYRSIEVLIGAG-YSTPADIWSTACMAFELATGDYLFEPHSGEDYSRDEDHIAH 302
Query: 169 IIKVLGTPTREEIKCMNPNYTEFKFPQ-------IKAHPW---HKIFQKRMPP-----EA 213
           II++LG+  R     ++  Y+   F +        K  PW     + +K   P     + 
Sbjct: 303 IIELLGSIPRH--FALSGKYSREFFNRRGELRHITKLKPWSLFDVLVEKYGWPHEDAAQF 360
Query: 214 VDLVSRLLQYSPNLRSTALEALIHPFFD 241
            D +  +L+  P  R++A E L HP+ +
Sbjct: 361 TDFLIPMLEMVPEKRASAGECLRHPWLN 388

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 75/167 (44%), Gaps = 11/167 (6%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           +R L HPN+V     +    ++    L +V+EY     +  VI    K  Q +   +V  
Sbjct: 59  LRELKHPNIVRY---YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLR 115
Query: 60  YFYQICRALAYIHNTIG----VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NI 114
              Q+  AL   H        V HRD+KP N+ ++     +KL DFG A++L   E    
Sbjct: 116 VMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDEDFAK 174
Query: 115 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 161
            ++ + YY +PE +     Y    DIWS GC+L EL    P F   S
Sbjct: 175 EFVGTPYYMSPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/132 (34%), Positives = 67/132 (50%), Gaps = 15/132 (11%)
Query: 27  LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQN 86
           L LV+EY+P    R     ++   R+    + LY  QIC+ + Y+ +   V HRD+  +N
Sbjct: 88  LRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGSRRCV-HRDLAARN 144
Query: 87  LLVNPHTHQLKLCDFGSAKVL-------VKGEPNISYICSRYYRAPELIFGATEYTAAID 139
           +LV    H +K+ DFG AK+L       V  EP  S I   ++ APE +     ++   D
Sbjct: 145 ILVESEAH-VKIADFGLAKLLPLDKDYYVVREPGQSPI---FWYAPESL-SDNIFSRQSD 199
Query: 140 IWSAGCVLAELL 151
           +WS G VL EL 
Sbjct: 200 VWSFGVVLYELF 211

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 100/236 (42%), Gaps = 38/236 (16%)
Query: 47  KMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA-K 105
           K   R+P    + Y  ++  A+  +H  +   HRDIKP N+L++ + H ++L DFGS  K
Sbjct: 167 KFEDRLPEEMARFYLAEMVIAIDSVHQ-LHYVHRDIKPDNILMDMNGH-IRLADFGSCLK 224
Query: 106 VLVKGEPNISY-ICSRYYRAPELI----FGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 160
           ++  G    S  + +  Y +PE++     G   Y    D WS G  + E+L G+  F  E
Sbjct: 225 LMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 284
Query: 161 SGVDQLVEIIKVLGTPTREEIKCMNPNYTE-FKFPQIKAHPWHKIFQKRMPPEAVDLVSR 219
           S V+   +I+                N+ E F+FP              +   A DL+ R
Sbjct: 285 SLVETYGKIM----------------NHKERFQFPTQVTD---------VSENAKDLIRR 319
Query: 220 LL-QYSPNLRSTALEAL-IHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVD 273
           L+      L    +E    HPFF  +   N R     ++P + +  P +     VD
Sbjct: 320 LICSREHRLGQNGIEDFKKHPFFSGIDWDNIRNCEAPYIPEVSS--PTDTSNFDVD 373

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/132 (34%), Positives = 67/132 (50%), Gaps = 15/132 (11%)
Query: 27  LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQN 86
           L LV+EY+P    R     ++   R+    + LY  QIC+ + Y+ +   V HRD+  +N
Sbjct: 89  LRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGSRRCV-HRDLAARN 145
Query: 87  LLVNPHTHQLKLCDFGSAKVL-------VKGEPNISYICSRYYRAPELIFGATEYTAAID 139
           +LV    H +K+ DFG AK+L       V  EP  S I   ++ APE +     ++   D
Sbjct: 146 ILVESEAH-VKIADFGLAKLLPLDKDYYVVREPGQSPI---FWYAPESL-SDNIFSRQSD 200
Query: 140 IWSAGCVLAELL 151
           +WS G VL EL 
Sbjct: 201 VWSFGVVLYELF 212

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/132 (34%), Positives = 67/132 (50%), Gaps = 15/132 (11%)
Query: 27  LNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQN 86
           L LV+EY+P    R     ++   R+    + LY  QIC+ + Y+ +   V HRD+  +N
Sbjct: 101 LRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGSRRCV-HRDLAARN 157
Query: 87  LLVNPHTHQLKLCDFGSAKVL-------VKGEPNISYICSRYYRAPELIFGATEYTAAID 139
           +LV    H +K+ DFG AK+L       V  EP  S I   ++ APE +     ++   D
Sbjct: 158 ILVESEAH-VKIADFGLAKLLPLDKDYYVVREPGQSPI---FWYAPESL-SDNIFSRQSD 212
Query: 140 IWSAGCVLAELL 151
           +WS G VL EL 
Sbjct: 213 VWSFGVVLYELF 224

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 85/171 (49%), Gaps = 16/171 (9%)
Query: 6   HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQIC 65
           HP++V + +    T    +    +V+EYV     +  K      Q++P+     Y  +I 
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK-----GQKLPVAEAIAYLLEIL 192
Query: 66  RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI-CSRYYRA 124
            AL+Y+H +IG+ + D+KP+N+++     QLKL D G+   +     +  Y+  +  ++A
Sbjct: 193 PALSYLH-SIGLVYNDLKPENIMLT--EEQLKLIDLGAVSRI----NSFGYLYGTPGFQA 245
Query: 125 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
           PE++   T  T A DI++ G  LA L L  P   G   VD L E   VL T
Sbjct: 246 PEIV--RTGPTVATDIYTVGRTLAALTLDLPTRNGRY-VDGLPEDDPVLKT 293

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 54/94 (57%), Gaps = 4/94 (4%)
Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRY 121
           +I + L Y+H+   + HRDIK  N+L++ H  ++KL DFG A  L   +    +++ + +
Sbjct: 112 EILKGLDYLHSEKKI-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNTFVGTPF 169
Query: 122 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQP 155
           + APE+I   + Y +  DIWS G    EL  G+P
Sbjct: 170 WMAPEVI-KQSAYDSKADIWSLGITAIELARGEP 202

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 54/94 (57%), Gaps = 4/94 (4%)
Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRY 121
           +I + L Y+H+   + HRDIK  N+L++ H  ++KL DFG A  L   +    +++ + +
Sbjct: 132 EILKGLDYLHSEKKI-HRDIKAANVLLSEH-GEVKLADFGVAGQLTDTQIKRNTFVGTPF 189
Query: 122 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQP 155
           + APE+I   + Y +  DIWS G    EL  G+P
Sbjct: 190 WMAPEVI-KQSAYDSKADIWSLGITAIELARGEP 222

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 77/165 (46%), Gaps = 13/165 (7%)
Query: 7   PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 66
           P +  L  CF +    D LY   V+EYV       + +H +   R    +   Y  +I  
Sbjct: 81  PFLTQLHSCFQTM---DRLYF--VMEYVNGGD---LMYHIQQVGRFKEPHAVFYAAEIAI 132
Query: 67  ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAP 125
            L ++ +  G+ +RD+K  N++++   H +K+ DFG  K  +         C    Y AP
Sbjct: 133 GLFFLQSK-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKXFCGTPDYIAP 190
Query: 126 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 170
           E+I     Y  ++D W+ G +L E+L GQ  F GE   D+L + I
Sbjct: 191 EII-AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSI 233

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 66/270 (24%), Positives = 103/270 (38%), Gaps = 77/270 (28%)
Query: 41  VIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV----------- 89
           +IK +Y   Q +PL  VK    Q+ + L Y+H    + H DIKP+N+L+           
Sbjct: 135 IIKSNY---QGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA 191
Query: 90  -------------------------------------NPHTHQLKLCDFGSAKVLVKGEP 112
                                                N    ++K+ D G+A  + K   
Sbjct: 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--H 249
Query: 113 NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV------DQL 166
               I +R YR+ E++ G+  Y    DIWS  C+  EL  G  LF   SG       D +
Sbjct: 250 FTEDIQTRQYRSLEVLIGSG-YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHI 308
Query: 167 VEIIKVLGTPTREEIKCMNPNYTEFKFPQ-------IKAHPWHKI--------FQKRMPP 211
             II++LG   R+ I  +   Y++  F +        K  PW           + +    
Sbjct: 309 ALIIELLGKVPRKLI--VAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAA 366
Query: 212 EAVDLVSRLLQYSPNLRSTALEALIHPFFD 241
              D +  +L+  P  R+TA E L HP+ +
Sbjct: 367 GFTDFLLPMLELIPEKRATAAECLRHPWLN 396

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 66/270 (24%), Positives = 103/270 (38%), Gaps = 77/270 (28%)
Query: 41  VIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV----------- 89
           +IK +Y   Q +PL  VK    Q+ + L Y+H    + H DIKP+N+L+           
Sbjct: 119 IIKSNY---QGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA 175
Query: 90  -------------------------------------NPHTHQLKLCDFGSAKVLVKGEP 112
                                                N    ++K+ D G+A  + K   
Sbjct: 176 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--H 233
Query: 113 NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV------DQL 166
               I +R YR+ E++ G+  Y    DIWS  C+  EL  G  LF   SG       D +
Sbjct: 234 FTEDIQTRQYRSLEVLIGSG-YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHI 292
Query: 167 VEIIKVLGTPTREEIKCMNPNYTEFKFPQ-------IKAHPWHKI--------FQKRMPP 211
             II++LG   R+ I  +   Y++  F +        K  PW           + +    
Sbjct: 293 ALIIELLGKVPRKLI--VAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAA 350
Query: 212 EAVDLVSRLLQYSPNLRSTALEALIHPFFD 241
              D +  +L+  P  R+TA E L HP+ +
Sbjct: 351 GFTDFLLPMLELIPEKRATAAECLRHPWLN 380

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 74/151 (49%), Gaps = 13/151 (8%)
Query: 6   HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY--VKLYFYQ 63
           HP V+ L   F    E  E ++ LVLE  P     +  +   ++++ PL     + +F Q
Sbjct: 97  HPGVIRLLDWF----ETQEGFM-LVLER-PLPAQDLFDY---ITEKGPLGEGPSRCFFGQ 147
Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 123
           +  A+ + H+  GV HRDIK +N+L++      KL DFGS   L+  EP   +  +R Y 
Sbjct: 148 VVAAIQHCHSR-GVVHRDIKDENILIDLRRGCAKLIDFGSG-ALLHDEPYTDFDGTRVYS 205
Query: 124 APELIFGATEYTAAIDIWSAGCVLAELLLGQ 154
            PE I     +     +WS G +L +++ G 
Sbjct: 206 PPEWISRHQYHALPATVWSLGILLYDMVCGD 236

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/253 (23%), Positives = 105/253 (41%), Gaps = 40/253 (15%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           +R + HPN+++L   F + T+     + L+LE V    +   +     +++     ++K 
Sbjct: 62  LREIRHPNIITLHDIFENKTD-----VVLILELVSGGELFDFLAEKESLTEDEATQFLK- 115
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISY 116
              QI   + Y+H+   + H D+KP+N+++   N    ++KL DFG A  +  G    + 
Sbjct: 116 ---QILDGVHYLHSK-RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNI 171
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
             +  + APE++          D+WS G +   LL G   F GE+  + L  I       
Sbjct: 172 FGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNI------- 223
Query: 177 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 236
                  +N ++ E  F                   A D + RLL   P  R T  ++L 
Sbjct: 224 -----SAVNYDFDEEYFSN-------------TSELAKDFIRRLLVKDPKRRMTIAQSLE 265
Query: 237 HPFFDELRDPNTR 249
           H +   +R  N R
Sbjct: 266 HSWIKAIRRRNVR 278

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 86/176 (48%), Gaps = 15/176 (8%)
Query: 52  MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 111
           + L ++  Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K  
Sbjct: 145 LTLEHLIXYSFQVAKGMEFLASRKXI-HRDLAARNILLS-EKNVVKICDFGLARDIXKDP 202
Query: 112 PNISYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLV 167
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 203 DXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 254
Query: 168 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 222
           +I +      +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 255 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 78/157 (49%), Gaps = 16/157 (10%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHR--VIKHHYKMSQRMPLIYVK 58
           +R L H N+V  K      TE     + L++E++P    +  + K+  K++ +  L Y  
Sbjct: 77  LRNLYHENIVKYKGI---CTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYA- 132
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 118
               QIC+ + Y+ +   V HRD+  +N+LV    HQ+K+ DFG  K +   +   +   
Sbjct: 133 ---VQICKGMDYLGSRQYV-HRDLAARNVLVESE-HQVKIGDFGLTKAIETDKEXXTVKD 187
Query: 119 SR----YYRAPELIFGATEYTAAIDIWSAGCVLAELL 151
            R    ++ APE +  +  Y A+ D+WS G  L ELL
Sbjct: 188 DRDSPVFWYAPECLMQSKFYIAS-DVWSFGVTLHELL 223

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 77/165 (46%), Gaps = 13/165 (7%)
Query: 7   PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR 66
           P +  L  CF +    D LY   V+EYV       + +H +   R    +   Y  +I  
Sbjct: 402 PFLTQLHSCFQTM---DRLYF--VMEYVNGGD---LMYHIQQVGRFKEPHAVFYAAEIAI 453
Query: 67  ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR-YYRAP 125
            L ++ +  G+ +RD+K  N++++   H +K+ DFG  K  +         C    Y AP
Sbjct: 454 GLFFLQSK-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKXFCGTPDYIAP 511
Query: 126 ELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 170
           E+I     Y  ++D W+ G +L E+L GQ  F GE   D+L + I
Sbjct: 512 EII-AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSI 554

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 78/157 (49%), Gaps = 16/157 (10%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHR--VIKHHYKMSQRMPLIYVK 58
           +R L H N+V  K      TE     + L++E++P    +  + K+  K++ +  L Y  
Sbjct: 65  LRNLYHENIVKYKGI---CTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYA- 120
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 118
               QIC+ + Y+ +   V HRD+  +N+LV    HQ+K+ DFG  K +   +   +   
Sbjct: 121 ---VQICKGMDYLGSRQYV-HRDLAARNVLVESE-HQVKIGDFGLTKAIETDKEXXTVKD 175
Query: 119 SR----YYRAPELIFGATEYTAAIDIWSAGCVLAELL 151
            R    ++ APE +  +  Y A+ D+WS G  L ELL
Sbjct: 176 DRDSPVFWYAPECLMQSKFYIAS-DVWSFGVTLHELL 211

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 53/94 (56%), Gaps = 4/94 (4%)
Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRY 121
           +I + L Y+H+   + HRDIK  N+L++ H  ++KL DFG A  L   +     ++ + +
Sbjct: 112 EILKGLDYLHSEKKI-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNXFVGTPF 169
Query: 122 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQP 155
           + APE+I   + Y +  DIWS G    EL  G+P
Sbjct: 170 WMAPEVI-KQSAYDSKADIWSLGITAIELARGEP 202

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 53/94 (56%), Gaps = 4/94 (4%)
Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRY 121
           +I + L Y+H+   + HRDIK  N+L++ H  ++KL DFG A  L   +     ++ + +
Sbjct: 127 EILKGLDYLHSEKKI-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNXFVGTPF 184
Query: 122 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQP 155
           + APE+I   + Y +  DIWS G    EL  G+P
Sbjct: 185 WMAPEVI-KQSAYDSKADIWSLGITAIELARGEP 217

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 109/246 (44%), Gaps = 44/246 (17%)
Query: 5   DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQI 64
           +HPNV+      +  TEKD  +  + +E    T+   ++   K    + L  + L   Q 
Sbjct: 76  EHPNVIR-----YFCTEKDRQFQYIAIELCAATLQEYVEQ--KDFAHLGLEPITL-LQQT 127
Query: 65  CRALAYIHNTIGVCHRDIKPQNLLVN-PHTH---QLKLCDFGSAKVLVKGEPNISYIC-- 118
              LA++H ++ + HRD+KP N+L++ P+ H   +  + DFG  K L  G  + S     
Sbjct: 128 TSGLAHLH-SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGV 186
Query: 119 --SRYYRAPELIFGATEY--TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 174
             +  + APE++    +   T  +DI+SAGCV    ++ +   P    + +   I+  LG
Sbjct: 187 PGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFY-YVISEGSHPFGKSLQRQANIL--LG 243
Query: 175 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 234
             +   + C++P                   +K     A +L+ +++   P  R +A   
Sbjct: 244 ACS---LDCLHP-------------------EKHEDVIARELIEKMIAMDPQKRPSAKHV 281
Query: 235 LIHPFF 240
           L HPFF
Sbjct: 282 LKHPFF 287

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 75/167 (44%), Gaps = 11/167 (6%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           +R L HPN+V     +    ++    L +V+EY     +  VI    K  Q +   +V  
Sbjct: 59  LRELKHPNIVRY---YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLR 115
Query: 60  YFYQICRALAYIHNTIG----VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NI 114
              Q+  AL   H        V HRD+KP N+ ++     +KL DFG A++L        
Sbjct: 116 VMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAK 174
Query: 115 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 161
           +++ + YY +PE +     Y    DIWS GC+L EL    P F   S
Sbjct: 175 TFVGTPYYMSPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 82/168 (48%), Gaps = 15/168 (8%)
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K    +    +
Sbjct: 153 YSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIXKDPDXVRKGDA 210
Query: 120 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGT 175
           R    + APE IF    YT   D+WS G +L E+  LG   +PG       V+I +    
Sbjct: 211 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFCR 262
Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 222
             +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 263 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 86/176 (48%), Gaps = 15/176 (8%)
Query: 52  MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 111
           + L ++  Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K  
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIXKDP 202
Query: 112 PNISYICSRY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLV 167
             +    +R    + APE IF    YT   D+WS G +L E+  LG   +PG       V
Sbjct: 203 DXVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------V 254
Query: 168 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 222
           +I +      +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 255 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 79/158 (50%), Gaps = 20/158 (12%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           +R L H +++  K C     EK    L LV+EYVP    R     Y     + L  + L+
Sbjct: 70  LRTLYHEHIIKYKGCCEDQGEKS---LQLVMEYVPLGSLR----DYLPRHSIGLAQLLLF 122
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPN 113
             QIC  +AY+H+   + HR++  +N+L++ +   +K+ DFG AK + +G       E  
Sbjct: 123 AQQICEGMAYLHSQHYI-HRNLAARNVLLD-NDRLVKIGDFGLAKAVPEGHEYYRVREDG 180
Query: 114 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL 151
            S +   ++ APE +     Y A+ D+WS G  L ELL
Sbjct: 181 DSPV---FWYAPECLKEYKFYYAS-DVWSFGVTLYELL 214

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 75/167 (44%), Gaps = 11/167 (6%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           +R L HPN+V     +    ++    L +V+EY     +  VI    K  Q +   +V  
Sbjct: 59  LRELKHPNIVRY---YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLR 115
Query: 60  YFYQICRALAYIHNTIG----VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NI 114
              Q+  AL   H        V HRD+KP N+ ++     +KL DFG A++L        
Sbjct: 116 VMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAK 174
Query: 115 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 161
           +++ + YY +PE +     Y    DIWS GC+L EL    P F   S
Sbjct: 175 AFVGTPYYMSPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 74/167 (44%), Gaps = 18/167 (10%)
Query: 2   RLLDHPNVVSL-KHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           RL +HPN++ L  +C      K E +L L   +   T+   I+        +    +   
Sbjct: 81  RLFNHPNILRLVAYCLRERGAKHEAWLLLPF-FKRGTLWNEIERLKDKGNFLTEDQILWL 139
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS---AKVLVKG------- 110
              ICR L  IH   G  HRD+KP N+L+     Q  L D GS   A + V+G       
Sbjct: 140 LLGICRGLEAIHAK-GYAHRDLKPTNILLGDEG-QPVLMDLGSMNQACIHVEGSRQALTL 197
Query: 111 EPNISYICSRYYRAPELIFGATEYTA---AIDIWSAGCVLAELLLGQ 154
           +   +  C+  YRAPEL F    +       D+WS GCVL  ++ G+
Sbjct: 198 QDWAAQRCTISYRAPEL-FSVQSHCVIDERTDVWSLGCVLYAMMFGE 243

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 82/168 (48%), Gaps = 15/168 (8%)
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K    +    +
Sbjct: 144 YSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIXKDPDXVRKGDA 201
Query: 120 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGT 175
           R    + APE IF    YT   D+WS G +L E+  LG   +PG       V+I +    
Sbjct: 202 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFCR 253
Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 222
             +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 254 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 301

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 82/168 (48%), Gaps = 15/168 (8%)
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K    +    +
Sbjct: 153 YSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIYKDPDXVRKGDA 210
Query: 120 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGT 175
           R    + APE IF    YT   D+WS G +L E+  LG   +PG       V+I +    
Sbjct: 211 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFCR 262
Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 222
             +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 263 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 82/168 (48%), Gaps = 15/168 (8%)
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K    +    +
Sbjct: 149 YSFQVAKGMEFLASRKXI-HRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDA 206
Query: 120 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGT 175
           R    + APE IF    YT   D+WS G +L E+  LG   +PG       V+I +    
Sbjct: 207 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFCR 258
Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 222
             +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 259 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 306

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 82/168 (48%), Gaps = 15/168 (8%)
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K    +    +
Sbjct: 144 YSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIXKDPDXVRKGDA 201
Query: 120 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGT 175
           R    + APE IF    YT   D+WS G +L E+  LG   +PG       V+I +    
Sbjct: 202 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFCR 253
Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 222
             +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 254 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 301

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 82/168 (48%), Gaps = 15/168 (8%)
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K    +    +
Sbjct: 203 YSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDA 260
Query: 120 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGT 175
           R    + APE IF    YT   D+WS G +L E+  LG   +PG       V+I +    
Sbjct: 261 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFCR 312
Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 222
             +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 313 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 360

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 82/168 (48%), Gaps = 15/168 (8%)
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K    +    +
Sbjct: 153 YSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDA 210
Query: 120 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGT 175
           R    + APE IF    YT   D+WS G +L E+  LG   +PG       V+I +    
Sbjct: 211 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFCR 262
Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 222
             +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 263 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 82/168 (48%), Gaps = 15/168 (8%)
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K    +    +
Sbjct: 190 YSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDA 247
Query: 120 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGT 175
           R    + APE IF    YT   D+WS G +L E+  LG   +PG       V+I +    
Sbjct: 248 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFCR 299
Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 222
             +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 300 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 78/158 (49%), Gaps = 20/158 (12%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           +R L H +++  K C     EK    L LV+EYVP    R     Y     + L  + L+
Sbjct: 70  LRTLYHEHIIKYKGCCEDQGEKS---LQLVMEYVPLGSLR----DYLPRHSIGLAQLLLF 122
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPN 113
             QIC  +AY+H    + HR++  +N+L++ +   +K+ DFG AK + +G       E  
Sbjct: 123 AQQICEGMAYLHAQHYI-HRNLAARNVLLD-NDRLVKIGDFGLAKAVPEGHEYYRVREDG 180
Query: 114 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL 151
            S +   ++ APE +     Y A+ D+WS G  L ELL
Sbjct: 181 DSPV---FWYAPECLKEYKFYYAS-DVWSFGVTLYELL 214

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 82/168 (48%), Gaps = 15/168 (8%)
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K    +    +
Sbjct: 196 YSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDA 253
Query: 120 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGT 175
           R    + APE IF    YT   D+WS G +L E+  LG   +PG       V+I +    
Sbjct: 254 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFCR 305
Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 222
             +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 306 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 353

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 82/168 (48%), Gaps = 15/168 (8%)
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K    +    +
Sbjct: 205 YSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDA 262
Query: 120 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGT 175
           R    + APE IF    YT   D+WS G +L E+  LG   +PG       V+I +    
Sbjct: 263 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFCR 314
Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 222
             +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 315 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 362

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 82/168 (48%), Gaps = 15/168 (8%)
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K    +    +
Sbjct: 198 YSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDA 255
Query: 120 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGT 175
           R    + APE IF    YT   D+WS G +L E+  LG   +PG       V+I +    
Sbjct: 256 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFCR 307
Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 222
             +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 308 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 82/168 (48%), Gaps = 15/168 (8%)
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K    +    +
Sbjct: 155 YSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDA 212
Query: 120 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGT 175
           R    + APE IF    YT   D+WS G +L E+  LG   +PG       V+I +    
Sbjct: 213 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFCR 264
Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 222
             +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 265 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 312

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/250 (24%), Positives = 99/250 (39%), Gaps = 35/250 (14%)
Query: 6   HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY----VKLYF 61
           HPN+VS    + S   KDEL+L + L     +V  +IKH     +    +     +    
Sbjct: 72  HPNIVSY---YTSFVVKDELWLVMKL-LSGGSVLDIIKHIVAKGEHKSGVLDESTIATIL 127
Query: 62  YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG------EPNIS 115
            ++   L Y+H   G  HRD+K  N+L+      +++ DFG +  L  G      +   +
Sbjct: 128 REVLEGLEYLHKN-GQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNKVRKT 185
Query: 116 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
           ++ +  + APE++     Y    DIWS G    EL  G    P        V ++ +   
Sbjct: 186 FVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAA--PYHKYPPMKVLMLTLQND 243
Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 235
           P                 P ++     K   K+       ++S  LQ  P  R TA E L
Sbjct: 244 P-----------------PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 286
Query: 236 IHPFFDELRD 245
            H FF + ++
Sbjct: 287 RHKFFQKAKN 296

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 82/168 (48%), Gaps = 15/168 (8%)
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K    +    +
Sbjct: 144 YSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDA 201
Query: 120 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGT 175
           R    + APE IF    YT   D+WS G +L E+  LG   +PG       V+I +    
Sbjct: 202 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFCR 253
Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 222
             +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 254 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 301

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 82/168 (48%), Gaps = 15/168 (8%)
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+CDFG A+ + K    +    +
Sbjct: 144 YSFQVAKGMEFLASRKCI-HRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDA 201
Query: 120 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGT 175
           R    + APE IF    YT   D+WS G +L E+  LG   +PG       V+I +    
Sbjct: 202 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFCR 253
Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 222
             +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 254 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 301

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 77/158 (48%), Gaps = 20/158 (12%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           +R L H +++  K C     +     L LV+EYVP    R     Y     + L  + L+
Sbjct: 87  LRTLYHEHIIKYKGC---CEDAGAASLQLVMEYVPLGSLR----DYLPRHSIGLAQLLLF 139
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPN 113
             QIC  +AY+H    + HRD+  +N+L++ +   +K+ DFG AK + +G       E  
Sbjct: 140 AQQICEGMAYLHAQHYI-HRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGHEXYRVREDG 197
Query: 114 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL 151
            S +   ++ APE +     Y A+ D+WS G  L ELL
Sbjct: 198 DSPV---FWYAPECLKEYKFYYAS-DVWSFGVTLYELL 231

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/249 (24%), Positives = 98/249 (39%), Gaps = 35/249 (14%)
Query: 6   HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY----VKLYF 61
           HPN+VS    + S   KDEL+L + L     +V  +IKH     +    +     +    
Sbjct: 67  HPNIVSY---YTSFVVKDELWLVMKL-LSGGSVLDIIKHIVAKGEHKSGVLDESTIATIL 122
Query: 62  YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG------EPNIS 115
            ++   L Y+H   G  HRD+K  N+L+      +++ DFG +  L  G      +   +
Sbjct: 123 REVLEGLEYLHKN-GQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNKVRKT 180
Query: 116 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
           ++ +  + APE++     Y    DIWS G    EL  G    P        V ++ +   
Sbjct: 181 FVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAA--PYHKYPPMKVLMLTLQND 238
Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 235
           P                 P ++     K   K+       ++S  LQ  P  R TA E L
Sbjct: 239 P-----------------PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 281
Query: 236 IHPFFDELR 244
            H FF + +
Sbjct: 282 RHKFFQKAK 290

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 63/245 (25%), Positives = 104/245 (42%), Gaps = 47/245 (19%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           MR   +PN+V+    +      DEL++  V+EY+       +     M +          
Sbjct: 71  MRENKNPNIVNYLDSYLVG---DELWV--VMEYLAGGSLTDVVTETCMDEGQ-------- 117
Query: 61  FYQICR----ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNIS 115
              +CR    AL ++H+   V HRDIK  N+L+      +KL DFG  A++  +     +
Sbjct: 118 IAAVCRECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRST 175
Query: 116 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
            + + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   GT
Sbjct: 176 MVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGT 233
Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 235
           P             E + P+        IF+        D ++R L      R +A E L
Sbjct: 234 P-------------ELQNPE----KLSAIFR--------DFLNRCLDMDVEKRGSAKELL 268
Query: 236 IHPFF 240
            H F 
Sbjct: 269 QHQFL 273

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/253 (23%), Positives = 104/253 (41%), Gaps = 40/253 (15%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           +R + HPN+++L   F + T+     + L+LE V    +   +     +++     ++K 
Sbjct: 83  LREIRHPNIITLHDIFENKTD-----VVLILELVSGGELFDFLAEKESLTEDEATQFLK- 136
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISY 116
              QI   + Y+H+   + H D+KP+N+++   N    ++KL DFG A  +  G    + 
Sbjct: 137 ---QILDGVHYLHSK-RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNI 192
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
             +  + APE++          D+WS G +   LL G   F GE+  + L  I       
Sbjct: 193 FGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNI------- 244
Query: 177 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 236
                  +N ++ E  F                   A D + RLL   P  R    ++L 
Sbjct: 245 -----SAVNYDFDEEYFSN-------------TSELAKDFIRRLLVKDPKRRMXIAQSLE 286
Query: 237 HPFFDELRDPNTR 249
           H +   +R  N R
Sbjct: 287 HSWIKAIRRRNVR 299

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 63/245 (25%), Positives = 104/245 (42%), Gaps = 47/245 (19%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           MR   +PN+V+    +      DEL++  V+EY+       +     M +          
Sbjct: 71  MRENKNPNIVNYLDSYLVG---DELWV--VMEYLAGGSLTDVVTETCMDEGQ-------- 117
Query: 61  FYQICR----ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNIS 115
              +CR    AL ++H+   V HRDIK  N+L+      +KL DFG  A++  +      
Sbjct: 118 IAAVCRECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSX 175
Query: 116 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
            + + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   GT
Sbjct: 176 MVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGT 233
Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 235
           P             E + P+        IF+        D ++R L+     R +A E L
Sbjct: 234 P-------------ELQNPE----KLSAIFR--------DFLNRCLEMDVEKRGSAKELL 268
Query: 236 IHPFF 240
            H F 
Sbjct: 269 QHQFL 273

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 41/134 (30%), Positives = 67/134 (50%), Gaps = 23/134 (17%)
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK-------VLVKGEPN 113
           F QI  AL+YIH+  G+ HR++KP N+ ++  +  +K+ DFG AK       +L     N
Sbjct: 122 FRQILEALSYIHSQ-GIIHRNLKPXNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 114 I--------SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQ 165
           +        S I +  Y A E++ G   Y   ID +S G +  E      ++P  +G ++
Sbjct: 180 LPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFE-----XIYPFSTGXER 234
Query: 166 LVEIIKVLGTPTRE 179
            V I+K L + + E
Sbjct: 235 -VNILKKLRSVSIE 247

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 63/244 (25%), Positives = 98/244 (40%), Gaps = 40/244 (16%)
Query: 5   DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQI 64
           DHP +V L   ++   +     L +++E+ P      I          P I V     Q+
Sbjct: 66  DHPYIVKLLGAYYHDGK-----LWIMIEFCPGGAVDAIMLELDRGLTEPQIQV--VCRQM 118
Query: 65  CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYR 123
             AL ++H+   + HRD+K  N+L+      ++L DFG SAK L   +   S+I + Y+ 
Sbjct: 119 LEALNFLHSK-RIIHRDLKAGNVLMTLEG-DIRLADFGVSAKNLKTLQKRDSFIGTPYWM 176
Query: 124 APELIF----GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
           APE++       T Y    DIWS G  L E+   +P                    P  E
Sbjct: 177 APEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP--------------------PHHE 216
Query: 180 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
               +NP     K    K+ P   +   +   E  D +   L  +P  R +A + L HPF
Sbjct: 217 ----LNPMRVLLKIA--KSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPF 270
Query: 240 FDEL 243
              +
Sbjct: 271 VSSI 274

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/188 (30%), Positives = 82/188 (43%), Gaps = 35/188 (18%)
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNI--- 114
           Y  QI  AL Y H+   + HRD+KP  +L+    +   +KL  FG A  L  GE  +   
Sbjct: 137 YMRQILEALRYCHDN-NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL--GESGLVAG 193
Query: 115 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 174
             + + ++ APE++     Y   +D+W  G +L  LL G   F G    ++L E I    
Sbjct: 194 GRVGTPHFMAPEVV-KREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGI---- 246
Query: 175 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 234
              + + K MNP              W  I +      A DLV R+L   P  R T  EA
Sbjct: 247 --IKGKYK-MNPR------------QWSHISES-----AKDLVRRMLMLDPAERITVYEA 286
Query: 235 LIHPFFDE 242
           L HP+  E
Sbjct: 287 LNHPWLKE 294

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 52/94 (55%), Gaps = 4/94 (4%)
Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRY 121
           +I + L Y+H+   + HRDIK  N+L++     +KL DFG A  L   +    +++ + +
Sbjct: 128 EILKGLDYLHSEKKI-HRDIKAANVLLSEQ-GDVKLADFGVAGQLTDTQIKRNTFVGTPF 185
Query: 122 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQP 155
           + APE+I   + Y +  DIWS G    EL  G+P
Sbjct: 186 WMAPEVI-QQSAYDSKADIWSLGITAIELAKGEP 218

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/188 (30%), Positives = 82/188 (43%), Gaps = 35/188 (18%)
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNI--- 114
           Y  QI  AL Y H+   + HRD+KP  +L+    +   +KL  FG A  L  GE  +   
Sbjct: 135 YMRQILEALRYCHDN-NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL--GESGLVAG 191
Query: 115 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 174
             + + ++ APE++     Y   +D+W  G +L  LL G   F G    ++L E I    
Sbjct: 192 GRVGTPHFMAPEVV-KREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGI---- 244
Query: 175 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 234
              + + K MNP              W  I +      A DLV R+L   P  R T  EA
Sbjct: 245 --IKGKYK-MNPR------------QWSHISES-----AKDLVRRMLMLDPAERITVYEA 284
Query: 235 LIHPFFDE 242
           L HP+  E
Sbjct: 285 LNHPWLKE 292

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 63/245 (25%), Positives = 103/245 (42%), Gaps = 47/245 (19%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           MR   +PN+V+    +      DEL++  V+EY+       +     M +          
Sbjct: 71  MRENKNPNIVNYLDSYLVG---DELWV--VMEYLAGGSLTDVVTETCMDEGQ-------- 117
Query: 61  FYQICR----ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNIS 115
              +CR    AL ++H+   V HRDIK  N+L+      +KL DFG  A++  +      
Sbjct: 118 IAAVCRECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSE 175
Query: 116 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
            + + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   GT
Sbjct: 176 MVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGT 233
Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 235
           P             E + P+        IF+        D ++R L      R +A E L
Sbjct: 234 P-------------ELQNPE----KLSAIFR--------DFLNRCLDMDVEKRGSAKELL 268
Query: 236 IHPFF 240
            H F 
Sbjct: 269 QHQFL 273

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 52/101 (51%), Gaps = 4/101 (3%)
Query: 56  YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNI 114
           Y+     +I + L Y+H+   + HRDIK  N+L++     +KL DFG A  L   +    
Sbjct: 117 YIATILREILKGLDYLHSERKI-HRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRN 174
Query: 115 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQP 155
            ++ + ++ APE+I   + Y    DIWS G    EL  G+P
Sbjct: 175 XFVGTPFWMAPEVI-KQSAYDFKADIWSLGITAIELAKGEP 214

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 72/156 (46%), Gaps = 14/156 (8%)
Query: 5   DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQI 64
           DHP +V L   ++   +     L +++E+ P      I          P I V     Q+
Sbjct: 74  DHPYIVKLLGAYYHDGK-----LWIMIEFCPGGAVDAIMLELDRGLTEPQIQV--VCRQM 126
Query: 65  CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYR 123
             AL ++H+   + HRD+K  N+L+      ++L DFG SAK L   +   S+I + Y+ 
Sbjct: 127 LEALNFLHSK-RIIHRDLKAGNVLMTLEG-DIRLADFGVSAKNLKTLQKRDSFIGTPYWM 184
Query: 124 APELIF----GATEYTAAIDIWSAGCVLAELLLGQP 155
           APE++       T Y    DIWS G  L E+   +P
Sbjct: 185 APEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP 220

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 73/156 (46%), Gaps = 14/156 (8%)
Query: 5   DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQI 64
           DHPN+V L   F+      E  L +++E+        +    ++ + +    +++   Q 
Sbjct: 92  DHPNIVKLLDAFYY-----ENNLWILIEFCAGGAVDAV--MLELERPLTESQIQVVCKQT 144
Query: 65  CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYR 123
             AL Y+H+   + HRD+K  N+L       +KL DFG SAK     +   S+I + Y+ 
Sbjct: 145 LDALNYLHDN-KIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRXIQRRDSFIGTPYWM 202
Query: 124 APELIFGATE----YTAAIDIWSAGCVLAELLLGQP 155
           APE++   T     Y    D+WS G  L E+   +P
Sbjct: 203 APEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEP 238

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 73/156 (46%), Gaps = 14/156 (8%)
Query: 5   DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQI 64
           DHPN+V L   F+      E  L +++E+        +    ++ + +    +++   Q 
Sbjct: 92  DHPNIVKLLDAFYY-----ENNLWILIEFCAGGAVDAV--MLELERPLTESQIQVVCKQT 144
Query: 65  CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYR 123
             AL Y+H+   + HRD+K  N+L       +KL DFG SAK     +   S+I + Y+ 
Sbjct: 145 LDALNYLHDN-KIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQRRDSFIGTPYWM 202
Query: 124 APELIFGATE----YTAAIDIWSAGCVLAELLLGQP 155
           APE++   T     Y    D+WS G  L E+   +P
Sbjct: 203 APEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEP 238

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 62/245 (25%), Positives = 104/245 (42%), Gaps = 47/245 (19%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           MR   +PN+V+    +      DEL++  V+EY+       +     M +          
Sbjct: 72  MRENKNPNIVNYLDSYLVG---DELWV--VMEYLAGGSLTDVVTETCMDEGQ-------- 118
Query: 61  FYQICR----ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNIS 115
              +CR    AL ++H+   V HRDIK  N+L+      +KL DFG  A++  +      
Sbjct: 119 IAAVCRECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSX 176
Query: 116 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
            + + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   GT
Sbjct: 177 MVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGT 234
Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 235
           P             E + P+        IF+        D ++R L+     R +A E +
Sbjct: 235 P-------------ELQNPE----KLSAIFR--------DFLNRCLEMDVEKRGSAKELI 269
Query: 236 IHPFF 240
            H F 
Sbjct: 270 QHQFL 274

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 77/158 (48%), Gaps = 20/158 (12%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           +R L H ++V  K C     EK    + LV+EYVP    R     Y     + L  + L+
Sbjct: 65  LRTLYHEHIVKYKGCCEDQGEKS---VQLVMEYVPLGSLR----DYLPRHCVGLAQLLLF 117
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------EPN 113
             QIC  +AY+H    + HR +  +N+L++ +   +K+ DFG AK + +G       E  
Sbjct: 118 AQQICEGMAYLHAQHYI-HRALAARNVLLD-NDRLVKIGDFGLAKAVPEGHEYYRVREDG 175
Query: 114 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL 151
            S +   ++ APE +     Y A+ D+WS G  L ELL
Sbjct: 176 DSPV---FWYAPECLKECKFYYAS-DVWSFGVTLYELL 209

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 80/160 (50%), Gaps = 24/160 (15%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHR--VIKHHYKMSQRMPLIYVK 58
           +R L H ++V  K C     EK    + LV+EYVP    R  + +H   ++Q +      
Sbjct: 64  LRTLYHEHIVKYKGCCEDQGEKS---VQLVMEYVPLGSLRDYLPRHCVGLAQLL------ 114
Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------E 111
           L+  QIC  +AY+H    + HR +  +N+L++ +   +K+ DFG AK + +G       E
Sbjct: 115 LFAQQICEGMAYLHAQHYI-HRALAARNVLLD-NDRLVKIGDFGLAKAVPEGHEYYRVRE 172
Query: 112 PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL 151
              S +   ++ APE +     Y A+ D+WS G  L ELL
Sbjct: 173 DGDSPV---FWYAPECLKECKFYYAS-DVWSFGVTLYELL 208

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 49/91 (53%), Gaps = 3/91 (3%)
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
           F QI + + YIH+   + HRD+KP N+ +   T Q+K+ DFG    L           + 
Sbjct: 142 FEQITKGVDYIHSK-KLIHRDLKPSNIFL-VDTKQVKIGDFGLVTSLKNDGKRTRSKGTL 199
Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELL 151
            Y +PE I  + +Y   +D+++ G +LAELL
Sbjct: 200 RYMSPEQI-SSQDYGKEVDLYALGLILAELL 229

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 81/168 (48%), Gaps = 15/168 (8%)
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           Y +Q+ + + ++ +   + HRD+  +N+L++   + +K+ DFG A+ + K    +    +
Sbjct: 149 YSFQVAKGMEFLASRKXI-HRDLAARNILLS-EKNVVKIXDFGLARDIYKDPDYVRKGDA 206
Query: 120 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGT 175
           R    + APE IF    YT   D+WS G +L E+  LG   +PG       V+I +    
Sbjct: 207 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFXR 258
Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPWH-KIFQKRMPPEAVDLVSRLLQ 222
             +E  +   P+YT  +  Q     WH +  Q+    E V+ +  LLQ
Sbjct: 259 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 306

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/245 (24%), Positives = 105/245 (42%), Gaps = 47/245 (19%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           MR   +PN+V+    +      DEL++  V+EY+       +     M +          
Sbjct: 72  MRENKNPNIVNYLDSYLVG---DELWV--VMEYLAGGSLTDVVTETCMDEGQ-------- 118
Query: 61  FYQICR----ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNIS 115
              +CR    AL ++H+   V HR+IK  N+L+      +KL DFG  A++  +     +
Sbjct: 119 IAAVCRECLQALEFLHSN-QVIHRNIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRST 176
Query: 116 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
            + + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  +I   GT
Sbjct: 177 MVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGT 234
Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 235
           P             E + P+        IF+        D ++R L+     R +A E +
Sbjct: 235 P-------------ELQNPE----KLSAIFR--------DFLNRCLEMDVEKRGSAKELI 269
Query: 236 IHPFF 240
            H F 
Sbjct: 270 QHQFL 274

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           M   DHPN++ L+     +       + +V EY+   ++   ++ H     +  +I +  
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKH---DAQFTVIQLVG 151
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
               I   + Y+ + +G  HRD+  +N+L+N +    K+ DFG A+VL + +P  +Y   
Sbjct: 152 MLRGIASGMKYLSD-MGYVHRDLAARNILINSNL-VCKVSDFGLARVL-EDDPEAAYTTR 208
Query: 120 R-----YYRAPELIFGATEYTAAIDIWSAGCVLAELL 151
                  + +PE I    ++T+A D+WS G VL E++
Sbjct: 209 GGKIPIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 85/175 (48%), Gaps = 20/175 (11%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           MR  DHP++V L         ++ +++ + L  + E   R      K S  + L  + LY
Sbjct: 65  MRQFDHPHIVKL----IGVITENPVWIIMELCTLGEL--RSFLQVRKFS--LDLASLILY 116
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
            YQ+  ALAY+ +   V HRDI  +N+LV+  T  +KL DFG ++ +   E +  Y  S+
Sbjct: 117 AYQLSTALAYLESKRFV-HRDIAARNVLVSA-TDCVKLGDFGLSRYM---EDSTYYKASK 171
Query: 121 -----YYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEI 169
                 + APE I     +T+A D+W  G  + E+L+ G   F G    D +  I
Sbjct: 172 GKLPIKWMAPESI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 225

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 79/175 (45%), Gaps = 21/175 (12%)
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           + YQ+ + +A++ +     HRD+  +N+L+  H    K+CDFG A+  +K + N  Y+  
Sbjct: 150 FSYQVAKGMAFLASK-NCIHRDLAARNILLT-HGRITKICDFGLARD-IKNDSN--YVVK 204
Query: 120 RYYR------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKV 172
              R      APE IF    YT   D+WS G  L EL  LG   +PG     +  ++IK 
Sbjct: 205 GNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK- 262
Query: 173 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKR-MPPEAVDLVSRLLQYSPN 226
                 E  + ++P +   +   I    W     KR    + V L+ + +  S N
Sbjct: 263 ------EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTN 311

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 79/175 (45%), Gaps = 21/175 (12%)
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           + YQ+ + +A++ +     HRD+  +N+L+  H    K+CDFG A+  +K + N  Y+  
Sbjct: 168 FSYQVAKGMAFLASK-NCIHRDLAARNILLT-HGRITKICDFGLARD-IKNDSN--YVVK 222
Query: 120 RYYR------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKV 172
              R      APE IF    YT   D+WS G  L EL  LG   +PG     +  ++IK 
Sbjct: 223 GNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK- 280
Query: 173 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKR-MPPEAVDLVSRLLQYSPN 226
                 E  + ++P +   +   I    W     KR    + V L+ + +  S N
Sbjct: 281 ------EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTN 329

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 79/175 (45%), Gaps = 21/175 (12%)
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           + YQ+ + +A++ +     HRD+  +N+L+  H    K+CDFG A+  +K + N  Y+  
Sbjct: 166 FSYQVAKGMAFLASK-NCIHRDLAARNILLT-HGRITKICDFGLARD-IKNDSN--YVVK 220
Query: 120 RYYR------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKV 172
              R      APE IF    YT   D+WS G  L EL  LG   +PG     +  ++IK 
Sbjct: 221 GNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK- 278
Query: 173 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKR-MPPEAVDLVSRLLQYSPN 226
                 E  + ++P +   +   I    W     KR    + V L+ + +  S N
Sbjct: 279 ------EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTN 327

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 79/175 (45%), Gaps = 21/175 (12%)
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           + YQ+ + +A++ +     HRD+  +N+L+  H    K+CDFG A+  +K + N  Y+  
Sbjct: 173 FSYQVAKGMAFLASK-NCIHRDLAARNILLT-HGRITKICDFGLARD-IKNDSN--YVVK 227
Query: 120 RYYR------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKV 172
              R      APE IF    YT   D+WS G  L EL  LG   +PG     +  ++IK 
Sbjct: 228 GNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK- 285
Query: 173 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKR-MPPEAVDLVSRLLQYSPN 226
                 E  + ++P +   +   I    W     KR    + V L+ + +  S N
Sbjct: 286 ------EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTN 334

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/175 (30%), Positives = 85/175 (48%), Gaps = 20/175 (11%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           MR  DHP++V L         ++ +++ + L  + E   R      K S  + L  + LY
Sbjct: 445 MRQFDHPHIVKL----IGVITENPVWIIMELCTLGEL--RSFLQVRKFS--LDLASLILY 496
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
            YQ+  ALAY+ +   V HRDI  +N+LV+  T  +KL DFG ++ +   E +  Y  S+
Sbjct: 497 AYQLSTALAYLESKRFV-HRDIAARNVLVSA-TDCVKLGDFGLSRYM---EDSTYYKASK 551
Query: 121 -----YYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEI 169
                 + APE I     +T+A D+W  G  + E+L+ G   F G    D +  I
Sbjct: 552 GKLPIKWMAPESI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 605

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 72/156 (46%), Gaps = 14/156 (8%)
Query: 5   DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQI 64
           DHPN+V L   F+      E  L +++E+        +    ++ + +    +++   Q 
Sbjct: 92  DHPNIVKLLDAFYY-----ENNLWILIEFCAGGAVDAV--MLELERPLTESQIQVVCKQT 144
Query: 65  CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYICSRYYR 123
             AL Y+H+   + HRD+K  N+L       +KL DFG SAK     +    +I + Y+ 
Sbjct: 145 LDALNYLHDN-KIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRXIQRRDXFIGTPYWM 202
Query: 124 APELIFGATE----YTAAIDIWSAGCVLAELLLGQP 155
           APE++   T     Y    D+WS G  L E+   +P
Sbjct: 203 APEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEP 238

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 78/176 (44%), Gaps = 23/176 (13%)
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK-------VLVKGEP 112
           + YQ+ + +A++ +     HRD+  +N+L+  H    K+CDFG A+        +VKG  
Sbjct: 173 FSYQVAKGMAFLASK-NCIHRDLAARNILLT-HGRITKICDFGLARHIKNDSNYVVKGNA 230
Query: 113 NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIK 171
            +       + APE IF    YT   D+WS G  L EL  LG   +PG     +  ++IK
Sbjct: 231 RLPV----KWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 285
Query: 172 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKR-MPPEAVDLVSRLLQYSPN 226
                  E  + ++P +   +   I    W     KR    + V L+ + +  S N
Sbjct: 286 -------EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTN 334

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 103/243 (42%), Gaps = 40/243 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           ++ + HPNV++L   + + T+     + L+LE V    +   +     +++     ++K 
Sbjct: 68  LKEIQHPNVITLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK- 121
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISY 116
              QI   + Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    + 
Sbjct: 122 ---QILNGVYYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
             +  + APE++          D+WS G +   LL G   F G++  + L  +       
Sbjct: 178 FGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------- 229
Query: 177 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 236
                  +N  + +  F    A              A D + RLL   P  R T  ++L 
Sbjct: 230 -----SAVNYEFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQ 271
Query: 237 HPF 239
           HP+
Sbjct: 272 HPW 274

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 103/243 (42%), Gaps = 40/243 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           ++ + HPNV++L   + + T+     + L+LE V    +   +     +++     ++K 
Sbjct: 68  LKEIQHPNVITLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK- 121
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISY 116
              QI   + Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    + 
Sbjct: 122 ---QILNGVYYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
             +  + APE++          D+WS G +   LL G   F G++  + L  +       
Sbjct: 178 FGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------- 229
Query: 177 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 236
                  +N  + +  F    A              A D + RLL   P  R T  ++L 
Sbjct: 230 -----SAVNYEFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQ 271
Query: 237 HPF 239
           HP+
Sbjct: 272 HPW 274

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           M   DHPN++ L+     +       + +V EY+   ++   ++ H     +  +I +  
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKH---DAQFTVIQLVG 151
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
               I   + Y+ + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y   
Sbjct: 152 MLRGIASGMKYLSD-MGFVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTR 208
Query: 120 R-----YYRAPELIFGATEYTAAIDIWSAGCVLAELL 151
                  + +PE I    ++T+A D+WS G VL E++
Sbjct: 209 GGKIPIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 103/243 (42%), Gaps = 40/243 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           ++ + HPNV++L   + + T+     + L+LE V    +   +     +++     ++K 
Sbjct: 68  LKEIQHPNVITLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK- 121
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISY 116
              QI   + Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    + 
Sbjct: 122 ---QILNGVYYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
             +  + APE++          D+WS G +   LL G   F G++  + L  +       
Sbjct: 178 FGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------- 229
Query: 177 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 236
                  +N  + +  F    A              A D + RLL   P  R T  ++L 
Sbjct: 230 -----SAVNYEFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQ 271
Query: 237 HPF 239
           HP+
Sbjct: 272 HPW 274

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 103/243 (42%), Gaps = 40/243 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           ++ + HPNV++L   + + T+     + L+LE V    +   +     +++     ++K 
Sbjct: 68  LKEIQHPNVITLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK- 121
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISY 116
              QI   + Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    + 
Sbjct: 122 ---QILNGVYYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
             +  + APE++          D+WS G +   LL G   F G++  + L  +       
Sbjct: 178 FGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------- 229
Query: 177 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 236
                  +N  + +  F    A              A D + RLL   P  R T  ++L 
Sbjct: 230 -----SAVNYEFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQ 271
Query: 237 HPF 239
           HP+
Sbjct: 272 HPW 274

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 103/243 (42%), Gaps = 40/243 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           ++ + HPNV++L   + + T+     + L+LE V    +   +     +++     ++K 
Sbjct: 67  LKEIQHPNVITLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK- 120
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISY 116
              QI   + Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    + 
Sbjct: 121 ---QILNGVYYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 176
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
             +  + APE++          D+WS G +   LL G   F G++  + L  +       
Sbjct: 177 FGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------- 228
Query: 177 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 236
                  +N  + +  F    A              A D + RLL   P  R T  ++L 
Sbjct: 229 -----SAVNYEFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQ 270
Query: 237 HPF 239
           HP+
Sbjct: 271 HPW 273

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 74/164 (45%), Gaps = 20/164 (12%)
Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 63
           ++HPN+V L     +        + LV+EY        + H  +        +   +  Q
Sbjct: 59  VNHPNIVKLYGACLNP-------VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQ 111
Query: 64  ICRALAYIHNT--IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY 121
             + +AY+H+     + HRD+KP NLL+      LK+CDFG+A  +     N     S  
Sbjct: 112 CSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK--GSAA 169
Query: 122 YRAPELIFGATEYTAAIDIWSAGCVLAELL--------LGQPLF 157
           + APE +F  + Y+   D++S G +L E++        +G P F
Sbjct: 170 WMAPE-VFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF 212

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 103/243 (42%), Gaps = 40/243 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           ++ + HPNV++L   + + T+     + L+LE V    +   +     +++     ++K 
Sbjct: 68  LKEIQHPNVITLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK- 121
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISY 116
              QI   + Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    + 
Sbjct: 122 ---QILNGVYYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
             +  + APE++          D+WS G +   LL G   F G++  + L  +       
Sbjct: 178 FGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------- 229
Query: 177 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 236
                  +N  + +  F    A              A D + RLL   P  R T  ++L 
Sbjct: 230 -----SAVNYEFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQ 271
Query: 237 HPF 239
           HP+
Sbjct: 272 HPW 274

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 84/175 (48%), Gaps = 20/175 (11%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           MR  DHP++V L         ++ +++ + L  + E    +    Y +     L  + LY
Sbjct: 65  MRQFDHPHIVKL----IGVITENPVWIIMELCTLGELRSFLQVRKYSLD----LASLILY 116
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
            YQ+  ALAY+ +   V HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+
Sbjct: 117 AYQLSTALAYLESKRFV-HRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASK 171
Query: 121 -----YYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEI 169
                 + APE I     +T+A D+W  G  + E+L+ G   F G    D +  I
Sbjct: 172 GKLPIKWMAPESI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 225

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 103/243 (42%), Gaps = 40/243 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           ++ + HPNV++L   + + T+     + L+LE V    +   +     +++     ++K 
Sbjct: 67  LKEIQHPNVITLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK- 120
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISY 116
              QI   + Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    + 
Sbjct: 121 ---QILNGVYYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 176
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
             +  + APE++          D+WS G +   LL G   F G++  + L  +       
Sbjct: 177 FGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------- 228
Query: 177 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 236
                  +N  + +  F    A              A D + RLL   P  R T  ++L 
Sbjct: 229 -----SAVNYEFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQ 270
Query: 237 HPF 239
           HP+
Sbjct: 271 HPW 273

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 103/243 (42%), Gaps = 40/243 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           ++ + HPNV++L   + + T+     + L+LE V    +   +     +++     ++K 
Sbjct: 68  LKEIQHPNVITLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK- 121
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISY 116
              QI   + Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    + 
Sbjct: 122 ---QILNGVYYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
             +  + APE++          D+WS G +   LL G   F G++  + L  +       
Sbjct: 178 FGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------- 229
Query: 177 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 236
                  +N  + +  F    A              A D + RLL   P  R T  ++L 
Sbjct: 230 -----SAVNYEFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQ 271
Query: 237 HPF 239
           HP+
Sbjct: 272 HPW 274

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 84/175 (48%), Gaps = 20/175 (11%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           MR  DHP++V L         ++ +++ + L  + E    +    Y +     L  + LY
Sbjct: 65  MRQFDHPHIVKL----IGVITENPVWIIMELCTLGELRSFLQVRKYSLD----LASLILY 116
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
            YQ+  ALAY+ +   V HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+
Sbjct: 117 AYQLSTALAYLESKRFV-HRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASK 171
Query: 121 -----YYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEI 169
                 + APE I     +T+A D+W  G  + E+L+ G   F G    D +  I
Sbjct: 172 GKLPIKWMAPESI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 225

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 74/164 (45%), Gaps = 20/164 (12%)
Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQ 63
           ++HPN+V L     +        + LV+EY        + H  +        +   +  Q
Sbjct: 58  VNHPNIVKLYGACLNP-------VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQ 110
Query: 64  ICRALAYIHNT--IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY 121
             + +AY+H+     + HRD+KP NLL+      LK+CDFG+A  +     N     S  
Sbjct: 111 CSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK--GSAA 168
Query: 122 YRAPELIFGATEYTAAIDIWSAGCVLAELL--------LGQPLF 157
           + APE +F  + Y+   D++S G +L E++        +G P F
Sbjct: 169 WMAPE-VFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF 211

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 84/175 (48%), Gaps = 20/175 (11%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           MR  DHP++V L         ++ +++ + L  + E    +    Y +     L  + LY
Sbjct: 93  MRQFDHPHIVKL----IGVITENPVWIIMELCTLGELRSFLQVRKYSLD----LASLILY 144
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
            YQ+  ALAY+ +   V HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+
Sbjct: 145 AYQLSTALAYLESKRFV-HRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASK 199
Query: 121 -----YYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEI 169
                 + APE I     +T+A D+W  G  + E+L+ G   F G    D +  I
Sbjct: 200 GKLPIKWMAPESI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 253

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 84/175 (48%), Gaps = 20/175 (11%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           MR  DHP++V L         ++ +++ + L  + E    +    Y +     L  + LY
Sbjct: 68  MRQFDHPHIVKL----IGVITENPVWIIMELCTLGELRSFLQVRKYSLD----LASLILY 119
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
            YQ+  ALAY+ +   V HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+
Sbjct: 120 AYQLSTALAYLESKRFV-HRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASK 174
Query: 121 -----YYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEI 169
                 + APE I     +T+A D+W  G  + E+L+ G   F G    D +  I
Sbjct: 175 GKLPIKWMAPESI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 228

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 84/175 (48%), Gaps = 20/175 (11%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           MR  DHP++V L         ++ +++ + L  + E    +    Y +     L  + LY
Sbjct: 70  MRQFDHPHIVKL----IGVITENPVWIIMELCTLGELRSFLQVRKYSLD----LASLILY 121
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
            YQ+  ALAY+ +   V HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+
Sbjct: 122 AYQLSTALAYLESKRFV-HRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASK 176
Query: 121 -----YYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEI 169
                 + APE I     +T+A D+W  G  + E+L+ G   F G    D +  I
Sbjct: 177 GKLPIKWMAPESI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 230

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 84/175 (48%), Gaps = 20/175 (11%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           MR  DHP++V L         ++ +++ + L  + E    +    Y +     L  + LY
Sbjct: 67  MRQFDHPHIVKL----IGVITENPVWIIMELCTLGELRSFLQVRKYSLD----LASLILY 118
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
            YQ+  ALAY+ +   V HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+
Sbjct: 119 AYQLSTALAYLESKRFV-HRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASK 173
Query: 121 -----YYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEI 169
                 + APE I     +T+A D+W  G  + E+L+ G   F G    D +  I
Sbjct: 174 GKLPIKWMAPESI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 227

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 84/175 (48%), Gaps = 20/175 (11%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           MR  DHP++V L         ++ +++ + L  + E    +    Y +     L  + LY
Sbjct: 62  MRQFDHPHIVKL----IGVITENPVWIIMELCTLGELRSFLQVRKYSLD----LASLILY 113
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
            YQ+  ALAY+ +   V HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+
Sbjct: 114 AYQLSTALAYLESKRFV-HRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASK 168
Query: 121 -----YYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEI 169
                 + APE I     +T+A D+W  G  + E+L+ G   F G    D +  I
Sbjct: 169 GKLPIKWMAPESI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 222

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           M   DHPN++ L+     +       + +V EY+   ++   ++ H     +  +I +  
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKH---DAQFTVIQLVG 151
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
               I   + Y+ + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y   
Sbjct: 152 MLRGIASGMKYLSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTR 208
Query: 120 R-----YYRAPELIFGATEYTAAIDIWSAGCVLAELL 151
                  + +PE I    ++T+A D+WS G VL E++
Sbjct: 209 GGKIPIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 103/243 (42%), Gaps = 40/243 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           ++ + HPNV++L   + + T+     + L+LE V    +   +     +++     ++K 
Sbjct: 68  LKEIQHPNVITLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK- 121
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISY 116
              QI   + Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    + 
Sbjct: 122 ---QILNGVYYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
             +  + APE++          D+WS G +   LL G   F G++  + L  +       
Sbjct: 178 FGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------- 229
Query: 177 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 236
                  +N  + +  F    A              A D + RLL   P  R T  ++L 
Sbjct: 230 -----SAVNYEFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQ 271
Query: 237 HPF 239
           HP+
Sbjct: 272 HPW 274

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 76/157 (48%), Gaps = 18/157 (11%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           M   DHPN++ L+     +       + +V EY+   ++   ++ H     +  +I +  
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKH---DAQFTVIQLVG 151
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
               I   + Y+ + +G  HRD+  +N+L+N +    K+ DFG  +VL + +P  +Y   
Sbjct: 152 MLRGIASGMKYLSD-MGYVHRDLAARNILINSNL-VCKVSDFGLGRVL-EDDPEAAYTTR 208
Query: 120 R-----YYRAPELIFGATEYTAAIDIWSAGCVLAELL 151
                  + +PE I    ++T+A D+WS G VL E++
Sbjct: 209 GGKIPIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 80/196 (40%), Gaps = 47/196 (23%)
Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPH--THQLKLCDFGSAKVLVKGEPNISYICSRY 121
           I  A+ Y+H +I + HRD+KP+NLL         LKL DFG AK    GE          
Sbjct: 126 IGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-GE---------- 173
Query: 122 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 181
                      +Y  + D+WS G ++  LL G P F    G    + I   + T  R   
Sbjct: 174 -----------KYDKSCDMWSLGVIMYILLCGYPPFYSNHG----LAISPGMKTRIR--- 215
Query: 182 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF-F 240
                   +++FP  +   W ++ +     E   L+  LL+  P  R T  E + HP+  
Sbjct: 216 ------MGQYEFPNPE---WSEVSE-----EVKMLIRNLLKTEPTQRMTITEFMNHPWIM 261
Query: 241 DELRDPNTRLPNGRFL 256
              + P T L   R L
Sbjct: 262 QSTKVPQTPLHTSRVL 277

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           M   DHPN++ L+     +       + +V EY+   ++   ++ H     +  +I +  
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKH---DAQFTVIQLVG 151
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
               I   + Y+ + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y   
Sbjct: 152 MLRGIASGMKYLSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTR 208
Query: 120 R-----YYRAPELIFGATEYTAAIDIWSAGCVLAELL 151
                  + +PE I    ++T+A D+WS G VL E++
Sbjct: 209 GGKIPIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           M   DHPN++ L+     +       + +V EY+   ++   ++ H     +  +I +  
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKH---DAQFTVIQLVG 151
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
               I   + Y+ + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y   
Sbjct: 152 MLRGIASGMKYLSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTR 208
Query: 120 R-----YYRAPELIFGATEYTAAIDIWSAGCVLAELL 151
                  + +PE I    ++T+A D+WS G VL E++
Sbjct: 209 GGKIPIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           M   DHPN++ L+     +       + +V EY+   ++   ++ H     +  +I +  
Sbjct: 98  MGQFDHPNIIRLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKH---DAQFTVIQLVG 149
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
               I   + Y+ + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y   
Sbjct: 150 MLRGIASGMKYLSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTR 206
Query: 120 R-----YYRAPELIFGATEYTAAIDIWSAGCVLAELL 151
                  + +PE I    ++T+A D+WS G VL E++
Sbjct: 207 GGKIPIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVM 242

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 103/243 (42%), Gaps = 40/243 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           ++ + HPNV++L   + + T+     + L+LE V    +   +     +++     ++K 
Sbjct: 68  LKEIQHPNVITLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK- 121
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISY 116
              QI   + Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    + 
Sbjct: 122 ---QILNGVYYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
             +  + APE++          D+WS G +   LL G   F G++  + L  +       
Sbjct: 178 FGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------- 229
Query: 177 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 236
                  +N  + +  F    A              A D + RLL   P  R T  ++L 
Sbjct: 230 -----SAVNYEFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQ 271
Query: 237 HPF 239
           HP+
Sbjct: 272 HPW 274

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           M   DHPN++ L+     +       + +V EY+   ++   ++ H     +  +I +  
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKH---DAQFTVIQLVG 151
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
               I   + Y+ + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y   
Sbjct: 152 MLRGIASGMKYLSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTR 208
Query: 120 R-----YYRAPELIFGATEYTAAIDIWSAGCVLAELL 151
                  + +PE I    ++T+A D+WS G VL E++
Sbjct: 209 GGKIPIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           M   DHPN++ L+     +       + +V EY+   ++   ++ H     +  +I +  
Sbjct: 88  MGQFDHPNIIRLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKH---DAQFTVIQLVG 139
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
               I   + Y+ + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y   
Sbjct: 140 MLRGIASGMKYLSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTR 196
Query: 120 R-----YYRAPELIFGATEYTAAIDIWSAGCVLAELL 151
                  + +PE I    ++T+A D+WS G VL E++
Sbjct: 197 GGKIPIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVM 232

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           M   DHPN++ L+     +       + +V EY+   ++   ++ H     +  +I +  
Sbjct: 71  MGQFDHPNIIRLEGVVTKSKP-----VMIVTEYMENGSLDSFLRKH---DAQFTVIQLVG 122
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
               I   + Y+ + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y   
Sbjct: 123 MLRGIASGMKYLSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTR 179
Query: 120 R-----YYRAPELIFGATEYTAAIDIWSAGCVLAELL 151
                  + +PE I    ++T+A D+WS G VL E++
Sbjct: 180 GGKIPIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVM 215

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 85/175 (48%), Gaps = 20/175 (11%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           MR  DHP++V L         ++ +++ + L  + E   R      K S  + L  + LY
Sbjct: 445 MRQFDHPHIVKL----IGVITENPVWIIMELCTLGEL--RSFLQVRKFS--LDLASLILY 496
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
            YQ+  ALAY+ +   V HRDI  +N+LV+ +   +KL DFG ++ +   E +  Y  S+
Sbjct: 497 AYQLSTALAYLESKRFV-HRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASK 551
Query: 121 -----YYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEI 169
                 + APE I     +T+A D+W  G  + E+L+ G   F G    D +  I
Sbjct: 552 GKLPIKWMAPESI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 605

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 103/243 (42%), Gaps = 40/243 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           ++ + HPNV++L   + + T+     + L+LE V    +   +     +++     ++K 
Sbjct: 68  LKEIQHPNVITLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK- 121
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISY 116
              QI   + Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    + 
Sbjct: 122 ---QILNGVYYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
             +  + APE++          D+WS G +   LL G   F G++  + L  +       
Sbjct: 178 FGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------- 229
Query: 177 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 236
                  +N  + +  F    A              A D + RLL   P  R T  ++L 
Sbjct: 230 -----SAVNYEFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQ 271
Query: 237 HPF 239
           HP+
Sbjct: 272 HPW 274

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/243 (23%), Positives = 101/243 (41%), Gaps = 40/243 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           +R + HPN+++L   + + T+     + L+LE V    +   +     +S+     ++K 
Sbjct: 69  LRQVLHPNIITLHDVYENRTD-----VVLILELVSGGELFDFLAQKESLSEEEATSFIK- 122
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISY 116
              QI   + Y+H T  + H D+KP+N+++   N     +KL DFG A  +  G    + 
Sbjct: 123 ---QILDGVNYLH-TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI 178
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
             +  + APE++          D+WS G +   LL G   F G++  + L  I  V    
Sbjct: 179 FGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV---- 233
Query: 177 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 236
                                ++ + + F  +    A D + +LL      R T  EAL 
Sbjct: 234 ---------------------SYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272
Query: 237 HPF 239
           HP+
Sbjct: 273 HPW 275

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 37/100 (37%), Positives = 55/100 (55%), Gaps = 11/100 (11%)
Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK--GEPNISYICSR 120
           +I R L+++H    V HRDIK QN+L+  +  ++KL DFG +  L +  G  N ++I + 
Sbjct: 137 EILRGLSHLHQH-KVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDRTVGRRN-TFIGTP 193
Query: 121 YYRAPELIF-----GATEYTAAIDIWSAGCVLAELLLGQP 155
           Y+ APE+I       AT Y    D+WS G    E+  G P
Sbjct: 194 YWMAPEVIACDENPDAT-YDFKSDLWSLGITAIEMAEGAP 232

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 80/157 (50%), Gaps = 18/157 (11%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           M   DHPN++ L+        +  L + +V EY+   ++   ++ H      M L+ +  
Sbjct: 104 MGQFDHPNIIRLE----GVVTRGRLAM-IVTEYMENGSLDTFLRTHDGQFTIMQLVGM-- 156
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
               +   + Y+ + +G  HRD+  +N+LV+ +    K+ DFG ++VL + +P+ +Y  +
Sbjct: 157 -LRGVGAGMRYLSD-LGYVHRDLAARNVLVDSNL-VCKVSDFGLSRVL-EDDPDAAYTTT 212
Query: 120 R-----YYRAPELIFGATEYTAAIDIWSAGCVLAELL 151
                  + APE I   T +++A D+WS G V+ E+L
Sbjct: 213 GGKIPIRWTAPEAIAFRT-FSSASDVWSFGVVMWEVL 248

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 49/91 (53%), Gaps = 3/91 (3%)
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
           F QI + + YIH+   + +RD+KP N+ +   T Q+K+ DFG    L           + 
Sbjct: 128 FEQITKGVDYIHSK-KLINRDLKPSNIFL-VDTKQVKIGDFGLVTSLKNDGKRXRSKGTL 185
Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELL 151
            Y +PE I  + +Y   +D+++ G +LAELL
Sbjct: 186 RYMSPEQI-SSQDYGKEVDLYALGLILAELL 215

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 76/156 (48%), Gaps = 16/156 (10%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M   DHPN++ L+     T  K  + +   +E    ++   ++ H     +  +I +   
Sbjct: 100 MGQFDHPNIIRLEGVV--TKSKPVMIVTEXMEN--GSLDSFLRKH---DAQFTVIQLVGM 152
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
              I   + Y+ + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y    
Sbjct: 153 LRGIASGMKYLSD-MGAVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRG 209
Query: 121 -----YYRAPELIFGATEYTAAIDIWSAGCVLAELL 151
                 + +PE I    ++T+A D+WS G VL E++
Sbjct: 210 GKIPIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 55/245 (22%), Positives = 105/245 (42%), Gaps = 28/245 (11%)
Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVH--RVIKHHYKMSQRMPLIYVKLYF 61
           ++H N++ +   F     +++ +  LV+E     +     I  H ++ +  PL      F
Sbjct: 86  VEHANIIKVLDIF-----ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDE--PL--ASYIF 136
Query: 62  YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY 121
            Q+  A+ Y+     + HRDIK +N+++      +KL DFGSA  L +G+   ++  +  
Sbjct: 137 RQLVSAVGYLRLK-DIIHRDIKDENIVI-AEDFTIKLIDFGSAAYLERGKLFYTFCGTIE 194
Query: 122 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVD-----------QLVEI 169
           Y APE++ G       +++WS G  L  L+  + P    E  V+           +L+ +
Sbjct: 195 YCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKELMSL 254
Query: 170 IKVLGTPTREEIKCMNPNYTEFKFPQ---IKAHPWHKIFQKRMPPEAVDLVSRLLQYSPN 226
           +  L  P  E    +    T+    Q   +  + W ++F+   P   V   + L   + +
Sbjct: 255 VSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKPESGVLSAASLEMGNRS 314
Query: 227 LRSTA 231
           L   A
Sbjct: 315 LSDVA 319

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 56/243 (23%), Positives = 100/243 (41%), Gaps = 40/243 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           +R + HPN+++L   F + T+     + L+LE V    +   +     +++     ++K 
Sbjct: 69  LREIRHPNIITLHDIFENKTD-----VVLILELVSGGELFDFLAEKESLTEDEATQFLK- 122
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISY 116
              QI   + Y+H+   + H D+KP+N+++   N    ++KL DFG A  +  G    + 
Sbjct: 123 ---QILDGVHYLHSK-RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNI 178
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
             +  + APE++          D+WS G +   LL G   F GE+  + L          
Sbjct: 179 FGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLT--------- 228
Query: 177 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 236
               I  +N ++ E  F                   A D + RLL   P  R    ++L 
Sbjct: 229 ---NISAVNYDFDEEYFSN-------------TSELAKDFIRRLLVKDPKRRMXIAQSLE 272
Query: 237 HPF 239
           H +
Sbjct: 273 HSW 275

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 103/243 (42%), Gaps = 40/243 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           ++ + HPNV++L   + + T+     + L+LE V    +   +     +++     ++K 
Sbjct: 68  LKEIQHPNVITLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK- 121
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISY 116
              QI   + Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    + 
Sbjct: 122 ---QILNGVYYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
             +  + APE++          D+WS G +   LL G   F G++  + L  +       
Sbjct: 178 FGTPAFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------- 229
Query: 177 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 236
                  +N  + +  F    A              A D + RLL   P  R T  ++L 
Sbjct: 230 -----SAVNYEFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQ 271
Query: 237 HPF 239
           HP+
Sbjct: 272 HPW 274

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/243 (22%), Positives = 103/243 (42%), Gaps = 40/243 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           ++ + HPNV++L   + + T+     + L+LE V    +   +     +++     ++K 
Sbjct: 68  LKEIQHPNVITLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK- 121
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISY 116
              QI   + Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    + 
Sbjct: 122 ---QILNGVYYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
             +  + APE++          D+WS G +   LL G   F G++  + L  +       
Sbjct: 178 FGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------- 229
Query: 177 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 236
                  +N  + +  F    A              A D + RLL   P  R T  ++L 
Sbjct: 230 -----SAVNYEFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQ 271
Query: 237 HPF 239
           HP+
Sbjct: 272 HPW 274

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 48/100 (48%), Gaps = 8/100 (8%)
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           Y  Q    L Y+H+   + H D+K  N+L++       LCDFG A  L       S +  
Sbjct: 190 YLGQALEGLEYLHSRR-ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTG 248
Query: 120 RY------YRAPELIFGATEYTAAIDIWSAGCVLAELLLG 153
            Y      + APE++ G +   A +D+WS+ C++  +L G
Sbjct: 249 DYIPGTETHMAPEVVLGRS-CDAKVDVWSSCCMMLHMLNG 287

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 48/100 (48%), Gaps = 8/100 (8%)
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           Y  Q    L Y+H T  + H D+K  N+L++    +  LCDFG A  L       S +  
Sbjct: 171 YLGQALEGLEYLH-TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTG 229
Query: 120 RY------YRAPELIFGATEYTAAIDIWSAGCVLAELLLG 153
            Y      + APE++ G     A +DIWS+ C++  +L G
Sbjct: 230 DYIPGTETHMAPEVVMGKP-CDAKVDIWSSCCMMLHMLNG 268

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 48/100 (48%), Gaps = 8/100 (8%)
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           Y  Q    L Y+H T  + H D+K  N+L++    +  LCDFG A  L       S +  
Sbjct: 169 YLGQALEGLEYLH-TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTG 227
Query: 120 RY------YRAPELIFGATEYTAAIDIWSAGCVLAELLLG 153
            Y      + APE++ G     A +DIWS+ C++  +L G
Sbjct: 228 DYIPGTETHMAPEVVMGKP-CDAKVDIWSSCCMMLHMLNG 266

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 48/100 (48%), Gaps = 8/100 (8%)
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           Y  Q    L Y+H T  + H D+K  N+L++    +  LCDFG A  L       S +  
Sbjct: 155 YLGQALEGLEYLH-TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTG 213
Query: 120 RY------YRAPELIFGATEYTAAIDIWSAGCVLAELLLG 153
            Y      + APE++ G     A +DIWS+ C++  +L G
Sbjct: 214 DYIPGTETHMAPEVVMGKP-CDAKVDIWSSCCMMLHMLNG 252

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 76/156 (48%), Gaps = 16/156 (10%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M   DHPN++ L+     T  K  + +   +E    ++   ++ H     +  +I +   
Sbjct: 100 MGQFDHPNIIRLEGVV--TKSKPVMIVTEXME--NGSLDSFLRKH---DAQFTVIQLVGM 152
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
              I   + Y+ + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y    
Sbjct: 153 LRGIASGMKYLSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRG 209
Query: 121 -----YYRAPELIFGATEYTAAIDIWSAGCVLAELL 151
                 + +PE I    ++T+A D+WS G VL E++
Sbjct: 210 GKIPIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 76/156 (48%), Gaps = 16/156 (10%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M   DHPN++ L+     T  K  + +   +E    ++   ++ H     +  +I +   
Sbjct: 71  MGQFDHPNIIRLEGVV--TKSKPVMIVTEXME--NGSLDSFLRKH---DAQFTVIQLVGM 123
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
              I   + Y+ + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y    
Sbjct: 124 LRGIASGMKYLSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRG 180
Query: 121 -----YYRAPELIFGATEYTAAIDIWSAGCVLAELL 151
                 + +PE I    ++T+A D+WS G VL E++
Sbjct: 181 GKIPIRWTSPEAI-AYRKFTSASDVWSYGIVLWEVM 215

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 79/162 (48%), Gaps = 17/162 (10%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M+ LDHP++V L        E++  ++ + L    E  H + ++       + ++ + LY
Sbjct: 79  MKNLDHPHIVKL----IGIIEEEPTWIIMELYPYGELGHYLERN----KNSLKVLTLVLY 130
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
             QIC+A+AY+  +I   HRDI  +N+LV      +KL DFG ++  ++ E       +R
Sbjct: 131 SLQICKAMAYLE-SINCVHRDIAVRNILV-ASPECVKLGDFGLSR-YIEDEDYYKASVTR 187
Query: 121 Y---YRAPELIFGATEYTAAIDIWSAGCVLAELLL--GQPLF 157
               + +PE I     +T A D+W     + E+L    QP F
Sbjct: 188 LPIKWMSPESI-NFRRFTTASDVWMFAVCMWEILSFGKQPFF 228

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 87/200 (43%), Gaps = 46/200 (23%)
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-------- 112
           F QI  A+ ++H+  G+ HRD+KP N+        +K+ DFG    + + E         
Sbjct: 124 FLQIAEAVEFLHSK-GLMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 113 -----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV 167
                +   + ++ Y +PE I G + Y+  +DI+S G +L EL     L+P  + ++++ 
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNS-YSHKVDIFSLGLILFEL-----LYPFSTQMERVR 235
Query: 168 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL 227
            +  V                   KFP         +F ++ P E V +V  +L  SP  
Sbjct: 236 TLTDV----------------RNLKFP--------PLFTQKYPCEYV-MVQDMLSPSPME 270
Query: 228 RSTALEALIHPFFDELRDPN 247
           R  A+  + +  F++L  P 
Sbjct: 271 RPEAINIIENAVFEDLDFPG 290

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 79/162 (48%), Gaps = 17/162 (10%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M+ LDHP++V L        E++  ++ + L    E  H + ++       + ++ + LY
Sbjct: 63  MKNLDHPHIVKL----IGIIEEEPTWIIMELYPYGELGHYLERN----KNSLKVLTLVLY 114
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
             QIC+A+AY+  +I   HRDI  +N+LV      +KL DFG ++  ++ E       +R
Sbjct: 115 SLQICKAMAYLE-SINCVHRDIAVRNILV-ASPECVKLGDFGLSR-YIEDEDYYKASVTR 171
Query: 121 Y---YRAPELIFGATEYTAAIDIWSAGCVLAELLL--GQPLF 157
               + +PE I     +T A D+W     + E+L    QP F
Sbjct: 172 LPIKWMSPESI-NFRRFTTASDVWMFAVCMWEILSFGKQPFF 212

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 54/102 (52%), Gaps = 7/102 (6%)
Query: 62  YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY 121
           YQ+ + + ++     V HRD+  +N+LV  H   +K+CDFG A+ ++     +    +R 
Sbjct: 179 YQVAKGMEFLEFKSCV-HRDLAARNVLV-THGKVVKICDFGLARDIMSDSNYVVRGNARL 236
Query: 122 ---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 159
              + APE +F    YT   D+WS G +L E+  LG   +PG
Sbjct: 237 PVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPG 277

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/162 (28%), Positives = 79/162 (48%), Gaps = 17/162 (10%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M+ LDHP++V L        E++  ++ + L    E  H + ++       + ++ + LY
Sbjct: 67  MKNLDHPHIVKL----IGIIEEEPTWIIMELYPYGELGHYLERN----KNSLKVLTLVLY 118
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
             QIC+A+AY+  +I   HRDI  +N+LV      +KL DFG ++  ++ E       +R
Sbjct: 119 SLQICKAMAYLE-SINCVHRDIAVRNILV-ASPECVKLGDFGLSR-YIEDEDYYKASVTR 175
Query: 121 Y---YRAPELIFGATEYTAAIDIWSAGCVLAELLL--GQPLF 157
               + +PE I     +T A D+W     + E+L    QP F
Sbjct: 176 LPIKWMSPESI-NFRRFTTASDVWMFAVCMWEILSFGKQPFF 216

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 85/178 (47%), Gaps = 26/178 (14%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           MR  DHP++V L         ++ +++ + L  + E   R      K S  + L  + LY
Sbjct: 65  MRQFDHPHIVKL----IGVITENPVWIIMELCTLGEL--RSFLQVRKFS--LDLASLILY 116
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL--------VKGEP 112
            YQ+  ALAY+ +   V HRDI  +N+LV+ +   +KL DFG ++ +         KG+ 
Sbjct: 117 AYQLSTALAYLESKRFV-HRDIAARNVLVSSNDC-VKLGDFGLSRYMEDSTXXKASKGKL 174
Query: 113 NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEI 169
            I ++      APE I     +T+A D+W  G  + E+L+ G   F G    D +  I
Sbjct: 175 PIKWM------APESI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 225

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           M   DHPN++ L+     +       + +V EY+   ++   +K   K   +  +I +  
Sbjct: 77  MGQFDHPNIIHLEGVVTKSKP-----VMIVTEYMENGSLDTFLK---KNDGQFTVIQLVG 128
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
               I   + Y+ + +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y   
Sbjct: 129 MLRGISAGMKYLSD-MGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTR 185
Query: 120 R-----YYRAPELIFGATEYTAAIDIWSAGCVLAELL 151
                  + APE I    ++T+A D+WS G V+ E++
Sbjct: 186 GGKIPIRWTAPEAI-AFRKFTSASDVWSYGIVMWEVV 221

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 73/173 (42%), Gaps = 28/173 (16%)
Query: 2   RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 61
           ++  HP  V L+  +    E   LYL   L         + +H       +P   V  Y 
Sbjct: 112 KVGQHPCCVRLEQAW---EEGGILYLQTEL-----CGPSLQQHCEAWGASLPEAQVWGYL 163
Query: 62  YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG--------SAKVLVKGEPN 113
                ALA++H+  G+ H D+KP N+ + P   + KL DFG         A  + +G+P 
Sbjct: 164 RDTLLALAHLHSQ-GLVHLDVKPANIFLGPRG-RCKLGDFGLLVELGTAGAGEVQEGDPR 221
Query: 114 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQL 166
                   Y APEL+ G+  Y  A D++S G  + E+     L  G  G  QL
Sbjct: 222 --------YMAPELLQGS--YGTAADVFSLGLTILEVACNMELPHGGEGWQQL 264

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/243 (21%), Positives = 102/243 (41%), Gaps = 40/243 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           ++ + HPNV++L   + + T+     + L+ E V    +   +     +++     ++K 
Sbjct: 68  LKEIQHPNVITLHEVYENKTD-----VILIGELVAGGELFDFLAEKESLTEEEATEFLK- 121
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISY 116
              QI   + Y+H ++ + H D+KP+N+++   N    ++K+ DFG A  +  G    + 
Sbjct: 122 ---QILNGVYYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
             +  + APE++          D+WS G +   LL G   F G++  + L  +       
Sbjct: 178 FGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV------- 229
Query: 177 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 236
                  +N  + +  F    A              A D + RLL   P  R T  ++L 
Sbjct: 230 -----SAVNYEFEDEYFSNTSAL-------------AKDFIRRLLVKDPKKRMTIQDSLQ 271
Query: 237 HPF 239
           HP+
Sbjct: 272 HPW 274

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 67/298 (22%), Positives = 112/298 (37%), Gaps = 52/298 (17%)
Query: 2   RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 61
           +L +HPN+V  +  F +    +EL++             +  H       + + Y+    
Sbjct: 65  KLFNHPNIVPYRATFIA---DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYI---L 118
Query: 62  YQICRALAYIHNTIGVCHRDIKPQNLLVNPHT--------HQLKLCDFGSAKVLVKGEPN 113
             + +AL YIH+ +G  HR +K  ++L++             L +   G  + +V   P 
Sbjct: 119 QGVLKALDYIHH-MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPK 177
Query: 114 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL 173
            S     +     L      Y A  DI+S G    EL  G   F        L+E  K+ 
Sbjct: 178 YSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE--KLN 235
Query: 174 GT------------------PTR--------EEIKCMNPNYTEFKFPQIKAHPWHKIFQK 207
           GT                  P+R        + +    P  +    P   +HP+H+ F  
Sbjct: 236 GTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSP---SHPYHRTFS- 291
Query: 208 RMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL-RDPNTRLPN-GRFLPPLFNFK 263
              P     V + LQ +P+ R +A   L H FF ++ R  +  LP   R + P+ NF+
Sbjct: 292 ---PHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFE 346

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/243 (23%), Positives = 100/243 (41%), Gaps = 40/243 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           +R + H NV++L   + + T+     + L+LE V    +   +     +S+     ++K 
Sbjct: 69  LRQVLHHNVITLHDVYENRTD-----VVLILELVSGGELFDFLAQKESLSEEEATSFIK- 122
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISY 116
              QI   + Y+H T  + H D+KP+N+++   N     +KL DFG A  +  G    + 
Sbjct: 123 ---QILDGVNYLH-TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI 178
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
             +  + APE++          D+WS G +   LL G   F G++  + L  I  V    
Sbjct: 179 FGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV---- 233
Query: 177 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 236
                                ++ + + F  +    A D + +LL      R T  EAL 
Sbjct: 234 ---------------------SYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272
Query: 237 HPF 239
           HP+
Sbjct: 273 HPW 275

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 47/100 (47%), Gaps = 8/100 (8%)
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           Y  Q    L Y+H+   + H D+K  N+L++       LCDFG A  L         +  
Sbjct: 171 YLGQALEGLEYLHSRR-ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTG 229
Query: 120 RY------YRAPELIFGATEYTAAIDIWSAGCVLAELLLG 153
            Y      + APE++ G +   A +D+WS+ C++  +L G
Sbjct: 230 DYIPGTETHMAPEVVLGRS-CDAKVDVWSSCCMMLHMLNG 268

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 67/298 (22%), Positives = 112/298 (37%), Gaps = 52/298 (17%)
Query: 2   RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 61
           +L +HPN+V  +  F +    +EL++             +  H       + + Y+    
Sbjct: 81  KLFNHPNIVPYRATFIA---DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYI---L 134
Query: 62  YQICRALAYIHNTIGVCHRDIKPQNLLVNPHT--------HQLKLCDFGSAKVLVKGEPN 113
             + +AL YIH+ +G  HR +K  ++L++             L +   G  + +V   P 
Sbjct: 135 QGVLKALDYIHH-MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPK 193
Query: 114 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL 173
            S     +     L      Y A  DI+S G    EL  G   F        L+E  K+ 
Sbjct: 194 YSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE--KLN 251
Query: 174 GT------------------PTR--------EEIKCMNPNYTEFKFPQIKAHPWHKIFQK 207
           GT                  P+R        + +    P  +    P   +HP+H+ F  
Sbjct: 252 GTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSP---SHPYHRTFS- 307
Query: 208 RMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL-RDPNTRLPN-GRFLPPLFNFK 263
              P     V + LQ +P+ R +A   L H FF ++ R  +  LP   R + P+ NF+
Sbjct: 308 ---PHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFE 362

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/243 (23%), Positives = 100/243 (41%), Gaps = 40/243 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           +R + H NV++L   + + T+     + L+LE V    +   +     +S+     ++K 
Sbjct: 69  LRQVLHHNVITLHDVYENRTD-----VVLILELVSGGELFDFLAQKESLSEEEATSFIK- 122
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISY 116
              QI   + Y+H T  + H D+KP+N+++   N     +KL DFG A  +  G    + 
Sbjct: 123 ---QILDGVNYLH-TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI 178
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
             +  + APE++          D+WS G +   LL G   F G++  + L  I  V    
Sbjct: 179 FGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV---- 233
Query: 177 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 236
                                ++ + + F  +    A D + +LL      R T  EAL 
Sbjct: 234 ---------------------SYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272
Query: 237 HPF 239
           HP+
Sbjct: 273 HPW 275

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/240 (24%), Positives = 96/240 (40%), Gaps = 39/240 (16%)
Query: 7   PNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQI 64
           P V++L   + +T+E     + L+LEY    E     +    +M     +I +     QI
Sbjct: 89  PRVINLHEVYENTSE-----IILILEYAAGGEIFSLCLPELAEMVSENDVIRL---IKQI 140
Query: 65  CRALAYIHNTIGVCHRDIKPQNLLVNPH--THQLKLCDFGSAKVLVKGEPNISYICSRYY 122
              + Y+H    + H D+KPQN+L++       +K+ DFG ++ +         + +  Y
Sbjct: 141 LEGVYYLHQN-NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEY 199
Query: 123 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 182
            APE I      T A D+W+ G +   LL     F GE   +  + I +V          
Sbjct: 200 LAPE-ILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV---------- 248
Query: 183 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 242
             N +Y+E  F  +                A D +  LL  +P  R TA   L H +  +
Sbjct: 249 --NVDYSEETFSSVSQL-------------ATDFIQSLLVKNPEKRPTAEICLSHSWLQQ 293

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 71/156 (45%), Gaps = 16/156 (10%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M   DHPN++ L+             + ++ EY+            K   R  +I +   
Sbjct: 84  MGQFDHPNIIHLEGVVTKCKP-----VMIITEYMENGSLDAFLR--KNDGRFTVIQLVGM 136
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
              I   + Y+ +   V HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y    
Sbjct: 137 LRGIGSGMKYLSDMSAV-HRDLAARNILVNSNL-VCKVSDFGMSRVL-EDDPEAAYTTRG 193
Query: 121 -----YYRAPELIFGATEYTAAIDIWSAGCVLAELL 151
                 + APE I    ++T+A D+WS G V+ E++
Sbjct: 194 GKIPIRWTAPEAI-AYRKFTSASDVWSYGIVMWEVM 228

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/243 (23%), Positives = 99/243 (40%), Gaps = 40/243 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           +R + H NV++L   + + T+     + L+LE V    +   +     +S+     ++K 
Sbjct: 69  LRQVLHHNVITLHDVYENRTD-----VVLILELVSGGELFDFLAQKESLSEEEATSFIK- 122
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISY 116
              QI   + Y+H T  + H D+KP+N+++   N     +KL DFG A  +  G    + 
Sbjct: 123 ---QILDGVNYLH-TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI 178
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
             +  + APE++          D+WS G +   LL G   F G++  + L  I  V    
Sbjct: 179 FGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV---- 233
Query: 177 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 236
                                ++ + + F       A D + +LL      R T  EAL 
Sbjct: 234 ---------------------SYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272
Query: 237 HPF 239
           HP+
Sbjct: 273 HPW 275

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 52/93 (55%), Gaps = 9/93 (9%)
Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR--- 120
           I   + Y+ N +   HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y  S    
Sbjct: 156 IAAGMKYLAN-MNYVHRDLAARNILVNSNL-VCKVSDFGLSRVL-EDDPEATYTTSGGKI 212
Query: 121 --YYRAPELIFGATEYTAAIDIWSAGCVLAELL 151
              + APE I    ++T+A D+WS G V+ E++
Sbjct: 213 PIRWTAPEAI-SYRKFTSASDVWSFGIVMWEVM 244

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 65/261 (24%), Positives = 104/261 (39%), Gaps = 48/261 (18%)
Query: 9   VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY---VKLYFYQIC 65
           +VSL + F + T+     L LV+  +     R   H Y + +  P         Y  QI 
Sbjct: 247 IVSLAYAFETKTD-----LCLVMTIMNGGDIRY--HIYNVDEDNPGFQEPRAIFYTAQIV 299
Query: 66  RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-SYICSRYYRA 124
             L ++H    + +RD+KP+N+L++   + +++ D G A  L  G+     Y  +  + A
Sbjct: 300 SGLEHLHQR-NIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYAGTPGFMA 357
Query: 125 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 184
           PEL+ G  EY  ++D ++ G  L E++  +  F                    R E K  
Sbjct: 358 PELLLG-EEYDFSVDYFALGVTLYEMIAARGPF------------------RARGE-KVE 397
Query: 185 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSP----NLRSTALEAL-IHPF 239
           N    +    Q   +P       +  P + D    LLQ  P      R  + + L  HP 
Sbjct: 398 NKELKQRVLEQAVTYP------DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPL 451
Query: 240 FDELRDPNTR-LPNGRFLPPL 259
           F   RD + R L  G   PP 
Sbjct: 452 F---RDISWRQLEAGMLTPPF 469

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 53/104 (50%), Gaps = 16/104 (15%)
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-------PN 113
           F QI  A+ ++H+  G+ HRD+KP N+        +K+ DFG    + + E       P 
Sbjct: 170 FIQIAEAVEFLHSK-GLMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPM 227
Query: 114 ISY------ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL 151
            +Y      + ++ Y +PE I G   Y+  +DI+S G +L ELL
Sbjct: 228 PAYATHXGQVGTKLYMSPEQIHG-NNYSHKVDIFSLGLILFELL 270

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 65/261 (24%), Positives = 104/261 (39%), Gaps = 48/261 (18%)
Query: 9   VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY---VKLYFYQIC 65
           +VSL + F + T+     L LV+  +     R   H Y + +  P         Y  QI 
Sbjct: 247 IVSLAYAFETKTD-----LCLVMTIMNGGDIRY--HIYNVDEDNPGFQEPRAIFYTAQIV 299
Query: 66  RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-SYICSRYYRA 124
             L ++H    + +RD+KP+N+L++   + +++ D G A  L  G+     Y  +  + A
Sbjct: 300 SGLEHLHQR-NIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYAGTPGFMA 357
Query: 125 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 184
           PEL+ G  EY  ++D ++ G  L E++  +  F                    R E K  
Sbjct: 358 PELLLG-EEYDFSVDYFALGVTLYEMIAARGPF------------------RARGE-KVE 397
Query: 185 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSP----NLRSTALEAL-IHPF 239
           N    +    Q   +P       +  P + D    LLQ  P      R  + + L  HP 
Sbjct: 398 NKELKQRVLEQAVTYP------DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPL 451
Query: 240 FDELRDPNTR-LPNGRFLPPL 259
           F   RD + R L  G   PP 
Sbjct: 452 F---RDISWRQLEAGMLTPPF 469

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 65/261 (24%), Positives = 104/261 (39%), Gaps = 48/261 (18%)
Query: 9   VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY---VKLYFYQIC 65
           +VSL + F + T+     L LV+  +     R   H Y + +  P         Y  QI 
Sbjct: 247 IVSLAYAFETKTD-----LCLVMTIMNGGDIRY--HIYNVDEDNPGFQEPRAIFYTAQIV 299
Query: 66  RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-SYICSRYYRA 124
             L ++H    + +RD+KP+N+L++   + +++ D G A  L  G+     Y  +  + A
Sbjct: 300 SGLEHLHQR-NIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYAGTPGFMA 357
Query: 125 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 184
           PEL+ G  EY  ++D ++ G  L E++  +  F                    R E K  
Sbjct: 358 PELLLG-EEYDFSVDYFALGVTLYEMIAARGPF------------------RARGE-KVE 397
Query: 185 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSP----NLRSTALEAL-IHPF 239
           N    +    Q   +P       +  P + D    LLQ  P      R  + + L  HP 
Sbjct: 398 NKELKQRVLEQAVTYP------DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPL 451
Query: 240 FDELRDPNTR-LPNGRFLPPL 259
           F   RD + R L  G   PP 
Sbjct: 452 F---RDISWRQLEAGMLTPPF 469

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/243 (23%), Positives = 99/243 (40%), Gaps = 40/243 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           +R + H NV++L   + + T+     + L+LE V    +   +     +S+     ++K 
Sbjct: 69  LRQVLHHNVITLHDVYENRTD-----VVLILELVSGGELFDFLAQKESLSEEEATSFIK- 122
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISY 116
              QI   + Y+H T  + H D+KP+N+++   N     +KL DFG A  +  G    + 
Sbjct: 123 ---QILDGVNYLH-TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI 178
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
             +  + APE++          D+WS G +   LL G   F G++  + L  I  V    
Sbjct: 179 FGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV---- 233
Query: 177 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 236
                                ++ + + F       A D + +LL      R T  EAL 
Sbjct: 234 ---------------------SYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272
Query: 237 HPF 239
           HP+
Sbjct: 273 HPW 275

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/243 (23%), Positives = 99/243 (40%), Gaps = 40/243 (16%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           +R + H NV++L   + + T+     + L+LE V    +   +     +S+     ++K 
Sbjct: 69  LRQVLHHNVITLHDVYENRTD-----VVLILELVSGGELFDFLAQKESLSEEEATSFIK- 122
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISY 116
              QI   + Y+H T  + H D+KP+N+++   N     +KL DFG A  +  G    + 
Sbjct: 123 ---QILDGVNYLH-TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI 178
Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
             +  + APE++          D+WS G +   LL G   F G++  + L  I  V    
Sbjct: 179 FGTPEFVAPEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV---- 233
Query: 177 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 236
                                ++ + + F       A D + +LL      R T  EAL 
Sbjct: 234 ---------------------SYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272
Query: 237 HPF 239
           HP+
Sbjct: 273 HPW 275

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 65/261 (24%), Positives = 104/261 (39%), Gaps = 48/261 (18%)
Query: 9   VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY---VKLYFYQIC 65
           +VSL + F + T+     L LV+  +     R   H Y + +  P         Y  QI 
Sbjct: 247 IVSLAYAFETKTD-----LCLVMTIMNGGDIRY--HIYNVDEDNPGFQEPRAIFYTAQIV 299
Query: 66  RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-SYICSRYYRA 124
             L ++H    + +RD+KP+N+L++   + +++ D G A  L  G+     Y  +  + A
Sbjct: 300 SGLEHLHQR-NIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYAGTPGFMA 357
Query: 125 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 184
           PEL+ G  EY  ++D ++ G  L E++  +  F                    R E K  
Sbjct: 358 PELLLG-EEYDFSVDYFALGVTLYEMIAARGPF------------------RARGE-KVE 397
Query: 185 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSP----NLRSTALEAL-IHPF 239
           N    +    Q   +P       +  P + D    LLQ  P      R  + + L  HP 
Sbjct: 398 NKELKQRVLEQAVTYP------DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPL 451
Query: 240 FDELRDPNTR-LPNGRFLPPL 259
           F   RD + R L  G   PP 
Sbjct: 452 F---RDISWRQLEAGMLTPPF 469

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 79/157 (50%), Gaps = 18/157 (11%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           M   DHPN++ L+        +  L + +V EY+   ++   ++ H      M L+ +  
Sbjct: 104 MGQFDHPNIIRLE----GVVTRGRLAM-IVTEYMENGSLDTFLRTHDGQFTIMQLVGM-- 156
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
               +   + Y+ + +G  HRD+  +N+LV+ +    K+ DFG ++VL + +P+ +   +
Sbjct: 157 -LRGVGAGMRYLSD-LGYVHRDLAARNVLVDSNL-VCKVSDFGLSRVL-EDDPDAAXTTT 212
Query: 120 R-----YYRAPELIFGATEYTAAIDIWSAGCVLAELL 151
                  + APE I   T +++A D+WS G V+ E+L
Sbjct: 213 GGKIPIRWTAPEAIAFRT-FSSASDVWSFGVVMWEVL 248

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 32/113 (28%), Positives = 59/113 (52%), Gaps = 7/113 (6%)
Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICS 119
           Q  R + Y+H    + HRD+K  N+ ++   + +K+ DFG A V  +   +  +     S
Sbjct: 116 QTARGMDYLHAK-SIIHRDLKSNNIFLH-EDNTVKIGDFGLATVKSRWSGSHQFEQLSGS 173
Query: 120 RYYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 170
             + APE+I    +  Y+   D+++ G VL EL+ GQ  +   +  DQ++E++
Sbjct: 174 ILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 226

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 76/157 (48%), Gaps = 18/157 (11%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           M   DHPNVV L+             + +V+E++    +   ++ H     +  +I +  
Sbjct: 98  MGQFDHPNVVHLEGVVTRGKP-----VMIVIEFMENGALDAFLRKH---DGQFTVIQLVG 149
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
               I   + Y+ + +G  HRD+  +N+LVN +    K+ DFG ++V ++ +P   Y  +
Sbjct: 150 MLRGIAAGMRYLAD-MGYVHRDLAARNILVNSNL-VCKVSDFGLSRV-IEDDPEAVYTTT 206
Query: 120 R-----YYRAPELIFGATEYTAAIDIWSAGCVLAELL 151
                  + APE I    ++T+A D+WS G V+ E++
Sbjct: 207 GGKIPVRWTAPEAI-QYRKFTSASDVWSYGIVMWEVM 242

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 71/156 (45%), Gaps = 16/156 (10%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M   DHPN++ L+             + ++ EY+            K   R  +I +   
Sbjct: 69  MGQFDHPNIIHLEGVVTKCKP-----VMIITEYMENGSLDAFLR--KNDGRFTVIQLVGM 121
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
              I   + Y+ + +   HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y    
Sbjct: 122 LRGIGSGMKYLSD-MSYVHRDLAARNILVNSNL-VCKVSDFGMSRVL-EDDPEAAYTTRG 178
Query: 121 -----YYRAPELIFGATEYTAAIDIWSAGCVLAELL 151
                 + APE I    ++T+A D+WS G V+ E++
Sbjct: 179 GKIPIRWTAPEAI-AYRKFTSASDVWSYGIVMWEVM 213

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 71/156 (45%), Gaps = 16/156 (10%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M   DHPN++ L+             + ++ EY+            K   R  +I +   
Sbjct: 63  MGQFDHPNIIHLEGVVTKCKP-----VMIITEYMENGSLDAFLR--KNDGRFTVIQLVGM 115
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
              I   + Y+ + +   HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y    
Sbjct: 116 LRGIGSGMKYLSD-MSYVHRDLAARNILVNSNL-VCKVSDFGMSRVL-EDDPEAAYTTRG 172
Query: 121 -----YYRAPELIFGATEYTAAIDIWSAGCVLAELL 151
                 + APE I    ++T+A D+WS G V+ E++
Sbjct: 173 GKIPIRWTAPEAI-AYRKFTSASDVWSYGIVMWEVM 207

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 58/113 (51%), Gaps = 7/113 (6%)
Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA--KVLVKGEPNISYIC-S 119
           Q  R + Y+H    + HRD+K  N+ ++   + +K+ DFG A  K    G      +  S
Sbjct: 128 QTARGMDYLH-AKSIIHRDLKSNNIFLH-EDNTVKIGDFGLATEKSRWSGSHQFEQLSGS 185
Query: 120 RYYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 170
             + APE+I    +  Y+   D+++ G VL EL+ GQ  +   +  DQ++E++
Sbjct: 186 ILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 58/113 (51%), Gaps = 7/113 (6%)
Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA--KVLVKGEPNISYIC-S 119
           Q  R + Y+H    + HRD+K  N+ ++   + +K+ DFG A  K    G      +  S
Sbjct: 128 QTARGMDYLHAK-SIIHRDLKSNNIFLH-EDNTVKIGDFGLATEKSRWSGSHQFEQLSGS 185
Query: 120 RYYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 170
             + APE+I    +  Y+   D+++ G VL EL+ GQ  +   +  DQ++E++
Sbjct: 186 ILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/85 (37%), Positives = 44/85 (51%), Gaps = 4/85 (4%)
Query: 78  CHRDIKPQNLLVNPHTHQLKLCDFG--SAKVLVKGEPNISYICSRYYRAPELIFGATEYT 135
            HRD+KP+N+LV+       L DFG  SA    K     + + + YY APE  F  +  T
Sbjct: 156 THRDVKPENILVSADDFAY-LVDFGIASATTDEKLTQLGNTVGTLYYXAPER-FSESHAT 213
Query: 136 AAIDIWSAGCVLAELLLGQPLFPGE 160
              DI++  CVL E L G P + G+
Sbjct: 214 YRADIYALTCVLYECLTGSPPYQGD 238

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 82/176 (46%), Gaps = 23/176 (13%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIK---HHYKMSQRMPLIY 56
           ++ L+H N+V L      TT + ++   L++E+ P  +++ V++   + Y + +   LI 
Sbjct: 61  LKKLNHKNIVKLFAIEEETTTRHKV---LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIV 117
Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLL--VNPHTHQL-KLCDFGSAKVLVKGEPN 113
           ++     +   + ++    G+ HR+IKP N++  +      + KL DFG+A+ L   E  
Sbjct: 118 LR----DVVGGMNHLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF 172
Query: 114 ISYICSRYYRAPELIFGAT-------EYTAAIDIWSAGCVLAELLLGQ-PLFPGES 161
           +S   +  Y  P++   A        +Y A +D+WS G        G  P  P E 
Sbjct: 173 VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG 228

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/104 (27%), Positives = 55/104 (52%), Gaps = 7/104 (6%)
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           + +QI + + Y+   + + HRD+  +N+LV     ++K+ DFG ++ + + +  +     
Sbjct: 155 FAWQISQGMQYLAE-MSLVHRDLAARNILV-AEGRKMKISDFGLSRDVYEEDSXVKRSQG 212
Query: 120 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 159
           R    + A E +F    YT   D+WS G +L E++ LG   +PG
Sbjct: 213 RIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 255

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 53/101 (52%), Gaps = 7/101 (6%)
Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY- 121
           Q+ + +A++ +     HRD+  +N+L+  + H  K+ DFG A+ ++     I    +R  
Sbjct: 168 QVAQGMAFLASK-NCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKGNARLP 225
Query: 122 --YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 159
             + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 226 VKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 265

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 53/101 (52%), Gaps = 7/101 (6%)
Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY- 121
           Q+ + +A++ +     HRD+  +N+L+  + H  K+ DFG A+ ++     I    +R  
Sbjct: 172 QVAQGMAFLASK-NCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKGNARLP 229
Query: 122 --YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 159
             + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 230 VKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 269

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 53/101 (52%), Gaps = 7/101 (6%)
Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY- 121
           Q+ + +A++ +     HRD+  +N+L+  + H  K+ DFG A+ ++     I    +R  
Sbjct: 174 QVAQGMAFLASK-NCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKGNARLP 231
Query: 122 --YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 159
             + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 232 VKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 271

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 74/163 (45%), Gaps = 20/163 (12%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M+ L HPN+V      F         L++V EY+       + H     +++        
Sbjct: 88  MKRLRHPNIV-----LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSM 142
Query: 61  FYQICRALAYIHN-TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
            Y + + + Y+HN    + HRD+K  NLLV+   + +K+CDFG +++         ++ S
Sbjct: 143 AYDVAKGMNYLHNRNPPIVHRDLKSPNLLVD-KKYTVKVCDFGLSRLKAS-----XFLXS 196
Query: 120 RY------YRAPELIFGATEYTAAIDIWSAGCVLAEL-LLGQP 155
           +       + APE++        + D++S G +L EL  L QP
Sbjct: 197 KXAAGTPEWMAPEVLRDEPSNEKS-DVYSFGVILWELATLQQP 238

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 53/101 (52%), Gaps = 7/101 (6%)
Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY- 121
           Q+ + +A++ +     HRD+  +N+L+  + H  K+ DFG A+ ++     I    +R  
Sbjct: 160 QVAQGMAFLASK-NCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKGNARLP 217
Query: 122 --YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 159
             + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 218 VKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 257

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 53/101 (52%), Gaps = 7/101 (6%)
Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY- 121
           Q+ + +A++ +     HRD+  +N+L+  + H  K+ DFG A+ ++     I    +R  
Sbjct: 172 QVAQGMAFLASK-NCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKGNARLP 229
Query: 122 --YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 159
             + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 230 VKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 269

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 53/101 (52%), Gaps = 7/101 (6%)
Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY- 121
           Q+ + +A++ +     HRD+  +N+L+  + H  K+ DFG A+ ++     I    +R  
Sbjct: 166 QVAQGMAFLASK-NCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKGNARLP 223
Query: 122 --YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 159
             + APE IF    YT   D+WS G +L E+  LG   +PG
Sbjct: 224 VKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 263

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 29/104 (27%), Positives = 55/104 (52%), Gaps = 7/104 (6%)
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           + +QI + + Y+   + + HRD+  +N+LV     ++K+ DFG ++ + + +  +     
Sbjct: 155 FAWQISQGMQYLAE-MKLVHRDLAARNILV-AEGRKMKISDFGLSRDVYEEDSXVKRSQG 212
Query: 120 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 159
           R    + A E +F    YT   D+WS G +L E++ LG   +PG
Sbjct: 213 RIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 255

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/163 (25%), Positives = 75/163 (46%), Gaps = 20/163 (12%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M+ L HPN+V      F         L++V EY+       + H     +++        
Sbjct: 88  MKRLRHPNIV-----LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSM 142
Query: 61  FYQICRALAYIHN-TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
            Y + + + Y+HN    + HR++K  NLLV+   + +K+CDFG +++        +++ S
Sbjct: 143 AYDVAKGMNYLHNRNPPIVHRNLKSPNLLVD-KKYTVKVCDFGLSRLKAS-----TFLSS 196
Query: 120 RY------YRAPELIFGATEYTAAIDIWSAGCVLAEL-LLGQP 155
           +       + APE++        + D++S G +L EL  L QP
Sbjct: 197 KSAAGTPEWMAPEVLRDEPSNEKS-DVYSFGVILWELATLQQP 238

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 83/211 (39%), Gaps = 46/211 (21%)
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI--- 114
           K Y+  +  A+  IH   G+ H D+KP N L+      LKL DFG A  +     ++   
Sbjct: 130 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKD 186
Query: 115 SYICSRYYRAPELIFGATE----------YTAAIDIWSAGCVLAELLLGQPLFPGESGVD 164
           S + +  Y  PE I   +            +   D+WS GC+L  +  G+  F       
Sbjct: 187 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ------ 240
Query: 165 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEA--VDLVSRLLQ 222
           Q++  I  L          ++PN+ E +FP I              PE    D++   L+
Sbjct: 241 QIINQISKLHA-------IIDPNH-EIEFPDI--------------PEKDLQDVLKCCLK 278
Query: 223 YSPNLRSTALEALIHPFFDELRDPNTRLPNG 253
             P  R +  E L HP+      P  ++  G
Sbjct: 279 RDPKQRISIPELLAHPYVQIQTHPVNQMAKG 309

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 83/211 (39%), Gaps = 46/211 (21%)
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI--- 114
           K Y+  +  A+  IH   G+ H D+KP N L+      LKL DFG A  +     ++   
Sbjct: 114 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKD 170
Query: 115 SYICSRYYRAPELIFGATE----------YTAAIDIWSAGCVLAELLLGQPLFPGESGVD 164
           S + +  Y  PE I   +            +   D+WS GC+L  +  G+  F       
Sbjct: 171 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------Q 224
Query: 165 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEA--VDLVSRLLQ 222
           Q++  I  L          ++PN+ E +FP I              PE    D++   L+
Sbjct: 225 QIINQISKLHA-------IIDPNH-EIEFPDI--------------PEKDLQDVLKCCLK 262
Query: 223 YSPNLRSTALEALIHPFFDELRDPNTRLPNG 253
             P  R +  E L HP+      P  ++  G
Sbjct: 263 RDPKQRISIPELLAHPYVQIQTHPVNQMAKG 293

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 83/211 (39%), Gaps = 46/211 (21%)
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI--- 114
           K Y+  +  A+  IH   G+ H D+KP N L+      LKL DFG A  +     ++   
Sbjct: 111 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKD 167
Query: 115 SYICSRYYRAPELIFGATE----------YTAAIDIWSAGCVLAELLLGQPLFPGESGVD 164
           S + +  Y  PE I   +            +   D+WS GC+L  +  G+  F       
Sbjct: 168 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------Q 221
Query: 165 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEA--VDLVSRLLQ 222
           Q++  I  L          ++PN+ E +FP I              PE    D++   L+
Sbjct: 222 QIINQISKLHA-------IIDPNH-EIEFPDI--------------PEKDLQDVLKCCLK 259
Query: 223 YSPNLRSTALEALIHPFFDELRDPNTRLPNG 253
             P  R +  E L HP+      P  ++  G
Sbjct: 260 RDPKQRISIPELLAHPYVQIQTHPVNQMAKG 290

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 83/211 (39%), Gaps = 46/211 (21%)
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI--- 114
           K Y+  +  A+  IH   G+ H D+KP N L+      LKL DFG A  +     ++   
Sbjct: 110 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKD 166
Query: 115 SYICSRYYRAPELIFGATE----------YTAAIDIWSAGCVLAELLLGQPLFPGESGVD 164
           S + +  Y  PE I   +            +   D+WS GC+L  +  G+  F       
Sbjct: 167 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------Q 220
Query: 165 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEA--VDLVSRLLQ 222
           Q++  I  L          ++PN+ E +FP I              PE    D++   L+
Sbjct: 221 QIINQISKLHA-------IIDPNH-EIEFPDI--------------PEKDLQDVLKCCLK 258
Query: 223 YSPNLRSTALEALIHPFFDELRDPNTRLPNG 253
             P  R +  E L HP+      P  ++  G
Sbjct: 259 RDPKQRISIPELLAHPYVQIQTHPVNQMAKG 289

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 99/223 (44%), Gaps = 39/223 (17%)
Query: 3   LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHH---YKMSQRMPLIYVK 58
           L++H N+          T    +   LV+EY P  ++ + +  H   +  S R+      
Sbjct: 63  LMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLA----- 117
Query: 59  LYFYQICRALAYIHNTI--------GVCHRDIKPQNLLVNPHTHQLKLCDFG-----SAK 105
              + + R LAY+H  +         + HRD+  +N+LV  +     + DFG     +  
Sbjct: 118 ---HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVK-NDGTCVISDFGLSMRLTGN 173
Query: 106 VLVK-GEPN---ISYICSRYYRAPELIFGATEYT------AAIDIWSAGCVLAELLLG-Q 154
            LV+ GE +   IS + +  Y APE++ GA            +D+++ G +  E+ +   
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233
Query: 155 PLFPGESGVD-QLVEIIKVLGTPTREEIKCMNPNYTEF-KFPQ 195
            LFPGES  + Q+    +V   PT E+++ +     +  KFP+
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPE 276

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 83/211 (39%), Gaps = 46/211 (21%)
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI--- 114
           K Y+  +  A+  IH   G+ H D+KP N L+      LKL DFG A  +     ++   
Sbjct: 158 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKD 214
Query: 115 SYICSRYYRAPELIFGATE----------YTAAIDIWSAGCVLAELLLGQPLFPGESGVD 164
           S + +  Y  PE I   +            +   D+WS GC+L  +  G+  F       
Sbjct: 215 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ------ 268
Query: 165 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEA--VDLVSRLLQ 222
           Q++  I  L          ++PN+ E +FP I              PE    D++   L+
Sbjct: 269 QIINQISKLHA-------IIDPNH-EIEFPDI--------------PEKDLQDVLKCCLK 306
Query: 223 YSPNLRSTALEALIHPFFDELRDPNTRLPNG 253
             P  R +  E L HP+      P  ++  G
Sbjct: 307 RDPKQRISIPELLAHPYVQIQTHPVNQMAKG 337

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 37/158 (23%), Positives = 75/158 (47%), Gaps = 18/158 (11%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           M   DHPNV+ L+     +T      + ++ E++   ++   ++ +     +  +I +  
Sbjct: 88  MGQFDHPNVIHLEGVVTKSTP-----VMIITEFMENGSLDSFLRQN---DGQFTVIQLVG 139
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
               I   + Y+ + +   HRD+  +N+LVN +    K+ DFG ++ L     + +Y  +
Sbjct: 140 MLRGIAAGMKYLAD-MNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSA 197
Query: 120 R------YYRAPELIFGATEYTAAIDIWSAGCVLAELL 151
                   + APE I    ++T+A D+WS G V+ E++
Sbjct: 198 LGGKIPIRWTAPEAI-QYRKFTSASDVWSYGIVMWEVM 234

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 29/104 (27%), Positives = 55/104 (52%), Gaps = 7/104 (6%)
Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           + +QI + + Y+   + + HRD+  +N+LV     ++K+ DFG ++ + + +  +     
Sbjct: 155 FAWQISQGMQYLAE-MKLVHRDLAARNILV-AEGRKMKISDFGLSRDVYEEDSYVKRSQG 212
Query: 120 RY---YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 159
           R    + A E +F    YT   D+WS G +L E++ LG   +PG
Sbjct: 213 RIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 255

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 83/211 (39%), Gaps = 46/211 (21%)
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI--- 114
           K Y+  +  A+  IH   G+ H D+KP N L+      LKL DFG A  +     ++   
Sbjct: 158 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKD 214
Query: 115 SYICSRYYRAPELIFGATE----------YTAAIDIWSAGCVLAELLLGQPLFPGESGVD 164
           S + +  Y  PE I   +            +   D+WS GC+L  +  G+  F       
Sbjct: 215 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ------ 268
Query: 165 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEA--VDLVSRLLQ 222
           Q++  I  L          ++PN+ E +FP I              PE    D++   L+
Sbjct: 269 QIINQISKLHA-------IIDPNH-EIEFPDI--------------PEKDLQDVLKCCLK 306
Query: 223 YSPNLRSTALEALIHPFFDELRDPNTRLPNG 253
             P  R +  E L HP+      P  ++  G
Sbjct: 307 RDPKQRISIPELLAHPYVQIQTHPVNQMAKG 337

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 83/211 (39%), Gaps = 46/211 (21%)
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI--- 114
           K Y+  +  A+  IH   G+ H D+KP N L+      LKL DFG A  +     ++   
Sbjct: 158 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKD 214
Query: 115 SYICSRYYRAPELIFGATE----------YTAAIDIWSAGCVLAELLLGQPLFPGESGVD 164
           S + +  Y  PE I   +            +   D+WS GC+L  +  G+  F       
Sbjct: 215 SQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ------ 268
Query: 165 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEA--VDLVSRLLQ 222
           Q++  I  L          ++PN+ E +FP I              PE    D++   L+
Sbjct: 269 QIINQISKLHA-------IIDPNH-EIEFPDI--------------PEKDLQDVLKCCLK 306
Query: 223 YSPNLRSTALEALIHPFFDELRDPNTRLPNG 253
             P  R +  E L HP+      P  ++  G
Sbjct: 307 RDPKQRISIPELLAHPYVQIQTHPVNQMAKG 337

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 82/211 (38%), Gaps = 46/211 (21%)
Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI--- 114
           K Y+  +  A+  IH   G+ H D+KP N L+      LKL DFG A  +      +   
Sbjct: 130 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDXXXVVKD 186
Query: 115 SYICSRYYRAPELIFGATE----------YTAAIDIWSAGCVLAELLLGQPLFPGESGVD 164
           S + +  Y  PE I   +            +   D+WS GC+L  +  G+  F       
Sbjct: 187 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ------ 240
Query: 165 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEA--VDLVSRLLQ 222
           Q++  I  L          ++PN+ E +FP I              PE    D++   L+
Sbjct: 241 QIINQISKLHA-------IIDPNH-EIEFPDI--------------PEKDLQDVLKCCLK 278
Query: 223 YSPNLRSTALEALIHPFFDELRDPNTRLPNG 253
             P  R +  E L HP+      P  ++  G
Sbjct: 279 RDPKQRISIPELLAHPYVQIQTHPVNQMAKG 309

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 81/176 (46%), Gaps = 23/176 (13%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIK---HHYKMSQRMPLIY 56
           ++ L+H N+V L      TT + ++   L++E+ P  +++ V++   + Y + +   LI 
Sbjct: 61  LKKLNHKNIVKLFAIEEETTTRHKV---LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIV 117
Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLL--VNPHTHQL-KLCDFGSAKVLVKGEPN 113
           ++     +   + ++    G+ HR+IKP N++  +      + KL DFG+A+ L   E  
Sbjct: 118 LR----DVVGGMNHLREN-GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF 172
Query: 114 ISYICSRYYRAPELIFGAT-------EYTAAIDIWSAGCVLAELLLGQ-PLFPGES 161
           +    +  Y  P++   A        +Y A +D+WS G        G  P  P E 
Sbjct: 173 VXLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG 228

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 50/105 (47%), Gaps = 21/105 (20%)
Query: 64  ICRALAYIHNTI---------GVCHRDIKPQNLLVNPHTHQLKLC--DFGSAKVLVKGEP 112
           + R LAY+H  I          + HRDIK +N+L+    + L  C  DFG A     G+ 
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLK---NNLTACIADFGLALKFEAGKS 186
Query: 113 ---NISYICSRYYRAPELIFGATEYTAA----IDIWSAGCVLAEL 150
                  + +R Y APE++ GA  +       ID+++ G VL EL
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWEL 231

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 73/160 (45%), Gaps = 16/160 (10%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M  +DHP++V L     S T      + LV + +P        H +K +    L+    +
Sbjct: 71  MASMDHPHLVRLLGVCLSPT------IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLN--W 122
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
             QI + + Y+     + HRD+  +N+LV    H +K+ DFG A++L   E   +    +
Sbjct: 123 CVQIAKGMMYLEER-RLVHRDLAARNVLVKSPNH-VKITDFGLARLLEGDEKEYNADGGK 180
Query: 121 Y---YRAPELIFGATEYTAAIDIWSAGCVLAELLL--GQP 155
               + A E I    ++T   D+WS G  + EL+   G+P
Sbjct: 181 MPIKWMALECIH-YRKFTHQSDVWSYGVTIWELMTFGGKP 219

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 73/160 (45%), Gaps = 16/160 (10%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M  +DHP++V L     S T      + LV + +P        H +K +    L+    +
Sbjct: 94  MASMDHPHLVRLLGVCLSPT------IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLN--W 145
Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
             QI + + Y+     + HRD+  +N+LV    H +K+ DFG A++L   E   +    +
Sbjct: 146 CVQIAKGMMYLEER-RLVHRDLAARNVLVKSPNH-VKITDFGLARLLEGDEKEYNADGGK 203
Query: 121 Y---YRAPELIFGATEYTAAIDIWSAGCVLAELLL--GQP 155
               + A E I    ++T   D+WS G  + EL+   G+P
Sbjct: 204 MPIKWMALECIH-YRKFTHQSDVWSYGVTIWELMTFGGKP 242

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/80 (36%), Positives = 41/80 (51%), Gaps = 6/80 (7%)
Query: 79  HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI---SYICSRYYRAPELIFGATEYT 135
           HRDIK  N+L++      K+ DFG A+   K    +     + +  Y APE + G  E T
Sbjct: 156 HRDIKSANILLD-EAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEALRG--EIT 212
Query: 136 AAIDIWSAGCVLAELLLGQP 155
              DI+S G VL E++ G P
Sbjct: 213 PKSDIYSFGVVLLEIITGLP 232

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/80 (36%), Positives = 41/80 (51%), Gaps = 6/80 (7%)
Query: 79  HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI---SYICSRYYRAPELIFGATEYT 135
           HRDIK  N+L++      K+ DFG A+   K    +     + +  Y APE + G  E T
Sbjct: 156 HRDIKSANILLD-EAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEALRG--EIT 212
Query: 136 AAIDIWSAGCVLAELLLGQP 155
              DI+S G VL E++ G P
Sbjct: 213 PKSDIYSFGVVLLEIITGLP 232

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 18/158 (11%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           MR L+HPNV++L            + L       P   H  +    +  QR P +   + 
Sbjct: 76  MRGLNHPNVLALIGIMLPPEGLPHVLL-------PYMCHGDLLQFIRSPQRNPTVKDLIS 128
Query: 61  F-YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           F  Q+ R + Y+     V HRD+  +N +++  +  +K+ DFG A+ ++  E   S    
Sbjct: 129 FGLQVARGMEYLAEQKFV-HRDLAARNCMLD-ESFTVKVADFGLARDILDRE-YYSVQQH 185
Query: 120 RYYRAPELIFGATE------YTAAIDIWSAGCVLAELL 151
           R+ R P + + A E      +T   D+WS G +L ELL
Sbjct: 186 RHARLP-VKWTALESLQTYRFTTKSDVWSFGVLLWELL 222

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 76/154 (49%), Gaps = 20/154 (12%)
Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYF 61
           LDH ++V L      ++      L LV +Y+P    +  V +H   +  ++ L +     
Sbjct: 90  LDHAHIVRLLGLCPGSS------LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW----G 139
Query: 62  YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY 121
            QI + + Y+    G+ HR++  +N+L+   + Q+++ DFG A +L   +  + Y  ++ 
Sbjct: 140 VQIAKGMYYLEEH-GMVHRNLAARNVLLKSPS-QVQVADFGVADLLPPDDKQLLYSEAKT 197
Query: 122 ---YRAPELI-FGATEYTAAIDIWSAGCVLAELL 151
              + A E I FG  +YT   D+WS G  + EL+
Sbjct: 198 PIKWMALESIHFG--KYTHQSDVWSYGVTVWELM 229

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/80 (36%), Positives = 41/80 (51%), Gaps = 6/80 (7%)
Query: 79  HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI---SYICSRYYRAPELIFGATEYT 135
           HRDIK  N+L++      K+ DFG A+   K    +     + +  Y APE + G  E T
Sbjct: 150 HRDIKSANILLD-EAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEALRG--EIT 206
Query: 136 AAIDIWSAGCVLAELLLGQP 155
              DI+S G VL E++ G P
Sbjct: 207 PKSDIYSFGVVLLEIITGLP 226

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/80 (36%), Positives = 41/80 (51%), Gaps = 6/80 (7%)
Query: 79  HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEYT 135
           HRDIK  N+L++      K+ DFG A+   K    +     + +  Y APE + G  E T
Sbjct: 147 HRDIKSANILLD-EAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEALRG--EIT 203
Query: 136 AAIDIWSAGCVLAELLLGQP 155
              DI+S G VL E++ G P
Sbjct: 204 PKSDIYSFGVVLLEIITGLP 223

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 76/154 (49%), Gaps = 20/154 (12%)
Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYF 61
           LDH ++V L      ++      L LV +Y+P    +  V +H   +  ++ L +     
Sbjct: 72  LDHAHIVRLLGLCPGSS------LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW----G 121
Query: 62  YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY 121
            QI + + Y+    G+ HR++  +N+L+   + Q+++ DFG A +L   +  + Y  ++ 
Sbjct: 122 VQIAKGMYYLEEH-GMVHRNLAARNVLLKSPS-QVQVADFGVADLLPPDDKQLLYSEAKT 179
Query: 122 ---YRAPELI-FGATEYTAAIDIWSAGCVLAELL 151
              + A E I FG  +YT   D+WS G  + EL+
Sbjct: 180 PIKWMALESIHFG--KYTHQSDVWSYGVTVWELM 211

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 26/79 (32%), Positives = 43/79 (54%), Gaps = 8/79 (10%)
Query: 79  HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR------YYRAPELIFGAT 132
           HRD+  +N+LVN +    K+ DFG ++ L +   + +Y  S        + APE I    
Sbjct: 139 HRDLAARNILVNSNL-VCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAI-AFR 196
Query: 133 EYTAAIDIWSAGCVLAELL 151
           ++T+A D WS G V+ E++
Sbjct: 197 KFTSASDAWSYGIVMWEVM 215

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 46/191 (24%), Positives = 81/191 (42%), Gaps = 41/191 (21%)
Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE---PNISYICS 119
           +I   +AY+ N     HRD+  +N +V  H   +K+ DFG  + + + +        +  
Sbjct: 138 EIADGMAYL-NAKKFVHRDLAARNCMV-AHDFTVKIGDFGMTRDIXETDXXRKGGKGLLP 195
Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTR 178
             + APE +     +T + D+WS G VL E+  L +  + G S  +Q+++ +        
Sbjct: 196 VRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSN-EQVLKFV-------- 245
Query: 179 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL--- 235
                M+  Y +         P         P    DL+    Q++PN+R T LE +   
Sbjct: 246 -----MDGGYLD--------QP------DNCPERVTDLMRMCWQFNPNMRPTFLEIVNLL 286
Query: 236 ---IHPFFDEL 243
              +HP F E+
Sbjct: 287 KDDLHPSFPEV 297

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 30/113 (26%), Positives = 57/113 (50%), Gaps = 7/113 (6%)
Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICS 119
           Q  + + Y+H    + HRD+K  N+ ++     +K+ DFG A V  +   +  +     S
Sbjct: 139 QTAQGMDYLHAK-SIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGS 196
Query: 120 RYYRAPELIFGATE--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 170
             + APE+I    +  Y+   D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 197 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 249

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 41.2 bits (95), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 30/113 (26%), Positives = 57/113 (50%), Gaps = 7/113 (6%)
Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICS 119
           Q  + + Y+H    + HRD+K  N+ ++     +K+ DFG A V  +   +  +     S
Sbjct: 114 QTAQGMDYLHAK-SIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGS 171
Query: 120 RYYRAPELIFGATE--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 170
             + APE+I    +  Y+   D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 172 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 224

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 30/113 (26%), Positives = 57/113 (50%), Gaps = 7/113 (6%)
Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICS 119
           Q  + + Y+H    + HRD+K  N+ ++     +K+ DFG A V  +   +  +     S
Sbjct: 117 QTAQGMDYLHAK-SIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGS 174
Query: 120 RYYRAPELIFGATE--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 170
             + APE+I    +  Y+   D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 175 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 227

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 30/113 (26%), Positives = 57/113 (50%), Gaps = 7/113 (6%)
Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICS 119
           Q  + + Y+H    + HRD+K  N+ ++     +K+ DFG A V  +   +  +     S
Sbjct: 112 QTAQGMDYLHAK-SIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGS 169
Query: 120 RYYRAPELIFGATE--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 170
             + APE+I    +  Y+   D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 170 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 30/113 (26%), Positives = 57/113 (50%), Gaps = 7/113 (6%)
Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICS 119
           Q  + + Y+H    + HRD+K  N+ ++     +K+ DFG A V  +   +  +     S
Sbjct: 112 QTAQGMDYLHAK-SIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGS 169
Query: 120 RYYRAPELIFGATE--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 170
             + APE+I    +  Y+   D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 170 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 37/149 (24%), Positives = 70/149 (46%), Gaps = 9/149 (6%)
Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ L HPN+V     + ST  K +  + LV E       +     +K+ +   +  ++ +
Sbjct: 79  LKGLQHPNIVRFYDSWESTV-KGKKCIVLVTELXTSGTLKTYLKRFKVXK---IKVLRSW 134
Query: 61  FYQICRALAYIHN-TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
             QI + L ++H  T  + HRD+K  N+ +   T  +K+ D G A  L +     + I +
Sbjct: 135 CRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA-TLKRASFAKAVIGT 193
Query: 120 RYYRAPELIFGATEYTAAIDIWSAG-CVL 147
             + APE      +Y  ++D+++ G C L
Sbjct: 194 PEFXAPEXY--EEKYDESVDVYAFGXCXL 220

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 30/113 (26%), Positives = 57/113 (50%), Gaps = 7/113 (6%)
Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICS 119
           Q  + + Y+H    + HRD+K  N+ ++     +K+ DFG A V  +   +  +     S
Sbjct: 140 QTAQGMDYLHAK-SIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGS 197
Query: 120 RYYRAPELIFGATE--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 170
             + APE+I    +  Y+   D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 198 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 250

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 40.8 bits (94), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 30/113 (26%), Positives = 57/113 (50%), Gaps = 7/113 (6%)
Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---ICS 119
           Q  + + Y+H    + HRD+K  N+ ++     +K+ DFG A V  +   +  +     S
Sbjct: 117 QTAQGMDYLHAK-SIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGS 174
Query: 120 RYYRAPELIFGATE--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 170
             + APE+I    +  Y+   D+++ G VL EL+ GQ  +   +  DQ++ ++
Sbjct: 175 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 227

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	292
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	0.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	0.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-178
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-172
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-84
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	5e-84
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-83
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	9e-83
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	9e-83
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-81
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-81
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-81
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-80
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	4e-80
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-79
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-79
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-79
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	4e-79
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-78
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	5e-78
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	6e-76
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	7e-76
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-75
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-75
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	4e-75
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	9e-75
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-73
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-73
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-72
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-72
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	7e-69
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	8e-51
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	7e-50
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	5e-49
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-48
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-48
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-48
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	5e-48
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	5e-48
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	4e-47
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	5e-47
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-45
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	5e-45
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	8e-45
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-44
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-44
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-44
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-44
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-44
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	3e-44
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	6e-44
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-43
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-42
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-42
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	7e-42
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-41
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-41
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-41
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-41
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	5e-41
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-40
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-40
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-40
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-40
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-40
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-40
3bhy_A	283	Death-associated protein kinase 3; death associate	5e-40
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	6e-40
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	6e-40
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	7e-40
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	8e-40
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-39
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-39
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-39
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-39
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	4e-39
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	4e-39
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	4e-39
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	5e-39
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	5e-39
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	9e-39
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	9e-39
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-38
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-38
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-38
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-38
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-38
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-38
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	4e-38
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-37
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-37
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-37
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-37
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-37
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	4e-37
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-36
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	4e-36
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	7e-36
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	9e-36
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-35
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-34
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-33
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	5e-33
3fme_A	290	Dual specificity mitogen-activated protein kinase;	5e-33
3an0_A	340	Dual specificity mitogen-activated protein kinase;	5e-32
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	5e-32
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-31
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-31
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	4e-31
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	7e-31
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-30
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-30
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-30
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	6e-30
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-29
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-29
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-29
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-29
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-29
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-29
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	6e-29
3aln_A	327	Dual specificity mitogen-activated protein kinase;	8e-29
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	8e-29
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	8e-29
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	9e-29
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-28
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-28
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-28
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	6e-28
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	7e-28
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-27
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-27
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	4e-27
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	6e-27
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	7e-27
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	9e-27
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-26
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-26
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-26
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-26
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-26
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	4e-26
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	4e-26
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	6e-26
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	9e-26
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-25
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	6e-25
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-24
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	7e-23
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	7e-22
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-21
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	7e-21
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-20
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	5e-20
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	6e-20
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-19
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-19
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-19
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-19
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-19
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-19
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-19
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-19
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-19
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	9e-19
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-18
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-18
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	5e-18
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	6e-18
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-17
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-16
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-16
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	8e-13
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-12
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	3e-12
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-12
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-11
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-11
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-11
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-11
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-11
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-11
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	3e-11
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-11
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-11
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	5e-11
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	6e-11
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	6e-11
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-10
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-10
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-10
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-10
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-10
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-10
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-10
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-10
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-10
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-10
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-10
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	4e-10
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	8e-10
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	9e-10
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-09
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-09
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-09
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-09
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-09
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	3e-09
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-09
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	4e-09
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	5e-09
4aoj_A	329	High affinity nerve growth factor receptor; transf	7e-09
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-08
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-08
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-08
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-08
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-08
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-08
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-08
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	3e-08
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-08
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	4e-08
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	4e-08
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	4e-08
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	5e-08
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	6e-08
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	8e-08
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-07
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-07
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	9e-07
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-06
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-06
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-06
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	3e-06
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	4e-06
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-05

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  520 bits (1340), Expect = 0.0
 Identities = 203/289 (70%), Positives = 239/289 (82%), Gaps = 3/289 (1%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL 59
           MR LDH N+V L++ F+S+ EK DE+YLNLVL+YVPETV+RV +H+ +  Q +P+IYVKL
Sbjct: 101 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 160

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           Y YQ+ R+LAYIH + G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+SYICS
Sbjct: 161 YMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS 219

Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
           RYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE
Sbjct: 220 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 279

Query: 180 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
           +I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  R T LEA  H F
Sbjct: 280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339

Query: 240 FDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCA 288
           FDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR Q A
Sbjct: 340 FDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHARIQAA 387

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  514 bits (1327), Expect = 0.0
 Identities = 190/293 (64%), Positives = 238/293 (81%), Gaps = 3/293 (1%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL 59
           MR++ HPNVV LK  F+S  +K DE++LNLVLEYVPETV+R  +H+ K+ Q MP++ +KL
Sbjct: 86  MRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKL 145

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           Y YQ+ R+LAYIH +IG+CHRDIKPQNLL++P +  LKL DFGSAK+L+ GEPN+SYICS
Sbjct: 146 YMYQLLRSLAYIH-SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICS 204

Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
           RYYRAPELIFGAT YT  IDIWS GCV+AEL+ GQPLFPGESG+DQLVEIIKVLGTP+RE
Sbjct: 205 RYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSRE 264

Query: 180 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
           +IK MNPNY E KFPQI+ HP+ K+F+ R PP+A+DL+SRLL+Y+P+ R TA+EAL HPF
Sbjct: 265 QIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPF 324

Query: 240 FDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARKQCAFLGL 292
           FDELR    R+PNGR LPPLFN+   EL  V  D++ +L+P+HA  +    G+
Sbjct: 325 FDELRTGEARMPNGRELPPLFNWTKEELS-VRPDLISRLVPQHAEAELLSRGI 376

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  493 bits (1272), Expect = e-178
 Identities = 135/288 (46%), Positives = 194/288 (67%), Gaps = 7/288 (2%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEK--DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 58
           + +L HPN+V L+  F++  E+   ++YLN+V+EYVP+T+HR  +++Y+     P I +K
Sbjct: 73  LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIK 132

Query: 59  LYFYQICRALAYIH-NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           ++ +Q+ R++  +H  ++ VCHRDIKP N+LVN     LKLCDFGSAK L   EPN++YI
Sbjct: 133 VFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYI 192

Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
           CSRYYRAPELIFG   YT A+DIWS GC+ AE++LG+P+F G++   QL EI++VLG P+
Sbjct: 193 CSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS 252

Query: 178 REEIKCMNPNYTEFKFPQIKAHPWHKIFQK---RMPPEAVDLVSRLLQYSPNLRSTALEA 234
           RE ++ +NP++T+      K  PW  +F     +   EA DL+S LLQY P  R    EA
Sbjct: 253 REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEA 312

Query: 235 LIHPFFDELRDPNTRLPNGRFLPP-LFNFKPHELKGVPVDMLVKLIPE 281
           L HP+FDEL DP T+LPN + LP  LF F P+E++ +      KL+ +
Sbjct: 313 LCHPYFDELHDPATKLPNNKDLPEDLFRFLPNEIEVMSEAQKAKLVRK 360

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  480 bits (1238), Expect = e-172
 Identities = 143/329 (43%), Positives = 214/329 (65%), Gaps = 43/329 (13%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEK---------------------------------DELYL 27
           M++LDH N++ L   F++T ++                                    YL
Sbjct: 54  MKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYL 113

Query: 28  NLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNL 87
           N+++EYVP+T+H+V+K   +  + +P+  + +Y YQ+ RA+ +IH ++G+CHRDIKPQNL
Sbjct: 114 NVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH-SLGICHRDIKPQNL 172

Query: 88  LVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVL 147
           LVN   + LKLCDFGSAK L+  EP+++YICSR+YRAPEL+ GATEYT +ID+WS GCV 
Sbjct: 173 LVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232

Query: 148 AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQK 207
            EL+LG+PLF GE+ +DQLV II+++GTPT+E++  MNP+YTE +FP +KA  W KI  +
Sbjct: 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPE 292

Query: 208 RMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP-------NTRLPNG--RFLPP 258
             P  A+DL+ ++L+Y P+LR    EA+ HPFFD LR+        N+  P+G  + +P 
Sbjct: 293 GTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQ 352

Query: 259 LFNFKPHELKGVPVDMLVKLIPEHARKQC 287
           LFNF P+EL  +P ++L +++P++     
Sbjct: 353 LFNFSPYELSIIPGNVLNRILPKNFSPNY 381

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  254 bits (652), Expect = 3e-84
 Identities = 77/264 (29%), Positives = 129/264 (48%), Gaps = 26/264 (9%)

Query: 1   MRLLDHPNVVSLKHCF-----------FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMS 49
           +R LDH N+V +                S TE + +Y+  V EY+   +  V++      
Sbjct: 62  IRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYI--VQEYMETDLANVLE-----Q 114

Query: 50  QRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK 109
             +   + +L+ YQ+ R L YIH +  V HRD+KP NL +N     LK+ DFG A+++  
Sbjct: 115 GPLLEEHARLFMYQLLRGLKYIH-SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDP 173

Query: 110 GEPNIS----YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQ 165
              +       + +++YR+P L+     YT AID+W+AGC+ AE+L G+ LF G   ++Q
Sbjct: 174 HYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ 233

Query: 166 LVEIIKVLGTPTREEIKCMNPNYTEF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQY 223
           +  I++ +     E+ + +      +          P  ++    +  EAVD + ++L +
Sbjct: 234 MQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPG-ISREAVDFLEQILTF 292

Query: 224 SPNLRSTALEALIHPFFDELRDPN 247
           SP  R TA EAL HP+      P 
Sbjct: 293 SPMDRLTAEEALSHPYMSIYSFPM 316

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  255 bits (654), Expect = 5e-84
 Identities = 78/255 (30%), Positives = 133/255 (52%), Gaps = 18/255 (7%)

Query: 1   MRLLDHPNVVSLKHCF--FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPL--IY 56
           +    HPN++ L+  F  F      +LYL  V E +   + +VI       QR+ +   +
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYL--VTELMRTDLAQVIH-----DQRIVISPQH 135

Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
           ++ + Y I   L  +H   GV HRD+ P N+L+    + + +CDF  A+          Y
Sbjct: 136 IQYFMYHILLGLHVLH-EAGVVHRDLHPGNILLA-DNNDITICDFNLAREDTADANKTHY 193

Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
           +  R+YRAPEL+     +T  +D+WSAGCV+AE+   + LF G +  +QL +I++V+GTP
Sbjct: 194 VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP 253

Query: 177 TREEIKCMNP----NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAL 232
             E++   +     +Y       + A  W  +      P A+DL++++L+++P  R +  
Sbjct: 254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPT-ADPVALDLIAKMLEFNPQRRISTE 312

Query: 233 EALIHPFFDELRDPN 247
           +AL HP+F+ L DP 
Sbjct: 313 QALRHPYFESLFDPL 327

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  252 bits (647), Expect = 1e-83
 Identities = 85/251 (33%), Positives = 130/251 (51%), Gaps = 15/251 (5%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ L HPN+V+L   F     K  L+L  V EY   TV   +    +  + +P   VK  
Sbjct: 56  LKQLKHPNLVNLLEVF---RRKRRLHL--VFEYCDHTVLHELD---RYQRGVPEHLVKSI 107

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNISYICS 119
            +Q  +A+ + H      HRD+KP+N+L+  H+  +KLCDFG A++L    +     + +
Sbjct: 108 TWQTLQAVNFCHKH-NCIHRDVKPENILITKHS-VIKLCDFGFARLLTGPSDYYDDEVAT 165

Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
           R+YR+PEL+ G T+Y   +D+W+ GCV AELL G PL+PG+S VDQL  I K LG     
Sbjct: 166 RWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPR 225

Query: 180 EIKCM--NPNYTEFKFPQIK-AHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 236
             +    N  ++  K P  +   P    F   +   A+ L+   L   P  R T  + L 
Sbjct: 226 HQQVFSTNQYFSGVKIPDPEDMEPLELKF-PNISYPALGLLKGCLHMDPTERLTCEQLLH 284

Query: 237 HPFFDELRDPN 247
           HP+F+ +R+  
Sbjct: 285 HPYFENIREIE 295

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  252 bits (646), Expect = 9e-83
 Identities = 93/288 (32%), Positives = 161/288 (55%), Gaps = 24/288 (8%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKD--ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 58
           +    H N++ +     + T +   ++Y+  V + +   +++++K     +Q +   ++ 
Sbjct: 79  LLRFRHENIIGINDIIRAPTIEQMKDVYI--VQDLMETDLYKLLK-----TQHLSNDHIC 131

Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS--- 115
            + YQI R L YIH +  V HRD+KP NLL+N  T  LK+CDFG A+V      +     
Sbjct: 132 YFLYQILRGLKYIH-SANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLT 189

Query: 116 -YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 174
            Y+ +R+YRAPE++  +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG
Sbjct: 190 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG 249

Query: 175 TPTREEIKCM-NPNYTEF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 231
           +P++E++ C+ N     +    P     PW+++F      +A+DL+ ++L ++P+ R   
Sbjct: 250 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEV 308

Query: 232 LEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI 279
            +AL HP+ ++  DP+   P        F F   EL  +P + L +LI
Sbjct: 309 EQALAHPYLEQYYDPS-DEPI---AEAPFKF-DMELDDLPKEKLKELI 351

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  252 bits (645), Expect = 9e-83
 Identities = 93/296 (31%), Positives = 155/296 (52%), Gaps = 28/296 (9%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKD--ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 58
           ++   H N++++ +     + ++  E+Y+  + E +   +HRVI      +Q +   +++
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYI--IQELMQTDLHRVIS-----TQMLSDDHIQ 115

Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS--- 115
            + YQ  RA+  +H    V HRD+KP NLL+N     LK+CDFG A+++ +   + S   
Sbjct: 116 YFIYQTLRAVKVLH-GSNVIHRDLKPSNLLIN-SNCDLKVCDFGLARIIDESAADNSEPT 173

Query: 116 --------YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV 167
                   ++ +R+YRAPE++  + +Y+ A+D+WS GC+LAEL L +P+FPG     QL+
Sbjct: 174 GQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLL 233

Query: 168 EIIKVLGTPTREEI--KCMNPNYTEF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQY 223
            I  ++GTP  +       +P   E+    P   A P  K+F + + P+ +DL+ R+L +
Sbjct: 234 LIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPR-VNPKGIDLLQRMLVF 292

Query: 224 SPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI 279
            P  R TA EAL HP+     DPN         P  F F  H  + +    L KLI
Sbjct: 293 DPAKRITAKEALEHPYLQTYHDPNDEPEGEPIPPSFFEFD-HYKEALTTKDLKKLI 347

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  248 bits (636), Expect = 1e-81
 Identities = 89/274 (32%), Positives = 146/274 (53%), Gaps = 23/274 (8%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ L H N+V+L         +  L L  V EY+ + + + +         + +  VKL+
Sbjct: 54  LKDLKHANIVTLHDII---HTEKSLTL--VFEYLDKDLKQYLDD---CGNIINMHNVKLF 105

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---I 117
            +Q+ R LAY H    V HRD+KPQNLL+N    +LKL DFG A+   K  P  +Y   +
Sbjct: 106 LFQLLRGLAYCHRQ-KVLHRDLKPQNLLIN-ERGELKLADFGLARA--KSIPTKTYDNEV 161

Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            + +YR P+++ G+T+Y+  ID+W  GC+  E+  G+PLFPG +  +QL  I ++LGTPT
Sbjct: 162 VTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPT 221

Query: 178 RE---EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 234
            E    I      +  + +P+ +A         R+  +  DL+++LLQ+    R +A +A
Sbjct: 222 EETWPGILSN-EEFKTYNYPKYRAEALLSHA-PRLDSDGADLLTKLLQFEGRNRISAEDA 279

Query: 235 LIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELK 268
           + HPFF  L +   +LP+      +F  K  +L+
Sbjct: 280 MKHPFFLSLGERIHKLPD---TTSIFALKEIQLQ 310

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  247 bits (633), Expect = 3e-81
 Identities = 81/250 (32%), Positives = 130/250 (52%), Gaps = 15/250 (6%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ L H N+V+L        +K   YL  V E+V  T+   ++        +    V+ Y
Sbjct: 78  LKQLRHENLVNLLEVC---KKKKRWYL--VFEFVDHTILDDLEL---FPNGLDYQVVQKY 129

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNISYICS 119
            +QI   + + H+   + HRDIKP+N+LV+  +  +KLCDFG A+ L   GE     + +
Sbjct: 130 LFQIINGIGFCHSH-NIIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVYDDEVAT 187

Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
           R+YRAPEL+ G  +Y  A+D+W+ GC++ E+ +G+PLFPG+S +DQL  I+  LG     
Sbjct: 188 RWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPR 247

Query: 180 --EIKCMNPNYTEFKFPQIKAH-PWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 236
             E+   NP +   + P+IK   P  + +  ++    +DL  + L   P+ R    E L 
Sbjct: 248 HQELFNKNPVFAGVRLPEIKEREPLERRY-PKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306

Query: 237 HPFFDELRDP 246
           H FF      
Sbjct: 307 HDFFQMDGFA 316

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  247 bits (633), Expect = 3e-81
 Identities = 75/254 (29%), Positives = 122/254 (48%), Gaps = 21/254 (8%)

Query: 3   LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPET-VHRVIKHHYKMSQRMPLIYVKLYF 61
           L   PN+++L         +       V E+V  T   ++        Q +    ++ Y 
Sbjct: 87  LRGGPNIITLADIVKDPVSRTPAL---VFEHVNNTDFKQLY-------QTLTDYDIRFYM 136

Query: 62  YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY 121
           Y+I +AL Y H ++G+ HRD+KP N++++    +L+L D+G A+    G+     + SRY
Sbjct: 137 YEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY 195

Query: 122 YRAPELIFGATEYTAAIDIWSAGCVLAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREE 180
           ++ PEL+     Y  ++D+WS GC+LA ++   +P F G    DQLV I KVLGT    +
Sbjct: 196 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 255

Query: 181 I--KCMNPNYTEFK--FPQIKAHPWHKIF----QKRMPPEAVDLVSRLLQYSPNLRSTAL 232
              K        F     +     W +      Q  + PEA+D + +LL+Y    R TA 
Sbjct: 256 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR 315

Query: 233 EALIHPFFDELRDP 246
           EA+ HP+F  +   
Sbjct: 316 EAMEHPYFYTVVKD 329

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  245 bits (628), Expect = 1e-80
 Identities = 87/249 (34%), Positives = 141/249 (56%), Gaps = 20/249 (8%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ L HPN+VSL         +  L L  V E++ + + +V+         +    +K+Y
Sbjct: 73  LKELHHPNIVSLIDVI---HSERCLTL--VFEFMEKDLKKVLDE---NKTGLQDSQIKIY 124

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---I 117
            YQ+ R +A+ H    + HRD+KPQNLL+N     LKL DFG A+    G P  SY   +
Sbjct: 125 LYQLLRGVAHCHQH-RILHRDLKPQNLLIN-SDGALKLADFGLARA--FGIPVRSYTHEV 180

Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            + +YRAP+++ G+ +Y+ ++DIWS GC+ AE++ G+PLFPG +  DQL +I  +LGTP 
Sbjct: 181 VTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPN 240

Query: 178 RE---EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 234
                +++ + P + +  F   +  PW  I       E +DL+S +L + PN R +A +A
Sbjct: 241 PREWPQVQEL-PLWKQRTFQVFEKKPWSSII-PGFCQEGIDLLSNMLCFDPNKRISARDA 298

Query: 235 LIHPFFDEL 243
           + HP+F +L
Sbjct: 299 MNHPYFKDL 307

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  246 bits (629), Expect = 4e-80
 Identities = 82/254 (32%), Positives = 137/254 (53%), Gaps = 20/254 (7%)

Query: 1   MRLLDHPNVVSLKHCFF---STTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++ + H NV+ L   F    +  +  + YL  V+ ++   + +++K      +++    +
Sbjct: 78  LKHMRHENVIGLLDVFTPDETLDDFTDFYL--VMPFMGTDLGKLMK-----HEKLGEDRI 130

Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-Y 116
           +   YQ+ + L YIH   G+ HRD+KP NL VN     LK+ DFG A+     +  ++ Y
Sbjct: 131 QFLVYQMLKGLRYIH-AAGIIHRDLKPGNLAVNEDCE-LKILDFGLARQA---DSEMTGY 185

Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
           + +R+YRAPE+I     YT  +DIWS GC++AE++ G+ LF G   +DQL EI+KV GTP
Sbjct: 186 VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTP 245

Query: 177 TREEIKCM-NPNYTEF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
             E ++ + +     +    P+++   +  I      P AV+L+ ++L      R TA E
Sbjct: 246 PAEFVQRLQSDEAKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGE 304

Query: 234 ALIHPFFDELRDPN 247
           AL HP+F+ L D  
Sbjct: 305 ALAHPYFESLHDTE 318

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  244 bits (624), Expect = 1e-79
 Identities = 88/286 (30%), Positives = 146/286 (51%), Gaps = 26/286 (9%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKD---ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++ + H NV+ L   F   +      + YL  V+ ++   + +++        +     +
Sbjct: 77  LKHMQHENVIGLLDVFTPASSLRNFYDFYL--VMPFMQTDLQKIMG------LKFSEEKI 128

Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-Y 116
           +   YQ+ + L YIH+  GV HRD+KP NL VN     LK+ DFG A+     +  ++ Y
Sbjct: 129 QYLVYQMLKGLKYIHSA-GVVHRDLKPGNLAVNEDCE-LKILDFGLARHA---DAEMTGY 183

Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
           + +R+YRAPE+I     Y   +DIWS GC++AE+L G+ LF G+  +DQL +I+KV G P
Sbjct: 184 VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVP 243

Query: 177 TREEIKCM-NPNYTEF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
             E ++ + +     +    PQ     + ++F  R  P+A DL+ ++L+   + R TA +
Sbjct: 244 GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLF-PRASPQAADLLEKMLELDVDKRLTAAQ 302

Query: 234 ALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI 279
           AL HPFF+  RDP             F+    E + + VD   + I
Sbjct: 303 ALTHPFFEPFRDPE-EETE---AQQPFDD-SLEHEKLTVDEWKQHI 343

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  241 bits (617), Expect = 2e-79
 Identities = 86/249 (34%), Positives = 134/249 (53%), Gaps = 21/249 (8%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ L H N+V L         K  L L  V E++ + + +++         +  +  K +
Sbjct: 54  LKELKHSNIVKLYDVI---HTKKRLVL--VFEHLDQDLKKLLDV---CEGGLESVTAKSF 105

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---I 117
             Q+   +AY H+   V HRD+KPQNLL+N    +LK+ DFG A+    G P   Y   I
Sbjct: 106 LLQLLNGIAYCHDR-RVLHRDLKPQNLLIN-REGELKIADFGLARA--FGIPVRKYTHEI 161

Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            + +YRAP+++ G+ +Y+  IDIWS GC+ AE++ G PLFPG S  DQL+ I ++LGTP 
Sbjct: 162 VTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPN 221

Query: 178 RE---EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 234
            +    +  + P Y +  F   +  PW     K +    +DL+S++L+  PN R TA +A
Sbjct: 222 SKNWPNVTEL-PKY-DPNFTVYEPLPWESFL-KGLDESGIDLLSKMLKLDPNQRITAKQA 278

Query: 235 LIHPFFDEL 243
           L H +F E 
Sbjct: 279 LEHAYFKEN 287

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  243 bits (622), Expect = 3e-79
 Identities = 92/252 (36%), Positives = 131/252 (51%), Gaps = 22/252 (8%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ L HPN++ L   F     K  + L  V +++   +  +IK     S  +   ++K Y
Sbjct: 66  LQELSHPNIIGLLDAF---GHKSNISL--VFDFMETDLEVIIKD---NSLVLTPSHIKAY 117

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---I 117
                + L Y+H    + HRD+KP NLL++     LKL DFG AK    G PN +Y   +
Sbjct: 118 MLMTLQGLEYLHQH-WILHRDLKPNNLLLD-ENGVLKLADFGLAKS--FGSPNRAYTHQV 173

Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +R+YRAPEL+FGA  Y   +D+W+ GC+LAELLL  P  PG+S +DQL  I + LGTPT
Sbjct: 174 VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPT 233

Query: 178 REEI---KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 234
            EE     C  P+Y    F      P H IF      + +DL+  L  ++P  R TA +A
Sbjct: 234 -EEQWPDMCSLPDYVT--FKSFPGIPLHHIF-SAAGDDLLDLIQGLFLFNPCARITATQA 289

Query: 235 LIHPFFDELRDP 246
           L   +F     P
Sbjct: 290 LKMKYFSNRPGP 301

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  243 bits (622), Expect = 4e-79
 Identities = 83/254 (32%), Positives = 137/254 (53%), Gaps = 20/254 (7%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKD---ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++ + H NV+ L   F      +   ++YL  V   +   ++ ++K      Q++   +V
Sbjct: 82  LKHMKHENVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHV 134

Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS-Y 116
           +   YQI R L YIH+   + HRD+KP NL VN    +LK+ DFG A+        ++ Y
Sbjct: 135 QFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVN-EDCELKILDFGLARHT---ADEMTGY 189

Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
           + +R+YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP
Sbjct: 190 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 249

Query: 177 TREEIKCM-NPNYTEF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
             E +K + + +   +     Q+    +  +F     P AVDL+ ++L    + R TA +
Sbjct: 250 GAELLKKISSESARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQ 308

Query: 234 ALIHPFFDELRDPN 247
           AL H +F +  DP+
Sbjct: 309 ALAHAYFAQYHDPD 322

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  239 bits (612), Expect = 5e-78
 Identities = 76/253 (30%), Positives = 132/253 (52%), Gaps = 24/253 (9%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ L H N++ LK           L+L  + EY    + + +  +  +S R+    +K +
Sbjct: 87  LKELQHRNIIELKSVI---HHNHRLHL--IFEYAENDLKKYMDKNPDVSMRV----IKSF 137

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH----QLKLCDFGSAKVLVKGEPNISY 116
            YQ+   + + H+     HRD+KPQNLL++         LK+ DFG A+    G P   +
Sbjct: 138 LYQLINGVNFCHSR-RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA--FGIPIRQF 194

Query: 117 ---ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL 173
              I + +YR PE++ G+  Y+ ++DIWS  C+ AE+L+  PLFPG+S +DQL +I +VL
Sbjct: 195 THEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVL 254

Query: 174 GTPTRE---EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 230
           G P       +  + P++ +  FP+ +     ++    +  E +DL++ +L+  P  R +
Sbjct: 255 GLPDDTTWPGVTAL-PDWKQS-FPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRIS 312

Query: 231 ALEALIHPFFDEL 243
           A  AL HP+F   
Sbjct: 313 AKNALEHPYFSHN 325

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  235 bits (601), Expect = 6e-76
 Identities = 81/295 (27%), Positives = 142/295 (48%), Gaps = 31/295 (10%)

Query: 1   MRLLDHPNVVSLKHCF---FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           M+ ++H N++ L + F    S  E  ++Y+  V+E +   + +VI+        +    +
Sbjct: 78  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYI--VMELMDANLCQVIQ------MELDHERM 129

Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
               YQ+   + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+
Sbjct: 130 SYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYV 187

Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +RYYRAPE+I G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LGTP 
Sbjct: 188 VTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 246

Query: 178 REEIKCMNPNYTEF--KFPQIKAHPWHKIFQKRMP-----------PEAVDLVSRLLQYS 224
            E +K + P    +    P+   + + K+F   +             +A DL+S++L   
Sbjct: 247 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVID 306

Query: 225 PNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI 279
            + R +  EAL HP+ +   DP+          P       + +   ++   +LI
Sbjct: 307 ASKRISVDEALQHPYINVWYDPS-EAEAPPPKIPDKQL---DEREHTIEEWKELI 357

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  233 bits (596), Expect = 7e-76
 Identities = 82/258 (31%), Positives = 135/258 (52%), Gaps = 23/258 (8%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHH--YKMSQRMPLIYVK 58
           M+ L H N+V L         +++L L  V E++   + + +         + + L  VK
Sbjct: 57  MKELKHENIVRLYDVI---HTENKLTL--VFEFMDNDLKKYMDSRTVGNTPRGLELNLVK 111

Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-- 116
            + +Q+ + LA+ H    + HRD+KPQNLL+N    QLKL DFG A+    G P  ++  
Sbjct: 112 YFQWQLLQGLAFCHEN-KILHRDLKPQNLLIN-KRGQLKLGDFGLARA--FGIPVNTFSS 167

Query: 117 -ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
            + + +YRAP+++ G+  Y+ +IDIWS GC+LAE++ G+PLFPG +  +QL  I  ++GT
Sbjct: 168 EVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGT 227

Query: 176 PTRE---EIKCMNPNYTEFKFPQIKAHPWHKIFQK----RMPPEAVDLVSRLLQYSPNLR 228
           P       +  + P Y      Q       ++ Q      +    +D +  LLQ +P++R
Sbjct: 228 PNESLWPSVTKL-PKY-NPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMR 285

Query: 229 STALEALIHPFFDELRDP 246
            +A +AL HP+F E    
Sbjct: 286 LSAKQALHHPWFAEYYHH 303

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  237 bits (606), Expect = 1e-75
 Identities = 82/295 (27%), Positives = 145/295 (49%), Gaps = 31/295 (10%)

Query: 1   MRLLDHPNVVSLKHCF---FSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           M+ ++H N++SL + F    +  E  ++YL  V+E +   + +VI+        +    +
Sbjct: 115 MKCVNHKNIISLLNVFTPQKTLEEFQDVYL--VMELMDANLCQVIQ------MELDHERM 166

Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
               YQ+   + ++H+  G+ HRD+KP N++V      LK+ DFG A+          Y+
Sbjct: 167 SYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYV 224

Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +RYYRAPE+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP 
Sbjct: 225 VTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 283

Query: 178 REEIKCMNPNYTEF--KFPQIKAHPWHKIF-----------QKRMPPEAVDLVSRLLQYS 224
            E +K + P    +    P+     + K+F            K    +A DL+S++L   
Sbjct: 284 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 343

Query: 225 PNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI 279
           P  R +  +AL HP+ +   DP          P +++ +  + +   ++   +LI
Sbjct: 344 PAKRISVDDALQHPYINVWYDPAEVEA---PPPQIYDKQ-LDEREHTIEEWKELI 394

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  231 bits (591), Expect = 2e-75
 Identities = 83/253 (32%), Positives = 130/253 (51%), Gaps = 22/253 (8%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ L H N+V L           +L L  V E+  + + +        +  +    VK +
Sbjct: 55  LKELKHKNIVRLHDVL---HSDKKLTL--VFEFCDQDLKKYFDS---CNGDLDPEIVKSF 106

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---I 117
            +Q+ + L + H+   V HRD+KPQNLL+N    +LKL +FG A+    G P   Y   +
Sbjct: 107 LFQLLKGLGFCHSR-NVLHRDLKPQNLLIN-RNGELKLANFGLARA--FGIPVRCYSAEV 162

Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTP 176
            + +YR P+++FGA  Y+ +ID+WSAGC+ AEL   G+PLFPG    DQL  I ++LGTP
Sbjct: 163 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP 222

Query: 177 TRE---EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
           T E    +  + P+Y  +            +   ++     DL+  LL+ +P  R +A E
Sbjct: 223 TEEQWPSMTKL-PDYKPYPMYPAT-TSLVNVV-PKLNATGRDLLQNLLKCNPVQRISAEE 279

Query: 234 ALIHPFFDELRDP 246
           AL HP+F +   P
Sbjct: 280 ALQHPYFSDFCPP 292

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  233 bits (597), Expect = 4e-75
 Identities = 86/318 (27%), Positives = 151/318 (47%), Gaps = 54/318 (16%)

Query: 2   RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYF 61
            L  H N+V+L +   +  ++D +YL  V +Y+   +H VI+     +  +  ++ +   
Sbjct: 64  ELSGHENIVNLLNVLRADNDRD-VYL--VFDYMETDLHAVIR-----ANILEPVHKQYVV 115

Query: 62  YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS------ 115
           YQ+ + + Y+H + G+ HRD+KP N+L+N   H +K+ DFG ++  V      +      
Sbjct: 116 YQLIKVIKYLH-SGGLLHRDMKPSNILLNAECH-VKVADFGLSRSFVNIRRVTNNIPLSI 173

Query: 116 ----------------YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG 159
                           Y+ +R+YRAPE++ G+T+YT  ID+WS GC+L E+L G+P+FPG
Sbjct: 174 NENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG 233

Query: 160 ESGVDQLVEIIKVLGTPTREEIKCM-NPNYTEF--KFPQIKAHPWHKIFQKRMP------ 210
            S ++QL  II V+  P+ E+++ + +P          +                     
Sbjct: 234 SSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLL 293

Query: 211 ---------PEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFN 261
                     EA+DL+ +LLQ++PN R +A +AL HPF     +PN           +  
Sbjct: 294 KINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPN----EEPNCDHIIT 349

Query: 262 FKPHELKGVPVDMLVKLI 279
              ++     +D    L+
Sbjct: 350 IPINDNVKHSIDDYRNLV 367

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  230 bits (590), Expect = 9e-75
 Identities = 83/274 (30%), Positives = 130/274 (47%), Gaps = 25/274 (9%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           +   +HPNVV L      +    E  L LV E+V + +   +         +P   +K  
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDM 125

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---I 117
            +Q+ R L ++H+   V HRD+KPQN+LV   + Q+KL DFG A++       ++    +
Sbjct: 126 MFQLLRGLDFLHSH-RVVHRDLKPQNILVT-SSGQIKLADFGLARI--YSFQ-MALTSVV 180

Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            + +YRAPE++  ++ Y   +D+WS GC+ AE+   +PLF G S VDQL +I+ V+G P 
Sbjct: 181 VTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 239

Query: 178 REEIKCMNPNYTE---FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 234
            E+     P         F    A P  K     +     DL+ + L ++P  R +A  A
Sbjct: 240 EEDW----PRDVALPRQAFHSKSAQPIEKFV-TDIDELGKDLLLKCLTFNPAKRISAYSA 294

Query: 235 LIHPFFDELRDPNTRLPNGRFLPPLFNFKP-HEL 267
           L HP+F +L      L        L   +   EL
Sbjct: 295 LSHPYFQDLERCKENLD-----SHLPPSQNTSEL 323

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  227 bits (581), Expect = 1e-73
 Identities = 70/253 (27%), Positives = 119/253 (47%), Gaps = 20/253 (7%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           +   +HPNVV L     ++    E+ + LV E+V + +   +         +P   +K  
Sbjct: 68  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKA--PPPGLPAETIKDL 125

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY---I 117
             Q  R L ++H    + HRD+KP+N+LV      +KL DFG A++       ++    +
Sbjct: 126 MRQFLRGLDFLHAN-CIVHRDLKPENILVT-SGGTVKLADFGLARI--YSYQ-MALTPVV 180

Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            + +YRAPE++  +T Y   +D+WS GC+ AE+   +PLF G S  DQL +I  ++G P 
Sbjct: 181 VTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP 239

Query: 178 REEIKCMNPNYTE---FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 234
            ++     P         FP     P   +    M      L+  +L ++P+ R +A  A
Sbjct: 240 EDDW----PRDVSLPRGAFPPRGPRPVQSVV-PEMEESGAQLLLEMLTFNPHKRISAFRA 294

Query: 235 LIHPFFDELRDPN 247
           L H +  +  + N
Sbjct: 295 LQHSYLHKD-EGN 306

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  231 bits (590), Expect = 2e-73
 Identities = 91/343 (26%), Positives = 140/343 (40%), Gaps = 77/343 (22%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEK--DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 58
           +  L+H +VV +         +  DELY+  VLE       ++ +        +  +++K
Sbjct: 106 LNRLNHDHVVKVLDIVIPKDVEKFDELYV--VLEIADSDFKKLFRT----PVYLTELHIK 159

Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS--- 115
              Y +   + Y+H + G+ HRD+KP N LVN     +K+CDFG A+ +   E   S   
Sbjct: 160 TLLYNLLVGVKYVH-SAGILHRDLKPANCLVNQDCS-VKVCDFGLARTVDYPENGNSQLP 217

Query: 116 -------------------------YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAEL 150
                                    ++ +R+YRAPELI     YT AID+WS GC+ AEL
Sbjct: 218 ISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAEL 277

Query: 151 LL-----------GQPLFPGES--------------------GVDQLVEIIKVLGTPTRE 179
           L              PLFPG S                      DQL  I  +LGTP+ E
Sbjct: 278 LNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEE 337

Query: 180 EIKCM-NPNYTEF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 236
           +I+ +   +   +   FP+ +     + F      +A+ L+ R+L ++PN R T  E L 
Sbjct: 338 DIEALEKEDAKRYIRIFPKREGTDLAERF-PASSADAIHLLKRMLVFNPNKRITINECLA 396

Query: 237 HPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI 279
           HPFF E+R       N            ++   +    L    
Sbjct: 397 HPFFKEVRIAE-VETN---ATEKVRLPFNDWMNMDEPQLRYAF 435

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  228 bits (584), Expect = 1e-72
 Identities = 81/335 (24%), Positives = 135/335 (40%), Gaps = 69/335 (20%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKD--ELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 58
           +  L    ++ L             ELY+  VLE     + ++ K    +++     ++K
Sbjct: 79  LNRLKSDYIIRLYDLIIPDDLLKFDELYI--VLEIADSDLKKLFKTPIFLTE----EHIK 132

Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS--- 115
              Y +     +IH   G+ HRD+KP N L+N     +K+CDFG A+ +   +       
Sbjct: 133 TILYNLLLGENFIH-ESGIIHRDLKPANCLLNQDCS-VKVCDFGLARTINSEKDTNIVND 190

Query: 116 --------------------YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ- 154
                               ++ +R+YRAPELI     YT +IDIWS GC+ AELL    
Sbjct: 191 LEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQ 250

Query: 155 ----------PLFPGESG-----------------VDQLVEIIKVLGTPTREEIKCM-NP 186
                     PLFPG S                   DQL  I  ++GTPT +++K +  P
Sbjct: 251 SHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKP 310

Query: 187 NYTEF--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 244
              ++   FP  K     + +   +  + ++L+  +L+++PN R T  +AL HP+  ++R
Sbjct: 311 EVIKYIKLFPHRKPINLKQKY-PSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVR 369

Query: 245 DPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLI 279
                     F          +   +    L  + 
Sbjct: 370 KKK-LEN---FSTKKIILPFDDWMVLSETQLRYIF 400

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  225 bits (576), Expect = 2e-72
 Identities = 73/280 (26%), Positives = 118/280 (42%), Gaps = 22/280 (7%)

Query: 1   MRLLDHPNVVSLK---HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++LL H NVV+L        S   + +  + LV ++     H +      +  +  L  +
Sbjct: 70  LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE---HDLAGLLSNVLVKFTLSEI 126

Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV--LVKGEPNIS 115
           K     +   L YIH    + HRD+K  N+L+      LKL DFG A+   L K      
Sbjct: 127 KRVMQMLLNGLYYIHRN-KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNR 184

Query: 116 Y---ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 172
           Y   + + +YR PEL+ G  +Y   ID+W AGC++AE+    P+  G +   QL  I ++
Sbjct: 185 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 244

Query: 173 LGTPTRE---EIKCMNPNYTEFKFPQIKAHPWHKIFQK-RMPPEAVDLVSRLLQYSPNLR 228
            G+ T E    +      Y + +  + +        +     P A+DL+ +LL   P  R
Sbjct: 245 CGSITPEVWPNVDNY-ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQR 303

Query: 229 STALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELK 268
             + +AL H FF    DP       + +         E  
Sbjct: 304 IDSDDALNHDFFWS--DPMPSDL--KGMLSTHLTSMFEYL 339

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  218 bits (556), Expect = 7e-69
 Identities = 85/300 (28%), Positives = 132/300 (44%), Gaps = 42/300 (14%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHH-----YKMSQRMPLI 55
           +R L HPNV+SL+  F S  ++    + L+ +Y    +  +IK H      K   ++P  
Sbjct: 72  LRELKHPNVISLQKVFLSHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRG 128

Query: 56  YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN---PHTHQLKLCDFGSAKVLVKGEP 112
            VK   YQI   + Y+H    V HRD+KP N+LV    P   ++K+ D G A++     P
Sbjct: 129 MVKSLLYQILDGIHYLHAN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF--NSP 185

Query: 113 NISY------ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES----- 161
                     + + +YRAPEL+ GA  YT AIDIW+ GC+ AELL  +P+F         
Sbjct: 186 LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKT 245

Query: 162 ----GVDQLVEIIKVLGTPTRE---------EIKCMNPNYTEFKFPQIKAHPWHKIFQKR 208
                 DQL  I  V+G P  +         E   +  ++    +       + +  + +
Sbjct: 246 SNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVK 305

Query: 209 MPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELK 268
              +A  L+ +LL   P  R T+ +A+  P+F E  DP        F      +   E  
Sbjct: 306 PDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLE--DPLPTSD--VFAGCQIPYPKREFL 361

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  171 bits (436), Expect = 8e-51
 Identities = 67/224 (29%), Positives = 105/224 (46%), Gaps = 35/224 (15%)

Query: 50  QRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLV 108
           Q   L  V+ + + I + L  +H    + H D+KP+N LL       +K+ DFGS+    
Sbjct: 195 QGFSLPLVRKFAHSILQCLDALHK-NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE- 252

Query: 109 KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE 168
             +   +YI SR+YRAPE+I GA  Y   ID+WS GC+LAELL G PL PGE   DQL  
Sbjct: 253 -HQRVYTYIQSRFYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLAC 310

Query: 169 IIKVLGTPTREEIK-----------CMNPNYTEFKF---------------PQIKAHPWH 202
           +I++LG P+++ +               P Y                     +++  P  
Sbjct: 311 MIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPES 370

Query: 203 KIFQKRMPPEA----VDLVSRLLQYSPNLRSTALEALIHPFFDE 242
           + +   +        +D + + L++ P +R T  +AL HP+   
Sbjct: 371 REWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRR 414

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  168 bits (427), Expect = 7e-50
 Identities = 69/231 (29%), Positives = 104/231 (45%), Gaps = 40/231 (17%)

Query: 52  MPLIYVKLYFYQICRALAYIH-NTIGVCHRDIKPQN-LLVNPHTHQLKLCDFGSAKVLVK 109
           + L   + +  Q+C AL ++    + + H D+KP+N LL NP    +K+ DFGS+     
Sbjct: 154 VSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS--CQL 211

Query: 110 GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEI 169
           G+    YI SR+YR+PE++ G   Y  AID+WS GC+L E+  G+PLF G + VDQ+ +I
Sbjct: 212 GQRIYQYIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKI 270

Query: 170 IKVLGTPTREEIK-----------CMNPNYTEFKFPQIKAH---PWHKIFQ-----KRMP 210
           ++VLG P    +              +  +   K    K     P  +        +   
Sbjct: 271 VEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGG 330

Query: 211 PEA----------------VDLVSRLLQYSPNLRSTALEALIHPFFDELRD 245
           P                   DL+ R+L Y P  R     AL H FF +  D
Sbjct: 331 PGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTAD 381

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  164 bits (416), Expect = 5e-49
 Identities = 55/268 (20%), Positives = 99/268 (36%), Gaps = 53/268 (19%)

Query: 1   MRLLDHPN--VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 58
           +  L   +  ++ L           + Y+ +V+E     ++  +K      + +     K
Sbjct: 80  LNKLQQHSDKIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKK----KSIDPWERK 130

Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI---S 115
            Y+  +  A+  IH   G+ H D+KP N L+      LKL DFG A  +     ++   S
Sbjct: 131 SYWKNMLEAVHTIHQH-GIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDS 187

Query: 116 YICSRYYRAPELIFGA----------TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQ 165
            + +  Y  PE I             ++ +   D+WS GC+L  +  G+  F        
Sbjct: 188 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS 247

Query: 166 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSP 225
            +  I             ++PN+ E +FP I               +  D++   L+  P
Sbjct: 248 KLHAI-------------IDPNH-EIEFPDI------------PEKDLQDVLKCCLKRDP 281

Query: 226 NLRSTALEALIHPFFDELRDPNTRLPNG 253
             R +  E L HP+      P  ++  G
Sbjct: 282 KQRISIPELLAHPYVQIQTHPVNQMAKG 309

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  164 bits (418), Expect = 1e-48
 Identities = 68/274 (24%), Positives = 118/274 (43%), Gaps = 30/274 (10%)

Query: 5   DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQI 64
              +++ L    F+    + +++ +V E + E +  +IK +    + +PLIYVK    Q+
Sbjct: 84  GANHILKLLD-HFNHKGPNGVHVVMVFEVLGENLLALIKKY--EHRGIPLIYVKQISKQL 140

Query: 65  CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ-----LKLCDFGSAKVLVKGEPNISYICS 119
              L Y+H   G+ H DIKP+N+L+           +K+ D G+A      E   + I +
Sbjct: 141 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDEHYTNSIQT 198

Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG------VDQLVEIIKVL 173
           R YR+PE++ GA  +    DIWS  C++ EL+ G  LF  + G       D + +II++L
Sbjct: 199 REYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELL 257

Query: 174 GTPTREEI-------KCMNPNYTEFKFPQIKAHPWHKIFQKRMP------PEAVDLVSRL 220
           G      +          N         ++K  P   +  ++         E  D +S +
Sbjct: 258 GELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPM 317

Query: 221 LQYSPNLRSTALEALIHPFFDELRDPNTRLPNGR 254
           LQ  P  R+ A   + HP+  +           R
Sbjct: 318 LQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDR 351

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  163 bits (416), Expect = 1e-48
 Identities = 60/230 (26%), Positives = 100/230 (43%), Gaps = 37/230 (16%)

Query: 50  QRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN------------------P 91
               L +++   YQIC+++ ++H+   + H D+KP+N+L                     
Sbjct: 113 LPFRLDHIRKMAYQICKSVNFLHS-NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTL 171

Query: 92  HTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL 151
               +K+ DFGSA      E + + + +R+YRAPE+I     ++   D+WS GC+L E  
Sbjct: 172 INPDIKVVDFGSA--TYDDEHHSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYY 228

Query: 152 LGQPLFPGESGVDQLVEIIKVLGTPTREEI-KCMNPNY-TEFKFPQIKAHPWHKIFQKRM 209
           LG  +FP     + L  + ++LG   +  I K     Y    +    +     +   +  
Sbjct: 229 LGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRAC 288

Query: 210 PP-------------EAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDP 246
            P                DL+ ++L+Y P  R T  EAL HPFFD L+  
Sbjct: 289 KPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKS 338

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  164 bits (417), Expect = 1e-48
 Identities = 63/238 (26%), Positives = 96/238 (40%), Gaps = 37/238 (15%)

Query: 50  QRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN------------------P 91
           Q  PL +V+   YQ+C AL ++H    + H D+KP+N+L                     
Sbjct: 118 QPYPLPHVRHMAYQLCHALRFLHE-NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSV 176

Query: 92  HTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL 151
               +++ DFGSA      E + + + +R+YR PE+I     +    D+WS GC+L E  
Sbjct: 177 KNTSIRVADFGSA--TFDHEHHTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYY 233

Query: 152 LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM---------NPNYTEFKFPQIKAHPWH 202
            G  LF      + LV + K+LG      I               + E            
Sbjct: 234 RGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENC 293

Query: 203 KIFQKRMPPEA------VDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGR 254
           K  +  M  ++       DL+ R+L++ P  R T  EAL+HPFF  L          R
Sbjct: 294 KPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSR 351

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  163 bits (415), Expect = 5e-48
 Identities = 55/268 (20%), Positives = 99/268 (36%), Gaps = 53/268 (19%)

Query: 1   MRLLDHPN--VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 58
           +  L   +  ++ L           + Y+ +V+E     ++  +K      + +     K
Sbjct: 108 LNKLQQHSDKIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKK----KSIDPWERK 158

Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI---S 115
            Y+  +  A+  IH   G+ H D+KP N L+      LKL DFG A  +     ++   S
Sbjct: 159 SYWKNMLEAVHTIHQH-GIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDS 215

Query: 116 YICSRYYRAPELIFGA----------TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQ 165
            + +  Y  PE I             ++ +   D+WS GC+L  +  G+  F        
Sbjct: 216 QVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS 275

Query: 166 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSP 225
            +  I             ++PN+ E +FP I               +  D++   L+  P
Sbjct: 276 KLHAI-------------IDPNH-EIEFPDI------------PEKDLQDVLKCCLKRDP 309

Query: 226 NLRSTALEALIHPFFDELRDPNTRLPNG 253
             R +  E L HP+      P  ++  G
Sbjct: 310 KQRISIPELLAHPYVQIQTHPVNQMAKG 337

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  162 bits (412), Expect = 5e-48
 Identities = 55/268 (20%), Positives = 99/268 (36%), Gaps = 53/268 (19%)

Query: 1   MRLLDHPN--VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVK 58
           +  L   +  ++ L           + Y+ +V+E     ++  +K      + +     K
Sbjct: 61  LNKLQQHSDKIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKK----KSIDPWERK 111

Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI---S 115
            Y+  +  A+  IH   G+ H D+KP N L+      LKL DFG A  +     ++   S
Sbjct: 112 SYWKNMLEAVHTIHQH-GIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDS 168

Query: 116 YICSRYYRAPELIFG----------ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQ 165
            + +  Y  PE I             ++ +   D+WS GC+L  +  G+  F        
Sbjct: 169 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS 228

Query: 166 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSP 225
            +  I             ++PN+ E +FP I               +  D++   L+  P
Sbjct: 229 KLHAI-------------IDPNH-EIEFPDI------------PEKDLQDVLKCCLKRDP 262

Query: 226 NLRSTALEALIHPFFDELRDPNTRLPNG 253
             R +  E L HP+      P  ++  G
Sbjct: 263 KQRISIPELLAHPYVQIQTHPVNQMAKG 290

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  160 bits (407), Expect = 4e-47
 Identities = 58/233 (24%), Positives = 97/233 (41%), Gaps = 45/233 (19%)

Query: 50  QRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVN------------------- 90
               +  +KLY  +I +AL Y+   + + H D+KP+N+L++                   
Sbjct: 132 NGFHIEDIKLYCIEILKALNYLRK-MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKK 190

Query: 91  -----PHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGC 145
                  +  +KL DFG A    K + + S I +R YRAPE+I     +  + D+WS GC
Sbjct: 191 IQIYRTKSTGIKLIDFGCA--TFKSDYHGSIINTRQYRAPEVILNL-GWDVSSDMWSFGC 247

Query: 146 VLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI---------KCMNPNYTEFKFPQI 196
           VLAEL  G  LF     ++ L  +  ++    +  +         K +N +  +  +P+ 
Sbjct: 248 VLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPEN 307

Query: 197 KAHPWHKIFQKRMPPEA--------VDLVSRLLQYSPNLRSTALEALIHPFFD 241
            +        K+  P           D +  +LQ  P LR +  E L H F +
Sbjct: 308 ASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  159 bits (403), Expect = 5e-47
 Identities = 55/248 (22%), Positives = 84/248 (33%), Gaps = 58/248 (23%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
            ++  HP  V L+  +    E   LYL    E    ++ +  +        +P   V  Y
Sbjct: 111 EKVGQHPCCVRLEQAWE---EGGILYL--QTELCGPSLQQHCE---AWGASLPEAQVWGY 162

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
                 ALA++H+  G+ H D+KP N+ + P     KL DFG    L             
Sbjct: 163 LRDTLLALAHLHSQ-GLVHLDVKPANIFLGPRGR-CKLGDFGLLVELGTAGAGEVQEGDP 220

Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 180
            Y APEL+     Y  A D++S G  + E+     L  G                     
Sbjct: 221 RYMAPELL--QGSYGTAADVFSLGLTILEVACNMELPHG--------------------- 257

Query: 181 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPP--------EAVDLVSRLLQYSPNLRSTAL 232
                               W ++ Q  +PP        E   ++  +L+  P LR+TA 
Sbjct: 258 -----------------GEGWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAE 300

Query: 233 EALIHPFF 240
             L  P  
Sbjct: 301 ALLALPVL 308

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  155 bits (393), Expect = 1e-45
 Identities = 56/265 (21%), Positives = 85/265 (32%), Gaps = 44/265 (16%)

Query: 1   MRLLDHPNVVSLKHCFFSTTE-KDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVK 58
            RL +HPN++ L          K E +L  +L +    T+   I+        +    + 
Sbjct: 80  HRLFNHPNILRLVAYCLRERGAKHEAWL--LLPFFKRGTLWNEIERLKDKGNFLTEDQIL 137

Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-------- 110
                ICR L  IH   G  HRD+KP N+L+     Q  L D GS               
Sbjct: 138 WLLLGICRGLEAIHAK-GYAHRDLKPTNILLG-DEGQPVLMDLGSMNQACIHVEGSRQAL 195

Query: 111 --EPNISYICSRYYRAPELIFGA--TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQL 166
             +   +  C+  YRAPEL             D+WS GCVL  ++ G+  +         
Sbjct: 196 TLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS 255

Query: 167 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPN 226
           V +  V                 +   PQ            R       L++ ++   P+
Sbjct: 256 VALA-VQN---------------QLSIPQ----------SPRHSSALWQLLNSMMTVDPH 289

Query: 227 LRSTALEALIHPFFDELRDPNTRLP 251
            R      L      +   P     
Sbjct: 290 QRPHIPLLLSQLEALQPPAPGQHTT 314

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  157 bits (400), Expect = 5e-45
 Identities = 65/266 (24%), Positives = 111/266 (41%), Gaps = 44/266 (16%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH-HYKMSQRMPLIYV 57
           ++LLDHPN++ L   F     +D+    LV+E     E    +I    +  ++       
Sbjct: 90  LKLLDHPNIMKLYDFF-----EDKRNYYLVMECYKGGELFDEIIHRMKF--NEV----DA 138

Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQN-LLVNPHTH-QLKLCDFGSAKVLVKGEPNIS 115
            +   Q+   + Y+H    + HRD+KP+N LL +      +K+ DFG + V    +    
Sbjct: 139 AVIIKQVLSGVTYLHK-HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKE 197

Query: 116 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
            + + YY APE++    +Y    D+WS G +L  LL G P F G++  DQ  EI+     
Sbjct: 198 RLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQT--DQ--EIL----- 246

Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 235
               +++     +            W  +        A DL+ ++LQ+    R +A +AL
Sbjct: 247 ---RKVEKGKYTFDS--------PEWKNV-----SEGAKDLIKQMLQFDSQRRISAQQAL 290

Query: 236 IHPFFDELRDPNTRLPNGRFLPPLFN 261
            HP+  E+            L     
Sbjct: 291 EHPWIKEMCSKKESGIELPSLANAIE 316

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  156 bits (395), Expect = 8e-45
 Identities = 54/251 (21%), Positives = 97/251 (38%), Gaps = 48/251 (19%)

Query: 2   RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVI-KHHYKMSQRMPLIYVKLY 60
              +HPNV+         TEKD  +  + +E    T+   + +  +      P+  ++  
Sbjct: 73  ESDEHPNVIRYFC-----TEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQ-- 125

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPH----THQLKLCDFGSAKVLVKGEPNISY 116
             Q    LA++H+ + + HRD+KP N+L++        +  + DFG  K L  G  + S 
Sbjct: 126 --QTTSGLAHLHS-LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSR 182

Query: 117 ---IC-SRYYRAPELIFGATE--YTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEI 169
              +  +  + APE++    +   T  +DI+SAGCV   ++  G   F            
Sbjct: 183 RSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF------------ 230

Query: 170 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS 229
               G   + +   +               P            A +L+ +++   P  R 
Sbjct: 231 ----GKSLQRQANILLGAC-SLDCLH----PEKHE-----DVIARELIEKMIAMDPQKRP 276

Query: 230 TALEALIHPFF 240
           +A   L HPFF
Sbjct: 277 SAKHVLKHPFF 287

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  156 bits (396), Expect = 1e-44
 Identities = 62/245 (25%), Positives = 106/245 (43%), Gaps = 44/245 (17%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH-HYKMSQRMPLIYV 57
           ++ LDHPN++ L   F     +D+ Y  LV E     E    +I    +  S+       
Sbjct: 80  LKQLDHPNIMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIISRKRF--SEV----DA 128

Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQN-LLVNPHTH-QLKLCDFGSAKVLVKGEPNIS 115
                Q+   + Y+H    + HRD+KP+N LL +      +++ DFG +      +    
Sbjct: 129 ARIIRQVLSGITYMHK-NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD 187

Query: 116 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
            I + YY APE++ G   Y    D+WS G +L  LL G P F G +  +   +I+     
Sbjct: 188 KIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGAN--EY--DIL----- 236

Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 235
              ++++     +            W K+        A DL+ ++L Y P++R +A +AL
Sbjct: 237 ---KKVEKGKYTFEL--------PQWKKV-----SESAKDLIRKMLTYVPSMRISARDAL 280

Query: 236 IHPFF 240
            H + 
Sbjct: 281 DHEWI 285

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  154 bits (389), Expect = 2e-44
 Identities = 41/256 (16%), Positives = 77/256 (30%), Gaps = 26/256 (10%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           + +   P    L          + L L        E +   +   Y       ++ + + 
Sbjct: 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHIL 199

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
             Q+ R  A + +  G+ H    P NL + P    L L D  +   +  G    +     
Sbjct: 200 TAQLIRLAANLQSK-GLVHGHFTPDNLFIMPDGR-LMLGDVSALWKV--GTRGPASSVPV 255

Query: 121 YYRAPELIFG-ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
            Y   E +      +T A++ W  G  +  +      F   +   +       L  P  +
Sbjct: 256 TYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTD 315

Query: 180 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
                                        +P     L+ R L +    R   LEA+  P 
Sbjct: 316 --------------------SLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPE 355

Query: 240 FDELRD-PNTRLPNGR 254
           F +L++  ++ L  G+
Sbjct: 356 FLQLQNEISSSLSTGQ 371

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  156 bits (397), Expect = 2e-44
 Identities = 67/245 (27%), Positives = 108/245 (44%), Gaps = 44/245 (17%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH-HYKMSQRMPLIYV 57
           ++ LDHPN++ L   F     +D+ Y  LV E+    E   ++I    +   +       
Sbjct: 100 LKSLDHPNIIKLFDVF-----EDKKYFYLVTEFYEGGELFEQIINRHKF--DEC----DA 148

Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQN-LLVNPHTH-QLKLCDFGSAKVLVKGEPNIS 115
                QI   + Y+H    + HRDIKP+N LL N ++   +K+ DFG +    K      
Sbjct: 149 ANIMKQILSGICYLHK-HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRD 207

Query: 116 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
            + + YY APE++    +Y    D+WS G ++  LL G P F G++  DQ  +II     
Sbjct: 208 RLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQN--DQ--DII----- 256

Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 235
              ++++     +          + W  I       EA +L+  +L Y  N R TA EAL
Sbjct: 257 ---KKVEKGKYYFDF--------NDWKNI-----SDEAKELIKLMLTYDYNKRCTAEEAL 300

Query: 236 IHPFF 240
              + 
Sbjct: 301 NSRWI 305

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  156 bits (396), Expect = 2e-44
 Identities = 64/266 (24%), Positives = 109/266 (40%), Gaps = 44/266 (16%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH-HYKMSQRMPLIYV 57
           ++ LDHPN++ L         +D     +V E     E    +IK   +  S+       
Sbjct: 75  LKKLDHPNIMKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKRF--SEH----DA 123

Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQN-LLVNPHTH-QLKLCDFGSAKVLVKGEPNIS 115
                Q+   + Y+H    + HRD+KP+N LL +      +K+ DFG +    +      
Sbjct: 124 ARIIKQVFSGITYMHK-HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD 182

Query: 116 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
            I + YY APE++ G   Y    D+WSAG +L  LL G P F G++  +   +I+     
Sbjct: 183 RIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKN--EY--DIL----- 231

Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 235
              + ++     +            W  I       +A DL+ ++L + P+LR TA + L
Sbjct: 232 ---KRVETGKYAFDL--------PQWRTI-----SDDAKDLIRKMLTFHPSLRITATQCL 275

Query: 236 IHPFFDELRDPNTRLPNGRFLPPLFN 261
            HP+  +       + +   L     
Sbjct: 276 EHPWIQKYSSETPTISDLPSLESAMT 301

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  154 bits (392), Expect = 3e-44
 Identities = 63/267 (23%), Positives = 111/267 (41%), Gaps = 57/267 (21%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIY---V 57
               DHPNV+         +E  + +L + LE     +  +++      + + L      
Sbjct: 63  TESDDHPNVIRYYC-----SETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNP 117

Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH------------QLKLCDFGSAK 105
                QI   +A++H+ + + HRD+KPQN+LV+  +             ++ + DFG  K
Sbjct: 118 ISLLRQIASGVAHLHS-LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK 176

Query: 106 VLVKGE----PNISYIC-SRYYRAPELIFGATE------YTAAIDIWSAGCVLAELL-LG 153
            L  G+     N++    +  +RAPEL+  +         T +IDI+S GCV   +L  G
Sbjct: 177 KLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKG 236

Query: 154 QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEA 213
           +  F  +    +   II+                   F   ++K      +       EA
Sbjct: 237 KHPFGDKY--SRESNIIR-----------------GIFSLDEMKCLHDRSL-----IAEA 272

Query: 214 VDLVSRLLQYSPNLRSTALEALIHPFF 240
            DL+S+++ + P  R TA++ L HP F
Sbjct: 273 TDLISQMIDHDPLKRPTAMKVLRHPLF 299

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  150 bits (382), Expect = 3e-44
 Identities = 64/248 (25%), Positives = 95/248 (38%), Gaps = 39/248 (15%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           +R L HPN+V          ++    L +V+EY     +  VI    K  Q +   +V  
Sbjct: 59  LRELKHPNIVRYYDRII---DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLR 115

Query: 60  YFYQICRALAYIH----NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS 115
              Q+  AL   H        V HRD+KP N+ ++     +KL DFG A++L        
Sbjct: 116 VMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD-GKQNVKLGDFGLARILNHDTSFAK 174

Query: 116 YIC-SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 174
               + YY +PE +     Y    DIWS GC+L EL    P F   S   +L   I+   
Sbjct: 175 TFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFS-QKELAGKIR--- 229

Query: 175 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 234
                          E KF +I               E  ++++R+L      R +  E 
Sbjct: 230 ---------------EGKFRRIPYR---------YSDELNEIITRMLNLKDYHRPSVEEI 265

Query: 235 LIHPFFDE 242
           L +P   E
Sbjct: 266 LENPLILE 273

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  151 bits (384), Expect = 6e-44
 Identities = 55/266 (20%), Positives = 108/266 (40%), Gaps = 29/266 (10%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-----ETVHRVIKHHYKMSQRMPLI 55
           +  + +   ++      +    DE+Y+  + EY+      +            +  +P+ 
Sbjct: 97  ITDIKNEYCLTC-EGIITN--YDEVYI--IYEYMENDSILKFDEYFFVLDKNYTCFIPIQ 151

Query: 56  YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS 115
            +K     +  + +YIHN   +CHRD+KP N+L++ +   +KL DFG ++ +V  +  I 
Sbjct: 152 VIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGR-VKLSDFGESEYMVDKK--IK 208

Query: 116 YIC-SRYYRAPELIFGATEY-TAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL 173
               +  +  PE     + Y  A +DIWS G  L  +      F  +  + +L   I+  
Sbjct: 209 GSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIR-- 266

Query: 174 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
                + I+   P      F     +         +  E +D +   L+ +P  R T+ +
Sbjct: 267 ----TKNIEY--PLDRN-HFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSED 319

Query: 234 ALIHPFF-----DELRDPNTRLPNGR 254
           AL H +      ++LR+ +  L   R
Sbjct: 320 ALKHEWLADTNIEDLREFSKELYKKR 345

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  151 bits (384), Expect = 3e-43
 Identities = 69/249 (27%), Positives = 118/249 (47%), Gaps = 44/249 (17%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVK 58
           ++ L+HP ++ +K+ F    + ++ Y+  VLE +   E   +V+ +  ++ +       K
Sbjct: 194 LKKLNHPCIIKIKNFF----DAEDYYI--VLELMEGGELFDKVVGNK-RLKEAT----CK 242

Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNISY 116
           LYFYQ+  A+ Y+H   G+ HRD+KP+N+L++       +K+ DFG +K+L +    +  
Sbjct: 243 LYFYQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRT 300

Query: 117 IC-SRYYRAPELIFGATE--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL 173
           +C +  Y APE++       Y  A+D WS G +L   L G P F        L + I   
Sbjct: 301 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT-S 359

Query: 174 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
           G               ++ F       W ++       +A+DLV +LL   P  R T  E
Sbjct: 360 G---------------KYNFI---PEVWAEV-----SEKALDLVKKLLVVDPKARFTTEE 396

Query: 234 ALIHPFFDE 242
           AL HP+  +
Sbjct: 397 ALRHPWLQD 405

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  146 bits (371), Expect = 3e-42
 Identities = 43/252 (17%), Positives = 84/252 (33%), Gaps = 18/252 (7%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVK 58
           ++ L+H N+V L      TT      L  ++E+ P       + +     +  +P     
Sbjct: 61  LKKLNHKNIVKLFAIEEETT-TRHKVL--IMEFCPCGSLYTVLEEP--SNAYGLPESEFL 115

Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP---HTHQLKLCDFGSAKVLVKGEPNIS 115
           +    +   + ++    G+ HR+IKP N++           KL DFG+A+ L   E  +S
Sbjct: 116 IVLRDVVGGMNHLRE-NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS 174

Query: 116 YICSRYYRAPELIFGAT-------EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE 168
              +  Y  P++   A        +Y A +D+WS G        G   F    G  +  E
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE 234

Query: 169 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 228
           ++  + T                        P      + +      +++ +L+      
Sbjct: 235 VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKC 294

Query: 229 STALEALIHPFF 240
               +       
Sbjct: 295 WGFDQFFAETSD 306

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  145 bits (369), Expect = 3e-42
 Identities = 63/255 (24%), Positives = 106/255 (41%), Gaps = 38/255 (14%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHY-KMSQRMPLIYVK 58
            + L H N+V      +  +  +  ++ + +E VP  ++  +++  +  +      I   
Sbjct: 73  HKHLKHKNIVQ-----YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTI--G 125

Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-SYI 117
            Y  QI   L Y+H+   + HRDIK  N+L+N ++  LK+ DFG++K L    P   ++ 
Sbjct: 126 FYTKQILEGLKYLHDN-QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT 184

Query: 118 CSRYYRAPELIFGATE-YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
            +  Y APE+I      Y  A DIWS GC + E+  G+P F       +L E    +   
Sbjct: 185 GTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFY------ELGEPQAAM--- 235

Query: 177 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 236
                         FK    K HP      + M  EA   + +  +  P+ R+ A + L+
Sbjct: 236 --------------FKVGMFKVHP---EIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278

Query: 237 HPFFDELRDPNTRLP 251
             F           P
Sbjct: 279 DEFLKVSSKKKKTQP 293

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  145 bits (369), Expect = 7e-42
 Identities = 69/247 (27%), Positives = 117/247 (47%), Gaps = 44/247 (17%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVK 58
           ++ L+HP ++ +K+ F    + ++ Y+  VLE +   E   +V+ +  ++ +       K
Sbjct: 69  LKKLNHPCIIKIKNFF----DAEDYYI--VLELMEGGELFDKVVGNK-RLKEA----TCK 117

Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNISY 116
           LYFYQ+  A+ Y+H   G+ HRD+KP+N+L++       +K+ DFG +K+L +    +  
Sbjct: 118 LYFYQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRT 175

Query: 117 IC-SRYYRAPELIFGATE--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL 173
           +C +  Y APE++       Y  A+D WS G +L   L G P F        L + I   
Sbjct: 176 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT-S 234

Query: 174 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
           G               ++ F       W ++       +A+DLV +LL   P  R T  E
Sbjct: 235 G---------------KYNFI---PEVWAEV-----SEKALDLVKKLLVVDPKARFTTEE 271

Query: 234 ALIHPFF 240
           AL HP+ 
Sbjct: 272 ALRHPWL 278

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  144 bits (366), Expect = 1e-41
 Identities = 60/264 (22%), Positives = 97/264 (36%), Gaps = 56/264 (21%)

Query: 1   MRLLDHPNVVSLKHCF--------FSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQR 51
           +  L+H  VV     +          T  K +  L + +EY    T++ +I       QR
Sbjct: 56  LASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQR 115

Query: 52  MPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 111
                    F QI  AL+YIH+  G+ HRD+KP N+ ++  +  +K+ DFG AK + +  
Sbjct: 116 D---EYWRLFRQILEALSYIHSQ-GIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSL 170

Query: 112 PNISYICSR---------------YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPL 156
             +                      Y A E++ G   Y   ID++S G +  E++   P 
Sbjct: 171 DILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPF 228

Query: 157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDL 216
             G       V I+K L +                +FP     P    F          +
Sbjct: 229 STGME----RVNILKKLRSV-------------SIEFP-----PD---FDDNKMKVEKKI 263

Query: 217 VSRLLQYSPNLRSTALEALIHPFF 240
           +  L+ + PN R  A   L   + 
Sbjct: 264 IRLLIDHDPNKRPGARTLLNSGWL 287

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  146 bits (371), Expect = 1e-41
 Identities = 67/267 (25%), Positives = 112/267 (41%), Gaps = 40/267 (14%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVK 58
           M  L HP +++L   F     +D+  + L+LE++   E   R+    YKMS+   + Y++
Sbjct: 102 MNQLHHPKLINLHDAF-----EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMR 156

Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLL-VNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
               Q C  L ++H    + H DIKP+N++        +K+ DFG A  L   E      
Sbjct: 157 ----QACEGLKHMHE-HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT 211

Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +  + APE I          D+W+ G +   LL G   F GE  ++ L  + +      
Sbjct: 212 ATAEFAAPE-IVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC----- 265

Query: 178 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 237
                       +++F       +  +      PEA D +  LLQ  P  R T  +AL H
Sbjct: 266 ------------DWEFD---EDAFSSV-----SPEAKDFIKNLLQKEPRKRLTVHDALEH 305

Query: 238 PFF-DELRDPNTRLPNGRFLPPLFNFK 263
           P+   +  +  +R+P+ R+       K
Sbjct: 306 PWLKGDHSNLTSRIPSSRYNKIRQKIK 332

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  145 bits (368), Expect = 1e-41
 Identities = 73/294 (24%), Positives = 115/294 (39%), Gaps = 75/294 (25%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVK 58
           M+ L HPN+  L   +     +DE Y+ LV+E       + ++       + +  +  VK
Sbjct: 82  MKKLHHPNIARLYEVY-----EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVK 136

Query: 59  L-----------------------------------YFYQICRALAYIHNTIGVCHRDIK 83
                                                  QI  AL Y+HN  G+CHRDIK
Sbjct: 137 TQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN-QGICHRDIK 195

Query: 84  PQN-LLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-----SRYYRAPELIFGATE-YTA 136
           P+N L     + ++KL DFG +K   K      Y       + Y+ APE++    E Y  
Sbjct: 196 PENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP 255

Query: 137 AIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 196
             D WSAG +L  LL+G   FPG +  D + +++                   +  F   
Sbjct: 256 KCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLN-----------------KKLCFE-- 296

Query: 197 KAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRL 250
               ++ +      P A DL+S LL  + + R  A+ AL HP+  +  D   ++
Sbjct: 297 -NPNYNVL-----SPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDKIYKM 344

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  149 bits (377), Expect = 3e-41
 Identities = 65/268 (24%), Positives = 114/268 (42%), Gaps = 41/268 (15%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVK 58
           M +L HP +V+L   F     +D+  + ++ E++   E   +V   H KMS+   + Y++
Sbjct: 208 MSVLRHPTLVNLHDAF-----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR 262

Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLL-VNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
               Q+C+ L ++H      H D+KP+N++     +++LKL DFG    L   +      
Sbjct: 263 ----QVCKGLCHMHE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT 317

Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +  + APE+  G        D+WS G +   LL G   F GE+  +            T
Sbjct: 318 GTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE------------T 364

Query: 178 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 237
              +K  + N  +  F  I               +  D + +LL   PN R T  +AL H
Sbjct: 365 LRNVKSCDWNMDDSAFSGIS-------------EDGKDFIRKLLLADPNTRMTIHQALEH 411

Query: 238 PFF--DELRDPNTRLPNGRFLPPLFNFK 263
           P+         ++++P+ R+     + K
Sbjct: 412 PWLTPGNAPGRDSQIPSSRYTKIRDSIK 439

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  143 bits (362), Expect = 5e-41
 Identities = 65/242 (26%), Positives = 97/242 (40%), Gaps = 37/242 (15%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           ++ L+HPNV+     F    E +EL +  VLE      + R+IKH  K  + +P   V  
Sbjct: 86  LKQLNHPNVIKYYASFI---EDNELNI--VLELADAGDLSRMIKHFKKQKRLIPERTVWK 140

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV-KGEPNISYIC 118
           YF Q+C AL ++H+   V HRDIKP N+ +      +KL D G  +    K     S + 
Sbjct: 141 YFVQLCSALEHMHSR-RVMHRDIKPANVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVG 198

Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG-VDQLVEIIKVLGTPT 177
           + YY +PE I     Y    DIWS GC+L E+   Q  F G+   +  L + I+      
Sbjct: 199 TPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE------ 251

Query: 178 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 237
                       +  +P +               E   LV+  +   P  R         
Sbjct: 252 ------------QCDYPPLP--------SDHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291

Query: 238 PF 239
             
Sbjct: 292 AK 293

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  142 bits (360), Expect = 1e-40
 Identities = 63/242 (26%), Positives = 108/242 (44%), Gaps = 41/242 (16%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVK 58
           + +  H N++ L   F     +    L ++ E++   +   R+    +++++R  + YV 
Sbjct: 55  LNIARHRNILHLHESF-----ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVH 109

Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLL-VNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
               Q+C AL ++H+   + H DI+P+N++     +  +K+ +FG A+ L  G+     +
Sbjct: 110 ----QVCEALQFLHS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-FRLL 163

Query: 118 C-SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
             +  Y APE +      + A D+WS G ++  LL G   F  E+  +Q  +II      
Sbjct: 164 FTAPEYYAPE-VHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET--NQ--QII------ 212

Query: 177 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 236
             E I      + E  F +I               EA+D V RLL      R TA EAL 
Sbjct: 213 --ENIMNAEYTFDEEAFKEIS-------------IEAMDFVDRLLVKERKSRMTASEALQ 257

Query: 237 HP 238
           HP
Sbjct: 258 HP 259

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  143 bits (362), Expect = 1e-40
 Identities = 60/242 (24%), Positives = 94/242 (38%), Gaps = 40/242 (16%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           +  + HPN+V  +  F    E   LY+  V++Y     + + I              +  
Sbjct: 77  LANMKHPNIVQYRESFE---ENGSLYI--VMDYCEGGDLFKRINAQKG--VLFQEDQILD 129

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC- 118
           +F QIC AL ++H+   + HRDIK QN+ +      ++L DFG A+VL            
Sbjct: 130 WFVQICLALKHVHDR-KILHRDIKSQNIFLTKD-GTVQLGDFGIARVLNSTVELARACIG 187

Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 178
           + YY +PE+      Y    DIW+ GCVL EL   +  F   S +  LV  I        
Sbjct: 188 TPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGS-MKNLVLKII------S 239

Query: 179 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 238
                ++ +Y                       +   LVS+L + +P  R +    L   
Sbjct: 240 GSFPPVSLHY---------------------SYDLRSLVSQLFKRNPRDRPSVNSILEKG 278

Query: 239 FF 240
           F 
Sbjct: 279 FI 280

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  141 bits (358), Expect = 1e-40
 Identities = 69/274 (25%), Positives = 105/274 (38%), Gaps = 59/274 (21%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
            R L H +VV     F      D +++  VLE     ++  + K      + +     + 
Sbjct: 69  HRSLAHQHVVGFHGFFED---NDFVFV--VLELCRRRSLLELHKRR----KALTEPEARY 119

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGE------- 111
           Y  QI     Y+H    V HRD+K  NL +N    ++K+ DFG + KV   GE       
Sbjct: 120 YLRQIVLGCQYLHRN-RVIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDGERKKVLCG 177

Query: 112 -PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 170
            PN        Y APE++     ++  +D+WS GC++  LL+G+P F      +  + I 
Sbjct: 178 TPN--------YIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK 228

Query: 171 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 230
           K                  E+  P              + P A  L+ ++LQ  P  R T
Sbjct: 229 KN-----------------EYSIP-----KH-------INPVAASLIQKMLQTDPTARPT 259

Query: 231 ALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKP 264
             E L   FF     P         +PP F+  P
Sbjct: 260 INELLNDEFFTSGYIPARLPITCLTIPPRFSIAP 293

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  141 bits (357), Expect = 1e-40
 Identities = 64/247 (25%), Positives = 104/247 (42%), Gaps = 44/247 (17%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH-HYKMSQRMPLIYV 57
           ++ LDHPN++ L         +D     +V E     E    +IK   +  S+       
Sbjct: 75  LKKLDHPNIMKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKRF--SEHD----A 123

Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLV--NPHTHQLKLCDFGSAKVLVKGEPNIS 115
                Q+   + Y+H    + HRD+KP+N+L+        +K+ DFG +    +      
Sbjct: 124 ARIIKQVFSGITYMHK-HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD 182

Query: 116 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
            I + YY APE++ G   Y    D+WSAG +L  LL G P F G++  D L  +      
Sbjct: 183 RIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET---- 236

Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 235
                         ++ F       W  I       +A DL+ ++L + P+LR TA + L
Sbjct: 237 -------------GKYAFD---LPQWRTI-----SDDAKDLIRKMLTFHPSLRITATQCL 275

Query: 236 IHPFFDE 242
            HP+  +
Sbjct: 276 EHPWIQK 282

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  141 bits (357), Expect = 2e-40
 Identities = 70/247 (28%), Positives = 109/247 (44%), Gaps = 44/247 (17%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH-HYKMSQRMPLIYV 57
           M+ LDHPN++ L   F     +D   + LV+E     E   RV+    +   +       
Sbjct: 60  MKSLDHPNIIRLYETF-----EDNTDIYLVMELCTGGELFERVVHKRVF--RES----DA 108

Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNIS 115
                 +  A+AY H  + V HRD+KP+N L    +    LKL DFG A     G+   +
Sbjct: 109 ARIMKDVLSAVAYCHK-LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT 167

Query: 116 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
            + + YY +P+++ G   Y    D WSAG ++  LL G P F   +  + +++I +    
Sbjct: 168 KVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREG--- 222

Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 235
                          F FP      W  +      P+A  L+ RLL  SP  R T+L+AL
Sbjct: 223 --------------TFTFP---EKDWLNV-----SPQAESLIRRLLTKSPKQRITSLQAL 260

Query: 236 IHPFFDE 242
            H +F++
Sbjct: 261 EHEWFEK 267

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  140 bits (356), Expect = 2e-40
 Identities = 58/259 (22%), Positives = 110/259 (42%), Gaps = 58/259 (22%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
              L HP+++ L + F      + +YL  VLE      ++R +K+  K          + 
Sbjct: 65  HCQLKHPSILELYNYFED---SNYVYL--VLEMCHNGEMNRYLKNRVK---PFSENEARH 116

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGE------- 111
           + +QI   + Y+H+  G+ HRD+   NLL+  +   +K+ DFG + ++ +  E       
Sbjct: 117 FMHQIITGMLYLHSH-GILHRDLTLSNLLLTRN-MNIKIADFGLATQLKMPHEKHYTLCG 174

Query: 112 -PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 170
            PN        Y +PE+    + +    D+WS GC+   LL+G+P F  ++  + L +++
Sbjct: 175 TPN--------YISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV 225

Query: 171 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 230
                              +++ P      +       +  EA DL+ +LL+ +P  R +
Sbjct: 226 LA-----------------DYEMP-----SF-------LSIEAKDLIHQLLRRNPADRLS 256

Query: 231 ALEALIHPFFDELRDPNTR 249
               L HPF        ++
Sbjct: 257 LSSVLDHPFMSRNSSTKSK 275

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  140 bits (354), Expect = 5e-40
 Identities = 61/256 (23%), Positives = 100/256 (39%), Gaps = 46/256 (17%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVI-KHHYKMSQRMPLIYV 57
           +R + HPN+++L   F     +++  + L+LE V   E    +  K     ++       
Sbjct: 62  LREIRHPNIITLHDIF-----ENKTDVVLILELVSGGELFDFLAEKESL--TEDE----A 110

Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNI 114
             +  QI   + Y+H+   + H D+KP+N+++   N    ++KL DFG A  +  G    
Sbjct: 111 TQFLKQILDGVHYLHS-KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-F 168

Query: 115 SYIC-SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL 173
             I  +  + APE I          D+WS G +   LL G   F GE+  + L  I  V 
Sbjct: 169 KNIFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV- 226

Query: 174 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
                            + F       +           A D + RLL   P  R T  +
Sbjct: 227 ----------------NYDFD---EEYFSNT-----SELAKDFIRRLLVKDPKRRMTIAQ 262

Query: 234 ALIHPFFDELRDPNTR 249
           +L H +   +R  N R
Sbjct: 263 SLEHSWIKAIRRRNVR 278

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  141 bits (357), Expect = 6e-40
 Identities = 70/274 (25%), Positives = 106/274 (38%), Gaps = 59/274 (21%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
            R L H +VV     F      D +++  VLE     ++  + K      + +     + 
Sbjct: 95  HRSLAHQHVVGFHGFFED---NDFVFV--VLELCRRRSLLELHKRR----KALTEPEARY 145

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGE------- 111
           Y  QI     Y+H    V HRD+K  NL +N    ++K+ DFG + KV   GE       
Sbjct: 146 YLRQIVLGCQYLHRN-RVIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDGERKKVLCG 203

Query: 112 -PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 170
            PN        Y APE++     ++  +D+WS GC++  LL+G+P F      +  + I 
Sbjct: 204 TPN--------YIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK 254

Query: 171 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST 230
           K                  E+  P            K + P A  L+ ++LQ  P  R T
Sbjct: 255 KN-----------------EYSIP------------KHINPVAASLIQKMLQTDPTARPT 285

Query: 231 ALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKP 264
             E L   FF     P         +PP F+  P
Sbjct: 286 INELLNDEFFTSGYIPARLPITCLTIPPRFSIAP 319

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  141 bits (357), Expect = 6e-40
 Identities = 66/271 (24%), Positives = 101/271 (37%), Gaps = 47/271 (17%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIY-- 56
             +L HP++V L   +       +  L +V E++   +    ++K           +Y  
Sbjct: 80  CHMLKHPHIVELLETY-----SSDGMLYMVFEFMDGADLCFEIVKR-----ADAGFVYSE 129

Query: 57  --VKLYFYQICRALAYIHNTIGVCHRDIKPQN-LLVNPH-THQLKLCDFGSAKVLVKGEP 112
                Y  QI  AL Y H+   + HRD+KP   LL +   +  +KL  FG A  L +   
Sbjct: 130 AVASHYMRQILEALRYCHD-NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL 188

Query: 113 NISYIC-SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 171
                  + ++ APE +     Y   +D+W  G +L  LL G   F G    ++L E I 
Sbjct: 189 VAGGRVGTPHFMAPE-VVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGII 245

Query: 172 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 231
                             ++K        W  I        A DLV R+L   P  R T 
Sbjct: 246 ----------------KGKYKMN---PRQWSHI-----SESAKDLVRRMLMLDPAERITV 281

Query: 232 LEALIHPFFDELRDPNTRLPNGRFLPPLFNF 262
            EAL HP+  E      ++     +  L  F
Sbjct: 282 YEALNHPWLKERDRYAYKIHLPETVEQLRKF 312

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  139 bits (353), Expect = 7e-40
 Identities = 64/249 (25%), Positives = 107/249 (42%), Gaps = 45/249 (18%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKM---SQRMPLI 55
           ++ LDHPN++ +   F     +D   + +V+E     E + R++    +    S+     
Sbjct: 74  LKSLDHPNIIKIFEVF-----EDYHNMYIVMETCEGGELLERIVSAQARGKALSEG---- 124

Query: 56  YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPN 113
           YV     Q+  ALAY H+   V H+D+KP+N+L    +    +K+ DFG A++    E +
Sbjct: 125 YVAELMKQMMNALAYFHS-QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS 183

Query: 114 ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL 173
            +   +  Y APE+     + T   DIWSAG V+  LL G   F G S  +   +     
Sbjct: 184 TNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYK- 240

Query: 174 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
                           E  +               + P+AVDL+ ++L   P  R +A +
Sbjct: 241 ----------------EPNYAV---ECRP------LTPQAVDLLKQMLTKDPERRPSAAQ 275

Query: 234 ALIHPFFDE 242
            L H +F +
Sbjct: 276 VLHHEWFKQ 284

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  141 bits (358), Expect = 8e-40
 Identities = 63/241 (26%), Positives = 105/241 (43%), Gaps = 39/241 (16%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVK 58
           M  LDH N++ L   F     + +  + LV+EYV   E   R+I   Y +++   ++++K
Sbjct: 140 MNQLDHANLIQLYDAF-----ESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMK 194

Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLL-VNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
               QIC  + ++H  + + H D+KP+N+L VN    Q+K+ DFG A+     E      
Sbjct: 195 ----QICEGIRHMHQ-MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF 249

Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +  + APE +      +   D+WS G +   LL G   F G++  + L  I+       
Sbjct: 250 GTPEFLAPE-VVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILAC----- 303

Query: 178 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 237
                        +         +  I       EA + +S+LL    + R +A EAL H
Sbjct: 304 ------------RWDLE---DEEFQDI-----SEEAKEFISKLLIKEKSWRISASEALKH 343

Query: 238 P 238
           P
Sbjct: 344 P 344

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  139 bits (352), Expect = 1e-39
 Identities = 50/251 (19%), Positives = 99/251 (39%), Gaps = 50/251 (19%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           ++ L HPN+V     + ST +  +  + LV E +   T+   +K      + M +  ++ 
Sbjct: 79  LKGLQHPNIVRFYDSWESTVKGKK-CIVLVTELMTSGTLKTYLKRF----KVMKIKVLRS 133

Query: 60  YFYQICRALAYIH-NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-------VKGE 111
           +  QI + L ++H  T  + HRD+K  N+ +   T  +K+ D G A +        V G 
Sbjct: 134 WCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGT 193

Query: 112 PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 171
           P         + APE+     +Y  ++D+++ G  + E+   +  +       Q+     
Sbjct: 194 P--------EFMAPEMY--EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI----- 238

Query: 172 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 231
                              ++       P    F K   PE  +++   ++ + + R + 
Sbjct: 239 -------------------YRRVTSGVKP--ASFDKVAIPEVKEIIEGCIRQNKDERYSI 277

Query: 232 LEALIHPFFDE 242
            + L H FF E
Sbjct: 278 KDLLNHAFFQE 288

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  139 bits (353), Expect = 2e-39
 Identities = 62/270 (22%), Positives = 99/270 (36%), Gaps = 47/270 (17%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVI-KHHYKMSQRMPLIYV 57
           +R + H NV++L   +     ++   + L+LE V   E    +  K     S+       
Sbjct: 69  LRQVLHHNVITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESL--SEEE----A 117

Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNI 114
             +  QI   + Y+H    + H D+KP+N+++   N     +KL DFG A  +  G    
Sbjct: 118 TSFIKQILDGVNYLHT-KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-F 175

Query: 115 SYIC-SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL 173
             I  +  + APE I          D+WS G +   LL G   F G++  + L  I  V 
Sbjct: 176 KNIFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV- 233

Query: 174 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
                            + F       +           A D + +LL      R T  E
Sbjct: 234 ----------------SYDFD---EEFFSHT-----SELAKDFIRKLLVKETRKRLTIQE 269

Query: 234 ALIHPFFDELRDPNTRLPNGRFLPPLFNFK 263
           AL HP+     D    +     +  L NF+
Sbjct: 270 ALRHPWITP-VDNQQAMVRRESVVNLENFR 298

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  140 bits (354), Expect = 3e-39
 Identities = 63/270 (23%), Positives = 101/270 (37%), Gaps = 47/270 (17%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVI-KHHYKMSQRMPLIYV 57
           +R + HPN+++L   +     ++   + L+LE V   E    +  K     S+       
Sbjct: 69  LRQVLHPNIITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESL--SEEE----A 117

Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNI 114
             +  QI   + Y+H    + H D+KP+N+++   N     +KL DFG A  +  G    
Sbjct: 118 TSFIKQILDGVNYLHT-KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-F 175

Query: 115 SYIC-SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL 173
             I  +  + APE I          D+WS G +   LL G   F G++  + L  I  V 
Sbjct: 176 KNIFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV- 233

Query: 174 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
                            + F       + +         A D + +LL      R T  E
Sbjct: 234 ----------------SYDFD---EEFFSQT-----SELAKDFIRKLLVKETRKRLTIQE 269

Query: 234 ALIHPFFDELRDPNTRLPNGRFLPPLFNFK 263
           AL HP+     D    +     +  L NFK
Sbjct: 270 ALRHPWITP-VDTQQAMVRRESVVNLENFK 298

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  137 bits (348), Expect = 3e-39
 Identities = 68/261 (26%), Positives = 102/261 (39%), Gaps = 59/261 (22%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVK 58
              L HPN++ L   F      D   + L+LEY P       + K       +       
Sbjct: 63  QSHLRHPNILRLYGYF-----HDATRVYLILEYAPLGTVYRELQKL-----SKFDEQRTA 112

Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-------GE 111
            Y  ++  AL+Y H+   V HRDIKP+NLL+      LK+ DFG +            G 
Sbjct: 113 TYITELANALSYCHSK-RVIHRDIKPENLLLGSAGE-LKIADFGWSVHAPSSRRTDLCGT 170

Query: 112 PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 171
            +        Y  PE+I G   +   +D+WS G +  E L+G+P F   +  +    I +
Sbjct: 171 LD--------YLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR 221

Query: 172 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 231
           V                 EF FP      +       +   A DL+SRLL+++P+ R   
Sbjct: 222 V-----------------EFTFP-----DF-------VTEGARDLISRLLKHNPSQRPML 252

Query: 232 LEALIHPFFDELRDPNTRLPN 252
            E L HP+        +   N
Sbjct: 253 REVLEHPWITANSSKPSNCQN 273

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  138 bits (351), Expect = 4e-39
 Identities = 54/262 (20%), Positives = 101/262 (38%), Gaps = 44/262 (16%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVK 58
           ++ + HPNV++L   +     +++  + L+LE V   E    + +    +++        
Sbjct: 68  LKEIQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKES-LTEEE----AT 117

Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNIS 115
            +  QI   + Y+H+ + + H D+KP+N+++   N    ++K+ DFG A  +  G     
Sbjct: 118 EFLKQILNGVYYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FK 175

Query: 116 YIC-SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 174
            I  +  + APE I          D+WS G +   LL G   F G++  + L  +  V  
Sbjct: 176 NIFGTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV-- 232

Query: 175 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 234
                           ++F       +           A D + RLL   P  R T  ++
Sbjct: 233 ---------------NYEFE---DEYFSNT-----SALAKDFIRRLLVKDPKKRMTIQDS 269

Query: 235 LIHPFFDELRDPNTRLPNGRFL 256
           L HP+                +
Sbjct: 270 LQHPWIKPKDTQQALSRKASAV 291

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  139 bits (352), Expect = 4e-39
 Identities = 66/267 (24%), Positives = 106/267 (39%), Gaps = 43/267 (16%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH-HYKMSQRMPLIYV 57
            R L HPN+V L         ++E +  LV + V   E    ++    Y  S+       
Sbjct: 82  CRKLQHPNIVRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFY--SEAD----A 130

Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLV--NPHTHQLKLCDFGSAKVLVKGEPNIS 115
                QI  ++AY H+  G+ HR++KP+NLL+        +KL DFG A  +   E    
Sbjct: 131 SHCIQQILESIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG 189

Query: 116 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
           +  +  Y +PE +     Y+  +DIW+ G +L  LL+G P F  E       +I      
Sbjct: 190 FAGTPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG--- 245

Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 235
                          + +P   +  W  +      PEA  L+  +L  +P  R TA +AL
Sbjct: 246 --------------AYDYP---SPEWDTV-----TPEAKSLIDSMLTVNPKKRITADQAL 283

Query: 236 IHPFFDELRDPNTRLPNGRFLPPLFNF 262
             P+        + +     +  L  F
Sbjct: 284 KVPWICNRERVASAIHRQDTVDCLKKF 310

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  137 bits (348), Expect = 4e-39
 Identities = 53/268 (19%), Positives = 97/268 (36%), Gaps = 55/268 (20%)

Query: 1   MRLLDHPNVVSLKHCFF-------STTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRM 52
           +  L+HP +V   + +              ++YL + ++    E +   +       +  
Sbjct: 57  LAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGR-CTIEER 115

Query: 53  PLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 112
                   F QI  A+ ++H+  G+ HRD+KP N+        +K+ DFG    + + E 
Sbjct: 116 ERSVCLHIFLQIAEAVEFLHSK-GLMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEE 173

Query: 113 NISYICSR-------------YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG 159
             + +                 Y +PE I G   Y+  +DI+S G +L ELL   P F  
Sbjct: 174 EQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELL--YP-FST 229

Query: 160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSR 219
           +    + +  ++                    KFP +              P    +V  
Sbjct: 230 QMERVRTLTDVR------------------NLKFPPLFTQ---------KYPCEYVMVQD 262

Query: 220 LLQYSPNLRSTALEALIHPFFDELRDPN 247
           +L  SP  R  A+  + +  F++L  P 
Sbjct: 263 MLSPSPMERPEAINIIENAVFEDLDFPG 290

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  137 bits (347), Expect = 5e-39
 Identities = 45/275 (16%), Positives = 82/275 (29%), Gaps = 83/275 (30%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
             L  H +VV     +    E D + +    EY    ++   I  +Y++        +K 
Sbjct: 65  AVLGQHSHVVRYFSAWA---EDDHMLI--QNEYCNGGSLADAISENYRIMSYFKEAELKD 119

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPH------------------THQLKLCDF 101
              Q+ R L YIH+   + H DIKP N+ ++                        K+ D 
Sbjct: 120 LLLQVGRGLRYIHSM-SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDL 178

Query: 102 GSAKVL-----VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPL 156
           G    +      +G+          + A E++     +    DI++    +      +PL
Sbjct: 179 GHVTRISSPQVEEGDS--------RFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230

Query: 157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPP----- 211
                                                       WH+I Q R+P      
Sbjct: 231 PRN--------------------------------------GDQWHEIRQGRLPRIPQVL 252

Query: 212 --EAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 244
             E  +L+  ++   P  R +A+  + H       
Sbjct: 253 SQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 287

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  138 bits (350), Expect = 5e-39
 Identities = 62/271 (22%), Positives = 109/271 (40%), Gaps = 37/271 (13%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVI-KHHYKMSQRMPLIYV 57
            +    P++V +    +      +  L +++E +   E   R+  +     ++R      
Sbjct: 76  WQASGGPHIVCILD-VYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTERE----A 130

Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNIS 115
                 I  A+ ++H+   + HRD+KP+NLL  +      LKL DFG AK   +    + 
Sbjct: 131 AEIMRDIGTAIQFLHS-HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQ 187

Query: 116 YIC-SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 174
             C + YY APE + G  +Y  + D+WS G ++  LL G P F   +G      + +   
Sbjct: 188 TPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR--- 243

Query: 175 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 234
                 I+       ++ FP      W ++       +A  L+  LL+  P  R T  + 
Sbjct: 244 -----RIRLG-----QYGFP---NPEWSEV-----SEDAKQLIRLLLKTDPTERLTITQF 285

Query: 235 LIHPFF-DELRDPNTRLPNGRFLPPLFNFKP 264
           + HP+    +  P T L   R L    +   
Sbjct: 286 MNHPWINQSMVVPQTPLHTARVLQEDKDHWD 316

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  139 bits (351), Expect = 9e-39
 Identities = 49/263 (18%), Positives = 92/263 (34%), Gaps = 27/263 (10%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVK 58
           ++ L+H N+V L      TT      L  ++E+ P       + +     +  +P     
Sbjct: 61  LKKLNHKNIVKLFAIEEETT-TRHKVL--IMEFCPCGSLYTVLEEP--SNAYGLPESEFL 115

Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNIS 115
           +    +   + ++    G+ HR+IKP N++           KL DFG+A+ L   E  +S
Sbjct: 116 IVLRDVVGGMNHLRE-NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS 174

Query: 116 YICSRYYRAPELIFGAT-------EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE 168
              +  Y  P++   A        +Y A +D+WS G        G   F    G  +  E
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE 234

Query: 169 IIK--VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPN 226
           ++   + G P+               +      P      + +      +++ +L+    
Sbjct: 235 VMYKIITGKPSGAISGVQKAENGPIDWSG--DMPVSCSLSRGLQVLLTPVLANILEADQE 292

Query: 227 LRSTALEALIHPFFDELRDPNTR 249
                 +     FF E  D   R
Sbjct: 293 KCWGFDQ-----FFAETSDILHR 310

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  140 bits (354), Expect = 9e-39
 Identities = 68/268 (25%), Positives = 109/268 (40%), Gaps = 44/268 (16%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH-HYKMSQRMPLIYV 57
            RLL HPN+V L          +E +  L+ + V   E    ++   +Y  S+       
Sbjct: 64  CRLLKHPNIVRLHDSI-----SEEGHHYLIFDLVTGGELFEDIVAREYY--SEAD----A 112

Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNIS 115
                QI  A+ + H  +GV HR++KP+NLL  +      +KL DFG A  +   +    
Sbjct: 113 SHCIQQILEAVLHCHQ-MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF 171

Query: 116 YIC-SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 174
               +  Y +PE +     Y   +D+W+ G +L  LL+G P F  E       +I     
Sbjct: 172 GFAGTPGYLSPE-VLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKA--- 227

Query: 175 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 234
                           + FP   +  W  +      PEA DL++++L  +P+ R TA EA
Sbjct: 228 --------------GAYDFP---SPEWDTV-----TPEAKDLINKMLTINPSKRITAAEA 265

Query: 235 LIHPFFDELRDPNTRLPNGRFLPPLFNF 262
           L HP+        + +     +  L  F
Sbjct: 266 LKHPWISHRSTVASCMHRQETVDCLKKF 293

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  136 bits (346), Expect = 1e-38
 Identities = 66/256 (25%), Positives = 111/256 (43%), Gaps = 46/256 (17%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVI-KHHYKMSQRMPLIYV 57
           ++ + H N+V+L+  +         YL  V++ V   E   R++ +  Y  +++      
Sbjct: 60  LKKIKHENIVTLEDIY---ESTTHYYL--VMQLVSGGELFDRILERGVY--TEKDA---- 108

Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLV-NPHTH-QLKLCDFGSAKVLVKGEPNIS 115
            L   Q+  A+ Y+H   G+ HRD+KP+NLL   P  + ++ + DFG +K+   G   +S
Sbjct: 109 SLVIQQVLSAVKYLHE-NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MS 165

Query: 116 YIC-SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 174
             C +  Y APE +     Y+ A+D WS G +   LL G P F  E+      +I +   
Sbjct: 166 TACGTPGYVAPE-VLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEG-- 222

Query: 175 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 234
                           ++F    +  W  I        A D +  LL+  PN R T  +A
Sbjct: 223 ---------------YYEFE---SPFWDDI-----SESAKDFICHLLEKDPNERYTCEKA 259

Query: 235 LIHPFFDELRDPNTRL 250
           L HP+ D     +  +
Sbjct: 260 LSHPWIDGNTALHRDI 275

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  136 bits (344), Expect = 1e-38
 Identities = 64/246 (26%), Positives = 101/246 (41%), Gaps = 45/246 (18%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVI-KHHYKMSQRMPLIYV 57
            R L HPN+V L         ++E +  LV + V   E    ++ +  Y  S+       
Sbjct: 59  CRKLQHPNIVRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFY--SEAD----A 107

Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLV--NPHTHQLKLCDFGSAKVLVKGEPNIS 115
                QI  ++AY H+  G+ HR++KP+NLL+        +KL DFG A  +   E    
Sbjct: 108 SHCIQQILESIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-WH 165

Query: 116 YIC-SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 174
               +  Y +PE +     Y+  +DIW+ G +L  LL+G P F  E       +I     
Sbjct: 166 GFAGTPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG-- 222

Query: 175 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 234
                           + +P   +  W  +      PEA  L+  +L  +P  R TA +A
Sbjct: 223 ---------------AYDYP---SPEWDTV-----TPEAKSLIDSMLTVNPKKRITADQA 259

Query: 235 LIHPFF 240
           L  P+ 
Sbjct: 260 LKVPWI 265

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  139 bits (351), Expect = 1e-38
 Identities = 67/274 (24%), Positives = 108/274 (39%), Gaps = 35/274 (12%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVI-KHHYKMSQRMPLIYV 57
            R    P++V +    +         L +V+E +   E   R+  +     ++R      
Sbjct: 109 WRASQCPHIVRI-VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER----EA 163

Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNIS 115
                 I  A+ Y+H+ I + HRD+KP+NLL         LKL DFG AK         +
Sbjct: 164 SEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT 222

Query: 116 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
              + YY APE + G  +Y  + D+WS G ++  LL G P F    G+     +      
Sbjct: 223 PCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK----- 276

Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 235
                I+       +++FP      W ++       E   L+  LL+  P  R T  E +
Sbjct: 277 ---TRIR-----MGQYEFP---NPEWSEV-----SEEVKMLIRNLLKTEPTQRMTITEFM 320

Query: 236 IHPFFDELRD-PNTRLPNGRFLPPLFNFKPHELK 268
            HP+  +    P T L   R L      +  ++K
Sbjct: 321 NHPWIMQSTKVPQTPLHTSRVL-KEDKERWEDVK 353

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  135 bits (343), Expect = 2e-38
 Identities = 49/252 (19%), Positives = 87/252 (34%), Gaps = 50/252 (19%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDEL-----------YLNLVLEYVPE-TVHRVIKHHYKM 48
           +  LDH N+V    C+       E             L + +E+  + T+ + I+   + 
Sbjct: 58  LAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE--KRR 115

Query: 49  SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 108
            +++  +     F QI + + YIH+   + +RD+KP N+ +   T Q+K+ DFG    L 
Sbjct: 116 GEKLDKVLALELFEQITKGVDYIHSK-KLINRDLKPSNIFLV-DTKQVKIGDFGLVTSLK 173

Query: 109 KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE 168
                     +  Y +PE I    +Y   +D+++ G +LAELL                +
Sbjct: 174 NDGKRTRSKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELL--HVCDTAFETSKFFTD 230

Query: 169 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR 228
           +                                  I       +   L+ +LL   P  R
Sbjct: 231 LRD-------------------------------GIISDIFDKKEKTLLQKLLSKKPEDR 259

Query: 229 STALEALIHPFF 240
               E L     
Sbjct: 260 PNTSEILRTLTV 271

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  136 bits (344), Expect = 2e-38
 Identities = 63/258 (24%), Positives = 105/258 (40%), Gaps = 48/258 (18%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH-HYKMSQRMPLIYV 57
            ++  HPN++ LK  +     +   +  LV + +   E    + +      S++      
Sbjct: 78  RKVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTL--SEK----ET 126

Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           +     +   +  +H  + + HRD+KP+N+L++   + +KL DFG +  L  GE  +  +
Sbjct: 127 RKIMRALLEVICALHK-LNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEK-LREV 183

Query: 118 C-SRYYRAPELIFGATE-----YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 171
           C +  Y APE+I  +       Y   +D+WS G ++  LL G P F     +  L  I+ 
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 243

Query: 172 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 231
                              ++F    +  W             DLVSR L   P  R TA
Sbjct: 244 G-----------------NYQFG---SPEWDDY-----SDTVKDLVSRFLVVQPQKRYTA 278

Query: 232 LEALIHPFFDELRDPNTR 249
            EAL HPFF +      R
Sbjct: 279 EEALAHPFFQQYVVEEVR 296

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  137 bits (346), Expect = 2e-38
 Identities = 64/248 (25%), Positives = 106/248 (42%), Gaps = 44/248 (17%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH-HYKMSQRMPLIYV 57
           +R   HPN+++LK  +      D  Y+ +V E +   E + ++++   +  S+R      
Sbjct: 70  LRYGQHPNIITLKDVY-----DDGKYVYVVTELMKGGELLDKILRQKFF--SERE----A 118

Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNI 114
               + I + + Y+H   GV HRD+KP N+L    + +   +++CDFG AK L      +
Sbjct: 119 SAVLFTITKTVEYLHA-QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL 177

Query: 115 SYIC-SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL 173
              C +  + APE +     Y AA DIWS G +L  +L G   F           + ++ 
Sbjct: 178 MTPCYTANFVAPE-VLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIG 236

Query: 174 -GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAL 232
            G               +F         W+ +        A DLVS++L   P+ R TA 
Sbjct: 237 SG---------------KFSLS---GGYWNSV-----SDTAKDLVSKMLHVDPHQRLTAA 273

Query: 233 EALIHPFF 240
             L HP+ 
Sbjct: 274 LVLRHPWI 281

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  136 bits (344), Expect = 4e-38
 Identities = 47/246 (19%), Positives = 86/246 (34%), Gaps = 44/246 (17%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
              L  P +V L         ++  ++N+ +E +   ++ ++IK    + +         
Sbjct: 104 CAGLSSPRIVPLYGA-----VREGPWVNIFMELLEGGSLGQLIKQMGCLPED----RALY 154

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           Y  Q    L Y+H    + H D+K  N+L++    +  LCDFG A  L       S +  
Sbjct: 155 YLGQALEGLEYLHTR-RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTG 213

Query: 120 R------YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL 173
                   + APE++ G     A +DIWS+ C++  +L G   +         ++I    
Sbjct: 214 DYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS-E 271

Query: 174 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
             P                  +I              P     +   L+  P  R++A+E
Sbjct: 272 PPPI----------------REIPPS---------CAPLTAQAIQEGLRKEPVHRASAME 306

Query: 234 ALIHPF 239
                 
Sbjct: 307 LRRKVG 312

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  135 bits (341), Expect = 1e-37
 Identities = 65/264 (24%), Positives = 115/264 (43%), Gaps = 39/264 (14%)

Query: 1   MRLLD-HPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVI-KHHYKMSQRMPLIY 56
           ++L + HPN+V L   F      D+L+  LV+E +   E   R+  K H+  S+      
Sbjct: 59  LKLCEGHPNIVKLHEVF-----HDQLHTFLVMELLNGGELFERIKKKKHF--SETE---- 107

Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNI 114
                 ++  A++++H+ +GV HRD+KP+NLL  + + + ++K+ DFG A++       +
Sbjct: 108 ASYIMRKLVSAVSHMHD-VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL 166

Query: 115 SYIC-SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL 173
              C + +Y APE +     Y  + D+WS G +L  +L GQ  F            ++++
Sbjct: 167 KTPCFTLHYAAPE-LLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM 225

Query: 174 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
                ++IK       +F F       W  +       EA DL+  LL   PN R     
Sbjct: 226 -----KKIKKG-----DFSFE---GEAWKNV-----SQEAKDLIQGLLTVDPNKRLKMSG 267

Query: 234 ALIHPFFDELRD-PNTRLPNGRFL 256
              + +  +     +  L     L
Sbjct: 268 LRYNEWLQDGSQLSSNPLMTPDIL 291

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  133 bits (338), Expect = 1e-37
 Identities = 65/249 (26%), Positives = 99/249 (39%), Gaps = 59/249 (23%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVK 58
              L HPN++ + + F     +  +YL  +LE+ P  E    + KH      R       
Sbjct: 68  QSHLRHPNILRMYNYFHD---RKRIYL--MLEFAPRGELYKELQKH-----GRFDEQRSA 117

Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-------GE 111
            +  ++  AL Y H    V HRDIKP+NLL+      LK+ DFG +            G 
Sbjct: 118 TFMEELADALHYCHER-KVIHRDIKPENLLMGYKGE-LKIADFGWSVHAPSLRRRTMCGT 175

Query: 112 PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 171
            +        Y  PE+I G   +   +D+W AG +  E L+G P F   S  +    I+ 
Sbjct: 176 LD--------YLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVN 226

Query: 172 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 231
           V                 + KFP     P+       +   + DL+S+LL+Y P  R   
Sbjct: 227 V-----------------DLKFP-----PF-------LSDGSKDLISKLLRYHPPQRLPL 257

Query: 232 LEALIHPFF 240
              + HP+ 
Sbjct: 258 KGVMEHPWV 266

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  135 bits (342), Expect = 1e-37
 Identities = 39/257 (15%), Positives = 83/257 (32%), Gaps = 52/257 (20%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++      ++ ++            +L   ++   +T   V+  H    + +        
Sbjct: 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQL 211

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
             Q+ R LA +H+  G+ H  ++P +++++     + L  F      V+    +    SR
Sbjct: 212 TLQVIRLLASLHHY-GLVHTYLRPVDIVLDQRGG-VFLTGFEHL---VRDGARVVSSVSR 266

Query: 121 YYRAPELI----------FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 170
            +  PEL              T  T + D W+ G V+  +         ++ +       
Sbjct: 267 GFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALG------ 320

Query: 171 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQ--KRMPPEAVDLVSRLLQYSPNLR 228
                                            IF+  K +P     L+   L+Y    R
Sbjct: 321 -----------------------------GSEWIFRSCKNIPQPVRALLEGFLRYPKEDR 351

Query: 229 STALEALIHPFFDELRD 245
              L+A+  P +++LR 
Sbjct: 352 LLPLQAMETPEYEQLRT 368

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  134 bits (340), Expect = 2e-37
 Identities = 73/244 (29%), Positives = 107/244 (43%), Gaps = 44/244 (18%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH-HYKMSQRMPLIYV 57
           +  L HPN++ LK  F     +    ++LVLE V   E   R+++  +Y  S+R      
Sbjct: 102 LLRLSHPNIIKLKEIF-----ETPTEISLVLELVTGGELFDRIVEKGYY--SERD----A 150

Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNIS 115
                QI  A+AY+H   G+ HRD+KP+NLL   P     LK+ DFG +K++      + 
Sbjct: 151 ADAVKQILEAVAYLHE-NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL-MK 208

Query: 116 YIC-SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 174
            +C +  Y APE I     Y   +D+WS G +   LL G   F  E G   +   I    
Sbjct: 209 TVCGTPGYCAPE-ILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRIL--- 264

Query: 175 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 234
                   C      E+ F    +  W ++        A DLV +L+   P  R T  +A
Sbjct: 265 -------NC------EYYFI---SPWWDEV-----SLNAKDLVRKLIVLDPKKRLTTFQA 303

Query: 235 LIHP 238
           L HP
Sbjct: 304 LQHP 307

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  134 bits (340), Expect = 2e-37
 Identities = 60/249 (24%), Positives = 112/249 (44%), Gaps = 48/249 (19%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH-HYKMSQRMPLIYV 57
            ++  HP++++L   +     +   ++ LV + +   E    + +      S++      
Sbjct: 154 RQVAGHPHIITLIDSY-----ESSSFMFLVFDLMRKGELFDYLTEKVAL--SEK----ET 202

Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           +     +  A++++H    + HRD+KP+N+L++ +  Q++L DFG +  L  GE  +  +
Sbjct: 203 RSIMRSLLEAVSFLHA-NNIVHRDLKPENILLDDNM-QIRLSDFGFSCHLEPGEK-LREL 259

Query: 118 C-SRYYRAPELIFGATE-----YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 171
           C +  Y APE++  + +     Y   +D+W+ G +L  LL G P F     +  L  I++
Sbjct: 260 CGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIME 319

Query: 172 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 231
                             +++F    +  W             DL+SRLLQ  P  R TA
Sbjct: 320 G-----------------QYQFS---SPEWDDR-----SSTVKDLISRLLQVDPEARLTA 354

Query: 232 LEALIHPFF 240
            +AL HPFF
Sbjct: 355 EQALQHPFF 363

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  138 bits (349), Expect = 4e-37
 Identities = 58/272 (21%), Positives = 100/272 (36%), Gaps = 14/272 (5%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLN-LVLEYVP--ETVHRVIKHHYKMSQRMPLIYV 57
           M+ L+HPNVVS +       +     L  L +EY    +    + +        +    +
Sbjct: 66  MKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFEN--CCGLKEGPI 123

Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNIS 115
           +     I  AL Y+H    + HRD+KP+N+++ P   +   K+ D G AK L +GE    
Sbjct: 124 RTLLSDISSALRYLHE-NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE 182

Query: 116 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
           ++ +  Y APEL+    +YT  +D WS G +  E + G   F       Q    ++    
Sbjct: 183 FVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR---E 238

Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 235
            + E I   +      KF  +   P H         +    +  +L +    R T  +  
Sbjct: 239 KSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAG--KLERWLQCMLMWHQRQRGTDPQNP 296

Query: 236 IHPFFDELRDPNTRLPNGRFLPPLFNFKPHEL 267
               F  L    +                + +
Sbjct: 297 NVGCFQALDSILSLKLLSVMNMVSGRVHTYPV 328

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  132 bits (334), Expect = 1e-36
 Identities = 57/258 (22%), Positives = 95/258 (36%), Gaps = 44/258 (17%)

Query: 1   MRLLDH-PNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVI-KHHYKMSQRMPLIY 56
           + L    P V++L   +     ++   + L+LEY    E     + +    +S+      
Sbjct: 82  LELAKSCPRVINLHEVY-----ENTSEIILILEYAAGGEIFSLCLPELAEMVSEND---- 132

Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQN-LLVNPH-THQLKLCDFGSAKVLVKGEPNI 114
           V     QI   + Y+H    + H D+KPQN LL + +    +K+ DFG ++ +      +
Sbjct: 133 VIRLIKQILEGVYYLHQ-NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE-L 190

Query: 115 SYIC-SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL 173
             I  +  Y APE I      T A D+W+ G +   LL     F GE   +  + I +V 
Sbjct: 191 REIMGTPEYLAPE-ILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV- 248

Query: 174 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
                              +       +  +        A D +  LL  +P  R TA  
Sbjct: 249 ----------------NVDYS---EETFSSV-----SQLATDFIQSLLVKNPEKRPTAEI 284

Query: 234 ALIHPFFDELRDPNTRLP 251
            L H +  +    N   P
Sbjct: 285 CLSHSWLQQWDFENLFHP 302

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  132 bits (334), Expect = 4e-36
 Identities = 41/286 (14%), Positives = 86/286 (30%), Gaps = 52/286 (18%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++      ++ ++            +L   ++   +T   V+  H    + +        
Sbjct: 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQL 216

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
             Q+ R LA +H+  G+ H  ++P +++++     + L  F        G   +S I   
Sbjct: 217 TLQVIRLLASLHH-YGLVHTYLRPVDIVLDQRGG-VFLTGFEHLVRD--GASAVSPIGRG 272

Query: 121 Y----YRAPELIFGA----TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 172
           +      A  ++       T  T A D W+ G  +  +         ++ +         
Sbjct: 273 FAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGS------ 326

Query: 173 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQ--KRMPPEAVDLVSRLLQYSPNLRST 230
                                          IF+  K +P     L+   L+Y    R  
Sbjct: 327 -----------------------------EWIFRSCKNIPQPVRALLEGFLRYPKEDRLL 357

Query: 231 ALEALIHPFFDELRD---PNTRLPNGRFLPPLFNFKPHELKGVPVD 273
            L+A+  P +++LR        L      P      P      P +
Sbjct: 358 PLQAMETPEYEQLRTELSAALPLYQTDGEPTREGGAPPSGTSQPDE 403

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  130 bits (329), Expect = 7e-36
 Identities = 63/291 (21%), Positives = 101/291 (34%), Gaps = 55/291 (18%)

Query: 2   RLLDHPNVVSLKHCFFSTTE----KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           +L  HPN+V          E        +L L+ E     +   +K   +    +    V
Sbjct: 81  KLSGHPNIVQFCSAASIGKEESDTGQAEFL-LLTELCKGQLVEFLKKM-ESRGPLSCDTV 138

Query: 58  KLYFYQICRALAYIHN-TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG------ 110
              FYQ CRA+ ++H     + HRD+K +NLL++     +KLCDFGSA  +         
Sbjct: 139 LKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQ-GTIKLCDFGSATTISHYPDYSWS 197

Query: 111 -------EPNISYICSRYYRAPELI--FGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 161
                  E  I+   +  YR PE+I  +         DIW+ GC+L  L   Q  F   +
Sbjct: 198 AQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 257

Query: 162 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLL 221
                             +++ +N  Y+                          L+  +L
Sbjct: 258 ------------------KLRIVNGKYSIPPHD-------------TQYTVFHSLIRAML 286

Query: 222 QYSPNLRSTALEALIHPF-FDELRDPNTRLPNGRFLPPLFNFKPHELKGVP 271
           Q +P  R +  E +         R+ N + P    L     +    L   P
Sbjct: 287 QVNPEERLSIAEVVHQLQEIAAARNVNPKSPITELLEQNGGYGSATLSRGP 337

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  129 bits (327), Expect = 9e-36
 Identities = 71/275 (25%), Positives = 110/275 (40%), Gaps = 46/275 (16%)

Query: 2   RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKH-HYKMSQRMPLIYVK 58
           +   H NV+ L   F     ++E    LV E +     +  + K  H+  ++        
Sbjct: 66  QCQGHRNVLELIEFF-----EEEDRFYLVFEKMRGGSILSHIHKRRHF--NEL----EAS 114

Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLL-VNP-HTHQLKLCDFGSAKVLVKGE----- 111
           +    +  AL ++HN  G+ HRD+KP+N+L  +P     +K+CDF     +         
Sbjct: 115 VVVQDVASALDFLHN-KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPI 173

Query: 112 --PNISYIC-SRYYRAPELI----FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD 164
             P +   C S  Y APE++      A+ Y    D+WS G +L  LL G P F G  G D
Sbjct: 174 STPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSD 233

Query: 165 QLVEIIKVLGTPTR---EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLL 221
              +  +          E I+       +++FP      W  I        A DL+S+LL
Sbjct: 234 CGWDRGEACPACQNMLFESIQEG-----KYEFP---DKDWAHI-----SCAAKDLISKLL 280

Query: 222 QYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFL 256
                 R +A + L HP+      P   LP    L
Sbjct: 281 VRDAKQRLSAAQVLQHPWVQG-CAPENTLPTPMVL 314

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  128 bits (323), Expect = 2e-35
 Identities = 62/245 (25%), Positives = 98/245 (40%), Gaps = 43/245 (17%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVK 58
           ++ LDHPNVV L         +D LY+  V E V     V  V        + +     +
Sbjct: 90  LKKLDHPNVVKL-VEVLDDPNEDHLYM--VFELVNQGP-VMEVPTL-----KPLSEDQAR 140

Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 118
            YF  + + + Y+H    + HRDIKP NLLV      +K+ DFG +      +  +S   
Sbjct: 141 FYFQDLIKGIEYLHYQ-KIIHRDIKPSNLLVG-EDGHIKIADFGVSNEFKGSDALLSNTV 198

Query: 119 -SRYYRAPELIFGAT-EYT-AAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
            +  + APE +      ++  A+D+W+ G  L   + GQ  F  E  +  L   IK    
Sbjct: 199 GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER-IMCLHSKIK---- 253

Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 235
                           +FP     P        +  +  DL++R+L  +P  R    E  
Sbjct: 254 ------------SQALEFPD---QPD-------IAEDLKDLITRMLDKNPESRIVVPEIK 291

Query: 236 IHPFF 240
           +HP+ 
Sbjct: 292 LHPWV 296

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  127 bits (320), Expect = 2e-34
 Identities = 57/266 (21%), Positives = 105/266 (39%), Gaps = 28/266 (10%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKL 59
           +   + P +V     F+S  E     +++ +E++   ++ +V     K + R+P   +  
Sbjct: 85  LHECNSPYIVGFYGAFYSDGE-----ISICMEHMDGGSLDQV----LKKAGRIPEQILGK 135

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
               + + L Y+     + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +
Sbjct: 136 VSIAVIKGLTYLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMAN-SFVGT 193

Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
           R Y +PE + G   Y+   DIWS G  L E+ +G+   P     +  +     +     E
Sbjct: 194 RSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 252

Query: 180 EIKCMNPNYTEFKFPQIKAHPWHKIFQ---------------KRMPPEAVDLVSRLLQYS 224
                           + + P   IF+                    E  D V++ L  +
Sbjct: 253 TPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKN 312

Query: 225 PNLRSTALEALIHPFFDELRDPNTRL 250
           P  R+   + ++H F           
Sbjct: 313 PAERADLKQLMVHAFIKRSDAEEVDF 338

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  122 bits (309), Expect = 2e-33
 Identities = 64/267 (23%), Positives = 103/267 (38%), Gaps = 54/267 (20%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP----ETVHRVIKHHYKMSQRMPLIY 56
           +R L H NV+ L    ++  ++  +Y+  V+EY      E +  V +       R P+  
Sbjct: 60  LRRLRHKNVIQLVDVLYNEEKQK-MYM--VMEYCVCGMQEMLDSVPEK------RFPVCQ 110

Query: 57  VKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN--I 114
              YF Q+   L Y+H+  G+ H+DIKP NLL+      LK+   G A+ L     +   
Sbjct: 111 AHGYFCQLIDGLEYLHS-QGIVHKDIKPGNLLLTTG-GTLKISALGVAEALHPFAADDTC 168

Query: 115 SYIC-SRYYRAPELIFGATEYT-AAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 172
                S  ++ PE+  G   ++   +DIWSAG  L  +  G   F G++        I  
Sbjct: 169 RTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN--------IYK 220

Query: 173 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAL 232
           L     E I         +  P                P   DL+  +L+Y P  R +  
Sbjct: 221 L----FENIG-----KGSYAIP-----GD-------CGPPLSDLLKGMLEYEPAKRFSIR 259

Query: 233 EALIHPFFDELRDPNTRLPNGRFLPPL 259
           +   H +F        + P      P+
Sbjct: 260 QIRQHSWF------RKKHPPAEAPVPI 280

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  122 bits (307), Expect = 5e-33
 Identities = 61/274 (22%), Positives = 101/274 (36%), Gaps = 56/274 (20%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVI-KHHYKMSQRMPLIYV 57
            R    P++V +    +         L +V+E +   E   R+  +     ++R      
Sbjct: 65  WRASQCPHIVRIVD-VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE----A 119

Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLL-VNPHTH-QLKLCDFGSAKVLVKGEPNIS 115
                 I  A+ Y+H+ I + HRD+KP+NLL  +   +  LKL DFG AK     +    
Sbjct: 120 SEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEK---- 174

Query: 116 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
                             Y  + D+WS G ++  LL G P F    G+     +      
Sbjct: 175 ------------------YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK----- 211

Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 235
                I+       +++FP      W ++       E   L+  LL+  P  R T  E +
Sbjct: 212 ---TRIR-----MGQYEFP---NPEWSEV-----SEEVKMLIRNLLKTEPTQRMTITEFM 255

Query: 236 IHPFFDELRD-PNTRLPNGRFLPPLFNFKPHELK 268
            HP+  +    P T L   R L      +  ++K
Sbjct: 256 NHPWIMQSTKVPQTPLHTSRVL-KEDKERWEDVK 288

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  121 bits (307), Expect = 5e-33
 Identities = 62/253 (24%), Positives = 101/253 (39%), Gaps = 35/253 (13%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           MR +D P  V+     F   +     + + +E +  ++ +  K      Q +P   +   
Sbjct: 60  MRTVDCPFTVTFYGALFREGD-----VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKI 114

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
              I +AL ++H+ + V HRD+KP N+L+N    Q+K+CDFG +  LV           +
Sbjct: 115 AVSIVKALEHLHSKLSVIHRDVKPSNVLIN-ALGQVKMCDFGISGYLVDDVAKDIDAGCK 173

Query: 121 YYRAPELIFG---ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            Y APE I        Y+   DIWS G  + EL + +  +       Q ++ + V     
Sbjct: 174 PYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV-VEEPS- 231

Query: 178 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 237
                           PQ+ A  +          E VD  S+ L+ +   R T  E + H
Sbjct: 232 ----------------PQLPADKF--------SAEFVDFTSQCLKKNSKERPTYPELMQH 267

Query: 238 PFFDELRDPNTRL 250
           PFF       T +
Sbjct: 268 PFFTLHESKGTDV 280

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  120 bits (303), Expect = 5e-32
 Identities = 61/244 (25%), Positives = 98/244 (40%), Gaps = 39/244 (15%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVK 58
            R L HPN+V  K    +      L +  ++EY    E   R+         R      +
Sbjct: 70  HRSLRHPNIVRFKEVILT---PTHLAI--IMEYASGGELYERICNA-----GRFSEDEAR 119

Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH-QLKLCDFGSAKVLVKGEPNISYI 117
            +F Q+   ++Y H+ + +CHRD+K +N L++     +LK+CDFG +K  V      S +
Sbjct: 120 FFFQQLLSGVSYCHS-MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 178

Query: 118 CSRYYRAPELIFGATEYT-AAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
            +  Y APE++    EY     D+WS G  L  +L+G   F                   
Sbjct: 179 GTPAYIAPEVLLR-QEYDGKIADVWSCGVTLYVMLVGAYPFEDPE--------EPRDYRK 229

Query: 177 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 236
           T + I  +     ++  P             R+ PE   L+SR+    P  R +  E   
Sbjct: 230 TIQRILSV-----KYSIPD----------DIRISPECCHLISRIFVADPATRISIPEIKT 274

Query: 237 HPFF 240
           H +F
Sbjct: 275 HSWF 278

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  118 bits (296), Expect = 3e-31
 Identities = 51/257 (19%), Positives = 97/257 (37%), Gaps = 50/257 (19%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKL 59
           +R +D  +  +       ++ K  LY+   ++    E +   +       +         
Sbjct: 112 IRRMDPFSTKNTVGQLQPSSPKVYLYI--QMQLCRKENLKDWMNRR-CSLEDREHGVCLH 168

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL------------ 107
            F QI  A+ ++H+  G+ HRD+KP N+        +K+ DFG    +            
Sbjct: 169 IFIQIAEAVEFLHS-KGLMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTP 226

Query: 108 -VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQL 166
                 +   + ++ Y +PE I G   Y+  +DI+S G +L ELL     F  +    ++
Sbjct: 227 MPAYATHTGQVGTKLYMSPEQIHG-NNYSHKVDIFSLGLILFELLYS---FSTQMERVRI 282

Query: 167 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPN 226
           +  ++                    KFP         +F ++ P E   +V  +L  SP 
Sbjct: 283 ITDVR------------------NLKFP--------LLFTQKYPQEH-MMVQDMLSPSPT 315

Query: 227 LRSTALEALIHPFFDEL 243
            R  A + + +  F+ L
Sbjct: 316 ERPEATDIIENAIFENL 332

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  116 bits (293), Expect = 3e-31
 Identities = 63/246 (25%), Positives = 104/246 (42%), Gaps = 45/246 (18%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVK 58
            ++L+H NVV          E +  YL   LEY    E   R+          MP    +
Sbjct: 59  NKMLNHENVVKFYGHR---REGNIQYL--FLEYCSGGELFDRIEPD-----IGMPEPDAQ 108

Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN--ISY 116
            +F+Q+   + Y+H  IG+ HRDIKP+NLL++     LK+ DFG A V         ++ 
Sbjct: 109 RFFHQLMAGVVYLHG-IGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNK 166

Query: 117 IC-SRYYRAPELIFGATEYTAA-IDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 174
           +C +  Y APEL+    E+ A  +D+WS G VL  +L G+  +      DQ  +  +   
Sbjct: 167 MCGTLPYVAPELLKR-REFHAEPVDVWSCGIVLTAMLAGELPW------DQPSDSCQEYS 219

Query: 175 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 234
               ++                   PW K     +    + L+ ++L  +P+ R T  + 
Sbjct: 220 DWKEKKTYLN---------------PWKK-----IDSAPLALLHKILVENPSARITIPDI 259

Query: 235 LIHPFF 240
               ++
Sbjct: 260 KKDRWY 265

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  117 bits (295), Expect = 4e-31
 Identities = 63/260 (24%), Positives = 100/260 (38%), Gaps = 65/260 (25%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVK 58
           M  LDHP  V L   F     +D+  L   L Y    E     +  + +          +
Sbjct: 84  MSRLDHPFFVKLYFTF-----QDDEKLYFGLSYAKNGE-----LLKYIRKIGSFDETCTR 133

Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS--- 115
            Y  +I  AL Y+H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL           
Sbjct: 134 FYTAEIVSALEYLHG-KGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANS 191

Query: 116 ------YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEI 169
                 Y+      +PEL+        + D+W+ GC++ +L+ G P F   +    + + 
Sbjct: 192 FVGTAQYV------SPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGN-EYLIFQK 243

Query: 170 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSP---- 225
           I                   E+ FP            ++  P+A DLV +LL        
Sbjct: 244 II----------------KLEYDFP------------EKFFPKARDLVEKLLVLDATKRL 275

Query: 226 --NLRSTALEALIHPFFDEL 243
                        HPFF+ +
Sbjct: 276 GCEEMEGYGPLKAHPFFESV 295

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  116 bits (293), Expect = 7e-31
 Identities = 63/246 (25%), Positives = 104/246 (42%), Gaps = 45/246 (18%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVK 58
            ++L+H NVV          E +  YL   LEY    E   R+          MP    +
Sbjct: 59  NKMLNHENVVKFYGHR---REGNIQYL--FLEYCSGGELFDRIEPD-----IGMPEPDAQ 108

Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN--ISY 116
            +F+Q+   + Y+H  IG+ HRDIKP+NLL++     LK+ DFG A V         ++ 
Sbjct: 109 RFFHQLMAGVVYLHG-IGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNK 166

Query: 117 IC-SRYYRAPELIFGATEYTAA-IDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 174
           +C +  Y APEL+    E+ A  +D+WS G VL  +L G+  +      DQ  +  +   
Sbjct: 167 MCGTLPYVAPELLKR-REFHAEPVDVWSCGIVLTAMLAGELPW------DQPSDSCQEYS 219

Query: 175 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 234
               ++                   PW K     +    + L+ ++L  +P+ R T  + 
Sbjct: 220 DWKEKKTYLN---------------PWKK-----IDSAPLALLHKILVENPSARITIPDI 259

Query: 235 LIHPFF 240
               ++
Sbjct: 260 KKDRWY 265

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  118 bits (297), Expect = 1e-30
 Identities = 70/270 (25%), Positives = 112/270 (41%), Gaps = 56/270 (20%)

Query: 5   DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFY 62
            HP + +LK+ F +    D L    V+EY    E     +  H    +       + Y  
Sbjct: 206 RHPFLTALKYSFQT---HDRLCF--VMEYANGGE-----LFFHLSRERVFSEDRARFYGA 255

Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRY 121
           +I  AL Y+H+   V +RD+K +NL+++   H +K+ DFG  K  +K    +   C +  
Sbjct: 256 EIVSALDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPE 314

Query: 122 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 181
           Y APE++    +Y  A+D W  G V+ E++ G+  F  +   ++L E+I           
Sbjct: 315 YLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HEKLFELIL---------- 362

Query: 182 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALI 236
                   E +FP            + + PEA  L+S LL+  P  R       A E + 
Sbjct: 363 ------MEEIRFP------------RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404

Query: 237 HPFFDELRDPN-TRLPNGRFLPPLFNFKPH 265
           H FF          +   +  PP   FKP 
Sbjct: 405 HRFF---AGIVWQHVYEKKLSPP---FKPQ 428

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  116 bits (293), Expect = 3e-30
 Identities = 71/289 (24%), Positives = 104/289 (35%), Gaps = 78/289 (26%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVK 58
           +   D   +  L   F     +DE YL LV+EY    + +        K  +R+P    +
Sbjct: 115 LVNGDRRWITQLHFAF-----QDENYLYLVMEYYVGGDLLT----LLSKFGERIPAEMAR 165

Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS--- 115
            Y  +I  A+  +H  +G  HRDIKP N+L++   H ++L DFGS   L       S   
Sbjct: 166 FYLAEIVMAIDSVHR-LGYVHRDIKPDNILLDRCGH-IRLADFGSCLKLRADGTVRSLVA 223

Query: 116 -----YICSRYYRAPELI------FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVD 164
                Y+      +PE++       G   Y    D W+ G    E+  GQ  F  +S   
Sbjct: 224 VGTPDYL------SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS-TA 276

Query: 165 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYS 224
           +    I             ++        P            + +P EA D + RLL   
Sbjct: 277 ETYGKI-------------VHYK-EHLSLPL---------VDEGVPEEARDFIQRLLC-P 312

Query: 225 PNLR---STALEALIHPFF-----DELRDPNTRLPNGRFLPPLFNFKPH 265
           P  R     A +   HPFF     D LR           +PP   F P 
Sbjct: 313 PETRLGRGGAGDFRTHPFFFGLDWDGLR---------DSVPP---FTPD 349

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  118 bits (298), Expect = 3e-30
 Identities = 62/289 (21%), Positives = 106/289 (36%), Gaps = 59/289 (20%)

Query: 5   DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFY 62
           D P +V + + F +    D+L    +L+ +   +     + +H           ++ Y  
Sbjct: 250 DCPFIVCMSYAFHT---PDKLSF--ILDLMNGGD-----LHYHLSQHGVFSEADMRFYAA 299

Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 122
           +I   L ++HN   V +RD+KP N+L++ H H +++ D G A    K +P+ + + +  Y
Sbjct: 300 EIILGLEHMHN-RFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPH-ASVGTHGY 356

Query: 123 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 182
            APE++     Y ++ D +S GC+L +LL G   F      D             + EI 
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-------------KHEI- 402

Query: 183 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIH 237
                                       PE   L+  LLQ   N R       A E    
Sbjct: 403 ----------DRMTLTMA--VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450

Query: 238 PFF-----DELRD--------PNTRLPNGRFLPPLFNFKPHELKGVPVD 273
           PFF       +          P     N      + +F   + KG+ + 
Sbjct: 451 PFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDEEDTKGIKLL 499

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  114 bits (287), Expect = 6e-30
 Identities = 64/255 (25%), Positives = 108/255 (42%), Gaps = 47/255 (18%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVK 58
           M++L+HPN+V L       TEK    L L++EY    E    ++ H      RM     +
Sbjct: 68  MKILNHPNIVKLFEVI--ETEKT---LYLIMEYASGGEVFDYLVAH-----GRMKEKEAR 117

Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 118
             F QI  A+ Y H    + HRD+K +NLL++     +K+ DFG +     G   +   C
Sbjct: 118 SKFRQIVSAVQYCHQ-KRIVHRDLKAENLLLD-ADMNIKIADFGFSNEFTVGGK-LDAFC 174

Query: 119 -SRYYRAPELIFGATEYT-AAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
            +  Y APEL  G  +Y    +D+WS G +L  L+ G   F G++ + +L E +      
Sbjct: 175 GAPPYAAPELFQG-KKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-LKELRERVL----- 227

Query: 177 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 236
                        +++ P      +       M  +  +L+ R L  +P  R T  + + 
Sbjct: 228 -----------RGKYRIP-----FY-------MSTDCENLLKRFLVLNPIKRGTLEQIMK 264

Query: 237 HPFFDELRDPNTRLP 251
             + +   + +   P
Sbjct: 265 DRWINAGHEEDELKP 279

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  113 bits (285), Expect = 1e-29
 Identities = 58/266 (21%), Positives = 99/266 (37%), Gaps = 57/266 (21%)

Query: 1   MRLLDH--PNVVSLKHCFFSTTEKDELYLNLVLEYVP---ETVHRVIKHHYKMSQRMPLI 55
           ++ +      V+ L   +F     D   L  +LE      +    + +        +   
Sbjct: 100 LKKVSSGFSGVIRLLD-WFER--PDSFVL--ILERPEPVQDLFDFITER-----GALQEE 149

Query: 56  YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS 115
             + +F+Q+  A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS  +L       +
Sbjct: 150 LARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYT 206

Query: 116 YIC-SRYYRAPELIFGATEYTAA-IDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL 173
               +R Y  PE I     Y      +WS G +L +++ G   F  +       EII+  
Sbjct: 207 DFDGTRVYSPPEWIRY-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR-- 257

Query: 174 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
                           +  F             +R+  E   L+   L   P+ R T  E
Sbjct: 258 ---------------GQVFFR------------QRVSSECQHLIRWCLALRPSDRPTFEE 290

Query: 234 ALIHPFFDELRDPNTRLP-NGRFLPP 258
              HP+  ++  P      +   L P
Sbjct: 291 IQNHPWMQDVLLPQETAEIHLHSLSP 316

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  113 bits (284), Expect = 1e-29
 Identities = 56/255 (21%), Positives = 91/255 (35%), Gaps = 40/255 (15%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++  D P +V     F + T+     + + +E +     ++ K   +M   +P   +   
Sbjct: 78  LKSHDCPYIVQCFGTFITNTD-----VFIAMELMGTCAEKLKK---RMQGPIPERILGKM 129

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
              I +AL Y+    GV HRD+KP N+L++    Q+KLCDFG +  LV  +         
Sbjct: 130 TVAIVKALYYLKEKHGVIHRDVKPSNILLD-ERGQIKLCDFGISGRLVDDKAKDRSAGCA 188

Query: 121 YYRAPELI----FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV-DQLVEIIKVLGT 175
            Y APE I        +Y    D+WS G  L EL  GQ  +       + L ++++    
Sbjct: 189 AYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ--EE 246

Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 235
           P                 P +  H            +    V   L      R    + L
Sbjct: 247 P-----------------PLLPGH-------MGFSGDFQSFVKDCLTKDHRKRPKYNKLL 282

Query: 236 IHPFFDELRDPNTRL 250
            H F          +
Sbjct: 283 EHSFIKRYETLEVDV 297

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score =  115 bits (288), Expect = 1e-29
 Identities = 61/280 (21%), Positives = 102/280 (36%), Gaps = 72/280 (25%)

Query: 29  LVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL 88
           +V E +   + + I       Q +PL  VK    Q+ + L Y+H    + H DIKP+N+L
Sbjct: 122 MVFEVLGHHLLKWIIKSN--YQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENIL 179

Query: 89  V------------------------------------------------NPHTHQLKLCD 100
           +                                                N    ++K+ D
Sbjct: 180 LSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIAD 239

Query: 101 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE 160
            G+A  +   +     I +R YR+ E++ G+  Y    DIWS  C+  EL  G  LF   
Sbjct: 240 LGNACWV--HKHFTEDIQTRQYRSLEVLIGS-GYNTPADIWSTACMAFELATGDYLFEPH 296

Query: 161 SG------VDQLVEIIKVLGTPTREEI-------KCMNPNYTEFKFPQIKAHPWHKIFQK 207
           SG       D +  II++LG   R+ I       +            ++K     ++  +
Sbjct: 297 SGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVE 356

Query: 208 RMP------PEAVDLVSRLLQYSPNLRSTALEALIHPFFD 241
           +            D +  +L+  P  R+TA E L HP+ +
Sbjct: 357 KYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  112 bits (282), Expect = 1e-29
 Identities = 64/243 (26%), Positives = 103/243 (42%), Gaps = 45/243 (18%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVK 58
           ++L  HP+++ L     +     + ++  V+EYV   E    + KH      R+  +  +
Sbjct: 65  LKLFRHPHIIKLYQVIST---PTDFFM--VMEYVSGGELFDYICKH-----GRVEEMEAR 114

Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 118
             F QI  A+ Y H    V HRD+KP+N+L++ H    K+ DFG + ++  GE  +   C
Sbjct: 115 RLFQQILSAVDYCHR-HMVVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGEF-LRTSC 171

Query: 119 -SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            S  Y APE+I G       +DIWS G +L  LL G   F  E         +  L    
Sbjct: 172 GSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH--------VPTL---- 219

Query: 178 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 237
            ++I+        F  P      +       +      L+  +LQ  P  R+T  +   H
Sbjct: 220 FKKIR-----GGVFYIP-----EY-------LNRSVATLLMHMLQVDPLKRATIKDIREH 262

Query: 238 PFF 240
            +F
Sbjct: 263 EWF 265

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  114 bits (286), Expect = 3e-29
 Identities = 71/313 (22%), Positives = 119/313 (38%), Gaps = 62/313 (19%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVK 58
           +   D   + +L + F     +D+  L LV++Y    + +        K   R+P    +
Sbjct: 128 LVNGDSKWITTLHYAF-----QDDNNLYLVMDYYVGGDLLT----LLSKFEDRLPEEMAR 178

Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-I 117
            Y  ++  A+  +H  +   HRDIKP N+L++ + H ++L DFGS   L++     S   
Sbjct: 179 FYLAEMVIAIDSVHQ-LHYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVA 236

Query: 118 CSRY-YRAPELI----FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 172
                Y +PE++     G   Y    D WS G  + E+L G+  F  ES + +    I  
Sbjct: 237 VGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES-LVETYGKI-- 293

Query: 173 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPN-LRSTA 231
                      MN     F+FP              +   A DL+ RL+    + L    
Sbjct: 294 -----------MNHK-ERFQFPT---------QVTDVSENAKDLIRRLICSREHRLGQNG 332

Query: 232 LEAL-IHPFF-----DELRDPNTRLPNGRFLPPL------FNFKPHELKGVPVDMLV-KL 278
           +E    HPFF     D +R  N   P   ++P +       NF   +      + +    
Sbjct: 333 IEDFKKHPFFSGIDWDNIR--NCEAP---YIPEVSSPTDTSNFDVDDDCLKNSETMPPPT 387

Query: 279 IPEHARKQCAFLG 291
               +     F+G
Sbjct: 388 HTAFSGHHLPFVG 400

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  112 bits (283), Expect = 6e-29
 Identities = 58/250 (23%), Positives = 110/250 (44%), Gaps = 47/250 (18%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVK 58
           M+ L+HP +V+L + F     +DE  + +V++ +   +     +++H + +       VK
Sbjct: 69  MQGLEHPFLVNLWYSF-----QDEEDMFMVVDLLLGGD-----LRYHLQQNVHFKEETVK 118

Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 118
           L+  ++  AL Y+ N   + HRD+KP N+L++ H H + + DF  A +L +     +   
Sbjct: 119 LFICELVMALDYLQN-QRIIHRDMKPDNILLDEHGH-VHITDFNIAAMLPRETQITTMAG 176

Query: 119 SRYYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPLFPGESG--VDQLVEIIKVLG 174
           ++ Y APE+        Y+ A+D WS G    ELL G+  +   S     ++V   +   
Sbjct: 177 TKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE--- 233

Query: 175 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-STALE 233
                         T   +P                 E V L+ +LL+ +P+ R S   +
Sbjct: 234 -------------TTVVTYPS------------AWSQEMVSLLKKLLEPNPDQRFSQLSD 268

Query: 234 ALIHPFFDEL 243
               P+ +++
Sbjct: 269 VQNFPYMNDI 278

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  111 bits (279), Expect = 8e-29
 Identities = 60/254 (23%), Positives = 97/254 (38%), Gaps = 33/254 (12%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKM-SQRMPLIYVKL 59
           MR  D P +V      F   +       + +E +  +  +  K+ Y +    +P   +  
Sbjct: 75  MRSSDCPYIVQFYGALFREGD-----CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGK 129

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
                 +AL ++   + + HRDIKP N+L++  +  +KLCDFG +  LV           
Sbjct: 130 ITLATVKALNHLKENLKIIHRDIKPSNILLD-RSGNIKLCDFGISGQLVDSIAKTRDAGC 188

Query: 120 RYYRAPELIFGATE---YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
           R Y APE I  +     Y    D+WS G  L EL  G+  +P  + V   +  + V G P
Sbjct: 189 RPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV-VKGDP 247

Query: 177 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 236
                            PQ+      + F     P  ++ V+  L    + R    E L 
Sbjct: 248 -----------------PQLSNSEERE-F----SPSFINFVNLCLTKDESKRPKYKELLK 285

Query: 237 HPFFDELRDPNTRL 250
           HPF     +    +
Sbjct: 286 HPFILMYEERAVEV 299

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  114 bits (287), Expect = 8e-29
 Identities = 68/274 (24%), Positives = 116/274 (42%), Gaps = 56/274 (20%)

Query: 3   LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPET-----VHRVIKHHYKMSQRMPLIYV 57
            ++   VVSL + + +   KD L L  VL  +        ++ + +  +  ++       
Sbjct: 240 KVNSRFVVSLAYAYET---KDALCL--VLTLMNGGDLKFHIYHMGQAGFPEAR------A 288

Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
             Y  +IC  L  +H    + +RD+KP+N+L++ H H +++ D G A  + +G+     +
Sbjct: 289 VFYAAEICCGLEDLHR-ERIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRV 346

Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +  Y APE++     YT + D W+ GC+L E++ GQ  F       +  E+ ++     
Sbjct: 347 GTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL----- 400

Query: 178 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STAL 232
              +K +   Y+E                    P+A  L S+LL   P  R      +A 
Sbjct: 401 ---VKEVPEEYSER-----------------FSPQARSLCSQLLCKDPAERLGCRGGSAR 440

Query: 233 EALIHPFFDELRDPN-TRLPNGRFLPPLFNFKPH 265
           E   HP F   +  N  RL  G   PP   FKP 
Sbjct: 441 EVKEHPLF---KKLNFKRLGAGMLEPP---FKPD 468

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  111 bits (280), Expect = 8e-29
 Identities = 31/260 (11%), Positives = 73/260 (28%), Gaps = 55/260 (21%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVK 58
           ++       +           ++   L  V E       ++ +  +     + MP   V 
Sbjct: 121 LKPSMQHMFMKFYSAHLF---QNGSVL--VGELYSYGTLLNAINLYKNTPEKVMPQGLVI 175

Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ----------LKLCDFGSA---K 105
            +  ++   +  +H+   + H DIKP N ++     +          L L D G +   K
Sbjct: 176 SFAMRMLYMIEQVHD-CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234

Query: 106 VLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQ 165
           +  KG    +   +  ++  E++     +   ID +     +  +L G  +     G   
Sbjct: 235 LFPKGTIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEG--- 290

Query: 166 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSP 225
                         + + +                W++ F              +L    
Sbjct: 291 -----------GECKPEGLFRRL-------PHLDMWNEFFHV------------MLNIPD 320

Query: 226 NLRSTALEALIHPFFDELRD 245
                +L+ L        + 
Sbjct: 321 CHHLPSLDLLRQKLKKVFQQ 340

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  114 bits (286), Expect = 9e-29
 Identities = 55/274 (20%), Positives = 100/274 (36%), Gaps = 45/274 (16%)

Query: 3   LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLY 60
            +    +VSL + F +   K +L L  V+  +   +  +  I +  + +          Y
Sbjct: 241 KVHSRFIVSLAYAFET---KTDLCL--VMTIMNGGDIRYH-IYNVDEDNPGFQEPRAIFY 294

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-S 119
             QI   L ++H    + +RD+KP+N+L++   + +++ D G A  L  G+        +
Sbjct: 295 TAQIVSGLEHLHQ-RNIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYAGT 352

Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
             + APEL+ G  EY  ++D ++ G  L E++  +  F       +  E+         +
Sbjct: 353 PGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK--------Q 403

Query: 180 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEA 234
            +      Y +                    P + D    LLQ  P  R      +    
Sbjct: 404 RVLEQAVTYPDK-----------------FSPASKDFCEALLQKDPEKRLGFRDGSCDGL 446

Query: 235 LIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELK 268
             HP F   RD + R      L P F      + 
Sbjct: 447 RTHPLF---RDISWRQLEAGMLTPPFVPDSRTVY 477

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  110 bits (278), Expect = 1e-28
 Identities = 60/242 (24%), Positives = 105/242 (43%), Gaps = 44/242 (18%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKL 59
           ++LL HP+++ L     +     ++ +  V+EY   E    +++      +RM     + 
Sbjct: 63  LKLLRHPHIIKLYDVITT---PTDIVM--VIEYAGGELFDYIVEK-----KRMTEDEGRR 112

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC- 118
           +F QI  A+ Y H    + HRD+KP+NLL++ +   +K+ DFG + ++  G   +   C 
Sbjct: 113 FFQQIICAIEYCHR-HKIVHRDLKPENLLLDDN-LNVKIADFGLSNIMTDGNF-LKTSCG 169

Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 178
           S  Y APE+I G       +D+WS G VL  +L+G+  F  E  +  L + +        
Sbjct: 170 SPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF-IPNLFKKVN------- 221

Query: 179 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 238
                       +  P      +       + P A  L+ R++   P  R T  E    P
Sbjct: 222 ---------SCVYVMP-----DF-------LSPGAQSLIRRMIVADPMQRITIQEIRRDP 260

Query: 239 FF 240
           +F
Sbjct: 261 WF 262

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  110 bits (278), Expect = 1e-28
 Identities = 72/270 (26%), Positives = 114/270 (42%), Gaps = 57/270 (21%)

Query: 5   DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFY 62
            HP + +LK+ F  T ++  L    V+EY    E     +  H    +       + Y  
Sbjct: 63  RHPFLTALKYAF-QTHDR--LCF--VMEYANGGE-----LFFHLSRERVFTEERARFYGA 112

Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY- 121
           +I  AL Y+H+   V +RDIK +NL+++   H +K+ DFG  K  +     +   C    
Sbjct: 113 EIVSALEYLHS-RDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPE 170

Query: 122 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 181
           Y APE++    +Y  A+D W  G V+ E++ G+  F  +   ++L E+I           
Sbjct: 171 YLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HERLFELIL---------- 218

Query: 182 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALI 236
                   E +FP            + + PEA  L++ LL+  P  R     S A E + 
Sbjct: 219 ------MEEIRFP------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260

Query: 237 HPFFDELRDPN-TRLPNGRFLPPLFNFKPH 265
           H FF      N   +   + LPP   FKP 
Sbjct: 261 HRFF---LSINWQDVVQKKLLPP---FKPQ 284

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  110 bits (277), Expect = 2e-28
 Identities = 72/270 (26%), Positives = 110/270 (40%), Gaps = 57/270 (21%)

Query: 5   DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFY 62
            HP +V L + F  T  K  LYL  +LEY+   E     +    +            Y  
Sbjct: 79  KHPFIVDLIYAF-QTGGK--LYL--ILEYLSGGE-----LFMQLEREGIFMEDTACFYLA 128

Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY- 121
           +I  AL ++H   G+ +RD+KP+N+++N   H +KL DFG  K  +         C    
Sbjct: 129 EISMALGHLHQ-KGIIYRDLKPENIMLNHQGH-VKLTDFGLCKESIHDGTVTHTFCGTIE 186

Query: 122 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 181
           Y APE++   + +  A+D WS G ++ ++L G P F GE+   + ++ I           
Sbjct: 187 YMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGEN-RKKTIDKIL---------- 234

Query: 182 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALI 236
                   +   P              +  EA DL+ +LL+ +   R       A E   
Sbjct: 235 ------KCKLNLP------------PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276

Query: 237 HPFFDELRDPN-TRLPNGRFLPPLFNFKPH 265
           HPFF   R  N   L   +  PP   FKP 
Sbjct: 277 HPFF---RHINWEELLARKVEPP---FKPL 300

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  108 bits (272), Expect = 6e-28
 Identities = 62/268 (23%), Positives = 102/268 (38%), Gaps = 58/268 (21%)

Query: 1   MRLLD----HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRV---IKHHYKMSQRMP 53
           +  +     HP V+ L   +F T  ++   L  VLE  P     +   I     + +   
Sbjct: 88  LWKVGAGGGHPGVIRL-LDWFET--QEGFML--VLER-PLPAQDLFDYITEKGPLGEGP- 140

Query: 54  LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 113
               + +F Q+  A+ + H+  GV HRDIK +N+L++      KL DFGS  +L      
Sbjct: 141 ---SRCFFGQVVAAIQHCHS-RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE--P 194

Query: 114 ISYIC-SRYYRAPELIFGATEYTAA-IDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIK 171
            +    +R Y  PE I    +Y A    +WS G +L +++ G   F  +       EI++
Sbjct: 195 YTDFDGTRVYSPPEWISR-HQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILE 247

Query: 172 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA 231
                             E  FP              + P+   L+ R L   P+ R + 
Sbjct: 248 A-----------------ELHFP------------AHVSPDCCALIRRCLAPKPSSRPSL 278

Query: 232 LEALIHPFFDELRDPNTRLPNGRFLPPL 259
            E L+ P+     +     P+     PL
Sbjct: 279 EEILLDPWMQTPAEDVPLNPSKGGPAPL 306

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  108 bits (273), Expect = 7e-28
 Identities = 67/270 (24%), Positives = 111/270 (41%), Gaps = 57/270 (21%)

Query: 5   DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFY 62
           +HP +V L + F  T  K  LYL  +L+++   +     +              VK Y  
Sbjct: 84  NHPFIVKLHYAF-QTEGK--LYL--ILDFLRGGD-----LFTRLSKEVMFTEEDVKFYLA 133

Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRY 121
           ++  AL ++H+ +G+ +RD+KP+N+L++   H +KL DFG +K  +  E      C +  
Sbjct: 134 ELALALDHLHS-LGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVE 191

Query: 122 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 181
           Y APE++     +T + D WS G ++ E+L G   F G+    + + +I           
Sbjct: 192 YMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKD-RKETMTMIL---------- 239

Query: 182 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALI 236
                   +   PQ             + PEA  L+  L + +P  R         E   
Sbjct: 240 ------KAKLGMPQ------------FLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281

Query: 237 HPFFDELRDPN-TRLPNGRFLPPLFNFKPH 265
           H FF      +  +L      PP   FKP 
Sbjct: 282 HSFF---STIDWNKLYRREIHPP---FKPA 305

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  108 bits (272), Expect = 1e-27
 Identities = 76/271 (28%), Positives = 116/271 (42%), Gaps = 54/271 (19%)

Query: 6   HPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQ 63
            P +V+L + F  T  K  L+L  +L+Y+   E     +  H    +R     V++Y  +
Sbjct: 118 SPFLVTLHYAF-QTETK--LHL--ILDYINGGE-----LFTHLSQRERFTEHEVQIYVGE 167

Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY-IC-SRY 121
           I  AL ++H  +G+ +RDIK +N+L++ + H + L DFG +K  V  E   +Y  C +  
Sbjct: 168 IVLALEHLHK-LGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETERAYDFCGTIE 225

Query: 122 YRAPELIFGATE-YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 180
           Y AP+++ G    +  A+D WS G ++ ELL G   F  +   +   EI           
Sbjct: 226 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS--------RR 277

Query: 181 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEAL 235
           I       +E  +PQ             M   A DL+ RLL   P  R       A E  
Sbjct: 278 IL-----KSEPPYPQ------------EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIK 320

Query: 236 IHPFFDELRDPN-TRLPNGRFLPPLFNFKPH 265
            H FF   +  N   L   +   P   FKP 
Sbjct: 321 EHLFF---QKINWDDLAAKKVPAP---FKPV 345

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  109 bits (275), Expect = 2e-27
 Identities = 63/243 (25%), Positives = 103/243 (42%), Gaps = 45/243 (18%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVK 58
           ++L  HP+++ L     +     ++++  V+EYV   E    + K+      R+     +
Sbjct: 70  LKLFRHPHIIKLYQVIST---PSDIFM--VMEYVSGGELFDYICKN-----GRLDEKESR 119

Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 118
             F QI   + Y H    V HRD+KP+N+L++ H    K+ DFG + ++  GE  +   C
Sbjct: 120 RLFQQILSGVDYCHR-HMVVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGEF-LRTSC 176

Query: 119 -SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            S  Y APE+I G       +DIWS+G +L  LL G   F  +  V  L + I       
Sbjct: 177 GSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH-VPTLFKKIC------ 229

Query: 178 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 237
                        F  P      +       + P  + L+  +LQ  P  R+T  +   H
Sbjct: 230 ----------DGIFYTP-----QY-------LNPSVISLLKHMLQVDPMKRATIKDIREH 267

Query: 238 PFF 240
            +F
Sbjct: 268 EWF 270

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  109 bits (275), Expect = 4e-27
 Identities = 46/165 (27%), Positives = 81/165 (49%), Gaps = 27/165 (16%)

Query: 4   LDHPNVVSLKHCFFSTTEKDELYLN-LVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYF 61
           + HP++V +   F   T++    +  +V+EYV  +++ R         Q++P+     Y 
Sbjct: 136 VVHPSIVQI-FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG------QKLPVAEAIAYL 188

Query: 62  YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-----VKGEPNISY 116
            +I  AL+Y+H+ IG+ + D+KP+N+++     QLKL D G+   +     + G P    
Sbjct: 189 LEILPALSYLHS-IGLVYNDLKPENIMLTEE--QLKLIDLGAVSRINSFGYLYGTP---- 241

Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 161
                ++APE++      T A DI++ G  LA L L  P   G  
Sbjct: 242 ----GFQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGRY 280

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  106 bits (267), Expect = 6e-27
 Identities = 63/279 (22%), Positives = 108/279 (38%), Gaps = 70/279 (25%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVK 58
           ++ ++ P +V L+  F     KD   L +V+EYV   E     +  H +   R    + +
Sbjct: 95  LQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVAGGE-----MFSHLRRIGRFSEPHAR 144

Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK------GEP 112
            Y  QI     Y+H+ + + +RD+KP+NLL++   + +++ DFG AK +        G P
Sbjct: 145 FYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKGRTWTLCGTP 202

Query: 113 NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 172
                      APE+I     Y  A+D W+ G ++ E+  G P F  +    Q+ E I  
Sbjct: 203 E--------ALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIV- 251

Query: 173 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSP-----NL 227
                            + +FP                 +  DL+  LLQ        NL
Sbjct: 252 ---------------SGKVRFP------------SHFSSDLKDLLRNLLQVDLTKRFGNL 284

Query: 228 RSTALEALIHPFFDELRDPN-TRLPNGRFLPPLFNFKPH 265
           ++   +   H +F      +   +   +   P   F P 
Sbjct: 285 KNGVNDIKNHKWFATT---DWIAIYQRKVEAP---FIPK 317

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  107 bits (269), Expect = 7e-27
 Identities = 70/282 (24%), Positives = 106/282 (37%), Gaps = 68/282 (24%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVK 58
           M   + P VV L + F     +D+ YL +V+EY+P  + V+ +  +       +P  + +
Sbjct: 123 MAFANSPWVVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMSNY------DVPEKWAR 171

Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS--- 115
            Y  ++  AL  IH+ +G  HRD+KP N+L++   H LKL DFG+   + K         
Sbjct: 172 FYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTA 229

Query: 116 -----YICSRYYRAPELIF---GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV 167
                YI      +PE++    G   Y    D WS G  L E+L+G   F  +S    LV
Sbjct: 230 VGTPDYI------SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS----LV 279

Query: 168 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL 227
                         K MN       FP              +  EA +L+   L     +
Sbjct: 280 GTYS----------KIMNHK-NSLTFPD---DND-------ISKEAKNLICAFLT-DREV 317

Query: 228 R---STALEALIHPFFDELRDPN-TRLPNGRFLPPLFNFKPH 265
           R   +   E   H FF                + P     P 
Sbjct: 318 RLGRNGVEEIKRHLFFKND---QWAWETLRDTVAP---VVPD 353

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  106 bits (266), Expect = 9e-27
 Identities = 66/271 (24%), Positives = 112/271 (41%), Gaps = 58/271 (21%)

Query: 5   DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFY 62
           +HP +  L  CF  T ++  L+   V+E+V   +     +  H + S+R      + Y  
Sbjct: 82  NHPFLTQLFCCF-QTPDR--LFF--VMEFVNGGD-----LMFHIQKSRRFDEARARFYAA 131

Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY- 121
           +I  AL ++H+  G+ +RD+K  N+L++   H  KL DFG  K  +      +  C    
Sbjct: 132 EIISALMFLHD-KGIIYRDLKLDNVLLDHEGH-CKLADFGMCKEGICNGVTTATFCGTPD 189

Query: 122 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 181
           Y APE++     Y  A+D W+ G +L E+L G   F  E+  D L E I           
Sbjct: 190 YIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAEN-EDDLFEAIL---------- 237

Query: 182 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR------STALEAL 235
                   E  +P              +  +A  ++   +  +P +R            L
Sbjct: 238 ------NDEVVYP------------TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAIL 279

Query: 236 IHPFFDELRDPN-TRLPNGRFLPPLFNFKPH 265
            HPFF   ++ +  +L + +  PP   F+P 
Sbjct: 280 RHPFF---KEIDWAQLNHRQIEPP---FRPR 304

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  105 bits (265), Expect = 1e-26
 Identities = 66/269 (24%), Positives = 104/269 (38%), Gaps = 57/269 (21%)

Query: 6   HPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQ 63
            P +  L  CF  T ++  LY   V+EYV   +     + +H +   R    +   Y  +
Sbjct: 80  PPFLTQLHSCF-QTMDR--LYF--VMEYVNGGD-----LMYHIQQVGRFKEPHAVFYAAE 129

Query: 64  ICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY-Y 122
           I   L ++ +  G+ +RD+K  N++++   H +K+ DFG  K  +         C    Y
Sbjct: 130 IAIGLFFLQS-KGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPDY 187

Query: 123 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 182
            APE+I     Y  ++D W+ G +L E+L GQ  F GE   D+L + I            
Sbjct: 188 IAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSIM----------- 234

Query: 183 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALIH 237
                     +P            K M  EAV +   L+   P  R         +   H
Sbjct: 235 -----EHNVAYP------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277

Query: 238 PFFDELRDPN-TRLPNGRFLPPLFNFKPH 265
            FF   R  +  +L      PP   +KP 
Sbjct: 278 AFF---RYIDWEKLERKEIQPP---YKPK 300

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  105 bits (264), Expect = 2e-26
 Identities = 66/266 (24%), Positives = 112/266 (42%), Gaps = 53/266 (19%)

Query: 5   DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFY 62
           +HP +  +   F  T E   L+   V+EY+   +     + +H +   +  L     Y  
Sbjct: 76  EHPFLTHMFCTF-QTKEN--LFF--VMEYLNGGD-----LMYHIQSCHKFDLSRATFYAA 125

Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY- 121
           +I   L ++H+  G+ +RD+K  N+L++   H +K+ DFG  K  + G+   +  C    
Sbjct: 126 EIILGLQFLHS-KGIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNTFCGTPD 183

Query: 122 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 181
           Y APE++ G  +Y  ++D WS G +L E+L+GQ  F G+   ++L   I+          
Sbjct: 184 YIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQD-EEELFHSIR---------- 231

Query: 182 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL-IHPFF 240
                      +P            + +  EA DL+ +L    P  R      +  HP F
Sbjct: 232 ------MDNPFYP------------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF 273

Query: 241 DELRDPN-TRLPNGRFLPPLFNFKPH 265
              R+ N   L      PP   F+P 
Sbjct: 274 ---REINWEELERKEIDPP---FRPK 293

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  105 bits (265), Expect = 2e-26
 Identities = 67/269 (24%), Positives = 104/269 (38%), Gaps = 56/269 (20%)

Query: 5   DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFY 62
            HP +V L   F  T +K  LY   VL+Y+   E     + +H +  +       + Y  
Sbjct: 97  KHPFLVGLHFSF-QTADK--LYF--VLDYINGGE-----LFYHLQRERCFLEPRARFYAA 146

Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY- 121
           +I  AL Y+H+ + + +RD+KP+N+L++   H + L DFG  K  ++     S  C    
Sbjct: 147 EIASALGYLHS-LNIVYRDLKPENILLDSQGH-IVLTDFGLCKENIEHNSTTSTFCGTPE 204

Query: 122 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 181
           Y APE++     Y   +D W  G VL E+L G P F   +   ++ + I           
Sbjct: 205 YLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-TAEMYDNIL---------- 252

Query: 182 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR----STALEALIH 237
                     +                +   A  L+  LLQ     R       +E   H
Sbjct: 253 ------NKPLQLK------------PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSH 294

Query: 238 PFFDELRDPN-TRLPNGRFLPPLFNFKPH 265
            FF      N   L N +  PP   F P+
Sbjct: 295 VFF---SLINWDDLINKKITPP---FNPN 317

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  104 bits (262), Expect = 2e-26
 Identities = 54/251 (21%), Positives = 96/251 (38%), Gaps = 54/251 (21%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP---ETVHRVIKHHYKMSQRMPLIYV 57
           +  ++H N++ +    F    +    L  V+E      +    + +H      R+     
Sbjct: 83  LSRVEHANIIKVLD-IFEN--QGFFQL--VMEKHGSGLDLFAFIDRH-----PRLDEPLA 132

Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
              F Q+  A+ Y+     + HRDIK +N+++      +KL DFGSA  L +G+      
Sbjct: 133 SYIFRQLVSAVGYLRLK-DIIHRDIKDENIVIAED-FTIKLIDFGSAAYLERGKL-FYTF 189

Query: 118 C-SRYYRAPELIFGATEYT-AAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
           C +  Y APE++ G   Y    +++WS G  L  L+  +  F       +L E ++    
Sbjct: 190 CGTIEYCAPEVLMG-NPYRGPELEMWSLGVTLYTLVFEENPF------CELEETVE---- 238

Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 235
                             P              +  E + LVS LLQ  P  R+T  + +
Sbjct: 239 -------------AAIHPP-----YL-------VSKELMSLVSGLLQPVPERRTTLEKLV 273

Query: 236 IHPFFDELRDP 246
             P+  +  + 
Sbjct: 274 TDPWVTQPVNL 284

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  104 bits (261), Expect = 3e-26
 Identities = 49/168 (29%), Positives = 88/168 (52%), Gaps = 19/168 (11%)

Query: 4   LDHPNVVSLKHCFFSTTEKDELYLN---LVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKL 59
           L+HP +V++    + T E +        +V+EYV   T+  ++     M+ +  +  +  
Sbjct: 69  LNHPAIVAV----YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIA- 123

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY--- 116
                C+AL + H   G+ HRD+KP N++++  T+ +K+ DFG A+ +     +++    
Sbjct: 124 ---DACQALNFSHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSVTQTAA 178

Query: 117 -ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 163
            I +  Y +PE   G +   A  D++S GCVL E+L G+P F G+S V
Sbjct: 179 VIGTAQYLSPEQARGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  103 bits (260), Expect = 4e-26
 Identities = 42/163 (25%), Positives = 69/163 (42%), Gaps = 19/163 (11%)

Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFY 62
           L  P+VV +        E D     + +  +    +  +++    ++    +  V+    
Sbjct: 91  LQEPHVVPI----HDFGEIDGQLY-VDMRLINGVDLAAMLRRQGPLAPPRAVAIVR---- 141

Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI----SYIC 118
           QI  AL   H   G  HRD+KP+N+LV+       L DFG A      +  +    + + 
Sbjct: 142 QIGSALDAAHAA-GATHRDVKPENILVSA-DDFAYLVDFGIASAT--TDEKLTQLGNTVG 197

Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES 161
           + YY APE    +   T   DI++  CVL E L G P + G+ 
Sbjct: 198 TLYYMAPERFSES-HATYRADIYALTCVLYECLTGSPPYQGDQ 239

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  103 bits (259), Expect = 4e-26
 Identities = 55/165 (33%), Positives = 85/165 (51%), Gaps = 19/165 (11%)

Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFY 62
           L H N+VS+        E+D+ Y  LV+EY+   T+   I+ H  +S    + +      
Sbjct: 68  LSHQNIVSM----IDVDEEDDCYY-LVMEYIEGPTLSEYIESHGPLSVDTAINFTN---- 118

Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY----IC 118
           QI   + + H+   + HRDIKPQN+L++     LK+ DFG AK L   E +++     + 
Sbjct: 119 QILDGIKHAHDM-RIVHRDIKPQNILIDS-NKTLKIFDFGIAKAL--SETSLTQTNHVLG 174

Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 163
           +  Y +PE   G        DI+S G VL E+L+G+P F GE+ V
Sbjct: 175 TVQYFSPEQAKGEAT-DECTDIYSIGIVLYEMLVGEPPFNGETAV 218

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  103 bits (259), Expect = 6e-26
 Identities = 66/284 (23%), Positives = 118/284 (41%), Gaps = 71/284 (25%)

Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYF 61
           + HP ++ +   F     +D   + ++++Y+   E     +    + SQR P    K Y 
Sbjct: 63  VTHPFIIRMWGTF-----QDAQQIFMIMDYIEGGE-----LFSLLRKSQRFPNPVAKFYA 112

Query: 62  YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK------GEPNIS 115
            ++C AL Y+H+   + +RD+KP+N+L++ + H +K+ DFG AK +        G P+  
Sbjct: 113 AEVCLALEYLHS-KDIIYRDLKPENILLDKNGH-IKITDFGFAKYVPDVTYTLCGTPD-- 168

Query: 116 YICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
                 Y APE++     Y  +ID WS G ++ E+L G   F   +   +  E I     
Sbjct: 169 ------YIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSN-TMKTYEKIL---- 216

Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSP-----NLRST 230
                         E +FP                 +  DL+SRL+         NL++ 
Sbjct: 217 ------------NAELRFP------------PFFNEDVKDLLSRLITRDLSQRLGNLQNG 252

Query: 231 ALEALIHPFFDELRDPN-TRLPNGRFLPPLFNFKPHELKGVPVD 273
             +   HP+F E+      +L +     P   ++P  ++    D
Sbjct: 253 TEDVKNHPWFKEV---VWEKLLSRNIETP---YEPP-IQQGQGD 289

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  103 bits (259), Expect = 9e-26
 Identities = 64/271 (23%), Positives = 117/271 (43%), Gaps = 49/271 (18%)

Query: 5   DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFY 62
           +HP +V L  CF  T  +  L+   V+EYV   +     +  H +  +++P  + + Y  
Sbjct: 68  NHPFLVGLHSCF-QTESR--LFF--VIEYVNGGD-----LMFHMQRQRKLPEEHARFYSA 117

Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRY 121
           +I  AL Y+H   G+ +RD+K  N+L++   H +KL D+G  K  ++     S  C +  
Sbjct: 118 EISLALNYLHE-RGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPN 175

Query: 122 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 181
           Y APE++ G  +Y  ++D W+ G ++ E++ G+  F      D   +        T + +
Sbjct: 176 YIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTEDYL 227

Query: 182 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR------STALEAL 235
                      F  I          + +  +A  ++   L   P  R      +   +  
Sbjct: 228 -----------FQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQ 274

Query: 236 IHPFFDELRDPN-TRLPNGRFLPPLFNFKPH 265
            HPFF   R+ +   +   + +PP   FKP+
Sbjct: 275 GHPFF---RNVDWDMMEQKQVVPP---FKPN 299

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  103 bits (258), Expect = 2e-25
 Identities = 50/267 (18%), Positives = 94/267 (35%), Gaps = 36/267 (13%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
            +L +HPN+V  +  F +    +EL++  V  ++   +   +I  H+     M  + +  
Sbjct: 80  SKLFNHPNIVPYRATFIA---DNELWV--VTSFMAYGSAKDLICTHFM--DGMNELAIAY 132

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSA--------KVLVKGE 111
               + +AL YIH+  G  HR +K  ++L++    ++ L    S         +  V  +
Sbjct: 133 ILQGVLKALDYIHHM-GYVHRSVKASHILIS-VDGKVYLSGLRSNLSMISHGQRQRVVHD 190

Query: 112 PNISYICSRYYRAPELIF-GATEYTAAIDIWSAGCVLAELLLGQP----------LF--- 157
                +    + +PE++      Y A  DI+S G    EL  G            L    
Sbjct: 191 FPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL 250

Query: 158 ----PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEA 213
               P       +      +          ++ + T               + +   P  
Sbjct: 251 NGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHF 310

Query: 214 VDLVSRLLQYSPNLRSTALEALIHPFF 240
              V + LQ +P+ R +A   L H FF
Sbjct: 311 HHFVEQCLQRNPDARPSASTLLNHSFF 337

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  103 bits (257), Expect = 6e-25
 Identities = 66/270 (24%), Positives = 104/270 (38%), Gaps = 57/270 (21%)

Query: 5   DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFY 62
             P +  L  CF +    D LY   V+EYV   +     + +H +   R    +   Y  
Sbjct: 400 KPPFLTQLHSCFQT---MDRLYF--VMEYVNGGD-----LMYHIQQVGRFKEPHAVFYAA 449

Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRY 121
           +I   L ++ +  G+ +RD+K  N++++   H +K+ DFG  K  +         C +  
Sbjct: 450 EIAIGLFFLQSK-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPD 507

Query: 122 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 181
           Y APE+I     Y  ++D W+ G +L E+L GQ  F GE   D+L + I           
Sbjct: 508 YIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSIM---------- 555

Query: 182 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEALI 236
                      +P            K M  EAV +   L+   P  R         +   
Sbjct: 556 ------EHNVAYP------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597

Query: 237 HPFFDELRDPN-TRLPNGRFLPPLFNFKPH 265
           H FF   R  +  +L      PP   +KP 
Sbjct: 598 HAFF---RYIDWEKLERKEIQPP---YKPK 621

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  101 bits (253), Expect = 1e-24
 Identities = 64/271 (23%), Positives = 117/271 (43%), Gaps = 49/271 (18%)

Query: 5   DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFY 62
           +HP +V L  CF  T  +  L+   V+EYV   +     +  H +  +++P  + + Y  
Sbjct: 111 NHPFLVGLHSCF-QTESR--LFF--VIEYVNGGD-----LMFHMQRQRKLPEEHARFYSA 160

Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRY 121
           +I  AL Y+H   G+ +RD+K  N+L++   H +KL D+G  K  ++     S  C +  
Sbjct: 161 EISLALNYLHE-RGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPN 218

Query: 122 YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 181
           Y APE++ G  +Y  ++D W+ G ++ E++ G+  F      D   +        T + +
Sbjct: 219 YIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTEDYL 270

Query: 182 KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR------STALEAL 235
                      F  I          + +  +A  ++   L   P  R      +   +  
Sbjct: 271 -----------FQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQ 317

Query: 236 IHPFFDELRDPN-TRLPNGRFLPPLFNFKPH 265
            HPFF   R+ +   +   + +PP   FKP+
Sbjct: 318 GHPFF---RNVDWDMMEQKQVVPP---FKPN 342

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 94.7 bits (236), Expect = 7e-23
 Identities = 65/261 (24%), Positives = 101/261 (38%), Gaps = 41/261 (15%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           M    HPN+VS    F     KDEL+L  V++ +   +V  +IKH     +    +  + 
Sbjct: 67  MSQCHHPNIVSYYTSFV---VKDELWL--VMKLLSGGSVLDIIKHIVAKGEHKSGVLDES 121

Query: 60  YFYQICR----ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNI 114
               I R     L Y+H   G  HRD+K  N+L+      +++ DFG SA +   G+   
Sbjct: 122 TIATILREVLEGLEYLHKN-GQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITR 179

Query: 115 SYICSR-------YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV 167
           +    R        + APE++     Y    DIWS G    EL  G   +     +  L+
Sbjct: 180 NK--VRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM 237

Query: 168 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL 227
             ++             N        P ++     K   K+       ++S  LQ  P  
Sbjct: 238 LTLQ-------------ND------PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEK 278

Query: 228 RSTALEALIHPFFDELRDPNT 248
           R TA E L H FF + ++   
Sbjct: 279 RPTAAELLRHKFFQKAKNKEF 299

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score = 92.0 bits (229), Expect = 7e-22
 Identities = 43/171 (25%), Positives = 76/171 (44%), Gaps = 14/171 (8%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           +  ++HPN+V L              + LV+EY    +++ V+ H  +        +   
Sbjct: 55  LSRVNHPNIVKLYGA---CLNP----VCLVMEYAEGGSLYNVL-HGAEPLPYYTAAHAMS 106

Query: 60  YFYQICRALAYIH--NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           +  Q  + +AY+H      + HRD+KP NLL+      LK+CDFG+A          +  
Sbjct: 107 WCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC--DIQTHMTNNK 164

Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE 168
            S  + APE+  G + Y+   D++S G +L E++  +  F    G    + 
Sbjct: 165 GSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM 214

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 91.3 bits (227), Expect = 2e-21
 Identities = 59/250 (23%), Positives = 104/250 (41%), Gaps = 42/250 (16%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ L HPN +  + C+     +   +L  V+EY   +   +++ H K    +  + +   
Sbjct: 108 LQKLRHPNTIQYRGCYL---REHTAWL--VMEYCLGSASDLLEVHKK---PLQEVEIAAV 159

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
            +   + LAY+H+   + HRD+K  N+L++     +KL DFGSA ++       S++ + 
Sbjct: 160 THGALQGLAYLHSH-NMIHRDVKAGNILLS-EPGLVKLGDFGSASIMAPAN---SFVGTP 214

Query: 121 YYRAPELIFGATE--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 178
           Y+ APE+I    E  Y   +D+WS G    EL   +P     + +  L  I +       
Sbjct: 215 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ------- 267

Query: 179 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 238
                          P +++  W + F+        + V   LQ  P  R T+   L H 
Sbjct: 268 -----NES-------PALQSGHWSEYFR--------NFVDSCLQKIPQDRPTSEVLLKHR 307

Query: 239 FFDELRDPNT 248
           F    R P  
Sbjct: 308 FVLRERPPTV 317

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score = 88.9 bits (221), Expect = 7e-21
 Identities = 45/171 (26%), Positives = 78/171 (45%), Gaps = 26/171 (15%)

Query: 1   MRLLDHPNVVSLK-HCFFSTTEKDELYLNLVLEYVPE-TVHRVI-KHHYKMSQRMPLIYV 57
             +L HPN+++L+  C     ++  L L  V+E+     ++RV+          +     
Sbjct: 60  FAMLKHPNIIALRGVC----LKEPNLCL--VMEFARGGPLNRVLSGKRIPPDILVNWAV- 112

Query: 58  KLYFYQICRALAYIH--NTIGVCHRDIKPQNLLVN-------PHTHQLKLCDFGSAKVLV 108
                QI R + Y+H    + + HRD+K  N+L+             LK+ DFG A+   
Sbjct: 113 -----QIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH 167

Query: 109 KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG 159
           +    +S   +  + APE+I  +  ++   D+WS G +L ELL G+  F G
Sbjct: 168 RTT-KMSAAGAYAWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGEVPFRG 216

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score = 88.1 bits (219), Expect = 1e-20
 Identities = 37/172 (21%), Positives = 66/172 (38%), Gaps = 21/172 (12%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVI-KHHYKMSQRMPLIYVK 58
           M  L+HPN+V L                +V+E+VP   ++  +    + +   + L  + 
Sbjct: 77  MSNLNHPNIVKLYGL---MHNP----PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLM- 128

Query: 59  LYFYQICRALAYIHN-TIGVCHRDIKPQNLLVNPHTHQ----LKLCDFGSAKVLVKGEPN 113
                I   + Y+ N    + HRD++  N+ +           K+ DFG ++        
Sbjct: 129 ---LDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSV 183

Query: 114 ISYICSRYYRAPELIFGATE-YTAAIDIWSAGCVLAELLLGQPLFPGESGVD 164
              + +  + APE I    E YT   D +S   +L  +L G+  F   S   
Sbjct: 184 SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK 235

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 87.4 bits (217), Expect = 5e-20
 Identities = 59/258 (22%), Positives = 100/258 (38%), Gaps = 38/258 (14%)

Query: 1   MRLLDHPNVVSLKHCFF-STTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVK 58
            +   H N+ +    F        +  L LV+E+    +V  +IK+       +   ++ 
Sbjct: 75  KKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIA 132

Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYI 117
               +I R L+++H    V HRDIK QN+L+     ++KL DFG SA++        ++I
Sbjct: 133 YICREILRGLSHLHQH-KVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFI 190

Query: 118 CSRYYRAPELI----FGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVL 173
            + Y+ APE+I         Y    D+WS G    E+  G P       +  L  I +  
Sbjct: 191 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR-- 248

Query: 174 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
                      NP       P++K+  W K FQ          +   L  + + R    +
Sbjct: 249 -----------NP------APRLKSKKWSKKFQ--------SFIESCLVKNHSQRPATEQ 283

Query: 234 ALIHPFFDELRDPNTRLP 251
            + HPF  +  +      
Sbjct: 284 LMKHPFIRDQPNERQVRI 301

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 87.1 bits (216), Expect = 6e-20
 Identities = 32/171 (18%), Positives = 64/171 (37%), Gaps = 29/171 (16%)

Query: 1   MRLLDHPNVVS-LKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHH-YKMSQRMPLIYV 57
             L+ H N++  +      T    +LYL  + +Y    +++  +K         + L Y 
Sbjct: 85  TVLMRHENILGFIAADIKGTGSWTQLYL--ITDYHENGSLYDYLKSTTLDAKSMLKLAY- 141

Query: 58  KLYFYQICRALAYIHNTI-------GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 110
                     L ++H  I        + HRD+K +N+LV  +     + D G A   +  
Sbjct: 142 -----SSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVKFISD 195

Query: 111 EPNISYICS-----RYYRAPELIFGAT-----EYTAAIDIWSAGCVLAELL 151
              +    +     + Y  PE++  +      +     D++S G +L E+ 
Sbjct: 196 TNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score = 85.8 bits (213), Expect = 1e-19
 Identities = 37/176 (21%), Positives = 78/176 (44%), Gaps = 17/176 (9%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           +R   H N++     F   +   +L +  V ++    +++  +        +  +  +  
Sbjct: 74  LRKTRHVNILL----FMGYSTAPQLAI--VTQWCEGSSLYHHLH---ASETKFEMKKLID 124

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY--- 116
              Q  R + Y+H    + HRD+K  N+ ++   + +K+ DFG A    +   +  +   
Sbjct: 125 IARQTARGMDYLH-AKSIIHRDLKSNNIFLHED-NTVKIGDFGLATEKSRWSGSHQFEQL 182

Query: 117 ICSRYYRAPELIFGATE--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 170
             S  + APE+I       Y+   D+++ G VL EL+ GQ  +   +  DQ++E++
Sbjct: 183 SGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 85.8 bits (213), Expect = 1e-19
 Identities = 59/242 (24%), Positives = 101/242 (41%), Gaps = 41/242 (16%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           MR   +PN+V+    +      DEL++  V+EY+   ++  V+         M    +  
Sbjct: 71  MRENKNPNIVNYLDSYLV---GDELWV--VMEYLAGGSLTDVVTET-----CMDEGQIAA 120

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-ISYIC 118
              +  +AL ++H+   V HRDIK  N+L+      +KL DFG    +   +    + + 
Sbjct: 121 VCRECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVG 178

Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 178
           + Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  I    GTP  
Sbjct: 179 TPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPEL 236

Query: 179 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 238
           +                        IF+        D ++R L+     R +A E L H 
Sbjct: 237 QN-----------------PEKLSAIFR--------DFLNRCLEMDVEKRGSAKELLQHQ 271

Query: 239 FF 240
           F 
Sbjct: 272 FL 273

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score = 85.8 bits (213), Expect = 1e-19
 Identities = 40/162 (24%), Positives = 77/162 (47%), Gaps = 11/162 (6%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           M+ L HPN+V       + T+   L +  V EY+   +++R++ H     +++       
Sbjct: 88  MKRLRHPNIVLFMG---AVTQPPNLSI--VTEYLSRGSLYRLL-HKSGAREQLDERRRLS 141

Query: 60  YFYQICRALAYIHN-TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI-SYI 117
             Y + + + Y+HN    + HR++K  NLLV+   + +K+CDFG +++      +  S  
Sbjct: 142 MAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKK-YTVKVCDFGLSRLKASTFLSSKSAA 200

Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG 159
            +  + APE++          D++S G +L EL   Q  +  
Sbjct: 201 GTPEWMAPEVLRD-EPSNEKSDVYSFGVILWELATLQQPWGN 241

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 86.3 bits (214), Expect = 1e-19
 Identities = 60/242 (24%), Positives = 106/242 (43%), Gaps = 41/242 (16%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           MR   H NVV +   +      +EL++  ++E++    +  ++        R+    +  
Sbjct: 96  MRDYQHFNVVEMYKSYLV---GEELWV--LMEFLQGGALTDIVSQ-----VRLNEEQIAT 145

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYIC 118
               + +ALAY+H   GV HRDIK  ++L+     ++KL DFG  A++        S + 
Sbjct: 146 VCEAVLQALAYLHAQ-GVIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKSLVG 203

Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 178
           + Y+ APE+I   + Y   +DIWS G ++ E++ G+P +  +S V  +  +      P  
Sbjct: 204 TPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS-PPPKL 261

Query: 179 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 238
           +                  +H    + +        D + R+L   P  R+TA E L HP
Sbjct: 262 KN-----------------SHKVSPVLR--------DFLERMLVRDPQERATAQELLDHP 296

Query: 239 FF 240
           F 
Sbjct: 297 FL 298

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 85.8 bits (213), Expect = 1e-19
 Identities = 59/254 (23%), Positives = 103/254 (40%), Gaps = 42/254 (16%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           +   DHP +V L   ++   +     L +++E+ P   V  ++    +    +    +++
Sbjct: 70  LATCDHPYIVKLLGAYYHDGK-----LWIMIEFCPGGAVDAIMLELDR---GLTEPQIQV 121

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYIC 118
              Q+  AL ++H+   + HRD+K  N+L+      ++L DFG SAK L   +   S+I 
Sbjct: 122 VCRQMLEALNFLHSK-RIIHRDLKAGNVLMT-LEGDIRLADFGVSAKNLKTLQKRDSFIG 179

Query: 119 SRYYRAPELIFGAT----EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 174
           + Y+ APE++   T     Y    DIWS G  L E+   +P     + +  L++I K   
Sbjct: 180 TPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-D 238

Query: 175 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 234
            PT                       W   F+        D +   L  +P  R +A + 
Sbjct: 239 PPTLLT-----------------PSKWSVEFR--------DFLKIALDKNPETRPSAAQL 273

Query: 235 LIHPFFDELRDPNT 248
           L HPF   +     
Sbjct: 274 LEHPFVSSITSNKA 287

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 85.9 bits (213), Expect = 1e-19
 Identities = 60/250 (24%), Positives = 96/250 (38%), Gaps = 39/250 (15%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           M+  D P+VV     +F  T+     L +V+EY    +V  +I+     ++ +    +  
Sbjct: 78  MQQCDSPHVVKYYGSYFKNTD-----LWIVMEYCGAGSVSDIIRLR---NKTLTEDEIAT 129

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYIC 118
                 + L Y+H      HRDIK  N+L+N      KL DFG + ++        + I 
Sbjct: 130 ILQSTLKGLEYLHFM-RKIHRDIKAGNILLN-TEGHAKLADFGVAGQLTDTMAKRNTVIG 187

Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 178
           + ++ APE+I     Y    DIWS G    E+  G+P +     +  +  I      PT 
Sbjct: 188 TPFWMAPEVIQEI-GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN-PPPTF 245

Query: 179 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 238
            +                    W   F         D V + L  SP  R+TA + L HP
Sbjct: 246 RK-----------------PELWSDNFT--------DFVKQCLVKSPEQRATATQLLQHP 280

Query: 239 FFDELRDPNT 248
           F    +  + 
Sbjct: 281 FVRSAKGVSI 290

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 85.4 bits (212), Expect = 2e-19
 Identities = 55/252 (21%), Positives = 96/252 (38%), Gaps = 43/252 (17%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           +   D P V      +   T+     L +++EY+   +   +++        +    +  
Sbjct: 74  LSQCDSPYVTKYYGSYLKDTK-----LWIIMEYLGGGSALDLLEP-----GPLDETQIAT 123

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFG-SAKVLVKGEPNISYIC 118
              +I + L Y+H+     HRDIK  N+L++    ++KL DFG + ++        +++ 
Sbjct: 124 ILREILKGLDYLHSE-KKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVG 181

Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 178
           + ++ APE+I  +  Y +  DIWS G    EL  G+P       +  L  I K    PT 
Sbjct: 182 TPFWMAPEVIKQS-AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN-NPPTL 239

Query: 179 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 238
           E                     + K  +        + V   L   P+ R TA E L H 
Sbjct: 240 EG-------------------NYSKPLK--------EFVEACLNKEPSFRPTAKELLKHK 272

Query: 239 FFDELRDPNTRL 250
           F        + L
Sbjct: 273 FILRNAKKTSYL 284

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score = 85.0 bits (211), Expect = 2e-19
 Identities = 22/163 (13%), Positives = 60/163 (36%), Gaps = 14/163 (8%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           +R+  HPNV+ +             +  L+  ++P  +++ V+  H   +  +       
Sbjct: 61  LRIFSHPNVLPVLGA---CQSPPAPHPTLITHWMPYGSLYNVL--HEGTNFVVDQSQAVK 115

Query: 60  YFYQICRALAYIHN-TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 118
           +   + R +A++H     +    +  ++++++      ++                  + 
Sbjct: 116 FALDMARGMAFLHTLEPLIPRHALNSRSVMIDED-MTARISMADVKFSFQSP----GRMY 170

Query: 119 SRYYRAPELIFG--ATEYTAAIDIWSAGCVLAELLLGQPLFPG 159
           +  + APE +          + D+WS   +L EL+  +  F  
Sbjct: 171 APAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD 213

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 85.1 bits (211), Expect = 2e-19
 Identities = 33/171 (19%), Positives = 66/171 (38%), Gaps = 29/171 (16%)

Query: 1   MRLLDHPNVVS-LKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHH-YKMSQRMPLIYV 57
             +L H N++  +     S     +L+L  +  Y    +++  ++         + +   
Sbjct: 56  TVMLRHENILGFIASDMTSRHSSTQLWL--ITHYHEMGSLYDYLQLTTLDTVSCLRI--- 110

Query: 58  KLYFYQICRALAYIHNTI-------GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 110
                 I   LA++H  I        + HRD+K +N+LV  +     + D G A +  + 
Sbjct: 111 ---VLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQ-CCIADLGLAVMHSQS 166

Query: 111 EPNISYICS-----RYYRAPELI-----FGATEYTAAIDIWSAGCVLAELL 151
              +    +     + Y APE++         +    +DIW+ G VL E+ 
Sbjct: 167 TNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 82.8 bits (205), Expect = 2e-18
 Identities = 42/204 (20%), Positives = 81/204 (39%), Gaps = 34/204 (16%)

Query: 1   MRLLDHPNVVS-LKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHY-KMSQRMPLIYV 57
           +  + H N++  +      T+   +L+L  +  +  + ++   +K +    ++   +   
Sbjct: 72  LPGMKHENILQFIGAEKRGTSVDVDLWL--ITAFHEKGSLSDFLKANVVSWNELCHIAET 129

Query: 58  KLYFYQICRALAYIHNTI---------GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 108
                 + R LAY+H  I          + HRDIK +N+L+  +     + DFG A    
Sbjct: 130 ------MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN-LTACIADFGLALKF- 181

Query: 109 KGEPNISYICSRY------YRAPELIFGA----TEYTAAIDIWSAGCVLAELLLGQPLFP 158
             E   S   +        Y APE++ GA     +    ID+++ G VL EL        
Sbjct: 182 --EAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239

Query: 159 GESGVDQLVEIIKVLGTPTREEIK 182
           G      L    ++   P+ E+++
Sbjct: 240 GPVDEYMLPFEEEIGQHPSLEDMQ 263

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 83.3 bits (206), Expect = 2e-18
 Identities = 33/171 (19%), Positives = 62/171 (36%), Gaps = 29/171 (16%)

Query: 1   MRLLDHPNVVS-LKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHH-YKMSQRMPLIYV 57
             +L H N++  +           +L+L  V +Y    ++   +  +   +   + L   
Sbjct: 90  TVMLRHENILGFIAADNKDNGTWTQLWL--VSDYHEHGSLFDYLNRYTVTVEGMIKLAL- 146

Query: 58  KLYFYQICRALAYIHNTI-------GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 110
                     LA++H  I        + HRD+K +N+LV  +     + D G A      
Sbjct: 147 -----STASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT-CCIADLGLAVRHDSA 200

Query: 111 EPNISYICS-----RYYRAPELIFGAT-----EYTAAIDIWSAGCVLAELL 151
              I    +     + Y APE++  +      E     DI++ G V  E+ 
Sbjct: 201 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score = 81.2 bits (201), Expect = 6e-18
 Identities = 61/266 (22%), Positives = 96/266 (36%), Gaps = 42/266 (15%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           MR L+HPNV+          +   L    + EY+   T+  +IK    M  + P    ++
Sbjct: 61  MRCLEHPNVLKF---IGVLYKDKRLNF--ITEYIKGGTLRGIIK---SMDSQYPWS-QRV 111

Query: 60  YF-YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 118
            F   I   +AY+H+ + + HRD+   N LV      + + DFG A+++V  +     + 
Sbjct: 112 SFAKDIASGMAYLHS-MNIIHRDLNSHNCLVR-ENKNVVVADFGLARLMVDEKTQPEGLR 169

Query: 119 SR---------------YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV 163
           S                Y+ APE+I G   Y   +D++S G VL E++      P     
Sbjct: 170 SLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPR 228

Query: 164 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQY 223
                +                P      F  I         +KR  P  V L   L   
Sbjct: 229 TMDFGLNVRGF--LDRYC----PPNCPPSFFPITVRCCDLDPEKR--PSFVKLEHWLETL 280

Query: 224 SPNLRSTA-----LEALIHPFFDELR 244
             +L         LE L   F++  R
Sbjct: 281 RMHLAGHLPLGPQLEQLDRGFWETYR 306

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score = 80.1 bits (198), Expect = 2e-17
 Identities = 31/178 (17%), Positives = 64/178 (35%), Gaps = 34/178 (19%)

Query: 1   MRLLDHPNVVSLK-HCFFSTTEKDELYLNLVLEYVPE-TVHRVI---KHHYKMSQRMPLI 55
            R   H NVV     C         L +  +       T++ V+   K    +++   + 
Sbjct: 83  YRQTRHENVVLFMGAC----MSPPHLAI--ITSLCKGRTLYSVVRDAKIVLDVNKTRQIA 136

Query: 56  YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS 115
                  +I + + Y+H   G+ H+D+K +N+  +     + + DFG   +    +    
Sbjct: 137 Q------EIVKGMGYLH-AKGILHKDLKSKNVFYDNGK--VVITDFGLFSISGVLQAGRR 187

Query: 116 YICSR------YYRAPELIFGATE--------YTAAIDIWSAGCVLAELLLGQPLFPG 159
               R       + APE+I   +         ++   D+++ G +  EL   +  F  
Sbjct: 188 EDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT 245

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 76.7 bits (189), Expect = 2e-16
 Identities = 30/258 (11%), Positives = 59/258 (22%), Gaps = 69/258 (26%)

Query: 4   LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFY 62
           +D P V  +              L +V E++   ++  V             +       
Sbjct: 88  IDKPGVARV----LDVVHTRAGGL-VVAEWIRGGSLQEVAD------TSPSPVGAIRAMQ 136

Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 122
            +  A    H   GV      P  + V+     + L                        
Sbjct: 137 SLAAAADAAHRA-GVALSIDHPSRVRVSI-DGDVVLAYPA-------------------T 175

Query: 123 RAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 182
                           DI   G  L  LL+ +   P       L    +        E  
Sbjct: 176 MPDA--------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPI-EPA 226

Query: 183 CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE 242
            ++ +                     +P +   + +R +Q    +RS +         + 
Sbjct: 227 DIDRD---------------------IPFQISAVAARSVQGDGGIRSASTLL------NL 259

Query: 243 LRDPNTRLPNGRFLPPLF 260
           ++           L P+ 
Sbjct: 260 MQQATAVADRTEVLGPID 277

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 76.8 bits (189), Expect = 3e-16
 Identities = 45/208 (21%), Positives = 81/208 (38%), Gaps = 32/208 (15%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           + L++H N+          T    +   LV+EY P  ++ + +  H         +    
Sbjct: 61  VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRL---- 116

Query: 60  YFYQICRALAYIHNTI--------GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 111
             + + R LAY+H  +         + HRD+  +N+LV        + DFG +  L    
Sbjct: 117 -AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT-CVISDFGLSMRLTGNR 174

Query: 112 PNISYICSRY---------YRAPELIFGA------TEYTAAIDIWSAGCVLAELLLG-QP 155
                              Y APE++ GA            +D+++ G +  E+ +    
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234

Query: 156 LFPGESGVD-QLVEIIKVLGTPTREEIK 182
           LFPGES  + Q+    +V   PT E+++
Sbjct: 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQ 262

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 66.5 bits (163), Expect = 8e-13
 Identities = 41/187 (21%), Positives = 72/187 (38%), Gaps = 43/187 (22%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVK 58
           M  +D+P+V  L            +   L+ + +P    +  V +H       +   Y+ 
Sbjct: 71  MASVDNPHVCRL----LGICLTSTVQ--LITQLMPFGCLLDYVREH----KDNIGSQYLL 120

Query: 59  LYFYQICRALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
            +  QI + + Y+     +   HRD+  +N+LV      +K+ DFG AK+L   E     
Sbjct: 121 NWCVQIAKGMNYLEDRRLV---HRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEK---- 172

Query: 117 ICSRYYR-----------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGV 163
                Y            A E ++     YT   D+WS G  + EL+  G   + G    
Sbjct: 173 ----EYHAEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 226

Query: 164 D--QLVE 168
           +   ++E
Sbjct: 227 EISSILE 233

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 66.1 bits (160), Expect = 1e-12
 Identities = 33/229 (14%), Positives = 76/229 (33%), Gaps = 36/229 (15%)

Query: 21  EKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR 80
           + D+L++ L  E+    + ++      ++        K   +Q+  +LA    ++   HR
Sbjct: 133 KDDQLFIVLEFEFGGIDLEQMRTKLSSLAT------AKSILHQLTASLAVAEASLRFEHR 186

Query: 81  DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDI 140
           D+   N+L+   + + KL    + K                     L     +YT +   
Sbjct: 187 DLHWGNVLLKKTSLK-KLHYTLNGKSSTIPSCG-------------LQVSIIDYTLSRLE 232

Query: 141 WSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-------NYTEFKF 193
                V  ++ + + LF G+   D   +I +++           +P       +Y   K 
Sbjct: 233 RDGIVVFCDVSMDEDLFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKM 290

Query: 194 PQIKAHPWHKIFQ--KRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
            +             K++  +  +    +L +     S+A + L     
Sbjct: 291 LKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNF-----SSATDLLCQHSL 334

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 64.7 bits (158), Expect = 3e-12
 Identities = 51/184 (27%), Positives = 81/184 (44%), Gaps = 35/184 (19%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           +R L H +++  K C     +     L LV+EYVP      ++  Y     + L  + L+
Sbjct: 87  LRTLYHEHIIKYKGC---CEDAGAASLQLVMEYVP---LGSLR-DYLPRHSIGLAQLLLF 139

Query: 61  FYQICRALAYIH--NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 118
             QIC  +AY+H  + I   HRD+  +N+L++ +   +K+ DFG AK + +G        
Sbjct: 140 AQQICEGMAYLHAQHYI---HRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGH------- 188

Query: 119 SRYYR------------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQ 165
             YYR            APE +     +  A D+WS G  L ELL          +   +
Sbjct: 189 -EYYRVREDGDSPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLE 246

Query: 166 LVEI 169
           L+ I
Sbjct: 247 LIGI 250

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 64.2 bits (157), Expect = 4e-12
 Identities = 44/167 (26%), Positives = 75/167 (44%), Gaps = 36/167 (21%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVK 58
           ++ L H N+V  K             L L++EY+P       + KH  ++     L Y  
Sbjct: 65  LKSLQHDNIVKYKGV---CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT- 120

Query: 59  LYFYQICRALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
               QIC+ + Y+     I   HRD+  +N+LV  + +++K+ DFG  KVL + +     
Sbjct: 121 ---SQICKGMEYLGTKRYI---HRDLATRNILVE-NENRVKIGDFGLTKVLPQDKE---- 169

Query: 117 ICSRYYR------------APELIFGATEYTAAIDIWSAGCVLAELL 151
               +++            APE +   ++++ A D+WS G VL EL 
Sbjct: 170 ----FFKVKEPGESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELF 211

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 63.5 bits (155), Expect = 1e-11
 Identities = 46/167 (27%), Positives = 74/167 (44%), Gaps = 36/167 (21%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVK 58
           ++ L H N+V  K             L L++EY+P       + KH  ++     L Y  
Sbjct: 96  LKSLQHDNIVKYKGV---CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT- 151

Query: 59  LYFYQICRALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
               QIC+ + Y+     I   HRD+  +N+LV    +++K+ DFG  KVL + +     
Sbjct: 152 ---SQICKGMEYLGTKRYI---HRDLATRNILVENE-NRVKIGDFGLTKVLPQDK----- 199

Query: 117 ICSRYYR------------APELIFGATEYTAAIDIWSAGCVLAELL 151
               YY+            APE +   ++++ A D+WS G VL EL 
Sbjct: 200 ---EYYKVKEPGESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELF 242

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 62.7 bits (153), Expect = 2e-11
 Identities = 36/182 (19%), Positives = 67/182 (36%), Gaps = 31/182 (17%)

Query: 1   MRLLDHPNVVSLKH-CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVK 58
           M+  DHP+V  L      S  +       ++L ++    +H  +           L    
Sbjct: 79  MKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQT 138

Query: 59  L--YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
           L  +   I   + Y+ ++    HRD+  +N ++      + + DFG ++ +  G+     
Sbjct: 139 LVRFMVDIACGMEYL-SSRNFIHRDLAARNCMLAED-MTVCVADFGLSRKIYSGD----- 191

Query: 117 ICSRYYR------------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESG 162
               YYR            A E L      YT   D+W+ G  + E++  GQ  + G   
Sbjct: 192 ----YYRQGCASKLPVKWLALESLADN--LYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN 245

Query: 163 VD 164
            +
Sbjct: 246 AE 247

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 62.3 bits (152), Expect = 2e-11
 Identities = 44/166 (26%), Positives = 72/166 (43%), Gaps = 34/166 (20%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           +R L H N+V  K      TE     + L++E++P  ++   +  +     ++ L     
Sbjct: 77  LRNLYHENIVKYKGI---CTEDGGNGIKLIMEFLPSGSLKEYLPKN---KNKINLKQQLK 130

Query: 60  YFYQICRALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           Y  QIC+ + Y+     +   HRD+  +N+LV    HQ+K+ DFG  K +   +      
Sbjct: 131 YAVQICKGMDYLGSRQYV---HRDLAARNVLVE-SEHQVKIGDFGLTKAIETDK------ 180

Query: 118 CSRYYR------------APELIFGATEYTAAIDIWSAGCVLAELL 151
              YY             APE +  +  +  A D+WS G  L ELL
Sbjct: 181 --EYYTVKDDRDSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELL 223

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 62.3 bits (152), Expect = 2e-11
 Identities = 36/183 (19%), Positives = 69/183 (37%), Gaps = 34/183 (18%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           M+   HPNV+ L       + +      ++L ++    +H  + +    +    +    L
Sbjct: 90  MKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTL 149

Query: 60  --YFYQICRALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS 115
             +   I   + Y+   N +   HRD+  +N ++      + + DFG +K +  G+    
Sbjct: 150 LKFMVDIALGMEYLSNRNFL---HRDLAARNCMLRDD-MTVCVADFGLSKKIYSGD---- 201

Query: 116 YICSRYYR------------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGES 161
                YYR            A E L      YT+  D+W+ G  + E+   G   +PG  
Sbjct: 202 -----YYRQGRIAKMPVKWIAIESLADRV--YTSKSDVWAFGVTMWEIATRGMTPYPGVQ 254

Query: 162 GVD 164
             +
Sbjct: 255 NHE 257

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 62.0 bits (151), Expect = 3e-11
 Identities = 41/185 (22%), Positives = 71/185 (38%), Gaps = 39/185 (21%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           M  +D+P+V  L            +   L+ + +P   +   ++ H      +   Y+  
Sbjct: 71  MASVDNPHVCRL----LGICLTSTVQ--LITQLMPFGCLLDYVREH---KDNIGSQYLLN 121

Query: 60  YFYQICRALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           +  QI + + Y+     +   HRD+  +N+LV      +K+ DFG AK+L   E      
Sbjct: 122 WCVQIAKGMNYLEDRRLV---HRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEK----- 172

Query: 118 CSRYYR-----------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD- 164
               Y            A E I     YT   D+WS G  + EL+  G   + G    + 
Sbjct: 173 ---EYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 228

Query: 165 -QLVE 168
             ++E
Sbjct: 229 SSILE 233

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 62.0 bits (151), Expect = 3e-11
 Identities = 40/180 (22%), Positives = 74/180 (41%), Gaps = 29/180 (16%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           +  LDH ++V L            L   LV +Y+P  ++   ++ H      +    +  
Sbjct: 69  IGSLDHAHIVRL----LGLCPGSSLQ--LVTQYLPLGSLLDHVRQH---RGALGPQLLLN 119

Query: 60  YFYQICRALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           +  QI + + Y+  H  +   HR++  +N+L+     Q+++ DFG A +L   +     +
Sbjct: 120 WGVQIAKGMYYLEEHGMV---HRNLAARNVLLKSP-SQVQVADFGVADLLPPDD---KQL 172

Query: 118 CSRYYR------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD--QLVE 168
                +      A E I     YT   D+WS G  + EL+  G   + G    +   L+E
Sbjct: 173 LYSEAKTPIKWMALESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE 231

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 62.0 bits (151), Expect = 3e-11
 Identities = 41/167 (24%), Positives = 69/167 (41%), Gaps = 36/167 (21%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVK 58
           ++ L    +V  +   +    +  L   LV+EY+P       + +H  ++     L+Y  
Sbjct: 78  LKALHSDFIVKYRGVSYGPGRQS-LR--LVMEYLPSGCLRDFLQRHRARLDASRLLLYS- 133

Query: 59  LYFYQICRALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
               QIC+ + Y+     +   HRD+  +N+LV      +K+ DFG AK+L   +     
Sbjct: 134 ---SQICKGMEYLGSRRCV---HRDLAARNILVE-SEAHVKIADFGLAKLLPLDK----- 181

Query: 117 ICSRYYR------------APELIFGATEYTAAIDIWSAGCVLAELL 151
               YY             APE +     ++   D+WS G VL EL 
Sbjct: 182 ---DYYVVREPGQSPIFWYAPESLS-DNIFSRQSDVWSFGVVLYELF 224

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 61.5 bits (150), Expect = 3e-11
 Identities = 39/180 (21%), Positives = 75/180 (41%), Gaps = 39/180 (21%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M+ LD+P +V +        E +     LV+E         +  + + ++ +    +   
Sbjct: 72  MQQLDNPYIVRM----IGICEAESWM--LVMEMAE---LGPLNKYLQQNRHVKDKNIIEL 122

Query: 61  FYQICRALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 118
            +Q+   + Y+   N +   HRD+  +N+L+    H  K+ DFG +K L   E       
Sbjct: 123 VHQVSMGMKYLEESNFV---HRDLAARNVLLVTQ-HYAKISDFGLSKALRADEN------ 172

Query: 119 SRYYR------------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 164
             YY+            APE + +   ++++  D+WS G ++ E    GQ  + G  G +
Sbjct: 173 --YYKAQTHGKWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 228

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 62.7 bits (152), Expect = 3e-11
 Identities = 42/181 (23%), Positives = 76/181 (41%), Gaps = 40/181 (22%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           M  LD+P +V L        + + L   LV+E      +H+ +       + +P+  V  
Sbjct: 390 MHQLDNPYIVRL----IGVCQAEALM--LVMEMAGGGPLHKFLVGK---REEIPVSNVAE 440

Query: 60  YFYQICRALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
             +Q+   + Y+   N +   HR++  +N+L+  + H  K+ DFG +K L   +      
Sbjct: 441 LLHQVSMGMKYLEEKNFV---HRNLAARNVLLV-NRHYAKISDFGLSKALGADDS----- 491

Query: 118 CSRYYR------------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGV 163
              YY             APE + F   ++++  D+WS G  + E L  GQ  +    G 
Sbjct: 492 ---YYTARSAGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP 546

Query: 164 D 164
           +
Sbjct: 547 E 547

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 61.2 bits (149), Expect = 5e-11
 Identities = 36/182 (19%), Positives = 60/182 (32%), Gaps = 39/182 (21%)

Query: 1   MRLLDHPNVVSLKH-CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL 59
           M  L H ++V     C       DE  L  V E+V       +  + K ++    I  KL
Sbjct: 66  MSKLSHKHLVLNYGVC----VCGDENIL--VQEFVK---FGSLDTYLKKNKNCINILWKL 116

Query: 60  YF-YQICRALAYI--HNTIGVCHRDIKPQNLLVNPHTHQL-------KLCDFGSAKVLVK 109
               Q+  A+ ++  +  I   H ++  +N+L+     +        KL D G +  ++ 
Sbjct: 117 EVAKQLAAAMHFLEENTLI---HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP 173

Query: 110 GEPNISYICSRYYR------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESG 162
            +           +       PE I        A D WS G  L E+   G         
Sbjct: 174 KD---------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS 224

Query: 163 VD 164
             
Sbjct: 225 QR 226

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 61.7 bits (150), Expect = 6e-11
 Identities = 45/179 (25%), Positives = 75/179 (41%), Gaps = 27/179 (15%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL- 59
           M+ L H  +V L    ++   ++ +Y  +V EY+       +    K      L   +L 
Sbjct: 233 MKKLRHEKLVQL----YAVVSEEPIY--IVTEYMS---KGSLLDFLKGETGKYLRLPQLV 283

Query: 60  -YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 118
               QI   +AY+   +   HRD++  N+LV  +    K+ DFG A+++   E    Y  
Sbjct: 284 DMAAQIASGMAYVER-MNYVHRDLRAANILVGEN-LVCKVADFGLARLIEDNE----YTA 337

Query: 119 SRYYR------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD--QLVE 168
            +  +      APE       +T   D+WS G +L EL   G+  +PG    +    VE
Sbjct: 338 RQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 395

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 61.4 bits (149), Expect = 6e-11
 Identities = 44/175 (25%), Positives = 74/175 (42%), Gaps = 29/175 (16%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL- 59
           M+ L H  +V L    ++   ++ +Y  +V EY+       +    K      L   +L 
Sbjct: 316 MKKLRHEKLVQL----YAVVSEEPIY--IVTEYMS---KGSLLDFLKGETGKYLRLPQLV 366

Query: 60  -YFYQICRALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
               QI   +AY+   N +   HRD++  N+LV  +    K+ DFG A+++   E    Y
Sbjct: 367 DMAAQIASGMAYVERMNYV---HRDLRAANILVGEN-LVCKVADFGLARLIEDNE----Y 418

Query: 117 ICSRYYR------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 164
              +  +      APE       +T   D+WS G +L EL   G+  +PG    +
Sbjct: 419 TARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNRE 472

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 60.3 bits (147), Expect = 1e-10
 Identities = 43/175 (24%), Positives = 74/175 (42%), Gaps = 50/175 (28%)

Query: 4   LDHPNVVSL-KHCFFSTTEKDELYLNLVLEYVP-----ETVHRVIKHHYKMS--QRMPLI 55
             HP++VSL   C     E++E+ L  + +Y+        ++        MS  QR+   
Sbjct: 92  CRHPHLVSLIGFC----DERNEMIL--IYKYMENGNLKRHLYGSDLPTMSMSWEQRL--- 142

Query: 56  YVKLYFYQIC----RALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE 111
                  +IC    R L Y+H    + HRD+K  N+L++ +    K+ DFG +K   + +
Sbjct: 143 -------EICIGAARGLHYLHTR-AIIHRDVKSINILLDENFVP-KITDFGISKKGTELD 193

Query: 112 PNISYICSRY-----YRAPELIFGATEY------TAAIDIWSAGCVLAELLLGQP 155
              +++ +       Y  P       EY      T   D++S G VL E+L  + 
Sbjct: 194 Q--THLSTVVKGTLGYIDP-------EYFIKGRLTEKSDVYSFGVVLFEVLCARS 239

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 60.9 bits (148), Expect = 1e-10
 Identities = 40/175 (22%), Positives = 73/175 (41%), Gaps = 28/175 (16%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL- 59
           M+ + HPN+V L       T +   Y  ++ E++    +  +  + +   R  +  V L 
Sbjct: 270 MKEIKHPNLVQLLGV---CTREPPFY--IITEFMT---YGNLLDYLRECNRQEVSAVVLL 321

Query: 60  -YFYQICRALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
               QI  A+ Y+   N I   HR++  +N LV    H +K+ DFG ++++        Y
Sbjct: 322 YMATQISSAMEYLEKKNFI---HRNLAARNCLVG-ENHLVKVADFGLSRLMTGDT----Y 373

Query: 117 ICSRYYR------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 164
                 +      APE +     ++   D+W+ G +L E+   G   +PG     
Sbjct: 374 TAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 427

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 60.0 bits (146), Expect = 1e-10
 Identities = 41/181 (22%), Positives = 73/181 (40%), Gaps = 40/181 (22%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           M  LD+P +V L        + + L   LV+E      +H+ +    +      +     
Sbjct: 64  MHQLDNPYIVRL----IGVCQAEALM--LVMEMAGGGPLHKFLVGKREEIPVSNVAE--- 114

Query: 60  YFYQICRALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
             +Q+   + Y+   N +   HRD+  +N+L+  + H  K+ DFG +K L   +      
Sbjct: 115 LLHQVSMGMKYLEEKNFV---HRDLAARNVLLV-NRHYAKISDFGLSKALGADDS----- 165

Query: 118 CSRYYR------------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGV 163
              YY             APE + F   ++++  D+WS G  + E L  GQ  +    G 
Sbjct: 166 ---YYTARSAGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP 220

Query: 164 D 164
           +
Sbjct: 221 E 221

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 59.6 bits (145), Expect = 2e-10
 Identities = 43/180 (23%), Positives = 67/180 (37%), Gaps = 38/180 (21%)

Query: 1   MRLLDHPNVVSLKH-CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL 59
           ++   HPN+V L   C    T+K  +Y  +V+E V            +       +   L
Sbjct: 166 LKQYSHPNIVRLIGVC----TQKQPIY--IVMELVQ---GGDFLTFLRTEGARLRVKTLL 216

Query: 60  YF-YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 118
                    + Y+ +     HRD+  +N LV    + LK+ DFG ++    G        
Sbjct: 217 QMVGDAAAGMEYLES-KCCIHRDLAARNCLVTEK-NVLKISDFGMSREEADGV------- 267

Query: 119 SRYYR------------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 164
             Y              APE L +G   Y++  D+WS G +L E   LG   +P  S   
Sbjct: 268 --YAASGGLRQVPVKWTAPEALNYG--RYSSESDVWSFGILLWETFSLGASPYPNLSNQQ 323

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 59.7 bits (145), Expect = 2e-10
 Identities = 43/171 (25%), Positives = 70/171 (40%), Gaps = 33/171 (19%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL- 59
           M  L H N+V L        EK  LY  +V EY+       +  + +   R  L    L 
Sbjct: 240 MTQLRHSNLVQLLGV--IVEEKGGLY--IVTEYMA---KGSLVDYLRSRGRSVLGGDCLL 292

Query: 60  -YFYQICRALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
            +   +C A+ Y+  +N +   HRD+  +N+LV+   +  K+ DFG  K           
Sbjct: 293 KFSLDVCEAMEYLEGNNFV---HRDLAARNVLVSED-NVAKVSDFGLTKEA--------S 340

Query: 117 ICSRYYR------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 159
                 +      APE L     +++   D+WS G +L E+   G+  +P 
Sbjct: 341 STQDTGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPR 389

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 58.8 bits (143), Expect = 2e-10
 Identities = 44/176 (25%), Positives = 71/176 (40%), Gaps = 33/176 (18%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL- 59
           M  L H N+V L        EK  LY  +V EY+       +  + +   R  L    L 
Sbjct: 68  MTQLRHSNLVQLLGV--IVEEKGGLY--IVTEYMA---KGSLVDYLRSRGRSVLGGDCLL 120

Query: 60  -YFYQICRALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
            +   +C A+ Y+  +N +   HRD+  +N+LV+   +  K+ DFG  K           
Sbjct: 121 KFSLDVCEAMEYLEGNNFV---HRDLAARNVLVSED-NVAKVSDFGLTKEA--------S 168

Query: 117 ICSRYYR------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 164
                 +      APE L     +++   D+WS G +L E+   G+  +P     D
Sbjct: 169 STQDTGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 222

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 59.2 bits (144), Expect = 2e-10
 Identities = 45/198 (22%), Positives = 70/198 (35%), Gaps = 45/198 (22%)

Query: 2   RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYV-------------PETVHRVIKHHYKM 48
            L +H N+V+L       T        ++ EY                 +          
Sbjct: 82  YLGNHMNIVNLLGA---CTIGGPTL--VITEYCCYGDLLNFLRRKRDSFICSKTSPAIME 136

Query: 49  SQRMPLIYVKLYF--YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV 106
              + L    L    YQ+ + +A++  +    HRD+  +N+L+       K+CDFG A+ 
Sbjct: 137 DDELALDLEDLLSFSYQVAKGMAFL-ASKNCIHRDLAARNILLTHG-RITKICDFGLARD 194

Query: 107 LVKGEPNISYICSRYYR------------APELIFGATEYTAAIDIWSAGCVLAELL-LG 153
           +              Y             APE IF    YT   D+WS G  L EL  LG
Sbjct: 195 IKNDS---------NYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLG 244

Query: 154 QPLFPGESGVDQLVEIIK 171
              +PG     +  ++IK
Sbjct: 245 SSPYPGMPVDSKFYKMIK 262

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 59.7 bits (145), Expect = 3e-10
 Identities = 47/181 (25%), Positives = 77/181 (42%), Gaps = 41/181 (22%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL- 59
           M+ L H  +V L     +   K+ +Y  ++ E++       +    K  +       KL 
Sbjct: 237 MKTLQHDKLVKL----HAVVTKEPIY--IITEFMA---KGSLLDFLKSDEGSKQPLPKLI 287

Query: 60  -YFYQICRALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
            +  QI   +A+I   N I   HRD++  N+LV+      K+ DFG A+V+   E     
Sbjct: 288 DFSAQIAEGMAFIEQRNYI---HRDLRAANILVSAS-LVCKIADFGLARVIEDNE----- 338

Query: 117 ICSRYYR-----------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGV 163
               Y             APE + FG   +T   D+WS G +L E++  G+  +PG S  
Sbjct: 339 ----YTAREGAKFPIKWTAPEAINFG--SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP 392

Query: 164 D 164
           +
Sbjct: 393 E 393

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 58.4 bits (142), Expect = 3e-10
 Identities = 40/184 (21%), Positives = 75/184 (40%), Gaps = 47/184 (25%)

Query: 1   MRLLDHPNVVSLKH-CFFSTTEKDELYLNLVLEYVPE----TVHRVIKHHYKMSQRMPLI 55
           M  L HP +V     C    +++  +Y  +V EY+         R      + SQ   L+
Sbjct: 57  MMKLSHPKLVKFYGVC----SKEYPIY--IVTEYISNGCLLNYLRSHGKGLEPSQ---LL 107

Query: 56  YVKLYFYQICRALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 113
                 Y +C  +A++  H  I   HRD+  +N LV+     +K+ DFG  + ++  +  
Sbjct: 108 E---MCYDVCEGMAFLESHQFI---HRDLAARNCLVDRD-LCVKVSDFGMTRYVLDDQ-- 158

Query: 114 ISYICSRYYR-----------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGE 160
                  Y             APE   +   +Y++  D+W+ G ++ E+  LG+  +   
Sbjct: 159 -------YVSSVGTKFPVKWSAPEVFHYF--KYSSKSDVWAFGILMWEVFSLGKMPYDLY 209

Query: 161 SGVD 164
           +  +
Sbjct: 210 TNSE 213

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 58.4 bits (142), Expect = 3e-10
 Identities = 42/171 (24%), Positives = 76/171 (44%), Gaps = 30/171 (17%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL- 59
           M+ + HPN+V L       T +   Y  ++ E++    +  +  + +   R  +  V L 
Sbjct: 63  MKEIKHPNLVQLLGV---CTREPPFY--IITEFMT---YGNLLDYLRECNRQEVSAVVLL 114

Query: 60  -YFYQICRALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
               QI  A+ Y+   N I   HRD+  +N LV  + H +K+ DFG ++++        Y
Sbjct: 115 YMATQISSAMEYLEKKNFI---HRDLAARNCLVGEN-HLVKVADFGLSRLMTGDT----Y 166

Query: 117 ICSRYYR------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 159
                 +      APE L +   +++   D+W+ G +L E+   G   +PG
Sbjct: 167 TAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPG 215

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 58.4 bits (142), Expect = 3e-10
 Identities = 43/188 (22%), Positives = 70/188 (37%), Gaps = 44/188 (23%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVK 58
           M  LDH N++ L    +       +   +V E  P    + R+ KH         L  + 
Sbjct: 75  MHSLDHRNLIRL----YGVVLTPPMK--MVTELAPLGSLLDRLRKH----QGHFLLGTLS 124

Query: 59  LYFYQICRALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
            Y  Q+   + Y+     I   HRD+  +NLL+      +K+ DFG  + L + +     
Sbjct: 125 RYAVQVAEGMGYLESKRFI---HRDLAARNLLLATR-DLVKIGDFGLMRALPQNDD---- 176

Query: 117 ICSRYYR------------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESG 162
               +Y             APE L      ++ A D W  G  L E+   GQ  + G +G
Sbjct: 177 ----HYVMQEHRKVPFAWCAPESLKTRT--FSHASDTWMFGVTLWEMFTYGQEPWIGLNG 230

Query: 163 VD--QLVE 168
                 ++
Sbjct: 231 SQILHKID 238

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 59.5 bits (144), Expect = 4e-10
 Identities = 49/189 (25%), Positives = 81/189 (42%), Gaps = 48/189 (25%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE----TVHRVIKHHYKMSQRMPLIY 56
           MR  DHP++V L         ++ ++  +++E        +  +V K    ++    LI 
Sbjct: 445 MRQFDHPHIVKL----IGVITENPVW--IIMELCTLGELRSFLQVRKFSLDLAS---LIL 495

Query: 57  VKLYFYQICRALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 114
              Y YQ+  ALAY+     +   HRDI  +N+LV+ +   +KL DFG ++ +       
Sbjct: 496 ---YAYQLSTALAYLESKRFV---HRDIAARNVLVSSN-DCVKLGDFGLSRYMEDST--- 545

Query: 115 SYICSRYYR-----------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGES 161
                 YY+           APE + F    +T+A D+W  G  + E+L  G   F G  
Sbjct: 546 ------YYKASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVK 597

Query: 162 G--VDQLVE 168
              V   +E
Sbjct: 598 NNDVIGRIE 606

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 57.6 bits (140), Expect = 8e-10
 Identities = 48/187 (25%), Positives = 82/187 (43%), Gaps = 43/187 (22%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL- 59
           M+ L H  +V L    ++   ++ +Y  ++ EY+    +  +    K    + L   KL 
Sbjct: 62  MKQLQHQRLVRL----YAVVTQEPIY--IITEYME---NGSLVDFLKTPSGIKLTINKLL 112

Query: 60  -YFYQICRALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
               QI   +A+I   N I   HRD++  N+LV+      K+ DFG A+++   E     
Sbjct: 113 DMAAQIAEGMAFIEERNYI---HRDLRAANILVSDT-LSCKIADFGLARLIEDNE----- 163

Query: 117 ICSRYYR-----------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESG- 162
               Y             APE + +G   +T   D+WS G +L E++  G+  +PG +  
Sbjct: 164 ----YTAREGAKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP 217

Query: 163 -VDQLVE 168
            V Q +E
Sbjct: 218 EVIQNLE 224

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 57.2 bits (139), Expect = 9e-10
 Identities = 48/183 (26%), Positives = 80/183 (43%), Gaps = 46/183 (25%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE----TVHRVIKHHYKMSQRMPLIY 56
           MR  DHP++V L         ++ ++  +++E        +  +V K+   ++    LI 
Sbjct: 70  MRQFDHPHIVKL----IGVITENPVW--IIMELCTLGELRSFLQVRKYSLDLAS---LIL 120

Query: 57  VKLYFYQICRALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 114
              Y YQ+  ALAY+     +   HRDI  +N+LV+ +   +KL DFG ++ +       
Sbjct: 121 ---YAYQLSTALAYLESKRFV---HRDIAARNVLVSSN-DCVKLGDFGLSRYMEDST--- 170

Query: 115 SYICSRYYR-----------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGES 161
                 YY+           APE + F    +T+A D+W  G  + E+L  G   F G  
Sbjct: 171 ------YYKASKGKLPIKWMAPESINFRR--FTSASDVWMFGVCMWEILMHGVKPFQGVK 222

Query: 162 GVD 164
             D
Sbjct: 223 NND 225

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 57.3 bits (139), Expect = 1e-09
 Identities = 39/192 (20%), Positives = 73/192 (38%), Gaps = 40/192 (20%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-------TVHRVIKHHYKMSQRMP 53
           M+  +  +VV L       ++       +++E +            R    +  +     
Sbjct: 82  MKEFNCHHVVRLLGV---VSQGQPTL--VIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 136

Query: 54  LIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 113
           L  +     +I   +AY+ N     HRD+  +N +V      +K+ DFG  + + + +  
Sbjct: 137 LSKMIQMAGEIADGMAYL-NANKFVHRDLAARNCMVAED-FTVKIGDFGMTRDIYETD-- 192

Query: 114 ISYICSRYYR------------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPG 159
                  YYR            +PE L  G   +T   D+WS G VL E+  L +  + G
Sbjct: 193 -------YYRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQG 243

Query: 160 ESGVDQLVEIIK 171
            S  +Q++  + 
Sbjct: 244 LS-NEQVLRFVM 254

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 56.8 bits (138), Expect = 1e-09
 Identities = 38/181 (20%), Positives = 70/181 (38%), Gaps = 41/181 (22%)

Query: 1   MRLLDHPNVVSLKH-CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVK 58
           M  L HP +V L   C     E+  +   LV E++    +   ++    +     L+   
Sbjct: 57  MMKLSHPKLVQLYGVC----LEQAPIC--LVTEFMEHGCLSDYLRTQRGLFAAETLLG-- 108

Query: 59  LYFYQICRALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
                +C  +AY+     I   HRD+  +N LV  +   +K+ DFG  + ++  +     
Sbjct: 109 -MCLDVCEGMAYLEEACVI---HRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQ----- 158

Query: 117 ICSRYYR-----------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGV 163
               Y             +PE   F    Y++  D+WS G ++ E+   G+  +   S  
Sbjct: 159 ----YTSSTGTKFPVKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS 212

Query: 164 D 164
           +
Sbjct: 213 E 213

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 56.8 bits (138), Expect = 1e-09
 Identities = 47/183 (25%), Positives = 78/183 (42%), Gaps = 46/183 (25%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE----TVHRVIKHHYKMSQRMPLIY 56
           M+ LDHP++V L        E++  +  +++E  P           K+  K+     L+ 
Sbjct: 67  MKNLDHPHIVKL----IGIIEEEPTW--IIMELYPYGELGHYLERNKNSLKVLT---LVL 117

Query: 57  VKLYFYQICRALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 114
              Y  QIC+A+AY+   N +   HRDI  +N+LV      +KL DFG ++ +   +   
Sbjct: 118 ---YSLQICKAMAYLESINCV---HRDIAVRNILVASP-ECVKLGDFGLSRYIEDED--- 167

Query: 115 SYICSRYYR-----------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGES 161
                 YY+           +PE + F    +T A D+W     + E+L  G+  F    
Sbjct: 168 ------YYKASVTRLPIKWMSPESINFRR--FTTASDVWMFAVCMWEILSFGKQPFFWLE 219

Query: 162 GVD 164
             D
Sbjct: 220 NKD 222

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 56.9 bits (138), Expect = 1e-09
 Identities = 45/183 (24%), Positives = 76/183 (41%), Gaps = 41/183 (22%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           MR L+HPNV++L         +   +  ++L Y+    H  +    +  QR P +   + 
Sbjct: 76  MRGLNHPNVLALIGI--MLPPEGLPH--VLLPYMC---HGDLLQFIRSPQRNPTVKDLIS 128

Query: 61  F-YQICRALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYI 117
           F  Q+ R + Y+     +   HRD+  +N +++  +  +K+ DFG A+ ++  E      
Sbjct: 129 FGLQVARGMEYLAEQKFV---HRDLAARNCMLD-ESFTVKVADFGLARDILDRE------ 178

Query: 118 CSRYYR--------------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGES 161
              YY               A E L      +T   D+WS G +L ELL  G P +    
Sbjct: 179 ---YYSVQQHRHARLPVKWTALESLQTYR--FTTKSDVWSFGVLLWELLTRGAPPYRHID 233

Query: 162 GVD 164
             D
Sbjct: 234 PFD 236

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 56.8 bits (138), Expect = 2e-09
 Identities = 40/173 (23%), Positives = 72/173 (41%), Gaps = 44/173 (25%)

Query: 3   LLDHPNVVSLK-HCFFSTTEKDELYLNLVLEYVP-----ETVHRVIKHHYKM--SQRMPL 54
           +  H N++ L+  C        E  L  V  Y+        +    +    +   +R   
Sbjct: 83  MAVHRNLLRLRGFC----MTPTERLL--VYPYMANGSVASCLRERPESQPPLDWPKRQ-- 134

Query: 55  IYVKLYFYQIC----RALAYIHNTIGVC--HRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 108
                   +I     R LAY+H+       HRD+K  N+L++    +  + DFG AK++ 
Sbjct: 135 --------RIALGSARGLAYLHDHCDPKIIHRDVKAANILLD-EEFEAVVGDFGLAKLM- 184

Query: 109 KGEPNISYICSRY-----YRAPE-LIFG-ATEYTAAIDIWSAGCVLAELLLGQ 154
             +   +++ +       + APE L  G ++E T   D++  G +L EL+ GQ
Sbjct: 185 --DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT---DVFGYGVMLLELITGQ 232

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 55.6 bits (135), Expect = 3e-09
 Identities = 45/168 (26%), Positives = 68/168 (40%), Gaps = 36/168 (21%)

Query: 3   LLDHPNVVSLK-HCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLY 60
              H N+V L        ++ D+L L  V  Y+P  ++         +    PL +    
Sbjct: 86  KCQHENLVELLGFS----SDGDDLCL--VYVYMPNGSLLD---RLSCLDGTPPLSWHMRC 136

Query: 61  FYQIC----RALAYIHNTIGVCHRDIKPQNLLV----NPHTHQLKLCDFGSAKVLVKGEP 112
             +I       + ++H      HRDIK  N+L+           K+ DFG A+   K   
Sbjct: 137 --KIAQGAANGINFLHEN-HHIHRDIKSANILLDEAFTA-----KISDFGLARASEKFA- 187

Query: 113 NISYICSR----Y-YRAPELIFGATEYTAAIDIWSAGCVLAELLLGQP 155
             + + SR      Y APE + G  E T   DI+S G VL E++ G P
Sbjct: 188 -QTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLP 232

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 55.7 bits (135), Expect = 3e-09
 Identities = 40/201 (19%), Positives = 76/201 (37%), Gaps = 52/201 (25%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-----------ETVHRVIKHHYKMS 49
           +  L H ++V          + D L   +V EY+                 ++       
Sbjct: 71  LTNLQHEHIVKFYGV---CGDGDPLI--MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125

Query: 50  QRMPLIYVKLYF--YQICRALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK 105
            +  L   ++     QI   + Y+   + +   HRD+  +N LV  +   +K+ DFG ++
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLASQHFV---HRDLATRNCLVGAN-LLVKIGDFGMSR 181

Query: 106 VLVKGEPNISYICSRYYR------------APE-LIFGATEYTAAIDIWSAGCVLAELL- 151
            +   +         YYR             PE +++   ++T   D+WS G +L E+  
Sbjct: 182 DVYSTD---------YYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVILWEIFT 230

Query: 152 LG-QPLFPGESGVDQLVEIIK 171
            G QP +   S   +++E I 
Sbjct: 231 YGKQP-WFQLS-NTEVIECIT 249

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 55.7 bits (135), Expect = 4e-09
 Identities = 44/198 (22%), Positives = 79/198 (39%), Gaps = 43/198 (21%)

Query: 1   MRLLD-HPNVVSLKHCFFSTTEKDELYLNLVLEYV-------------PETVHRVIKHHY 46
           +  +  H NVV+L      T     L +  ++E+               E V   +    
Sbjct: 84  LIHIGHHLNVVNLLGA--CTKPGGPLMV--IVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139

Query: 47  KMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV 106
                + L ++  Y +Q+ + + ++  +    HRD+  +N+L++   + +K+CDFG A+ 
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFL-ASRKCIHRDLAARNILLSEK-NVVKICDFGLARD 197

Query: 107 LVKGEPNISYICSRYYR------------APELIFGATEYTAAIDIWSAGCVLAELL-LG 153
           + K            Y             APE IF    YT   D+WS G +L E+  LG
Sbjct: 198 IYKDP---------DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLG 247

Query: 154 QPLFPGESGVDQLVEIIK 171
              +PG    ++    +K
Sbjct: 248 ASPYPGVKIDEEFCRRLK 265

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 54.9 bits (133), Expect = 5e-09
 Identities = 39/184 (21%), Positives = 78/184 (42%), Gaps = 47/184 (25%)

Query: 1   MRLLDHPNVVSLKH-CFFSTTEKDELYLNLVLEYVPE----TVHRVIKHHYKMSQRMPLI 55
           M  L H  +V L   C    T++  ++  ++ EY+         R ++H ++  Q   L+
Sbjct: 73  MMNLSHEKLVQLYGVC----TKQRPIF--IITEYMANGCLLNYLREMRHRFQTQQ---LL 123

Query: 56  YVKLYFYQICRALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 113
                   +C A+ Y+     +   HRD+  +N LVN     +K+ DFG ++ ++  E  
Sbjct: 124 E---MCKDVCEAMEYLESKQFL---HRDLAARNCLVNDQ-GVVKVSDFGLSRYVLDDE-- 174

Query: 114 ISYICSRYYR-----------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGE 160
                  Y              PE L++   ++++  DIW+ G ++ E+  LG+  +   
Sbjct: 175 -------YTSSVGSKFPVRWSPPEVLMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYERF 225

Query: 161 SGVD 164
           +  +
Sbjct: 226 TNSE 229

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 55.0 bits (133), Expect = 7e-09
 Identities = 42/198 (21%), Positives = 74/198 (37%), Gaps = 47/198 (23%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP----------ETVHRVIKHHYKMSQ 50
           + +L H ++V         TE   L   +V EY+                 +    +   
Sbjct: 97  LTMLQHQHIVRFFGV---CTEGRPLL--MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVA 151

Query: 51  RMPLIYVKLYF--YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 108
             PL   +L     Q+   + Y+   +   HRD+  +N LV      +K+ DFG ++ + 
Sbjct: 152 PGPLGLGQLLAVASQVAAGMVYL-AGLHFVHRDLATRNCLVGQG-LVVKIGDFGMSRDIY 209

Query: 109 KGEPNISYICSRYYR------------APE-LIFGATEYTAAIDIWSAGCVLAELL-LG- 153
             +         YYR             PE +++   ++T   D+WS G VL E+   G 
Sbjct: 210 STD---------YYRVGGRTMLPIRWMPPESILYR--KFTTESDVWSFGVVLWEIFTYGK 258

Query: 154 QPLFPGESGVDQLVEIIK 171
           QP +   S   + ++ I 
Sbjct: 259 QP-WYQLS-NTEAIDCIT 274

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 54.2 bits (131), Expect = 1e-08
 Identities = 40/182 (21%), Positives = 72/182 (39%), Gaps = 41/182 (22%)

Query: 1   MRLLDHPNVVSLKH-CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVK 58
           M   DHPN++ L+       T        +V EY+   ++   ++ H      M L+   
Sbjct: 104 MGQFDHPNIIRLEGVV----TRGRLAM--IVTEYMENGSLDTFLRTHDGQFTIMQLVG-- 155

Query: 59  LYFYQICRALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
                +   + Y+     +   HRD+  +N+LV+ +    K+ DFG ++VL         
Sbjct: 156 -MLRGVGAGMRYLSDLGYV---HRDLAARNVLVDSN-LVCKVSDFGLSRVLEDDP----- 205

Query: 117 ICSRYYR------------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESG 162
                              APE + F    +++A D+WS G V+ E+L  G+  +   + 
Sbjct: 206 ---DAAYTTTGGKIPIRWTAPEAIAFR--TFSSASDVWSFGVVMWEVLAYGERPYWNMTN 260

Query: 163 VD 164
            D
Sbjct: 261 RD 262

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 54.2 bits (131), Expect = 1e-08
 Identities = 42/186 (22%), Positives = 73/186 (39%), Gaps = 47/186 (25%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH----HYKMSQRMPLIY 56
           M+   HPNV+SL         +      +VL Y+        KH    ++  ++      
Sbjct: 80  MKDFSHPNVLSLLGI--CLRSEGSPL--VVLPYM--------KHGDLRNFIRNETHNPTV 127

Query: 57  VKL--YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 114
             L  +  Q+ + + Y+ +     HRD+  +N +++     +K+ DFG A+ +   E   
Sbjct: 128 KDLIGFGLQVAKGMKYLAS-KKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKE--- 182

Query: 115 SYICSRYYR--------------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFP 158
                 YY               A E L     ++T   D+WS G +L EL+  G P +P
Sbjct: 183 ------YYSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYP 234

Query: 159 GESGVD 164
             +  D
Sbjct: 235 DVNTFD 240

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 54.3 bits (131), Expect = 1e-08
 Identities = 42/179 (23%), Positives = 77/179 (43%), Gaps = 35/179 (19%)

Query: 1   MRLLDHPNVVSLKH-CFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVK 58
           M   DHPN++ L+       T+   +   +V EY+   ++   ++ H      + L+   
Sbjct: 100 MGQFDHPNIIRLEGVV----TKSKPVM--IVTEYMENGSLDSFLRKHDAQFTVIQLVG-- 151

Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC 118
                I   + Y+ + +G  HRD+  +N+L+N +    K+ DFG  +VL           
Sbjct: 152 -MLRGIASGMKYL-SDMGYVHRDLAARNILINSN-LVCKVSDFGLGRVLEDDP------- 201

Query: 119 SRYYR-----------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVD 164
              Y            +PE + +   ++T+A D+WS G VL E++  G+  +   S  D
Sbjct: 202 EAAYTTRGGKIPIRWTSPEAIAYR--KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 258

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 53.9 bits (130), Expect = 2e-08
 Identities = 36/181 (19%), Positives = 71/181 (39%), Gaps = 39/181 (21%)

Query: 1   MRLLDHPNVVSLKH-CFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL 59
           M    H N++ L+       ++   +   ++ EY+    +  +    +       +   +
Sbjct: 100 MGQFSHHNIIRLEGVI----SKYKPMM--IITEYME---NGALDKFLREKDGEFSVLQLV 150

Query: 60  YF-YQICRALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY 116
                I   + Y+   N +   HRD+  +N+LVN +    K+ DFG ++VL         
Sbjct: 151 GMLRGIAAGMKYLANMNYV---HRDLAARNILVNSN-LVCKVSDFGLSRVLEDDP----- 201

Query: 117 ICSRYYR-----------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGV 163
                Y            APE + +    +T+A D+WS G V+ E++  G+  +   S  
Sbjct: 202 --EATYTTSGGKIPIRWTAPEAISYRK--FTSASDVWSFGIVMWEVMTYGERPYWELSNH 257

Query: 164 D 164
           +
Sbjct: 258 E 258

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 53.2 bits (128), Expect = 3e-08
 Identities = 41/193 (21%), Positives = 72/193 (37%), Gaps = 42/193 (21%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE----TVHRVIKHHYKMSQRMPLIY 56
           +   +H N+V        + +    +  ++LE +      +  R  +   + SQ   L  
Sbjct: 128 ISKFNHQNIVRCIGV---SLQSLPRF--ILLELMAGGDLKSFLR--ETRPRPSQPSSLAM 180

Query: 57  VKLYF--YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQL--KLCDFGSAKVLVKGEP 112
           + L      I     Y+       HRDI  +N L+         K+ DFG A+ + +   
Sbjct: 181 LDLLHVARDIACGCQYL-EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG- 238

Query: 113 NISYICSRYYR------------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFP 158
                   YYR             PE  + G   +T+  D WS G +L E+  LG   +P
Sbjct: 239 --------YYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYP 288

Query: 159 GESGVDQLVEIIK 171
            +S   +++E + 
Sbjct: 289 SKS-NQEVLEFVT 300

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 53.1 bits (128), Expect = 3e-08
 Identities = 44/204 (21%), Positives = 79/204 (38%), Gaps = 52/204 (25%)

Query: 2   RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-----------------ETVHRVIKH 44
           +L  H N+V+L       T    +YL  + EY                   + +    + 
Sbjct: 104 QLGSHENIVNLLGA---CTLSGPIYL--IFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 158

Query: 45  HYKMSQRMPLIYVK--LYF-YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF 101
             +  + + ++  +  L F YQ+ + + ++       HRD+  +N+LV      +K+CDF
Sbjct: 159 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFL-EFKSCVHRDLAARNVLVTHG-KVVKICDF 216

Query: 102 GSAKVLVKGEPNISYICSRYYR------------APELIFGATEYTAAIDIWSAGCVLAE 149
           G A+ ++             Y             APE +F    YT   D+WS G +L E
Sbjct: 217 GLARDIMSDS---------NYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWE 266

Query: 150 L--LLGQPLFPGESGVDQLVEIIK 171
           +  L   P +PG        ++I+
Sbjct: 267 IFSLGVNP-YPGIPVDANFYKLIQ 289

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 52.6 bits (127), Expect = 3e-08
 Identities = 46/199 (23%), Positives = 76/199 (38%), Gaps = 48/199 (24%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-----------ETVHRVIKHHYKMS 49
              L HPNVV L       T+   L   ++  Y                  V       +
Sbjct: 66  RARLQHPNVVCLLGV---VTKDQPLS--MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 120

Query: 50  QRMPLIYVKLYF--YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 107
            +  L          QI   + Y+ ++  V H+D+  +N+LV      +K+ D G  + +
Sbjct: 121 VKSALEPPDFVHLVAQIAAGMEYL-SSHHVVHKDLATRNVLVYDK-LNVKISDLGLFREV 178

Query: 108 VKGEPNISYICSRYYR------------APE-LIFGATEYTAAIDIWSAGCVLAELL-LG 153
              +         YY+            APE +++G  +++   DIWS G VL E+   G
Sbjct: 179 YAAD---------YYKLLGNSLLPIRWMAPEAIMYG--KFSIDSDIWSYGVVLWEVFSYG 227

Query: 154 -QPLFPGESGVDQLVEIIK 171
            QP + G S    +VE+I+
Sbjct: 228 LQP-YCGYS-NQDVVEMIR 244

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 52.6 bits (127), Expect = 3e-08
 Identities = 44/206 (21%), Positives = 83/206 (40%), Gaps = 54/206 (26%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-------TVHRVIKHHYKMSQRMP 53
           ++ ++HP+V+ L       ++   L L  ++EY             R +   Y  S    
Sbjct: 80  LKQVNHPHVIKLYGA---CSQDGPLLL--IVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134

Query: 54  LIYVK-------------LYF-YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLC 99
                             + F +QI + + Y+   + + HRD+  +N+LV     ++K+ 
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYL-AEMKLVHRDLAARNILVAEG-RKMKIS 192

Query: 100 DFGSAKVLVKGEPNISYICSRYYR------------APELIFGATEYTAAIDIWSAGCVL 147
           DFG ++ + + +          Y             A E +F    YT   D+WS G +L
Sbjct: 193 DFGLSRDVYEED---------SYVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLL 242

Query: 148 AELL-LG-QPLFPGESGVDQLVEIIK 171
            E++ LG  P +PG    ++L  ++K
Sbjct: 243 WEIVTLGGNP-YPGIP-PERLFNLLK 266

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 52.7 bits (127), Expect = 3e-08
 Identities = 40/193 (20%), Positives = 72/193 (37%), Gaps = 42/193 (21%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE----TVHRVIKHHYKMSQRMPLIY 56
           +   +H N+V        + +    +  +++E +      +  R  +   + SQ   L  
Sbjct: 87  ISKFNHQNIVRCIGV---SLQSLPRF--ILMELMAGGDLKSFLR--ETRPRPSQPSSLAM 139

Query: 57  VKLYF--YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQL--KLCDFGSAKVLVKGEP 112
           + L      I     Y+       HRDI  +N L+         K+ DFG A+ + +   
Sbjct: 140 LDLLHVARDIACGCQYL-EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS- 197

Query: 113 NISYICSRYYR------------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFP 158
                   YYR             PE  + G   +T+  D WS G +L E+  LG   +P
Sbjct: 198 --------YYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYP 247

Query: 159 GESGVDQLVEIIK 171
            +S   +++E + 
Sbjct: 248 SKS-NQEVLEFVT 259

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 52.8 bits (127), Expect = 4e-08
 Identities = 46/196 (23%), Positives = 81/196 (41%), Gaps = 44/196 (22%)

Query: 2   RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-----------ETVHRVIKHHYKMSQ 50
            +  H N+++L       T+   LY  +++EY                     ++   + 
Sbjct: 130 MIGKHKNIINLLGA---CTQDGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 184

Query: 51  RMPLIYVKLYF--YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 108
              L    L    YQ+ R + Y+  +    HRD+  +N+LV    + +K+ DFG A+ + 
Sbjct: 185 EEQLSSKDLVSCAYQVARGMEYL-ASKKCIHRDLAARNVLVTED-NVMKIADFGLARDIH 242

Query: 109 KGEPNISYICSRYYR------------APELIFGATEYTAAIDIWSAGCVLAELL-LGQP 155
             +         YY+            APE +F    YT   D+WS G +L E+  LG  
Sbjct: 243 HID---------YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGS 292

Query: 156 LFPGESGVDQLVEIIK 171
            +PG   V++L +++K
Sbjct: 293 PYPGVP-VEELFKLLK 307

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 52.7 bits (127), Expect = 4e-08
 Identities = 42/194 (21%), Positives = 71/194 (36%), Gaps = 41/194 (21%)

Query: 2   RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP---------ETVHRVIKHHYKMSQRM 52
            L  H N+V+L       T    +   ++ EY                +           
Sbjct: 105 HLGQHENIVNLLGA---CTHGGPVL--VITEYCCYGDLLNFLRRKSRVLETDPAFAIANS 159

Query: 53  PLIYVKL-YF-YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG 110
                 L +F  Q+ + +A++  +    HRD+  +N+L+    H  K+ DFG A+ ++  
Sbjct: 160 TASTRDLLHFSSQVAQGMAFL-ASKNCIHRDVAARNVLLTNG-HVAKIGDFGLARDIMND 217

Query: 111 EPNISYICSRYYR------------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLF 157
                      Y             APE IF    YT   D+WS G +L E+  LG   +
Sbjct: 218 S---------NYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPY 267

Query: 158 PGESGVDQLVEIIK 171
           PG     +  +++K
Sbjct: 268 PGILVNSKFYKLVK 281

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 52.7 bits (127), Expect = 4e-08
 Identities = 45/196 (22%), Positives = 84/196 (42%), Gaps = 44/196 (22%)

Query: 2   RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYV-------------PETVHRVIKHHYKM 48
            +  H N+++L       T+   LY  +++EY              P  +      +   
Sbjct: 142 MIGKHKNIINLLGA---CTQDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVP 196

Query: 49  SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 108
            ++M    +    YQ+ R + Y+  +    HRD+  +N+LV  + + +K+ DFG A+ + 
Sbjct: 197 EEQMTFKDLVSCTYQLARGMEYL-ASQKCIHRDLAARNVLVTEN-NVMKIADFGLARDIN 254

Query: 109 KGEPNISYICSRYYR------------APELIFGATEYTAAIDIWSAGCVLAELL-LGQP 155
             +         YY+            APE +F    YT   D+WS G ++ E+  LG  
Sbjct: 255 NID---------YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGS 304

Query: 156 LFPGESGVDQLVEIIK 171
            +PG   V++L +++K
Sbjct: 305 PYPGIP-VEELFKLLK 319

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 52.5 bits (126), Expect = 5e-08
 Identities = 39/183 (21%), Positives = 73/183 (39%), Gaps = 41/183 (22%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKH----HYKMSQRMPLIY 56
           M+   HPNV+SL         +      +VL Y+        KH    ++  ++      
Sbjct: 144 MKDFSHPNVLSLLGI--CLRSEGSPL--VVLPYM--------KHGDLRNFIRNETHNPTV 191

Query: 57  VKL--YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI 114
             L  +  Q+ + + ++  +    HRD+  +N +++     +K+ DFG A+ +   E + 
Sbjct: 192 KDLIGFGLQVAKGMKFL-ASKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFD- 248

Query: 115 SYICSRYYR-----------APE-LIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGES 161
                  +            A E L     ++T   D+WS G +L EL+  G P +P  +
Sbjct: 249 -----SVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVN 301

Query: 162 GVD 164
             D
Sbjct: 302 TFD 304

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 51.9 bits (125), Expect = 6e-08
 Identities = 40/207 (19%), Positives = 74/207 (35%), Gaps = 56/207 (27%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-------------------ETVHRV 41
           M   D+PN+V L            + L  + EY+                          
Sbjct: 104 MAEFDNPNIVKLLGV---CAVGKPMCL--LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 158

Query: 42  IKHHYKMSQRMPLIYVKLYF--YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLC 99
            +         PL   +      Q+   +AY+ +     HRD+  +N LV  +   +K+ 
Sbjct: 159 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYL-SERKFVHRDLATRNCLVGEN-MVVKIA 216

Query: 100 DFGSAKVLVKGEPNISYICSRYYR------------APE-LIFGATEYTAAIDIWSAGCV 146
           DFG ++ +   +         YY+             PE + +    YT   D+W+ G V
Sbjct: 217 DFGLSRNIYSAD---------YYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGVV 265

Query: 147 LAELL-LG-QPLFPGESGVDQLVEIIK 171
           L E+   G QP + G +  ++++  ++
Sbjct: 266 LWEIFSYGLQP-YYGMA-HEEVIYYVR 290

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 51.9 bits (124), Expect = 8e-08
 Identities = 32/123 (26%), Positives = 56/123 (45%), Gaps = 25/123 (20%)

Query: 62  YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRY 121
           +Q+ + + ++  +    HRD+  +N+L++   + +K+CDFG A+ + K            
Sbjct: 200 FQVAKGMEFL-ASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDP---------D 248

Query: 122 YR------------APELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVE 168
           Y             APE IF    YT   D+WS G +L E+  LG   +PG    ++   
Sbjct: 249 YVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 307

Query: 169 IIK 171
            +K
Sbjct: 308 RLK 310

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 51.1 bits (123), Expect = 1e-07
 Identities = 44/196 (22%), Positives = 82/196 (41%), Gaps = 44/196 (22%)

Query: 2   RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-----------TVHRVIKHHYKMSQ 50
            +  H N+++L       T+   LY  +++EY  +                  +      
Sbjct: 96  MIGKHKNIINLLGA---CTQDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150

Query: 51  RMPLIYVKLYF--YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLV 108
              + +  L    YQ+ R + Y+  +    HRD+  +N+LV  + + +K+ DFG A+ + 
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYL-ASQKCIHRDLAARNVLVTEN-NVMKIADFGLARDIN 208

Query: 109 KGEPNISYICSRYYR------------APELIFGATEYTAAIDIWSAGCVLAELL-LGQP 155
             +         YY+            APE +F    YT   D+WS G ++ E+  LG  
Sbjct: 209 NID---------YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGS 258

Query: 156 LFPGESGVDQLVEIIK 171
            +PG   V++L +++K
Sbjct: 259 PYPGIP-VEELFKLLK 273

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 50.9 bits (122), Expect = 1e-07
 Identities = 28/154 (18%), Positives = 52/154 (33%), Gaps = 23/154 (14%)

Query: 14  HCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN 73
           +    T  K   Y  +V+E +   + ++   +    +      V     ++   L YIH 
Sbjct: 114 YGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKST----VLQLGIRMLDVLEYIHE 169

Query: 74  TIGVCHRDIKPQNLLVNP-HTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 132
                H DIK  NLL+   +  Q+ L D+G +        +  Y         +   G  
Sbjct: 170 N-EYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQ----ENPRKGHNGTI 224

Query: 133 EYTAAI------------DIWSAGCVLAELLLGQ 154
           E+  ++            D+   G  +   L G+
Sbjct: 225 EF-TSLDAHKGVALSRRSDVEILGYCMLRWLCGK 257

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 48.5 bits (116), Expect = 9e-07
 Identities = 26/129 (20%), Positives = 45/129 (34%), Gaps = 32/129 (24%)

Query: 47  KMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV----NPHTHQLKLCDFG 102
              ++  +  V +   Q+   +  IH    + +RDIKP N L+    + + + + + DFG
Sbjct: 98  LCGRKFSVKTVAMAAKQMLARVQSIHEK-SLVYRDIKPDNFLIGRPNSKNANMIYVVDFG 156

Query: 103 SAKVLVKGEPNISYICSRY-----YRAPELIFGATEYTAAI------------DIWSAGC 145
             K          Y          YR  + + G   Y  +I            D+ + G 
Sbjct: 157 MVK---------FYRDPVTKQHIPYREKKNLSGTARY-MSINTHLGREQSRRDDLEALGH 206

Query: 146 VLAELLLGQ 154
           V    L G 
Sbjct: 207 VFMYFLRGS 215

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 47.8 bits (114), Expect = 2e-06
 Identities = 19/105 (18%), Positives = 39/105 (37%), Gaps = 19/105 (18%)

Query: 63  QICRALAYIHNTIGVCHRDIKPQNLLVNP-HTHQLKLCDFGSAKVLVKGEPNISYICSRY 121
           ++  AL ++H      H ++  +N+ V+P    Q+ L  +G A        +++Y     
Sbjct: 167 RLLDALEFLHEN-EYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAY---VE 222

Query: 122 YRAPELIFGATEYTAAI------------DIWSAGCVLAELLLGQ 154
                   G  E+  ++            D+ S G  + + L G 
Sbjct: 223 GSRSPHE-GDLEF-ISMDLHKGCGPSRRSDLQSLGYCMLKWLYGF 265

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 47.3 bits (112), Expect = 2e-06
 Identities = 32/127 (25%), Positives = 51/127 (40%), Gaps = 30/127 (23%)

Query: 47  KMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV--NPHTHQLKLCDFGSA 104
             S+++ L  V +   Q+   + ++H+     HRDIKP N L+      +Q+ + DFG A
Sbjct: 95  FCSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153

Query: 105 KVLVKGEPNISYICSRY-----YRAPELIFGATEYTAAI------------DIWSAGCVL 147
           K          Y  +       YR  + + G   Y A++            D+ S G VL
Sbjct: 154 K---------KYRDTSTHQHIPYRENKNLTGTARY-ASVNTHLGIEQSRRDDLESLGYVL 203

Query: 148 AELLLGQ 154
              L G 
Sbjct: 204 MYFLRGS 210

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 47.0 bits (112), Expect = 3e-06
 Identities = 27/129 (20%), Positives = 46/129 (35%), Gaps = 32/129 (24%)

Query: 47  KMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV----NPHTHQLKLCDFG 102
              +   L  V +   Q+   + Y+H+   + +RD+KP+N L+    N     + + DF 
Sbjct: 97  LCDRTFSLKTVLMIAIQLISRMEYVHSK-NLIYRDVKPENFLIGRPGNKTQQVIHIIDFA 155

Query: 103 SAKVLVKGEPNISYICSRY-----YRAPELIFGATEYTAAI------------DIWSAGC 145
            AK          YI         YR  + + G   Y  +I            D+ + G 
Sbjct: 156 LAKE---------YIDPETKKHIPYREHKSLTGTARY-MSINTHLGKEQSRRDDLEALGH 205

Query: 146 VLAELLLGQ 154
           +    L G 
Sbjct: 206 MFMYFLRGS 214

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 46.7 bits (111), Expect = 3e-06
 Identities = 28/119 (23%), Positives = 42/119 (35%), Gaps = 19/119 (15%)

Query: 49  SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNP-HTHQLKLCDFGSAKVL 107
           ++R     V     +I   L YIH      H DIK  NLL+N  +  Q+ L D+G A   
Sbjct: 146 AKRFSRKTVLQLSLRILDILEYIHEH-EYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRY 204

Query: 108 VKGEPNISYICSRYYRAPELIFGATEYTAAI------------DIWSAGCVLAELLLGQ 154
                + +Y             G  E+  +I            D+   G  + + L G 
Sbjct: 205 CPEGVHKAYA----ADPKRCHDGTIEF-TSIDAHNGVAPSRRGDLEILGYCMIQWLTGH 258

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 46.6 bits (111), Expect = 4e-06
 Identities = 35/127 (27%), Positives = 50/127 (39%), Gaps = 30/127 (23%)

Query: 47  KMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLV--NPHTHQLKLCDFGSA 104
             S++  L  V L   Q+   + YIH+     HRD+KP N L+      + + + DFG A
Sbjct: 97  FCSRKFSLKTVLLLADQMISRIEYIHSK-NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155

Query: 105 KVLVKGEPNISYICSR-----YYRAPELIFGATEYTAAI------------DIWSAGCVL 147
           K          Y  +R      YR  + + G   Y A+I            D+ S G VL
Sbjct: 156 K---------KYRDARTHQHIPYRENKNLTGTARY-ASINTHLGIEQSRRDDLESLGYVL 205

Query: 148 AELLLGQ 154
               LG 
Sbjct: 206 MYFNLGS 212

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 44.6 bits (106), Expect = 2e-05
 Identities = 43/186 (23%), Positives = 68/186 (36%), Gaps = 52/186 (27%)

Query: 3   LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-----------ETVHRVIKHHYKMSQR 51
           L  HPN+++L         +  LYL   +EY P             +          S  
Sbjct: 82  LGHHPNIINLLGA---CEHRGYLYL--AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 136

Query: 52  MPLIYVKL-YF-YQICRALAYI--HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 107
             L   +L +F   + R + Y+     I   HRD+  +N+LV  + +  K+ DFG ++  
Sbjct: 137 STLSSQQLLHFAADVARGMDYLSQKQFI---HRDLAARNILVGEN-YVAKIADFGLSRG- 191

Query: 108 VKGEPNISYICSRYYR------------APE-LIFGATEYTAAIDIWSAGCVLAELL-LG 153
                         Y             A E L +    YT   D+WS G +L E++ LG
Sbjct: 192 -----------QEVYVKKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLG 238

Query: 154 QPLFPG 159
              + G
Sbjct: 239 GTPYCG 244

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	292
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.87
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.63
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.39
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.16
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	98.53
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.32
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.27
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.18
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	98.07
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	97.49
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	97.26
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	97.12
3ats_A	357	Putative uncharacterized protein; hypothetical pro	96.18
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	96.08
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	95.97
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	94.38
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	92.79
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	91.48
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	91.32
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	90.38
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	90.09
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	90.05
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	89.82
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	89.44
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	88.63
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	87.38
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	86.84
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	84.34
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	81.87

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.3e-57  Score=396.91  Aligned_cols=270  Identities=34%  Similarity=0.646  Sum_probs=213.1

Q ss_pred             CCCCCCCCeeeeceeeeccCC-CCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTE-KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~-~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.|+|||||++++++..... .+...+|||||||+|+|.+++..    .+++++..++.+++||+.||.|||++ ||+|
T Consensus       107 l~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~~-~iiH  181 (398)
T 4b99_A          107 LKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHSA-QVIH  181 (398)
T ss_dssp             HHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCSEEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHHT-TCBC
T ss_pred             HHhcCCCCcceEeeeeecccccccCCEEEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-cCcC
Confidence            457899999999998864332 34456899999999999998865    46899999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccC-----CCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-----EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ  154 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~  154 (292)
                      |||||+|||++.++ .+||+|||+|+.+...     ....+.+||+.|+|||++.+...++.++||||+||++|||++|+
T Consensus       182 RDlKP~NIl~~~~~-~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~  260 (398)
T 4b99_A          182 RDLKPSNLLVNENC-ELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARR  260 (398)
T ss_dssp             CCCCGGGEEECTTC-CEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTS
T ss_pred             CCcCccccccCCCC-CEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCC
Confidence            99999999999988 7999999999876332     23346789999999999988777899999999999999999999


Q ss_pred             CCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc---ccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccH
Q 022799          155 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE---FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA  231 (292)
Q Consensus       155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~  231 (292)
                      +||.+.+..+++..|.+..+.|+...+.........   ..++.....+|...+ +.++++++|||.+||++||++|+|+
T Consensus       261 ~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dLl~~mL~~dP~~R~ta  339 (398)
T 4b99_A          261 QLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVY-PGADRQALSLLGRMLRFEPSARISA  339 (398)
T ss_dssp             CSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHS-TTCCHHHHHHHHHHSCSSTTTSCCH
T ss_pred             CCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhC-CCCCHHHHHHHHHHCcCChhHCcCH
Confidence            999999999999999999999987765443221110   123333444455444 5789999999999999999999999


Q ss_pred             HHHhcCCCccccCCCCCCCCCCCCCCCCCCCChhccCCCCHHHHhhhchHH
Q 022799          232 LEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEH  282 (292)
Q Consensus       232 ~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (292)
                      +|+|+||||+.+.++.....    ..+.+++. .+....+.+.+++.+.+.
T Consensus       340 ~e~L~Hp~f~~~~~p~~~p~----~~~~~~~~-~~~~~~~~~~~k~~i~~e  385 (398)
T 4b99_A          340 AAALRHPFLAKYHDPDDEPD----CAPPFDFA-FDREALTRERIKEAIVAE  385 (398)
T ss_dssp             HHHTTSGGGTTTCCGGGSCC----CSSCCCCH-HHHSCCCHHHHHHHHHHH
T ss_pred             HHHhcCHhhCcCCCCccccC----CCCCCCCc-cchhhcCHHHHHHHHHHH
Confidence            99999999998876544322    22333333 345566777777766554

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=3.8e-57  Score=384.40  Aligned_cols=206  Identities=33%  Similarity=0.571  Sum_probs=178.9

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++|+|||||+++++|     ++..++|+|||||+ |+|.+++...    +.+++..++.++.||+.||+|||++ ||+|
T Consensus        86 l~~l~HpnIv~l~~~~-----~~~~~~yivmEy~~gG~L~~~i~~~----~~l~e~~~~~~~~qi~~al~ylH~~-~IiH  155 (311)
T 4aw0_A           86 MSRLDHPFFVKLYFTF-----QDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHGK-GIIH  155 (311)
T ss_dssp             HTTCCCTTBCCEEEEE-----ECSSEEEEEECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TEEC
T ss_pred             HHhCCCCCCCeEEEEE-----EeCCEEEEEEecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CCcc
Confidence            5789999999999999     45556999999998 6999999763    6799999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccC---CCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG---EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPL  156 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~p  156 (292)
                      |||||+|||++.++ .+||+|||+|+.....   ....+.+||+.|||||++.+. .|+.++|+||+||++|+|++|..|
T Consensus       156 RDlKPeNILl~~~g-~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~P  233 (311)
T 4aw0_A          156 RDLKPENILLNEDM-HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPP  233 (311)
T ss_dssp             SCCSGGGEEECTTS-CEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHS-CBCHHHHHHHHHHHHHHHHHSSCS
T ss_pred             CCCCHHHeEEcCCC-CEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCC
Confidence            99999999999988 7999999999876433   234567899999999999765 489999999999999999999999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHH---
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE---  233 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e---  233 (292)
                      |.+.+..+.+.++.+.                 .+.            ++..+|+++++||.+||++||++|+|++|   
T Consensus       234 F~~~~~~~~~~~i~~~-----------------~~~------------~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~  284 (311)
T 4aw0_A          234 FRAGNEGLIFAKIIKL-----------------EYD------------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEG  284 (311)
T ss_dssp             SCCSSHHHHHHHHHHT-----------------CCC------------CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred             CCCCCHHHHHHHHHcC-----------------CCC------------CCcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence            9998888877777652                 111            23468999999999999999999999887   


Q ss_pred             ---HhcCCCccccCCCC
Q 022799          234 ---ALIHPFFDELRDPN  247 (292)
Q Consensus       234 ---~l~hp~~~~~~~~~  247 (292)
                         +++||||+++++..
T Consensus       285 ~~~i~~Hp~F~~idw~~  301 (311)
T 4aw0_A          285 YGPLKAHPFFESVTWEN  301 (311)
T ss_dssp             HHHHHTSGGGTTCCCTT
T ss_pred             CHHHHCCCCcCCCCHHH
Confidence               68999999988653

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=3.8e-57  Score=379.23  Aligned_cols=202  Identities=29%  Similarity=0.485  Sum_probs=164.8

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      |++++|||||+++++|     .+...+|+|||||+|+|.+.+..    .+++++..++.++.||+.||+|||++ ||+||
T Consensus        67 l~~l~HpnIv~~~~~~-----~~~~~~~ivmEy~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~-~IiHR  136 (275)
T 3hyh_A           67 LRLLRHPHIIKLYDVI-----KSKDEIIMVIEYAGNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRH-KIVHR  136 (275)
T ss_dssp             HHHCCCTTBCCEEEEE-----ECSSEEEEEEECCCEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHT-TCCCC
T ss_pred             HHHCCCCCCCeEEEEE-----EECCEEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-Ccccc
Confidence            4568999999999999     44456999999999999998875    46799999999999999999999998 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE  160 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  160 (292)
                      ||||+|||++.++ .+||+|||+|+.........+.+||+.|||||++.+...++.++||||+||++|+|++|+.||.+.
T Consensus       137 DiKP~NILl~~~~-~vkl~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~  215 (275)
T 3hyh_A          137 DLKPENLLLDEHL-NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE  215 (275)
T ss_dssp             CCCTTTEEECTTC-CEEECCSSCC---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cCChHHeEECCCC-CEEEeecCCCeecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC
Confidence            9999999999988 799999999988766666667899999999999987665678999999999999999999999988


Q ss_pred             CcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCCc
Q 022799          161 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  240 (292)
Q Consensus       161 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~~  240 (292)
                      +.......+....                 .            .++..+|+++++||.+||+.||++|||++|+++||||
T Consensus       216 ~~~~~~~~i~~~~-----------------~------------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~  266 (275)
T 3hyh_A          216 SIPVLFKNISNGV-----------------Y------------TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWF  266 (275)
T ss_dssp             SHHHHHHHHHHTC-----------------C------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHH
T ss_pred             CHHHHHHHHHcCC-----------------C------------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccc
Confidence            7766666554421                 0            0224689999999999999999999999999999999


Q ss_pred             cc
Q 022799          241 DE  242 (292)
Q Consensus       241 ~~  242 (292)
                      +.
T Consensus       267 k~  268 (275)
T 3hyh_A          267 KV  268 (275)
T ss_dssp             HT
T ss_pred             cc
Confidence            73

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.3e-56  Score=380.96  Aligned_cols=204  Identities=27%  Similarity=0.444  Sum_probs=175.9

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++|||||+++++|.     ++..+|+|||||+ |+|.+++...    +.+++..++.++.||+.||+|||++ ||+|
T Consensus        80 l~~l~HpnIv~l~~~~~-----~~~~~~ivmEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~-~IiH  149 (304)
T 3ubd_A           80 LVEVNHPFIVKLHYAFQ-----TEGKLYLILDFLRGGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLHSL-GIIY  149 (304)
T ss_dssp             CCCCCCTTEECEEEEEE-----ETTEEEEEECCCTTCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT-TCCC
T ss_pred             HHHCCCCCCCeEEEEEE-----ECCEEEEEEEcCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CCcC
Confidence            67899999999999994     4445999999998 6999998763    6799999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccC-CCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      |||||+|||++.++ .+||+|||+|+..... ....+.+||+.|||||++.+. .|+.++|+||+||++|||++|+.||.
T Consensus       150 RDlKp~NILl~~~g-~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~PF~  227 (304)
T 3ubd_A          150 RDLKPENILLDEEG-HIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGTLPFQ  227 (304)
T ss_dssp             SSCCGGGEEECTTS-CEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CCCCHHHeEEcCCC-CEEecccccceeccCCCccccccccCcccCCHHHhccC-CCCCCCcccchHHHHHHHHhCCCCCC
Confidence            99999999999988 7999999999865433 334567899999999999765 49999999999999999999999999


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCccc-----HHH
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----ALE  233 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t-----~~e  233 (292)
                      +.+..+.+.++.+..                 ..            ++..+|+++++||.+||++||++|||     ++|
T Consensus       228 ~~~~~~~~~~i~~~~-----------------~~------------~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~e  278 (304)
T 3ubd_A          228 GKDRKETMTMILKAK-----------------LG------------MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEE  278 (304)
T ss_dssp             CSSHHHHHHHHHHCC-----------------CC------------CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHH
T ss_pred             CcCHHHHHHHHHcCC-----------------CC------------CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHH
Confidence            988888777776521                 00            22468999999999999999999998     589


Q ss_pred             HhcCCCccccCC
Q 022799          234 ALIHPFFDELRD  245 (292)
Q Consensus       234 ~l~hp~~~~~~~  245 (292)
                      +++||||+++++
T Consensus       279 il~Hp~f~~idw  290 (304)
T 3ubd_A          279 IKRHSFFSTIDW  290 (304)
T ss_dssp             HHTSGGGTTCCH
T ss_pred             HHcCccccCCCH
Confidence            999999999864

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.2e-56  Score=385.12  Aligned_cols=205  Identities=30%  Similarity=0.493  Sum_probs=174.8

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++|||||+++++|.+     ...+|||||||+ |+|.+++.+     .++++..++.++.||+.||+|||++ ||+|
T Consensus       125 l~~l~HpnIV~l~~~~~~-----~~~~~ivmEy~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~-~IiH  193 (346)
T 4fih_A          125 MRDYQHENVVEMYNSYLV-----GDELWVVMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ-GVIH  193 (346)
T ss_dssp             HHHCCCTTBCCEEEEEEE-----TTEEEEEECCCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT-TEEC
T ss_pred             HHhCCCCCCCcEEEEEEE-----CCEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC-Cccc
Confidence            457899999999999944     445999999999 689888864     5699999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccC-CCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      |||||+|||++.++ .+||+|||+|+..... ....+.+||+.|||||++.+. .|+.++||||+||++|||++|..||.
T Consensus       194 RDlKp~NILl~~~g-~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~  271 (346)
T 4fih_A          194 RDIKSDSILLTHDG-RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYF  271 (346)
T ss_dssp             CCCSGGGEEECTTC-CEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             ccCCHHHEEECCCC-CEEEecCcCceecCCCCCcccccccCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence            99999999999988 7999999999876543 344567899999999999654 59999999999999999999999999


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCC
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  238 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp  238 (292)
                      +.+..+.+..+..... +          ..               .....+|+++++||.+||+.||++|||++|+|+||
T Consensus       272 ~~~~~~~~~~i~~~~~-~----------~~---------------~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp  325 (346)
T 4fih_A          272 NEPPLKAMKMIRDNLP-P----------RL---------------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHP  325 (346)
T ss_dssp             TSCHHHHHHHHHHSSC-C----------CC---------------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCG
T ss_pred             CcCHHHHHHHHHcCCC-C----------CC---------------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCH
Confidence            9888877776654211 0          00               01145899999999999999999999999999999


Q ss_pred             CccccC
Q 022799          239 FFDELR  244 (292)
Q Consensus       239 ~~~~~~  244 (292)
                      ||+...
T Consensus       326 ~~~~~~  331 (346)
T 4fih_A          326 FLAKAG  331 (346)
T ss_dssp             GGGGCC
T ss_pred             hhcCCC
Confidence            998754

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.8e-55  Score=370.97  Aligned_cols=206  Identities=23%  Similarity=0.390  Sum_probs=170.6

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCC--c
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG--V   77 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~--i   77 (292)
                      |++|+|||||+++++|.+.. .+..++|||||||+ |+|.+++...    +.+++..++.++.||+.||+|||++ |  |
T Consensus        79 l~~l~HpnIV~~~~~~~~~~-~~~~~~~lvmEy~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~ylH~~-~~~I  152 (290)
T 3fpq_A           79 LKGLQHPNIVRFYDSWESTV-KGKKCIVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR-TPPI  152 (290)
T ss_dssp             HHTCCCTTBCCEEEEEEEEE-TTEEEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS-SSCC
T ss_pred             HHhCCCCCCCcEEEEEeecc-CCCcEEEEEEeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CCCE
Confidence            46799999999999985533 34456899999998 6999998763    6799999999999999999999987 8  9


Q ss_pred             cccCCCCCcEEEeC-CCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCC
Q 022799           78 CHRDIKPQNLLVNP-HTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPL  156 (292)
Q Consensus        78 ~H~dlkp~Nill~~-~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~p  156 (292)
                      +||||||+|||++. ++ .+||+|||+|+.. ......+.+||+.|||||++.+  .|+.++||||+||++|||+||+.|
T Consensus       153 iHRDlKp~NILl~~~~g-~vKl~DFGla~~~-~~~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~P  228 (290)
T 3fpq_A          153 IHRDLKCDNIFITGPTG-SVKIGDLGLATLK-RASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYP  228 (290)
T ss_dssp             CCCCCCGGGEEESSTTS-CEEECCTTGGGGC-CTTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCT
T ss_pred             EecccChhheeEECCCC-CEEEEeCcCCEeC-CCCccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCC
Confidence            99999999999985 55 7999999999754 3334556789999999999854  499999999999999999999999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      |.+.+....+.+.+.....|                          ..++...++++++||.+||+.||++|||++|+|+
T Consensus       229 f~~~~~~~~~~~~i~~~~~~--------------------------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          229 YSECQNAAQIYRRVTSGVKP--------------------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             TTTCSSHHHHHHHHTTTCCC--------------------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCCCcHHHHHHHHHcCCCC--------------------------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            98776655554433211111                          1123567899999999999999999999999999


Q ss_pred             CCCccc
Q 022799          237 HPFFDE  242 (292)
Q Consensus       237 hp~~~~  242 (292)
                      ||||++
T Consensus       283 Hp~~~~  288 (290)
T 3fpq_A          283 HAFFQE  288 (290)
T ss_dssp             SGGGC-
T ss_pred             CccccC
Confidence            999974

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=8.1e-55  Score=374.24  Aligned_cols=209  Identities=24%  Similarity=0.394  Sum_probs=173.9

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.|+|||||+++++|     .+..++|||||||+ |+|.+++...    +.+++..++.++.||+.||+|||++ ||+|
T Consensus       104 l~~l~HpnIV~l~~~~-----~~~~~~~ivmEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~-~IiH  173 (336)
T 4g3f_A          104 CAGLSSPRIVPLYGAV-----REGPWVNIFMELLEGGSLGQLIKQM----GCLPEDRALYYLGQALEGLEYLHTR-RILH  173 (336)
T ss_dssp             TTTCCCTTBCCEEEEE-----EETTEEEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT-TEEC
T ss_pred             HHhCCCCCCCcEEEEE-----EECCEEEEEEeccCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-Ccee
Confidence            6789999999999999     44445999999998 6999999763    6799999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCC------cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG  153 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g  153 (292)
                      |||||+|||++.++..+||+|||+|+.......      ....+||+.|||||++.+. .|+.++||||+||++|||++|
T Consensus       174 RDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG  252 (336)
T 4g3f_A          174 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK-PCDAKVDIWSSCCMMLHMLNG  252 (336)
T ss_dssp             SCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHS
T ss_pred             cccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHC
Confidence            999999999998875699999999987644321      1235799999999999775 499999999999999999999


Q ss_pred             CCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHH
Q 022799          154 QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE  233 (292)
Q Consensus       154 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e  233 (292)
                      +.||.+.+..+.+.++...  .++                        ...+++.+|+++++||.+||++||.+|||+.|
T Consensus       253 ~~Pf~~~~~~~~~~~i~~~--~~~------------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~e  306 (336)
T 4g3f_A          253 CHPWTQYFRGPLCLKIASE--PPP------------------------IREIPPSCAPLTAQAIQEGLRKEPVHRASAME  306 (336)
T ss_dssp             SCSSTTTCCSCCHHHHHHS--CCG------------------------GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             cCCCCCCCHHHHHHHHHcC--CCC------------------------chhcCccCCHHHHHHHHHHccCCHhHCcCHHH
Confidence            9999988777666666542  110                        01133578999999999999999999999999


Q ss_pred             H-------------hcCCCccccCCC
Q 022799          234 A-------------LIHPFFDELRDP  246 (292)
Q Consensus       234 ~-------------l~hp~~~~~~~~  246 (292)
                      +             ++|||+..+..+
T Consensus       307 l~~~l~~~l~~~~~l~hPw~~~~~~P  332 (336)
T 4g3f_A          307 LRRKVGKALQEVGGLKSPWKGEYKEP  332 (336)
T ss_dssp             HHHHHHHHHHHTTSSCSCSSSSCCCC
T ss_pred             HHHHHHHHHhhhhhccCCCcCCCCCC
Confidence            7             579999887654

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=3.5e-55  Score=386.44  Aligned_cols=205  Identities=30%  Similarity=0.493  Sum_probs=175.0

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.|+|||||+++++|.+     ...+|||||||+ |+|.+++..     .++++..++.++.||+.||+|||++ ||+|
T Consensus       202 l~~l~HpnIV~l~~~~~~-----~~~~~iVmEy~~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~-~IiH  270 (423)
T 4fie_A          202 MRDYQHENVVEMYNSYLV-----GDELWVVMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ-GVIH  270 (423)
T ss_dssp             HHHCCCTTBCCEEEEEEE-----TTEEEEEEECCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT-TEEC
T ss_pred             HHhCCCCCCCceEEEEEE-----CCEEEEEEeCCCCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHC-Ceec
Confidence            457899999999999944     345999999999 689888864     5699999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccC-CCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      |||||+|||++.++ .+||+|||+|+.+... ....+.+||+.|||||++.+. .|+.++|||||||++|||++|..||.
T Consensus       271 RDiKp~NILl~~~g-~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~  348 (423)
T 4fie_A          271 RDIKSDSILLTHDG-RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYF  348 (423)
T ss_dssp             CCCSTTTEEECTTC-CEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             ccCCHHHEEEcCCC-CEEEecCccceECCCCCccccccccCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence            99999999999988 7999999999876543 344567899999999999654 59999999999999999999999999


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCC
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  238 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp  238 (292)
                      +.+..+.+..+..... +          ..               .....+|+++++||.+||+.||++|+|++|+|+||
T Consensus       349 ~~~~~~~~~~i~~~~~-~----------~~---------------~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp  402 (423)
T 4fie_A          349 NEPPLKAMKMIRDNLP-P----------RL---------------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHP  402 (423)
T ss_dssp             TSCHHHHHHHHHHSCC-C----------CC---------------SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCG
T ss_pred             CcCHHHHHHHHHcCCC-C----------CC---------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCH
Confidence            9888877776654210 0          00               01146899999999999999999999999999999


Q ss_pred             CccccC
Q 022799          239 FFDELR  244 (292)
Q Consensus       239 ~~~~~~  244 (292)
                      ||+...
T Consensus       403 ~~~~~~  408 (423)
T 4fie_A          403 FLAKAG  408 (423)
T ss_dssp             GGGGCC
T ss_pred             HhcCCC
Confidence            998754

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.4e-55  Score=380.70  Aligned_cols=204  Identities=28%  Similarity=0.430  Sum_probs=174.4

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++|+|||||+++++|.     +...+|||||||+ |+|.+++....  ...+++..++.++.||+.||+|||++ ||+|
T Consensus        77 l~~l~HpnIV~~~~~~~-----~~~~~yiVmEy~~gg~L~~~i~~~~--~~~~~e~~~~~~~~qi~~aL~ylH~~-~IiH  148 (350)
T 4b9d_A           77 LANMKHPNIVQYRESFE-----ENGSLYIVMDYCEGGDLFKRINAQK--GVLFQEDQILDWFVQICLALKHVHDR-KILH  148 (350)
T ss_dssp             HHHCCCTTBCCEEEEEE-----ETTEEEEEEECCTTCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT-TCEE
T ss_pred             HHHCCCCCCCcEEEEEE-----ECCEEEEEEeCCCCCcHHHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHC-Ceee
Confidence            45789999999999994     4445999999998 69999987532  35679999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCC-CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      |||||+|||++.++ .+||+|||+|+...... ...+.+||+.|||||++.+. .|+.++|||||||++|||++|+.||.
T Consensus       149 RDlKp~NILl~~~g-~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~-~y~~~~DiwSlGvilyemltG~~PF~  226 (350)
T 4b9d_A          149 RDIKSQNIFLTKDG-TVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENK-PYNNKSDIWALGCVLYELCTLKHAFE  226 (350)
T ss_dssp             TTCCGGGEEECTTC-CEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             ccCCHHHEEECCCC-CEEEcccccceeecCCcccccccCCCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence            99999999999988 79999999998764332 22456799999999999765 59999999999999999999999999


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCC
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  238 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp  238 (292)
                      +.+..+.+.++..... |                           .++..+|+++++||.+||+.||++|||++|+|+||
T Consensus       227 ~~~~~~~~~~i~~~~~-~---------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp  278 (350)
T 4b9d_A          227 AGSMKNLVLKIISGSF-P---------------------------PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKG  278 (350)
T ss_dssp             CSSHHHHHHHHHHTCC-C---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSH
T ss_pred             CcCHHHHHHHHHcCCC-C---------------------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence            9988888777765211 0                           01246899999999999999999999999999999


Q ss_pred             Cccc
Q 022799          239 FFDE  242 (292)
Q Consensus       239 ~~~~  242 (292)
                      ||+.
T Consensus       279 ~~~~  282 (350)
T 4b9d_A          279 FIAK  282 (350)
T ss_dssp             HHHT
T ss_pred             Hhhc
Confidence            9975

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.5e-53  Score=377.87  Aligned_cols=280  Identities=67%  Similarity=1.183  Sum_probs=248.8

Q ss_pred             CCCCCCCCeeeeceeeeccCC-CCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTE-KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~-~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||++++++|..... .+..++++||||+++++.+.+.........+++..++.++.||+.||.|||++ ||+|
T Consensus        86 l~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH  164 (394)
T 4e7w_A           86 MRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI-GICH  164 (394)
T ss_dssp             HHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT-TEEC
T ss_pred             HHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC-CccC
Confidence            457899999999999876554 56677899999999988887776655567899999999999999999999988 9999


Q ss_pred             cCCCCCcEEEe-CCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           80 RDIKPQNLLVN-PHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        80 ~dlkp~Nill~-~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      |||||+||+++ .++ .+||+|||+++............||+.|+|||++.+...++.++|+||+||++|+|++|..||.
T Consensus       165 rDlkp~Nill~~~~~-~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~  243 (394)
T 4e7w_A          165 RDIKPQNLLLDPPSG-VLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFP  243 (394)
T ss_dssp             SCCSGGGEEEETTTT-EEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CCCCHHHEEEcCCCC-cEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            99999999999 555 8999999999887666666677899999999999776679999999999999999999999999


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCC
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  238 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp  238 (292)
                      +.+..+++..+.+.++.|+.+.+..+++.+....++.....++...++..+++++.+||.+||++||.+|||+.|+++||
T Consensus       244 ~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp  323 (394)
T 4e7w_A          244 GESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHP  323 (394)
T ss_dssp             CSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred             CCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcCh
Confidence            99999999999999999999999999988888888888888888888888999999999999999999999999999999


Q ss_pred             CccccCCCCCCCCCCCCCCCCCCCChhccCCCCHHHHhhhchHHH
Q 022799          239 FFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHA  283 (292)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (292)
                      ||+++++.....+.+...|++++|...+... .++.+..+++++.
T Consensus       324 ~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  367 (394)
T 4e7w_A          324 FFDELRTGEARMPNGRELPPLFNWTKEELSV-RPDLISRLVPQHA  367 (394)
T ss_dssp             GGSTTTSSCCCCTTSSCCCCSCCCCHHHHHT-CGGGHHHHSCGGG
T ss_pred             hhhhhccccccCCCCCCCCCcCCCCHHHhhc-CHHHHHhhccHhh
Confidence            9999998877777878889999998776655 4577777776655

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.5e-53  Score=376.75  Aligned_cols=283  Identities=51%  Similarity=1.024  Sum_probs=241.8

Q ss_pred             CCCCCCCCeeeeceeeeccCC---------------------------------CCceeEEEEeecccCCHHHHHHhhhh
Q 022799            1 MRLLDHPNVVSLKHCFFSTTE---------------------------------KDELYLNLVLEYVPETVHRVIKHHYK   47 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~---------------------------------~~~~~~~lv~e~~~g~L~~~l~~~~~   47 (292)
                      |+.++||||++++++|.....                                 .+..++++||||++|+|.+.+.....
T Consensus        54 l~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~  133 (383)
T 3eb0_A           54 MKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIR  133 (383)
T ss_dssp             HTTCCCTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCSEEHHHHHHHHHH
T ss_pred             HHHcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHh
Confidence            468899999999999865443                                 34556899999999999998887666


Q ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCcc
Q 022799           48 MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPEL  127 (292)
Q Consensus        48 ~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~  127 (292)
                      ....+++..++.++.||+.||.|||++ ||+||||||+||+++.+.+.+||+|||+++............||+.|+|||+
T Consensus       134 ~~~~l~~~~~~~i~~qi~~aL~~LH~~-gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~  212 (383)
T 3eb0_A          134 SGRSIPMNLISIYIYQLFRAVGFIHSL-GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPEL  212 (383)
T ss_dssp             TTCCCCHHHHHHHHHHHHHHHHHHHTT-TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHH
T ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHHHC-cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHH
Confidence            678899999999999999999999987 9999999999999985434899999999988766666667788999999999


Q ss_pred             ccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhcc
Q 022799          128 IFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQK  207 (292)
Q Consensus       128 ~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  207 (292)
                      +.+...++.++|+||+||++|+|++|..||.+.+..+++.++.+..+.|+.+.+..+++.+....++......|...++.
T Consensus       213 ~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (383)
T 3eb0_A          213 MLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPE  292 (383)
T ss_dssp             HTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCT
T ss_pred             hcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCC
Confidence            97766689999999999999999999999999999999999999999999999999999999999999989999999999


Q ss_pred             CCChhHHHHHHHHhccCCCCcccHHHHhcCCCccccCC-------CCCCCCCC--CCCCCCCCCChhccCCCCHHHHhhh
Q 022799          208 RMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD-------PNTRLPNG--RFLPPLFNFKPHELKGVPVDMLVKL  278 (292)
Q Consensus       208 ~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~~~~~~~-------~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  278 (292)
                      .+++++.+||.+||+.||.+|||+.|+++||||+++++       .....+++  ...|++++|++.+++..+++.+..+
T Consensus       293 ~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  372 (383)
T 3eb0_A          293 GTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSPYELSIIPGNVLNRI  372 (383)
T ss_dssp             TCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHHHHHC------------------CCCCSCCCHHHHHHSCHHHHHHH
T ss_pred             CCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHHHHhhccccccccccCCCcccCCCCCCCCCCHHHHhcCCHHHHhhc
Confidence            99999999999999999999999999999999998754       23333444  5678899999999999999999999


Q ss_pred             chHHHH
Q 022799          279 IPEHAR  284 (292)
Q Consensus       279 ~~~~~~  284 (292)
                      ++++..
T Consensus       373 ~~~~~~  378 (383)
T 3eb0_A          373 LPKNFS  378 (383)
T ss_dssp             SCC---
T ss_pred             Cchhhc
Confidence            988754

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=9.7e-53  Score=375.63  Aligned_cols=268  Identities=72%  Similarity=1.237  Sum_probs=238.4

Q ss_pred             CCCCCCCCeeeeceeeeccCC-CCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTE-KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~-~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++|||||+++++|..... .+..++++||||+++++.+.+.........+++..++.++.||+.||.|||++ ||+|
T Consensus       101 l~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivH  179 (420)
T 1j1b_A          101 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-GICH  179 (420)
T ss_dssp             HHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT-TEEC
T ss_pred             HHHcCCCCccceeeEEeccCCCCcceeEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC-Cccc
Confidence            457899999999998865433 45667889999999998888876555567899999999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      |||||+|||++.++..+||+|||+++............||+.|+|||++.+...++.++||||+||++|||++|+.||.+
T Consensus       180 rDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~  259 (420)
T 1j1b_A          180 RDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG  259 (420)
T ss_dssp             SCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cCCChhhEEEeCCCCeEEeccchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCC
Confidence            99999999999776578999999998776655556678999999999997766699999999999999999999999999


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCC
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF  239 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~  239 (292)
                      .+..+++.++++.++.|..+.+..+.+.+..+.++.....+|...++..+++++++||.+||++||.+|||+.|+++|||
T Consensus       260 ~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~  339 (420)
T 1j1b_A          260 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF  339 (420)
T ss_dssp             SSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             CCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHh
Confidence            99999999999999999999999999999888899888889998888899999999999999999999999999999999


Q ss_pred             ccccCCCCCCCCCCCCCCCCCCCChhccCC
Q 022799          240 FDELRDPNTRLPNGRFLPPLFNFKPHELKG  269 (292)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (292)
                      |+++.++....+.+...|..++|...++..
T Consensus       340 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (420)
T 1j1b_A          340 FDELRDPNVKLPNGRDTPALFNFTTQELSS  369 (420)
T ss_dssp             GGGGGCTTCCCTTSCCCCCCCCCCHHHHTT
T ss_pred             hcccccccccCCCCCCCCccCCCCHHHhcc
Confidence            999988777777777778888888766554

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=5.5e-53  Score=368.64  Aligned_cols=227  Identities=29%  Similarity=0.494  Sum_probs=173.8

Q ss_pred             CCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCC
Q 022799            5 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIK   83 (292)
Q Consensus         5 ~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlk   83 (292)
                      +|||||+++++|     .+..++|+|||||+ |+|.+++.       .+++.+++.+++||+.||+|||++ ||+|||||
T Consensus        78 ~h~nIv~l~~~~-----~~~~~~~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~-gIiHRDiK  144 (361)
T 4f9c_A           78 GQDNVMGVKYCF-----RKNDHVVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQF-GIVHRDVK  144 (361)
T ss_dssp             SBTTBCCCSEEE-----EETTEEEEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCS
T ss_pred             CCCCCceEEEEE-----EECCEEEEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC-CeEeCcCC
Confidence            699999999999     44456999999998 68888773       489999999999999999999998 99999999


Q ss_pred             CCcEEEeCCCCcEEEeecCCccccccCC-----------------------------CcccccccccccCCccccCCCCC
Q 022799           84 PQNLLVNPHTHQLKLCDFGSAKVLVKGE-----------------------------PNISYICSRYYRAPELIFGATEY  134 (292)
Q Consensus        84 p~Nill~~~~~~ikl~Dfg~a~~~~~~~-----------------------------~~~~~~gt~~y~aPE~~~~~~~~  134 (292)
                      |+|||++.+.+.+||+|||+|+......                             ...+.+||+.|+|||++.+...|
T Consensus       145 PeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y  224 (361)
T 4f9c_A          145 PSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQ  224 (361)
T ss_dssp             GGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCC
T ss_pred             HHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCC
Confidence            9999999874589999999997543221                             12345799999999999887779


Q ss_pred             CchhHhhhhhHHHHHHHhCCCCCC-CCCcHHHHHHHHHHhCCCCHHHHhhcCCC-------Cc--------------ccc
Q 022799          135 TAAIDIWSAGCVLAELLLGQPLFP-GESGVDQLVEIIKVLGTPTREEIKCMNPN-------YT--------------EFK  192 (292)
Q Consensus       135 ~~~~DvwslG~il~el~~g~~pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-------~~--------------~~~  192 (292)
                      +.++|+||+||++|+|++|+.||. +.++.+++..|.+..|.+...........       ..              ...
T Consensus       225 ~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~  304 (361)
T 4f9c_A          225 TTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSS  304 (361)
T ss_dssp             CTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC-----
T ss_pred             CCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccc
Confidence            999999999999999999999985 56677888999988886554333211000       00              000


Q ss_pred             CCCC----CCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCCccccC
Q 022799          193 FPQI----KAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  244 (292)
Q Consensus       193 ~~~~----~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~~~~~~  244 (292)
                      .+..    ............+|++++|||++||++||++|+|++|+|+||||+++.
T Consensus       305 ~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~  360 (361)
T 4f9c_A          305 TPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDMS  360 (361)
T ss_dssp             -----------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred             ccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence            0000    000000011246899999999999999999999999999999999863

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=5.9e-52  Score=381.84  Aligned_cols=204  Identities=26%  Similarity=0.385  Sum_probs=172.6

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      +.++|||||+++++|     ++..++|+|||||+ |+|.+++...    +.+++..++.|+.||+.||+|||++ ||+||
T Consensus       247 ~~~~HP~IV~l~~~f-----~~~~~lylVmEy~~GGdL~~~l~~~----~~l~E~~a~~y~~qIl~aL~yLH~~-gIiHR  316 (689)
T 3v5w_A          247 STGDCPFIVCMSYAF-----HTPDKLSFILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHNR-FVVYR  316 (689)
T ss_dssp             SSSCCTTBCCEEEEE-----ECSSEEEEEECCCCSCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHTT-TEECC
T ss_pred             hhCCCCCEeEEEEEE-----EECCEEEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-Ccccc
Confidence            567999999999999     55556999999998 6999998763    6799999999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE  160 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  160 (292)
                      ||||+|||++.+| .+||+|||+|+..... ...+.+||+.|||||++.+...|+.++|+|||||++|||++|.+||.+.
T Consensus       317 DLKPeNILld~~G-~vKL~DFGlA~~~~~~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~  394 (689)
T 3v5w_A          317 DLKPANILLDEHG-HVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH  394 (689)
T ss_dssp             CCSGGGEEECTTS-CEEECCCTTCEECSSC-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGG
T ss_pred             CCchHHeEEeCCC-CEEecccceeeecCCC-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999999998 6999999999876543 3456799999999999975556999999999999999999999999865


Q ss_pred             CcHHH---HHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCccc-----HH
Q 022799          161 SGVDQ---LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----AL  232 (292)
Q Consensus       161 ~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t-----~~  232 (292)
                      +..+.   ...+...                 ..            .++..+|+++++||.+||+.||.+|++     ++
T Consensus       395 ~~~~~~~i~~~i~~~-----------------~~------------~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~  445 (689)
T 3v5w_A          395 KTKDKHEIDRMTLTM-----------------AV------------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQ  445 (689)
T ss_dssp             GCCCHHHHHHHHHHC-----------------CC------------CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHH
T ss_pred             ChHHHHHHHHhhcCC-----------------CC------------CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHH
Confidence            43222   2222210                 00            123568999999999999999999998     89


Q ss_pred             HHhcCCCccccCCC
Q 022799          233 EALIHPFFDELRDP  246 (292)
Q Consensus       233 e~l~hp~~~~~~~~  246 (292)
                      |+++||||+++++.
T Consensus       446 ei~~HpfF~~idW~  459 (689)
T 3v5w_A          446 EVKESPFFRSLDWQ  459 (689)
T ss_dssp             HHTTSGGGTTCCHH
T ss_pred             HHhcCccccCCCHH
Confidence            99999999998764

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=4.7e-52  Score=353.83  Aligned_cols=213  Identities=23%  Similarity=0.430  Sum_probs=155.9

Q ss_pred             CCCCCCCCeeeeceeeeccCC-------CCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHH
Q 022799            1 MRLLDHPNVVSLKHCFFSTTE-------KDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH   72 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~-------~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH   72 (292)
                      |++|+|||||+++++|.+.+.       ....++|+|||||+ |+|.+++..... ....+...++.++.||+.||+|||
T Consensus        57 l~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH  135 (299)
T 4g31_A           57 LAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLH  135 (299)
T ss_dssp             HTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHH
Confidence            578999999999999865442       23456899999998 699999875322 123456778999999999999999


Q ss_pred             hcCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCCC-------------cccccccccccCCccccCCCCCCchhH
Q 022799           73 NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-------------NISYICSRYYRAPELIFGATEYTAAID  139 (292)
Q Consensus        73 ~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~~D  139 (292)
                      ++ ||+||||||+|||++.++ .+||+|||+|+.......             ..+.+||+.|||||++.+. .|+.++|
T Consensus       136 ~~-~IiHRDlKp~NILl~~~~-~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~D  212 (299)
T 4g31_A          136 SK-GLMHRDLKPSNIFFTMDD-VVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN-SYSHKVD  212 (299)
T ss_dssp             HT-TCCCCCCCGGGEEECTTC-CEEECCCCCC--------------------------CCCTTSCHHHHTTC-CCCTHHH
T ss_pred             HC-cCccccCcHHHeEECCCC-cEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCC-CCCCHHH
Confidence            98 999999999999999988 799999999987644321             2345799999999999765 5999999


Q ss_pred             hhhhhHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHH
Q 022799          140 IWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSR  219 (292)
Q Consensus       140 vwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  219 (292)
                      |||+||++|||++   ||.+..  +....+..........                         .....++.+.+||.+
T Consensus       213 iwSlGvilyell~---Pf~~~~--~~~~~~~~~~~~~~p~-------------------------~~~~~~~~~~~li~~  262 (299)
T 4g31_A          213 IFSLGLILFELLY---PFSTQM--ERVRTLTDVRNLKFPP-------------------------LFTQKYPCEYVMVQD  262 (299)
T ss_dssp             HHHHHHHHHHHHS---CCSSHH--HHHHHHHHHHTTCCCH-------------------------HHHHHCHHHHHHHHH
T ss_pred             HHHHHHHHHHHcc---CCCCcc--HHHHHHHHHhcCCCCC-------------------------CCcccCHHHHHHHHH
Confidence            9999999999996   775432  2222222211111000                         012356788999999


Q ss_pred             HhccCCCCcccHHHHhcCCCccccCCCC
Q 022799          220 LLQYSPNLRSTALEALIHPFFDELRDPN  247 (292)
Q Consensus       220 ~l~~dp~~R~t~~e~l~hp~~~~~~~~~  247 (292)
                      ||+.||.+|||+.|+++||||++++.+.
T Consensus       263 ~L~~dP~~Rps~~eil~h~~~~~~~~p~  290 (299)
T 4g31_A          263 MLSPSPMERPEAINIIENAVFEDLDFPG  290 (299)
T ss_dssp             HTCSSGGGSCCHHHHHTSGGGCCC----
T ss_pred             HcCCChhHCcCHHHHhcCHhhCCCCCCC
Confidence            9999999999999999999999887654

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=8.2e-51  Score=374.71  Aligned_cols=211  Identities=26%  Similarity=0.419  Sum_probs=179.9

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.|+|||||+++++|     .+...+|||||||+ |+|.+++...   .+.+++..++.+++||+.||.|||++ ||+|
T Consensus       208 l~~l~hpnIv~l~~~~-----~~~~~~~iv~E~~~gg~L~~~i~~~---~~~l~e~~~~~~~~qi~~al~ylH~~-~iiH  278 (573)
T 3uto_A          208 MSVLRHPTLVNLHDAF-----EDDNEMVMIYEFMSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN-NYVH  278 (573)
T ss_dssp             HHHTCCTTBCCEEEEE-----ECSSEEEEEEECCCCCBHHHHHTCT---TSCEEHHHHHHHHHHHHHHHHHHHHT-TEEC
T ss_pred             HHhCCCCCCCeEEEEE-----EECCEEEEEEeecCCCcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHC-Ceee
Confidence            4578999999999999     55556999999998 6998888642   45799999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCC-CCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           80 RDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        80 ~dlkp~Nill~~~-~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      |||||+|||++.+ .+.+||+|||+|+.+.........+||+.|||||++.+. .|+.++||||+||++|+|++|..||.
T Consensus       279 RDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~~~~-~y~~~~DiWSlGvilyeml~G~~Pf~  357 (573)
T 3uto_A          279 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFG  357 (573)
T ss_dssp             CCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSC
T ss_pred             ccCChhhccccCCCCCCEEEeeccceeEccCCCceeeeEECccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence            9999999999754 237999999999988666666677899999999999765 48999999999999999999999999


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCC
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  238 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp  238 (292)
                      +.+..+.+..+.......+.                         .....+|+++++||.+||++||.+|||+.|+|+||
T Consensus       358 ~~~~~~~~~~i~~~~~~~~~-------------------------~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hp  412 (573)
T 3uto_A          358 GENDDETLRNVKSCDWNMDD-------------------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHP  412 (573)
T ss_dssp             CSSHHHHHHHHHTTCCCCCS-------------------------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHST
T ss_pred             CcCHHHHHHHHHhCCCCCCc-------------------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence            99888887777653211111                         11246899999999999999999999999999999


Q ss_pred             CccccCCC
Q 022799          239 FFDELRDP  246 (292)
Q Consensus       239 ~~~~~~~~  246 (292)
                      ||+...++
T Consensus       413 w~~~~~~~  420 (573)
T 3uto_A          413 WLTPGNAP  420 (573)
T ss_dssp             TTSCCCCT
T ss_pred             CcCCCCCC
Confidence            99976654

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-49  Score=338.06  Aligned_cols=202  Identities=20%  Similarity=0.287  Sum_probs=161.3

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++|||||++++++..     + .+|||||||+ |+|.+++...   ..++++..+..++.||+.||.|||++ ||+|
T Consensus        86 l~~l~HpNIV~l~g~~~~-----~-~~~iVmEy~~gGsL~~~l~~~---~~~l~~~~~~~i~~qia~gL~yLH~~-~IiH  155 (307)
T 3omv_A           86 LRKTRHVNILLFMGYMTK-----D-NLAIVTQWCEGSSLYKHLHVQ---ETKFQMFQLIDIARQTAQGMDYLHAK-NIIH  155 (307)
T ss_dssp             HTTCCCTTBCCEEEEECS-----S-SCEEEEECCSSCBHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT-TCBC
T ss_pred             HHhCCCCCEeeEEEEEEC-----C-eEEEEEEcCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CccC
Confidence            578999999999997621     1 2789999999 7999988753   46799999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCC---CcccccccccccCCccccCC--CCCCchhHhhhhhHHHHHHHhCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGA--TEYTAAIDIWSAGCVLAELLLGQ  154 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwslG~il~el~~g~  154 (292)
                      |||||+|||++.++ .+||+|||+|+......   .....+||+.|||||++.+.  ..|+.++|||||||++|||+||+
T Consensus       156 RDlKp~NILl~~~~-~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~  234 (307)
T 3omv_A          156 RDMKSNNIFLHEGL-TVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGE  234 (307)
T ss_dssp             SCCCSSSEEEETTE-EEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred             CccCHHHEEECCCC-cEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCC
Confidence            99999999999988 79999999998654322   23456899999999999643  34899999999999999999999


Q ss_pred             CCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHH
Q 022799          155 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA  234 (292)
Q Consensus       155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~  234 (292)
                      .||.+.+....+..+......++                 ..      ...+.++|+++.+||.+||+.||++|||+.++
T Consensus       235 ~Pf~~~~~~~~~~~~~~~~~~~p-----------------~~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei  291 (307)
T 3omv_A          235 LPYSHINNRDQIIFMVGRGYASP-----------------DL------SKLYKNCPKAMKRLVADCVKKVKEERPLFPQI  291 (307)
T ss_dssp             CTTTTCCCHHHHHHHHHTTCCCC-----------------CS------TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHH
T ss_pred             CCCCCCChHHHHHHHHhcCCCCC-----------------Cc------ccccccchHHHHHHHHHHcCCCHhHCcCHHHH
Confidence            99998777666655544211111                 00      01235689999999999999999999999987


Q ss_pred             hc
Q 022799          235 LI  236 (292)
Q Consensus       235 l~  236 (292)
                      ++
T Consensus       292 ~~  293 (307)
T 3omv_A          292 LS  293 (307)
T ss_dssp             HH
T ss_pred             HH
Confidence            64

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=3e-50  Score=342.32  Aligned_cols=206  Identities=20%  Similarity=0.296  Sum_probs=171.1

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhh---------hcCCCCCHHHHHHHHHHHHHHHHH
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHY---------KMSQRMPLIYVKLYFYQICRALAY   70 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~---------~~~~~~~~~~~~~~~~qil~al~~   70 (292)
                      |++|+|||||++++++.+     ...+|||||||+ |+|.+++....         .....+++..+..++.||+.||.|
T Consensus        69 l~~l~HpnIV~l~g~~~~-----~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~y  143 (299)
T 4asz_A           69 LTNLQHEHIVKFYGVCVE-----GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVY  143 (299)
T ss_dssp             HTTCCCTTBCCEEEEECS-----SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHH
T ss_pred             HHhCCCCCCccEEEEEee-----CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHH
Confidence            578999999999999943     334899999998 79999997642         123579999999999999999999


Q ss_pred             HHhcCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCCC---cccccccccccCCccccCCCCCCchhHhhhhhHHH
Q 022799           71 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVL  147 (292)
Q Consensus        71 LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il  147 (292)
                      ||++ +|+||||||+|||++.++ .+||+|||+|+.......   .....||+.|||||++.+. .|+.++||||+||++
T Consensus       144 LH~~-~iiHRDlKp~NILl~~~~-~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~k~DVwS~Gvvl  220 (299)
T 4asz_A          144 LASQ-HFVHRDLATRNCLVGENL-LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVL  220 (299)
T ss_dssp             HHHT-TCCCSCCSGGGEEECGGG-CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHH
T ss_pred             HHhC-CcccCccCHhhEEECCCC-cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCC-CCCchhhHHHHHHHH
Confidence            9998 999999999999999988 799999999986644322   1234689999999999765 499999999999999


Q ss_pred             HHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCC
Q 022799          148 AELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPN  226 (292)
Q Consensus       148 ~el~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~  226 (292)
                      |||+| |+.||.+.+..+.+..+.+.. .+                           ..|..+|+++.+||.+||+.||+
T Consensus       221 ~Ellt~G~~Pf~~~~~~~~~~~i~~~~-~~---------------------------~~p~~~~~~~~~li~~cl~~dP~  272 (299)
T 4asz_A          221 WEIFTYGKQPWYQLSNNEVIECITQGR-VL---------------------------QRPRTCPQEVYELMLGCWQREPH  272 (299)
T ss_dssp             HHHHTTTCCTTTTSCHHHHHHHHHHTC-CC---------------------------CCCTTCCHHHHHHHHHHTCSSGG
T ss_pred             HHHHcCCCCCCCCCCHHHHHHHHHcCC-CC---------------------------CCCccchHHHHHHHHHHcCCChh
Confidence            99998 899999988877766665421 00                           02256899999999999999999


Q ss_pred             CcccHHHHhcCCCccccC
Q 022799          227 LRSTALEALIHPFFDELR  244 (292)
Q Consensus       227 ~R~t~~e~l~hp~~~~~~  244 (292)
                      +|||+.++.  +|++++.
T Consensus       273 ~RPs~~~i~--~~L~~~~  288 (299)
T 4asz_A          273 MRKNIKGIH--TLLQNLA  288 (299)
T ss_dssp             GSCCHHHHH--HHHHHHH
T ss_pred             HCcCHHHHH--HHHHHHH
Confidence            999999994  6777654

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2e-48  Score=340.82  Aligned_cols=264  Identities=50%  Similarity=0.981  Sum_probs=219.4

Q ss_pred             CCCCCCeeeeceeeeccCC--CCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHH--hcCCcc
Q 022799            3 LLDHPNVVSLKHCFFSTTE--KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH--NTIGVC   78 (292)
Q Consensus         3 ~l~HpnIv~~~~~~~~~~~--~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH--~~~~i~   78 (292)
                      .++||||++++++|.....  ....++++||||++++|...+.........+++..++.++.|++.||.|||  ++ ||+
T Consensus        75 ~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~-~iv  153 (360)
T 3e3p_A           75 VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV-NVC  153 (360)
T ss_dssp             HHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT-CCB
T ss_pred             hcCCCCcccHHHhhhccccccccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC-Cee
Confidence            4689999999999875443  345578899999999988887766555678999999999999999999999  88 999


Q ss_pred             ccCCCCCcEEEeC-CCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCC
Q 022799           79 HRDIKPQNLLVNP-HTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF  157 (292)
Q Consensus        79 H~dlkp~Nill~~-~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf  157 (292)
                      ||||||+||+++. ++ .+||+|||++.............||+.|+|||++.+...++.++|+||+||++|+|++|..||
T Consensus       154 H~Dlkp~NIll~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf  232 (360)
T 3e3p_A          154 HRDIKPHNVLVNEADG-TLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIF  232 (360)
T ss_dssp             CSCCCGGGEEEETTTT-EEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             cCcCCHHHEEEeCCCC-cEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCc
Confidence            9999999999997 55 899999999988766655566788999999999977666899999999999999999999999


Q ss_pred             CCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhcc---CCChhHHHHHHHHhccCCCCcccHHHH
Q 022799          158 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQK---RMPPEAVDLVSRLLQYSPNLRSTALEA  234 (292)
Q Consensus       158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~dp~~R~t~~e~  234 (292)
                      .+.+....+..+.+..+.++.+.+....+.............+|...++.   ..++++.+||.+||+.||.+|||+.|+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~  312 (360)
T 3e3p_A          233 RGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEA  312 (360)
T ss_dssp             CCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHH
Confidence            99999999999999999999999888877766665555555555555433   367899999999999999999999999


Q ss_pred             hcCCCccccCCCCCCCCCCCCCC-CCCCCChhccC
Q 022799          235 LIHPFFDELRDPNTRLPNGRFLP-PLFNFKPHELK  268 (292)
Q Consensus       235 l~hp~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  268 (292)
                      ++||||+++..+....+.....+ ...++.+++.+
T Consensus       313 l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (360)
T 3e3p_A          313 LCHPYFDELHDPATKLPNNKDLPEDLFRFLPNEIE  347 (360)
T ss_dssp             TTSGGGGGGGCTTCCCTTSCCCCGGGGCCCHHHHH
T ss_pred             hcCccccccCCccccCCCCCCCCcHHHHcCchHHH
Confidence            99999999987766554444333 33444444443

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=6.1e-49  Score=338.56  Aligned_cols=205  Identities=21%  Similarity=0.310  Sum_probs=162.6

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhh-----------cCCCCCHHHHHHHHHHHHHHH
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYK-----------MSQRMPLIYVKLYFYQICRAL   68 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~-----------~~~~~~~~~~~~~~~qil~al   68 (292)
                      |++|+|||||++++++.     +...+|||||||+ |+|.+++.....           ...++++.++..++.||+.||
T Consensus        97 l~~l~HpnIV~l~g~~~-----~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl  171 (329)
T 4aoj_A           97 LTMLQHQHIVRFFGVCT-----EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGM  171 (329)
T ss_dssp             HTTCCCTTBCCEEEEEC-----SSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHH
T ss_pred             HHhCCCCCCCcEEEEEE-----ECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHH
Confidence            57899999999999994     3444899999999 799999875421           134699999999999999999


Q ss_pred             HHHHhcCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCCC---cccccccccccCCccccCCCCCCchhHhhhhhH
Q 022799           69 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGC  145 (292)
Q Consensus        69 ~~LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~  145 (292)
                      .|||++ +|+||||||+|||++.++ .+||+|||+|+.......   .....||+.|||||++.+. .|+.++|||||||
T Consensus       172 ~yLH~~-~iiHRDLKp~NILl~~~~-~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~~sDvwS~Gv  248 (329)
T 4aoj_A          172 VYLAGL-HFVHRDLATRNCLVGQGL-VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDVWSFGV  248 (329)
T ss_dssp             HHHHHT-TCCCSCCCGGGEEEETTT-EEEECCCC----------------CCCCGGGCCHHHHTTC-CCCHHHHHHHHHH
T ss_pred             HHHhcC-CeecccccHhhEEECCCC-cEEEcccccceeccCCCcceecCcccccccccChhhhcCC-CCCccccccchHH
Confidence            999998 999999999999999988 899999999987643322   2345789999999999765 4999999999999


Q ss_pred             HHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccC
Q 022799          146 VLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYS  224 (292)
Q Consensus       146 il~el~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  224 (292)
                      ++|||+| |+.||.+.+..+.+..+.+.. .+                           ..|..+|+++.+||.+||+.|
T Consensus       249 vl~Ellt~G~~Pf~~~~~~~~~~~i~~g~-~~---------------------------~~p~~~~~~~~~li~~cl~~d  300 (329)
T 4aoj_A          249 VLWEIFTYGKQPWYQLSNTEAIDCITQGR-EL---------------------------ERPRACPPEVYAIMRGCWQRE  300 (329)
T ss_dssp             HHHHHHTTSCCTTCSSCHHHHHHHHHHTC-CC---------------------------CCCTTCCHHHHHHHHHHCCSS
T ss_pred             HHHHHHcCCCCCCCCCCHHHHHHHHHcCC-CC---------------------------CCcccccHHHHHHHHHHcCcC
Confidence            9999999 899999888777666655421 00                           022468999999999999999


Q ss_pred             CCCcccHHHHhcCCCcccc
Q 022799          225 PNLRSTALEALIHPFFDEL  243 (292)
Q Consensus       225 p~~R~t~~e~l~hp~~~~~  243 (292)
                      |++|||++|++++  ++.+
T Consensus       301 P~~RPs~~ei~~~--L~~l  317 (329)
T 4aoj_A          301 PQQRHSIKDVHAR--LQAL  317 (329)
T ss_dssp             TTTSCCHHHHHHH--HHHH
T ss_pred             hhHCcCHHHHHHH--HHHH
Confidence            9999999999853  4443

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=4.9e-48  Score=349.06  Aligned_cols=273  Identities=32%  Similarity=0.547  Sum_probs=205.8

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      |+.++|||||++++++.....++...+|+||||++++|.+++..    ...+++..++.+++||+.||.|||++ ||+||
T Consensus       106 l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~-~iiHr  180 (458)
T 3rp9_A          106 LNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHSA-GILHR  180 (458)
T ss_dssp             HHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCCSEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHT-TCBCC
T ss_pred             HHhCCCCCCCceEEEEecCCcccCceEEEEEeccccchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhC-CcCCC
Confidence            34679999999999986554444556899999999999998875    46799999999999999999999998 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCC----------------------------CcccccccccccCCccccCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE----------------------------PNISYICSRYYRAPELIFGAT  132 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~  132 (292)
                      ||||+|||++.++ .+||+|||+++......                            .....+||+.|+|||++.+..
T Consensus       181 DlKp~NILl~~~~-~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~  259 (458)
T 3rp9_A          181 DLKPANCLVNQDC-SVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQE  259 (458)
T ss_dssp             CCCGGGEEECTTC-CEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCC
T ss_pred             CCChhhEEECCCC-CEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCC
Confidence            9999999999988 79999999998754221                            123457899999999876666


Q ss_pred             CCCchhHhhhhhHHHHHHHh-----------CCCCCCCCC--------------------cHHHHHHHHHHhCCCCHHHH
Q 022799          133 EYTAAIDIWSAGCVLAELLL-----------GQPLFPGES--------------------GVDQLVEIIKVLGTPTREEI  181 (292)
Q Consensus       133 ~~~~~~DvwslG~il~el~~-----------g~~pf~~~~--------------------~~~~~~~i~~~~~~~~~~~~  181 (292)
                      .++.++||||+||++|||++           |.++|++.+                    ..+++..+.+.++.|+.+.+
T Consensus       260 ~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~  339 (458)
T 3rp9_A          260 NYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDI  339 (458)
T ss_dssp             CCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHH
T ss_pred             CCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHH
Confidence            69999999999999999998           778887754                    36788899999999999887


Q ss_pred             hhcCCCCcc---ccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCCccccCCCCCCCCCCCCCCC
Q 022799          182 KCMNPNYTE---FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPP  258 (292)
Q Consensus       182 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~  258 (292)
                      .........   ..++......+...+ +..++++.+||++||++||.+|||++|+|+||||++++++.......  .+.
T Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~e~~~~--~~~  416 (458)
T 3rp9_A          340 EALEKEDAKRYIRIFPKREGTDLAERF-PASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNAT--EKV  416 (458)
T ss_dssp             HTSSCHHHHHHHTTSCCCCCCCGGGGS-TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGGCCCCS--SCC
T ss_pred             hhcCCHHHHHHHHhcCCCCCCCHHHHC-CCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCccCCCCC--CCC
Confidence            655322110   012222233333333 46799999999999999999999999999999999988764432221  111


Q ss_pred             CCCCChhccCCCCHHHHhhhchHHHH
Q 022799          259 LFNFKPHELKGVPVDMLVKLIPEHAR  284 (292)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (292)
                      ...|+  +....+.+.++..+.++..
T Consensus       417 ~~~~~--~~~~~~~~~~~~~~~~e~~  440 (458)
T 3rp9_A          417 RLPFN--DWMNMDEPQLRYAFVKEIQ  440 (458)
T ss_dssp             CCSSC--TTSCCCHHHHHHHHHHHHT
T ss_pred             CCCcc--ccccCCHHHHHHHHHHHHH
Confidence            22222  4456777777777666554

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.7e-48  Score=340.73  Aligned_cols=268  Identities=32%  Similarity=0.620  Sum_probs=201.1

Q ss_pred             CCC-CCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccC
Q 022799            3 LLD-HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRD   81 (292)
Q Consensus         3 ~l~-HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~d   81 (292)
                      .+. ||||+++++++...   +...+|+||||++++|..++..     ..+++..++.++.||+.||.|||++ ||+|||
T Consensus        64 ~l~~h~niv~l~~~~~~~---~~~~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~-~ivHrD  134 (388)
T 3oz6_A           64 ELSGHENIVNLLNVLRAD---NDRDVYLVFDYMETDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSG-GLLHRD  134 (388)
T ss_dssp             HTTTCTTBCCEEEEEECT---TSSCEEEEEECCSEEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHT-TEECCC
T ss_pred             hccCCCCCCeeeeEEecC---CCCEEEEEecccCcCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC-CEEeCC
Confidence            454 99999999998542   2335899999999999988874     5689999999999999999999998 999999


Q ss_pred             CCCCcEEEeCCCCcEEEeecCCccccccC----------------------CCcccccccccccCCccccCCCCCCchhH
Q 022799           82 IKPQNLLVNPHTHQLKLCDFGSAKVLVKG----------------------EPNISYICSRYYRAPELIFGATEYTAAID  139 (292)
Q Consensus        82 lkp~Nill~~~~~~ikl~Dfg~a~~~~~~----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~D  139 (292)
                      |||+||+++.++ .+||+|||+++.....                      ......+||+.|+|||++.+...++.++|
T Consensus       135 lkp~NIll~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D  213 (388)
T 3oz6_A          135 MKPSNILLNAEC-HVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGID  213 (388)
T ss_dssp             CCGGGEEECTTC-CEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHH
T ss_pred             CCHHHeEEcCCC-CEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhh
Confidence            999999999988 7999999999765321                      11234578999999999987667999999


Q ss_pred             hhhhhHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccC------CCCCCCCchhhh--------
Q 022799          140 IWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF------PQIKAHPWHKIF--------  205 (292)
Q Consensus       140 vwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~--------  205 (292)
                      +||+||++|+|++|.+||.+.+..+++..+...++.|..+.+..+...+.....      .......+...+        
T Consensus       214 iwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (388)
T 3oz6_A          214 MWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLL  293 (388)
T ss_dssp             HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcc
Confidence            999999999999999999999999999999999999998887655433211000      000000011111        


Q ss_pred             ----ccCCChhHHHHHHHHhccCCCCcccHHHHhcCCCccccCCCCCCCCCCCCCCCCCCCChhccCCCCHHHHhhhchH
Q 022799          206 ----QKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPE  281 (292)
Q Consensus       206 ----~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (292)
                          ...+++++.+||.+||+.||++|||++|+|+||||+.+..+.........    +.+.-.+....+.+.++..+.+
T Consensus       294 ~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~  369 (388)
T 3oz6_A          294 KINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHI----ITIPINDNVKHSIDDYRNLVYS  369 (388)
T ss_dssp             HHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTTTCCGGGCCCCSSC----CCCC------CCHHHHHHHHHH
T ss_pred             cccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHHHHHhcCCccCCCCCCC----CCCCccccccCCHHHHHHHHHH
Confidence                12678999999999999999999999999999999988766543322221    1121122334567777776665


Q ss_pred             HHH
Q 022799          282 HAR  284 (292)
Q Consensus       282 ~~~  284 (292)
                      ...
T Consensus       370 ~~~  372 (388)
T 3oz6_A          370 EIS  372 (388)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            543

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2.1e-48  Score=351.45  Aligned_cols=269  Identities=29%  Similarity=0.551  Sum_probs=196.6

Q ss_pred             CCCCCCCCeeeeceeeeccCC-CCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTE-KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~-~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++|||||++++++..... .+...+|+||||++++|.+.+.      ..+++..++.++.||+.||.|||++ ||+|
T Consensus       115 l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~-~iiH  187 (464)
T 3ttj_A          115 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA-GIIH  187 (464)
T ss_dssp             HHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT-TCCC
T ss_pred             HHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCCCHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHC-Cccc
Confidence            356799999999999865432 2335689999999998887764      3489999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      |||||+|||++.++ .+||+|||+++...........+||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+
T Consensus       188 rDlkp~NIll~~~~-~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pF~g  265 (464)
T 3ttj_A          188 RDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPG  265 (464)
T ss_dssp             CCCCGGGEEECTTS-CEEECCCCCC-----CCCC----CCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CCCChHhEEEeCCC-CEEEEEEEeeeecCCCcccCCCcccccccCHHHHcCC-CCCHHHHHHHHHHHHHHHHhCCCCCCC
Confidence            99999999999988 7999999999887655555667899999999999775 599999999999999999999999999


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccc--cCCCCCCCCchhhhccC-----------CChhHHHHHHHHhccCCC
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF--KFPQIKAHPWHKIFQKR-----------MPPEAVDLVSRLLQYSPN  226 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~-----------~~~~~~~li~~~l~~dp~  226 (292)
                      .+..+++.++.+.++.|..+.+....+....+  ..+......+...++..           .++++++||.+||++||+
T Consensus       266 ~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~  345 (464)
T 3ttj_A          266 RDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA  345 (464)
T ss_dssp             SSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTT
T ss_pred             CCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChh
Confidence            99999999999999999988776554322111  11222222233222221           256799999999999999


Q ss_pred             CcccHHHHhcCCCccccCCCCCCCCCCCCCCCCCCCChhccCCCCHHHHhhhchHH
Q 022799          227 LRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEH  282 (292)
Q Consensus       227 ~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (292)
                      +|||++|+|+||||+...++.....   ..+..+.+. .+....+.+.+++.+.+.
T Consensus       346 ~R~ta~e~L~Hp~~~~~~~~~~~~~---~~~~~~~~~-~~~~~~~~~~~~~~~~~e  397 (464)
T 3ttj_A          346 KRISVDDALQHPYINVWYDPAEVEA---PPPQIYDKQ-LDEREHTIEEWKELIYKE  397 (464)
T ss_dssp             TSCCHHHHHTSTTTGGGCCHHHHSC---CC------------CCCHHHHHHHHHHH
T ss_pred             hCCCHHHHhcChhhhhccCcccccC---CCCccCCcc-hhhccCCHHHHHHHHHHH
Confidence            9999999999999997665432211   111222222 223344566666665544

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=4.8e-49  Score=336.22  Aligned_cols=201  Identities=21%  Similarity=0.270  Sum_probs=166.1

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHH
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYK------------MSQRMPLIYVKLYFYQICRA   67 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~------------~~~~~~~~~~~~~~~qil~a   67 (292)
                      |++++|||||++++++.+     ...++||||||+ |+|.+++.....            ....+++..+..++.||+.|
T Consensus        83 l~~l~HpNIV~l~g~~~~-----~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~g  157 (308)
T 4gt4_A           83 RARLQHPNVVCLLGVVTK-----DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAG  157 (308)
T ss_dssp             HHHCCCTTBCCEEEEECS-----SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHH
T ss_pred             HHhCCCCCCCCcceEEEE-----CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHH
Confidence            356899999999999843     334899999998 799999975321            12468999999999999999


Q ss_pred             HHHHHhcCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCC---CcccccccccccCCccccCCCCCCchhHhhhhh
Q 022799           68 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTAAIDIWSAG  144 (292)
Q Consensus        68 l~~LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG  144 (292)
                      |.|||++ +|+||||||+|||++.++ .+||+|||+|+......   ......||+.|||||++.+. .|+.++||||+|
T Consensus       158 l~yLH~~-~iiHRDLK~~NILl~~~~-~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~~s~ksDVwSfG  234 (308)
T 4gt4_A          158 MEYLSSH-HVVHKDLATRNVLVYDKL-NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG-KFSIDSDIWSYG  234 (308)
T ss_dssp             HHHHHHT-TCCCSCCSGGGEEECGGG-CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHC-CCCHHHHHHHHH
T ss_pred             HHHHHhC-CCCCCCccccceEECCCC-CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCC-CCCccchhhhHH
Confidence            9999998 999999999999999988 79999999998764332   23346789999999999765 499999999999


Q ss_pred             HHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhcc
Q 022799          145 CVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQY  223 (292)
Q Consensus       145 ~il~el~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  223 (292)
                      |++|||+| |..||.+.+..+....+..... +                           ..+..+|+++.+||.+||+.
T Consensus       235 vvl~El~t~g~~Pf~~~~~~~~~~~i~~~~~-~---------------------------~~p~~~~~~~~~li~~C~~~  286 (308)
T 4gt4_A          235 VVLWEVFSYGLQPYCGYSNQDVVEMIRNRQV-L---------------------------PCPDDCPAWVYALMIECWNE  286 (308)
T ss_dssp             HHHHHHHTTTCCTTTTCCHHHHHHHHHTTCC-C---------------------------CCCTTCCHHHHHHHHHHTCS
T ss_pred             HHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-C---------------------------CCcccchHHHHHHHHHHcCC
Confidence            99999998 8999998887776655543110 0                           01256899999999999999


Q ss_pred             CCCCcccHHHHhcC
Q 022799          224 SPNLRSTALEALIH  237 (292)
Q Consensus       224 dp~~R~t~~e~l~h  237 (292)
                      ||++|||+.|++++
T Consensus       287 dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          287 FPSRRPRFKDIHSR  300 (308)
T ss_dssp             SGGGSCCHHHHHHH
T ss_pred             ChhHCcCHHHHHHH
Confidence            99999999999854

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.9e-47  Score=342.60  Aligned_cols=273  Identities=29%  Similarity=0.522  Sum_probs=205.2

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      |++++||||+++++++..........+|+||||++|+|.+++..    ...+++..++.++.||+.||.|||++ ||+||
T Consensus        79 l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~-givHr  153 (432)
T 3n9x_A           79 LNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHES-GIIHR  153 (432)
T ss_dssp             HHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCSEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHT-TEECC
T ss_pred             HHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCCcCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCCCC
Confidence            35689999999999986543333356899999999999998875    46799999999999999999999998 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCC-----------------------CcccccccccccCCccccCCCCCCch
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-----------------------PNISYICSRYYRAPELIFGATEYTAA  137 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-----------------------~~~~~~gt~~y~aPE~~~~~~~~~~~  137 (292)
                      ||||+|||++.++ .+||+|||+++......                       .....+||+.|+|||++.+...++.+
T Consensus       154 Dlkp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~  232 (432)
T 3n9x_A          154 DLKPANCLLNQDC-SVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKS  232 (432)
T ss_dssp             CCCGGGEEECTTC-CEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTH
T ss_pred             CCCHHHeEECCCC-CEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcc
Confidence            9999999999988 79999999998764332                       12456889999999997666679999


Q ss_pred             hHhhhhhHHHHHHHh-----------CCCCCCCCC-----------------cHHHHHHHHHHhCCCCHHHHhhcCCCCc
Q 022799          138 IDIWSAGCVLAELLL-----------GQPLFPGES-----------------GVDQLVEIIKVLGTPTREEIKCMNPNYT  189 (292)
Q Consensus       138 ~DvwslG~il~el~~-----------g~~pf~~~~-----------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~  189 (292)
                      +|+||+||++|||++           |.++|.+.+                 ..+++..+.+.+|.|+.+.+..+.....
T Consensus       233 ~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~  312 (432)
T 3n9x_A          233 IDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEV  312 (432)
T ss_dssp             HHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHH
T ss_pred             cccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHH
Confidence            999999999999998           455565544                 3678899999999999988765532210


Q ss_pred             c-c--cCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCCccccCCCCCCCCCCCCCCCCCCCChhc
Q 022799          190 E-F--KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHE  266 (292)
Q Consensus       190 ~-~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (292)
                      . +  ..+......+...+ +.+++++.+||++||++||++|||++|+|+||||++++++........  +....|+  +
T Consensus       313 ~~~~~~~~~~~~~~~~~~~-~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~e~~~~~--~~~~~~~--~  387 (432)
T 3n9x_A          313 IKYIKLFPHRKPINLKQKY-PSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTK--KIILPFD--D  387 (432)
T ss_dssp             HHHHHTSCCCCCCCHHHHS-TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTTC---CC--CCCCSSC--T
T ss_pred             HHHHHhCCCCCCCCHHHHC-CCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCcccCcCCCC--CCCCChh--h
Confidence            0 0  12222222333333 468999999999999999999999999999999999987654332211  1112222  3


Q ss_pred             cCCCCHHHHhhhchHHHH
Q 022799          267 LKGVPVDMLVKLIPEHAR  284 (292)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~  284 (292)
                      ....+.+.++.++.++..
T Consensus       388 ~~~~~~~~~~~~~~~e~~  405 (432)
T 3n9x_A          388 WMVLSETQLRYIFLKEVQ  405 (432)
T ss_dssp             TCCCCHHHHHHHHHHHHH
T ss_pred             cccCCHHHHHHHHHHHHH
Confidence            356777888877766654

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.2e-47  Score=329.86  Aligned_cols=232  Identities=36%  Similarity=0.700  Sum_probs=189.7

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccC
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRD   81 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~d   81 (292)
                      +.++||||+++++++     .+...+++||||++++|.+.+...   ...+++..++.++.||+.||.|||++ ||+|||
T Consensus        74 ~~l~hp~iv~~~~~~-----~~~~~~~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivH~D  144 (311)
T 3niz_A           74 KELHHPNIVSLIDVI-----HSERCLTLVFEFMEKDLKKVLDEN---KTGLQDSQIKIYLYQLLRGVAHCHQH-RILHRD  144 (311)
T ss_dssp             HHCCCTTBCCEEEEE-----CCSSCEEEEEECCSEEHHHHHHTC---TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCC
T ss_pred             HHcCCCCEeeeeeEE-----ccCCEEEEEEcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCC
Confidence            467999999999998     444568999999999998888753   35699999999999999999999998 999999


Q ss_pred             CCCCcEEEeCCCCcEEEeecCCccccccCC-CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCC
Q 022799           82 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE  160 (292)
Q Consensus        82 lkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  160 (292)
                      |||+||+++.++ .+||+|||++....... ......||+.|+|||++.+...++.++|+||+||++|+|++|..||.+.
T Consensus       145 ikp~NIl~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  223 (311)
T 3niz_A          145 LKPQNLLINSDG-ALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGV  223 (311)
T ss_dssp             CCGGGEEECTTC-CEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             CchHhEEECCCC-CEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCC
Confidence            999999999988 79999999998764332 2334578999999999977666899999999999999999999999999


Q ss_pred             CcHHHHHHHHHHhCCCCHHHHhhcCCC--CccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCC
Q 022799          161 SGVDQLVEIIKVLGTPTREEIKCMNPN--YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  238 (292)
Q Consensus       161 ~~~~~~~~i~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp  238 (292)
                      ...+.+..+....+.+....+......  +....+.......+.. ..+.+++++.+||.+||+.||++|||++|+++||
T Consensus       224 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  302 (311)
T 3niz_A          224 TDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSS-IIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHP  302 (311)
T ss_dssp             STTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHH-HSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred             ChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHH-hCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCc
Confidence            999999999999998877655433211  0111122222233333 3357899999999999999999999999999999


Q ss_pred             CccccC
Q 022799          239 FFDELR  244 (292)
Q Consensus       239 ~~~~~~  244 (292)
                      ||+++.
T Consensus       303 ~f~~~~  308 (311)
T 3niz_A          303 YFKDLD  308 (311)
T ss_dssp             GGTTSC
T ss_pred             ccccCC
Confidence            999875

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=2.5e-47  Score=324.80  Aligned_cols=234  Identities=33%  Similarity=0.568  Sum_probs=188.1

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      |++++||||+++++++.     +...+++||||+++++.+.+...   ...+++..++.++.||+.||.|||++ ||+||
T Consensus        55 l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~-~ivH~  125 (292)
T 3o0g_A           55 LKELKHKNIVRLHDVLH-----SDKKLTLVFEFCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSR-NVLHR  125 (292)
T ss_dssp             HTTCCCTTBCCEEEEEE-----ETTEEEEEEECCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECC
T ss_pred             HhcCCCCCEeeEEeEEE-----eCCEEEEEEecCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC-CeecC
Confidence            46789999999999984     44458999999999888877653   46799999999999999999999998 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCC-CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCC-CC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPL-FP  158 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~p-f~  158 (292)
                      ||||+||+++.++ .+||+|||++....... ......||+.|+|||++.+...++.++|+||+||++|+|++|..| |.
T Consensus       126 dikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~  204 (292)
T 3o0g_A          126 DLKPQNLLINRNG-ELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP  204 (292)
T ss_dssp             CCSGGGEEECTTS-CEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred             CCCHHHEEEcCCC-CEEEeecccceecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcC
Confidence            9999999999988 79999999998764332 234457899999999997766689999999999999999987766 67


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCC
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  238 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp  238 (292)
                      +.+..+.+..+.+..+.+..+.+............+............+.+++.+++||.+||+.||++|||++|+++||
T Consensus       205 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp  284 (292)
T 3o0g_A          205 GNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHP  284 (292)
T ss_dssp             CSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             CCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCc
Confidence            77778888999999999887765543221111111211111112223356899999999999999999999999999999


Q ss_pred             CccccC
Q 022799          239 FFDELR  244 (292)
Q Consensus       239 ~~~~~~  244 (292)
                      ||+++.
T Consensus       285 ~f~~~~  290 (292)
T 3o0g_A          285 YFSDFC  290 (292)
T ss_dssp             GGTTC-
T ss_pred             ccccCC
Confidence            999754

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.1e-47  Score=330.10  Aligned_cols=241  Identities=35%  Similarity=0.675  Sum_probs=191.8

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      |+.++||||+++++++.     +....++||||++|+|.+++...   ...+++..++.++.||+.||.|||++ ||+||
T Consensus        54 l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~  124 (324)
T 3mtl_A           54 LKDLKHANIVTLHDIIH-----TEKSLTLVFEYLDKDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHRQ-KVLHR  124 (324)
T ss_dssp             HSCCCCTTBCCEEEEEE-----CSSCEEEEEECCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TEEES
T ss_pred             HHhcCCCCCCeeeeEEe-----eCCEEEEEecccccCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CccCC
Confidence            46789999999999984     34458999999999999988753   45699999999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCC-CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      ||||+||+++.++ .+||+|||++....... ......||+.|+|||++.+...++.++|+||+||++|+|++|..||.+
T Consensus       125 Dikp~NIl~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  203 (324)
T 3mtl_A          125 DLKPQNLLINERG-ELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPG  203 (324)
T ss_dssp             SCCGGGEEECTTC-CEEECSSSEEECC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             CcCHHHEEECCCC-CEEEccCcccccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999988 79999999997654322 223457899999999997766689999999999999999999999999


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCC--CccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPN--YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      .+..+.+..+.+..+.|..+.+......  +..+.++......... ..+.+++++.+||.+||+.||++|||++|+++|
T Consensus       204 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  282 (324)
T 3mtl_A          204 STVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLS-HAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH  282 (324)
T ss_dssp             SSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHH-HCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             CCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhh-hcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            9999999999999999887665433211  1122233322222222 235789999999999999999999999999999


Q ss_pred             CCccccCCCCCCCCC
Q 022799          238 PFFDELRDPNTRLPN  252 (292)
Q Consensus       238 p~~~~~~~~~~~~~~  252 (292)
                      |||.++.......+.
T Consensus       283 p~f~~~~~~~~~~~~  297 (324)
T 3mtl_A          283 PFFLSLGERIHKLPD  297 (324)
T ss_dssp             GGGGGGCSTTSSSCT
T ss_pred             hhhhhcccccccCCC
Confidence            999998765544443

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=3.2e-48  Score=336.78  Aligned_cols=201  Identities=23%  Similarity=0.351  Sum_probs=164.4

Q ss_pred             CCC-CCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhc------------CCCCCHHHHHHHHHHHHHHH
Q 022799            3 LLD-HPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKM------------SQRMPLIYVKLYFYQICRAL   68 (292)
Q Consensus         3 ~l~-HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~------------~~~~~~~~~~~~~~qil~al   68 (292)
                      ++. |||||++++++....    ..+|||||||+ |+|.+++......            ...+++..+..++.||+.||
T Consensus       123 ~l~hhpnIV~l~g~~~~~~----~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl  198 (353)
T 4ase_A          123 HIGHHLNVVNLLGACTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGM  198 (353)
T ss_dssp             HHCCCTTBCCEEEEECCTT----SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHH
T ss_pred             HcCCCCcEEEEEEEEEecC----CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHH
Confidence            454 599999999874332    23789999999 7999999764321            24589999999999999999


Q ss_pred             HHHHhcCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCCC---cccccccccccCCccccCCCCCCchhHhhhhhH
Q 022799           69 AYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGC  145 (292)
Q Consensus        69 ~~LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~  145 (292)
                      +|||++ +|+||||||+|||++.++ .+||+|||+|+.......   .....||+.|||||++.+. .|+.++||||+||
T Consensus       199 ~yLH~~-~iiHRDLK~~NILl~~~~-~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~y~~ksDVwS~Gv  275 (353)
T 4ase_A          199 EFLASR-KCIHRDLAARNILLSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGV  275 (353)
T ss_dssp             HHHHHT-TCCCSCCSGGGEEECGGG-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHH
T ss_pred             HhHhhC-CeecCccCccceeeCCCC-CEEECcchhhhhcccCCCceeeccccccccccCHHHHhcC-CCCCcccEeehHH
Confidence            999998 999999999999999988 799999999987644332   2345789999999999765 4999999999999


Q ss_pred             HHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccC
Q 022799          146 VLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYS  224 (292)
Q Consensus       146 il~el~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  224 (292)
                      ++|||+| |..||.+.+..+.+.+++.....+.                           .|..+++++.++|.+||+.|
T Consensus       276 ~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~---------------------------~p~~~~~~~~~li~~c~~~d  328 (353)
T 4ase_A          276 LLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR---------------------------APDYTTPEMYQTMLDCWHGE  328 (353)
T ss_dssp             HHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCC---------------------------CCTTCCHHHHHHHHHHTCSS
T ss_pred             HHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCCC---------------------------CCccCCHHHHHHHHHHcCcC
Confidence            9999998 9999998776555555544321111                           22468999999999999999


Q ss_pred             CCCcccHHHHhcC
Q 022799          225 PNLRSTALEALIH  237 (292)
Q Consensus       225 p~~R~t~~e~l~h  237 (292)
                      |++|||+.++++|
T Consensus       329 P~~RPt~~eil~~  341 (353)
T 4ase_A          329 PSQRPTFSELVEH  341 (353)
T ss_dssp             GGGSCCHHHHHHH
T ss_pred             hhHCcCHHHHHHH
Confidence            9999999999987

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.2e-47  Score=331.34  Aligned_cols=266  Identities=32%  Similarity=0.580  Sum_probs=204.4

Q ss_pred             CCCCCCCeeeeceeeeccCC-CCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTE-KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~-~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      +.++||||+++++++..... .+...+|+||||++++|.+++..     ..+++..++.++.||+.||.|||++ ||+||
T Consensus        79 ~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~-~ivH~  152 (367)
T 1cm8_A           79 KHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA-GIIHR  152 (367)
T ss_dssp             HHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT-TEECC
T ss_pred             HhCCCcCCCCceeeEecCCccccCceEEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-Ccccc
Confidence            56789999999999854432 12245789999998899998864     5689999999999999999999998 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE  160 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  160 (292)
                      ||||+||+++.++ .+||+|||+++....  .....++|+.|+|||++.+...++.++|+||+||++|+|++|+.||.+.
T Consensus       153 Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  229 (367)
T 1cm8_A          153 DLKPGNLAVNEDC-ELKILDFGLARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS  229 (367)
T ss_dssp             CCCGGGEEECTTC-CEEECCCTTCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CcCHHHEEEcCCC-CEEEEeeeccccccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999999988 799999999987533  2345678999999999987566999999999999999999999999999


Q ss_pred             CcHHHHHHHHHHhCCCCHHHHhhcCCCCcc---ccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          161 SGVDQLVEIIKVLGTPTREEIKCMNPNYTE---FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       161 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      +..+++..+.+..+.|+.+.+..+......   ...+......+...+ ...++.+.+||.+||+.||.+|||++++|+|
T Consensus       230 ~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          230 DHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             SHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTC-TTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHC-CCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence            999999999999999998877654322110   012222333333333 5689999999999999999999999999999


Q ss_pred             CCccccCCCCCCCCCCCCCCCCCCCChhccCCCCHHHHhhhchHHH
Q 022799          238 PFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHA  283 (292)
Q Consensus       238 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (292)
                      |||+++.++.......     .+++. .+....+.+.+++.+.+..
T Consensus       309 p~f~~~~~~~~~~~~~-----~~~~~-~~~~~~~~~~~~~~~~~~~  348 (367)
T 1cm8_A          309 PYFESLHDTEDEPQVQ-----KYDDS-FDDVDRTLDEWKRVTYKEV  348 (367)
T ss_dssp             GGGTTTC------CCC-----CCCCC------CCHHHHHHHHHHHH
T ss_pred             hHHHhhcCCccCCCCC-----CCCCC-hhhhcCCHHHHHHHHHHHH
Confidence            9999987654432211     12222 2223456777777665544

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.9e-46  Score=323.05  Aligned_cols=241  Identities=33%  Similarity=0.600  Sum_probs=191.4

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCcc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKM--SQRMPLIYVKLYFYQICRALAYIHNTIGVC   78 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~--~~~~~~~~~~~~~~qil~al~~LH~~~~i~   78 (292)
                      |++++||||+++++++     .+...+++||||++|+|.+++......  ...+++..++.++.||+.||.|||++ ||+
T Consensus        57 l~~l~hp~iv~~~~~~-----~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~-~iv  130 (317)
T 2pmi_A           57 MKELKHENIVRLYDVI-----HTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN-KIL  130 (317)
T ss_dssp             HTTCCBTTBCCEEEEE-----CCTTEEEEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT-TEE
T ss_pred             HHhcCCCCcceEEEEE-----EECCeEEEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC-Cee
Confidence            4678999999999998     444568999999999999988764321  24589999999999999999999988 999


Q ss_pred             ccCCCCCcEEEeCCCCcEEEeecCCccccccC-CCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCC
Q 022799           79 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF  157 (292)
Q Consensus        79 H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf  157 (292)
                      ||||||+||+++.++ .+||+|||++...... .......||+.|+|||++.+...++.++|+||+||++|+|++|..||
T Consensus       131 H~Dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf  209 (317)
T 2pmi_A          131 HRDLKPQNLLINKRG-QLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLF  209 (317)
T ss_dssp             CCCCCGGGEEECTTC-CEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             eCCCChHHeEEcCCC-CEEECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            999999999999988 7999999999876433 22344578999999999977666899999999999999999999999


Q ss_pred             CCCCcHHHHHHHHHHhCCCCHHHHhhcCC--CCccccCCCCCCCCch----hhhccCCChhHHHHHHHHhccCCCCcccH
Q 022799          158 PGESGVDQLVEIIKVLGTPTREEIKCMNP--NYTEFKFPQIKAHPWH----KIFQKRMPPEAVDLVSRLLQYSPNLRSTA  231 (292)
Q Consensus       158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~dp~~R~t~  231 (292)
                      .+.+..+.+..+.+..+.++...+.....  .+.. .........+.    ...+..+++++.+||.+||+.||++|||+
T Consensus       210 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~  288 (317)
T 2pmi_A          210 PGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNP-NIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSA  288 (317)
T ss_dssp             CCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCT-TCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred             CCCChHHHHHHHHHHhCCCChhHhhhhhhhhhccc-ccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCH
Confidence            99999999999999998887665543321  1100 11111111111    11234688999999999999999999999


Q ss_pred             HHHhcCCCccccCCCCCC
Q 022799          232 LEALIHPFFDELRDPNTR  249 (292)
Q Consensus       232 ~e~l~hp~~~~~~~~~~~  249 (292)
                      +|+++||||++....+..
T Consensus       289 ~e~l~hp~f~~~~~~~~~  306 (317)
T 2pmi_A          289 KQALHHPWFAEYYHHASM  306 (317)
T ss_dssp             HHHTTSGGGGGGCC----
T ss_pred             HHHhCChhhhcccchhhc
Confidence            999999999998765433

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=8.5e-47  Score=320.91  Aligned_cols=232  Identities=35%  Similarity=0.647  Sum_probs=184.2

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      |+.++||||+++++++..     ....++||||++++|.+++...   ...+++..++.++.||+.||.|||++ ||+||
T Consensus        54 l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~  124 (288)
T 1ob3_A           54 LKELKHSNIVKLYDVIHT-----KKRLVLVFEHLDQDLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDR-RVLHR  124 (288)
T ss_dssp             GGGCCCTTBCCEEEEEEC-----SSCEEEEEECCSEEHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCS
T ss_pred             HHhcCCCCEeeeeeEEcc-----CCeEEEEEEecCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC-CeecC
Confidence            467899999999999843     3458999999999999888753   36789999999999999999999998 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCC-CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      ||||+||+++.++ .+||+|||++....... ......||+.|+|||++.+...++.++|+||+||++|+|++|..||.+
T Consensus       125 dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  203 (288)
T 1ob3_A          125 DLKPQNLLINREG-ELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPG  203 (288)
T ss_dssp             CCCGGGEEECTTS-CEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             CCCHHHEEEcCCC-CEEEeECccccccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999888 79999999998654322 233457899999999997766689999999999999999999999999


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCC-ccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCC
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNY-TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  238 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp  238 (292)
                      .+..+.+..+.+..+.+....+....... ....+......++.. +...+++++.+||.+||+.||++|||++++++||
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp  282 (288)
T 1ob3_A          204 VSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWES-FLKGLDESGIDLLSKMLKLDPNQRITAKQALEHA  282 (288)
T ss_dssp             SSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGG-TCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred             CCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHH-HhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence            99999999999988887765443321100 000111122222322 2357899999999999999999999999999999


Q ss_pred             Ccccc
Q 022799          239 FFDEL  243 (292)
Q Consensus       239 ~~~~~  243 (292)
                      ||++.
T Consensus       283 ~f~~~  287 (288)
T 1ob3_A          283 YFKEN  287 (288)
T ss_dssp             GGGC-
T ss_pred             chhhc
Confidence            99864

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.9e-46  Score=321.66  Aligned_cols=234  Identities=29%  Similarity=0.545  Sum_probs=191.5

Q ss_pred             CCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCC
Q 022799            4 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIK   83 (292)
Q Consensus         4 l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlk   83 (292)
                      ++||||+++++++..........+++||||++++|.+++....  ...+++..++.++.||+.||.|||++ ||+|||||
T Consensus        71 ~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlk  147 (308)
T 3g33_A           71 FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAP--PPGLPAETIKDLMRQFLRGLDFLHAN-CIVHRDLK  147 (308)
T ss_dssp             HCCTTBCCEEEEEEECCSSSEEEEEEEEECCCCBHHHHHHTCC--TTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCC
T ss_pred             cCCCCeEEeeeeeeccCCCCceeEEEEehhhhcCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCC
Confidence            4699999999998766655566789999999999999987532  23489999999999999999999998 99999999


Q ss_pred             CCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCCCcH
Q 022799           84 PQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV  163 (292)
Q Consensus        84 p~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~  163 (292)
                      |+||+++.++ .+||+|||++.............||+.|+|||++.+.. ++.++|+||+||++|+|++|..||.+.+..
T Consensus       148 p~Nil~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~  225 (308)
T 3g33_A          148 PENILVTSGG-TVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEA  225 (308)
T ss_dssp             TTTEEECTTS-CEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSC-CCSTHHHHHHHHHHHHTTTSSCSCCCSSHH
T ss_pred             HHHEEEcCCC-CEEEeeCccccccCCCcccCCccccccccCchHHcCCC-CCchHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            9999999888 79999999998776555566678999999999997654 899999999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCCcccc
Q 022799          164 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  243 (292)
Q Consensus       164 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~~~~~  243 (292)
                      +.+.++.+..+.++...+..... .....++......... ..+.+++.+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus       226 ~~~~~i~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~  303 (308)
T 3g33_A          226 DQLGKIFDLIGLPPEDDWPRDVS-LPRGAFPPRGPRPVQS-VVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD  303 (308)
T ss_dssp             HHHHHHHHHHCCCCTTTSCSSCS-SCGGGSCCCCCCCHHH-HSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred             HHHHHHHHHhCCCChhhccchhh-ccccccCCCCCCcHHH-hCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence            99999999999888765532211 1111222222222222 335789999999999999999999999999999999864


Q ss_pred             C
Q 022799          244 R  244 (292)
Q Consensus       244 ~  244 (292)
                      .
T Consensus       304 ~  304 (308)
T 3g33_A          304 E  304 (308)
T ss_dssp             -
T ss_pred             C
Confidence            3

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=3.3e-46  Score=327.52  Aligned_cols=269  Identities=33%  Similarity=0.658  Sum_probs=208.6

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccC
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRD   81 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~d   81 (292)
                      ++++||||+++++++......+....|+||||++|+|.+++..     ..+++..++.++.||+.||.|||++ ||+|||
T Consensus        80 ~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~D  153 (364)
T 3qyz_A           80 LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-NVLHRD  153 (364)
T ss_dssp             HHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCC
T ss_pred             HhcCCCCCccceeEEecCCccccceEEEEEcccCcCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC-CeecCC
Confidence            4679999999999986554444456899999999999998864     5699999999999999999999998 999999


Q ss_pred             CCCCcEEEeCCCCcEEEeecCCccccccCCC----cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCC
Q 022799           82 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF  157 (292)
Q Consensus        82 lkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf  157 (292)
                      |||+||+++.++ .+||+|||++........    .....||+.|+|||++.+...++.++|+||+||++|+|++|..||
T Consensus       154 ikp~NIl~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf  232 (364)
T 3qyz_A          154 LKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF  232 (364)
T ss_dssp             CCGGGEEECTTC-CEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             CChHhEEECCCC-CEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCC
Confidence            999999999888 799999999986643321    234578999999999877666899999999999999999999999


Q ss_pred             CCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCc---cccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHH
Q 022799          158 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYT---EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA  234 (292)
Q Consensus       158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~  234 (292)
                      .+.+..+.+..+....+.|+.+.+........   ....+.....++.. +.+.+++++.+||.+||+.||++|||+.++
T Consensus       233 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~e~  311 (364)
T 3qyz_A          233 PGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNR-LFPNADSKALDLLDKMLTFNPHKRIEVEQA  311 (364)
T ss_dssp             CCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHH-HCTTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             CCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHH-hCCCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence            99999999999999999999887765421100   01122222233333 235689999999999999999999999999


Q ss_pred             hcCCCccccCCCCCCCCCCCCCCCCCCCChhccCCCCHHHHhhhchHHH
Q 022799          235 LIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHA  283 (292)
Q Consensus       235 l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (292)
                      ++||||+....+.....    ....+.++ .+...++.+.+.+++.+..
T Consensus       312 l~hp~~~~~~~~~~~~~----~~~~~~~~-~~~~~~~~~~~~~~~~~e~  355 (364)
T 3qyz_A          312 LAHPYLEQYYDPSDEPI----AEAPFKFD-MELDDLPKEKLKELIFEET  355 (364)
T ss_dssp             HTSGGGTTTCCGGGSCC----CSSCCCCC------CCHHHHHHHHHHHT
T ss_pred             hcCcchhhccCcccccC----CCCcCCcc-cccccCCHHHHHHHHHHHH
Confidence            99999998765433221    12223332 4566777888877766644

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.9e-46  Score=323.22  Aligned_cols=205  Identities=27%  Similarity=0.465  Sum_probs=175.7

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++     .+...+|+||||++ |+|.+++...    +++++..++.++.||+.||.|||++ ||+|
T Consensus        68 l~~l~hpnIv~l~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~-~ivH  137 (328)
T 3fe3_A           68 MKILNHPNIVKLFEVI-----ETEKTLYLIMEYASGGEVFDYLVAH----GRMKEKEARSKFRQIVSAVQYCHQK-RIVH  137 (328)
T ss_dssp             HHHCCCTTBCCEEEEE-----ECSSEEEEEECCCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT-TCCC
T ss_pred             HHhCCCCCEeeEEEEE-----EECCEEEEEEECCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CEec
Confidence            3568999999999998     44445899999997 6999988753    6799999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      |||||+||+++.++ .+||+|||++............+||+.|+|||++.+....+.++|+||+||++|+|++|..||.+
T Consensus       138 rDlkp~NIll~~~~-~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  216 (328)
T 3fe3_A          138 RDLKAENLLLDADM-NIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG  216 (328)
T ss_dssp             SCCCGGGEEECTTS-CEEECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cCCCHHHEEEcCCC-CEEEeeccCceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCC
Confidence            99999999999988 79999999998776665566778999999999998776556899999999999999999999998


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCC
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF  239 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~  239 (292)
                      .+..+....+....                 ..            ++..+++++.+||++||..||.+|||++++++|||
T Consensus       217 ~~~~~~~~~i~~~~-----------------~~------------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~  267 (328)
T 3fe3_A          217 QNLKELRERVLRGK-----------------YR------------IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRW  267 (328)
T ss_dssp             SSHHHHHHHHHHCC-----------------CC------------CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTT
T ss_pred             CCHHHHHHHHHhCC-----------------CC------------CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHh
Confidence            88766666554410                 00            12357899999999999999999999999999999


Q ss_pred             ccccCC
Q 022799          240 FDELRD  245 (292)
Q Consensus       240 ~~~~~~  245 (292)
                      |+....
T Consensus       268 ~~~~~~  273 (328)
T 3fe3_A          268 INAGHE  273 (328)
T ss_dssp             TTTTCT
T ss_pred             hcCCCc
Confidence            987654

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.5e-46  Score=325.39  Aligned_cols=235  Identities=30%  Similarity=0.597  Sum_probs=188.1

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      |++++||||+++++++.     +...+++||||++|+|.+++..    ...+++..++.++.||+.||.|||++ ||+||
T Consensus        87 l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~~~~~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~~-~ivH~  156 (329)
T 3gbz_A           87 LKELQHRNIIELKSVIH-----HNHRLHLIFEYAENDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSR-RCLHR  156 (329)
T ss_dssp             GGGCCCTTBCCEEEEEE-----ETTEEEEEEECCSEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCS
T ss_pred             HHHcCCCCcceEEEEEe-----cCCEEEEEEecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CEECC
Confidence            46789999999999984     3445899999999999998875    35699999999999999999999998 99999


Q ss_pred             CCCCCcEEEeCCC----CcEEEeecCCccccccC-CCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCC
Q 022799           81 DIKPQNLLVNPHT----HQLKLCDFGSAKVLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQP  155 (292)
Q Consensus        81 dlkp~Nill~~~~----~~ikl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~  155 (292)
                      ||||+||+++.++    ..+||+|||++...... .......||+.|+|||++.+...++.++|+||+||++|+|++|..
T Consensus       157 Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~  236 (329)
T 3gbz_A          157 DLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTP  236 (329)
T ss_dssp             CCCGGGEEEEC-----CCEEEECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CCCHHHEEEecCCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence            9999999995332    25999999999876433 223445779999999999776668999999999999999999999


Q ss_pred             CCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC-CccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHH
Q 022799          156 LFPGESGVDQLVEIIKVLGTPTREEIKCMNPN-YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA  234 (292)
Q Consensus       156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~  234 (292)
                      ||.+.+..+.+..+.+..+.|....+...... .....++......+...++..+++++.+||.+||+.||.+|||++|+
T Consensus       237 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~  316 (329)
T 3gbz_A          237 LFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNA  316 (329)
T ss_dssp             SSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHH
Confidence            99999999999999999998887655433111 01113334444455555666789999999999999999999999999


Q ss_pred             hcCCCccccCC
Q 022799          235 LIHPFFDELRD  245 (292)
Q Consensus       235 l~hp~~~~~~~  245 (292)
                      ++||||++..+
T Consensus       317 l~hp~f~~~~~  327 (329)
T 3gbz_A          317 LEHPYFSHNDF  327 (329)
T ss_dssp             HTSGGGSSSCS
T ss_pred             hCCcccCCCCC
Confidence            99999998654

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.6e-46  Score=329.65  Aligned_cols=268  Identities=32%  Similarity=0.568  Sum_probs=198.3

Q ss_pred             CCCCCCCeeeeceeeeccCC-CCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTE-KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~-~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      +.++||||+++++++..... .+...+|+|||+++++|.+++..     ..+++..++.++.||+.||.|||++ ||+||
T Consensus        83 ~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~-givH~  156 (367)
T 2fst_X           83 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA-DIIHR  156 (367)
T ss_dssp             HHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCC
T ss_pred             HhCCCCCCCcEEEEEecCCccccCCeEEEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CeeeC
Confidence            46799999999999854321 22345789999999999888763     5699999999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE  160 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  160 (292)
                      ||||+||+++.++ .+||+|||+++....  ......||+.|+|||++.+...++.++|+||+||++|+|++|..||.+.
T Consensus       157 Dlkp~NIll~~~~-~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  233 (367)
T 2fst_X          157 DLKPSNLAVNEDC-ELKILDFGLARHTAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT  233 (367)
T ss_dssp             CCCGGGEEECTTC-CEEECC-----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             CCCHhhEEECCCC-CEEEeeccccccccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999999988 799999999986533  2345678999999999977566899999999999999999999999999


Q ss_pred             CcHHHHHHHHHHhCCCCHHHHhhcCCCCcc---ccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          161 SGVDQLVEIIKVLGTPTREEIKCMNPNYTE---FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       161 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      +..+++..+.+..+.|..+.+..+......   ...+......+...+ ...++.+.+||.+||+.||++|||+.++|+|
T Consensus       234 ~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          234 DHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             SHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHT-TTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHC-CCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence            999999999999999998877655322110   012222333344333 4689999999999999999999999999999


Q ss_pred             CCccccCCCCCCCCCCCCCCCCCCCChhccCCCCHHHHhhhchHHHHh
Q 022799          238 PFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARK  285 (292)
Q Consensus       238 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (292)
                      |||+.+..+......     +.+.+. .+......+.+++++.+...+
T Consensus       313 p~~~~~~~~~~~~~~-----~~~~~~-~~~~~~~~~~~~~~~~~e~~~  354 (367)
T 2fst_X          313 AYFAQYHDPDDEPVA-----DPYDQS-LESRDLLIDEWKSLTYDEVIS  354 (367)
T ss_dssp             GGGTTTCCGGGCCCC-----CCCCGG-GSSCCCCHHHHHHHHHHHHHH
T ss_pred             hhhhhccCCCCCCCC-----CCCCcc-hhhccCCHHHHHHHHHHHHHH
Confidence            999988766543221     122222 344566788888877665543

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=5.2e-46  Score=325.47  Aligned_cols=208  Identities=25%  Similarity=0.404  Sum_probs=176.5

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||++++++|     .+...+++||||++ |+|.+++..    ...+++..++.++.||+.||.|||++ ||+|
T Consensus        69 l~~l~hpnIv~l~~~~-----~~~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~-givH  138 (361)
T 2yab_A           69 LRQVLHPNIITLHDVY-----ENRTDVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK-KIAH  138 (361)
T ss_dssp             HTTCCCTTBCCEEEEE-----ECSSEEEEEEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHHT-TEEC
T ss_pred             HHhCCCcCCCcEEEEE-----EeCCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-Cccc
Confidence            4678999999999998     44456999999997 799988864    46799999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCC---cEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCC
Q 022799           80 RDIKPQNLLVNPHTH---QLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPL  156 (292)
Q Consensus        80 ~dlkp~Nill~~~~~---~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~p  156 (292)
                      |||||+||+++.++.   .+||+|||++............+||+.|+|||++.+. .++.++|+||+||++|+|++|..|
T Consensus       139 rDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~~ll~g~~P  217 (361)
T 2yab_A          139 FDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASP  217 (361)
T ss_dssp             CCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCS
T ss_pred             CCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCCccccCCCCccEECchHHcCC-CCCccccHHHHHHHHHHHHhCCCC
Confidence            999999999987653   5999999999887665555667899999999999654 589999999999999999999999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      |.+.+..+.+..+.......+.                         .+...+++.+++||.+||..||.+|||+.++++
T Consensus       218 f~~~~~~~~~~~i~~~~~~~~~-------------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          218 FLGDTKQETLANITAVSYDFDE-------------------------EFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             SCCSSHHHHHHHHHTTCCCCCH-------------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCCCHHHHHHHHHhcCCCCCc-------------------------hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            9998877776666543221111                         122468999999999999999999999999999


Q ss_pred             CCCccccC
Q 022799          237 HPFFDELR  244 (292)
Q Consensus       237 hp~~~~~~  244 (292)
                      ||||+.+.
T Consensus       273 hp~~~~~~  280 (361)
T 2yab_A          273 HPWITPVD  280 (361)
T ss_dssp             STTTSCSS
T ss_pred             CcCcCCCc
Confidence            99998654

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=8e-46  Score=321.47  Aligned_cols=204  Identities=28%  Similarity=0.447  Sum_probs=173.2

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++     .+...+|+||||++ |+|...+...    ..+++..++.++.||+.||.|||++ ||+|
T Consensus        59 l~~l~hp~iv~l~~~~-----~~~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH  128 (337)
T 1o6l_A           59 LQNTRHPFLTALKYAF-----QTHDRLCFVMEYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSR-DVVY  128 (337)
T ss_dssp             HHSCCCTTBCCEEEEE-----ECSSEEEEEEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT-TCBC
T ss_pred             HHhCCCCcCcceEEEE-----EeCCEEEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-Ceec
Confidence            3568999999999999     44446999999998 5998888753    6799999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCcccccc-CCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      |||||+||+++.++ .+||+|||+++.... .......+||+.|+|||++.+. .++.++|+||+||++|+|++|..||.
T Consensus       129 rDlkp~NIll~~~g-~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~  206 (337)
T 1o6l_A          129 RDIKLENLMLDKDG-HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFY  206 (337)
T ss_dssp             CCCCGGGEEECTTS-CEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CcCCHHHEEECCCC-CEEEeeccchhhcccCCCcccccccChhhCChhhhcCC-CCCchhhcccchhHHHHHhcCCCCCC
Confidence            99999999999988 799999999986432 3344567899999999999664 58999999999999999999999998


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcc-----cHHH
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALE  233 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----t~~e  233 (292)
                      +.+.......+...                 ..            .++..+++++++||.+||+.||.+|+     ++++
T Consensus       207 ~~~~~~~~~~i~~~-----------------~~------------~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~e  257 (337)
T 1o6l_A          207 NQDHERLFELILME-----------------EI------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKE  257 (337)
T ss_dssp             CSSHHHHHHHHHHC-----------------CC------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHH
T ss_pred             CCCHHHHHHHHHcC-----------------CC------------CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHH
Confidence            88776666555431                 00            12246899999999999999999999     8999


Q ss_pred             HhcCCCccccCC
Q 022799          234 ALIHPFFDELRD  245 (292)
Q Consensus       234 ~l~hp~~~~~~~  245 (292)
                      +++||||+++++
T Consensus       258 i~~h~~f~~~~~  269 (337)
T 1o6l_A          258 VMEHRFFLSINW  269 (337)
T ss_dssp             HHTSGGGTTCCH
T ss_pred             HHcCCCcCCCCH
Confidence            999999998764

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6e-46  Score=323.74  Aligned_cols=234  Identities=35%  Similarity=0.626  Sum_probs=190.8

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccC
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRD   81 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~d   81 (292)
                      +.++||||+++++++     .+....++||||++++|...+...   ...+++..++.++.|++.||.|||++ ||+|||
T Consensus        67 ~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~D  137 (346)
T 1ua2_A           67 QELSHPNIIGLLDAF-----GHKSNISLVFDFMETDLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQH-WILHRD  137 (346)
T ss_dssp             HHCCCTTBCCEEEEE-----CCTTCCEEEEECCSEEHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHHT-TCCCCC
T ss_pred             hhCCCCCCCeEEEEE-----eeCCceEEEEEcCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC-CEECCC
Confidence            457899999999998     344458999999999988887642   35688899999999999999999998 999999


Q ss_pred             CCCCcEEEeCCCCcEEEeecCCccccccCC-CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCC
Q 022799           82 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE  160 (292)
Q Consensus        82 lkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  160 (292)
                      |||+||+++.++ .+||+|||+++...... ......||+.|+|||++.+...++.++|+||+||++|+|++|.+||.+.
T Consensus       138 lkp~Nil~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~  216 (346)
T 1ua2_A          138 LKPNNLLLDENG-VLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD  216 (346)
T ss_dssp             CCGGGEEECTTC-CEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CCHHHEEEcCCC-CEEEEecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence            999999999988 79999999998764332 2345678999999999977666899999999999999999999999999


Q ss_pred             CcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCCc
Q 022799          161 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  240 (292)
Q Consensus       161 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~~  240 (292)
                      +..+.+.++.+..+.+..+.+...........+......++.. +...+++++++||.+||..||++|||++|+++||||
T Consensus       217 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f  295 (346)
T 1ua2_A          217 SDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHH-IFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF  295 (346)
T ss_dssp             SHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHH-HCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGG
T ss_pred             CHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHH-hhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhh
Confidence            9999999999999988877665432211111222222222222 225688999999999999999999999999999999


Q ss_pred             cccCCC
Q 022799          241 DELRDP  246 (292)
Q Consensus       241 ~~~~~~  246 (292)
                      ++...+
T Consensus       296 ~~~~~~  301 (346)
T 1ua2_A          296 SNRPGP  301 (346)
T ss_dssp             TSSSCC
T ss_pred             hcCCCC
Confidence            976544

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.8e-46  Score=330.09  Aligned_cols=271  Identities=30%  Similarity=0.545  Sum_probs=192.9

Q ss_pred             CCCCCCCeeeeceeeeccCC-CCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTE-KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~-~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      +.++||||+++++++..... .+...+|+||||++++|.+.+.      ..+++..+..++.||+.||.|||++ ||+||
T Consensus        79 ~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~  151 (371)
T 2xrw_A           79 KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA-GIIHR  151 (371)
T ss_dssp             HHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSEEHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCS
T ss_pred             HhcCCCCccceEEeeccccccccccceEEEEEcCCCCHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHC-Ceecc
Confidence            46799999999999854332 2234689999999999888875      3589999999999999999999998 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE  160 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  160 (292)
                      ||||+||+++.++ .+||+|||+++............||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+.
T Consensus       152 Dlkp~NIl~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~  229 (371)
T 2xrw_A          152 DLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGT  229 (371)
T ss_dssp             CCCGGGEEECTTS-CEEECCCCC----------------CTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cCCHHHEEEcCCC-CEEEEEeecccccccccccCCceecCCccCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999999888 7999999999876554444566889999999999765 4899999999999999999999999999


Q ss_pred             CcHHHHHHHHHHhCCCCHHHHhhcCCCCccc--cCCCCCCCCchhhhc-----------cCCChhHHHHHHHHhccCCCC
Q 022799          161 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEF--KFPQIKAHPWHKIFQ-----------KRMPPEAVDLVSRLLQYSPNL  227 (292)
Q Consensus       161 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~-----------~~~~~~~~~li~~~l~~dp~~  227 (292)
                      +..+.+..+.+..+.|..+.+..+.+....+  ..+......+...++           ...++++++||.+||+.||++
T Consensus       230 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~  309 (371)
T 2xrw_A          230 DHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASK  309 (371)
T ss_dssp             SHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGG
T ss_pred             CHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhh
Confidence            9999999999999998887765443211110  011111111111111           112578999999999999999


Q ss_pred             cccHHHHhcCCCccccCCCCCCCCCCCCCCCCCCCChhccCCCCHHHHhhhchHHHHh
Q 022799          228 RSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARK  285 (292)
Q Consensus       228 R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (292)
                      |||++|+++||||+...++.....   . ++...-...+......+.+++++.+...+
T Consensus       310 R~t~~e~l~hp~~~~~~~~~~~~~---~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (371)
T 2xrw_A          310 RISVDEALQHPYINVWYDPSEAEA---P-PPKIPDKQLDEREHTIEEWKELIYKEVMD  363 (371)
T ss_dssp             SCCHHHHHHSHHHHTTCCHHHHTC---C-CCCCCTTTTCCCCCCHHHHHHHHHHHHHH
T ss_pred             CCCHHHHhCCcchhhhcCccccCC---C-CCCCCChhhccccCcHHHHHHHHHHHHHH
Confidence            999999999999987654322111   1 11111122334456788888887766544

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=3e-46  Score=326.10  Aligned_cols=200  Identities=28%  Similarity=0.489  Sum_probs=168.3

Q ss_pred             CCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCC
Q 022799            5 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIK   83 (292)
Q Consensus         5 ~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlk   83 (292)
                      +||||++++++|     .+...+|+||||++ |+|...+...    ..+++..++.++.||+.||.|||++ ||+|||||
T Consensus        82 ~hp~Iv~l~~~~-----~~~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~-givHrDlk  151 (353)
T 3txo_A           82 NHPFLTQLFCCF-----QTPDRLFFVMEFVNGGDLMFHIQKS----RRFDEARARFYAAEIISALMFLHDK-GIIYRDLK  151 (353)
T ss_dssp             TCTTBCCEEEEE-----ECSSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCC
T ss_pred             CCCceeeEEEEE-----EeCCEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCC
Confidence            799999999999     44456999999998 6998888753    6799999999999999999999998 99999999


Q ss_pred             CCcEEEeCCCCcEEEeecCCcccccc-CCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCCCc
Q 022799           84 PQNLLVNPHTHQLKLCDFGSAKVLVK-GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG  162 (292)
Q Consensus        84 p~Nill~~~~~~ikl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~  162 (292)
                      |+|||++.++ .+||+|||+++.... .......+||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+.+.
T Consensus       152 p~NILl~~~g-~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~  229 (353)
T 3txo_A          152 LDNVLLDHEG-HCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEM-LYGPAVDWWAMGVLLYEMLCGHAPFEAENE  229 (353)
T ss_dssp             GGGEEECTTS-CEEECCCTTCBCSCC---------CCGGGCCHHHHHHH-HCTTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             HHHEEECCCC-CEEEccccceeecccCCccccccCCCcCeEChhhcCCC-CcCCccCCCcchHHHHHHHhCCCCCCCCCH
Confidence            9999999988 799999999986432 2334456899999999999664 489999999999999999999999999888


Q ss_pred             HHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccH------HHHhc
Q 022799          163 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA------LEALI  236 (292)
Q Consensus       163 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~------~e~l~  236 (292)
                      .+...++....                 .            .++..+++++.+||++||+.||.+|+++      +++++
T Consensus       230 ~~~~~~i~~~~-----------------~------------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          230 DDLFEAILNDE-----------------V------------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             HHHHHHHHHCC-----------------C------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             HHHHHHHHcCC-----------------C------------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence            87777776521                 0            1224588999999999999999999998      99999


Q ss_pred             CCCccccCC
Q 022799          237 HPFFDELRD  245 (292)
Q Consensus       237 hp~~~~~~~  245 (292)
                      ||||+++++
T Consensus       281 hp~f~~~~w  289 (353)
T 3txo_A          281 HPFFKEIDW  289 (353)
T ss_dssp             SGGGTTCCH
T ss_pred             CCcccCCCH
Confidence            999998865

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-46  Score=322.10  Aligned_cols=201  Identities=27%  Similarity=0.503  Sum_probs=173.4

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      +.++||||+++++++     .+...+|+||||++ |+|.+++..    ...+++..++.++.||+.||.|||++ ||+||
T Consensus        61 ~~l~hp~Iv~~~~~~-----~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHr  130 (318)
T 1fot_A           61 SIVTHPFIIRMWGTF-----QDAQQIFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK-DIIYR  130 (318)
T ss_dssp             HSCCBTTBCCEEEEE-----ECSSEEEEEECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT-TEECC
T ss_pred             hhCCCCCCceEeEEE-----EeCCEEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-Ccccc
Confidence            568999999999998     44456999999998 699998875    36799999999999999999999987 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE  160 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  160 (292)
                      ||||+||+++.++ .+||+|||+++....  .....+||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+.
T Consensus       131 Dlkp~NIll~~~g-~~kL~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~  206 (318)
T 1fot_A          131 DLKPENILLDKNG-HIKITDFGFAKYVPD--VTYTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDS  206 (318)
T ss_dssp             CCCGGGEEECTTS-CEEECCCSSCEECSS--CBCCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             CCChheEEEcCCC-CEEEeecCcceecCC--ccccccCCccccCHhHhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence            9999999999988 799999999987533  34456899999999999664 4899999999999999999999999988


Q ss_pred             CcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcc-----cHHHHh
Q 022799          161 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEAL  235 (292)
Q Consensus       161 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----t~~e~l  235 (292)
                      +......++....                 .            .++..++++++++|.+||..||++|+     ++++++
T Consensus       207 ~~~~~~~~i~~~~-----------------~------------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~  257 (318)
T 1fot_A          207 NTMKTYEKILNAE-----------------L------------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVK  257 (318)
T ss_dssp             SHHHHHHHHHHCC-----------------C------------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHH
T ss_pred             CHHHHHHHHHhCC-----------------C------------CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHh
Confidence            8777766665420                 0            12245889999999999999999999     899999


Q ss_pred             cCCCccccCC
Q 022799          236 IHPFFDELRD  245 (292)
Q Consensus       236 ~hp~~~~~~~  245 (292)
                      +||||+++.+
T Consensus       258 ~hp~f~~~~~  267 (318)
T 1fot_A          258 NHPWFKEVVW  267 (318)
T ss_dssp             TSGGGSSCCH
T ss_pred             cCccccCCCH
Confidence            9999998764

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.6e-46  Score=333.63  Aligned_cols=223  Identities=26%  Similarity=0.446  Sum_probs=181.0

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      +.++||||++++++|     .+...+|+|||||+ |+|.+++...   ...+++..++.++.||+.||.|||++ ||+||
T Consensus       129 ~~~~hp~Iv~l~~~~-----~~~~~~~lV~Ey~~gg~L~~~l~~~---~~~l~e~~~~~~~~qi~~aL~~LH~~-giiHr  199 (437)
T 4aw2_A          129 VNGDSKWITTLHYAF-----QDDNNLYLVMDYYVGGDLLTLLSKF---EDRLPEEMARFYLAEMVIAIDSVHQL-HYVHR  199 (437)
T ss_dssp             HHSCTTTBCCEEEEE-----ECSSEEEEEECCCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECC
T ss_pred             HhCCCCCEEEEEEEE-----eeCCEEEEEEecCCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEec
Confidence            357899999999999     44556999999997 7999998753   46799999999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCCc--ccccccccccCCcccc----CCCCCCchhHhhhhhHHHHHHHhCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN--ISYICSRYYRAPELIF----GATEYTAAIDIWSAGCVLAELLLGQ  154 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~----~~~~~~~~~DvwslG~il~el~~g~  154 (292)
                      ||||+|||++.++ .+||+|||+++........  ...+||+.|+|||++.    +...++.++|+||+||++|||++|.
T Consensus       200 DLKp~NILl~~~g-~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~  278 (437)
T 4aw2_A          200 DIKPDNILMDMNG-HIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE  278 (437)
T ss_dssp             CCSGGGEEECTTS-CEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSS
T ss_pred             ccCHHHeeEcCCC-CEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCC
Confidence            9999999999988 7999999999776443332  2357999999999986    2345899999999999999999999


Q ss_pred             CCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCC--cccHH
Q 022799          155 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL--RSTAL  232 (292)
Q Consensus       155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--R~t~~  232 (292)
                      .||.+.+..+...++......               ..++.         ....+++++++||++||+.+|.+  |++++
T Consensus       279 ~Pf~~~~~~~~~~~i~~~~~~---------------~~~p~---------~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~  334 (437)
T 4aw2_A          279 TPFYAESLVETYGKIMNHKER---------------FQFPT---------QVTDVSENAKDLIRRLICSREHRLGQNGIE  334 (437)
T ss_dssp             CTTCCSSHHHHHHHHHTHHHH---------------CCCCS---------SCCCSCHHHHHHHHTTSSCGGGCTTTTTTH
T ss_pred             CCCCCCChhHHHHhhhhcccc---------------ccCCc---------ccccCCHHHHHHHHHHhcccccccCCCCHH
Confidence            999998888887777642110               01111         01358999999999999998888  99999


Q ss_pred             HHhcCCCccccCCCCCCCCCCCCCCC
Q 022799          233 EALIHPFFDELRDPNTRLPNGRFLPP  258 (292)
Q Consensus       233 e~l~hp~~~~~~~~~~~~~~~~~~~~  258 (292)
                      |+++||||+++++...+....++.|.
T Consensus       335 eil~Hpff~~i~w~~l~~~~~p~~P~  360 (437)
T 4aw2_A          335 DFKKHPFFSGIDWDNIRNCEAPYIPE  360 (437)
T ss_dssp             HHHTSGGGTTCCTTTGGGSCCSCCCC
T ss_pred             HHhCCCccCCCCHHHHhhCCCCCCCc
Confidence            99999999999876554333334443

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.9e-45  Score=323.08  Aligned_cols=205  Identities=26%  Similarity=0.451  Sum_probs=174.5

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||++++++|     .+...+|+||||++ |+|.+.+...    ..+++..++.++.||+.||+|||++ ||+|
T Consensus        93 l~~~~hp~Iv~l~~~~-----~~~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~-givH  162 (373)
T 2r5t_A           93 LKNVKHPFLVGLHFSF-----QTADKLYFVLDYINGGELFYHLQRE----RCFLEPRARFYAAEIASALGYLHSL-NIVY  162 (373)
T ss_dssp             BCCCCCTTBCCEEEEE-----ECSSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TCCC
T ss_pred             HHhCCCCCCCCEEEEE-----EeCCEEEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-Ccee
Confidence            3568999999999999     44456999999998 5998888753    5689999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCcccccc-CCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      |||||+||+++.++ .+||+|||+++.... .......+||+.|+|||++.+. .++.++|+|||||++|||++|..||.
T Consensus       163 rDlkp~NIll~~~g-~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~  240 (373)
T 2r5t_A          163 RDLKPENILLDSQG-HIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFY  240 (373)
T ss_dssp             CCCCGGGEEECTTS-CEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred             cCCCHHHEEECCCC-CEEEeeCccccccccCCCccccccCCccccCHHHhCCC-CCCchhhhHHHHHHHHHHHcCCCCCC
Confidence            99999999999988 799999999986432 3344567899999999999764 48999999999999999999999999


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccH----HHH
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA----LEA  234 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~----~e~  234 (292)
                      +.+..+...++....                 .            .++..+++++++||.+||+.||.+|+++    .++
T Consensus       241 ~~~~~~~~~~i~~~~-----------------~------------~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i  291 (373)
T 2r5t_A          241 SRNTAEMYDNILNKP-----------------L------------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEI  291 (373)
T ss_dssp             CSBHHHHHHHHHHSC-----------------C------------CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHH
T ss_pred             CCCHHHHHHHHHhcc-----------------c------------CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHH
Confidence            888777776665420                 0            1224689999999999999999999986    699


Q ss_pred             hcCCCccccCCC
Q 022799          235 LIHPFFDELRDP  246 (292)
Q Consensus       235 l~hp~~~~~~~~  246 (292)
                      ++||||+.+++.
T Consensus       292 ~~h~~f~~~~w~  303 (373)
T 2r5t_A          292 KSHVFFSLINWD  303 (373)
T ss_dssp             HTSGGGTTCCHH
T ss_pred             hCCccccCCCHH
Confidence            999999988653

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=7.7e-46  Score=322.48  Aligned_cols=201  Identities=27%  Similarity=0.489  Sum_probs=171.8

Q ss_pred             CCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCC
Q 022799            4 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDI   82 (292)
Q Consensus         4 l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dl   82 (292)
                      ++||||+++++++     .+...+|+||||++ |+|.+++...    ..+++..++.++.||+.||.|||++ ||+||||
T Consensus        75 ~~hp~iv~l~~~~-----~~~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDl  144 (345)
T 1xjd_A           75 WEHPFLTHMFCTF-----QTKENLFFVMEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSK-GIVYRDL  144 (345)
T ss_dssp             TTCTTBCCEEEEE-----ECSSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCC
T ss_pred             CCCCCCCcEEEEE-----EeCCEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCC
Confidence            4899999999999     44456999999997 6999888753    5799999999999999999999998 9999999


Q ss_pred             CCCcEEEeCCCCcEEEeecCCcccccc-CCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCCC
Q 022799           83 KPQNLLVNPHTHQLKLCDFGSAKVLVK-GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES  161 (292)
Q Consensus        83 kp~Nill~~~~~~ikl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~  161 (292)
                      ||+||+++.++ .+||+|||+++.... .......+||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+.+
T Consensus       145 kp~NIll~~~g-~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~  222 (345)
T 1xjd_A          145 KLDNILLDKDG-HIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQD  222 (345)
T ss_dssp             CGGGEEECTTS-CEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ChhhEEECCCC-CEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcCC-CCCChhhhHHHHHHHHHHhcCCCCCCCCC
Confidence            99999999988 799999999986432 2334567899999999999765 48999999999999999999999999888


Q ss_pred             cHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHH-HHhcCCCc
Q 022799          162 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAL-EALIHPFF  240 (292)
Q Consensus       162 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~-e~l~hp~~  240 (292)
                      ..+....+....            +                 .++..+++++++||.+||+.||++||++. ++++||||
T Consensus       223 ~~~~~~~i~~~~------------~-----------------~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f  273 (345)
T 1xjd_A          223 EEELFHSIRMDN------------P-----------------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF  273 (345)
T ss_dssp             HHHHHHHHHHCC------------C-----------------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGG
T ss_pred             HHHHHHHHHhCC------------C-----------------CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccc
Confidence            777666654310            0                 12245899999999999999999999998 99999999


Q ss_pred             cccCC
Q 022799          241 DELRD  245 (292)
Q Consensus       241 ~~~~~  245 (292)
                      +++++
T Consensus       274 ~~~~w  278 (345)
T 1xjd_A          274 REINW  278 (345)
T ss_dssp             TTCCH
T ss_pred             cCCCH
Confidence            98864

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=9.2e-46  Score=327.04  Aligned_cols=203  Identities=27%  Similarity=0.497  Sum_probs=166.5

Q ss_pred             CCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCC
Q 022799            4 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDI   82 (292)
Q Consensus         4 l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dl   82 (292)
                      .+|||||+++++|     .+...+|+||||++ |+|...+...    ..+++..++.++.||+.||.|||++ ||+||||
T Consensus       110 ~~hp~Iv~l~~~~-----~~~~~~~lV~E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDL  179 (396)
T 4dc2_A          110 SNHPFLVGLHSCF-----QTESRLFFVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER-GIIYRDL  179 (396)
T ss_dssp             TTCTTBCCEEEEE-----ECSSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCC
T ss_pred             CCCCCcCeeEEEE-----EECCEEEEEEEcCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CEEeccC
Confidence            3899999999999     44456999999998 6998888753    6799999999999999999999998 9999999


Q ss_pred             CCCcEEEeCCCCcEEEeecCCcccc-ccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCCC
Q 022799           83 KPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES  161 (292)
Q Consensus        83 kp~Nill~~~~~~ikl~Dfg~a~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~  161 (292)
                      ||+|||++.++ .+||+|||+++.. .......+.+||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+..
T Consensus       180 Kp~NILl~~~g-~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~~DiwslGvllyell~G~~Pf~~~~  257 (396)
T 4dc2_A          180 KLDNVLLDSEG-HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVG  257 (396)
T ss_dssp             CGGGEEECTTS-CEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSTTTT
T ss_pred             CHHHEEECCCC-CEEEeecceeeecccCCCccccccCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCcccc
Confidence            99999999988 7999999999863 333445567899999999999765 58999999999999999999999996432


Q ss_pred             c--------HHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccH--
Q 022799          162 G--------VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA--  231 (292)
Q Consensus       162 ~--------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~--  231 (292)
                      .        .+.+.+.+...                ..            .++..+++++++||++||+.||.+|+++  
T Consensus       258 ~~~~~~~~~~~~~~~~i~~~----------------~~------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~  309 (396)
T 4dc2_A          258 SSDNPDQNTEDYLFQVILEK----------------QI------------RIPRSLSVKAASVLKSFLNKDPKERLGCHP  309 (396)
T ss_dssp             C------CCHHHHHHHHHHC----------------CC------------CCCTTSCHHHHHHHHHHTCSCTTTSTTCST
T ss_pred             cccccchhhHHHHHHHHhcc----------------cc------------CCCCcCCHHHHHHHHHHhcCCHhHcCCCCC
Confidence            1        11122111110                00            1235689999999999999999999984  


Q ss_pred             ----HHHhcCCCccccCCC
Q 022799          232 ----LEALIHPFFDELRDP  246 (292)
Q Consensus       232 ----~e~l~hp~~~~~~~~  246 (292)
                          +++++||||+++++.
T Consensus       310 ~~~~~ei~~Hpff~~i~w~  328 (396)
T 4dc2_A          310 QTGFADIQGHPFFRNVDWD  328 (396)
T ss_dssp             TTHHHHHHHSTTTTTCCHH
T ss_pred             CCCHHHHhcCccccCCCHH
Confidence                899999999988653

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1e-44  Score=317.67  Aligned_cols=239  Identities=31%  Similarity=0.627  Sum_probs=187.4

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccC
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRD   81 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~d   81 (292)
                      ++++||||+++++++....+.....+|+||||++|+|.+.+...   ...+++..++.++.||+.||.|||++ ||+|||
T Consensus        84 ~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~D  159 (362)
T 3pg1_A           84 NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQ---RIVISPQHIQYFMYHILLGLHVLHEA-GVVHRD  159 (362)
T ss_dssp             HHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCSEEHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCC
T ss_pred             HhCCCcCccceeeeEEeccCCCcceEEEEEccCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC-cCEecC
Confidence            46799999999999877665566678999999999999888743   45799999999999999999999998 999999


Q ss_pred             CCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCCC
Q 022799           82 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES  161 (292)
Q Consensus        82 lkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~  161 (292)
                      |||+||+++.++ .+||+|||++.............||+.|+|||++.+...++.++|+||+||++|+|++|..||.+.+
T Consensus       160 lkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~  238 (362)
T 3pg1_A          160 LHPGNILLADNN-DITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST  238 (362)
T ss_dssp             CCGGGEEECTTC-CEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             CChHHEEEcCCC-CEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC
Confidence            999999999888 7999999999866555555566889999999999775668999999999999999999999999999


Q ss_pred             cHHHHHHHHHHhCCCCHHHHhhcCCC----CccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          162 GVDQLVEIIKVLGTPTREEIKCMNPN----YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       162 ~~~~~~~i~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      ..+.+..+.+..+.+..+........    +............+.. ..+.+++.+.+||.+||+.||.+|||+.++++|
T Consensus       239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  317 (362)
T 3pg1_A          239 FYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTA-VVPTADPVALDLIAKMLEFNPQRRISTEQALRH  317 (362)
T ss_dssp             HHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHH-HSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHh-hCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence            99999999999999987755432111    0001111122222222 335789999999999999999999999999999


Q ss_pred             CCccccCCC
Q 022799          238 PFFDELRDP  246 (292)
Q Consensus       238 p~~~~~~~~  246 (292)
                      |||+++..+
T Consensus       318 p~f~~~~~~  326 (362)
T 3pg1_A          318 PYFESLFDP  326 (362)
T ss_dssp             GGGTTTCCG
T ss_pred             chhhhccCc
Confidence            999987654

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.8e-45  Score=320.89  Aligned_cols=202  Identities=26%  Similarity=0.424  Sum_probs=174.2

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++     .+...+|+||||++ |+|.+++...    +.+++..++.++.||+.||.|||++ ||+|
T Consensus        95 l~~l~hp~iv~~~~~~-----~~~~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH  164 (350)
T 1rdq_E           95 LQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL-DLIY  164 (350)
T ss_dssp             HTTCCCTTBCCEEEEE-----ECSSEEEEEEECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT-TEEC
T ss_pred             HHhCCCCCCCeEEEEE-----EcCCEEEEEEcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-Cccc
Confidence            4678999999999998     44456999999997 6999988763    5699999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      |||||+||+++.++ .+||+|||+++....  .....+||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+
T Consensus       165 rDlkp~NIll~~~g-~~kL~DFg~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~  240 (350)
T 1rdq_E          165 RDLKPENLLIDQQG-YIQVTDFGFAKRVKG--RTWTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFA  240 (350)
T ss_dssp             CCCSGGGEEECTTS-CEEECCCTTCEECSS--CBCCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ccCccceEEECCCC-CEEEcccccceeccC--CcccccCCccccCHHHhcCC-CCCCcCCEecccHhHhHHhhCCCCCCC
Confidence            99999999999988 799999999987643  33456899999999999764 489999999999999999999999998


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCccc-----HHHH
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----ALEA  234 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t-----~~e~  234 (292)
                      .+..+....+....                 .            .++..+++++.++|.+||+.||.+|++     ++++
T Consensus       241 ~~~~~~~~~i~~~~-----------------~------------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei  291 (350)
T 1rdq_E          241 DQPIQIYEKIVSGK-----------------V------------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDI  291 (350)
T ss_dssp             SSHHHHHHHHHHCC-----------------C------------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHH
T ss_pred             CCHHHHHHHHHcCC-----------------C------------CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHH
Confidence            88777666665420                 0            122468999999999999999999998     9999


Q ss_pred             hcCCCccccCC
Q 022799          235 LIHPFFDELRD  245 (292)
Q Consensus       235 l~hp~~~~~~~  245 (292)
                      ++||||+++++
T Consensus       292 ~~h~~f~~~~w  302 (350)
T 1rdq_E          292 KNHKWFATTDW  302 (350)
T ss_dssp             HTSGGGTTCCH
T ss_pred             HhCcCcCCCCH
Confidence            99999998764

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=3.1e-46  Score=331.64  Aligned_cols=209  Identities=29%  Similarity=0.472  Sum_probs=174.8

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      +.++|||||+++++|     .+..++|+|||||+ |+|.+++..     ..+++..++.++.||+.||.|||++ ||+||
T Consensus       124 ~~l~hp~Iv~l~~~~-----~~~~~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~-givHr  192 (410)
T 3v8s_A          124 AFANSPWVVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM-GFIHR  192 (410)
T ss_dssp             HHCCCTTBCCEEEEE-----ECSSEEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT-TEECC
T ss_pred             HhCCCCCCCeEEEEE-----EECCEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CeEec
Confidence            457999999999999     45556999999997 699988864     4689999999999999999999998 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCC--cccccccccccCCccccCCCC---CCchhHhhhhhHHHHHHHhCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP--NISYICSRYYRAPELIFGATE---YTAAIDIWSAGCVLAELLLGQP  155 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~---~~~~~DvwslG~il~el~~g~~  155 (292)
                      ||||+|||++.++ .+||+|||+++.......  ..+.+||+.|+|||++.+...   ++.++|+||+||++|+|++|..
T Consensus       193 DLKp~NILl~~~g-~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~  271 (410)
T 3v8s_A          193 DVKPDNMLLDKSG-HLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT  271 (410)
T ss_dssp             CCSGGGEEECTTS-CEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSC
T ss_pred             cCCHHHeeECCCC-CEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCC
Confidence            9999999999988 799999999987644332  235689999999999975432   7889999999999999999999


Q ss_pred             CCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCC--cccHHH
Q 022799          156 LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL--RSTALE  233 (292)
Q Consensus       156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~--R~t~~e  233 (292)
                      ||.+.+..+...++......               ..++.          ...+|+++++||++||+.+|.+  |++++|
T Consensus       272 Pf~~~~~~~~~~~i~~~~~~---------------~~~p~----------~~~~s~~~~~li~~lL~~~~~rlgR~~~~e  326 (410)
T 3v8s_A          272 PFYADSLVGTYSKIMNHKNS---------------LTFPD----------DNDISKEAKNLICAFLTDREVRLGRNGVEE  326 (410)
T ss_dssp             TTCCSSHHHHHHHHHTHHHH---------------CCCCT----------TCCCCHHHHHHHHHHSSCGGGCTTSSCHHH
T ss_pred             CCCCCChhhHHHHHHhcccc---------------ccCCC----------cccccHHHHHHHHHHccChhhhCCCCCHHH
Confidence            99998888877777653110               01110          1358999999999999999988  999999


Q ss_pred             HhcCCCccccCCCC
Q 022799          234 ALIHPFFDELRDPN  247 (292)
Q Consensus       234 ~l~hp~~~~~~~~~  247 (292)
                      +++||||+++++.+
T Consensus       327 i~~Hp~f~~~~w~~  340 (410)
T 3v8s_A          327 IKRHLFFKNDQWAW  340 (410)
T ss_dssp             HHTSGGGCCSSCCS
T ss_pred             HhcCccccCCCHHH
Confidence            99999999987653

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.4e-45  Score=326.47  Aligned_cols=242  Identities=33%  Similarity=0.563  Sum_probs=178.6

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKM-----SQRMPLIYVKLYFYQICRALAYIHNTI   75 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~-----~~~~~~~~~~~~~~qil~al~~LH~~~   75 (292)
                      |++++||||+++++++...   +...+|+||||++|+|.+++......     ...+++..++.++.||+.||.|||++ 
T Consensus        72 l~~l~hpniv~~~~~~~~~---~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-  147 (405)
T 3rgf_A           72 LRELKHPNVISLQKVFLSH---ADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN-  147 (405)
T ss_dssp             HHHCCCTTBCCCCEEEEET---TTTEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHhcCCCCeeeEeeEEecC---CCCeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence            3568999999999998542   23458999999999999988754322     22499999999999999999999998 


Q ss_pred             CccccCCCCCcEEE----eCCCCcEEEeecCCccccccC----CCcccccccccccCCccccCCCCCCchhHhhhhhHHH
Q 022799           76 GVCHRDIKPQNLLV----NPHTHQLKLCDFGSAKVLVKG----EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVL  147 (292)
Q Consensus        76 ~i~H~dlkp~Nill----~~~~~~ikl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il  147 (292)
                      ||+||||||+|||+    +.++ .+||+|||+++.....    .......||+.|+|||++.+...++.++||||+||++
T Consensus       148 ~ivH~Dlkp~NIll~~~~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il  226 (405)
T 3rgf_A          148 WVLHRDLKPANILVMGEGPERG-RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIF  226 (405)
T ss_dssp             TCCCCCCCGGGEEECCSSTTTT-CEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHH
T ss_pred             CEeCCCcCHHHeEEecCCCCCC-cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHH
Confidence            99999999999999    4455 7999999999876432    1223467899999999997766689999999999999


Q ss_pred             HHHHhCCCCCCCCCc---------HHHHHHHHHHhCCCCHHHHhhcCCCCc------cccCCCCCCCC---chhhhccCC
Q 022799          148 AELLLGQPLFPGESG---------VDQLVEIIKVLGTPTREEIKCMNPNYT------EFKFPQIKAHP---WHKIFQKRM  209 (292)
Q Consensus       148 ~el~~g~~pf~~~~~---------~~~~~~i~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~---~~~~~~~~~  209 (292)
                      |+|++|..||.+...         .+++..+...++.|....+..+.....      .+.........   +........
T Consensus       227 ~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (405)
T 3rgf_A          227 AELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKP  306 (405)
T ss_dssp             HHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCT
T ss_pred             HHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCC
Confidence            999999999976654         478899999999998765543321100      00000000000   001111234


Q ss_pred             ChhHHHHHHHHhccCCCCcccHHHHhcCCCccccCCCC
Q 022799          210 PPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRDPN  247 (292)
Q Consensus       210 ~~~~~~li~~~l~~dp~~R~t~~e~l~hp~~~~~~~~~  247 (292)
                      ++.+.+||.+||++||.+|||++|+|+||||.+...+.
T Consensus       307 ~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~~~~  344 (405)
T 3rgf_A          307 DSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPT  344 (405)
T ss_dssp             TSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSSSCCC
T ss_pred             CHHHHHHHHHHccCCcccCCCHHHHhcChhhccCCCCc
Confidence            78999999999999999999999999999999765443

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1e-44  Score=318.92  Aligned_cols=266  Identities=32%  Similarity=0.590  Sum_probs=201.7

Q ss_pred             CCCCCCCeeeeceeeeccCCC-CceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~-~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      +.++||||+++++++...... ....+|+||||++++|.+.+.      ..+++..++.++.||+.||.|||++ ||+||
T Consensus        96 ~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~  168 (371)
T 4exu_A           96 KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSA-GVVHR  168 (371)
T ss_dssp             HHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCCEEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCS
T ss_pred             HhcCCCCchhhhhheeccCCcccceeEEEEEccccccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHC-CCcCC
Confidence            467999999999998544321 122348999999999877763      4599999999999999999999998 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE  160 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  160 (292)
                      ||||+||+++.++ .+||+|||+++....  ......||+.|+|||++.+...++.++|+||+||++|+|++|..||.+.
T Consensus       169 Dikp~NIll~~~~-~~kL~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  245 (371)
T 4exu_A          169 DLKPGNLAVNEDC-ELKILDFGLARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK  245 (371)
T ss_dssp             CCCGGGEEECTTC-CEEECSTTCC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             CcCHHHeEECCCC-CEEEEecCccccccc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999999888 799999999986533  2345678999999999977566899999999999999999999999999


Q ss_pred             CcHHHHHHHHHHhCCCCHHHHhhcCCCCccc---cCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          161 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEF---KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       161 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      +..+.+..+.+..+.+..+.+..........   ..+......+.. ..+.+++.+.+||.+||+.||.+|||+.++++|
T Consensus       246 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          246 DYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQ-LFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             SHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHH-HSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             ChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHH-hccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence            9999999999999999887765443221100   111111222222 235689999999999999999999999999999


Q ss_pred             CCccccCCCCCCCCCCCCCCCCCCCChhccCCCCHHHHhhhchHHH
Q 022799          238 PFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHA  283 (292)
Q Consensus       238 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (292)
                      |||+.+..+.......+...     ...+....+.+.+++.+.++.
T Consensus       325 p~f~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~  365 (371)
T 4exu_A          325 PFFEPFRDPEEETEAQQPFD-----DSLEHEKLTVDEWKQHIYKEI  365 (371)
T ss_dssp             GGGTTTCCGGGCCCCSSCCC-----CTTSSCCCCHHHHHHHHHHHH
T ss_pred             cccccCCCcccccccccCcC-----cchhhcccchHHHHHHHHHHH
Confidence            99998876544332222111     123445567777877766643

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.2e-44  Score=316.05  Aligned_cols=271  Identities=33%  Similarity=0.645  Sum_probs=200.4

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccC
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRD   81 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~d   81 (292)
                      +.++||||+++++++......+....++||||++++|.+.+..     ..+++..++.++.||+.||.|||++ ||+|||
T Consensus        64 ~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~-~ivH~D  137 (353)
T 2b9h_A           64 KHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS-NVIHRD  137 (353)
T ss_dssp             HHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT-TEECSC
T ss_pred             HhCcCCCcCCeeeeecccccCccceEEEEEeccCccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC-CeecCC
Confidence            4679999999999875433233456899999999999988864     5689999999999999999999988 999999


Q ss_pred             CCCCcEEEeCCCCcEEEeecCCccccccCCC-----------cccccccccccCCccccCCCCCCchhHhhhhhHHHHHH
Q 022799           82 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-----------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAEL  150 (292)
Q Consensus        82 lkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el  150 (292)
                      |||+||+++.++ .+||+|||++........           .....||+.|+|||++.+...++.++|+||+||++|+|
T Consensus       138 lkp~Nil~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l  216 (353)
T 2b9h_A          138 LKPSNLLINSNC-DLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL  216 (353)
T ss_dssp             CCGGGEEECTTC-CEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHH
T ss_pred             CCHHHeEEcCCC-cEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHH
Confidence            999999999888 799999999987643211           12346899999999886656689999999999999999


Q ss_pred             HhCCCCCCCCCcHHHHHHHHHHhCCCCHHHH-hhcCCC-Ccc--ccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCC
Q 022799          151 LLGQPLFPGESGVDQLVEIIKVLGTPTREEI-KCMNPN-YTE--FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPN  226 (292)
Q Consensus       151 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~-~~~~~~-~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~  226 (292)
                      ++|..||.+.+..+.+..+....+.|..... .+.... ...  ...+......+.. ..+.+++++.+||.+||..||+
T Consensus       217 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~  295 (353)
T 2b9h_A          217 FLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEK-MFPRVNPKGIDLLQRMLVFDPA  295 (353)
T ss_dssp             HHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHH-HSTTSCHHHHHHHHHHSCSSGG
T ss_pred             HhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhh-hcccCCHHHHHHHHHhcCcCcc
Confidence            9999999999988888888888887763211 110000 000  0111111122222 2257899999999999999999


Q ss_pred             CcccHHHHhcCCCccccCCCCCCCCCCCCCCCCCCCChhccCCCCHHHHhhhchH
Q 022799          227 LRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPE  281 (292)
Q Consensus       227 ~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (292)
                      +|||+.++++||||+....+..........+..+.+. ......+.+.+++.+.+
T Consensus       296 ~Rpt~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  349 (353)
T 2b9h_A          296 KRITAKEALEHPYLQTYHDPNDEPEGEPIPPSFFEFD-HYKEALTTKDLKKLIWN  349 (353)
T ss_dssp             GSCCHHHHHTSGGGTTTCCTTSSCCCCCCCGGGGGGG-CCSSCCCHHHHHHHHHH
T ss_pred             cCCCHHHHhcCccccccCCcccccccCCCCcceeeec-chhhcCCHHHHHHHHHH
Confidence            9999999999999999877654433322322333333 33444556666655544

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-45  Score=318.95  Aligned_cols=206  Identities=28%  Similarity=0.431  Sum_probs=174.7

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      +.++||||+++++++.     +...+++||||++ |+|.+.+...   ...+++..++.++.||+.||.|||++ ||+||
T Consensus        56 ~~l~hpnIv~~~~~~~-----~~~~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~-givH~  126 (321)
T 1tki_A           56 NIARHRNILHLHESFE-----SMEELVMIFEFISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH-NIGHF  126 (321)
T ss_dssp             HHSCCTTBCCEEEEEE-----ETTEEEEEECCCCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT-TEECC
T ss_pred             HhCCCCCCCeEeEEEe-----cCCEEEEEEEeCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CCCcC
Confidence            4679999999999984     3445899999998 5998888542   34699999999999999999999998 99999


Q ss_pred             CCCCCcEEEeC--CCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           81 DIKPQNLLVNP--HTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        81 dlkp~Nill~~--~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      ||||+||+++.  ++ .+||+|||++.............||+.|+|||++.+. .++.++|+||+||++|+|++|..||.
T Consensus       127 Dlkp~NIl~~~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~  204 (321)
T 1tki_A          127 DIRPENIIYQTRRSS-TIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFL  204 (321)
T ss_dssp             CCCGGGEEESSSSCC-CEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred             CCCHHHEEEccCCCC-CEEEEECCCCeECCCCCccccccCChhhcCcHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCc
Confidence            99999999986  45 7999999999887655555567899999999999664 47999999999999999999999999


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCC
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  238 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp  238 (292)
                      +.+..+....+.......+...                         ...+|+++.+||.+||..||.+|||+.|+++||
T Consensus       205 ~~~~~~~~~~i~~~~~~~~~~~-------------------------~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp  259 (321)
T 1tki_A          205 AETNQQIIENIMNAEYTFDEEA-------------------------FKEISIEAMDFVDRLLVKERKSRMTASEALQHP  259 (321)
T ss_dssp             CSSHHHHHHHHHHTCCCCCHHH-------------------------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             CCCHHHHHHHHHcCCCCCChhh-------------------------hccCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence            9888777777665433222221                         146899999999999999999999999999999


Q ss_pred             Ccccc
Q 022799          239 FFDEL  243 (292)
Q Consensus       239 ~~~~~  243 (292)
                      ||+..
T Consensus       260 ~~~~~  264 (321)
T 1tki_A          260 WLKQK  264 (321)
T ss_dssp             HHHSC
T ss_pred             hhccC
Confidence            99864

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=4.9e-46  Score=322.58  Aligned_cols=202  Identities=28%  Similarity=0.462  Sum_probs=169.0

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      |+.++||||+++++++.     +...+++||||++|+|.+++...    +.+++..++.++.||+.||.|||++ ||+||
T Consensus        63 l~~l~hpnIv~l~~~~~-----~~~~~~lv~E~~~g~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~-givH~  132 (336)
T 3h4j_B           63 LKLLRHPHIIKLYDVIT-----TPTDIVMVIEYAGGELFDYIVEK----KRMTEDEGRRFFQQIICAIEYCHRH-KIVHR  132 (336)
T ss_dssp             HTTCCCTTBCCEEEEEE-----CSSEEEEEECCCCEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH-TCCCC
T ss_pred             HHhCCCCCCCeEEEEEE-----eCCEEEEEEECCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeEec
Confidence            46789999999999984     34458999999999999988753    6799999999999999999999998 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE  160 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  160 (292)
                      ||||+||+++.++ .+||+|||++............+||+.|+|||++.+....+.++|+||+||++|+|++|..||.+.
T Consensus       133 Dlkp~NIll~~~~-~~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~  211 (336)
T 3h4j_B          133 DLKPENLLLDDNL-NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE  211 (336)
T ss_dssp             CCSTTTEEECTTC-CEEECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCS
T ss_pred             CCchhhEEEcCCC-CEEEEEeccceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCc
Confidence            9999999999888 799999999987766655566789999999999977654589999999999999999999999764


Q ss_pred             CcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCCc
Q 022799          161 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  240 (292)
Q Consensus       161 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~~  240 (292)
                      ......                      .....       ....++..+++++.+||++||..||.+|||++|+++||||
T Consensus       212 ~~~~~~----------------------~~i~~-------~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~  262 (336)
T 3h4j_B          212 FIPNLF----------------------KKVNS-------CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWF  262 (336)
T ss_dssp             SSTTCB----------------------CCCCS-------SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHH
T ss_pred             cHHHHH----------------------HHHHc-------CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhh
Confidence            321100                      00000       0011335689999999999999999999999999999999


Q ss_pred             cc
Q 022799          241 DE  242 (292)
Q Consensus       241 ~~  242 (292)
                      +.
T Consensus       263 ~~  264 (336)
T 3h4j_B          263 NV  264 (336)
T ss_dssp             HT
T ss_pred             cc
Confidence            85

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.5e-44  Score=310.06  Aligned_cols=234  Identities=34%  Similarity=0.610  Sum_probs=179.5

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeecccC-CHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      ++++||||+++++++.     +....++||||+++ +|..++..    ...+++..+..++.|++.||.|||++ ||+||
T Consensus        57 ~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~-~ivH~  126 (311)
T 4agu_A           57 KQLKHPNLVNLLEVFR-----RKRRLHLVFEYCDHTVLHELDRY----QRGVPEHLVKSITWQTLQAVNFCHKH-NCIHR  126 (311)
T ss_dssp             HHCCCTTBCCEEEEEE-----ETTEEEEEEECCSEEHHHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHT-TEECC
T ss_pred             HhCCCCCccchhheee-----cCCeEEEEEEeCCCchHHHHHhh----hcCCCHHHHHHHHHHHHHHHHHHHHC-CCcCC
Confidence            4679999999999984     34458999999996 55555443    46699999999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCC-CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      ||||+||+++.++ .++|+|||.+....... ......||+.|+|||++.+...++.++|+||+||++|+|++|..||.+
T Consensus       127 dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  205 (311)
T 4agu_A          127 DVKPENILITKHS-VIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPG  205 (311)
T ss_dssp             CCSGGGEEECTTS-CEEECCCTTCEECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             CCChhhEEEcCCC-CEEEeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence            9999999999888 79999999998764332 234557899999999998766689999999999999999999999999


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcC--CCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      .+..+....+.+..+...........  ..+.....+............+.+++++.+||.+||..||.+|||++++++|
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          206 KSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             SSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             CCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            99999998888888877665433221  1111122222211111111224689999999999999999999999999999


Q ss_pred             CCccccCCC
Q 022799          238 PFFDELRDP  246 (292)
Q Consensus       238 p~~~~~~~~  246 (292)
                      |||+++.+.
T Consensus       286 p~f~~~~~~  294 (311)
T 4agu_A          286 PYFENIREI  294 (311)
T ss_dssp             GGGTTCC--
T ss_pred             hHHHhccCH
Confidence            999988754

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=8.9e-45  Score=316.73  Aligned_cols=201  Identities=27%  Similarity=0.433  Sum_probs=172.0

Q ss_pred             CCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCC
Q 022799            5 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIK   83 (292)
Q Consensus         5 ~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlk   83 (292)
                      +||||++++++|     ++...+|+||||++ |+|.+++...    +.+++..++.++.||+.||.|||++ ||+|||||
T Consensus        79 ~hp~iv~l~~~~-----~~~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~-givHrDlk  148 (353)
T 2i0e_A           79 KPPFLTQLHSCF-----QTMDRLYFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK-GIIYRDLK  148 (353)
T ss_dssp             CCTTBCCEEEEE-----ECSSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCC
T ss_pred             CCCEEeeEEEEE-----EcCCEEEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CEEeccCC
Confidence            799999999999     44456999999998 6999888753    5699999999999999999999998 99999999


Q ss_pred             CCcEEEeCCCCcEEEeecCCcccccc-CCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCCCc
Q 022799           84 PQNLLVNPHTHQLKLCDFGSAKVLVK-GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG  162 (292)
Q Consensus        84 p~Nill~~~~~~ikl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~  162 (292)
                      |+||+++.++ .+||+|||+++.... .......+||+.|+|||++.+. .++.++|+|||||++|+|++|..||.+.+.
T Consensus       149 p~NIll~~~g-~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~  226 (353)
T 2i0e_A          149 LDNVMLDSEG-HIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDE  226 (353)
T ss_dssp             GGGEEECTTS-CEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             HHHEEEcCCC-cEEEEeCCcccccccCCcccccccCCccccChhhhcCC-CcCCcccccchHHHHHHHHcCCCCCCCCCH
Confidence            9999999988 799999999986432 3344567899999999999664 489999999999999999999999998887


Q ss_pred             HHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcc-----cHHHHhcC
Q 022799          163 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEALIH  237 (292)
Q Consensus       163 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----t~~e~l~h  237 (292)
                      .+....+....                 .            .++..+++++++||.+||..||.+|+     +++++++|
T Consensus       227 ~~~~~~i~~~~-----------------~------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          227 DELFQSIMEHN-----------------V------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             HHHHHHHHHCC-----------------C------------CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred             HHHHHHHHhCC-----------------C------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            77776665420                 0            12246899999999999999999999     57999999


Q ss_pred             CCccccCCC
Q 022799          238 PFFDELRDP  246 (292)
Q Consensus       238 p~~~~~~~~  246 (292)
                      |||+++++.
T Consensus       278 ~~f~~~~w~  286 (353)
T 2i0e_A          278 AFFRYIDWE  286 (353)
T ss_dssp             GGGTTCCHH
T ss_pred             ccccCCCHH
Confidence            999987653

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.5e-45  Score=319.47  Aligned_cols=201  Identities=27%  Similarity=0.509  Sum_probs=164.9

Q ss_pred             CCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCC
Q 022799            4 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDI   82 (292)
Q Consensus         4 l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dl   82 (292)
                      .+||||++++++|     .+...+|+||||++ |+|.+.+...    ..+++..++.++.||+.||.|||++ ||+||||
T Consensus        67 ~~hp~iv~l~~~~-----~~~~~~~lv~e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDl  136 (345)
T 3a8x_A           67 SNHPFLVGLHSCF-----QTESRLFFVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER-GIIYRDL  136 (345)
T ss_dssp             TTCTTBCCEEEEE-----ECSSEEEEEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCC
T ss_pred             CCCCccCeEEEEE-----EeCCEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CceecCC
Confidence            3899999999998     44456999999998 6998888753    5799999999999999999999998 9999999


Q ss_pred             CCCcEEEeCCCCcEEEeecCCccccc-cCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCCC
Q 022799           83 KPQNLLVNPHTHQLKLCDFGSAKVLV-KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES  161 (292)
Q Consensus        83 kp~Nill~~~~~~ikl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~  161 (292)
                      ||+||+++.++ .+||+|||+++... ........+||+.|+|||++.+. .++.++|+||+||++|+|++|..||....
T Consensus       137 kp~NIll~~~g-~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~  214 (345)
T 3a8x_A          137 KLDNVLLDSEG-HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVG  214 (345)
T ss_dssp             CGGGEEECTTS-CEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTTT
T ss_pred             CHHHEEECCCC-CEEEEeccccccccCCCCcccccCCCccccCccccCCC-CCChHHhHHHHHHHHHHHHhCCCCcCCcc
Confidence            99999999988 79999999998643 23344566899999999999764 48999999999999999999999996532


Q ss_pred             c--------HHHH-HHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccH-
Q 022799          162 G--------VDQL-VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA-  231 (292)
Q Consensus       162 ~--------~~~~-~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~-  231 (292)
                      .        ...+ ..+...                 ..            .++..+++++++||.+||+.||.+|+++ 
T Consensus       215 ~~~~~~~~~~~~~~~~i~~~-----------------~~------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~  265 (345)
T 3a8x_A          215 SSDNPDQNTEDYLFQVILEK-----------------QI------------RIPRSLSVKAASVLKSFLNKDPKERLGCH  265 (345)
T ss_dssp             C-------CHHHHHHHHHHC-----------------CC------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCC
T ss_pred             cccccccccHHHHHHHHHcC-----------------CC------------CCCCCCCHHHHHHHHHHhcCCHhHCCCCC
Confidence            1        1111 122110                 00            1234689999999999999999999985 


Q ss_pred             -----HHHhcCCCccccCC
Q 022799          232 -----LEALIHPFFDELRD  245 (292)
Q Consensus       232 -----~e~l~hp~~~~~~~  245 (292)
                           +++++||||+++++
T Consensus       266 ~~~~~~~i~~hp~f~~~~w  284 (345)
T 3a8x_A          266 PQTGFADIQGHPFFRNVDW  284 (345)
T ss_dssp             TTTHHHHHHTSGGGTTCCH
T ss_pred             CcCCHHHHhcCCccCCCCH
Confidence                 89999999998764

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2.4e-44  Score=322.14  Aligned_cols=231  Identities=31%  Similarity=0.525  Sum_probs=187.6

Q ss_pred             CCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCC
Q 022799            3 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDI   82 (292)
Q Consensus         3 ~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dl   82 (292)
                      ..+||||+++++++.     ....+++||||++++|.+++....  ...+++..++.++.||+.||.|||++ ||+||||
T Consensus       155 ~~~~~~iv~~~~~~~-----~~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDl  226 (429)
T 3kvw_A          155 KDNTMNVIHMLENFT-----FRNHICMTFELLSMNLYELIKKNK--FQGFSLPLVRKFAHSILQCLDALHKN-RIIHCDL  226 (429)
T ss_dssp             TTSCSCBCCEEEEEE-----ETTEEEEEECCCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHH-TEECSCC
T ss_pred             ccCCcCEEEEEeecc-----cCCeEEEEEeccCCCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCC
Confidence            458999999999984     344599999999999999887642  24589999999999999999999998 9999999


Q ss_pred             CCCcEEEeCCCC-cEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCCC
Q 022799           83 KPQNLLVNPHTH-QLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES  161 (292)
Q Consensus        83 kp~Nill~~~~~-~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~  161 (292)
                      ||+|||++.++. .+||+|||++....  .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+
T Consensus       227 Kp~NILl~~~~~~~vkL~DFG~a~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~pf~~~~  303 (429)
T 3kvw_A          227 KPENILLKQQGRSGIKVIDFGSSCYEH--QRVYTYIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGED  303 (429)
T ss_dssp             SGGGEEESSTTSCCEEECCCTTCEETT--CCCCSSCSCGGGCCHHHHHTBC-CCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CHHHeEEccCCCcceEEeecccceecC--CcccccCCCCCccChHHHhCCC-CCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence            999999998772 29999999997653  3344568899999999997754 8999999999999999999999999999


Q ss_pred             cHHHHHHHHHHhCCCCHHHHhhcCCCC--------ccc----------------------cCCCCCCCCchhhhccCCCh
Q 022799          162 GVDQLVEIIKVLGTPTREEIKCMNPNY--------TEF----------------------KFPQIKAHPWHKIFQKRMPP  211 (292)
Q Consensus       162 ~~~~~~~i~~~~~~~~~~~~~~~~~~~--------~~~----------------------~~~~~~~~~~~~~~~~~~~~  211 (292)
                      ..+++..+.+.++.|+...+.......        ..+                      .........|...++...++
T Consensus       304 ~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  383 (429)
T 3kvw_A          304 EGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDP  383 (429)
T ss_dssp             HHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCH
T ss_pred             HHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchH
Confidence            999999999999999988765432110        000                      00011223444455556789


Q ss_pred             hHHHHHHHHhccCCCCcccHHHHhcCCCccccC
Q 022799          212 EAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  244 (292)
Q Consensus       212 ~~~~li~~~l~~dp~~R~t~~e~l~hp~~~~~~  244 (292)
                      .+.+||.+||++||++|||++|+|+||||++..
T Consensus       384 ~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~~  416 (429)
T 3kvw_A          384 LFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRL  416 (429)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHTSTTTC---
T ss_pred             HHHHHHHHHCCCChhhCCCHHHHhCChhhccCC
Confidence            999999999999999999999999999998743

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.6e-45  Score=324.33  Aligned_cols=213  Identities=29%  Similarity=0.493  Sum_probs=175.1

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      +.++||||++++++|     .+..++|+||||++ |+|.+++...   ...+++..++.++.||+.||+|||++ ||+||
T Consensus       116 ~~~~hp~Iv~l~~~~-----~~~~~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~-giiHr  186 (412)
T 2vd5_A          116 VNGDRRWITQLHFAF-----QDENYLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRL-GYVHR  186 (412)
T ss_dssp             HHSCTTTBCCEEEEE-----ECSSEEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHT-TEECC
T ss_pred             HhcCCCCeeeEEEEE-----eeCCEEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-Ceeec
Confidence            357899999999999     45556999999997 7999998753   35799999999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCC--cccccccccccCCccccC------CCCCCchhHhhhhhHHHHHHHh
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP--NISYICSRYYRAPELIFG------ATEYTAAIDIWSAGCVLAELLL  152 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~------~~~~~~~~DvwslG~il~el~~  152 (292)
                      ||||+|||++.++ .+||+|||+++.......  ....+||+.|+|||++.+      ...++.++|+||+||++|||++
T Consensus       187 DLKp~NILld~~g-~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyellt  265 (412)
T 2vd5_A          187 DIKPDNILLDRCG-HIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFY  265 (412)
T ss_dssp             CCSGGGEEECTTS-CEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHH
T ss_pred             ccCHHHeeecCCC-CEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHh
Confidence            9999999999988 799999999987644432  234579999999999862      2358999999999999999999


Q ss_pred             CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCc---c
Q 022799          153 GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR---S  229 (292)
Q Consensus       153 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R---~  229 (292)
                      |..||.+.+..+...++......               ..++.         ++..+|+++++||++||+ +|.+|   +
T Consensus       266 G~~Pf~~~~~~~~~~~i~~~~~~---------------~~~p~---------~~~~~s~~~~dli~~lL~-~p~~Rlgr~  320 (412)
T 2vd5_A          266 GQTPFYADSTAETYGKIVHYKEH---------------LSLPL---------VDEGVPEEARDFIQRLLC-PPETRLGRG  320 (412)
T ss_dssp             SSCTTCCSSHHHHHHHHHTHHHH---------------CCCC-------------CCCHHHHHHHHTTSS-CGGGCTTTT
T ss_pred             CCCCCCCCCHHHHHHHHHhcccC---------------cCCCc---------cccCCCHHHHHHHHHHcC-ChhhcCCCC
Confidence            99999998888777776642100               00010         114689999999999999 99998   5


Q ss_pred             cHHHHhcCCCccccCCCCCC
Q 022799          230 TALEALIHPFFDELRDPNTR  249 (292)
Q Consensus       230 t~~e~l~hp~~~~~~~~~~~  249 (292)
                      +++++++||||+++++..-+
T Consensus       321 ~~~ei~~Hpff~~i~w~~l~  340 (412)
T 2vd5_A          321 GAGDFRTHPFFFGLDWDGLR  340 (412)
T ss_dssp             THHHHHTSGGGTTCCSTTST
T ss_pred             CHHHHhcCCCcCCCCHHHHh
Confidence            89999999999999876544

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.4e-44  Score=312.58  Aligned_cols=207  Identities=24%  Similarity=0.397  Sum_probs=173.6

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      +.++||||+++++++     .+....++||||++ ++|.+++..    ...+++..++.++.||+.||.|||++ ||+||
T Consensus        69 ~~l~hp~iv~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~  138 (326)
T 2y0a_A           69 KEIQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL-QIAHF  138 (326)
T ss_dssp             HHCCCTTBCCEEEEE-----ECSSEEEEEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHHT-TEECC
T ss_pred             HhCCCCCCCcEEEEE-----EeCCEEEEEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHHC-CeEcC
Confidence            467899999999998     44445899999997 699988864    46799999999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCC---cEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCC
Q 022799           81 DIKPQNLLVNPHTH---QLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF  157 (292)
Q Consensus        81 dlkp~Nill~~~~~---~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf  157 (292)
                      ||||+||+++.++.   .+||+|||++.............||+.|+|||++.+. .++.++|+||+||++|+|++|..||
T Consensus       139 Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf  217 (326)
T 2y0a_A          139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPF  217 (326)
T ss_dssp             CCCGGGEEESCSSSSSCCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSS
T ss_pred             CCCHHHEEEecCCCCCCCEEEEECCCCeECCCCCccccccCCcCcCCceeecCC-CCCcHHHHHHHHHHHHHHHHCcCCC
Confidence            99999999987652   5999999999887555555567899999999999654 4899999999999999999999999


Q ss_pred             CCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          158 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      .+....+.+..+.......+.                         .....+++.+.+||.+||..||.+|||+.++++|
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          218 LGDTKQETLANVSAVNYEFED-------------------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             CCSSHHHHHHHHHHTCCCCCH-------------------------HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             CCCCHHHHHHHHHhcCCCcCc-------------------------cccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            988877766665543221111                         1224688999999999999999999999999999


Q ss_pred             CCccccC
Q 022799          238 PFFDELR  244 (292)
Q Consensus       238 p~~~~~~  244 (292)
                      |||+...
T Consensus       273 p~~~~~~  279 (326)
T 2y0a_A          273 PWIKPKD  279 (326)
T ss_dssp             TTTSCCS
T ss_pred             CCccCCc
Confidence            9998643

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=8.1e-45  Score=319.90  Aligned_cols=206  Identities=26%  Similarity=0.452  Sum_probs=170.9

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++|||||+++++|     .+...+|+||||+. |+|...+..    ...+++..++.++.||+.||.|||++ ||+|
T Consensus        69 l~~l~hp~Iv~l~~~~-----~~~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~-givH  138 (384)
T 4fr4_A           69 MQGLEHPFLVNLWYSF-----QDEEDMFMVVDLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQ-RIIH  138 (384)
T ss_dssp             HHTCCCTTBCCEEEEE-----ECSSEEEEEECCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHT-TEEC
T ss_pred             HHhCCCCCCCcEEEEE-----EeCCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-Ccee
Confidence            3578999999999999     44445999999997 698888875    46799999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCC--CCCCchhHhhhhhHHHHHHHhCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA--TEYTAAIDIWSAGCVLAELLLGQPLF  157 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwslG~il~el~~g~~pf  157 (292)
                      |||||+||+++.++ .+||+|||++............+||+.|+|||++.+.  ..++.++|+|||||++|+|++|..||
T Consensus       139 rDlkp~NIll~~~g-~vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf  217 (384)
T 4fr4_A          139 RDMKPDNILLDEHG-HVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPY  217 (384)
T ss_dssp             CCCSGGGEEECTTS-CEEECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred             ccCcHHHeEECCCC-CEEEeccceeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCC
Confidence            99999999999988 7999999999887666666678899999999999642  34899999999999999999999999


Q ss_pred             CCCCcHH--HHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCccc-HHHH
Q 022799          158 PGESGVD--QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-ALEA  234 (292)
Q Consensus       158 ~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t-~~e~  234 (292)
                      .+.....  .........                ..            .++..+++.+.+||.+||..||.+||+ ++++
T Consensus       218 ~~~~~~~~~~~~~~~~~~----------------~~------------~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l  269 (384)
T 4fr4_A          218 HIRSSTSSKEIVHTFETT----------------VV------------TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDV  269 (384)
T ss_dssp             CCCTTSCHHHHHHHHHHC----------------CC------------CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHH
T ss_pred             CCCCCccHHHHHHHHhhc----------------cc------------CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHH
Confidence            7543322  111111110                00            122468999999999999999999998 8999


Q ss_pred             hcCCCccccCC
Q 022799          235 LIHPFFDELRD  245 (292)
Q Consensus       235 l~hp~~~~~~~  245 (292)
                      ++||||+++++
T Consensus       270 ~~hp~f~~~~w  280 (384)
T 4fr4_A          270 QNFPYMNDINW  280 (384)
T ss_dssp             HTSGGGTTCCH
T ss_pred             HcChhhhcCCH
Confidence            99999998765

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.6e-44  Score=308.28  Aligned_cols=204  Identities=25%  Similarity=0.398  Sum_probs=170.8

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      +.++||||+++++++..     ...+|+||||++ |+|.+++..     ..+++..++.++.|++.||.|||++ ||+||
T Consensus        72 ~~l~hp~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~  140 (297)
T 3fxz_A           72 RENKNPNIVNYLDSYLV-----GDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN-QVIHR  140 (297)
T ss_dssp             HHCCCTTBCCEEEEEEE-----TTEEEEEEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT-TEECC
T ss_pred             hcCCCCCCCeEeEEEEE-----CCEEEEEEECCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC-CceeC
Confidence            46799999999999844     334899999997 699988864     4689999999999999999999998 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCC-CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      ||||+||+++.++ .+||+|||++....... ......||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+
T Consensus       141 Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~  218 (297)
T 3fxz_A          141 DIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLN  218 (297)
T ss_dssp             CCSGGGEEECTTC-CEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCS-CBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             CCCHHHEEECCCC-CEEEeeCCCceecCCcccccCCccCCcCccChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999888 79999999988764433 23456799999999999765 489999999999999999999999988


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCC
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF  239 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~  239 (292)
                      .+.......+........                          ..+..+++.+.+||.+||+.||.+|||++++++|||
T Consensus       219 ~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~  272 (297)
T 3fxz_A          219 ENPLRALYLIATNGTPEL--------------------------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQF  272 (297)
T ss_dssp             SCHHHHHHHHHHHCSCCC--------------------------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGG
T ss_pred             CCHHHHHHHHHhCCCCCC--------------------------CCccccCHHHHHHHHHHccCChhHCcCHHHHhhChh
Confidence            877766655544211000                          012458899999999999999999999999999999


Q ss_pred             ccccC
Q 022799          240 FDELR  244 (292)
Q Consensus       240 ~~~~~  244 (292)
                      |+...
T Consensus       273 ~~~~~  277 (297)
T 3fxz_A          273 LKIAK  277 (297)
T ss_dssp             GGGCC
T ss_pred             hcccC
Confidence            98643

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.4e-44  Score=324.41  Aligned_cols=207  Identities=29%  Similarity=0.425  Sum_probs=171.9

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++     .+....|+|||||. |+|.+.+..    ...+++..+..++.||+.||.|||++ ||+|
T Consensus        64 l~~l~hpnIv~l~~~~-----~~~~~~~lv~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~-givH  133 (444)
T 3soa_A           64 CRLLKHPNIVRLHDSI-----SEEGHHYLIFDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQM-GVVH  133 (444)
T ss_dssp             HHHCCBTTBCCEEEEE-----ECSSEEEEEECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT-TCBC
T ss_pred             HHhCCCcCCCeEEEEE-----EECCEEEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-Cccc
Confidence            3568999999999998     44556899999998 699888875    36799999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCC--CCcEEEeecCCccccccCCC-cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCC
Q 022799           80 RDIKPQNLLVNPH--THQLKLCDFGSAKVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPL  156 (292)
Q Consensus        80 ~dlkp~Nill~~~--~~~ikl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~p  156 (292)
                      |||||+||+++.+  ++.+||+|||++........ .....||+.|+|||++.+. .++.++|+||+||++|+|++|..|
T Consensus       134 rDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyell~G~~P  212 (444)
T 3soa_A          134 RNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKD-PYGKPVDLWACGVILYILLVGYPP  212 (444)
T ss_dssp             CCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             cCCCHHHEEEeccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcCC-CCCCccccHHHHHHHHHHHhCCCC
Confidence            9999999999842  23799999999987654332 2456799999999999654 489999999999999999999999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      |.+.+.......+.......+..                         ....+++++++||.+||+.||.+|||+.|+|+
T Consensus       213 f~~~~~~~~~~~i~~~~~~~~~~-------------------------~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          213 FWDEDQHRLYQQIKAGAYDFPSP-------------------------EWDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             CCCSSHHHHHHHHHHTCCCCCTT-------------------------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCccHHHHHHHHHhCCCCCCcc-------------------------ccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            99888777776665532111100                         01357999999999999999999999999999


Q ss_pred             CCCcccc
Q 022799          237 HPFFDEL  243 (292)
Q Consensus       237 hp~~~~~  243 (292)
                      ||||+..
T Consensus       268 hp~~~~~  274 (444)
T 3soa_A          268 HPWISHR  274 (444)
T ss_dssp             SCTTHHH
T ss_pred             CccccCC
Confidence            9999864

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.8e-44  Score=314.91  Aligned_cols=239  Identities=27%  Similarity=0.461  Sum_probs=185.6

Q ss_pred             CCCCCCCeeeeceeeeccCC---CCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcc
Q 022799            2 RLLDHPNVVSLKHCFFSTTE---KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVC   78 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~---~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~   78 (292)
                      +.++||||+++++++.....   .....+|+||||++++|.+.+...   ...+++..++.++.||+.||.|||++ ||+
T Consensus        71 ~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~-~iv  146 (351)
T 3mi9_A           71 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRN-KIL  146 (351)
T ss_dssp             HHCCCTTBCCEEEEEEEC--------CEEEEEEECCSEEHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHT-TEE
T ss_pred             HhccCCCcccHhheeeccccccccCCceEEEEEeccCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC-Cee
Confidence            46789999999999865321   113468999999999988888653   35699999999999999999999998 999


Q ss_pred             ccCCCCCcEEEeCCCCcEEEeecCCccccccC-----CCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhC
Q 022799           79 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-----EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG  153 (292)
Q Consensus        79 H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g  153 (292)
                      ||||||+||+++.++ .+||+|||++......     .......||+.|+|||++.+...++.++|+||+||++|+|++|
T Consensus       147 H~Dlkp~NIl~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g  225 (351)
T 3mi9_A          147 HRDMKAANVLITRDG-VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR  225 (351)
T ss_dssp             CCCCSGGGEEECTTS-CEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHS
T ss_pred             CCCCCHHHEEEcCCC-CEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhC
Confidence            999999999999888 7999999999865422     2223457899999999997766689999999999999999999


Q ss_pred             CCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCC--CccccCCCCCCCCchhhhc-cCCChhHHHHHHHHhccCCCCccc
Q 022799          154 QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN--YTEFKFPQIKAHPWHKIFQ-KRMPPEAVDLVSRLLQYSPNLRST  230 (292)
Q Consensus       154 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~dp~~R~t  230 (292)
                      ..||.+.+.......+.+..+.++.+.+......  +................+. ...++.+.+||.+||+.||++|||
T Consensus       226 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  305 (351)
T 3mi9_A          226 SPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID  305 (351)
T ss_dssp             SCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCC
T ss_pred             CCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCC
Confidence            9999999999999999998888876654432111  1111111111111111110 124788999999999999999999


Q ss_pred             HHHHhcCCCccccCC
Q 022799          231 ALEALIHPFFDELRD  245 (292)
Q Consensus       231 ~~e~l~hp~~~~~~~  245 (292)
                      ++|+++||||.+...
T Consensus       306 ~~e~l~hp~f~~~~~  320 (351)
T 3mi9_A          306 SDDALNHDFFWSDPM  320 (351)
T ss_dssp             HHHHHTSGGGGSSSC
T ss_pred             HHHHhCCCCcCCCCC
Confidence            999999999987543

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=8.4e-46  Score=316.46  Aligned_cols=222  Identities=18%  Similarity=0.145  Sum_probs=152.3

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhc-----
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT-----   74 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~-----   74 (292)
                      |.+++|||||++++++.... .....+|||||||+ |+|.+++..     .++++..+..++.|++.||.|||++     
T Consensus        51 ~~~l~HpNIv~l~g~~~~~~-~~~~~~~lV~Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~  124 (303)
T 3hmm_A           51 TVMLRHENILGFIAADNKDN-GTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQ  124 (303)
T ss_dssp             STTCCCTTBCCEEEEEEEEC-SSSEEEEEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTT
T ss_pred             HhcCCCCCCCcEEEEEEecC-CCceEEEEEecCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhcc
Confidence            46789999999999986543 22345899999999 799999864     5689999999999999999999963     


Q ss_pred             --CCccccCCCCCcEEEeCCCCcEEEeecCCccccccCCC-----cccccccccccCCccccCCC-----CCCchhHhhh
Q 022799           75 --IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-----NISYICSRYYRAPELIFGAT-----EYTAAIDIWS  142 (292)
Q Consensus        75 --~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~-----~~~~~~Dvws  142 (292)
                        .+|+||||||+|||++.++ .+||+|||+|+.......     ....+||+.|||||++.+..     .++.++||||
T Consensus       125 ~~~~IiHRDlKp~NILl~~~~-~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS  203 (303)
T 3hmm_A          125 GKPAIAHRDLKSKNILVKKNG-TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYA  203 (303)
T ss_dssp             CBCCEECSCCCGGGEEECTTS-CEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHH
T ss_pred             CCCCEeeccCCcccEEECCCC-CEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhh
Confidence              2899999999999999988 799999999987654332     22457999999999996542     2577999999


Q ss_pred             hhHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhh-cCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHh
Q 022799          143 AGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC-MNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLL  221 (292)
Q Consensus       143 lG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  221 (292)
                      +||++|||+||..||...........- .....+..+.+.. .....   ..+..+.    ...+...+..+.+||.+||
T Consensus       204 ~Gvvl~El~tg~~~~~~~~~~~~p~~~-~~~~~~~~~~~~~~~~~~~---~rp~~p~----~~~~~~~~~~l~~li~~cl  275 (303)
T 3hmm_A          204 MGLVFWEIARRCSIGGIHEDYQLPYYD-LVPSDPSVEEMRKVVCEQK---LRPNIPN----RWQSCEALRVMAKIMRECW  275 (303)
T ss_dssp             HHHHHHHHHHTBCBTTBCCCCCCTTTT-TSCSSCCHHHHHHHHTTSC---CCCCCCG----GGGSSHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHCCCCCCccccccccchh-cccccchHHHHHHHHhccc---CCCCCCc----cccchHHHHHHHHHHHHHc
Confidence            999999999998776432211000000 0000000000000 00000   0000000    0000123457889999999


Q ss_pred             ccCCCCcccHHHHhcC
Q 022799          222 QYSPNLRSTALEALIH  237 (292)
Q Consensus       222 ~~dp~~R~t~~e~l~h  237 (292)
                      +.||++|||+.|+++.
T Consensus       276 ~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          276 YANGAARLTALRIKKT  291 (303)
T ss_dssp             CSSGGGSCCHHHHHHH
T ss_pred             ccCHhHCcCHHHHHHH
Confidence            9999999999999853

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.1e-44  Score=314.52  Aligned_cols=210  Identities=28%  Similarity=0.400  Sum_probs=169.7

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      +.++||||+++++++.     +...+|+|||||+ ++|.+.+.........+++..++.++.||+.||.|||++ ||+||
T Consensus        81 ~~l~hpnIv~~~~~~~-----~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~ivHr  154 (351)
T 3c0i_A           81 HMLKHPHIVELLETYS-----SDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN-NIIHR  154 (351)
T ss_dssp             HHCCCTTBCCEEEEEE-----ETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECS
T ss_pred             HhCCCCCCCcEEEEEE-----eCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC-Cceec
Confidence            4679999999999984     3445899999998 699888876655556799999999999999999999998 99999


Q ss_pred             CCCCCcEEEeCCC--CcEEEeecCCccccccCCC-cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCC
Q 022799           81 DIKPQNLLVNPHT--HQLKLCDFGSAKVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF  157 (292)
Q Consensus        81 dlkp~Nill~~~~--~~ikl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf  157 (292)
                      ||||+||+++.++  ..+||+|||++........ .....||+.|+|||++.+. .++.++|+||+||++|+|++|..||
T Consensus       155 Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf  233 (351)
T 3c0i_A          155 DVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKRE-PYGKPVDVWGCGVILFILLSGCLPF  233 (351)
T ss_dssp             CCSGGGEEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             cCChHHeEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCC-CCCchHhhHHHHHHHHHHHHCCCCC
Confidence            9999999997654  2499999999987654332 3346799999999999664 4899999999999999999999999


Q ss_pred             CCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          158 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      .+.. ......+..........                         ....+++++++||.+||..||++|||+.++++|
T Consensus       234 ~~~~-~~~~~~i~~~~~~~~~~-------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  287 (351)
T 3c0i_A          234 YGTK-ERLFEGIIKGKYKMNPR-------------------------QWSHISESAKDLVRRMLMLDPAERITVYEALNH  287 (351)
T ss_dssp             CSSH-HHHHHHHHHTCCCCCHH-------------------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCcH-HHHHHHHHcCCCCCCcc-------------------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            8743 33333333321111111                         114589999999999999999999999999999


Q ss_pred             CCccccC
Q 022799          238 PFFDELR  244 (292)
Q Consensus       238 p~~~~~~  244 (292)
                      |||+...
T Consensus       288 p~~~~~~  294 (351)
T 3c0i_A          288 PWLKERD  294 (351)
T ss_dssp             HHHHTHH
T ss_pred             hhhcCCc
Confidence            9998643

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1e-44  Score=317.76  Aligned_cols=206  Identities=29%  Similarity=0.435  Sum_probs=171.6

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      +.++||||+++++++     .+....|+||||+. |+|.+.+..    ...+++..+..++.||+.||.|||++ ||+||
T Consensus        83 ~~l~hpnIv~~~~~~-----~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~  152 (362)
T 2bdw_A           83 RKLQHPNIVRLHDSI-----QEESFHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSN-GIVHR  152 (362)
T ss_dssp             HHCCCTTBCCEEEEE-----ECSSEEEEEECCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCC
T ss_pred             HhCCCCCCCeEEEEE-----EeCCEEEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEec
Confidence            468999999999998     44456899999998 598888764    35789999999999999999999998 99999


Q ss_pred             CCCCCcEEEeCCC--CcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           81 DIKPQNLLVNPHT--HQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        81 dlkp~Nill~~~~--~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      ||||+||+++.++  ..+||+|||++.............||+.|+|||++.+. .++.++|+||+||++|+|++|..||.
T Consensus       153 Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~Pf~  231 (362)
T 2bdw_A          153 NLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFW  231 (362)
T ss_dssp             CCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             cCchHHEEEecCCCCCCEEEeecCcceEecCCcccccCCCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHHCCCCCC
Confidence            9999999997643  25999999999877655555567899999999999654 48999999999999999999999999


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCC
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  238 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp  238 (292)
                      +.+.......+.......+..                         ....+++++++||.+||..||.+|||+.++|+||
T Consensus       232 ~~~~~~~~~~i~~~~~~~~~~-------------------------~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp  286 (362)
T 2bdw_A          232 DEDQHRLYAQIKAGAYDYPSP-------------------------EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVP  286 (362)
T ss_dssp             CSSHHHHHHHHHHTCCCCCTT-------------------------GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSH
T ss_pred             CCCHHHHHHHHHhCCCCCCcc-------------------------cccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence            887766666655421111100                         0135789999999999999999999999999999


Q ss_pred             Ccccc
Q 022799          239 FFDEL  243 (292)
Q Consensus       239 ~~~~~  243 (292)
                      ||...
T Consensus       287 ~~~~~  291 (362)
T 2bdw_A          287 WICNR  291 (362)
T ss_dssp             HHHTH
T ss_pred             ccCCC
Confidence            99854

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=3.4e-44  Score=322.86  Aligned_cols=204  Identities=28%  Similarity=0.431  Sum_probs=171.8

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCcc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN-TIGVC   78 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~-~~~i~   78 (292)
                      |+.++||||+++++++.     +...+|+||||++ |+|...+...    ..+++..++.++.||+.||.|||+ + ||+
T Consensus       202 l~~l~h~~iv~l~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~-gii  271 (446)
T 4ejn_A          202 LQNSRHPFLTALKYSFQ-----THDRLCFVMEYANGGELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHSEK-NVV  271 (446)
T ss_dssp             CCCCSCTTSCCEEEEEE-----ETTEEEEEECCCSSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHHT-CCC
T ss_pred             HHhCCCCeEeeEEEEEe-----eCCEEEEEEeeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhcC-CEE
Confidence            57789999999999984     3345899999998 5888888653    579999999999999999999997 6 999


Q ss_pred             ccCCCCCcEEEeCCCCcEEEeecCCcccccc-CCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCC
Q 022799           79 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF  157 (292)
Q Consensus        79 H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf  157 (292)
                      ||||||+|||++.++ .+||+|||+++.... .......+||+.|+|||++.+. .++.++|+||+||++|+|++|..||
T Consensus       272 HrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf  349 (446)
T 4ejn_A          272 YRDLKLENLMLDKDG-HIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPF  349 (446)
T ss_dssp             CCCCCGGGEEECSSS-CEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             ECCCCHHHEEECCCC-CEEEccCCCceeccCCCcccccccCCccccCHhhcCCC-CCCCccchhhhHHHHHHHhhCCCCC
Confidence            999999999999988 799999999976432 2334456899999999999765 4899999999999999999999999


Q ss_pred             CCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcc-----cHH
Q 022799          158 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TAL  232 (292)
Q Consensus       158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----t~~  232 (292)
                      .+.+.......+....                 .            .++..+++++.+||.+||..||.+||     |++
T Consensus       350 ~~~~~~~~~~~i~~~~-----------------~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~  400 (446)
T 4ejn_A          350 YNQDHEKLFELILMEE-----------------I------------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAK  400 (446)
T ss_dssp             CCSSHHHHHHHHHHCC-----------------C------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHH
T ss_pred             CCCCHHHHHHHHHhCC-----------------C------------CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHH
Confidence            8887766666554311                 0            12246899999999999999999999     999


Q ss_pred             HHhcCCCccccCC
Q 022799          233 EALIHPFFDELRD  245 (292)
Q Consensus       233 e~l~hp~~~~~~~  245 (292)
                      ++++||||+++.+
T Consensus       401 ell~hp~f~~~~~  413 (446)
T 4ejn_A          401 EIMQHRFFAGIVW  413 (446)
T ss_dssp             HHHTSGGGTTCCH
T ss_pred             HHHhCccccCCCH
Confidence            9999999998764

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=2.9e-43  Score=303.95  Aligned_cols=237  Identities=33%  Similarity=0.574  Sum_probs=191.7

Q ss_pred             CCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCC
Q 022799            4 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIK   83 (292)
Q Consensus         4 l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlk   83 (292)
                      ++||||+++++++...........++||||++|+|.+++....  ...+++..++.++.||+.||.|||++ ||+|||||
T Consensus        71 ~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~-gi~H~dlk  147 (326)
T 1blx_A           71 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH-RVVHRDLK  147 (326)
T ss_dssp             TCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCC
T ss_pred             cCCCCeEeeeeeeeecccCCCceEEEEEecCCCCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCC
Confidence            5899999999998644334566789999999999999887532  24589999999999999999999998 99999999


Q ss_pred             CCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCCCcH
Q 022799           84 PQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV  163 (292)
Q Consensus        84 p~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~  163 (292)
                      |+||+++.++ .+||+|||++.............||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+.+..
T Consensus       148 p~Nili~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  225 (326)
T 1blx_A          148 PQNILVTSSG-QIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDV  225 (326)
T ss_dssp             GGGEEECTTC-CEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             HHHeEEcCCC-CEEEecCcccccccCCCCccccccccceeCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCHH
Confidence            9999999888 7999999999876444334456789999999999665 4899999999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCCcccc
Q 022799          164 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  243 (292)
Q Consensus       164 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~~~~~  243 (292)
                      +.+..+....+.+....+...... ....+....... ...+...+++.+++||.+||..||.+|||+.++++||||+++
T Consensus       226 ~~~~~i~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  303 (326)
T 1blx_A          226 DQLGKILDVIGLPGEEDWPRDVAL-PRQAFHSKSAQP-IEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL  303 (326)
T ss_dssp             HHHHHHHHHHCCCCGGGSCTTCSS-CGGGSCCCCCCC-GGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             HHHHHHHHHcCCCCcccCcccccc-chhhhcccCcch-hhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccccc
Confidence            999999999888877655432110 011111111111 122346789999999999999999999999999999999988


Q ss_pred             CCCC
Q 022799          244 RDPN  247 (292)
Q Consensus       244 ~~~~  247 (292)
                      ....
T Consensus       304 ~~~~  307 (326)
T 1blx_A          304 ERCK  307 (326)
T ss_dssp             CCCC
T ss_pred             chhh
Confidence            7543

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=7.3e-44  Score=311.35  Aligned_cols=266  Identities=33%  Similarity=0.596  Sum_probs=199.1

Q ss_pred             CCCCCCCeeeeceeeeccCCC-CceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEK-DELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~-~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      +.++||||+++++++...... ....+|+||||++++|.+.+.      ..+++..++.++.||+.||.|||++ ||+||
T Consensus        78 ~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~-~ivH~  150 (353)
T 3coi_A           78 KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSA-GVVHR  150 (353)
T ss_dssp             HHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCSEEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCS
T ss_pred             HhcCCCCcccHhheEecccccccceeEEEEeccccCCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC-CcccC
Confidence            467899999999998543321 122468999999998876653      4589999999999999999999998 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE  160 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  160 (292)
                      ||||+||+++.++ .+||+|||++.....  ......+|+.|+|||++.+...++.++|+||+||++|+|++|..||.+.
T Consensus       151 dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  227 (353)
T 3coi_A          151 DLKPGNLAVNEDC-ELKILDFGLARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK  227 (353)
T ss_dssp             SCCGGGEEECTTC-CEEECSTTCTTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSS
T ss_pred             CCCHHHEeECCCC-cEEEeecccccCCCC--CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999999888 799999999976532  2344578999999999977566899999999999999999999999999


Q ss_pred             CcHHHHHHHHHHhCCCCHHHHhhcCCCCccc---cCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          161 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEF---KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       161 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      +..+.+..+.+..+.++.+.+..+.......   ..+......+.. ....+++++.+||.+||..||++|||++++++|
T Consensus       228 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          228 DYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQ-LFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             CHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTT-TCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             CHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHH-hcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            9999999999999999887665443211000   111111111111 224689999999999999999999999999999


Q ss_pred             CCccccCCCCCCCCCCCCCCCCCCCChhccCCCCHHHHhhhchHHH
Q 022799          238 PFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHA  283 (292)
Q Consensus       238 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (292)
                      |||+.+..+.......    ..++. ..+....+.+.+++.+.++.
T Consensus       307 p~f~~~~~~~~~~~~~----~~~~~-~~~~~~~~~~~~~~~~~~~~  347 (353)
T 3coi_A          307 PFFEPFRDPEEETEAQ----QPFDD-SLEHEKLTVDEWKQHIYKEI  347 (353)
T ss_dssp             GGGTTTCCGGGCCCCS----SCCCC-TTTTCCCCHHHHHHHHHHHH
T ss_pred             cchhhccCccccccCC----CCCcc-chhhccCCHHHHHHHHHHHH
Confidence            9999877654332211    11111 23345667787777665543

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2e-44  Score=316.99  Aligned_cols=208  Identities=28%  Similarity=0.413  Sum_probs=174.1

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++.     +...+++||||++ ++|.+.+...   ...+++..++.++.||+.||.|||++ ||+|
T Consensus       140 l~~l~hpnIv~~~~~~~-----~~~~~~lv~E~~~~~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH  210 (373)
T 2x4f_A          140 MNQLDHANLIQLYDAFE-----SKNDIVLVMEYVDGGELFDRIIDE---SYNLTELDTILFMKQICEGIRHMHQM-YILH  210 (373)
T ss_dssp             HTTCCCTTBCCEEEEEE-----CSSEEEEEEECCTTCEEHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT-TEEC
T ss_pred             HHhCCCCCCCeEEEEEE-----ECCEEEEEEeCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-Cccc
Confidence            46789999999999983     3445899999998 6888887643   34689999999999999999999988 9999


Q ss_pred             cCCCCCcEEEe--CCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCC
Q 022799           80 RDIKPQNLLVN--PHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF  157 (292)
Q Consensus        80 ~dlkp~Nill~--~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf  157 (292)
                      |||||+||++.  .++ .+||+|||+++............||+.|+|||++.+. .++.++|+|||||++|+|++|..||
T Consensus       211 ~Dlkp~NIll~~~~~~-~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf  288 (373)
T 2x4f_A          211 LDLKPENILCVNRDAK-QIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYD-FVSFPTDMWSVGVIAYMLLSGLSPF  288 (373)
T ss_dssp             CCCCGGGEEEEETTTT-EEEECCCSSCEECCTTCBCCCCCSSCTTCCHHHHTTC-BCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             ccCCHHHEEEecCCCC-cEEEEeCCCceecCCccccccccCCCcEeChhhccCC-CCCcHHhHHHHHHHHHHHHhCCCCC
Confidence            99999999984  344 7999999999887655555566799999999999654 4899999999999999999999999


Q ss_pred             CCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          158 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      .+.+..+.+..+.......+..                         ....+++++++||.+||..||.+|||+.++++|
T Consensus       289 ~~~~~~~~~~~i~~~~~~~~~~-------------------------~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h  343 (373)
T 2x4f_A          289 LGDNDAETLNNILACRWDLEDE-------------------------EFQDISEEAKEFISKLLIKEKSWRISASEALKH  343 (373)
T ss_dssp             CCSSHHHHHHHHHHTCCCSCSG-------------------------GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CCCCHHHHHHHHHhccCCCChh-------------------------hhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            9988887777776532111100                         114589999999999999999999999999999


Q ss_pred             CCccccC
Q 022799          238 PFFDELR  244 (292)
Q Consensus       238 p~~~~~~  244 (292)
                      |||++..
T Consensus       344 p~~~~~~  350 (373)
T 2x4f_A          344 PWLSDHK  350 (373)
T ss_dssp             HHHHCHH
T ss_pred             cCcCCCc
Confidence            9999764

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=3.5e-44  Score=336.98  Aligned_cols=201  Identities=27%  Similarity=0.441  Sum_probs=173.5

Q ss_pred             CCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCC
Q 022799            5 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIK   83 (292)
Q Consensus         5 ~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlk   83 (292)
                      +||||++++++|     ++...+|+||||++ |+|..++...    +.+++..++.++.||+.||.|||++ ||+|||||
T Consensus       400 ~~~~i~~l~~~~-----~~~~~~~lV~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~-gIiHrDLK  469 (674)
T 3pfq_A          400 KPPFLTQLHSCF-----QTMDRLYFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK-GIIYRDLK  469 (674)
T ss_dssp             CCTTBCCEEEEC-----BCSSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-SEECCCCC
T ss_pred             CCCeEEEEEEEE-----EeCCEEEEEEeCcCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CeEeccCC
Confidence            799999999998     55556999999998 6999888753    5799999999999999999999998 99999999


Q ss_pred             CCcEEEeCCCCcEEEeecCCccccc-cCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCCCc
Q 022799           84 PQNLLVNPHTHQLKLCDFGSAKVLV-KGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG  162 (292)
Q Consensus        84 p~Nill~~~~~~ikl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~  162 (292)
                      |+|||++.++ .+||+|||+++... ........+||+.|+|||++.+. .++.++|+|||||++|||++|..||.+.+.
T Consensus       470 p~NILl~~~g-~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~  547 (674)
T 3pfq_A          470 LDNVMLDSEG-HIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDE  547 (674)
T ss_dssp             STTEEECSSS-CEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             hhhEEEcCCC-cEEEeecceeeccccCCcccccccCCCcccCHhhhcCC-CCCccceEechHHHHHHHHcCCCCCCCCCH
Confidence            9999999988 79999999998643 23344567899999999999654 589999999999999999999999999888


Q ss_pred             HHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccH-----HHHhcC
Q 022799          163 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA-----LEALIH  237 (292)
Q Consensus       163 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~-----~e~l~h  237 (292)
                      .+....+....                 .            .++..+++++++||++||+.||.+|+++     +++++|
T Consensus       548 ~~~~~~i~~~~-----------------~------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h  598 (674)
T 3pfq_A          548 DELFQSIMEHN-----------------V------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  598 (674)
T ss_dssp             HHHHHHHHSSC-----------------C------------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred             HHHHHHHHhCC-----------------C------------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence            77777765410                 0            1235689999999999999999999997     999999


Q ss_pred             CCccccCCC
Q 022799          238 PFFDELRDP  246 (292)
Q Consensus       238 p~~~~~~~~  246 (292)
                      |||+++++.
T Consensus       599 ~ff~~i~w~  607 (674)
T 3pfq_A          599 AFFRYIDWE  607 (674)
T ss_dssp             GGGSSCCHH
T ss_pred             ccccCCCHH
Confidence            999998753

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=4.5e-44  Score=310.02  Aligned_cols=232  Identities=32%  Similarity=0.605  Sum_probs=182.2

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccC
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRD   81 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~d   81 (292)
                      ++++||||+++++++.     +....++||||+++++...+...   ...+++..+..++.||+.||.|||++ ||+|||
T Consensus        79 ~~l~h~~iv~~~~~~~-----~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivH~d  149 (331)
T 4aaa_A           79 KQLRHENLVNLLEVCK-----KKKRWYLVFEFVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSH-NIIHRD  149 (331)
T ss_dssp             HHCCCTTBCCEEEEEE-----ETTEEEEEEECCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCC
T ss_pred             hhCCCCCEeeEEEEee-----cCCEEEEEEecCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHC-CEEccC
Confidence            4679999999999983     44458999999996544443322   46799999999999999999999998 999999


Q ss_pred             CCCCcEEEeCCCCcEEEeecCCccccccCC-CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCC
Q 022799           82 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE  160 (292)
Q Consensus        82 lkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  160 (292)
                      |||+||+++.++ .+||+|||++....... ......||+.|+|||++.+...++.++|+||+||++|+|++|..||.+.
T Consensus       150 lkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  228 (331)
T 4aaa_A          150 IKPENILVSQSG-VVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGD  228 (331)
T ss_dssp             CCGGGEEECTTS-CEEECCCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cChheEEEcCCC-cEEEEeCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            999999999888 79999999997654322 2344578999999999977656899999999999999999999999999


Q ss_pred             CcHHHHHHHHHHhCCCCHHHHhhc--CCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCC
Q 022799          161 SGVDQLVEIIKVLGTPTREEIKCM--NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  238 (292)
Q Consensus       161 ~~~~~~~~i~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp  238 (292)
                      +..+.+..+....+..........  .+.+.....+............+.+++.+.+||.+||..||.+|||+.|+|+||
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp  308 (331)
T 4aaa_A          229 SDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHD  308 (331)
T ss_dssp             SHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred             CcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCc
Confidence            999999999988888776543322  222333333433333333333457899999999999999999999999999999


Q ss_pred             Ccccc
Q 022799          239 FFDEL  243 (292)
Q Consensus       239 ~~~~~  243 (292)
                      ||+..
T Consensus       309 ~f~~~  313 (331)
T 4aaa_A          309 FFQMD  313 (331)
T ss_dssp             HHHGG
T ss_pred             hhccC
Confidence            99864

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.1e-43  Score=301.43  Aligned_cols=207  Identities=31%  Similarity=0.493  Sum_probs=164.8

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++     .+....++||||++ |+|.+.+.........+++..++.++.||+.||.|||++ ||+|
T Consensus        74 l~~l~hp~iv~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH  147 (285)
T 3is5_A           74 LKSLDHPNIIKIFEVF-----EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ-HVVH  147 (285)
T ss_dssp             HHTCCCTTBCCEEEEE-----ECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT-TCCC
T ss_pred             HHhCCCchHHhHHHhe-----ecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC-CEEE
Confidence            3578999999999998     44445899999998 599998876655567899999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeC---CCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCC
Q 022799           80 RDIKPQNLLVNP---HTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPL  156 (292)
Q Consensus        80 ~dlkp~Nill~~---~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~p  156 (292)
                      |||||+||+++.   ++ .+||+|||++.............||+.|+|||++.+  .++.++|+||+||++|+|++|..|
T Consensus       148 ~dikp~NIl~~~~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~p  224 (285)
T 3is5_A          148 KDLKPENILFQDTSPHS-PIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLP  224 (285)
T ss_dssp             CCCSGGGEEESSSSTTC-CEEECCCCCCCC----------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred             CCCCHHHEEEecCCCCC-CEEEEeeecceecCCcccCcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCC
Confidence            999999999943   34 799999999987655555556778999999999843  489999999999999999999999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      |.+.+..+....+....            +.+..              ....+++++.+||.+||..||++|||+.|+++
T Consensus       225 f~~~~~~~~~~~~~~~~------------~~~~~--------------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          225 FTGTSLEEVQQKATYKE------------PNYAV--------------ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             SCCSSHHHHHHHHHHCC------------CCCCC----------------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             CCCCCHHHHHhhhccCC------------ccccc--------------ccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            98877655444433210            00000              01347899999999999999999999999999


Q ss_pred             CCCccc
Q 022799          237 HPFFDE  242 (292)
Q Consensus       237 hp~~~~  242 (292)
                      ||||++
T Consensus       279 hp~f~~  284 (285)
T 3is5_A          279 HEWFKQ  284 (285)
T ss_dssp             SGGGGC
T ss_pred             CHHhhc
Confidence            999985

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=4.5e-44  Score=323.18  Aligned_cols=203  Identities=28%  Similarity=0.444  Sum_probs=173.7

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++.     +...+|+||||++ |+|.+++..    .+.+++..++.++.||+.||.|||++ ||+|
T Consensus        70 l~~l~HpnIv~l~~~~~-----~~~~~~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~-givH  139 (476)
T 2y94_A           70 LKLFRHPHIIKLYQVIS-----TPSDIFMVMEYVSGGELFDYICK----NGRLDEKESRRLFQQILSGVDYCHRH-MVVH  139 (476)
T ss_dssp             HTTCCCTTBCCEEEEEE-----CSSEEEEEEECCSSEEHHHHTTS----SSSCCHHHHHHHHHHHHHHHHHHHTT-TEEC
T ss_pred             HHhCCCCCCCcEEEEEE-----ECCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCCc
Confidence            46789999999999984     3345899999997 699888764    46799999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      |||||+||+++.++ .+||+|||++..........+.+||+.|+|||++.+....+.++|+||+||++|+|++|..||.+
T Consensus       140 rDLkp~NIll~~~~-~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~  218 (476)
T 2y94_A          140 RDLKPENVLLDAHM-NAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD  218 (476)
T ss_dssp             SCCSGGGEEECTTC-CEEECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ccccHHHEEEecCC-CeEEEeccchhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCC
Confidence            99999999999888 79999999998876655556678999999999997765458899999999999999999999998


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCC
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF  239 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~  239 (292)
                      .+......++.....                 .            .+..+++++.+||++||..||.+|||+.++++|||
T Consensus       219 ~~~~~~~~~i~~~~~-----------------~------------~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~  269 (476)
T 2y94_A          219 DHVPTLFKKICDGIF-----------------Y------------TPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEW  269 (476)
T ss_dssp             SSSHHHHHHHHTTCC-----------------C------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHH
T ss_pred             CCHHHHHHHHhcCCc-----------------C------------CCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHH
Confidence            877666655543110                 0            12457899999999999999999999999999999


Q ss_pred             cccc
Q 022799          240 FDEL  243 (292)
Q Consensus       240 ~~~~  243 (292)
                      |+..
T Consensus       270 ~~~~  273 (476)
T 2y94_A          270 FKQD  273 (476)
T ss_dssp             HHTT
T ss_pred             hhhc
Confidence            9863

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=6e-44  Score=308.81  Aligned_cols=203  Identities=29%  Similarity=0.454  Sum_probs=168.0

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      +.++||||+++++++.     +...+|+||||++ ++|.+.+...    ..+++..++.++.||+.||.|||++ ||+||
T Consensus        76 ~~l~hp~iv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~  145 (327)
T 3a62_A           76 EEVKHPFIVDLIYAFQ-----TGGKLYLILEYLSGGELFMQLERE----GIFMEDTACFYLAEISMALGHLHQK-GIIYR  145 (327)
T ss_dssp             HHCCCTTBCCEEEEEE-----CSSCEEEEEECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TCCCC
T ss_pred             HhCCCCCccceeEEEE-----cCCEEEEEEeCCCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhC-CEEcc
Confidence            4678999999999984     3445899999998 6998888753    5689999999999999999999998 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccC-CCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      ||||+||+++.++ .+||+|||+++..... .......||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+
T Consensus       146 Dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~  223 (327)
T 3a62_A          146 DLKPENIMLNHQG-HVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRS-GHNRAVDWWSLGALMYDMLTGAPPFTG  223 (327)
T ss_dssp             CCCTTTEEECTTS-CEEECCCSCC----------CTTSSCCTTSCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cCCHHHeEECCCC-cEEEEeCCcccccccCCccccccCCCcCccCHhhCcCC-CCCCcccchhHHHHHHHHHHCCCCCCC
Confidence            9999999999888 7999999998764322 223456789999999999664 489999999999999999999999998


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcc-----cHHHH
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEA  234 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----t~~e~  234 (292)
                      .+.......+.+...                             .++..+++++.+||.+||..||.+||     ++.++
T Consensus       224 ~~~~~~~~~i~~~~~-----------------------------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~  274 (327)
T 3a62_A          224 ENRKKTIDKILKCKL-----------------------------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEV  274 (327)
T ss_dssp             SSHHHHHHHHHHTCC-----------------------------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHH
T ss_pred             CCHHHHHHHHHhCCC-----------------------------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHH
Confidence            887776666654210                             02245789999999999999999999     89999


Q ss_pred             hcCCCccccCC
Q 022799          235 LIHPFFDELRD  245 (292)
Q Consensus       235 l~hp~~~~~~~  245 (292)
                      ++||||+++.+
T Consensus       275 l~hp~f~~~~~  285 (327)
T 3a62_A          275 QAHPFFRHINW  285 (327)
T ss_dssp             HHSGGGSSCCH
T ss_pred             HcCCcccCCCH
Confidence            99999998754

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=5.4e-44  Score=315.40  Aligned_cols=209  Identities=28%  Similarity=0.451  Sum_probs=173.1

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++     .+...+++||||++ |+|.+.+...   ...+++..++.++.||+.||.|||++ ||+|
T Consensus       102 l~~l~hpnIv~~~~~~-----~~~~~~~lv~E~~~gg~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~-givH  172 (387)
T 1kob_A          102 MNQLHHPKLINLHDAF-----EDKYEMVLILEFLSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEH-SIVH  172 (387)
T ss_dssp             HTTCCSTTBCCEEEEE-----ECSSEEEEEEECCCCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHT-TEEC
T ss_pred             HHhCCCcCCCeEEEEE-----EeCCEEEEEEEcCCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhC-Ceee
Confidence            4678999999999998     44455899999998 6988877642   34689999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCC-CCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           80 RDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        80 ~dlkp~Nill~~~-~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      |||||+||+++.+ ...+||+|||++.............||+.|+|||++.+. .++.++|+||+||++|+|++|..||.
T Consensus       173 rDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~  251 (387)
T 1kob_A          173 LDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFA  251 (387)
T ss_dssp             CCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSC
T ss_pred             cccchHHeEEecCCCCceEEEecccceecCCCcceeeeccCCCccCchhccCC-CCCCcccEeeHhHHHHHHHhCCCCCC
Confidence            9999999999743 236999999999887655555566899999999999654 48999999999999999999999999


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCC
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  238 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp  238 (292)
                      +.+..+.+..+......                 ++.        .....+++++++||.+||..||.+|||+.++++||
T Consensus       252 ~~~~~~~~~~i~~~~~~-----------------~~~--------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp  306 (387)
T 1kob_A          252 GEDDLETLQNVKRCDWE-----------------FDE--------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHP  306 (387)
T ss_dssp             CSSHHHHHHHHHHCCCC-----------------CCS--------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTST
T ss_pred             CCCHHHHHHHHHhCCCC-----------------CCc--------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCc
Confidence            88877766665442110                 000        01145799999999999999999999999999999


Q ss_pred             CccccC
Q 022799          239 FFDELR  244 (292)
Q Consensus       239 ~~~~~~  244 (292)
                      ||++..
T Consensus       307 ~~~~~~  312 (387)
T 1kob_A          307 WLKGDH  312 (387)
T ss_dssp             TTSSCC
T ss_pred             cccCCc
Confidence            998643

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=3.1e-44  Score=314.60  Aligned_cols=209  Identities=27%  Similarity=0.477  Sum_probs=155.0

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      +.++||||+++++++.     +...+++||||++ |+|.+.+...    +++++..++.++.||+.||.|||++ ||+||
T Consensus        71 ~~l~hpniv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~ql~~~L~~LH~~-~ivH~  140 (361)
T 3uc3_A           71 RSLRHPNIVRFKEVIL-----TPTHLAIIMEYASGGELYERICNA----GRFSEDEARFFFQQLLSGVSYCHSM-QICHR  140 (361)
T ss_dssp             HHCCCTTBCCEEEEEE-----CSSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TCCSC
T ss_pred             HhCCCCCCCcEEEEEe-----eCCEEEEEEEeCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CcccC
Confidence            4689999999999994     3445899999997 6998888653    5799999999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCC-cEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           81 DIKPQNLLVNPHTH-QLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        81 dlkp~Nill~~~~~-~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      ||||+||+++.++. .+||+|||+++............||+.|+|||++.+....+.++|+||+||++|+|++|..||.+
T Consensus       141 Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~  220 (361)
T 3uc3_A          141 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFED  220 (361)
T ss_dssp             CCCGGGEEECSSSSCCEEECCCCCC---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC-
T ss_pred             CCCHHHEEEcCCCCceEEEeecCccccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCC
Confidence            99999999986652 49999999998654444455668999999999997766445559999999999999999999987


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCC
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF  239 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~  239 (292)
                      .........+.+.....             ....+.          ...+++++++||.+||..||.+|||+.++++|||
T Consensus       221 ~~~~~~~~~~~~~~~~~-------------~~~~~~----------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~  277 (361)
T 3uc3_A          221 PEEPRDYRKTIQRILSV-------------KYSIPD----------DIRISPECCHLISRIFVADPATRISIPEIKTHSW  277 (361)
T ss_dssp             ---CCCHHHHHHHHHTT-------------CCCCCT----------TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHH
T ss_pred             CccHHHHHHHHHHHhcC-------------CCCCCC----------cCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcc
Confidence            65433333333221110             001110          1357899999999999999999999999999999


Q ss_pred             cccc
Q 022799          240 FDEL  243 (292)
Q Consensus       240 ~~~~  243 (292)
                      |...
T Consensus       278 f~~~  281 (361)
T 3uc3_A          278 FLKN  281 (361)
T ss_dssp             HHTT
T ss_pred             hhcC
Confidence            9753

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2.5e-43  Score=308.69  Aligned_cols=227  Identities=26%  Similarity=0.448  Sum_probs=179.0

Q ss_pred             CCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCC
Q 022799            3 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDI   82 (292)
Q Consensus         3 ~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dl   82 (292)
                      .+.||||+++++++..     ....|+||||++++|.+++....  ...+++..++.++.||+.||.|||++ ||+||||
T Consensus        92 ~~~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDl  163 (360)
T 3llt_A           92 DINNNNIVKYHGKFMY-----YDHMCLIFEPLGPSLYEIITRNN--YNGFHIEDIKLYCIEILKALNYLRKM-SLTHTDL  163 (360)
T ss_dssp             STTGGGBCCEEEEEEE-----TTEEEEEECCCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCC
T ss_pred             CCCCCCeecccceeeE-----CCeeEEEEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCC
Confidence            3469999999999844     34589999999889999987542  24589999999999999999999988 9999999


Q ss_pred             CCCcEEEeC-------------------------CCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCch
Q 022799           83 KPQNLLVNP-------------------------HTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAA  137 (292)
Q Consensus        83 kp~Nill~~-------------------------~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  137 (292)
                      ||+||+++.                         ++ .+||+|||++.....  ......||+.|+|||++.+. .++.+
T Consensus       164 kp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~  239 (360)
T 3llt_A          164 KPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKST-GIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNL-GWDVS  239 (360)
T ss_dssp             SGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCC-CEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTC-CCCTT
T ss_pred             CcccEEEccccccccccchhcccccccccccccCCC-CEEEEeccCceecCC--CCcCccCcccccCcHHHcCC-CCCCc
Confidence            999999974                         44 799999999986533  33456789999999999765 48999


Q ss_pred             hHhhhhhHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc---------ccCCCCCCC--------C
Q 022799          138 IDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE---------FKFPQIKAH--------P  200 (292)
Q Consensus       138 ~DvwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~--------~  200 (292)
                      +|+||+||++|+|++|..||.+.+..+.+..+....+.++...+.........         ..++.....        .
T Consensus       240 ~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~  319 (360)
T 3llt_A          240 SDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKK  319 (360)
T ss_dssp             HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHT
T ss_pred             cchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhh
Confidence            99999999999999999999999999999999888888887665433211100         001110000        0


Q ss_pred             chhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCCcc
Q 022799          201 WHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFD  241 (292)
Q Consensus       201 ~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~~~  241 (292)
                      ....++...++.+.+||.+||+.||++|||++|+|+||||+
T Consensus       320 ~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          320 CLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             CCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred             cccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence            00011223457889999999999999999999999999995

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=2e-43  Score=298.27  Aligned_cols=207  Identities=32%  Similarity=0.519  Sum_probs=174.5

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++     .+....++||||++ ++|.+.+...    ..+++..++.++.|++.||.|||++ ||+|
T Consensus        60 l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H  129 (277)
T 3f3z_A           60 MKSLDHPNIIRLYETF-----EDNTDIYLVMELCTGGELFERVVHK----RVFRESDAARIMKDVLSAVAYCHKL-NVAH  129 (277)
T ss_dssp             HHTCCCTTBCCEEEEE-----ECSSEEEEEEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT-TEEC
T ss_pred             HHhCCCCCEeeEEEEE-----ecCCeEEEEEeccCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CccC
Confidence            3578999999999998     44445899999998 5998888753    5689999999999999999999998 9999


Q ss_pred             cCCCCCcEEE---eCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCC
Q 022799           80 RDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPL  156 (292)
Q Consensus        80 ~dlkp~Nill---~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~p  156 (292)
                      |||||+||++   +.++ .++|+|||.+.............||+.|+|||++.+  .++.++|+||+||++|+|++|..|
T Consensus       130 ~dlkp~Nil~~~~~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p  206 (277)
T 3f3z_A          130 RDLKPENFLFLTDSPDS-PLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPP  206 (277)
T ss_dssp             CCCSGGGEEESSSSTTC-CEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCS
T ss_pred             CCCCHHHEEEecCCCCC-cEEEEecccceeccCccchhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCC
Confidence            9999999999   5555 799999999987766655566789999999999855  389999999999999999999999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      |.+....+....+.+.....+...+                         ..+++.+.++|.+||+.||.+|||+.++++
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          207 FSAPTDSEVMLKIREGTFTFPEKDW-------------------------LNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             SCCSSHHHHHHHHHHCCCCCCHHHH-------------------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCCCCHHHHHHHHHhCCCCCCchhh-------------------------hcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            9988877776666553322222211                         357899999999999999999999999999


Q ss_pred             CCCccccCC
Q 022799          237 HPFFDELRD  245 (292)
Q Consensus       237 hp~~~~~~~  245 (292)
                      ||||++...
T Consensus       262 h~~~~~~~~  270 (277)
T 3f3z_A          262 HEWFEKQLS  270 (277)
T ss_dssp             SHHHHHHHC
T ss_pred             CHHHhcccc
Confidence            999987543

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=6.9e-44  Score=302.87  Aligned_cols=210  Identities=28%  Similarity=0.432  Sum_probs=160.7

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccC
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRD   81 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~d   81 (292)
                      +.++||||+++++++..     ....++||||++|+|.+++.........+++..++.++.||+.||.|||++.||+|||
T Consensus        61 ~~~~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~d  135 (290)
T 3fme_A           61 RTVDCPFTVTFYGALFR-----EGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRD  135 (290)
T ss_dssp             TTCCCTTBCCEEEEEEC-----SSSEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCC
T ss_pred             HhCCCCeEEEEeeeeec-----cCCEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCC
Confidence            56899999999999843     3348999999999998888776666778999999999999999999999755999999


Q ss_pred             CCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccc---cCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           82 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELI---FGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        82 lkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      |||+||+++.++ .+||+|||++.............||+.|+|||++   .....++.++|+||+||++|+|++|..||.
T Consensus       136 lkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~  214 (290)
T 3fme_A          136 VKPSNVLINALG-QVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYD  214 (290)
T ss_dssp             CSGGGCEECTTC-CEEBCCC---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSC
T ss_pred             CCHHHEEECCCC-CEEEeecCCcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCcc
Confidence            999999999888 7999999999877555555556789999999997   234458999999999999999999999997


Q ss_pred             CCC-cHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          159 GES-GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       159 ~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      ... ....+....... .+.                          .....+++++.++|.+||..||.+|||+.++++|
T Consensus       215 ~~~~~~~~~~~~~~~~-~~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h  267 (290)
T 3fme_A          215 SWGTPFQQLKQVVEEP-SPQ--------------------------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH  267 (290)
T ss_dssp             CCSCHHHHHHHHHHSC-CCC--------------------------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             ccCchHHHHHHHhccC-CCC--------------------------cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence            643 333333332210 000                          0013578999999999999999999999999999


Q ss_pred             CCccccC
Q 022799          238 PFFDELR  244 (292)
Q Consensus       238 p~~~~~~  244 (292)
                      |||+...
T Consensus       268 p~f~~~~  274 (290)
T 3fme_A          268 PFFTLHE  274 (290)
T ss_dssp             HHHHHHH
T ss_pred             cccccCc
Confidence            9998643

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2e-43  Score=321.79  Aligned_cols=207  Identities=30%  Similarity=0.514  Sum_probs=174.3

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++|||||++++++     .+...+|+|||||. |+|.+.+...    ..+++..++.++.||+.||.|||++ ||+|
T Consensus        90 l~~l~hpniv~~~~~~-----~~~~~~~lv~e~~~~g~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH  159 (494)
T 3lij_A           90 LKLLDHPNIMKLYDFF-----EDKRNYYLVMECYKGGELFDEIIHR----MKFNEVDAAVIIKQVLSGVTYLHKH-NIVH  159 (494)
T ss_dssp             HTTCCCTTBCCEEEEE-----ECSSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TEEC
T ss_pred             HHhCCCCCCCeEEEEE-----EeCCEEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-Ccee
Confidence            4688999999999999     44455899999998 6998887653    5689999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCC--CcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCC
Q 022799           80 RDIKPQNLLVNPHT--HQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF  157 (292)
Q Consensus        80 ~dlkp~Nill~~~~--~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf  157 (292)
                      |||||+||+++..+  ..+||+|||++.............||+.|+|||++.+  .++.++|+||+||++|+|++|..||
T Consensus       160 ~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf  237 (494)
T 3lij_A          160 RDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPF  237 (494)
T ss_dssp             SCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             ccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCC
Confidence            99999999997543  2599999999988766555566789999999999853  4899999999999999999999999


Q ss_pred             CCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          158 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      .+.+..+.+..+..........                         ....+|+.+++||++||+.||.+|||+.++|+|
T Consensus       238 ~~~~~~~~~~~i~~~~~~~~~~-------------------------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          238 GGQTDQEILRKVEKGKYTFDSP-------------------------EWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             CCSSHHHHHHHHHHTCCCCCSG-------------------------GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             CCCCHHHHHHHHHhCCCCCCch-------------------------hcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence            9988877777665532111111                         114589999999999999999999999999999


Q ss_pred             CCccccC
Q 022799          238 PFFDELR  244 (292)
Q Consensus       238 p~~~~~~  244 (292)
                      |||+...
T Consensus       293 p~~~~~~  299 (494)
T 3lij_A          293 PWIKEMC  299 (494)
T ss_dssp             HHHHHHH
T ss_pred             cccccCc
Confidence            9998753

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.4e-43  Score=304.22  Aligned_cols=207  Identities=25%  Similarity=0.389  Sum_probs=173.9

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      ++++||||+++++++     .+....++||||++ ++|.+++..    ...+++..++.++.||+.||.|||++ ||+||
T Consensus        70 ~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~-~ivH~  139 (321)
T 2a2a_A           70 RQVLHHNVITLHDVY-----ENRTDVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK-KIAHF  139 (321)
T ss_dssp             HHCCCTTBCCEEEEE-----ECSSEEEEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHT-TEECC
T ss_pred             HhCCCCCcceEEEEE-----ecCCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeecC
Confidence            467899999999998     44445899999997 699998875    35789999999999999999999998 99999


Q ss_pred             CCCCCcEEEeCCCC---cEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCC
Q 022799           81 DIKPQNLLVNPHTH---QLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF  157 (292)
Q Consensus        81 dlkp~Nill~~~~~---~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf  157 (292)
                      ||||+||+++.++.   .++|+|||++.............||+.|+|||++.+. .++.++|+||+||++|+|++|..||
T Consensus       140 dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf  218 (321)
T 2a2a_A          140 DLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPF  218 (321)
T ss_dssp             CCSGGGEEESCTTSSSCCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSS
T ss_pred             CCChHHEEEecCCCCcCCEEEccCccceecCccccccccCCCCCccCcccccCC-CCCCccccHHHHHHHHHHHHCCCCC
Confidence            99999999987663   5999999999877655555566799999999999654 4899999999999999999999999


Q ss_pred             CCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          158 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      .+....+....+.......+                         ..+...+++.+.+||.+||..||++|||+.++++|
T Consensus       219 ~~~~~~~~~~~i~~~~~~~~-------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          219 LGDTKQETLANITSVSYDFD-------------------------EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             CCSSHHHHHHHHHTTCCCCC-------------------------HHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             CCCCHHHHHHHHHhcccccC-------------------------hhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            98877766665543221111                         11224689999999999999999999999999999


Q ss_pred             CCccccC
Q 022799          238 PFFDELR  244 (292)
Q Consensus       238 p~~~~~~  244 (292)
                      |||+.+.
T Consensus       274 p~~~~~~  280 (321)
T 2a2a_A          274 PWITPVD  280 (321)
T ss_dssp             TTTSCSS
T ss_pred             ccccCCC
Confidence            9998764

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=3.4e-43  Score=297.84  Aligned_cols=211  Identities=28%  Similarity=0.425  Sum_probs=173.8

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      ++++||||+++++++     .+....++||||++ ++|.+.+...    ..+++..+..++.|++.||.|||++ ||+||
T Consensus        60 ~~l~h~~i~~~~~~~-----~~~~~~~~v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~  129 (284)
T 3kk8_A           60 RKLQHPNIVRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHSN-GIVHR  129 (284)
T ss_dssp             HHCCCTTBCCEEEEE-----ECSSEEEEEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TEECS
T ss_pred             HHcCCCCcCeEEEEE-----EcCCEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CcCcC
Confidence            467999999999998     44455899999998 5888887653    5689999999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCC--CcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           81 DIKPQNLLVNPHT--HQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        81 dlkp~Nill~~~~--~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      ||||+||+++.++  ..+||+|||.+.............||+.|+|||++.+. .++.++|+||+||++|+|++|..||.
T Consensus       130 dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~  208 (284)
T 3kk8_A          130 NLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFW  208 (284)
T ss_dssp             CCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CCCHHHEEEecCCCCCcEEEeeceeeEEcccCccccCCCCCcCCcCchhhcCC-CCCcccchHHHHHHHHHHHHCCCCCC
Confidence            9999999997654  24999999999877655555566899999999999664 48999999999999999999999998


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCC
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  238 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp  238 (292)
                      +.+.......+.......+..                         ....+++++.+||.+||+.||++|||+.++++||
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~  263 (284)
T 3kk8_A          209 DEDQHRLYAQIKAGAYDYPSP-------------------------EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVP  263 (284)
T ss_dssp             CSSHHHHHHHHHHTCCCCCTT-------------------------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSH
T ss_pred             CCchhHHHHHHHhccccCCch-------------------------hhcccCHHHHHHHHHHcccChhhCCCHHHHhcCc
Confidence            887766666554421111100                         0135789999999999999999999999999999


Q ss_pred             CccccCCCCC
Q 022799          239 FFDELRDPNT  248 (292)
Q Consensus       239 ~~~~~~~~~~  248 (292)
                      ||++......
T Consensus       264 ~~~~~~~~~~  273 (284)
T 3kk8_A          264 WICNRERVAS  273 (284)
T ss_dssp             HHHSCCCGGG
T ss_pred             cccCChhHHh
Confidence            9998655433

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=9.5e-44  Score=323.16  Aligned_cols=207  Identities=30%  Similarity=0.515  Sum_probs=175.3

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++     .+...+++||||+. |+|.+.+..    ...+++..++.++.||+.||.|||++ ||+|
T Consensus        80 l~~l~hpniv~~~~~~-----~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH  149 (484)
T 3nyv_A           80 LKQLDHPNIMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKN-KIVH  149 (484)
T ss_dssp             HTTCCCTTBCCEEEEE-----ECSSEEEEEECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHHT-TCCC
T ss_pred             HHhCCCCCCCcEEEEE-----EeCCEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-Ceee
Confidence            4688999999999998     44556999999998 699888865    46799999999999999999999998 9999


Q ss_pred             cCCCCCcEEEe---CCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCC
Q 022799           80 RDIKPQNLLVN---PHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPL  156 (292)
Q Consensus        80 ~dlkp~Nill~---~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~p  156 (292)
                      |||||+||+++   .++ .+||+|||++.............||+.|+|||++.+  .++.++|+||+||++|+|++|..|
T Consensus       150 ~Dlkp~Nil~~~~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~p  226 (484)
T 3nyv_A          150 RDLKPENLLLESKSKDA-NIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPP  226 (484)
T ss_dssp             SCCCGGGEEESSSSTTC-CEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             CCCCHHHEEEecCCCCC-cEEEEeeeeeEEcccccccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCC
Confidence            99999999994   444 799999999988766655566789999999999965  489999999999999999999999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      |.+.+..+.+..+..........                         ....+|+++++||.+||+.||++|||+.++|+
T Consensus       227 f~~~~~~~~~~~i~~~~~~~~~~-------------------------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          227 FNGANEYDILKKVEKGKYTFELP-------------------------QWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             SCCSSHHHHHHHHHHCCCCCCSG-------------------------GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCCCHHHHHHHHHcCCCCCCCc-------------------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence            99988877777665421111100                         11357999999999999999999999999999


Q ss_pred             CCCccccCC
Q 022799          237 HPFFDELRD  245 (292)
Q Consensus       237 hp~~~~~~~  245 (292)
                      ||||+....
T Consensus       282 h~~~~~~~~  290 (484)
T 3nyv_A          282 HEWIQTYTK  290 (484)
T ss_dssp             SHHHHHHTC
T ss_pred             Chhhccccc
Confidence            999998654

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2.2e-43  Score=320.87  Aligned_cols=208  Identities=28%  Similarity=0.492  Sum_probs=171.6

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++     .+...+|+|||||. |+|.+.+...    ..+++..++.++.||+.||.|||++ ||+|
T Consensus        75 l~~l~hpniv~~~~~~-----~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~-~ivH  144 (486)
T 3mwu_A           75 LKKLDHPNIMKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKH-NIVH  144 (486)
T ss_dssp             HHHCCCTTBCCEEEEE-----ECSSEEEEEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TCCC
T ss_pred             HHhCCCCCcCeEEEEE-----EcCCEEEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeEe
Confidence            3568999999999998     44456999999998 6998887653    5799999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCC--CcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCC
Q 022799           80 RDIKPQNLLVNPHT--HQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF  157 (292)
Q Consensus        80 ~dlkp~Nill~~~~--~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf  157 (292)
                      |||||+||+++..+  ..+||+|||++.............||+.|+|||++.+  .++.++|+||+||++|+|++|..||
T Consensus       145 ~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf  222 (486)
T 3mwu_A          145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPF  222 (486)
T ss_dssp             SCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             ccCchHHEEEecCCCCCCEEEEECCcCeECCCCCccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCC
Confidence            99999999995422  2699999999987765555566789999999999965  4899999999999999999999999


Q ss_pred             CCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          158 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      .+.+..+.+..+..........                         ....+|+++++||.+||+.||.+|||+.++|+|
T Consensus       223 ~~~~~~~~~~~i~~~~~~~~~~-------------------------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          223 YGKNEYDILKRVETGKYAFDLP-------------------------QWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             CCSSHHHHHHHHHHTCCCSCSG-------------------------GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             CCCCHHHHHHHHHhCCCCCCCc-------------------------ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            9988877777665421111100                         013579999999999999999999999999999


Q ss_pred             CCccccCC
Q 022799          238 PFFDELRD  245 (292)
Q Consensus       238 p~~~~~~~  245 (292)
                      |||+....
T Consensus       278 p~~~~~~~  285 (486)
T 3mwu_A          278 PWIQKYSS  285 (486)
T ss_dssp             HHHHHTCC
T ss_pred             HhhccCcc
Confidence            99997653

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.6e-44  Score=329.53  Aligned_cols=206  Identities=28%  Similarity=0.459  Sum_probs=171.0

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      +.++|||||++++++     .+...+|+||||++ |+|.+.+....  ...+++..++.++.||+.||.|||++ ||+||
T Consensus       239 ~~l~hp~Iv~l~~~~-----~~~~~l~lVmEy~~gg~L~~~l~~~~--~~~l~e~~~~~i~~qIl~aL~yLH~~-gIvHr  310 (576)
T 2acx_A          239 EKVNSRFVVSLAYAY-----ETKDALCLVLTLMNGGDLKFHIYHMG--QAGFPEARAVFYAAEICCGLEDLHRE-RIVYR  310 (576)
T ss_dssp             HHCCCTTBCCEEEEE-----ECSSEEEEEECCCCSCBHHHHHHSSS--SCCCCHHHHHHHHHHHHHHHHHHHHT-TEECC
T ss_pred             HHcCCCCEeeEEEEE-----eeCCEEEEEEEcCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC-CEecc
Confidence            467999999999998     44456999999997 69988887531  24599999999999999999999998 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE  160 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  160 (292)
                      ||||+||+++.++ .+||+|||+++...........+||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+.
T Consensus       311 DLKPeNILld~~g-~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~-~~~~~~DiwSLGvilyeLltG~~PF~~~  388 (576)
T 2acx_A          311 DLKPENILLDDHG-HIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQR  388 (576)
T ss_dssp             CCCGGGEEECTTS-CEEECCCTTCEECCTTCCEECCCSCGGGCCHHHHTTC-EESSHHHHHHHHHHHHHHHHSSCSSSCS
T ss_pred             CCchheEEEeCCC-CeEEEecccceecccCccccccCCCccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCCCccc
Confidence            9999999999988 7999999999887655555667899999999999764 4899999999999999999999999876


Q ss_pred             CcH---HHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcc-----cHH
Q 022799          161 SGV---DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TAL  232 (292)
Q Consensus       161 ~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----t~~  232 (292)
                      +..   ..+...+...           .                 ..++..+++++++||.+||+.||.+|+     +++
T Consensus       389 ~~~~~~~~i~~~i~~~-----------~-----------------~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~  440 (576)
T 2acx_A          389 KKKIKREEVERLVKEV-----------P-----------------EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAR  440 (576)
T ss_dssp             SSCCCHHHHHHHHHHC-----------C-----------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHH
T ss_pred             ccchhHHHHHHHhhcc-----------c-----------------ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHH
Confidence            432   2222222210           0                 012246899999999999999999999     899


Q ss_pred             HHhcCCCccccCC
Q 022799          233 EALIHPFFDELRD  245 (292)
Q Consensus       233 e~l~hp~~~~~~~  245 (292)
                      |+++||||+++++
T Consensus       441 eil~HpfF~~i~w  453 (576)
T 2acx_A          441 EVKEHPLFKKLNF  453 (576)
T ss_dssp             HHHTSGGGTTCCH
T ss_pred             HHHhChhhccCCH
Confidence            9999999998764

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=3.1e-43  Score=321.20  Aligned_cols=208  Identities=29%  Similarity=0.491  Sum_probs=176.4

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++     .+...+|+|||||+ |+|.+.+...    ..+++..++.++.||+.||.|||++ ||+|
T Consensus       100 l~~l~hpniv~~~~~~-----~~~~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH  169 (504)
T 3q5i_A          100 LKSLDHPNIIKLFDVF-----EDKKYFYLVTEFYEGGELFEQIINR----HKFDECDAANIMKQILSGICYLHKH-NIVH  169 (504)
T ss_dssp             HHTCCCTTBCCEEEEE-----ECSSEEEEEEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT-TEEC
T ss_pred             HHhCCCCCCCeEEEEE-----EcCCEEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeEe
Confidence            3578999999999999     44556999999998 6998888653    5699999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCC--cEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCC
Q 022799           80 RDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF  157 (292)
Q Consensus        80 ~dlkp~Nill~~~~~--~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf  157 (292)
                      |||||+||+++.++.  .+||+|||++.............||+.|+|||++.+  .++.++|+||+||++|+|++|..||
T Consensus       170 ~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf  247 (504)
T 3q5i_A          170 RDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPF  247 (504)
T ss_dssp             SCCSGGGEEESSTTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             CCCcHHHEEEecCCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCC
Confidence            999999999987653  599999999988766555566789999999999853  4899999999999999999999999


Q ss_pred             CCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          158 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      .+.+..+.+..+.......+...                         ...+|+++++||++||+.||.+|||++++|+|
T Consensus       248 ~~~~~~~~~~~i~~~~~~~~~~~-------------------------~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          248 GGQNDQDIIKKVEKGKYYFDFND-------------------------WKNISDEAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             CCSSHHHHHHHHHHCCCCCCHHH-------------------------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCCCHHHHHHHHHcCCCCCCccc-------------------------cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            99888777777665322222111                         14689999999999999999999999999999


Q ss_pred             CCccccCC
Q 022799          238 PFFDELRD  245 (292)
Q Consensus       238 p~~~~~~~  245 (292)
                      |||+....
T Consensus       303 ~~~~~~~~  310 (504)
T 3q5i_A          303 RWIKKYAN  310 (504)
T ss_dssp             HHHHHTCC
T ss_pred             Hhhhhchh
Confidence            99997543

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.5e-43  Score=313.38  Aligned_cols=235  Identities=21%  Similarity=0.351  Sum_probs=166.8

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      ++++|||||++++++..     ...+|+||||++ |+|.+++....  ...+++..++.++.||+.||.|||++ ||+||
T Consensus        81 ~~l~h~niv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivHr  152 (389)
T 3gni_B           81 KLFNHPNIVPYRATFIA-----DNELWVVTSFMAYGSAKDLICTHF--MDGMNELAIAYILQGVLKALDYIHHM-GYVHR  152 (389)
T ss_dssp             HHCCCTTBCCEEEEEEE-----TTEEEEEEECCTTCBHHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECC
T ss_pred             HhCCCCCCCcEeEEEEE-----CCEEEEEEEccCCCCHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC-CeecC
Confidence            56899999999999943     345899999998 69999887532  35699999999999999999999998 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCC--------CcccccccccccCCccccCC-CCCCchhHhhhhhHHHHHHH
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE--------PNISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELL  151 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~  151 (292)
                      ||||+||+++.++ .+||+|||.+.......        ......||+.|+|||++.+. ..++.++|+||+||++|+|+
T Consensus       153 Dlkp~NIll~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~  231 (389)
T 3gni_B          153 SVKASHILISVDG-KVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELA  231 (389)
T ss_dssp             CCSGGGEEECTTC-CEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHH
T ss_pred             CCCHHHEEEcCCC-CEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHH
Confidence            9999999999888 79999999876542221        12234789999999999764 45899999999999999999


Q ss_pred             hCCCCCCCCCcHHHHHHHHHHhCCC--------CHHHHhhcCCC-----Ccc-----ccCCCCCCCCchhhhccCCChhH
Q 022799          152 LGQPLFPGESGVDQLVEIIKVLGTP--------TREEIKCMNPN-----YTE-----FKFPQIKAHPWHKIFQKRMPPEA  213 (292)
Q Consensus       152 ~g~~pf~~~~~~~~~~~i~~~~~~~--------~~~~~~~~~~~-----~~~-----~~~~~~~~~~~~~~~~~~~~~~~  213 (292)
                      +|..||.+.+.......+.......        ...........     ...     ...+. ........++..+++.+
T Consensus       232 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~  310 (389)
T 3gni_B          232 NGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPS-NGDSPSHPYHRTFSPHF  310 (389)
T ss_dssp             HSSCTTTTCCSTTHHHHC---------------------------------------------------------CCHHH
T ss_pred             HCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccc-cCCCCCCccccccCHHH
Confidence            9999998877666554433211100        00000000000     000     00000 00001112345689999


Q ss_pred             HHHHHHHhccCCCCcccHHHHhcCCCccccCCC
Q 022799          214 VDLVSRLLQYSPNLRSTALEALIHPFFDELRDP  246 (292)
Q Consensus       214 ~~li~~~l~~dp~~R~t~~e~l~hp~~~~~~~~  246 (292)
                      .+||.+||+.||++|||+.|+|+||||+.+...
T Consensus       311 ~~li~~~L~~dP~~Rpta~ell~hp~f~~~~~~  343 (389)
T 3gni_B          311 HHFVEQCLQRNPDARPSASTLLNHSFFKQIKRR  343 (389)
T ss_dssp             HHHHHHHTCSCTTTSCCHHHHTTSGGGGGC---
T ss_pred             HHHHHHHhhcCcccCCCHHHHhcCHHHHHHhhc
Confidence            999999999999999999999999999987654

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.8e-43  Score=302.54  Aligned_cols=197  Identities=27%  Similarity=0.382  Sum_probs=160.9

Q ss_pred             CCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCC
Q 022799            4 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIK   83 (292)
Q Consensus         4 l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlk   83 (292)
                      .+||||+++++++     .+...+++||||++++|.+.+...   ...+++..++.++.||+.||.|||++ ||+|||||
T Consensus       114 ~~h~~iv~l~~~~-----~~~~~~~lv~e~~~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dik  184 (311)
T 3p1a_A          114 GQHPCCVRLEQAW-----EEGGILYLQTELCGPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQ-GLVHLDVK  184 (311)
T ss_dssp             CCCTTBCCEEEEE-----EETTEEEEEEECCCCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCS
T ss_pred             cCCCcEEEEEEEE-----EeCCEEEEEEeccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCC
Confidence            4899999999998     444458999999999999988764   45799999999999999999999998 99999999


Q ss_pred             CCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCCCcH
Q 022799           84 PQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV  163 (292)
Q Consensus        84 p~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~  163 (292)
                      |+||+++.++ .+||+|||++.............||+.|+|||++.+  .++.++|+||+||++|+|++|..|+.+....
T Consensus       185 p~NIll~~~~-~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~  261 (311)
T 3p1a_A          185 PANIFLGPRG-RCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGW  261 (311)
T ss_dssp             GGGEEECGGG-CEEECCCTTCEECC------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH
T ss_pred             HHHEEECCCC-CEEEccceeeeecccCCCCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHH
Confidence            9999999888 799999999987755555555679999999999865  4899999999999999999998776543222


Q ss_pred             HHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCCccc
Q 022799          164 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  242 (292)
Q Consensus       164 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~~~~  242 (292)
                      .   .+..  +.                         ....++..+++++.++|.+||+.||.+|||++++++||||++
T Consensus       262 ~---~~~~--~~-------------------------~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          262 Q---QLRQ--GY-------------------------LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             H---HHTT--TC-------------------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             H---HHhc--cC-------------------------CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence            1   1110  00                         011233568999999999999999999999999999999974

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.6e-43  Score=302.25  Aligned_cols=240  Identities=30%  Similarity=0.526  Sum_probs=184.6

Q ss_pred             CCCCCCCCeeeeceeeeccCC---------CCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHH
Q 022799            1 MRLLDHPNVVSLKHCFFSTTE---------KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI   71 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~---------~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~L   71 (292)
                      |++++||||+++++++.....         .+....++||||++|+|.+++.     ..++++..++.++.||+.||.||
T Consensus        62 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~l  136 (320)
T 2i6l_A           62 IRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLE-----QGPLLEEHARLFMYQLLRGLKYI  136 (320)
T ss_dssp             HHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccCCCHHHHhh-----cCCccHHHHHHHHHHHHHHHHHH
Confidence            357899999999998743221         2335689999999999998875     35789999999999999999999


Q ss_pred             HhcCCccccCCCCCcEEEeCCCCcEEEeecCCccccccC----CCcccccccccccCCccccCCCCCCchhHhhhhhHHH
Q 022799           72 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG----EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVL  147 (292)
Q Consensus        72 H~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il  147 (292)
                      |++ ||+||||||+||+++.++..+||+|||++......    .......+|+.|+|||.+.+...++.++|+||+||++
T Consensus       137 H~~-~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il  215 (320)
T 2i6l_A          137 HSA-NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIF  215 (320)
T ss_dssp             HHT-TCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHH
T ss_pred             HhC-CEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHH
Confidence            988 99999999999999855548999999999865322    1223456789999999987656689999999999999


Q ss_pred             HHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCC--CCCCCCchhhhccCCChhHHHHHHHHhccCC
Q 022799          148 AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP--QIKAHPWHKIFQKRMPPEAVDLVSRLLQYSP  225 (292)
Q Consensus       148 ~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp  225 (292)
                      |+|++|..||.+.+..+....+......+..+...........+...  .....++ ....+.+++++.+||.+||+.||
T Consensus       216 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP  294 (320)
T 2i6l_A          216 AEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPL-TQLLPGISREAVDFLEQILTFSP  294 (320)
T ss_dssp             HHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCH-HHHSTTCCHHHHHHHHTTSCSSG
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCCh-hHhcchhhHHHHHHHHHHcCCCc
Confidence            99999999999999888888888877776665543322111110000  0001111 12335689999999999999999


Q ss_pred             CCcccHHHHhcCCCccccCCCC
Q 022799          226 NLRSTALEALIHPFFDELRDPN  247 (292)
Q Consensus       226 ~~R~t~~e~l~hp~~~~~~~~~  247 (292)
                      .+|||++++++||||+....+.
T Consensus       295 ~~Rpt~~ell~hp~~~~~~~p~  316 (320)
T 2i6l_A          295 MDRLTAEEALSHPYMSIYSFPM  316 (320)
T ss_dssp             GGSCCHHHHHTSHHHHTTCC--
T ss_pred             cccCCHHHHhCCcccccccCcc
Confidence            9999999999999999876543

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.3e-43  Score=323.85  Aligned_cols=207  Identities=23%  Similarity=0.372  Sum_probs=170.9

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      ++++||||++++++|     .+...+|+||||++ |+|...+.........+++..++.++.||+.||.|||++ ||+||
T Consensus       240 ~~l~hp~Iv~l~~~~-----~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~-gIvHr  313 (543)
T 3c4z_A          240 AKVHSRFIVSLAYAF-----ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR-NIIYR  313 (543)
T ss_dssp             HHCCCTTBCCEEEEE-----ECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT-TEECC
T ss_pred             HhcCCCCEeeEEEEE-----eeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc-CCccc
Confidence            467999999999998     44455999999998 699988876544456799999999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCC-cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      ||||+||+++.++ .+||+|||+++....... ....+||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+
T Consensus       314 DLKP~NILl~~~g-~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiwSlGvilyelltG~~PF~~  391 (543)
T 3c4z_A          314 DLKPENVLLDDDG-NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGE-EYDFSVDYFALGVTLYEMIAARGPFRA  391 (543)
T ss_dssp             CCCGGGEEECTTS-CEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CCChHHEEEeCCC-CEEEeecceeeeccCCCcccccccCCccccChhhhcCC-CCChHHhcCcchHHHHHHHhCCCCCCC
Confidence            9999999999988 799999999987654433 2345899999999999764 589999999999999999999999987


Q ss_pred             CCc----HHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCccc-----
Q 022799          160 ESG----VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----  230 (292)
Q Consensus       160 ~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t-----  230 (292)
                      .+.    ......+...                 ..            .++..+++++++||.+||+.||.+||+     
T Consensus       392 ~~~~~~~~~~~~~i~~~-----------------~~------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~  442 (543)
T 3c4z_A          392 RGEKVENKELKQRVLEQ-----------------AV------------TYPDKFSPASKDFCEALLQKDPEKRLGFRDGS  442 (543)
T ss_dssp             TTCCCCHHHHHHHHHHC-----------------CC------------CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTB
T ss_pred             CccchhHHHHHHHHhhc-----------------cc------------CCCcccCHHHHHHHHHhccCCHhHCCCCcccC
Confidence            642    2222222221                 00            122468999999999999999999995     


Q ss_pred             HHHHhcCCCccccCC
Q 022799          231 ALEALIHPFFDELRD  245 (292)
Q Consensus       231 ~~e~l~hp~~~~~~~  245 (292)
                      ++++++||||+++.+
T Consensus       443 a~ei~~Hpff~~i~w  457 (543)
T 3c4z_A          443 CDGLRTHPLFRDISW  457 (543)
T ss_dssp             SHHHHTSGGGTTCCH
T ss_pred             HHHHHcCccccCCCH
Confidence            589999999998764

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.4e-43  Score=302.55  Aligned_cols=205  Identities=28%  Similarity=0.472  Sum_probs=164.8

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++...   ....+++||||++ ++|.+++.     ...+++..++.++.||+.||.|||++ ||+|
T Consensus        90 l~~l~h~~iv~~~~~~~~~---~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH  160 (298)
T 2zv2_A           90 LKKLDHPNVVKLVEVLDDP---NEDHLYMVFELVNQGPVMEVPT-----LKPLSEDQARFYFQDLIKGIEYLHYQ-KIIH  160 (298)
T ss_dssp             HHTCCCTTBCCEEEEEECS---SSSEEEEEEECCTTCBSCCSSC-----SSCCCHHHHHHHHHHHHHHHHHHHHT-TEEC
T ss_pred             HHhCCCCCCCeEEEEEEcC---CCCEEEEEEecCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-Ceec
Confidence            3578999999999998542   2345899999998 57655432     45799999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCC-cccccccccccCCccccCCCC--CCchhHhhhhhHHHHHHHhCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NISYICSRYYRAPELIFGATE--YTAAIDIWSAGCVLAELLLGQPL  156 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~--~~~~~DvwslG~il~el~~g~~p  156 (292)
                      |||||+||+++.++ .+||+|||++........ .....||+.|+|||++.+...  ++.++|+||+||++|+|++|..|
T Consensus       161 ~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p  239 (298)
T 2zv2_A          161 RDIKPSNLLVGEDG-HIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP  239 (298)
T ss_dssp             CCCCGGGEEECTTS-CEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCS
T ss_pred             cCCCHHHEEECCCC-CEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCC
Confidence            99999999999888 799999999987644322 234578999999999965432  47899999999999999999999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      |.+.........+....                 ..++.          ...+++++.++|.+||..||++|||+.|+++
T Consensus       240 f~~~~~~~~~~~~~~~~-----------------~~~~~----------~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          240 FMDERIMCLHSKIKSQA-----------------LEFPD----------QPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             SCCSSHHHHHHHHHHCC-----------------CCCCS----------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCCccHHHHHHHHhccc-----------------CCCCC----------ccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            98776555444433210                 00010          1458899999999999999999999999999


Q ss_pred             CCCccc
Q 022799          237 HPFFDE  242 (292)
Q Consensus       237 hp~~~~  242 (292)
                      ||||+.
T Consensus       293 hp~~~~  298 (298)
T 2zv2_A          293 HPWVTR  298 (298)
T ss_dssp             CHHHHC
T ss_pred             CccccC
Confidence            999963

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.3e-43  Score=306.13  Aligned_cols=206  Identities=27%  Similarity=0.384  Sum_probs=166.2

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      +.++||||+++++++     .+....|+||||++ |+|.+++..    ...+++..++.++.||+.||.|||++ ||+||
T Consensus        60 ~~l~hpnIv~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~-givH~  129 (323)
T 3tki_A           60 KMLNHENVVKFYGHR-----REGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI-GITHR  129 (323)
T ss_dssp             HHCCCTTBCCEEEEE-----ECSSEEEEEEECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT-TEECS
T ss_pred             HhCCCCCCCeEEEEE-----ecCCeEEEEEEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC-Ccccc
Confidence            467999999999998     44456899999998 588877753    35699999999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCC---CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF  157 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf  157 (292)
                      ||||+||+++.++ .+||+|||++.......   ......||+.|+|||++.+...++.++|+||+||++|+|++|..||
T Consensus       130 Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf  208 (323)
T 3tki_A          130 DIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW  208 (323)
T ss_dssp             CCSGGGEEECTTC-CEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSC
T ss_pred             ccchHHEEEeCCC-CEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCC
Confidence            9999999999888 79999999997653322   2235678999999999977665588999999999999999999999


Q ss_pred             CCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          158 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      .+.................                     ..     ....+++.+.+||.+||..||++|||+.|+++|
T Consensus       209 ~~~~~~~~~~~~~~~~~~~---------------------~~-----~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          209 DQPSDSCQEYSDWKEKKTY---------------------LN-----PWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             SSSCTTSHHHHHHHTTCTT---------------------ST-----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCCchHHHHHHHHhccccc---------------------CC-----ccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            8765543322222110000                     00     013578999999999999999999999999999


Q ss_pred             CCccccC
Q 022799          238 PFFDELR  244 (292)
Q Consensus       238 p~~~~~~  244 (292)
                      |||+...
T Consensus       263 ~~~~~~~  269 (323)
T 3tki_A          263 RWYNKPL  269 (323)
T ss_dssp             TTTTCCC
T ss_pred             hhhcccc
Confidence            9998643

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=3.1e-43  Score=306.89  Aligned_cols=206  Identities=31%  Similarity=0.447  Sum_probs=157.4

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      ++++||||+++++++.     +....++||||++ |+|.+.+..    ...+++..++.++.||+.||.|||++ ||+||
T Consensus       103 ~~l~h~niv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~  172 (349)
T 2w4o_A          103 LRLSHPNIIKLKEIFE-----TPTEISLVLELVTGGELFDRIVE----KGYYSERDAADAVKQILEAVAYLHEN-GIVHR  172 (349)
T ss_dssp             HHCCCTTBCCEEEEEE-----CSSEEEEEECCCCSCBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCC
T ss_pred             HhCCCCCCcceeeeEe-----cCCeEEEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEec
Confidence            4678999999999984     3445899999998 699888764    35689999999999999999999988 99999


Q ss_pred             CCCCCcEEEeC---CCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCC
Q 022799           81 DIKPQNLLVNP---HTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF  157 (292)
Q Consensus        81 dlkp~Nill~~---~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf  157 (292)
                      ||||+||+++.   ++ .+||+|||+++............||+.|+|||++.+. .++.++|+|||||++|+|++|..||
T Consensus       173 Dikp~NIll~~~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf  250 (349)
T 2w4o_A          173 DLKPENLLYATPAPDA-PLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGC-AYGPEVDMWSVGIITYILLCGFEPF  250 (349)
T ss_dssp             CCCGGGEEESSSSTTC-CEEECCCC----------------CGGGSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             CCCcccEEEecCCCCC-CEEEccCccccccCcccccccccCCCCccCHHHhcCC-CCCcccchHHHHHHHHHHHhCCCCC
Confidence            99999999975   55 7999999999876554444566789999999999765 4899999999999999999999999


Q ss_pred             CCCCcHHHH-HHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          158 PGESGVDQL-VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       158 ~~~~~~~~~-~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      .+....... ..+......                 ..        ......++.++.+||.+||..||++|||+.++++
T Consensus       251 ~~~~~~~~~~~~i~~~~~~-----------------~~--------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          251 YDERGDQFMFRRILNCEYY-----------------FI--------SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             CCTTCHHHHHHHHHTTCCC-----------------CC--------TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCCcccHHHHHHHHhCCCc-----------------cC--------CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            877655433 333221000                 00        0011457899999999999999999999999999


Q ss_pred             CCCccccC
Q 022799          237 HPFFDELR  244 (292)
Q Consensus       237 hp~~~~~~  244 (292)
                      ||||.+..
T Consensus       306 hp~~~~~~  313 (349)
T 2w4o_A          306 HPWVTGKA  313 (349)
T ss_dssp             STTTTSTT
T ss_pred             CcccCCCc
Confidence            99998643

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=3.2e-43  Score=305.84  Aligned_cols=204  Identities=29%  Similarity=0.482  Sum_probs=163.5

Q ss_pred             CCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCC
Q 022799            5 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIK   83 (292)
Q Consensus         5 ~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlk   83 (292)
                      +||||+++++++     .+...+|+|||||+ |+|.+.+..    .+.+++..++.++.||+.||.|||++ ||+|||||
T Consensus        74 ~hp~iv~~~~~~-----~~~~~~~lv~E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~-givHrDlk  143 (342)
T 2qr7_A           74 QHPNIITLKDVY-----DDGKYVYVVTELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQ-GVVHRDLK  143 (342)
T ss_dssp             TSTTBCCEEEEE-----ECSSEEEEEECCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCC
T ss_pred             CCCCcCeEEEEE-----EcCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcEeccCC
Confidence            799999999998     45556999999998 699988875    36799999999999999999999998 99999999


Q ss_pred             CCcEEEeCCC---CcEEEeecCCccccccC-CCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           84 PQNLLVNPHT---HQLKLCDFGSAKVLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        84 p~Nill~~~~---~~ikl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      |+||++..+.   ..+||+|||+++..... ......+||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+
T Consensus       144 p~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~  222 (342)
T 2qr7_A          144 PSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQ-GYDAACDIWSLGVLLYTMLTGYTPFAN  222 (342)
T ss_dssp             GGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHH-HHHHHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred             HHHEEEecCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcCC-CCCCccCeeeHhHHHHHHhcCCCCCCC
Confidence            9999985432   24999999999876443 234456789999999999654 388999999999999999999999976


Q ss_pred             C---CcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          160 E---SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       160 ~---~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      .   ...+....+....                 +..+        ......+++++++||++||..||++|||+.++++
T Consensus       223 ~~~~~~~~~~~~i~~~~-----------------~~~~--------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          223 GPDDTPEEILARIGSGK-----------------FSLS--------GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             STTSCHHHHHHHHHHCC-----------------CCCC--------STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCcCCHHHHHHHHccCC-----------------cccC--------ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            3   2233333332210                 0000        0112458999999999999999999999999999


Q ss_pred             CCCccccC
Q 022799          237 HPFFDELR  244 (292)
Q Consensus       237 hp~~~~~~  244 (292)
                      ||||.+..
T Consensus       278 hp~~~~~~  285 (342)
T 2qr7_A          278 HPWIVHWD  285 (342)
T ss_dssp             SHHHHTGG
T ss_pred             CCeecCcc
Confidence            99997643

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.2e-42  Score=299.78  Aligned_cols=205  Identities=29%  Similarity=0.478  Sum_probs=169.1

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++...     ...++||||++ ++|.+++.     ...+++..+..++.||+.||.|||++ ||+|
T Consensus        96 l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~-----~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivH  164 (321)
T 2c30_A           96 MRDYQHFNVVEMYKSYLVG-----EELWVLMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHAQ-GVIH  164 (321)
T ss_dssp             HTTCCCTTBCCEEEEEEET-----TEEEEEECCCCSCBHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT-TEEC
T ss_pred             HHhCCCCCcceEEEEEEEC-----CEEEEEEecCCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC-Ceec
Confidence            4678999999999998543     34899999998 68888765     35699999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCC-CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      |||||+||+++.++ .+||+|||++....... ......||+.|+|||++.+. .++.++|+||+||++|+|++|..||.
T Consensus       165 ~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~pf~  242 (321)
T 2c30_A          165 RDIKSDSILLTLDG-RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRS-LYATEVDIWSLGIMVIEMVDGEPPYF  242 (321)
T ss_dssp             CCCSGGGEEECTTC-CEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             CCCCHHHEEECCCC-cEEEeeeeeeeecccCccccccccCCccccCHhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            99999999999888 79999999988764432 23456789999999999654 48999999999999999999999998


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCC
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  238 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp  238 (292)
                      +.+.......+.... .+.          .               .....+++.+.++|.+||..||++|||+.++++||
T Consensus       243 ~~~~~~~~~~~~~~~-~~~----------~---------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp  296 (321)
T 2c30_A          243 SDSPVQAMKRLRDSP-PPK----------L---------------KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHP  296 (321)
T ss_dssp             TSCHHHHHHHHHHSS-CCC----------C---------------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred             CCCHHHHHHHHhcCC-CCC----------c---------------CccccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence            877766555443311 000          0               01135789999999999999999999999999999


Q ss_pred             CccccC
Q 022799          239 FFDELR  244 (292)
Q Consensus       239 ~~~~~~  244 (292)
                      ||....
T Consensus       297 ~~~~~~  302 (321)
T 2c30_A          297 FLLQTG  302 (321)
T ss_dssp             GGGGCC
T ss_pred             hhccCC
Confidence            998643

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=4e-43  Score=303.34  Aligned_cols=206  Identities=29%  Similarity=0.457  Sum_probs=145.6

Q ss_pred             CCC-CCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            3 LLD-HPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         3 ~l~-HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      .+. ||||+++++++     .+....|+||||++ |+|.+.+..    ...+++..++.++.||+.||.|||++ ||+||
T Consensus        61 ~l~~h~niv~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivH~  130 (325)
T 3kn6_A           61 LCEGHPNIVKLHEVF-----HDQLHTFLVMELLNGGELFERIKK----KKHFSETEASYIMRKLVSAVSHMHDV-GVVHR  130 (325)
T ss_dssp             HTTTCTTBCCEEEEE-----ECSSEEEEEECCCCSCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT-TEECC
T ss_pred             HhcCCCCeeEEEEEE-----EcCCEEEEEEEccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCeec
Confidence            354 99999999999     44556899999998 599998875    46799999999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCC--cEEEeecCCccccccCC-CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCC
Q 022799           81 DIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF  157 (292)
Q Consensus        81 dlkp~Nill~~~~~--~ikl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf  157 (292)
                      ||||+||+++.++.  .+||+|||+++...... ......||+.|+|||++.+. .++.++|+||+||++|+|++|..||
T Consensus       131 Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf  209 (325)
T 3kn6_A          131 DLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQN-GYDESCDLWSLGVILYTMLSGQVPF  209 (325)
T ss_dssp             CCCGGGEEEEC----CEEEECCCTTCEECCC----------------------C-CCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             CCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCC
Confidence            99999999976542  69999999998654332 23456789999999999654 4899999999999999999999999


Q ss_pred             CCCCcH-------HHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCccc
Q 022799          158 PGESGV-------DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST  230 (292)
Q Consensus       158 ~~~~~~-------~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t  230 (292)
                      .+.+..       +....+....                 +        .+.......+++++++||.+||..||.+|||
T Consensus       210 ~~~~~~~~~~~~~~~~~~i~~~~-----------------~--------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt  264 (325)
T 3kn6_A          210 QSHDRSLTCTSAVEIMKKIKKGD-----------------F--------SFEGEAWKNVSQEAKDLIQGLLTVDPNKRLK  264 (325)
T ss_dssp             C-------CCCHHHHHHHHTTTC-----------------C--------CCCSHHHHTSCHHHHHHHHHHHCCCTTTCCC
T ss_pred             CCCccccccccHHHHHHHHHcCC-----------------C--------CCCcccccCCCHHHHHHHHHHCCCChhHCCC
Confidence            765431       1122111100                 0        0011111468999999999999999999999


Q ss_pred             HHHHhcCCCccccC
Q 022799          231 ALEALIHPFFDELR  244 (292)
Q Consensus       231 ~~e~l~hp~~~~~~  244 (292)
                      ++++++||||++..
T Consensus       265 ~~ell~h~w~~~~~  278 (325)
T 3kn6_A          265 MSGLRYNEWLQDGS  278 (325)
T ss_dssp             TTTSTTCGGGCTTC
T ss_pred             HHHHhcChhhccCc
Confidence            99999999998743

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=3.7e-43  Score=311.73  Aligned_cols=210  Identities=27%  Similarity=0.408  Sum_probs=159.5

Q ss_pred             CCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccC
Q 022799            3 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRD   81 (292)
Q Consensus         3 ~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~d   81 (292)
                      ..+||||++++++|.... .+..++|+|||||+ |+|.+++....  ...+++..++.++.||+.||.|||++ ||+|||
T Consensus       111 ~~~hp~iv~l~~~~~~~~-~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrD  186 (400)
T 1nxk_A          111 ASQCPHIVRIVDVYENLY-AGRKCLLIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI-NIAHRD  186 (400)
T ss_dssp             HTTSTTBCCEEEEEEEEE-TTEEEEEEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT-TEECCC
T ss_pred             hcCCCCcceEeEEEeecc-cCCcEEEEEEEeCCCCcHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC-CccccC
Confidence            358999999999884322 23557899999998 59999987531  24699999999999999999999988 999999


Q ss_pred             CCCCcEEEeC---CCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           82 IKPQNLLVNP---HTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        82 lkp~Nill~~---~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      |||+||+++.   ++ .+||+|||+++...........+||+.|+|||++.+. .++.++||||+||++|+|++|..||.
T Consensus       187 lkp~Nill~~~~~~~-~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~  264 (400)
T 1nxk_A          187 VKPENLLYTSKRPNA-ILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFY  264 (400)
T ss_dssp             CCGGGEEESSSSTTC-CEEECCCTTCEECC-----------CTTCCGGGSCCC-CSSSHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             cCcceEEEecCCCCc-cEEEEecccccccCCCCccccCCCCCCccCHhhcCCC-CCCCcccHHHHHHHHHHHHhCCCCCC
Confidence            9999999987   45 7999999999876555555567889999999999654 58999999999999999999999998


Q ss_pred             CCCcHH----HHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHH
Q 022799          159 GESGVD----QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA  234 (292)
Q Consensus       159 ~~~~~~----~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~  234 (292)
                      +.....    ....+...                 .+.++.   .     ....+++++++||++||..||.+|||+.++
T Consensus       265 ~~~~~~~~~~~~~~i~~~-----------------~~~~~~---~-----~~~~~s~~~~~li~~~L~~dP~~Rpt~~ei  319 (400)
T 1nxk_A          265 SNHGLAISPGMKTRIRMG-----------------QYEFPN---P-----EWSEVSEEVKMLIRNLLKTEPTQRMTITEF  319 (400)
T ss_dssp             CCTTCSSCCSHHHHHHHT-----------------CCCCCT---T-----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred             CCccccccHHHHHHHHcC-----------------cccCCC---c-----ccccCCHHHHHHHHHHCCCChhHCcCHHHH
Confidence            765322    12222210                 011110   0     013589999999999999999999999999


Q ss_pred             hcCCCcccc
Q 022799          235 LIHPFFDEL  243 (292)
Q Consensus       235 l~hp~~~~~  243 (292)
                      ++||||...
T Consensus       320 l~hp~~~~~  328 (400)
T 1nxk_A          320 MNHPWIMQS  328 (400)
T ss_dssp             HHSHHHHTT
T ss_pred             hcCccccCC
Confidence            999999864

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=7.9e-43  Score=301.84  Aligned_cols=232  Identities=31%  Similarity=0.559  Sum_probs=175.7

Q ss_pred             CCC-CCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            3 LLD-HPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         3 ~l~-HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      +++ ||||+++++++...   .....++||||++ ++|.+++.       .+++..++.++.||+.||.|||++ ||+||
T Consensus        86 ~l~~~~~i~~~~~~~~~~---~~~~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~  154 (330)
T 3nsz_A           86 NLRGGPNIITLADIVKDP---VSRTPALVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM-GIMHR  154 (330)
T ss_dssp             HHTTSTTBCCEEEEEECT---TTCCEEEEEECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHT-TEECC
T ss_pred             HcCCCCCEEEeeeeeccC---CCCceEEEEeccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhC-CeeeC
Confidence            454 99999999998542   2345889999998 57776653       388999999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC-C
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP-G  159 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~-~  159 (292)
                      ||||+||+++.++..+||+|||+++............||+.|+|||++.+...++.++|+||+||++|+|++|..||. +
T Consensus       155 Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~  234 (330)
T 3nsz_A          155 DVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG  234 (330)
T ss_dssp             CCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred             CCCHHHEEEcCCCCEEEEEeCCCceEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence            999999999977767999999999877655555667889999999999775668999999999999999999999985 4


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHH-hhcCCCCccc---cCCCCCCCCchhh----hccCCChhHHHHHHHHhccCCCCcccH
Q 022799          160 ESGVDQLVEIIKVLGTPTREEI-KCMNPNYTEF---KFPQIKAHPWHKI----FQKRMPPEAVDLVSRLLQYSPNLRSTA  231 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~dp~~R~t~  231 (292)
                      ....+.+..+.+..+.+..... ..........   .........|...    .+..+++++.+||.+||..||.+|||+
T Consensus       235 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta  314 (330)
T 3nsz_A          235 HDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA  314 (330)
T ss_dssp             SSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCH
T ss_pred             CchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCH
Confidence            5566666777666664433221 1111000000   0000011111111    123479999999999999999999999


Q ss_pred             HHHhcCCCccccCC
Q 022799          232 LEALIHPFFDELRD  245 (292)
Q Consensus       232 ~e~l~hp~~~~~~~  245 (292)
                      +|+|+||||+++..
T Consensus       315 ~e~l~hp~f~~~~~  328 (330)
T 3nsz_A          315 REAMEHPYFYTVVK  328 (330)
T ss_dssp             HHHHTSGGGTTCC-
T ss_pred             HHHhcCccHhhhcc
Confidence            99999999998753

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.5e-42  Score=304.41  Aligned_cols=202  Identities=28%  Similarity=0.480  Sum_probs=169.8

Q ss_pred             CCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCC
Q 022799            5 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIK   83 (292)
Q Consensus         5 ~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlk   83 (292)
                      +||||+++++++     ......|+||||++ ++|.+++...    ..+++..++.++.||+.||.|||++ ||+|||||
T Consensus       158 ~hp~iv~~~~~~-----~~~~~~~lv~e~~~g~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~-gi~H~Dlk  227 (365)
T 2y7j_A          158 GHPHIITLIDSY-----ESSSFMFLVFDLMRKGELFDYLTEK----VALSEKETRSIMRSLLEAVSFLHAN-NIVHRDLK  227 (365)
T ss_dssp             TCTTBCCEEEEE-----EBSSEEEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCS
T ss_pred             CCCCEeEEEEEE-----eeCCEEEEEEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCC
Confidence            799999999998     34445899999998 5999888753    5699999999999999999999988 99999999


Q ss_pred             CCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCC-----CCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           84 PQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA-----TEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        84 p~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      |+||+++.++ .++|+|||++.............||+.|+|||++.+.     ..++.++|+|||||++|+|++|..||.
T Consensus       228 p~NIl~~~~~-~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~  306 (365)
T 2y7j_A          228 PENILLDDNM-QIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFW  306 (365)
T ss_dssp             GGGEEECTTC-CEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred             HHHEEECCCC-CEEEEecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCC
Confidence            9999999888 7999999999887665555667899999999998532     347899999999999999999999998


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCC
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  238 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp  238 (292)
                      +.+.......+...........                         ...+++.+.++|.+||..||++|||+.++++||
T Consensus       307 ~~~~~~~~~~i~~~~~~~~~~~-------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp  361 (365)
T 2y7j_A          307 HRRQILMLRMIMEGQYQFSSPE-------------------------WDDRSSTVKDLISRLLQVDPEARLTAEQALQHP  361 (365)
T ss_dssp             CSSHHHHHHHHHHTCCCCCHHH-------------------------HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred             CCCHHHHHHHHHhCCCCCCCcc-------------------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCc
Confidence            8776666655544222111111                         135788999999999999999999999999999


Q ss_pred             Cccc
Q 022799          239 FFDE  242 (292)
Q Consensus       239 ~~~~  242 (292)
                      ||+.
T Consensus       362 ~f~r  365 (365)
T 2y7j_A          362 FFER  365 (365)
T ss_dssp             GGCC
T ss_pred             ccCC
Confidence            9973

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=7.4e-43  Score=302.88  Aligned_cols=197  Identities=25%  Similarity=0.420  Sum_probs=166.4

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-C-CHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-E-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVC   78 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g-~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~   78 (292)
                      |++++||||+++++++     .+...+++||||+. | +|.+++..    ...+++..++.++.||+.||.|||++ ||+
T Consensus        83 l~~l~h~~Iv~~~~~~-----~~~~~~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~-~iv  152 (335)
T 3dls_A           83 LSRVEHANIIKVLDIF-----ENQGFFQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRLK-DII  152 (335)
T ss_dssp             HTTCCCTTBCCEEEEE-----ECSSEEEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHHT-TEE
T ss_pred             HHhCCCCCEeeEEEEE-----eeCCEEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeE
Confidence            4678999999999998     44556899999986 5 88888875    46799999999999999999999998 999


Q ss_pred             ccCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           79 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        79 H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      ||||||+||+++.++ .+||+|||++.............||+.|+|||++.+...++.++|+||+||++|+|++|..||.
T Consensus       153 H~Dlkp~NIll~~~~-~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~  231 (335)
T 3dls_A          153 HRDIKDENIVIAEDF-TIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFC  231 (335)
T ss_dssp             CSCCSGGGEEECTTS-CEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCS
T ss_pred             EeccCHHHEEEcCCC-cEEEeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchh
Confidence            999999999999888 7999999999887666656667899999999999776645899999999999999999999996


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCC
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  238 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp  238 (292)
                      .....      ..              .   ..            ..+..+++++.+||.+||..||.+|||+.++++||
T Consensus       232 ~~~~~------~~--------------~---~~------------~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp  276 (335)
T 3dls_A          232 ELEET------VE--------------A---AI------------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDP  276 (335)
T ss_dssp             SGGGG------TT--------------T---CC------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCT
T ss_pred             hHHHH------Hh--------------h---cc------------CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence            42210      00              0   00            01235789999999999999999999999999999


Q ss_pred             Ccccc
Q 022799          239 FFDEL  243 (292)
Q Consensus       239 ~~~~~  243 (292)
                      ||++.
T Consensus       277 ~~~~~  281 (335)
T 3dls_A          277 WVTQP  281 (335)
T ss_dssp             TTTCC
T ss_pred             cccCC
Confidence            99763

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=5.2e-42  Score=291.56  Aligned_cols=206  Identities=23%  Similarity=0.382  Sum_probs=167.7

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCC--c
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG--V   77 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~--i   77 (292)
                      |+.++||||+++++++.... .+..++++||||++ ++|.+++...    ..+++..++.++.||+.||.|||++ |  |
T Consensus        79 l~~l~h~~iv~~~~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~-~~~i  152 (290)
T 1t4h_A           79 LKGLQHPNIVRFYDSWESTV-KGKKCIVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR-TPPI  152 (290)
T ss_dssp             HTTCCCTTBCCEEEEEEEES-SSCEEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS-SSCC
T ss_pred             HHhCCCCCeeeeeeeecccc-CCCceEEEEEEecCCCCHHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHcC-CCCE
Confidence            46789999999999886543 34567899999997 6999998753    6689999999999999999999987 8  9


Q ss_pred             cccCCCCCcEEEe-CCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCC
Q 022799           78 CHRDIKPQNLLVN-PHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPL  156 (292)
Q Consensus        78 ~H~dlkp~Nill~-~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~p  156 (292)
                      +||||||+||+++ .++ .+||+|||++..... .......||+.|+|||++.+  .++.++|+||+||++|+|++|..|
T Consensus       153 ~H~dikp~Nil~~~~~~-~~kl~Dfg~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p  228 (290)
T 1t4h_A          153 IHRDLKCDNIFITGPTG-SVKIGDLGLATLKRA-SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYP  228 (290)
T ss_dssp             CCSCCCGGGEEESSTTS-CEEECCTTGGGGCCT-TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCT
T ss_pred             EECCCCHHHEEEECCCC-CEEEeeCCCcccccc-cccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCC
Confidence            9999999999998 555 799999999975432 23345678999999999854  489999999999999999999999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      |.+................                          ...++...++++.++|.+||..||.+|||+.++++
T Consensus       229 f~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          229 YSECQNAAQIYRRVTSGVK--------------------------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             TTTCSSHHHHHHHHTTTCC--------------------------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCcCcHHHHHHHHhccCC--------------------------ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            9876655444333221100                          01123567889999999999999999999999999


Q ss_pred             CCCccc
Q 022799          237 HPFFDE  242 (292)
Q Consensus       237 hp~~~~  242 (292)
                      ||||++
T Consensus       283 h~~f~~  288 (290)
T 1t4h_A          283 HAFFQE  288 (290)
T ss_dssp             SGGGC-
T ss_pred             Cccccc
Confidence            999985

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=7.2e-43  Score=304.39  Aligned_cols=202  Identities=27%  Similarity=0.442  Sum_probs=169.0

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccC
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRD   81 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~d   81 (292)
                      +.++||||+++++++..     ....++||||+.|+|.+.+...   ...+++..+..++.|++.||.|||++ ||+|||
T Consensus       109 ~~l~hpniv~~~~~~~~-----~~~~~lv~e~~~g~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~D  179 (348)
T 1u5q_A          109 QKLRHPNTIQYRGCYLR-----EHTAWLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH-NMIHRD  179 (348)
T ss_dssp             HHCCCTTBCCEEEEEEE-----TTEEEEEEECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCC
T ss_pred             HhCCCCCEeeEEEEEEE-----CCeEEEEEecCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCC
Confidence            46799999999999844     3358999999999998888643   46799999999999999999999998 999999


Q ss_pred             CCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccC--CCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           82 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG--ATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        82 lkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      |||+||+++.++ .+||+|||++.....   .....||+.|+|||++.+  ...++.++|+||+||++|+|++|..||.+
T Consensus       180 lkp~NIll~~~~-~~kL~DfG~a~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~  255 (348)
T 1u5q_A          180 VKAGNILLSEPG-LVKLGDFGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN  255 (348)
T ss_dssp             CSGGGEEEETTT-EEEECCCTTCBSSSS---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             CCHHHEEECCCC-CEEEeeccCceecCC---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            999999999888 899999999976533   234678999999999853  34589999999999999999999999988


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCC
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF  239 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~  239 (292)
                      .+....+..+.... .+.                          ..+..+++.+.+||.+||..||++|||++++++|||
T Consensus       256 ~~~~~~~~~~~~~~-~~~--------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~  308 (348)
T 1u5q_A          256 MNAMSALYHIAQNE-SPA--------------------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF  308 (348)
T ss_dssp             SCHHHHHHHHHHSC-CCC--------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred             CChHHHHHHHHhcC-CCC--------------------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence            87766665554311 000                          011357889999999999999999999999999999


Q ss_pred             cccc
Q 022799          240 FDEL  243 (292)
Q Consensus       240 ~~~~  243 (292)
                      |...
T Consensus       309 ~~~~  312 (348)
T 1u5q_A          309 VLRE  312 (348)
T ss_dssp             HHSC
T ss_pred             hhcc
Confidence            9753

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.8e-42  Score=292.78  Aligned_cols=203  Identities=32%  Similarity=0.498  Sum_probs=167.6

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++     .+....++||||++ ++|.+.+...    ..+++..+..++.||+.||.|||++ ||+|
T Consensus        63 l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~qi~~~l~~LH~~-~i~H  132 (279)
T 3fdn_A           63 QSHLRHPNILRLYGYF-----HDATRVYLILEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSK-RVIH  132 (279)
T ss_dssp             HTTCCCTTBCCEEEEE-----ECSSEEEEEECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT-TCEE
T ss_pred             HHcCCCCCCcchhheE-----ecCCEEEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CEec
Confidence            4678999999999998     44445899999998 6998888753    5689999999999999999999987 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      |||||+||+++.++ .++|+|||++...... ......||+.|+|||.+.+. .++.++|+||+||++|+|++|..||.+
T Consensus       133 ~dlkp~Nili~~~~-~~~l~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~  209 (279)
T 3fdn_A          133 RDIKPENLLLGSAG-ELKIADFGWSVHAPSS-RRTDLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEA  209 (279)
T ss_dssp             CCCCGGGEEECTTS-CEEECSCCEESCC---------CCCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             ccCChHhEEEcCCC-CEEEEeccccccCCcc-cccccCCCCCccCHhHhccC-CCCccchhHhHHHHHHHHHHCCCCCCC
Confidence            99999999999888 7999999998654332 23455789999999999664 489999999999999999999999988


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCC
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF  239 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~  239 (292)
                      .+..+....+.....                             .++..+++.+.+||.+||..||.+|||+.++++|||
T Consensus       210 ~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~  260 (279)
T 3fdn_A          210 NTYQETYKRISRVEF-----------------------------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW  260 (279)
T ss_dssp             SSHHHHHHHHHHTCC-----------------------------CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHH
T ss_pred             CcHHHHHHHHHhCCC-----------------------------CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCcc
Confidence            776666555543110                             012457899999999999999999999999999999


Q ss_pred             ccccCC
Q 022799          240 FDELRD  245 (292)
Q Consensus       240 ~~~~~~  245 (292)
                      |+....
T Consensus       261 ~~~~~~  266 (279)
T 3fdn_A          261 ITANSS  266 (279)
T ss_dssp             HHHHCS
T ss_pred             ccCCcc
Confidence            997653

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.1e-42  Score=294.55  Aligned_cols=205  Identities=30%  Similarity=0.476  Sum_probs=170.3

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      +.++||||+++++++     .+....++||||++ ++|.+++...    ..+++..+..++.||+.||.|||++ ||+||
T Consensus        70 ~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~  139 (294)
T 2rku_A           70 RSLAHQHVVGFHGFF-----EDNDFVFVVLELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHRN-RVIHR  139 (294)
T ss_dssp             HTCCCTTBCCEEEEE-----ECSSEEEEEEECCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT-TEECC
T ss_pred             HhCCCCCEeeeeeee-----ccCCEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-Ccccc
Confidence            578999999999998     44446899999998 6888877653    5789999999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccC-CCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      ||||+||+++.++ .+||+|||.+...... .......||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+
T Consensus       140 dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~  217 (294)
T 2rku_A          140 DLKLGNLFLNEDL-EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFET  217 (294)
T ss_dssp             CCCGGGEEECTTC-CEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTS-CBCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             CCChHhEEEcCCC-CEEEEeccCceecccCccccccccCCCCcCCcchhccC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999888 7999999999876432 223445789999999999654 489999999999999999999999988


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCC
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF  239 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~  239 (292)
                      ....+....+...                 ..            .++..+++.+.++|.+||..||++|||++++++|||
T Consensus       218 ~~~~~~~~~~~~~-----------------~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~  268 (294)
T 2rku_A          218 SCLKETYLRIKKN-----------------EY------------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEF  268 (294)
T ss_dssp             SSHHHHHHHHHTT-----------------CC------------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred             CCHHHHHHHHhhc-----------------cC------------CCccccCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence            7765544433221                 00            012457899999999999999999999999999999


Q ss_pred             ccccCCCC
Q 022799          240 FDELRDPN  247 (292)
Q Consensus       240 ~~~~~~~~  247 (292)
                      |.+...+.
T Consensus       269 ~~~~~~~~  276 (294)
T 2rku_A          269 FTSGYIPA  276 (294)
T ss_dssp             HHTSCCCS
T ss_pred             eecCCcCC
Confidence            99765544

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=6.4e-43  Score=312.05  Aligned_cols=207  Identities=31%  Similarity=0.515  Sum_probs=157.3

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      ++++||||+++++++     .+. ..++||||++ |+|.+.+..    ...+++..++.++.||+.||.|||++ ||+||
T Consensus       195 ~~l~hpniv~l~~~~-----~~~-~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivHr  263 (419)
T 3i6u_A          195 KKLNHPCIIKIKNFF-----DAE-DYYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHEN-GIIHR  263 (419)
T ss_dssp             HHCCCTTBCCCCEEE-----ESS-EEEEEEECCTTCBGGGGTSS----SCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCS
T ss_pred             HhCCCCCEeeEEEEE-----ecC-ceEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC-Ccccc
Confidence            568999999999987     222 2689999998 688776653    46799999999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCC--CcEEEeecCCccccccCCCcccccccccccCCccccC--CCCCCchhHhhhhhHHHHHHHhCCCC
Q 022799           81 DIKPQNLLVNPHT--HQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG--ATEYTAAIDIWSAGCVLAELLLGQPL  156 (292)
Q Consensus        81 dlkp~Nill~~~~--~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslG~il~el~~g~~p  156 (292)
                      ||||+||+++.++  ..+||+|||+++............||+.|+|||++.+  ...++.++|+||+||++|+|++|..|
T Consensus       264 Dlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~p  343 (419)
T 3i6u_A          264 DLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP  343 (419)
T ss_dssp             CCCGGGEEESSSSSSCCEEECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCS
T ss_pred             CCChHhEEEecCCCcceEEEeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCC
Confidence            9999999997543  2599999999988765555556789999999999853  34578999999999999999999999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      |.+......+...+......                        +.......+++.+.+||.+||+.||.+|||++++++
T Consensus       344 f~~~~~~~~~~~~i~~~~~~------------------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          344 FSEHRTQVSLKDQITSGKYN------------------------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             SCCCSSSCCHHHHHHTTCCC------------------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCCcchHHHHHHHhcCCCC------------------------CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            98755433333322211110                        001112468999999999999999999999999999


Q ss_pred             CCCcccc
Q 022799          237 HPFFDEL  243 (292)
Q Consensus       237 hp~~~~~  243 (292)
                      ||||++.
T Consensus       400 hp~~~~~  406 (419)
T 3i6u_A          400 HPWLQDE  406 (419)
T ss_dssp             SGGGCCH
T ss_pred             CcccCCh
Confidence            9999864

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.6e-43  Score=305.75  Aligned_cols=213  Identities=31%  Similarity=0.505  Sum_probs=167.4

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhc--------------------------------
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKM--------------------------------   48 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~--------------------------------   48 (292)
                      ++++||||+++++++     .+....++||||++ |+|.+++......                                
T Consensus        83 ~~l~hpniv~~~~~~-----~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (345)
T 3hko_A           83 KKLHHPNIARLYEVY-----EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGF  157 (345)
T ss_dssp             HHCCCTTBCCEEEEE-----ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--C
T ss_pred             HhCCCCCcceeehhh-----ccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccc
Confidence            467899999999998     44456999999997 6998887421110                                


Q ss_pred             ----CCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEeCCCC-cEEEeecCCccccccCC-----Ccccccc
Q 022799           49 ----SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH-QLKLCDFGSAKVLVKGE-----PNISYIC  118 (292)
Q Consensus        49 ----~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlkp~Nill~~~~~-~ikl~Dfg~a~~~~~~~-----~~~~~~g  118 (292)
                          ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++. .+||+|||++.......     ......|
T Consensus       158 ~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g  236 (345)
T 3hko_A          158 RESLDFVQREKLISNIMRQIFSALHYLHNQ-GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAG  236 (345)
T ss_dssp             EEECCHHHHHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CC
T ss_pred             cccccccccHHHHHHHHHHHHHHHHHHHHC-CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCC
Confidence                11246778899999999999999998 9999999999999976542 69999999998653322     1234578


Q ss_pred             cccccCCccccCC-CCCCchhHhhhhhHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCC
Q 022799          119 SRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK  197 (292)
Q Consensus       119 t~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (292)
                      |+.|+|||++.+. ..++.++|+|||||++|+|++|..||.+.+..+....+.........                   
T Consensus       237 t~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------------  297 (345)
T 3hko_A          237 TPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFEN-------------------  297 (345)
T ss_dssp             CGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTS-------------------
T ss_pred             CccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCC-------------------
Confidence            9999999998653 45899999999999999999999999988887777666552111110                   


Q ss_pred             CCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCCccccCC
Q 022799          198 AHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  245 (292)
Q Consensus       198 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~~~~~~~  245 (292)
                            .....+++.+.+||.+||..||.+|||+.++++||||+++.+
T Consensus       298 ------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~  339 (345)
T 3hko_A          298 ------PNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD  339 (345)
T ss_dssp             ------GGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSS
T ss_pred             ------cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccChH
Confidence                  011347899999999999999999999999999999998754

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=3e-42  Score=290.85  Aligned_cols=202  Identities=29%  Similarity=0.449  Sum_probs=160.6

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++.     +....++||||++ ++|.+++...    ..+++..+..++.||+.||.|||++ |++|
T Consensus        65 l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H  134 (276)
T 2h6d_A           65 LKLFRHPHIIKLYQVIS-----TPTDFFMVMEYVSGGELFDYICKH----GRVEEMEARRLFQQILSAVDYCHRH-MVVH  134 (276)
T ss_dssp             HHTCCCTTBCCEEEEEE-----CSSEEEEEEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH-CSSC
T ss_pred             HhcCCCCCEeEEEEEEe-----cCCeEEEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC-CCcc
Confidence            35689999999999983     3445899999997 6999988753    5689999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      |||||+||+++.++ .++|+|||.+.............+|+.|+|||.+.+....+.++|+||+||++|+|++|..||.+
T Consensus       135 ~dl~p~Nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~  213 (276)
T 2h6d_A          135 RDLKPENVLLDAHM-NAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD  213 (276)
T ss_dssp             CCCCGGGEEECTTS-CEEECCCCGGGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CCCChhhEEECCCC-CEEEeecccccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence            99999999999888 79999999998765554445567899999999997655457899999999999999999999987


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCC
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF  239 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~  239 (292)
                      .........+.....                             .++..+++.+.++|.+||..||.+|||+.++++|||
T Consensus       214 ~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~  264 (276)
T 2h6d_A          214 EHVPTLFKKIRGGVF-----------------------------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEW  264 (276)
T ss_dssp             SSHHHHHHHHHHCCC-----------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHH
T ss_pred             CcHHHHHHHhhcCcc-----------------------------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChh
Confidence            766555444432100                             012457889999999999999999999999999999


Q ss_pred             ccc
Q 022799          240 FDE  242 (292)
Q Consensus       240 ~~~  242 (292)
                      |++
T Consensus       265 ~~~  267 (276)
T 2h6d_A          265 FKQ  267 (276)
T ss_dssp             HHT
T ss_pred             hcc
Confidence            986

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=3e-42  Score=299.08  Aligned_cols=205  Identities=29%  Similarity=0.464  Sum_probs=171.2

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++     .+....++||||++ ++|.+++...    ..+++..++.++.||+.||.|||++ ||+|
T Consensus        95 l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~~~~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH  164 (335)
T 2owb_A           95 HRSLAHQHVVGFHGFF-----EDNDFVFVVLELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHRN-RVIH  164 (335)
T ss_dssp             HHTCCCTTBCCEEEEE-----ECSSEEEEEECCCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT-TEEC
T ss_pred             HHhCCCCCCCeEEEEE-----ecCCeEEEEEecCCCCCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC-CCEe
Confidence            3578999999999998     44456899999998 6888887653    5789999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccC-CCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      |||||+||+++.++ .+||+|||++...... .......||+.|+|||++.+. .++.++|+|||||++|+|++|..||.
T Consensus       165 ~dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~  242 (335)
T 2owb_A          165 RDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFE  242 (335)
T ss_dssp             SCCCGGGEEECTTC-CEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTS-CBCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred             cCCCchhEEEcCCC-CEEEeeccCceecccCcccccccCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHHHCcCCCC
Confidence            99999999999888 7999999999876432 233445789999999999765 48999999999999999999999998


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCC
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  238 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp  238 (292)
                      +....+....+....                 .            .++..+++.+.+||.+||..||.+|||++++++||
T Consensus       243 ~~~~~~~~~~~~~~~-----------------~------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~  293 (335)
T 2owb_A          243 TSCLKETYLRIKKNE-----------------Y------------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDE  293 (335)
T ss_dssp             CSSHHHHHHHHHHTC-----------------C------------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred             CCCHHHHHHHHhcCC-----------------C------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence            877665554443310                 0            01245789999999999999999999999999999


Q ss_pred             CccccCCC
Q 022799          239 FFDELRDP  246 (292)
Q Consensus       239 ~~~~~~~~  246 (292)
                      ||.+...+
T Consensus       294 ~~~~~~~~  301 (335)
T 2owb_A          294 FFTSGYIP  301 (335)
T ss_dssp             HHHTSCCC
T ss_pred             cccCCCcc
Confidence            99976544

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.6e-42  Score=299.79  Aligned_cols=208  Identities=25%  Similarity=0.374  Sum_probs=167.0

Q ss_pred             CCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCC
Q 022799            5 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIK   83 (292)
Q Consensus         5 ~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlk   83 (292)
                      .||||+++++++     .+...+++||||+. |+|.+++...  ....+++..++.++.||+.||.|||++ ||+|||||
T Consensus        87 ~~~~iv~~~~~~-----~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~L~~LH~~-givH~Dik  158 (327)
T 3lm5_A           87 SCPRVINLHEVY-----ENTSEIILILEYAAGGEIFSLCLPE--LAEMVSENDVIRLIKQILEGVYYLHQN-NIVHLDLK  158 (327)
T ss_dssp             TCTTBCCEEEEE-----ECSSEEEEEEECCTTEEGGGGGSSC--C-CCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCC
T ss_pred             CCCCEEEEEEEE-----EeCCeEEEEEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC-CeecCcCC
Confidence            579999999998     44445899999998 5887776432  236799999999999999999999998 99999999


Q ss_pred             CCcEEEeC---CCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCC
Q 022799           84 PQNLLVNP---HTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE  160 (292)
Q Consensus        84 p~Nill~~---~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  160 (292)
                      |+||+++.   ++ .+||+|||++.............||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+.
T Consensus       159 p~NIl~~~~~~~~-~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~  236 (327)
T 3lm5_A          159 PQNILLSSIYPLG-DIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYD-PITTATDMWNIGIIAYMLLTHTSPFVGE  236 (327)
T ss_dssp             GGGEEESCBTTBC-CEEECCGGGCEEC---------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             hHHEEEecCCCCC-cEEEeeCccccccCCccccccccCCcCccCCeeecCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            99999987   45 7999999999877555555566899999999999654 4899999999999999999999999988


Q ss_pred             CcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCCc
Q 022799          161 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  240 (292)
Q Consensus       161 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~~  240 (292)
                      +..+....+.......+..                         ....+++.+.++|.+||..||.+|||++++++||||
T Consensus       237 ~~~~~~~~i~~~~~~~~~~-------------------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~  291 (327)
T 3lm5_A          237 DNQETYLNISQVNVDYSEE-------------------------TFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWL  291 (327)
T ss_dssp             SHHHHHHHHHHTCCCCCTT-------------------------TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGG
T ss_pred             CchHHHHHHHhcccccCch-------------------------hhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhh
Confidence            8777666655432211110                         114578999999999999999999999999999999


Q ss_pred             cccCCCC
Q 022799          241 DELRDPN  247 (292)
Q Consensus       241 ~~~~~~~  247 (292)
                      ++.....
T Consensus       292 ~~~~~~~  298 (327)
T 3lm5_A          292 QQWDFEN  298 (327)
T ss_dssp             CCCCTTC
T ss_pred             ccccccc
Confidence            9876543

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.6e-42  Score=293.54  Aligned_cols=209  Identities=25%  Similarity=0.407  Sum_probs=168.9

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      ++++||||+++++++.     +....++||||++ ++|.+++...    ..+++..+..++.||+.||.|||++ |++||
T Consensus        63 ~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~  132 (283)
T 3bhy_A           63 REIRHPNIITLHDIFE-----NKTDVVLILELVSGGELFDFLAEK----ESLTEDEATQFLKQILDGVHYLHSK-RIAHF  132 (283)
T ss_dssp             HHCCCTTBCCEEEEEE-----CSSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TEECS
T ss_pred             HhCCCCCeeehhheec-----CCCeEEEEEeecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CccCC
Confidence            4678999999999984     3445899999997 7999988753    5689999999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCC---cEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCC
Q 022799           81 DIKPQNLLVNPHTH---QLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF  157 (292)
Q Consensus        81 dlkp~Nill~~~~~---~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf  157 (292)
                      ||||+||+++.++.   .++|+|||.+.............||+.|+|||++.+. .++.++|+||+||++|+|++|..||
T Consensus       133 dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~  211 (283)
T 3bhy_A          133 DLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPF  211 (283)
T ss_dssp             CCSGGGEEESCSSSSSCCEEECCCTTCEECC--------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             CCChHHEEEecCCCCCCceEEEecccceeccCCCcccccCCCcCccCcceecCC-CCCcchhhhhHHHHHHHHHHCCCCC
Confidence            99999999976552   5999999999877555444556789999999999654 4899999999999999999999999


Q ss_pred             CCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          158 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      .+....+....+........                         ......+++.+.++|.+||..||++|||+.++++|
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  266 (283)
T 3bhy_A          212 LGETKQETLTNISAVNYDFD-------------------------EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH  266 (283)
T ss_dssp             CCSSHHHHHHHHHTTCCCCC-------------------------HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred             CCcchHHHHHHhHhcccCCc-------------------------chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence            88876665555433211111                         11224678999999999999999999999999999


Q ss_pred             CCccccCCC
Q 022799          238 PFFDELRDP  246 (292)
Q Consensus       238 p~~~~~~~~  246 (292)
                      |||+.++..
T Consensus       267 ~~~~~~~~~  275 (283)
T 3bhy_A          267 SWIKAIRRR  275 (283)
T ss_dssp             HHHHHHHHC
T ss_pred             HHHHHHHHH
Confidence            999987644

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=4.7e-42  Score=303.06  Aligned_cols=228  Identities=31%  Similarity=0.562  Sum_probs=175.1

Q ss_pred             CCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCccccCCCC
Q 022799            6 HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN-TIGVCHRDIKP   84 (292)
Q Consensus         6 HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~-~~~i~H~dlkp   84 (292)
                      |++|+++++++..     ....|+||||++++|.+++....  ...+++..++.++.||+.||.|||+ ..||+||||||
T Consensus       115 ~~~iv~~~~~~~~-----~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp  187 (382)
T 2vx3_A          115 KYYIVHLKRHFMF-----RNHLCLVFEMLSYNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKP  187 (382)
T ss_dssp             GGGBCCEEEEEEE-----TTEEEEEEECCCCBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSG
T ss_pred             ceeEEEeeeeecc-----CCceEEEEecCCCCHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCc
Confidence            4469999998843     34589999999999999987642  2458999999999999999999994 23999999999


Q ss_pred             CcEEEeC--CCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCCCc
Q 022799           85 QNLLVNP--HTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG  162 (292)
Q Consensus        85 ~Nill~~--~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~  162 (292)
                      +||+++.  ++ .+||+|||+++....  ......||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+.+.
T Consensus       188 ~NIll~~~~~~-~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~  263 (382)
T 2vx3_A          188 ENILLCNPKRS-AIKIVDFGSSCQLGQ--RIYQYIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANE  263 (382)
T ss_dssp             GGEEESSTTSC-CEEECCCTTCEETTC--CCCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             ccEEEecCCCC-cEEEEeccCceeccc--ccccccCCccccChHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            9999954  44 799999999987633  33456889999999999765 489999999999999999999999999999


Q ss_pred             HHHHHHHHHHhCCCCHHHHhhcCCCC--------cccc----------CCCCCCCCchhhhcc-----------------
Q 022799          163 VDQLVEIIKVLGTPTREEIKCMNPNY--------TEFK----------FPQIKAHPWHKIFQK-----------------  207 (292)
Q Consensus       163 ~~~~~~i~~~~~~~~~~~~~~~~~~~--------~~~~----------~~~~~~~~~~~~~~~-----------------  207 (292)
                      .+.+..+.+..+.++...+.......        ..+.          +.......+...+..                 
T Consensus       264 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  343 (382)
T 2vx3_A          264 VDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTV  343 (382)
T ss_dssp             HHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCH
T ss_pred             HHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccc
Confidence            99999999999999877654321100        0000          000000011111100                 


Q ss_pred             CCChhHHHHHHHHhccCCCCcccHHHHhcCCCccccC
Q 022799          208 RMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  244 (292)
Q Consensus       208 ~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~~~~~~  244 (292)
                      ..++++++||.+||++||++|||++|+|+||||++..
T Consensus       344 ~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~~  380 (382)
T 2vx3_A          344 ADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTA  380 (382)
T ss_dssp             HHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC--
T ss_pred             hhhHHHHHHHHHhcCCChhhCCCHHHHhcCcccccCC
Confidence            0014789999999999999999999999999998753

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=3.9e-42  Score=295.33  Aligned_cols=212  Identities=25%  Similarity=0.399  Sum_probs=168.0

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++.... ......|+||||++ ++|.+++...    ..+++..+..++.||+.||.|||++ ||+|
T Consensus        66 l~~l~hp~iv~~~~~~~~~~-~~~~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH  139 (311)
T 3ork_A           66 AAALNHPAIVAVYDTGEAET-PAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN-GIIH  139 (311)
T ss_dssp             CCCCCCTTBCCEEEEEEEEE-TTEEEEEEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT-TCCC
T ss_pred             HHcCCCCCcceEEEeeeccC-CCCcccEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CCCc
Confidence            57889999999999885443 23345689999997 6999988753    5799999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCC----cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQP  155 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~  155 (292)
                      |||||+||+++.++ .+||+|||++........    .....||+.|+|||++.+. .++.++|+||+||++|+|++|..
T Consensus       140 ~dlkp~Nil~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~  217 (311)
T 3ork_A          140 RDVKPANIMISATN-AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEP  217 (311)
T ss_dssp             CCCCGGGEEEETTS-CEEECCCSCC------------------CCTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSC
T ss_pred             CCCCHHHEEEcCCC-CEEEeeccCcccccccccccccccccCcCcccCCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCC
Confidence            99999999999888 799999999986543321    2235689999999999765 48999999999999999999999


Q ss_pred             CCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHh
Q 022799          156 LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL  235 (292)
Q Consensus       156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l  235 (292)
                      ||.+.+.......+......++.                         .....+++++.++|.+||..||.+||++.+++
T Consensus       218 pf~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l  272 (311)
T 3ork_A          218 PFTGDSPVSVAYQHVREDPIPPS-------------------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEM  272 (311)
T ss_dssp             SCCCSSHHHHHHHHHHCCCCCHH-------------------------HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHH
T ss_pred             CCCCCChHHHHHHHhcCCCCCcc-------------------------cccCCCCHHHHHHHHHHHhcCHhhChhhHHHH
Confidence            99988877666655543222111                         11246899999999999999999999999999


Q ss_pred             cCCCccccCC
Q 022799          236 IHPFFDELRD  245 (292)
Q Consensus       236 ~hp~~~~~~~  245 (292)
                      .|+|++....
T Consensus       273 ~~~l~~~~~~  282 (311)
T 3ork_A          273 RADLVRVHNG  282 (311)
T ss_dssp             HHHHHHHHTT
T ss_pred             HHHHHHHhcC
Confidence            9999986554

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=4.8e-42  Score=295.16  Aligned_cols=206  Identities=28%  Similarity=0.405  Sum_probs=156.4

Q ss_pred             CCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCC
Q 022799            4 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDI   82 (292)
Q Consensus         4 l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dl   82 (292)
                      ++||||+++++++..     ...+|+||||++ |+|.+++...    ..+++..++.++.||+.||.|||++ ||+||||
T Consensus        68 ~~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dl  137 (316)
T 2ac3_A           68 QGHRNVLELIEFFEE-----EDRFYLVFEKMRGGSILSHIHKR----RHFNELEASVVVQDVASALDFLHNK-GIAHRDL  137 (316)
T ss_dssp             CCCTTBCCEEEEEEE-----TTEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCC
T ss_pred             cCCCCeeeEEEEEee-----CCEEEEEEEcCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCC
Confidence            579999999999843     345899999998 7999988763    5689999999999999999999998 9999999


Q ss_pred             CCCcEEEeCCCC--cEEEeecCCccccccCC--------CcccccccccccCCccccCC----CCCCchhHhhhhhHHHH
Q 022799           83 KPQNLLVNPHTH--QLKLCDFGSAKVLVKGE--------PNISYICSRYYRAPELIFGA----TEYTAAIDIWSAGCVLA  148 (292)
Q Consensus        83 kp~Nill~~~~~--~ikl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~----~~~~~~~DvwslG~il~  148 (292)
                      ||+||+++.++.  .+||+|||++.......        ......||+.|+|||++.+.    ..++.++|+||+||++|
T Consensus       138 kp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~  217 (316)
T 2ac3_A          138 KPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILY  217 (316)
T ss_dssp             CGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHH
T ss_pred             CHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHH
Confidence            999999987652  39999999987653221        12234689999999998541    23788999999999999


Q ss_pred             HHHhCCCCCCCCCcHH---------------HHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhH
Q 022799          149 ELLLGQPLFPGESGVD---------------QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEA  213 (292)
Q Consensus       149 el~~g~~pf~~~~~~~---------------~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  213 (292)
                      +|++|..||.+....+               ....+.......                         .......+++.+
T Consensus       218 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-------------------------~~~~~~~~~~~~  272 (316)
T 2ac3_A          218 ILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEF-------------------------PDKDWAHISCAA  272 (316)
T ss_dssp             HHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCC-------------------------CHHHHTTSCHHH
T ss_pred             HHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCccc-------------------------CchhcccCCHHH
Confidence            9999999998754311               111221110000                         001113578999


Q ss_pred             HHHHHHHhccCCCCcccHHHHhcCCCccccC
Q 022799          214 VDLVSRLLQYSPNLRSTALEALIHPFFDELR  244 (292)
Q Consensus       214 ~~li~~~l~~dp~~R~t~~e~l~hp~~~~~~  244 (292)
                      ++||.+||..||.+|||++++++||||++..
T Consensus       273 ~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~  303 (316)
T 2ac3_A          273 KDLISKLLVRDAKQRLSAAQVLQHPWVQGCA  303 (316)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred             HHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence            9999999999999999999999999999764

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=5.6e-42  Score=292.31  Aligned_cols=205  Identities=28%  Similarity=0.424  Sum_probs=170.6

Q ss_pred             CCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCC
Q 022799            5 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIK   83 (292)
Q Consensus         5 ~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlk   83 (292)
                      +||||+++++++     .+....++||||++ ++|.+++...    ..+++..+..++.||+.||.|||++ |++|||||
T Consensus        82 ~h~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~  151 (298)
T 1phk_A           82 GHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKL-NIVHRDLK  151 (298)
T ss_dssp             TCTTBCCEEEEE-----ECSSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCS
T ss_pred             CCCCEeeeeeee-----ccCCeEEEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCC
Confidence            499999999998     44456899999998 6999988753    5689999999999999999999988 99999999


Q ss_pred             CCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCcccc-----CCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           84 PQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF-----GATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        84 p~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      |+||+++.++ .++|+|||.+.............||+.|+|||++.     ....++.++|+||+||++|+|++|..||.
T Consensus       152 p~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~  230 (298)
T 1phk_A          152 PENILLDDDM-NIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW  230 (298)
T ss_dssp             GGGEEECTTC-CEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             cceEEEcCCC-cEEEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCc
Confidence            9999999888 79999999998776555555677899999999985     23457899999999999999999999998


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCC
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  238 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp  238 (292)
                      +.+.......+.........                         .....+++.+.++|.+||..||.+|||+.++++||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~  285 (298)
T 1phk_A          231 HRKQMLMLRMIMSGNYQFGS-------------------------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHP  285 (298)
T ss_dssp             CSSHHHHHHHHHHTCCCCCT-------------------------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSG
T ss_pred             CccHHHHHHHHhcCCcccCc-------------------------ccccccCHHHHHHHHHHccCCcccCCCHHHHHhCh
Confidence            87766655555442111100                         01135789999999999999999999999999999


Q ss_pred             CccccCC
Q 022799          239 FFDELRD  245 (292)
Q Consensus       239 ~~~~~~~  245 (292)
                      ||++...
T Consensus       286 ~~~~~~~  292 (298)
T 1phk_A          286 FFQQYVV  292 (298)
T ss_dssp             GGCTTC-
T ss_pred             Hhhhccc
Confidence            9997654

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.6e-41  Score=290.39  Aligned_cols=210  Identities=27%  Similarity=0.447  Sum_probs=170.0

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      |++++||||+++++++...   +....++||||++++|.+.+....  ...+++..+..++.||+.||.|||++ ||+||
T Consensus        60 l~~l~h~~i~~~~~~~~~~---~~~~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~-~i~H~  133 (305)
T 2wtk_C           60 LRRLRHKNVIQLVDVLYNE---EKQKMYMVMEYCVCGMQEMLDSVP--EKRFPVCQAHGYFCQLIDGLEYLHSQ-GIVHK  133 (305)
T ss_dssp             HTTCCCTTBCCEEEEEECC------CEEEEEECCSEEHHHHHHHST--TCSCCHHHHHHHHHHHHHHHHHHHHT-TEECS
T ss_pred             HHhcCCCCeeEEEEEEEcC---CCCeEEEEehhccCCHHHHHHhCc--ccccCHHHHHHHHHHHHHHHHHHHHC-Ceeec
Confidence            4678999999999987532   233589999999988888776532  45799999999999999999999998 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCC---CcccccccccccCCccccCCC-CCCchhHhhhhhHHHHHHHhCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGAT-EYTAAIDIWSAGCVLAELLLGQPL  156 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwslG~il~el~~g~~p  156 (292)
                      ||||+||+++.++ .++|+|||.+.......   ......||+.|+|||++.+.. .++.++|+||+||++|+|++|..|
T Consensus       134 dlkp~NIl~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p  212 (305)
T 2wtk_C          134 DIKPGNLLLTTGG-TLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP  212 (305)
T ss_dssp             CCSGGGEEECTTC-CEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCS
T ss_pred             CCCcccEEEcCCC-cEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCC
Confidence            9999999999888 79999999998654321   223456899999999986543 247899999999999999999999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      |.+.+.......+....                 .            .++..+++.+.++|.+||..||.+|||+.++++
T Consensus       213 ~~~~~~~~~~~~i~~~~-----------------~------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  263 (305)
T 2wtk_C          213 FEGDNIYKLFENIGKGS-----------------Y------------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ  263 (305)
T ss_dssp             CCCSSHHHHHHHHHHCC-----------------C------------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CCCchHHHHHHHHhcCC-----------------C------------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            98877665555443310                 0            012457899999999999999999999999999


Q ss_pred             CCCccccCCC
Q 022799          237 HPFFDELRDP  246 (292)
Q Consensus       237 hp~~~~~~~~  246 (292)
                      ||||+.....
T Consensus       264 ~~~~~~~~~~  273 (305)
T 2wtk_C          264 HSWFRKKHPP  273 (305)
T ss_dssp             SHHHHSCCCC
T ss_pred             CcccccCCCC
Confidence            9999976544

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=9e-42  Score=291.48  Aligned_cols=219  Identities=26%  Similarity=0.401  Sum_probs=164.6

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhh----cCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYK----MSQRMPLIYVKLYFYQICRALAYIHNTI   75 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~----~~~~~~~~~~~~~~~qil~al~~LH~~~   75 (292)
                      |++++||||+++++++...     ...++||||++ ++|.+++.....    ....+++..+..++.||+.||.|||++ 
T Consensus        67 l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-  140 (303)
T 2vwi_A           67 MSQCHHPNIVSYYTSFVVK-----DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN-  140 (303)
T ss_dssp             CCCCCCTTBCCEEEEEESS-----SCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HhhcCCCCEeeEEEEEeec-----CCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence            5678999999999998443     34899999997 699998875322    235589999999999999999999988 


Q ss_pred             CccccCCCCCcEEEeCCCCcEEEeecCCccccccCC------CcccccccccccCCccccCCCCCCchhHhhhhhHHHHH
Q 022799           76 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE------PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAE  149 (292)
Q Consensus        76 ~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~e  149 (292)
                      ||+||||||+||+++.++ .++|+|||.+.......      ......||+.|+|||++.+...++.++|+||+||++|+
T Consensus       141 ~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~  219 (303)
T 2vwi_A          141 GQIHRDVKAGNILLGEDG-SVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIE  219 (303)
T ss_dssp             TCCCCCCSGGGEEECTTC-CEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHH
T ss_pred             CCCCCCCChhhEEEcCCC-CEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHH
Confidence            999999999999999888 79999999987653321      12345689999999998654458999999999999999


Q ss_pred             HHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcc
Q 022799          150 LLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS  229 (292)
Q Consensus       150 l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~  229 (292)
                      |++|..||.+..............  +.         ..        ............+++++.++|.+||..||.+||
T Consensus       220 l~~g~~pf~~~~~~~~~~~~~~~~--~~---------~~--------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp  280 (303)
T 2vwi_A          220 LATGAAPYHKYPPMKVLMLTLQND--PP---------SL--------ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRP  280 (303)
T ss_dssp             HHHSSCTTTTSCGGGHHHHHHTSS--CC---------CT--------TC-----CCCCCCCHHHHHHHHHHCCSSGGGSC
T ss_pred             HHhCCCCCccCchhhHHHHHhccC--CC---------cc--------ccccccchhhhhhhHHHHHHHHHHccCChhhCc
Confidence            999999998877665544332211  00         00        000000112246889999999999999999999


Q ss_pred             cHHHHhcCCCccccCC
Q 022799          230 TALEALIHPFFDELRD  245 (292)
Q Consensus       230 t~~e~l~hp~~~~~~~  245 (292)
                      |+.++++||||++...
T Consensus       281 s~~~ll~h~~~~~~~~  296 (303)
T 2vwi_A          281 TAAELLRHKFFQKAKN  296 (303)
T ss_dssp             CHHHHHTSTTC-----
T ss_pred             CHHHHhhChhhhcCCC
Confidence            9999999999997653

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.2e-41  Score=294.19  Aligned_cols=185  Identities=24%  Similarity=0.399  Sum_probs=142.9

Q ss_pred             eeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEeCCCCcEEEeecCC
Q 022799           25 LYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGS  103 (292)
Q Consensus        25 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~  103 (292)
                      .++++|||||+ ++|.+++..... ....++..+..++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+
T Consensus       134 ~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~-~~kL~DfG~  210 (332)
T 3qd2_B          134 VYLYIQMQLCRKENLKDWMNRRCS-LEDREHGVCLHIFIQIAEAVEFLHSK-GLMHRDLKPSNIFFTMDD-VVKVGDFGL  210 (332)
T ss_dssp             CEEEEEEECCCSSCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTC-CEEECCCTT
T ss_pred             ceEEEEEEecCCCCHHHHHhcccC-ccchhhHHHHHHHHHHHHHHHHHHhC-CeeecCCCcccEEEeCCC-CEEEeecCc
Confidence            35899999998 599998876432 23456677899999999999999988 999999999999999888 799999999


Q ss_pred             ccccccCC-------------CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCCCcHHHHHHHH
Q 022799          104 AKVLVKGE-------------PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII  170 (292)
Q Consensus       104 a~~~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~i~  170 (292)
                      ++......             ......||+.|+|||++.+. .++.++|+||+||++|+|++|..|+..     ....+.
T Consensus       211 a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~  284 (332)
T 3qd2_B          211 VTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGN-NYSHKVDIFSLGLILFELLYSFSTQME-----RVRIIT  284 (332)
T ss_dssp             CEECSCC--------------CCCSCC-CGGGSCHHHHHCC-CCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHH
T ss_pred             ccccccchhhccccccccccccccccCCCcCccChHHhcCC-CCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHH
Confidence            98765432             12335689999999999765 489999999999999999998766421     111111


Q ss_pred             HHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCCcccc
Q 022799          171 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  243 (292)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~~~~~  243 (292)
                      .........                         .....++++.+||.+||..||.+|||+.++++||||+++
T Consensus       285 ~~~~~~~~~-------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~  332 (332)
T 3qd2_B          285 DVRNLKFPL-------------------------LFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL  332 (332)
T ss_dssp             HHHTTCCCH-------------------------HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred             HhhccCCCc-------------------------ccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence            111100000                         112357788999999999999999999999999999864

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=7.8e-44  Score=313.90  Aligned_cols=206  Identities=17%  Similarity=0.227  Sum_probs=157.1

Q ss_pred             CCCCCCCCeeeec-------eeeeccC---------CCCce---eEEEEeecccCCHHHHHHhhhhcCC---CCCHHHHH
Q 022799            1 MRLLDHPNVVSLK-------HCFFSTT---------EKDEL---YLNLVLEYVPETVHRVIKHHYKMSQ---RMPLIYVK   58 (292)
Q Consensus         1 L~~l~HpnIv~~~-------~~~~~~~---------~~~~~---~~~lv~e~~~g~L~~~l~~~~~~~~---~~~~~~~~   58 (292)
                      |+.++|||||+++       +++....         +.+..   ..|+||||++|+|.+++........   .+++..+.
T Consensus       130 l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~  209 (377)
T 3byv_A          130 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARL  209 (377)
T ss_dssp             STTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHH
T ss_pred             ccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHH
Confidence            4677999999998       4432221         11111   3789999999999999986532211   23357888


Q ss_pred             HHHHHHHHHHHHHHhcCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCC-------
Q 022799           59 LYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA-------  131 (292)
Q Consensus        59 ~~~~qil~al~~LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-------  131 (292)
                      .++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+++...  .......| +.|+|||++.+.       
T Consensus       210 ~i~~qi~~aL~~LH~~-~ivHrDikp~NIll~~~~-~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~  284 (377)
T 3byv_A          210 QLTLQVIRLLASLHHY-GLVHTYLRPVDIVLDQRG-GVFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHR  284 (377)
T ss_dssp             HHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTC-CEEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHH
T ss_pred             HHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCC-CEEEEechhheecC--CcccCCCC-cCccChhhhcccccccccc
Confidence            8999999999999998 999999999999999888 79999999998642  23345567 999999999765       


Q ss_pred             ---CCCCchhHhhhhhHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccC
Q 022799          132 ---TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKR  208 (292)
Q Consensus       132 ---~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  208 (292)
                         ..++.++|+|||||++|+|++|..||.+.+.......+.                       .          ....
T Consensus       285 ~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~-----------------------~----------~~~~  331 (377)
T 3byv_A          285 DRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIF-----------------------R----------SCKN  331 (377)
T ss_dssp             CCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGGG-----------------------S----------SCCC
T ss_pred             cccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhhh-----------------------h----------hccC
Confidence               248999999999999999999999997544221110000                       0          0146


Q ss_pred             CChhHHHHHHHHhccCCCCcccHHHHhcCCCccccC
Q 022799          209 MPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  244 (292)
Q Consensus       209 ~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~~~~~~  244 (292)
                      +++++.+||.+||..||.+|||+.++++||||+++.
T Consensus       332 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~  367 (377)
T 3byv_A          332 IPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR  367 (377)
T ss_dssp             CCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHH
Confidence            899999999999999999999999999999999865

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.1e-42  Score=291.16  Aligned_cols=204  Identities=28%  Similarity=0.496  Sum_probs=144.8

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++     .+....++||||++ ++|.+++...   ...+++..++.++.|++.||.|||++ ||+|
T Consensus        65 l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H  135 (278)
T 3cok_A           65 HCQLKHPSILELYNYF-----EDSNYVYLVLEMCHNGEMNRYLKNR---VKPFSENEARHFMHQIITGMLYLHSH-GILH  135 (278)
T ss_dssp             HTTBCCTTBCCEEEEE-----ECSSEEEEEEECCTTEEHHHHHHTC---SSCCCHHHHHHHHHHHHHHHHHHHHT-TEEC
T ss_pred             HHhCCCCCeEeEEEEE-----ccCCeEEEEEecCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC-Ceec
Confidence            3678999999999998     44456899999998 6998888753   35789999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccC-CCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      |||||+||+++.++ .++|+|||.+...... .......||+.|+|||++.+. .++.++|+||+||++|+|++|..||.
T Consensus       136 ~dl~p~Nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~  213 (278)
T 3cok_A          136 RDLTLSNLLLTRNM-NIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRS-AHGLESDVWSLGCMFYTLLIGRPPFD  213 (278)
T ss_dssp             SSCCGGGEEECTTC-CEEECCCTTCEECC-----------------------------CTHHHHHHHHHHHHHHSSCSSC
T ss_pred             CCCCHHHEEEcCCC-CEEEEeecceeeccCCCCcceeccCCCCcCCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            99999999999888 7999999999865432 223345789999999999654 48999999999999999999999997


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCC
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  238 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp  238 (292)
                      ..........+..                 ...            ..+..++.++.++|.+||..||++|||++++++||
T Consensus       214 ~~~~~~~~~~~~~-----------------~~~------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~  264 (278)
T 3cok_A          214 TDTVKNTLNKVVL-----------------ADY------------EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHP  264 (278)
T ss_dssp             CCSCC-----CCS-----------------SCC------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTST
T ss_pred             ChhHHHHHHHHhh-----------------ccc------------CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCc
Confidence            6554322211100                 000            12245789999999999999999999999999999


Q ss_pred             CccccC
Q 022799          239 FFDELR  244 (292)
Q Consensus       239 ~~~~~~  244 (292)
                      ||.+..
T Consensus       265 ~~~~~~  270 (278)
T 3cok_A          265 FMSRNS  270 (278)
T ss_dssp             TTC---
T ss_pred             cccCCC
Confidence            998643

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=9.5e-42  Score=301.97  Aligned_cols=232  Identities=28%  Similarity=0.430  Sum_probs=177.4

Q ss_pred             CCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCC
Q 022799            5 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKP   84 (292)
Q Consensus         5 ~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlkp   84 (292)
                      .||||+++++++.... .+..++|+||||++++|.+.+....  ...+++..++.++.||+.||.|||++.||+||||||
T Consensus        99 ~~~~iv~~~~~~~~~~-~~~~~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp  175 (397)
T 1wak_A           99 NREMVVQLLDDFKISG-VNGTHICMVFEVLGHHLLKWIIKSN--YQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKP  175 (397)
T ss_dssp             GGGGBCCEEEEEEEEE-TTEEEEEEEECCCCCBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSG
T ss_pred             CcceeeeeecceeecC-CCCceEEEEEeccCccHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCH
Confidence            4889999999885332 2455799999999998888876531  256999999999999999999999744999999999


Q ss_pred             CcEEEeCCC------------------------------------------------CcEEEeecCCccccccCCCcccc
Q 022799           85 QNLLVNPHT------------------------------------------------HQLKLCDFGSAKVLVKGEPNISY  116 (292)
Q Consensus        85 ~Nill~~~~------------------------------------------------~~ikl~Dfg~a~~~~~~~~~~~~  116 (292)
                      +|||++.++                                                ..+||+|||.+......  ....
T Consensus       176 ~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~  253 (397)
T 1wak_A          176 ENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTED  253 (397)
T ss_dssp             GGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSC
T ss_pred             HHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccC
Confidence            999998664                                                26999999999876432  3456


Q ss_pred             cccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCCC------cHHHHHHHHHHhCCCCHHHHhhcCCCCcc
Q 022799          117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGES------GVDQLVEIIKVLGTPTREEIKCMNPNYTE  190 (292)
Q Consensus       117 ~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  190 (292)
                      .||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+      ..+.+..+.+..+.++...+.........
T Consensus       254 ~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~  332 (397)
T 1wak_A          254 IQTRQYRSLEVLIGSG-YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEF  332 (397)
T ss_dssp             CSCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGT
T ss_pred             CCCCcccCChhhcCCC-CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccc
Confidence            7899999999997754 8999999999999999999999997655      45677888888998887765432211100


Q ss_pred             cc-------CCCCCCCCchh------hhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCCccc
Q 022799          191 FK-------FPQIKAHPWHK------IFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  242 (292)
Q Consensus       191 ~~-------~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~~~~  242 (292)
                      +.       ...........      .++...++.+.+||.+||+.||++|||++|+|+||||++
T Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          333 FTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             BCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             cCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence            00       00000000000      011234567899999999999999999999999999974

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=8.7e-42  Score=292.15  Aligned_cols=204  Identities=28%  Similarity=0.435  Sum_probs=168.3

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      +.++||||+++++++     .+....++||||++ ++|.+.+...    +.+++..+..++.||+.||.|||++ ||+||
T Consensus        61 ~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~  130 (304)
T 2jam_A           61 KKIKHENIVTLEDIY-----ESTTHYYLVMQLVSGGELFDRILER----GVYTEKDASLVIQQVLSAVKYLHEN-GIVHR  130 (304)
T ss_dssp             HHCCCTTBCCEEEEE-----ECSSEEEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCC
T ss_pred             HhCCCCCeeehhhhc-----ccCCEEEEEEEcCCCccHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-Ccccc
Confidence            467999999999998     44445899999998 6998888653    5689999999999999999999998 99999


Q ss_pred             CCCCCcEEE---eCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCC
Q 022799           81 DIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF  157 (292)
Q Consensus        81 dlkp~Nill---~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf  157 (292)
                      ||||+||++   +.++ .++|+|||++...... ......||+.|+|||++.+. .++.++|+||+||++|+|++|..||
T Consensus       131 dikp~NIl~~~~~~~~-~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf  207 (304)
T 2jam_A          131 DLKPENLLYLTPEENS-KIMITDFGLSKMEQNG-IMSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVITYILLCGYPPF  207 (304)
T ss_dssp             SCCGGGCEESSSSTTC-CEEBCSCSTTCCCCCB-TTHHHHSCCCBCCTTTBSSC-SCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             CCCHHHEEEecCCCCC-CEEEccCCcceecCCC-ccccccCCCCccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCC
Confidence            999999999   5555 7999999998754322 23445789999999999664 4899999999999999999999999


Q ss_pred             CCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          158 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      .+.........+.+.....                         ...+...+++.+.++|.+||..||++|||++++++|
T Consensus       208 ~~~~~~~~~~~i~~~~~~~-------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (304)
T 2jam_A          208 YEETESKLFEKIKEGYYEF-------------------------ESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH  262 (304)
T ss_dssp             TTSCHHHHHHHHHHCCCCC-------------------------CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             CCCCHHHHHHHHHcCCCCC-------------------------CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            8887766665554421100                         011224688999999999999999999999999999


Q ss_pred             CCcccc
Q 022799          238 PFFDEL  243 (292)
Q Consensus       238 p~~~~~  243 (292)
                      |||++.
T Consensus       263 ~~~~~~  268 (304)
T 2jam_A          263 PWIDGN  268 (304)
T ss_dssp             HHHHSS
T ss_pred             ccccCC
Confidence            999864

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=9.1e-42  Score=289.20  Aligned_cols=201  Identities=29%  Similarity=0.501  Sum_probs=168.8

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      +.++||||+++++++     .+....++||||++ ++|.+.+...    ..+++..+..++.||+.||.|||++ ||+||
T Consensus        69 ~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~  138 (284)
T 2vgo_A           69 SHLRHPNILRMYNYF-----HDRKRIYLMLEFAPRGELYKELQKH----GRFDEQRSATFMEELADALHYCHER-KVIHR  138 (284)
T ss_dssp             HTCCCTTBCCEEEEE-----ECSSEEEEEECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT-TEECC
T ss_pred             hcCCCCCEeeEEEEE-----EcCCEEEEEEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-Cceec
Confidence            578999999999998     34445899999998 5999988753    5689999999999999999999987 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE  160 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  160 (292)
                      ||||+||+++.++ .++|+|||++...... ......||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+.
T Consensus       139 dl~p~Nil~~~~~-~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~  215 (284)
T 2vgo_A          139 DIKPENLLMGYKG-ELKIADFGWSVHAPSL-RRRTMCGTLDYLPPEMIEGK-THDEKVDLWCAGVLCYEFLVGMPPFDSP  215 (284)
T ss_dssp             CCSGGGEEECTTC-CEEECCCTTCEECSSS-CBCCCCSCGGGCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             CCCHHHEEEcCCC-CEEEecccccccCccc-ccccccCCCCcCCHHHhccC-CCCcccchhhHHHHHHHHHHCCCCCCCC
Confidence            9999999999888 7999999998765332 23456789999999999764 4899999999999999999999999887


Q ss_pred             CcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCCc
Q 022799          161 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  240 (292)
Q Consensus       161 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~~  240 (292)
                      +..+....+...                 ..            .++..+++.++++|.+||..||.+|||++++++||||
T Consensus       216 ~~~~~~~~~~~~-----------------~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~  266 (284)
T 2vgo_A          216 SHTETHRRIVNV-----------------DL------------KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWV  266 (284)
T ss_dssp             SHHHHHHHHHTT-----------------CC------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHH
T ss_pred             CHhHHHHHHhcc-----------------cc------------CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHH
Confidence            766554444321                 00            0224578999999999999999999999999999999


Q ss_pred             cccC
Q 022799          241 DELR  244 (292)
Q Consensus       241 ~~~~  244 (292)
                      +...
T Consensus       267 ~~~~  270 (284)
T 2vgo_A          267 KANS  270 (284)
T ss_dssp             HHHC
T ss_pred             Hhhc
Confidence            9754

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=4.8e-41  Score=291.14  Aligned_cols=230  Identities=28%  Similarity=0.506  Sum_probs=178.9

Q ss_pred             CCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCC
Q 022799            4 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIK   83 (292)
Q Consensus         4 l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlk   83 (292)
                      ..|++|+++++++     .+..++++||||++++|.+++....  ...+++..++.++.||+.||.|||++ ||+|||||
T Consensus        74 ~~~~~i~~~~~~~-----~~~~~~~lv~e~~~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlk  145 (339)
T 1z57_A           74 NSTFRCVQMLEWF-----EHHGHICIVFELLGLSTYDFIKENG--FLPFRLDHIRKMAYQICKSVNFLHSN-KLTHTDLK  145 (339)
T ss_dssp             TCTTCBCCEEEEE-----EETTEEEEEEECCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCC
T ss_pred             CCceeeEeeeccc-----ccCCcEEEEEcCCCCCHHHHHHhcC--CCCCcHHHHHHHHHHHHHHHHHHHHC-CCcCCCCC
Confidence            3567799999998     3344699999999999999887532  24689999999999999999999998 99999999


Q ss_pred             CCcEEEeC-------------------CCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhh
Q 022799           84 PQNLLVNP-------------------HTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAG  144 (292)
Q Consensus        84 p~Nill~~-------------------~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG  144 (292)
                      |+||+++.                   ++ .+||+|||++.....  ......||+.|+|||++.+. .++.++|+||+|
T Consensus       146 p~Nil~~~~~~~~~~~~~~~~~~~~~~~~-~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG  221 (339)
T 1z57_A          146 PENILFVQSDYTEAYNPKIKRDERTLINP-DIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILAL-GWSQPCDVWSIG  221 (339)
T ss_dssp             GGGEEESCCCEEEEEC----CEEEEESCC-CEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTS-CCCTHHHHHHHH
T ss_pred             HHHEEEeccccccccCCccccccccccCC-CceEeeCcccccCcc--ccccccCCccccChHHhhCC-CCCcchhhHHHH
Confidence            99999976                   34 699999999986532  33456789999999999764 489999999999


Q ss_pred             HHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCc----cccCCCCC---------CCCchh--hhccCC
Q 022799          145 CVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT----EFKFPQIK---------AHPWHK--IFQKRM  209 (292)
Q Consensus       145 ~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~----~~~~~~~~---------~~~~~~--~~~~~~  209 (292)
                      |++|+|++|..||.+.+..+....+.+..+..+...+........    ...+....         ......  ......
T Consensus       222 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (339)
T 1z57_A          222 CILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVE  301 (339)
T ss_dssp             HHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHH
T ss_pred             HHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhh
Confidence            999999999999999998888888888888888766554321100    00000000         000000  001123


Q ss_pred             ChhHHHHHHHHhccCCCCcccHHHHhcCCCccccCC
Q 022799          210 PPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  245 (292)
Q Consensus       210 ~~~~~~li~~~l~~dp~~R~t~~e~l~hp~~~~~~~  245 (292)
                      ++++.+||.+||..||.+|||+.|+++||||+.++.
T Consensus       302 ~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  337 (339)
T 1z57_A          302 HERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKK  337 (339)
T ss_dssp             HHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGGGC
T ss_pred             HHHHHHHHHHHhCcCcccccCHHHHhcCHHHHHHhc
Confidence            567899999999999999999999999999998753

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2.6e-42  Score=303.50  Aligned_cols=194  Identities=16%  Similarity=0.161  Sum_probs=147.0

Q ss_pred             eeEEEEeecccCCHHHHHHhhhhcCCCCCHHHH------HHHHHHHHHHHHHHHhcCCccccCCCCCcEEEeCCCCcEEE
Q 022799           25 LYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV------KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKL   98 (292)
Q Consensus        25 ~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~------~~~~~qil~al~~LH~~~~i~H~dlkp~Nill~~~~~~ikl   98 (292)
                      ..+|+||||++|+|.+++.....   .++....      ..++.||+.||.|||++ ||+||||||+|||++.++ .+||
T Consensus       161 ~~~~lv~e~~~~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~-~ivHrDikp~NIll~~~~-~~kL  235 (371)
T 3q60_A          161 ANYLLLMPAASVDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAANLQSK-GLVHGHFTPDNLFIMPDG-RLML  235 (371)
T ss_dssp             EEEEEEECCCSEEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT-TEEETTCSGGGEEECTTS-CEEE
T ss_pred             eeEEEEecCCCCCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHHHHHHC-CCccCcCCHHHEEECCCC-CEEE
Confidence            45899999999999999986522   2333334      56669999999999988 999999999999999988 7999


Q ss_pred             eecCCccccccCCCcccccccccccCCccccCC-CCCCchhHhhhhhHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 022799           99 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT  177 (292)
Q Consensus        99 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  177 (292)
                      +|||+++....  ......+|+.|+|||++.+. ..++.++|+||+||++|+|++|..||.+.....             
T Consensus       236 ~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-------------  300 (371)
T 3q60_A          236 GDVSALWKVGT--RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI-------------  300 (371)
T ss_dssp             CCGGGEEETTC--EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTC-------------
T ss_pred             EecceeeecCC--CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCccc-------------
Confidence            99999986532  22245678999999999652 358999999999999999999999997664211             


Q ss_pred             HHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCCccccCC
Q 022799          178 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  245 (292)
Q Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~~~~~~~  245 (292)
                             ...+....................+++.+.+||.+||+.||++|||+.++++||||+++.+
T Consensus       301 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~  361 (371)
T 3q60_A          301 -------KGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQN  361 (371)
T ss_dssp             -------TTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHH
T ss_pred             -------ccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHH
Confidence                   0001110001111111111112478999999999999999999999999999999998753

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=7.3e-42  Score=288.36  Aligned_cols=206  Identities=27%  Similarity=0.377  Sum_probs=164.6

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      +.++||||+++++++.     +....++||||++ ++|.+++..    ...+++..+..++.||+.||.|||++ |++||
T Consensus        60 ~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~  129 (276)
T 2yex_A           60 KMLNHENVVKFYGHRR-----EGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI-GITHR  129 (276)
T ss_dssp             HTCCCTTBCCEEEEEE-----ETTEEEEEEECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT-TEECS
T ss_pred             HhcCCCCceeeeeEEE-----cCCEEEEEEEecCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhC-Ceecc
Confidence            5689999999999984     3445899999998 588877653    35689999999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCC---CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF  157 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf  157 (292)
                      ||||+||+++.++ .++|+|||.+.......   ......||+.|+|||++.+...++.++|+||+||++|+|++|..||
T Consensus       130 dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~  208 (276)
T 2yex_A          130 DIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW  208 (276)
T ss_dssp             CCSGGGEEECTTC-CEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCC
T ss_pred             CCChHHEEEccCC-CEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCC
Confidence            9999999999888 79999999997653322   2334578999999999976554578999999999999999999999


Q ss_pred             CCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          158 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      .+...............           .     ..     .     ....+++.+.++|.+||..||++|||++++++|
T Consensus       209 ~~~~~~~~~~~~~~~~~-----------~-----~~-----~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (276)
T 2yex_A          209 DQPSDSCQEYSDWKEKK-----------T-----YL-----N-----PWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (276)
T ss_dssp             SCSCTTSHHHHHHHTTC-----------T-----TS-----T-----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCCchHHHHHHHhhhcc-----------c-----cc-----C-----chhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence            87654332222111000           0     00     0     013578999999999999999999999999999


Q ss_pred             CCccccC
Q 022799          238 PFFDELR  244 (292)
Q Consensus       238 p~~~~~~  244 (292)
                      |||++..
T Consensus       263 ~~~~~~~  269 (276)
T 2yex_A          263 RWYNKPL  269 (276)
T ss_dssp             TTTTCCC
T ss_pred             ccccChh
Confidence            9998653

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=6.7e-42  Score=295.21  Aligned_cols=207  Identities=31%  Similarity=0.511  Sum_probs=164.2

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      ++++||||+++++++..     .. .|+||||++ ++|.+.+..    ...+++..++.++.||+.||.|||++ ||+||
T Consensus        70 ~~l~h~~i~~~~~~~~~-----~~-~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~  138 (322)
T 2ycf_A           70 KKLNHPCIIKIKNFFDA-----ED-YYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHEN-GIIHR  138 (322)
T ss_dssp             HHCCCTTBCCEEEEEES-----SS-EEEEEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHHHT-TEECC
T ss_pred             HhCCCCCCceEeeEEcC-----Cc-eEEEEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC-Ceecc
Confidence            46799999999998732     21 789999998 598887764    46799999999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCC--cEEEeecCCccccccCCCcccccccccccCCcccc--CCCCCCchhHhhhhhHHHHHHHhCCCC
Q 022799           81 DIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF--GATEYTAAIDIWSAGCVLAELLLGQPL  156 (292)
Q Consensus        81 dlkp~Nill~~~~~--~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DvwslG~il~el~~g~~p  156 (292)
                      ||||+||+++.++.  .+||+|||++.............||+.|+|||++.  +...++.++|+||+||++|+|++|..|
T Consensus       139 dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p  218 (322)
T 2ycf_A          139 DLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP  218 (322)
T ss_dssp             CCSGGGEEESSSSSSCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCS
T ss_pred             CCCHHHEEEecCCCCCeEEEccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            99999999986542  49999999998764433334457899999999974  344589999999999999999999999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      |.+......+...+.......                        .......+++.+.+||.+||..||.+|||+.++++
T Consensus       219 f~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          219 FSEHRTQVSLKDQITSGKYNF------------------------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             SCSTTCSSCHHHHHHHTCCCC------------------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CcccchHHHHHHHHHhCcccc------------------------CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            976554333333222211100                        01122468999999999999999999999999999


Q ss_pred             CCCcccc
Q 022799          237 HPFFDEL  243 (292)
Q Consensus       237 hp~~~~~  243 (292)
                      ||||++.
T Consensus       275 h~~~~~~  281 (322)
T 2ycf_A          275 HPWLQDE  281 (322)
T ss_dssp             SGGGCCH
T ss_pred             CcCcCCH
Confidence            9999764

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=6e-42  Score=290.23  Aligned_cols=199  Identities=19%  Similarity=0.266  Sum_probs=159.6

Q ss_pred             CCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCC
Q 022799            5 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIK   83 (292)
Q Consensus         5 ~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlk   83 (292)
                      +||||+++++++..     ....++||||++ ++|.+++.........+++..++.++.||+.||.|||++ ||+|||||
T Consensus        69 ~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dik  142 (289)
T 1x8b_A           69 QHSHVVRYFSAWAE-----DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM-SLVHMDIK  142 (289)
T ss_dssp             SCTTBCCEEEEEEE-----TTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCS
T ss_pred             CCCCeeeeeeeeec-----CCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC-CEeecCCC
Confidence            89999999999843     345899999998 599999987665567899999999999999999999998 99999999


Q ss_pred             CCcEEEeCCC------------------CcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhH
Q 022799           84 PQNLLVNPHT------------------HQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGC  145 (292)
Q Consensus        84 p~Nill~~~~------------------~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~  145 (292)
                      |+||+++.++                  ..++|+|||.+......   ....||+.|+|||++.+...++.++|+||+||
T Consensus       143 p~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~  219 (289)
T 1x8b_A          143 PSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALAL  219 (289)
T ss_dssp             GGGEEEC--------------------CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHH
T ss_pred             HHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHH
Confidence            9999997432                  26999999999876433   23468999999999977656778999999999


Q ss_pred             HHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCC
Q 022799          146 VLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSP  225 (292)
Q Consensus       146 il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp  225 (292)
                      ++|+|++|.+++.....   ...+.+.                   ..         ..++..+++++.++|.+||..||
T Consensus       220 il~~l~~~~~~~~~~~~---~~~~~~~-------------------~~---------~~~~~~~~~~~~~li~~~l~~dp  268 (289)
T 1x8b_A          220 TVVCAAGAEPLPRNGDQ---WHEIRQG-------------------RL---------PRIPQVLSQEFTELLKVMIHPDP  268 (289)
T ss_dssp             HHHHHTTCCCCCSSSHH---HHHHHTT-------------------CC---------CCCSSCCCHHHHHHHHHHTCSSG
T ss_pred             HHHHHhcCCCCCcchhH---HHHHHcC-------------------CC---------CCCCcccCHHHHHHHHHHhCCCc
Confidence            99999999987754422   1121110                   00         01224689999999999999999


Q ss_pred             CCcccHHHHhcCCCcccc
Q 022799          226 NLRSTALEALIHPFFDEL  243 (292)
Q Consensus       226 ~~R~t~~e~l~hp~~~~~  243 (292)
                      ++|||+.++++||||++.
T Consensus       269 ~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          269 ERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             GGSCCHHHHHTCTTC---
T ss_pred             ccCCCHHHHhhChHhhhh
Confidence            999999999999999864

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.8e-41  Score=287.82  Aligned_cols=208  Identities=29%  Similarity=0.503  Sum_probs=170.4

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++.     +....++||||+. ++|.+.+...    ..+++..++.++.||+.||.|||++ |++|
T Consensus        75 l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H  144 (287)
T 2wei_A           75 LKKLDHPNIMKLFEILE-----DSSSFYIVGELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKH-NIVH  144 (287)
T ss_dssp             HHTCCCTTBCCEEEEEE-----CSSEEEEEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TCCC
T ss_pred             HHhccCCCccEEEEEEe-----CCCeEEEEEEccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-Ceec
Confidence            35789999999999983     3445899999997 6988887653    5689999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCC--CcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCC
Q 022799           80 RDIKPQNLLVNPHT--HQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF  157 (292)
Q Consensus        80 ~dlkp~Nill~~~~--~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf  157 (292)
                      |||||+||+++.++  ..+||+|||++.............+|+.|+|||++.+  .++.++|+||+||++|+|++|..||
T Consensus       145 ~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~  222 (287)
T 2wei_A          145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPF  222 (287)
T ss_dssp             SCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             cCCChhhEEEecCCCcccEEEeccCcceeecCCCccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCC
Confidence            99999999997543  2699999999987655544455678999999999865  3899999999999999999999999


Q ss_pred             CCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          158 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      .+.+..+....+........               .+          ....+++++.++|.+||..||.+|||+.++++|
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~---------------~~----------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  277 (287)
T 2wei_A          223 YGKNEYDILKRVETGKYAFD---------------LP----------QWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (287)
T ss_dssp             CCSSHHHHHHHHHHCCCCCC---------------SG----------GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             CCCCHHHHHHHHHcCCCCCC---------------ch----------hhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence            88877665555443110000               00          013578999999999999999999999999999


Q ss_pred             CCccccCC
Q 022799          238 PFFDELRD  245 (292)
Q Consensus       238 p~~~~~~~  245 (292)
                      |||++...
T Consensus       278 p~~~~~~~  285 (287)
T 2wei_A          278 PWIQKYSS  285 (287)
T ss_dssp             HHHHHHCC
T ss_pred             HHHhcccc
Confidence            99997653

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-41  Score=298.06  Aligned_cols=205  Identities=30%  Similarity=0.468  Sum_probs=162.8

Q ss_pred             CCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCC
Q 022799            5 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIK   83 (292)
Q Consensus         5 ~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlk   83 (292)
                      +||||+++++++.     +...+++||||++ |+|.+++...    ..+++..++.++.||+.||.|||++ ||+|||||
T Consensus       117 ~h~~iv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~Dlk  186 (355)
T 1vzo_A          117 QSPFLVTLHYAFQ-----TETKLHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKL-GIIYRDIK  186 (355)
T ss_dssp             TCTTBCCEEEEEE-----ETTEEEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCC
T ss_pred             CCCceeEEEEEEe-----eCceEEEEeecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCC
Confidence            6999999999984     3345899999998 6999988753    5689999999999999999999988 99999999


Q ss_pred             CCcEEEeCCCCcEEEeecCCccccccCC--CcccccccccccCCccccCC-CCCCchhHhhhhhHHHHHHHhCCCCCCCC
Q 022799           84 PQNLLVNPHTHQLKLCDFGSAKVLVKGE--PNISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLLGQPLFPGE  160 (292)
Q Consensus        84 p~Nill~~~~~~ikl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~  160 (292)
                      |+||+++.++ .+||+|||+++......  ......||+.|+|||++.+. ..++.++|+|||||++|+|++|..||...
T Consensus       187 p~NIll~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~  265 (355)
T 1vzo_A          187 LENILLDSNG-HVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD  265 (355)
T ss_dssp             GGGEEECTTS-CEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCT
T ss_pred             HHHEEECCCC-cEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccC
Confidence            9999999888 79999999997653322  22345789999999999753 34789999999999999999999999754


Q ss_pred             CcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcc-----cHHHHh
Q 022799          161 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEAL  235 (292)
Q Consensus       161 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----t~~e~l  235 (292)
                      ........+.+...        ...+                 .++..+++.+.+||.+||..||.+||     |+++++
T Consensus       266 ~~~~~~~~~~~~~~--------~~~~-----------------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell  320 (355)
T 1vzo_A          266 GEKNSQAEISRRIL--------KSEP-----------------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIK  320 (355)
T ss_dssp             TSCCCHHHHHHHHH--------HCCC-----------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHH
T ss_pred             CccchHHHHHHHHh--------ccCC-----------------CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHH
Confidence            43222222221110        0000                 12246889999999999999999999     999999


Q ss_pred             cCCCccccCC
Q 022799          236 IHPFFDELRD  245 (292)
Q Consensus       236 ~hp~~~~~~~  245 (292)
                      +||||+.+.+
T Consensus       321 ~h~~f~~~~~  330 (355)
T 1vzo_A          321 EHLFFQKINW  330 (355)
T ss_dssp             TSGGGTTCCH
T ss_pred             cCcchhcCCh
Confidence            9999998754

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.1e-41  Score=298.24  Aligned_cols=233  Identities=24%  Similarity=0.402  Sum_probs=165.6

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++..     ....++||||++ ++|.+++...    ..+++..+..++.|++.||.|||++.||+|
T Consensus        85 l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H  155 (360)
T 3eqc_A           85 LHECNSPYIVGFYGAFYS-----DGEISICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKHKIMH  155 (360)
T ss_dssp             GGGCCCTTBCCEEEEEEE-----TTEEEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHHCCCC
T ss_pred             HHHCCCCCEEEEeEEEEE-----CCEEEEEEECCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHhCCEEc
Confidence            467899999999999843     345899999998 5999988753    568999999999999999999997338999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      |||||+||+++.++ .++|+|||++...... ......||+.|+|||++.+. .++.++|+||+||++|+|++|..||..
T Consensus       156 ~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~  232 (360)
T 3eqc_A          156 RDVKPSNILVNSRG-EIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPP  232 (360)
T ss_dssp             SCCSGGGEEECTTC-CEEECCCCCCHHHHHH-C----CCCCTTCCHHHHTTC-CCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred             CCccHHHEEECCCC-CEEEEECCCCcccccc-cccCCCCCCCeECHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            99999999999888 7999999998765332 23345789999999999764 489999999999999999999999987


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhh---cCCCCccccCCCCCCC------------CchhhhccCCChhHHHHHHHHhccC
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKC---MNPNYTEFKFPQIKAH------------PWHKIFQKRMPPEAVDLVSRLLQYS  224 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~li~~~l~~d  224 (292)
                      .+..+....+..............   .......+........            .........++.++.+||.+||..|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  312 (360)
T 3eqc_A          233 PDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKN  312 (360)
T ss_dssp             CCHHHHHHHHC------------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSS
T ss_pred             CCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcC
Confidence            765443322211110000000000   0000000000000000            0000011347889999999999999


Q ss_pred             CCCcccHHHHhcCCCccccCC
Q 022799          225 PNLRSTALEALIHPFFDELRD  245 (292)
Q Consensus       225 p~~R~t~~e~l~hp~~~~~~~  245 (292)
                      |++|||++++++||||+....
T Consensus       313 P~~Rpt~~ell~hp~~~~~~~  333 (360)
T 3eqc_A          313 PAERADLKQLMVHAFIKRSDA  333 (360)
T ss_dssp             TTTSCCHHHHHTSHHHHHHHH
T ss_pred             hhhCCCHHHHhhChHhhcchH
Confidence            999999999999999997653

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=5e-41  Score=295.19  Aligned_cols=235  Identities=29%  Similarity=0.478  Sum_probs=177.0

Q ss_pred             CCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCC
Q 022799            5 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKP   84 (292)
Q Consensus         5 ~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlkp   84 (292)
                      .||||+++++++.... .+..++++||||++++|.+++....  ...+++..++.++.||+.||.|||++.||+||||||
T Consensus        84 ~~~~i~~~~~~~~~~~-~~~~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp  160 (373)
T 1q8y_A           84 GANHILKLLDHFNHKG-PNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKP  160 (373)
T ss_dssp             HHTTBCCCCEEEEEEE-TTEEEEEEEECCCCEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSG
T ss_pred             ccchHHHHHHHhhccC-CCCceEEEEEecCCCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCCh
Confidence            4899999999985433 3445789999999889999987542  345899999999999999999999744999999999


Q ss_pred             CcEEEeCCC-----CcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           85 QNLLVNPHT-----HQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        85 ~Nill~~~~-----~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      +||+++.++     ..+||+|||++......  .....||+.|+|||++.+.. ++.++|+||+||++|+|++|..||.+
T Consensus       161 ~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~  237 (373)
T 1q8y_A          161 ENVLMEIVDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEP  237 (373)
T ss_dssp             GGEEEEEEETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred             HHeEEeccCCCcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCC-CCchHhHHHHHHHHHHHHhCCCCCCC
Confidence            999995322     26999999999876432  34457899999999997754 89999999999999999999999986


Q ss_pred             CC------cHHHHHHHHHHhCCCCHHHHhhcCCCCccc-------cCCCCCCCCchh------hhccCCChhHHHHHHHH
Q 022799          160 ES------GVDQLVEIIKVLGTPTREEIKCMNPNYTEF-------KFPQIKAHPWHK------IFQKRMPPEAVDLVSRL  220 (292)
Q Consensus       160 ~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~------~~~~~~~~~~~~li~~~  220 (292)
                      .+      ..+.+..+.+..+.++...+.........+       ........+...      .++..+++++.+||.+|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  317 (373)
T 1q8y_A          238 DEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPM  317 (373)
T ss_dssp             -------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGG
T ss_pred             CcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHH
Confidence            54      556778888888888876554321110000       000011111111      12234567899999999


Q ss_pred             hccCCCCcccHHHHhcCCCccccCC
Q 022799          221 LQYSPNLRSTALEALIHPFFDELRD  245 (292)
Q Consensus       221 l~~dp~~R~t~~e~l~hp~~~~~~~  245 (292)
                      |+.||.+|||++|+++||||++...
T Consensus       318 L~~dP~~Rpt~~ell~hp~f~~~~~  342 (373)
T 1q8y_A          318 LQLDPRKRADAGGLVNHPWLKDTLG  342 (373)
T ss_dssp             GCSSTTTCBCHHHHHTCGGGTTCTT
T ss_pred             hccCccccCCHHHHhhChhhhcccC
Confidence            9999999999999999999997543

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.5e-41  Score=294.23  Aligned_cols=203  Identities=25%  Similarity=0.384  Sum_probs=157.1

Q ss_pred             CCCC--CCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            3 LLDH--PNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         3 ~l~H--pnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      .++|  |||+++++++     .+..++++|||+.+++|.+++..    ...+++..++.++.||+.||.|||++ ||+||
T Consensus        63 ~l~~~~~~iv~~~~~~-----~~~~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~-~iiHr  132 (343)
T 3dbq_A           63 KLQQHSDKIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH-GIVHS  132 (343)
T ss_dssp             HHTTTCTTBCCEEEEE-----ECSSEEEEEECCCSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCC
T ss_pred             hhhhcCCceEEEeeeE-----eeCCEEEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeecC
Confidence            3555  9999999998     44456999999888999999875    46799999999999999999999998 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCC---cccccccccccCCccccC----------CCCCCchhHhhhhhHHH
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFG----------ATEYTAAIDIWSAGCVL  147 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~----------~~~~~~~~DvwslG~il  147 (292)
                      ||||+||+++. + .+||+|||+++.......   .....||+.|+|||++.+          ...++.++||||+||++
T Consensus       133 Dikp~NIll~~-~-~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il  210 (343)
T 3dbq_A          133 DLKPANFLIVD-G-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL  210 (343)
T ss_dssp             CCCGGGEEEET-T-EEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHH
T ss_pred             CCCcceEEEEC-C-cEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHH
Confidence            99999999974 5 699999999987643322   234578999999999853          24589999999999999


Q ss_pred             HHHHhCCCCCCCCCcH-HHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCC
Q 022799          148 AELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPN  226 (292)
Q Consensus       148 ~el~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~  226 (292)
                      |+|++|..||.+.... ..+..+..   ...            .            ..++...++++.+||.+||..||.
T Consensus       211 ~ell~g~~pf~~~~~~~~~~~~~~~---~~~------------~------------~~~~~~~~~~l~~li~~~L~~dp~  263 (343)
T 3dbq_A          211 YYMTYGKTPFQQIINQISKLHAIID---PNH------------E------------IEFPDIPEKDLQDVLKCCLKRDPK  263 (343)
T ss_dssp             HHHHHSSCTTTTCCSHHHHHHHHHC---TTS------------C------------CCCCCCSCHHHHHHHHHHTCSSTT
T ss_pred             HHHHhCCCcchhhhhHHHHHHHHhc---CCc------------c------------cCCcccCCHHHHHHHHHHcCCChh
Confidence            9999999999765432 22221111   000            0            012244678999999999999999


Q ss_pred             CcccHHHHhcCCCccccC
Q 022799          227 LRSTALEALIHPFFDELR  244 (292)
Q Consensus       227 ~R~t~~e~l~hp~~~~~~  244 (292)
                      +|||+.++++||||+...
T Consensus       264 ~Rpt~~e~l~hp~~~~~~  281 (343)
T 3dbq_A          264 QRISIPELLAHPYVQIQT  281 (343)
T ss_dssp             TSCCHHHHHTSHHHHSCC
T ss_pred             HCCCHHHHHhCccccccC
Confidence            999999999999998543

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=3.8e-41  Score=297.86  Aligned_cols=200  Identities=26%  Similarity=0.396  Sum_probs=157.0

Q ss_pred             CCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCC
Q 022799            6 HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQ   85 (292)
Q Consensus         6 HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlkp~   85 (292)
                      ||||+++++++.     ...++|+|||+.+++|.+++..    ...+++..++.++.||+.||.|||++ ||+||||||+
T Consensus       115 ~~~iv~~~~~~~-----~~~~~~lv~E~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~-~ivHrDlkp~  184 (390)
T 2zmd_A          115 SDKIIRLYDYEI-----TDQYIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH-GIVHSDLKPA  184 (390)
T ss_dssp             CTTBCCEEEEEE-----CSSEEEEEEECCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHTT-TCCCCCCCGG
T ss_pred             CCeEEEEEEEEe-----cCCEEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHH
Confidence            699999999884     3345899999777899999875    35789999999999999999999988 9999999999


Q ss_pred             cEEEeCCCCcEEEeecCCccccccCCC---cccccccccccCCccccCC----------CCCCchhHhhhhhHHHHHHHh
Q 022799           86 NLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGA----------TEYTAAIDIWSAGCVLAELLL  152 (292)
Q Consensus        86 Nill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~----------~~~~~~~DvwslG~il~el~~  152 (292)
                      |||++. + .+||+|||+++.......   ....+||+.|+|||++.+.          ..++.++|||||||++|+|++
T Consensus       185 NIll~~-~-~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~  262 (390)
T 2zmd_A          185 NFLIVD-G-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY  262 (390)
T ss_dssp             GEEESS-S-CEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHH
T ss_pred             HEEEEC-C-eEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHH
Confidence            999964 5 699999999987643321   2345799999999998651          358999999999999999999


Q ss_pred             CCCCCCCCCcH-HHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccH
Q 022799          153 GQPLFPGESGV-DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA  231 (292)
Q Consensus       153 g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~  231 (292)
                      |..||.+.... ..+..+..   .           .. ..            .++...++++.+||.+||..||.+|||+
T Consensus       263 G~~Pf~~~~~~~~~~~~~~~---~-----------~~-~~------------~~~~~~~~~~~~li~~~L~~dP~~Rps~  315 (390)
T 2zmd_A          263 GKTPFQQIINQISKLHAIID---P-----------NH-EI------------EFPDIPEKDLQDVLKCCLKRDPKQRISI  315 (390)
T ss_dssp             SSCTTTTCCCHHHHHHHHHC---T-----------TS-CC------------CCCCCSCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             CCCcchhhhHHHHHHHHHhC---c-----------cc-cC------------CCCccchHHHHHHHHHHcccChhhCCCH
Confidence            99999765432 22222221   0           00 00            0123457899999999999999999999


Q ss_pred             HHHhcCCCccccC
Q 022799          232 LEALIHPFFDELR  244 (292)
Q Consensus       232 ~e~l~hp~~~~~~  244 (292)
                      .++++||||+...
T Consensus       316 ~ell~hp~~~~~~  328 (390)
T 2zmd_A          316 PELLAHPYVQIQT  328 (390)
T ss_dssp             HHHHTSHHHHSCC
T ss_pred             HHHhhCcCccccC
Confidence            9999999998644

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=2.5e-41  Score=288.82  Aligned_cols=207  Identities=27%  Similarity=0.451  Sum_probs=164.6

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      +.++||||+++++++..     ....++||||++ ++|.+++...   ...+++..++.++.||+.||.|||++ |++||
T Consensus        71 ~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~  141 (302)
T 2j7t_A           71 ATCDHPYIVKLLGAYYH-----DGKLWIMIEFCPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSK-RIIHR  141 (302)
T ss_dssp             HHCCCTTBCCEEEEEEC-----C-CEEEEEECCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCC
T ss_pred             hcCCCCCEeeeeeeeee-----CCeEEEEEEeCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhcC-CcccC
Confidence            45799999999999843     345899999998 5888877653   46699999999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccC-CCcccccccccccCCcccc----CCCCCCchhHhhhhhHHHHHHHhCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNISYICSRYYRAPELIF----GATEYTAAIDIWSAGCVLAELLLGQP  155 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DvwslG~il~el~~g~~  155 (292)
                      ||||+||+++.++ .+||+|||++...... .......||+.|+|||++.    ....++.++|+||+||++|+|++|..
T Consensus       142 dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~  220 (302)
T 2j7t_A          142 DLKAGNVLMTLEG-DIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP  220 (302)
T ss_dssp             CCSGGGEEECTTS-CEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSC
T ss_pred             CCCHHHEEECCCC-CEEEEECCCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCC
Confidence            9999999999888 7999999987543211 1223457899999999984    33458999999999999999999999


Q ss_pred             CCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHh
Q 022799          156 LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL  235 (292)
Q Consensus       156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l  235 (292)
                      ||.+.+.......+..... +.                         ...+..++..+.++|.+||..||.+|||+.+++
T Consensus       221 p~~~~~~~~~~~~~~~~~~-~~-------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll  274 (302)
T 2j7t_A          221 PHHELNPMRVLLKIAKSDP-PT-------------------------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLL  274 (302)
T ss_dssp             TTTTSCHHHHHHHHHHSCC-CC-------------------------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHT
T ss_pred             CCccCCHHHHHHHHhccCC-cc-------------------------cCCccccCHHHHHHHHHHcccChhhCCCHHHHh
Confidence            9988776665554443110 00                         001245788999999999999999999999999


Q ss_pred             cCCCccccC
Q 022799          236 IHPFFDELR  244 (292)
Q Consensus       236 ~hp~~~~~~  244 (292)
                      +||||+++.
T Consensus       275 ~h~~~~~~~  283 (302)
T 2j7t_A          275 EHPFVSSIT  283 (302)
T ss_dssp             TSTTTTTCC
T ss_pred             cChHHhhhc
Confidence            999998765

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=9.4e-41  Score=286.87  Aligned_cols=207  Identities=29%  Similarity=0.440  Sum_probs=168.7

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++..     ....++||||++ ++|.+++...   ...+++..+..++.||+.||.|||++ |++|
T Consensus        78 l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H  148 (314)
T 3com_A           78 MQQCDSPHVVKYYGSYFK-----NTDLWIVMEYCGAGSVSDIIRLR---NKTLTEDEIATILQSTLKGLEYLHFM-RKIH  148 (314)
T ss_dssp             HHTCCCTTBCCEEEEEEE-----TTEEEEEEECCTTEEHHHHHHHH---TCCCCHHHHHHHHHHHHHHHHHHHHT-TEEC
T ss_pred             HHhCCCCCCccEEEEEEe-----CCEEEEEeecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CCcC
Confidence            357899999999999844     334899999998 5999888643   46799999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCC-CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      +||||+||+++.++ .++|+|||.+....... ......||+.|+|||++.+. .++.++|+||+||++|+|++|..||.
T Consensus       149 ~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~  226 (314)
T 3com_A          149 RDIKAGNILLNTEG-HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI-GYNCVADIWSLGITAIEMAEGKPPYA  226 (314)
T ss_dssp             CCCSGGGEEECTTC-CEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSS-CBCTTHHHHHHHHHHHHHHHSSCTTT
T ss_pred             CCcCHHHEEECCCC-CEEEeecccchhhhhhccccCccCCCCCccChhhcCCC-CCCccccHHHHHHHHHHHHhCCCCCC
Confidence            99999999999888 79999999997664332 23345789999999999664 48999999999999999999999998


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCC
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  238 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp  238 (292)
                      +.........+....  +         +.+               ..+..+++.+.++|.+||..||.+|||+.++++||
T Consensus       227 ~~~~~~~~~~~~~~~--~---------~~~---------------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~  280 (314)
T 3com_A          227 DIHPMRAIFMIPTNP--P---------PTF---------------RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHP  280 (314)
T ss_dssp             TSCHHHHHHHHHHSC--C---------CCC---------------SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSH
T ss_pred             CCChHHHHHHHhcCC--C---------ccc---------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCH
Confidence            776655443332210  0         000               01245789999999999999999999999999999


Q ss_pred             CccccC
Q 022799          239 FFDELR  244 (292)
Q Consensus       239 ~~~~~~  244 (292)
                      ||++..
T Consensus       281 ~~~~~~  286 (314)
T 3com_A          281 FVRSAK  286 (314)
T ss_dssp             HHHTCC
T ss_pred             HHhcCC
Confidence            998754

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=4e-40  Score=287.23  Aligned_cols=229  Identities=28%  Similarity=0.488  Sum_probs=176.8

Q ss_pred             CCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCC
Q 022799            5 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKP   84 (292)
Q Consensus         5 ~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlkp   84 (292)
                      .|++|+.+++++     ......++||||+++++.+.+....  ...+++..++.++.||+.||.|||++ ||+||||||
T Consensus        80 ~~~~~~~~~~~~-----~~~~~~~lv~e~~~~~l~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~-~ivH~Dlkp  151 (355)
T 2eu9_A           80 NKFLCVLMSDWF-----NFHGHMCIAFELLGKNTFEFLKENN--FQPYPLPHVRHMAYQLCHALRFLHEN-QLTHTDLKP  151 (355)
T ss_dssp             SCSCBCCEEEEE-----EETTEEEEEEECCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCG
T ss_pred             CceeEEEeeeee-----eeCCeEEEEEeccCCChHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCH
Confidence            345599998888     3344589999999999888876532  24699999999999999999999988 999999999


Q ss_pred             CcEEE-------------------eCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhH
Q 022799           85 QNLLV-------------------NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGC  145 (292)
Q Consensus        85 ~Nill-------------------~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~  145 (292)
                      +||++                   +.++ .+||+|||++.....  ......||+.|+|||++.+. .++.++|+||+||
T Consensus       152 ~NIll~~~~~~~~~~~~~~~~~~~~~~~-~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~  227 (355)
T 2eu9_A          152 ENILFVNSEFETLYNEHKSCEEKSVKNT-SIRVADFGSATFDHE--HHTTIVATRHYRPPEVILEL-GWAQPCDVWSIGC  227 (355)
T ss_dssp             GGEEESCCCEEEEECCC-CCCEEEESCC-CEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHH
T ss_pred             HHEEEecccccccccccccccccccCCC-cEEEeecCccccccc--cccCCcCCCcccCCeeeecC-CCCCccchHHHHH
Confidence            99999                   4455 799999999986533  33456789999999999765 4899999999999


Q ss_pred             HHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccc----cCCCCC---------CCCchhh--hccCCC
Q 022799          146 VLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF----KFPQIK---------AHPWHKI--FQKRMP  210 (292)
Q Consensus       146 il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~----~~~~~~---------~~~~~~~--~~~~~~  210 (292)
                      ++|+|++|..||.+.+..+.+..+.+..+.++...+..........    .++...         ...+...  .....+
T Consensus       228 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (355)
T 2eu9_A          228 ILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEH  307 (355)
T ss_dssp             HHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHH
T ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhH
Confidence            9999999999999999888888888888888877665432111000    000000         0000000  001224


Q ss_pred             hhHHHHHHHHhccCCCCcccHHHHhcCCCccccCC
Q 022799          211 PEAVDLVSRLLQYSPNLRSTALEALIHPFFDELRD  245 (292)
Q Consensus       211 ~~~~~li~~~l~~dp~~R~t~~e~l~hp~~~~~~~  245 (292)
                      .++.+||.+||..||++|||+.++++||||+++..
T Consensus       308 ~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~  342 (355)
T 2eu9_A          308 VQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTP  342 (355)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGCCH
T ss_pred             HHHHHHHHHHhcCChhhCcCHHHHhcChhhcCCCh
Confidence            58899999999999999999999999999998754

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=5.4e-42  Score=295.44  Aligned_cols=226  Identities=19%  Similarity=0.295  Sum_probs=165.5

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      ++++||||+++++++...   +....++||||++ ++|.+++..... ...+++..++.++.||+.||.|||++ ||+||
T Consensus        62 ~~l~h~~iv~~~~~~~~~---~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~  136 (319)
T 4euu_A           62 KKLNHKNIVKLFAIEEET---TTRHKVLIMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN-GIVHR  136 (319)
T ss_dssp             HHCCCTTBCCEEEEEECT---TTCCEEEEEECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECS
T ss_pred             HhcCCCCcceEEEEeecC---CCceEEEEEeCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC-CEecC
Confidence            467899999999988543   2335889999998 699999876432 34499999999999999999999998 99999


Q ss_pred             CCCCCcEEE----eCCCCcEEEeecCCccccccCCCcccccccccccCCccccC-------CCCCCchhHhhhhhHHHHH
Q 022799           81 DIKPQNLLV----NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG-------ATEYTAAIDIWSAGCVLAE  149 (292)
Q Consensus        81 dlkp~Nill----~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DvwslG~il~e  149 (292)
                      ||||+||++    +.++ .+||+|||+++............||+.|+|||++.+       ...++.++|+||+||++|+
T Consensus       137 Dlkp~NIll~~~~~~~~-~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~e  215 (319)
T 4euu_A          137 NIKPGNIMRVIGEDGQS-VYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYH  215 (319)
T ss_dssp             CCSGGGEEEEECTTSCE-EEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHH
T ss_pred             CCCHHHEEEeccCCCCc-eEEEccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHH
Confidence            999999998    5555 699999999988766665566789999999999852       2458999999999999999


Q ss_pred             HHhCCCCCCCCCc----HHHHHHHHHHhCCCCHHHHhhcCC-CCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccC
Q 022799          150 LLLGQPLFPGESG----VDQLVEIIKVLGTPTREEIKCMNP-NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYS  224 (292)
Q Consensus       150 l~~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  224 (292)
                      |++|..||.....    .+.+.++....   +...+..... ....+.+..  ..+....++..+++.+.++|++||+.|
T Consensus       216 l~~g~~pf~~~~~~~~~~~~~~~~~~~~---p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~ll~~~L~~d  290 (319)
T 4euu_A          216 AATGSLPFRPFEGPRRNKEVMYKIITGK---PSGAISGVQKAENGPIDWSG--DMPVSCSLSRGLQVLLTPVLANILEAD  290 (319)
T ss_dssp             HHHSSCSEECTTCGGGCHHHHHHHHHHC---CTTCCEEEECSTTCCEEEES--SCCTTCSSCHHHHHHHHHHHHHHSCCC
T ss_pred             HHhCCCCCCCCCccchhHHHHHHHhcCC---CcccchhhhcccCCccccCc--cCCcccccchhHHHHhHHHHHHhccCC
Confidence            9999999975332    33444443321   1111110000 000000000  000011122345678999999999999


Q ss_pred             CCCcccHHHHhcCC
Q 022799          225 PNLRSTALEALIHP  238 (292)
Q Consensus       225 p~~R~t~~e~l~hp  238 (292)
                      |++|||++|+|+||
T Consensus       291 P~~R~s~~ell~h~  304 (319)
T 4euu_A          291 QEKCWGFDQFFAET  304 (319)
T ss_dssp             TTTSCCHHHHHHHH
T ss_pred             hhhhccHHHhhhcc
Confidence            99999999999997

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=5.7e-41  Score=283.40  Aligned_cols=208  Identities=29%  Similarity=0.417  Sum_probs=168.9

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCC----
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG----   76 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~----   76 (292)
                      ++++||||+++++++...   ....+++||||++ ++|.+++.........+++..++.++.||+.||.|||++ |    
T Consensus        60 ~~l~h~~i~~~~~~~~~~---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~~~~~  135 (279)
T 2w5a_A           60 RELKHPNIVRYYDRIIDR---TNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR-SDGGH  135 (279)
T ss_dssp             HHCCCTTBCCEEEEEEEG---GGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH-C----
T ss_pred             HhcCCCCCCeEEEEEecC---CCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc-cCCCC
Confidence            467999999999987542   2335889999998 599999987655556799999999999999999999998 8    


Q ss_pred             -ccccCCCCCcEEEeCCCCcEEEeecCCccccccCCC-cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCC
Q 022799           77 -VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ  154 (292)
Q Consensus        77 -i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~  154 (292)
                       |+||||||+||+++.++ .+||+|||.+........ .....||+.|+|||++.+. .++.++|+||+||++|+|++|.
T Consensus       136 ~ivH~dl~p~NIl~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~  213 (279)
T 2w5a_A          136 TVLHRDLKPANVFLDGKQ-NVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALM  213 (279)
T ss_dssp             --CCCCCSGGGEEECSSS-CEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSS
T ss_pred             eeEEeccchhhEEEcCCC-CEEEecCchheeeccccccccccCCCccccChHHhccC-CCCchhhHHHHHHHHHHHHHCC
Confidence             99999999999999888 799999999976543321 2235689999999999765 4899999999999999999999


Q ss_pred             CCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHH
Q 022799          155 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA  234 (292)
Q Consensus       155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~  234 (292)
                      .||.+.+..+....+.... .                  +         .++..+++++.++|.+||..||.+|||+.++
T Consensus       214 ~p~~~~~~~~~~~~i~~~~-~------------------~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l  265 (279)
T 2w5a_A          214 PPFTAFSQKELAGKIREGK-F------------------R---------RIPYRYSDELNEIITRMLNLKDYHRPSVEEI  265 (279)
T ss_dssp             CSSCCSSHHHHHHHHHHTC-C------------------C---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCcccCHHHHHHHHhhcc-c------------------c---------cCCcccCHHHHHHHHHHcCCCcccCCCHHHH
Confidence            9998877655554443310 0                  0         0124578999999999999999999999999


Q ss_pred             hcCCCcccc
Q 022799          235 LIHPFFDEL  243 (292)
Q Consensus       235 l~hp~~~~~  243 (292)
                      ++|+|+..-
T Consensus       266 l~~~~~~~~  274 (279)
T 2w5a_A          266 LENPLILEH  274 (279)
T ss_dssp             HTSTTCCGG
T ss_pred             HhChhhhhh
Confidence            999999863

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.1e-40  Score=283.67  Aligned_cols=210  Identities=26%  Similarity=0.438  Sum_probs=162.9

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++.     +....++||||++ ++|.+++.... ....+++..+..++.||+.||.|||++ ||+|
T Consensus        73 l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H  145 (295)
T 2clq_A           73 HKHLKHKNIVQYLGSFS-----ENGFIKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDN-QIVH  145 (295)
T ss_dssp             HHTCCCTTBCCEEEEEE-----ETTEEEEEEECCSEEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHT-TEEC
T ss_pred             HHhCCCCCEeeEeeEEE-----eCCcEEEEEEeCCCCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhC-CEEc
Confidence            35689999999999984     3345899999997 69998887532 123567899999999999999999988 9999


Q ss_pred             cCCCCCcEEEeC-CCCcEEEeecCCccccccCC-CcccccccccccCCccccCC-CCCCchhHhhhhhHHHHHHHhCCCC
Q 022799           80 RDIKPQNLLVNP-HTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELLLGQPL  156 (292)
Q Consensus        80 ~dlkp~Nill~~-~~~~ikl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~p  156 (292)
                      |||||+||+++. ++ .++|+|||.+....... ......||+.|+|||++.+. ..++.++|+||+||++|+|++|..|
T Consensus       146 ~dl~p~Nil~~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p  224 (295)
T 2clq_A          146 RDIKGDNVLINTYSG-VLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP  224 (295)
T ss_dssp             CCCSGGGEEEETTTC-CEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCT
T ss_pred             cCCChhhEEEECCCC-CEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence            999999999987 55 79999999998764322 22345789999999998653 2378999999999999999999999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      |.+.................                          ..++..+++++.++|.+||..||++|||++++++
T Consensus       225 f~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          225 FYELGEPQAAMFKVGMFKVH--------------------------PEIPESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             TGGGSSHHHHHHHHHHHCCC--------------------------CCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             ccCCCchhHHHHhhcccccc--------------------------ccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            97644332221111111100                          0122468899999999999999999999999999


Q ss_pred             CCCccccC
Q 022799          237 HPFFDELR  244 (292)
Q Consensus       237 hp~~~~~~  244 (292)
                      ||||+...
T Consensus       279 ~~~~~~~~  286 (295)
T 2clq_A          279 DEFLKVSS  286 (295)
T ss_dssp             SGGGCC--
T ss_pred             Chhhhhcc
Confidence            99998654

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=7.2e-41  Score=289.32  Aligned_cols=215  Identities=26%  Similarity=0.383  Sum_probs=148.6

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYK-MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~-~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      +.++||||+++++++..     ....++||||++|+|.+++..... ....+++..+..++.|++.||.|||++.||+||
T Consensus        76 ~~~~h~niv~~~~~~~~-----~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~  150 (327)
T 3aln_A           76 RSSDCPYIVQFYGALFR-----EGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHR  150 (327)
T ss_dssp             SSCCCTTBCCEEEEEEC-----SSEEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCS
T ss_pred             HcCCCCcEeeeeeEEEe-----CCceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeEC
Confidence            56899999999999843     345899999999999888774332 256799999999999999999999974499999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCcccc---CCCCCCchhHhhhhhHHHHHHHhCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF---GATEYTAAIDIWSAGCVLAELLLGQPLF  157 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DvwslG~il~el~~g~~pf  157 (292)
                      ||||+||+++.++ .+||+|||++.............||+.|+|||++.   ....++.++|+||+||++|+|++|..||
T Consensus       151 dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf  229 (327)
T 3aln_A          151 DIKPSNILLDRSG-NIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPY  229 (327)
T ss_dssp             CCCGGGEEEETTT-EEEECCCSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCS
T ss_pred             CCCHHHEEEcCCC-CEEEccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence            9999999999888 79999999998765544444557899999999983   2334899999999999999999999999


Q ss_pred             CCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          158 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      .+......  .+            ...    .....+     .+.......+++.+.+||.+||..||.+|||+.++++|
T Consensus       230 ~~~~~~~~--~~------------~~~----~~~~~~-----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  286 (327)
T 3aln_A          230 PKWNSVFD--QL------------TQV----VKGDPP-----QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH  286 (327)
T ss_dssp             SCC---------------------CCC----CCSCCC-----CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             CCcchHHH--HH------------HHH----hcCCCC-----CCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence            76432110  00            000    000000     01111124588999999999999999999999999999


Q ss_pred             CCccccCC
Q 022799          238 PFFDELRD  245 (292)
Q Consensus       238 p~~~~~~~  245 (292)
                      |||.....
T Consensus       287 p~~~~~~~  294 (327)
T 3aln_A          287 PFILMYEE  294 (327)
T ss_dssp             HHHHHHHH
T ss_pred             hHHHHhHh
Confidence            99987653

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.2e-40  Score=283.89  Aligned_cols=207  Identities=28%  Similarity=0.417  Sum_probs=162.0

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++     .+...+|+||||++ ++|.+++...    +.+++..+..++.||+.||.|||++ ||+|
T Consensus        65 l~~l~hp~iv~~~~~~-----~~~~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H  134 (294)
T 4eqm_A           65 SSQLSHQNIVSMIDVD-----EEDDCYYLVMEYIEGPTLSEYIESH----GPLSVDTAINFTNQILDGIKHAHDM-RIVH  134 (294)
T ss_dssp             HTTCCBTTBCCEEEEE-----ECSSEEEEEEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT-TCCC
T ss_pred             HhcCCCCCCceEEEee-----eeCCeEEEEEeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-Cccc
Confidence            4678999999999998     44456899999998 5999988753    5799999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCC--CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF  157 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf  157 (292)
                      |||||+||+++.++ .+||+|||++.......  ......||+.|+|||.+.+.. ++.++|+||+||++|+|++|..||
T Consensus       135 ~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~pf  212 (294)
T 4eqm_A          135 RDIKPQNILIDSNK-TLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEA-TDECTDIYSIGIVLYEMLVGEPPF  212 (294)
T ss_dssp             CCCCGGGEEECTTS-CEEECCCSSSTTC-------------CCSSCCHHHHHTCC-CCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred             CCCCHHHEEECCCC-CEEEEeCCCccccccccccccCccccCccccCHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCC
Confidence            99999999999888 79999999998764332  123456899999999997654 899999999999999999999999


Q ss_pred             CCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          158 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      .+.+......+..... .+                       ......+..+++.+.++|.+||..||.+||+..+.+.+
T Consensus       213 ~~~~~~~~~~~~~~~~-~~-----------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~  268 (294)
T 4eqm_A          213 NGETAVSIAIKHIQDS-VP-----------------------NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKD  268 (294)
T ss_dssp             CSSCHHHHHHHHHSSC-CC-----------------------CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHH
T ss_pred             CCCChHHHHHHHhhcc-CC-----------------------CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHH
Confidence            8887665544433210 00                       01112235689999999999999999999966666666


Q ss_pred             CCcccc
Q 022799          238 PFFDEL  243 (292)
Q Consensus       238 p~~~~~  243 (292)
                      .|.+-+
T Consensus       269 ~l~~~~  274 (294)
T 4eqm_A          269 DLSSVL  274 (294)
T ss_dssp             HHHTSS
T ss_pred             HHHHHH
Confidence            665443

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=9.2e-41  Score=290.91  Aligned_cols=224  Identities=20%  Similarity=0.381  Sum_probs=167.2

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccC-CHHHH------HHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRV------IKHHYKMSQRMPLIYVKLYFYQICRALAYIHN   73 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~------l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~   73 (292)
                      |++++||||+++++++.     +....++||||++| +|.++      +...  ....+++..++.++.||+.||.|||+
T Consensus        97 l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~  169 (348)
T 2pml_X           97 ITDIKNEYCLTCEGIIT-----NYDEVYIIYEYMENDSILKFDEYFFVLDKN--YTCFIPIQVIKCIIKSVLNSFSYIHN  169 (348)
T ss_dssp             HTTCCCTTBCCCSEEEE-----SSSEEEEEEECCTTCBSSEESSSEESSCSS--SCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHhCCCCCcceEEEEEe-----eCCeEEEEEeccCCCcHHHHHHHhhhhhhc--cccCCCHHHHHHHHHHHHHHHHHHhc
Confidence            46789999999999984     34458999999984 88877      3321  14679999999999999999999998


Q ss_pred             -cCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCc-hhHhhhhhHHHHHHH
Q 022799           74 -TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTA-AIDIWSAGCVLAELL  151 (292)
Q Consensus        74 -~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~DvwslG~il~el~  151 (292)
                       + ||+||||||+||+++.++ .++|+|||.+...... ......||+.|+|||++.+...++. ++|+||+||++|+|+
T Consensus       170 ~~-~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~  246 (348)
T 2pml_X          170 EK-NICHRDVKPSNILMDKNG-RVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMF  246 (348)
T ss_dssp             TS-CEECCCCCGGGEEECTTS-CEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHH
T ss_pred             cC-CEeecCCChHhEEEcCCC-cEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHH
Confidence             7 999999999999999888 7999999999875433 3344678999999999976544555 999999999999999


Q ss_pred             hCCCCCCCCCc-HHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCccc
Q 022799          152 LGQPLFPGESG-VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST  230 (292)
Q Consensus       152 ~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t  230 (292)
                      +|..||.+... .+....+.......+.        ....+..+ .. ..........+++++.+||.+||+.||.+|||
T Consensus       247 ~g~~pf~~~~~~~~~~~~i~~~~~~~~~--------~~~~~~~~-~~-~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps  316 (348)
T 2pml_X          247 YNVVPFSLKISLVELFNNIRTKNIEYPL--------DRNHFLYP-LT-NKKSTCSNNFLSNEDIDFLKLFLRKNPAERIT  316 (348)
T ss_dssp             HSSCSSCCSSCSHHHHHHHTSCCCCCCC--------SSSSSTTT-TC-C--------CCCHHHHHHHHHHCCSSGGGSCC
T ss_pred             hCCCCCCCCCcHHHHHHHHhccCcCCcc--------chhhhhcc-cc-ccccccchhhcCHHHHHHHHHHccCChhhCCC
Confidence            99999987766 3433333221000000        00000000 00 00011122568999999999999999999999


Q ss_pred             HHHHhcCCCccccC
Q 022799          231 ALEALIHPFFDELR  244 (292)
Q Consensus       231 ~~e~l~hp~~~~~~  244 (292)
                      +.++++||||++..
T Consensus       317 ~~e~l~hp~f~~~~  330 (348)
T 2pml_X          317 SEDALKHEWLADTN  330 (348)
T ss_dssp             HHHHHTSGGGTTCC
T ss_pred             HHHHhcCccccCCC
Confidence            99999999998754

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.6e-40  Score=285.66  Aligned_cols=208  Identities=25%  Similarity=0.381  Sum_probs=155.9

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccC
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRD   81 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~d   81 (292)
                      +.++||||+++++++.     +....++||||+++.+..+....   ...+++..+..++.||+.||.|||++.||+|||
T Consensus        79 ~~~~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~d  150 (318)
T 2dyl_A           79 KSHDCPYIVQCFGTFI-----TNTDVFIAMELMGTCAEKLKKRM---QGPIPERILGKMTVAIVKALYYLKEKHGVIHRD  150 (318)
T ss_dssp             HTTTCTTBCCEEEEEE-----CSSEEEEEECCCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCC
T ss_pred             HhcCCCceeeEEEEEe-----cCCcEEEEEeccCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCC
Confidence            4679999999999984     33458999999976666555432   467999999999999999999999723999999


Q ss_pred             CCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccC----CCCCCchhHhhhhhHHHHHHHhCCCCC
Q 022799           82 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG----ATEYTAAIDIWSAGCVLAELLLGQPLF  157 (292)
Q Consensus        82 lkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslG~il~el~~g~~pf  157 (292)
                      |||+||+++.++ .+||+|||++.............||+.|+|||++.+    ...++.++|+||+||++|+|++|..||
T Consensus       151 lkp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf  229 (318)
T 2dyl_A          151 VKPSNILLDERG-QIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPY  229 (318)
T ss_dssp             CCGGGEEECTTS-CEEECCCTTC--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             CCHHHEEECCCC-CEEEEECCCchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCC
Confidence            999999999888 799999999987655544455678999999999852    345789999999999999999999999


Q ss_pred             CCCC-cHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          158 PGES-GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       158 ~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      .... ..+.+..+.... .+               ..+          ....+++++.++|.+||..||.+|||++++++
T Consensus       230 ~~~~~~~~~~~~~~~~~-~~---------------~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          230 KNCKTDFEVLTKVLQEE-PP---------------LLP----------GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             TTCCSHHHHHHHHHHSC-CC---------------CCC----------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCCCccHHHHHHHhccC-CC---------------CCC----------ccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            8743 334444333310 00               000          01357899999999999999999999999999


Q ss_pred             CCCccccC
Q 022799          237 HPFFDELR  244 (292)
Q Consensus       237 hp~~~~~~  244 (292)
                      ||||++..
T Consensus       284 h~~~~~~~  291 (318)
T 2dyl_A          284 HSFIKRYE  291 (318)
T ss_dssp             SHHHHHHH
T ss_pred             CHHHHhcc
Confidence            99998764

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.9e-40  Score=290.92  Aligned_cols=209  Identities=16%  Similarity=0.136  Sum_probs=162.0

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccC
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRD   81 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~d   81 (292)
                      +.++||||+++++++.... .+..+.|+||||++++|.+++...   ...+++..+..++.||+.||.|||++ ||+|||
T Consensus       103 ~~l~h~~iv~~~~~~~~~~-~~~~~~~lv~e~~g~~L~~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~-~iiHrD  177 (364)
T 3op5_A          103 RKLKYLGVPKYWGSGLHDK-NGKSYRFMIMDRFGSDLQKIYEAN---AKRFSRKTVLQLSLRILDILEYIHEH-EYVHGD  177 (364)
T ss_dssp             TTCSCCCSCCEEEEEEEEE-TTEEEEEEEEECEEEEHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCC
T ss_pred             hhccCCCCCeEEeeeeecc-CCcceEEEEEeCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEEec
Confidence            5789999999999886543 345678999999988999998753   46799999999999999999999998 999999


Q ss_pred             CCCCcEEEe--CCCCcEEEeecCCccccccCCC--------cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHH
Q 022799           82 IKPQNLLVN--PHTHQLKLCDFGSAKVLVKGEP--------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL  151 (292)
Q Consensus        82 lkp~Nill~--~~~~~ikl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~  151 (292)
                      |||+|||++  .++ .+||+|||+++.......        .....||+.|+|||++.+.. ++.++|||||||++|+|+
T Consensus       178 lkp~Nill~~~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~  255 (364)
T 3op5_A          178 IKASNLLLNYKNPD-QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVA-PSRRGDLEILGYCMIQWL  255 (364)
T ss_dssp             CCGGGEEEESSCTT-CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHH
T ss_pred             CCHHHEEEecCCCC-eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCC-CCchhhHHHHHHHHHHHH
Confidence            999999998  666 799999999976543221        12345899999999997654 899999999999999999


Q ss_pred             hCCCCCCCCCcHHHHHHHHHH-hCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCccc
Q 022799          152 LGQPLFPGESGVDQLVEIIKV-LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST  230 (292)
Q Consensus       152 ~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t  230 (292)
                      +|..||.+............. ............        +           ....+++++.++|..||..||.+||+
T Consensus       256 ~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~-----------~~~~~~~~~~~li~~cl~~~p~~RP~  316 (364)
T 3op5_A          256 TGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKC--------F-----------PAANAPGEIAKYMETVKLLDYTEKPL  316 (364)
T ss_dssp             HSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHH--------S-----------CTTCCCHHHHHHHHHHHTCCTTCCCC
T ss_pred             hCCCCccccccCHHHHHHHHHHhhhhHHHHHHHh--------c-----------ccccCHHHHHHHHHHHhcCCCCCCCC
Confidence            999999864433332222221 111111111100        0           01457899999999999999999999


Q ss_pred             HHHHhc
Q 022799          231 ALEALI  236 (292)
Q Consensus       231 ~~e~l~  236 (292)
                      +.++++
T Consensus       317 ~~~l~~  322 (364)
T 3op5_A          317 YENLRD  322 (364)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999874

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.8e-41  Score=303.51  Aligned_cols=207  Identities=25%  Similarity=0.364  Sum_probs=152.7

Q ss_pred             CC-CCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccC
Q 022799            3 LL-DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRD   81 (292)
Q Consensus         3 ~l-~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~d   81 (292)
                      .+ +|||||++++++     .+..+.|+|||||+|+|.+++...   .....+..+..++.||+.||.|||++ ||+|||
T Consensus        73 ~l~~HpnIv~l~~~~-----~~~~~~~lv~E~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrD  143 (432)
T 3p23_A           73 ESDEHPNVIRYFCTE-----KDRQFQYIAIELCAATLQEYVEQK---DFAHLGLEPITLLQQTTSGLAHLHSL-NIVHRD  143 (432)
T ss_dssp             HSCCCTTBCCEEEEE-----EETTEEEEEEECCSEEHHHHHHSS---SCCCCSSCHHHHHHHHHHHHHHHHHT-TCCCCC
T ss_pred             hccCCCCcCeEEEEE-----ecCCEEEEEEECCCCCHHHHHHhc---CCCccchhHHHHHHHHHHHHHHHHHC-cCEeCC
Confidence            45 799999999988     445568999999999999998754   23345556788999999999999998 999999


Q ss_pred             CCCCcEEEeCC---C-CcEEEeecCCccccccCC----CcccccccccccCCccccC--CCCCCchhHhhhhhHHHHHHH
Q 022799           82 IKPQNLLVNPH---T-HQLKLCDFGSAKVLVKGE----PNISYICSRYYRAPELIFG--ATEYTAAIDIWSAGCVLAELL  151 (292)
Q Consensus        82 lkp~Nill~~~---~-~~ikl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslG~il~el~  151 (292)
                      |||+||+++.+   + ..+||+|||+++......    ......||+.|+|||++.+  ...++.++||||+||++|+|+
T Consensus       144 lKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ell  223 (432)
T 3p23_A          144 LKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVI  223 (432)
T ss_dssp             CSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHH
T ss_pred             CCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHH
Confidence            99999999532   2 157899999998764332    2334578999999999964  244788999999999999999


Q ss_pred             h-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCccc
Q 022799          152 L-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST  230 (292)
Q Consensus       152 ~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t  230 (292)
                      + |..||....... ...+.   +...               .....       .....+..+.+||.+||+.||.+|||
T Consensus       224 t~g~~pf~~~~~~~-~~~~~---~~~~---------------~~~~~-------~~~~~~~~~~~li~~~L~~dP~~Rps  277 (432)
T 3p23_A          224 SEGSHPFGKSLQRQ-ANILL---GACS---------------LDCLH-------PEKHEDVIARELIEKMIAMDPQKRPS  277 (432)
T ss_dssp             TTSCBTTBSTTTHH-HHHHT---TCCC---------------CTTSC-------TTCHHHHHHHHHHHHHSCSSGGGSCC
T ss_pred             cCCCCCcchhhHHH-HHHHh---ccCC---------------ccccC-------ccccccHHHHHHHHHHHhCCHhhCCC
Confidence            9 899996543322 11111   1000               00000       00123556899999999999999999


Q ss_pred             HHHHhcCCCccccC
Q 022799          231 ALEALIHPFFDELR  244 (292)
Q Consensus       231 ~~e~l~hp~~~~~~  244 (292)
                      ++++++||||.++.
T Consensus       278 ~~evl~hp~f~~~~  291 (432)
T 3p23_A          278 AKHVLKHPFFWSLE  291 (432)
T ss_dssp             HHHHHTSTTTCCHH
T ss_pred             HHHHHhCccccChH
Confidence            99999999997643

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-40  Score=287.24  Aligned_cols=208  Identities=25%  Similarity=0.392  Sum_probs=161.2

Q ss_pred             CCCCeeeeceeeeccCC-CCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCC
Q 022799            5 DHPNVVSLKHCFFSTTE-KDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDI   82 (292)
Q Consensus         5 ~HpnIv~~~~~~~~~~~-~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dl   82 (292)
                      +||||+++++++..... .....+++||||++ |+|.+++....  ...+++..++.++.||+.||.|||++ ||+||||
T Consensus        79 ~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dl  155 (326)
T 2x7f_A           79 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH-KVIHRDI  155 (326)
T ss_dssp             CSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCC
T ss_pred             CCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCC
Confidence            79999999999865432 12346899999998 59999987542  35689999999999999999999998 9999999


Q ss_pred             CCCcEEEeCCCCcEEEeecCCccccccCC-CcccccccccccCCccccC----CCCCCchhHhhhhhHHHHHHHhCCCCC
Q 022799           83 KPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFG----ATEYTAAIDIWSAGCVLAELLLGQPLF  157 (292)
Q Consensus        83 kp~Nill~~~~~~ikl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslG~il~el~~g~~pf  157 (292)
                      ||+||+++.++ .+||+|||++....... ......||+.|+|||++.+    ...++.++|+|||||++|+|++|..||
T Consensus       156 kp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~  234 (326)
T 2x7f_A          156 KGQNVLLTENA-EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL  234 (326)
T ss_dssp             SGGGEEECTTC-CEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTT
T ss_pred             cHHHEEEcCCC-CEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCC
Confidence            99999999888 79999999987654322 2334578999999999862    234889999999999999999999999


Q ss_pred             CCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          158 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      .+.+.......+.... .+                  .        ..+..+++.+.+||.+||..||.+|||+.++++|
T Consensus       235 ~~~~~~~~~~~~~~~~-~~------------------~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  287 (326)
T 2x7f_A          235 CDMHPMRALFLIPRNP-AP------------------R--------LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH  287 (326)
T ss_dssp             TTSCHHHHHHHHHHSC-CC------------------C--------CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             CCCcHHHHHHHhhcCc-cc------------------c--------CCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            8877665554433210 00                  0        0114578999999999999999999999999999


Q ss_pred             CCcccc
Q 022799          238 PFFDEL  243 (292)
Q Consensus       238 p~~~~~  243 (292)
                      |||++.
T Consensus       288 p~~~~~  293 (326)
T 2x7f_A          288 PFIRDQ  293 (326)
T ss_dssp             HHHHCC
T ss_pred             hHHhhC
Confidence            999864

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2.6e-40  Score=282.13  Aligned_cols=210  Identities=24%  Similarity=0.380  Sum_probs=157.0

Q ss_pred             CCCCCCCCeeeeceeeeccCC--------CCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHH
Q 022799            1 MRLLDHPNVVSLKHCFFSTTE--------KDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYI   71 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~--------~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~L   71 (292)
                      |++++||||+++++++.....        .+....|+||||++ |+|.+++...   ...+++..++.++.||+.||.||
T Consensus        56 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~L  132 (303)
T 1zy4_A           56 LASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWRLFRQILEALSYI  132 (303)
T ss_dssp             HTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHS---CGGGCHHHHHHHHHHHHHHHHHH
T ss_pred             HHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhcc---ccccchHHHHHHHHHHHHHHHHH
Confidence            467899999999998754321        23567899999998 6999998753   34578889999999999999999


Q ss_pred             HhcCCccccCCCCCcEEEeCCCCcEEEeecCCccccccC---------------CCcccccccccccCCccccCCCCCCc
Q 022799           72 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG---------------EPNISYICSRYYRAPELIFGATEYTA  136 (292)
Q Consensus        72 H~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~  136 (292)
                      |++ ||+||||||+||+++.++ .+||+|||.+......               .......||+.|+|||++.+...++.
T Consensus       133 H~~-~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  210 (303)
T 1zy4_A          133 HSQ-GIIHRDLKPMNIFIDESR-NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNE  210 (303)
T ss_dssp             HHT-TCCCSCCCGGGEEECTTS-CEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCT
T ss_pred             HhC-CeecccCCHHhEEEcCCC-CEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcc
Confidence            998 999999999999999888 7999999999765321               12234568999999999976656899


Q ss_pred             hhHhhhhhHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHH
Q 022799          137 AIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDL  216 (292)
Q Consensus       137 ~~DvwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  216 (292)
                      ++|+||+||++|+|++   ||................           .     ..        +...++...++.+.++
T Consensus       211 ~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~~-----------~-----~~--------~~~~~~~~~~~~~~~l  263 (303)
T 1zy4_A          211 KIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSV-----------S-----IE--------FPPDFDDNKMKVEKKI  263 (303)
T ss_dssp             HHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHST-----------T-----CC--------CCTTCCTTTSHHHHHH
T ss_pred             hhhHHHHHHHHHHHHh---ccCCchhHHHHHHhcccc-----------c-----cc--------cCccccccchHHHHHH
Confidence            9999999999999998   554322221111111100           0     00        0111234577889999


Q ss_pred             HHHHhccCCCCcccHHHHhcCCCccc
Q 022799          217 VSRLLQYSPNLRSTALEALIHPFFDE  242 (292)
Q Consensus       217 i~~~l~~dp~~R~t~~e~l~hp~~~~  242 (292)
                      |.+||..||.+|||+.++++||||+.
T Consensus       264 i~~~l~~dp~~Rps~~~ll~h~~~~~  289 (303)
T 1zy4_A          264 IRLLIDHDPNKRPGARTLLNSGWLPV  289 (303)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred             HHHHHhcCcccCcCHHHHhCCCCcCC
Confidence            99999999999999999999999975

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.6e-40  Score=284.06  Aligned_cols=201  Identities=26%  Similarity=0.429  Sum_probs=166.9

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      +.++||||+++++++..     ....++||||++ ++|.+++.     ...+++..+..++.||+.||.|||++ ||+||
T Consensus        75 ~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~  143 (303)
T 3a7i_A           75 SQCDSPYVTKYYGSYLK-----DTKLWIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSE-KKIHR  143 (303)
T ss_dssp             HHCCCTTBCCEEEEEEE-----TTEEEEEEECCTTEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHT-TEECC
T ss_pred             HhCCCCCEeEEEEEEec-----CCeEEEEEEeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCccC
Confidence            45799999999999843     345899999998 58888775     35789999999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCC-CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      ||||+||+++.++ .++|+|||.+....... ......||+.|+|||++.+. .++.++|+||+||++|+|++|..||..
T Consensus       144 dl~p~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~  221 (303)
T 3a7i_A          144 DIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELARGEPPHSE  221 (303)
T ss_dssp             CCSGGGEEECTTS-CEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             CCChheEEECCCC-CEEEeecccceecCccccccCccCCCcCccCHHHHhcC-CCCchhhhHHHHHHHHHHccCCCCCCC
Confidence            9999999999888 79999999997764432 23345789999999999664 489999999999999999999999987


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCC
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF  239 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~  239 (292)
                      .........+... . +                          ..++..++..+.++|.+||..||.+|||+.++++|||
T Consensus       222 ~~~~~~~~~~~~~-~-~--------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~  273 (303)
T 3a7i_A          222 LHPMKVLFLIPKN-N-P--------------------------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKF  273 (303)
T ss_dssp             SCHHHHHHHHHHS-C-C--------------------------CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred             cCHHHHHHHhhcC-C-C--------------------------CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence            7665544443321 0 0                          0112468899999999999999999999999999999


Q ss_pred             cccc
Q 022799          240 FDEL  243 (292)
Q Consensus       240 ~~~~  243 (292)
                      |...
T Consensus       274 ~~~~  277 (303)
T 3a7i_A          274 ILRN  277 (303)
T ss_dssp             HHHH
T ss_pred             hhcC
Confidence            9864

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2.4e-40  Score=283.98  Aligned_cols=205  Identities=20%  Similarity=0.325  Sum_probs=156.2

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCC--cc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG--VC   78 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~--i~   78 (292)
                      ++++||||+++++++     .+...+++||||++ |+|.+++..... ...+++..+..++.||+.||.|||++ |  |+
T Consensus        89 ~~l~hp~iv~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~-~~~iv  161 (309)
T 3p86_A           89 KRLRHPNIVLFMGAV-----TQPPNLSIVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNR-NPPIV  161 (309)
T ss_dssp             HHCCCTTBCCEEEEE-----CSTTCCEEEEECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHTS-SSCCC
T ss_pred             HhCCCCCEeeEEEEE-----EECCceEEEEecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcC-CCCEE
Confidence            467999999999998     34444899999998 699998875321 12489999999999999999999987 9  99


Q ss_pred             ccCCCCCcEEEeCCCCcEEEeecCCccccccCC-CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCC
Q 022799           79 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF  157 (292)
Q Consensus        79 H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf  157 (292)
                      ||||||+||+++.++ .+||+|||+++...... ......||+.|+|||++.+. .++.++|+||+||++|+|++|..||
T Consensus       162 H~Dikp~NIll~~~~-~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf  239 (309)
T 3p86_A          162 HRNLKSPNLLVDKKY-TVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDVYSFGVILWELATLQQPW  239 (309)
T ss_dssp             CTTCCGGGEEECTTC-CEEECCCC-----------------CCTTSCHHHHTTC-CCCTTHHHHHHHHHHHHHHHCCCTT
T ss_pred             CCCCChhhEEEeCCC-cEEECCCCCCccccccccccccCCCCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCC
Confidence            999999999999888 79999999997653332 23346789999999999765 4899999999999999999999999


Q ss_pred             CCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc-
Q 022799          158 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI-  236 (292)
Q Consensus       158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~-  236 (292)
                      .+.+..+....+......+                           .++..+++.+.++|.+||..||.+|||+.++++ 
T Consensus       240 ~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~  292 (309)
T 3p86_A          240 GNLNPAQVVAAVGFKCKRL---------------------------EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDL  292 (309)
T ss_dssp             TTSCHHHHHHHHHHSCCCC---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCHHHHHHHHHhcCCCC---------------------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            8877666554443211100                           122568999999999999999999999999986 


Q ss_pred             -CCCccc
Q 022799          237 -HPFFDE  242 (292)
Q Consensus       237 -hp~~~~  242 (292)
                       .+++++
T Consensus       293 L~~~~~~  299 (309)
T 3p86_A          293 LRPLIKS  299 (309)
T ss_dssp             HHHHHC-
T ss_pred             HHHHHHh
Confidence             455543

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=6.7e-41  Score=290.73  Aligned_cols=214  Identities=24%  Similarity=0.396  Sum_probs=144.3

Q ss_pred             CCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccC
Q 022799            3 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRD   81 (292)
Q Consensus         3 ~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~d   81 (292)
                      .++||||+++++++.... .+..++++||||++ |+|.+++....  ...+++..++.++.||+.||.|||++ ||+|||
T Consensus        78 ~~~h~~i~~~~~~~~~~~-~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~~LH~~-~ivH~d  153 (336)
T 3fhr_A           78 ASGGPHIVCILDVYENMH-HGKRCLLIIMECMEGGELFSRIQERG--DQAFTEREAAEIMRDIGTAIQFLHSH-NIAHRD  153 (336)
T ss_dssp             HTTSTTBCCEEEEEEEEE-TTEEEEEEEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHT-TEECSC
T ss_pred             hcCCCChHHHHHHHhhcc-CCCceEEEEEeccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCC
Confidence            468999999999985433 33556899999998 59999987532  24699999999999999999999998 999999


Q ss_pred             CCCCcEEEeCCC--CcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           82 IKPQNLLVNPHT--HQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        82 lkp~Nill~~~~--~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      |||+||+++.++  ..+||+|||++...... ......||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+
T Consensus       154 lkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~  231 (336)
T 3fhr_A          154 VKPENLLYTSKEKDAVLKLTDFGFAKETTQN-ALQTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGFPPFYS  231 (336)
T ss_dssp             CSGGGEEESCSSTTCCEEECCCTTCEEC-----------------------C-HHHHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred             CCHHHEEEEecCCCceEEEeccccceecccc-ccccCCCCcCccChhhhCCC-CCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            999999997532  25999999999865432 23456789999999998554 489999999999999999999999976


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCC
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF  239 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~  239 (292)
                      ................             .....+        ......+++++.+||.+||..||.+|||+.++++|||
T Consensus       232 ~~~~~~~~~~~~~~~~-------------~~~~~~--------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  290 (336)
T 3fhr_A          232 NTGQAISPGMKRRIRL-------------GQYGFP--------NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPW  290 (336)
T ss_dssp             --------------------------------CCC--------TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred             ccchhhhhhHHHhhhc-------------cccccC--------chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence            6543322111111000             000000        0011458999999999999999999999999999999


Q ss_pred             cccc
Q 022799          240 FDEL  243 (292)
Q Consensus       240 ~~~~  243 (292)
                      |++.
T Consensus       291 ~~~~  294 (336)
T 3fhr_A          291 INQS  294 (336)
T ss_dssp             HHTG
T ss_pred             cccc
Confidence            9864

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=4.3e-40  Score=289.22  Aligned_cols=200  Identities=20%  Similarity=0.328  Sum_probs=161.4

Q ss_pred             CCC-CCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHH
Q 022799            2 RLL-DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYK------------MSQRMPLIYVKLYFYQICRA   67 (292)
Q Consensus         2 ~~l-~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~------------~~~~~~~~~~~~~~~qil~a   67 (292)
                      +++ +||||+++++++     .+...+|+||||++ |+|.+++.....            ....+++..+..++.||+.|
T Consensus       141 ~~l~~hpnIv~~~~~~-----~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~a  215 (370)
T 2psq_A          141 KMIGKHKNIINLLGAC-----TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARG  215 (370)
T ss_dssp             HHSCCCTTBCCEEEEE-----CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHH
T ss_pred             HHhcCCCCEeeEEEEE-----ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHH
Confidence            346 899999999998     33445899999998 699999876421            12458999999999999999


Q ss_pred             HHHHHhcCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCCC---cccccccccccCCccccCCCCCCchhHhhhhh
Q 022799           68 LAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAG  144 (292)
Q Consensus        68 l~~LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG  144 (292)
                      |.|||++ ||+||||||+||+++.++ .+||+|||+++.......   .....+|+.|+|||++.+. .++.++|+||||
T Consensus       216 L~~LH~~-~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG  292 (370)
T 2psq_A          216 MEYLASQ-KCIHRDLAARNVLVTENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFG  292 (370)
T ss_dssp             HHHHHHT-TEECSCCCGGGEEECTTC-CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTC-CCCHHHHHHHHH
T ss_pred             HHHHHhC-CeeccccchhhEEECCCC-CEEEccccCCcccCcccceecccCCCcccceECHhHhcCC-CCCcHHHHHHHH
Confidence            9999998 999999999999999888 799999999986643321   2234568899999999765 489999999999


Q ss_pred             HHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhcc
Q 022799          145 CVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQY  223 (292)
Q Consensus       145 ~il~el~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  223 (292)
                      |++|+|++ |..||.+....+....+.... .                           ...+..+++++.++|.+||..
T Consensus       293 ~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~---------------------------~~~~~~~~~~l~~li~~~l~~  344 (370)
T 2psq_A          293 VLMWEIFTLGGSPYPGIPVEELFKLLKEGH-R---------------------------MDKPANCTNELYMMMRDCWHA  344 (370)
T ss_dssp             HHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-C---------------------------CCCCTTSCHHHHHHHHHHTCS
T ss_pred             HHHHHHHcCCCCCCCCCCHHHHHHHHhcCC-C---------------------------CCCCCCCCHHHHHHHHHHcCC
Confidence            99999999 999998877655544433210 0                           001246789999999999999


Q ss_pred             CCCCcccHHHHhcC
Q 022799          224 SPNLRSTALEALIH  237 (292)
Q Consensus       224 dp~~R~t~~e~l~h  237 (292)
                      ||.+|||+.+++++
T Consensus       345 dP~~Rpt~~ell~~  358 (370)
T 2psq_A          345 VPSQRPTFKQLVED  358 (370)
T ss_dssp             SGGGSCCHHHHHHH
T ss_pred             ChhhCcCHHHHHHH
Confidence            99999999999853

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2e-40  Score=297.20  Aligned_cols=209  Identities=28%  Similarity=0.436  Sum_probs=151.5

Q ss_pred             CCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCC---CCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            4 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQR---MPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         4 l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~---~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      .+|||||++++++     .+..++|+|||||+|+|.+++.........   .++..+..++.||+.||.|||++ ||+||
T Consensus        66 ~~HpnIv~~~~~~-----~~~~~~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHr  139 (434)
T 2rio_A           66 DDHPNVIRYYCSE-----TTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL-KIIHR  139 (434)
T ss_dssp             TTSTTBCCEEEEE-----ECSSEEEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT-TEECC
T ss_pred             cCCCCcCeEEEEE-----ecCCeEEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC-Ccccc
Confidence            4899999999988     445569999999999999999754322111   13334677999999999999988 99999


Q ss_pred             CCCCCcEEEeCCC------------CcEEEeecCCccccccCCC-----cccccccccccCCccccC------CCCCCch
Q 022799           81 DIKPQNLLVNPHT------------HQLKLCDFGSAKVLVKGEP-----NISYICSRYYRAPELIFG------ATEYTAA  137 (292)
Q Consensus        81 dlkp~Nill~~~~------------~~ikl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~------~~~~~~~  137 (292)
                      ||||+||+++.++            ..+||+|||+++.......     .....||+.|+|||++.+      ...++.+
T Consensus       140 DLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~  219 (434)
T 2rio_A          140 DLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRS  219 (434)
T ss_dssp             CCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTH
T ss_pred             CCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchh
Confidence            9999999997532            2699999999987644321     224578999999999965      2458999


Q ss_pred             hHhhhhhHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHH
Q 022799          138 IDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDL  216 (292)
Q Consensus       138 ~DvwslG~il~el~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  216 (292)
                      +|+||+||++|+|++ |..||.+.....  ..+.....                 ..+....     ..+..+++++.++
T Consensus       220 ~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~i~~~~~-----------------~~~~~~~-----~~~~~~~~~~~~l  275 (434)
T 2rio_A          220 IDIFSMGCVFYYILSKGKHPFGDKYSRE--SNIIRGIF-----------------SLDEMKC-----LHDRSLIAEATDL  275 (434)
T ss_dssp             HHHHHHHHHHHHHHTTSCCTTCSTTTHH--HHHHHTCC-----------------CCCCCTT-----CCCHHHHHHHHHH
T ss_pred             hhhHhHHHHHHHHHhCCCCCCCCchhhH--HHHhcCCC-----------------Ccccccc-----cccccchHHHHHH
Confidence            999999999999999 999997654332  22222110                 0000000     0012356789999


Q ss_pred             HHHHhccCCCCcccHHHHhcCCCccc
Q 022799          217 VSRLLQYSPNLRSTALEALIHPFFDE  242 (292)
Q Consensus       217 i~~~l~~dp~~R~t~~e~l~hp~~~~  242 (292)
                      |.+||+.||.+|||+.++++||||.+
T Consensus       276 i~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          276 ISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             HHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             HHHHhhCChhhCCCHHHHHhCCccCC
Confidence            99999999999999999999999964

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-40  Score=291.93  Aligned_cols=205  Identities=19%  Similarity=0.238  Sum_probs=165.3

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYK---MSQRMPLIYVKLYFYQICRALAYIHNTIGV   77 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~---~~~~~~~~~~~~~~~qil~al~~LH~~~~i   77 (292)
                      ++++||||+++++++.     +....++||||++ |+|.+++.....   ....+++..+..++.||+.||.|||++ ||
T Consensus       129 ~~l~hpnIv~~~~~~~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~i  202 (367)
T 3l9p_A          129 SKFNHQNIVRCIGVSL-----QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN-HF  202 (367)
T ss_dssp             HHCCCTTBCCEEEEEC-----SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT-TC
T ss_pred             HhCCCCCCCeEEEEEe-----cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC-Ce
Confidence            4579999999999983     3444789999997 699999886532   224589999999999999999999998 99


Q ss_pred             cccCCCCCcEEEeCCC--CcEEEeecCCccccccC---CCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh
Q 022799           78 CHRDIKPQNLLVNPHT--HQLKLCDFGSAKVLVKG---EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL  152 (292)
Q Consensus        78 ~H~dlkp~Nill~~~~--~~ikl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~  152 (292)
                      +||||||+|||++.++  ..+||+|||+++.....   .......||+.|+|||++.+. .++.++|+|||||++|+|++
T Consensus       203 vHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt  281 (367)
T 3l9p_A          203 IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFS  281 (367)
T ss_dssp             CCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHT
T ss_pred             eCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCC-CCCcHHHHHHHHHHHHHHHh
Confidence            9999999999998544  25999999999754222   223345678999999999665 48999999999999999998


Q ss_pred             -CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccH
Q 022799          153 -GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA  231 (292)
Q Consensus       153 -g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~  231 (292)
                       |..||.+....+....+......                            ..+..+++.+.+||.+||+.||.+|||+
T Consensus       282 ~g~~pf~~~~~~~~~~~i~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~  333 (367)
T 3l9p_A          282 LGYMPYPSKSNQEVLEFVTSGGRM----------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNF  333 (367)
T ss_dssp             TSCCSSTTCCHHHHHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCCCCCCCCCHHHHHHHHHcCCCC----------------------------CCCccCCHHHHHHHHHHcCCCHhHCcCH
Confidence             99999888776655554431100                            0124578999999999999999999999


Q ss_pred             HHHhcCCCcc
Q 022799          232 LEALIHPFFD  241 (292)
Q Consensus       232 ~e~l~hp~~~  241 (292)
                      .+++++.++-
T Consensus       334 ~eil~~l~~~  343 (367)
T 3l9p_A          334 AIILERIEYC  343 (367)
T ss_dssp             HHHHHHHHHH
T ss_pred             HHHHHHHHHH
Confidence            9999987664

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=4.3e-40  Score=284.39  Aligned_cols=197  Identities=21%  Similarity=0.343  Sum_probs=160.4

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++     .+....++||||++ |+|.+++...   ...+++..+..++.||+.||.|||++ ||+|
T Consensus       104 l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH  174 (325)
T 3kul_A          104 MGQFDHPNIIRLEGVV-----TRGRLAMIVTEYMENGSLDTFLRTH---DGQFTIMQLVGMLRGVGAGMRYLSDL-GYVH  174 (325)
T ss_dssp             HTTCCCTTBCCEEEEE-----CGGGCCEEEEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT-TEEC
T ss_pred             HHhCCCCCCCcEEEEE-----EeCCccEEEeeCCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC-CeeC
Confidence            4678999999999998     44455899999997 6999988653   45799999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCc----ccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQ  154 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~  154 (292)
                      |||||+||+++.++ .+||+|||+++........    ....+|+.|+|||++.+. .++.++|+||+||++|+|++ |.
T Consensus       175 ~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~  252 (325)
T 3kul_A          175 RDLAARNVLVDSNL-VCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR-TFSSASDVWSFGVVMWEVLAYGE  252 (325)
T ss_dssp             SCCSGGGEEECTTC-CEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSC
T ss_pred             CCCCcceEEECCCC-CEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCC
Confidence            99999999999888 7999999999876443211    122457789999999654 48999999999999999999 99


Q ss_pred             CCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHH
Q 022799          155 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA  234 (292)
Q Consensus       155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~  234 (292)
                      .||.+....+....+......+                            .+..+++.+.++|.+||..||.+|||+.++
T Consensus       253 ~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ei  304 (325)
T 3kul_A          253 RPYWNMTNRDVISSVEEGYRLP----------------------------APMGCPHALHQLMLDCWHKDRAQRPRFSQI  304 (325)
T ss_dssp             CTTTTSCHHHHHHHHHTTCCCC----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCcccCCHHHHHHHHHcCCCCC----------------------------CCCCcCHHHHHHHHHHccCChhhCcCHHHH
Confidence            9998887766655554321110                            124688999999999999999999999999


Q ss_pred             hc
Q 022799          235 LI  236 (292)
Q Consensus       235 l~  236 (292)
                      ++
T Consensus       305 l~  306 (325)
T 3kul_A          305 VS  306 (325)
T ss_dssp             HH
T ss_pred             HH
Confidence            84

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=6.7e-40  Score=282.71  Aligned_cols=213  Identities=19%  Similarity=0.265  Sum_probs=156.5

Q ss_pred             CCCCCCCCeeeeceeeeccCCCC-ceeEEEEeeccc-CCHHHHHHhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKD-ELYLNLVLEYVP-ETVHRVIKHHYKM--SQRMPLIYVKLYFYQICRALAYIHNTIG   76 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~-~~~~~lv~e~~~-g~L~~~l~~~~~~--~~~~~~~~~~~~~~qil~al~~LH~~~~   76 (292)
                      |++++||||+++++++......+ ....++||||+. |+|.+++......  ...+++..+..++.||+.||.|||++ |
T Consensus        79 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~-~  157 (323)
T 3qup_A           79 MKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR-N  157 (323)
T ss_dssp             HTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT-T
T ss_pred             HHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC-C
Confidence            46789999999999986543321 123489999998 5999988754321  22689999999999999999999998 9


Q ss_pred             ccccCCCCCcEEEeCCCCcEEEeecCCccccccCCC---cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-
Q 022799           77 VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-  152 (292)
Q Consensus        77 i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-  152 (292)
                      |+||||||+||+++.++ .+||+|||+++.......   .....+|+.|+|||.+.+. .++.++|+||+||++|+|++ 
T Consensus       158 ivH~Dikp~NIli~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~  235 (323)
T 3qup_A          158 FIHRDLAARNCMLAEDM-TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADN-LYTVHSDVWAFGVTMWEIMTR  235 (323)
T ss_dssp             CCCSCCSGGGEEECTTS-CEEECCCCC-----------------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTT
T ss_pred             cccCCCCcceEEEcCCC-CEEEeeccccccccccccccccccccCcccccCchhhcCC-CCCCccchhhHHHHHHHHHhC
Confidence            99999999999999888 799999999987644322   1234567889999999664 48999999999999999999 


Q ss_pred             CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCccc--
Q 022799          153 GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST--  230 (292)
Q Consensus       153 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t--  230 (292)
                      |..||.+....+....+......                            ..+..+++++.++|.+||..||.+|||  
T Consensus       236 g~~p~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~  287 (323)
T 3qup_A          236 GQTPYAGIENAEIYNYLIGGNRL----------------------------KQPPECMEEVYDLMYQCWSADPKQRPSFT  287 (323)
T ss_dssp             SCCTTTTCCGGGHHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHH
T ss_pred             CCCCccccChHHHHHHHhcCCCC----------------------------CCCCccCHHHHHHHHHHccCChhhCcCHH
Confidence            99999888776665554431100                            012468899999999999999999999  


Q ss_pred             -----HHHHhcCCCccccC
Q 022799          231 -----ALEALIHPFFDELR  244 (292)
Q Consensus       231 -----~~e~l~hp~~~~~~  244 (292)
                           +++++.|||+....
T Consensus       288 ~l~~~l~~~l~~~~~~~~~  306 (323)
T 3qup_A          288 CLRMELENILGHLSVLSTS  306 (323)
T ss_dssp             HHHHHHHHHHHC-------
T ss_pred             HHHHHHHHHHHHhhhcCCC
Confidence                 77888999998643

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5e-40  Score=276.38  Aligned_cols=198  Identities=19%  Similarity=0.337  Sum_probs=161.8

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++     .+....++||||++ ++|.+++...   ...+++..+..++.|++.||.|||++ ||+|
T Consensus        59 l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H  129 (269)
T 4hcu_A           59 MMKLSHPKLVQLYGVC-----LEQAPICLVFEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA-CVIH  129 (269)
T ss_dssp             HHTCCCTTBCCEEEEE-----CSSSSEEEEEECCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TCCC
T ss_pred             HHhCCCCCEeeEEEEE-----ecCCceEEEEEeCCCCcHHHHHHhc---CcccCHHHHHHHHHHHHHHHHHHHhC-Ceec
Confidence            3578999999999998     44445899999998 6899888653   35689999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCC--CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPL  156 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~p  156 (292)
                      |||||+||+++.++ .++|+|||++.......  ......+|+.|+|||++.+. .++.++|+||+||++|+|++ |..|
T Consensus       130 ~dikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~~g~~p  207 (269)
T 4hcu_A          130 RDLAARNCLVGENQ-VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIP  207 (269)
T ss_dssp             SCCCGGGEEECGGG-CEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             CCcchheEEEcCCC-CEEeccccccccccccccccccCcccccccCCHHHhcCC-CCCchhhhHHHHHHHHHHhcCCCCC
Confidence            99999999999887 79999999997653321  12234567889999999654 48999999999999999999 9999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      |.+....+....+......                            ..+..+++.+.++|.+||..||.+|||+.++++
T Consensus       208 ~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  259 (269)
T 4hcu_A          208 YENRSNSEVVEDISTGFRL----------------------------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLR  259 (269)
T ss_dssp             TTTCCHHHHHHHHHTTCCC----------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCHHHHHHHHhcCccC----------------------------CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            9887776655554331100                            012457899999999999999999999999986


Q ss_pred             C
Q 022799          237 H  237 (292)
Q Consensus       237 h  237 (292)
                      +
T Consensus       260 ~  260 (269)
T 4hcu_A          260 Q  260 (269)
T ss_dssp             H
T ss_pred             H
Confidence            5

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=8e-40  Score=280.71  Aligned_cols=205  Identities=25%  Similarity=0.428  Sum_probs=160.4

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++..     ....++||||++ |+|.+++...   ...+++..+..++.||+.||.|||++ ||+|
T Consensus        61 l~~l~hp~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH  131 (310)
T 3s95_A           61 MRCLEHPNVLKFIGVLYK-----DKRLNFITEYIKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSM-NIIH  131 (310)
T ss_dssp             HTTCCCTTBCCEEEEEEE-----TTEEEEEEECCTTCBHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHHT-TEEC
T ss_pred             HHhCCCcCcccEEEEEec-----CCeeEEEEEecCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC-CccC
Confidence            467899999999999843     345899999998 5999998753   46799999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCc---------------ccccccccccCCccccCCCCCCchhHhhhhh
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN---------------ISYICSRYYRAPELIFGATEYTAAIDIWSAG  144 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~---------------~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG  144 (292)
                      |||||+||+++.++ .+||+|||++.........               ....||+.|+|||++.+. .++.++||||+|
T Consensus       132 ~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG  209 (310)
T 3s95_A          132 RDLNSHNCLVRENK-NVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR-SYDEKVDVFSFG  209 (310)
T ss_dssp             SCCSTTSEEECTTS-CEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTC-CCCTHHHHHHHH
T ss_pred             CCCCcCeEEECCCC-CEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCC-CCCcHHHHHHHH
Confidence            99999999999888 7999999999875433211               145789999999999764 589999999999


Q ss_pred             HHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccC
Q 022799          145 CVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYS  224 (292)
Q Consensus       145 ~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  224 (292)
                      |++|+|++|..||..........                          ............+..+++.+.++|.+||..|
T Consensus       210 ~~l~el~~g~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d  263 (310)
T 3s95_A          210 IVLCEIIGRVNADPDYLPRTMDF--------------------------GLNVRGFLDRYCPPNCPPSFFPITVRCCDLD  263 (310)
T ss_dssp             HHHHHHHHTCCSSTTTSCBCTTS--------------------------SBCHHHHHHHTCCTTCCTTHHHHHHHHTCSS
T ss_pred             HHHHHHhcCCCCCcchhhhHHHH--------------------------hhhhhccccccCCCCCCHHHHHHHHHHccCC
Confidence            99999999999986532211000                          0000000011123568899999999999999


Q ss_pred             CCCcccHHHHhcCCCccccC
Q 022799          225 PNLRSTALEALIHPFFDELR  244 (292)
Q Consensus       225 p~~R~t~~e~l~hp~~~~~~  244 (292)
                      |++|||+.++++  +++.+.
T Consensus       264 P~~Rps~~~l~~--~L~~l~  281 (310)
T 3s95_A          264 PEKRPSFVKLEH--WLETLR  281 (310)
T ss_dssp             GGGSCCHHHHHH--HHHHHH
T ss_pred             hhhCcCHHHHHH--HHHHHH
Confidence            999999999985  666654

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.2e-39  Score=276.16  Aligned_cols=198  Identities=16%  Similarity=0.160  Sum_probs=159.0

Q ss_pred             CCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCC
Q 022799            5 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKP   84 (292)
Q Consensus         5 ~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlkp   84 (292)
                      +||||+++++++     .+....++||||++++|.+++...   ...+++..+..++.||+.||.|||++ ||+||||||
T Consensus        64 ~~~~i~~~~~~~-----~~~~~~~lv~e~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dlkp  134 (298)
T 1csn_A           64 GCTGIPNVYYFG-----QEGLHNVLVIDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK-SLVYRDIKP  134 (298)
T ss_dssp             TCTTCCCEEEEE-----EETTEEEEEEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCG
T ss_pred             cCCCCCeEEeec-----CCCceeEEEEEecCCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCH
Confidence            799999999988     444458999999988999998753   35699999999999999999999987 999999999


Q ss_pred             CcEEEeCCCC----cEEEeecCCccccccCCC--------cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh
Q 022799           85 QNLLVNPHTH----QLKLCDFGSAKVLVKGEP--------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL  152 (292)
Q Consensus        85 ~Nill~~~~~----~ikl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~  152 (292)
                      +||+++.++.    .+||+|||++........        .....||+.|+|||++.+. .++.++|+||+||++|+|++
T Consensus       135 ~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~  213 (298)
T 1csn_A          135 DNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLR  213 (298)
T ss_dssp             GGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHH
T ss_pred             HHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHc
Confidence            9999986652    399999999987654322        2345689999999999664 48999999999999999999


Q ss_pred             CCCCCCCCC---cHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcc
Q 022799          153 GQPLFPGES---GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS  229 (292)
Q Consensus       153 g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~  229 (292)
                      |..||.+.+   .......+......++...                        +...+++++.++|.+||..||++||
T Consensus       214 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~l~~li~~~l~~dp~~RP  269 (298)
T 1csn_A          214 GSLPWQGLKAATNKQKYERIGEKKQSTPLRE------------------------LCAGFPEEFYKYMHYARNLAFDATP  269 (298)
T ss_dssp             SSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH------------------------HTTTSCHHHHHHHHHHHHCCTTCCC
T ss_pred             CCCCcchhhccccHHHHHHHHhhccCccHHH------------------------HHhhCcHHHHHHHHHHhcCCcccCC
Confidence            999998753   2333333333221111111                        1246899999999999999999999


Q ss_pred             cHHHHhc
Q 022799          230 TALEALI  236 (292)
Q Consensus       230 t~~e~l~  236 (292)
                      |++++++
T Consensus       270 ~~~~l~~  276 (298)
T 1csn_A          270 DYDYLQG  276 (298)
T ss_dssp             CHHHHHH
T ss_pred             CHHHHHH
Confidence            9999974

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.1e-39  Score=282.37  Aligned_cols=198  Identities=17%  Similarity=0.194  Sum_probs=157.6

Q ss_pred             CC-CCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccC
Q 022799            3 LL-DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRD   81 (292)
Q Consensus         3 ~l-~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~d   81 (292)
                      .+ +||||+++++++.     +..+.++||||++++|.+++...   ...+++..+..++.||+.||.|||++ ||+|||
T Consensus        60 ~l~~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~-~iiHrD  130 (330)
T 2izr_A           60 QLGSGDGIPQVYYFGP-----CGKYNAMVLELLGPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSK-NLIYRD  130 (330)
T ss_dssp             HHCSCTTSCCEEEEEE-----ETTEEEEEEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCC
T ss_pred             HhhCCCCCCEEEEEEe-----cCCccEEEEEeCCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccC
Confidence            45 8999999999884     34458999999988999998753   46799999999999999999999998 999999


Q ss_pred             CCCCcEEEeCCCCc-----EEEeecCCccccccCCC--------cccccccccccCCccccCCCCCCchhHhhhhhHHHH
Q 022799           82 IKPQNLLVNPHTHQ-----LKLCDFGSAKVLVKGEP--------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLA  148 (292)
Q Consensus        82 lkp~Nill~~~~~~-----ikl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~  148 (292)
                      |||+||+++.++ .     +||+|||+++.......        .....||+.|+|||++.+. .++.++|+|||||++|
T Consensus       131 lkp~Nill~~~~-~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~  208 (330)
T 2izr_A          131 VKPENFLIGRPG-NKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGK-EQSRRDDLEALGHMFM  208 (330)
T ss_dssp             CCGGGEEECCGG-GTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHH
T ss_pred             CCHHHeeeccCC-CCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCC-CCCchhHHHHHHHHHH
Confidence            999999998776 4     99999999987644322        2356789999999999764 4899999999999999


Q ss_pred             HHHhCCCCCCCCCcH---HHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCC
Q 022799          149 ELLLGQPLFPGESGV---DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSP  225 (292)
Q Consensus       149 el~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp  225 (292)
                      +|++|..||.+.+..   +.+..+.......+.+.                        ....++ ++.++|.+||..||
T Consensus       209 ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~------------------------~~~~~p-~~~~li~~~l~~~p  263 (330)
T 2izr_A          209 YFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEV------------------------LCENFP-EMATYLRYVRRLDF  263 (330)
T ss_dssp             HHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHH------------------------HTTTCH-HHHHHHHHHHHCCT
T ss_pred             HHhcCCCCccccccccHHHHHHHHHhhhccCCHHH------------------------HhccCh-HHHHHHHHHHhCCC
Confidence            999999999875433   22333322211111111                        112344 99999999999999


Q ss_pred             CCcccHHHHhc
Q 022799          226 NLRSTALEALI  236 (292)
Q Consensus       226 ~~R~t~~e~l~  236 (292)
                      .+||+++++++
T Consensus       264 ~~RP~~~~l~~  274 (330)
T 2izr_A          264 FEKPDYDYLRK  274 (330)
T ss_dssp             TCCCCHHHHHH
T ss_pred             CCCCCHHHHHH
Confidence            99999988865

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.2e-39  Score=279.67  Aligned_cols=201  Identities=20%  Similarity=0.327  Sum_probs=162.1

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhh--------------------cCCCCCHHHHHH
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYK--------------------MSQRMPLIYVKL   59 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~--------------------~~~~~~~~~~~~   59 (292)
                      |+.++||||+++++++     .+....++||||++ ++|.+++.....                    ....+++..+..
T Consensus        80 l~~l~hp~iv~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (314)
T 2ivs_A           80 LKQVNHPHVIKLYGAC-----SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLIS  154 (314)
T ss_dssp             HTTCCCTTBCCEEEEE-----CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHH
T ss_pred             HhhCCCCceeeEEEEE-----ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHH
Confidence            4678999999999998     33445899999998 799999876432                    123489999999


Q ss_pred             HHHHHHHHHHHHHhcCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCCC---cccccccccccCCccccCCCCCCc
Q 022799           60 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTA  136 (292)
Q Consensus        60 ~~~qil~al~~LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~  136 (292)
                      ++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++........   .....+|+.|+|||.+.+. .++.
T Consensus       155 i~~qi~~~l~~lH~~-~ivH~dikp~NIli~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~  231 (314)
T 2ivs_A          155 FAWQISQGMQYLAEM-KLVHRDLAARNILVAEGR-KMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH-IYTT  231 (314)
T ss_dssp             HHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTT-EEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC-EECH
T ss_pred             HHHHHHHHHHHHHHC-CCcccccchheEEEcCCC-CEEEccccccccccccccceeccCCCCcccccChhhhcCC-CcCc
Confidence            999999999999998 999999999999999887 799999999986643322   2234567889999999664 4899


Q ss_pred             hhHhhhhhHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHH
Q 022799          137 AIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVD  215 (292)
Q Consensus       137 ~~DvwslG~il~el~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  215 (292)
                      ++|+||+||++|+|++ |..||.+.........+.... .                           ...+..+++.+.+
T Consensus       232 ~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-~---------------------------~~~~~~~~~~~~~  283 (314)
T 2ivs_A          232 QSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGH-R---------------------------MERPDNCSEEMYR  283 (314)
T ss_dssp             HHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-C---------------------------CCCCTTCCHHHHH
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCC-c---------------------------CCCCccCCHHHHH
Confidence            9999999999999999 999998877655444332210 0                           0012468999999


Q ss_pred             HHHHHhccCCCCcccHHHHhcC
Q 022799          216 LVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       216 li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      +|.+||..||.+|||+.+++++
T Consensus       284 li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          284 LMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHccCChhhCcCHHHHHHH
Confidence            9999999999999999999864

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=8.2e-40  Score=282.23  Aligned_cols=222  Identities=21%  Similarity=0.234  Sum_probs=161.6

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC----
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI----   75 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~----   75 (292)
                      |++++||||+++++++.... .....+++||||++ |+|.+++..     ..+++..+..++.||+.||.|||+..    
T Consensus        72 l~~l~hpniv~~~~~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~  145 (322)
T 3soc_A           72 LPGMKHENILQFIGAEKRGT-SVDVDLWLITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLK  145 (322)
T ss_dssp             STTCCCTTBCCEEEEEEEEC-SSSEEEEEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEET
T ss_pred             HhcCCCCCchhhcceeccCC-CCCceEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccc
Confidence            57889999999999986543 22445799999998 699999864     45899999999999999999999532    


Q ss_pred             -----CccccCCCCCcEEEeCCCCcEEEeecCCccccccCCC---cccccccccccCCccccCC----CCCCchhHhhhh
Q 022799           76 -----GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGA----TEYTAAIDIWSA  143 (292)
Q Consensus        76 -----~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~----~~~~~~~Dvwsl  143 (292)
                           ||+||||||+||+++.++ .+||+|||+++.......   .....||+.|+|||++.+.    ..++.++||||+
T Consensus       146 ~~~~~~ivH~Dlkp~Nill~~~~-~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diwsl  224 (322)
T 3soc_A          146 DGHKPAISHRDIKSKNVLLKNNL-TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAM  224 (322)
T ss_dssp             TEEECEEECSCCSGGGEEECTTC-CEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHH
T ss_pred             cccCCCEEeCCCChHhEEECCCC-eEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHH
Confidence                 999999999999999888 799999999977644322   2335789999999999763    235668899999


Q ss_pred             hHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhh-ccCCChhHHHHHHHHhc
Q 022799          144 GCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIF-QKRMPPEAVDLVSRLLQ  222 (292)
Q Consensus       144 G~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~  222 (292)
                      ||++|+|++|..||.+................+....+......  ....+.     ....+ ....++.+.+||.+||+
T Consensus       225 G~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~-----~~~~~~~~~~~~~l~~li~~cl~  297 (322)
T 3soc_A          225 GLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVH--KKKRPV-----LRDYWQKHAGMAMLCETIEECWD  297 (322)
T ss_dssp             HHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTT--SCCCCC-----CCGGGGSSHHHHHHHHHHHHHTC
T ss_pred             HHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhc--ccCCCC-----ccccccccchHHHHHHHHHHHcc
Confidence            99999999999999876543222222222333333332211000  000000     00000 01234569999999999


Q ss_pred             cCCCCcccHHHHhc
Q 022799          223 YSPNLRSTALEALI  236 (292)
Q Consensus       223 ~dp~~R~t~~e~l~  236 (292)
                      .||++|||+.++++
T Consensus       298 ~dP~~Rps~~ell~  311 (322)
T 3soc_A          298 HDAEARLSAGCVGE  311 (322)
T ss_dssp             SSGGGSCCHHHHHH
T ss_pred             CChhhCcCHHHHHH
Confidence            99999999999985

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=2.6e-39  Score=281.69  Aligned_cols=208  Identities=14%  Similarity=0.114  Sum_probs=160.3

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccC
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRD   81 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~d   81 (292)
                      +.++||||+++++++.... .+..+.|+||||++++|.+++...    ..+++..++.++.||+.||.|||++ ||+|||
T Consensus       103 ~~l~h~ni~~~~~~~~~~~-~~~~~~~lv~e~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~D  176 (345)
T 2v62_A          103 KQLDYLGIPLFYGSGLTEF-KGRSYRFMVMERLGIDLQKISGQN----GTFKKSTVLQLGIRMLDVLEYIHEN-EYVHGD  176 (345)
T ss_dssp             HTCSCCCCCCEEEEEEEES-SSCEEEEEEEECEEEEHHHHCBGG----GBCCHHHHHHHHHHHHHHHHHHHHT-TEECSC
T ss_pred             ccccccCcceeeccccccc-CCCcEEEEEEeccCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCC
Confidence            4679999999999986533 335678999999988999888653    3799999999999999999999998 999999


Q ss_pred             CCCCcEEEeCCC-CcEEEeecCCccccccCCC--------cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh
Q 022799           82 IKPQNLLVNPHT-HQLKLCDFGSAKVLVKGEP--------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL  152 (292)
Q Consensus        82 lkp~Nill~~~~-~~ikl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~  152 (292)
                      |||+||+++.++ ..+||+|||+++.......        .....||+.|+|||++.+. .++.++|+|||||++|+|++
T Consensus       177 lkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~  255 (345)
T 2v62_A          177 IKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV-ALSRRSDVEILGYCMLRWLC  255 (345)
T ss_dssp             CSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHH
T ss_pred             cCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHh
Confidence            999999998654 2699999999976533211        1345789999999999765 48999999999999999999


Q ss_pred             CCCCCCCCC-cHHHHHH-HHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCccc
Q 022799          153 GQPLFPGES-GVDQLVE-IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST  230 (292)
Q Consensus       153 g~~pf~~~~-~~~~~~~-i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t  230 (292)
                      |..||.+.. ....... ........+........                    ...+++++.++|.+||..||++|||
T Consensus       256 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~l~~li~~~l~~dp~~Rps  315 (345)
T 2v62_A          256 GKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAP--------------------SGSSCCEIAQFLVCAHSLAYDEKPN  315 (345)
T ss_dssp             SSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSC--------------------TTSCCHHHHHHHHHHHTCCTTCCCC
T ss_pred             CCCCccccccccHHHHHHHHhhcccccHHHHhhcc--------------------ccccHHHHHHHHHHHhhcCcccCCC
Confidence            999996532 2222222 22222112211111100                    0268999999999999999999999


Q ss_pred             HHHHhc
Q 022799          231 ALEALI  236 (292)
Q Consensus       231 ~~e~l~  236 (292)
                      ++++++
T Consensus       316 ~~~l~~  321 (345)
T 2v62_A          316 YQALKK  321 (345)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999984

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.1e-39  Score=286.12  Aligned_cols=197  Identities=20%  Similarity=0.307  Sum_probs=160.8

Q ss_pred             CCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhc------------CCCCCHHHHHHHHHHHHHHHHHH
Q 022799            5 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKM------------SQRMPLIYVKLYFYQICRALAYI   71 (292)
Q Consensus         5 ~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~------------~~~~~~~~~~~~~~qil~al~~L   71 (292)
                      +||||+++++++.     +....++||||++ |+|.+++......            ...+++..++.++.||+.||.||
T Consensus       133 ~hpnIv~~~~~~~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  207 (382)
T 3tt0_A          133 KHKNIINLLGACT-----QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL  207 (382)
T ss_dssp             CCTTBCCEEEEEC-----SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             CCchhhhheeeec-----cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHH
Confidence            8999999999983     3444899999998 6999999864311            24599999999999999999999


Q ss_pred             HhcCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCC---CcccccccccccCCccccCCCCCCchhHhhhhhHHHH
Q 022799           72 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLA  148 (292)
Q Consensus        72 H~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~  148 (292)
                      |++ ||+||||||+||+++.++ .+||+|||+++......   ......+|+.|+|||++.+. .++.++||||+||++|
T Consensus       208 H~~-~ivH~Dlkp~NIll~~~~-~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~  284 (382)
T 3tt0_A          208 ASK-KCIHRDLAARNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLW  284 (382)
T ss_dssp             HHT-TCCCSCCCGGGEEECTTC-CEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSC-CCCHHHHHHHHHHHHH
T ss_pred             HhC-CEecCCCCcceEEEcCCC-cEEEcccCcccccccccccccccCCCCCcceeCHHHhcCC-CCCchhHHHHHHHHHH
Confidence            998 999999999999999888 79999999998664332   22334568899999999764 4899999999999999


Q ss_pred             HHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCC
Q 022799          149 ELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL  227 (292)
Q Consensus       149 el~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~  227 (292)
                      +|++ |..||.+....+....+..... +                           ..+..+++++.++|.+||..||++
T Consensus       285 ellt~g~~p~~~~~~~~~~~~~~~~~~-~---------------------------~~~~~~~~~l~~li~~~l~~dP~~  336 (382)
T 3tt0_A          285 EIFTLGGSPYPGVPVEELFKLLKEGHR-M---------------------------DKPSNCTNELYMMMRDCWHAVPSQ  336 (382)
T ss_dssp             HHHTTSCCSSTTCCHHHHHHHHHTTCC-C---------------------------CCCSSCCHHHHHHHHHHTCSSGGG
T ss_pred             HHHhCCCCCCCCCCHHHHHHHHHcCCC-C---------------------------CCCccCCHHHHHHHHHHcCCChhh
Confidence            9999 9999988776555444332100 0                           012468899999999999999999


Q ss_pred             cccHHHHhcC
Q 022799          228 RSTALEALIH  237 (292)
Q Consensus       228 R~t~~e~l~h  237 (292)
                      |||+.+++++
T Consensus       337 Rps~~ell~~  346 (382)
T 3tt0_A          337 RPTFKQLVED  346 (382)
T ss_dssp             SCCHHHHHHH
T ss_pred             CcCHHHHHHH
Confidence            9999999864

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.4e-39  Score=276.25  Aligned_cols=195  Identities=17%  Similarity=0.217  Sum_probs=154.7

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++..     ....++||||++ |+|.+++...   ...+++..+..++.||+.||.|||++ ||+|
T Consensus        66 l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH  136 (289)
T 4fvq_A           66 MSKLSHKHLVLNYGVCVC-----GDENILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEEN-TLIH  136 (289)
T ss_dssp             HHTSCCTTBCCEEEEECC-----TTCCEEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT-TCCC
T ss_pred             HHhCCCCCEeEEEEEEEe-----CCCCEEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhhC-CeEC
Confidence            357899999999999843     334789999998 6999998763   23489999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCc--------EEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHH
Q 022799           80 RDIKPQNLLVNPHTHQ--------LKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL  151 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~--------ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~  151 (292)
                      |||||+||+++.++ .        +||+|||.+.....   .....+|+.|+|||++.+...++.++|+||+||++|+|+
T Consensus       137 ~Dlkp~NIll~~~~-~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~  212 (289)
T 4fvq_A          137 GNVCAKNILLIREE-DRKTGNPPFIKLSDPGISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEIC  212 (289)
T ss_dssp             CCCCGGGEEEEECC-BGGGTBCCEEEECCCCSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHH
T ss_pred             CCcCcceEEEecCC-cccccccceeeeccCcccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHH
Confidence            99999999998876 4        99999999865422   234567899999999977556899999999999999999


Q ss_pred             hCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccH
Q 022799          152 LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA  231 (292)
Q Consensus       152 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~  231 (292)
                      +|..|+.................                             .++...++++.++|.+||+.||.+|||+
T Consensus       213 ~g~~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~  263 (289)
T 4fvq_A          213 SGGDKPLSALDSQRKLQFYEDRH-----------------------------QLPAPKAAELANLINNCMDYEPDHRPSF  263 (289)
T ss_dssp             TTTCCTTTTSCHHHHHHHHHTTC-----------------------------CCCCCSSCTTHHHHHHHSCSSGGGSCCH
T ss_pred             cCCCCCccccchHHHHHHhhccC-----------------------------CCCCCCCHHHHHHHHHHcCCChhHCcCH
Confidence            96544444333332222222100                             0123467889999999999999999999


Q ss_pred             HHHhcC
Q 022799          232 LEALIH  237 (292)
Q Consensus       232 ~e~l~h  237 (292)
                      .+++++
T Consensus       264 ~~ll~~  269 (289)
T 4fvq_A          264 RAIIRD  269 (289)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999964

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.6e-39  Score=274.96  Aligned_cols=196  Identities=27%  Similarity=0.405  Sum_probs=150.5

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++.     +. ..++||||++ ++|.+++...   ...+++..+..++.|++.||.|||++ ||+|
T Consensus        70 l~~l~h~~iv~~~~~~~-----~~-~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H  139 (281)
T 1mp8_A           70 MRQFDHPHIVKLIGVIT-----EN-PVWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK-RFVH  139 (281)
T ss_dssp             HHTCCCTTBCCEEEEEC-----SS-SCEEEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT-TCCC
T ss_pred             HHhCCCCccceEEEEEc-----cC-ccEEEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC-Ceec
Confidence            35789999999999872     11 3789999999 5999988753   34689999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCC--cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPL  156 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~p  156 (292)
                      |||||+||+++.++ .+||+|||++........  .....+|+.|+|||++.+. .++.++|+||+||++|+|++ |..|
T Consensus       140 ~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~p  217 (281)
T 1mp8_A          140 RDIAARNVLVSSND-CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKP  217 (281)
T ss_dssp             SCCSGGGEEEEETT-EEEECC-------------------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             ccccHHHEEECCCC-CEEECccccccccCcccccccccCCCcccccChhhcccC-CCCCccCchHHHHHHHHHHhcCCCC
Confidence            99999999999887 799999999987644322  2233567889999999654 48999999999999999996 9999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      |.+....+....+......                            .++..+++.+.++|.+||..||.+|||+.++++
T Consensus       218 f~~~~~~~~~~~i~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  269 (281)
T 1mp8_A          218 FQGVKNNDVIGRIENGERL----------------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA  269 (281)
T ss_dssp             TTTCCGGGHHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCcCCHHHHHHHHHcCCCC----------------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            9888776665554331000                            022468999999999999999999999999985

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=9e-40  Score=282.49  Aligned_cols=201  Identities=20%  Similarity=0.288  Sum_probs=160.5

Q ss_pred             CCCC-CCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhh------------hcCCCCCHHHHHHHHHHHHH
Q 022799            1 MRLL-DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHY------------KMSQRMPLIYVKLYFYQICR   66 (292)
Q Consensus         1 L~~l-~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~------------~~~~~~~~~~~~~~~~qil~   66 (292)
                      |+++ +||||+++++++.     +....++||||++ |+|.+++....            .....+++..++.++.||+.
T Consensus        79 l~~l~~hp~iv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  153 (327)
T 1fvr_A           79 LCKLGHHPNIINLLGACE-----HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVAR  153 (327)
T ss_dssp             HTTCCCCTTBCCEEEEEE-----ETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHH
T ss_pred             HHhccCCCchhhhceeee-----eCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHH
Confidence            3567 8999999999983     3445899999997 69999987542            22357999999999999999


Q ss_pred             HHHHHHhcCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHH
Q 022799           67 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCV  146 (292)
Q Consensus        67 al~~LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~i  146 (292)
                      ||.|||++ ||+||||||+||+++.++ .+||+|||+++............+|+.|+|||++.+. .++.++|+||+||+
T Consensus       154 aL~~LH~~-~ivH~dlkp~NIl~~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~i  230 (327)
T 1fvr_A          154 GMDYLSQK-QFIHRDLAARNILVGENY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVL  230 (327)
T ss_dssp             HHHHHHHT-TEECSCCSGGGEEECGGG-CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHC-EECHHHHHHHHHHH
T ss_pred             HHHHHHhC-CccCCCCccceEEEcCCC-eEEEcccCcCccccccccccCCCCCccccChhhhccc-cCCchhcchHHHHH
Confidence            99999988 999999999999999887 7999999999754333333445668899999999654 48999999999999


Q ss_pred             HHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCC
Q 022799          147 LAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSP  225 (292)
Q Consensus       147 l~el~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp  225 (292)
                      +|+|++ |..||.+.+..+....+....                .            ...+..+++.+.++|.+||..||
T Consensus       231 l~ellt~g~~pf~~~~~~~~~~~~~~~~----------------~------------~~~~~~~~~~l~~li~~~l~~dp  282 (327)
T 1fvr_A          231 LWEIVSLGGTPYCGMTCAELYEKLPQGY----------------R------------LEKPLNCDDEVYDLMRQCWREKP  282 (327)
T ss_dssp             HHHHHTTSCCTTTTCCHHHHHHHGGGTC----------------C------------CCCCTTBCHHHHHHHHHHTCSSG
T ss_pred             HHHHHcCCCCCCCCCcHHHHHHHhhcCC----------------C------------CCCCCCCCHHHHHHHHHHccCCh
Confidence            999998 999998877655443332110                0            00124578999999999999999


Q ss_pred             CCcccHHHHhcC
Q 022799          226 NLRSTALEALIH  237 (292)
Q Consensus       226 ~~R~t~~e~l~h  237 (292)
                      .+|||+++++++
T Consensus       283 ~~Rps~~ell~~  294 (327)
T 1fvr_A          283 YERPSFAQILVS  294 (327)
T ss_dssp             GGSCCHHHHHHH
T ss_pred             hhCcCHHHHHHH
Confidence            999999999864

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-39  Score=282.67  Aligned_cols=206  Identities=20%  Similarity=0.277  Sum_probs=163.6

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhc--------------------CCCCCHHHHHH
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKM--------------------SQRMPLIYVKL   59 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~--------------------~~~~~~~~~~~   59 (292)
                      |++++||||+++++++.     +....++||||++ |+|.+++......                    ...+++..++.
T Consensus       104 l~~l~hp~iv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  178 (343)
T 1luf_A          104 MAEFDNPNIVKLLGVCA-----VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLC  178 (343)
T ss_dssp             HHTCCCTTBCCEEEEEC-----SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHH
T ss_pred             HHhCCCCCEEEEEEEEc-----cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHH
Confidence            35789999999999983     3445899999998 6999998764211                    25789999999


Q ss_pred             HHHHHHHHHHHHHhcCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCC---CcccccccccccCCccccCCCCCCc
Q 022799           60 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTA  136 (292)
Q Consensus        60 ~~~qil~al~~LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~  136 (292)
                      ++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++.......   ......+|+.|+|||++.+. .++.
T Consensus       179 i~~qi~~~l~~LH~~-~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~  255 (343)
T 1luf_A          179 IARQVAAGMAYLSER-KFVHRDLATRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTT  255 (343)
T ss_dssp             HHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCH
T ss_pred             HHHHHHHHHHHHHhC-CeecCCCCcceEEECCCC-eEEEeecCCCcccccCccccccCCCcccceecChhhhccC-CcCc
Confidence            999999999999998 999999999999999888 79999999997653322   22345678899999998764 4899


Q ss_pred             hhHhhhhhHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHH
Q 022799          137 AIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVD  215 (292)
Q Consensus       137 ~~DvwslG~il~el~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  215 (292)
                      ++|+||+||++|+|++ |..||.+....+....+.....                   .         ..+..+++.+.+
T Consensus       256 ~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~-------------------~---------~~~~~~~~~l~~  307 (343)
T 1luf_A          256 ESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNI-------------------L---------ACPENCPLELYN  307 (343)
T ss_dssp             HHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC-------------------C---------CCCTTCCHHHHH
T ss_pred             ccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCCc-------------------C---------CCCCCCCHHHHH
Confidence            9999999999999999 9999988776655544432100                   0         012468899999


Q ss_pred             HHHHHhccCCCCcccHHHHhcCCCccccC
Q 022799          216 LVSRLLQYSPNLRSTALEALIHPFFDELR  244 (292)
Q Consensus       216 li~~~l~~dp~~R~t~~e~l~hp~~~~~~  244 (292)
                      +|.+||..||.+|||+.++++  .++++.
T Consensus       308 li~~~l~~~p~~Rps~~~~~~--~L~~~~  334 (343)
T 1luf_A          308 LMRLCWSKLPADRPSFCSIHR--ILQRMC  334 (343)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHH--HHHHTT
T ss_pred             HHHHHcccCcccCCCHHHHHH--HHHHHH
Confidence            999999999999999999985  344443

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.2e-39  Score=273.73  Aligned_cols=197  Identities=18%  Similarity=0.318  Sum_probs=160.8

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      ++++||||+++++++     .+....++||||++ ++|.+++...   ...+++..+..++.|++.||.|||++ ||+||
T Consensus        58 ~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~  128 (268)
T 3sxs_A           58 MKLSHPKLVKFYGVC-----SKEYPIYIVTEYISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESH-QFIHR  128 (268)
T ss_dssp             HHCCCTTBCCEEEEE-----CSSSSEEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT-TEEES
T ss_pred             HhCCCCCEeeEEEEE-----ccCCceEEEEEccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecC
Confidence            467899999999998     44445899999997 6899988764   34589999999999999999999998 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCCc--ccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLF  157 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf  157 (292)
                      ||||+||+++.++ .++|+|||.+.........  ....+|+.|+|||.+.+.. ++.++|+||+||++|+|++ |..||
T Consensus       129 dikp~Nil~~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~  206 (268)
T 3sxs_A          129 DLAARNCLVDRDL-CVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFK-YSSKSDVWAFGILMWEVFSLGKMPY  206 (268)
T ss_dssp             SCSGGGEEECTTC-CEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSE-EETTHHHHHHHHHHHHHHTTTCCTT
T ss_pred             CcCcceEEECCCC-CEEEccCccceecchhhhhcccCCCcCcccCCHHHHhccC-CchhhhhHHHHHHHHHHHcCCCCCc
Confidence            9999999999888 7999999999866443221  2234567899999996644 8999999999999999999 99999


Q ss_pred             CCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          158 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      .+.........+......                            ..+...++.+.++|.+||..||++|||+.+++++
T Consensus       207 ~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          207 DLYTNSEVVLKVSQGHRL----------------------------YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             TTSCHHHHHHHHHTTCCC----------------------------CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             cccChHHHHHHHHcCCCC----------------------------CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            887766655544321100                            0123468899999999999999999999999965

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2e-39  Score=285.75  Aligned_cols=197  Identities=21%  Similarity=0.317  Sum_probs=158.7

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++     .+...+++||||++ |+|.+++...   ...+++..+..++.||+.||.|||++ ||+|
T Consensus       166 l~~l~hpniv~~~~~~-----~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivH  236 (377)
T 3cbl_A          166 LKQYSHPNIVRLIGVC-----TQKQPIYIVMELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESK-CCIH  236 (377)
T ss_dssp             HTTCCCTTBCCEEEEE-----CSSSSCEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT-TEEC
T ss_pred             HHhCCCCCEEEEEEEE-----ecCCCcEEEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CcCC
Confidence            4688999999999998     33344899999998 7999988754   34589999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCC---cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQP  155 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~  155 (292)
                      |||||+||+++.++ .+||+|||+++.......   .....+++.|+|||++.+. .++.++|+||+||++|||++ |..
T Consensus       237 rDlkp~Nil~~~~~-~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~t~g~~  314 (377)
T 3cbl_A          237 RDLAARNCLVTEKN-VLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYG-RYSSESDVWSFGILLWETFSLGAS  314 (377)
T ss_dssp             SCCSGGGEEECTTC-CEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCC
T ss_pred             cccCHHHEEEcCCC-cEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccC-CCCchhhHHHHHHHHHHHHhCCCC
Confidence            99999999999888 799999999976432211   1122357789999999654 48999999999999999998 999


Q ss_pred             CCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHh
Q 022799          156 LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL  235 (292)
Q Consensus       156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l  235 (292)
                      ||.+.+..+....+... ..+                           ..+..+++.+.++|.+||..||++|||+.+++
T Consensus       315 p~~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~  366 (377)
T 3cbl_A          315 PYPNLSNQQTREFVEKG-GRL---------------------------PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIY  366 (377)
T ss_dssp             SSTTSCHHHHHHHHHTT-CCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCCCCHHHHHHHHHcC-CCC---------------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence            99887765544333221 000                           01245789999999999999999999999997


Q ss_pred             c
Q 022799          236 I  236 (292)
Q Consensus       236 ~  236 (292)
                      +
T Consensus       367 ~  367 (377)
T 3cbl_A          367 Q  367 (377)
T ss_dssp             H
T ss_pred             H
Confidence            4

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=7.4e-40  Score=282.29  Aligned_cols=195  Identities=27%  Similarity=0.419  Sum_probs=160.4

Q ss_pred             CCCCeeeeceeeeccCCCCceeEEEEeeccc--CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCC
Q 022799            5 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDI   82 (292)
Q Consensus         5 ~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~--g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dl   82 (292)
                      .||||+++++++.     +....++|||++.  ++|.+++...    ..+++..++.++.||+.||.|||++ ||+||||
T Consensus       106 ~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dl  175 (320)
T 3a99_A          106 GFSGVIRLLDWFE-----RPDSFVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHNC-GVLHRDI  175 (320)
T ss_dssp             SSCSBCCEEEEEE-----CSSEEEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCC
T ss_pred             CCCCceEEEEEEe-----cCCcEEEEEEcCCCCccHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC-CcEeCCC
Confidence            4799999999984     3445899999997  6999988753    6789999999999999999999988 9999999


Q ss_pred             CCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCCCc
Q 022799           83 KPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG  162 (292)
Q Consensus        83 kp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~  162 (292)
                      ||+||+++.+...+||+|||++...... ......||+.|+|||++.+...++.++|+|||||++|+|++|..||.+...
T Consensus       176 kp~NIll~~~~~~~kL~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  254 (320)
T 3a99_A          176 KDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE  254 (320)
T ss_dssp             SGGGEEEETTTTEEEECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH
T ss_pred             CHHHEEEeCCCCCEEEeeCccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh
Confidence            9999999943338999999999876433 234457899999999987665457899999999999999999999965321


Q ss_pred             HHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCCccc
Q 022799          163 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  242 (292)
Q Consensus       163 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~~~~  242 (292)
                            +...                 ..            .++..+++++.+||.+||..||.+|||++++++||||++
T Consensus       255 ------~~~~-----------------~~------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~  299 (320)
T 3a99_A          255 ------IIRG-----------------QV------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD  299 (320)
T ss_dssp             ------HHHC-----------------CC------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred             ------hhcc-----------------cc------------cccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcC
Confidence                  1110                 00            022468999999999999999999999999999999997


Q ss_pred             cCC
Q 022799          243 LRD  245 (292)
Q Consensus       243 ~~~  245 (292)
                      ...
T Consensus       300 ~~~  302 (320)
T 3a99_A          300 VLL  302 (320)
T ss_dssp             CCC
T ss_pred             ccC
Confidence            643

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.1e-39  Score=274.44  Aligned_cols=198  Identities=18%  Similarity=0.307  Sum_probs=162.0

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++     .+....++||||++ ++|.+++...   ...+++..+..++.|++.||.|||++ ||+|
T Consensus        73 l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H  143 (283)
T 3gen_A           73 MMNLSHEKLVQLYGVC-----TKQRPIFIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK-QFLH  143 (283)
T ss_dssp             HHTCCCTTBCCEEEEE-----CSSSSEEEEECCCTTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHT-TCCC
T ss_pred             HhcCCCCCEeeEEEEE-----ecCCCeEEEEeccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHC-CccC
Confidence            3578999999999998     44445899999997 6999988753   35699999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCC--CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPL  156 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~p  156 (292)
                      |||||+||+++.++ .++|+|||.+.......  ......+|+.|+|||++.+. .++.++|+||+||++|+|++ |..|
T Consensus       144 ~dikp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~t~g~~p  221 (283)
T 3gen_A          144 RDLAARNCLVNDQG-VVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMP  221 (283)
T ss_dssp             SSCSGGGEEECTTS-CEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             CCCccceEEEcCCC-CEEEccccccccccccccccccCCccCcccCCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCC
Confidence            99999999999888 79999999997653321  12233467889999999755 48999999999999999998 9999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      |.+.+.......+......                            ..+...++.+.++|.+||..||.+|||+.++++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  273 (283)
T 3gen_A          222 YERFTNSETAEHIAQGLRL----------------------------YRPHLASEKVYTIMYSCWHEKADERPTFKILLS  273 (283)
T ss_dssp             TTTSCHHHHHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             ccccChhHHHHHHhcccCC----------------------------CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence            9887776655554432110                            012357889999999999999999999999986


Q ss_pred             C
Q 022799          237 H  237 (292)
Q Consensus       237 h  237 (292)
                      |
T Consensus       274 ~  274 (283)
T 3gen_A          274 N  274 (283)
T ss_dssp             H
T ss_pred             H
Confidence            5

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=5e-39  Score=277.04  Aligned_cols=210  Identities=20%  Similarity=0.261  Sum_probs=167.8

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhc------CCCCCHHHHHHHHHHHHHHHHHHHh
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKM------SQRMPLIYVKLYFYQICRALAYIHN   73 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~------~~~~~~~~~~~~~~qil~al~~LH~   73 (292)
                      |+.++||||+++++++     .+....++||||++ |+|.+++......      ...+++..+..++.||+.||.|||+
T Consensus        82 l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~  156 (322)
T 1p4o_A           82 MKEFNCHHVVRLLGVV-----SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA  156 (322)
T ss_dssp             GGGCCCTTBCCEEEEE-----CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHhcCCCCEeeeEEEE-----ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH
Confidence            4678999999999998     33445889999998 6999998764321      2457899999999999999999999


Q ss_pred             cCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCCC---cccccccccccCCccccCCCCCCchhHhhhhhHHHHHH
Q 022799           74 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAEL  150 (292)
Q Consensus        74 ~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el  150 (292)
                      + ||+||||||+||+++.++ .+||+|||++........   .....+|+.|+|||++.+. .++.++|+||+||++|+|
T Consensus       157 ~-~i~H~dikp~NIli~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el  233 (322)
T 1p4o_A          157 N-KFVHRDLAARNCMVAEDF-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEI  233 (322)
T ss_dssp             T-TCBCSCCSGGGEEECTTC-CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHH
T ss_pred             C-CCccCCCccceEEEcCCC-eEEECcCccccccccccccccccCCCCCCCccChhhhccC-CCCchhhHHHHHHHHHHH
Confidence            8 999999999999999888 799999999976543321   1234568899999998654 489999999999999999


Q ss_pred             Hh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcc
Q 022799          151 LL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS  229 (292)
Q Consensus       151 ~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~  229 (292)
                      ++ |..||.+.+..+....+.... .+                           ..+..+++.+.++|.+||..||.+||
T Consensus       234 ~~~g~~p~~~~~~~~~~~~~~~~~-~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rp  285 (322)
T 1p4o_A          234 ATLAEQPYQGLSNEQVLRFVMEGG-LL---------------------------DKPDNCPDMLFELMRMCWQYNPKMRP  285 (322)
T ss_dssp             HHTSCCTTTTSCHHHHHHHHHTTC-CC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred             HhcCCCccccCCHHHHHHHHHcCC-cC---------------------------CCCCCCCHHHHHHHHHHcCCCcccCc
Confidence            99 899998877655544443210 00                           01246889999999999999999999


Q ss_pred             cHHHHhcC------CCccccCCC
Q 022799          230 TALEALIH------PFFDELRDP  246 (292)
Q Consensus       230 t~~e~l~h------p~~~~~~~~  246 (292)
                      |+.+++++      ++|+++...
T Consensus       286 s~~e~l~~L~~~~~~~~~~~~~~  308 (322)
T 1p4o_A          286 SFLEIISSIKEEMEPGFREVSFY  308 (322)
T ss_dssp             CHHHHHHHHGGGSCTTHHHHCST
T ss_pred             CHHHHHHHHHHhhccCCcccccc
Confidence            99999875      777766543

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=4.9e-39  Score=276.12  Aligned_cols=206  Identities=18%  Similarity=0.272  Sum_probs=157.3

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhh--hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHY--KMSQRMPLIYVKLYFYQICRALAYIHNTIGV   77 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~--~~~~~~~~~~~~~~~~qil~al~~LH~~~~i   77 (292)
                      |++++||||+++++++......+....++||||++ |+|.+++....  .....+++..++.++.||+.||.|||++ ||
T Consensus        90 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~i  168 (313)
T 3brb_A           90 MKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR-NF  168 (313)
T ss_dssp             HHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT-TC
T ss_pred             HhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC-Cc
Confidence            35789999999999986655444445789999998 69999886432  2345799999999999999999999988 99


Q ss_pred             cccCCCCCcEEEeCCCCcEEEeecCCccccccCC---CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-C
Q 022799           78 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-G  153 (292)
Q Consensus        78 ~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g  153 (292)
                      +||||||+||+++.++ .+||+|||++.......   ......+++.|+|||.+.+. .++.++|+||+||++|+|++ |
T Consensus       169 vH~dikp~NIli~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g  246 (313)
T 3brb_A          169 LHRDLAARNCMLRDDM-TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRG  246 (313)
T ss_dssp             CCCCCSGGGEEECTTS-CEEECSCSCC----------------CCGGGSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTS
T ss_pred             ccCCCCcceEEEcCCC-cEEEeecCcceecccccccCcccccCCCccccCchhhcCC-CccchhhhHHHHHHHHHHHhcC
Confidence            9999999999999888 79999999998664332   12234568899999999764 48999999999999999999 8


Q ss_pred             CCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHH
Q 022799          154 QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE  233 (292)
Q Consensus       154 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e  233 (292)
                      ..||.+.........+.....                            ...+..+++.+.++|.+||..||.+|||+.+
T Consensus       247 ~~p~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~  298 (313)
T 3brb_A          247 MTPYPGVQNHEMYDYLLHGHR----------------------------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSV  298 (313)
T ss_dssp             CCSSTTCCGGGHHHHHHTTCC----------------------------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHH
T ss_pred             CCCCccCCHHHHHHHHHcCCC----------------------------CCCCccccHHHHHHHHHHcCCChhhCcCHHH
Confidence            999988776665554433110                            0112468899999999999999999999999


Q ss_pred             HhcC
Q 022799          234 ALIH  237 (292)
Q Consensus       234 ~l~h  237 (292)
                      ++++
T Consensus       299 l~~~  302 (313)
T 3brb_A          299 LRLQ  302 (313)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9864

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.7e-39  Score=273.25  Aligned_cols=195  Identities=27%  Similarity=0.437  Sum_probs=151.0

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCC---c
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG---V   77 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~---i   77 (292)
                      +.++||||+++++++     .+....++||||++ ++|.+++.     ...+++..+..++.|++.||.|||++ |   |
T Consensus        61 ~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~-~~~~i  129 (271)
T 3dtc_A           61 AMLKHPNIIALRGVC-----LKEPNLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDE-AIVPI  129 (271)
T ss_dssp             HHCCCTTBCCEEEEE-----CCC--CEEEEECCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHS-SSSCC
T ss_pred             HhcCCCCEeeEEEEE-----ecCCceEEEEEcCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CCCce
Confidence            457899999999998     44445899999998 68877764     46799999999999999999999988 8   8


Q ss_pred             cccCCCCCcEEEeC--------CCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHH
Q 022799           78 CHRDIKPQNLLVNP--------HTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAE  149 (292)
Q Consensus        78 ~H~dlkp~Nill~~--------~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~e  149 (292)
                      +||||||+||+++.        ++ .++|+|||.+....... .....||+.|+|||.+.+. .++.++|+||+||++|+
T Consensus       130 ~H~dikp~Nil~~~~~~~~~~~~~-~~kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~  206 (271)
T 3dtc_A          130 IHRDLKSSNILILQKVENGDLSNK-ILKITDFGLAREWHRTT-KMSAAGAYAWMAPEVIRAS-MFSKGSDVWSYGVLLWE  206 (271)
T ss_dssp             CCSCCSGGGEEESSCCSSSCCSSC-CEEECCCCC--------------CCGGGSCHHHHHHC-CCSHHHHHHHHHHHHHH
T ss_pred             eecCCchHHEEEecccccccccCc-ceEEccCCccccccccc-ccCCCCccceeCHHHhccC-CCCchhhHHHHHHHHHH
Confidence            99999999999975        44 69999999998654332 2345789999999999664 48999999999999999


Q ss_pred             HHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcc
Q 022799          150 LLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS  229 (292)
Q Consensus       150 l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~  229 (292)
                      |++|..||.+.+.......+.....                           ....+..+++.+.++|.+||..||.+||
T Consensus       207 l~~g~~p~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp  259 (271)
T 3dtc_A          207 LLTGEVPFRGIDGLAVAYGVAMNKL---------------------------ALPIPSTCPEPFAKLMEDCWNPDPHSRP  259 (271)
T ss_dssp             HHHCCCTTTTSCHHHHHHHHHTSCC---------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred             HHhCCCCCCCCCHHHHHHhhhcCCC---------------------------CCCCCcccCHHHHHHHHHHhcCCcccCc
Confidence            9999999988776554443332100                           0012246789999999999999999999


Q ss_pred             cHHHHhcC
Q 022799          230 TALEALIH  237 (292)
Q Consensus       230 t~~e~l~h  237 (292)
                      |+.+++++
T Consensus       260 s~~e~l~~  267 (271)
T 3dtc_A          260 SFTNILDQ  267 (271)
T ss_dssp             CHHHHHHH
T ss_pred             CHHHHHHH
Confidence            99999864

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.4e-39  Score=284.54  Aligned_cols=199  Identities=23%  Similarity=0.354  Sum_probs=160.0

Q ss_pred             CCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhc-----------------------------------
Q 022799            5 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKM-----------------------------------   48 (292)
Q Consensus         5 ~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~-----------------------------------   48 (292)
                      +||||+++++++...    ...+++||||++ |+|.+++......                                   
T Consensus        84 ~hpniv~~~~~~~~~----~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (359)
T 3vhe_A           84 HHLNVVNLLGACTKP----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSS  159 (359)
T ss_dssp             CCTTBCCEEEEECST----TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------
T ss_pred             CCcceeeeeeeeecC----CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcc
Confidence            799999999988432    224789999998 6999998764321                                   


Q ss_pred             ---------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEeCCCCcEEEeec
Q 022799           49 ---------------------------SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  101 (292)
Q Consensus        49 ---------------------------~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlkp~Nill~~~~~~ikl~Df  101 (292)
                                                 ...+++..+..++.||+.||.|||++ ||+||||||+||+++.++ .+||+||
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~-~ivH~Dikp~NIll~~~~-~~kl~Df  237 (359)
T 3vhe_A          160 QSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR-KCIHRDLAARNILLSEKN-VVKICDF  237 (359)
T ss_dssp             ------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGG-CEEECCC
T ss_pred             ccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChhhEEEcCCC-cEEEEec
Confidence                                       12289999999999999999999998 999999999999999888 7999999


Q ss_pred             CCccccccCCC---cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 022799          102 GSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPT  177 (292)
Q Consensus       102 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~~~~~~~~~~~i~~~~~~~~  177 (292)
                      |++........   .....||+.|+|||++.+. .++.++||||+||++|+|++ |..||.+....+...........+.
T Consensus       238 g~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~  316 (359)
T 3vhe_A          238 GLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR  316 (359)
T ss_dssp             GGGSCTTSCTTCEEC--CEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCC
T ss_pred             cceeeecccccchhccccCCCceeEChhhhcCC-CCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCC
Confidence            99986543322   2335678899999999764 48999999999999999998 9999988776555555444321111


Q ss_pred             HHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          178 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                                                 .+..+++++.++|.+||..||.+|||+.++++|
T Consensus       317 ---------------------------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          317 ---------------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             ---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---------------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence                                       124578999999999999999999999999975

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.6e-39  Score=280.74  Aligned_cols=196  Identities=22%  Similarity=0.288  Sum_probs=156.8

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      +.++||||+++++++.     + ...++||||+. |+|.+.+...   ...+++..+..++.||+.||.|||++ ||+||
T Consensus        70 ~~l~h~~iv~~~~~~~-----~-~~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~  139 (325)
T 3kex_A           70 GSLDHAHIVRLLGLCP-----G-SSLQLVTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEH-GMVHR  139 (325)
T ss_dssp             HTCCCTTBCCEEEEEC-----B-SSEEEEEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHT-TCCCS
T ss_pred             hcCCCCCcCeEEEEEc-----C-CccEEEEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhC-CCCCC
Confidence            4679999999999872     1 23789999998 7999988753   24688889999999999999999998 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCC---cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPL  156 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~p  156 (292)
                      ||||+||+++.++ .+||+|||+++.......   .....+|+.|+|||.+.+. .++.++|+||+||++|+|++ |..|
T Consensus       140 Dikp~Nil~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p  217 (325)
T 3kex_A          140 NLAARNVLLKSPS-QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG-KYTHQSDVWSYGVTVWELMTFGAEP  217 (325)
T ss_dssp             CCSSTTEEESSSS-CEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             ccchheEEECCCC-eEEECCCCcccccCcccccccccCCCCcccccChHHhccC-CCChhhHhHHhHHHHHHHHhCCCCC
Confidence            9999999999888 799999999987644332   2334567899999999754 48999999999999999999 9999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      |.+....+....+.... .+                           ..+..+++++.++|.+||..||.+|||+.++++
T Consensus       218 ~~~~~~~~~~~~~~~~~-~~---------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~  269 (325)
T 3kex_A          218 YAGLRLAEVPDLLEKGE-RL---------------------------AQPQICTIDVYMVMVKCWMIDENIRPTFKELAN  269 (325)
T ss_dssp             TTTSCTTHHHHHHHTTC-BC---------------------------CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHH
T ss_pred             ccccCHHHHHHHHHcCC-CC---------------------------CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            98876655444333210 00                           012346788999999999999999999999987


Q ss_pred             C
Q 022799          237 H  237 (292)
Q Consensus       237 h  237 (292)
                      +
T Consensus       270 ~  270 (325)
T 3kex_A          270 E  270 (325)
T ss_dssp             H
T ss_pred             H
Confidence            5

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-39  Score=282.16  Aligned_cols=200  Identities=20%  Similarity=0.287  Sum_probs=160.5

Q ss_pred             CC-CCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhc-------------------CCCCCHHHHHHHH
Q 022799            3 LL-DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKM-------------------SQRMPLIYVKLYF   61 (292)
Q Consensus         3 ~l-~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~-------------------~~~~~~~~~~~~~   61 (292)
                      ++ +||||+++++++..     ....++||||++ |+|.+++......                   ...+++..+..++
T Consensus       104 ~l~~hp~iv~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~  178 (344)
T 1rjb_A          104 QLGSHENIVNLLGACTL-----SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFA  178 (344)
T ss_dssp             HHCCCTTBCCEEEEECS-----SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHH
T ss_pred             hhcCCCCeeeEEEEEee-----CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHH
Confidence            45 89999999999843     344899999998 6999998764221                   1347899999999


Q ss_pred             HHHHHHHHHHHhcCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCCCc---ccccccccccCCccccCCCCCCchh
Q 022799           62 YQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAI  138 (292)
Q Consensus        62 ~qil~al~~LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~  138 (292)
                      .||+.||.|||++ ||+||||||+||+++.++ .+||+|||++.........   ....+|+.|+|||++.+. .++.++
T Consensus       179 ~qi~~aL~~LH~~-~ivH~Dikp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~  255 (344)
T 1rjb_A          179 YQVAKGMEFLEFK-SCVHRDLAARNVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKS  255 (344)
T ss_dssp             HHHHHHHHHHHHT-TEEETTCSGGGEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHH
T ss_pred             HHHHHHHHHHHhC-CcccCCCChhhEEEcCCC-cEEeCCCccCcccccCccceeccCccCccCccCHHHhccC-CCChhH
Confidence            9999999999998 999999999999999888 7999999999876444322   234568899999998664 489999


Q ss_pred             HhhhhhHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHH
Q 022799          139 DIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLV  217 (292)
Q Consensus       139 DvwslG~il~el~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  217 (292)
                      |+|||||++|+|++ |..||.+.........+......+                           ..+..+++++.++|
T Consensus       256 Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li  308 (344)
T 1rjb_A          256 DVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKM---------------------------DQPFYATEEIYIIM  308 (344)
T ss_dssp             HHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCC---------------------------CCCTTCCHHHHHHH
T ss_pred             hHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCC---------------------------CCCCCCCHHHHHHH
Confidence            99999999999998 999998876655555444321100                           01245789999999


Q ss_pred             HHHhccCCCCcccHHHHhcC
Q 022799          218 SRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       218 ~~~l~~dp~~R~t~~e~l~h  237 (292)
                      .+||..||.+|||+.+++++
T Consensus       309 ~~~l~~dp~~Rps~~~l~~~  328 (344)
T 1rjb_A          309 QSCWAFDSRKRPSFPNLTSF  328 (344)
T ss_dssp             HHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHcCCCchhCcCHHHHHHH
Confidence            99999999999999999975

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3.3e-39  Score=276.90  Aligned_cols=200  Identities=24%  Similarity=0.329  Sum_probs=161.5

Q ss_pred             CC-CCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhh--------------cCCCCCHHHHHHHHHHHHH
Q 022799            3 LL-DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYK--------------MSQRMPLIYVKLYFYQICR   66 (292)
Q Consensus         3 ~l-~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~--------------~~~~~~~~~~~~~~~qil~   66 (292)
                      ++ +||||+++++++.     +....++||||++ |+|.+++.....              ....+++..+..++.||+.
T Consensus        82 ~l~~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~  156 (313)
T 1t46_A           82 YLGNHMNIVNLLGACT-----IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAK  156 (313)
T ss_dssp             HHCCCTTBCCEEEEEC-----SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHH
T ss_pred             hcccCCCeeeEEEEEe-----cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHH
Confidence            45 8999999999983     3344889999998 599999876432              1235899999999999999


Q ss_pred             HHHHHHhcCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCCCc---ccccccccccCCccccCCCCCCchhHhhhh
Q 022799           67 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSA  143 (292)
Q Consensus        67 al~~LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Dvwsl  143 (292)
                      ||.|||++ ||+||||||+||+++.++ .+||+|||++.........   ....+|+.|+|||.+.+. .++.++|+||+
T Consensus       157 ~l~~lH~~-~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~sl  233 (313)
T 1t46_A          157 GMAFLASK-NCIHRDLAARNILLTHGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSY  233 (313)
T ss_dssp             HHHHHHHT-TCCCSCCSGGGEEEETTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHH
T ss_pred             HHHHHHHC-CeecCCCccceEEEcCCC-CEEEccccccccccccccceeccCCCCcceeeChHHhcCC-CCChHHHHHHH
Confidence            99999998 999999999999999887 7999999999876544321   234567889999998664 48999999999


Q ss_pred             hHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhc
Q 022799          144 GCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQ  222 (292)
Q Consensus       144 G~il~el~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  222 (292)
                      ||++|+|++ |..||.+................+                           ..+..+++.+.++|.+||.
T Consensus       234 G~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~  286 (313)
T 1t46_A          234 GIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRM---------------------------LSPEHAPAEMYDIMKTCWD  286 (313)
T ss_dssp             HHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCC---------------------------CCCTTSCHHHHHHHHHHTC
T ss_pred             HHHHHHHHhCCCCCCCcccchhHHHHHhccCCCC---------------------------CCcccCCHHHHHHHHHHcC
Confidence            999999998 999998877655555544432111                           0124578999999999999


Q ss_pred             cCCCCcccHHHHhcC
Q 022799          223 YSPNLRSTALEALIH  237 (292)
Q Consensus       223 ~dp~~R~t~~e~l~h  237 (292)
                      .||.+|||+.+++++
T Consensus       287 ~dp~~Rps~~ell~~  301 (313)
T 1t46_A          287 ADPLKRPTFKQIVQL  301 (313)
T ss_dssp             SSGGGSCCHHHHHHH
T ss_pred             CCchhCcCHHHHHHH
Confidence            999999999999864

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=3.1e-39  Score=278.92  Aligned_cols=218  Identities=20%  Similarity=0.230  Sum_probs=161.5

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC--Cc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI--GV   77 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~--~i   77 (292)
                      |+.++||||+++++++.     +....++||||++ |+|.+++.........+++..+..++.|++.||.|||++.  ||
T Consensus        81 l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i  155 (326)
T 3uim_A           81 ISMAVHRNLLRLRGFCM-----TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKI  155 (326)
T ss_dssp             GGTCCCTTBCCCCEEEC-----CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCE
T ss_pred             HHhccCCCccceEEEEe-----cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Confidence            46789999999999984     3344789999998 5999999876555567999999999999999999999643  99


Q ss_pred             cccCCCCCcEEEeCCCCcEEEeecCCccccccCCC--cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCC
Q 022799           78 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQP  155 (292)
Q Consensus        78 ~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~  155 (292)
                      +||||||+||+++.++ .+||+|||++........  .....||+.|+|||++.+.. ++.++|+||+||++|+|++|..
T Consensus       156 vH~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~  233 (326)
T 3uim_A          156 IHRDVKAANILLDEEF-EAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQR  233 (326)
T ss_dssp             ECCCCSGGGEEECTTC-CEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSE-ECHHHHHHHHHHHHHHHHHCCC
T ss_pred             EeCCCchhhEEECCCC-CEEeccCccccccCcccccccccccCCcCccCHHHhccCC-CCccccchhHHHHHHHHHhCCC
Confidence            9999999999999887 799999999987643322  23345899999999996654 8999999999999999999999


Q ss_pred             CCCCC----CcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccH
Q 022799          156 LFPGE----SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA  231 (292)
Q Consensus       156 pf~~~----~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~  231 (292)
                      ||...    ...........           .   ..................++...++.+.+++.+||..||.+|||+
T Consensus       234 pf~~~~~~~~~~~~~~~~~~-----------~---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~  299 (326)
T 3uim_A          234 AFDLARLANDDDVMLLDWVK-----------G---LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKM  299 (326)
T ss_dssp             SBCHHHHTTTSCSBHHHHHT-----------T---TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCH
T ss_pred             cccccccccccchhHHHHHH-----------H---HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCH
Confidence            99521    10000001000           0   000001111111111112223445789999999999999999999


Q ss_pred             HHHhcCCC
Q 022799          232 LEALIHPF  239 (292)
Q Consensus       232 ~e~l~hp~  239 (292)
                      .++++|-.
T Consensus       300 ~ell~~L~  307 (326)
T 3uim_A          300 SEVVRMLE  307 (326)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHhc
Confidence            99997754

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.7e-38  Score=272.87  Aligned_cols=200  Identities=26%  Similarity=0.380  Sum_probs=154.4

Q ss_pred             CCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCC
Q 022799            6 HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQ   85 (292)
Q Consensus         6 HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlkp~   85 (292)
                      ||||+++++++     .+..+.++|||+.+++|.+++..    ...+++..++.++.||+.||.|||++ ||+||||||+
T Consensus        87 ~~~iv~~~~~~-----~~~~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~  156 (313)
T 3cek_A           87 SDKIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH-GIVHSDLKPA  156 (313)
T ss_dssp             CTTBCCEEEEE-----ECSSEEEEEECCCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGG
T ss_pred             CCceEEEEEEe-----ecCCEEEEEEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCcc
Confidence            69999999988     34445899999877899999875    35789999999999999999999988 9999999999


Q ss_pred             cEEEeCCCCcEEEeecCCccccccCCC---cccccccccccCCccccCC----------CCCCchhHhhhhhHHHHHHHh
Q 022799           86 NLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGA----------TEYTAAIDIWSAGCVLAELLL  152 (292)
Q Consensus        86 Nill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~----------~~~~~~~DvwslG~il~el~~  152 (292)
                      ||+++. + .+||+|||++........   .....||+.|+|||++.+.          ..++.++|+|||||++|+|++
T Consensus       157 NIl~~~-~-~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~  234 (313)
T 3cek_A          157 NFLIVD-G-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY  234 (313)
T ss_dssp             GEEEET-T-EEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHH
T ss_pred             cEEEEC-C-eEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHh
Confidence            999975 5 799999999987643321   2345689999999998651          358899999999999999999


Q ss_pred             CCCCCCCCCcHH-HHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccH
Q 022799          153 GQPLFPGESGVD-QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA  231 (292)
Q Consensus       153 g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~  231 (292)
                      |..||.+..... .+..+..   .           .. .            ..++...++++.++|.+||..||.+|||+
T Consensus       235 g~~pf~~~~~~~~~~~~~~~---~-----------~~-~------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~  287 (313)
T 3cek_A          235 GKTPFQQIINQISKLHAIID---P-----------NH-E------------IEFPDIPEKDLQDVLKCCLKRDPKQRISI  287 (313)
T ss_dssp             SSCTTTTCCSHHHHHHHHHC---T-----------TS-C------------CCCCCCSCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             CCCchhhHHHHHHHHHHHHh---c-----------cc-c------------cCCcccchHHHHHHHHHHccCCcccCcCH
Confidence            999997654322 2111111   0           00 0            01223467899999999999999999999


Q ss_pred             HHHhcCCCccccC
Q 022799          232 LEALIHPFFDELR  244 (292)
Q Consensus       232 ~e~l~hp~~~~~~  244 (292)
                      .++++||||+...
T Consensus       288 ~ell~h~~~~~~~  300 (313)
T 3cek_A          288 PELLAHPYVQIQT  300 (313)
T ss_dssp             HHHHTSHHHHCC-
T ss_pred             HHHhcCccccCCC
Confidence            9999999998643

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=4.1e-40  Score=283.90  Aligned_cols=214  Identities=20%  Similarity=0.223  Sum_probs=159.9

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++     .+....++||||++ |+|.+++.........+++..+..++.||+.||.|||++ ||+|
T Consensus        89 l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~ivH  162 (321)
T 2qkw_B           89 LSFCRHPHLVSLIGFC-----DERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR-AIIH  162 (321)
T ss_dssp             GGSCCCTTBCCEEEEC-----CCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT-TEEC
T ss_pred             HHhCCCCCEeeEEEEE-----cCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC-Ceec
Confidence            4678999999999998     33445889999998 698888765433334689999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCC---CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPL  156 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~p  156 (292)
                      |||||+||+++.++ .+||+|||++.......   ......||+.|+|||++.+. .++.++|+||+||++|+|++|+.|
T Consensus       163 ~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~p  240 (321)
T 2qkw_B          163 RDVKSINILLDENF-VPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKG-RLTEKSDVYSFGVVLFEVLCARSA  240 (321)
T ss_dssp             SCCCSTTEEECTTC-CEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHC-BCCTHHHHHHHHHHHHHHHHCCTT
T ss_pred             CCCCHHHEEECCCC-CEEEeecccccccccccccccccccCCCccccCHHHhcCC-CCCcccchHhHHHHHHHHHhCCCc
Confidence            99999999999888 79999999997643222   22344689999999998665 489999999999999999999999


Q ss_pred             CCCCCcHHHHHHH---HHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHH
Q 022799          157 FPGESGVDQLVEI---IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE  233 (292)
Q Consensus       157 f~~~~~~~~~~~i---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e  233 (292)
                      |.+....+.....   .....          .....     ..........++...+..+.+++.+||..||++|||+.+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~----------~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e  305 (321)
T 2qkw_B          241 IVQSLPREMVNLAEWAVESHN----------NGQLE-----QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGD  305 (321)
T ss_dssp             CSCSSSSSCCCHHHHTHHHHT----------TTCCC-----SSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             ccccCcHHHHHHHHHhhhccc----------cccHH-----HhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHH
Confidence            9765432211100   00000          00000     000111111122345678999999999999999999999


Q ss_pred             HhcC
Q 022799          234 ALIH  237 (292)
Q Consensus       234 ~l~h  237 (292)
                      ++++
T Consensus       306 ll~~  309 (321)
T 2qkw_B          306 VLWK  309 (321)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9965

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=3.3e-39  Score=279.02  Aligned_cols=196  Identities=21%  Similarity=0.315  Sum_probs=157.9

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      ++++||||+++++++..     .. .++|+||+. |+|.+++...   ...+++..+..++.||+.||.|||++ ||+||
T Consensus        72 ~~l~h~~iv~~~~~~~~-----~~-~~~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivH~  141 (327)
T 3poz_A           72 ASVDNPHVCRLLGICLT-----ST-VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR-RLVHR  141 (327)
T ss_dssp             HHCCBTTBCCEEEEEES-----SS-EEEEEECCTTCBHHHHHHHS---TTSCCHHHHHHHHHHHHHHHHHHHHT-TCCCS
T ss_pred             HhCCCCCEeEEEEEEec-----CC-eEEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC-CeeCC
Confidence            46899999999999843     11 668899988 7999988753   45699999999999999999999998 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCCc---ccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPL  156 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~p  156 (292)
                      ||||+||+++.++ .+||+|||+++........   ....+|+.|+|||.+.+. .++.++|+||+||++|+|++ |..|
T Consensus       142 Dikp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p  219 (327)
T 3poz_A          142 DLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKP  219 (327)
T ss_dssp             CCCGGGEEEEETT-EEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             CCChheEEECCCC-CEEEccCcceeEccCCcccccccCCCccccccChHHhccC-CCCchhhhhhhHHHHHHHHhcCCCC
Confidence            9999999999888 7999999999876443322   223457899999999764 48999999999999999999 9999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      |.+.........+.... .+                           ..+..++.++.++|.+||+.||.+|||+.++++
T Consensus       220 ~~~~~~~~~~~~~~~~~-~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~  271 (327)
T 3poz_A          220 YDGIPASEISSILEKGE-RL---------------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELII  271 (327)
T ss_dssp             TTTCCGGGHHHHHHTTC-CC---------------------------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHH
T ss_pred             ccCCCHHHHHHHHHcCC-CC---------------------------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            98876655443332210 00                           012457889999999999999999999999986


Q ss_pred             C
Q 022799          237 H  237 (292)
Q Consensus       237 h  237 (292)
                      +
T Consensus       272 ~  272 (327)
T 3poz_A          272 E  272 (327)
T ss_dssp             H
T ss_pred             H
Confidence            5

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=5.4e-39  Score=282.45  Aligned_cols=197  Identities=24%  Similarity=0.364  Sum_probs=150.1

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++     .+....++||||++ |+|.+++...   ...+++..+..++.||+.||.|||++ ||+|
T Consensus       100 l~~l~h~niv~~~~~~-----~~~~~~~lv~e~~~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH  170 (373)
T 2qol_A          100 MGQFDHPNIIRLEGVV-----TKSKPVMIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKYLSDM-GYVH  170 (373)
T ss_dssp             HTTCCCTTBCCEEEEE-----CSSSSCEEEEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT-TCCC
T ss_pred             HHhCCCCCCCeEEEEE-----eeCCceEEEEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeC
Confidence            4678999999999998     33445899999997 7999998753   35689999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCc----ccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQ  154 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~  154 (292)
                      |||||+||+++.++ .+||+|||+++........    ....+|+.|+|||++.+. .++.++|+||+||++|+|++ |.
T Consensus       171 ~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~SlG~il~ellt~g~  248 (373)
T 2qol_A          171 RDLAARNILINSNL-VCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR-KFTSASDVWSYGIVLWEVMSYGE  248 (373)
T ss_dssp             SCCCGGGEEECTTC-CEEECCC----------------------CTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTC-
T ss_pred             CCCCcceEEEcCCC-CEEECcCccccccccCCccceeccCCCcCCCccChhhhccC-CcCchhcHHHHHHHHHHHHhCCC
Confidence            99999999999888 7999999999876433211    112346789999999654 48999999999999999998 99


Q ss_pred             CCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHH
Q 022799          155 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA  234 (292)
Q Consensus       155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~  234 (292)
                      .||.+.+..+....+......+                            .+..++..+.++|.+||..||.+|||+.++
T Consensus       249 ~P~~~~~~~~~~~~i~~~~~~~----------------------------~~~~~~~~l~~li~~cl~~dp~~RPs~~~i  300 (373)
T 2qol_A          249 RPYWEMSNQDVIKAVDEGYRLP----------------------------PPMDCPAALYQLMLDCWQKDRNNRPKFEQI  300 (373)
T ss_dssp             CTTTTCCHHHHHHHHHTTEECC----------------------------CCTTCBHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCCCCCHHHHHHHHHcCCCCC----------------------------CCccccHHHHHHHHHHhCcChhhCcCHHHH
Confidence            9998877665554443211000                            113578899999999999999999999998


Q ss_pred             hc
Q 022799          235 LI  236 (292)
Q Consensus       235 l~  236 (292)
                      ++
T Consensus       301 ~~  302 (373)
T 2qol_A          301 VS  302 (373)
T ss_dssp             HH
T ss_pred             HH
Confidence            75

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=2.3e-38  Score=266.02  Aligned_cols=198  Identities=14%  Similarity=0.227  Sum_probs=159.7

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCC--c
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG--V   77 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~--i   77 (292)
                      |++++||||+++++++....   ....++||||++ |+|.+++....  ...+++..+..++.||+.||.|||++ |  |
T Consensus        61 l~~l~h~~iv~~~~~~~~~~---~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~-~~~i  134 (271)
T 3kmu_A           61 LRIFSHPNVLPVLGACQSPP---APHPTLITHWMPYGSLYNVLHEGT--NFVVDQSQAVKFALDMARGMAFLHTL-EPLI  134 (271)
T ss_dssp             GCCCSCTTEECEEEEECTTT---SSSCEEEEECCTTCBHHHHHHSCS--SCCCCHHHHHHHHHHHHHHHHHHTTS-SSCC
T ss_pred             HHhcCCCchhheEEEEccCC---CCCeEeeecccCCCcHHHHHhhcc--cCCCCHHHHHHHHHHHHHHHHHHhcC-CCce
Confidence            56789999999999984432   245889999998 69999987531  23589999999999999999999987 9  9


Q ss_pred             cccCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCC--CCCchhHhhhhhHHHHHHHhCCC
Q 022799           78 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT--EYTAAIDIWSAGCVLAELLLGQP  155 (292)
Q Consensus        78 ~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DvwslG~il~el~~g~~  155 (292)
                      +||||||+||+++.++ .++|+|||++....    .....||+.|+|||++.+..  .++.++|+||+||++|+|++|..
T Consensus       135 ~H~dikp~Nil~~~~~-~~~l~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~  209 (271)
T 3kmu_A          135 PRHALNSRSVMIDEDM-TARISMADVKFSFQ----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREV  209 (271)
T ss_dssp             TTCCCSGGGEEECTTS-CEEEEGGGSCCTTS----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSC
T ss_pred             ecCCCccceEEEcCCc-ceeEEeccceeeec----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCC
Confidence            9999999999999887 69999888775432    23357899999999997643  23448999999999999999999


Q ss_pred             CCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHh
Q 022799          156 LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL  235 (292)
Q Consensus       156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l  235 (292)
                      ||.+.+.......+......+                           .++..+++++.++|.+||..||.+|||+++++
T Consensus       210 p~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il  262 (271)
T 3kmu_A          210 PFADLSNMEIGMKVALEGLRP---------------------------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIV  262 (271)
T ss_dssp             TTTTSCHHHHHHHHHHSCCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CccccChHHHHHHHHhcCCCC---------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence            998887766655544321111                           12256899999999999999999999999998


Q ss_pred             c
Q 022799          236 I  236 (292)
Q Consensus       236 ~  236 (292)
                      +
T Consensus       263 ~  263 (271)
T 3kmu_A          263 P  263 (271)
T ss_dssp             H
T ss_pred             H
Confidence            4

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-38  Score=273.61  Aligned_cols=195  Identities=29%  Similarity=0.479  Sum_probs=156.7

Q ss_pred             CCCCCeeeeceeeeccCCCCceeEEEEeec-cc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccC
Q 022799            4 LDHPNVVSLKHCFFSTTEKDELYLNLVLEY-VP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRD   81 (292)
Q Consensus         4 l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~-~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~d   81 (292)
                      ++||||+++++++     .+....++|||| +. ++|.+++...    ..+++..++.++.||+.||.|||++ ||+|||
T Consensus        95 ~~h~~i~~~~~~~-----~~~~~~~~v~e~~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~d  164 (312)
T 2iwi_A           95 GGHPGVIRLLDWF-----ETQEGFMLVLERPLPAQDLFDYITEK----GPLGEGPSRCFFGQVVAAIQHCHSR-GVVHRD  164 (312)
T ss_dssp             CCCSSBCCEEEEC----------CEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH-TEECCC
T ss_pred             CCCCCeeeEEEEE-----ecCCeEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CeeecC
Confidence            3899999999998     333458899998 55 7999988763    5689999999999999999999998 999999


Q ss_pred             CCCCcEEEe-CCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCC
Q 022799           82 IKPQNLLVN-PHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE  160 (292)
Q Consensus        82 lkp~Nill~-~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  160 (292)
                      |||+||+++ .++ .+||+|||++...... ......||+.|+|||++.+....+.++|+||+||++|+|++|..||.+.
T Consensus       165 lkp~Nil~~~~~~-~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  242 (312)
T 2iwi_A          165 IKDENILIDLRRG-CAKLIDFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD  242 (312)
T ss_dssp             CSGGGEEEETTTT-EEEECCCSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred             CChhhEEEeCCCC-eEEEEEcchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh
Confidence            999999999 555 8999999999876443 3345678999999999876554456999999999999999999999643


Q ss_pred             CcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCCc
Q 022799          161 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF  240 (292)
Q Consensus       161 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~~  240 (292)
                      .      .+...                 ..            .++..+++.+.++|.+||..||++|||++++++||||
T Consensus       243 ~------~~~~~-----------------~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~  287 (312)
T 2iwi_A          243 Q------EILEA-----------------EL------------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWM  287 (312)
T ss_dssp             H------HHHHT-----------------CC------------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTT
T ss_pred             H------HHhhh-----------------cc------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence            1      11110                 00            1224688999999999999999999999999999999


Q ss_pred             cccCC
Q 022799          241 DELRD  245 (292)
Q Consensus       241 ~~~~~  245 (292)
                      +....
T Consensus       288 ~~~~~  292 (312)
T 2iwi_A          288 QTPAE  292 (312)
T ss_dssp             CC---
T ss_pred             cCchh
Confidence            87543

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.5e-39  Score=281.44  Aligned_cols=199  Identities=21%  Similarity=0.329  Sum_probs=151.2

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++...    ....++||||++ |+|.+++...   ...+++..+..++.||+.||.|||++ ||+|
T Consensus       144 l~~l~hpnIv~~~~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH  215 (373)
T 3c1x_A          144 MKDFSHPNVLSLLGICLRS----EGSPLVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK-KFVH  215 (373)
T ss_dssp             STTCCCTTBCCCCEEECCC----SSCCEEEEECCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT-TCCC
T ss_pred             HHhCCCCCcceEEEEEEcC----CCCeEEEEECCCCCCHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHC-CEec
Confidence            5788999999999986432    224789999998 6999998753   35688999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCC-----cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-C
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-G  153 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g  153 (292)
                      |||||+||+++.++ .+||+|||+++.......     .....+|+.|+|||.+.+. .++.++|+||+||++|+|++ |
T Consensus       216 rDlkp~NIll~~~~-~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~ellt~~  293 (373)
T 3c1x_A          216 RDLAARNCMLDEKF-TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRG  293 (373)
T ss_dssp             SCCCGGGEEECTTC-CEEECCC---------------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTS
T ss_pred             CccchheEEECCCC-CEEEeeccccccccccccccccccCCCCCcccccChHHhcCC-CCCcHHHHHHHHHHHHHHHhCc
Confidence            99999999999888 799999999986533221     1234567889999999654 48999999999999999999 7


Q ss_pred             CCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHH
Q 022799          154 QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE  233 (292)
Q Consensus       154 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e  233 (292)
                      .+||.+.+..+....+.....                            ...+..+++.+.++|.+||..||.+|||+.+
T Consensus       294 ~~p~~~~~~~~~~~~~~~~~~----------------------------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~e  345 (373)
T 3c1x_A          294 APPYPDVNTFDITVYLLQGRR----------------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSE  345 (373)
T ss_dssp             CCSCTTSCSSCHHHHHHTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCCCCCHHHHHHHHHcCCC----------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence            788877665554443332100                            0012457899999999999999999999999


Q ss_pred             HhcC
Q 022799          234 ALIH  237 (292)
Q Consensus       234 ~l~h  237 (292)
                      ++++
T Consensus       346 ll~~  349 (373)
T 3c1x_A          346 LVSR  349 (373)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9853

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=3.3e-38  Score=267.65  Aligned_cols=197  Identities=21%  Similarity=0.329  Sum_probs=156.0

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCC--c
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG--V   77 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~--i   77 (292)
                      |++++||||+++++++     .+..  ++||||++ |+|.+.+...   ...+++..+..++.|++.||.|||++ |  |
T Consensus        77 l~~l~h~~i~~~~~~~-----~~~~--~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~-~~~i  145 (287)
T 4f0f_A           77 MSNLNHPNIVKLYGLM-----HNPP--RMVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIALGIEYMQNQ-NPPI  145 (287)
T ss_dssp             HTTCCCTTBCCEEEEE-----TTTT--EEEEECCTTCBHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHTS-SSCC
T ss_pred             HHhCCCCCchhhheee-----cCCC--eEEEEecCCCCHHHHHhcc---cCCccHHHHHHHHHHHHHHHHHHHhC-CCCe
Confidence            4678999999999988     3332  58999998 7998887653   45799999999999999999999987 9  9


Q ss_pred             cccCCCCCcEEEeCCCC----cEEEeecCCccccccCCCcccccccccccCCccccC-CCCCCchhHhhhhhHHHHHHHh
Q 022799           78 CHRDIKPQNLLVNPHTH----QLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG-ATEYTAAIDIWSAGCVLAELLL  152 (292)
Q Consensus        78 ~H~dlkp~Nill~~~~~----~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DvwslG~il~el~~  152 (292)
                      +||||||+||+++.++.    .+||+|||+++....  ......||+.|+|||++.+ ...++.++|+||+||++|+|++
T Consensus       146 vH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~  223 (287)
T 4f0f_A          146 VHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILT  223 (287)
T ss_dssp             BCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHH
T ss_pred             ecCCCCcceEEEeccCCCCceeEEeCCCCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHc
Confidence            99999999999987662    299999999975432  3445678999999999843 2347899999999999999999


Q ss_pred             CCCCCCCCCcHHHH-HHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccH
Q 022799          153 GQPLFPGESGVDQL-VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA  231 (292)
Q Consensus       153 g~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~  231 (292)
                      |..||.+....... .......+..                          ..++..+++.+.++|.+||..||.+|||+
T Consensus       224 g~~pf~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~  277 (287)
T 4f0f_A          224 GEGPFDEYSYGKIKFINMIREEGLR--------------------------PTIPEDCPPRLRNVIELCWSGDPKKRPHF  277 (287)
T ss_dssp             SSCTTTTCCCCHHHHHHHHHHSCCC--------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCCCCccccccHHHHHHHHhccCCC--------------------------CCCCcccCHHHHHHHHHHhcCChhhCcCH
Confidence            99999876543321 1111111100                          01235689999999999999999999999


Q ss_pred             HHHhc
Q 022799          232 LEALI  236 (292)
Q Consensus       232 ~e~l~  236 (292)
                      +++++
T Consensus       278 ~~ll~  282 (287)
T 4f0f_A          278 SYIVK  282 (287)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            99985

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.1e-38  Score=271.11  Aligned_cols=202  Identities=20%  Similarity=0.292  Sum_probs=152.1

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||++++++.     . ....++||||++ ++|.+.+...   ...+++..+..++.||+.||.|||++ ||+|
T Consensus        74 l~~l~h~~iv~~~~~~-----~-~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~-~i~H  143 (289)
T 3og7_A           74 LRKTRHVNILLFMGYS-----T-APQLAIVTQWCEGSSLYHHLHAS---ETKFEMKKLIDIARQTARGMDYLHAK-SIIH  143 (289)
T ss_dssp             HTTCCCTTBCCEEEEE-----C-SSSCEEEEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT-TCCC
T ss_pred             HHhCCCCcEEEEEeec-----c-CCccEEEEEecCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhC-Cccc
Confidence            4688999999999864     1 123789999998 6888887542   45689999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccC---CCcccccccccccCCccccC--CCCCCchhHhhhhhHHHHHHHhCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG---EPNISYICSRYYRAPELIFG--ATEYTAAIDIWSAGCVLAELLLGQ  154 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslG~il~el~~g~  154 (292)
                      |||||+||+++.++ .++|+|||++......   .......||+.|+|||++..  ...++.++|+||+||++|+|++|.
T Consensus       144 ~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~  222 (289)
T 3og7_A          144 RDLKSNNIFLHEDN-TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ  222 (289)
T ss_dssp             SCCCGGGEEEETTT-EEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSS
T ss_pred             ccCccceEEECCCC-CEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCC
Confidence            99999999999988 8999999999765332   12234568999999999852  344788999999999999999999


Q ss_pred             CCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHH
Q 022799          155 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA  234 (292)
Q Consensus       155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~  234 (292)
                      .||.+....+...........++.                       ...+...+++.+.+||.+||..||.+|||+.++
T Consensus       223 ~p~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~el  279 (289)
T 3og7_A          223 LPYSNINNRDQIIEMVGRGSLSPD-----------------------LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRI  279 (289)
T ss_dssp             CTTSSCCCHHHHHHHHHHTSCCCC-----------------------TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCccccchHHHHHHHhcccccCcc-----------------------hhhccccCCHHHHHHHHHHccCChhhCCCHHHH
Confidence            999887776666665543221110                       001124678999999999999999999999999


Q ss_pred             hc
Q 022799          235 LI  236 (292)
Q Consensus       235 l~  236 (292)
                      ++
T Consensus       280 l~  281 (289)
T 3og7_A          280 LA  281 (289)
T ss_dssp             HH
T ss_pred             HH
Confidence            84

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=9.6e-39  Score=272.56  Aligned_cols=205  Identities=21%  Similarity=0.314  Sum_probs=155.5

Q ss_pred             CCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHH--------h
Q 022799            3 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH--------N   73 (292)
Q Consensus         3 ~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH--------~   73 (292)
                      .++||||+++++++.... .....+++||||++ |+|.+++.     ...+++..+..++.||+.||.|||        +
T Consensus        58 ~l~h~niv~~~~~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~  131 (301)
T 3q4u_A           58 MLRHENILGFIASDMTSR-HSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK  131 (301)
T ss_dssp             CCCCTTBCCEEEEEEEEE-TTEEEEEEEECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB
T ss_pred             hccCcCeeeEEEeecccc-CCCceeEEehhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCC
Confidence            479999999999875433 34556899999998 69999885     357999999999999999999999        8


Q ss_pred             cCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCCCc-----ccccccccccCCccccCCC-----CCCchhHhhhh
Q 022799           74 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-----ISYICSRYYRAPELIFGAT-----EYTAAIDIWSA  143 (292)
Q Consensus        74 ~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~-----~~~~~~Dvwsl  143 (292)
                      + ||+||||||+||+++.++ .+||+|||+++........     ....||+.|+|||++.+..     .++.++|+||+
T Consensus       132 ~-~ivH~Dlkp~Nill~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Dvwsl  209 (301)
T 3q4u_A          132 P-AIAHRDLKSKNILVKKNG-QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAF  209 (301)
T ss_dssp             C-EEECSCCCGGGEEECTTS-CEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHH
T ss_pred             C-CeecCCCChHhEEEcCCC-CEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHH
Confidence            7 999999999999999888 7999999999765443322     2347899999999997653     24479999999


Q ss_pred             hHHHHHHHhC----------CCCCCCCCcH----HHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCC
Q 022799          144 GCVLAELLLG----------QPLFPGESGV----DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRM  209 (292)
Q Consensus       144 G~il~el~~g----------~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  209 (292)
                      ||++|+|++|          ..||.+....    ...........                 ..+..    ....++...
T Consensus       210 G~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~----~~~~~~~~~  268 (301)
T 3q4u_A          210 GLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQ-----------------QRPNI----PNRWFSDPT  268 (301)
T ss_dssp             HHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSC-----------------CCCCC----CGGGGGSHH
T ss_pred             HHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccC-----------------CCCCC----ChhhccCcc
Confidence            9999999999          8888653221    22222111000                 00000    001122335


Q ss_pred             ChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          210 PPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       210 ~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      ++.+.++|.+||..||.+|||+.++++
T Consensus       269 ~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          269 LTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             HHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence            678999999999999999999999985

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=3.8e-39  Score=279.14  Aligned_cols=199  Identities=20%  Similarity=0.284  Sum_probs=161.0

Q ss_pred             CC-CCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhc----------CCCCCHHHHHHHHHHHHHHHHH
Q 022799            3 LL-DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKM----------SQRMPLIYVKLYFYQICRALAY   70 (292)
Q Consensus         3 ~l-~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~----------~~~~~~~~~~~~~~qil~al~~   70 (292)
                      ++ +||||+++++++.     +...+++||||++ |+|.+++......          ...+++..+..++.||+.||.|
T Consensus       105 ~l~~h~~iv~~~~~~~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~  179 (333)
T 2i1m_A          105 HLGQHENIVNLLGACT-----HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAF  179 (333)
T ss_dssp             HHCCCTTBCCEEEEEC-----SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHH
T ss_pred             hhcCCCCeeeEEEEEe-----cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHH
Confidence            45 7999999999983     3345899999998 5999998765321          3468999999999999999999


Q ss_pred             HHhcCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCCCc---ccccccccccCCccccCCCCCCchhHhhhhhHHH
Q 022799           71 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVL  147 (292)
Q Consensus        71 LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il  147 (292)
                      ||++ ||+||||||+||+++.++ .+||+|||++.........   ....+|+.|+|||++.+. .++.++|+|||||++
T Consensus       180 lH~~-~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il  256 (333)
T 2i1m_A          180 LASK-NCIHRDVAARNVLLTNGH-VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILL  256 (333)
T ss_dssp             HHHT-TEECSCCSGGGCEEEGGG-EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC-CCCHHHHHHHHHHHH
T ss_pred             HhcC-CcccCCcccceEEECCCC-eEEECccccccccccccceeecCCCCCCccccCHHHhccC-CCChHHHHHHHHHHH
Confidence            9998 999999999999999887 7999999999866443321   234567889999998664 489999999999999


Q ss_pred             HHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCC
Q 022799          148 AELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPN  226 (292)
Q Consensus       148 ~el~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~  226 (292)
                      |+|++ |..||.+.........+......+.                           .+...++.+.++|.+||..||.
T Consensus       257 ~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~~l~~~p~  309 (333)
T 2i1m_A          257 WEIFSLGLNPYPGILVNSKFYKLVKDGYQMA---------------------------QPAFAPKNIYSIMQACWALEPT  309 (333)
T ss_dssp             HHHTTTSCCSSTTCCSSHHHHHHHHHTCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGG
T ss_pred             HHHHcCCCCCCcccchhHHHHHHHhcCCCCC---------------------------CCCCCCHHHHHHHHHHhccChh
Confidence            99998 9999988766655555444321110                           1134788999999999999999


Q ss_pred             CcccHHHHhc
Q 022799          227 LRSTALEALI  236 (292)
Q Consensus       227 ~R~t~~e~l~  236 (292)
                      +|||+.++++
T Consensus       310 ~Rps~~~l~~  319 (333)
T 2i1m_A          310 HRPTFQQICS  319 (333)
T ss_dssp             GSCCHHHHHH
T ss_pred             hCcCHHHHHH
Confidence            9999999985

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-38  Score=275.37  Aligned_cols=198  Identities=21%  Similarity=0.325  Sum_probs=155.4

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++     .+....++||||++ |+|.+++...   ...+++..+..++.||+.||.|||++ ||+|
T Consensus       100 l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH  170 (333)
T 1mqb_A          100 MGQFSHHNIIRLEGVI-----SKYKPMMIITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM-NYVH  170 (333)
T ss_dssp             HHTCCCTTBCCEEEEE-----CSSSSEEEEEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT-TCCC
T ss_pred             HHhCCCCCCCcEEEEE-----ecCCCcEEEEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeC
Confidence            3578999999999998     44445899999998 5999988753   45799999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCC----cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQ  154 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~  154 (292)
                      |||||+||+++.++ .+||+|||++........    .....+|+.|+|||++.+. .++.++|+||+||++|+|++ |.
T Consensus       171 ~Dikp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~  248 (333)
T 1mqb_A          171 RDLAARNILVNSNL-VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGE  248 (333)
T ss_dssp             SCCCGGGEEECTTC-CEEECCCCC-----------------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             CCCChheEEECCCC-cEEECCCCcchhhccccccccccCCCCccccccCchhcccC-CCCchhhhHHHHHHHHHHHcCCC
Confidence            99999999999888 799999999987643321    1123457889999999654 48999999999999999998 99


Q ss_pred             CCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHH
Q 022799          155 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA  234 (292)
Q Consensus       155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~  234 (292)
                      .||.+....+....+......+                            .+..+++.+.++|.+||..||.+||++.++
T Consensus       249 ~pf~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l  300 (333)
T 1mqb_A          249 RPYWELSNHEVMKAINDGFRLP----------------------------TPMDCPSAIYQLMMQCWQQERARRPKFADI  300 (333)
T ss_dssp             CTTTTCCHHHHHHHHHTTCCCC----------------------------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             CCcccCCHHHHHHHHHCCCcCC----------------------------CcccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence            9998877665554443211000                            114578899999999999999999999999


Q ss_pred             hcC
Q 022799          235 LIH  237 (292)
Q Consensus       235 l~h  237 (292)
                      +++
T Consensus       301 ~~~  303 (333)
T 1mqb_A          301 VSI  303 (333)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            853

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.4e-38  Score=275.15  Aligned_cols=196  Identities=22%  Similarity=0.326  Sum_probs=153.5

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++...     . .++|+||+. |+|.+++...   ...+++..+..++.||+.||.|||++ ||+|
T Consensus        71 l~~l~hp~iv~~~~~~~~~-----~-~~~v~~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH  140 (327)
T 3lzb_A           71 MASVDNPHVCRLLGICLTS-----T-VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR-RLVH  140 (327)
T ss_dssp             HTTCCBTTBCCCCEEEESS-----S-EEEEECCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TCCC
T ss_pred             HHhCCCCCeeEEEEEEecC-----C-ceEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC-CCcC
Confidence            4678999999999988431     1 678889888 7999988754   45699999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCc---ccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQP  155 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~  155 (292)
                      |||||+||+++.++ .+||+|||+++........   ....+|+.|+|||.+.+. .++.++|+||+||++|+|++ |..
T Consensus       141 ~Dikp~NIl~~~~~-~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~  218 (327)
T 3lzb_A          141 RDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSK  218 (327)
T ss_dssp             SCCCGGGEEEEETT-EEEECCTTC----------------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred             CCCCHHHEEEcCCC-CEEEccCcceeEccCccccccccCCCccccccCHHHHcCC-CCChHHHHHHHHHHHHHHHHCCCC
Confidence            99999999999888 7999999999876433222   223457889999999764 48999999999999999999 999


Q ss_pred             CCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHh
Q 022799          156 LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL  235 (292)
Q Consensus       156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l  235 (292)
                      ||.+....+....+......                            ..+..++.++.++|.+||..||.+|||+.+++
T Consensus       219 p~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell  270 (327)
T 3lzb_A          219 PYDGIPASEISSILEKGERL----------------------------PQPPICTIDVYMIMRKCWMIDADSRPKFRELI  270 (327)
T ss_dssp             TTTTCCGGGHHHHHHTTCCC----------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCCCCHHHHHHHHHcCCCC----------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence            99887766544433321100                            01245788999999999999999999999998


Q ss_pred             c
Q 022799          236 I  236 (292)
Q Consensus       236 ~  236 (292)
                      +
T Consensus       271 ~  271 (327)
T 3lzb_A          271 I  271 (327)
T ss_dssp             H
T ss_pred             H
Confidence            5

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.2e-38  Score=269.64  Aligned_cols=196  Identities=26%  Similarity=0.382  Sum_probs=157.1

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      +.++||||+++++++.     +. ..++||||++ ++|.+++...   ...+++..+..++.||+.||.|||++ ||+||
T Consensus        68 ~~l~h~~i~~~~~~~~-----~~-~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~  137 (281)
T 3cc6_A           68 KNLDHPHIVKLIGIIE-----EE-PTWIIMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLESI-NCVHR  137 (281)
T ss_dssp             HHHCCTTBCCEEEEEC-----SS-SCEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCC
T ss_pred             HhCCCCCcceEEEEEc-----CC-CCEEEEecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHHC-CcccC
Confidence            4578999999999873     22 2579999998 6999988753   35689999999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCC--cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLF  157 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf  157 (292)
                      ||||+||+++.++ .+||+|||++........  .....+|+.|+|||++.+. .++.++|+||+||++|+|++ |..||
T Consensus       138 dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~llt~g~~p~  215 (281)
T 3cc6_A          138 DIAVRNILVASPE-CVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFR-RFTTASDVWMFAVCMWEILSFGKQPF  215 (281)
T ss_dssp             CCSGGGEEEEETT-EEEECCCCGGGCC---------CCCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             CCccceEEECCCC-cEEeCccCCCcccccccccccccCCCCcceeCchhhccC-CCCchhccHHHHHHHHHHHhCCCCCc
Confidence            9999999999888 799999999987643321  2234567889999999654 48999999999999999998 99999


Q ss_pred             CCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          158 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      ......+....+......+                            .+..+++.+.++|.+||..||.+|||+.+++++
T Consensus       216 ~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          216 FWLENKDVIGVLEKGDRLP----------------------------KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             TTSCGGGHHHHHHHTCCCC----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccCChHHHHHHHhcCCCCC----------------------------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence            8777666554443311100                            124578999999999999999999999999864

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1e-38  Score=267.78  Aligned_cols=198  Identities=19%  Similarity=0.337  Sum_probs=160.4

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++.     +....++||||++ ++|.+++...   ...+++..+..++.|++.||.|||++ |++|
T Consensus        57 l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H  127 (267)
T 3t9t_A           57 MMKLSHPKLVQLYGVCL-----EQAPICLVTEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA-CVIH  127 (267)
T ss_dssp             HHTCCCTTBCCEEEEEC-----SSSSCEEEECCCTTCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TCCC
T ss_pred             HHhCCCCCEeeEEEEEc-----cCCCeEEEEeCCCCCcHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHhC-Cccc
Confidence            35789999999999984     3344899999998 6999988753   35689999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCC--CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPL  156 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~p  156 (292)
                      |||||+||+++.++ .++|+|||.+.......  ......+|+.|+|||++.+. .++.++|+||+||++|+|++ |..|
T Consensus       128 ~dl~p~Nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p  205 (267)
T 3t9t_A          128 RDLAARNCLVGENQ-VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIP  205 (267)
T ss_dssp             SSCCGGGEEECGGG-CEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             CCCchheEEECCCC-CEEEcccccccccccccccccccccccccccChhhhcCC-CccchhchhhhHHHHHHHhccCCCC
Confidence            99999999999887 79999999997653221  11234567889999999654 48999999999999999999 8999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      |.+.+..+....+.....                            ...+..+++.+.++|.+||..||.+|||+.++++
T Consensus       206 ~~~~~~~~~~~~i~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  257 (267)
T 3t9t_A          206 YENRSNSEVVEDISTGFR----------------------------LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLR  257 (267)
T ss_dssp             TTTCCHHHHHHHHHTTCC----------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCHHHHHHHHhcCCc----------------------------CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            988776655554432100                            0012457889999999999999999999999986


Q ss_pred             C
Q 022799          237 H  237 (292)
Q Consensus       237 h  237 (292)
                      +
T Consensus       258 ~  258 (267)
T 3t9t_A          258 Q  258 (267)
T ss_dssp             H
T ss_pred             H
Confidence            3

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2.6e-38  Score=284.73  Aligned_cols=197  Identities=22%  Similarity=0.312  Sum_probs=158.9

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++....    ..+|+||||++ |+|.+++....  ...+++..+..++.||+.||.|||++ ||+|
T Consensus       240 l~~l~h~niv~~~~~~~~~~----~~~~iv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivH  312 (450)
T 1k9a_A          240 MTQLRHSNLVQLLGVIVEEK----GGLYIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN-NFVH  312 (450)
T ss_dssp             HHTCCCTTBCCEEEEEECTT----SCEEEEEECCTTCBHHHHHHHHC--TTTCCHHHHHHHHHHHHHHHHHHHHT-TEEC
T ss_pred             HHhccCCCEEEEEEEEEcCC----CceEEEEEecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeC
Confidence            46789999999999875432    24889999998 69999987641  23478999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFP  158 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~  158 (292)
                      |||||+||+++.++ .+||+|||+++.....  .....+|+.|+|||++.+. .++.++|+||+||++|||++ |..||.
T Consensus       313 rDlkp~Nill~~~~-~~kl~DfG~a~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~  388 (450)
T 1k9a_A          313 RDLAARNVLVSEDN-VAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYP  388 (450)
T ss_dssp             SCCCGGGEEECTTS-CEEECCCTTCEECC--------CCCTTTSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred             CCCCHhhEEECCCC-CEEEeeCCCccccccc--ccCCCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            99999999999888 7999999999865322  2233568899999999765 48999999999999999998 999998


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      +....+....+.+...                .            ..+..+++.+.++|.+||..||.+|||+.++++
T Consensus       389 ~~~~~~~~~~i~~~~~----------------~------------~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          389 RIPLKDVVPRVEKGYK----------------M------------DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             TSCTTTHHHHHHTTCC----------------C------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCHHHHHHHHHcCCC----------------C------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            8776655544432100                0            022468999999999999999999999999974

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.7e-38  Score=286.30  Aligned_cols=197  Identities=24%  Similarity=0.378  Sum_probs=160.4

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++|||||++++++.     + ..+++||||+. |+|.+++....  ...+++..+..++.||+.||.|||++ ||+|
T Consensus       237 l~~l~h~~iv~l~~~~~-----~-~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivH  307 (454)
T 1qcf_A          237 MKTLQHDKLVKLHAVVT-----K-EPIYIITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR-NYIH  307 (454)
T ss_dssp             HTTCCCTTBCCEEEEEC-----S-SSCEEEECCCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT-TCCC
T ss_pred             HhhCCCCCEeeEEEEEe-----C-CccEEEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC-CccC
Confidence            57899999999999873     1 13789999998 69999987542  23578899999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCC--CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPL  156 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~p  156 (292)
                      |||||+|||++.++ .+||+|||+++......  ......+|..|+|||++.+. .++.++|||||||++|||++ |..|
T Consensus       308 rDlkp~Nill~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~t~g~~P  385 (454)
T 1qcf_A          308 RDLRAANILVSASL-VCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIP  385 (454)
T ss_dssp             SSCSGGGEEECTTC-CEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             CCCCHHHEEECCCC-cEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccC-CCCcHHHHHhHHHHHHHHHhCCCCC
Confidence            99999999999888 79999999998753221  11223457789999999654 48999999999999999999 9999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      |.+.+..+....+......+                            .+..+++++.++|.+||..||.+|||++++++
T Consensus       386 ~~~~~~~~~~~~i~~~~~~~----------------------------~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          386 YPGMSNPEVIRALERGYRMP----------------------------RPENCPEELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             STTCCHHHHHHHHHHTCCCC----------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCHHHHHHHHHcCCCCC----------------------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence            99887776665554321111                            12457899999999999999999999999974

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2.1e-38  Score=270.24  Aligned_cols=198  Identities=21%  Similarity=0.341  Sum_probs=157.3

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++...    +...++||||++ |+|.+++...   ...+++..+..++.|++.||.|||++ ||+|
T Consensus        80 l~~l~h~~iv~~~~~~~~~----~~~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~ql~~~l~~lH~~-~i~H  151 (298)
T 3f66_A           80 MKDFSHPNVLSLLGICLRS----EGSPLVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKYLASK-KFVH  151 (298)
T ss_dssp             HHTCCCTTBCCCCEEECCS----SSCCEEEEECCTTCBHHHHHHCT---TCCCCHHHHHHHHHHHHHHHHHHHHT-TCCC
T ss_pred             HHhCCCCCEeeeeeEEEcC----CCceEEEEeCCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC-CccC
Confidence            3578999999999986432    234789999998 5999998753   45689999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCC-----CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-C
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-----PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-G  153 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g  153 (292)
                      |||||+||+++.++ .+||+|||++.......     ......+|+.|+|||.+.+. .++.++|+||+||++|+|++ |
T Consensus       152 ~dikp~Nil~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~  229 (298)
T 3f66_A          152 RDLAARNCMLDEKF-TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRG  229 (298)
T ss_dssp             SCCSGGGEEECTTC-CEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTS
T ss_pred             CCCchheEEECCCC-CEEECcccccccccccchhccccccCCCCCccccChHHhcCC-CCChHHHHHHHHHHHHHHHhCC
Confidence            99999999999888 79999999997653321     12334568899999999664 48999999999999999999 6


Q ss_pred             CCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHH
Q 022799          154 QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE  233 (292)
Q Consensus       154 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e  233 (292)
                      .+||.+.+..+....+......                            ..+..+++.+.++|.+||..||.+|||+.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~e  281 (298)
T 3f66_A          230 APPYPDVNTFDITVYLLQGRRL----------------------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSE  281 (298)
T ss_dssp             CCSSTTSCTTTHHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCccCCHHHHHHHHhcCCCC----------------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHH
Confidence            6777766655554444321100                            012457889999999999999999999999


Q ss_pred             Hhc
Q 022799          234 ALI  236 (292)
Q Consensus       234 ~l~  236 (292)
                      +++
T Consensus       282 ll~  284 (298)
T 3f66_A          282 LVS  284 (298)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            985

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=4.8e-38  Score=267.60  Aligned_cols=201  Identities=19%  Similarity=0.220  Sum_probs=156.4

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccC
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRD   81 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~d   81 (292)
                      +.++|++++..+..+..    +....++||||++++|.+++...   ...+++..+..++.||+.||.|||++ ||+|||
T Consensus        59 ~~l~~~~~i~~~~~~~~----~~~~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~d  130 (296)
T 3uzp_A           59 KMMQGGVGIPTIRWCGA----EGDYNVMVMELLGPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK-NFIHRD  130 (296)
T ss_dssp             HHHTTSTTCCCEEEEEE----ETTEEEEEEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECSC
T ss_pred             HHhhcCCCCCccccccC----CCCceEEEEEecCCCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCC
Confidence            34678887766655533    23357899999988999998743   45799999999999999999999998 999999


Q ss_pred             CCCCcEEEe---CCCCcEEEeecCCccccccCCC--------cccccccccccCCccccCCCCCCchhHhhhhhHHHHHH
Q 022799           82 IKPQNLLVN---PHTHQLKLCDFGSAKVLVKGEP--------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAEL  150 (292)
Q Consensus        82 lkp~Nill~---~~~~~ikl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el  150 (292)
                      |||+||+++   .++ .+||+|||++........        .....||+.|+|||++.+.. ++.++|+||+||++|+|
T Consensus       131 lkp~NIl~~~~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l  208 (296)
T 3uzp_A          131 VKPDNFLMGLGKKGN-LVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYF  208 (296)
T ss_dssp             CCGGGEEECCGGGTT-CEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHH
T ss_pred             CCHHHeEEecCCCCC-eEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCC-CCcchhhHHHHHHHHHH
Confidence            999999994   555 799999999987654332        23457899999999997654 89999999999999999


Q ss_pred             HhCCCCCCCCCc---HHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCC
Q 022799          151 LLGQPLFPGESG---VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL  227 (292)
Q Consensus       151 ~~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~  227 (292)
                      ++|..||.+...   ......+.......+..                        .+...+|+++.++|.+||+.||++
T Consensus       209 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~l~~li~~~l~~dp~~  264 (296)
T 3uzp_A          209 NLGSLPWQGLKAATKRQKYERISEKKMSTPIE------------------------VLCKGYPSEFATYLNFCRSLRFDD  264 (296)
T ss_dssp             HHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH------------------------HHTTTSCHHHHHHHHHHHTSCTTC
T ss_pred             HhCCCCCCCcCchhhhhhhhhhcccccCCchH------------------------HHHhhCCHHHHHHHHHHHhcCcCc
Confidence            999999986432   23333333321111111                        122468999999999999999999


Q ss_pred             cccHHHHhc
Q 022799          228 RSTALEALI  236 (292)
Q Consensus       228 R~t~~e~l~  236 (292)
                      |||++++++
T Consensus       265 Rps~~~l~~  273 (296)
T 3uzp_A          265 KPDYSYLRQ  273 (296)
T ss_dssp             CCCHHHHHH
T ss_pred             CCCHHHHHH
Confidence            999999984

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=7.6e-39  Score=272.67  Aligned_cols=209  Identities=24%  Similarity=0.426  Sum_probs=153.5

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++....   ...+++||||++ |+|.+++...   ...+++..+..++.||+.||.|||++ ||+|
T Consensus        65 l~~l~h~~iv~~~~~~~~~~---~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH  137 (295)
T 3ugc_A           65 LKSLQHDNIVKYKGVCYSAG---RRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK-RYIH  137 (295)
T ss_dssp             HHTCCCTTBCCEEEEECHHH---HTSCEEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHT-TCCC
T ss_pred             HHhCCCCCEeeEEEEEecCC---CCceEEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcC-Cccc
Confidence            35789999999999885422   234789999997 6999998764   24589999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCC----cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQP  155 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~  155 (292)
                      |||||+||+++.++ .+||+|||++........    .....+|..|+|||.+.+. .++.++|+||+||++|+|++|..
T Consensus       138 ~Dikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~  215 (295)
T 3ugc_A          138 RDLATRNILVENEN-RVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIE  215 (295)
T ss_dssp             SCCSGGGEEEEETT-EEEECCCCSCC-------------CTTCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTTC
T ss_pred             CCCCHhhEEEcCCC-eEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCC-CCChHHHHHHHHHHHHHHHhccc
Confidence            99999999999888 799999999987643321    2234567789999999765 48999999999999999999999


Q ss_pred             CCCCCCcHHHHHHHHHHhCCCCHHH------HhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcc
Q 022799          156 LFPGESGVDQLVEIIKVLGTPTREE------IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS  229 (292)
Q Consensus       156 pf~~~~~~~~~~~i~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~  229 (292)
                      |+......     .....+......      ........             ....+..+++++.++|.+||..||++||
T Consensus       216 ~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~l~~li~~~l~~dp~~Rp  277 (295)
T 3ugc_A          216 KSKSPPAE-----FMRMIGNDKQGQMIVFHLIELLKNNG-------------RLPRPDGCPDEIYMIMTECWNNNVNQRP  277 (295)
T ss_dssp             TTCSHHHH-----HHHHHCTTCCTHHHHHHHHHHHHTTC-------------CCCCCTTCCHHHHHHHHHHSCSSGGGSC
T ss_pred             ccCCChHH-----HHhhhcCccccchhHHHHHHHHhccC-------------cCCCCcCcCHHHHHHHHHHcCCChhhCC
Confidence            88543211     111111111000      00000000             0011256899999999999999999999


Q ss_pred             cHHHHhc
Q 022799          230 TALEALI  236 (292)
Q Consensus       230 t~~e~l~  236 (292)
                      |+.++++
T Consensus       278 s~~el~~  284 (295)
T 3ugc_A          278 SFRDLAL  284 (295)
T ss_dssp             CHHHHHH
T ss_pred             CHHHHHH
Confidence            9999984

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=5.7e-38  Score=267.04  Aligned_cols=200  Identities=20%  Similarity=0.221  Sum_probs=155.9

Q ss_pred             CCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCC
Q 022799            3 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDI   82 (292)
Q Consensus         3 ~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dl   82 (292)
                      .++|++++..+..+..    +....++||||++++|.+++...   ...+++..+..++.||+.||.|||++ ||+||||
T Consensus        60 ~l~~~~~i~~~~~~~~----~~~~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dl  131 (296)
T 4hgt_A           60 MMQGGVGIPTIRWCGA----EGDYNVMVMELLGPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK-NFIHRDV  131 (296)
T ss_dssp             HHTTSTTCCCEEEEEE----ETTEEEEEEECCCCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCC
T ss_pred             HhcCCCCCCeeeeecC----CCCceEEEEEccCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCC
Confidence            4677777777665533    23357899999988999988743   45699999999999999999999998 9999999


Q ss_pred             CCCcEEE---eCCCCcEEEeecCCccccccCCC--------cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHH
Q 022799           83 KPQNLLV---NPHTHQLKLCDFGSAKVLVKGEP--------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL  151 (292)
Q Consensus        83 kp~Nill---~~~~~~ikl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~  151 (292)
                      ||+||++   +.++ .+||+|||++........        .....||+.|+|||++.+.. ++.++|+||+||++|+|+
T Consensus       132 kp~NIl~~~~~~~~-~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~  209 (296)
T 4hgt_A          132 KPDNFLMGLGKKGN-LVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFN  209 (296)
T ss_dssp             SGGGEEECCGGGTT-CEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHH
T ss_pred             CHHHeeeeccCCCC-eEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCC-CCchhHHHHHHHHHHHHh
Confidence            9999999   5666 799999999987644322        23457899999999997654 899999999999999999


Q ss_pred             hCCCCCCCCCcH---HHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCc
Q 022799          152 LGQPLFPGESGV---DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR  228 (292)
Q Consensus       152 ~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R  228 (292)
                      +|..||.+.+..   .....+.......+..                        .....+++++.++|.+||+.||++|
T Consensus       210 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~l~~li~~~l~~~p~~R  265 (296)
T 4hgt_A          210 LGSLPWQGLKAATKRQKYERISEKKMSTPIE------------------------VLCKGYPSEFATYLNFCRSLRFDDK  265 (296)
T ss_dssp             HSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH------------------------HHTTTSCHHHHHHHHHHHTSCTTCC
T ss_pred             cCCCCCcccchhhhhhhhhhhhcccccchhh------------------------hhhccCCHHHHHHHHHHHhcCCCCC
Confidence            999999764432   2222222221111111                        1224678999999999999999999


Q ss_pred             ccHHHHhc
Q 022799          229 STALEALI  236 (292)
Q Consensus       229 ~t~~e~l~  236 (292)
                      ||++++++
T Consensus       266 pt~~~l~~  273 (296)
T 4hgt_A          266 PDYSYLRQ  273 (296)
T ss_dssp             CCHHHHHH
T ss_pred             CCHHHHHH
Confidence            99999985

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=2e-38  Score=269.04  Aligned_cols=197  Identities=20%  Similarity=0.325  Sum_probs=160.7

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      ++++||||+++++++     .+....++||||++ ++|.+++....  ...+++..+..++.||+.||.|||++ ||+||
T Consensus        64 ~~l~h~~i~~~~~~~-----~~~~~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~  135 (288)
T 3kfa_A           64 KEIKHPNLVQLLGVC-----TREPPFYIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK-NFIHR  135 (288)
T ss_dssp             HHCCCTTBCCEEEEE-----CSSSSEEEEEECCTTEEHHHHHHHCC--TTTSCHHHHHHHHHHHHHHHHHHHHH-TCCCS
T ss_pred             HhCCCCCEeeEEEEE-----ccCCCEEEEEEcCCCCcHHHHHHhcc--cCCccHhHHHHHHHHHHHHHHHHHHC-CccCC
Confidence            467899999999998     44445899999998 69999887532  35689999999999999999999998 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCC--cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLF  157 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf  157 (292)
                      ||||+||+++.++ .++|+|||.+........  .....+|+.|+|||++.+. .++.++|+||+||++|+|++ |..||
T Consensus       136 dikp~Nil~~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~~g~~p~  213 (288)
T 3kfa_A          136 DLAARNCLVGENH-LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPY  213 (288)
T ss_dssp             CCSGGGEEECGGG-CEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             CCCcceEEEcCCC-CEEEccCccceeccCCccccccCCccccCcCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            9999999999887 799999999987644332  1233567889999999654 48999999999999999999 99999


Q ss_pred             CCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          158 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      .+.+.......+......                            ..+..+++.+.++|.+||..||.+|||+.++++
T Consensus       214 ~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          214 PGIDLSQVYELLEKDYRM----------------------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             TTCCGGGHHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCHHHHHHHHhccCCC----------------------------CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence            887765544443321000                            012467899999999999999999999999974

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.2e-38  Score=272.81  Aligned_cols=212  Identities=22%  Similarity=0.239  Sum_probs=159.4

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      ++++||||+++++++.     +....++||||++ ++|.+++.... ....+++..+..++.||+.||.|||++ ||+||
T Consensus        85 ~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~  157 (307)
T 2nru_A           85 AKCQHENLVELLGFSS-----DGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHEN-HHIHR  157 (307)
T ss_dssp             HHCCCTTBCCEEEEEC-----SSSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHT-TEECS
T ss_pred             HhcCCCCeEEEEEEEe-----cCCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcC-CeecC
Confidence            4679999999999983     3344889999997 79998887532 245799999999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCC---cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF  157 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf  157 (292)
                      ||||+||+++.++ .++|+|||++........   .....||+.|+|||++.+  .++.++|+|||||++|+|++|..||
T Consensus       158 dlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~  234 (307)
T 2nru_A          158 DIKSANILLDEAF-TAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAV  234 (307)
T ss_dssp             CCCGGGEEECTTC-CEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSB
T ss_pred             CCCHHHEEEcCCC-cEEEeecccccccccccccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCc
Confidence            9999999999887 799999999876543222   223468999999999865  3789999999999999999999999


Q ss_pred             CCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          158 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      .+.........+.+..............+..        .      ..+...+..+.++|.+||..||.+|||+.+++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          235 DEHREPQLLLDIKEEIEDEEKTIEDYIDKKM--------N------DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             CTTBSSSBTTHHHHHHHTTSCCHHHHSCSSC--------S------CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ccCcchHHHHHHHHHhhhhhhhhhhhccccc--------c------ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            8765443333333222111100000000000        0      0112345789999999999999999999999853

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=5.6e-39  Score=271.67  Aligned_cols=202  Identities=24%  Similarity=0.347  Sum_probs=162.3

Q ss_pred             CCCCCCCeeeeceeeeccC-----------CCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHH
Q 022799            2 RLLDHPNVVSLKHCFFSTT-----------EKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALA   69 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~-----------~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~   69 (292)
                      ++++||||+++++++....           ......+++||||++ ++|.+++....  ...+++..+..++.||+.||.
T Consensus        59 ~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~  136 (284)
T 2a19_B           59 AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVD  136 (284)
T ss_dssp             HHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHH
T ss_pred             HhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHH
Confidence            4679999999999874311           022456899999999 59999987542  357899999999999999999


Q ss_pred             HHHhcCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHH
Q 022799           70 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAE  149 (292)
Q Consensus        70 ~LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~e  149 (292)
                      |||++ ||+||||||+||+++.++ .++|+|||++.............||+.|+|||++.+. .++.++|+||+||++|+
T Consensus       137 ~lH~~-~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~  213 (284)
T 2a19_B          137 YIHSK-KLINRDLKPSNIFLVDTK-QVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQ-DYGKEVDLYALGLILAE  213 (284)
T ss_dssp             HHHHT-TEECSCCSGGGEEEEETT-EEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCS-CCCTHHHHHHHHHHHHH
T ss_pred             HHHhC-CeeeccCCHHHEEEcCCC-CEEECcchhheeccccccccccCCcccccChhhhccC-CCcchhhhHHHHHHHHH
Confidence            99988 999999999999999888 7999999999877655555566789999999999765 48999999999999999


Q ss_pred             HHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcc
Q 022799          150 LLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS  229 (292)
Q Consensus       150 l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~  229 (292)
                      |++|..|+....      ........                           ..++..+++.+.++|.+||..||.+||
T Consensus       214 l~~~~~~~~~~~------~~~~~~~~---------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rp  260 (284)
T 2a19_B          214 LLHVCDTAFETS------KFFTDLRD---------------------------GIISDIFDKKEKTLLQKLLSKKPEDRP  260 (284)
T ss_dssp             HHSCCSSHHHHH------HHHHHHHT---------------------------TCCCTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred             HHhcCCcchhHH------HHHHHhhc---------------------------ccccccCCHHHHHHHHHHccCChhhCc
Confidence            999998874211      11111000                           001245788999999999999999999


Q ss_pred             cHHHHhcCCCcc
Q 022799          230 TALEALIHPFFD  241 (292)
Q Consensus       230 t~~e~l~hp~~~  241 (292)
                      |+.+++++.+.-
T Consensus       261 s~~e~l~~l~~~  272 (284)
T 2a19_B          261 NTSEILRTLTVW  272 (284)
T ss_dssp             CHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHH
Confidence            999999987654

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=5.2e-38  Score=270.22  Aligned_cols=204  Identities=19%  Similarity=0.243  Sum_probs=157.7

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++..     ...+++||||++ ++|.+++...   ...+++..+..++.||+.||.|||++ ||+|
T Consensus        83 l~~l~h~~iv~~~~~~~~-----~~~~~iv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~-~i~H  153 (319)
T 2y4i_B           83 YRQTRHENVVLFMGACMS-----PPHLAIITSLCKGRTLYSVVRDA---KIVLDVNKTRQIAQEIVKGMGYLHAK-GILH  153 (319)
T ss_dssp             GTTCCCTTBCCCCEEEEC-----SSCEEEECBCCCSEEHHHHTTSS---CCCCCSHHHHHHHHHHHHHHHHHHHT-TCCC
T ss_pred             HhcCCCCCEeEEEEEEec-----CCceEEEeecccCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC-Cccc
Confidence            467899999999999843     334899999998 6998888642   34689999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccC------CCcccccccccccCCccccC--------CCCCCchhHhhhhhH
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG------EPNISYICSRYYRAPELIFG--------ATEYTAAIDIWSAGC  145 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~------~~~~~~~gt~~y~aPE~~~~--------~~~~~~~~DvwslG~  145 (292)
                      |||||+||+++ ++ .++|+|||++......      .......||+.|+|||++.+        ...++.++|+||+||
T Consensus       154 ~dlkp~NIl~~-~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~  231 (319)
T 2y4i_B          154 KDLKSKNVFYD-NG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGT  231 (319)
T ss_dssp             CCCCSTTEEEC----CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHH
T ss_pred             cCCChhhEEEe-CC-CEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHH
Confidence            99999999998 45 6999999997654211      12233468999999999864        234789999999999


Q ss_pred             HHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCC
Q 022799          146 VLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSP  225 (292)
Q Consensus       146 il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp  225 (292)
                      ++|+|++|..||.+.........+.... .          +.                .....+++++.++|.+||..||
T Consensus       232 il~el~~g~~p~~~~~~~~~~~~~~~~~-~----------~~----------------~~~~~~~~~l~~li~~~l~~~p  284 (319)
T 2y4i_B          232 IWYELHAREWPFKTQPAEAIIWQMGTGM-K----------PN----------------LSQIGMGKEISDILLFCWAFEQ  284 (319)
T ss_dssp             HHHHHHHSSCSSSSCCHHHHHHHHHTTC-C----------CC----------------CCCSSCCTTHHHHHHHHHCSST
T ss_pred             HHHHHHhCCCCCCCCCHHHHHHHhccCC-C----------CC----------------CCcCCCCHHHHHHHHHHhcCCh
Confidence            9999999999998877665544433210 0          00                0013578899999999999999


Q ss_pred             CCcccHHHHhcCCCccccC
Q 022799          226 NLRSTALEALIHPFFDELR  244 (292)
Q Consensus       226 ~~R~t~~e~l~hp~~~~~~  244 (292)
                      .+|||+.++++  .++.+.
T Consensus       285 ~~Rpt~~~l~~--~l~~l~  301 (319)
T 2y4i_B          285 EERPTFTKLMD--MLEKLP  301 (319)
T ss_dssp             TTSCCHHHHHH--HHTTC-
T ss_pred             hhCcCHHHHHH--HHHHHH
Confidence            99999999985  344443

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.1e-38  Score=266.42  Aligned_cols=198  Identities=20%  Similarity=0.282  Sum_probs=156.0

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++....    ...++||||+. |+|.+++...   ...+++..+..++.|++.||.|||++ ||+|
T Consensus        76 l~~l~h~~iv~~~~~~~~~~----~~~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H  147 (298)
T 3pls_A           76 MRGLNHPNVLALIGIMLPPE----GLPHVLLPYMCHGDLLQFIRSP---QRNPTVKDLISFGLQVARGMEYLAEQ-KFVH  147 (298)
T ss_dssp             HHTCCCTTBCCCCEEECCSS----SCCEEEECCCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT-TCCC
T ss_pred             HHhCCCCCeeeEEEEEecCC----CCcEEEEecccCCCHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC-Cccc
Confidence            35789999999999984332    22479999997 7999988753   46789999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccC-----CCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-----EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ  154 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~  154 (292)
                      |||||+||+++.++ .+||+|||++......     .......+|+.|+|||.+.+. .++.++|+||+||++|+|++|.
T Consensus       148 ~dikp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~  225 (298)
T 3pls_A          148 RDLAARNCMLDESF-TVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTY-RFTTKSDVWSFGVLLWELLTRG  225 (298)
T ss_dssp             SCCSGGGEEECTTC-CEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTC-CCCHHHHHHHHHHHHHHHHHTS
T ss_pred             CCCCcceEEEcCCC-cEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccC-CCChhhchhhHHHHHHHHhhCC
Confidence            99999999999888 7999999999755322     122344678899999999654 4899999999999999999955


Q ss_pred             -CCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHH
Q 022799          155 -PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE  233 (292)
Q Consensus       155 -~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e  233 (292)
                       +||.+.+..+....+..... +                           ..+..+++.+.++|.+||..||.+|||+.+
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~-~---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~  277 (298)
T 3pls_A          226 APPYRHIDPFDLTHFLAQGRR-L---------------------------PQPEYCPDSLYQVMQQCWEADPAVRPTFRV  277 (298)
T ss_dssp             CCTTTTSCGGGHHHHHHTTCC-C---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCccCCHHHHHHHhhcCCC-C---------------------------CCCccchHHHHHHHHHHccCChhhCcCHHH
Confidence             55555554444333332110 0                           012457899999999999999999999999


Q ss_pred             Hhc
Q 022799          234 ALI  236 (292)
Q Consensus       234 ~l~  236 (292)
                      +++
T Consensus       278 ll~  280 (298)
T 3pls_A          278 LVG  280 (298)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            985

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=8.5e-38  Score=268.09  Aligned_cols=198  Identities=24%  Similarity=0.299  Sum_probs=149.6

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++..     ....++||||++ ++|.+++...    ..+++..+..++.||+.||.|||++ ||+|
T Consensus        88 l~~l~hp~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H  157 (309)
T 2h34_A           88 AGRLQEPHVVPIHDFGEI-----DGQLYVDMRLINGVDLAAMLRRQ----GPLAPPRAVAIVRQIGSALDAAHAA-GATH  157 (309)
T ss_dssp             HTTCCCTTBCCEEEEEEE-----TTEEEEEEECCCCEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT-TCCC
T ss_pred             HhhcCCCCeeEEEEEEee-----CCeEEEEEEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-cCCc
Confidence            467899999999999843     345899999998 5999988753    5689999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCC--CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF  157 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf  157 (292)
                      |||||+||+++.++ .+||+|||++.......  ......||+.|+|||++.+. .++.++|+||+||++|+|++|..||
T Consensus       158 ~dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf  235 (309)
T 2h34_A          158 RDVKPENILVSADD-FAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSES-HATYRADIYALTCVLYECLTGSPPY  235 (309)
T ss_dssp             SCCCGGGEEECTTS-CEEECSCCC----------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSS
T ss_pred             CCCChHHEEEcCCC-CEEEecCccCccccccccccccccCCCcCccCHHHHcCC-CCCchHhHHHHHHHHHHHHHCCCCC
Confidence            99999999999888 79999999987654332  12345789999999999664 4899999999999999999999999


Q ss_pred             CCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcc-cHHHHhc
Q 022799          158 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-TALEALI  236 (292)
Q Consensus       158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-t~~e~l~  236 (292)
                      .+.+.. .+....... .+                        .....+..+++.+.++|.+||..||.+|| |++++++
T Consensus       236 ~~~~~~-~~~~~~~~~-~~------------------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          236 QGDQLS-VMGAHINQA-IP------------------------RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             CSCHHH-HHHHHHHSC-CC------------------------CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             CCchHH-HHHHHhccC-CC------------------------CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence            876543 222222210 00                        01112356899999999999999999999 7877764

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.2e-38  Score=275.46  Aligned_cols=206  Identities=18%  Similarity=0.231  Sum_probs=163.1

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCCc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKM---SQRMPLIYVKLYFYQICRALAYIHNTIGV   77 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~---~~~~~~~~~~~~~~qil~al~~LH~~~~i   77 (292)
                      ++++||||+++++++.     +....|+||||++ ++|.+++......   ...+++..+..++.||+.||.|||++ ||
T Consensus        88 ~~l~h~~iv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~-~i  161 (327)
T 2yfx_A           88 SKFNHQNIVRCIGVSL-----QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN-HF  161 (327)
T ss_dssp             HHCCCTTBCCEEEEEC-----SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT-TC
T ss_pred             hhCCCCCCCeEEEEEc-----CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC-Ce
Confidence            4579999999999984     3344789999996 6999998864321   14589999999999999999999988 99


Q ss_pred             cccCCCCCcEEEeCCC--CcEEEeecCCccccccCC---CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh
Q 022799           78 CHRDIKPQNLLVNPHT--HQLKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL  152 (292)
Q Consensus        78 ~H~dlkp~Nill~~~~--~~ikl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~  152 (292)
                      +||||||+||+++.++  ..++|+|||++.......   ......+|+.|+|||++.+. .++.++|+|||||++|+|++
T Consensus       162 ~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt  240 (327)
T 2yfx_A          162 IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFS  240 (327)
T ss_dssp             CCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHT
T ss_pred             ecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCC-CCCchhhHHHHHHHHHHHHc
Confidence            9999999999998433  269999999987653322   22345678899999998654 48999999999999999998


Q ss_pred             -CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccH
Q 022799          153 -GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA  231 (292)
Q Consensus       153 -g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~  231 (292)
                       |..||.+....+....+.... .+                           ..+..+++.+.++|.+||..||.+|||+
T Consensus       241 ~g~~p~~~~~~~~~~~~~~~~~-~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~  292 (327)
T 2yfx_A          241 LGYMPYPSKSNQEVLEFVTSGG-RM---------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNF  292 (327)
T ss_dssp             TSCCSSTTCCHHHHHHHHHTTC-CC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCCCCCCCcCHHHHHHHHhcCC-CC---------------------------CCCCCCCHHHHHHHHHHhcCChhhCcCH
Confidence             999998877655444433210 00                           0124678999999999999999999999


Q ss_pred             HHHhcCCCccc
Q 022799          232 LEALIHPFFDE  242 (292)
Q Consensus       232 ~e~l~hp~~~~  242 (292)
                      .+++++.|+-.
T Consensus       293 ~~ll~~l~~~~  303 (327)
T 2yfx_A          293 AIILERIEYCT  303 (327)
T ss_dssp             HHHHHHHHHHH
T ss_pred             HHHHHHHHHHh
Confidence            99999987643

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.7e-38  Score=275.01  Aligned_cols=200  Identities=27%  Similarity=0.392  Sum_probs=141.4

Q ss_pred             CCCCeeeeceeeeccCC---CCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCC--ccc
Q 022799            5 DHPNVVSLKHCFFSTTE---KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG--VCH   79 (292)
Q Consensus         5 ~HpnIv~~~~~~~~~~~---~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~--i~H   79 (292)
                      +||||+++++++.....   .+...+++||||++|+|.+++..... ...+++..++.++.||+.||.|||++ |  |+|
T Consensus        84 ~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~ivH  161 (337)
T 3ll6_A           84 GHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHRQ-KPPIIH  161 (337)
T ss_dssp             TSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCSEEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHTS-SSCCBC
T ss_pred             cCCChhhccccccccccccccCCceEEEEEEecCCCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEE
Confidence            49999999998853221   44556899999999999998875432 45799999999999999999999987 9  999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCc-------------ccccccccccCCcccc--CCCCCCchhHhhhhh
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-------------ISYICSRYYRAPELIF--GATEYTAAIDIWSAG  144 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~-------------~~~~gt~~y~aPE~~~--~~~~~~~~~DvwslG  144 (292)
                      |||||+||+++.++ .+||+|||++.........             ....||+.|+|||++.  ....++.++|+||||
T Consensus       162 ~Dikp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG  240 (337)
T 3ll6_A          162 RDLKVENLLLSNQG-TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALG  240 (337)
T ss_dssp             CCCCGGGCEECTTS-CEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHH
T ss_pred             ccCCcccEEECCCC-CEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHH
Confidence            99999999999888 7999999999876433211             1446899999999983  234478999999999


Q ss_pred             HHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccC
Q 022799          145 CVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYS  224 (292)
Q Consensus       145 ~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  224 (292)
                      |++|+|++|..||.+..........                     ...+          .....+..+.+||.+||+.|
T Consensus       241 ~il~el~~g~~p~~~~~~~~~~~~~---------------------~~~~----------~~~~~~~~~~~li~~~l~~~  289 (337)
T 3ll6_A          241 CILYLLCFRQHPFEDGAKLRIVNGK---------------------YSIP----------PHDTQYTVFHSLIRAMLQVN  289 (337)
T ss_dssp             HHHHHHHHSSCCC---------------------------------CCCC----------TTCCSSGGGHHHHHHHSCSS
T ss_pred             HHHHHHHhCCCCCcchhHHHhhcCc---------------------ccCC----------cccccchHHHHHHHHHccCC
Confidence            9999999999999754432211100                     0000          11346788999999999999


Q ss_pred             CCCcccHHHHhcCC
Q 022799          225 PNLRSTALEALIHP  238 (292)
Q Consensus       225 p~~R~t~~e~l~hp  238 (292)
                      |.+|||+.+++++-
T Consensus       290 p~~Rps~~e~l~~l  303 (337)
T 3ll6_A          290 PEERLSIAEVVHQL  303 (337)
T ss_dssp             GGGSCCHHHHHHHH
T ss_pred             hhhCcCHHHHHHHH
Confidence            99999999999763

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.3e-38  Score=270.43  Aligned_cols=195  Identities=26%  Similarity=0.404  Sum_probs=148.2

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---cCCc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN---TIGV   77 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~---~~~i   77 (292)
                      ++++||||+++++++.     +.  .++||||++ |+|.+++..... ...++...+..++.|++.||.|||+   + ||
T Consensus        56 ~~l~hp~iv~~~~~~~-----~~--~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~-~i  126 (307)
T 2eva_A           56 SRVNHPNIVKLYGACL-----NP--VCLVMEYAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPK-AL  126 (307)
T ss_dssp             HHCCCTTBCCEEEBCT-----TT--TEEEEECCTTCBHHHHHHCSSS-EECCCHHHHHHHHHHHHHHHHHHHTCSSS-CC
T ss_pred             hcCCCCCcCeEEEEEc-----CC--cEEEEEcCCCCCHHHHHhccCC-CCccCHHHHHHHHHHHHHHHHHHHhCCCC-Ce
Confidence            4679999999999873     22  679999998 699998875321 2347889999999999999999998   6 99


Q ss_pred             cccCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCC
Q 022799           78 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF  157 (292)
Q Consensus        78 ~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf  157 (292)
                      +||||||+||+++.++..+||+|||++......  .....||+.|+|||++.+. .++.++|+||+||++|+|++|..||
T Consensus       127 vH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~  203 (307)
T 2eva_A          127 IHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--MTNNKGSAAWMAPEVFEGS-NYSEKCDVFSWGIILWEVITRRKPF  203 (307)
T ss_dssp             CCCCCSGGGEEEETTTTEEEECCCCC--------------CCTTSSCHHHHTCC-CCCTHHHHHHHHHHHHHHHHTCCTT
T ss_pred             ecCCCChhHEEEeCCCCEEEEcccccccccccc--cccCCCCCceEChhhhCCC-CCCcHHHHHHHHHHHHHHHHCCCCc
Confidence            999999999999988745899999999765332  2345689999999999664 5899999999999999999999999


Q ss_pred             CCCCcHH--HHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHh
Q 022799          158 PGESGVD--QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL  235 (292)
Q Consensus       158 ~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l  235 (292)
                      .......  ....+..  +..                          ...+..+++.+.++|.+||..||.+|||+++++
T Consensus       204 ~~~~~~~~~~~~~~~~--~~~--------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell  255 (307)
T 2eva_A          204 DEIGGPAFRIMWAVHN--GTR--------------------------PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIV  255 (307)
T ss_dssp             TTTCSSHHHHHHHHHT--TCC--------------------------CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             hhhCccHHHHHHHHhc--CCC--------------------------CCcccccCHHHHHHHHHHhcCChhhCcCHHHHH
Confidence            7543322  1111110  000                          001246889999999999999999999999998


Q ss_pred             c
Q 022799          236 I  236 (292)
Q Consensus       236 ~  236 (292)
                      +
T Consensus       256 ~  256 (307)
T 2eva_A          256 K  256 (307)
T ss_dssp             H
T ss_pred             H
Confidence            6

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=2.6e-38  Score=274.09  Aligned_cols=197  Identities=20%  Similarity=0.316  Sum_probs=158.8

Q ss_pred             CCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHH
Q 022799            5 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYK------------MSQRMPLIYVKLYFYQICRALAYI   71 (292)
Q Consensus         5 ~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~------------~~~~~~~~~~~~~~~qil~al~~L   71 (292)
                      +||||+++++++     .+...+++||||++ |+|.+++.....            ....+++..+..++.||+.||.||
T Consensus        99 ~hp~iv~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L  173 (334)
T 2pvf_A           99 KHKNIINLLGAC-----TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL  173 (334)
T ss_dssp             CCTTBCCEEEEE-----CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCEeeEEEEE-----ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHH
Confidence            899999999998     33445899999998 699999876432            123489999999999999999999


Q ss_pred             HhcCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCCC---cccccccccccCCccccCCCCCCchhHhhhhhHHHH
Q 022799           72 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLA  148 (292)
Q Consensus        72 H~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~  148 (292)
                      |++ ||+||||||+||+++.++ .+||+|||++........   .....+|+.|+|||++.+. .++.++|+||+||++|
T Consensus       174 H~~-~ivH~Dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~  250 (334)
T 2pvf_A          174 ASQ-KCIHRDLAARNVLVTENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMW  250 (334)
T ss_dssp             HHT-TEECSCCSGGGEEECTTC-CEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHH
T ss_pred             HhC-CeeCCCCccceEEEcCCC-CEEEccccccccccccccccccCCCCcccceeChHHhcCC-CcChHHHHHHHHHHHH
Confidence            998 999999999999999888 799999999987644322   2233567889999998664 4899999999999999


Q ss_pred             HHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCC
Q 022799          149 ELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL  227 (292)
Q Consensus       149 el~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~  227 (292)
                      +|++ |..||.+....+....+..... +                           ..+..+++.+.++|.+||..||.+
T Consensus       251 ellt~g~~p~~~~~~~~~~~~~~~~~~-~---------------------------~~~~~~~~~l~~li~~~l~~dp~~  302 (334)
T 2pvf_A          251 EIFTLGGSPYPGIPVEELFKLLKEGHR-M---------------------------DKPANCTNELYMMMRDCWHAVPSQ  302 (334)
T ss_dssp             HHHTTSCCSSTTCCHHHHHHHHHHTCC-C---------------------------CCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred             HHHhCCCCCcCcCCHHHHHHHHhcCCC-C---------------------------CCCccCCHHHHHHHHHHccCChhh
Confidence            9999 9999988776555444433110 0                           012457899999999999999999


Q ss_pred             cccHHHHhcC
Q 022799          228 RSTALEALIH  237 (292)
Q Consensus       228 R~t~~e~l~h  237 (292)
                      |||+.+++++
T Consensus       303 Rps~~ell~~  312 (334)
T 2pvf_A          303 RPTFKQLVED  312 (334)
T ss_dssp             SCCHHHHHHH
T ss_pred             CcCHHHHHHH
Confidence            9999999864

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-38  Score=268.71  Aligned_cols=197  Identities=24%  Similarity=0.322  Sum_probs=159.9

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      ++++||||+++++++ ...     ..++||||++ ++|.+++...   ...+++..+..++.||+.||.|||++ ||+||
T Consensus        65 ~~l~h~~i~~~~~~~-~~~-----~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~  134 (287)
T 1u59_A           65 HQLDNPYIVRLIGVC-QAE-----ALMLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK-NFVHR  134 (287)
T ss_dssp             HHCCCTTBCCEEEEE-ESS-----SEEEEEECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT-TEECC
T ss_pred             HhCCCCCEeEEEEEe-cCC-----CcEEEEEeCCCCCHHHHHHhC---CccCCHHHHHHHHHHHHHHHHHHHHC-CEeeC
Confidence            457999999999988 211     2789999998 5998888642   45699999999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCC----cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQP  155 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~  155 (292)
                      ||||+||+++.++ .++|+|||++........    .....+|+.|+|||++.+. .++.++|+||+||++|+|++ |..
T Consensus       135 dlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~  212 (287)
T 1u59_A          135 DLAARNVLLVNRH-YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQK  212 (287)
T ss_dssp             CCSGGGEEEEETT-EEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCC
T ss_pred             CCchheEEEcCCC-CEEECcccceeeeccCcceeeccccccccccccCHHHhccC-CCCchhhHHHHHHHHHHHHcCCCC
Confidence            9999999999887 899999999987643322    1223458899999999654 48999999999999999998 999


Q ss_pred             CCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHh
Q 022799          156 LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL  235 (292)
Q Consensus       156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l  235 (292)
                      ||.+....+....+.... .                           ..++..+++.+.++|.+||..||.+|||+.+++
T Consensus       213 p~~~~~~~~~~~~i~~~~-~---------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~  264 (287)
T 1u59_A          213 PYKKMKGPEVMAFIEQGK-R---------------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVE  264 (287)
T ss_dssp             TTTTCCTHHHHHHHHTTC-C---------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHH
T ss_pred             CcccCCHHHHHHHHhcCC-c---------------------------CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence            998877665554433210 0                           012246899999999999999999999999999


Q ss_pred             cCC
Q 022799          236 IHP  238 (292)
Q Consensus       236 ~hp  238 (292)
                      ++.
T Consensus       265 ~~l  267 (287)
T 1u59_A          265 QRM  267 (287)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            763

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=6e-38  Score=266.67  Aligned_cols=195  Identities=22%  Similarity=0.304  Sum_probs=157.6

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++ ...     ..++||||++ ++|.+++..    ...+++..+..++.||+.||.|||++ ||+|
T Consensus        72 l~~l~h~~i~~~~~~~-~~~-----~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H  140 (291)
T 1xbb_A           72 MQQLDNPYIVRMIGIC-EAE-----SWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES-NFVH  140 (291)
T ss_dssp             HHTCCCTTBCCEEEEE-ESS-----SEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT-TEEC
T ss_pred             HHhCCCCCEEEEEEEE-CCC-----CcEEEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhC-CeEc
Confidence            3568999999999987 211     2789999998 699998875    35699999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCc----ccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQ  154 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~  154 (292)
                      |||||+||+++.++ .++|+|||++.........    ....+|+.|+|||.+.+. .++.++|+||+||++|+|++ |.
T Consensus       141 ~dikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~  218 (291)
T 1xbb_A          141 RDLAARNVLLVTQH-YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQ  218 (291)
T ss_dssp             SCCSGGGEEEEETT-EEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTC
T ss_pred             CCCCcceEEEeCCC-cEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccC-CCChhhhHHHHHHHHHHHHhcCC
Confidence            99999999999888 7999999999876443321    123456889999999654 48899999999999999999 99


Q ss_pred             CCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHH
Q 022799          155 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA  234 (292)
Q Consensus       155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~  234 (292)
                      .||.+.+..+....+... ..+                           .++..+++.+.++|.+||..||.+|||+.++
T Consensus       219 ~p~~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  270 (291)
T 1xbb_A          219 KPYRGMKGSEVTAMLEKG-ERM---------------------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAV  270 (291)
T ss_dssp             CSSTTCCHHHHHHHHHTT-CCC---------------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             CCCCCCCHHHHHHHHHcC-CCC---------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence            999887765544433321 000                           0124689999999999999999999999999


Q ss_pred             hc
Q 022799          235 LI  236 (292)
Q Consensus       235 l~  236 (292)
                      ++
T Consensus       271 ~~  272 (291)
T 1xbb_A          271 EL  272 (291)
T ss_dssp             HH
T ss_pred             HH
Confidence            84

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.8e-38  Score=287.66  Aligned_cols=198  Identities=20%  Similarity=0.327  Sum_probs=160.2

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++|||||++++++.     +...+++||||++ |+|.+++....  ...+++..+..++.||+.||.|||++ ||+|
T Consensus       270 l~~l~hpniv~l~~~~~-----~~~~~~lv~E~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH  341 (495)
T 1opk_A          270 MKEIKHPNLVQLLGVCT-----REPPFYIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK-NFIH  341 (495)
T ss_dssp             HHHCCCTTBCCEEEEEC-----SSSSCEEEEECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHT-TEEC
T ss_pred             HHhcCCCCEeeEEEEEe-----cCCcEEEEEEccCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhC-Cccc
Confidence            35689999999999983     3344899999998 79999987532  34689999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCC--cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPL  156 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~p  156 (292)
                      |||||+|||++.++ .+||+|||+++.......  .....+|..|+|||++.+. .++.++|||||||++|||++ |..|
T Consensus       342 rDlkp~NIll~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlG~~l~el~t~g~~p  419 (495)
T 1opk_A          342 RNLAARNCLVGENH-LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSP  419 (495)
T ss_dssp             SCCSGGGEEECGGG-CEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             CCCChhhEEECCCC-cEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcC-CCCcHHhHHhHHHHHHHHHhCCCCC
Confidence            99999999999887 799999999987643221  1223456789999999654 48999999999999999999 9999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      |.+.+..+....+.....                  .          ..+..+++.+.+||.+||..||.+|||+.++++
T Consensus       420 ~~~~~~~~~~~~~~~~~~------------------~----------~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          420 YPGIDLSQVYELLEKDYR------------------M----------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             STTCCGGGHHHHHHTTCC------------------C----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCHHHHHHHHHcCCC------------------C----------CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence            988776655444322100                  0          012468899999999999999999999999984

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=4.1e-39  Score=298.33  Aligned_cols=236  Identities=23%  Similarity=0.325  Sum_probs=168.0

Q ss_pred             CCCCCCCeeeeceeeeccCC-CCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTE-KDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~-~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      ++++||||+++++++..... .+....++||||++ |+|.+++..... ...+++..++.++.||+.||.|||++ ||+|
T Consensus        67 ~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLHs~-gIVH  144 (676)
T 3qa8_A           67 KKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLHEN-RIIH  144 (676)
T ss_dssp             HHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHHHT-TBCC
T ss_pred             HhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHHC-CCcc
Confidence            46799999999998743211 22445789999997 699998875321 23688999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCC--cEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCC
Q 022799           80 RDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF  157 (292)
Q Consensus        80 ~dlkp~Nill~~~~~--~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf  157 (292)
                      |||||+||+++.++.  .++|+|||.+.............||+.|+|||++.+. .++.++|+||+||++|+|++|..||
T Consensus       145 rDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSLGviLyeLltG~~Pf  223 (676)
T 3qa8_A          145 RDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQK-KYTVTVDYWSFGTLAFECITGFRPF  223 (676)
T ss_dssp             CCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCS-CCSTTHHHHHHHHHHHHHHSSCSSC
T ss_pred             CCCCHHHeEeecCCCceeEEEcccccccccccccccccccCCcccCChHHhccC-CCCchhHHHHHHHHHHHHHHCCCCC
Confidence            999999999987652  3899999999887666555667899999999999664 5899999999999999999999999


Q ss_pred             CCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          158 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      .+...........   ...................+...  .+....+...+++.+.++|.+||.+||++|||+.++++|
T Consensus       224 ~~~~~~~~~~~~i---~~~~~~~~~~~~~l~g~~~~~~~--lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~h  298 (676)
T 3qa8_A          224 LPNWQPVQWHGKV---REKSNEHIVVYDDLTGAVKFSSV--LPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNV  298 (676)
T ss_dssp             CSSCHHHHSSTTC---C------CCSCCCCSSSCCCCSS--SCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCC
T ss_pred             Ccccchhhhhhhh---hcccchhhhhhhhhccccccccc--cCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcC
Confidence            7654322111100   00000000000000011111111  111122334567899999999999999999999999999


Q ss_pred             CCccccCC
Q 022799          238 PFFDELRD  245 (292)
Q Consensus       238 p~~~~~~~  245 (292)
                      |||+.+..
T Consensus       299 p~F~~l~~  306 (676)
T 3qa8_A          299 GCFQALDS  306 (676)
T ss_dssp             TTHHHHHH
T ss_pred             HHHHHHHH
Confidence            99988654

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=9.6e-38  Score=267.69  Aligned_cols=202  Identities=31%  Similarity=0.476  Sum_probs=150.5

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++..     ....++||||++ ++|.+++.........+++..+..++.||+.||.|||++ |++|
T Consensus        86 l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H  159 (310)
T 2wqm_A           86 LKQLNHPNVIKYYASFIE-----DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR-RVMH  159 (310)
T ss_dssp             HHTCCCTTBCCEEEEEEE-----TTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT-TCCC
T ss_pred             HHhCCCCCEeeEEEEEEc-----CCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC-CeeC
Confidence            357899999999999844     335899999998 599999887665567799999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCC-cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      |||||+||+++.++ .++|+|||++........ .....||+.|+|||.+.+. .++.++|+|||||++|+|++|..||.
T Consensus       160 ~dl~p~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~  237 (310)
T 2wqm_A          160 RDIKPANVFITATG-VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFY  237 (310)
T ss_dssp             CCCCGGGEEECTTS-CEEECCC------------------CCSSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred             CCCcHHHEEEcCCC-CEEEEeccceeeecCCCccccccCCCeeEeChHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCCc
Confidence            99999999999888 799999999876543322 2345689999999999664 48999999999999999999999997


Q ss_pred             CCCcH-HHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          159 GESGV-DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       159 ~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      +.... ............+                  .        .....+++++.++|.+||..||.+|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~------------------~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~  290 (310)
T 2wqm_A          238 GDKMNLYSLCKKIEQCDYP------------------P--------LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD  290 (310)
T ss_dssp             ---CCHHHHHHHHHTTCSC------------------C--------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccchhHHHHHHHhhcccCC------------------C--------CcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            65322 1222211111100                  0        001357899999999999999999999999985

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.2e-38  Score=272.47  Aligned_cols=212  Identities=25%  Similarity=0.386  Sum_probs=161.0

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++.... ......++||||+. |+|.+++.........+++..++.++.||+.||.|||++ ||+|
T Consensus        80 l~~l~h~~iv~~~~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH  157 (317)
T 2buj_A           80 HRLFNHPNILRLVAYCLRER-GAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK-GYAH  157 (317)
T ss_dssp             HHTCCCTTBCCCCEEEEEEE-TTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT-TEEC
T ss_pred             HhhcCCCCeeeEEEEEEecc-CCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-Cccc
Confidence            35689999999999885432 24456889999999 599999987655567899999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCC----------cccccccccccCCccccCCC--CCCchhHhhhhhHHH
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP----------NISYICSRYYRAPELIFGAT--EYTAAIDIWSAGCVL  147 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~--~~~~~~DvwslG~il  147 (292)
                      |||||+||+++.++ .++|+|||.+........          .....||+.|+|||++.+..  .++.++|+|||||++
T Consensus       158 ~dlkp~NIl~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il  236 (317)
T 2buj_A          158 RDLKPTNILLGDEG-QPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVL  236 (317)
T ss_dssp             CCCCGGGEEECTTS-CEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHH
T ss_pred             CCCCHHHEEEcCCC-CEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHH
Confidence            99999999999888 799999998875422111          01235699999999986543  268899999999999


Q ss_pred             HHHHhCCCCCCCCCcH-HHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCC
Q 022799          148 AELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPN  226 (292)
Q Consensus       148 ~el~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~  226 (292)
                      |+|++|..||...... .........                 ....+          .+..+++.+.++|.+||..||.
T Consensus       237 ~el~~g~~p~~~~~~~~~~~~~~~~~-----------------~~~~~----------~~~~~~~~l~~li~~~l~~dp~  289 (317)
T 2buj_A          237 YAMMFGEGPYDMVFQKGDSVALAVQN-----------------QLSIP----------QSPRHSSALWQLLNSMMTVDPH  289 (317)
T ss_dssp             HHHHHSSCTTHHHHHTTSCHHHHHHC-----------------C--CC----------CCTTSCHHHHHHHHHHTCSSGG
T ss_pred             HHHHhCCCChhhhhcccchhhHHhhc-----------------cCCCC----------ccccCCHHHHHHHHHHhhcChh
Confidence            9999999999531100 000010000                 00000          1145789999999999999999


Q ss_pred             CcccHHHHhcCCCccccC
Q 022799          227 LRSTALEALIHPFFDELR  244 (292)
Q Consensus       227 ~R~t~~e~l~hp~~~~~~  244 (292)
                      +|||+.+++++  +..+.
T Consensus       290 ~Rps~~~ll~~--L~~~~  305 (317)
T 2buj_A          290 QRPHIPLLLSQ--LEALQ  305 (317)
T ss_dssp             GSCCHHHHHHH--HHHTC
T ss_pred             hCCCHHHHHHH--hhhcC
Confidence            99999999975  44443

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2.6e-38  Score=271.67  Aligned_cols=199  Identities=23%  Similarity=0.347  Sum_probs=159.0

Q ss_pred             CCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhc------------CCCCCHHHHHHHHHHHHHHHHHH
Q 022799            5 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKM------------SQRMPLIYVKLYFYQICRALAYI   71 (292)
Q Consensus         5 ~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~------------~~~~~~~~~~~~~~qil~al~~L   71 (292)
                      +||||+++++++...    ...+++||||++ |+|.+++......            ...+++..+..++.||+.||.||
T Consensus        89 ~hp~iv~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~l  164 (316)
T 2xir_A           89 HHLNVVNLLGACTKP----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL  164 (316)
T ss_dssp             CCTTBCCEEEEECCT----TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCeeeEEEEEecC----CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHH
Confidence            699999999987432    234789999998 6999998764321            12388999999999999999999


Q ss_pred             HhcCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCCCc---ccccccccccCCccccCCCCCCchhHhhhhhHHHH
Q 022799           72 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLA  148 (292)
Q Consensus        72 H~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~  148 (292)
                      |++ ||+||||||+||+++.++ .+||+|||++.........   ....+|+.|+|||++.+. .++.++|+||+||++|
T Consensus       165 H~~-~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~  241 (316)
T 2xir_A          165 ASR-KCIHRDLAARNILLSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLW  241 (316)
T ss_dssp             HHT-TCCCSCCSGGGEEECGGG-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHH
T ss_pred             HhC-CcccccCccceEEECCCC-CEEECCCccccccccCccceeccCCCcceeecCchhhccc-cccchhHHHHHHHHHH
Confidence            998 999999999999999887 7999999999866443321   234578899999999664 4899999999999999


Q ss_pred             HHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCC
Q 022799          149 ELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL  227 (292)
Q Consensus       149 el~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~  227 (292)
                      +|++ |..||.+................+                           ..+..+++.+.++|.+||..||.+
T Consensus       242 ~l~t~g~~p~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~  294 (316)
T 2xir_A          242 EIFSLGASPYPGVKIDEEFCRRLKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQ  294 (316)
T ss_dssp             HHHTTSCCSSTTCCCSHHHHHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred             HHHhCCCCCCcccchhHHHHHHhccCccC---------------------------CCCCCCCHHHHHHHHHHcCCChhh
Confidence            9998 999998876555444443321111                           012457899999999999999999


Q ss_pred             cccHHHHhcC
Q 022799          228 RSTALEALIH  237 (292)
Q Consensus       228 R~t~~e~l~h  237 (292)
                      |||+.++++|
T Consensus       295 Rps~~ell~~  304 (316)
T 2xir_A          295 RPTFSELVEH  304 (316)
T ss_dssp             SCCHHHHHHH
T ss_pred             CcCHHHHHHH
Confidence            9999999975

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=5e-38  Score=265.37  Aligned_cols=197  Identities=21%  Similarity=0.319  Sum_probs=152.6

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++...    ....++||||++ ++|.+++.....  ..+++..+..++.|++.||.|||++ |++|
T Consensus        68 l~~l~h~~iv~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H  140 (278)
T 1byg_A           68 MTQLRHSNLVQLLGVIVEE----KGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGN-NFVH  140 (278)
T ss_dssp             HTTCCCTTBCCEEEEECCC------CCEEEECCCTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHHHT-TCCC
T ss_pred             HHhCCCCCEeeEEEEEEcC----CCceEEEEecCCCCCHHHHHHhccc--ccCCHHHHHHHHHHHHHHHHHHHhC-Cccc
Confidence            4678999999999986432    224789999998 599999875421  2378899999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFP  158 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~  158 (292)
                      |||||+||+++.++ .++|+|||++......  .....+++.|+|||.+.+. .++.++|+||+||++|+|++ |..||.
T Consensus       141 ~dlkp~Nil~~~~~-~~~l~Dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~  216 (278)
T 1byg_A          141 RDLAARNVLVSEDN-VAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYP  216 (278)
T ss_dssp             SCCSGGGEEECTTS-CEEECCCCC--------------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCT
T ss_pred             cCCCcceEEEeCCC-cEEEeecccccccccc--ccCCCccccccCHHHhCCC-CCCchhcHHHHHHHHHHHHhCCCCCCC
Confidence            99999999999888 7999999998765332  2334678899999999654 48999999999999999998 999998


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      +....+....+....                            ....+..+++.+.++|.+||..||.+|||+.++++
T Consensus       217 ~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          217 RIPLKDVVPRVEKGY----------------------------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             TSCGGGHHHHHTTTC----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCHHHHHHHHhcCC----------------------------CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence            776655444332110                            00122468999999999999999999999999984

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2.6e-38  Score=268.55  Aligned_cols=201  Identities=23%  Similarity=0.334  Sum_probs=160.4

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      ++++||||+++++++..     .. .++||||+. ++|.+++...   ...+++..+..++.||+.||.|||++ |++||
T Consensus        76 ~~l~h~~i~~~~~~~~~-----~~-~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~  145 (291)
T 1u46_A           76 HSLDHRNLIRLYGVVLT-----PP-MKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK-RFIHR  145 (291)
T ss_dssp             HHCCCTTBCCEEEEECS-----SS-CEEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT-TEECS
T ss_pred             HhCCCCCcccEEEEEcc-----CC-ceeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhC-CcccC
Confidence            45789999999998843     21 679999998 7999988754   34589999999999999999999998 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCCc----ccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQP  155 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~  155 (292)
                      ||||+||+++.++ .+||+|||++.........    ....+|+.|+|||++.+. .++.++|+||+||++|+|++ |..
T Consensus       146 dikp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~  223 (291)
T 1u46_A          146 DLAARNLLLATRD-LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQE  223 (291)
T ss_dssp             CCCGGGEEEEETT-EEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCC
T ss_pred             CCchheEEEcCCC-CEEEccccccccccccccchhhhccCCCCceeeCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCC
Confidence            9999999999888 7999999999876443321    234567889999999654 47899999999999999999 999


Q ss_pred             CCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHh
Q 022799          156 LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL  235 (292)
Q Consensus       156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l  235 (292)
                      ||.+.+..+....+......+                           ..+..+++++.++|.+||..||.+|||+.+++
T Consensus       224 p~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~  276 (291)
T 1u46_A          224 PWIGLNGSQILHKIDKEGERL---------------------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR  276 (291)
T ss_dssp             TTTTCCHHHHHHHHHTSCCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CcccCCHHHHHHHHHccCCCC---------------------------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHH
Confidence            998887666555443211000                           01246889999999999999999999999999


Q ss_pred             cCCCcccc
Q 022799          236 IHPFFDEL  243 (292)
Q Consensus       236 ~hp~~~~~  243 (292)
                      +  +++++
T Consensus       277 ~--~l~~~  282 (291)
T 1u46_A          277 D--FLLEA  282 (291)
T ss_dssp             H--HHHHH
T ss_pred             H--HHHHh
Confidence            5  45544

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=6.7e-38  Score=267.54  Aligned_cols=209  Identities=22%  Similarity=0.383  Sum_probs=156.7

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++||||+++++++...   +...+++||||++ |+|.+++...   ...+++..+..++.|++.||.|||++ ||+|
T Consensus        77 l~~l~h~~i~~~~~~~~~~---~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H  149 (302)
T 4e5w_A           77 LRNLYHENIVKYKGICTED---GGNGIKLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGSR-QYVH  149 (302)
T ss_dssp             HHTCCCTTBCCEEEEEEC------CCEEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT-TEEC
T ss_pred             HHhCCCCCeeeeeeEEecC---CCceEEEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhcC-Cccc
Confidence            3578999999999998543   2234889999998 5999998653   45699999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCC----cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQP  155 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~  155 (292)
                      |||||+||+++.++ .++|+|||++........    .....||..|+|||++.+.. ++.++|+||+||++|+|++|..
T Consensus       150 ~dikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~  227 (302)
T 4e5w_A          150 RDLAARNVLVESEH-QVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELLTYCD  227 (302)
T ss_dssp             SCCSGGGEEEEETT-EEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTC
T ss_pred             CCCchheEEEcCCC-CEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCC-CCcchhHHHHHHHHHHHHHccC
Confidence            99999999999888 799999999987654432    22346788899999996654 8899999999999999999998


Q ss_pred             CCCCCCcHHHHHHHHHHhCCCCHHH-----HhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCccc
Q 022799          156 LFPGESGVDQLVEIIKVLGTPTREE-----IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST  230 (292)
Q Consensus       156 pf~~~~~~~~~~~i~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t  230 (292)
                      |+....     .......+......     ........             ....+..+++.+.++|.+||..||.+|||
T Consensus       228 p~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps  289 (302)
T 4e5w_A          228 SDSSPM-----ALFLKMIGPTHGQMTVTRLVNTLKEGK-------------RLPCPPNCPDEVYQLMRKCWEFQPSNRTS  289 (302)
T ss_dssp             GGGSHH-----HHHHHHHCSCCGGGHHHHHHHHHHTTC-------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCC
T ss_pred             CCcchh-----hHHhhccCCcccccCHHHHHHHHhccC-------------CCCCCCCCCHHHHHHHHHHcCCCCCCCCC
Confidence            863221     11111111111100     00000000             00122568999999999999999999999


Q ss_pred             HHHHhc
Q 022799          231 ALEALI  236 (292)
Q Consensus       231 ~~e~l~  236 (292)
                      +.++++
T Consensus       290 ~~~ll~  295 (302)
T 4e5w_A          290 FQNLIE  295 (302)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999984

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=3.1e-38  Score=272.88  Aligned_cols=214  Identities=22%  Similarity=0.318  Sum_probs=158.3

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++..   .+...+++||||++ ++|.+++...   ...+++..+..++.||+.||.|||++ ||+|
T Consensus        78 l~~l~h~~i~~~~~~~~~---~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH  150 (327)
T 3lxl_A           78 LKALHSDFIVKYRGVSYG---PGRQSLRLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGSR-RCVH  150 (327)
T ss_dssp             HHTCCCTTBCCEEEEEEC---SSSCEEEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT-TEEC
T ss_pred             HHhcCCCceeEEEEEEec---CCCceEEEEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC-CccC
Confidence            357899999999998754   23445889999996 7999998764   24589999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCC----cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQP  155 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~  155 (292)
                      |||||+||+++.++ .+||+|||++........    .....+|+.|+|||++.+. .++.++|+||+||++|+|++|..
T Consensus       151 ~Dikp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~  228 (327)
T 3lxl_A          151 RDLAARNILVESEA-HVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN-IFSRQSDVWSFGVVLYELFTYCD  228 (327)
T ss_dssp             SCCSGGGEEEEETT-EEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTC
T ss_pred             CCCChhhEEECCCC-CEEEcccccceecccCCccceeeccCCccccccCHHHhccC-CCChHHhHHHHHHHHHHHHhCCC
Confidence            99999999999888 799999999987643332    2234578889999999664 48999999999999999999999


Q ss_pred             CCCCCCcHHHHHHHHHHhCCCCHHHH-hhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHH
Q 022799          156 LFPGESGVDQLVEIIKVLGTPTREEI-KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA  234 (292)
Q Consensus       156 pf~~~~~~~~~~~i~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~  234 (292)
                      ||........ .........+..... .......             ....+..+++.+.++|.+||..||.+|||+.++
T Consensus       229 p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el  294 (327)
T 3lxl_A          229 KSCSPSAEFL-RMMGCERDVPALSRLLELLEEGQ-------------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL  294 (327)
T ss_dssp             GGGSHHHHHH-HHCC----CCHHHHHHHHHHTTC-------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCccccchhh-hhcccccccccHHHHHHHhhccc-------------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHH
Confidence            9865432110 000000000000000 0000000             001125689999999999999999999999999


Q ss_pred             hcC
Q 022799          235 LIH  237 (292)
Q Consensus       235 l~h  237 (292)
                      +++
T Consensus       295 l~~  297 (327)
T 3lxl_A          295 GPQ  297 (327)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            743

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=4e-38  Score=283.66  Aligned_cols=197  Identities=24%  Similarity=0.329  Sum_probs=155.7

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++..      ...++||||++ |+|.+++....  ...+++..+..++.||+.||.|||++ ||+|
T Consensus       233 l~~l~hp~iv~~~~~~~~------~~~~iv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivH  303 (452)
T 1fmk_A          233 MKKLRHEKLVQLYAVVSE------EPIYIVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM-NYVH  303 (452)
T ss_dssp             HHHCCCTTBCCEEEEECS------SSCEEEECCCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT-TCCC
T ss_pred             HHhCCCCCEeeEEEEEcC------CceEEEehhhcCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeC
Confidence            356899999999998732      23789999998 69999986432  25689999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCC--cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPL  156 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~p  156 (292)
                      |||||+||+++.++ .+||+|||+++.......  .....+|..|+|||.+.+. .++.++|+||+||++|+|++ |..|
T Consensus       304 rDlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P  381 (452)
T 1fmk_A          304 RDLRAANILVGENL-VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVP  381 (452)
T ss_dssp             SCCSGGGEEECGGG-CEEECCCCTTC--------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred             CCCChhhEEECCCC-CEEECCCccceecCCCceecccCCcccccccCHhHHhcC-CCCccccHHhHHHHHHHHHhCCCCC
Confidence            99999999999887 799999999987643321  1233457889999998654 48999999999999999999 9999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      |.+....+....+......                            ..+..+++.+.++|.+||..||++|||++++++
T Consensus       382 ~~~~~~~~~~~~i~~~~~~----------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~  433 (452)
T 1fmk_A          382 YPGMVNREVLDQVERGYRM----------------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  433 (452)
T ss_dssp             STTCCHHHHHHHHHTTCCC----------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCHHHHHHHHHcCCCC----------------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            9988776655554321100                            012467899999999999999999999999985

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.8e-39  Score=287.85  Aligned_cols=224  Identities=19%  Similarity=0.291  Sum_probs=160.2

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      ++++||||+++++++...   +....++||||++ |+|.+++..... ...+++..++.++.||+.||.|||++ ||+||
T Consensus        62 ~~l~hpnIv~~~~~~~~~---~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~  136 (396)
T 4eut_A           62 KKLNHKNIVKLFAIEEET---TTRHKVLIMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN-GIVHR  136 (396)
T ss_dssp             HHCCCTTBCCEEEEEECT---TTCCEEEEECCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECC
T ss_pred             HhcCCCCCCeEEEeeccC---CCCeeEEEEecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC-CEEEC
Confidence            467999999999988543   2335789999998 699988865422 33499999999999999999999998 99999


Q ss_pred             CCCCCcEEE----eCCCCcEEEeecCCccccccCCCcccccccccccCCccccCC-------CCCCchhHhhhhhHHHHH
Q 022799           81 DIKPQNLLV----NPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA-------TEYTAAIDIWSAGCVLAE  149 (292)
Q Consensus        81 dlkp~Nill----~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~DvwslG~il~e  149 (292)
                      ||||+||++    +.++ .+||+|||+++............||+.|+|||++.+.       ..++.++|+||+||++|+
T Consensus       137 Dlkp~NIll~~~~~~~~-~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~e  215 (396)
T 4eut_A          137 NIKPGNIMRVIGEDGQS-VYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYH  215 (396)
T ss_dssp             CCCGGGEEEEECTTSCE-EEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHH
T ss_pred             CcCHHHEEEeecCCCce-eEEEecCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHH
Confidence            999999998    5555 6999999999877555444566799999999998541       347889999999999999


Q ss_pred             HHhCCCCCCCC----CcHHHHHHHHHHhCCCCHHHHhhcCC-CCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccC
Q 022799          150 LLLGQPLFPGE----SGVDQLVEIIKVLGTPTREEIKCMNP-NYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYS  224 (292)
Q Consensus       150 l~~g~~pf~~~----~~~~~~~~i~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  224 (292)
                      |++|..||...    ...+.+.++..   ..+...+..... ....+.+...  .+....++..+++.+.++|++||..|
T Consensus       216 l~tg~~Pf~~~~~~~~~~~~~~~~~~---~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~~~~~~l~~ll~~~L~~d  290 (396)
T 4eut_A          216 AATGSLPFRPFEGPRRNKEVMYKIIT---GKPSGAISGVQKAENGPIDWSGD--MPVSCSLSRGLQVLLTPVLANILEAD  290 (396)
T ss_dssp             HHHSSCSEECTTCTTTCHHHHHHHHH---SCCTTCCEEEECSTTCCEEEESS--CCTTCSSCHHHHHHHHHHHHHHSCCC
T ss_pred             HHHCCCCCCCCCcccchHHHHHHHhc---CCCcccchhheeccCCCcccCcc--CCcccccchHHHhhchHHHHHhhccC
Confidence            99999999643    23344444333   122111111000 0000000000  00011122345678899999999999


Q ss_pred             CCCcccHHHHhc
Q 022799          225 PNLRSTALEALI  236 (292)
Q Consensus       225 p~~R~t~~e~l~  236 (292)
                      |++|+|++++++
T Consensus       291 P~~R~s~~e~l~  302 (396)
T 4eut_A          291 QEKCWGFDQFFA  302 (396)
T ss_dssp             TTTSCCHHHHHH
T ss_pred             hhhhccHHHHHH
Confidence            999999999854

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=6.9e-38  Score=292.39  Aligned_cols=195  Identities=22%  Similarity=0.303  Sum_probs=157.2

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++|||||++++++.     +. .+++||||++ |+|.+++..    ...+++..+..++.||+.||.|||++ ||+|
T Consensus       424 l~~l~hpnIv~l~~~~~-----~~-~~~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~-~iiH  492 (635)
T 4fl3_A          424 MQQLDNPYIVRMIGICE-----AE-SWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES-NFVH  492 (635)
T ss_dssp             HHHCCCTTBCCEEEEEE-----SS-SEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT-TCCC
T ss_pred             HHhCCCCCEeeEEEEEe-----cC-CEEEEEEccCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHHC-CEeC
Confidence            35689999999999872     11 2789999998 699998864    46799999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCC----cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQ  154 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~  154 (292)
                      |||||+|||++.++ .+||+|||+++.......    .....+|+.|+|||++.+. .++.++||||+||++|||++ |.
T Consensus       493 rDLkp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~  570 (635)
T 4fl3_A          493 RDLAARNVLLVTQH-YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQ  570 (635)
T ss_dssp             SCCSGGGEEEEETT-EEEECCTTHHHHTTC-------------CGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTC
T ss_pred             CCCChHhEEEeCCC-CEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCC
Confidence            99999999999888 799999999987644322    1223457889999999654 48999999999999999998 99


Q ss_pred             CCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHH
Q 022799          155 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA  234 (292)
Q Consensus       155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~  234 (292)
                      .||.+.+..+....+......                            ..+..+++++.+||.+||..||.+|||++++
T Consensus       571 ~Pf~~~~~~~~~~~i~~~~~~----------------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l  622 (635)
T 4fl3_A          571 KPYRGMKGSEVTAMLEKGERM----------------------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAV  622 (635)
T ss_dssp             CSSTTCCHHHHHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             CCCCCCCHHHHHHHHHcCCCC----------------------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHH
Confidence            999988776655554431100                            0124689999999999999999999999998


Q ss_pred             hc
Q 022799          235 LI  236 (292)
Q Consensus       235 l~  236 (292)
                      ++
T Consensus       623 ~~  624 (635)
T 4fl3_A          623 EL  624 (635)
T ss_dssp             HH
T ss_pred             HH
Confidence            74

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=4.1e-38  Score=272.91  Aligned_cols=223  Identities=22%  Similarity=0.314  Sum_probs=154.7

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC-----
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI-----   75 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~-----   75 (292)
                      +.++||||+++++.+......+...+++||||++ |+|.+++..     ...++..+..++.||+.||.|||++.     
T Consensus        62 ~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~  136 (336)
T 3g2f_A           62 PLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDH  136 (336)
T ss_dssp             TTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGG
T ss_pred             HhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccc
Confidence            4689999999998665444455667899999997 699999864     44588899999999999999999532     


Q ss_pred             ---CccccCCCCCcEEEeCCCCcEEEeecCCccccccCC---------CcccccccccccCCccccCC------CCCCch
Q 022799           76 ---GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE---------PNISYICSRYYRAPELIFGA------TEYTAA  137 (292)
Q Consensus        76 ---~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~------~~~~~~  137 (292)
                         ||+||||||+||+++.++ .+||+|||+++......         ......||+.|+|||++.+.      ..++.+
T Consensus       137 ~~~~ivH~Dikp~Nill~~~~-~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~  215 (336)
T 3g2f_A          137 YKPAISHRDLNSRNVLVKNDG-TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQ  215 (336)
T ss_dssp             CBCCEECSSCSGGGEEECTTS-CEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHH
T ss_pred             cccceeecccccceEEEcCCC-cEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccc
Confidence               999999999999999888 79999999998664321         12245689999999999653      235678


Q ss_pred             hHhhhhhHHHHHHHhCCCCCCC-CCcHHHHHH-HHHHhCCCCHHHHhhcC-CCCccccCCCCCCCCchhhhccCCChhHH
Q 022799          138 IDIWSAGCVLAELLLGQPLFPG-ESGVDQLVE-IIKVLGTPTREEIKCMN-PNYTEFKFPQIKAHPWHKIFQKRMPPEAV  214 (292)
Q Consensus       138 ~DvwslG~il~el~~g~~pf~~-~~~~~~~~~-i~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  214 (292)
                      +||||+||++|+|++|..||.. ......... .......+....+.... .......++..    +..  ....++.+.
T Consensus       216 ~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~--~~~~~~~l~  289 (336)
T 3g2f_A          216 VDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEA----WKE--NSLAVRSLK  289 (336)
T ss_dssp             HHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTT----CCC--CSHHHHHHH
T ss_pred             cchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcc----ccc--ccchHHHHH
Confidence            9999999999999999766533 221111111 11112222222221110 00000011100    000  012445799


Q ss_pred             HHHHHHhccCCCCcccHHHHhc
Q 022799          215 DLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       215 ~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      +||.+||..||++|||+.|+++
T Consensus       290 ~li~~cl~~dP~~Rps~~e~l~  311 (336)
T 3g2f_A          290 ETIEDCWDQDAEARLTAQXAEE  311 (336)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHhcCChhhCcchHHHHH
Confidence            9999999999999999999953

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-37  Score=267.98  Aligned_cols=206  Identities=20%  Similarity=0.295  Sum_probs=150.7

Q ss_pred             CCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC------
Q 022799            3 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTI------   75 (292)
Q Consensus         3 ~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~------   75 (292)
                      .++||||+++++++.... .....+++||||++ |+|.+++..     ..+++..+..++.|++.||.|||++.      
T Consensus        87 ~~~h~~i~~~~~~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~  160 (337)
T 3mdy_A           87 LMRHENILGFIAADIKGT-GSWTQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGK  160 (337)
T ss_dssp             TCCCTTBCCEEEEEEESC-GGGCEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB
T ss_pred             hhcCCCeeeEEEEEccCC-CCCCceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccC
Confidence            468999999999885543 22256899999998 599999864     46899999999999999999999532      


Q ss_pred             -CccccCCCCCcEEEeCCCCcEEEeecCCccccccCCCc-----ccccccccccCCccccCCCCCCc------hhHhhhh
Q 022799           76 -GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN-----ISYICSRYYRAPELIFGATEYTA------AIDIWSA  143 (292)
Q Consensus        76 -~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~------~~Dvwsl  143 (292)
                       ||+||||||+||+++.++ .+||+|||++.........     ....||+.|+|||++.+.. ++.      ++|+||+
T Consensus       161 ~~ivH~Dikp~Nill~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~Diwsl  238 (337)
T 3mdy_A          161 PAIAHRDLKSKNILVKKNG-TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYSF  238 (337)
T ss_dssp             CCEECSCCCGGGEEECTTS-CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHHHHH
T ss_pred             CCEEecccchHHEEECCCC-CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhccccc-CCccccCccccchHHH
Confidence             899999999999999888 7999999999766433221     2457899999999996654 333      4999999


Q ss_pred             hHHHHHHHhC----------CCCCCCCCcH----HHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCC
Q 022799          144 GCVLAELLLG----------QPLFPGESGV----DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRM  209 (292)
Q Consensus       144 G~il~el~~g----------~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  209 (292)
                      ||++|+|++|          ..||......    ...........         ..+.     .+       ....+..+
T Consensus       239 G~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~~-----~~-------~~~~~~~~  297 (337)
T 3mdy_A          239 GLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKK---------LRPS-----FP-------NRWSSDEC  297 (337)
T ss_dssp             HHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSC---------CCCC-----CC-------GGGGGSHH
T ss_pred             HHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhc---------cCcc-----cc-------ccchhhHH
Confidence            9999999999          6666543211    11111111000         0000     00       00011245


Q ss_pred             ChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          210 PPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       210 ~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      ++.+.++|.+||+.||.+|||+.+++++
T Consensus       298 ~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          298 LRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             HHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence            6789999999999999999999999965

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.7e-37  Score=288.91  Aligned_cols=195  Identities=25%  Similarity=0.333  Sum_probs=156.9

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++|||||++++++..     + .+++||||++ |+|.+++...   ...+++..+..++.||+.||.|||++ ||+|
T Consensus       390 l~~l~hpniv~l~~~~~~-----~-~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~-~iiH  459 (613)
T 2ozo_A          390 MHQLDNPYIVRLIGVCQA-----E-ALMLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK-NFVH  459 (613)
T ss_dssp             HTTCCCTTBCCEEEEEES-----S-SEEEEEECCTTCBHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT-TCCC
T ss_pred             HHhCCCCCEeeEEEEecc-----C-CeEEEEEeCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC-CEEc
Confidence            468899999999998832     1 2889999998 6898888642   45699999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCc----ccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQ  154 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~  154 (292)
                      |||||+|||++.++ .+||+|||+++........    ....+|+.|+|||++.+. .++.++|||||||++|||++ |.
T Consensus       460 rDlkp~NILl~~~~-~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~  537 (613)
T 2ozo_A          460 RNLAARNVLLVNRH-YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQ  537 (613)
T ss_dssp             SCCSGGGEEEEETT-EEEECCCSTTTTCC--------------CCTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             CcCCHHHEEEcCCC-cEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCC-CCCcHHHHHHHHHHHHHHHHCCC
Confidence            99999999999888 7999999999876433221    122346889999999654 58999999999999999998 99


Q ss_pred             CCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHH
Q 022799          155 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA  234 (292)
Q Consensus       155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~  234 (292)
                      .||.+.+..+....+.+...                            ...+..+++++.++|.+||..||.+|||+.++
T Consensus       538 ~Pf~~~~~~~~~~~i~~~~~----------------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l  589 (613)
T 2ozo_A          538 KPYKKMKGPEVMAFIEQGKR----------------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTV  589 (613)
T ss_dssp             CTTTTCCSHHHHHHHHTTCC----------------------------CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHH
T ss_pred             CCCCCCCHHHHHHHHHcCCC----------------------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence            99998887766555443100                            01224689999999999999999999999998


Q ss_pred             h
Q 022799          235 L  235 (292)
Q Consensus       235 l  235 (292)
                      +
T Consensus       590 ~  590 (613)
T 2ozo_A          590 E  590 (613)
T ss_dssp             H
T ss_pred             H
Confidence            5

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.5e-38  Score=276.16  Aligned_cols=208  Identities=13%  Similarity=0.103  Sum_probs=155.9

Q ss_pred             CCCCCCCeee---------------eceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHH
Q 022799            2 RLLDHPNVVS---------------LKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICR   66 (292)
Q Consensus         2 ~~l~HpnIv~---------------~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~   66 (292)
                      ++++||||++               +++++..    +....++||||++++|.+++....  ...+++..+..++.||+.
T Consensus        97 ~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~----~~~~~~lv~e~~~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~  170 (352)
T 2jii_A           97 QRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVH----QDKYRFLVLPSLGRSLQSALDVSP--KHVLSERSVLQVACRLLD  170 (352)
T ss_dssp             HHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEE----TTTEEEEEEECCCEEHHHHHHHSG--GGCCCHHHHHHHHHHHHH
T ss_pred             HHhcccchhhhhhhhccCCccCccchhhcccc----CCcEEEEEecCCCcCHHHHHHhCC--cCCCCHHHHHHHHHHHHH
Confidence            3467888877               4444422    234689999999889999997532  357999999999999999


Q ss_pred             HHHHHHhcCCccccCCCCCcEEEeCCC-CcEEEeecCCccccccCCC--------cccccccccccCCccccCCCCCCch
Q 022799           67 ALAYIHNTIGVCHRDIKPQNLLVNPHT-HQLKLCDFGSAKVLVKGEP--------NISYICSRYYRAPELIFGATEYTAA  137 (292)
Q Consensus        67 al~~LH~~~~i~H~dlkp~Nill~~~~-~~ikl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~  137 (292)
                      ||.|||++ ||+||||||+||+++.++ ..+||+|||+++.......        .....||+.|+|||++.+. .++.+
T Consensus       171 ~L~~LH~~-~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~  248 (352)
T 2jii_A          171 ALEFLHEN-EYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC-GPSRR  248 (352)
T ss_dssp             HHHHHHHT-TCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC-CCCHH
T ss_pred             HHHHHHhC-CccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC-CCCch
Confidence            99999998 999999999999999765 2699999999976543221        1334789999999999764 48999


Q ss_pred             hHhhhhhHHHHHHHhCCCCCCCCC-cHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHH
Q 022799          138 IDIWSAGCVLAELLLGQPLFPGES-GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDL  216 (292)
Q Consensus       138 ~DvwslG~il~el~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  216 (292)
                      +|+|||||++|+|++|..||.+.. ....+...........        ......           ......+++.+.++
T Consensus       249 ~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------~~~~~~-----------~~~~~~~~~~l~~l  309 (352)
T 2jii_A          249 SDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKP--------GPFVGP-----------CGHWIRPSETLQKY  309 (352)
T ss_dssp             HHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSC--------CCEECT-----------TSCEECCCHHHHHH
T ss_pred             hhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCCh--------hhhhhh-----------ccccCCCcHHHHHH
Confidence            999999999999999999998754 3333333322111000        000000           00013578999999


Q ss_pred             HHHHhccCCCCcccHHHHhc
Q 022799          217 VSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       217 i~~~l~~dp~~R~t~~e~l~  236 (292)
                      |.+||..||++|||++++++
T Consensus       310 i~~~l~~dp~~Rps~~~l~~  329 (352)
T 2jii_A          310 LKVVMALTYEEKPPYAMLRN  329 (352)
T ss_dssp             HHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHhCChhhCCCHHHHHH
Confidence            99999999999999999985

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.5e-37  Score=262.45  Aligned_cols=196  Identities=22%  Similarity=0.330  Sum_probs=157.9

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      ++++||||+++++++.     ++ ..++||||++ ++|.+++....  ...+++..+..++.|++.||.|||++ ||+||
T Consensus        63 ~~l~h~~i~~~~~~~~-----~~-~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~  133 (279)
T 1qpc_A           63 KQLQHQRLVRLYAVVT-----QE-PIYIITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER-NYIHR  133 (279)
T ss_dssp             HHCCCTTBCCEEEEEC-----SS-SCEEEEECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT-TEECS
T ss_pred             HhCCCcCcceEEEEEc-----CC-CcEEEEecCCCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC-Ceecc
Confidence            4679999999999873     11 2789999997 69999886432  13689999999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCC--cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLF  157 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf  157 (292)
                      ||||+||+++.++ .++|+|||.+........  .....+|+.|+|||++.+. .++.++|+||+||++|+|++ |..||
T Consensus       134 dikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~  211 (279)
T 1qpc_A          134 DLRAANILVSDTL-SCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPY  211 (279)
T ss_dssp             CCSGGGEEECTTS-CEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred             CCCHhhEEEcCCC-CEEECCCcccccccCcccccccCCCCccCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCC
Confidence            9999999999887 799999999987643321  1233467889999999654 48999999999999999999 99999


Q ss_pred             CCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          158 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      .+.+..+....+.+...                            ...+..+++.+.++|.+||..||++|||++++++
T Consensus       212 ~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          212 PGMTNPEVIQNLERGYR----------------------------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             TTCCHHHHHHHHHTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cccCHHHHHHHHhcccC----------------------------CCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            88776655544432100                            0012467899999999999999999999999985

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=8.3e-37  Score=260.72  Aligned_cols=194  Identities=25%  Similarity=0.380  Sum_probs=147.4

Q ss_pred             CCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccC
Q 022799            3 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRD   81 (292)
Q Consensus         3 ~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~d   81 (292)
                      .++||||+++++++.... .+...+++||||++ |+|.+++....  ...+++..++.++.||+.||.|||++ ||+|||
T Consensus        67 ~~~h~~i~~~~~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~d  142 (299)
T 3m2w_A           67 ASQCPHIVRIVDVYENLY-AGRKCLLIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI-NIAHRD  142 (299)
T ss_dssp             HTTSTTBCCEEEEEEEEE-TTEEEEEEEECCCCSCBHHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHT-TEECCC
T ss_pred             hccCCCchhHHhhhhhhc-CCCceEEEEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCC
Confidence            468999999999884422 23556899999998 59999987632  24699999999999999999999998 999999


Q ss_pred             CCCCcEEEeC---CCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           82 IKPQNLLVNP---HTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        82 lkp~Nill~~---~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      |||+||+++.   ++ .++|+|||++....                      ...++.++|+||+||++|+|++|..||.
T Consensus       143 lkp~Nil~~~~~~~~-~~kl~Dfg~a~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~  199 (299)
T 3m2w_A          143 VKPENLLYTSKRPNA-ILKLTDFGFAKETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFY  199 (299)
T ss_dssp             CSGGGEEESSSSTTC-CEEECCCTTCEECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             CCHHHEEEecCCCCC-cEEEeccccccccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCC
Confidence            9999999987   45 79999999986431                      1237889999999999999999999997


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCC
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  238 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp  238 (292)
                      +.........+.                  ....   .............+++++.+||.+||..||.+|||+.++++||
T Consensus       200 ~~~~~~~~~~~~------------------~~~~---~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp  258 (299)
T 3m2w_A          200 SNHGLAISPGMK------------------TRIR---MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP  258 (299)
T ss_dssp             C-------CCSC------------------CSSC---TTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             CCcchhhhHHHH------------------HHHh---hccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence            654322110000                  0000   0001111112246899999999999999999999999999999


Q ss_pred             CccccC
Q 022799          239 FFDELR  244 (292)
Q Consensus       239 ~~~~~~  244 (292)
                      ||++..
T Consensus       259 ~~~~~~  264 (299)
T 3m2w_A          259 WIMQST  264 (299)
T ss_dssp             HHHTGG
T ss_pred             hhcccc
Confidence            998754

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.4e-37  Score=285.45  Aligned_cols=197  Identities=24%  Similarity=0.335  Sum_probs=159.4

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++..      ..+|+||||+. |+|.+++....  ...+++..+..++.||+.||.|||++ ||+|
T Consensus       316 l~~l~hpniv~~~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivH  386 (535)
T 2h8h_A          316 MKKLRHEKLVQLYAVVSE------EPIYIVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM-NYVH  386 (535)
T ss_dssp             HHHCCCTTBCCEEEEECS------SSCEEEECCCTTEEHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT-TCCC
T ss_pred             HHhCCCCCEeeEEEEEee------ccceEeeehhcCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeC
Confidence            456899999999998732      23789999998 69999986432  24689999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCC--CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE--PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPL  156 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~p  156 (292)
                      |||||+|||++.++ .+||+|||+++......  ......++..|+|||++.+. .++.++|||||||++|||++ |..|
T Consensus       387 rDlkp~NIll~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~t~g~~P  464 (535)
T 2h8h_A          387 RDLRAANILVGENL-VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVP  464 (535)
T ss_dssp             SCCSGGGEEECGGG-CEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTTCCS
T ss_pred             CCCCHhhEEEcCCC-cEEEcccccceecCCCceecccCCcCcccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCC
Confidence            99999999999887 79999999998653221  11223457889999998654 48999999999999999999 9999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      |.+....+....+......                            ..+..+++.+.+||.+||..||++|||++++++
T Consensus       465 ~~~~~~~~~~~~i~~~~~~----------------------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  516 (535)
T 2h8h_A          465 YPGMVNREVLDQVERGYRM----------------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  516 (535)
T ss_dssp             STTCCHHHHHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCHHHHHHHHHcCCCC----------------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            9888776655554321100                            012468899999999999999999999999985

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=2.2e-37  Score=266.63  Aligned_cols=206  Identities=24%  Similarity=0.402  Sum_probs=155.3

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      ++++||||+++++++...   +...+++||||++ |+|.+++..     ..+++..+..++.||+.||.|||++ ||+||
T Consensus        88 ~~l~h~~iv~~~~~~~~~---~~~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~-~ivH~  158 (318)
T 3lxp_A           88 RTLYHEHIIKYKGCCEDA---GAASLQLVMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQ-HYIHR  158 (318)
T ss_dssp             HHCCCTTBCCEEEEEEET---TTTEEEEEECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHT-TEECS
T ss_pred             HhCCCcchhhEEEEEecC---CCceEEEEEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhC-CccCC
Confidence            467899999999998542   2345889999998 699888864     4589999999999999999999998 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCC----cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPL  156 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~p  156 (292)
                      ||||+||+++.++ .+||+|||++........    .....+|+.|+|||++.+.. ++.++|+||+||++|+|++|..|
T Consensus       159 Dikp~Nil~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p  236 (318)
T 3lxp_A          159 DLAARNVLLDNDR-LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDS  236 (318)
T ss_dssp             CCSGGGEEECTTC-CEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCG
T ss_pred             CCchheEEEcCCC-CEEECCccccccccccccccccccCCCCCceeeChHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCc
Confidence            9999999999888 799999999987654332    22345788899999997644 88999999999999999999999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHH----H-hhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccH
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREE----I-KCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA  231 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~----~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~  231 (292)
                      |......     ............    + ...... .            ....+..+++++.+||++||..||.+|||+
T Consensus       237 ~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~-~------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~  298 (318)
T 3lxp_A          237 SQSPPTK-----FLELIGIAQGQMTVLRLTELLERG-E------------RLPRPDKCPAEVYHLMKNCWETEASFRPTF  298 (318)
T ss_dssp             GGSHHHH-----HHHHHCSCCHHHHHHHHHHHHHTT-C------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             ccccchh-----hhhhhcccccchhHHHHHHHHhcc-c------------CCCCCccccHHHHHHHHHHcCCCcccCcCH
Confidence            8643211     011111111000    0 000000 0            001124688999999999999999999999


Q ss_pred             HHHhc
Q 022799          232 LEALI  236 (292)
Q Consensus       232 ~e~l~  236 (292)
                      .++++
T Consensus       299 ~ell~  303 (318)
T 3lxp_A          299 ENLIP  303 (318)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            99983

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=7.1e-37  Score=286.57  Aligned_cols=195  Identities=26%  Similarity=0.398  Sum_probs=158.0

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      ++++||||+++++++.     +. ..++||||++ |+|.+++...   ...+++..+..++.||+.||.|||++ ||+||
T Consensus       446 ~~l~HpnIv~l~~~~~-----~~-~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~-givHr  515 (656)
T 2j0j_A          446 RQFDHPHIVKLIGVIT-----EN-PVWIIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESK-RFVHR  515 (656)
T ss_dssp             HHCCCTTBCCEEEEEC-----SS-SCEEEEECCTTCBHHHHHHHT---TTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCS
T ss_pred             HhCCCCCCCeEEEEEe-----cC-ceEEEEEcCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC-Ccccc
Confidence            4679999999999872     11 2789999998 7999988753   34689999999999999999999998 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCC--cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLF  157 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf  157 (292)
                      ||||+||+++.++ .+||+|||+++.......  .....+|+.|+|||++.+. .++.++|+||+||++|||++ |..||
T Consensus       516 Dikp~NILl~~~~-~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ellt~g~~Pf  593 (656)
T 2j0j_A          516 DIAARNVLVSSND-CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPF  593 (656)
T ss_dssp             CCSGGGEEEEETT-EEEECCCCCCCSCCC----------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             ccchHhEEEeCCC-CEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCC-CCCchhhHHHHHHHHHHHHHcCCCCC
Confidence            9999999999888 799999999987643322  1233567899999999654 58999999999999999997 99999


Q ss_pred             CCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          158 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      .+....+....+......                            ..+..+++.+.++|.+||..||.+|||+.++++
T Consensus       594 ~~~~~~~~~~~i~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~  644 (656)
T 2j0j_A          594 QGVKNNDVIGRIENGERL----------------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA  644 (656)
T ss_dssp             TTCCHHHHHHHHHHTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHcCCCC----------------------------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            988877766655442100                            012468899999999999999999999999985

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2e-36  Score=273.75  Aligned_cols=199  Identities=20%  Similarity=0.234  Sum_probs=153.0

Q ss_pred             CCCCCC-eeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccC
Q 022799            3 LLDHPN-VVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRD   81 (292)
Q Consensus         3 ~l~Hpn-Iv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~d   81 (292)
                      .|.|++ |..+..++     .+..+.++||||++++|.+++...   ...+++..++.++.||+.||.|||++ ||+|||
T Consensus        58 ~L~~~~~i~~i~~~~-----~~~~~~~lvme~~g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~-gIvHrD  128 (483)
T 3sv0_A           58 ILQGGTGIPNVRWFG-----VEGDYNVLVMDLLGPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK-SFLHRD  128 (483)
T ss_dssp             HTTTSTTCCCEEEEE-----EETTEEEEEEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCC
T ss_pred             HhcCCCCCCeEEEEE-----eeCCEEEEEEECCCCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecc
Confidence            456644 44444443     223357899999999999998753   46799999999999999999999998 999999


Q ss_pred             CCCCcEEE---eCCCCcEEEeecCCccccccCCC--------cccccccccccCCccccCCCCCCchhHhhhhhHHHHHH
Q 022799           82 IKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEP--------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAEL  150 (292)
Q Consensus        82 lkp~Nill---~~~~~~ikl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el  150 (292)
                      |||+|||+   +.++ .+||+|||+++.......        .....||+.|+|||++.+. .++.++|||||||++|+|
T Consensus       129 IKP~NILl~~~~~~~-~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDvwSlGvil~el  206 (483)
T 3sv0_A          129 IKPDNFLMGLGRRAN-QVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGI-EQSRRDDLESLGYVLMYF  206 (483)
T ss_dssp             CCGGGEEECCGGGTT-CEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHH
T ss_pred             cCcceEEEecCCCCC-eEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCC-CCChHHHHHHHHHHHHHH
Confidence            99999999   4555 799999999987654332        1256789999999999765 489999999999999999


Q ss_pred             HhCCCCCCCCCcH---HHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCC
Q 022799          151 LLGQPLFPGESGV---DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL  227 (292)
Q Consensus       151 ~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~  227 (292)
                      ++|..||.+....   ..+.++.........+                        .+...+++++.+||.+||..||.+
T Consensus       207 ltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~------------------------~l~~~~p~~l~~li~~cl~~dP~~  262 (483)
T 3sv0_A          207 LRGSLPWQGLKAGTKKQKYEKISEKKVATSIE------------------------ALCRGYPTEFASYFHYCRSLRFDD  262 (483)
T ss_dssp             HHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH------------------------HHHTTSCHHHHHHHHHHHTCCTTC
T ss_pred             HhCCCCCccccchhHHHHHHHHhhccccccHH------------------------HHhcCCcHHHHHHHHHHhcCChhh
Confidence            9999999875543   2223332221111111                        122468999999999999999999


Q ss_pred             cccHHHHhc
Q 022799          228 RSTALEALI  236 (292)
Q Consensus       228 R~t~~e~l~  236 (292)
                      ||++.++++
T Consensus       263 RPs~~el~~  271 (483)
T 3sv0_A          263 KPDYSYLKR  271 (483)
T ss_dssp             CCCHHHHHH
T ss_pred             CcCHHHHHH
Confidence            999988754

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.8e-36  Score=263.15  Aligned_cols=206  Identities=18%  Similarity=0.212  Sum_probs=154.2

Q ss_pred             CCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHH--------h
Q 022799            3 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH--------N   73 (292)
Q Consensus         3 ~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH--------~   73 (292)
                      .++||||+++++++.... .....+++||||++ |+|.+++..     ..+++..+..++.|++.||.|||        +
T Consensus        92 ~l~h~ni~~~~~~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~  165 (342)
T 1b6c_B           92 MLRHENILGFIAADNKDN-GTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGK  165 (342)
T ss_dssp             CCCCTTBCCEEEEEECCC-SSCCCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB
T ss_pred             hcCCCcEEEEEeeecccC-CccceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhccc
Confidence            379999999999985433 22235899999998 599999864     46899999999999999999999        7


Q ss_pred             cCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCCC-----cccccccccccCCccccCCCC-----CCchhHhhhh
Q 022799           74 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-----NISYICSRYYRAPELIFGATE-----YTAAIDIWSA  143 (292)
Q Consensus        74 ~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~-----~~~~~Dvwsl  143 (292)
                      + ||+||||||+||+++.++ .+||+|||++........     .....||+.|+|||++.+...     ++.++|+||+
T Consensus       166 ~-~ivH~Dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~sl  243 (342)
T 1b6c_B          166 P-AIAHRDLKSKNILVKKNG-TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAM  243 (342)
T ss_dssp             C-EEECSCCSGGGEEECTTS-CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHH
T ss_pred             C-CeeeCCCCHHHEEECCCC-CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHH
Confidence            7 999999999999999888 799999999987654432     234578999999999966432     2368999999


Q ss_pred             hHHHHHHHhC----------CCCCCCCCc----HHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCC
Q 022799          144 GCVLAELLLG----------QPLFPGESG----VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRM  209 (292)
Q Consensus       144 G~il~el~~g----------~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  209 (292)
                      ||++|+|++|          ..||.....    ...+........         ..+.     .+       ........
T Consensus       244 G~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~~-----~~-------~~~~~~~~  302 (342)
T 1b6c_B          244 GLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQK---------LRPN-----IP-------NRWQSCEA  302 (342)
T ss_dssp             HHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSC---------CCCC-----CC-------GGGGTSHH
T ss_pred             HHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHH---------hCCC-----Cc-------ccccchhH
Confidence            9999999999          778865432    122211111000         0000     00       00011234


Q ss_pred             ChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          210 PPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       210 ~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      ++.+.++|.+||..||++|||+.+++++
T Consensus       303 ~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          303 LRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             HHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            5689999999999999999999999865

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=6.2e-38  Score=279.30  Aligned_cols=182  Identities=19%  Similarity=0.238  Sum_probs=146.2

Q ss_pred             eeEEEEeecccCCHHHHHHhhh---hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEeCCCCcEEEeec
Q 022799           25 LYLNLVLEYVPETVHRVIKHHY---KMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDF  101 (292)
Q Consensus        25 ~~~~lv~e~~~g~L~~~l~~~~---~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlkp~Nill~~~~~~ikl~Df  101 (292)
                      ..++++|+++.++|.+++....   .....+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+||
T Consensus       178 ~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~iiHrDiKp~NILl~~~~-~~kL~DF  255 (413)
T 3dzo_A          178 LSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY-GLVHTYLRPVDIVLDQRG-GVFLTGF  255 (413)
T ss_dssp             CSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTC-CEEECCG
T ss_pred             cceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCcccceEEEecCC-eEEEEec
Confidence            3478899999999998886331   2234577888899999999999999988 999999999999999988 6999999


Q ss_pred             CCccccccCCCcccccccccccCCcccc---------CCCCCCchhHhhhhhHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Q 022799          102 GSAKVLVKGEPNISYICSRYYRAPELIF---------GATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV  172 (292)
Q Consensus       102 g~a~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~i~~~  172 (292)
                      |+++.....  ....+| +.|+|||++.         ....++.++|+|||||++|+|++|+.||.+.+.......+   
T Consensus       256 G~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~---  329 (413)
T 3dzo_A          256 EHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWI---  329 (413)
T ss_dssp             GGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGG---
T ss_pred             cceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHH---
Confidence            998765333  344567 9999999983         3334788999999999999999999999765432211100   


Q ss_pred             hCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCCccccC
Q 022799          173 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR  244 (292)
Q Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~~~~~~  244 (292)
                                          +..          ...+|+++.+||.+||..||.+|||+.++++||||+.+.
T Consensus       330 --------------------~~~----------~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~  371 (413)
T 3dzo_A          330 --------------------FRS----------CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR  371 (413)
T ss_dssp             --------------------GSS----------CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             --------------------Hhh----------cccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHHH
Confidence                                000          035789999999999999999999999999999998764

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=5.6e-37  Score=268.91  Aligned_cols=193  Identities=16%  Similarity=0.149  Sum_probs=150.3

Q ss_pred             CCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccC
Q 022799            4 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYK-MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRD   81 (292)
Q Consensus         4 l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~d   81 (292)
                      ..|+||+++++++...     ...|+||||++ |+|.+++..... ....+++..++.++.||+.||+|||++ ||+|||
T Consensus       124 ~~~~~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~-~ivHrD  197 (365)
T 3e7e_A          124 SMQHMFMKFYSAHLFQ-----NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC-EIIHGD  197 (365)
T ss_dssp             GGGGGBCCEEEEEECS-----SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT-TEECCC
T ss_pred             hhhhhhhhhheeeecC-----CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC-CeecCC
Confidence            4599999999998443     34889999998 799999976443 246799999999999999999999987 999999


Q ss_pred             CCCCcEEEeC-----------CCCcEEEeecCCcccccc---CCCcccccccccccCCccccCCCCCCchhHhhhhhHHH
Q 022799           82 IKPQNLLVNP-----------HTHQLKLCDFGSAKVLVK---GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVL  147 (292)
Q Consensus        82 lkp~Nill~~-----------~~~~ikl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il  147 (292)
                      |||+|||++.           ++ .+||+|||+++....   .......+||+.|+|||++.+.. ++.++|+|||||++
T Consensus       198 iKp~NIll~~~~~~~~~~~~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il  275 (365)
T 3e7e_A          198 IKPDNFILGNGFLEQDDEDDLSA-GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP-WNYQIDYFGVAATV  275 (365)
T ss_dssp             CSGGGEEECGGGTCC------CT-TEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCC-BSTHHHHHHHHHHH
T ss_pred             CCHHHEEecccccCccccccccC-CEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCC-CCccccHHHHHHHH
Confidence            9999999987           56 799999999975532   22234567899999999997654 89999999999999


Q ss_pred             HHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCC
Q 022799          148 AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL  227 (292)
Q Consensus       148 ~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~  227 (292)
                      |+|++|+.||.......                 .....     .+..           ...++.+.+++.+||..+|.+
T Consensus       276 ~elltg~~pf~~~~~~~-----------------~~~~~-----~~~~-----------~~~~~~~~~~~~~~l~~~p~~  322 (365)
T 3e7e_A          276 YCMLFGTYMKVKNEGGE-----------------CKPEG-----LFRR-----------LPHLDMWNEFFHVMLNIPDCH  322 (365)
T ss_dssp             HHHHHSSCCCEEEETTE-----------------EEECS-----CCTT-----------CSSHHHHHHHHHHHHCCCCTT
T ss_pred             HHHHhCCCccccCCCCc-----------------eeech-----hccc-----------cCcHHHHHHHHHHHcCCCCCC
Confidence            99999999995432110                 00000     0000           123567899999999999999


Q ss_pred             cccHHHHhcC
Q 022799          228 RSTALEALIH  237 (292)
Q Consensus       228 R~t~~e~l~h  237 (292)
                      |++..+.+.+
T Consensus       323 r~~~~~~l~~  332 (365)
T 3e7e_A          323 HLPSLDLLRQ  332 (365)
T ss_dssp             CCCCHHHHHH
T ss_pred             cchHHHHHHH
Confidence            9765554443

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1e-36  Score=263.19  Aligned_cols=209  Identities=25%  Similarity=0.445  Sum_probs=155.3

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++....   ...+++||||++ ++|.+++...   ...+++..+..++.||+.||.|||++ ||+|
T Consensus        96 l~~l~h~~iv~~~~~~~~~~---~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH  168 (326)
T 2w1i_A           96 LKSLQHDNIVKYKGVCYSAG---RRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK-RYIH  168 (326)
T ss_dssp             HHTCCCTTBCCEEEEECC-------CCEEEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHT-TEEC
T ss_pred             HHhCCCCCeeeEEEEEEecC---CCceEEEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC-CEec
Confidence            35789999999999874422   234789999998 6999998753   35689999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCC----cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQP  155 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~  155 (292)
                      |||||+||+++.++ .+||+|||++........    .....++..|+|||.+.+. .++.++|+|||||++|+|++|..
T Consensus       169 ~dikp~NIli~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~  246 (326)
T 2w1i_A          169 RDLATRNILVENEN-RVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIE  246 (326)
T ss_dssp             SCCCGGGEEEEETT-EEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHHTTC
T ss_pred             cCCCcceEEEcCCC-cEEEecCcchhhccccccccccccCCCCceeEECchhhcCC-CCCchhhHHHHHHHHHHHHhcCC
Confidence            99999999999888 799999999987644332    1233567789999999664 48999999999999999999998


Q ss_pred             CCCCCCcHHHHHHHHHHhCCCCHHH------HhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcc
Q 022799          156 LFPGESGVDQLVEIIKVLGTPTREE------IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS  229 (292)
Q Consensus       156 pf~~~~~~~~~~~i~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~  229 (292)
                      ||.....     ...+..+......      ...+....   ..          ..+..+++++.++|.+||..||++||
T Consensus       247 ~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~----------~~~~~~~~~l~~li~~cl~~dP~~Rp  308 (326)
T 2w1i_A          247 KSKSPPA-----EFMRMIGNDKQGQMIVFHLIELLKNNG---RL----------PRPDGCPDEIYMIMTECWNNNVNQRP  308 (326)
T ss_dssp             GGGSHHH-----HHHHHHCTTCCTHHHHHHHHHHHHTTC---CC----------CCCTTCCHHHHHHHHHHSCSSGGGSC
T ss_pred             CCCCCHH-----HHHHhhccccchhhhHHHHHHHhhcCC---CC----------CCCCcccHHHHHHHHHHcCCChhhCc
Confidence            8853211     1111111111100      00000000   00          01246889999999999999999999


Q ss_pred             cHHHHhc
Q 022799          230 TALEALI  236 (292)
Q Consensus       230 t~~e~l~  236 (292)
                      |+.++++
T Consensus       309 s~~el~~  315 (326)
T 2w1i_A          309 SFRDLAL  315 (326)
T ss_dssp             CHHHHHH
T ss_pred             CHHHHHH
Confidence            9999984

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.5e-36  Score=263.29  Aligned_cols=179  Identities=16%  Similarity=0.165  Sum_probs=134.4

Q ss_pred             ceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHH-hcCCccccCCCCCcEEEeCCC--------
Q 022799           24 ELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH-NTIGVCHRDIKPQNLLVNPHT--------   93 (292)
Q Consensus        24 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH-~~~~i~H~dlkp~Nill~~~~--------   93 (292)
                      ...+|+|||||. |++.+.+.     ...+++..++.++.||+.||.||| ++ ||+||||||+|||++.++        
T Consensus       134 ~~~~~lv~E~~~~g~ll~~~~-----~~~~~~~~~~~i~~qi~~aL~~lH~~~-~ivHrDlKp~NILl~~~~~~~~~~~~  207 (336)
T 2vuw_A          134 DDQLFIVLEFEFGGIDLEQMR-----TKLSSLATAKSILHQLTASLAVAEASL-RFEHRDLHWGNVLLKKTSLKKLHYTL  207 (336)
T ss_dssp             TTCEEEEEEEECCCEETGGGT-----TTCCCHHHHHHHHHHHHHHHHHHHHHH-CCBCSCCCGGGEEEEECSCSEEEEEE
T ss_pred             cCeEEEEEEecCCCccHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHhC-CEeECCCCHHHEEEeccCCcceeeec
Confidence            456899999997 55555553     256899999999999999999999 88 999999999999998764        


Q ss_pred             -----------CcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHH-HHHHHhCCCCCCCCC
Q 022799           94 -----------HQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCV-LAELLLGQPLFPGES  161 (292)
Q Consensus        94 -----------~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~i-l~el~~g~~pf~~~~  161 (292)
                                 ..+||+|||+|+.....    ..+||+.|+|||++.+..  +.++||||+|++ .+++++|..||.+..
T Consensus       208 ~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~  281 (336)
T 2vuw_A          208 NGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVL  281 (336)
T ss_dssp             TTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHH
T ss_pred             cCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhcCCC--ccceehhhhhCCCCcccccccCCCcchh
Confidence                       26999999999876432    458999999999997643  889999998777 778889999984321


Q ss_pred             cHH-HHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHh-cCCC
Q 022799          162 GVD-QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL-IHPF  239 (292)
Q Consensus       162 ~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l-~hp~  239 (292)
                      ... ....+......                  ....    .....+.+++++++||++||++|     |++|+| +|||
T Consensus       282 ~~~~~~~~~~~~~~~------------------~~~~----~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~  334 (336)
T 2vuw_A          282 WLHYLTDKMLKQMTF------------------KTKC----NTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSL  334 (336)
T ss_dssp             HHHHHHHHHHHTCCC------------------SSCC----CSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGG
T ss_pred             hhhHHHHhhhhhhcc------------------Cccc----chhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCC
Confidence            101 11112111000                  0000    01122457889999999999987     999999 9999


Q ss_pred             cc
Q 022799          240 FD  241 (292)
Q Consensus       240 ~~  241 (292)
                      |+
T Consensus       335 f~  336 (336)
T 2vuw_A          335 FK  336 (336)
T ss_dssp             GC
T ss_pred             cC
Confidence            95

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.7e-36  Score=284.55  Aligned_cols=194  Identities=26%  Similarity=0.368  Sum_probs=154.4

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++||||+++++++......+....|+||||++ ++|.+.+.      ..+++..+..++.||+.||.|||++ ||+|
T Consensus       133 l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~------~~l~~~~~~~~~~qi~~aL~~lH~~-giiH  205 (681)
T 2pzi_A          133 LAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYLHSI-GLVY  205 (681)
T ss_dssp             GGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT-TEEC
T ss_pred             HHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHC-CCee
Confidence            46789999999999987655444555799999998 58776553      3699999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      |||||+||+++.+  .+||+|||+++.....   ....||+.|+|||++.+.  ++.++||||+||++|+|++|..||.+
T Consensus       206 rDlkp~NIll~~~--~~kl~DFG~a~~~~~~---~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~  278 (681)
T 2pzi_A          206 NDLKPENIMLTEE--QLKLIDLGAVSRINSF---GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNG  278 (681)
T ss_dssp             CCCSGGGEEECSS--CEEECCCTTCEETTCC---SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred             cccChHHeEEeCC--cEEEEecccchhcccC---CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCcc
Confidence            9999999999874  6999999999876433   456799999999998653  58999999999999999999988864


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCC
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF  239 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~  239 (292)
                      .....                            .+.  ..     .....++.+.++|.+||..||++||+..+++.|+|
T Consensus       279 ~~~~~----------------------------~~~--~~-----~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l  323 (681)
T 2pzi_A          279 RYVDG----------------------------LPE--DD-----PVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQL  323 (681)
T ss_dssp             EECSS----------------------------CCT--TC-----HHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred             ccccc----------------------------ccc--cc-----cccccCHHHHHHHhhhccCChhhCCCHHHHHHHHH
Confidence            21100                            000  00     00124678999999999999999999999999998


Q ss_pred             cccc
Q 022799          240 FDEL  243 (292)
Q Consensus       240 ~~~~  243 (292)
                      +.-+
T Consensus       324 ~~~~  327 (681)
T 2pzi_A          324 TGVL  327 (681)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            8643

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=5.9e-33  Score=235.41  Aligned_cols=172  Identities=16%  Similarity=0.119  Sum_probs=132.6

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      ++++||||+++++++..     ....|+||||++ ++|.+++..     + .....+..++.||+.||.|||++ ||+||
T Consensus        86 ~~l~hp~iv~~~~~~~~-----~~~~~lv~e~~~g~~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~lH~~-givH~  153 (286)
T 3uqc_A           86 SRIDKPGVARVLDVVHT-----RAGGLVVAEWIRGGSLQEVADT-----S-PSPVGAIRAMQSLAAAADAAHRA-GVALS  153 (286)
T ss_dssp             HTCCCTTBCCEEEEEEE-----TTEEEEEEECCCEEEHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHHHHT-TCCCC
T ss_pred             hcCCCCCcceeeEEEEE-----CCcEEEEEEecCCCCHHHHHhc-----C-CChHHHHHHHHHHHHHHHHHHHC-CCccC
Confidence            57899999999999843     345899999998 699888742     2 35567888999999999999998 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE  160 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  160 (292)
                      ||||+||+++.++ .+||+++|                   |++        .++.++|+|||||++|+|++|+.||.+.
T Consensus       154 Dikp~NIll~~~g-~~kl~~~~-------------------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~  205 (286)
T 3uqc_A          154 IDHPSRVRVSIDG-DVVLAYPA-------------------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEA  205 (286)
T ss_dssp             CCSGGGEEEETTS-CEEECSCC-------------------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCC
T ss_pred             CCCcccEEEcCCC-CEEEEecc-------------------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence            9999999999888 78988443                   232        2789999999999999999999999876


Q ss_pred             CcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          161 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       161 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      +..+.+..                     ... ...........+...+++++.++|.+||+.||.+| |+.++++
T Consensus       206 ~~~~~~~~---------------------~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~  258 (286)
T 3uqc_A          206 GVRSGLAP---------------------AER-DTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN  258 (286)
T ss_dssp             SBCCCSEE---------------------CCB-CTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred             CcchhhHH---------------------HHH-HhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence            54211000                     000 00000111123346789999999999999999999 9999985

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=1.2e-32  Score=253.65  Aligned_cols=139  Identities=17%  Similarity=0.128  Sum_probs=101.1

Q ss_pred             CCCC-CCCCeeeeceeeeccCCCCceeEEEEeecccC-CHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcc
Q 022799            1 MRLL-DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVC   78 (292)
Q Consensus         1 L~~l-~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~   78 (292)
                      |+++ .|+||+++++++     +++...|||||||+| +|.+++..    .+++++.   .|+.||+.||+|||++ ||+
T Consensus       295 l~~~~~~~~i~~~~~~~-----ed~~~~yLVMEyv~G~~L~d~i~~----~~~l~~~---~I~~QIl~AL~ylH~~-GII  361 (569)
T 4azs_A          295 LTQPPAGFDAPAVLAHG-----ENAQSGWLVMEKLPGRLLSDMLAA----GEEIDRE---KILGSLLRSLAALEKQ-GFW  361 (569)
T ss_dssp             HHSCCTTCCCCCEEEEE-----ECSSEEEEEEECCCSEEHHHHHHT----TCCCCHH---HHHHHHHHHHHHHHHT-TCE
T ss_pred             HHhcCCCCCeeEEEEEE-----EECCEEEEEEecCCCCcHHHHHHh----CCCCCHH---HHHHHHHHHHHHHHHC-Cce
Confidence            3456 799999999999     566669999999995 99999976    3566654   5789999999999998 999


Q ss_pred             ccCCCCCcEEEeCCCCcEEEeecCCccccccC-CCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCC
Q 022799           79 HRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQP  155 (292)
Q Consensus        79 H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~  155 (292)
                      ||||||+|||++.++ .+||+|||+|+..... ....+.+||+.|+|||++.+.  +..++|+||+|++++++.++..
T Consensus       362 HRDIKPeNILL~~dg-~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g~--~~~~~d~~s~g~~~~~l~~~~~  436 (569)
T 4azs_A          362 HDDVRPWNVMVDARQ-HARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAEN--KSWNGFWRSAPVHPFNLPQPWS  436 (569)
T ss_dssp             ESCCCGGGEEECTTS-CEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC-------------------CCCCTTHH
T ss_pred             eccCchHhEEECCCC-CEEEeecccCeeCCCCCccccCceechhhccHHHhCCC--CCCcccccccccchhhhccccc
Confidence            999999999999988 7999999999876443 334567899999999999763  5778999999999887765543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.87  E-value=5.6e-24  Score=194.95  Aligned_cols=135  Identities=16%  Similarity=0.228  Sum_probs=106.6

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      ++++||||+++..+.....     ..|+||||++ ++|.+++..            +..++.||+.||.|||++ ||+||
T Consensus       394 ~~l~h~nIv~~~~~~~~~~-----~~~lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~-gIiHr  455 (540)
T 3en9_A          394 ALVKDFGIPAPYIFDVDLD-----NKRIMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN-DVIHN  455 (540)
T ss_dssp             HHGGGGTCCCCCEEEEETT-----TTEEEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT-TEECT
T ss_pred             HhcCCCCcCceEEEEEeCC-----ccEEEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC-cCccC
Confidence            4679999995544443222     2589999998 799888753            568899999999999988 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCC--------cccccccccccCCccccCC-CCCCchhHhhhhhHHHHHHH
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP--------NISYICSRYYRAPELIFGA-TEYTAAIDIWSAGCVLAELL  151 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~  151 (292)
                      ||||+|||++.   .+||+|||+++.......        .....||+.|+|||++.+. ..|+..+|+||..+-..+.+
T Consensus       456 DiKp~NILl~~---~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v  532 (540)
T 3en9_A          456 DLTTSNFIFDK---DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDV  532 (540)
T ss_dssp             TCCTTSEEESS---SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHH
T ss_pred             CCCHHHEEECC---eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHH
Confidence            99999999997   599999999987644321        1356789999999999541 33788899999988888877


Q ss_pred             hCCCCC
Q 022799          152 LGQPLF  157 (292)
Q Consensus       152 ~g~~pf  157 (292)
                      .++.+|
T Consensus       533 ~~r~rY  538 (540)
T 3en9_A          533 ERRARY  538 (540)
T ss_dssp             HTCSCC
T ss_pred             Hhcccc
Confidence            776655

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.63  E-value=1.6e-17  Score=140.05  Aligned_cols=88  Identities=15%  Similarity=0.179  Sum_probs=68.1

Q ss_pred             eeeceeeeccCCCCceeEEEEeecccC-CHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEE
Q 022799           10 VSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLL   88 (292)
Q Consensus        10 v~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlkp~Nil   88 (292)
                      +++.+++..      ...|+||||++| +|.+ +.          ......++.||+.||.|||++ ||+||||||+||+
T Consensus       164 ~~v~~~~~~------~~~~lvmE~~~g~~L~~-l~----------~~~~~~i~~qi~~~l~~lH~~-giiHrDlkp~NIL  225 (282)
T 1zar_A          164 LAVPKVYAW------EGNAVLMELIDAKELYR-VR----------VENPDEVLDMILEEVAKFYHR-GIVHGDLSQYNVL  225 (282)
T ss_dssp             SSSCCEEEE------ETTEEEEECCCCEEGGG-CC----------CSCHHHHHHHHHHHHHHHHHT-TEECSCCSTTSEE
T ss_pred             CCcCeEEec------cceEEEEEecCCCcHHH-cc----------hhhHHHHHHHHHHHHHHHHHC-CCEeCCCCHHHEE
Confidence            666665421      236899999984 8776 31          123457899999999999987 9999999999999


Q ss_pred             EeCCCCcEEEeecCCccccccCCCcccccccccccCCcccc
Q 022799           89 VNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF  129 (292)
Q Consensus        89 l~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~  129 (292)
                      ++ ++ .+||+|||+++.            +..++|||++.
T Consensus       226 l~-~~-~vkl~DFG~a~~------------~~~~~a~e~l~  252 (282)
T 1zar_A          226 VS-EE-GIWIIDFPQSVE------------VGEEGWREILE  252 (282)
T ss_dssp             EE-TT-EEEECCCTTCEE------------TTSTTHHHHHH
T ss_pred             EE-CC-cEEEEECCCCeE------------CCCCCHHHHHH
Confidence            99 77 799999999863            33467888773

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.39  E-value=2.4e-13  Score=112.91  Aligned_cols=70  Identities=19%  Similarity=0.321  Sum_probs=56.9

Q ss_pred             EEEEeeccc--C----CHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHH-hcCCccccCCCCCcEEEeCCCCcEEEe
Q 022799           27 LNLVLEYVP--E----TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIH-NTIGVCHRDIKPQNLLVNPHTHQLKLC   99 (292)
Q Consensus        27 ~~lv~e~~~--g----~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH-~~~~i~H~dlkp~Nill~~~~~~ikl~   99 (292)
                      .+|||||++  |    +|.+....       .++..+..++.|++.||.||| +. ||+||||||+|||++.   .++|+
T Consensus       143 ~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~-givHrDlkp~NILl~~---~~~li  211 (258)
T 1zth_A          143 NVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA-ELVHADLSEYNIMYID---KVYFI  211 (258)
T ss_dssp             TEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS-CEECSSCSTTSEEESS---SEEEC
T ss_pred             CEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC-CEEeCCCCHHHEEEcC---cEEEE
Confidence            679999995  3    55554321       124457889999999999999 87 9999999999999987   59999


Q ss_pred             ecCCcccc
Q 022799          100 DFGSAKVL  107 (292)
Q Consensus       100 Dfg~a~~~  107 (292)
                      |||+|...
T Consensus       212 DFG~a~~~  219 (258)
T 1zth_A          212 DMGQAVTL  219 (258)
T ss_dssp             CCTTCEET
T ss_pred             ECcccccC
Confidence            99999654

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.16  E-value=4.6e-12  Score=110.14  Aligned_cols=91  Identities=13%  Similarity=0.170  Sum_probs=62.2

Q ss_pred             CCCeeeeceeeeccCC-CCceeEEEEeecccC-CHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCC
Q 022799            6 HPNVVSLKHCFFSTTE-KDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIK   83 (292)
Q Consensus         6 HpnIv~~~~~~~~~~~-~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlk   83 (292)
                      |+|++++++....... -+....+|||||++| +|.++.          ....+..++.||+.+|.+||++ ||||||||
T Consensus       164 ~~nL~rL~~~gv~vp~p~~~~~~~LVME~i~G~~L~~l~----------~~~~~~~l~~qll~~l~~lH~~-gIVHrDLK  232 (397)
T 4gyi_A          164 FAFMKALYEEGFPVPEPIAQSRHTIVMSLVDALPMRQVS----------SVPDPASLYADLIALILRLAKH-GLIHGDFN  232 (397)
T ss_dssp             HHHHHHHHHTTCSCCCEEEEETTEEEEECCSCEEGGGCC----------CCSCHHHHHHHHHHHHHHHHHT-TEECSCCS
T ss_pred             HHHHHHHHhcCCCCCeeeeccCceEEEEecCCccHhhhc----------ccHHHHHHHHHHHHHHHHHHHC-CCcCCCCC
Confidence            6677776554322111 001113699999996 543221          1123567889999999999987 99999999


Q ss_pred             CCcEEEeCCCC---------cEEEeecCCcccc
Q 022799           84 PQNLLVNPHTH---------QLKLCDFGSAKVL  107 (292)
Q Consensus        84 p~Nill~~~~~---------~ikl~Dfg~a~~~  107 (292)
                      |.|||++.++.         .+.|+||+.+...
T Consensus       233 p~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          233 EFNILIREEKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             TTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred             HHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence            99999976651         2789999987543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=98.53  E-value=1.3e-07  Score=78.16  Aligned_cols=84  Identities=13%  Similarity=0.109  Sum_probs=60.3

Q ss_pred             CCCeeeeceeeeccCCCCceeEEEEeecccC-CHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-----------
Q 022799            6 HPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN-----------   73 (292)
Q Consensus         6 HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~-----------   73 (292)
                      +.++.+++++..     +....|+||||++| +|.+.+.         +......++.++..+|..||+           
T Consensus        69 ~~~vP~v~~~~~-----~~~~~~lv~e~i~G~~l~~~~~---------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~  134 (263)
T 3tm0_A           69 KLPVPKVLHFER-----HDGWSNLLMSEADGVLCSEEYE---------DEQSPEKIIELYAECIRLFHSIDISDCPYTNS  134 (263)
T ss_dssp             TSCCCCEEEEEE-----ETTEEEEEEECCSSEEHHHHCC---------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCC
T ss_pred             CCCCCeEEEEEe-----cCCceEEEEEecCCeehhhccC---------CcccHHHHHHHHHHHHHHHhCCCcccCCCcch
Confidence            556777777663     23357899999997 6554321         111234667789999999997           


Q ss_pred             ------------------------------------------------cCCccccCCCCCcEEEeCCCCcEEEeecCCcc
Q 022799           74 ------------------------------------------------TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  105 (292)
Q Consensus        74 ------------------------------------------------~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~  105 (292)
                                                                      . +++|+|++|.||+++.++ .+.|+||+.+.
T Consensus       135 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~-~l~HgDl~~~Nil~~~~~-~~~lIDwe~a~  212 (263)
T 3tm0_A          135 LDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEEL-VFSHGDLGDSNIFVKDGK-VSGFIDLGRSG  212 (263)
T ss_dssp             HHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCE-EEECSSCCTTSEEEETTE-EEEECCCTTCE
T ss_pred             HHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCc-eEECCCCCcCcEEEECCc-EEEEEEchhcc
Confidence                                                            3 589999999999998643 45799998764

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.32  E-value=1.5e-07  Score=79.58  Aligned_cols=123  Identities=14%  Similarity=0.167  Sum_probs=75.5

Q ss_pred             eEEEEeecccC-CHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhc------------------------------
Q 022799           26 YLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT------------------------------   74 (292)
Q Consensus        26 ~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~------------------------------   74 (292)
                      ..|+||++++| ++.....      ..++......++.|++..+..||+.                              
T Consensus        90 ~~~~vm~~i~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (304)
T 3sg8_A           90 MSFAGFTKIKGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSR  163 (304)
T ss_dssp             CSCEEEECCCCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTT
T ss_pred             cceEEEcccCCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcc
Confidence            35789999997 5443222      2356666667777777777777740                              


Q ss_pred             ---------------------------CCccccCCCCCcEEEeCC-CCcEEEeecCCccccccCCCcccccccccc---c
Q 022799           75 ---------------------------IGVCHRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNISYICSRYY---R  123 (292)
Q Consensus        75 ---------------------------~~i~H~dlkp~Nill~~~-~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y---~  123 (292)
                                                 ..++|+|++|.||+++.+ +..+.|+||+.+.....   ..........   .
T Consensus       164 ~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~---~~Dl~~~~~~~~~~  240 (304)
T 3sg8_A          164 ELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDP---DNDFISLMEDDEEY  240 (304)
T ss_dssp             TSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECT---THHHHTTCCTTTSC
T ss_pred             cCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCCh---HHHHHHHHhhcccc
Confidence                                       147999999999999874 33578999998865311   1100000000   1


Q ss_pred             CCccc----c--CCC-------CCCchhHhhhhhHHHHHHHhCCCCC
Q 022799          124 APELI----F--GAT-------EYTAAIDIWSAGCVLAELLLGQPLF  157 (292)
Q Consensus       124 aPE~~----~--~~~-------~~~~~~DvwslG~il~el~~g~~pf  157 (292)
                      +|+..    .  +..       ......+.|++|.++|.+.+|..+|
T Consensus       241 ~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          241 GMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             CHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            11111    0  000       0122368999999999999998776

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.27  E-value=7.9e-07  Score=76.99  Aligned_cols=93  Identities=15%  Similarity=0.177  Sum_probs=65.6

Q ss_pred             CCCeeeeceeeeccCCCCceeEEEEeecccC-CHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-----------
Q 022799            6 HPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHN-----------   73 (292)
Q Consensus         6 HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~-----------   73 (292)
                      +.++.+++.++...  ......++||||++| .+.+.      ....++......++.+++..|..||+           
T Consensus        97 ~vpvP~~~~~~~~~--~~~g~~~~vme~v~G~~l~~~------~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~  168 (359)
T 3dxp_A           97 DVPVAKMYALCEDE--SVIGRAFYIMEFVSGRVLWDQ------SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDY  168 (359)
T ss_dssp             SSCCCCEEEEECCT--TTTSSCEEEEECCCCBCCCCT------TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTS
T ss_pred             CCCCCcEEEECCCC--CccCCeEEEEEecCCeecCCC------ccccCCHHHHHHHHHHHHHHHHHHhCCCchhcccccc
Confidence            34466666655222  111346799999997 33221      12346777888889999999999996           


Q ss_pred             ----------------------------------------------cCCccccCCCCCcEEEeCCCC-cEEEeecCCccc
Q 022799           74 ----------------------------------------------TIGVCHRDIKPQNLLVNPHTH-QLKLCDFGSAKV  106 (292)
Q Consensus        74 ----------------------------------------------~~~i~H~dlkp~Nill~~~~~-~ikl~Dfg~a~~  106 (292)
                                                                    ..+++|+|+++.||+++.++. .+.|+||+.+..
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          169 GKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             SCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             CCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                                          137999999999999987652 368999998864

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.18  E-value=1.7e-06  Score=71.01  Aligned_cols=28  Identities=25%  Similarity=0.249  Sum_probs=23.9

Q ss_pred             ccccCCCCCcEEEeCCCCcEEEeecCCcc
Q 022799           77 VCHRDIKPQNLLVNPHTHQLKLCDFGSAK  105 (292)
Q Consensus        77 i~H~dlkp~Nill~~~~~~ikl~Dfg~a~  105 (292)
                      ++|+|++|.||+++.++ .+.|+||+.+.
T Consensus       186 l~HgDl~~~Nil~~~~~-~~~liD~~~a~  213 (264)
T 1nd4_A          186 VTHGDACLPNIMVENGR-FSGFIDCGRLG  213 (264)
T ss_dssp             EECSSCCGGGEEEETTE-EEEECCCTTCE
T ss_pred             EECCCCCCCcEEEECCc-EEEEEcchhcc
Confidence            99999999999998654 45699999874

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=98.07  E-value=0.00016  Score=57.21  Aligned_cols=100  Identities=15%  Similarity=0.075  Sum_probs=65.6

Q ss_pred             CHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccc
Q 022799           37 TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY  116 (292)
Q Consensus        37 ~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~  116 (292)
                      +|.+++..+   +.++++++++.+++|.+.+|.-+-....-..+=+.|..|++..+| .|.+.+ +.+.           
T Consensus        34 SL~eIL~~~---~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG-~V~f~~-~~s~-----------   97 (229)
T 2yle_A           34 SLEEILRLY---NQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDG-AVTLAP-AADD-----------   97 (229)
T ss_dssp             EHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTS-CEEECC-C--------------
T ss_pred             cHHHHHHHc---CCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCC-ceeccc-cccc-----------
Confidence            788998875   789999999999999999987762110222334456889999888 566653 1110           


Q ss_pred             cccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCC
Q 022799          117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ  154 (292)
Q Consensus       117 ~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~  154 (292)
                      .....+.|||...  ...+.+.=|+|||.++|.-+--.
T Consensus        98 ~~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDyg  133 (229)
T 2yle_A           98 AGEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYG  133 (229)
T ss_dssp             ---------CCSS--SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred             ccccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcC
Confidence            1122356888763  23578889999999999998644

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=97.26  E-value=0.001  Score=55.99  Aligned_cols=31  Identities=32%  Similarity=0.578  Sum_probs=25.1

Q ss_pred             CccccCCCCCcEEEeC---CCCcEEEeecCCccc
Q 022799           76 GVCHRDIKPQNLLVNP---HTHQLKLCDFGSAKV  106 (292)
Q Consensus        76 ~i~H~dlkp~Nill~~---~~~~ikl~Dfg~a~~  106 (292)
                      .++|+|+++.||+++.   ++..+.|+||+.+..
T Consensus       191 ~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          191 RLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             EEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             eeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence            5699999999999987   353458999998764

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=97.12  E-value=0.001  Score=54.66  Aligned_cols=28  Identities=25%  Similarity=0.372  Sum_probs=23.8

Q ss_pred             ccccCCCCCcEEEeCCCCcEEEeecCCcc
Q 022799           77 VCHRDIKPQNLLVNPHTHQLKLCDFGSAK  105 (292)
Q Consensus        77 i~H~dlkp~Nill~~~~~~ikl~Dfg~a~  105 (292)
                      ++|+|+.+.||+++.++ .+-|+||+.+.
T Consensus       195 l~HGDl~~~Nil~~~~~-~~~viDwe~a~  222 (272)
T 4gkh_A          195 VTHGDFSLDNLIFDEGK-LIGCIDVGRVG  222 (272)
T ss_dssp             EECSCCCTTSEEEETTE-EEEECCCTTCE
T ss_pred             EEcCCCCCCeEEEECCe-EEEEEECcccc
Confidence            68999999999998755 56799998774

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=96.18  E-value=0.012  Score=50.33  Aligned_cols=31  Identities=13%  Similarity=0.138  Sum_probs=25.4

Q ss_pred             CCccccCCCCCcEEEeCCCCcEEEeecCCccc
Q 022799           75 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  106 (292)
Q Consensus        75 ~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~  106 (292)
                      ..++|+|+.+.||+++. +..+.|+||+.+..
T Consensus       222 ~~l~HgDl~~~Nil~~~-~~~~~vIDwe~a~~  252 (357)
T 3ats_A          222 PVLLWGDARVGNVLYRD-FQPVAVLDWEMVAL  252 (357)
T ss_dssp             CEEECSSCSGGGEEEET-TEEEEECCGGGCEE
T ss_pred             ceEEeCCCCCCeEEEeC-CcEEEEEccccccc
Confidence            37999999999999985 42478999998753

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=95.97  E-value=0.01  Score=50.27  Aligned_cols=30  Identities=23%  Similarity=0.458  Sum_probs=26.0

Q ss_pred             CCccccCCCCCcEEEeCCCCcEEEeecCCcc
Q 022799           75 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  105 (292)
Q Consensus        75 ~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~  105 (292)
                      .+++|+|+++.||+++.++ .+.|+||+.+.
T Consensus       222 ~~l~HgD~~~~Nil~~~~~-~~~lIDfe~a~  251 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENE-QIWVIDLDTVS  251 (346)
T ss_dssp             CCEECSSCSTTSEEECGGG-CEEECCCTTCE
T ss_pred             CceecCCCCcccEEEeCCC-cEEEEehhhcc
Confidence            4899999999999997666 69999998764

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=94.38  E-value=0.035  Score=48.72  Aligned_cols=76  Identities=12%  Similarity=-0.049  Sum_probs=43.3

Q ss_pred             CccccCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccc--cccccCCccccCCCC--CCchhHhhhhhHHHHHHH
Q 022799           76 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC--SRYYRAPELIFGATE--YTAAIDIWSAGCVLAELL  151 (292)
Q Consensus        76 ~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~--~~~~~DvwslG~il~el~  151 (292)
                      .++|+|+++.||+++.++  ++++||+.+......-......+  ...|.+|+.......  .....++.+....+++..
T Consensus       233 ~liHGDl~~~Nil~~~~~--~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y  310 (420)
T 2pyw_A          233 ALIHGDLHTGSVMVTQDS--TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLF  310 (420)
T ss_dssp             EEECSCCSGGGEEECSSC--EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHH
T ss_pred             eEEecCCCCCcEEEeCCC--CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHH
Confidence            899999999999998765  99999998865311100001111  234566654421110  112234446666666666


Q ss_pred             hC
Q 022799          152 LG  153 (292)
Q Consensus       152 ~g  153 (292)
                      ++
T Consensus       311 ~~  312 (420)
T 2pyw_A          311 NK  312 (420)
T ss_dssp             HH
T ss_pred             HH
Confidence            53

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=92.79  E-value=0.036  Score=46.49  Aligned_cols=29  Identities=31%  Similarity=0.291  Sum_probs=24.6

Q ss_pred             CccccCCCCCcEEEeCCCCcEEEeecCCcc
Q 022799           76 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  105 (292)
Q Consensus        76 ~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~  105 (292)
                      +++|+|+++.||+++.++ .+.|+||+.+.
T Consensus       188 ~liHgDl~~~Nil~~~~~-~~~lIDf~~a~  216 (322)
T 2ppq_A          188 GVIHADLFQDNVFFLGDE-LSGLIDFYFAC  216 (322)
T ss_dssp             EEECSCCCGGGEEEETTE-EEEECCCTTCE
T ss_pred             ccCCCCCCccCEEEeCCc-eEEEecchhcc
Confidence            799999999999998754 45799998774

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=91.48  E-value=0.18  Score=42.32  Aligned_cols=28  Identities=21%  Similarity=0.202  Sum_probs=24.0

Q ss_pred             CccccCCCCCcEEEeCCCCcEEEeecCCccc
Q 022799           76 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  106 (292)
Q Consensus        76 ~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~  106 (292)
                      .++|+|+++.||+++ +  .+.++||+.+..
T Consensus       196 ~l~HgD~~~~Nil~~-~--~~~lIDfe~a~~  223 (328)
T 1zyl_A          196 LRLHGDCHAGNILWR-D--GPMFVDLDDARN  223 (328)
T ss_dssp             EECCSSCSGGGEEES-S--SEEECCCTTCCE
T ss_pred             eeeeCCCCcccEeEc-C--CCEEEECCCCCc
Confidence            689999999999998 3  589999987643

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=91.32  E-value=0.072  Score=44.97  Aligned_cols=31  Identities=39%  Similarity=0.543  Sum_probs=26.0

Q ss_pred             CccccCCCCCcEEEeCC---CCcEEEeecCCccc
Q 022799           76 GVCHRDIKPQNLLVNPH---THQLKLCDFGSAKV  106 (292)
Q Consensus        76 ~i~H~dlkp~Nill~~~---~~~ikl~Dfg~a~~  106 (292)
                      .++|+|+.+.||+++.+   ...+.|+||+.+..
T Consensus       184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            79999999999999864   12689999998764

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=90.38  E-value=0.2  Score=44.55  Aligned_cols=15  Identities=27%  Similarity=0.612  Sum_probs=14.1

Q ss_pred             CccccCCCCCcEEEe
Q 022799           76 GVCHRDIKPQNLLVN   90 (292)
Q Consensus        76 ~i~H~dlkp~Nill~   90 (292)
                      .++|+|+.+.||+++
T Consensus       291 v~cHnDl~~gNIL~~  305 (458)
T 2qg7_A          291 VLCHCDLLSSNIINT  305 (458)
T ss_dssp             EEECSCCCGGGEEEC
T ss_pred             eEEecCCCCCcEEee
Confidence            689999999999998

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=90.09  E-value=0.11  Score=44.45  Aligned_cols=29  Identities=28%  Similarity=0.568  Sum_probs=24.2

Q ss_pred             CccccCCCCCcEEEeCCCCcEEEeecCCccc
Q 022799           76 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  106 (292)
Q Consensus        76 ~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~  106 (292)
                      +++|+|+.+.||+++.++  +.++||..+..
T Consensus       213 ~l~HgDl~~~Nil~~~~~--~~lID~e~a~~  241 (369)
T 3c5i_A          213 VFCHNDLQENNIINTNKC--LRLIDFEYSGF  241 (369)
T ss_dssp             EEECSCCCGGGEEECC-C--EEECCCTTCEE
T ss_pred             EEEeCCCCcccEEecCCc--EEEEEecCCCC
Confidence            689999999999997543  89999987753

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=90.05  E-value=0.11  Score=44.13  Aligned_cols=30  Identities=27%  Similarity=0.546  Sum_probs=26.0

Q ss_pred             CccccCCCCCcEEEeCCCCcEEEeecCCccc
Q 022799           76 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  106 (292)
Q Consensus        76 ~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~  106 (292)
                      +++|+|+.+.||+++.++ .+.|+||+.+..
T Consensus       207 ~~~HgD~~~~N~l~~~~~-~~~~iD~e~~~~  236 (339)
T 3i1a_A          207 VLCHSDIHAGNVLVGNEE-SIYIIDWDEPML  236 (339)
T ss_dssp             EEECSCCCGGGEEECGGG-CEEECCCSSCEE
T ss_pred             eeEeCCCCcCCEEEeCCC-eEEEEECCCCee
Confidence            799999999999998766 699999987754

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=89.82  E-value=0.25  Score=40.94  Aligned_cols=29  Identities=21%  Similarity=0.355  Sum_probs=23.9

Q ss_pred             CccccCCCCCcEEEeCCCCcEEEeecCCccc
Q 022799           76 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  106 (292)
Q Consensus        76 ~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~  106 (292)
                      .++|+|+.+.||+. .++ .+.++||..+..
T Consensus       174 ~l~HgDl~~~Nil~-~~~-~~~lID~e~a~~  202 (301)
T 3dxq_A          174 AACHCDPLCENFLD-TGE-RMWIVDWEYSGM  202 (301)
T ss_dssp             EEECSCCCGGGEEE-CSS-CEEECCCTTCEE
T ss_pred             eeeccCCCcCCEEE-CCC-CEEEEecccccC
Confidence            58999999999994 445 589999988754

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=89.44  E-value=0.16  Score=43.98  Aligned_cols=30  Identities=20%  Similarity=0.214  Sum_probs=25.4

Q ss_pred             CCccccCCCCCcEEEeCCCCcEEEeecCCccc
Q 022799           75 IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  106 (292)
Q Consensus        75 ~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~  106 (292)
                      ..++|+|+.+.||+++.++  ++++||..+..
T Consensus       227 ~~L~HGDl~~~Nil~~~~~--~~lID~e~a~~  256 (397)
T 2olc_A          227 ETLIHGDLHTGSIFASEHE--TKVIDPEFAFY  256 (397)
T ss_dssp             CEEECSCCSGGGEEECSSC--EEECCCTTCEE
T ss_pred             CceeeCCCCcCcEEEeCCC--eEEEeCccccc
Confidence            3799999999999998654  89999987753

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=88.63  E-value=0.16  Score=44.62  Aligned_cols=17  Identities=29%  Similarity=0.675  Sum_probs=14.9

Q ss_pred             CccccCCCCCcEEEeCC
Q 022799           76 GVCHRDIKPQNLLVNPH   92 (292)
Q Consensus        76 ~i~H~dlkp~Nill~~~   92 (292)
                      .++|+|+.+.||+++.+
T Consensus       250 v~~H~Dl~~gNiL~~~~  266 (429)
T 1nw1_A          250 TFCHNDLQEGNILLPKA  266 (429)
T ss_dssp             EEECSCCCGGGEEEEC-
T ss_pred             EEEeCCCCCCeEEeeCC
Confidence            58999999999999875

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=87.38  E-value=0.32  Score=41.98  Aligned_cols=31  Identities=32%  Similarity=0.543  Sum_probs=25.7

Q ss_pred             CccccCCCCCcEEEeCC---CCcEEEeecCCccc
Q 022799           76 GVCHRDIKPQNLLVNPH---THQLKLCDFGSAKV  106 (292)
Q Consensus        76 ~i~H~dlkp~Nill~~~---~~~ikl~Dfg~a~~  106 (292)
                      .++|+|+.+.||+++.+   ...+.++||..+..
T Consensus       221 ~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          221 VFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             EEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             EEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            68999999999999876   12699999988753

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=81.87  E-value=0.69  Score=40.15  Aligned_cols=31  Identities=29%  Similarity=0.484  Sum_probs=24.3

Q ss_pred             CccccCCCCCcEEEeC-----CCCcEEEeecCCccc
Q 022799           76 GVCHRDIKPQNLLVNP-----HTHQLKLCDFGSAKV  106 (292)
Q Consensus        76 ~i~H~dlkp~Nill~~-----~~~~ikl~Dfg~a~~  106 (292)
                      .++|+|+.+.||++..     +...+.++||..|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            3679999999999932     233699999988754

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	292
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-100
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-58
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	8e-56
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-55
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-52
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	6e-51
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	8e-51
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-50
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-50
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-50
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	5e-50
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	7e-49
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	8e-49
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	8e-48
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-47
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	3e-47
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	5e-47
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	5e-47
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	9e-47
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-46
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	5e-46
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	4e-45
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	5e-45
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-44
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	8e-44
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	4e-42
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	4e-42
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	8e-42
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-39
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	4e-39
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-38
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-37
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-37
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	3e-37
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-36
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-35
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-31
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-31
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	3e-31
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-29
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-29
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	5e-29
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	6e-29
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	9e-29
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-28
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-28
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	5e-28
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	7e-28
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-27
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-27
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-27
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-26
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-25
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-25
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	4e-25
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-24
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	5e-24
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	5e-24
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-23
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	7e-23
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	4e-22
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	6e-20
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	4e-12

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  294 bits (754), Expect = e-100
 Identities = 201/285 (70%), Positives = 237/285 (83%), Gaps = 3/285 (1%)

Query: 1   MRLLDHPNVVSLKHCFFSTTE-KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL 59
           MR LDH N+V L++ F+S+ E KDE+YLNLVL+YVPETV+RV +H+ +  Q +P+IYVKL
Sbjct: 67  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 126

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           Y YQ+ R+LAYIH+  G+CHRDIKPQNLL++P T  LKLCDFGSAK LV+GEPN+SYICS
Sbjct: 127 YMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS 185

Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
           RYYRAPELIFGAT+YT++ID+WSAGCVLAELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 245

Query: 180 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
           +I+ MNPNYTEFKFPQIKAHPW K+F+ R PPEA+ L SRLL+Y+P  R T LEA  H F
Sbjct: 246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 305

Query: 240 FDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHAR 284
           FDELRDPN +LPNGR  P LFNF   EL   P  +   LIP HAR
Sbjct: 306 FDELRDPNVKLPNGRDTPALFNFTTQELSSNP-PLATILIPPHAR 349

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 1e-58
 Identities = 92/292 (31%), Positives = 156/292 (53%), Gaps = 20/292 (6%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           +    H N++ +     + T +    + LV   +   +++++K      Q +   ++  +
Sbjct: 60  LLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-----QHLSNDHICYF 114

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI----SY 116
            YQI R L YIH+   V HRD+KP NLL+N  T  LK+CDFG A+V      +      Y
Sbjct: 115 LYQILRGLKYIHS-ANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEY 172

Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
           + +R+YRAPE++  +  YT +IDIWS GC+LAE+L  +P+FPG+  +DQL  I+ +LG+P
Sbjct: 173 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 232

Query: 177 TREEIKCM---NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
           ++E++ C+            P     PW+++F      +A+DL+ ++L ++P+ R    +
Sbjct: 233 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQ 291

Query: 234 ALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHARK 285
           AL HP+ ++  DP+            F F   EL  +P + L +LI E   +
Sbjct: 292 ALAHPYLEQYYDPSDE----PIAEAPFKF-DMELDDLPKEKLKELIFEETAR 338

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (459), Expect = 8e-56
 Identities = 59/255 (23%), Positives = 102/255 (40%), Gaps = 26/255 (10%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           +   + P +V     F       E+ +   +E++       +    K + R+P   +   
Sbjct: 58  LHECNSPYIVGFYGAF---YSDGEISI--CMEHMD---GGSLDQVLKKAGRIPEQILGKV 109

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
              + + L Y+     + HRD+KP N+LVN     +KLCDFG +  L+    N S++ +R
Sbjct: 110 SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE-IKLCDFGVSGQLIDSMAN-SFVGTR 167

Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG-VDQLVEIIKVLGTPTRE 179
            Y +PE + G T Y+   DIWS G  L E+ +G+   P       +L+   +V G     
Sbjct: 168 SYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAET 226

Query: 180 EIKCMNPNYTEFKF--------------PQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSP 225
             +   P      +                I   P  K+       E  D V++ L  +P
Sbjct: 227 PPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNP 286

Query: 226 NLRSTALEALIHPFF 240
             R+   + ++H F 
Sbjct: 287 AERADLKQLMVHAFI 301

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 3e-55
 Identities = 82/247 (33%), Positives = 123/247 (49%), Gaps = 12/247 (4%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ L HPN++ L   F       +  ++LV +++   +          S  +   ++K Y
Sbjct: 54  LQELSHPNIIGLLDAF-----GHKSNISLVFDFMETDLEV---IIKDNSLVLTPSHIKAY 105

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-S 119
                + L Y+H    + HRD+KP NLL++ +   LKL DFG AK         ++   +
Sbjct: 106 MLMTLQGLEYLHQHW-ILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTHQVVT 163

Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
           R+YRAPEL+FGA  Y   +D+W+ GC+LAELLL  P  PG+S +DQL  I + LGTPT E
Sbjct: 164 RWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEE 223

Query: 180 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
           +   M        F      P H IF      + +DL+  L  ++P  R TA +AL   +
Sbjct: 224 QWPDMCSLPDYVTFKSFPGIPLHHIF-SAAGDDLLDLIQGLFLFNPCARITATQALKMKY 282

Query: 240 FDELRDP 246
           F     P
Sbjct: 283 FSNRPGP 289

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 2e-52
 Identities = 79/244 (32%), Positives = 124/244 (50%), Gaps = 7/244 (2%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           +   +HPNVV L      +    E  L LV E+V + +   +    +    +P   +K  
Sbjct: 64  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE--PGVPTETIKDM 121

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
            +Q+ R L ++H+   V HRD+KPQN+LV   + Q+KL DFG A++        S + + 
Sbjct: 122 MFQLLRGLDFLHSH-RVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALTSVVVTL 179

Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 180
           +YRAPE++   + Y   +D+WS GC+ AE+   +PLF G S VDQL +I+ V+G P  E+
Sbjct: 180 WYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238

Query: 181 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
               +       F    A P  K     +     DL+ + L ++P  R +A  AL HP+F
Sbjct: 239 WP-RDVALPRQAFHSKSAQPIEKFV-TDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 296

Query: 241 DELR 244
            +L 
Sbjct: 297 QDLE 300

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (424), Expect = 6e-51
 Identities = 87/256 (33%), Positives = 136/256 (53%), Gaps = 15/256 (5%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ L+HPN+V L           E  L LV E++ + + + +         +PLI  K Y
Sbjct: 55  LKELNHPNIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLI--KSY 107

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNISYICS 119
            +Q+ + LA+ H+   V HRD+KPQNLL+N     +KL DFG A+   V        + +
Sbjct: 108 LFQLLQGLAFCHSHR-VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVT 165

Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
            +YRAPE++ G   Y+ A+DIWS GC+ AE++  + LFPG+S +DQL  I + LGTP   
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 225

Query: 180 EIK-CMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 238
                 +    +  FP+     + K+    +  +   L+S++L Y PN R +A  AL HP
Sbjct: 226 VWPGVTSMPDYKPSFPKWARQDFSKVV-PPLDEDGRSLLSQMLHYDPNKRISAKAALAHP 284

Query: 239 FFDELRDPNTRLPNGR 254
           FF ++  P   +P+ R
Sbjct: 285 FFQDVTKP---VPHLR 297

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (427), Expect = 8e-51
 Identities = 83/251 (33%), Positives = 132/251 (52%), Gaps = 14/251 (5%)

Query: 1   MRLLDHPNVVSLKHCFFS-TTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL 59
           ++ + H NV+ L   F    T  D     LV+ ++   + +++KH     +++    ++ 
Sbjct: 71  LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-----EKLGEDRIQF 125

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
             YQ+ + L YIH   G+ HRD+KP NL VN      K+ DFG A+          Y+ +
Sbjct: 126 LVYQMLKGLRYIHAA-GIIHRDLKPGNLAVNEDCEL-KILDFGLARQA--DSEMTGYVVT 181

Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
           R+YRAPE+I     YT  +DIWS GC++AE++ G+ LF G   +DQL EI+KV GTP  E
Sbjct: 182 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 241

Query: 180 EIKCMNPNYTEF---KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 236
            ++ +  +  +      P+++   +  I      P AV+L+ ++L      R TA EAL 
Sbjct: 242 FVQRLQSDEAKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALA 300

Query: 237 HPFFDELRDPN 247
           HP+F+ L D  
Sbjct: 301 HPYFESLHDTE 311

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (423), Expect = 1e-50
 Identities = 68/258 (26%), Positives = 115/258 (44%), Gaps = 16/258 (6%)

Query: 1   MRLLDHPNVVSLKHCFFSTTE---KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYV 57
           ++LL H NVV+L     +      + +  + LV ++     H +      +  +  L  +
Sbjct: 63  LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE---HDLAGLLSNVLVKFTLSEI 119

Query: 58  KLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI--- 114
           K     +   L YIH    + HRD+K  N+L+      LKL DFG A+     + +    
Sbjct: 120 KRVMQMLLNGLYYIHR-NKILHRDMKAANVLITRDGV-LKLADFGLARAFSLAKNSQPNR 177

Query: 115 --SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKV 172
             + + + +YR PEL+ G  +Y   ID+W AGC++AE+    P+  G +   QL  I ++
Sbjct: 178 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237

Query: 173 LGTPTREEIKCMNPNYTEFKFPQIKAHP---WHKIFQKRMPPEAVDLVSRLLQYSPNLRS 229
            G+ T E    ++      K   +K        ++      P A+DL+ +LL   P  R 
Sbjct: 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 297

Query: 230 TALEALIHPFFDELRDPN 247
            + +AL H FF     P+
Sbjct: 298 DSDDALNHDFFWSDPMPS 315

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  167 bits (424), Expect = 1e-50
 Identities = 76/253 (30%), Positives = 125/253 (49%), Gaps = 19/253 (7%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
             L   PN+++L        +       LV E+V  T  +      ++ Q +    ++ Y
Sbjct: 84  ENLRGGPNIITLADIV---KDPVSRTPALVFEHVNNTDFK------QLYQTLTDYDIRFY 134

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
            Y+I +AL Y H+ +G+ HRD+KP N++++    +L+L D+G A+    G+     + SR
Sbjct: 135 MYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASR 193

Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTRE 179
           Y++ PEL+     Y  ++D+WS GC+LA ++  + P F G    DQLV I KVLGT    
Sbjct: 194 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY 253

Query: 180 EIKCMNPNYTEFKFPQI----KAHPWHKIF----QKRMPPEAVDLVSRLLQYSPNLRSTA 231
           +         + +F  I        W +      Q  + PEA+D + +LL+Y    R TA
Sbjct: 254 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA 313

Query: 232 LEALIHPFFDELR 244
            EA+ HP+F  + 
Sbjct: 314 REAMEHPYFYTVV 326

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (423), Expect = 3e-50
 Identities = 82/284 (28%), Positives = 138/284 (48%), Gaps = 18/284 (6%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ + H NV+ L   F      +E     ++ ++         ++    Q++   +V+  
Sbjct: 71  LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL----NNIVKCQKLTDDHVQFL 126

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
            YQI R L YIH+   + HRD+KP NL VN      K+ DFG A+     +    Y+ +R
Sbjct: 127 IYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCEL-KILDFGLARHT--DDEMTGYVATR 182

Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 180
           +YRAPE++     Y   +DIWS GC++AELL G+ LFPG   +DQL  I++++GTP  E 
Sbjct: 183 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 242

Query: 181 IKCMNPNYTEF---KFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 237
           +K ++            Q+    +  +F     P AVDL+ ++L    + R TA +AL H
Sbjct: 243 LKKISSESARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAH 301

Query: 238 PFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPE 281
            +F +  DP+        +   ++    E + + +D    L  +
Sbjct: 302 AYFAQYHDPDDEP-----VADPYDQ-SFESRDLLIDEWKSLTYD 339

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  166 bits (422), Expect = 5e-50
 Identities = 56/260 (21%), Positives = 101/260 (38%), Gaps = 37/260 (14%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M +L HP +V+L   F     +D+  + ++ E++      + +       +M       Y
Sbjct: 77  MSVLRHPTLVNLHDAF-----EDDNEMVMIYEFMSG--GELFEKVADEHNKMSEDEAVEY 129

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNISYICS 119
             Q+C+ L ++H      H D+KP+N++     +++LKL DFG    L   +       +
Sbjct: 130 MRQVCKGLCHMHE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGT 188

Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
             + APE+  G        D+WS G +   LL G   F GE+  + L  +          
Sbjct: 189 AEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDS 247

Query: 180 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
                                        +  +  D + +LL   PN R T  +AL HP+
Sbjct: 248 AF-------------------------SGISEDGKDFIRKLLLADPNTRMTIHQALEHPW 282

Query: 240 FDELRDP--NTRLPNGRFLP 257
                 P  ++++P+ R+  
Sbjct: 283 LTPGNAPGRDSQIPSSRYTK 302

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (410), Expect = 7e-49
 Identities = 80/248 (32%), Positives = 125/248 (50%), Gaps = 12/248 (4%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ L H N+V L           +  L LV E+       + K+    +  +    VK +
Sbjct: 55  LKELKHKNIVRLHDVL-----HSDKKLTLVFEFCD---QDLKKYFDSCNGDLDPEIVKSF 106

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNISYICS 119
            +Q+ + L + H+   V HRD+KPQNLL+N +    KL +FG A+   +      + + +
Sbjct: 107 LFQLLKGLGFCHSR-NVLHRDLKPQNLLINRNGEL-KLANFGLARAFGIPVRCYSAEVVT 164

Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG-QPLFPGESGVDQLVEIIKVLGTPTR 178
            +YR P+++FGA  Y+ +ID+WSAGC+ AEL    +PLFPG    DQL  I ++LGTPT 
Sbjct: 165 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE 224

Query: 179 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 238
           E+   M        +P   A         ++     DL+  LL+ +P  R +A EAL HP
Sbjct: 225 EQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHP 284

Query: 239 FFDELRDP 246
           +F +   P
Sbjct: 285 YFSDFCPP 292

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  161 bits (409), Expect = 8e-49
 Identities = 80/244 (32%), Positives = 129/244 (52%), Gaps = 13/244 (5%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ L H N+V L           +  L LV E++ + + +++         +  +  K +
Sbjct: 54  LKELKHSNIVKLYDVIH-----TKKRLVLVFEHLDQDLKKLLDVCEG---GLESVTAKSF 105

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL-VKGEPNISYICS 119
             Q+   +AY H+   V HRD+KPQNLL+N    +LK+ DFG A+   +        I +
Sbjct: 106 LLQLLNGIAYCHDR-RVLHRDLKPQNLLIN-REGELKIADFGLARAFGIPVRKYTHEIVT 163

Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
            +YRAP+++ G+ +Y+  IDIWS GC+ AE++ G PLFPG S  DQL+ I ++LGTP  +
Sbjct: 164 LWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSK 223

Query: 180 EIKCMNPN-YTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 238
               +      +  F   +  PW     K +    +DL+S++L+  PN R TA +AL H 
Sbjct: 224 NWPNVTELPKYDPNFTVYEPLPWESFL-KGLDESGIDLLSKMLKLDPNQRITAKQALEHA 282

Query: 239 FFDE 242
           +F E
Sbjct: 283 YFKE 286

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  160 bits (407), Expect = 8e-48
 Identities = 67/285 (23%), Positives = 109/285 (38%), Gaps = 40/285 (14%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVK 58
           M  L HP +++L   F     +D+  + L+LE++   E   R+    YKMS+      V 
Sbjct: 80  MNQLHHPKLINLHDAF-----EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAE----VI 130

Query: 59  LYFYQICRALAYIHNTIGVCHRDIKPQNLLV-NPHTHQLKLCDFGSAKVLVKGEPNISYI 117
            Y  Q C  L ++H    + H DIKP+N++        +K+ DFG A  L   E      
Sbjct: 131 NYMRQACEGLKHMHE-HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT 189

Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +  + APE++          D+W+ G +   LL G   F GE  ++ L  + +      
Sbjct: 190 ATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD 248

Query: 178 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 237
            +                             + PEA D +  LLQ  P  R T  +AL H
Sbjct: 249 EDAF-------------------------SSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283

Query: 238 PFF-DELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPE 281
           P+   +  +  +R+P+ R+       K            +  I  
Sbjct: 284 PWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQPAIGRIAN 328

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 1e-47
 Identities = 62/262 (23%), Positives = 102/262 (38%), Gaps = 30/262 (11%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKL 59
            R    P++V +   + +     +  L +V+E +    +   I+   +  Q         
Sbjct: 59  WRASQCPHIVRIVDVYENLYAGRK-CLLIVMECLDGGELFSRIQD--RGDQAFTEREASE 115

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQ--LKLCDFGSAKVLVKGEPNISYI 117
               I  A+ Y+H+ I + HRD+KP+NLL         LKL DFG AK         +  
Sbjct: 116 IMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC 174

Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            + YY APE++    +Y  + D+WS G ++  LL G P F    G+     +   +    
Sbjct: 175 YTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG- 232

Query: 178 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 237
                       +++FP  +           +  E   L+  LL+  P  R T  E + H
Sbjct: 233 ------------QYEFPNPE--------WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272

Query: 238 PFF-DELRDPNTRLPNGRFLPP 258
           P+     + P T L   R L  
Sbjct: 273 PWIMQSTKVPQTPLHTSRVLKE 294

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 3e-47
 Identities = 47/241 (19%), Positives = 99/241 (41%), Gaps = 34/241 (14%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ L HPN+V   +  + +T K +  + LV E +       +K + K  + M +  ++ +
Sbjct: 62  LKGLQHPNIVRF-YDSWESTVKGKKCIVLVTELMT---SGTLKTYLKRFKVMKIKVLRSW 117

Query: 61  FYQICRALAYIH-NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
             QI + L ++H  T  + HRD+K  N+ +   T  +K+ D G A  L +     + I +
Sbjct: 118 CRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT-LKRASFAKAVIGT 176

Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
             + APE+     +Y  ++D+++ G  + E+   +  +       Q+             
Sbjct: 177 PEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR---------- 224

Query: 180 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
                           + +      F K   PE  +++   ++ + + R +  + L H F
Sbjct: 225 ----------------VTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 268

Query: 240 F 240
           F
Sbjct: 269 F 269

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 5e-47
 Identities = 54/245 (22%), Positives = 95/245 (38%), Gaps = 40/245 (16%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           +   DHPN+V L   F       E  L +++E+             ++ + +    +++ 
Sbjct: 63  LASCDHPNIVKLLDAF-----YYENNLWILIEFCAGGAVD--AVMLELERPLTESQIQVV 115

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNISYICS 119
             Q   AL Y+H+   + HRD+K  N+L       +KL DFG +    +  +   S+I +
Sbjct: 116 CKQTLDALNYLHDN-KIIHRDLKAGNILFTLDGD-IKLADFGVSAKNTRTIQRRDSFIGT 173

Query: 120 RYYRAPELIFGAT----EYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 175
            Y+ APE++   T     Y    D+WS G  L E+   +P     + +  L++I      
Sbjct: 174 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI------ 227

Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 235
                                K+ P       R      D + + L+ + + R T  + L
Sbjct: 228 --------------------AKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLL 267

Query: 236 IHPFF 240
            HPF 
Sbjct: 268 QHPFV 272

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 5e-47
 Identities = 65/240 (27%), Positives = 99/240 (41%), Gaps = 41/240 (17%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
              L HPN++ L   F      D   + L+LEY P      +    +   +        Y
Sbjct: 60  QSHLRHPNILRLYGYF-----HDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATY 111

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
             ++  AL+Y H+   V HRDIKP+NLL+      LK+ DFG +          +   + 
Sbjct: 112 ITELANALSYCHS-KRVIHRDIKPENLLLGSAGE-LKIADFGWSV-HAPSSRRTTLCGTL 168

Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 180
            Y  PE+I G   +   +D+WS G +  E L+G+P F   +  +    I +V        
Sbjct: 169 DYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-------- 219

Query: 181 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFF 240
                    EF FP              +   A DL+SRLL+++P+ R    E L HP+ 
Sbjct: 220 ---------EFTFP------------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 258

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (394), Expect = 9e-47
 Identities = 59/245 (24%), Positives = 95/245 (38%), Gaps = 39/245 (15%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
            ++L+H NVV                  L LEY             +    MP    + +
Sbjct: 57  NKMLNHENVVKFYGHRREGN-----IQYLFLEYCSGGELF---DRIEPDIGMPEPDAQRF 108

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI---SYI 117
           F+Q+   + Y+H  IG+ HRDIKP+NLL++   + LK+ DFG A V              
Sbjct: 109 FHQLMAGVVYLHG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMC 166

Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +  Y APEL+     +   +D+WS G VL  +L G+  +   S   Q     K   T  
Sbjct: 167 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL 226

Query: 178 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 237
                                +PW KI         + L+ ++L  +P+ R T  +    
Sbjct: 227 ---------------------NPWKKI-----DSAPLALLHKILVENPSARITIPDIKKD 260

Query: 238 PFFDE 242
            ++++
Sbjct: 261 RWYNK 265

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 1e-46
 Identities = 63/245 (25%), Positives = 96/245 (39%), Gaps = 39/245 (15%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKL 59
           +R L HPN+V         T      L +V+EY     +  VI    K  Q +   +V  
Sbjct: 57  LRELKHPNIVRYYDRIIDRTNT---TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLR 113

Query: 60  YFYQICRALAYIH----NTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI- 114
              Q+  AL   H        V HRD+KP N+ ++   + +KL DFG A++L        
Sbjct: 114 VMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN-VKLGDFGLARILNHDTSFAK 172

Query: 115 SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 174
           +++ + YY +PE +     Y    DIWS GC+L EL    P F   S  +   +I     
Sbjct: 173 AFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR---- 227

Query: 175 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 234
                          E KF +I               E  ++++R+L      R +  E 
Sbjct: 228 ---------------EGKFRRIPYR---------YSDELNEIITRMLNLKDYHRPSVEEI 263

Query: 235 LIHPF 239
           L +P 
Sbjct: 264 LENPL 268

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  155 bits (392), Expect = 5e-46
 Identities = 58/253 (22%), Positives = 99/253 (39%), Gaps = 42/253 (16%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ L HPN +  + C+       E    LV+EY   +   +++ H K    +  + +   
Sbjct: 69  LQKLRHPNTIQYRGCYL-----REHTAWLVMEYCLGSASDLLEVHKK---PLQEVEIAAV 120

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
            +   + LAY+H+   + HRD+K  N+L++     +KL DFGSA ++    P  S++ + 
Sbjct: 121 THGALQGLAYLHS-HNMIHRDVKAGNILLS-EPGLVKLGDFGSASIM---APANSFVGTP 175

Query: 121 YYRAPELIFGATE--YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 178
           Y+ APE+I    E  Y   +D+WS G    EL   +P     + +  L  I +       
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ------- 228

Query: 179 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 238
                               +    +          + V   LQ  P  R T+   L H 
Sbjct: 229 --------------------NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268

Query: 239 FFDELRDPNTRLP 251
           F    R P   + 
Sbjct: 269 FVLRERPPTVIMD 281

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 4e-45
 Identities = 57/244 (23%), Positives = 99/244 (40%), Gaps = 37/244 (15%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKL 59
           + +  H N++ L   F     +    L ++ E++    +   I      +  +    +  
Sbjct: 55  LNIARHRNILHLHESF-----ESMEELVMIFEFISGLDIFERINTS---AFELNEREIVS 106

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLV-NPHTHQLKLCDFGSAKVLVKGEPNISYIC 118
           Y +Q+C AL ++H+   + H DI+P+N++     +  +K+ +FG A+ L  G+       
Sbjct: 107 YVHQVCEALQFLHS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT 165

Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 178
           +  Y APE+       + A D+WS G ++  LL G   F  E+    +  I+    T   
Sbjct: 166 APEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDE 224

Query: 179 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 238
           E                           K +  EA+D V RLL      R TA EAL HP
Sbjct: 225 EAF-------------------------KEISIEAMDFVDRLLVKERKSRMTASEALQHP 259

Query: 239 FFDE 242
           +  +
Sbjct: 260 WLKQ 263

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  151 bits (383), Expect = 5e-45
 Identities = 63/248 (25%), Positives = 102/248 (41%), Gaps = 42/248 (16%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKL 59
            ++  HPN++ LK  +     +   +  LV + +    +   +     +S++      + 
Sbjct: 64  RKVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKE----TRK 114

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
               +   +  +H    + HRD+KP+N+L++   + +KL DFG +  L  GE       +
Sbjct: 115 IMRALLEVICALHKL-NIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLREVCGT 172

Query: 120 RYYRAPELIFGATE-----YTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 174
             Y APE+I  +       Y   +D+WS G ++  LL G P F     +  L  I     
Sbjct: 173 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI----- 227

Query: 175 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 234
                    M+ NY +F  P+                   DLVSR L   P  R TA EA
Sbjct: 228 ---------MSGNY-QFGSPEW----------DDYSDTVKDLVSRFLVVQPQKRYTAEEA 267

Query: 235 LIHPFFDE 242
           L HPFF +
Sbjct: 268 LAHPFFQQ 275

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (386), Expect = 1e-44
 Identities = 79/282 (28%), Positives = 138/282 (48%), Gaps = 26/282 (9%)

Query: 1   MRLLDHPNVVSLKHCFFS-TTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKL 59
           M+ ++H N++SL + F    T ++   + LV+E +   + +VI+      +      +  
Sbjct: 70  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER------MSY 123

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
             YQ+   + ++H+  G+ HRD+KP N++V       K+ DFG A+          Y+ +
Sbjct: 124 LLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTL-KILDFGLARTAGTSFMMTPYVVT 181

Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
           RYYRAPE+I G   Y   +DIWS GC++ E++  + LFPG   +DQ  ++I+ LGTP  E
Sbjct: 182 RYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 240

Query: 180 EIKCMNPNYTEF--KFPQIKAHPWHKIF-----------QKRMPPEAVDLVSRLLQYSPN 226
            +K + P    +    P+     + K+F            K    +A DL+S++L   P 
Sbjct: 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 300

Query: 227 LRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELK 268
            R +  +AL HP+ +   DP          P +++ +  E +
Sbjct: 301 KRISVDDALQHPYINVWYDPAEVEAP---PPQIYDKQLDERE 339

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (376), Expect = 8e-44
 Identities = 60/252 (23%), Positives = 102/252 (40%), Gaps = 39/252 (15%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           MR   +PN+V+    +      DEL++  V+EY+                 M    +   
Sbjct: 71  MRENKNPNIVNYLDSY---LVGDELWV--VMEYLAGGSL----TDVVTETCMDEGQIAAV 121

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-S 119
             +  +AL ++H+   V HRDIK  N+L+      +KL DFG    +   +   S +  +
Sbjct: 122 CRECLQALEFLHSN-QVIHRDIKSDNILLGMDGS-VKLTDFGFCAQITPEQSKRSTMVGT 179

Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
            Y+ APE++     Y   +DIWS G +  E++ G+P +  E+ +  L  I    GTP   
Sbjct: 180 PYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTP--- 234

Query: 180 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF 239
                     E + P            +++     D ++R L      R +A E L H F
Sbjct: 235 ----------ELQNP------------EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQF 272

Query: 240 FDELRDPNTRLP 251
               +  ++  P
Sbjct: 273 LKIAKPLSSLTP 284

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  146 bits (369), Expect = 4e-42
 Identities = 75/289 (25%), Positives = 127/289 (43%), Gaps = 33/289 (11%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
              +   +++ L    F+    + +++ +V E + E +  +IK +    + +PLIYVK  
Sbjct: 74  EDSMGANHILKL-LDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEH--RGIPLIYVKQI 130

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV---LVKGEPNISYI 117
             Q+   L Y+H   G+ H DIKP+N+L+        L     A +       E   + I
Sbjct: 131 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 190

Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG------VDQLVEIIK 171
            +R YR+PE++ GA  +    DIWS  C++ EL+ G  LF  + G       D + +II+
Sbjct: 191 QTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249

Query: 172 VLGTPTREEIKCMNPNYTEF-------KFPQIKAHPWHKI------FQKRMPPEAVDLVS 218
           +LG      ++      T F          ++K  P   +      F K    E  D +S
Sbjct: 250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 309

Query: 219 RLLQYSPNLRSTALEALIHPFF------DELRDPNTRL-PNGRFLPPLF 260
            +LQ  P  R+ A   + HP+       +E+R P+  L  +G  +P  F
Sbjct: 310 PMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWF 358

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  145 bits (366), Expect = 4e-42
 Identities = 56/254 (22%), Positives = 99/254 (38%), Gaps = 39/254 (15%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKL 59
           +  + HPN+V+L   +        LYL  +++ V    +   I      ++R        
Sbjct: 61  LHKIKHPNIVALDDIY---ESGGHLYL--IMQLVSGGELFDRIVEKGFYTERD----ASR 111

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTH--QLKLCDFGSAKVLVKGEPNISYI 117
             +Q+  A+ Y+H+   + HRD+KP+NLL        ++ + DFG +K+   G    +  
Sbjct: 112 LIFQVLDAVKYLHDLG-IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC 170

Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +  Y APE++     Y+ A+D WS G +   LL G P F  E+      +I+K      
Sbjct: 171 GTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFD 229

Query: 178 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 237
                                      +   +   A D +  L++  P  R T  +AL H
Sbjct: 230 SP-------------------------YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264

Query: 238 PFFDELRDPNTRLP 251
           P+       +  + 
Sbjct: 265 PWIAGDTALDKNIH 278

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 8e-42
 Identities = 66/252 (26%), Positives = 107/252 (42%), Gaps = 49/252 (19%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M  LDHP  V L   F    + ++LY    L Y     +  +  + +          + Y
Sbjct: 62  MSRLDHPFFVKLYFTF---QDDEKLYF--GLSYAK---NGELLKYIRKIGSFDETCTRFY 113

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI---SYI 117
             +I  AL Y+H    + HRD+KP+N+L+N   H +++ DFG+AKVL          S++
Sbjct: 114 TAEIVSALEYLHGKG-IIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFV 171

Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +  Y +PEL+        + D+W+ GC++ +L+ G P F   +      +IIK+     
Sbjct: 172 GTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL----- 225

Query: 178 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI- 236
                       E+ FP+            +  P+A DLV +LL      R    E    
Sbjct: 226 ------------EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEGY 261

Query: 237 -----HPFFDEL 243
                HPFF+ +
Sbjct: 262 GPLKAHPFFESV 273

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 2e-39
 Identities = 68/303 (22%), Positives = 113/303 (37%), Gaps = 54/303 (17%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
               +HP +  +   F     + +  L  V+EY+       + +H +   +  L     Y
Sbjct: 57  SLAWEHPFLTHMFCTF-----QTKENLFFVMEYLN---GGDLMYHIQSCHKFDLSRATFY 108

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-S 119
             +I   L ++H+  G+ +RD+K  N+L++   H  K+ DFG  K  + G+   +  C +
Sbjct: 109 AAEIILGLQFLHSK-GIVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKTNTFCGT 166

Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
             Y APE++ G  +Y  ++D WS G +L E+L+GQ  F G+   +               
Sbjct: 167 PDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF------------H 213

Query: 180 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-STALEALIHP 238
            I+  NP Y  +                 +  EA DL+ +L    P  R     +   HP
Sbjct: 214 SIRMDNPFYPRW-----------------LEKEAKDLLVKLFVREPEKRLGVRGDIRQHP 256

Query: 239 FFDELRDPNTRLPNGRFLPP----------LFNFKPHELKGVPVDMLVKLIPEHARKQCA 288
            F E+      L      PP            NF    L   P          ++  Q  
Sbjct: 257 LFREIN--WEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLSFADRALINSMDQNM 314

Query: 289 FLG 291
           F  
Sbjct: 315 FRN 317

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 4e-39
 Identities = 53/263 (20%), Positives = 100/263 (38%), Gaps = 40/263 (15%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ + HPNV++L   +     +++  + L+LE V       +       + +       +
Sbjct: 67  LKEIQHPNVITLHEVY-----ENKTDVILILELVA---GGELFDFLAEKESLTEEEATEF 118

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLV---NPHTHQLKLCDFGSAKVLVKGEPNISYI 117
             QI   + Y+H+   + H D+KP+N+++   N    ++K+ DFG A  +  G    +  
Sbjct: 119 LKQILNGVYYLHSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF 177

Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
            +  + APE++          D+WS G +   LL G   F G++  + L  +  V     
Sbjct: 178 GTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE 236

Query: 178 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 237
            E                         +       A D + RLL   P  R T  ++L H
Sbjct: 237 DE-------------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271

Query: 238 PFFDELRDPNTRLPNGRFLPPLF 260
           P+         +  +  +  P F
Sbjct: 272 PWIKPK--DTQQALSSAWSHPQF 292

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  137 bits (345), Expect = 1e-38
 Identities = 62/271 (22%), Positives = 101/271 (37%), Gaps = 49/271 (18%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKL 59
           +   D P +V + + F          L+ +L+ +    +H  +  H   S+      ++ 
Sbjct: 61  VSTGDCPFIVCMSYAF-----HTPDKLSFILDLMNGGDLHYHLSQHGVFSEAD----MRF 111

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           Y  +I   L ++HN   V +RD+KP N+L++ H H +++ D G A    K +P+ S   +
Sbjct: 112 YAAEIILGLEHMHN-RFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHASV-GT 168

Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 179
             Y APE++     Y ++ D +S GC+L +LL G   F      D+       L      
Sbjct: 169 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE- 227

Query: 180 EIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----ALEA 234
                                          PE   L+  LLQ   N R       A E 
Sbjct: 228 -------------------------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEV 262

Query: 235 LIHPFFDELRDPNTRLPNGRFLPPLFNFKPH 265
              PFF  L      +   ++ PP     P 
Sbjct: 263 KESPFFRSL--DWQMVFLQKYPPP---LIPP 288

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (334), Expect = 1e-37
 Identities = 42/243 (17%), Positives = 89/243 (36%), Gaps = 40/243 (16%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKL 59
           +R   H N++                L +V ++    +++  +     +  +  +I +  
Sbjct: 58  LRKTRHVNILLFMGYS------TAPQLAIVTQWCEGSSLYHHLH---IIETKFEMIKLID 108

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISY--- 116
              Q  + + Y+H    + HRD+K  N+ ++     +K+ DFG A V  +   +  +   
Sbjct: 109 IARQTAQGMDYLHAK-SIIHRDLKSNNIFLHEDLT-VKIGDFGLATVKSRWSGSHQFEQL 166

Query: 117 ICSRYYRAPELIFG--ATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 174
             S  + APE+I       Y+   D+++ G VL EL+ GQ  +   +  DQ++ ++    
Sbjct: 167 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG--- 223

Query: 175 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA 234
                           +  P +             P     L++  L+   + R    + 
Sbjct: 224 --------------RGYLSPDLSKVR------SNCPKAMKRLMAECLKKKRDERPLFPQI 263

Query: 235 LIH 237
           L  
Sbjct: 264 LAS 266

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 1e-37
 Identities = 55/242 (22%), Positives = 92/242 (38%), Gaps = 44/242 (18%)

Query: 5   DHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQI 64
               V+ L   F            L+LE       + +         +     + +F+Q+
Sbjct: 67  GFSGVIRLLDWFE-----RPDSFVLILERPEP--VQDLFDFITERGALQEELARSFFWQV 119

Query: 65  CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRA 124
             A+ + HN  GV HRDIK +N+L++ +  +LKL DFGS   L+K      +  +R Y  
Sbjct: 120 LEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVYSP 177

Query: 125 PELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 184
           PE I     +  +  +WS G +L +++ G   F  +       EII+             
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR------------- 218

Query: 185 NPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDELR 244
                               F++R+  E   L+   L   P+ R T  E   HP+  ++ 
Sbjct: 219 ----------------GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262

Query: 245 DP 246
            P
Sbjct: 263 LP 264

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  132 bits (333), Expect = 3e-37
 Identities = 61/271 (22%), Positives = 116/271 (42%), Gaps = 55/271 (20%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           + ++ HP ++ +   F     +D   + ++++Y+       +    + SQR P    K Y
Sbjct: 58  LSIVTHPFIIRMWGTF-----QDAQQIFMIMDYIE---GGELFSLLRKSQRFPNPVAKFY 109

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
             ++C AL Y+H+   + +RD+KP+N+L++ + H +K+ DFG AK +   +   +   + 
Sbjct: 110 AAEVCLALEYLHS-KDIIYRDLKPENILLDKNGH-IKITDFGFAKYV--PDVTYTLCGTP 165

Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 180
            Y APE++     Y  +ID WS G ++ E+L G   F   + +    +I+          
Sbjct: 166 DYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN--------- 215

Query: 181 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEAL 235
                    E +FP                 +  DL+SRL+    + R     +   +  
Sbjct: 216 --------AELRFP------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVK 255

Query: 236 IHPFF-----DELRDPNTRLPNGRFLPPLFN 261
            HP+F     ++L   N   P   + PP+  
Sbjct: 256 NHPWFKEVVWEKLLSRNIETP---YEPPIQQ 283

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  129 bits (324), Expect = 2e-36
 Identities = 50/243 (20%), Positives = 92/243 (37%), Gaps = 36/243 (14%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
              L+HP +V++ +              +V+EYV       ++        M        
Sbjct: 61  AAALNHPAIVAV-YDTGEAETPAGPLPYIVMEYVD---GVTLRDIVHTEGPMTPKRAIEV 116

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI----SY 116
               C+AL + H   G+ HRD+KP N++++   + +K+ DFG A+ +     ++    + 
Sbjct: 117 IADACQALNFSHQ-NGIIHRDVKPANIMISAT-NAVKVMDFGIARAIADSGNSVTQTAAV 174

Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
           I +  Y +PE   G     A  D++S GCVL E+L G+P F G+S V    + ++    P
Sbjct: 175 IGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP 233

Query: 177 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 236
                                         + +  +   +V + L  +P  R      + 
Sbjct: 234 PSA-------------------------RHEGLSADLDAVVLKALAKNPENRYQTAAEMR 268

Query: 237 HPF 239
              
Sbjct: 269 ADL 271

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 1e-35
 Identities = 61/270 (22%), Positives = 101/270 (37%), Gaps = 49/270 (18%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++   HP + +LK+ F      D L        +       +  H    +       + Y
Sbjct: 59  LQNTRHPFLTALKYAF---QTHDRLCF-----VMEYANGGELFFHLSRERVFTEERARFY 110

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
             +I  AL Y+H+   V +RDIK +NL+++   H +K+ DFG  K  +     +   C  
Sbjct: 111 GAEIVSALEYLHS-RDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGT 168

Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 180
                  +    +Y  A+D W  G V+ E++ G+  F  +        I+          
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--------- 219

Query: 181 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STALEAL 235
                    E +FP            + + PEA  L++ LL+  P  R     S A E +
Sbjct: 220 --------EEIRFP------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVM 259

Query: 236 IHPFFDELRDPNTRLPNGRFLPPLFNFKPH 265
            H FF  +      +   + LPP   FKP 
Sbjct: 260 EHRFFLSIN--WQDVVQKKLLPP---FKPQ 284

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (290), Expect = 2e-31
 Identities = 42/239 (17%), Positives = 85/239 (35%), Gaps = 41/239 (17%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKL 59
           M  L H N+V L         +++  L +V EY+ + ++   ++   +    +    +  
Sbjct: 54  MTQLRHSNLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLK 107

Query: 60  YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICS 119
           +   +C A+ Y+       HRD+  +N+LV+      K+ DFG  K         +    
Sbjct: 108 FSLDVCEAMEYLEGN-NFVHRDLAARNVLVSEDNV-AKVSDFGLTKEA--SSTQDTGKLP 163

Query: 120 RYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTR 178
             + APE +    +++   D+WS G +L E+   G+  +P     D +  + K       
Sbjct: 164 VKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY----- 217

Query: 179 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 237
                      +   P               PP   +++         +R + L+    
Sbjct: 218 -----------KMDAPD------------GCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (292), Expect = 2e-31
 Identities = 67/273 (24%), Positives = 112/273 (41%), Gaps = 48/273 (17%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
             +   P +V+L + F     + E  L+L+L+Y+       +  H    +R     V++Y
Sbjct: 83  EHIRQSPFLVTLHYAF-----QTETKLHLILDYIN---GGELFTHLSQRERFTEHEVQIY 134

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-- 118
             +I  AL ++H  +G+ +RDIK +N+L++ + H + L DFG +K  V  E   +Y    
Sbjct: 135 VGEIVLALEHLHK-LGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETERAYDFCG 192

Query: 119 -SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
              Y     +  G + +  A+D WS G ++ ELL G   F  +   +   EI +      
Sbjct: 193 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR------ 246

Query: 178 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-----STAL 232
                       + + P          + + M   A DL+ RLL   P  R       A 
Sbjct: 247 ---------RILKSEPP----------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDAD 287

Query: 233 EALIHPFFDELRDPNTRLPNGRFLPPLFNFKPH 265
           E   H FF ++   +  L   +   P   FKP 
Sbjct: 288 EIKEHLFFQKINWDD--LAAKKVPAP---FKPV 315

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  116 bits (290), Expect = 3e-31
 Identities = 40/255 (15%), Positives = 79/255 (30%), Gaps = 43/255 (16%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
            +++     +       +    +  Y  +V+E +  ++          S++  L  V L 
Sbjct: 56  YKMMQGGVGIPTIRWCGA----EGDYNVMVMELLGPSLED---LFNFCSRKFSLKTVLLL 108

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLC--DFGSAKVLVKGEPNI---- 114
             Q+   + YIH+     HRD+KP N L+        +   DFG AK       +     
Sbjct: 109 ADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPY 167

Query: 115 ----SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEII 170
               +   +  Y +     G  E +   D+ S G VL    LG   + G     +  +  
Sbjct: 168 RENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE 226

Query: 171 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR-- 228
           ++        I+ +   Y                     P E    ++       + +  
Sbjct: 227 RISEKKMSTPIEVLCKGY---------------------PSEFATYLNFCRSLRFDDKPD 265

Query: 229 -STALEALIHPFFDE 242
            S   +   + F  +
Sbjct: 266 YSYLRQLFRNLFHRQ 280

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  111 bits (277), Expect = 2e-29
 Identities = 33/220 (15%), Positives = 76/220 (34%), Gaps = 22/220 (10%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
            +LL     +   + F      + L+  LV++ +  ++  ++       ++  +  V + 
Sbjct: 54  YKLLAGCTGIPNVYYFGQ----EGLHNVLVIDLLGPSLEDLLDLC---GRKFSVKTVAMA 106

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVN----PHTHQLKLCDFGSAKVLVKGEPNI-- 114
             Q+   +  IH    + +RDIKP N L+      + + + + DFG  K           
Sbjct: 107 AKQMLARVQSIHE-KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHI 165

Query: 115 ------SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVE 168
                 +   +  Y +     G  E +   D+ + G V    L G   + G        +
Sbjct: 166 PYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK 224

Query: 169 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKR 208
             ++        ++ +   + E +F +   +  +  F   
Sbjct: 225 YERIGEKKQSTPLRELCAGFPE-EFYKYMHYARNLAFDAT 263

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (275), Expect = 3e-29
 Identities = 46/248 (18%), Positives = 84/248 (33%), Gaps = 43/248 (17%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M  LDH N++ L     +        + +V E  P     ++    K      L  +  Y
Sbjct: 65  MHSLDHRNLIRLYGVVLTP------PMKMVTELAPL--GSLLDRLRKHQGHFLLGTLSRY 116

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI---SYI 117
             Q+   + Y+ +     HRD+  +NLL+      +K+ DFG  + L + + +     + 
Sbjct: 117 AVQVAEGMGYLESK-RFIHRDLAARNLLLA-TRDLVKIGDFGLMRALPQNDDHYVMQEHR 174

Query: 118 CSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTP 176
              +            ++ A D W  G  L E+   GQ  + G +G   L +I K     
Sbjct: 175 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL 234

Query: 177 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI 236
            R E                             P +  +++ +   + P  R T +   +
Sbjct: 235 PRPE---------------------------DCPQDIYNVMVQCWAHKPEDRPTFVA--L 265

Query: 237 HPFFDELR 244
             F  E +
Sbjct: 266 RDFLLEAQ 273

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  111 bits (277), Expect = 5e-29
 Identities = 49/265 (18%), Positives = 93/265 (35%), Gaps = 50/265 (18%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           ++ ++ P +V L+  F   +    +                +  H +   R    + + Y
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVM--------EYVAGGEMFSHLRRIGRFSEPHARFY 146

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
             QI     Y+H+ + + +RD+KP+NLL++   + +++ DFG AK         +   + 
Sbjct: 147 AAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQGY-IQVTDFGFAKR--VKGRTWTLCGTP 202

Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 180
              APE+I     Y  A+D W+ G ++ E+  G P F  +  +    +I           
Sbjct: 203 EALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----------- 250

Query: 181 IKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSP-----NLRSTALEAL 235
                                   F      +  DL+  LLQ        NL++   +  
Sbjct: 251 ------------------VSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIK 292

Query: 236 IHPFFDELRDPNTRLPNGRFLPPLF 260
            H +F      +      R +   F
Sbjct: 293 NHKWF---ATTDWIAIYQRKVEAPF 314

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (273), Expect = 6e-29
 Identities = 46/245 (18%), Positives = 86/245 (35%), Gaps = 43/245 (17%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M+ L H  +V L         ++ +Y+  + EY+                ++ +  +   
Sbjct: 62  MKQLQHQRLVRLYAVV----TQEPIYI--ITEYMENGSLVDFLKTPS-GIKLTINKLLDM 114

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-- 118
             QI   +A+I       HRD++  N+LV+      K+ DFG A+++   E         
Sbjct: 115 AAQIAEGMAFIEER-NYIHRDLRAANILVSDTLSC-KIADFGLARLIEDNEYTAREGAKF 172

Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPT 177
              + APE I     +T   D+WS G +L E++  G+  +PG +  + +  + +      
Sbjct: 173 PIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER------ 225

Query: 178 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL-- 235
                                  +  +     P E   L+    +  P  R T       
Sbjct: 226 ----------------------GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSV 263

Query: 236 IHPFF 240
           +  FF
Sbjct: 264 LEDFF 268

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (272), Expect = 9e-29
 Identities = 52/251 (20%), Positives = 91/251 (36%), Gaps = 43/251 (17%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M+ L H  +V L         ++ +Y+  V EY+ +          +  + + L  +   
Sbjct: 66  MKKLRHEKLVQLYAVV----SEEPIYI--VTEYMSKGSLLDF-LKGETGKYLRLPQLVDM 118

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNI--SYIC 118
             QI   +AY+   +   HRD++  N+LV  +    K+ DFG A+++   E         
Sbjct: 119 AAQIASGMAYVER-MNYVHRDLRAANILVGENLV-CKVADFGLARLIEDNEYTARQGAKF 176

Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPT 177
              + APE       +T   D+WS G +L EL   G+  +PG    + L ++ +    P 
Sbjct: 177 PIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 235

Query: 178 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA--LEAL 235
             E                             P    DL+ +  +  P  R T   L+A 
Sbjct: 236 PPEC----------------------------PESLHDLMCQCWRKEPEERPTFEYLQAF 267

Query: 236 IHPFFDELRDP 246
           +  +F      
Sbjct: 268 LEDYFTSTEPQ 278

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (271), Expect = 2e-28
 Identities = 46/261 (17%), Positives = 87/261 (33%), Gaps = 59/261 (22%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYK------------ 47
            +L  H N+V+L       T    +YL  + EY     +   ++   +            
Sbjct: 95  TQLGSHENIVNLLGAC---TLSGPIYL--IFEYCCYGDLLNYLRSKREKFSEDEIEYENQ 149

Query: 48  -------MSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCD 100
                      +    +  + YQ+ + + ++       HRD+  +N+LV      +K+CD
Sbjct: 150 KRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK-SCVHRDLAARNVLVTHGKV-VKICD 207

Query: 101 FGSAKVLVKGEPNISYICSR---YYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPL 156
           FG A+ ++     +    +R    + APE +F    YT   D+WS G +L E+  LG   
Sbjct: 208 FGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNP 266

Query: 157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDL 216
           +PG        ++I+               N  +   P                 E   +
Sbjct: 267 YPGIPVDANFYKLIQ---------------NGFKMDQP------------FYATEEIYII 299

Query: 217 VSRLLQYSPNLRSTALEALIH 237
           +     +    R +       
Sbjct: 300 MQSCWAFDSRKRPSFPNLTSF 320

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (270), Expect = 3e-28
 Identities = 43/253 (16%), Positives = 85/253 (33%), Gaps = 32/253 (12%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKL 59
             +L H N++       +        L LV +Y    ++   +  +      + +  +  
Sbjct: 51  TVMLRHENILGF-IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIK 104

Query: 60  YFYQICRALAYIHNTI-------GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP 112
                   LA++H  I        + HRD+K +N+LV        + D G A        
Sbjct: 105 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSATD 163

Query: 113 NIS-----YICSRYYRAPELIFGA-----TEYTAAIDIWSAGCVLAELLLGQPLFPGESG 162
            I       + ++ Y APE++  +      E     DI++ G V  E+     +  G   
Sbjct: 164 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHE 222

Query: 163 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQ 222
             QL     V   P+ EE++ +          +++ +  ++            ++     
Sbjct: 223 DYQLPYYDLVPSDPSVEEMRKV------VCEQKLRPNIPNRWQSCEALRVMAKIMRECWY 276

Query: 223 YSPNLRSTALEAL 235
            +   R TAL   
Sbjct: 277 ANGAARLTALRIK 289

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (267), Expect = 5e-28
 Identities = 49/249 (19%), Positives = 87/249 (34%), Gaps = 47/249 (18%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M  LD+P +V L        + + L L  V+E          K      + +P+  V   
Sbjct: 63  MHQLDNPYIVRLIGVC----QAEALML--VMEMAGGGPLH--KFLVGKREEIPVSNVAEL 114

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
            +Q+   + Y+       HRD+  +N+L+    +  K+ DFG +K L   +   +   + 
Sbjct: 115 LHQVSMGMKYLEEK-NFVHRDLAARNVLLVNRHY-AKISDFGLSKALGADDSYYTARSAG 172

Query: 121 ----YYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGT 175
                + APE I    ++++  D+WS G  + E L  GQ  +    G + +  I +    
Sbjct: 173 KWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM 231

Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR---STAL 232
               E                             PPE   L+S    Y    R    T  
Sbjct: 232 ECPPEC----------------------------PPELYALMSDCWIYKWEDRPDFLTVE 263

Query: 233 EALIHPFFD 241
           + +   ++ 
Sbjct: 264 QRMRACYYS 272

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (266), Expect = 7e-28
 Identities = 46/249 (18%), Positives = 86/249 (34%), Gaps = 48/249 (19%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M+ LD+P +V +        E +   L  V+E         +  + + ++ +    +   
Sbjct: 62  MQQLDNPYIVRMIGIC----EAESWML--VMEMAE---LGPLNKYLQQNRHVKDKNIIEL 112

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS----Y 116
            +Q+   + Y+  +    HRD+  +N+L+    H  K+ DFG +K L   E         
Sbjct: 113 VHQVSMGMKYLEES-NFVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENYYKAQTHG 170

Query: 117 ICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGT 175
                + APE I    ++++  D+WS G ++ E    GQ  + G  G +    + K    
Sbjct: 171 KWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM 229

Query: 176 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA---L 232
                                             P E  DL++    Y    R       
Sbjct: 230 G----------------------------CPAGCPREMYDLMNLCWTYDVENRPGFAAVE 261

Query: 233 EALIHPFFD 241
             L + ++D
Sbjct: 262 LRLRNYYYD 270

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  106 bits (265), Expect = 1e-27
 Identities = 49/255 (19%), Positives = 95/255 (37%), Gaps = 46/255 (18%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M   DHPNV+ L+      T+   + +  + E++            +   +  +I +   
Sbjct: 81  MGQFDHPNVIHLEGVV---TKSTPVMI--ITEFMENGSLD--SFLRQNDGQFTVIQLVGM 133

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
              I   + Y+ + +   HRD+  +N+LVN +    K+ DFG ++ L     + +Y  + 
Sbjct: 134 LRGIAAGMKYLAD-MNYVHRDLAARNILVNSNLV-CKVSDFGLSRFLEDDTSDPTYTSAL 191

Query: 121 ------YYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVL 173
                  + APE I    ++T+A D+WS G V+ E++  G+  +   +  D +  I +  
Sbjct: 192 GGKIPIRWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDY 250

Query: 174 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE 233
             P   +                             P     L+    Q   N R    +
Sbjct: 251 RLPPPMDC----------------------------PSALHQLMLDCWQKDRNHRPKFGQ 282

Query: 234 ALIHPFFDELRDPNT 248
            +       +R+PN+
Sbjct: 283 IVNT-LDKMIRNPNS 296

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (265), Expect = 2e-27
 Identities = 48/253 (18%), Positives = 91/253 (35%), Gaps = 42/253 (16%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M  +D+P+V  L     ++T      + L+ + +P     ++ +  +    +   Y+  +
Sbjct: 65  MASVDNPHVCRLLGICLTST------VQLITQLMPF--GCLLDYVREHKDNIGSQYLLNW 116

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
             QI + + Y+ +   + HRD+  +N+LV    H +K+ DFG AK+L   E        +
Sbjct: 117 CVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGK 174

Query: 121 ---YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 177
               + A E I     YT   D+WS G  + EL+             ++  I++      
Sbjct: 175 VPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 233

Query: 178 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 237
           +  I                              +   ++ +      + R    E +I 
Sbjct: 234 QPPI---------------------------CTIDVYMIMVKCWMIDADSRPKFRELIIE 266

Query: 238 PFFDELRDPNTRL 250
            F    RDP   L
Sbjct: 267 -FSKMARDPQRYL 278

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (261), Expect = 2e-27
 Identities = 39/239 (16%), Positives = 77/239 (32%), Gaps = 39/239 (16%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M  L HP +V L        E+  + L  V E++         +            +   
Sbjct: 54  MMKLSHPKLVQLYGVC---LEQAPICL--VFEFMEHGCLS--DYLRTQRGLFAAETLLGM 106

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-- 118
              +C  +AY+     V HRD+  +N LV  +   +K+ DFG  + ++  +   S     
Sbjct: 107 CLDVCEGMAYLEEA-CVIHRDLAARNCLVGENQV-IKVSDFGMTRFVLDDQYTSSTGTKF 164

Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 178
              + +PE+    + Y++  D+WS G ++ E+     +        ++VE I        
Sbjct: 165 PVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS------- 216

Query: 179 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 237
                                 +     +        +++   +  P  R      L  
Sbjct: 217 --------------------TGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (257), Expect = 1e-26
 Identities = 40/240 (16%), Positives = 85/240 (35%), Gaps = 41/240 (17%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M  L H  +V L       T++  +++  + EY+         +  +M  R     +   
Sbjct: 53  MMNLSHEKLVQLYGVC---TKQRPIFI--ITEYMANGCLL--NYLREMRHRFQTQQLLEM 105

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNIS--YIC 118
              +C A+ Y+ +     HRD+  +N LVN     +K+ DFG ++ ++  E   S     
Sbjct: 106 CKDVCEAMEYLESK-QFLHRDLAARNCLVNDQGV-VKVSDFGLSRYVLDDEYTSSVGSKF 163

Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPT 177
              +  PE++   +++++  DIW+ G ++ E+  LG+  +   +  +    I + L    
Sbjct: 164 PVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY- 221

Query: 178 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 237
                                             +   ++        + R T    L +
Sbjct: 222 ---------------------------RPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (251), Expect = 1e-25
 Identities = 43/254 (16%), Positives = 92/254 (36%), Gaps = 49/254 (19%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M+   HPNV+SL         + E    +VL Y+     R        +    +  +  +
Sbjct: 82  MKDFSHPNVLSLLGICL----RSEGSPLVVLPYMKHGDLR--NFIRNETHNPTVKDLIGF 135

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
             Q+ + + ++ +     HRD+  +N +++     +K+ DFG A+ +   E +  +  + 
Sbjct: 136 GLQVAKGMKFLAS-KKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFDSVHNKTG 193

Query: 121 Y-----YRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEIIKVLG 174
                 + A E +    ++T   D+WS G +L EL+  G P +P  +  D  V +++   
Sbjct: 194 AKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ--- 249

Query: 175 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTA--- 231
                                        +  +  P    +++ +       +R +    
Sbjct: 250 -------------------------GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSEL 284

Query: 232 ---LEALIHPFFDE 242
              + A+   F  E
Sbjct: 285 VSRISAIFSTFIGE 298

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (249), Expect = 3e-25
 Identities = 50/254 (19%), Positives = 89/254 (35%), Gaps = 54/254 (21%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKM----------- 48
             L +H N+V+L       T      +  + EY     +   ++                
Sbjct: 81  SYLGNHMNIVNLLGAC---TIGGPTLV--ITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135

Query: 49  ---SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAK 105
                 + L  +  + YQ+ + +A++ +     HRD+  +N+L+       K+CDFG A+
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARNILLTHGRIT-KICDFGLAR 193

Query: 106 VLVKGEPNISYICSR---YYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGES 161
            +      +    +R    + APE IF    YT   D+WS G  L EL  LG   +PG  
Sbjct: 194 DIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252

Query: 162 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLL 221
              +  ++IK                             +  +  +  P E  D++    
Sbjct: 253 VDSKFYKMIK---------------------------EGFRMLSPEHAPAEMYDIMKTCW 285

Query: 222 QYSPNLRSTALEAL 235
              P  R T  + +
Sbjct: 286 DADPLKRPTFKQIV 299

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.1 bits (246), Expect = 4e-25
 Identities = 55/240 (22%), Positives = 87/240 (36%), Gaps = 42/240 (17%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           MR  DHP++V L           E  + +++E       R           + L  + LY
Sbjct: 62  MRQFDHPHIVKLIGVI------TENPVWIIMELCTLGELR--SFLQVRKYSLDLASLILY 113

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-- 118
            YQ+  ALAY+ +     HRDI  +N+LV+ +   +KL DFG ++ +       +     
Sbjct: 114 AYQLSTALAYLESK-RFVHRDIAARNVLVSSNDC-VKLGDFGLSRYMEDSTYYKASKGKL 171

Query: 119 SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPT 177
              + APE I     +T+A D+W  G  + E+L+ G   F G    D +  I      P 
Sbjct: 172 PIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM 230

Query: 178 REEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH 237
                                           PP    L+++   Y P+ R    E    
Sbjct: 231 PPNC----------------------------PPTLYSLMTKCWAYDPSRRPRFTELKAQ 262

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.3 bits (244), Expect = 1e-24
 Identities = 42/250 (16%), Positives = 82/250 (32%), Gaps = 48/250 (19%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKM----------- 48
            +L  HPN+++L             YL L +EY P   +   ++    +           
Sbjct: 65  CKLGHHPNIINLLGACEHRG-----YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANS 119

Query: 49  -SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 107
            +  +    +  +   + R + Y+       HRD+  +N+LV  + +  K+ DFG ++  
Sbjct: 120 TASTLSSQQLLHFAADVARGMDYLSQK-QFIHRDLAARNILVGEN-YVAKIADFGLSRGQ 177

Query: 108 VKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLV 167
                         + A E +   + YT   D+WS G +L E++             +L 
Sbjct: 178 EVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 236

Query: 168 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL 227
           E +                     + P                 E  DL+ +  +  P  
Sbjct: 237 EKLP---------------QGYRLEKP------------LNCDDEVYDLMRQCWREKPYE 269

Query: 228 RSTALEALIH 237
           R +  + L+ 
Sbjct: 270 RPSFAQILVS 279

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.4 bits (239), Expect = 5e-24
 Identities = 40/239 (16%), Positives = 77/239 (32%), Gaps = 41/239 (17%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M    H N++ L+             + ++ EY+        K   +      ++ +   
Sbjct: 63  MGQFSHHNIIRLEGVIS-----KYKPMMIITEYMENGALD--KFLREKDGEFSVLQLVGM 115

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-- 118
              I   + Y+ N +   HRD+  +N+LVN +    K+ DFG ++VL             
Sbjct: 116 LRGIAAGMKYLAN-MNYVHRDLAARNILVNSNLV-CKVSDFGLSRVLEDDPEATYTTSGG 173

Query: 119 --SRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 176
                + APE I      +A+ D+WS G V+ E++        E    ++++ I      
Sbjct: 174 KIPIRWTAPEAISYRKFTSAS-DVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN----- 227

Query: 177 TREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL 235
                                   +        P     L+ +  Q     R    + +
Sbjct: 228 ----------------------DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIV 264

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 96.3 bits (239), Expect = 5e-24
 Identities = 45/245 (18%), Positives = 91/245 (37%), Gaps = 40/245 (16%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
           M+ + HPN+V L       T +   Y+    E++               Q +  + +   
Sbjct: 67  MKEIKHPNLVQLLGVC---TREPPFYIIT--EFMTYGNLLDY-LRECNRQEVSAVVLLYM 120

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
             QI  A+ Y+       HRD+  +N LV  + H +K+ DFG ++++             
Sbjct: 121 ATQISSAMEYLEK-KNFIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTYTAHAGAKF 178

Query: 121 --YYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 178
              + APE +    +++   D+W+ G +L E+            + Q+ E+++       
Sbjct: 179 PIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE------- 230

Query: 179 EEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP 238
                        + P            +  P +  +L+    Q++P+ R +  E  IH 
Sbjct: 231 --------KDYRMERP------------EGCPEKVYELMRACWQWNPSDRPSFAE--IHQ 268

Query: 239 FFDEL 243
            F+ +
Sbjct: 269 AFETM 273

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.3 bits (236), Expect = 1e-23
 Identities = 45/252 (17%), Positives = 89/252 (35%), Gaps = 53/252 (21%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMS---------- 49
             +  H N+++L           +  L +++EY  +  +   ++                
Sbjct: 73  KMIGKHKNIINLLGACT-----QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 127

Query: 50  --QRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 107
             +++    +    YQ+ R + Y+ +     HRD+  +N+LV       K+ DFG A+ +
Sbjct: 128 PEEQLSSKDLVSCAYQVARGMEYLASK-KCIHRDLAARNVLVTEDNVM-KIADFGLARDI 185

Query: 108 VKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGV 163
              +      +      + APE +F    YT   D+WS G +L E+  LG   +PG   V
Sbjct: 186 HHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-V 243

Query: 164 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQY 223
           ++L +++K                      P                 E   ++      
Sbjct: 244 EELFKLLK---------------EGHRMDKP------------SNCTNELYMMMRDCWHA 276

Query: 224 SPNLRSTALEAL 235
            P+ R T  + +
Sbjct: 277 VPSQRPTFKQLV 288

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 93.8 bits (232), Expect = 7e-23
 Identities = 41/260 (15%), Positives = 74/260 (28%), Gaps = 61/260 (23%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP---------------------ETVH 39
           M   D+PN+V              + L  + EY+                        + 
Sbjct: 70  MAEFDNPNIV---KLLGVCAVGKPMCL--LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124

Query: 40  RVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLC 99
              +        +          Q+   +AY+       HRD+  +N LV  +   +K+ 
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE-RKFVHRDLATRNCLVGENMV-VKIA 182

Query: 100 DFGSAKVLVKGEPNI---SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQP 155
           DFG ++ +   +      +      +  PE IF    YT   D+W+ G VL E+   G  
Sbjct: 183 DFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQ 241

Query: 156 LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVD 215
            + G +  + +  +         E                              P E  +
Sbjct: 242 PYYGMAHEEVIYYVRDGNILACPENC----------------------------PLELYN 273

Query: 216 LVSRLLQYSPNLRSTALEAL 235
           L+       P  R +     
Sbjct: 274 LMRLCWSKLPADRPSFCSIH 293

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.5 bits (226), Expect = 4e-22
 Identities = 47/254 (18%), Positives = 87/254 (34%), Gaps = 51/254 (20%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKM------------ 48
           + +  H NVV+L              L +++E+             +             
Sbjct: 71  IHIGHHLNVVNLLGACTKPGG----PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 126

Query: 49  -SQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVL 107
               + L ++  Y +Q+ + + ++ +     HRD+  +N+L++     +K+CDFG A+ +
Sbjct: 127 YKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSEKNV-VKICDFGLARDI 184

Query: 108 VKGEPNI---SYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG-QPLFPGESGV 163
            K    +          + APE IF    YT   D+WS G +L E+       +PG    
Sbjct: 185 YKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243

Query: 164 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQY 223
           ++    +K                 T  + P                PE    +      
Sbjct: 244 EEFCRRLK---------------EGTRMRAPDY------------TTPEMYQTMLDCWHG 276

Query: 224 SPNLRSTALEALIH 237
            P+ R T  E + H
Sbjct: 277 EPSQRPTFSELVEH 290

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 85.7 bits (211), Expect = 6e-20
 Identities = 41/260 (15%), Positives = 87/260 (33%), Gaps = 53/260 (20%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLI---- 55
           M+  +  +VV L                +++E +    +   ++         P++    
Sbjct: 77  MKEFNCHHVVRLLGVVSQGQP-----TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 131

Query: 56  --YVKLYFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN 113
              +     +I   +AY++      HRD+  +N +V      +K+ DFG  + + + +  
Sbjct: 132 LSKMIQMAGEIADGMAYLNAN-KFVHRDLAARNCMVAEDFT-VKIGDFGMTRDIYETDYY 189

Query: 114 ISYIC---SRYYRAPELIFGATEYTAAIDIWSAGCVLAELL-LGQPLFPGESGVDQLVEI 169
                      + +PE +     +T   D+WS G VL E+  L +  + G S    L  +
Sbjct: 190 RKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 248

Query: 170 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS 229
           ++                                      P    +L+    QY+P +R 
Sbjct: 249 ME----------------------------GGLLDKPDNCPDMLFELMRMCWQYNPKMRP 280

Query: 230 TA------LEALIHPFFDEL 243
           +       ++  + P F E+
Sbjct: 281 SFLEIISSIKEEMEPGFREV 300

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 61.3 bits (148), Expect = 4e-12
 Identities = 24/149 (16%), Positives = 44/149 (29%), Gaps = 17/149 (11%)

Query: 1   MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLY 60
               +   +  L+               +++E              K   R+ +      
Sbjct: 60  SARNEFRALQKLQGLAV-PKVYAWEGNAVLMEL----------IDAKELYRVRVENPDEV 108

Query: 61  FYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSR 120
              I   +A  ++   + H D+   N+LV      + + DF  +  +  GE     I  R
Sbjct: 109 LDMILEEVAKFYHRG-IVHGDLSQYNVLV--SEEGIWIIDFPQSVEV--GEEGWREILER 163

Query: 121 YYRAPELIFGATEYTAAIDIWSAGCVLAE 149
             R     F    Y    DI SA   + +
Sbjct: 164 DVRNIITYFS-RTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	292
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.67
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	96.62
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	94.79
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	91.95
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	90.48
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	89.21

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-56  Score=386.72  Aligned_cols=268  Identities=72%  Similarity=1.237  Sum_probs=234.5

Q ss_pred             CCCCCCCCeeeeceeeeccCC-CCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTE-KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~-~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++|||||+++++|....+ .+..++|||||||++++...+.........+++..++.++.||+.||+|||++ ||+|
T Consensus        67 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~-~IiH  145 (350)
T d1q5ka_          67 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-GICH  145 (350)
T ss_dssp             HHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT-TEEC
T ss_pred             HHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc-CCcc
Confidence            456899999999999876543 45678899999999888777766555567899999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      |||||+|||++.++..+||+|||+++.........+.+||+.|+|||.+.+...++.++||||+||++|||++|..||.+
T Consensus       146 rDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~  225 (350)
T d1q5ka_         146 RDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG  225 (350)
T ss_dssp             CCCCGGGEEECTTTCCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred             cCCCcceEEEecCCCceeEecccchhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCC
Confidence            99999999999877679999999998876666667788999999999987776799999999999999999999999999


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCC
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF  239 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~  239 (292)
                      .+..+++.++.+..+.+..+.+....+.+....++.....++.....+..++++.+||.+||++||.+|||+.|+|+|||
T Consensus       226 ~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~  305 (350)
T d1q5ka_         226 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF  305 (350)
T ss_dssp             SSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             CCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence            99999999999999999999999888888888888877777777777889999999999999999999999999999999


Q ss_pred             ccccCCCCCCCCCCCCCCCCCCCChhccCC
Q 022799          240 FDELRDPNTRLPNGRFLPPLFNFKPHELKG  269 (292)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (292)
                      |+++..+....++.+..+..++++..++..
T Consensus       306 f~~~~~~~~~~~~~~~~~~~~~~~~~e~~~  335 (350)
T d1q5ka_         306 FDELRDPNVKLPNGRDTPALFNFTTQELSS  335 (350)
T ss_dssp             GGGGGCTTCCCTTSCCCCCCCCCCHHHHTT
T ss_pred             hccccCCCCCCCCCCCCCccCCCCHhhccC
Confidence            999988877777777778888888777665

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-54  Score=365.69  Aligned_cols=235  Identities=36%  Similarity=0.641  Sum_probs=193.3

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      |++++|||||+++++|     .+..++|+||||+.|++...+..   ....+++..++.+++||+.||+|||++ ||+||
T Consensus        54 l~~l~hpnIv~~~~~~-----~~~~~~~ivmE~~~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~~-~iiHr  124 (299)
T d1ua2a_          54 LQELSHPNIIGLLDAF-----GHKSNISLVFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQH-WILHR  124 (299)
T ss_dssp             HHHCCCTTBCCEEEEE-----CCTTCCEEEEECCSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHT-TCCCC
T ss_pred             HHhCCCCCEeEEEeee-----ccCCceeehhhhhcchHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhcc-ceecc
Confidence            3568999999999999     44445899999999766555543   246789999999999999999999998 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCC-CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      ||||+|||++.++ .+||+|||+|+...... .....+||+.|+|||++.+...|+.++||||+||++|+|++|.+||.+
T Consensus       125 DiKp~NIli~~~~-~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~  203 (299)
T d1ua2a_         125 DLKPNNLLLDENG-VLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG  203 (299)
T ss_dssp             CCCGGGEEECTTC-CEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cCCcceEEecCCC-ccccccCccccccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCC
Confidence            9999999999888 79999999998764433 334567999999999997766789999999999999999999999999


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCC
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF  239 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~  239 (292)
                      .+..+++.++.+..+.|..+.+..................++...+ +.+++++++||.+||+.||++|||++|+|+|||
T Consensus       204 ~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~  282 (299)
T d1ua2a_         204 DSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIF-SAAGDDLLDLIQGLFLFNPCARITATQALKMKY  282 (299)
T ss_dssp             SSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHC-TTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred             CCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhc-ccCCHHHHHHHHHHccCChhhCcCHHHHhCCHh
Confidence            9999999999999999988766544332222233333333333333 568999999999999999999999999999999


Q ss_pred             ccccCCC
Q 022799          240 FDELRDP  246 (292)
Q Consensus       240 ~~~~~~~  246 (292)
                      |++...+
T Consensus       283 f~~~p~p  289 (299)
T d1ua2a_         283 FSNRPGP  289 (299)
T ss_dssp             GTSSSCC
T ss_pred             hCCCCCC
Confidence            9975443

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-54  Score=357.32  Aligned_cols=200  Identities=33%  Similarity=0.532  Sum_probs=172.7

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++|||||++++++     .+...+|+|||||+ |+|.+++...    ..+++..++.++.||+.||+|||++ ||+|
T Consensus        60 l~~l~hpnIv~~~~~~-----~~~~~~~ivmEy~~~g~L~~~l~~~----~~l~e~~~~~i~~qi~~al~~lH~~-~ivH  129 (263)
T d2j4za1          60 QSHLRHPNILRLYGYF-----HDATRVYLILEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSK-RVIH  129 (263)
T ss_dssp             HHTCCCTTBCCEEEEE-----ECSSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TCCC
T ss_pred             HHhcCCCCCCeEEEEE-----EECCEEEEEEeecCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHC-Ceee
Confidence            4678999999999999     44456999999998 6999988753    6799999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      |||||+|||++.++ .+||+|||+|+..... ......||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+
T Consensus       130 rDiKp~Nill~~~~-~~kl~DFG~a~~~~~~-~~~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~  206 (263)
T d2j4za1         130 RDIKPENLLLGSAG-ELKIADFGWSVHAPSS-RRTTLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEA  206 (263)
T ss_dssp             CCCCGGGEEECTTS-CEEECCCCSCSCCCCC-CCEETTEEGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             eeeccccceecCCC-CEeecccceeeecCCC-cccccCCCCcccCHHHHcCC-CCCchhhhhhHhHHHHHHhcCCCCCCC
Confidence            99999999999988 7999999999876443 34556899999999999765 489999999999999999999999998


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCC
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF  239 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~  239 (292)
                      .+..+.+.++.+.-                 .            .++..+|+++++||.+||+.||++|||++|+|+|||
T Consensus       207 ~~~~~~~~~i~~~~-----------------~------------~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~  257 (263)
T d2j4za1         207 NTYQETYKRISRVE-----------------F------------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW  257 (263)
T ss_dssp             SSHHHHHHHHHTTC-----------------C------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHH
T ss_pred             CCHHHHHHHHHcCC-----------------C------------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcC
Confidence            88777666554310                 0            122458999999999999999999999999999999


Q ss_pred             ccc
Q 022799          240 FDE  242 (292)
Q Consensus       240 ~~~  242 (292)
                      |++
T Consensus       258 ~~~  260 (263)
T d2j4za1         258 ITA  260 (263)
T ss_dssp             HHH
T ss_pred             cCC
Confidence            975

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-54  Score=360.51  Aligned_cols=205  Identities=27%  Similarity=0.380  Sum_probs=168.8

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++|||||++++++.     +...+|+|||||+ |+|.+++..    ...+++..++.++.||+.||+|||++ ||+|
T Consensus        57 l~~l~HpnIv~~~~~~~-----~~~~~~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~al~ylH~~-~IiH  126 (271)
T d1nvra_          57 NKMLNHENVVKFYGHRR-----EGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGI-GITH  126 (271)
T ss_dssp             HHTCCCTTBCCEEEEEE-----ETTEEEEEEECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHT-TEEC
T ss_pred             HHhCCCCCEeeEeeeec-----cCceeEEEEeccCCCcHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHc-CCcc
Confidence            46789999999999994     4445999999998 699888754    46799999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCC---CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPL  156 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~p  156 (292)
                      |||||+|||++.++ .+||+|||+|+......   .....+||+.|+|||++.+...++.++||||+||++|+|++|+.|
T Consensus       127 rDiKp~NILl~~~~-~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~p  205 (271)
T d1nvra_         127 RDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP  205 (271)
T ss_dssp             SCCCGGGEEECTTC-CEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCS
T ss_pred             CcccHHHEEECCCC-CEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCC
Confidence            99999999999888 79999999998764332   234568999999999998766567889999999999999999999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      |.+.................                     ..     ....+|+++++||.+||+.||++|||++|+++
T Consensus       206 f~~~~~~~~~~~~~~~~~~~---------------------~~-----~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         206 WDQPSDSCQEYSDWKEKKTY---------------------LN-----PWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             CSSSSTTSHHHHHHHTTCTT---------------------ST-----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCCChHHHHHHHHhcCCCC---------------------CC-----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            98766544333332211000                     00     11457999999999999999999999999999


Q ss_pred             CCCccc
Q 022799          237 HPFFDE  242 (292)
Q Consensus       237 hp~~~~  242 (292)
                      ||||+.
T Consensus       260 hpwf~~  265 (271)
T d1nvra_         260 DRWYNK  265 (271)
T ss_dssp             CTTTTC
T ss_pred             CHhhCc
Confidence            999974

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-53  Score=357.59  Aligned_cols=203  Identities=26%  Similarity=0.422  Sum_probs=172.5

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++|||||+++++|.+     ..++|+|||||+ |+|.+++..     +.+++..++.++.||+.||+|||++ ||+|
T Consensus        71 l~~l~HpnIv~~~~~~~~-----~~~~~ivmEy~~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~-~iiH  139 (293)
T d1yhwa1          71 MRENKNPNIVNYLDSYLV-----GDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN-QVIH  139 (293)
T ss_dssp             HHHCCCTTBCCEEEEEEE-----TTEEEEEEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT-TEEC
T ss_pred             HHhCCCCCEeeEeEEEEE-----CCEEEEEEEecCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHC-CCcc
Confidence            457899999999999944     445999999998 688877653     5699999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCC-CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      |||||+|||++.++ .+||+|||+|+...... .....+||+.|+|||++.+. .++.++||||+||++|+|++|..||.
T Consensus       140 rDiKp~NILl~~~~-~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~  217 (293)
T d1yhwa1         140 RDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYL  217 (293)
T ss_dssp             CCCSGGGEEECTTC-CEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSS-CBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             cCCcHHHeEECCCC-cEeeccchhheeeccccccccccccCCCccChhhhcCC-CCCchhceehHhHHHHHHhhCCCCCC
Confidence            99999999999888 79999999998765433 34566799999999999764 58999999999999999999999999


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCC
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  238 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp  238 (292)
                      +.+..+.+..+..... +.             .            ..+..+|+++++||.+||..||.+|||++|+|+||
T Consensus       218 ~~~~~~~~~~~~~~~~-~~-------------~------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp  271 (293)
T d1yhwa1         218 NENPLRALYLIATNGT-PE-------------L------------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQ  271 (293)
T ss_dssp             TSCHHHHHHHHHHHCS-CC-------------C------------SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCG
T ss_pred             CCCHHHHHHHHHhCCC-CC-------------C------------CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence            8888777776655311 10             0            01246899999999999999999999999999999


Q ss_pred             Cccc
Q 022799          239 FFDE  242 (292)
Q Consensus       239 ~~~~  242 (292)
                      ||+.
T Consensus       272 ~~~~  275 (293)
T d1yhwa1         272 FLKI  275 (293)
T ss_dssp             GGGG
T ss_pred             hhCC
Confidence            9974

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-52  Score=350.57  Aligned_cols=205  Identities=22%  Similarity=0.378  Sum_probs=169.5

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCC--c
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG--V   77 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~--i   77 (292)
                      |++++|||||+++++|.... .+...+|+|||||+ |+|.+++...    ..+++..++.++.||+.||+|||++ |  |
T Consensus        62 l~~l~HpnIv~~~~~~~~~~-~~~~~~~ivmE~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~gl~yLH~~-~~~I  135 (270)
T d1t4ha_          62 LKGLQHPNIVRFYDSWESTV-KGKKCIVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR-TPPI  135 (270)
T ss_dssp             HTTCCCTTBCCEEEEEEEES-SSCEEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS-SSCC
T ss_pred             HHhCCCCCeeeEEEEEeecc-ccCCEEEEEEeCCCCCcHHHHHhcc----ccccHHHHHHHHHHHHHHHHHHHHC-CCCE
Confidence            57899999999999986543 34556899999998 6999988753    6799999999999999999999987 8  9


Q ss_pred             cccCCCCCcEEEeC-CCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCC
Q 022799           78 CHRDIKPQNLLVNP-HTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPL  156 (292)
Q Consensus        78 ~H~dlkp~Nill~~-~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~p  156 (292)
                      +||||||+|||++. ++ .+||+|||+|+... .....+.+||+.|+|||++.+  .++.++||||+||++|+|++|+.|
T Consensus       136 iHrDiKp~NILl~~~~~-~~Kl~DFGla~~~~-~~~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~P  211 (270)
T d1t4ha_         136 IHRDLKCDNIFITGPTG-SVKIGDLGLATLKR-ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYP  211 (270)
T ss_dssp             CCSCCCGGGEEESSTTS-CEEECCTTGGGGCC-TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCT
T ss_pred             EeCCcChhhceeeCCCC-CEEEeecCcceecc-CCccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCC
Confidence            99999999999975 55 79999999997643 333456789999999999854  489999999999999999999999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      |.+......+.+.+.....|                          ..++...++++++||.+||..||++|||++|+|+
T Consensus       212 f~~~~~~~~~~~~i~~~~~~--------------------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         212 YSECQNAAQIYRRVTSGVKP--------------------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             TTTCSSHHHHHHHHTTTCCC--------------------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCcccHHHHHHHHHcCCCC--------------------------cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence            98766555444333211000                          1133567899999999999999999999999999


Q ss_pred             CCCcc
Q 022799          237 HPFFD  241 (292)
Q Consensus       237 hp~~~  241 (292)
                      ||||+
T Consensus       266 Hp~fk  270 (270)
T d1t4ha_         266 HAFFQ  270 (270)
T ss_dssp             SGGGC
T ss_pred             CcccC
Confidence            99996

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-53  Score=358.20  Aligned_cols=205  Identities=32%  Similarity=0.569  Sum_probs=172.6

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++|||||+++++|     .++..+|+|||||+ |+|.+++...    +.+++..++.++.|++.||+|||++ ||+|
T Consensus        62 l~~l~HpnIv~l~~~~-----~~~~~~~ivmEy~~gg~L~~~~~~~----~~l~e~~~~~~~~qi~~al~ylH~~-~iiH  131 (288)
T d1uu3a_          62 MSRLDHPFFVKLYFTF-----QDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHGK-GIIH  131 (288)
T ss_dssp             HHHCCSTTBCCEEEEE-----ECSSEEEEEECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TEEC
T ss_pred             HHHcCCCCeeEEEEEE-----EECCEEEEEEEccCCCCHHHhhhcc----CCCCHHHHHHHHHHHHHHHHhhccc-cEEc
Confidence            3568999999999999     44456999999998 6998887753    6799999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCC---CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPL  156 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~p  156 (292)
                      |||||+||+++.++ .+||+|||+|+......   ...+.+||+.|+|||++.+. .++.++||||+||++|+|++|..|
T Consensus       132 rDiKp~NIll~~~~-~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~P  209 (288)
T d1uu3a_         132 RDLKPENILLNEDM-HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPP  209 (288)
T ss_dssp             SCCSGGGEEECTTS-CEEECCCTTCEECC----------CCCCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred             CcCCccccccCCCc-eEEecccccceecccCCcccccccccCCccccCceeeccC-CCCcccceehhhHHHHHHhhCCCC
Confidence            99999999999988 79999999998764332   23456799999999999765 489999999999999999999999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHH---
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE---  233 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e---  233 (292)
                      |.+.+..+...++.+.                 .+.            ++..+|+++++||.+||+.||++|||++|   
T Consensus       210 f~~~~~~~~~~~i~~~-----------------~~~------------~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         210 FRAGNEYLIFQKIIKL-----------------EYD------------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             SCCSSHHHHHHHHHTT-----------------CCC------------CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             CCCcCHHHHHHHHHcC-----------------CCC------------CCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence            9998887777666531                 011            22468999999999999999999999987   


Q ss_pred             ---HhcCCCccccCCC
Q 022799          234 ---ALIHPFFDELRDP  246 (292)
Q Consensus       234 ---~l~hp~~~~~~~~  246 (292)
                         +++||||+++++.
T Consensus       261 ~~~i~~Hpff~~i~w~  276 (288)
T d1uu3a_         261 YGPLKAHPFFESVTWE  276 (288)
T ss_dssp             HHHHHTSGGGTTCCCT
T ss_pred             CHHHHcCCccCCCCHH
Confidence               6899999998754

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-52  Score=358.92  Aligned_cols=204  Identities=28%  Similarity=0.445  Sum_probs=176.0

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++|||||+++++|     .+..++|+|||||+ |+|.+++...    ..+++..++.++.||+.||+|||++ ||+|
T Consensus        59 l~~l~hp~Iv~l~~~~-----~~~~~~~iv~ey~~gg~L~~~~~~~----~~~~e~~~~~~~~qil~al~ylH~~-~iiH  128 (337)
T d1o6la_          59 LQNTRHPFLTALKYAF-----QTHDRLCFVMEYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSR-DVVY  128 (337)
T ss_dssp             HHSCCCTTBCCEEEEE-----ECSSEEEEEEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT-TCBC
T ss_pred             HHhCCCCCEEEEEeee-----ccccccccceeccCCCchhhhhhcc----cCCcHHHHHHHHHHHhhhhhhhhhc-Cccc
Confidence            4678999999999999     55556999999999 6898888763    6799999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCcccccc-CCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVK-GEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      |||||+|||++.++ .+||+|||+|+.... .......+||+.|+|||++.+. .|+.++|+||+||++|||++|.+||.
T Consensus       129 RDlKP~NILl~~~g-~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~-~y~~~~DiwSlGvilyeml~G~~pf~  206 (337)
T d1o6la_         129 RDIKLENLMLDKDG-HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFY  206 (337)
T ss_dssp             CCCCGGGEEECTTS-CEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred             cccCHHHeEecCCC-CEEEeecccccccccCCcccccceeCHHHhhhhhccCC-CCChhhcccchhhHHHHHHHCCCCCC
Confidence            99999999999988 799999999987643 3345567899999999999765 48999999999999999999999999


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCccc-----HHH
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----ALE  233 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t-----~~e  233 (292)
                      +.+..+....+...                 ..            .++..+|+++++||++||++||.+|++     +++
T Consensus       207 ~~~~~~~~~~i~~~-----------------~~------------~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~e  257 (337)
T d1o6la_         207 NQDHERLFELILME-----------------EI------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKE  257 (337)
T ss_dssp             CSSHHHHHHHHHHC-----------------CC------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHH
T ss_pred             CcCHHHHHHHHhcC-----------------CC------------CCCccCCHHHHHHHHhhccCCchhhcccccccHHH
Confidence            98877766665541                 01            123568999999999999999999994     999


Q ss_pred             HhcCCCccccCC
Q 022799          234 ALIHPFFDELRD  245 (292)
Q Consensus       234 ~l~hp~~~~~~~  245 (292)
                      +++||||+++++
T Consensus       258 il~Hp~f~~i~~  269 (337)
T d1o6la_         258 VMEHRFFLSINW  269 (337)
T ss_dssp             HHTSGGGTTCCH
T ss_pred             HHcCcccccCCH
Confidence            999999998753

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-52  Score=357.32  Aligned_cols=205  Identities=27%  Similarity=0.441  Sum_probs=161.2

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++|||||+++++|     .++.++|+|||||+ |+|.+++..    .+.+++..++.++.||+.||.|||++ ||+|
T Consensus        61 l~~l~HpnIv~l~~~~-----~~~~~~~lvmE~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~-~iiH  130 (307)
T d1a06a_          61 LHKIKHPNIVALDDIY-----ESGGHLYLIMQLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDL-GIVH  130 (307)
T ss_dssp             HHTCCCTTBCCEEEEE-----ECSSEEEEEECCCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHT-TCCC
T ss_pred             HHhCCCCCCCcEEEEE-----EECCEEEEEEeccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhhc-eeee
Confidence            4678999999999999     44556999999998 799999875    46799999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeC---CCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCC
Q 022799           80 RDIKPQNLLVNP---HTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPL  156 (292)
Q Consensus        80 ~dlkp~Nill~~---~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~p  156 (292)
                      |||||+||++..   ++ .+||+|||+|+.........+.+||+.|+|||++.+. .|+.++||||+||++|+|++|..|
T Consensus       131 rDiKp~Nil~~~~~~~~-~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~P  208 (307)
T d1a06a_         131 RDLKPENLLYYSLDEDS-KIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVIAYILLCGYPP  208 (307)
T ss_dssp             SCCCGGGEEESSSSTTC-CEEECCC------------------CTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             EEecccceeecccCCCc-eEEEeccceeEEccCCCeeeeeeeCccccCcHHHcCC-CCCcHHHhhhhhHHHHHHHhCCCC
Confidence            999999999953   45 7999999999877666656677899999999999765 589999999999999999999999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      |.+.+..+....+.+....++                         ....+.+|+++++||.+||+.||++|||++|+++
T Consensus       209 f~~~~~~~~~~~i~~~~~~~~-------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         209 FYDENDAKLFEQILKAEYEFD-------------------------SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             CCCSSHHHHHHHHHTTCCCCC-------------------------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCCCCHHHHHHHHhccCCCCC-------------------------CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            998887776666654211110                         1122468999999999999999999999999999


Q ss_pred             CCCccc
Q 022799          237 HPFFDE  242 (292)
Q Consensus       237 hp~~~~  242 (292)
                      ||||++
T Consensus       264 hp~~~~  269 (307)
T d1a06a_         264 HPWIAG  269 (307)
T ss_dssp             STTTTS
T ss_pred             CHhhCC
Confidence            999985

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-52  Score=353.62  Aligned_cols=236  Identities=33%  Similarity=0.572  Sum_probs=194.0

Q ss_pred             CCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCCC
Q 022799            4 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDIK   83 (292)
Q Consensus         4 l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dlk   83 (292)
                      ++||||++++++|.........+++++|||+++++..+....  ....+++..++.++.||+.||+|||++ ||+|||||
T Consensus        67 ~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH~~-~ivHrDiK  143 (305)
T d1blxa_          67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH-RVVHRDLK  143 (305)
T ss_dssp             TCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCC
T ss_pred             cCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC-CEEecCCC
Confidence            589999999999876555566789999999998766554432  246799999999999999999999998 99999999


Q ss_pred             CCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCCCcH
Q 022799           84 PQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESGV  163 (292)
Q Consensus        84 p~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~  163 (292)
                      |+|||++.++ .+||+|||+++............||+.|+|||++.+. .|+.++||||+||++|||++|+.||.+.+..
T Consensus       144 p~NILi~~~~-~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~-~y~~~~DiwSlG~il~ell~g~~pf~~~~~~  221 (305)
T d1blxa_         144 PQNILVTSSG-QIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDV  221 (305)
T ss_dssp             GGGEEECTTC-CEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             ccEEEEcCCC-CeeecchhhhhhhcccccCCCcccChhhcCcchhcCC-CCChhehhhchHHHHHHHHHCCCCCCCCCHH
Confidence            9999999888 7999999999876555555677899999999999765 4999999999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCCcccc
Q 022799          164 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDEL  243 (292)
Q Consensus       164 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~~~~~  243 (292)
                      +++.++.+..+.+....+....... ...+......+. ..+...+++.+++||.+||++||++|||++|+|+||||+++
T Consensus       222 ~~~~~i~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i  299 (305)
T d1blxa_         222 DQLGKILDVIGLPGEEDWPRDVALP-RQAFHSKSAQPI-EKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL  299 (305)
T ss_dssp             HHHHHHHHHHCCCCGGGSCTTCSSC-GGGSCCCCCCCG-GGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             HHHHHHHHhhCCCchhcccccccch-hhhhccccccch-hhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence            9999999999998877654321111 111111111122 22346789999999999999999999999999999999998


Q ss_pred             CCC
Q 022799          244 RDP  246 (292)
Q Consensus       244 ~~~  246 (292)
                      +..
T Consensus       300 ~~~  302 (305)
T d1blxa_         300 ERC  302 (305)
T ss_dssp             CCC
T ss_pred             hhh
Confidence            654

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-52  Score=351.00  Aligned_cols=206  Identities=29%  Similarity=0.417  Sum_probs=164.0

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCC---
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIG---   76 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~---   76 (292)
                      |++++|||||++++++.+.   ....+|+|||||+ |+|.+++.........+++..++.++.||+.||.|||++ |   
T Consensus        57 l~~l~HpnIv~~~~~~~~~---~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~-~~~~  132 (269)
T d2java1          57 LRELKHPNIVRYYDRIIDR---TNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR-SDGG  132 (269)
T ss_dssp             TTSCCCTTBCCEEEEEEC-------CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHH-CC--
T ss_pred             HHHCCCCCEeeEEEEEEeC---CCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHh-cCCC
Confidence            6789999999999988542   2334889999998 699999987666678899999999999999999999986 6   


Q ss_pred             --ccccCCCCCcEEEeCCCCcEEEeecCCccccccCC-CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhC
Q 022799           77 --VCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLG  153 (292)
Q Consensus        77 --i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g  153 (292)
                        |+||||||+|||++.++ .+||+|||+|+...... ......||+.|+|||++.+. .++.++||||+||++|||++|
T Consensus       133 ~~IiHrDiKp~NIll~~~~-~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyel~tg  210 (269)
T d2java1         133 HTVLHRDLKPANVFLDGKQ-NVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCAL  210 (269)
T ss_dssp             -------CCGGGEEECTTS-CEEECCHHHHHHC-----------CCCSCCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHS
T ss_pred             CCEEeCcCchhhcCcCCCC-cEEEeeccceeecccCCCccccCCCCcccCCHHHHcCC-CCChHHHHHhhCHHHHHHhhC
Confidence              99999999999999988 79999999998765433 23456899999999999654 589999999999999999999


Q ss_pred             CCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHH
Q 022799          154 QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE  233 (292)
Q Consensus       154 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e  233 (292)
                      ..||.+.+..+...++.....                   +         .++..+|+++++||.+||+.||.+|||++|
T Consensus       211 ~~Pf~~~~~~~~~~~i~~~~~-------------------~---------~~~~~~s~~l~~li~~~L~~dp~~Rps~~e  262 (269)
T d2java1         211 MPPFTAFSQKELAGKIREGKF-------------------R---------RIPYRYSDELNEIITRMLNLKDYHRPSVEE  262 (269)
T ss_dssp             SCSCCCSSHHHHHHHHHHTCC-------------------C---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCCCCCHHHHHHHHHcCCC-------------------C---------CCCcccCHHHHHHHHHHcCCChhHCcCHHH
Confidence            999998887776666544100                   0         122468999999999999999999999999


Q ss_pred             HhcCCCc
Q 022799          234 ALIHPFF  240 (292)
Q Consensus       234 ~l~hp~~  240 (292)
                      +++|||+
T Consensus       263 ll~hp~i  269 (269)
T d2java1         263 ILENPLI  269 (269)
T ss_dssp             HHTSTTC
T ss_pred             HHhCCcC
Confidence            9999996

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-52  Score=354.68  Aligned_cols=209  Identities=23%  Similarity=0.400  Sum_probs=177.1

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++|||||+++++|     .+..++|+|||||+ |+|.+++...    +.+++..++.++.||+.||+|||++ ||+|
T Consensus        67 l~~l~HpnIv~~~~~~-----~~~~~~~iv~E~~~gg~L~~~i~~~----~~l~~~~~~~~~~qi~~al~yLH~~-~ivH  136 (293)
T d1jksa_          67 LKEIQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHSL-QIAH  136 (293)
T ss_dssp             HHHCCCTTBCCEEEEE-----ECSSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TEEC
T ss_pred             HHhCCCCCCCcEEEEE-----EECCEEEEEEEcCCCccccchhccc----cccchhHHHHHHHHHHHHHHhhhhc-ceee
Confidence            3568999999999999     44556999999998 6999988763    5799999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCC---cEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCC
Q 022799           80 RDIKPQNLLVNPHTH---QLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPL  156 (292)
Q Consensus        80 ~dlkp~Nill~~~~~---~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~p  156 (292)
                      |||||+||+++.++.   .+||+|||+|..........+..||+.|+|||++.+. .++.++||||+||++|+|++|..|
T Consensus       137 rDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~P  215 (293)
T d1jksa_         137 FDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASP  215 (293)
T ss_dssp             CCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             cccccceEEEecCCCcccceEecchhhhhhcCCCccccccCCCCcccCHHHHcCC-CCCCcccchhhhHHHHHHHcCCCC
Confidence            999999999987652   4999999999887666666677899999999999664 589999999999999999999999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      |.+.+..+.+..+.......+                         ...++.+|+++++||++||+.||++|||++|+++
T Consensus       216 f~~~~~~~~~~~i~~~~~~~~-------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         216 FLGDTKQETLANVSAVNYEFE-------------------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             SCCSSHHHHHHHHHTTCCCCC-------------------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCCCCHHHHHHHHHhcCCCCC-------------------------chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            999888777776654321111                         1233568999999999999999999999999999


Q ss_pred             CCCccccCC
Q 022799          237 HPFFDELRD  245 (292)
Q Consensus       237 hp~~~~~~~  245 (292)
                      ||||+....
T Consensus       271 hp~~~~~~~  279 (293)
T d1jksa_         271 HPWIKPKDT  279 (293)
T ss_dssp             STTTCC---
T ss_pred             CcccCCCCh
Confidence            999987653

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-53  Score=354.57  Aligned_cols=206  Identities=27%  Similarity=0.424  Sum_probs=171.5

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++|||||++++++.+     ...+|+|||||+ |+|.+++...   ...+++..++.++.||+.||.|||++ ||+|
T Consensus        63 l~~l~HpnIv~l~~~~~~-----~~~~~lvmEy~~~g~L~~~~~~~---~~~l~e~~~~~i~~qi~~gL~ylH~~-~ivH  133 (288)
T d2jfla1          63 LASCDHPNIVKLLDAFYY-----ENNLWILIEFCAGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDN-KIIH  133 (288)
T ss_dssp             HHHCCCTTBCCEEEEEEE-----TTEEEEEEECCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT-TEEC
T ss_pred             HHhCCCCCCCeEEEEEee-----CCeEEEEEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CEEE
Confidence            456899999999999943     445899999998 6888887653   46799999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCC-CcccccccccccCCccccC----CCCCCchhHhhhhhHHHHHHHhCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFG----ATEYTAAIDIWSAGCVLAELLLGQ  154 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslG~il~el~~g~  154 (292)
                      |||||+|||++.++ .+||+|||+|+...... ...+..||+.|+|||++.+    ...|+.++||||+||++|+|++|+
T Consensus       134 rDiKp~NIll~~~~-~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~  212 (288)
T d2jfla1         134 RDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIE  212 (288)
T ss_dssp             CCCSGGGEEECTTS-CEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSS
T ss_pred             eecChhheeECCCC-CEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCC
Confidence            99999999999988 79999999997653321 2235679999999999842    344889999999999999999999


Q ss_pred             CCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHH
Q 022799          155 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA  234 (292)
Q Consensus       155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~  234 (292)
                      .||.+.+..+.+.++.+... +             ..            ..+..+|+++++||.+||+.||++|||++|+
T Consensus       213 ~Pf~~~~~~~~~~~i~~~~~-~-------------~~------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~el  266 (288)
T d2jfla1         213 PPHHELNPMRVLLKIAKSEP-P-------------TL------------AQPSRWSSNFKDFLKKCLEKNVDARWTTSQL  266 (288)
T ss_dssp             CTTTTSCGGGHHHHHHHSCC-C-------------CC------------SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             CCCCCCCHHHHHHHHHcCCC-C-------------CC------------CccccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence            99999888887777665210 0             00            0124689999999999999999999999999


Q ss_pred             hcCCCccc
Q 022799          235 LIHPFFDE  242 (292)
Q Consensus       235 l~hp~~~~  242 (292)
                      ++||||+.
T Consensus       267 l~hp~~~~  274 (288)
T d2jfla1         267 LQHPFVTV  274 (288)
T ss_dssp             TTSGGGCC
T ss_pred             hcCcccCC
Confidence            99999974

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-51  Score=349.71  Aligned_cols=236  Identities=35%  Similarity=0.671  Sum_probs=191.9

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      |++++|||||+++++|.+     ...+|+||||+++++...+...  ....+++..++.++.||+.||+|||++ ||+||
T Consensus        55 l~~l~Hp~Iv~~~~~~~~-----~~~~~iv~e~~~~~~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~~-~IiHr  126 (298)
T d1gz8a_          55 LKELNHPNIVKLLDVIHT-----ENKLYLVFEFLHQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHSH-RVLHR  126 (298)
T ss_dssp             HTTCCCTTBCCEEEEEEE-----TTEEEEEEECCSEEHHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCS
T ss_pred             HHhCCCCcEEEecccccc-----ccceeEEEeecCCchhhhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcC-CEEcc
Confidence            578999999999999944     4459999999998877766543  246799999999999999999999998 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccC-CCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      ||||+|||++.++ .+||+|||.|+..... .......||+.|+|||++.....++.++|+||+||++|+|++|+.||.+
T Consensus       127 DiKpeNIl~~~~~-~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~  205 (298)
T d1gz8a_         127 DLKPQNLLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG  205 (298)
T ss_dssp             CCCGGGEEECTTS-CEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ccCchheeecccC-cceeccCCcceeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCC
Confidence            9999999999888 7999999999876433 3344568999999999987777678999999999999999999999999


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCC-ccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCC
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNY-TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  238 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp  238 (292)
                      .+..+.+.++.+..+.+....+....... .....+......+... ...+|+++++||++||++||++|||++|+++||
T Consensus       206 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~  284 (298)
T d1gz8a_         206 DSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKV-VPPLDEDGRSLLSQMLHYDPNKRISAKAALAHP  284 (298)
T ss_dssp             SSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHH-STTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred             CCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhh-ccCCCHHHHHHHHHHccCChhHCcCHHHHhCCH
Confidence            99999999999998888765544321110 0111222222222222 246899999999999999999999999999999


Q ss_pred             CccccCCC
Q 022799          239 FFDELRDP  246 (292)
Q Consensus       239 ~~~~~~~~  246 (292)
                      ||+++..+
T Consensus       285 ff~~~~~p  292 (298)
T d1gz8a_         285 FFQDVTKP  292 (298)
T ss_dssp             GGTTCCCC
T ss_pred             hhccCCCC
Confidence            99988654

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2e-52  Score=361.58  Aligned_cols=211  Identities=26%  Similarity=0.411  Sum_probs=178.6

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++|||||+++++|.     +...+|+|||||+ |+|.+.+...   .+++++..++.++.||+.||.|||++ ||+|
T Consensus        77 l~~l~HpnIv~~~~~~~-----~~~~~~ivmE~~~gg~L~~~l~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~-~iiH  147 (350)
T d1koaa2          77 MSVLRHPTLVNLHDAFE-----DDNEMVMIYEFMSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN-NYVH  147 (350)
T ss_dssp             HHHTCCTTBCCEEEEEE-----ETTEEEEEECCCCSCBHHHHHTCT---TSCBCHHHHHHHHHHHHHHHHHHHHT-TEEC
T ss_pred             HHhCCCCCCCcEEEEEE-----ECCEEEEEEEcCCCCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhc-CCee
Confidence            35689999999999994     4445999999998 6998888542   45799999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCC-CCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           80 RDIKPQNLLVNPH-THQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        80 ~dlkp~Nill~~~-~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      |||||+|||++.+ .+.+||+|||+|+.........+..||+.|+|||++.+. .++.++||||+||++|+|++|+.||.
T Consensus       148 rDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~~-~~~~~~DiwSlGvilyell~G~~Pf~  226 (350)
T d1koaa2         148 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFG  226 (350)
T ss_dssp             CCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHHTC-CBCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             eeechhHeeeccCCCCeEEEeecchheecccccccceecCcccccCHHHHcCC-CCChhHhhhhhhHHHHHHHhCCCCCC
Confidence            9999999999643 237999999999988766666678899999999999775 48999999999999999999999999


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCC
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  238 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp  238 (292)
                      +.+..+.+..+......++.                         .....+|+++++||.+||+.||++|||++|+|+||
T Consensus       227 ~~~~~~~~~~i~~~~~~~~~-------------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp  281 (350)
T d1koaa2         227 GENDDETLRNVKSCDWNMDD-------------------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHP  281 (350)
T ss_dssp             CSSHHHHHHHHHHTCCCSCC-------------------------GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHST
T ss_pred             CCCHHHHHHHHHhCCCCCCc-------------------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence            98888887777653221111                         11246899999999999999999999999999999


Q ss_pred             CccccCCC
Q 022799          239 FFDELRDP  246 (292)
Q Consensus       239 ~~~~~~~~  246 (292)
                      ||+....+
T Consensus       282 ~~~~~~~~  289 (350)
T d1koaa2         282 WLTPGNAP  289 (350)
T ss_dssp             TTSCTTCC
T ss_pred             ccCCCCCC
Confidence            99976543

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.2e-52  Score=356.88  Aligned_cols=202  Identities=27%  Similarity=0.505  Sum_probs=174.3

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++|||||++++++     .+...+|+|||||+ |+|..++..    ...+++..++.++.||+.||.|||++ ||+|
T Consensus        58 l~~l~HpnIv~~~~~~-----~~~~~~~ivmE~~~gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~-~iiH  127 (316)
T d1fota_          58 LSIVTHPFIIRMWGTF-----QDAQQIFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK-DIIY  127 (316)
T ss_dssp             HHSCCBTTBCCEEEEE-----ECSSEEEEEECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT-TEEC
T ss_pred             HHhccCcChhheeeeE-----eeCCeeeeEeeecCCccccccccc----cccccccHHHHHHHHHHHhhhhhccC-cEEc
Confidence            4678999999999999     44556999999998 577777665    46789999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      |||||+|||++.++ .+||+|||+|+....  ...+.+||+.|+|||++.+. .|+.++|+||+||++|+|++|+.||.+
T Consensus       128 rDiKp~NILl~~~g-~vkL~DFG~a~~~~~--~~~~~~Gt~~Y~APE~l~~~-~y~~~~DiwSlGvilyemltG~~Pf~~  203 (316)
T d1fota_         128 RDLKPENILLDKNG-HIKITDFGFAKYVPD--VTYTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYD  203 (316)
T ss_dssp             CCCCGGGEEECTTS-CEEECCCSSCEECSS--CBCCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             cccCchheeEcCCC-CEEEecCccceEecc--ccccccCcccccCHHHHcCC-CCCchhhccccchhHHHHHhCCCCCCC
Confidence            99999999999988 799999999987643  34567899999999999664 489999999999999999999999999


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcc-----cHHHH
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEA  234 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----t~~e~  234 (292)
                      .+..+...++.+.-                 .            .+++.+|++++++|.+||..||.+|+     |++++
T Consensus       204 ~~~~~~~~~i~~~~-----------------~------------~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~i  254 (316)
T d1fota_         204 SNTMKTYEKILNAE-----------------L------------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDV  254 (316)
T ss_dssp             SSHHHHHHHHHHCC-----------------C------------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHH
T ss_pred             cCHHHHHHHHHcCC-----------------C------------CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHH
Confidence            88887777766521                 0            12246899999999999999999996     99999


Q ss_pred             hcCCCccccCC
Q 022799          235 LIHPFFDELRD  245 (292)
Q Consensus       235 l~hp~~~~~~~  245 (292)
                      ++||||+++.+
T Consensus       255 l~Hp~f~~i~~  265 (316)
T d1fota_         255 KNHPWFKEVVW  265 (316)
T ss_dssp             HTSGGGSSCCH
T ss_pred             HcCcccccCCH
Confidence            99999998764

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=3.8e-52  Score=360.08  Aligned_cols=207  Identities=28%  Similarity=0.435  Sum_probs=176.8

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++|+|||||+++++|     .++..+|+|||||+ |+|.+.+...   ..++++..++.++.||+.||.|||++ ||+|
T Consensus        80 l~~l~HpnIv~~~~~~-----~~~~~~~ivmE~~~gg~L~~~~~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~-~iiH  150 (352)
T d1koba_          80 MNQLHHPKLINLHDAF-----EDKYEMVLILEFLSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEH-SIVH  150 (352)
T ss_dssp             HTTCCSTTBCCEEEEE-----ECSSEEEEEEECCCCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHT-TEEC
T ss_pred             HHhCCCCCCCcEEEEE-----EECCEEEEEEEcCCCChHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-Ceee
Confidence            5789999999999999     44556999999999 6887766542   45799999999999999999999988 9999


Q ss_pred             cCCCCCcEEEe--CCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCC
Q 022799           80 RDIKPQNLLVN--PHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF  157 (292)
Q Consensus        80 ~dlkp~Nill~--~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf  157 (292)
                      |||||+|||++  .++ .+||+|||+|+............||+.|+|||++.+. .++.++||||+||++|+|++|..||
T Consensus       151 RDiKp~NILl~~~~~~-~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf  228 (352)
T d1koba_         151 LDIKPENIMCETKKAS-SVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPF  228 (352)
T ss_dssp             CCCCGGGEEESSTTCC-CEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSS
T ss_pred             cccccccccccccCCC-eEEEeecccceecCCCCceeeccCcccccCHHHHcCC-CCCCccchHHHHHHHHHHHhCCCCC
Confidence            99999999997  345 7999999999988766666677899999999999764 4899999999999999999999999


Q ss_pred             CCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          158 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      .+.+..+.+.++.+....++.                         .....+|+++++||.+||++||.+|||++|+|+|
T Consensus       229 ~~~~~~~~~~~i~~~~~~~~~-------------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         229 AGEDDLETLQNVKRCDWEFDE-------------------------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             CCSSHHHHHHHHHHCCCCCCS-------------------------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CCCCHHHHHHHHHhCCCCCCc-------------------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            998888877777653211110                         1124689999999999999999999999999999


Q ss_pred             CCcccc
Q 022799          238 PFFDEL  243 (292)
Q Consensus       238 p~~~~~  243 (292)
                      |||+..
T Consensus       284 p~~~~~  289 (352)
T d1koba_         284 PWLKGD  289 (352)
T ss_dssp             TTTSSC
T ss_pred             HhhCCC
Confidence            999864

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-52  Score=357.03  Aligned_cols=232  Identities=24%  Similarity=0.436  Sum_probs=166.4

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++|||||+++++|.     +...+|+|||||+ |+|.+++.+.    +.+++..++.++.||+.||.|||++.||+|
T Consensus        58 l~~l~HpnIv~l~~~~~-----~~~~~~iVmEy~~gg~L~~~l~~~----~~l~~~~~~~~~~qil~aL~yLH~~~~IiH  128 (322)
T d1s9ja_          58 LHECNSPYIVGFYGAFY-----SDGEISICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKHKIMH  128 (322)
T ss_dssp             GGGCCCTTBCCEEEEEE-----CSSEEEEEEECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHHCCCC
T ss_pred             HHhCCCCCCCcEEEEEE-----ECCEEEEEEEcCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHhCCEEc
Confidence            57899999999999994     4445999999999 5999988753    579999999999999999999996339999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      |||||+|||++.++ .+||+|||+|+..... ...+.+||+.|+|||++.+.. |+.++||||+||++|||++|+.||.+
T Consensus       129 RDiKP~NILl~~~~-~vkl~DFGla~~~~~~-~~~~~~GT~~Y~APEvl~~~~-y~~~~DiWSlGvil~ell~G~~Pf~~  205 (322)
T d1s9ja_         129 RDVKPSNILVNSRG-EIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPP  205 (322)
T ss_dssp             SCCSGGGEEECTTC-CEEECCCCCCHHHHHH-TC---CCSSCCCCHHHHHCSC-CCTTHHHHHHHHHHHHHHHSSCCSSC
T ss_pred             cccCHHHeeECCCC-CEEEeeCCCccccCCC-ccccccCCccccCchHHcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            99999999999988 7999999999876433 234578999999999998754 99999999999999999999999987


Q ss_pred             CCcHHH-HHHHHHHhCCCCHHHHhhcCCC--CccccCCCCCCC------------CchhhhccCCChhHHHHHHHHhccC
Q 022799          160 ESGVDQ-LVEIIKVLGTPTREEIKCMNPN--YTEFKFPQIKAH------------PWHKIFQKRMPPEAVDLVSRLLQYS  224 (292)
Q Consensus       160 ~~~~~~-~~~i~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~li~~~l~~d  224 (292)
                      .+.... ...+....+.+...........  ............            .........+|++++|||.+||++|
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d  285 (322)
T d1s9ja_         206 PDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKN  285 (322)
T ss_dssp             CCTTHHHHHC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSS
T ss_pred             CCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCC
Confidence            654332 2222222221111100000000  000000000000            0000011246889999999999999


Q ss_pred             CCCcccHHHHhcCCCccccC
Q 022799          225 PNLRSTALEALIHPFFDELR  244 (292)
Q Consensus       225 p~~R~t~~e~l~hp~~~~~~  244 (292)
                      |.+|||++|+|+||||++.+
T Consensus       286 P~~R~ta~e~L~Hpf~~~~~  305 (322)
T d1s9ja_         286 PAERADLKQLMVHAFIKRSD  305 (322)
T ss_dssp             TTTSCCHHHHHTSHHHHHHH
T ss_pred             hhHCcCHHHHhhCHhhCcCC
Confidence            99999999999999998754

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.2e-51  Score=351.07  Aligned_cols=202  Identities=26%  Similarity=0.435  Sum_probs=168.5

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      |++++|||||++++++.+     ...+|+|||||.|++...+...   .+++++..++.++.||+.||.|||++ ||+||
T Consensus        69 l~~l~HpnIv~~~~~~~~-----~~~~~iv~E~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH~~-~iiHr  139 (309)
T d1u5ra_          69 LQKLRHPNTIQYRGCYLR-----EHTAWLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH-NMIHR  139 (309)
T ss_dssp             HTTCCCTTBCCEEEEEEE-----TTEEEEEEECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCC
T ss_pred             HHHCCCCCEeeEEEEEEE-----CCEEEEEEEecCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhC-CEecc
Confidence            578999999999999944     3459999999995444433222   46799999999999999999999998 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCC--CCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA--TEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      ||||+|||++.++ .+||+|||+|.....   .....||+.|+|||++.+.  ..|+.++||||+||++|||++|..||.
T Consensus       140 DiKp~NILl~~~~-~~Kl~DFG~a~~~~~---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~  215 (309)
T d1u5ra_         140 DVKAGNILLSEPG-LVKLGDFGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF  215 (309)
T ss_dssp             CCSGGGEEEETTT-EEEECCCTTCBSSSS---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             CCCcceEEECCCC-CEEEeecccccccCC---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCC
Confidence            9999999999888 899999999987533   3456899999999998643  348999999999999999999999999


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCC
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  238 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp  238 (292)
                      +.+..+.+.++......+                           ..+..+|+++++||.+||+.||.+|||++|+|+||
T Consensus       216 ~~~~~~~~~~i~~~~~~~---------------------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp  268 (309)
T d1u5ra_         216 NMNAMSALYHIAQNESPA---------------------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (309)
T ss_dssp             TSCHHHHHHHHHHSCCCC---------------------------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred             CCCHHHHHHHHHhCCCCC---------------------------CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCH
Confidence            888777776665421100                           01145799999999999999999999999999999


Q ss_pred             Cccc
Q 022799          239 FFDE  242 (292)
Q Consensus       239 ~~~~  242 (292)
                      ||..
T Consensus       269 ~~~~  272 (309)
T d1u5ra_         269 FVLR  272 (309)
T ss_dssp             HHHS
T ss_pred             HhcC
Confidence            9975

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-51  Score=351.97  Aligned_cols=202  Identities=27%  Similarity=0.505  Sum_probs=173.6

Q ss_pred             CCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccC
Q 022799            3 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRD   81 (292)
Q Consensus         3 ~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~d   81 (292)
                      .++|||||++++++     .+...+|+|||||+ |+|.+++...    ..+++..++.++.||+.||+|||++ ||+|||
T Consensus        59 ~~~hp~Iv~~~~~~-----~~~~~~yivmEy~~~g~L~~~i~~~----~~~~e~~~~~~~~qi~~al~ylH~~-~iiHrD  128 (320)
T d1xjda_          59 AWEHPFLTHMFCTF-----QTKENLFFVMEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSK-GIVYRD  128 (320)
T ss_dssp             HTTCTTBCCEEEEE-----ECSSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCC
T ss_pred             hCCCCcEEEEEEEE-----ccCCceeEEEeecCCCcHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHhC-Ceeecc
Confidence            57999999999999     44556999999998 6999988753    6789999999999999999999998 999999


Q ss_pred             CCCCcEEEeCCCCcEEEeecCCccccccCC-CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCC
Q 022799           82 IKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGE  160 (292)
Q Consensus        82 lkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~  160 (292)
                      |||+|||++.++ .+||+|||+++...... ......||+.|+|||++.+. .++.++|+||+||++|+|++|+.||.+.
T Consensus       129 ikp~NiL~~~~~-~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~PF~~~  206 (320)
T d1xjda_         129 LKLDNILLDKDG-HIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQ  206 (320)
T ss_dssp             CCGGGEEECTTS-CEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CcccceeecCCC-ceeccccchhhhcccccccccccCCCCCcCCHHHHcCC-CCCchhhhhhhhHHHHHHHhCCCCCCCC
Confidence            999999999888 79999999998664433 33456899999999999765 4899999999999999999999999998


Q ss_pred             CcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHH-HHhcCCC
Q 022799          161 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAL-EALIHPF  239 (292)
Q Consensus       161 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~-e~l~hp~  239 (292)
                      +..+...++...  .+                           .++..+|+++++||++||+.||++|||+. ++++|||
T Consensus       207 ~~~~~~~~i~~~--~~---------------------------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpf  257 (320)
T d1xjda_         207 DEEELFHSIRMD--NP---------------------------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPL  257 (320)
T ss_dssp             SHHHHHHHHHHC--CC---------------------------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGG
T ss_pred             CHHHHHHHHHcC--CC---------------------------CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCch
Confidence            887777666431  11                           12246899999999999999999999995 8999999


Q ss_pred             ccccCC
Q 022799          240 FDELRD  245 (292)
Q Consensus       240 ~~~~~~  245 (292)
                      |+++++
T Consensus       258 f~~~~~  263 (320)
T d1xjda_         258 FREINW  263 (320)
T ss_dssp             GTTCCH
T ss_pred             hccCCH
Confidence            998753

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-50  Score=350.04  Aligned_cols=267  Identities=31%  Similarity=0.582  Sum_probs=204.3

Q ss_pred             CCCCCCCCeeeeceeeeccCC-CCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTE-KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~-~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++|||||+++++|..... ....++|+|||||+++|..++..     .++++..++.++.||+.||.|||++ ||+|
T Consensus        71 l~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~-~IiH  144 (346)
T d1cm8a_          71 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA-GIIH  144 (346)
T ss_dssp             HHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT-TEEC
T ss_pred             HHhcCCCCeeEEEEEeccCccccccceEEEEEecccccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHhC-CCcc
Confidence            457899999999999865432 23446899999998888877653     6799999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      |||||+|||++.++ .+|++|||.|+....  ......||+.|+|||++.+...++.++|+||+||++|+|++|..||.+
T Consensus       145 rDiKp~NIL~~~~~-~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~  221 (346)
T d1cm8a_         145 RDLKPGNLAVNEDC-ELKILDFGLARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG  221 (346)
T ss_dssp             CCCCGGGEEECTTC-CEEECCCTTCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cccCcchhhccccc-ccccccccceeccCC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCC
Confidence            99999999999988 799999999987643  345578999999999998777789999999999999999999999999


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc---ccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTE---FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      .+..+.+..+....+.++.+.+.........   ...+......+... ...++++++|||.+||++||++|||++|+|+
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~  300 (346)
T d1cm8a_         222 SDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASI-LTNASPLAVNLLEKMLVLDAEQRVTAGEALA  300 (346)
T ss_dssp             SSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGT-CTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHh-ccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            9999999999999999998876554322110   01222222333322 2578999999999999999999999999999


Q ss_pred             CCCccccCCCCCCCCCCCCCCCCCCCChhccCCCCHHHHhhhchHHH
Q 022799          237 HPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHA  283 (292)
Q Consensus       237 hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (292)
                      ||||+++.+........     .+...-.+. ..+.+.+++++.++.
T Consensus       301 Hp~f~~~~~~~~~~~~~-----~~~~~~~~~-~~~~~e~k~~~~~e~  341 (346)
T d1cm8a_         301 HPYFESLHDTEDEPQVQ-----KYDDSFDDV-DRTLDEWKRVTYKEV  341 (346)
T ss_dssp             SGGGTTTC------CCC-----CCCCC------CCHHHHHHHHHHHH
T ss_pred             ChhhCcCCCccccccCC-----CCCCchhhh-hcCHHHHHHHHHHHh
Confidence            99999987654332111     111111222 245677777655543

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=4.5e-51  Score=355.08  Aligned_cols=207  Identities=27%  Similarity=0.379  Sum_probs=171.6

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++|||||+++++|     .+...+|+|||||+ |+|.+++...    ..+++..++.++.||+.||.|||++ ||+|
T Consensus        61 l~~~~hpnIv~l~~~~-----~~~~~~~ivmE~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~ylH~~-~iiH  130 (364)
T d1omwa3          61 VSTGDCPFIVCMSYAF-----HTPDKLSFILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHNR-FVVY  130 (364)
T ss_dssp             HSSSCCTTBCCEEEEE-----ECSSEEEEEECCCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT-TEEC
T ss_pred             HhcCCCCcEEEEEEEE-----EECCEEEEEEEecCCCcHHHHHHhc----ccccHHHHHHHHHHHHHHHHHHHHC-Cccc
Confidence            3567899999999999     44445999999998 7999988763    6789999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      |||||+|||++.++ .+||+|||+|+...... .....||+.|+|||++.+...|+.++||||+||++|+|++|+.||.+
T Consensus       131 rDlKP~NILl~~~g-~iKl~DFGla~~~~~~~-~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~  208 (364)
T d1omwa3         131 RDLKPANILLDEHG-HVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ  208 (364)
T ss_dssp             CCCSGGGEEECSSS-CEEECCCTTCEECSSSC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred             eeeccceeEEcCCC-cEEEeeeceeeecCCCc-ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCC
Confidence            99999999999988 79999999998765443 34568999999999997666689999999999999999999999987


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCccc-----HHHH
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRST-----ALEA  234 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t-----~~e~  234 (292)
                      .+..+... +.+.....                         ...++..+|+++++||.+||+.||++|||     |+|+
T Consensus       209 ~~~~~~~~-~~~~~~~~-------------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~ei  262 (364)
T d1omwa3         209 HKTKDKHE-IDRMTLTM-------------------------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEV  262 (364)
T ss_dssp             SCSSCHHH-HHHHSSSC-------------------------CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHH
T ss_pred             CCHHHHHH-HHHhcccC-------------------------CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHH
Confidence            65433322 22211000                         00123568999999999999999999999     8999


Q ss_pred             hcCCCccccCC
Q 022799          235 LIHPFFDELRD  245 (292)
Q Consensus       235 l~hp~~~~~~~  245 (292)
                      ++||||+++++
T Consensus       263 l~Hp~f~~i~~  273 (364)
T d1omwa3         263 KESPFFRSLDW  273 (364)
T ss_dssp             HTSGGGTTCCH
T ss_pred             HcCccccCCCH
Confidence            99999998764

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=3.2e-51  Score=343.34  Aligned_cols=205  Identities=28%  Similarity=0.429  Sum_probs=175.4

Q ss_pred             CCC-CCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            3 LLD-HPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         3 ~l~-HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      +++ |||||+++++|     .++.++|||||||+ |+|.+++...    +.+++..++.++.||+.||+|||++ ||+||
T Consensus        65 ~l~~hpnIv~~~~~~-----~~~~~~~ivmE~~~~g~L~~~l~~~----~~l~e~~~~~~~~qi~~al~~lH~~-~ivHr  134 (277)
T d1phka_          65 KVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKL-NIVHR  134 (277)
T ss_dssp             HHTTCTTBCCEEEEE-----ECSSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT-TEECS
T ss_pred             HhcCCCCeEEEEeec-----ccCcceEEEEEcCCCchHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHc-CCccc
Confidence            455 99999999999     45556999999998 6999999753    6799999999999999999999988 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccC-----CCCCCchhHhhhhhHHHHHHHhCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG-----ATEYTAAIDIWSAGCVLAELLLGQP  155 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DvwslG~il~el~~g~~  155 (292)
                      ||||+||+++.++ .+||+|||+++............||+.|+|||.+.+     ...++.++|+||+||++|+|++|+.
T Consensus       135 Dlkp~Nill~~~~-~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~  213 (277)
T d1phka_         135 DLKPENILLDDDM-NIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP  213 (277)
T ss_dssp             CCSGGGEEECTTC-CEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred             ccccceEEEcCCC-CeEEccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCC
Confidence            9999999999888 799999999998876666667789999999999853     3347899999999999999999999


Q ss_pred             CCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHh
Q 022799          156 LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL  235 (292)
Q Consensus       156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l  235 (292)
                      ||.+.+.......+.+.-..++                         .....++|+++++||.+||+.||++|||++|+|
T Consensus       214 Pf~~~~~~~~~~~i~~~~~~~~-------------------------~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil  268 (277)
T d1phka_         214 PFWHRKQMLMLRMIMSGNYQFG-------------------------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEAL  268 (277)
T ss_dssp             SSCCSSHHHHHHHHHHTCCCCC-------------------------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHT
T ss_pred             CCCCCCHHHHHHHHHhCCCCCC-------------------------CcccccCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence            9999888777777665311111                         001246899999999999999999999999999


Q ss_pred             cCCCcccc
Q 022799          236 IHPFFDEL  243 (292)
Q Consensus       236 ~hp~~~~~  243 (292)
                      +||||+.+
T Consensus       269 ~h~~~~~~  276 (277)
T d1phka_         269 AHPFFQQY  276 (277)
T ss_dssp             TSGGGCTT
T ss_pred             cCHHHHHh
Confidence            99999863

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1e-50  Score=351.11  Aligned_cols=202  Identities=26%  Similarity=0.418  Sum_probs=175.0

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++|||||+++++|     .+...+++||||+. |+|...+...    +.+++..++.++.||+.||.|||++ ||+|
T Consensus        95 l~~l~hpnIv~~~~~~-----~~~~~~~~v~e~~~~g~l~~~l~~~----~~l~e~~~~~i~~qi~~aL~yLH~~-~iiH  164 (350)
T d1rdqe_          95 LQAVNFPFLVKLEFSF-----KDNSNLYMVMEYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL-DLIY  164 (350)
T ss_dssp             HTTCCCTTBCCEEEEE-----ECSSEEEEEEECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT-TEEC
T ss_pred             HHHcCCCcEeeccccc-----ccccccccccccccccchhhhHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC-CEec
Confidence            5789999999999999     44555899999998 6888888653    6799999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      |||||+|||++.++ .+||+|||+|+....  ...+..||+.|+|||++.+. .++.++|+|||||++|+|++|..||.+
T Consensus       165 RDIKP~NILl~~~g-~ikL~DFG~a~~~~~--~~~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~  240 (350)
T d1rdqe_         165 RDLKPENLLIDQQG-YIQVTDFGFAKRVKG--RTWTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFA  240 (350)
T ss_dssp             CCCSGGGEEECTTS-CEEECCCTTCEECSS--CBCCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CcCCHHHcccCCCC-CEEeeeceeeeeccc--ccccccCccccCCHHHHcCC-CCCccccccchhHHHHHHHhCCCCCCC
Confidence            99999999999988 799999999987643  34567899999999999765 489999999999999999999999999


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcc-----cHHHH
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TALEA  234 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----t~~e~  234 (292)
                      .+......++.....                             .++..+|+++.+||++||+.||.+|+     |++++
T Consensus       241 ~~~~~~~~~i~~~~~-----------------------------~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~el  291 (350)
T d1rdqe_         241 DQPIQIYEKIVSGKV-----------------------------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDI  291 (350)
T ss_dssp             SSHHHHHHHHHHCCC-----------------------------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHH
T ss_pred             cCHHHHHHHHhcCCC-----------------------------CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHH
Confidence            888777777654210                             01246899999999999999999995     99999


Q ss_pred             hcCCCccccCC
Q 022799          235 LIHPFFDELRD  245 (292)
Q Consensus       235 l~hp~~~~~~~  245 (292)
                      ++||||+++++
T Consensus       292 l~Hp~f~~~~~  302 (350)
T d1rdqe_         292 KNHKWFATTDW  302 (350)
T ss_dssp             HTSGGGTTCCH
T ss_pred             HcCccccCCCH
Confidence            99999998764

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=4e-50  Score=339.15  Aligned_cols=231  Identities=35%  Similarity=0.654  Sum_probs=185.5

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      |++++|||||+++++|..     ....+++|||+.+++...+...   .+.+++..++.++.||+.||+|||++ ||+||
T Consensus        54 l~~l~hpnIv~~~~~~~~-----~~~~~i~~e~~~~~~~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~-~IvHr  124 (286)
T d1ob3a_          54 LKELKHSNIVKLYDVIHT-----KKRLVLVFEHLDQDLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDR-RVLHR  124 (286)
T ss_dssp             GGGCCCTTBCCEEEEEEC-----SSCEEEEEECCSEEHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCS
T ss_pred             HHhCCCCcEEeeeeeccc-----CCceeEEEEeehhhhHHHHHhh---cCCcchhhhHHHHHHHHHHHHHhccC-cEEec
Confidence            578899999999999943     4448999999998776666543   47799999999999999999999987 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCCC-cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      ||||+|||++.++ .+|++|||.+........ .....+++.|+|||.+.+...++.++|+||+||++|||++|+.||.+
T Consensus       125 DiKp~NIll~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~  203 (286)
T d1ob3a_         125 DLKPQNLLINREG-ELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPG  203 (286)
T ss_dssp             CCCGGGEEECTTS-CEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             CCCCceeeEcCCC-CEEecccccceecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCC
Confidence            9999999999988 799999999987644322 34456899999999998777789999999999999999999999999


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCc-cccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCC
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYT-EFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  238 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp  238 (292)
                      .+..+++.++.+..+.+....+........ ..........++. .+...+++++.|||++||++||++|||++|+|+||
T Consensus       204 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp  282 (286)
T d1ob3a_         204 VSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWE-SFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHA  282 (286)
T ss_dssp             SSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGG-GTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred             CCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchh-hhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence            999999999999999988766543321111 1111222222222 23467899999999999999999999999999999


Q ss_pred             Cccc
Q 022799          239 FFDE  242 (292)
Q Consensus       239 ~~~~  242 (292)
                      ||++
T Consensus       283 ~f~~  286 (286)
T d1ob3a_         283 YFKE  286 (286)
T ss_dssp             GGGC
T ss_pred             ccCc
Confidence            9974

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-50  Score=347.45  Aligned_cols=207  Identities=28%  Similarity=0.443  Sum_probs=176.9

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++|||||+++++|     .+...+|+|||||+ |+|.+++...   ...+++.+++.++.||+.||+|||++ ||+|
T Consensus        55 l~~l~HpnIv~~~~~~-----~~~~~~~lvmE~~~gg~L~~~i~~~---~~~l~e~~~~~i~~qi~~al~yLH~~-~iiH  125 (321)
T d1tkia_          55 LNIARHRNILHLHESF-----ESMEELVMIFEFISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH-NIGH  125 (321)
T ss_dssp             HHHSCCTTBCCEEEEE-----EETTEEEEEECCCCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT-TEEC
T ss_pred             HHhCCCCCCCeEEEEE-----EECCEEEEEEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHc-CCCc
Confidence            4568999999999999     44445999999999 5999888642   34799999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCC-CcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCC
Q 022799           80 RDIKPQNLLVNPHT-HQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFP  158 (292)
Q Consensus        80 ~dlkp~Nill~~~~-~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~  158 (292)
                      |||||+|||++.++ ..+||+|||+++............+|+.|+|||.+.+. .++.++|+||+||++|+|++|..||.
T Consensus       126 rDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~~~-~~~~~~DiWSlGvily~ll~G~~Pf~  204 (321)
T d1tkia_         126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFL  204 (321)
T ss_dssp             CCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred             ccccccceeecCCCceEEEEcccchhhccccCCcccccccccccccchhccCC-CCCchhhcccHHHHHHHHHhCCCCCC
Confidence            99999999997532 36999999999887665556667899999999999665 48999999999999999999999999


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCC
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHP  238 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp  238 (292)
                      +.+..+.+.++.+....++...                         .+.+|+++++||.+||+.||.+|||++|+++||
T Consensus       205 ~~~~~~~~~~i~~~~~~~~~~~-------------------------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp  259 (321)
T d1tkia_         205 AETNQQIIENIMNAEYTFDEEA-------------------------FKEISIEAMDFVDRLLVKERKSRMTASEALQHP  259 (321)
T ss_dssp             CSSHHHHHHHHHHTCCCCCHHH-------------------------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             CCCHHHHHHHHHhCCCCCChhh-------------------------ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence            9998888888776433332222                         246899999999999999999999999999999


Q ss_pred             Cccc
Q 022799          239 FFDE  242 (292)
Q Consensus       239 ~~~~  242 (292)
                      ||+.
T Consensus       260 ~~~~  263 (321)
T d1tkia_         260 WLKQ  263 (321)
T ss_dssp             HHHS
T ss_pred             hhcc
Confidence            9975

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-49  Score=341.33  Aligned_cols=271  Identities=34%  Similarity=0.664  Sum_probs=205.9

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHR   80 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~   80 (292)
                      |++++||||+++++++.........++|++|++++|+|.+++..     .++++..++.++.||+.||+|||++ ||+||
T Consensus        60 l~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~-~iiHR  133 (345)
T d1pmea_          60 LLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-NVLHR  133 (345)
T ss_dssp             HHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT-TEECC
T ss_pred             HHHcCCCCCCcEEEEEeeccccccceEEEEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CCcCC
Confidence            45789999999999986654444556788888777999999864     4699999999999999999999998 99999


Q ss_pred             CCCCCcEEEeCCCCcEEEeecCCccccccCC----CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCC
Q 022799           81 DIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE----PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPL  156 (292)
Q Consensus        81 dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~p  156 (292)
                      ||||+|||++.++ .+||+|||+++......    .....+||+.|+|||++.....++.++|+||+||++|+|++|..|
T Consensus       134 DIKp~NILl~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~p  212 (345)
T d1pmea_         134 DLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI  212 (345)
T ss_dssp             CCCGGGEEECTTC-CEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCS
T ss_pred             CCCcceEEECCCC-CEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCC
Confidence            9999999999888 79999999997653322    234467899999999986666689999999999999999999999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCC---ccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHH
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNY---TEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE  233 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e  233 (292)
                      |.+.+..++..........+............   .....+.....++...+ +.+++++++||.+||++||.+|||++|
T Consensus       213 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~~li~~~L~~dP~~R~ta~e  291 (345)
T d1pmea_         213 FPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQ  291 (345)
T ss_dssp             CCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHC-TTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred             CCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhC-CCCCHHHHHHHHHHccCChhHCcCHHH
Confidence            99999999999999988888876543321110   00112222233333333 578999999999999999999999999


Q ss_pred             HhcCCCccccCCCCCCCCCCCCCCCCCCCChhccCCCCHHHHhhhchHHHH
Q 022799          234 ALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHAR  284 (292)
Q Consensus       234 ~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (292)
                      +|+||||+....+....    ..+...++. .+....+.+.+++++.++..
T Consensus       292 ~L~hpf~~~~~~~~~~~----~~~~~~~~~-~~~~~~~~~~l~~l~~~e~~  337 (345)
T d1pmea_         292 ALAHPYLEQYYDPSDEP----IAEAPFKFD-MELDDLPKEKLKELIFEETA  337 (345)
T ss_dssp             HHTSGGGTTTCCGGGSC----CCSSCC---------CCHHHHHHHHHHHSG
T ss_pred             HhcCHhhccCCCCccCc----cccCccCCC-hhhhhCCHHHHHHHHHHHHH
Confidence            99999999766543332    223334443 66777788888776555433

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-50  Score=343.16  Aligned_cols=214  Identities=26%  Similarity=0.396  Sum_probs=168.9

Q ss_pred             CCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccC
Q 022799            3 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRD   81 (292)
Q Consensus         3 ~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~d   81 (292)
                      .++|||||+++++|.+.. ....++|+|||||+ |+|.+++...  ...++++.+++.++.||+.||+|||++ ||+|||
T Consensus        61 ~~~hpnIv~l~~~~~~~~-~~~~~~~ivmEy~~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~-~iiHRD  136 (335)
T d2ozaa1          61 ASQCPHIVRIVDVYENLY-AGRKCLLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI-NIAHRD  136 (335)
T ss_dssp             HTTSTTBCCEEEEEEEEE-TTEEEEEEEEECCCSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHHT-TEECCC
T ss_pred             hcCCCCCCeEEEEEeecc-cCCCEEEEEEECCCCCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHHHHc-CCcccc
Confidence            358999999999985432 33567899999998 6999998753  135699999999999999999999988 999999


Q ss_pred             CCCCcEEEeCCC--CcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           82 IKPQNLLVNPHT--HQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        82 lkp~Nill~~~~--~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      |||+|||++.+.  ..+||+|||+|+............||+.|+|||++.+. .|+.++|+||+||++|+|+||..||.+
T Consensus       137 iKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~y~~~~DiwSlGvily~lltg~~Pf~~  215 (335)
T d2ozaa1         137 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYS  215 (335)
T ss_dssp             CSGGGEEESCSSTTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGG-GGSHHHHHHHHHHHHHHHTTSSCSCEE
T ss_pred             ccccccccccccccccccccccceeeeccCCCccccccCCcccCCcHHHcCC-CCCHHHHHHhhchhHHHHhhCCCCCCC
Confidence            999999997522  26999999999987766666778899999999999654 499999999999999999999999987


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCC
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPF  239 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~  239 (292)
                      .+.......+.....             ...+.++        ......+|+++++||++||+.||++|||+.|+++|||
T Consensus       216 ~~~~~~~~~~~~~i~-------------~~~~~~~--------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~  274 (335)
T d2ozaa1         216 NHGLAISPGMKTRIR-------------MGQYEFP--------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW  274 (335)
T ss_dssp             TTCC--------CCC-------------SCSSSCC--------TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHH
T ss_pred             CCHHHHHHHHHHHHh-------------cCCCCCC--------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHH
Confidence            765544333322110             0011111        1111358999999999999999999999999999999


Q ss_pred             ccc
Q 022799          240 FDE  242 (292)
Q Consensus       240 ~~~  242 (292)
                      |.+
T Consensus       275 ~~~  277 (335)
T d2ozaa1         275 IMQ  277 (335)
T ss_dssp             HHT
T ss_pred             hhC
Confidence            975

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-50  Score=334.33  Aligned_cols=194  Identities=28%  Similarity=0.444  Sum_probs=161.5

Q ss_pred             CCCCeeeeceeeeccCCCCceeEEEEeeccc--CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCC
Q 022799            5 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDI   82 (292)
Q Consensus         5 ~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~--g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dl   82 (292)
                      .|||||+++++|     .+...+++||||+.  +++.+++..    ...+++..++.++.||+.||.|||++ ||+||||
T Consensus        67 ~h~nIv~~~~~~-----~~~~~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~~-~iiHrDi  136 (273)
T d1xwsa_          67 GFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC-GVLHRDI  136 (273)
T ss_dssp             SSCSBCCEEEEE-----ECSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCC
T ss_pred             CCCCccEEEEEE-----eeCCeEEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCccccC
Confidence            399999999999     44445899999997  377777765    36799999999999999999999998 9999999


Q ss_pred             CCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCCCCc
Q 022799           83 KPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPGESG  162 (292)
Q Consensus        83 kp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~  162 (292)
                      ||+||+++.+...+||+|||+|+.... ....+..||+.|+|||++.+...++.++|+||+||++|+|++|+.||.+.+ 
T Consensus       137 Kp~NIll~~~~~~vkl~DFG~a~~~~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-  214 (273)
T d1xwsa_         137 KDENILIDLNRGELKLIDFGSGALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-  214 (273)
T ss_dssp             SGGGEEEETTTTEEEECCCTTCEECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-
T ss_pred             cccceEEecCCCeEEECccccceeccc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-
Confidence            999999997655899999999986533 334567899999999999776656788999999999999999999997532 


Q ss_pred             HHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcCCCccc
Q 022799          163 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIHPFFDE  242 (292)
Q Consensus       163 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~hp~~~~  242 (292)
                           .+.+.                 ..            .++..+|+++++||++||+.||++|||++|+++||||++
T Consensus       215 -----~i~~~-----------------~~------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~  260 (273)
T d1xwsa_         215 -----EIIRG-----------------QV------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD  260 (273)
T ss_dssp             -----HHHHC-----------------CC------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred             -----HHhhc-----------------cc------------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence                 11110                 00            123568999999999999999999999999999999987


Q ss_pred             cC
Q 022799          243 LR  244 (292)
Q Consensus       243 ~~  244 (292)
                      +.
T Consensus       261 ~~  262 (273)
T d1xwsa_         261 VL  262 (273)
T ss_dssp             CC
T ss_pred             CC
Confidence            54

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-48  Score=334.27  Aligned_cols=267  Identities=32%  Similarity=0.580  Sum_probs=202.7

Q ss_pred             CCCCCCCCeeeeceeeeccCC-CCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTE-KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~-~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++|||||+++++|..... ++...+++++++++|+|.+++.     .+++++..++.++.||+.||+|||++ ||+|
T Consensus        71 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~LH~~-giiH  144 (348)
T d2gfsa1          71 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA-DIIH  144 (348)
T ss_dssp             HHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT-TCCC
T ss_pred             HHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhcc-----cccccHHHHHHHHHHHHHHHHHHHhC-CCcc
Confidence            357899999999999865443 2334455666665689998875     35799999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      |||||+|||++.++ .+|++|||.+....  ....+..||+.|+|||+..+...++.++|+||+||++|+|++|..||.+
T Consensus       145 rDiKp~NILi~~~~-~~kl~dfg~a~~~~--~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~  221 (348)
T d2gfsa1         145 RDLKPSNLAVNEDC-ELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG  221 (348)
T ss_dssp             CCCCGGGEEECTTC-CEEECCC----CCT--GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccCCccccccccc-cccccccchhcccC--cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCC
Confidence            99999999999988 79999999997653  3344567899999999987777689999999999999999999999999


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc---ccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTE---FKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      .+.......+.+..+.+..+...........   ..........+...+ ..++++++|||++||+.||.+|||++|+|+
T Consensus       222 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         222 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             SSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHS-TTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhc-CCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence            9999999999999999887765433211100   011222222333222 468999999999999999999999999999


Q ss_pred             CCCccccCCCCCCCCCCCCCCCCCCCChhccCCCCHHHHhhhchHHH
Q 022799          237 HPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEHA  283 (292)
Q Consensus       237 hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (292)
                      ||||+.+.++......     ..+.. ..+.+....+.+++++.++.
T Consensus       301 Hp~f~~~~~~~~~~~~-----~~~~~-~~~~~~~~~~~~k~~~~~e~  341 (348)
T d2gfsa1         301 HAYFAQYHDPDDEPVA-----DPYDQ-SFESRDLLIDEWKSLTYDEV  341 (348)
T ss_dssp             SGGGTTTCCTTSCCCC-----CCCCC-GGGGCCCCHHHHHHHHHHHH
T ss_pred             CHhhCCCCCCccCCCC-----CCCCC-cccchhcCHHHHHHHHHHHh
Confidence            9999988765443221     22222 24556778888888765543

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-48  Score=337.04  Aligned_cols=269  Identities=29%  Similarity=0.538  Sum_probs=193.4

Q ss_pred             CCCCCCCCeeeeceeeeccCC-CCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTE-KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~-~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++|||||+++++|..... ++..++|+|||||.|++.+.+.      ..+++..++.++.||+.||.|||+. ||+|
T Consensus        70 l~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~-giiH  142 (355)
T d2b1pa1          70 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA-GIIH  142 (355)
T ss_dssp             HHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT-TCCC
T ss_pred             HHhcCCCCeeEEEEEEecccccccCceeEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhc-cccc
Confidence            356899999999999865432 3456799999999988777653      5689999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      |||||+|||++.++ .++++|||.++............+|+.|+|||++.+. .++.++|+||+||++|+|++|+.||.+
T Consensus       143 rDlKP~Nil~~~~~-~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~-~~~~~~DiwSlG~~l~ell~g~~pF~~  220 (355)
T d2b1pa1         143 RDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPG  220 (355)
T ss_dssp             SCCCGGGEEECTTC-CEEECCCCC---------------CCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ccCCcccccccccc-ceeeechhhhhccccccccccccccccccChhhhcCC-CCCCCcccccccchHHHHhhCCCCCCC
Confidence            99999999999988 6999999999877666666677899999999999775 589999999999999999999999999


Q ss_pred             CCcHHHHHHHHHHhCCCCHHHHhhcCCCCccc--cCCCCCCCCchh-----------hhccCCChhHHHHHHHHhccCCC
Q 022799          160 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF--KFPQIKAHPWHK-----------IFQKRMPPEAVDLVSRLLQYSPN  226 (292)
Q Consensus       160 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~-----------~~~~~~~~~~~~li~~~l~~dp~  226 (292)
                      .+......++....+.+..+.+..........  ..+......+..           ......+++++|||++||++||+
T Consensus       221 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~  300 (355)
T d2b1pa1         221 RDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA  300 (355)
T ss_dssp             SSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTT
T ss_pred             CCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChh
Confidence            99999999999999999888775443221111  000111111111           11123577899999999999999


Q ss_pred             CcccHHHHhcCCCccccCCCCCCCCCCCCCCCCCCCChhccCCCCHHHHhhhchHH
Q 022799          227 LRSTALEALIHPFFDELRDPNTRLPNGRFLPPLFNFKPHELKGVPVDMLVKLIPEH  282 (292)
Q Consensus       227 ~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (292)
                      +||||+|+|+||||+...++.....   ..|..++.. .+.+..+.+.|+.++...
T Consensus       301 ~R~ta~elL~Hpw~~~~~~~~~~~~---~~~~~~~~~-~~~~~~~~~~~~~~~~~~  352 (355)
T d2b1pa1         301 KRISVDDALQHPYINVWYDPAEVEA---PPPQIYDKQ-LDEREHTIEEWKELIYKE  352 (355)
T ss_dssp             TSCCHHHHHTSTTTGGGCCHHHHTC---CCC--------CCCCCCHHHHHHHHHHH
T ss_pred             HCcCHHHHhcCcccCCCCCcccccC---CCCCCCCcc-hhhhhcCHHHHHHHHHHH
Confidence            9999999999999997654322211   112223322 233566777787766543

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-48  Score=322.73  Aligned_cols=203  Identities=20%  Similarity=0.268  Sum_probs=162.8

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++|||||++++++..      ..+++|||||+ |+|.+++...   ...+++..+..++.||+.||+|||++ ||+|
T Consensus        58 l~~l~HpnIv~~~~~~~~------~~~~lv~Ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~-~ivH  127 (276)
T d1uwha_          58 LRKTRHVNILLFMGYSTA------PQLAIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAK-SIIH  127 (276)
T ss_dssp             HTTCCCTTBCCEEEEECS------SSCEEEEECCCEEEHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT-TCCC
T ss_pred             HHhCCCCCEeeeeEEEec------cEEEEEEecCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHhcC-CEec
Confidence            578999999999997521      13789999999 7999988653   45699999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCC---CcccccccccccCCccccCC--CCCCchhHhhhhhHHHHHHHhCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGA--TEYTAAIDIWSAGCVLAELLLGQ  154 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwslG~il~el~~g~  154 (292)
                      |||||+|||++.++ .+||+|||+|+......   ......||+.|+|||++.+.  ..|+.++||||+||++|||+||+
T Consensus       128 rDlKp~NiLl~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~  206 (276)
T d1uwha_         128 RDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ  206 (276)
T ss_dssp             SCCCGGGEEEETTS-SEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred             cccCHHHEEEcCCC-CEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCC
Confidence            99999999999988 79999999997764322   22345789999999998643  34799999999999999999999


Q ss_pred             CCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHH
Q 022799          155 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA  234 (292)
Q Consensus       155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~  234 (292)
                      .||.+.+....+.........++.                       ....+.++|+++.+||.+||..||++|||++++
T Consensus       207 ~Pf~~~~~~~~~~~~~~~~~~~p~-----------------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i  263 (276)
T d1uwha_         207 LPYSNINNRDQIIFMVGRGYLSPD-----------------------LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQI  263 (276)
T ss_dssp             CTTTTCCCHHHHHHHHHHTSCCCC-----------------------GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCCCCChHHHHHHHHhcCCCCCc-----------------------chhccccchHHHHHHHHHHcCCCHhHCcCHHHH
Confidence            999988777666655543221110                       011235689999999999999999999999999


Q ss_pred             hcC
Q 022799          235 LIH  237 (292)
Q Consensus       235 l~h  237 (292)
                      +++
T Consensus       264 l~~  266 (276)
T d1uwha_         264 LAS  266 (276)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            975

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-47  Score=322.53  Aligned_cols=234  Identities=32%  Similarity=0.542  Sum_probs=184.0

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeecccC-CHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPE-TVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++|||||++++++     .+....++|+|++.| ++..++..    .+.+++..++.++.|++.||+|||++ ||+|
T Consensus        55 l~~l~h~niv~~~~~~-----~~~~~~~iv~~~~~~~~l~~~~~~----~~~~~~~~~~~~~~q~~~aL~~lH~~-~IvH  124 (292)
T d1unla_          55 LKELKHKNIVRLHDVL-----HSDKKLTLVFEFCDQDLKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCHSR-NVLH  124 (292)
T ss_dssp             HTTCCCTTBCCEEEEE-----ECSSEEEEEEECCSEEHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHT-TEEC
T ss_pred             HHhcCcCCEEeecccc-----ccccceeEEeeecccccccccccc----ccccchhHHHHHHHHHHHHHHHhhcC-CEee
Confidence            5789999999999999     444458999999996 44444443    57789999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCC-CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCC-
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF-  157 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf-  157 (292)
                      |||||+|||++.++ .+||+|||.++...... ......+++.|+|||++.+...++.++|+||+||++|+|++|..|| 
T Consensus       125 rDiKP~NIli~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  203 (292)
T d1unla_         125 RDLKPQNLLINRNG-ELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF  203 (292)
T ss_dssp             CCCSGGGEEECTTC-CEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred             ecccCcccccccCC-ceeeeecchhhcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCC
Confidence            99999999999888 79999999998765443 2334467889999999977766899999999999999999999875 


Q ss_pred             CCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          158 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      .+.+..+.+.++....+.+....+............+..............+++.+.+||++||++||.+||||+|+|+|
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         204 PGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             CCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             CCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            55666777788888888877655443322111111122222222223346789999999999999999999999999999


Q ss_pred             CCccccCC
Q 022799          238 PFFDELRD  245 (292)
Q Consensus       238 p~~~~~~~  245 (292)
                      |||+++.+
T Consensus       284 p~f~~~~~  291 (292)
T d1unla_         284 PYFSDFCP  291 (292)
T ss_dssp             GGGSSCSC
T ss_pred             hhhcCCCC
Confidence            99998653

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=4.3e-48  Score=332.81  Aligned_cols=233  Identities=30%  Similarity=0.521  Sum_probs=179.5

Q ss_pred             CCC-CCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            2 RLL-DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         2 ~~l-~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      +.+ .||||++++++|...   ...++++|||||+ ++|...       .+.+++..++.++.||+.||+|||++ ||+|
T Consensus        84 ~~l~~hpnIv~~~~~~~~~---~~~~~~~v~e~~~~~~L~~~-------~~~l~e~~i~~i~~qil~aL~~LH~~-gIvH  152 (328)
T d3bqca1          84 ENLRGGPNIITLADIVKDP---VSRTPALVFEHVNNTDFKQL-------YQTLTDYDIRFYMYEILKALDYCHSM-GIMH  152 (328)
T ss_dssp             HHHTTSTTBCCEEEEEECT---TTCSEEEEEECCCSCBGGGT-------TTSCCHHHHHHHHHHHHHHHHHHHHT-TEEC
T ss_pred             HhccCCCCCcEEEEEEEec---CCCceeEEEeecCCCcHHHH-------hcCCCHHHHHHHHHHHHHHHHHHhhc-cccc
Confidence            345 499999999998542   3345899999999 465433       35699999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLFPG  159 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  159 (292)
                      |||||+|||++.++..+||+|||+|+............+|+.|+|||.+.+...++.++|+||+||++|+|++|..||..
T Consensus       153 rDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~  232 (328)
T d3bqca1         153 RDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH  232 (328)
T ss_dssp             CCCSGGGEEEETTTTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred             ccccccceEEcCCCCeeeecccccceeccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCC
Confidence            99999999999777579999999998876666667778999999999998777789999999999999999999999975


Q ss_pred             C-CcHHHHHHHHHHhCCCCHHHHhhcCCCCccc----cCCCCCCCCchh----hhccCCChhHHHHHHHHhccCCCCccc
Q 022799          160 E-SGVDQLVEIIKVLGTPTREEIKCMNPNYTEF----KFPQIKAHPWHK----IFQKRMPPEAVDLVSRLLQYSPNLRST  230 (292)
Q Consensus       160 ~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~R~t  230 (292)
                      . +..++...+.+.++.+....+..........    .........+..    .....++++++|||++||++||++|||
T Consensus       233 ~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t  312 (328)
T d3bqca1         233 GHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT  312 (328)
T ss_dssp             CSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCC
T ss_pred             CchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcC
Confidence            4 4455666777777665444332211110000    011111111111    112457899999999999999999999


Q ss_pred             HHHHhcCCCccccCC
Q 022799          231 ALEALIHPFFDELRD  245 (292)
Q Consensus       231 ~~e~l~hp~~~~~~~  245 (292)
                      ++|+|+||||+++.+
T Consensus       313 a~e~L~Hp~F~~v~~  327 (328)
T d3bqca1         313 AREAMEHPYFYTVVK  327 (328)
T ss_dssp             HHHHHTSGGGTTSCC
T ss_pred             HHHHhcCcccCCCCC
Confidence            999999999998754

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-47  Score=328.14  Aligned_cols=237  Identities=27%  Similarity=0.455  Sum_probs=182.8

Q ss_pred             CCCCCCCCeeeeceeeeccCC---CCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTE---KDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGV   77 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~---~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i   77 (292)
                      |+.++||||+++++++.....   .....+|+||||+++++.......   ...+++..++.++.||+.||.|||++ ||
T Consensus        63 l~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~---~~~~~~~~~~~i~~qil~~l~~lH~~-~i  138 (318)
T d3blha1          63 LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRN-KI  138 (318)
T ss_dssp             HHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTCT---TCCCCHHHHHHHHHHHHHHHHHHHHT-TE
T ss_pred             HHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhhhc---ccccccHHHHHHHHHHHHHHHHhccC-CE
Confidence            457899999999998854321   223468999999997666554432   46799999999999999999999998 99


Q ss_pred             cccCCCCCcEEEeCCCCcEEEeecCCccccccC-----CCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh
Q 022799           78 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKG-----EPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL  152 (292)
Q Consensus        78 ~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~  152 (292)
                      +||||||+|||++.++ .+||+|||+++.....     ......+||+.|+|||++.+...++.++|+||+||++|+|++
T Consensus       139 vHrDlKp~NILl~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~  217 (318)
T d3blha1         139 LHRDMKAANVLITRDG-VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT  217 (318)
T ss_dssp             ECCCCCGGGEEECTTS-CEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred             EecCcCchheeecCCC-cEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhh
Confidence            9999999999999988 7999999999765322     223345789999999999877679999999999999999999


Q ss_pred             CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCcc--ccCCCCCCCCchhhh-ccCCChhHHHHHHHHhccCCCCcc
Q 022799          153 GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE--FKFPQIKAHPWHKIF-QKRMPPEAVDLVSRLLQYSPNLRS  229 (292)
Q Consensus       153 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~dp~~R~  229 (292)
                      |+.||.+.+.......+.+..+.++.+...........  ..............+ +...+++++|||.+||++||++|+
T Consensus       218 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~  297 (318)
T d3blha1         218 RSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI  297 (318)
T ss_dssp             SSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSC
T ss_pred             CCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCc
Confidence            99999999999999999999988887654443221111  111111111111111 123578899999999999999999


Q ss_pred             cHHHHhcCCCccc
Q 022799          230 TALEALIHPFFDE  242 (292)
Q Consensus       230 t~~e~l~hp~~~~  242 (292)
                      |++|+|+||||+.
T Consensus       298 sa~elL~Hpff~~  310 (318)
T d3blha1         298 DSDDALNHDFFWS  310 (318)
T ss_dssp             CHHHHHHSGGGSS
T ss_pred             CHHHHHcChhhcc
Confidence            9999999999985

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-48  Score=331.36  Aligned_cols=198  Identities=20%  Similarity=0.280  Sum_probs=163.4

Q ss_pred             CCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhh-------------------cCCCCCHHHHHHHHHHH
Q 022799            5 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYK-------------------MSQRMPLIYVKLYFYQI   64 (292)
Q Consensus         5 ~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~-------------------~~~~~~~~~~~~~~~qi   64 (292)
                      +|||||++++++.     +...+|+|||||+ |+|.+++.....                   ....+++..++.++.||
T Consensus        99 ~HpnIv~l~~~~~-----~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi  173 (325)
T d1rjba_          99 SHENIVNLLGACT-----LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQV  173 (325)
T ss_dssp             CCTTBCCEEEEEC-----SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHH
T ss_pred             CCCcEeEEEEEEe-----eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHH
Confidence            8999999999994     4445899999998 799999975432                   12458999999999999


Q ss_pred             HHHHHHHHhcCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCCCc---ccccccccccCCccccCCCCCCchhHhh
Q 022799           65 CRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIW  141 (292)
Q Consensus        65 l~al~~LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Dvw  141 (292)
                      +.||.|||++ ||+||||||+||+++.++ .+||+|||+|+........   .+..||+.|+|||++.+. .++.++|||
T Consensus       174 ~~gl~yLH~~-~IiHRDlKp~Nill~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~Diw  250 (325)
T d1rjba_         174 AKGMEFLEFK-SCVHRDLAARNVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVW  250 (325)
T ss_dssp             HHHHHHHHHT-TEEETTCSGGGEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHH
T ss_pred             HHHHHHHHhC-CeeeccCchhccccccCC-eEEEeeccccccccCCCceeeeccccCCCccCChHHHcCC-CCCcceecc
Confidence            9999999998 999999999999999988 8999999999876554432   245679999999998765 489999999


Q ss_pred             hhhHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHH
Q 022799          142 SAGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRL  220 (292)
Q Consensus       142 slG~il~el~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  220 (292)
                      |+||++|||+| |..||.+.+....+.++.+....+                           ..+..+|+++++||.+|
T Consensus       251 S~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~---------------------------~~p~~~~~~l~~li~~c  303 (325)
T d1rjba_         251 SYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKM---------------------------DQPFYATEEIYIIMQSC  303 (325)
T ss_dssp             HHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCC---------------------------CCCTTCCHHHHHHHHHH
T ss_pred             chhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC---------------------------CCCCcCCHHHHHHHHHH
Confidence            99999999997 899999877766666665521111                           02246899999999999


Q ss_pred             hccCCCCcccHHHHhcC
Q 022799          221 LQYSPNLRSTALEALIH  237 (292)
Q Consensus       221 l~~dp~~R~t~~e~l~h  237 (292)
                      |+.||++|||++|+++|
T Consensus       304 l~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         304 WAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             TCSSGGGSCCHHHHHHH
T ss_pred             cCCChhHCcCHHHHHHH
Confidence            99999999999999875

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.3e-47  Score=323.51  Aligned_cols=198  Identities=22%  Similarity=0.344  Sum_probs=154.5

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++|||||++++++..     ...+++|||||+ |+|.+++...   .+.+++..+..++.||+.||.|||++ ||+|
T Consensus        81 l~~l~HpnIv~l~g~~~~-----~~~~~iv~Ey~~~g~L~~~~~~~---~~~l~~~~~~~i~~qia~gl~yLH~~-~iiH  151 (299)
T d1jpaa_          81 MGQFDHPNVIHLEGVVTK-----STPVMIITEFMENGSLDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLADM-NYVH  151 (299)
T ss_dssp             HTTCCCTTBCCEEEEECS-----SSSCEEEEECCTTEEHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT-TCCC
T ss_pred             HHhCCCCCCccEEEEEee-----CCEEEEEEEecCCCcceeeeccc---cCCCCHHHHHHHHHHHHHHHHHHhhC-CCcc
Confidence            578999999999999843     334899999999 6888877653   45699999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCc------ccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN------ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-  152 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-  152 (292)
                      |||||+|||++.++ .+||+|||+++........      ....||+.|+|||.+.+. .++.++||||+||++|||+| 
T Consensus       152 rDlKp~NILl~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~el~t~  229 (299)
T d1jpaa_         152 RDLAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR-KFTSASDVWSYGIVMWEVMSY  229 (299)
T ss_dssp             SCCCGGGEEECTTC-CEEECCC-----------------------CGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTT
T ss_pred             CccccceEEECCCC-cEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcC-CCCcccccccchHHHHHHHhC
Confidence            99999999999988 7999999999876443221      123568999999999764 58999999999999999998 


Q ss_pred             CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHH
Q 022799          153 GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTAL  232 (292)
Q Consensus       153 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~  232 (292)
                      |..||.+.+..+....+.+....+                            .+..+++.+.+||.+||+.||++|||+.
T Consensus       230 g~~Pf~~~~~~~~~~~i~~~~~~~----------------------------~~~~~~~~l~~li~~cl~~~P~~RPs~~  281 (299)
T d1jpaa_         230 GERPYWDMTNQDVINAIEQDYRLP----------------------------PPMDCPSALHQLMLDCWQKDRNHRPKFG  281 (299)
T ss_dssp             SCCTTTTCCHHHHHHHHHTTCCCC----------------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCCC----------------------------CCccchHHHHHHHHHHcCCCHhHCcCHH
Confidence            899999888776665554321100                            1246889999999999999999999999


Q ss_pred             HHhcC
Q 022799          233 EALIH  237 (292)
Q Consensus       233 e~l~h  237 (292)
                      +++++
T Consensus       282 ei~~~  286 (299)
T d1jpaa_         282 QIVNT  286 (299)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            98854

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-47  Score=320.59  Aligned_cols=200  Identities=23%  Similarity=0.320  Sum_probs=162.6

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++|||||++++++..     + ..++|||||+ |+|.+++..    ...+++..+..++.||+.||.|||++ ||+|
T Consensus        62 l~~l~HpnIv~~~g~~~~-----~-~~~lvmE~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~-~iiH  130 (277)
T d1xbba_          62 MQQLDNPYIVRMIGICEA-----E-SWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES-NFVH  130 (277)
T ss_dssp             HHTCCCTTBCCEEEEEES-----S-SEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT-TEEC
T ss_pred             HHhCCCCCCceEEEEecc-----C-CEEEEEEcCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHhC-Cccc
Confidence            467899999999998732     1 2679999998 699988875    46799999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCc----ccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQ  154 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~  154 (292)
                      |||||+|||++.++ .+||+|||+++........    ....||+.|+|||++.+. .++.++||||+||++|||+| |.
T Consensus       131 rDlKp~Nill~~~~-~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gv~l~ellt~g~  208 (277)
T d1xbba_         131 RDLAARNVLLVTQH-YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQ  208 (277)
T ss_dssp             SCCSGGGEEEEETT-EEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTC
T ss_pred             CCCcchhhcccccC-cccccchhhhhhccccccccccccccCCCceecCchhhcCC-CCCchhhhccchhhhhHHhhCCC
Confidence            99999999999988 7999999999876443322    234689999999999765 48999999999999999998 89


Q ss_pred             CCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHH
Q 022799          155 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA  234 (292)
Q Consensus       155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~  234 (292)
                      .||.+.+..+....+.+. ..+                           ..+..+|+++.+||.+||+.||++|||++++
T Consensus       209 ~Pf~~~~~~~~~~~i~~~-~~~---------------------------~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i  260 (277)
T d1xbba_         209 KPYRGMKGSEVTAMLEKG-ERM---------------------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAV  260 (277)
T ss_dssp             CSSTTCCHHHHHHHHHTT-CCC---------------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             CCCCCCCHHHHHHHHHcC-CCC---------------------------CCCcccCHHHHHHHHHHcCCCHhHCcCHHHH
Confidence            999988766555444321 000                           1225689999999999999999999999998


Q ss_pred             ---hcCCCcc
Q 022799          235 ---LIHPFFD  241 (292)
Q Consensus       235 ---l~hp~~~  241 (292)
                         |+|+|++
T Consensus       261 ~~~L~~~~~~  270 (277)
T d1xbba_         261 ELRLRNYYYD  270 (277)
T ss_dssp             HHHHHHHHHH
T ss_pred             HHHhhCHHhh
Confidence               4566654

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-47  Score=314.92  Aligned_cols=198  Identities=19%  Similarity=0.328  Sum_probs=152.6

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++|||||++++++...     ..+++|||||+ |+|.+++...   ...+++..+..++.||+.||.|||++ +|+|
T Consensus        54 l~~l~HpnIv~~~g~~~~~-----~~~~lv~E~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qia~gl~~lH~~-~iiH  124 (263)
T d1sm2a_          54 MMKLSHPKLVQLYGVCLEQ-----APICLVFEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA-CVIH  124 (263)
T ss_dssp             HHHCCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TCCC
T ss_pred             HHhcCCCCcccccceeccC-----CceEEEEEecCCCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHhhhcc-ceee
Confidence            3568999999999998443     34889999998 7999887653   45689999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCc--ccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPL  156 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~p  156 (292)
                      |||||+||+++.++ .+||+|||+++........  ....||+.|+|||++.+. .++.++||||+||++|||+| |.+|
T Consensus       125 rDlKp~Nill~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvil~el~t~~~~~  202 (263)
T d1sm2a_         125 RDLAARNCLVGENQ-VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIP  202 (263)
T ss_dssp             TTCSGGGEEECGGG-CEEECSCC------------------CTTSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             cccchhheeecCCC-CeEecccchheeccCCCceeecceecCcccCChHHhcCC-CCCchhhhcchHHHHHHHHHCCCCC
Confidence            99999999999988 7999999999876443322  235689999999999765 49999999999999999999 5666


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      |.+.+..+....+..... +                           ..+..+++++.+||.+||+.||++|||++++++
T Consensus       203 ~~~~~~~~~~~~i~~~~~-~---------------------------~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~  254 (263)
T d1sm2a_         203 YENRSNSEVVEDISTGFR-L---------------------------YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLR  254 (263)
T ss_dssp             TCSCCHHHHHHHHHHTCC-C---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCHHHHHHHHHhcCC-C---------------------------CCccccCHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            666665555555443110 0                           012457899999999999999999999999997


Q ss_pred             C
Q 022799          237 H  237 (292)
Q Consensus       237 h  237 (292)
                      |
T Consensus       255 ~  255 (263)
T d1sm2a_         255 Q  255 (263)
T ss_dssp             H
T ss_pred             H
Confidence            5

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-47  Score=320.26  Aligned_cols=202  Identities=24%  Similarity=0.334  Sum_probs=165.4

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++|||||++++++.. +     .+|+|||||+ |+|.+++...   ...+++..+..++.||+.||.|||++ ||+|
T Consensus        63 l~~l~HpnIv~l~g~~~~-~-----~~~lvmE~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~gL~ylH~~-~iiH  132 (285)
T d1u59a_          63 MHQLDNPYIVRLIGVCQA-E-----ALMLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK-NFVH  132 (285)
T ss_dssp             HHHCCCTTBCCEEEEEES-S-----SEEEEEECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT-TEEC
T ss_pred             HHhCCCCCEeeEeeeecc-C-----eEEEEEEeCCCCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC-Ceec
Confidence            356899999999998732 1     2789999999 6998887542   35799999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCC----cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQ  154 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~  154 (292)
                      |||||+||+++.++ .+||+|||+++.......    .....||+.|+|||++.+. .++.++||||+||++|||+| |.
T Consensus       133 rDlKp~Nill~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gv~l~E~lt~G~  210 (285)
T d1u59a_         133 RDLAARNVLLVNRH-YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQ  210 (285)
T ss_dssp             CCCSGGGEEEEETT-EEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSC
T ss_pred             CcCchhheeeccCC-ceeeccchhhhcccccccccccccccccCccccChHHHhCC-CCCccchhhcchHHHHHHHhCCC
Confidence            99999999999988 799999999987654332    2234678999999999655 48999999999999999998 89


Q ss_pred             CCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHH
Q 022799          155 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA  234 (292)
Q Consensus       155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~  234 (292)
                      .||.+.+..+....+.+.. .+                           ..++.+|+++.+||.+||..||++|||+.++
T Consensus       211 ~Pf~~~~~~~~~~~i~~~~-~~---------------------------~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i  262 (285)
T d1u59a_         211 KPYKKMKGPEVMAFIEQGK-RM---------------------------ECPPECPPELYALMSDCWIYKWEDRPDFLTV  262 (285)
T ss_dssp             CTTTTCCTHHHHHHHHTTC-CC---------------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHH
T ss_pred             CCCCCCCHHHHHHHHHcCC-CC---------------------------CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHH
Confidence            9999887766555543210 00                           1235689999999999999999999999887


Q ss_pred             ---hcCCCccc
Q 022799          235 ---LIHPFFDE  242 (292)
Q Consensus       235 ---l~hp~~~~  242 (292)
                         |+|+|++-
T Consensus       263 ~~~L~~~~~~~  273 (285)
T d1u59a_         263 EQRMRACYYSL  273 (285)
T ss_dssp             HHHHHHHHHHH
T ss_pred             HHHHHHHHHHh
Confidence               67888754

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=9.9e-47  Score=316.74  Aligned_cols=208  Identities=25%  Similarity=0.414  Sum_probs=162.1

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |+.++|||||++++++.... .....+|+|||||+ ++|.+.+..    .+.+++.+++.++.||+.||.|||++ ||+|
T Consensus        61 l~~~~hpniv~~~~~~~~~~-~~~~~~~lvmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~~-~iiH  134 (277)
T d1o6ya_          61 AAALNHPAIVAVYDTGEAET-PAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQN-GIIH  134 (277)
T ss_dssp             HHTCCCTTBCCEEEEEEEEC-SSSEEEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT-TEEC
T ss_pred             HHhcCCCCCCcccceeeecc-CCCceEEEEEECCCCCEehhhhcc----cCCCCHHHHHHHHHHHHHHHHHHHhC-CccC
Confidence            45789999999999986544 34456889999999 688887765    36799999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCC----CcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE----PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQP  155 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~  155 (292)
                      |||||+||+++.++ .++++|||.+.......    .....+||+.|+|||++.+. .++.++||||+||++|+|+||..
T Consensus       135 rDiKP~NIll~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~  212 (277)
T d1o6ya_         135 RDVKPANIMISATN-AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEP  212 (277)
T ss_dssp             CCCSGGGEEEETTS-CEEECCCTTCEECC----------------TTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSC
T ss_pred             ccccCcccccCccc-cceeehhhhhhhhccccccccccccccCcccccCHHHHcCC-CCCcceecccchHHHHHHHhCCC
Confidence            99999999999888 79999999887553322    23456799999999999664 58999999999999999999999


Q ss_pred             CCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHh
Q 022799          156 LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL  235 (292)
Q Consensus       156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l  235 (292)
                      ||.+.+..+...++......++                         ....+.+|+++.+||.+||+.||++||+..+.+
T Consensus       213 Pf~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l  267 (277)
T d1o6ya_         213 PFTGDSPVSVAYQHVREDPIPP-------------------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEM  267 (277)
T ss_dssp             SCCCSSHHHHHHHHHHCCCCCG-------------------------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHH
T ss_pred             CCCCcCHHHHHHHHHhcCCCCC-------------------------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHH
Confidence            9999888777776665321111                         112256899999999999999999999544445


Q ss_pred             cCCCcc
Q 022799          236 IHPFFD  241 (292)
Q Consensus       236 ~hp~~~  241 (292)
                      .|+|.+
T Consensus       268 ~~~l~r  273 (277)
T d1o6ya_         268 RADLVR  273 (277)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            566654

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.8e-46  Score=316.11  Aligned_cols=204  Identities=20%  Similarity=0.290  Sum_probs=162.9

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++|||||++++++.     +...+++|||||+ |+|.+++...  ....+++..+..++.||+.||+|||++ ||+|
T Consensus        67 l~~l~HpnIv~~~~~~~-----~~~~~~iv~E~~~~g~l~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~-~iiH  138 (287)
T d1opja_          67 MKEIKHPNLVQLLGVCT-----REPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK-NFIH  138 (287)
T ss_dssp             HHHCCCTTBCCEEEEEC-----SSSSCEEEEECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT-TCCC
T ss_pred             HHhCCCCCEecCCccEe-----eCCeeEEEeecccCcchHHHhhhc--cccchHHHHHHHHHHHHHHHHHHHHHC-Cccc
Confidence            45789999999999984     3344889999999 7998888643  245789999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCc--ccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN--ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF  157 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf  157 (292)
                      |||||+|||++.++ .+||+|||+|+........  ....||+.|+|||++.+. .++.++||||+||++|||++|..||
T Consensus       139 rDlKp~NILl~~~~-~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~k~DiwS~Gv~l~ell~~~~p~  216 (287)
T d1opja_         139 RDLAARNCLVGENH-LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSP  216 (287)
T ss_dssp             SCCSGGGEEECGGG-CEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             CccccCeEEECCCC-cEEEccccceeecCCCCceeeccccccccccChHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCC
Confidence            99999999999988 7999999999876443322  233578999999998765 4899999999999999999977666


Q ss_pred             CCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          158 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       158 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      ........+.+++.....+                           .++..+|+++++||.+||+.||.+|||++++++ 
T Consensus       217 ~~~~~~~~~~~~i~~~~~~---------------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~-  268 (287)
T d1opja_         217 YPGIDLSQVYELLEKDYRM---------------------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ-  268 (287)
T ss_dssp             STTCCHHHHHHHHHTTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH-
T ss_pred             CCcchHHHHHHHHhcCCCC---------------------------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH-
Confidence            5555544444443321100                           122568999999999999999999999999974 


Q ss_pred             CCcccc
Q 022799          238 PFFDEL  243 (292)
Q Consensus       238 p~~~~~  243 (292)
                       +|+.+
T Consensus       269 -~L~~~  273 (287)
T d1opja_         269 -AFETM  273 (287)
T ss_dssp             -HHHHT
T ss_pred             -HHHHH
Confidence             45544

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-46  Score=308.55  Aligned_cols=198  Identities=18%  Similarity=0.296  Sum_probs=164.2

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++|||||++++++.+     ...+++||||++ |+|..++...   ...+++..+..++.||+.||.|||++ ||+|
T Consensus        53 ~~~l~HpnIv~~~g~~~~-----~~~~~iv~Ey~~~g~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~~LH~~-~iiH  123 (258)
T d1k2pa_          53 MMNLSHEKLVQLYGVCTK-----QRPIFIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK-QFLH  123 (258)
T ss_dssp             HHTCCCTTBCCEEEEECC-----SSSEEEEEECCTTEEHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHT-TBCC
T ss_pred             HHhcCCCceeeEEEEEee-----CCceEEEEEccCCCcHHHhhhcc---ccCCcHHHHHHHHHHHHHHHHHHhhc-Cccc
Confidence            457899999999999843     334899999998 7888887653   35688999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCC--cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPL  156 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~p  156 (292)
                      |||||+||+++.++ .+||+|||+++.......  .....||+.|+|||++.+. .++.++||||+||++|||+| |+.|
T Consensus       124 ~dlk~~Nill~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~ksDiwS~G~~l~el~t~g~~P  201 (258)
T d1k2pa_         124 RDLAARNCLVNDQG-VVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMP  201 (258)
T ss_dssp             SCCSGGGEEECTTC-CEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             ccccceeEEEcCCC-cEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCC-CCCcceeecccchhhHhHHhcCCCC
Confidence            99999999999888 799999999986644332  2235689999999999765 48999999999999999998 8999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      |.+.+..+....+.+....                            ..+...++++.+||.+||+.||++|||++++++
T Consensus       202 f~~~~~~~~~~~i~~~~~~----------------------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~  253 (258)
T d1k2pa_         202 YERFTNSETAEHIAQGLRL----------------------------YRPHLASEKVYTIMYSCWHEKADERPTFKILLS  253 (258)
T ss_dssp             TTTSCHHHHHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             CCCCCHHHHHHHHHhCCCC----------------------------CCcccccHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            9988877666555431100                            012457889999999999999999999999998


Q ss_pred             C
Q 022799          237 H  237 (292)
Q Consensus       237 h  237 (292)
                      |
T Consensus       254 ~  254 (258)
T d1k2pa_         254 N  254 (258)
T ss_dssp             H
T ss_pred             H
Confidence            6

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-46  Score=313.48  Aligned_cols=203  Identities=23%  Similarity=0.329  Sum_probs=161.7

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++|||||++++++.+     + .+++|||||+ |+|.+.+....  ..++++..+..++.||+.||.|||++ ||+|
T Consensus        62 l~~l~HpnIv~~~g~~~~-----~-~~~iv~Ey~~~g~L~~~~~~~~--~~~l~~~~~~~i~~qi~~gl~~lH~~-~ivH  132 (272)
T d1qpca_          62 MKQLQHQRLVRLYAVVTQ-----E-PIYIITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER-NYIH  132 (272)
T ss_dssp             HHHCCCTTBCCEEEEECS-----S-SCEEEEECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT-TEEC
T ss_pred             HHhCCCCCEeEEEeeecc-----C-CeEEEEEeCCCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC-Cccc
Confidence            356899999999997621     1 2689999998 78888765432  24589999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCC--cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCC-CC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ-PL  156 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~-~p  156 (292)
                      |||||+|||++.++ .+||+|||+|+.......  .....||+.|+|||++.+. .++.++||||+||++|||+||. +|
T Consensus       133 rDiKp~NIll~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~~~~sDvwS~Gvvl~ellt~~~~~  210 (272)
T d1qpca_         133 RDLRAANILVSDTL-SCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIP  210 (272)
T ss_dssp             SCCSGGGEEECTTS-CEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCS
T ss_pred             Cccchhheeeeccc-ceeeccccceEEccCCccccccccCCcccccChHHHhCC-CCCchhhhhhhHHHHHHHHhCCCCC
Confidence            99999999999988 799999999987654332  2345688999999999754 4899999999999999999955 55


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      |...+..+....+.... .+                           ..+..+++++.+||.+||+.||++|||++++++
T Consensus       211 ~~~~~~~~~~~~i~~~~-~~---------------------------~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~  262 (272)
T d1qpca_         211 YPGMTNPEVIQNLERGY-RM---------------------------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS  262 (272)
T ss_dssp             STTCCHHHHHHHHHTTC-CC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCHHHHHHHHHhcC-CC---------------------------CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            55555555444443210 00                           112468999999999999999999999999997


Q ss_pred             --CCCccc
Q 022799          237 --HPFFDE  242 (292)
Q Consensus       237 --hp~~~~  242 (292)
                        ++||.+
T Consensus       263 ~L~~~fts  270 (272)
T d1qpca_         263 VLEDFFTA  270 (272)
T ss_dssp             HHHHHHHH
T ss_pred             Hhhhhhhc
Confidence              788864

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-46  Score=310.55  Aligned_cols=197  Identities=26%  Similarity=0.396  Sum_probs=153.6

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++|||||++++++.     + ..+|+||||++ |+|.+++...   ...+++..++.++.||+.||.|||++ ||+|
T Consensus        62 l~~l~HpnIv~l~~~~~-----~-~~~~iv~E~~~~g~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~-~iiH  131 (273)
T d1mp8a_          62 MRQFDHPHIVKLIGVIT-----E-NPVWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK-RFVH  131 (273)
T ss_dssp             HHTCCCTTBCCEEEEEC-----S-SSCEEEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT-TCCC
T ss_pred             HHhCCCCCEeeEEEEEe-----c-CeEEEEEEeccCCcHHhhhhcc---CCCCCHHHHHHHHHHHHHHhhhhccc-Ceec
Confidence            46789999999999882     1 23789999999 6888776543   45789999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCC--cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPL  156 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~p  156 (292)
                      |||||+||+++.++ .+||+|||+|+.......  .....||+.|+|||++.+. .++.++||||+||++|||++ |.+|
T Consensus       132 rDlKp~NIll~~~~-~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~-~~~~~~DiwSlGvil~e~lt~g~~P  209 (273)
T d1mp8a_         132 RDIAARNVLVSSND-CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKP  209 (273)
T ss_dssp             SCCSGGGEEEEETT-EEEECC-------------------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             cccchhheeecCCC-cEEEccchhheeccCCcceeccceecCcccchhhHhccC-CCCCccccccchHHHHHHHhcCCCC
Confidence            99999999999988 799999999987643322  2345679999999999654 48999999999999999998 8999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      |.+.+..+....+..... +                           .+++++|+++.+||.+||+.||++|||+.|+++
T Consensus       210 ~~~~~~~~~~~~i~~~~~-~---------------------------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~  261 (273)
T d1mp8a_         210 FQGVKNNDVIGRIENGER-L---------------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA  261 (273)
T ss_dssp             TTTCCGGGHHHHHHTTCC-C---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCHHHHHHHHHcCCC-C---------------------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            998888777666543110 0                           123568999999999999999999999999987


Q ss_pred             C
Q 022799          237 H  237 (292)
Q Consensus       237 h  237 (292)
                      +
T Consensus       262 ~  262 (273)
T d1mp8a_         262 Q  262 (273)
T ss_dssp             H
T ss_pred             H
Confidence            5

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-46  Score=318.38  Aligned_cols=208  Identities=29%  Similarity=0.460  Sum_probs=168.8

Q ss_pred             CCCCC-CCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            2 RLLDH-PNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         2 ~~l~H-pnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      ++++| |||+++++++     .+...+++||||+. |+|.+.+...    +.+++..++.++.||+.||+|||++ ||+|
T Consensus        83 ~~l~h~pnIv~~~~~~-----~~~~~~~~v~e~~~~~~L~~~i~~~----~~~~e~~~~~~~~Qi~~al~~lH~~-~ivH  152 (322)
T d1vzoa_          83 EHIRQSPFLVTLHYAF-----QTETKLHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKL-GIIY  152 (322)
T ss_dssp             HHHHTCTTBCCEEEEE-----EETTEEEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT-TCCC
T ss_pred             HhccCCCeEEEeeeee-----ccCCceeeeeecccccHHHHHHHhc----ccccHHHHHHHHHHHHHHHHHhhcC-CEEe
Confidence            44556 8999999998     44445999999999 6999888764    5688999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCC--CcccccccccccCCccccCCC-CCCchhHhhhhhHHHHHHHhCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE--PNISYICSRYYRAPELIFGAT-EYTAAIDIWSAGCVLAELLLGQPL  156 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwslG~il~el~~g~~p  156 (292)
                      |||||+||+++.++ .+||+|||+++......  ...+..||+.|+|||.+.+.. .++.++||||+||++|+|++|..|
T Consensus       153 rDiKp~Nill~~~~-~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~P  231 (322)
T d1vzoa_         153 RDIKLENILLDSNG-HVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP  231 (322)
T ss_dssp             CCCCGGGEEECTTS-CEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCT
T ss_pred             ccCCccceeecCCC-CEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCC
Confidence            99999999999988 79999999998764332  234567899999999997543 478899999999999999999999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcc-----cH
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS-----TA  231 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~-----t~  231 (292)
                      |.+.+..+....+.+......                         ..++..+|+++.+||++||++||.+|+     |+
T Consensus       232 F~~~~~~~~~~~i~~~~~~~~-------------------------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~  286 (322)
T d1vzoa_         232 FTVDGEKNSQAEISRRILKSE-------------------------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDA  286 (322)
T ss_dssp             TSCTTSCCCHHHHHHHHHHCC-------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTH
T ss_pred             CCCCCHHHHHHHHHHhcccCC-------------------------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccH
Confidence            988766555544443211000                         012246899999999999999999999     58


Q ss_pred             HHHhcCCCccccCC
Q 022799          232 LEALIHPFFDELRD  245 (292)
Q Consensus       232 ~e~l~hp~~~~~~~  245 (292)
                      +|+++||||+++++
T Consensus       287 ~eil~Hpff~~i~~  300 (322)
T d1vzoa_         287 DEIKEHLFFQKINW  300 (322)
T ss_dssp             HHHHTSGGGTTCCH
T ss_pred             HHHHcCHhhcCCCH
Confidence            99999999998764

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-45  Score=306.01  Aligned_cols=197  Identities=20%  Similarity=0.262  Sum_probs=150.1

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++|||||++++++.+     ....++|||||. +++.+.+...   ...+++..+..++.||+.||+|||++ ||+|
T Consensus        63 l~~l~H~nIv~~~g~~~~-----~~~~~~v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~~i~~gl~~lH~~-~iiH  133 (283)
T d1mqba_          63 MGQFSHHNIIRLEGVISK-----YKPMMIITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM-NYVH  133 (283)
T ss_dssp             HHTCCCTTBCCEEEEECS-----SSSEEEEEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT-TCCC
T ss_pred             HHhcCCCCEeeeeEEEec-----CCceEEEEEecccCcchhhhhcc---cccccHHHHHHHHHHHHHhhhhcccc-cccc
Confidence            467899999999999843     334889999999 5676666543   46799999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCC----cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQP  155 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~  155 (292)
                      |||||+|||++.++ .+||+|||+++.......    .....||+.|+|||++.+. .++.++||||+||++|||++|..
T Consensus       134 rDlKp~NILl~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~sDI~S~Gvil~el~t~~~  211 (283)
T d1mqba_         134 RDLAARNILVNSNL-VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGE  211 (283)
T ss_dssp             SCCCGGGEEECTTC-CEEECCCCC-----------------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             CccccceEEECCCC-eEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccC-CCCCcccccccHHHHHHHHhCCC
Confidence            99999999999988 799999999987644322    1234579999999999665 59999999999999999999655


Q ss_pred             CCC-CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHH
Q 022799          156 LFP-GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA  234 (292)
Q Consensus       156 pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~  234 (292)
                      |+. +.+..+.+..+... ..+                           ..+..+++.+.+||.+||..||++|||+.++
T Consensus       212 ~~~~~~~~~~~~~~i~~~-~~~---------------------------~~~~~~~~~l~~li~~cl~~~p~~RPt~~ei  263 (283)
T d1mqba_         212 RPYWELSNHEVMKAINDG-FRL---------------------------PTPMDCPSAIYQLMMQCWQQERARRPKFADI  263 (283)
T ss_dssp             CTTTTCCHHHHHHHHHTT-CCC---------------------------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             CccccCCHHHHHHHHhcc-CCC---------------------------CCchhhHHHHHHHHHHHCcCCHhHCcCHHHH
Confidence            544 44444433333211 000                           1224578999999999999999999999999


Q ss_pred             hc
Q 022799          235 LI  236 (292)
Q Consensus       235 l~  236 (292)
                      ++
T Consensus       264 l~  265 (283)
T d1mqba_         264 VS  265 (283)
T ss_dssp             HH
T ss_pred             HH
Confidence            85

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-45  Score=305.78  Aligned_cols=204  Identities=24%  Similarity=0.342  Sum_probs=157.5

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++|||||++++++.     ++ .+++|||||+ |+|..++....  ...+++.++..++.||+.||+|||++ ||+|
T Consensus        66 l~~l~h~nIv~~~g~~~-----~~-~~~lv~Ey~~~g~l~~~~~~~~--~~~l~~~~~~~i~~~i~~gl~~LH~~-~ivH  136 (285)
T d1fmka3          66 MKKLRHEKLVQLYAVVS-----EE-PIYIVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM-NYVH  136 (285)
T ss_dssp             HHHCCCTTBCCEEEEEC-----SS-SCEEEECCCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT-TCCC
T ss_pred             HHhcccCCEeEEEEEEe-----cC-CeEEEEEecCCCchhhhhhhcc--cccchHHHHHHHHHHHHHHHHHHhhh-heec
Confidence            35689999999999872     22 1679999999 68887765432  35699999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCC--cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCC-
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP--NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPL-  156 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~p-  156 (292)
                      |||||+|||++.++ .+||+|||+++.......  .....||+.|+|||.+.+. .++.++||||+||++|||++|..| 
T Consensus       137 ~DlKp~NIll~~~~-~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~S~Giil~el~t~~~p~  214 (285)
T d1fmka3         137 RDLRAANILVGENL-VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVP  214 (285)
T ss_dssp             SCCSGGGEEECGGG-CEEECCCCTTC--------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred             ccccceEEEECCCC-cEEEcccchhhhccCCCceeeccccccccccChHHHhCC-CCCcHHhhhcchHHHHHHHhCCCCC
Confidence            99999999999888 799999999987643322  2335689999999999654 489999999999999999996544 


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhc
Q 022799          157 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       157 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~  236 (292)
                      +.+....+.+..+.+....                            ..+..+++++++||.+||+.||++|||++++++
T Consensus       215 ~~~~~~~~~~~~i~~~~~~----------------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  266 (285)
T d1fmka3         215 YPGMVNREVLDQVERGYRM----------------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  266 (285)
T ss_dssp             STTCCHHHHHHHHHTTCCC----------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCHHHHHHHHHhcCCC----------------------------CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence            5555554454444321100                            022468999999999999999999999999987


Q ss_pred             --CCCcccc
Q 022799          237 --HPFFDEL  243 (292)
Q Consensus       237 --hp~~~~~  243 (292)
                        ++||.+.
T Consensus       267 ~L~~~~~~~  275 (285)
T d1fmka3         267 FLEDYFTST  275 (285)
T ss_dssp             HHHTTTSCS
T ss_pred             HHhhhhcCC
Confidence              8888764

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-44  Score=306.52  Aligned_cols=200  Identities=23%  Similarity=0.329  Sum_probs=156.1

Q ss_pred             CCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHH
Q 022799            4 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYK------------MSQRMPLIYVKLYFYQICRALAY   70 (292)
Q Consensus         4 l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~------------~~~~~~~~~~~~~~~qil~al~~   70 (292)
                      .+|||||++++++....    ..+++|||||+ |+|.+++.....            ....+++..+..++.||+.||.|
T Consensus        74 ~~h~~iv~~~~~~~~~~----~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~y  149 (299)
T d1ywna1          74 GHHLNVVNLLGACTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEF  149 (299)
T ss_dssp             CCCTTBCCEEEEECSTT----SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHH
T ss_pred             cCCCeEEEeeeeeccCC----CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHH
Confidence            47999999998874332    24789999999 799999876432            13458999999999999999999


Q ss_pred             HHhcCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCCC---cccccccccccCCccccCCCCCCchhHhhhhhHHH
Q 022799           71 IHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVL  147 (292)
Q Consensus        71 LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il  147 (292)
                      ||++ ||+||||||+|||++.++ .+||+|||+|+.......   .....||+.|+|||++.+. .++.++||||+||++
T Consensus       150 lH~~-~ivHrDlKp~NILl~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gvil  226 (299)
T d1ywna1         150 LASR-KCIHRDLAARNILLSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLL  226 (299)
T ss_dssp             HHHT-TCCCSCCCGGGEEECGGG-CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHC-CCCHHHHHHHHHHHH
T ss_pred             HHhC-CCcCCcCCccceeECCCC-cEEEccCcchhhccccccccccCceeeCccccchhHhhcC-CCCcccceeehHHHH
Confidence            9998 999999999999999888 799999999986543322   2345789999999999765 489999999999999


Q ss_pred             HHHHhC-CCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCC
Q 022799          148 AELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPN  226 (292)
Q Consensus       148 ~el~~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~  226 (292)
                      |||++| ..||.+....+.+..+......+.                           .+..++++++++|.+||+.||+
T Consensus       227 ~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~cl~~dP~  279 (299)
T d1ywna1         227 WEIFSLGASPYPGVKIDEEFCRRLKEGTRMR---------------------------APDYTTPEMYQTMLDCWHGEPS  279 (299)
T ss_dssp             HHHHTTSCCSSTTCCCSHHHHHHHHHTCCCC---------------------------CCTTCCHHHHHHHHHHTCSSGG
T ss_pred             HHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC---------------------------CCccCCHHHHHHHHHHcCCChh
Confidence            999986 568887766666655554321111                           2245889999999999999999


Q ss_pred             CcccHHHHhcC
Q 022799          227 LRSTALEALIH  237 (292)
Q Consensus       227 ~R~t~~e~l~h  237 (292)
                      +|||++|+++|
T Consensus       280 ~Rpt~~eil~~  290 (299)
T d1ywna1         280 QRPTFSELVEH  290 (299)
T ss_dssp             GSCCHHHHHHH
T ss_pred             HCcCHHHHHHH
Confidence            99999999976

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-44  Score=303.28  Aligned_cols=196  Identities=23%  Similarity=0.343  Sum_probs=160.6

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++|||||++++++.+     . .+++|||||+ |++.+.+...   .+.+++..+..++.||+.||.|||++ ||+|
T Consensus        65 l~~l~H~nIv~~~g~~~~-----~-~~~lv~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~-~iiH  134 (273)
T d1u46a_          65 MHSLDHRNLIRLYGVVLT-----P-PMKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK-RFIH  134 (273)
T ss_dssp             HHHCCCTTBCCEEEEECS-----S-SCEEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT-TEEC
T ss_pred             HHhCCCCCEEEEEEEEee-----c-chheeeeeecCcchhhhhhcc---cCCCCHHHHHHHHHHHHHHHHHhhhC-CEee
Confidence            356899999999999832     2 2689999998 7888777654   35699999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCc----ccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN----ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQ  154 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~  154 (292)
                      |||||+||+++.++ .+||+|||+++........    ....||..|+|||.+.+. .++.++||||+||++|||+| |.
T Consensus       135 rDikp~NIll~~~~-~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~S~Gvil~emlt~G~  212 (273)
T d1u46a_         135 RDLAARNLLLATRD-LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQ  212 (273)
T ss_dssp             SCCCGGGEEEEETT-EEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSC
T ss_pred             eeecHHHhcccccc-ceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCC-CCCcchhhhhhHHHHHHHHhCCC
Confidence            99999999999988 8999999999876444322    233568899999999764 48999999999999999998 89


Q ss_pred             CCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHH
Q 022799          155 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEA  234 (292)
Q Consensus       155 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~  234 (292)
                      .||.+.+..+...++.+....+                           ..+..+|+++.+||.+||..||++|||+.++
T Consensus       213 ~Pf~~~~~~~~~~~i~~~~~~~---------------------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei  265 (273)
T d1u46a_         213 EPWIGLNGSQILHKIDKEGERL---------------------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVAL  265 (273)
T ss_dssp             CTTTTCCHHHHHHHHHTSCCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCCCcCHHHHHHHHHhCCCCC---------------------------CCcccccHHHHHHHHHHcCCChhHCcCHHHH
Confidence            9999988888777665421111                           0125689999999999999999999999998


Q ss_pred             h
Q 022799          235 L  235 (292)
Q Consensus       235 l  235 (292)
                      +
T Consensus       266 ~  266 (273)
T d1u46a_         266 R  266 (273)
T ss_dssp             H
T ss_pred             H
Confidence            6

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-44  Score=307.33  Aligned_cols=197  Identities=22%  Similarity=0.331  Sum_probs=158.7

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++|||||++++++.+.     . .+++|||+. |+|.+.+...   ...+++..++.++.||+.||.|||++ ||+|
T Consensus        65 l~~l~HpnIv~l~g~~~~~-----~-~~~v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~-~iiH  134 (317)
T d1xkka_          65 MASVDNPHVCRLLGICLTS-----T-VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR-RLVH  134 (317)
T ss_dssp             HHHCCCTTBCCEEEEEESS-----S-EEEEEECCTTCBHHHHHHHT---SSSCCHHHHHHHHHHHHHHHHHHHHT-TCCC
T ss_pred             HHhCCCCCEeeEEEEEecC-----C-eeEEEEeccCCccccccccc---ccCCCHHHHHHHHHHHHHHHHHHHHc-Cccc
Confidence            3568999999999998432     1 567777776 7888877653   56799999999999999999999998 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCc---ccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQP  155 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~  155 (292)
                      |||||+||+++.++ .+||+|||+|+........   ....||+.|+|||++.+. .++.++||||+||++|||+| |.+
T Consensus       135 rDlKp~NIll~~~~-~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDvwS~Gvil~el~t~g~~  212 (317)
T d1xkka_         135 RDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSK  212 (317)
T ss_dssp             SCCCGGGEEEEETT-EEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred             CcchhhcceeCCCC-CeEeeccccceecccccccccccccccCccccChHHHhcC-CCChhhhhhhHHHHHHHHHHCCCC
Confidence            99999999999988 7999999999876443322   234679999999999765 48999999999999999998 789


Q ss_pred             CCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHh
Q 022799          156 LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEAL  235 (292)
Q Consensus       156 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l  235 (292)
                      ||.+.+..+....+.+. ..++                           .+..+++++.+||.+||..||.+|||+.+++
T Consensus       213 p~~~~~~~~~~~~i~~~-~~~~---------------------------~p~~~~~~~~~li~~cl~~dP~~RPs~~eil  264 (317)
T d1xkka_         213 PYDGIPASEISSILEKG-ERLP---------------------------QPPICTIDVYMIMVKCWMIDADSRPKFRELI  264 (317)
T ss_dssp             TTTTSCGGGHHHHHHHT-CCCC---------------------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCCCCHHHHHHHHHcC-CCCC---------------------------CCcccCHHHHHHHHHhCCCChhhCcCHHHHH
Confidence            99877766554444331 1110                           1246789999999999999999999999999


Q ss_pred             cC
Q 022799          236 IH  237 (292)
Q Consensus       236 ~h  237 (292)
                      .|
T Consensus       265 ~~  266 (317)
T d1xkka_         265 IE  266 (317)
T ss_dssp             HH
T ss_pred             HH
Confidence            87

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-44  Score=298.63  Aligned_cols=198  Identities=21%  Similarity=0.313  Sum_probs=155.6

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++|||||++++++.+..    ..+|+||||++ |+|.+++....  ...+++..+..++.||+.||.|||++ +|+|
T Consensus        54 l~~l~HpnIv~~~g~~~~~~----~~~~lv~ey~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~~-~ivH  126 (262)
T d1byga_          54 MTQLRHSNLVQLLGVIVEEK----GGLYIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN-NFVH  126 (262)
T ss_dssp             HTTCCCTTBCCEEEEECCC------CCEEEECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT-TCCC
T ss_pred             HHhCCCCCEeeEEEEEEecC----CcEEEEEeccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHhhccccccC-ceec
Confidence            47899999999999874322    23789999998 79999986542  23589999999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHh-CCCCCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLL-GQPLFP  158 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~-g~~pf~  158 (292)
                      |||||+||+++.++ .+||+|||+++.....  .....+|+.|+|||.+.+. .++.++|||||||++|||+| |.+||.
T Consensus       127 ~dlkp~Nil~~~~~-~~kl~dfg~s~~~~~~--~~~~~~~~~y~aPE~l~~~-~~t~~sDIwSfG~il~el~t~~~~p~~  202 (262)
T d1byga_         127 RDLAARNVLVSEDN-VAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYP  202 (262)
T ss_dssp             SCCSGGGEEECTTS-CEEECCCCC--------------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCT
T ss_pred             cccchHhheecCCC-CEeecccccceecCCC--CccccccccCCChHHHhCC-CCChHHHHHhHHHHHHHHHHCCCCCCC
Confidence            99999999999988 7999999999875332  3345678999999999765 48999999999999999998 788888


Q ss_pred             CCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHHHhcC
Q 022799          159 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALEALIH  237 (292)
Q Consensus       159 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e~l~h  237 (292)
                      +.+..+....+.+..                            ...++..+++.+++||.+||..||.+|||+.+++++
T Consensus       203 ~~~~~~~~~~i~~~~----------------------------~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         203 RIPLKDVVPRVEKGY----------------------------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             TSCGGGHHHHHTTTC----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHHHcCC----------------------------CCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            777666555543210                            001235688999999999999999999999999863

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-44  Score=306.39  Aligned_cols=201  Identities=20%  Similarity=0.268  Sum_probs=162.6

Q ss_pred             CCCC-CCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhh------------hcCCCCCHHHHHHHHHHHHH
Q 022799            1 MRLL-DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHY------------KMSQRMPLIYVKLYFYQICR   66 (292)
Q Consensus         1 L~~l-~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~------------~~~~~~~~~~~~~~~~qil~   66 (292)
                      |+++ +|||||++++++..     ...+++||||++ |+|.+++....            .....+++..+..++.||+.
T Consensus        64 l~~l~~HpnIv~~~~~~~~-----~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~  138 (309)
T d1fvra_          64 LCKLGHHPNIINLLGACEH-----RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVAR  138 (309)
T ss_dssp             HTTCCCCTTBCCEEEEEEE-----TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHH
T ss_pred             HHhccCCCCEeeEEEEEec-----CCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHH
Confidence            4566 79999999999954     334899999999 79999986531            23467999999999999999


Q ss_pred             HHHHHHhcCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHH
Q 022799           67 ALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCV  146 (292)
Q Consensus        67 al~~LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~i  146 (292)
                      ||.|||++ ||+||||||+|||++.++ .+||+|||+++............||..|+|||.+.+. .++.++|||||||+
T Consensus       139 gl~~lH~~-~iiHrDlkp~NIL~~~~~-~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSfGvi  215 (309)
T d1fvra_         139 GMDYLSQK-QFIHRDLAARNILVGENY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVL  215 (309)
T ss_dssp             HHHHHHHT-TEECSCCSGGGEEECGGG-CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHC-EECHHHHHHHHHHH
T ss_pred             HHHhhhcC-CccccccccceEEEcCCC-ceEEccccccccccccccccceecCCcccchHHhccC-CCCccceeehhHHH
Confidence            99999998 999999999999999988 7999999999876555545556789999999999765 48999999999999


Q ss_pred             HHHHHhCC-CCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCC
Q 022799          147 LAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSP  225 (292)
Q Consensus       147 l~el~~g~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp  225 (292)
                      +|||++|. +||.+.+..+....+.+.. .                           ...+..+++++++||.+||+.||
T Consensus       216 l~ell~~~~~p~~~~~~~~~~~~i~~~~-~---------------------------~~~~~~~~~~~~~li~~cl~~dP  267 (309)
T d1fvra_         216 LWEIVSLGGTPYCGMTCAELYEKLPQGY-R---------------------------LEKPLNCDDEVYDLMRQCWREKP  267 (309)
T ss_dssp             HHHHHTTSCCTTTTCCHHHHHHHGGGTC-C---------------------------CCCCTTBCHHHHHHHHHHTCSSG
T ss_pred             HHHHHhcCCCCCCCCCHHHHHHHHHhcC-C---------------------------CCCCccCCHHHHHHHHHHcCCCh
Confidence            99999965 5787776655544433210 0                           01224688999999999999999


Q ss_pred             CCcccHHHHhcC
Q 022799          226 NLRSTALEALIH  237 (292)
Q Consensus       226 ~~R~t~~e~l~h  237 (292)
                      ++|||+++++++
T Consensus       268 ~~RPs~~eil~~  279 (309)
T d1fvra_         268 YERPSFAQILVS  279 (309)
T ss_dssp             GGSCCHHHHHHH
T ss_pred             hHCcCHHHHHHH
Confidence            999999999986

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-43  Score=297.84  Aligned_cols=196  Identities=20%  Similarity=0.304  Sum_probs=160.5

Q ss_pred             CCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhh------------cCCCCCHHHHHHHHHHHHHHHHHH
Q 022799            5 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYK------------MSQRMPLIYVKLYFYQICRALAYI   71 (292)
Q Consensus         5 ~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~------------~~~~~~~~~~~~~~~qil~al~~L   71 (292)
                      +|||||++++++.     ++..+++|||||+ |+|.+++.....            ....+++.++..++.||+.||+||
T Consensus        77 ~HpnIv~~~~~~~-----~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~yl  151 (299)
T d1fgka_          77 KHKNIINLLGACT-----QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL  151 (299)
T ss_dssp             CCTTBCCEEEEEC-----SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             CCCeEEecccccc-----cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHh
Confidence            7999999999994     3445899999999 799999875421            235689999999999999999999


Q ss_pred             HhcCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCCC---cccccccccccCCccccCCCCCCchhHhhhhhHHHH
Q 022799           72 HNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLA  148 (292)
Q Consensus        72 H~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~  148 (292)
                      |++ ||+||||||+|||++.++ .+||+|||+++.......   .....||+.|+|||.+.+. .|+.++|||||||++|
T Consensus       152 H~~-~ivHrDiKp~NiLl~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~-~y~~k~DiwS~Gvvl~  228 (299)
T d1fgka_         152 ASK-KCIHRDLAARNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLW  228 (299)
T ss_dssp             HHT-TCCCSCCSGGGEEECTTC-CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHC-CCCHHHHHHHHHHHHH
T ss_pred             hhC-CEEeeeecccceeecCCC-CeEeccchhhccccccccccccccCCCChhhhhhhHhcCC-CCCchhhhHHhHHHHH
Confidence            998 999999999999999988 799999999987654432   2345789999999999664 5999999999999999


Q ss_pred             HHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCC
Q 022799          149 ELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNL  227 (292)
Q Consensus       149 el~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~  227 (292)
                      ||++ |.+||.+.+..+....+.. ...+                           .++..+++++++||.+||+.||++
T Consensus       229 ell~~g~~p~~~~~~~~~~~~i~~-~~~~---------------------------~~p~~~~~~l~~li~~cl~~dP~~  280 (299)
T d1fgka_         229 EIFTLGGSPYPGVPVEELFKLLKE-GHRM---------------------------DKPSNCTNELYMMMRDCWHAVPSQ  280 (299)
T ss_dssp             HHHTTSCCSSTTCCHHHHHHHHHT-TCCC---------------------------CCCSSCCHHHHHHHHHHTCSSGGG
T ss_pred             HhccCCCCCCCCCCHHHHHHHHHc-CCCC---------------------------CCCccchHHHHHHHHHHccCCHhH
Confidence            9998 7888887766554433322 1110                           122468999999999999999999


Q ss_pred             cccHHHHhc
Q 022799          228 RSTALEALI  236 (292)
Q Consensus       228 R~t~~e~l~  236 (292)
                      |||+.|+++
T Consensus       281 Rps~~eil~  289 (299)
T d1fgka_         281 RPTFKQLVE  289 (299)
T ss_dssp             SCCHHHHHH
T ss_pred             CcCHHHHHH
Confidence            999999985

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.3e-43  Score=297.77  Aligned_cols=200  Identities=20%  Similarity=0.267  Sum_probs=160.7

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhh--------------------hcCCCCCHHHHHH
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHY--------------------KMSQRMPLIYVKL   59 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~--------------------~~~~~~~~~~~~~   59 (292)
                      |++++||||+++++++..     ....++||||++ |+|.+++....                    .....+++..+..
T Consensus        70 l~~l~h~niv~~~~~~~~-----~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  144 (301)
T d1lufa_          70 MAEFDNPNIVKLLGVCAV-----GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLC  144 (301)
T ss_dssp             HHTCCCTTBCCEEEEECS-----SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHH
T ss_pred             HHhcCCCCcccceeeecc-----CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHH
Confidence            467899999999999843     334889999998 79999886421                    1123588999999


Q ss_pred             HHHHHHHHHHHHHhcCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCC---CcccccccccccCCccccCCCCCCc
Q 022799           60 YFYQICRALAYIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTA  136 (292)
Q Consensus        60 ~~~qil~al~~LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~  136 (292)
                      ++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|+...+..   ...+..||+.|+|||.+.+. .++.
T Consensus       145 i~~qi~~gl~ylH~~-~ivHrDlKp~NILld~~~-~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~t~  221 (301)
T d1lufa_         145 IARQVAAGMAYLSER-KFVHRDLATRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTT  221 (301)
T ss_dssp             HHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCH
T ss_pred             HHHHHHHHhhhcccC-CeEeeEEcccceEECCCC-cEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccC-CCCh
Confidence            999999999999998 999999999999999988 79999999998654332   22345688999999999765 4999


Q ss_pred             hhHhhhhhHHHHHHHhCC-CCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHH
Q 022799          137 AIDIWSAGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVD  215 (292)
Q Consensus       137 ~~DvwslG~il~el~~g~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  215 (292)
                      ++||||+||++|||++|. +||.+.+..+....+.+.. .                  +         ..+..+++++.+
T Consensus       222 ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~-~------------------~---------~~p~~~~~~~~~  273 (301)
T d1lufa_         222 ESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGN-I------------------L---------ACPENCPLELYN  273 (301)
T ss_dssp             HHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC-C------------------C---------CCCTTCCHHHHH
T ss_pred             hhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCC-C------------------C---------CCCccchHHHHH
Confidence            999999999999999985 6788887777666544310 0                  0         022568999999


Q ss_pred             HHHHHhccCCCCcccHHHHhc
Q 022799          216 LVSRLLQYSPNLRSTALEALI  236 (292)
Q Consensus       216 li~~~l~~dp~~R~t~~e~l~  236 (292)
                      ||.+||+.||++|||+.|+++
T Consensus       274 li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         274 LMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHcCCChhHCcCHHHHHH
Confidence            999999999999999999963

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-43  Score=296.45  Aligned_cols=207  Identities=20%  Similarity=0.269  Sum_probs=167.3

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhh------cCCCCCHHHHHHHHHHHHHHHHHHHh
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYK------MSQRMPLIYVKLYFYQICRALAYIHN   73 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~------~~~~~~~~~~~~~~~qil~al~~LH~   73 (292)
                      |++++|||||++++++.     .....++|||||+ |+|.+++.....      ....+++..+..++.|++.||.|||+
T Consensus        77 l~~l~h~nIv~~~~~~~-----~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~  151 (308)
T d1p4oa_          77 MKEFNCHHVVRLLGVVS-----QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA  151 (308)
T ss_dssp             GGGCCCTTBCCEEEEEC-----SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHcCCCCEeeeeeEEe-----cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh
Confidence            56889999999999983     3334899999998 799998865432      12357889999999999999999999


Q ss_pred             cCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCCC---cccccccccccCCccccCCCCCCchhHhhhhhHHHHHH
Q 022799           74 TIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAEL  150 (292)
Q Consensus        74 ~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el  150 (292)
                      + +|+||||||+|||++.++ .+||+|||+++.......   .....||+.|+|||.+.+. .++.++|+||+||++|||
T Consensus       152 ~-~ivHrDlk~~NiLld~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~-~~~~~~Dv~S~G~il~El  228 (308)
T d1p4oa_         152 N-KFVHRDLAARNCMVAEDF-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEI  228 (308)
T ss_dssp             T-TCBCSCCSGGGEEECTTC-CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHH
T ss_pred             C-CeeeceEcCCceeecCCc-eEEEeecccceeccCCcceeeccceecccccCCHHHHccC-CCCcccccccHHHHHHHH
Confidence            8 999999999999999988 799999999986644332   2334689999999999765 489999999999999999


Q ss_pred             HhC-CCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcc
Q 022799          151 LLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRS  229 (292)
Q Consensus       151 ~~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~  229 (292)
                      +|| ..||.+.+..+.+..+.+.. .+                           ..+..+++.+.++|.+||+.||++||
T Consensus       229 ~t~~~~p~~~~~~~~~~~~i~~~~-~~---------------------------~~p~~~~~~l~~li~~cl~~~P~~RP  280 (308)
T d1p4oa_         229 ATLAEQPYQGLSNEQVLRFVMEGG-LL---------------------------DKPDNCPDMLFELMRMCWQYNPKMRP  280 (308)
T ss_dssp             HHTSCCTTTTSCHHHHHHHHHTTC-CC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred             HhCCCCCCCCCCHHHHHHHHHhCC-CC---------------------------CCcccchHHHHHHHHHHcCCChhHCc
Confidence            998 57888777766665554310 00                           01246889999999999999999999


Q ss_pred             cHHHHhc------CCCcccc
Q 022799          230 TALEALI------HPFFDEL  243 (292)
Q Consensus       230 t~~e~l~------hp~~~~~  243 (292)
                      |++++++      +|+|+++
T Consensus       281 s~~~il~~L~~~~~~~~~~~  300 (308)
T d1p4oa_         281 SFLEIISSIKEEMEPGFREV  300 (308)
T ss_dssp             CHHHHHHHHGGGSCTTHHHH
T ss_pred             CHHHHHHHHHHhcCCCCcCC
Confidence            9999987      6777654

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-43  Score=296.59  Aligned_cols=199  Identities=19%  Similarity=0.271  Sum_probs=156.1

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCH   79 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H   79 (292)
                      |++++|||||++++++....    ...++|||||+ |+|.+++...   ...+++..+..++.|++.||.|||+. ||+|
T Consensus        82 l~~l~HpnIv~~~g~~~~~~----~~~~lv~E~~~~g~l~~~~~~~---~~~~~~~~~~~i~~qia~gL~~lH~~-~iiH  153 (311)
T d1r0pa_          82 MKDFSHPNVLSLLGICLRSE----GSPLVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK-KFVH  153 (311)
T ss_dssp             HHTCCCTTBCCCCEEEEETT----TEEEEEEECCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT-TCCC
T ss_pred             HHhCCCCCEeEEeEEEEecC----CceEEEEEEeecCchhhhhccc---cccchHHHHHHHHHHHHHhhhhhccc-Cccc
Confidence            46789999999999875432    24889999999 6888877643   45678888999999999999999988 9999


Q ss_pred             cCCCCCcEEEeCCCCcEEEeecCCccccccCCC-----cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCC
Q 022799           80 RDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-----NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQ  154 (292)
Q Consensus        80 ~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~  154 (292)
                      |||||+|||+++++ .+||+|||+++.......     .....||+.|+|||.+.+. .++.++|||||||++|||++|.
T Consensus       154 rDLK~~NILl~~~~-~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~SfGivl~El~t~~  231 (311)
T d1r0pa_         154 RDLAARNCMLDEKF-TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRG  231 (311)
T ss_dssp             SCCSGGGEEECTTC-CEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTS
T ss_pred             CCccHHhEeECCCC-CEEEecccchhhccccccccceecccccccccccChHHHhcC-CCCChhHhhhhHHHHHHHHHCC
Confidence            99999999999887 799999999987644322     1234679999999998664 4899999999999999999988


Q ss_pred             CCCCCCCcH-HHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCcccHHH
Q 022799          155 PLFPGESGV-DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLRSTALE  233 (292)
Q Consensus       155 ~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~t~~e  233 (292)
                      .||...... +....+.+. ..+                           ..+..+++++.+||.+||..||++|||+.|
T Consensus       232 ~p~~~~~~~~~~~~~i~~g-~~~---------------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~e  283 (311)
T d1r0pa_         232 APPYPDVNTFDITVYLLQG-RRL---------------------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSE  283 (311)
T ss_dssp             CCSCC------CHHHHHTT-CCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCCCCCHHHHHHHHHcC-CCC---------------------------CCcccCcHHHHHHHHHHcCCCHhHCcCHHH
Confidence            777654332 222222210 000                           122467899999999999999999999999


Q ss_pred             HhcC
Q 022799          234 ALIH  237 (292)
Q Consensus       234 ~l~h  237 (292)
                      +++|
T Consensus       284 i~~~  287 (311)
T d1r0pa_         284 LVSR  287 (311)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9987

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-42  Score=292.13  Aligned_cols=197  Identities=23%  Similarity=0.324  Sum_probs=161.3

Q ss_pred             CCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhh--------------cCCCCCHHHHHHHHHHHHHHHH
Q 022799            5 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYK--------------MSQRMPLIYVKLYFYQICRALA   69 (292)
Q Consensus         5 ~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~--------------~~~~~~~~~~~~~~~qil~al~   69 (292)
                      +|||||++++++.     +...+++|||||+ |+|.+++.....              ....+++..+..++.||+.||+
T Consensus        85 ~HpnIv~~~g~~~-----~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~  159 (311)
T d1t46a_          85 NHMNIVNLLGACT-----IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMA  159 (311)
T ss_dssp             CCTTBCCEEEEEC-----SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHH
T ss_pred             CCCCEEEEEEEEe-----eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHH
Confidence            6999999999983     3444899999998 699988875421              2346899999999999999999


Q ss_pred             HHHhcCCccccCCCCCcEEEeCCCCcEEEeecCCccccccCCCc---ccccccccccCCccccCCCCCCchhHhhhhhHH
Q 022799           70 YIHNTIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTAAIDIWSAGCV  146 (292)
Q Consensus        70 ~LH~~~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~i  146 (292)
                      |||++ |++||||||+||+++.++ .++++|||.++........   ....||+.|+|||.+.+. .++.++|||||||+
T Consensus       160 ~LH~~-~ivHrDLKp~NIl~~~~~-~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwS~G~~  236 (311)
T d1t46a_         160 FLASK-NCIHRDLAARNILLTHGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIF  236 (311)
T ss_dssp             HHHHT-TCCCSCCSGGGEEEETTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHH
T ss_pred             HHHhC-CeeecccccccccccccC-cccccccchheeccCCCcceEeeecccChHHcCHHHhcCC-CCCCcccccchHHH
Confidence            99998 999999999999999888 8999999999876543322   235789999999999654 58999999999999


Q ss_pred             HHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCC
Q 022799          147 LAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSP  225 (292)
Q Consensus       147 l~el~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp  225 (292)
                      +|||+| |.+||.+.+..+.+.++.+.-..+.                           .+...++++.+||.+||+.||
T Consensus       237 l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~---------------------------~~~~~~~~l~~Li~~cl~~dP  289 (311)
T d1t46a_         237 LWELFSLGSSPYPGMPVDSKFYKMIKEGFRML---------------------------SPEHAPAEMYDIMKTCWDADP  289 (311)
T ss_dssp             HHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCC---------------------------CCTTSCHHHHHHHHHHTCSSG
T ss_pred             HHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC---------------------------CcccccHHHHHHHHHHcCCCh
Confidence            999998 6677777777677766665321111                           124578999999999999999


Q ss_pred             CCcccHHHHhc
Q 022799          226 NLRSTALEALI  236 (292)
Q Consensus       226 ~~R~t~~e~l~  236 (292)
                      .+|||++++++
T Consensus       290 ~~RPs~~~il~  300 (311)
T d1t46a_         290 LKRPTFKQIVQ  300 (311)
T ss_dssp             GGSCCHHHHHH
T ss_pred             hHCcCHHHHHH
Confidence            99999999985

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-42  Score=294.12  Aligned_cols=222  Identities=18%  Similarity=0.147  Sum_probs=153.8

Q ss_pred             CCCCCCCCeeeeceeeeccCCCCceeEEEEeeccc-CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhc-----
Q 022799            1 MRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVP-ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNT-----   74 (292)
Q Consensus         1 L~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~-----   74 (292)
                      +++++|||||++++++.+.. .....+|+|||||+ |+|.+++..     .++++.....++.|++.||.|||+.     
T Consensus        51 ~~~~~HpnIv~~~~~~~~~~-~~~~~~~lv~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~  124 (303)
T d1vjya_          51 TVMLRHENILGFIAADNKDN-GTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQ  124 (303)
T ss_dssp             STTCCCTTBCCEEEEEEEEC-SSSEEEEEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTT
T ss_pred             HhhCCCCcCcceEEEEEeCC-CcceEEEEEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhc
Confidence            45789999999999986544 34456899999998 799999974     4689999999999999999999951     


Q ss_pred             --CCccccCCCCCcEEEeCCCCcEEEeecCCccccccCCC-----cccccccccccCCccccCCC-----CCCchhHhhh
Q 022799           75 --IGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEP-----NISYICSRYYRAPELIFGAT-----EYTAAIDIWS  142 (292)
Q Consensus        75 --~~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~-----~~~~~~Dvws  142 (292)
                        .||+||||||+|||++.++ .+||+|||+++.......     .....||+.|+|||++.+..     .++.++||||
T Consensus       125 ~~~~IvHrDlKp~NILl~~~~-~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S  203 (303)
T d1vjya_         125 GKPAIAHRDLKSKNILVKKNG-TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYA  203 (303)
T ss_dssp             CBCEEECSCCCGGGEEECTTS-CEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHH
T ss_pred             cCCCeeccccCccceEEcCCC-CeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhh
Confidence              3999999999999999988 799999999987644332     23457899999999986532     1567899999


Q ss_pred             hhHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhc
Q 022799          143 AGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQ  222 (292)
Q Consensus       143 lG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  222 (292)
                      |||++|||+||..||........... ......+..+......  ......+...    ....+......+.+|+.+||+
T Consensus       204 ~Gvvl~el~tg~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~--~~~~~~p~~~----~~~~~~~~~~~l~~li~~cl~  276 (303)
T d1vjya_         204 MGLVFWEIARRCSIGGIHEDYQLPYY-DLVPSDPSVEEMRKVV--CEQKLRPNIP----NRWQSCEALRVMAKIMRECWY  276 (303)
T ss_dssp             HHHHHHHHHHTBCBTTBCCCCCCTTT-TTSCSSCCHHHHHHHH--TTSCCCCCCC----GGGGGCHHHHHHHHHHHTTCC
T ss_pred             hHHHHHHHhhCCCCCCcccccccchh-hcccccchHHHHHHHH--hccccCCCCC----cccCChHHHHHHHHHHHHHcc
Confidence            99999999999887743221100000 0000000101000000  0000000000    000011233568999999999


Q ss_pred             cCCCCcccHHHHhc
Q 022799          223 YSPNLRSTALEALI  236 (292)
Q Consensus       223 ~dp~~R~t~~e~l~  236 (292)
                      .||++|||+.|+++
T Consensus       277 ~dp~~Rps~~ei~~  290 (303)
T d1vjya_         277 ANGAARLTALRIKK  290 (303)
T ss_dssp             SSGGGSCCHHHHHH
T ss_pred             cCHhHCcCHHHHHH
Confidence            99999999999975

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.5e-40  Score=281.84  Aligned_cols=208  Identities=19%  Similarity=0.232  Sum_probs=154.5

Q ss_pred             CCCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccC
Q 022799            2 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRD   81 (292)
Q Consensus         2 ~~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~d   81 (292)
                      ++++|+|++..+..+.    .+....++||||+++++...+...   ...+++..+..++.|++.||+|||++ ||+|||
T Consensus        57 ~~l~~~~~i~~~~~~~----~~~~~~~ivme~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~-~iiHrD  128 (299)
T d1ckia_          57 KMMQGGVGIPTIRWCG----AEGDYNVMVMELLGPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK-NFIHRD  128 (299)
T ss_dssp             HHSTTSTTCCCEEEEE----EETTEEEEEEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECSC
T ss_pred             HHccCCCcccEEEEEE----ecCCEEEEEEEEcCCchhhhhhhc---cCCCcHHHHHHHHHHHHHHHHHHHHC-Ceeecc
Confidence            4567776555544332    233358899999999888776543   56799999999999999999999998 999999


Q ss_pred             CCCCcEEEeCC--CCcEEEeecCCccccccCCC--------cccccccccccCCccccCCCCCCchhHhhhhhHHHHHHH
Q 022799           82 IKPQNLLVNPH--THQLKLCDFGSAKVLVKGEP--------NISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELL  151 (292)
Q Consensus        82 lkp~Nill~~~--~~~ikl~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~  151 (292)
                      |||+||+++..  ...++|+|||+|+.......        .....||+.|+|||.+.+. .++.++||||+||++|||+
T Consensus       129 iKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~el~  207 (299)
T d1ckia_         129 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFN  207 (299)
T ss_dssp             CCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTB-CCCHHHHHHHHHHHHHHHH
T ss_pred             CCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCC-CCCChhhEEecCHHHHHHH
Confidence            99999998542  23699999999987654321        2345799999999999765 4899999999999999999


Q ss_pred             hCCCCCCCCCcHHHHHHHHHHhC---CCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCCCc
Q 022799          152 LGQPLFPGESGVDQLVEIIKVLG---TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPNLR  228 (292)
Q Consensus       152 ~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R  228 (292)
                      +|..||.+.........+.+...   .++.                        ..+..++|+++.++|.+||..||++|
T Consensus       208 tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~p~~~~~li~~cl~~~p~~R  263 (299)
T d1ckia_         208 LGSLPWQGLKAATKRQKYERISEKKMSTPI------------------------EVLCKGYPSEFATYLNFCRSLRFDDK  263 (299)
T ss_dssp             HSSCTTCCCC-------HHHHHHHHHHSCH------------------------HHHTTTSCHHHHHHHHHHHHSCTTCC
T ss_pred             hCCCcccccchHHHHHHHHHhhcccCCCCh------------------------hHhccCCCHHHHHHHHHHccCChhHC
Confidence            99999987665444333322110   0111                        11225689999999999999999999


Q ss_pred             ccHHH---HhcCCCccc
Q 022799          229 STALE---ALIHPFFDE  242 (292)
Q Consensus       229 ~t~~e---~l~hp~~~~  242 (292)
                      |++++   +|+|+|.+.
T Consensus       264 P~~~~i~~~l~~~~~~~  280 (299)
T d1ckia_         264 PDYSYLRQLFRNLFHRQ  280 (299)
T ss_dssp             CCHHHHHHHHHHHHHHH
T ss_pred             cCHHHHHHHHHHHHHHc
Confidence            99874   567776543

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5.2e-40  Score=285.83  Aligned_cols=232  Identities=29%  Similarity=0.469  Sum_probs=167.6

Q ss_pred             CCCCeeeeceeeeccCCCCceeEEEEeeccc--CCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCC
Q 022799            5 DHPNVVSLKHCFFSTTEKDELYLNLVLEYVP--ETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDI   82 (292)
Q Consensus         5 ~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~--g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dl   82 (292)
                      .||||+++++++....   ....+++|+++.  ++.......  .....+++..++.++.||+.||.|||+..||+||||
T Consensus        78 ~~~~iv~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDl  152 (362)
T d1q8ya_          78 GANHILKLLDHFNHKG---PNGVHVVMVFEVLGENLLALIKK--YEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDI  152 (362)
T ss_dssp             HHTTBCCCCEEEEEEE---TTEEEEEEEECCCCEEHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCC
T ss_pred             CcCceEEEEEEeeecc---ccceeeeeeeccccccccccccc--ccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccC
Confidence            5899999999874422   223445555554  444333332  235678999999999999999999998449999999


Q ss_pred             CCCcEEEeCCCC-----cEEEeecCCccccccCCCcccccccccccCCccccCCCCCCchhHhhhhhHHHHHHHhCCCCC
Q 022799           83 KPQNLLVNPHTH-----QLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAELLLGQPLF  157 (292)
Q Consensus        83 kp~Nill~~~~~-----~ikl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf  157 (292)
                      ||+|||++.++.     .++++|||.+.....  .....+||+.|+|||++.+. .++.++|+||+||++++|++|+.||
T Consensus       153 Kp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pF  229 (362)
T d1q8ya_         153 KPENVLMEIVDSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLF  229 (362)
T ss_dssp             SGGGEEEEEEETTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTC-CCCTHHHHHHHHHHHHHHHHSSCCC
T ss_pred             ChhHeeeeccCcccccceeeEeeccccccccc--ccccccccccccChhhcccc-CCCccccccchHHHHHHHHHCCCCC
Confidence            999999976542     489999999976533  33556899999999999765 4899999999999999999999999


Q ss_pred             CCCC------cHHHHHHHHHHhCCCCHHHHhhcCCCCcc-------ccCCCCCCCCchhh------hccCCChhHHHHHH
Q 022799          158 PGES------GVDQLVEIIKVLGTPTREEIKCMNPNYTE-------FKFPQIKAHPWHKI------FQKRMPPEAVDLVS  218 (292)
Q Consensus       158 ~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~------~~~~~~~~~~~li~  218 (292)
                      ....      ..+.+......++.++.+...........       .........++...      +....+++++|||.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~  309 (362)
T d1q8ya_         230 EPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS  309 (362)
T ss_dssp             ---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHG
T ss_pred             CCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHH
Confidence            7543      34567778888898887766432211100       01111111111111      12345678999999


Q ss_pred             HHhccCCCCcccHHHHhcCCCccccC
Q 022799          219 RLLQYSPNLRSTALEALIHPFFDELR  244 (292)
Q Consensus       219 ~~l~~dp~~R~t~~e~l~hp~~~~~~  244 (292)
                      +||++||.+|||++|+|+||||+++.
T Consensus       310 ~mL~~dP~~Rpta~e~L~Hp~f~~~~  335 (362)
T d1q8ya_         310 PMLQLDPRKRADAGGLVNHPWLKDTL  335 (362)
T ss_dssp             GGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred             HHCCCChhHCcCHHHHhcCcccCCCC
Confidence            99999999999999999999999654

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.2e-39  Score=275.26  Aligned_cols=199  Identities=17%  Similarity=0.182  Sum_probs=156.0

Q ss_pred             CCC-CCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccC
Q 022799            3 LLD-HPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRD   81 (292)
Q Consensus         3 ~l~-HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~d   81 (292)
                      .|. |+||+++++++     ......++||||++++|.+++...   ...++...+..++.|++.||+|||++ ||+|||
T Consensus        56 ~l~~~~~i~~~~~~~-----~~~~~~~~vme~~~~~l~~~~~~~---~~~~~~~~~~~i~~q~~~~l~~lH~~-giiHrD  126 (293)
T d1csna_          56 LLAGCTGIPNVYYFG-----QEGLHNVLVIDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK-SLVYRD  126 (293)
T ss_dssp             HTTTCTTCCCEEEEE-----EETTEEEEEEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT-TEECCC
T ss_pred             HhcCCCCCCEEEEEe-----ecCCccEEEEEecCCCHHHHHHhh---ccchhhHHHHHHHHHHHHHHHHHHHC-Cceecc
Confidence            354 48999999988     444458999999999999887653   45799999999999999999999988 999999


Q ss_pred             CCCCcEEEeCC----CCcEEEeecCCccccccCC--------CcccccccccccCCccccCCCCCCchhHhhhhhHHHHH
Q 022799           82 IKPQNLLVNPH----THQLKLCDFGSAKVLVKGE--------PNISYICSRYYRAPELIFGATEYTAAIDIWSAGCVLAE  149 (292)
Q Consensus        82 lkp~Nill~~~----~~~ikl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~il~e  149 (292)
                      |||+||+++.+    ...+||+|||+|+......        ......||+.|+|||++.+. .++.++|+||+||++||
T Consensus       127 iKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~-~~~~~~DiwSlG~~l~e  205 (293)
T d1csna_         127 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMY  205 (293)
T ss_dssp             CCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHH
T ss_pred             CCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCC-CCChHHHHHHhhHHHHH
Confidence            99999999642    2369999999998764321        22345799999999999765 59999999999999999


Q ss_pred             HHhCCCCCCCCCcHHH---HHHHHHHhCCCCHHHHhhcCCCCccccCCCCCCCCchhhhccCCChhHHHHHHHHhccCCC
Q 022799          150 LLLGQPLFPGESGVDQ---LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFQKRMPPEAVDLVSRLLQYSPN  226 (292)
Q Consensus       150 l~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~  226 (292)
                      |++|..||.+......   ..++......++...                        +.+++|+++.+++..|+..+|+
T Consensus       206 lltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~------------------------l~~~~p~~l~~ii~~~~~~~~~  261 (293)
T d1csna_         206 FLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE------------------------LCAGFPEEFYKYMHYARNLAFD  261 (293)
T ss_dssp             HHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH------------------------HTTTSCHHHHHHHHHHHHCCTT
T ss_pred             HHhCCCcCCCccchhHHHHHHHHHhccCCCChHH------------------------hcCCCCHHHHHHHHHHhcCCcc
Confidence            9999999986544322   223322211111111                        2246899999999999999999


Q ss_pred             CcccHHHHh
Q 022799          227 LRSTALEAL  235 (292)
Q Consensus       227 ~R~t~~e~l  235 (292)
                      +||+.+.+.
T Consensus       262 ~rP~y~~l~  270 (293)
T d1csna_         262 ATPDYDYLQ  270 (293)
T ss_dssp             CCCCHHHHH
T ss_pred             cCcCHHHHH
Confidence            999977765

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.67  E-value=1.4e-18  Score=136.14  Aligned_cols=117  Identities=16%  Similarity=0.090  Sum_probs=78.7

Q ss_pred             CCCCCCeeeeceeeeccCCCCceeEEEEeecccCCHHHHHHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCccccCC
Q 022799            3 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHHYKMSQRMPLIYVKLYFYQICRALAYIHNTIGVCHRDI   82 (292)
Q Consensus         3 ~l~HpnIv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~qil~al~~LH~~~~i~H~dl   82 (292)
                      ++.|+++++.+++.     .    .+++|||+++...          ..++...+..++.|++.|+.|||++ ||+||||
T Consensus        70 ~l~~~~v~~~~~~~-----~----~~lvme~~~~~~~----------~~l~~~~~~~i~~ql~~~l~~lH~~-giiHrDi  129 (191)
T d1zara2          70 KLQGLAVPKVYAWE-----G----NAVLMELIDAKEL----------YRVRVENPDEVLDMILEEVAKFYHR-GIVHGDL  129 (191)
T ss_dssp             HTTTSSSCCEEEEE-----T----TEEEEECCCCEEG----------GGCCCSCHHHHHHHHHHHHHHHHHT-TEECSCC
T ss_pred             HccCCCcceEEEec-----C----CEEEEEeeccccc----------cchhhHHHHHHHHHHHHHHHHHhhC-CEEEccC
Confidence            46788888776543     2    3689999996321          1234455778899999999999988 9999999


Q ss_pred             CCCcEEEeCCCCcEEEeecCCccccccCCCcccccc-cccccCCccccCCCCCCchhHhhhhhH
Q 022799           83 KPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEYTAAIDIWSAGC  145 (292)
Q Consensus        83 kp~Nill~~~~~~ikl~Dfg~a~~~~~~~~~~~~~g-t~~y~aPE~~~~~~~~~~~~DvwslG~  145 (292)
                      ||+|||++.++  ++|+|||.|........ ..... .... -.+.+ . +.|+.++|+||+.-
T Consensus       130 KP~NILv~~~~--~~liDFG~a~~~~~~~~-~~~l~rd~~~-~~~~f-~-r~y~~~~d~~s~~~  187 (191)
T d1zara2         130 SQYNVLVSEEG--IWIIDFPQSVEVGEEGW-REILERDVRN-IITYF-S-RTYRTEKDINSAID  187 (191)
T ss_dssp             STTSEEEETTE--EEECCCTTCEETTSTTH-HHHHHHHHHH-HHHHH-H-HHHCCCCCHHHHHH
T ss_pred             ChhheeeeCCC--EEEEECCCcccCCCCCc-HHHHHHHHHH-HHHHH-c-CCCCCcccHHHHHH
Confidence            99999999654  89999999876532211 11000 0000 01112 1 34788899999653

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=96.62  E-value=0.001  Score=52.43  Aligned_cols=28  Identities=21%  Similarity=0.373  Sum_probs=23.5

Q ss_pred             ccccCCCCCcEEEeCCCCcEEEeecCCcc
Q 022799           77 VCHRDIKPQNLLVNPHTHQLKLCDFGSAK  105 (292)
Q Consensus        77 i~H~dlkp~Nill~~~~~~ikl~Dfg~a~  105 (292)
                      ++|+|+.|.||+++.++ .+.|+||+.+.
T Consensus       185 l~HgD~~~~Nil~~~~~-~~~lIDwe~a~  212 (263)
T d1j7la_         185 FSHGDLGDSNIFVKDGK-VSGFIDLGRSG  212 (263)
T ss_dssp             EECSCCCTTSEEEETTE-EEEECCCTTCE
T ss_pred             EEEeeccCcceeecCCc-eEEEeechhcc
Confidence            78999999999998754 45699998774

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=94.79  E-value=0.0044  Score=50.14  Aligned_cols=29  Identities=31%  Similarity=0.291  Sum_probs=25.4

Q ss_pred             CccccCCCCCcEEEeCCCCcEEEeecCCcc
Q 022799           76 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  105 (292)
Q Consensus        76 ~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~  105 (292)
                      |+||+|+.++||+++.+. ..-+.||+.+.
T Consensus       184 giIHgDl~~dNvl~~~~~-v~gvIDF~~~~  212 (316)
T d2ppqa1         184 GVIHADLFQDNVFFLGDE-LSGLIDFYFAC  212 (316)
T ss_dssp             EEECSCCCGGGEEEETTE-EEEECCCTTCE
T ss_pred             ccccCCcchhhhhccccc-ceeEecccccc
Confidence            899999999999999765 56899999774

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=91.95  E-value=0.029  Score=43.31  Aligned_cols=29  Identities=24%  Similarity=0.203  Sum_probs=24.2

Q ss_pred             CccccCCCCCcEEEeCCCCcEEEeecCCcc
Q 022799           76 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  105 (292)
Q Consensus        76 ~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~  105 (292)
                      .++|+|+.|.||+++.+. .+-|+||+.+.
T Consensus       176 ~liHgD~~~~Nvl~~~~~-~~~iID~~~~~  204 (255)
T d1nd4a_         176 VVTHGDACLPNIMVENGR-FSGFIDCGRLG  204 (255)
T ss_dssp             EEECSSCCGGGEEEETTE-EEEECCCTTCE
T ss_pred             eEEeCCCCCcceEEeCCc-eEEEEEchhcc
Confidence            379999999999998754 46799998764

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=90.48  E-value=0.057  Score=44.88  Aligned_cols=29  Identities=21%  Similarity=0.252  Sum_probs=25.2

Q ss_pred             CccccCCCCCcEEEeCCCCcEEEeecCCccc
Q 022799           76 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAKV  106 (292)
Q Consensus        76 ~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~~  106 (292)
                      .++|+|+.+.||+++.++  ++|+||..+..
T Consensus       224 ~LiHGDl~~gNIlv~~~~--~~vID~E~a~~  252 (392)
T d2pula1         224 TLIHGDLHTGSIFASEHE--TKVIDPEFAFY  252 (392)
T ss_dssp             EEECSCCCGGGEEECSSC--EEECCCTTCEE
T ss_pred             ceeccCCcCCceeEcCCc--eEEechhhccc
Confidence            589999999999998765  89999988754

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=89.21  E-value=0.07  Score=43.00  Aligned_cols=27  Identities=22%  Similarity=0.222  Sum_probs=22.5

Q ss_pred             CccccCCCCCcEEEeCCCCcEEEeecCCcc
Q 022799           76 GVCHRDIKPQNLLVNPHTHQLKLCDFGSAK  105 (292)
Q Consensus        76 ~i~H~dlkp~Nill~~~~~~ikl~Dfg~a~  105 (292)
                      +++|+|+.+.||+++. +  ..++||+-+.
T Consensus       193 ~liHgDlh~~NvL~~~-~--~~~IDFdd~~  219 (325)
T d1zyla1         193 LRLHGDCHAGNILWRD-G--PMFVDLDDAR  219 (325)
T ss_dssp             EECCSSCSGGGEEESS-S--EEECCCTTCC
T ss_pred             eeecCCCCcccEEEeC-C--ceEEechhcc
Confidence            7899999999999974 3  4589998774